Citrus Sinensis ID: 040832
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 724 | 2.2.26 [Sep-21-2011] | |||||||
| Q9XI96 | 699 | Proline-rich receptor-lik | yes | no | 0.696 | 0.721 | 0.589 | 1e-169 | |
| Q9ZNQ8 | 633 | Proline-rich receptor-lik | no | no | 0.611 | 0.699 | 0.618 | 1e-164 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.533 | 0.592 | 0.660 | 1e-161 | |
| Q9LS95 | 700 | Putative proline-rich rec | no | no | 0.719 | 0.744 | 0.586 | 1e-155 | |
| Q8GX23 | 670 | Proline-rich receptor-lik | no | no | 0.585 | 0.632 | 0.556 | 1e-148 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.674 | 0.680 | 0.521 | 1e-142 | |
| Q9C821 | 509 | Proline-rich receptor-lik | no | no | 0.509 | 0.724 | 0.614 | 1e-141 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.435 | 0.614 | 0.687 | 1e-133 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.657 | 0.670 | 0.481 | 1e-132 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.592 | 0.595 | 0.502 | 1e-127 |
| >sp|Q9XI96|PERK7_ARATH Proline-rich receptor-like protein kinase PERK7 OS=Arabidopsis thaliana GN=PERK7 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 596 bits (1537), Expect = e-169, Method: Compositional matrix adjust.
Identities = 340/577 (58%), Positives = 401/577 (69%), Gaps = 73/577 (12%)
Query: 174 HPPPPPSSSSNSPNGNRSGALSPPNKSNGSSSSPSSNNGSMLSIPLVAAVAAGAAFLIIV 233
H PPPPS +S+ + ++ +L+PP ++GS+SS + L+I V + A A L IV
Sbjct: 134 HTPPPPSKTSDHSSHSQPRSLAPPTSNSGSNSSSNDG----LNIGAVIGLVAAAGILFIV 189
Query: 234 MLLVFFACRRKKNRERN-DQMPYYNNN-----HTTATDYY--------------NSAATP 273
M+L+ C RKK ++ DQMPYY +N T YY N
Sbjct: 190 MILLCVCCFRKKKKKSKLDQMPYYGSNAYPAGKTGGDQYYNQNAATQQQQHYNQNDHIVN 249
Query: 274 SPPP----------------RANWQQQTDHGWPTPP-PSQRGAVTVTSSDMSHNSSSGPY 316
PPP NWQ P+PP P GA + S +MS N SSGPY
Sbjct: 250 LPPPPGSMGTNWVSSPPPPPPGNWQPM-----PSPPAPVSGGANVIQSGEMSSNFSSGPY 304
Query: 317 GPVLPPPPPIVALGFSQSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVK 376
P LPPP P VALGF+ S FTYEEL++AT GFS+ LLGQGGFGYVHKG+LPNGKE+AVK
Sbjct: 305 APSLPPPHPSVALGFNNSTFTYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKEIAVK 364
Query: 377 SLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCI-AGGKRLLVYEYVPNNNLEFHLHG 435
SL++GSGQGEREF+AEVEIISRVHHRHLVSLVGYC AGG+RLLVYE++PN+ LEFHLHG
Sbjct: 365 SLKAGSGQGEREFQAEVEIISRVHHRHLVSLVGYCSNAGGQRLLVYEFLPNDTLEFHLHG 424
Query: 436 KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495
K VMDWPTRLKIA+GSAKGLAYLHEDCHP+IIHRDIK+SNILLD+ FE KVADFGLAK
Sbjct: 425 KSGTVMDWPTRLKIALGSAKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKVADFGLAK 484
Query: 496 LTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAME 555
L+ DNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR P+D +G ME
Sbjct: 485 LSQDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRGPVDLSGDME 544
Query: 556 DCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQ 615
D LVDWARPLC+R DG + E+ DP+LE Y EMARMVACAAA++RHS RRRPK+SQ
Sbjct: 545 DSLVDWARPLCMRVAQDGEYGELVDPFLEHQYEPYEMARMVACAAAAVRHSGRRRPKMSQ 604
Query: 616 IVRALEGDVSLEDLNDGIKPSQASILGGGTANSSAVGSASARSSDVDNISYTEDLKKLRR 675
IVR LEGD SL+DL+DG+KP Q+S S SSD + +Y +++K R+
Sbjct: 605 IVRTLEGDASLDDLDDGVKPKQSS-------------SGGEGSSDYEMGTYGAEMRKFRK 651
Query: 676 MAEGNASGAYVSSEYGA------TSEYGLNPSSSSSE 706
+ S +YGA TSEYGL+PSSSSSE
Sbjct: 652 VT-------LESRDYGASSEYGATSEYGLDPSSSSSE 681
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9ZNQ8|PERK4_ARATH Proline-rich receptor-like protein kinase PERK4 OS=Arabidopsis thaliana GN=PERK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 580 bits (1494), Expect = e-164, Method: Compositional matrix adjust.
Identities = 289/467 (61%), Positives = 353/467 (75%), Gaps = 24/467 (5%)
Query: 219 LVAAVAAGAAFLIIVMLLVFFACRRKKNRERNDQMPY-YNNNHTTATDYYNSAATPSPPP 277
++ V GA L+IV+++V C R+K + ++ P N N+ P
Sbjct: 152 IIVGVLVGAGLLMIVLIIV---CLRRKKKRKDSFYPEPMKGNQYQYYGNNNNNNASQNYP 208
Query: 278 RANWQ-------QQTDHGWPTPPPSQRGAVTVTSSDMSHNSSSGPYGPVLPPPPPIVALG 330
NW QQ+ GW PS + +S + SGP PVLPPP P +ALG
Sbjct: 209 --NWHLNSQGQNQQSTGGWGGGGPSPPPPPRMPTSGEDSSMYSGPSRPVLPPPSPALALG 266
Query: 331 FSQSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFK 390
F++S FTY+EL+AATGGF+ +NLLGQGGFGYVHKGVLP+GKEVAVKSL++GSGQGEREF+
Sbjct: 267 FNKSTFTYQELAAATGGFTDANLLGQGGFGYVHKGVLPSGKEVAVKSLKAGSGQGEREFQ 326
Query: 391 AEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIA 450
AEV+IISRVHHR+LVSLVGYCIA G+R+LVYE+VPN LE+HLHGK PVM++ TRL+IA
Sbjct: 327 AEVDIISRVHHRYLVSLVGYCIADGQRMLVYEFVPNKTLEYHLHGKNLPVMEFSTRLRIA 386
Query: 451 MGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMG 510
+G+AKGLAYLHEDCHPRIIHRDIKS+NILLD+ F+ VADFGLAKLT+DNNTHVSTRVMG
Sbjct: 387 LGAAKGLAYLHEDCHPRIIHRDIKSANILLDFNFDAMVADFGLAKLTSDNNTHVSTRVMG 446
Query: 511 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRAL 570
TFGYLAPEYASSGKLTEKSDVFS+GVMLLELITG+RP+D + M+D LVDWARPL RAL
Sbjct: 447 TFGYLAPEYASSGKLTEKSDVFSYGVMLLELITGKRPVDNSITMDDTLVDWARPLMARAL 506
Query: 571 DDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSLEDLN 630
+DGNFNE+AD LE NY +EMARMV CAAASIRHS R+RPK+SQIVRALEG+VSL+ LN
Sbjct: 507 EDGNFNELADARLEGNYNPQEMARMVTCAAASIRHSGRKRPKMSQIVRALEGEVSLDALN 566
Query: 631 DGIKPSQASILGGGTANSSAVGSASARSSDVDNISYTEDLKKLRRMA 677
+G+KP +++ G ++G+ SSD SY D+KK R++A
Sbjct: 567 EGVKPGHSNVYG-------SLGA----SSDYSQTSYNADMKKFRQIA 602
|
Required during abscisic acid (ABA)-mediated activation of Ca(2+) channels. Regulates ABA signaling pathways. Modulates the expression of genes related to cell elongation and ABA signaling during root growth. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 567 bits (1462), Expect = e-161, Method: Compositional matrix adjust.
Identities = 272/412 (66%), Positives = 326/412 (79%), Gaps = 26/412 (6%)
Query: 318 PVLPPPPPIVALGFSQSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKS 377
PVLPPP P + LGFS+S FTYEELS AT GFS++NLLGQGGFGYVHKG+LP+GKEVAVK
Sbjct: 250 PVLPPPSPGLVLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQ 309
Query: 378 LRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKG 437
L++GSGQGEREF+AEVEIISRVHHRHLVSL+GYC+AG +RLLVYE+VPNNNLEFHLHGKG
Sbjct: 310 LKAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKG 369
Query: 438 RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497
RP M+W TRLKIA+GSAKGL+YLHEDC+P+IIHRDIK+SNIL+D+ FE KVADFGLAK+
Sbjct: 370 RPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIA 429
Query: 498 TDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGA-MED 556
+D NTHVSTRVMGTFGYLAPEYA+SGKLTEKSDVFSFGV+LLELITGRRP+D ++D
Sbjct: 430 SDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDD 489
Query: 557 CLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQI 616
LVDWARPL RA ++G+F +AD + Y EEMARMVACAAA +RHSARRRP++SQI
Sbjct: 490 SLVDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQI 549
Query: 617 VRALEGDVSLEDLNDGIKPSQASILGGGTANSSAVGSASARSSDVDNISYTEDLKKLRRM 676
VRALEG+VSL DLN+G++P +++ S+ S+D D Y +D+ K R+M
Sbjct: 550 VRALEGNVSLSDLNEGMRPGHSNVY-----------SSYGGSTDYDTSQYNDDMIKFRKM 598
Query: 677 AEGNASGAYVSSEYGA-------TSEYGLNPSSSSSEFGSRGQSPNTKVKSS 721
A G + EYG TS+YGL PS SSSE + + K+K +
Sbjct: 599 ALG-------TQEYGTTGEYSNPTSDYGLYPSGSSSEGQATREMEMGKIKKT 643
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LS95|PERK6_ARATH Putative proline-rich receptor-like protein kinase PERK6 OS=Arabidopsis thaliana GN=PERK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 547 bits (1410), Expect = e-155, Method: Compositional matrix adjust.
Identities = 333/568 (58%), Positives = 404/568 (71%), Gaps = 47/568 (8%)
Query: 175 PPPPPSSSSNSPNGNRSGALSPPNKSNGSSSSPSSNNGSMLSIPLVAAVAAGAAFLIIVM 234
PPP +S NSP+ R AL+PP S G S+S +N + +I + AGA L +VM
Sbjct: 148 PPPSRNSDRNSPSPPR--ALAPPRSSGGGSNSSGNNEPNTAAI---VGIVAGAGLLFLVM 202
Query: 235 LLVFFACRRKKNRERNDQMPYY-NNNHTTA-------------TDYYNSAATPSPPPRAN 280
+L F + +++ QMPYY N + T +D+ + + P N
Sbjct: 203 IL--FCVCCCRKKKKKHQMPYYAGNGYATGKGDQYQQQQYNNQSDHVMNLSQQYPGSNGN 260
Query: 281 --WQ--------QQTDHGWPTPPPSQRGAVTVTSSDMSHNSSSGPYGPVLPPPPPIVALG 330
W P PPP G + SSD S N S GP +PPP P VALG
Sbjct: 261 NNWMNSPPPPPPGSWQPSPPPPPPPVSGGMNGNSSDFSSNYSGPH-GPSVPPPHPSVALG 319
Query: 331 FSQSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFK 390
F++S FTY+EL+AAT GFSQS LLGQGGFGYVHKG+LPNGKE+AVKSL++GSGQGEREF+
Sbjct: 320 FNKSTFTYDELAAATQGFSQSRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQ 379
Query: 391 AEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIA 450
AEV+IISRVHHR LVSLVGYCIAGG+R+LVYE++PN+ LEFHLHGK V+DWPTRLKIA
Sbjct: 380 AEVDIISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHGKSGKVLDWPTRLKIA 439
Query: 451 MGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMG 510
+GSAKGLAYLHEDCHPRIIHRDIK+SNILLD +FE KVADFGLAKL+ DN THVSTR+MG
Sbjct: 440 LGSAKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVADFGLAKLSQDNVTHVSTRIMG 499
Query: 511 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRAL 570
TFGYLAPEYASSGKLT++SDVFSFGVMLLEL+TGRRP+D TG MED LVDWARP+CL A
Sbjct: 500 TFGYLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVDLTGEMEDSLVDWARPICLNAA 559
Query: 571 DDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSLEDLN 630
DG+++E+ DP LE Y EMA+MVACAAA++RHSARRRPK+SQIVRALEGD +L+DL+
Sbjct: 560 QDGDYSELVDPRLENQYEPHEMAQMVACAAAAVRHSARRRPKMSQIVRALEGDATLDDLS 619
Query: 631 DGIKPSQASILGGGTANSSAVGSASARSSDVDNISYTEDLKKLRRMA-EGNASGAYVSSE 689
+G K Q+S LG G+++ + SA D+KK R++A + + GA SSE
Sbjct: 620 EGGKAGQSSFLGRGSSSDYDSSTYSA------------DMKKFRKVALDSHEYGA--SSE 665
Query: 690 YGATSEYGLNPSSSSSEFGSRGQSPNTK 717
YG TSEYGL+PSSSSSE RG + N K
Sbjct: 666 YGNTSEYGLDPSSSSSEEIRRGGANNNK 693
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GX23|PERK5_ARATH Proline-rich receptor-like protein kinase PERK5 OS=Arabidopsis thaliana GN=PERK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 527 bits (1357), Expect = e-148, Method: Compositional matrix adjust.
Identities = 282/507 (55%), Positives = 334/507 (65%), Gaps = 83/507 (16%)
Query: 237 VFFACRRKKNRE--RNDQMPYYNNNHTTATDYYNSAATPSPPPR--ANWQQQTDHGW-PT 291
+ C RKK ++ + + M YYNNN N P N Q W P
Sbjct: 207 ICICCNRKKKKKSPQVNHMHYYNNNPYGGAPSGNGGYYKGTPQDHVVNMAGQGGGNWGPQ 266
Query: 292 PPPSQRGAVTVTSSDMSHNSSSGPYGPVLPPPPPIVALGFSQSAFTYEELSAATGGFSQS 351
P S H+ +S G P P LG +QS FTY+ELS AT GF+QS
Sbjct: 267 QPVSG-----------PHSDASNLTGRTAIPSPQAATLGHNQSTFTYDELSIATEGFAQS 315
Query: 352 NLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
NLLGQGGFGYVHKGVLP+GKEVAVKSL+ GSGQGEREF+AEV+IISRVHHRHLVSLVGYC
Sbjct: 316 NLLGQGGFGYVHKGVLPSGKEVAVKSLKLGSGQGEREFQAEVDIISRVHHRHLVSLVGYC 375
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGK---------------------------GRPVMDWP 444
I+GG+RLLVYE++PNN LEFHLHGK
Sbjct: 376 ISGGQRLLVYEFIPNNTLEFHLHGKGRPVLDWPTRVKIALGSARGLAYLHED-------- 427
Query: 445 TRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504
CHPRIIHRDIK++NILLD++FETKVADFGLAKL+ DN THV
Sbjct: 428 -------------------CHPRIIHRDIKAANILLDFSFETKVADFGLAKLSQDNYTHV 468
Query: 505 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARP 564
STRVMGTFGYLAPEYASSGKL++KSDVFSFGVMLLELITGR P+D TG MED LVDWARP
Sbjct: 469 STRVMGTFGYLAPEYASSGKLSDKSDVFSFGVMLLELITGRPPLDLTGEMEDSLVDWARP 528
Query: 565 LCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624
LCL+A DG++N++ADP LE NY +EM +M +CAAA+IRHSARRRPK+SQIVRALEGD+
Sbjct: 529 LCLKAAQDGDYNQLADPRLELNYSHQEMVQMASCAAAAIRHSARRRPKMSQIVRALEGDM 588
Query: 625 SLEDLNDGIKPSQASILGGGTANSSAVGSASARSSDVDNISYTEDLKKLRRMAEGNASGA 684
S++DL++G +P Q++ L G+ SS+ D SYT D+KK +++A N
Sbjct: 589 SMDDLSEGTRPGQSTYLSPGSV-----------SSEYDASSYTADMKKFKKLALENKE-- 635
Query: 685 YVSSEYGATSEYGLNPSSSSSEFGSRG 711
Y SSEYG TSEYGLNPS+SSSE +RG
Sbjct: 636 YQSSEYGGTSEYGLNPSASSSEEMNRG 662
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 506 bits (1302), Expect = e-142, Method: Compositional matrix adjust.
Identities = 277/531 (52%), Positives = 341/531 (64%), Gaps = 43/531 (8%)
Query: 205 SSPSSNNGSMLSIPLVAAVAAGAAFLIIVML-LVFFACRRKKNRERN------DQMPYYN 257
SSP + + LS + +A G F+++V L L+FF C++K+ R+ D +PY
Sbjct: 213 SSPPAQSSKELSKGAMVGIAIGGGFVLLVALALIFFLCKKKRRRDNEAPPAPIDGVPYGG 272
Query: 258 NNHTTATDYYNSAATPSPPPRANWQQQTDHGWPTPPPSQRGAVTVTSSDMSHNSSSGPYG 317
A+ + PPP++ S SD S
Sbjct: 273 QQQQNASRRSDHVVMSVPPPKSPSSAPPRPPHFMSSGSSG-DYDSNYSDQS--------- 322
Query: 318 PVLPPPPPIVALGFS--QSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAV 375
VLPPP P +ALG Q F YEELS AT GFS++NLLGQGGFGYV KG+L NGKEVAV
Sbjct: 323 -VLPPPSPGLALGLGIYQGTFNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAV 381
Query: 376 KSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHG 435
K L+ GS QGEREF+AEV IISRVHHRHLV+LVGYCIA +RLLVYE+VPNN LEFHLHG
Sbjct: 382 KQLKEGSSQGEREFQAEVGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHG 441
Query: 436 KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495
KGRP M+W +RLKIA+GSAKGL+YLHE+C+P+IIHRDIK+SNIL+D+ FE KVADFGLAK
Sbjct: 442 KGRPTMEWSSRLKIAVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAK 501
Query: 496 LTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAME 555
+ +D NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV+LLELITGRRPID
Sbjct: 502 IASDTNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHA 561
Query: 556 D-CLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKIS 614
D LVDWARPL + + GNF + D L Y EEMARMVACAAA +R +A RRP++
Sbjct: 562 DNSLVDWARPLLNQVSELGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMD 621
Query: 615 QIVRALEGDVSLEDLNDGIKPSQASILGGGTANSSAVGSASARSSDVDNISYTEDLKKLR 674
Q+ R LEG++S DLN GI P +++ G +S S+D D+ E + K R
Sbjct: 622 QVARVLEGNISPSDLNQGITPGHSNVYG-----------SSGGSTDYDSSQDNEGMNKFR 670
Query: 675 RMAEGNASGAYVSSEYGA-TSEYGLNPSSSSSEFGSRGQSPNTKVKSSFRK 724
++ G Y SEY L PS SS++ GQ+ K + ++
Sbjct: 671 KV------GLETQDLYSNPISEYDLYPSWSSTD----GQTTQGKATGNIKR 711
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 504 bits (1297), Expect = e-141, Method: Compositional matrix adjust.
Identities = 241/392 (61%), Positives = 303/392 (77%), Gaps = 23/392 (5%)
Query: 333 QSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAE 392
Q+ FTYE+LS AT FS +NLLGQGGFGYVH+GVL +G VA+K L+SGSGQGEREF+AE
Sbjct: 128 QNLFTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAE 187
Query: 393 VEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMG 452
++ ISRVHHRHLVSL+GYCI G +RLLVYE+VPN LEFHLH K RPVM+W R+KIA+G
Sbjct: 188 IQTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKERPVMEWSKRMKIALG 247
Query: 453 SAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTF 512
+AKGLAYLHEDC+P+ IHRD+K++NIL+D ++E K+ADFGLA+ + D +THVSTR+MGTF
Sbjct: 248 AAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTHVSTRIMGTF 307
Query: 513 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTG--AMEDCLVDWARPLCLRAL 570
GYLAPEYASSGKLTEKSDVFS GV+LLELITGRRP+D + A +D +VDWA+PL ++AL
Sbjct: 308 GYLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDKSQPFADDDSIVDWAKPLMIQAL 367
Query: 571 DDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSLEDLN 630
+DGNF+ + DP LE ++ EM RMVACAAAS+RHSA+RRPK+SQIVRA EG++S++DL
Sbjct: 368 NDGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAKRRPKMSQIVRAFEGNISIDDLT 427
Query: 631 DGIKPSQASI--LGGGTANSSAVGSASARSSDVDNISYTEDLKKLRRMAEGNASGAYVSS 688
+G P Q++I L G SSD + Y EDLKK ++MA S + SS
Sbjct: 428 EGAAPGQSTIYSLDG--------------SSDYSSTQYKEDLKKFKKMA--FESKTFGSS 471
Query: 689 EY-GATSEYGLNPSSSSSEFGSRGQSPNTKVK 719
E G TS+ G NPS SSS + GQ +++
Sbjct: 472 ECSGLTSDNGQNPSGSSSI--TEGQRTTQEIE 501
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 477 bits (1228), Expect = e-133, Method: Compositional matrix adjust.
Identities = 218/317 (68%), Positives = 264/317 (83%), Gaps = 2/317 (0%)
Query: 320 LPPPPPIVALGFSQSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLR 379
LP P +V LG QS FTY EL+ AT FS++NLLG+GGFG+V+KG+L NG EVAVK L+
Sbjct: 156 LPAPIGLV-LGIHQSTFTYGELARATNKFSEANLLGEGGFGFVYKGILNNGNEVAVKQLK 214
Query: 380 SGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRP 439
GS QGE+EF+AEV IIS++HHR+LVSLVGYCIAG +RLLVYE+VPNN LEFHLHGKGRP
Sbjct: 215 VGSAQGEKEFQAEVNIISQIHHRNLVSLVGYCIAGAQRLLVYEFVPNNTLEFHLHGKGRP 274
Query: 440 VMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499
M+W RLKIA+ S+KGL+YLHE+C+P+IIHRDIK++NIL+D+ FE KVADFGLAK+ D
Sbjct: 275 TMEWSLRLKIAVSSSKGLSYLHENCNPKIIHRDIKAANILIDFKFEAKVADFGLAKIALD 334
Query: 500 NNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAM-EDCL 558
NTHVSTRVMGTFGYLAPEYA+SGKLTEKSDV+SFGV+LLELITGRRP+D +D L
Sbjct: 335 TNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVYSFGVVLLELITGRRPVDANNVYADDSL 394
Query: 559 VDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618
VDWARPL ++AL++ NF +AD L Y EEMARMVACAAA +R++ARRRP++ Q+VR
Sbjct: 395 VDWARPLLVQALEESNFEGLADIKLNNEYDREEMARMVACAAACVRYTARRRPRMDQVVR 454
Query: 619 ALEGDVSLEDLNDGIKP 635
LEG++S DLN GI P
Sbjct: 455 VLEGNISPSDLNQGITP 471
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 474 bits (1220), Expect = e-132, Method: Compositional matrix adjust.
Identities = 269/559 (48%), Positives = 345/559 (61%), Gaps = 83/559 (14%)
Query: 174 HPPPPPSSSSNSPNGNRSGALSPPNK---SNGSSSSPSSNNGSMLSIPLVAAVAAGAAFL 230
H PP S+++ P L+ P++ S+G+S P +N+G +A A A F
Sbjct: 194 HALPPKSTAAGGP-------LTSPSRGVPSSGNSVPPPANSGGGYQGKTMAGFAI-AGFA 245
Query: 231 IIVMLLVFFACRRKKNRERNDQMPYYNN-------NHTTATDYYNSAATP----SPPPRA 279
+I ++ V F RRKK R + Y++ N + +D + P S P
Sbjct: 246 VIALMAVVFLVRRKKKR----NIDAYSDSQYLPPSNFSIKSDGFLYGQNPTKGYSGPGGY 301
Query: 280 NWQQQTDHGWPTPPPSQRGAVTVTSSDMSHNSSSGPYGPVLPPPPPIVALGFSQSAFTYE 339
N QQQ++ G SQRG T S P +G Q+ FTYE
Sbjct: 302 NSQQQSNSG--NSFGSQRGGGGYTRS---------------GSAPDSAVMGSGQTHFTYE 344
Query: 340 ELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV 399
EL+ T GFS+ N+LG+GGFG V+KG L +GK VAVK L+ GSGQG+REFKAEVEIISRV
Sbjct: 345 ELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEIISRV 404
Query: 400 HHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAY 459
HHRHLVSLVGYCIA +RLL+YEYVPN LE HLHGKGRPV++W R++IA+GSAKGLAY
Sbjct: 405 HHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIAIGSAKGLAY 464
Query: 460 LHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEY 519
LHEDCHP+IIHRDIKS+NILLD FE +VADFGLAKL THVSTRVMGTFGYLAPEY
Sbjct: 465 LHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRVMGTFGYLAPEY 524
Query: 520 ASSGKLTEKSDVFSFGVMLLELITGRRPID---PTGAMEDCLVDWARPLCLRALDDGNFN 576
A SGKLT++SDVFSFGV+LLELITGR+P+D P G E+ LV+WARPL +A++ G+F+
Sbjct: 525 AQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLG--EESLVEWARPLLHKAIETGDFS 582
Query: 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSLEDLNDGIKPS 636
E+ D LEK+Y E+ RM+ AAA +RHS +RP++ Q+VRAL+ + + D+++G K
Sbjct: 583 ELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGDMGDISNGNKVG 642
Query: 637 QASILGGGTANSSAVGSASARSSDVDNISYTEDLKKLRRMAEG----NASGAYVSSEY-- 690
Q SS D+ Y D K R+MA G + SG Y S +Y
Sbjct: 643 Q--------------------SSAYDSGQYNNDTMKFRKMAFGFDDSSDSGMY-SGDYSV 681
Query: 691 --------GATSEYGLNPS 701
GA+SE+ N +
Sbjct: 682 QDSRKGSNGASSEFTRNET 700
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 456 bits (1173), Expect = e-127, Method: Compositional matrix adjust.
Identities = 247/492 (50%), Positives = 312/492 (63%), Gaps = 63/492 (12%)
Query: 225 AGAAFLIIVMLLVFFACRRKKNRERNDQMPYYNNNHTTATDYYN-SAATPSPPPRANWQQ 283
A A F I+ ++ V F RRKK R D YN S P P N+
Sbjct: 251 AVAGFAIMALIGVVFLVRRKKKRN---------------IDSYNHSQYLPHP----NFSV 291
Query: 284 QTDHGWPTPPPSQRGAVTVTSSDMSHNS---------SSGPYGPVLPP-------PPPIV 327
++D G+ +G + + M +NS S G G P P
Sbjct: 292 KSD-GFLYGQDPGKGYSSGPNGSMYNNSQQQQSSMGNSYGTAGGGYPHHQMQSSGTPDSA 350
Query: 328 ALGFSQSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGER 387
LG Q+ F+YEEL+ T GF++ N+LG+GGFG V+KG L +GK VAVK L++GSGQG+R
Sbjct: 351 ILGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDR 410
Query: 388 EFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRL 447
EFKAEVEIISRVHHRHLVSLVGYCI+ RLL+YEYV N LE HLHGKG PV++W R+
Sbjct: 411 EFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRV 470
Query: 448 KIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTR 507
+IA+GSAKGLAYLHEDCHP+IIHRDIKS+NILLD +E +VADFGLA+L THVSTR
Sbjct: 471 RIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTR 530
Query: 508 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAM-EDCLVDWARPLC 566
VMGTFGYLAPEYASSGKLT++SDVFSFGV+LLEL+TGR+P+D T + E+ LV+WARPL
Sbjct: 531 VMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLL 590
Query: 567 LRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSL 626
L+A++ G+ +E+ D LEK Y E+ RM+ AAA +RHS +RP++ Q+VRAL+ D
Sbjct: 591 LKAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALDCDGDS 650
Query: 627 EDLNDGIKPSQASILGGGTANSSAVGSASARSSDVDNISYTEDLKKLRRMAEGN----AS 682
D+++GIK Q S+ D+ Y ED+ K R+MA G S
Sbjct: 651 GDISNGIKIGQ--------------------STTYDSGQYNEDIMKFRKMAFGGDNSVES 690
Query: 683 GAYVSSEYGATS 694
G Y S Y A S
Sbjct: 691 GLY-SGNYSAKS 701
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 724 | ||||||
| 255536819 | 482 | somatic embryogenesis receptor kinase, p | 0.616 | 0.925 | 0.665 | 1e-177 | |
| 449462888 | 638 | PREDICTED: proline-rich receptor-like pr | 0.761 | 0.863 | 0.570 | 1e-171 | |
| 449516230 | 812 | PREDICTED: proline-rich receptor-like pr | 0.761 | 0.678 | 0.570 | 1e-170 | |
| 449462276 | 674 | PREDICTED: proline-rich receptor-like pr | 0.686 | 0.737 | 0.626 | 1e-170 | |
| 297802522 | 669 | predicted protein [Arabidopsis lyrata su | 0.538 | 0.582 | 0.709 | 1e-170 | |
| 15222081 | 699 | protein kinase-like protein [Arabidopsis | 0.696 | 0.721 | 0.589 | 1e-167 | |
| 351725713 | 443 | putative receptor protein kinase PERK1 [ | 0.534 | 0.873 | 0.700 | 1e-167 | |
| 224134338 | 575 | predicted protein [Populus trichocarpa] | 0.607 | 0.765 | 0.623 | 1e-166 | |
| 297834796 | 696 | hypothetical protein ARALYDRAFT_898257 [ | 0.720 | 0.75 | 0.597 | 1e-165 | |
| 359476577 | 630 | PREDICTED: proline-rich receptor-like pr | 0.611 | 0.703 | 0.642 | 1e-164 |
| >gi|255536819|ref|XP_002509476.1| somatic embryogenesis receptor kinase, putative [Ricinus communis] gi|223549375|gb|EEF50863.1| somatic embryogenesis receptor kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 628 bits (1619), Expect = e-177, Method: Compositional matrix adjust.
Identities = 324/487 (66%), Positives = 379/487 (77%), Gaps = 41/487 (8%)
Query: 241 CRRKKNRERNDQMPYYNNNH--TTATDYYNSAATPSPPPRANWQQQTDHGWPTPPP---- 294
C KK ++R + YY + A +Y+NS S P NWQ + G PPP
Sbjct: 2 CASKKKKKRI-EYDYYADQTPGGNAGNYFNS----STQPVNNWQAGSQKGTNLPPPPGVY 56
Query: 295 ---------------SQRGAVTVTSSDMSHNSSSGPYGPVLPPPPPIVALGFSQSAFTYE 339
GA+T SSD+S N S GPYGP LPPP P VALGF+QS+F+Y+
Sbjct: 57 GGWPSPPPPPGPQTPLPLGAMT--SSDLSSNFS-GPYGPPLPPPHPSVALGFTQSSFSYD 113
Query: 340 ELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV 399
EL+A TG FSQ+NLLGQGGFGYVHKGVLPNGKE+AVKSL++GSGQG+REF+AEVEIISRV
Sbjct: 114 ELAAVTGNFSQANLLGQGGFGYVHKGVLPNGKEIAVKSLKAGSGQGDREFQAEVEIISRV 173
Query: 400 HHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAY 459
HHRHLVSLVGYCIAGGKRLLVYE++PN+ LEFHL+GKGRP MDWPTRLKIA+GSA+GLAY
Sbjct: 174 HHRHLVSLVGYCIAGGKRLLVYEFLPNSTLEFHLYGKGRPTMDWPTRLKIALGSARGLAY 233
Query: 460 LHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEY 519
LHEDCHPRIIHRDIK++NILLDY FE KVADFGLAKL+ DNNTHVSTRVMGTFGYLAPEY
Sbjct: 234 LHEDCHPRIIHRDIKAANILLDYNFEAKVADFGLAKLSNDNNTHVSTRVMGTFGYLAPEY 293
Query: 520 ASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579
ASSGKLT+KSDVFSFGVMLLELITGRRP+D T M++ LVDWARP+C AL++G+F+E+A
Sbjct: 294 ASSGKLTDKSDVFSFGVMLLELITGRRPVDLTSDMDESLVDWARPICASALENGDFSELA 353
Query: 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSLEDLNDGIKPSQAS 639
DP LE NY EMARMVACA A++RHSARRR K+SQIVRALEGDVSLE LN+G+KP Q++
Sbjct: 354 DPRLEGNYDPAEMARMVACAGAAVRHSARRRAKMSQIVRALEGDVSLEHLNEGVKPGQST 413
Query: 640 ILGGGTANSSAVGSASARSSDVDNISYTEDLKKLRRMAEGNASGAYVSSEYGATSEYGLN 699
+ S+++ SSD D SY+ D++K R++ N S Y SSEYG TSEYGLN
Sbjct: 414 VF-----------SSTSGSSDNDTTSYSADMRKFRKVVMDN-SQEYESSEYGHTSEYGLN 461
Query: 700 PSSSSSE 706
PSSSSSE
Sbjct: 462 PSSSSSE 468
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449462888|ref|XP_004149167.1| PREDICTED: proline-rich receptor-like protein kinase PERK4-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 610 bits (1572), Expect = e-171, Method: Compositional matrix adjust.
Identities = 338/592 (57%), Positives = 415/592 (70%), Gaps = 41/592 (6%)
Query: 114 NSNASPPPS-QDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKN 172
NS+ SPPPS +++ S PPP S+N SP ++ ++++ K + ++ +
Sbjct: 52 NSDTSPPPSPENDDSSPPPPTSDNSPSPKSPSDGSSDDHKSH---PAPKEGGSSPLTSPA 108
Query: 173 WHPPPPPSSSSN---SPNGNRSGALSP--PNKSNGSSSSPSSNNGSMLSIPLVAAVAAGA 227
H PP SSS+ SP G SP P K G+ SS ++ S ++ ++ VA G
Sbjct: 109 AHSPPSRSSSAGDEFSPPALPEGKASPRSPAKQQGTPSSEKDSSPSEINPGIIIGVAVGV 168
Query: 228 AFLIIVMLLVFFACRRKKNRERNDQMPYYNNNHT---TATDYYNSAATPSPPPRANWQQQ 284
IIV++ V C +KK R+R D MPYY ++ DYYNS S + NW
Sbjct: 169 GVFIIVLISVIAVCSKKKKRKR-DPMPYYGDHGHGGPKGGDYYNS----SLQQQQNWHNG 223
Query: 285 TDHG-----WPTPPPSQRGAVT---VTSSDMSHNSSSGPYGPVLPPPPPIVALGFSQSAF 336
HG + PP S A T ++ +M+ SS GP LPPP P +A GF++S F
Sbjct: 224 M-HGPGTDQFGRPPVSGSPAGTGWPMSGENMTTGSSYA--GPPLPPPSPSIAFGFNKSTF 280
Query: 337 TYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEII 396
TY+EL+AATGGF+ NLLGQGGFGYVHKGVLPNGKEVAVKSL+ GSGQGEREF AEVEII
Sbjct: 281 TYDELAAATGGFAHGNLLGQGGFGYVHKGVLPNGKEVAVKSLKVGSGQGEREFMAEVEII 340
Query: 397 SRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKG 456
SRVHHRHLVSLVG+CIAGG+R+LVYE+VPNN +E HLH KG PVMDWP RL+IA+GSAKG
Sbjct: 341 SRVHHRHLVSLVGFCIAGGQRMLVYEFVPNNTMEHHLHAKGLPVMDWPARLRIAIGSAKG 400
Query: 457 LAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLA 516
LAYLHEDCHP+IIHRDIKS+NIL+D FE VADFGLAKL+TDN+THVSTRVMGTFGYLA
Sbjct: 401 LAYLHEDCHPKIIHRDIKSANILIDANFEAMVADFGLAKLSTDNHTHVSTRVMGTFGYLA 460
Query: 517 PEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576
PEYASSGKLTEKSDVFSFGVMLLELITG+RP+DPT MED LVDWARPL RAL +G ++
Sbjct: 461 PEYASSGKLTEKSDVFSFGVMLLELITGKRPVDPTHTMEDSLVDWARPLMTRALMEGIYD 520
Query: 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSLEDLNDGIKPS 636
E+ D LE+ + T+EMARMVACAAASIRHSAR+RPK+SQ+VRALEGDVSL+DLN+G +P
Sbjct: 521 ELVDIRLEREFNTQEMARMVACAAASIRHSARKRPKMSQVVRALEGDVSLDDLNEGTRPG 580
Query: 637 QASILGGGTANSSAVGSASARSSDVDNISYTEDLKKLRRMAEGNASGAYVSS 688
Q+SI SA SSD D+ +Y D+ K R++A + S +S
Sbjct: 581 QSSIF-------------SATSSDYDSSAYHADMSKFRKIALSDDSSELATS 619
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449516230|ref|XP_004165150.1| PREDICTED: proline-rich receptor-like protein kinase PERK4-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 606 bits (1563), Expect = e-170, Method: Compositional matrix adjust.
Identities = 338/592 (57%), Positives = 415/592 (70%), Gaps = 41/592 (6%)
Query: 114 NSNASPPPS-QDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKN 172
NS+ SPPPS +++ S PPP S+N SP ++ ++++ K + ++ +
Sbjct: 226 NSDTSPPPSPENDDSSPPPPTSDNSPSPKSPSDGSSDDHKSH---PAPKEGGSSPLTSPA 282
Query: 173 WHPPPPPSSSSN---SPNGNRSGALSP--PNKSNGSSSSPSSNNGSMLSIPLVAAVAAGA 227
H PP SSS+ SP G SP P K G+ SS ++ S ++ ++ VA G
Sbjct: 283 AHSPPSRSSSAGDEFSPPALPEGKASPRSPAKQQGTPSSEKDSSPSEINPGIIIGVAVGV 342
Query: 228 AFLIIVMLLVFFACRRKKNRERNDQMPYYNNNHT---TATDYYNSAATPSPPPRANWQQQ 284
IIV++ V C +KK R+R D MPYY ++ DYYNS S + NW
Sbjct: 343 GVFIIVLISVIAVCSKKKKRKR-DPMPYYGDHGHGGPKGGDYYNS----SLQQQQNWHNG 397
Query: 285 TDHG-----WPTPPPSQRGAVT---VTSSDMSHNSSSGPYGPVLPPPPPIVALGFSQSAF 336
HG + PP S A T ++ +M+ SS GP LPPP P +A GF++S F
Sbjct: 398 M-HGPGTDQFGRPPVSGSPAGTGWPMSGENMTTGSSYA--GPPLPPPSPSIAFGFNKSTF 454
Query: 337 TYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEII 396
TY+EL+AATGGF+ NLLGQGGFGYVHKGVLPNGKEVAVKSL+ GSGQGEREF AEVEII
Sbjct: 455 TYDELAAATGGFAHGNLLGQGGFGYVHKGVLPNGKEVAVKSLKVGSGQGEREFMAEVEII 514
Query: 397 SRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKG 456
SRVHHRHLVSLVG+CIAGG+R+LVYE+VPNN +E HLH KG PVMDWP RL+IA+GSAKG
Sbjct: 515 SRVHHRHLVSLVGFCIAGGQRMLVYEFVPNNTMEHHLHAKGLPVMDWPARLRIAIGSAKG 574
Query: 457 LAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLA 516
LAYLHEDCHP+IIHRDIKS+NIL+D FE VADFGLAKL+TDN+THVSTRVMGTFGYLA
Sbjct: 575 LAYLHEDCHPKIIHRDIKSANILIDANFEAMVADFGLAKLSTDNHTHVSTRVMGTFGYLA 634
Query: 517 PEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576
PEYASSGKLTEKSDVFSFGVMLLELITG+RP+DPT MED LVDWARPL RAL +G ++
Sbjct: 635 PEYASSGKLTEKSDVFSFGVMLLELITGKRPVDPTHTMEDSLVDWARPLMTRALMEGIYD 694
Query: 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSLEDLNDGIKPS 636
E+ D LE+ + T+EMARMVACAAASIRHSAR+RPK+SQ+VRALEGDVSL+DLN+G +P
Sbjct: 695 ELVDIRLEREFNTQEMARMVACAAASIRHSARKRPKMSQVVRALEGDVSLDDLNEGTRPG 754
Query: 637 QASILGGGTANSSAVGSASARSSDVDNISYTEDLKKLRRMAEGNASGAYVSS 688
Q+SI SA SSD D+ +Y D+ K R++A + S +S
Sbjct: 755 QSSIF-------------SATSSDYDSSAYHADMSKFRKIALSDDSSELATS 793
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449462276|ref|XP_004148867.1| PREDICTED: proline-rich receptor-like protein kinase PERK5-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 606 bits (1562), Expect = e-170, Method: Compositional matrix adjust.
Identities = 336/536 (62%), Positives = 394/536 (73%), Gaps = 39/536 (7%)
Query: 189 NRSGALSPPN-KSNGSSSSPSSNNGSM-LSIPLVAAVAAGAAFLIIVMLLVFFACRRKKN 246
N S SPP+ +S S S+ SS++GS ++P++ VA A FL+ M L+FFAC RKK
Sbjct: 143 NDSSRHSPPSPRSINSRSTDSSSDGSAPEAMPIIVGVAVAAGFLLFAMALIFFACTRKKK 202
Query: 247 RERNDQMPYYNNNHTTATD--YYNSAATPSPPPRANWQQQTDHGWPTPPPSQRGAVTV-- 302
++ N M Y + + D Y N P ++ P G V V
Sbjct: 203 KQNNSSMYYDDPSGPKGGDPYYNNGRNHNWNNPGEHYVNMA------PITGGGGQVGVWP 256
Query: 303 ----------TSSDMSHNSSSGPYGPVLPPPPPIVALGFSQSAFTYEELSAATGGFSQSN 352
SSDMS N S GP GP LPPP P VALGFS+S FT++EL AAT GFS +N
Sbjct: 257 SPPPPPPPPGASSDMSSNFS-GPQGPPLPPPHPAVALGFSKSTFTFDELMAATSGFSPAN 315
Query: 353 LLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCI 412
LLGQGGFGYVHKGVLPNGKE+AVKSL++GS QG+REF AEVEIISRVHHRHLVSLVGYCI
Sbjct: 316 LLGQGGFGYVHKGVLPNGKEIAVKSLKTGSRQGDREFAAEVEIISRVHHRHLVSLVGYCI 375
Query: 413 AGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRD 472
AG +++LVYE+VPNNNLEFHLHG+GRP +DW TR+KIA+GSAKGLAYLHEDCHPRIIHRD
Sbjct: 376 AGDRKMLVYEFVPNNNLEFHLHGEGRPPLDWSTRVKIALGSAKGLAYLHEDCHPRIIHRD 435
Query: 473 IKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 532
IK++NIL+D +FE KVADFGLAKL DN THVSTRVMGTFGYLAPEYASSGKLTEKSDVF
Sbjct: 436 IKTANILIDMSFEAKVADFGLAKLNQDNYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 495
Query: 533 SFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALD-DGNFNEIADPYLEKNYPTEE 591
SFGVMLLELITG++P+D TG MED LVDW+RPLC +A +GNF E+ DP LEKNY +E
Sbjct: 496 SFGVMLLELITGKQPVDATGEMEDSLVDWSRPLCTKATSPEGNF-ELVDPRLEKNYDIQE 554
Query: 592 MARMVACAAASIRHSARRRPKISQIVRALEGDVSLEDLNDGIKPSQASILGGGTANSSAV 651
MA MVACAAA +RHSARRRPK+SQ+VRALEGDVSLEDLNDG+KP Q+S G GT
Sbjct: 555 MACMVACAAACVRHSARRRPKMSQVVRALEGDVSLEDLNDGVKPGQSSYFGSGT------ 608
Query: 652 GSASARSSDVDNISYTEDLKKLRRMAEGNASGAYVSSEYGATSEYGLNPSSSSSEF 707
SS+ D SY+ D++K R++A Y SS+YG TSEYGLNPSS+SSE
Sbjct: 609 ------SSEYDASSYSADMRKFRKVALDTHE--YASSDYGGTSEYGLNPSSTSSEI 656
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297802522|ref|XP_002869145.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297314981|gb|EFH45404.1| predicted protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 605 bits (1559), Expect = e-170, Method: Compositional matrix adjust.
Identities = 286/403 (70%), Positives = 337/403 (83%), Gaps = 13/403 (3%)
Query: 309 HNSSSGPYGPVLPPPPPIVALGFSQSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGVLP 368
H+ +S G P P LG +QS FTY+ELS AT GF+QSNLLGQGGFGYVHKGVLP
Sbjct: 272 HSDTSNLTGRTATPSPQAATLGHNQSTFTYDELSIATEGFAQSNLLGQGGFGYVHKGVLP 331
Query: 369 NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNN 428
GKEVAVKSL+ GSGQGEREF+AEV+IISRVHHRHLVSLVGYCI+GG+RLLVYE++PNN
Sbjct: 332 GGKEVAVKSLKLGSGQGEREFQAEVDIISRVHHRHLVSLVGYCISGGQRLLVYEFIPNNT 391
Query: 429 LEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKV 488
LEFHLHGKGRPV+DWPTR+KIA+GSA+GLAYLHEDCHPRIIHRDIK++NILLD++FETKV
Sbjct: 392 LEFHLHGKGRPVLDWPTRVKIALGSARGLAYLHEDCHPRIIHRDIKAANILLDFSFETKV 451
Query: 489 ADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPI 548
ADFGLAKL+ DN THVSTRVMGTFGYLAPEYASSGKL++KSDVFSFGVMLLELITGR P+
Sbjct: 452 ADFGLAKLSQDNYTHVSTRVMGTFGYLAPEYASSGKLSDKSDVFSFGVMLLELITGRPPL 511
Query: 549 DPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSAR 608
D TG MED LVDWARPLCL+A DG+++++ADP LE NY +EM +M +CAAA+IRHSAR
Sbjct: 512 DLTGEMEDSLVDWARPLCLKAAQDGDYSQLADPRLELNYNHQEMVQMASCAAAAIRHSAR 571
Query: 609 RRPKISQIVRALEGDVSLEDLNDGIKPSQASILGGGTANSSAVGSASARSSDVDNISYTE 668
RRPK+SQIVRALEGD+S+EDL++G +P Q++ L G+ SS+ D SY+
Sbjct: 572 RRPKMSQIVRALEGDMSMEDLSEGTRPGQSTYLSPGSV-----------SSEYDASSYSA 620
Query: 669 DLKKLRRMAEGNASGAYVSSEYGATSEYGLNPSSSSSEFGSRG 711
D+KK +++A N Y SSEYG TSEYGLNPS+SSSE +RG
Sbjct: 621 DMKKFKKLALENKE--YQSSEYGGTSEYGLNPSASSSEEMNRG 661
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15222081|ref|NP_175353.1| protein kinase-like protein [Arabidopsis thaliana] gi|75338629|sp|Q9XI96.1|PERK7_ARATH RecName: Full=Proline-rich receptor-like protein kinase PERK7; AltName: Full=Proline-rich extensin-like receptor kinase 7; Short=AtPERK7 gi|5430769|gb|AAD43169.1|AC007504_24 Similar to somatic embryogenesis receptor-like kinase [Arabidopsis thaliana] gi|91805953|gb|ABE65705.1| protein kinase family protein [Arabidopsis thaliana] gi|332194291|gb|AEE32412.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 596 bits (1537), Expect = e-167, Method: Compositional matrix adjust.
Identities = 340/577 (58%), Positives = 401/577 (69%), Gaps = 73/577 (12%)
Query: 174 HPPPPPSSSSNSPNGNRSGALSPPNKSNGSSSSPSSNNGSMLSIPLVAAVAAGAAFLIIV 233
H PPPPS +S+ + ++ +L+PP ++GS+SS + L+I V + A A L IV
Sbjct: 134 HTPPPPSKTSDHSSHSQPRSLAPPTSNSGSNSSSNDG----LNIGAVIGLVAAAGILFIV 189
Query: 234 MLLVFFACRRKKNRERN-DQMPYYNNN-----HTTATDYY--------------NSAATP 273
M+L+ C RKK ++ DQMPYY +N T YY N
Sbjct: 190 MILLCVCCFRKKKKKSKLDQMPYYGSNAYPAGKTGGDQYYNQNAATQQQQHYNQNDHIVN 249
Query: 274 SPPP----------------RANWQQQTDHGWPTPP-PSQRGAVTVTSSDMSHNSSSGPY 316
PPP NWQ P+PP P GA + S +MS N SSGPY
Sbjct: 250 LPPPPGSMGTNWVSSPPPPPPGNWQPM-----PSPPAPVSGGANVIQSGEMSSNFSSGPY 304
Query: 317 GPVLPPPPPIVALGFSQSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVK 376
P LPPP P VALGF+ S FTYEEL++AT GFS+ LLGQGGFGYVHKG+LPNGKE+AVK
Sbjct: 305 APSLPPPHPSVALGFNNSTFTYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKEIAVK 364
Query: 377 SLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCI-AGGKRLLVYEYVPNNNLEFHLHG 435
SL++GSGQGEREF+AEVEIISRVHHRHLVSLVGYC AGG+RLLVYE++PN+ LEFHLHG
Sbjct: 365 SLKAGSGQGEREFQAEVEIISRVHHRHLVSLVGYCSNAGGQRLLVYEFLPNDTLEFHLHG 424
Query: 436 KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495
K VMDWPTRLKIA+GSAKGLAYLHEDCHP+IIHRDIK+SNILLD+ FE KVADFGLAK
Sbjct: 425 KSGTVMDWPTRLKIALGSAKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKVADFGLAK 484
Query: 496 LTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAME 555
L+ DNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR P+D +G ME
Sbjct: 485 LSQDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRGPVDLSGDME 544
Query: 556 DCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQ 615
D LVDWARPLC+R DG + E+ DP+LE Y EMARMVACAAA++RHS RRRPK+SQ
Sbjct: 545 DSLVDWARPLCMRVAQDGEYGELVDPFLEHQYEPYEMARMVACAAAAVRHSGRRRPKMSQ 604
Query: 616 IVRALEGDVSLEDLNDGIKPSQASILGGGTANSSAVGSASARSSDVDNISYTEDLKKLRR 675
IVR LEGD SL+DL+DG+KP Q+S S SSD + +Y +++K R+
Sbjct: 605 IVRTLEGDASLDDLDDGVKPKQSS-------------SGGEGSSDYEMGTYGAEMRKFRK 651
Query: 676 MAEGNASGAYVSSEYGA------TSEYGLNPSSSSSE 706
+ S +YGA TSEYGL+PSSSSSE
Sbjct: 652 VT-------LESRDYGASSEYGATSEYGLDPSSSSSE 681
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351725713|ref|NP_001237102.1| putative receptor protein kinase PERK1 [Glycine max] gi|77403742|dbj|BAE46451.1| putative receptor protein kinase PERK1 [Glycine max] gi|223452349|gb|ACM89502.1| PERK1-like protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 593 bits (1530), Expect = e-167, Method: Compositional matrix adjust.
Identities = 283/404 (70%), Positives = 329/404 (81%), Gaps = 17/404 (4%)
Query: 319 VLPPPPPIVALGFSQSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSL 378
LPPP P ++LGFS+S FTYEEL+ AT GFS +NLLGQGGFGYVH+G+LPNGKEVAVK L
Sbjct: 42 FLPPPSPGISLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGILPNGKEVAVKQL 101
Query: 379 RSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGR 438
++GSGQGEREF+AEVEIISRVHH+HLVSLVGYCI G +RLLVYE+VPNN LEFHLHGKGR
Sbjct: 102 KAGSGQGEREFQAEVEIISRVHHKHLVSLVGYCITGSQRLLVYEFVPNNTLEFHLHGKGR 161
Query: 439 PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498
P MDWPTRL+IA+GSAKGLAYLHEDCHP+IIHRDIKS+NILLD+ FE KVADFGLAK ++
Sbjct: 162 PTMDWPTRLRIALGSAKGLAYLHEDCHPKIIHRDIKSANILLDFKFEAKVADFGLAKFSS 221
Query: 499 DNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGA-MEDC 557
D NTHVSTRVMGTFGYLAPEYASSGKLT+KSDVFS+G+MLLELITGRRP+D MED
Sbjct: 222 DVNTHVSTRVMGTFGYLAPEYASSGKLTDKSDVFSYGIMLLELITGRRPVDKNQTYMEDS 281
Query: 558 LVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIV 617
LVDWARPL RAL++ +F+ I DP L+ +Y EMARMVA AAA IRHSA+RRP++SQ+V
Sbjct: 282 LVDWARPLLTRALEEDDFDSIIDPRLQNDYDPHEMARMVASAAACIRHSAKRRPRMSQVV 341
Query: 618 RALEGDVSLEDLNDGIKPSQASILGGGTANSSAVGSASARSSDVDNISYTEDLKKLRRMA 677
RALEGDVSL DLN+GI+P +++ +S SSD D Y ED+KK R+MA
Sbjct: 342 RALEGDVSLADLNEGIRPGHSTMY------------SSHESSDYDTAQYKEDMKKFRKMA 389
Query: 678 EGNAS-GAYVSSEY-GATSEYGLNPSSSSSEFGSRGQSPNTKVK 719
G GA SSEY ATSEYGLNPS SSSE SR + +++
Sbjct: 390 LGTQEYGA--SSEYSAATSEYGLNPSGSSSEAQSRQTTREMEMR 431
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224134338|ref|XP_002327813.1| predicted protein [Populus trichocarpa] gi|222836898|gb|EEE75291.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 590 bits (1522), Expect = e-166, Method: Compositional matrix adjust.
Identities = 300/481 (62%), Positives = 361/481 (75%), Gaps = 41/481 (8%)
Query: 229 FLIIVMLLVFFACRRKKNRERNDQMPYYNNNHTTATDYYNSAATPSPPPRANWQQQ--TD 286
+I M+ + C R+K R+ M YY N ++ + + + P ++NW T+
Sbjct: 118 IFLIAMIFICAYCSRRKKRK---NMHYYGENPQGGSEQF----SYNSPQQSNWHNGLPTE 170
Query: 287 HG-------------WPTPPPSQRGAVTVTSSDMSHNSSSGPYGPVLPPPPPIVALGFSQ 333
HG WP PPP + SSDMS N S GPY P LPPP P +ALGF++
Sbjct: 171 HGMKLSQSPGPMGSGWPAPPPPM-----MNSSDMSSNYS-GPYRPPLPPPSPNIALGFNK 224
Query: 334 SAFTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEV 393
S FTY+EL+AAT GF Q+NLLGQGGFGYVHKGVLPNGK++AVKSL+ GSGQGEREF+AEV
Sbjct: 225 STFTYDELAAATNGFDQANLLGQGGFGYVHKGVLPNGKDIAVKSLKLGSGQGEREFQAEV 284
Query: 394 EIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGS 453
+IISRVHHRHLVSLVGYCIAGG+R+LVYE+VPN LE HLHGKG PVMDWPTRL+IA+GS
Sbjct: 285 DIISRVHHRHLVSLVGYCIAGGQRMLVYEFVPNKTLEHHLHGKGLPVMDWPTRLRIALGS 344
Query: 454 AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFG 513
AKGLAYLHEDCHPRIIHRDIK++NIL+D FE VADFGLAKL++DN THVSTRVMGTFG
Sbjct: 345 AKGLAYLHEDCHPRIIHRDIKAANILIDNNFEAMVADFGLAKLSSDNYTHVSTRVMGTFG 404
Query: 514 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDG 573
YLAPEYASSGKLT+KSDVFS+GVMLLELITG++P+DP+ AMED LVDWARPL + +LD G
Sbjct: 405 YLAPEYASSGKLTDKSDVFSYGVMLLELITGKKPVDPSSAMEDSLVDWARPLMITSLDTG 464
Query: 574 NFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSLEDLNDGI 633
N+NE+ DP LE NY +EM RM+ACAAASIRHSAR+RPK+SQ+ RALEGDV L+DLN+G
Sbjct: 465 NYNELVDPMLENNYNHQEMQRMIACAAASIRHSARKRPKMSQVARALEGDVLLDDLNEGT 524
Query: 634 KPSQASILGGGTANSSAVGSASARSSDVDNISYTEDLKKLRRMAEGNASGAYVSSEYGAT 693
KP Q+S+ G S S+D D SY D+KK R++A S + S+E G +
Sbjct: 525 KPGQSSVFSG-----------SNGSADYDASSYNADMKKFRQVALN--SQEFGSNELGTS 571
Query: 694 S 694
S
Sbjct: 572 S 572
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297834796|ref|XP_002885280.1| hypothetical protein ARALYDRAFT_898257 [Arabidopsis lyrata subsp. lyrata] gi|297331120|gb|EFH61539.1| hypothetical protein ARALYDRAFT_898257 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 587 bits (1514), Expect = e-165, Method: Compositional matrix adjust.
Identities = 339/567 (59%), Positives = 409/567 (72%), Gaps = 45/567 (7%)
Query: 176 PPPPSSSSNSPNGNRSGALSPPNKSNGSSSSPSSNNGSMLSIPLVAAVAAGAAFLIIVML 235
PPPPS S+ + + AL+PP S G S+S S+N + +I + AGA L +VM+
Sbjct: 143 PPPPSRISDRNSSSPPRALAPPRSSGGGSNSSSNNEPNTAAI---VGIVAGAGLLFLVMI 199
Query: 236 LVFFACRRKKNRERNDQMPYY-NNNHTTA-------------TDYYNSAATPSPPPRAN- 280
L F + +++ QMPYY N + T +D+ + + P N
Sbjct: 200 L--FCVCCCRKKKKKHQMPYYAGNGYATGKGDQYQQQQYNNQSDHVMNLSQQYPGSNGNN 257
Query: 281 -WQ--------QQTDHGWPTPPPSQRGAVTVTSSDMSHNSSSGPYGPVLPPPPPIVALGF 331
W P PPP G + SSDMS N S GP+GP LPPP P VALGF
Sbjct: 258 NWMNSPPPPPPGSWQPSPPPPPPPVSGGMNGNSSDMSSNYS-GPHGPSLPPPHPSVALGF 316
Query: 332 SQSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKA 391
++S FTY+EL+AAT GFSQ+ LLGQGGFGYVHKG+LPNGKE+AVKSL++GSGQGEREF+A
Sbjct: 317 NKSTFTYDELAAATQGFSQARLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQA 376
Query: 392 EVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAM 451
EV+IISRVHHR LVSLVGYCIAGG+R+LVYE++PN+ LEFHLHGK V+DWPTRLKIA+
Sbjct: 377 EVDIISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHGKSGKVLDWPTRLKIAL 436
Query: 452 GSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGT 511
GSAKGLAYLHEDCHP+IIHRDIK+SNILLD +FE KVADFGLAKL+ DN THVSTR+MGT
Sbjct: 437 GSAKGLAYLHEDCHPKIIHRDIKASNILLDESFEAKVADFGLAKLSQDNVTHVSTRIMGT 496
Query: 512 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALD 571
FGYLAPEYASSGKLT++SDVFSFGVMLLEL+TGRRP+D TG MED LVDWARPLCL A
Sbjct: 497 FGYLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVDLTGEMEDSLVDWARPLCLNAAQ 556
Query: 572 DGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSLEDLND 631
DG+++E+ DP LE Y EMA+MVACAAA+IRHSARRRPK+SQIVRALEGD SL+DLN+
Sbjct: 557 DGDYSELVDPRLENQYEPHEMAQMVACAAAAIRHSARRRPKMSQIVRALEGDASLDDLNE 616
Query: 632 GIKPSQASILGGGTANSSAVGSASARSSDVDNISYTEDLKKLRRMA-EGNASGAYVSSEY 690
G KP Q+S LG G+++ + SA D+KK R++A + + GA SSEY
Sbjct: 617 GGKPGQSSFLGRGSSSDYDSSTYSA------------DMKKFRKVALDSHEYGA--SSEY 662
Query: 691 GATSEYGLNPSSSSSEFGSRGQSPNTK 717
G TSEYGL+PSSSSSE RG + N K
Sbjct: 663 GNTSEYGLDPSSSSSEEIRRGGANNNK 689
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359476577|ref|XP_002267433.2| PREDICTED: proline-rich receptor-like protein kinase PERK4-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 586 bits (1510), Expect = e-164, Method: Compositional matrix adjust.
Identities = 305/475 (64%), Positives = 360/475 (75%), Gaps = 32/475 (6%)
Query: 237 VFFACRRKKNRERNDQMPYYNNNHTTATDYYNSAATPSPPPRANWQ---QQTDHGWPT-- 291
V A RRKK ++ Q Y +N + +YYNS+ ++NW Q DH
Sbjct: 171 VTCAKRRKKRNQQASQATQYQSN-PSGDNYYNSS------QQSNWYNSPQSADHVVKLHQ 223
Query: 292 ---PPPSQRGAVTVTSSDMSHNSSSGPYGPVLPPPPPIVALGFSQSAFTYEELSAATGGF 348
+ ++S DMS N S GP P LPPP P +ALGF++S FTYEEL+AATGGF
Sbjct: 224 PPGGGWAPPPPPMISSGDMSSNYS-GPRHPPLPPPSPNLALGFNKSTFTYEELAAATGGF 282
Query: 349 SQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLV 408
+Q+NLLGQGGFGYVHKGVLPNGKE+AVKSL+SGSGQGEREF+AEVEIISRVHHRHLVSLV
Sbjct: 283 AQANLLGQGGFGYVHKGVLPNGKEIAVKSLKSGSGQGEREFQAEVEIISRVHHRHLVSLV 342
Query: 409 GYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRI 468
GYCIA G+R+LVYE+V N LE HLHG GRP+MDW +R++IA+GSAKGLAYLHEDCHP+I
Sbjct: 343 GYCIADGQRMLVYEFVHNKTLEHHLHGSGRPIMDWASRMRIALGSAKGLAYLHEDCHPKI 402
Query: 469 IHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEK 528
IHRDIK++NILLDY FE VADFGLAKL+TDN THVSTRVMGTFGYLAPEYASSGKLTEK
Sbjct: 403 IHRDIKTANILLDYNFEAMVADFGLAKLSTDNCTHVSTRVMGTFGYLAPEYASSGKLTEK 462
Query: 529 SDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYP 588
SDVFS+GVMLLELITGRRP+D E+ LVDWARPL RAL DGN++E+ D +LE NY
Sbjct: 463 SDVFSYGVMLLELITGRRPVD-NAIFEESLVDWARPLLSRALADGNYDELVDRFLENNYN 521
Query: 589 TEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSLEDLNDGIKPSQASILGGGTANS 648
T+EMARMVACAAASIRHSA+RRPK+SQIVRALEGDVSLEDLND K +Q+
Sbjct: 522 TQEMARMVACAAASIRHSAKRRPKMSQIVRALEGDVSLEDLNDVTKTNQSP--------- 572
Query: 649 SAVGSASARSSDVDNISYTEDLKKLRRMAEGNASGAYVSSEYGATSEYGLNPSSS 703
+++ SS+ + Y D++K ++MA +S + SSE G TSEYG NPSSS
Sbjct: 573 ---AYSTSMSSEYNTRMYNADMEKFKKMAL--SSQEFGSSEDG-TSEYGQNPSSS 621
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 724 | ||||||
| TAIR|locus:2010282 | 699 | PERK7 "proline-rich extensin-l | 0.578 | 0.599 | 0.635 | 5.7e-152 | |
| TAIR|locus:2093999 | 700 | PERK6 "proline-rich extensin-l | 0.616 | 0.637 | 0.604 | 3.6e-148 | |
| TAIR|locus:2139474 | 670 | PERK5 "proline-rich extensin-l | 0.632 | 0.683 | 0.585 | 5.3e-143 | |
| TAIR|locus:2046268 | 633 | PERK4 "proline-rich extensin-l | 0.589 | 0.674 | 0.586 | 1.8e-133 | |
| UNIPROTKB|Q9ARH1 | 647 | Q9ARH1 "Receptor protein kinas | 0.649 | 0.726 | 0.541 | 5e-131 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.658 | 0.731 | 0.529 | 8.1e-131 | |
| TAIR|locus:2018209 | 509 | PERK15 "proline-rich extensin- | 0.488 | 0.695 | 0.590 | 3.2e-113 | |
| TAIR|locus:2028911 | 720 | PERK12 "proline-rich extensin- | 0.429 | 0.431 | 0.621 | 2.4e-110 | |
| TAIR|locus:2026846 | 710 | PERK13 "proline-rich extensin- | 0.544 | 0.554 | 0.529 | 9.1e-109 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.484 | 0.515 | 0.560 | 4.5e-105 |
| TAIR|locus:2010282 PERK7 "proline-rich extensin-like receptor kinase 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1394 (495.8 bits), Expect = 5.7e-152, Sum P(2) = 5.7e-152
Identities = 281/442 (63%), Positives = 323/442 (73%)
Query: 268 NSAATPSPPPRANWQQQTDHGWPTPP-PSQRGAVTVTSSDMSHNSSSGXXXXXXXXXXXI 326
N ++P PPP NWQ P+PP P GA + S +MS N SSG
Sbjct: 260 NWVSSPPPPPPGNWQPM-----PSPPAPVSGGANVIQSGEMSSNFSSGPYAPSLPPPHPS 314
Query: 327 VALGFSQSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGE 386
VALGF+ S FTYEEL++AT GFS+ LLGQGGFGYVHKG+LPNGKE+AVKSL++GSGQGE
Sbjct: 315 VALGFNNSTFTYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGE 374
Query: 387 REFKAEVEIISRVHHRHLVSLVGYCI-AGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPT 445
REF+AEVEIISRVHHRHLVSLVGYC AGG+RLLVYE++PN+ LEFHLHGK VMDWPT
Sbjct: 375 REFQAEVEIISRVHHRHLVSLVGYCSNAGGQRLLVYEFLPNDTLEFHLHGKSGTVMDWPT 434
Query: 446 RLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVS 505
RLKIA+GSAKGLAYLHEDCHP+IIHRDIK+SNILLD+ FE KVADFGLAKL+ DNNTHVS
Sbjct: 435 RLKIALGSAKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKVADFGLAKLSQDNNTHVS 494
Query: 506 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPL 565
TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR P+D +G MED LVDWARPL
Sbjct: 495 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRGPVDLSGDMEDSLVDWARPL 554
Query: 566 CLRALDDGNFNEIADPYLEKNYPTEEMARMVXXXXXXXXXXXXXXPKISQIVRALEGDVS 625
C+R DG + E+ DP+LE Y EMARMV PK+SQIVR LEGD S
Sbjct: 555 CMRVAQDGEYGELVDPFLEHQYEPYEMARMVACAAAAVRHSGRRRPKMSQIVRTLEGDAS 614
Query: 626 LEDLNDGIKPSQASILXXXXXXXXXXXXXXXXXXDVDNISYTEDLKKLRRMA-EGNASGA 684
L+DL+DG+KP Q+S D + +Y +++K R++ E GA
Sbjct: 615 LDDLDDGVKPKQSS-------------SGGEGSSDYEMGTYGAEMRKFRKVTLESRDYGA 661
Query: 685 YVSSEYGATSEYGLNPXXXXXE 706
SSEYGATSEYGL+P E
Sbjct: 662 --SSEYGATSEYGLDPSSSSSE 681
|
|
| TAIR|locus:2093999 PERK6 "proline-rich extensin-like receptor kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1396 (496.5 bits), Expect = 3.6e-148, Sum P(2) = 3.6e-148
Identities = 286/473 (60%), Positives = 339/473 (71%)
Query: 250 NDQMPYYNNNHTTATDYYNSAATPSPPPRANWQQQTDHGWPTPPPSQRGAVTVTSSDMSH 309
+ Q P N N+ ++ NS P PPP +WQ P PPP G + SSD S
Sbjct: 251 SQQYPGSNGNN----NWMNS---PPPPPPGSWQPSP----PPPPPPVSGGMNGNSSDFSS 299
Query: 310 NSSSGXXXXXXXXXXXIVALGFSQSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPN 369
N S G VALGF++S FTY+EL+AAT GFSQS LLGQGGFGYVHKG+LPN
Sbjct: 300 NYS-GPHGPSVPPPHPSVALGFNKSTFTYDELAAATQGFSQSRLLGQGGFGYVHKGILPN 358
Query: 370 GKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNL 429
GKE+AVKSL++GSGQGEREF+AEV+IISRVHHR LVSLVGYCIAGG+R+LVYE++PN+ L
Sbjct: 359 GKEIAVKSLKAGSGQGEREFQAEVDIISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTL 418
Query: 430 EFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVA 489
EFHLHGK V+DWPTRLKIA+GSAKGLAYLHEDCHPRIIHRDIK+SNILLD +FE KVA
Sbjct: 419 EFHLHGKSGKVLDWPTRLKIALGSAKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVA 478
Query: 490 DFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPID 549
DFGLAKL+ DN THVSTR+MGTFGYLAPEYASSGKLT++SDVFSFGVMLLEL+TGRRP+D
Sbjct: 479 DFGLAKLSQDNVTHVSTRIMGTFGYLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVD 538
Query: 550 PTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVXXXXXXXXXXXXX 609
TG MED LVDWARP+CL A DG+++E+ DP LE Y EMA+MV
Sbjct: 539 LTGEMEDSLVDWARPICLNAAQDGDYSELVDPRLENQYEPHEMAQMVACAAAAVRHSARR 598
Query: 610 XPKISQIVRALEGDVSLEDLNDGIKPSQASILXXXXXXXXXXXXXXXXXXDVDNISYTED 669
PK+SQIVRALEGD +L+DL++G K Q+S L D D+ +Y+ D
Sbjct: 599 RPKMSQIVRALEGDATLDDLSEGGKAGQSSFLGRGSSS------------DYDSSTYSAD 646
Query: 670 LKKLRRMA-EGNASGAYVSSEYGATSEYGLNPXXXXXEFGSRGQSPNTKVKSS 721
+KK R++A + + GA SSEYG TSEYGL+P E RG + N K S
Sbjct: 647 MKKFRKVALDSHEYGA--SSEYGNTSEYGLDPSSSSSEEIRRGGANNNKTTPS 697
|
|
| TAIR|locus:2139474 PERK5 "proline-rich extensin-like receptor kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1398 (497.2 bits), Expect = 5.3e-143, P = 5.3e-143
Identities = 285/487 (58%), Positives = 341/487 (70%)
Query: 230 LIIVMLLVFFACRRKKNRE--RNDQMPYYNNNHTTATDYYNSAATPSPPPR--ANWQQQT 285
L+++ + + C RKK ++ + + M YYNNN N P N Q
Sbjct: 200 LLLLAVCICICCNRKKKKKSPQVNHMHYYNNNPYGGAPSGNGGYYKGTPQDHVVNMAGQG 259
Query: 286 DHGW-PTPPPSQRGAVTVTSSDMSHNSSSGXXXXXXXXXXXIVALGFSQSAFTYEELSAA 344
W P P S G H+ +S LG +QS FTY+ELS A
Sbjct: 260 GGNWGPQQPVS--GP---------HSDASNLTGRTAIPSPQAATLGHNQSTFTYDELSIA 308
Query: 345 TGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHL 404
T GF+QSNLLGQGGFGYVHKGVLP+GKEVAVKSL+ GSGQGEREF+AEV+IISRVHHRHL
Sbjct: 309 TEGFAQSNLLGQGGFGYVHKGVLPSGKEVAVKSLKLGSGQGEREFQAEVDIISRVHHRHL 368
Query: 405 VSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC 464
VSLVGYCI+GG+RLLVYE++PNN LEFHLHGKGRPV+DWPTR+KIA+GSA+GLAYLHEDC
Sbjct: 369 VSLVGYCISGGQRLLVYEFIPNNTLEFHLHGKGRPVLDWPTRVKIALGSARGLAYLHEDC 428
Query: 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGK 524
HPRIIHRDIK++NILLD++FETKVADFGLAKL+ DN THVSTRVMGTFGYLAPEYASSGK
Sbjct: 429 HPRIIHRDIKAANILLDFSFETKVADFGLAKLSQDNYTHVSTRVMGTFGYLAPEYASSGK 488
Query: 525 LTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLE 584
L++KSDVFSFGVMLLELITGR P+D TG MED LVDWARPLCL+A DG++N++ADP LE
Sbjct: 489 LSDKSDVFSFGVMLLELITGRPPLDLTGEMEDSLVDWARPLCLKAAQDGDYNQLADPRLE 548
Query: 585 KNYPTEEMARMVXXXXXXXXXXXXXXPKISQIVRALEGDVSLEDLNDGIKPSQASILXXX 644
NY +EM +M PK+SQIVRALEGD+S++DL++G +P Q++ L
Sbjct: 549 LNYSHQEMVQMASCAAAAIRHSARRRPKMSQIVRALEGDMSMDDLSEGTRPGQSTYLSPG 608
Query: 645 XXXXXXXXXXXXXXXDVDNISYTEDLKKLRRMAEGNASGAYVSSEYGATSEYGLNPXXXX 704
+ D SYT D+KK +++A N Y SSEYG TSEYGLNP
Sbjct: 609 SVSS-----------EYDASSYTADMKKFKKLALENKE--YQSSEYGGTSEYGLNPSASS 655
Query: 705 XEFGSRG 711
E +RG
Sbjct: 656 SEEMNRG 662
|
|
| TAIR|locus:2046268 PERK4 "proline-rich extensin-like receptor kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1308 (465.5 bits), Expect = 1.8e-133, P = 1.8e-133
Identities = 270/460 (58%), Positives = 329/460 (71%)
Query: 232 IVMLLVFFAC-RRKKNRE--------RNDQMPYY-NNNHTTATDYYNSAATPSPPPRANW 281
++M+++ C RRKK R+ + +Q YY NNN+ A+ Y + S
Sbjct: 162 LLMIVLIIVCLRRKKKRKDSFYPEPMKGNQYQYYGNNNNNNASQNYPNWHLNSQ----GQ 217
Query: 282 QQQTDHGW----PTPPPSQRGAVTVTSSDMSHNSSSGXXXXXXXXXXXIVALGFSQSAFT 337
QQ+ GW P+PPP R + S M SG +ALGF++S FT
Sbjct: 218 NQQSTGGWGGGGPSPPPPPRMPTSGEDSSMY----SGPSRPVLPPPSPALALGFNKSTFT 273
Query: 338 YEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIIS 397
Y+EL+AATGGF+ +NLLGQGGFGYVHKGVLP+GKEVAVKSL++GSGQGEREF+AEV+IIS
Sbjct: 274 YQELAAATGGFTDANLLGQGGFGYVHKGVLPSGKEVAVKSLKAGSGQGEREFQAEVDIIS 333
Query: 398 RVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGL 457
RVHHR+LVSLVGYCIA G+R+LVYE+VPN LE+HLHGK PVM++ TRL+IA+G+AKGL
Sbjct: 334 RVHHRYLVSLVGYCIADGQRMLVYEFVPNKTLEYHLHGKNLPVMEFSTRLRIALGAAKGL 393
Query: 458 AYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAP 517
AYLHEDCHPRIIHRDIKS+NILLD+ F+ VADFGLAKLT+DNNTHVSTRVMGTFGYLAP
Sbjct: 394 AYLHEDCHPRIIHRDIKSANILLDFNFDAMVADFGLAKLTSDNNTHVSTRVMGTFGYLAP 453
Query: 518 EYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577
EYASSGKLTEKSDVFS+GVMLLELITG+RP+D + M+D LVDWARPL RAL+DGNFNE
Sbjct: 454 EYASSGKLTEKSDVFSYGVMLLELITGKRPVDNSITMDDTLVDWARPLMARALEDGNFNE 513
Query: 578 IADPYLEKNYPTEEMARMVXXXXXXXXXXXXXXPKISQIVRALEGDVSLEDLNDGIKPSQ 637
+AD LE NY +EMARMV PK+SQIVRALEG+VSL+ LN+G+KP
Sbjct: 514 LADARLEGNYNPQEMARMVTCAAASIRHSGRKRPKMSQIVRALEGEVSLDALNEGVKPGH 573
Query: 638 ASILXXXXXXXXXXXXXXXXXXDVDNISYTEDLKKLRRMA 677
+++ D SY D+KK R++A
Sbjct: 574 SNVYGSLGASS-----------DYSQTSYNADMKKFRQIA 602
|
|
| UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)] | Back alignment and assigned GO terms |
|---|
Score = 1285 (457.4 bits), Expect = 5.0e-131, P = 5.0e-131
Identities = 275/508 (54%), Positives = 335/508 (65%)
Query: 230 LIIVMLLVFFACRRKKNRERNDQMPYYNNNHTTATDYYNSAATPSPPPRANWQQQ----- 284
L++++ L+ C++K+ R+ D YY A P + W+QQ
Sbjct: 149 LLVIVTLICLLCKKKRRRDEEDA--YYVPPPPPPGP---KAGGPYGGQQQQWRQQNATPP 203
Query: 285 TDH---GWPTPP--PSQRGAVTVTSSDMSHNSSSGXXXXXXXXX---XXIVALGFSQSAF 336
+DH P PP PS +SS G + LGFS+S F
Sbjct: 204 SDHVVTSLPPPPKAPSPPRQPPPPPPPPFMSSSGGSDYSDRPVLPPPSPGLVLGFSKSTF 263
Query: 337 TYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEII 396
TYEEL+ AT GFS++NLLGQGGFGYVHKGVLP+GKEVAVK L+ GSGQGEREF+AEVEII
Sbjct: 264 TYEELARATNGFSEANLLGQGGFGYVHKGVLPSGKEVAVKQLKVGSGQGEREFQAEVEII 323
Query: 397 SRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKG 456
SRVHHRHLVSLVGYCIAG KRLLVYE+VPNNNLE HLHG+GRP M+W TRLKIA+GSAKG
Sbjct: 324 SRVHHRHLVSLVGYCIAGAKRLLVYEFVPNNNLELHLHGEGRPTMEWSTRLKIALGSAKG 383
Query: 457 LAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLA 516
L+YLHEDC+P+IIHRDIK+SNIL+D+ FE KVADFGLAK+ +D NTHVSTRVMGTFGYLA
Sbjct: 384 LSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFGYLA 443
Query: 517 PEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGA-MEDCLVDWARPLCLRALDDGNF 575
PEYA+SGKLTEKSDVFSFGV+LLELITGRRP+D ++D LVDWARPL RA + G+F
Sbjct: 444 PEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASEQGDF 503
Query: 576 NEIADPYLEKNYPTEEMARMVXXXXXXXXXXXXXXPKISQIVRALEGDVSLEDLNDGIKP 635
+AD + Y EEMARMV P++SQIVRALEG+VSL DLN+G++P
Sbjct: 504 EGLADAKMNNGYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSLSDLNEGMRP 563
Query: 636 SQASILXXXXXXXXXXXXXXXXXXDVDNISYTEDLKKLRRMAEG----NASGAYVSSEYG 691
Q+++ D D+ Y ED+KK R+MA G NA+G Y +
Sbjct: 564 GQSNVYSSYGGST-----------DYDSSQYNEDMKKFRKMALGTQEYNATGEYSNP--- 609
Query: 692 ATSEYGLNPXXXXXEFGSRGQSPNTKVK 719
TS+YGL P E + + K+K
Sbjct: 610 -TSDYGLYPSGSSSEGQTTREMEMGKIK 636
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1283 (456.7 bits), Expect = 8.1e-131, P = 8.1e-131
Identities = 269/508 (52%), Positives = 335/508 (65%)
Query: 230 LIIVMLLVFFACRRKKNRERNDQMPYYNNNHTTATDYYNSAATPSPPPRANWQQQT---- 285
+++++ L+ C++K+ R +D+ YY + A P + WQQQ
Sbjct: 151 ILVILTLICLLCKKKRRRRHDDEAAYYVPPPPPSGP---KAGGPYGGQQQYWQQQNASRP 207
Query: 286 --DH---GWPTP-PPSQRGAVTVTSSDMSHNSSSGXXXXXXXXXXXI----VALGFSQSA 335
+H P P PPS + SSSG + LGFS+S
Sbjct: 208 SDNHVVTSLPPPKPPSPPRKPPPPPPPPAFMSSSGGSDYSDLPVLPPPSPGLVLGFSKST 267
Query: 336 FTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEI 395
FTYEELS AT GFS++NLLGQGGFGYVHKG+LP+GKEVAVK L++GSGQGEREF+AEVEI
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327
Query: 396 ISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAK 455
ISRVHHRHLVSL+GYC+AG +RLLVYE+VPNNNLEFHLHGKGRP M+W TRLKIA+GSAK
Sbjct: 328 ISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIALGSAK 387
Query: 456 GLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYL 515
GL+YLHEDC+P+IIHRDIK+SNIL+D+ FE KVADFGLAK+ +D NTHVSTRVMGTFGYL
Sbjct: 388 GLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFGYL 447
Query: 516 APEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGA-MEDCLVDWARPLCLRALDDGN 574
APEYA+SGKLTEKSDVFSFGV+LLELITGRRP+D ++D LVDWARPL RA ++G+
Sbjct: 448 APEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASEEGD 507
Query: 575 FNEIADPYLEKNYPTEEMARMVXXXXXXXXXXXXXXPKISQIVRALEGDVSLEDLNDGIK 634
F +AD + Y EEMARMV P++SQIVRALEG+VSL DLN+G++
Sbjct: 508 FEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSLSDLNEGMR 567
Query: 635 PSQASILXXXXXXXXXXXXXXXXXXDVDNISYTEDLKKLRRMAEGNASGAYVSSEYG-AT 693
P +++ D D Y +D+ K R+MA G + EY T
Sbjct: 568 PGHSNVYSSYGGST-----------DYDTSQYNDDMIKFRKMALGTQEYG-TTGEYSNPT 615
Query: 694 SEYGLNPXXXXXEFGSRGQSPNTKVKSS 721
S+YGL P E + + K+K +
Sbjct: 616 SDYGLYPSGSSSEGQATREMEMGKIKKT 643
|
|
| TAIR|locus:2018209 PERK15 "proline-rich extensin-like receptor kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1117 (398.3 bits), Expect = 3.2e-113, P = 3.2e-113
Identities = 219/371 (59%), Positives = 275/371 (74%)
Query: 333 QSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAE 392
Q+ FTYE+LS AT FS +NLLGQGGFGYVH+GVL +G VA+K L+SGSGQGEREF+AE
Sbjct: 128 QNLFTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAE 187
Query: 393 VEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMG 452
++ ISRVHHRHLVSL+GYCI G +RLLVYE+VPN LEFHLH K RPVM+W R+KIA+G
Sbjct: 188 IQTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKERPVMEWSKRMKIALG 247
Query: 453 SAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTF 512
+AKGLAYLHEDC+P+ IHRD+K++NIL+D ++E K+ADFGLA+ + D +THVSTR+MGTF
Sbjct: 248 AAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTHVSTRIMGTF 307
Query: 513 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTG--AMEDCLVDWARPLCLRAL 570
GYLAPEYASSGKLTEKSDVFS GV+LLELITGRRP+D + A +D +VDWA+PL ++AL
Sbjct: 308 GYLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDKSQPFADDDSIVDWAKPLMIQAL 367
Query: 571 DDGNFNEIADPYLEKNYPTEEMARMVXXXXXXXXXXXXXXPKISQIVRALEGDVSLEDLN 630
+DGNF+ + DP LE ++ EM RMV PK+SQIVRA EG++S++DL
Sbjct: 368 NDGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAKRRPKMSQIVRAFEGNISIDDLT 427
Query: 631 DGIKPSQASILXXXXXXXXXXXXXXXXXXDVDNISYTEDLKKLRRMAEGNASGAYVSSEY 690
+G P Q++I D + Y EDLKK ++MA S + SSE
Sbjct: 428 EGAAPGQSTIYSLDGSS------------DYSSTQYKEDLKKFKKMAF--ESKTFGSSEC 473
Query: 691 -GATSEYGLNP 700
G TS+ G NP
Sbjct: 474 SGLTSDNGQNP 484
|
|
| TAIR|locus:2028911 PERK12 "proline-rich extensin-like receptor kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1020 (364.1 bits), Expect = 2.4e-110, Sum P(3) = 2.4e-110
Identities = 194/312 (62%), Positives = 244/312 (78%)
Query: 329 LGFSQSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGERE 388
LG Q+ F+YEEL+ T GF++ N+LG+GGFG V+KG L +GK VAVK L++GSGQG+RE
Sbjct: 352 LGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDRE 411
Query: 389 FKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLK 448
FKAEVEIISRVHHRHLVSLVGYCI+ RLL+YEYV N LE HLHGKG PV++W R++
Sbjct: 412 FKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRVR 471
Query: 449 IAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRV 508
IA+GSAKGLAYLHEDCHP+IIHRDIKS+NILLD +E +VADFGLA+L THVSTRV
Sbjct: 472 IAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRV 531
Query: 509 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAM-EDCLVDWARPLCL 567
MGTFGYLAPEYASSGKLT++SDVFSFGV+LLEL+TGR+P+D T + E+ LV+WARPL L
Sbjct: 532 MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLL 591
Query: 568 RALDDGNFNEIADPYLEKNYPTEEMARMVXXXXXXXXXXXXXXPKISQIVRALEGDVSLE 627
+A++ G+ +E+ D LEK Y E+ RM+ P++ Q+VRAL+ D
Sbjct: 592 KAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALDCDGDSG 651
Query: 628 DLNDGIKPSQAS 639
D+++GIK Q++
Sbjct: 652 DISNGIKIGQST 663
|
|
| TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1047 (373.6 bits), Expect = 9.1e-109, Sum P(2) = 9.1e-109
Identities = 222/419 (52%), Positives = 279/419 (66%)
Query: 229 FLIIVMLLVFFACRRKKNRE---RNDQMPYYNNNHTTATD--YYNSAATPSPPPRANWQQ 283
F +I ++ V F RRKK R +D +N + +D Y T +
Sbjct: 244 FAVIALMAVVFLVRRKKKRNIDAYSDSQYLPPSNFSIKSDGFLYGQNPTKGYSGPGGYNS 303
Query: 284 QTDHGWPTPPPSQRGAVTVTSSDMSHNSSSGXXXXXXXXXXXIVALGFSQSAFTYEELSA 343
Q SQRG T S + +S+ +G Q+ FTYEEL+
Sbjct: 304 QQQSNSGNSFGSQRGGGGYTRSGSAPDSA---------------VMGSGQTHFTYEELTD 348
Query: 344 ATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRH 403
T GFS+ N+LG+GGFG V+KG L +GK VAVK L+ GSGQG+REFKAEVEIISRVHHRH
Sbjct: 349 ITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEIISRVHHRH 408
Query: 404 LVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHED 463
LVSLVGYCIA +RLL+YEYVPN LE HLHGKGRPV++W R++IA+GSAKGLAYLHED
Sbjct: 409 LVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIAIGSAKGLAYLHED 468
Query: 464 CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSG 523
CHP+IIHRDIKS+NILLD FE +VADFGLAKL THVSTRVMGTFGYLAPEYA SG
Sbjct: 469 CHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRVMGTFGYLAPEYAQSG 528
Query: 524 KLTEKSDVFSFGVMLLELITGRRPID---PTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580
KLT++SDVFSFGV+LLELITGR+P+D P G E+ LV+WARPL +A++ G+F+E+ D
Sbjct: 529 KLTDRSDVFSFGVVLLELITGRKPVDQYQPLG--EESLVEWARPLLHKAIETGDFSELVD 586
Query: 581 PYLEKNYPTEEMARMVXXXXXXXXXXXXXXPKISQIVRALEGDVSLEDLNDGIKPSQAS 639
LEK+Y E+ RM+ P++ Q+VRAL+ + + D+++G K Q+S
Sbjct: 587 RRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGDMGDISNGNKVGQSS 645
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1013 (361.7 bits), Expect = 4.5e-105, Sum P(2) = 4.5e-105
Identities = 204/364 (56%), Positives = 260/364 (71%)
Query: 288 GWPTPPP---SQRGAVTV-----TSSDMSHNSSSGXXXXXXXXXXXIVALGFSQSAFTYE 339
G+ PP S +G+ V +S+ S SG +V+ +S F+Y+
Sbjct: 273 GYTMPPSAYSSPQGSDVVLFNSRSSAPPKMRSHSGSDYMYASSDSGMVSN--QRSWFSYD 330
Query: 340 ELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV 399
ELS T GFS+ NLLG+GGFG V+KGVL +G+EVAVK L+ G QGEREFKAEVEIISRV
Sbjct: 331 ELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEIISRV 390
Query: 400 HHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAY 459
HHRHLV+LVGYCI+ RLLVY+YVPNN L +HLH GRPVM W TR+++A G+A+G+AY
Sbjct: 391 HHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAAGAARGIAY 450
Query: 460 LHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT--DNNTHVSTRVMGTFGYLAP 517
LHEDCHPRIIHRDIKSSNILLD +FE VADFGLAK+ D NTHVSTRVMGTFGY+AP
Sbjct: 451 LHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTFGYMAP 510
Query: 518 EYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMED-CLVDWARPLCLRALDDGNFN 576
EYA+SGKL+EK+DV+S+GV+LLELITGR+P+D + + D LV+WARPL +A+++ F+
Sbjct: 511 EYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAIENEEFD 570
Query: 577 EIADPYLEKNYPTEEMARMVXXXXXXXXXXXXXXPKISQIVRALEGDVSLEDLNDGIKPS 636
E+ DP L KN+ EM RMV PK+SQ+VRAL+ D+ +G++P
Sbjct: 571 ELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLEEATDITNGMRPG 630
Query: 637 QASI 640
Q+ +
Sbjct: 631 QSQV 634
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q9XI96 | PERK7_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5892 | 0.6961 | 0.7210 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 724 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-55 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-53 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-53 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-51 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-51 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-48 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-40 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-33 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-32 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-32 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-32 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-31 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-31 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-31 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-29 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-29 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-27 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-23 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-23 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-21 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-21 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-21 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-20 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-19 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-19 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-17 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-16 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 8e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-15 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 1e-15 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 2e-15 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 2e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-15 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 8e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-14 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 2e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-14 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 3e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-14 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 6e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-14 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 6e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-13 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 1e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-12 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 3e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-12 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 4e-12 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 5e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-12 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 6e-12 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 7e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-12 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 1e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-11 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 1e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-11 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-11 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 2e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-11 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 3e-11 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-11 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 5e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-11 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 9e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-11 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 1e-10 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 1e-10 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 1e-10 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 1e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-10 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 3e-10 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 3e-10 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 3e-10 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 4e-10 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 4e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-10 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 6e-10 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 7e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-09 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-09 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 2e-09 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 2e-09 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-09 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 3e-09 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 3e-09 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 3e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-09 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 3e-09 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 4e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-09 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 6e-09 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 6e-09 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 6e-09 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 6e-09 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 6e-09 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 7e-09 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 7e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-09 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 1e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-08 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 1e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-08 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 2e-08 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-08 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 2e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-08 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 3e-08 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 3e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-08 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 3e-08 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 4e-08 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 4e-08 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 4e-08 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 4e-08 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 4e-08 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 4e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-08 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 4e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 5e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 5e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-08 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 6e-08 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 6e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 6e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 6e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-08 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 7e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 7e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 8e-08 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 8e-08 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 9e-08 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 9e-08 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 1e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-07 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 1e-07 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 1e-07 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 1e-07 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 1e-07 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 1e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-07 | |
| PTZ00441 | 576 | PTZ00441, PTZ00441, sporozoite surface protein 2 ( | 1e-07 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 2e-07 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 2e-07 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 2e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-07 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 2e-07 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 2e-07 | |
| PRK12678 | 672 | PRK12678, PRK12678, transcription termination fact | 2e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-07 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 2e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-07 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 2e-07 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 2e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-07 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 3e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-07 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 3e-07 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 3e-07 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 3e-07 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 3e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-07 | |
| PRK08691 | 709 | PRK08691, PRK08691, DNA polymerase III subunits ga | 3e-07 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 3e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-07 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 4e-07 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 4e-07 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 4e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-07 | |
| pfam07415 | 489 | pfam07415, Herpes_LMP2, Gammaherpesvirus latent me | 4e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-07 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 5e-07 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 5e-07 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 5e-07 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 5e-07 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 5e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-07 | |
| PHA03201 | 318 | PHA03201, PHA03201, uracil DNA glycosylase; Provis | 5e-07 | |
| COG0810 | 244 | COG0810, TonB, Periplasmic protein TonB, links inn | 5e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-07 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 6e-07 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 6e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 7e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 7e-07 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 7e-07 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 8e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 8e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 8e-07 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 8e-07 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 8e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-07 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 9e-07 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 9e-07 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 9e-07 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 9e-07 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 9e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-06 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 1e-06 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 1e-06 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 1e-06 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 1e-06 | |
| PHA03201 | 318 | PHA03201, PHA03201, uracil DNA glycosylase; Provis | 1e-06 | |
| pfam02439 | 38 | pfam02439, Adeno_E3_CR2, Adenovirus E3 region prot | 1e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-06 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 1e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-06 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 2e-06 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 2e-06 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 2e-06 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 2e-06 | |
| pfam04929 | 381 | pfam04929, Herpes_DNAp_acc, Herpes DNA replication | 2e-06 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 3e-06 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 3e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-06 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 3e-06 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 3e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-06 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 3e-06 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 4e-06 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 4e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 4e-06 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 4e-06 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 4e-06 | |
| pfam10428 | 419 | pfam10428, SOG2, RAM signalling pathway protein | 4e-06 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 5e-06 | |
| pfam04484 | 313 | pfam04484, DUF566, Family of unknown function (DUF | 5e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 6e-06 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 6e-06 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 7e-06 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 7e-06 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 7e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-06 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 7e-06 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 7e-06 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 8e-06 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 8e-06 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 9e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 9e-06 | |
| PRK14963 | 504 | PRK14963, PRK14963, DNA polymerase III subunits ga | 9e-06 | |
| pfam05308 | 248 | pfam05308, Mito_fiss_reg, Mitochondrial fission re | 9e-06 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 1e-05 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 1e-05 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 1e-05 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 1e-05 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 1e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-05 | |
| TIGR03490 | 541 | TIGR03490, Mycoplas_LppA, mycoides cluster lipopro | 1e-05 | |
| pfam05539 | 408 | pfam05539, Pneumo_att_G, Pneumovirinae attachment | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-05 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 2e-05 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 2e-05 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 2e-05 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 2e-05 | |
| COG0810 | 244 | COG0810, TonB, Periplasmic protein TonB, links inn | 2e-05 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 2e-05 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 2e-05 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 2e-05 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 2e-05 | |
| pfam05539 | 408 | pfam05539, Pneumo_att_G, Pneumovirinae attachment | 2e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-05 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 2e-05 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 2e-05 | |
| PHA03169 | 413 | PHA03169, PHA03169, hypothetical protein; Provisio | 2e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-05 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 3e-05 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 3e-05 | |
| pfam07267 | 606 | pfam07267, Nucleo_P87, Nucleopolyhedrovirus capsid | 3e-05 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 3e-05 | |
| PHA03419 | 200 | PHA03419, PHA03419, E4 protein; Provisional | 3e-05 | |
| COG5099 | 777 | COG5099, COG5099, RNA-binding protein of the Puf f | 3e-05 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 3e-05 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 4e-05 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 4e-05 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 4e-05 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 4e-05 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 4e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-05 | |
| COG5422 | 1175 | COG5422, ROM1, RhoGEF, Guanine nucleotide exchange | 4e-05 | |
| PHA03369 | 663 | PHA03369, PHA03369, capsid maturational protease; | 4e-05 | |
| TIGR02927 | 579 | TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogena | 4e-05 | |
| PRK10819 | 246 | PRK10819, PRK10819, transport protein TonB; Provis | 4e-05 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 5e-05 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 5e-05 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 5e-05 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 5e-05 | |
| pfam05110 | 1154 | pfam05110, AF-4, AF-4 proto-oncoprotein | 5e-05 | |
| PLN02983 | 274 | PLN02983, PLN02983, biotin carboxyl carrier protei | 5e-05 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 5e-05 | |
| pfam09786 | 559 | pfam09786, CytochromB561_N, Cytochrome B561, N ter | 5e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 6e-05 | |
| TIGR03490 | 541 | TIGR03490, Mycoplas_LppA, mycoides cluster lipopro | 6e-05 | |
| PRK10819 | 246 | PRK10819, PRK10819, transport protein TonB; Provis | 6e-05 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 6e-05 | |
| PRK12495 | 226 | PRK12495, PRK12495, hypothetical protein; Provisio | 6e-05 | |
| pfam12526 | 115 | pfam12526, DUF3729, Protein of unknown function (D | 6e-05 | |
| COG3147 | 226 | COG3147, DedD, Uncharacterized protein conserved i | 6e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-05 | |
| pfam04484 | 313 | pfam04484, DUF566, Family of unknown function (DUF | 7e-05 | |
| TIGR02927 | 579 | TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogena | 7e-05 | |
| pfam08580 | 626 | pfam08580, KAR9, Yeast cortical protein KAR9 | 7e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 8e-05 | |
| TIGR02927 | 579 | TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogena | 8e-05 | |
| PLN02983 | 274 | PLN02983, PLN02983, biotin carboxyl carrier protei | 8e-05 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 8e-05 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 8e-05 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 8e-05 | |
| PRK11901 | 327 | PRK11901, PRK11901, hypothetical protein; Reviewed | 8e-05 | |
| PLN02217 | 670 | PLN02217, PLN02217, probable pectinesterase/pectin | 8e-05 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 9e-05 | |
| pfam07415 | 489 | pfam07415, Herpes_LMP2, Gammaherpesvirus latent me | 9e-05 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 1e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-04 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 1e-04 | |
| PHA03369 | 663 | PHA03369, PHA03369, capsid maturational protease; | 1e-04 | |
| pfam09786 | 559 | pfam09786, CytochromB561_N, Cytochrome B561, N ter | 1e-04 | |
| PRK12495 | 226 | PRK12495, PRK12495, hypothetical protein; Provisio | 1e-04 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 1e-04 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 1e-04 | |
| PRK13042 | 291 | PRK13042, PRK13042, superantigen-like protein; Rev | 1e-04 | |
| pfam09606 | 768 | pfam09606, Med15, ARC105 or Med15 subunit of Media | 1e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-04 | |
| pfam05518 | 753 | pfam05518, Totivirus_coat, Totivirus coat protein | 1e-04 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 2e-04 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 2e-04 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 2e-04 | |
| pfam04929 | 381 | pfam04929, Herpes_DNAp_acc, Herpes DNA replication | 2e-04 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 2e-04 | |
| pfam10428 | 419 | pfam10428, SOG2, RAM signalling pathway protein | 2e-04 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 2e-04 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 2e-04 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 2e-04 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 2e-04 | |
| TIGR02927 | 579 | TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogena | 2e-04 | |
| COG5373 | 931 | COG5373, COG5373, Predicted membrane protein [Func | 2e-04 | |
| COG5373 | 931 | COG5373, COG5373, Predicted membrane protein [Func | 2e-04 | |
| PHA02682 | 280 | PHA02682, PHA02682, ORF080 virion core protein; Pr | 2e-04 | |
| pfam04621 | 336 | pfam04621, ETS_PEA3_N, PEA3 subfamily ETS-domain t | 2e-04 | |
| pfam04621 | 336 | pfam04621, ETS_PEA3_N, PEA3 subfamily ETS-domain t | 2e-04 | |
| PRK00269 | 293 | PRK00269, zipA, cell division protein ZipA; Review | 2e-04 | |
| TIGR02102 | 1111 | TIGR02102, pullulan_Gpos, pullulanase, extracellul | 2e-04 | |
| pfam13254 | 414 | pfam13254, DUF4045, Domain of unknown function (DU | 2e-04 | |
| PTZ00249 | 516 | PTZ00249, PTZ00249, variable surface protein Vir28 | 2e-04 | |
| PHA03377 | 1000 | PHA03377, PHA03377, EBNA-3C; Provisional | 2e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-04 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 3e-04 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 3e-04 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 3e-04 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 3e-04 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 3e-04 | |
| PHA03201 | 318 | PHA03201, PHA03201, uracil DNA glycosylase; Provis | 3e-04 | |
| pfam04484 | 313 | pfam04484, DUF566, Family of unknown function (DUF | 3e-04 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 3e-04 | |
| PRK14963 | 504 | PRK14963, PRK14963, DNA polymerase III subunits ga | 3e-04 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 3e-04 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 3e-04 | |
| COG5099 | 777 | COG5099, COG5099, RNA-binding protein of the Puf f | 3e-04 | |
| TIGR02927 | 579 | TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogena | 3e-04 | |
| pfam08580 | 626 | pfam08580, KAR9, Yeast cortical protein KAR9 | 3e-04 | |
| pfam05518 | 753 | pfam05518, Totivirus_coat, Totivirus coat protein | 3e-04 | |
| pfam09507 | 427 | pfam09507, CDC27, DNA polymerase subunit Cdc27 | 3e-04 | |
| PTZ00395 | 1560 | PTZ00395, PTZ00395, Sec24-related protein; Provisi | 3e-04 | |
| PTZ00395 | 1560 | PTZ00395, PTZ00395, Sec24-related protein; Provisi | 3e-04 | |
| pfam03999 | 619 | pfam03999, MAP65_ASE1, Microtubule associated prot | 3e-04 | |
| PRK00404 | 141 | PRK00404, tatB, sec-independent translocase; Provi | 3e-04 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 4e-04 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 4e-04 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 4e-04 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 4e-04 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 4e-04 | |
| pfam10152 | 147 | pfam10152, DUF2360, Predicted coiled-coil domain-c | 4e-04 | |
| pfam10152 | 147 | pfam10152, DUF2360, Predicted coiled-coil domain-c | 4e-04 | |
| TIGR01628 | 562 | TIGR01628, PABP-1234, polyadenylate binding protei | 4e-04 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 4e-04 | |
| COG3456 | 430 | COG3456, COG3456, Predicted component of the type | 4e-04 | |
| PHA03325 | 418 | PHA03325, PHA03325, nuclear-egress-membrane-like p | 4e-04 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 5e-04 | |
| PHA03419 | 200 | PHA03419, PHA03419, E4 protein; Provisional | 5e-04 | |
| PHA03325 | 418 | PHA03325, PHA03325, nuclear-egress-membrane-like p | 5e-04 | |
| pfam02993 | 238 | pfam02993, MCPVI, Minor capsid protein VI | 5e-04 | |
| PHA01929 | 306 | PHA01929, PHA01929, putative scaffolding protein | 5e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 6e-04 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 6e-04 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 6e-04 | |
| TIGR03490 | 541 | TIGR03490, Mycoplas_LppA, mycoides cluster lipopro | 6e-04 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 6e-04 | |
| PTZ00470 | 522 | PTZ00470, PTZ00470, glycoside hydrolase family 47 | 6e-04 | |
| TIGR02442 | 633 | TIGR02442, Cob-chelat-sub, cobaltochelatase subuni | 6e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-04 | |
| PRK12372 | 413 | PRK12372, PRK12372, ribonuclease III; Reviewed | 6e-04 | |
| PLN02328 | 808 | PLN02328, PLN02328, lysine-specific histone demeth | 6e-04 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 7e-04 | |
| PRK13042 | 291 | PRK13042, PRK13042, superantigen-like protein; Rev | 7e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-04 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 8e-04 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 8e-04 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 8e-04 | |
| PRK00269 | 293 | PRK00269, zipA, cell division protein ZipA; Review | 8e-04 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 9e-04 | |
| PRK14963 | 504 | PRK14963, PRK14963, DNA polymerase III subunits ga | 9e-04 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 9e-04 | |
| PLN02983 | 274 | PLN02983, PLN02983, biotin carboxyl carrier protei | 9e-04 | |
| PRK14666 | 694 | PRK14666, uvrC, excinuclease ABC subunit C; Provis | 9e-04 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 0.001 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.001 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 0.001 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 0.001 | |
| pfam10428 | 419 | pfam10428, SOG2, RAM signalling pathway protein | 0.001 | |
| TIGR03490 | 541 | TIGR03490, Mycoplas_LppA, mycoides cluster lipopro | 0.001 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 0.001 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 0.001 | |
| PHA03369 | 663 | PHA03369, PHA03369, capsid maturational protease; | 0.001 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 0.001 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 0.001 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 0.001 | |
| pfam09786 | 559 | pfam09786, CytochromB561_N, Cytochrome B561, N ter | 0.001 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 0.001 | |
| PRK12495 | 226 | PRK12495, PRK12495, hypothetical protein; Provisio | 0.001 | |
| pfam12526 | 115 | pfam12526, DUF3729, Protein of unknown function (D | 0.001 | |
| PRK13042 | 291 | PRK13042, PRK13042, superantigen-like protein; Rev | 0.001 | |
| pfam05518 | 753 | pfam05518, Totivirus_coat, Totivirus coat protein | 0.001 | |
| PRK00404 | 141 | PRK00404, tatB, sec-independent translocase; Provi | 0.001 | |
| PRK00404 | 141 | PRK00404, tatB, sec-independent translocase; Provi | 0.001 | |
| pfam10152 | 147 | pfam10152, DUF2360, Predicted coiled-coil domain-c | 0.001 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 0.001 | |
| COG3456 | 430 | COG3456, COG3456, Predicted component of the type | 0.001 | |
| pfam02993 | 238 | pfam02993, MCPVI, Minor capsid protein VI | 0.001 | |
| PRK12372 | 413 | PRK12372, PRK12372, ribonuclease III; Reviewed | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.001 | |
| PRK06975 | 656 | PRK06975, PRK06975, bifunctional uroporphyrinogen- | 0.001 | |
| PRK06975 | 656 | PRK06975, PRK06975, bifunctional uroporphyrinogen- | 0.001 | |
| PLN02744 | 539 | PLN02744, PLN02744, dihydrolipoyllysine-residue ac | 0.001 | |
| pfam10349 | 111 | pfam10349, WWbp, WW-domain ligand protein | 0.001 | |
| pfam05297 | 382 | pfam05297, Herpes_LMP1, Herpesvirus latent membran | 0.001 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.001 | |
| cd07219 | 382 | cd07219, Pat_PNPLA1, Patatin-like phospholipase do | 0.001 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 0.002 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.002 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 0.002 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 0.002 | |
| pfam07415 | 489 | pfam07415, Herpes_LMP2, Gammaherpesvirus latent me | 0.002 | |
| PHA03201 | 318 | PHA03201, PHA03201, uracil DNA glycosylase; Provis | 0.002 | |
| COG0810 | 244 | COG0810, TonB, Periplasmic protein TonB, links inn | 0.002 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 0.002 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 0.002 | |
| PHA03169 | 413 | PHA03169, PHA03169, hypothetical protein; Provisio | 0.002 | |
| TIGR02927 | 579 | TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogena | 0.002 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 0.002 | |
| pfam12526 | 115 | pfam12526, DUF3729, Protein of unknown function (D | 0.002 | |
| PRK13042 | 291 | PRK13042, PRK13042, superantigen-like protein; Rev | 0.002 | |
| PRK13042 | 291 | PRK13042, PRK13042, superantigen-like protein; Rev | 0.002 | |
| PRK00404 | 141 | PRK00404, tatB, sec-independent translocase; Provi | 0.002 | |
| PRK08119 | 382 | PRK08119, PRK08119, flagellar motor switch protein | 0.002 | |
| PRK00708 | 209 | PRK00708, PRK00708, sec-independent translocase; P | 0.002 | |
| COG5178 | 2365 | COG5178, PRP8, U5 snRNP spliceosome subunit [RNA p | 0.002 | |
| smart00818 | 165 | smart00818, Amelogenin, Amelogenins, cell adhesion | 0.002 | |
| PRK11892 | 464 | PRK11892, PRK11892, pyruvate dehydrogenase subunit | 0.002 | |
| PHA03381 | 290 | PHA03381, PHA03381, tegument protein VP22; Provisi | 0.002 | |
| pfam10214 | 753 | pfam10214, Rrn6, RNA polymerase I-specific transcr | 0.002 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 0.003 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 0.003 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 0.003 | |
| pfam04929 | 381 | pfam04929, Herpes_DNAp_acc, Herpes DNA replication | 0.003 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 0.003 | |
| PHA03369 | 663 | PHA03369, PHA03369, capsid maturational protease; | 0.003 | |
| pfam09786 | 559 | pfam09786, CytochromB561_N, Cytochrome B561, N ter | 0.003 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 0.003 | |
| pfam09507 | 427 | pfam09507, CDC27, DNA polymerase subunit Cdc27 | 0.003 | |
| PRK06975 | 656 | PRK06975, PRK06975, bifunctional uroporphyrinogen- | 0.003 | |
| pfam10349 | 111 | pfam10349, WWbp, WW-domain ligand protein | 0.003 | |
| COG5178 | 2365 | COG5178, PRP8, U5 snRNP spliceosome subunit [RNA p | 0.003 | |
| pfam12868 | 135 | pfam12868, DUF3824, Domain of unknwon function (DU | 0.003 | |
| pfam06682 | 317 | pfam06682, DUF1183, Protein of unknown function (D | 0.003 | |
| COG0661 | 517 | COG0661, AarF, Predicted unusual protein kinase [G | 0.003 | |
| pfam03353 | 316 | pfam03353, Lin-8, Ras-mediated vulval-induction an | 0.003 | |
| PHA03321 | 694 | PHA03321, PHA03321, tegument protein VP11/12; Prov | 0.003 | |
| pfam03109 | 117 | pfam03109, ABC1, ABC1 family | 0.003 | |
| pfam12737 | 418 | pfam12737, Mating_C, C-terminal domain of homeodom | 0.003 | |
| pfam04502 | 321 | pfam04502, DUF572, Family of unknown function (DUF | 0.003 | |
| pfam10243 | 506 | pfam10243, MIP-T3, Microtubule-binding protein MIP | 0.003 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 0.004 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 0.004 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 0.004 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 0.004 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 0.004 | |
| TIGR02927 | 579 | TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogena | 0.004 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 0.004 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 0.004 | |
| PLN02217 | 670 | PLN02217, PLN02217, probable pectinesterase/pectin | 0.004 | |
| PHA02682 | 280 | PHA02682, PHA02682, ORF080 virion core protein; Pr | 0.004 | |
| PRK00404 | 141 | PRK00404, tatB, sec-independent translocase; Provi | 0.004 | |
| PRK00404 | 141 | PRK00404, tatB, sec-independent translocase; Provi | 0.004 | |
| PRK11892 | 464 | PRK11892, PRK11892, pyruvate dehydrogenase subunit | 0.004 | |
| PRK12438 | 991 | PRK12438, PRK12438, hypothetical protein; Provisio | 0.004 | |
| pfam05505 | 717 | pfam05505, Ebola_NP, Ebola nucleoprotein | 0.004 | |
| pfam11593 | 381 | pfam11593, Med3, Mediator complex subunit 3 fungal | 0.004 | |
| pfam06070 | 777 | pfam06070, Herpes_UL32, Herpesvirus large structur | 0.004 | |
| PLN03188 | 1320 | PLN03188, PLN03188, kinesin-12 family protein; Pro | 0.004 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 0.004 | |
| pfam02948 | 174 | pfam02948, Amelogenin, Amelogenin | 0.004 | |
| pfam03251 | 458 | pfam03251, Tymo_45kd_70kd, Tymovirus 45/70Kd prote | 0.004 | |
| PRK01741 | 332 | PRK01741, PRK01741, cell division protein ZipA; Pr | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 4e-55
Identities = 73/192 (38%), Positives = 104/192 (54%), Gaps = 9/192 (4%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLR-SGSGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
LG+GGFG V+ GK+VA+K ++ S E E+EI+ +++H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHR 471
LV EY +L+ L + L+I + +GL YLH + IIHR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHS--NG-IIHR 116
Query: 472 DIKSSNILLDYTFET-KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE-YASSGKLTEKS 529
D+K NILLD K+ADFGL+KL T + + + T V GT Y+APE G +EKS
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEKS 175
Query: 530 DVFSFGVMLLEL 541
D++S GV+L EL
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 2e-53
Identities = 81/278 (29%), Positives = 122/278 (43%), Gaps = 37/278 (13%)
Query: 354 LGQGGFGYVHKGVL-----PNGKEVAVKSLRSG-SGQGEREFKAEVEIISRVHHRHLVSL 407
LG+G FG V+KG L EVAVK+L+ S Q EF E I+ ++ H ++V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR 467
+G C ++V EY+P +L +L + L A+ A+G+ YL
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---N 123
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTE 527
IHRD+ + N L+ K++DFGL++ D++ + ++APE GK T
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTS 183
Query: 528 KSDVFSFGVMLLELIT-GRRP---IDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583
KSDV+SFGV+L E+ T G P + +E L G P
Sbjct: 184 KSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEY-------------LKKGYRLPK--P-- 226
Query: 584 EKNYPTEEMAR-MVACAAASIRHSARRRPKISQIVRAL 620
E+ + M+ C RP S++V L
Sbjct: 227 --PNCPPELYKLMLQC----WAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 3e-53
Identities = 83/278 (29%), Positives = 127/278 (45%), Gaps = 38/278 (13%)
Query: 354 LGQGGFGYVHKGVL--PNGK---EVAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVSL 407
LG+G FG V+KG L GK EVAVK+L+ + + + EF E I+ ++ H ++V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR 467
+G C +V EY+ +L +L K RP + L A+ A+G+ YL
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLR-KNRPKLSLSDLLSFALQIARGMEYLESK---N 122
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTE 527
IHRD+ + N L+ K++DFGL++ D++ + ++APE GK T
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTS 182
Query: 528 KSDVFSFGVMLLELIT-GRRP---IDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583
KSDV+SFGV+L E+ T G +P + +E L +G P
Sbjct: 183 KSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEY-------------LKNGYRLPQ--P-- 225
Query: 584 EKNYPTEEMAR-MVACAAASIRHSARRRPKISQIVRAL 620
E+ M+ C RP S++V L
Sbjct: 226 --PNCPPELYDLMLQC----WAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 1e-51
Identities = 86/279 (30%), Positives = 134/279 (48%), Gaps = 39/279 (13%)
Query: 354 LGQGGFGYVHKGVL-----PNGKEVAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVSL 407
LG+G FG V+KG L +VAVK+L+ G+ + ER EF E I+ ++ H ++V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR 467
+G C G +V EY+P +L L G + L++A+ AKG+ YL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKL-TLKDLLQMALQIAKGMEYLESK---N 122
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFG---YLAPEYASSGK 524
+HRD+ + N L+ K++DFGL++ +++ + G ++APE GK
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPIKWMAPESLKDGK 180
Query: 525 LTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583
T KSDV+SFGV+L E+ T G +P M + V L L+DG L
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEQPYP---GMSNEEV-------LELLEDGY-------RL 223
Query: 584 EKN-YPTEEMAR-MVACAAASIRHSARRRPKISQIVRAL 620
+ +E+ M+ C + RP S++V L
Sbjct: 224 PRPENCPDELYELMLQC----WAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 6e-51
Identities = 82/291 (28%), Positives = 130/291 (44%), Gaps = 50/291 (17%)
Query: 352 NLLGQGGFGYVHKGVL----PNGKEVAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVS 406
LG+G FG V+KG L EVAVK+L+ + + ER +F E ++ ++ H ++V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGK-------GRPVMDWPTRLKIAMGSAKGLAY 459
L+G C LV EY+ +L +L + + L A+ AKG+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 460 LHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST-------RVMGTF 512
L + +HRD+ + N L+ K++DFGL++ D++ + R
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----- 172
Query: 513 GYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALD 571
++APE G T KSDV+SFGV+L E+ T G P + + V L L
Sbjct: 173 -WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGA---TPYPGLSNEEV-------LEYLR 221
Query: 572 DGNFNEIADPYLEKNYPTEEMAR-MVACAAASIRHSARRRPKISQIVRALE 621
G P + P +E+ M++C + RP S++V LE
Sbjct: 222 KGYRLPK--P---EYCP-DELYELMLSC----WQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 2e-49
Identities = 67/198 (33%), Positives = 97/198 (48%), Gaps = 9/198 (4%)
Query: 352 NLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE-FKAEVEIISRVHHRHLVSLVG 409
LG+G FG V+ GK VA+K ++ + +RE E++I+ ++ H ++V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 410 YCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRII 469
K LV EY +L L +GR + L YLH I+
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGR--LSEDEARFYLRQILSALEYLHSK---GIV 119
Query: 470 HRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKS 529
HRD+K NILLD K+ADFGLA+ D ++T V GT Y+APE +
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQ-LDPGEKLTTFV-GTPEYMAPEVLLGKGYGKAV 177
Query: 530 DVFSFGVMLLELITGRRP 547
D++S GV+L EL+TG+ P
Sbjct: 178 DIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 5e-48
Identities = 75/198 (37%), Positives = 104/198 (52%), Gaps = 10/198 (5%)
Query: 354 LGQGGFGYVHKGVLPN-GKEVAVK--SLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGY 410
LG G FG V+K GK VAVK RS + ++ + E+ I+ R+ H ++V L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 411 CIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIH 470
LV EY +L +L G + KIA+ +GL YLH + IIH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSN---GIIH 121
Query: 471 RDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE-YASSGKLTEKS 529
RD+K NILLD K+ADFGLAK +++ ++T V GT Y+APE K
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPKV 180
Query: 530 DVFSFGVMLLELITGRRP 547
DV+S GV+L EL+TG+ P
Sbjct: 181 DVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 3e-40
Identities = 69/211 (32%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 348 FSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGE--REFKAEVEIISRVHHRHL 404
+++ LLG+G FG V+ + G+ +AVKS+ E + E+ I+S + H ++
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI 61
Query: 405 VSLVGYCI-AGGKRLLVY-EYVPNNNLEFHLHGKGR---PVMDWPTR--LKIAMGSAKGL 457
V G L ++ EYV +L L G+ PV+ TR L+ GL
Sbjct: 62 VRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE-------GL 114
Query: 458 AYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM-GTFGYLA 516
AYLH + I+HRDIK +NIL+D K+ADFG AK D T T + GT ++A
Sbjct: 115 AYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171
Query: 517 PEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
PE + +D++S G ++E+ TG+ P
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 352 NLLGQGGFGYVHKGV-LPNGKEVAVKSLR-SGSGQGEREF-KAEVEIISRVHHRHLVSLV 408
+G+G FG V+ +GK +K + S + ERE EV+I+ +++H +++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 409 GYCIAGGKRLLVYEYVPNNNLEFHLH---GKGRP-----VMDWPTRLKIAMGSAKGLAYL 460
GK +V EY +L + +G+P ++DW +L L YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------CLALKYL 119
Query: 461 HEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYA 520
H +I+HRDIK NI L K+ DFG++K+ + T V GT YL+PE
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELC 175
Query: 521 SSGKLTEKSDVFSFGVMLLELITGRRP 547
+ KSD++S G +L EL T + P
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 72/266 (27%), Positives = 117/266 (43%), Gaps = 26/266 (9%)
Query: 354 LGQGGFGYVHKGVL-PNGKEVAVKSLR-SGSGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
LGQG G V+K P GK A+K + G + ++ E++ + ++V G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRL--KIAMGSAKGLAYLHEDCHPRII 469
G+ +V EY+ +L L K P + IA KGL YLH H II
Sbjct: 69 YKEGEISIVLEYMDGGSLA-DLLKKVGK---IPEPVLAYIARQILKGLDYLHTKRH--II 122
Query: 470 HRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKS 529
HRDIK SN+L++ E K+ADFG++K+ + +T V GT Y++PE + +
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYAA 181
Query: 530 DVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPT 589
D++S G+ LLE G+ P P G + + + P L +
Sbjct: 182 DIWSLGLTLLECALGKFPFLPPGQP-----SFFELMQ-------AICDGPPPSLPAEEFS 229
Query: 590 EEMARMVACAAASIRHSARRRPKISQ 615
E ++ ++ ++RP ++
Sbjct: 230 PEFRDFISA---CLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 72/208 (34%), Positives = 106/208 (50%), Gaps = 16/208 (7%)
Query: 351 SNLLGQGGFGYVHKGVLPN-----GKEVAVKSLR-SGSGQGEREFKAEVEIISRVHHRHL 404
LG+G FG V G++VAVKSL SG Q +F+ E+EI+ + H ++
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 405 VSLVGYCIAGGKR--LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHE 462
V G C G R L+ EY+P+ +L +L + R ++ L + KG+ YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 463 DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMG---TFGYLAPEY 519
R IHRD+ + NIL++ K++DFGLAK+ ++ + + G F Y APE
Sbjct: 128 Q---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 520 ASSGKLTEKSDVFSFGVMLLELITGRRP 547
+ K + SDV+SFGV L EL T P
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDP 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 71/197 (36%), Positives = 102/197 (51%), Gaps = 9/197 (4%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA 413
LG G FG V G +VAVK+L+ G+ E F E +I+ ++ H LV L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 414 GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDI 473
+V EY+ +L L + P + +A A+G+AYL IHRD+
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDL 129
Query: 474 KSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTF--GYLAPEYASSGKLTEKSDV 531
+ NIL+ K+ADFGLA+L D+ + R F + APE A+ G+ T KSDV
Sbjct: 130 AARNILVGENLVCKIADFGLARLIEDD--EYTAREGAKFPIKWTAPEAANYGRFTIKSDV 187
Query: 532 FSFGVMLLELIT-GRRP 547
+SFG++L E++T GR P
Sbjct: 188 WSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA 413
LG G FG V +G+ N VAVK+L+ G+ + +F AE +I+ ++ H L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 414 GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDI 473
+V E + +L +L G + P + +A A G+AYL + IHRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY---IHRDL 129
Query: 474 KSSNILLDYTFETKVADFGLAKLTTDN--NTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 531
+ N+L+ KVADFGLA++ ++ + + APE A + + KSDV
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAALYNRFSIKSDV 187
Query: 532 FSFGVMLLELIT-GRRP 547
+SFG++L E++T GR P
Sbjct: 188 WSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 67/196 (34%), Positives = 103/196 (52%), Gaps = 10/196 (5%)
Query: 353 LLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCI 412
+G+G FG V G G++VAVK L+ S + F AE +++ + H +LV L+G +
Sbjct: 13 TIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 413 AGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRD 472
G +V EY+ +L +L +GR V+ +L A+ +G+ YL E +HRD
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 473 IKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 532
+ + N+L+ KV+DFGLAK + V T APE K + KSDV+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKSDVW 183
Query: 533 SFGVMLLELIT-GRRP 547
SFG++L E+ + GR P
Sbjct: 184 SFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 69/196 (35%), Positives = 109/196 (55%), Gaps = 4/196 (2%)
Query: 348 FSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSL 407
F+ LG G FG V +G+ N VA+K L+S +++F+ EV+ + R+ H+HL+SL
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR 467
C G ++ E + +L L V+ + + +A A+G+AYL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---N 124
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTE 527
IHRD+ + NIL+ KVADFGLA+L + + ++S+ + + APE AS G +
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKIPYKWTAPEAASHGTFST 183
Query: 528 KSDVFSFGVMLLELIT 543
KSDV+SFG++L E+ T
Sbjct: 184 KSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 15/211 (7%)
Query: 354 LGQGGFGYVHKGV-LPNGK----EVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSL 407
LG G FG V+KGV +P G+ VA+K LR + + +E E +++ V H H+V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 408 VGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHP 466
+G C+ ++ L+ + +P L ++ + + L + AKG++YL E
Sbjct: 75 LGICL--SSQVQLITQLMPLGCLLDYVR-NHKDNIGSQYLLNWCVQIAKGMSYLEEK--- 128
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAK-LTTDNNTHVSTRVMGTFGYLAPEYASSGKL 525
R++HRD+ + N+L+ K+ DFGLAK L D + + ++A E
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY 188
Query: 526 TEKSDVFSFGVMLLELIT-GRRPIDPTGAME 555
T KSDV+S+GV + EL+T G +P + A+E
Sbjct: 189 THKSDVWSYGVTVWELMTFGAKPYEGIPAVE 219
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 72/203 (35%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 354 LGQGGFGYV----HKGVLPNGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVS 406
LG+G FG V K GK A+K L+ + E I+SR++H +V
Sbjct: 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 407 LVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIA-MGSAKGLAYLHEDC 464
L Y ++L LV EY P L HL +GR + R A + A L YLH
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEER-ARFYAAEIVLA--LEYLHSL- 112
Query: 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGK 524
II+RD+K NILLD K+ DFGLAK + + +T GT YLAPE
Sbjct: 113 --GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKG 169
Query: 525 LTEKSDVFSFGVMLLELITGRRP 547
+ D +S GV+L E++TG+ P
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 62/205 (30%), Positives = 104/205 (50%), Gaps = 10/205 (4%)
Query: 354 LGQGGFGYVHKG-VLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCI 412
+G+GGFG V+K GKEVA+K ++ S + + + E++I+ + H ++V G +
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 413 AGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRD 472
+ +V E+ +L+ L + + + KGL YLH + IIHRD
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQT-LTESQIAYVCKELLKGLEYLHSN---GIIHRD 123
Query: 473 IKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 532
IK++NILL E K+ DFGL+ +D + +GT ++APE + K+D++
Sbjct: 124 IKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM--VGTPYWMAPEVINGKPYDYKADIW 181
Query: 533 SFGVMLLELITGRRPI---DPTGAM 554
S G+ +EL G+ P P A+
Sbjct: 182 SLGITAIELAEGKPPYSELPPMKAL 206
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 6/197 (3%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA 413
+G G FG V G ++VA+K++R G+ E +F E +++ ++ H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 414 GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDI 473
LV+E++ + L +L + R T L + + +G+AYL +IHRD+
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDL 126
Query: 474 KSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 533
+ N L+ KV+DFG+ + D+ ST + +PE S K + KSDV+S
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186
Query: 534 FGVMLLELIT-GRRPID 549
FGV++ E+ + G+ P +
Sbjct: 187 FGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 84/281 (29%), Positives = 137/281 (48%), Gaps = 40/281 (14%)
Query: 348 FSQSNLLGQGGFGYVHKGVLPNGKEV-AVK--SLRSGSGQGEREFKAEVEIISRVHHRHL 404
F N +G+G FG V K V K V A+K L + + E E +++++ ++
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 405 VSLVGYCIAGGKRLLVYEYVPNNNLEFHLHG-KGRPVMD---WPTRLKIAMGSAKGLAYL 460
+ + GK +V EY N +L L +GRP+ + W ++I +G LA+L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHL 117
Query: 461 HEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYA 520
H +I+HRDIKS N+ LD K+ D G+AKL +DN +T ++GT YL+PE
Sbjct: 118 HSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELC 173
Query: 521 SSGKLTEKSDVFSFGVMLLELITGRRPIDPT--GAMEDCLVDWARPLCLRALDDGNFNEI 578
EKSDV++ GV+L E TG+ P D GA+ + + G F +
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL------------ILKIIRGVFPPV 221
Query: 579 ADPYLEKNYPTEEMARMV-ACAAASIRHSARRRPKISQIVR 618
+ Y ++++A+++ C + R+RP Q++R
Sbjct: 222 SQMY------SQQLAQLIDQC----LTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 26/216 (12%)
Query: 354 LGQGGFGYVHKGVLPNGKE------VAVKSLRSGSGQGERE-FKAEVEIISRVHHRHLVS 406
LG+G FG V G + + VAVK+L+ + R+ F+ E E+++ H ++V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHL--HGKGRPVMDWP-------TR---LKIAMGSA 454
G C G ++V+EY+ + +L L HG + P T L+IA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK--LTTDNNTHVSTRVMGTF 512
G+ YL +HRD+ + N L+ Y K+ DFG+++ TTD V M
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD-YYRVGGHTMLPI 188
Query: 513 GYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
++ PE K T +SDV+SFGV+L E+ T G++P
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 71/201 (35%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 353 LLGQGGFGYVHKGVLP-----NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSL 407
LG+G FG V G+ VAVK L+ + + R+F+ E+EI+ + H ++V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 408 VGYCIAGGKR--LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCH 465
G C + G+R LV EY+P +L +L K R +D L A KG+ YL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYLGSK-- 127
Query: 466 PRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMG---TFGYLAPEYASS 522
R +HRD+ + NIL++ K+ DFGL K+ + + R G F Y APE +
Sbjct: 128 -RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTE 185
Query: 523 GKLTEKSDVFSFGVMLLELIT 543
K + SDV+SFGV+L EL T
Sbjct: 186 SKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 8e-28
Identities = 72/209 (34%), Positives = 96/209 (45%), Gaps = 19/209 (9%)
Query: 353 LLGQGGFGYVHKGVLPNGKEVAVKSLR---SGSGQGEREFKAEVEIISRV-HHRHLVSLV 408
LG+G FG V+ K VA+K L + F E++I++ + H ++V L
Sbjct: 7 KLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 409 GYCIAGGKRLLVYEYVPNNNLEFHL-HGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR 467
+ G LV EYV +LE L + + L I L YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---G 121
Query: 468 IIHRDIKSSNILLDY-TFETKVADFGLAKLTTDNNTHVSTR-----VMGTFGYLAPEYAS 521
IIHRDIK NILLD K+ DFGLAKL D + S +GT GY+APE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 522 SGKL---TEKSDVFSFGVMLLELITGRRP 547
L + SD++S G+ L EL+TG P
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 69/202 (34%), Positives = 108/202 (53%), Gaps = 14/202 (6%)
Query: 354 LGQGGFGYVHKGV--LPNGKE--VAVKSLRSG-SGQGEREFKAEVEIISRVHHRHLVSLV 408
LG G FG V KGV + +GKE VAVK+L+ G++EF E +++++ H +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 409 GYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRI 468
G C +LV E P L +L K R + ++A A G+AYL E H
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYL--KKRREIPVSDLKELAHQVAMGMAYL-ESKH--F 116
Query: 469 IHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTF--GYLAPEYASSGKLT 526
+HRD+ + N+LL + K++DFG+++ + + G + + APE + GK +
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176
Query: 527 EKSDVFSFGVMLLELIT-GRRP 547
KSDV+S+GV L E + G +P
Sbjct: 177 SKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 14/207 (6%)
Query: 350 QSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGE--REFKAEVEIISRVHHRHLVS 406
+ N +G G FG V+ V L G+ +AVK +R + +E E++++ + H +LV
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHP 466
G + K + EY LE L ++D + +GLAYLH
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSH--- 118
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRV---MGTFGYLAPEYASSG 523
I+HRDIK +NI LD+ K+ DFG A +N T + V GT Y+APE + G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 524 KLTEK---SDVFSFGVMLLELITGRRP 547
K +D++S G ++LE+ TG+RP
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 62/198 (31%), Positives = 98/198 (49%), Gaps = 8/198 (4%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA 413
LG G FG VH G +VA+K +R G+ E +F E +++ ++ H +LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 414 GGKRLLVYEYVPNNNLEFHLHG-KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRD 472
+V EY+ N L +L KG+ +W L + + + YL + IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 473 IKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 532
+ + N L+ KV+DFGLA+ D+ S + PE + + KSDV+
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVW 185
Query: 533 SFGVMLLELIT-GRRPID 549
SFGV++ E+ + G+ P +
Sbjct: 186 SFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 16/203 (7%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKA---EVEIISRVHHRHLVSLVG 409
LG G G V K + P GK +AVK++R E K E++I+ + + ++V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 410 YCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRII 469
G + EY+ +L+ + + + + KIA+ KGL YLHE II
Sbjct: 67 AFYNNGDISICMEYMDGGSLD-KILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--II 123
Query: 470 HRDIKSSNILLDYTFETKVADFGLAKLTTDN--NTHVSTRVMGTFGYLAPEYASSGKLTE 527
HRD+K SNIL++ + K+ DFG++ ++ T V GT Y+APE +
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERIQGNDYSV 178
Query: 528 KSDVFSFGVMLLELITGRRPIDP 550
KSD++S G+ L+EL TGR P P
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 16/215 (7%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVK--SLRSGSGQGEREFKAEVEIISRVHHRHL 404
+ +L+G+G FG V+KG+ L G VA+K SL + + E++++ + H ++
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 405 VSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSA--KGLAYLHE 462
V +G ++ EY N +L + G +P L +GLAYLHE
Sbjct: 62 VKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP----FPESLVAVYVYQVLQGLAYLHE 117
Query: 463 DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS 522
+IHRDIK++NIL K+ADFG+A ++ + V+GT ++APE
Sbjct: 118 Q---GVIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIEM 173
Query: 523 GKLTEKSDVFSFGVMLLELITGRRP---IDPTGAM 554
+ SD++S G ++EL+TG P ++P A+
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL 208
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 74/197 (37%), Positives = 108/197 (54%), Gaps = 10/197 (5%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA 413
LG G FG V G +VAVK+L+ G+ E F E +I+ ++ H LV L Y +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQL--YAVV 70
Query: 414 GGKRL-LVYEYVPNNNL-EFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHR 471
+ + +V EY+ +L +F G+GR + P + +A A G+AY+ + IHR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKDGEGR-ALKLPNLVDMAAQVAAGMAYIERMNY---IHR 126
Query: 472 DIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 531
D++S+NIL+ K+ADFGLA+L DN + APE A G+ T KSDV
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 532 FSFGVMLLELIT-GRRP 547
+SFG++L EL+T GR P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 82/283 (28%), Positives = 138/283 (48%), Gaps = 42/283 (14%)
Query: 352 NLLGQGGFGYVHKGVL--PNGKE--VAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVS 406
++G G FG V +G L P KE VA+K+L++GS +R +F E I+ + H +++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHL-HGKGRPVMDWPTRL-KIAMGSAKGLAYLHEDC 464
L G +++ EY+ N +L+ L G+ +L + G A G+ YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFT---VGQLVGMLRGIASGMKYLSEMN 126
Query: 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTR-----VMGTFGYLAPEY 519
+ +HRD+ + NIL++ KV+DFGL++ D+ +T+ + T APE
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEA 179
Query: 520 ASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEI 578
+ K T SDV+SFG+++ E+++ G RP D + ++A++DG +
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGERPYW----------DMSNQDVIKAVEDG--YRL 227
Query: 579 ADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
P + P+ M+ C R+ RP SQIV L+
Sbjct: 228 PPP---MDCPSALYQLMLDCWQKD-RN---ERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 67/195 (34%), Positives = 101/195 (51%), Gaps = 6/195 (3%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA 413
LG G FG V G +VA+KSL+ GS E F AE ++ ++ H LV L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYA-VVT 71
Query: 414 GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDI 473
++ EY+ N +L L + + +A A+G+A++ + IHRD+
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---IHRDL 128
Query: 474 KSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 533
+++NIL+ T K+ADFGLA+L DN + APE + G T KSDV+S
Sbjct: 129 RAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 188
Query: 534 FGVMLLELIT-GRRP 547
FG++L E++T GR P
Sbjct: 189 FGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 70/196 (35%), Positives = 104/196 (53%), Gaps = 8/196 (4%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA 413
LGQG FG V G VA+K+L+ G+ E F E +++ ++ H LV L Y +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAVV 70
Query: 414 GGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRD 472
+ + +V EY+ +L L G+ + P + +A A G+AY+ + +HRD
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRD 127
Query: 473 IKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 532
++++NIL+ KVADFGLA+L DN + APE A G+ T KSDV+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 533 SFGVMLLELIT-GRRP 547
SFG++L EL T GR P
Sbjct: 188 SFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 21/207 (10%)
Query: 354 LGQGGFGYVHKGVLPN------GKEVAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVS 406
LGQG FG V++G+ VA+K++ + ER EF E ++ + H+V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDW------PTRLKI---AMGSAKGL 457
L+G G L+V E + +L+ +L + RP + PT K A A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSR-RPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 458 AYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH-VSTRVMGTFGYLA 516
AYL + +HRD+ + N ++ K+ DFG+ + + + + + + ++A
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 517 PEYASSGKLTEKSDVFSFGVMLLELIT 543
PE G T KSDV+SFGV+L E+ T
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 65/205 (31%), Positives = 89/205 (43%), Gaps = 16/205 (7%)
Query: 353 LLGQGGFGYVHKG--VLPNGK--EVAVKSLRSGSGQG-EREFKAEVEIISRVHHRHLVSL 407
LG G FG V +G GK VAVK L+S +F E I+ + H +L+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR 467
G + ++V E P +L L T A+ A G+ YL R
Sbjct: 62 YGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---R 117
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST----RVMGTFGYLAPEYASSG 523
IHRD+ + NILL + K+ DFGL + N H +V F + APE +
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLRTR 175
Query: 524 KLTEKSDVFSFGVMLLELIT-GRRP 547
+ SDV+ FGV L E+ T G P
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 5/196 (2%)
Query: 349 SQSNLLGQGGFGYVHKGVLPN-GKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSL 407
+ + LG G +G V++GV VAVK+L+ + + E EF E ++ + H +LV L
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 67
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR 467
+G C ++ E++ NL +L R ++ L +A + + YL +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---N 124
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTE 527
IHRD+ + N L+ KVADFGL++L T + + APE + K +
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 528 KSDVFSFGVMLLELIT 543
KSDV++FGV+L E+ T
Sbjct: 185 KSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCI 412
+G+G G V+K GKEVA+K +R Q + E+ I+ H ++V +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 413 AGGKRLLVYEYVPNNNL----EFHLHGKGRPVMDWPTRLKIAMGSA------KGLAYLHE 462
G + +V EY+ +L + R+ + +GL YLH
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQN-----------FVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 463 DCHPRIIHRDIKSSNILLDYTFETKVADFGL-AKLTTDNNTHVSTRVMGTFGYLAPEYAS 521
+IHRDIKS NILL K+ADFG A+LT + + S V+GT ++APE
Sbjct: 135 Q---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIK 189
Query: 522 SGKLTEKSDVFSFGVMLLELITGRRP 547
K D++S G+M +E+ G P
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 71/204 (34%), Positives = 101/204 (49%), Gaps = 24/204 (11%)
Query: 354 LGQGGFGYVHKGVL----PN----GKEVAVKSLRSGSGQGERE-FKAEVEIISRVHHRHL 404
LG+G FG V L P G+ VAVK+L+ GQ +K E+ I+ ++H ++
Sbjct: 12 LGEGHFGKV---SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 405 VSLVGYCIAGGKR--LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHE 462
V G C G + L+ EYVP +L +L + ++ L A +G+AYLH
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 463 DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMG---TFGYLAPEY 519
IHRD+ + N+LLD K+ DFGLAK + + + R G F Y A E
Sbjct: 126 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVEC 181
Query: 520 ASSGKLTEKSDVFSFGVMLLELIT 543
K + SDV+SFGV L EL+T
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 73/219 (33%), Positives = 114/219 (52%), Gaps = 29/219 (13%)
Query: 352 NLLGQGGFGYVHKG----VLPNGKE---VAVKSLRSGSGQGER-EFKAEVEIISRVHHRH 403
N LG G FG V++G +L G VAVK+LR G+ E+ EF E ++S +H +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 404 LVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGK-----GRPVMDWPTRLKIAMGSAKGLA 458
+V L+G C+ + ++ E + +L +L G P++ L I + AKG
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 459 YLHEDCHPRIIHRDIKSSNILL---DYTFE--TKVADFGLAKLTTDNNTHVSTRVMGT-- 511
YL E H IHRD+ + N L+ Y + K+ DFGLA+ ++ + R G
Sbjct: 121 YL-EQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGEGL 174
Query: 512 --FGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
++APE GK T +SDV+SFGV++ E++T G++P
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 62/196 (31%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 353 LLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGERE-FKAEVEIISRVHHRHLVSLVGYC 411
+G+G FG V+KGVL EVAVK+ RS + F E EI+ + H ++V L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGR--PVMDWPTRLKIAMGSAKGLAYLHEDCHPRII 469
+ +V E VP +L L K V L++++ +A G+ YL I
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVK---KLLQMSLDAAAGMEYLESKN---CI 115
Query: 470 HRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGT-FGYLAPEYASSGKLTEK 528
HRD+ + N L+ K++DFG+++ VS + + APE + G+ T +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 529 SDVFSFGVMLLELITG 544
SDV+S+G++L E +
Sbjct: 176 SDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 66/215 (30%), Positives = 108/215 (50%), Gaps = 24/215 (11%)
Query: 354 LGQGGFGYVH----KGVLPNGKE--VAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSL 407
LG+G FG V +LP + VAVK+L+ S ++F+ E E+++ + H+H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHL--HGKGRPVMD-----------WPTRLKIAMGSA 454
G C G L+V+EY+ + +L L HG ++ L IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK-LTTDNNTHVSTRVMGTFG 513
G+ YL H +HRD+ + N L+ K+ DFG+++ + + + V R M
Sbjct: 133 SGMVYL-ASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 514 YLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
++ PE K T +SD++SFGV+L E+ T G++P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 63/198 (31%), Positives = 112/198 (56%), Gaps = 18/198 (9%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSG-SGQGEREFKAEVEIISRVHHRHLVSLVGYCI 412
+G+G FG V +G G++VAVK+++ + Q F E +++++HH++LV L+G +
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVIL 69
Query: 413 AGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRD 472
G + V E + NL L +GR ++ L+ ++ A+G+ YL +++HRD
Sbjct: 70 HNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRD 125
Query: 473 IKSSNILLDYTFETKVADFGLAKLTTD--NNTHVSTRVMGTFGYLAPEYASSGKLTEKSD 530
+ + NIL+ KV+DFGLA++ + +N+ + + + APE K + KSD
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSKSD 179
Query: 531 VFSFGVMLLELIT-GRRP 547
V+S+GV+L E+ + GR P
Sbjct: 180 VWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 50/220 (22%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE-----FKAEVEIISRVHHRHLVSL 407
+G+G +G V+K G+ VA+K +R + E+E E++++ ++ H ++V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 408 VGYCI----AGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAK-------- 455
I G +V+EY+ ++ L G ++D P +K K
Sbjct: 64 --KEIVTSKGKGSIYMVFEYMDHD-----LTG----LLDSPE-VKFTESQIKCYMKQLLE 111
Query: 456 GLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYL 515
GL YLH I+HRDIK SNIL++ K+ADFGLA+ T N+ T + T Y
Sbjct: 112 GLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYR 168
Query: 516 APE-------YASSGKLTEKSDVFSFGVMLLELITGRRPI 548
PE Y + D++S G +L EL G +PI
Sbjct: 169 PPELLLGATRY------GPEVDMWSVGCILAELFLG-KPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 71/197 (36%), Positives = 108/197 (54%), Gaps = 10/197 (5%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA 413
LGQG FG V G +VA+K+L+ G+ E F E +I+ ++ H LV L Y +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPL--YAVV 70
Query: 414 GGKRL-LVYEYVPNNNL-EFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHR 471
+ + +V E++ +L +F G G+ + P + +A A G+AY+ + IHR
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFLKEGDGK-YLKLPQLVDMAAQIADGMAYIERMNY---IHR 126
Query: 472 DIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 531
D++++NIL+ K+ADFGLA+L DN + APE A G+ T KSDV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 532 FSFGVMLLELIT-GRRP 547
+SFG++L EL+T GR P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 6e-23
Identities = 67/205 (32%), Positives = 104/205 (50%), Gaps = 20/205 (9%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVK--SLRSGSGQGE---REFKAEVEIISRVHHRHLVS 406
LLG G FG V++G+ L +G AVK SL G+ ++ + E+ ++S++ H ++V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGR---PVMDWPTRLKIAMGSAKGLAYLHED 463
+G + E VP +L L G PV+ TR + GL YLH+
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL-----LGLEYLHDR 121
Query: 464 CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEY-ASS 522
+HRDIK +NIL+D K+ADFG+AK + + S G+ ++APE A
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVIAQQ 176
Query: 523 GKLTEKSDVFSFGVMLLELITGRRP 547
G +D++S G +LE+ TG+ P
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 66/200 (33%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 354 LGQGGFGYVHK-GVLPNGKEVAVKSL---RSGSGQGEREFKAEVEIISRVHHRHLVSLVG 409
LG+GGFG V V GK A K L R +GE+ E +I+ +V R +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 410 YCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRI 468
Y L LV + +L++H++ G P + A GL +LH+ RI
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RI 116
Query: 469 IHRDIKSSNILLDYTFETKVADFGLA-KLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTE 527
++RD+K N+LLD +++D GLA +L GT GY+APE
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEVYDF 173
Query: 528 KSDVFSFGVMLLELITGRRP 547
D F+ G L E+I GR P
Sbjct: 174 SVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 63/196 (32%), Positives = 102/196 (52%), Gaps = 7/196 (3%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA 413
LG G FG V G N +VAVK+L+ G+ + F E ++ + H LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 414 GGKRLLVYEYVPNNNL-EFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRD 472
++ EY+ +L +F +G V+ P + + A+G+AY+ + IHRD
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKNY---IHRD 128
Query: 473 IKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 532
++++N+L+ + K+ADFGLA++ DN + APE + G T KSDV+
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188
Query: 533 SFGVMLLELIT-GRRP 547
SFG++L E++T G+ P
Sbjct: 189 SFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 3e-22
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 26/210 (12%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKA----EVEIISRVHHR 402
+ + LG+G +G V+K G+ VA+K +R E + E+ ++ + H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHP 58
Query: 403 HLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHE 462
++V L+ K LV+EY + +L+ +L + P + I +GLAY H
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGP-LSPNLIKSIMYQLLRGLAYCHS 116
Query: 463 DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE---- 518
H RI+HRD+K NIL++ K+ADFGLA+ + V+ T Y APE
Sbjct: 117 --H-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLG 172
Query: 519 ---YASSGKLTEKSDVFSFGVMLLELITGR 545
Y+++ D++S G + E+ITG+
Sbjct: 173 SKHYSTA------VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 3e-22
Identities = 66/273 (24%), Positives = 122/273 (44%), Gaps = 38/273 (13%)
Query: 354 LGQGGFG----YVHK--GVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSL 407
LG+G FG Y L KEV + L S + R+ E+ I+S + H ++++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRL---SEKERRDALNEIVILSLLQHPNIIAY 64
Query: 408 VGYCIAGGKRLLVYEYVPNNNL-EFHLHGKGRPVMDWPTRLKIAM--GSAKGLAYLHEDC 464
+ + L+ EY L + + KG+ + + + ++Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL---FEEEMVLWYLFQIVSAVSYIHKA- 120
Query: 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGK 524
I+HRDIK+ NI L K+ DFG++K+ + T V+GT Y++PE K
Sbjct: 121 --GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVK 177
Query: 525 LTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLE 584
KSD+++ G +L EL+T +R D T + L ++ + GN+ + Y
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFDATNPLN---------LVVKIV-QGNYTPVVSVY-- 225
Query: 585 KNYPTEEMARMVACAAASIRHSARRRPKISQIV 617
+ E+ +V + ++ +RP +++
Sbjct: 226 ----SSELISLV---HSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 17/209 (8%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
LG+G +G V+K + G+ VA+K + +E E+ I+ + ++V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL--QEIIKEISILKQCDSPYIVKYYGSY 67
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAM---GSAKGLAYLHEDCHPRI 468
+V EY ++ + + + T +IA + KGL YLH + +
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNKTL----TEEEIAAILYQTLKGLEYLHSN---KK 120
Query: 469 IHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEK 528
IHRDIK+ NILL+ + K+ADFG++ TD +T V+GT ++APE K
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYNNK 179
Query: 529 SDVFSFGVMLLELITGRRP---IDPTGAM 554
+D++S G+ +E+ G+ P I P A+
Sbjct: 180 ADIWSLGITAIEMAEGKPPYSDIHPMRAI 208
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 31/213 (14%)
Query: 354 LGQGGFGYVHKG--VLPNGKE----VAVKSLR-SGSGQGEREFKAEVEIISRVHHRHLVS 406
LG+G FG V+KG PN + VA+K+L+ + + ++EF+ E E++S + H ++V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 407 LVGYCIAGGKRLLVYEYVPNNNL-EFHL-------------HGKGRPVMDWPTRLKIAMG 452
L+G C +++EY+ + +L EF + + +D L IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 453 SAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGT- 511
A G+ YL +HRD+ + N L+ K++DFGL++ D + RV
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSR---DIYSADYYRVQSKS 186
Query: 512 ---FGYLAPEYASSGKLTEKSDVFSFGVMLLEL 541
++ PE GK T +SD++SFGV+L E+
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 70/214 (32%), Positives = 105/214 (49%), Gaps = 22/214 (10%)
Query: 352 NLLGQGGFGYVHKGVL------PNGKEVAVKSLR-SGSGQGEREFKAEVEIISRVHHRHL 404
LG G FG V++G+ +VAVK+L S S Q E +F E I+S+ +H+++
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 405 VSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRL------KIAMGSAKGLA 458
V L+G R ++ E + +L+ L + RP + P+ L A AKG
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLR-ENRPRPERPSSLTMKDLLFCARDVAKGCK 130
Query: 459 YLHEDCHPRIIHRDIKSSNILLDYTFE---TKVADFGLAK-LTTDNNTHVSTRVMGTFGY 514
YL E+ IHRDI + N LL K+ADFG+A+ + + R M +
Sbjct: 131 YLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187
Query: 515 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
+ PE G T K+DV+SFGV+L E+ + G P
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 67/217 (30%), Positives = 110/217 (50%), Gaps = 19/217 (8%)
Query: 353 LLGQGGFGYVHKGV-LPNGKE----VAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVS 406
LLG G FG VHKG+ +P G VA+K+++ SG Q +E + + + H ++V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHP 466
L+G C G LV + P +L H+ + R +D L + AKG+ YL E
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSLLDHVR-QHRDSLDPQRLLNWCVQIAKGMYYLEEHR-- 129
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAKLT-TDNNTHVSTRVMGTFGYLAPEYASSGKL 525
++HR++ + NILL ++ADFG+A L D+ + + ++A E G+
Sbjct: 130 -MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 526 TEKSDVFSFGVMLLELIT-------GRRPIDPTGAME 555
T +SDV+S+GV + E+++ G RP + +E
Sbjct: 189 THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 354 LGQGGFGYVH----KGVLPNGKE--VAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSL 407
LG+G FG V + P + VAVK+L+ S ++F E E+++ + H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHL--HGKGRPVM---DWPTRLK------IAMGSAKG 456
G C+ G ++V+EY+ + +L L HG +M + P L IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 457 LAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK-LTTDNNTHVSTRVMGTFGYL 515
+ YL +HRD+ + N L+ K+ DFG+++ + + + V M ++
Sbjct: 133 MVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 516 APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
PE K T +SDV+S GV+L E+ T G++P
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 78/286 (27%), Positives = 140/286 (48%), Gaps = 35/286 (12%)
Query: 346 GGFSQSNLLGQGGFGYVHKGVL--PNGKE--VAVKSLRSGSGQGER-EFKAEVEIISRVH 400
++ ++G G FG V +G+L P KE VA+K+L+ G + +R +F +E I+ +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 401 HRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAM--GSAKGLA 458
H +++ L G +++ EY+ N L+ +L ++ + + M G A G+
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMK 121
Query: 459 YLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFG--YLA 516
YL + + +HRD+ + NIL++ E KV+DFGL+++ D+ T G + A
Sbjct: 122 YLSDMNY---VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA 178
Query: 517 PEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNF 575
PE + K T SDV+SFG+++ E+++ G RP D + ++A++DG
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERP----------YWDMSNHEVMKAINDG-- 226
Query: 576 NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
+ P + P+ M+ C + RRP+ IV L+
Sbjct: 227 FRLPAPM---DCPSAVYQLMLQCW----QQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 68/204 (33%), Positives = 101/204 (49%), Gaps = 9/204 (4%)
Query: 348 FSQSNLLGQGGFGYVHK-GVLPNGKEVAVKSL---RSGSGQGEREFKAEVEIISRVHHRH 403
F Q +LG+GGFG V V GK A K L R +GE E +I+ +V+ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 404 LVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHED 463
+VSL LV + +L+FH++ G + + A GL LH++
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 464 CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSG 523
RI++RD+K NILLD +++D GLA + T + RV GT GY+APE +
Sbjct: 122 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNE 176
Query: 524 KLTEKSDVFSFGVMLLELITGRRP 547
+ T D ++ G +L E+I G+ P
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 12/200 (6%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA 413
LG G FG V G +VA+K ++ GS E EF E +++ ++ H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 414 GGKRLLVYEYVPNNNLEFHL--HGKG-RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIH 470
+V EY+ N L +L HGK +P L++ +G+AYL + IH
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQ----LLEMCKDVCEGMAYLESK---QFIH 123
Query: 471 RDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSD 530
RD+ + N L+D KV+DFGL++ D+ S + PE K + KSD
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183
Query: 531 VFSFGVMLLELIT-GRRPID 549
V++FGV++ E+ + G+ P +
Sbjct: 184 VWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 19/210 (9%)
Query: 347 GFSQSNLLGQGGFGYVHK-GVLPNGKEVAVKSLRSGS-GQGEREFKA-EVEIISRVHHRH 403
F LG+G +G V+K L + + A+K + GS Q ERE E+ I++ V+H +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 404 LVSLVGYCIAGGKRLLVYEYVPNNNLEFHL---HGKGRPV---MDWPTRLKIAMGSAKGL 457
++S + G K +V EY P +L + K + + W +++ G L
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG----L 116
Query: 458 AYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAP 517
LHE +I+HRD+KS+NILL K+ D G++K+ N +GT Y+AP
Sbjct: 117 QALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT---QIGTPHYMAP 170
Query: 518 EYASSGKLTEKSDVFSFGVMLLELITGRRP 547
E + KSD++S G +L E+ T P
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 64/221 (28%), Positives = 112/221 (50%), Gaps = 19/221 (8%)
Query: 348 FSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLR---SGSGQGEREFKA---EVEIISRVHH 401
+++ +LG+G +G V+ G+ G+ +AVK + S E+E++ EV+++ + H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 402 RHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLH 461
++V +G C+ + E+VP ++ L+ G P+ + P K G+AYLH
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG-PLPE-PVFCKYTKQILDGVAYLH 119
Query: 462 EDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM-----GTFGYLA 516
+C ++HRDIK +N++L K+ DFG A+ H + M GT ++A
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 517 PEYASSGKLTEKSDVFSFGVMLLELITGRRP---IDPTGAM 554
PE + KSD++S G + E+ TG+ P +D AM
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM 217
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 63/208 (30%), Positives = 93/208 (44%), Gaps = 17/208 (8%)
Query: 347 GFSQSNLLGQGGFGYVHKGVLPNGKEV-AVKSLRSG---SGQGEREFKAEVEIISRVHHR 402
F ++G+G FG V + K++ A+K + R E I+ ++H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 403 HLVSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIA-MGSAKGLAYL 460
LV+L Y + + LV + + +L +HL + + + I + A L YL
Sbjct: 61 FLVNLW-YSFQDEENMYLVVDLLLGGDLRYHL-SQKVKFSEEQVKFWICEIVLA--LEYL 116
Query: 461 HEDCHPRIIHRDIKSSNILLDYTFETKVADFGLA-KLTTDNNTHVSTRVMGTFGYLAPEY 519
H IIHRDIK NILLD + DF +A K+T D T T GT GY+APE
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEV 170
Query: 520 ASSGKLTEKSDVFSFGVMLLELITGRRP 547
+ D +S GV E + G+RP
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 62/196 (31%), Positives = 102/196 (52%), Gaps = 12/196 (6%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA 413
+G+G FG V G G +VAVK +++ + + F AE +++++ H +LV L+G +
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 414 -GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRD 472
G +V EY+ +L +L +GR V+ LK ++ + + YL + +HRD
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRD 127
Query: 473 IKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 532
+ + N+L+ KV+DFGL K + V T APE K + KSDV+
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKSDVW 183
Query: 533 SFGVMLLELIT-GRRP 547
SFG++L E+ + GR P
Sbjct: 184 SFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 59/197 (29%), Positives = 101/197 (51%), Gaps = 11/197 (5%)
Query: 354 LGQGGFGYVHK-GVLPNGKEVAVK--SLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGY 410
+G+G G V K G+ VA+K +LR G + E++ + H ++V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 411 CIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIH 470
G +LV EY+P++ L L + RP+ + + + M KG+AY+H + I+H
Sbjct: 68 FPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRM-LLKGVAYMHAN---GIMH 122
Query: 471 RDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE--YASSGKLTEK 528
RD+K +N+L+ K+ADFGLA+L ++ + + + T Y APE Y + K
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR-KYDPG 181
Query: 529 SDVFSFGVMLLELITGR 545
D+++ G + EL+ G
Sbjct: 182 VDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 72/207 (34%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 352 NLLGQGGFGYVHKGVL--PNGKEV--AVKSLRSGSGQGERE-FKAEVEIISRVHHRHLVS 406
++G+G FG V+ G L +G+++ AVKSL + E E F E I+ H +++S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTR---LKIAMG----SAKGLAY 459
L+G C L E P L + HG R + T +K +G AKG+ Y
Sbjct: 61 LLGIC-------LPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEY 113
Query: 460 LHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN---NTHVSTRVMGTFGYLA 516
L + +HRD+ + N +LD +F KVADFGLA+ D + H T ++A
Sbjct: 114 LASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 517 PEYASSGKLTEKSDVFSFGVMLLELIT 543
E + K T KSDV+SFGV+L EL+T
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 4e-21
Identities = 68/211 (32%), Positives = 110/211 (52%), Gaps = 19/211 (9%)
Query: 348 FSQSNL-----LGQGGFGYVHKGVLPN-GKE-----VAVKSLRSGSGQGERE-FKAEVEI 395
F ++NL LG G FG V + K VAVK L+ + ERE +E++I
Sbjct: 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKI 91
Query: 396 ISRV-HHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSA 454
+S + +H ++V+L+G C GG L++ EY +L L K + L + A
Sbjct: 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151
Query: 455 KGLAYL-HEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK-LTTDNNTHVSTRVMGTF 512
KG+A+L ++C IHRD+ + N+LL + K+ DFGLA+ + D+N V
Sbjct: 152 KGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV 207
Query: 513 GYLAPEYASSGKLTEKSDVFSFGVMLLELIT 543
++APE + T +SDV+S+G++L E+ +
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 5e-21
Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 354 LGQGGFGYVH---KGVLPNGKEVAVKSLRSGSGQGEREF---KAEVEIISRVHHRHLVSL 407
+ +G +G V K G A+K ++ + + E +I+S+ ++V L
Sbjct: 1 ISKGAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 408 VGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHP 466
Y G K L LV EY+P +L L G +D L YLH +
Sbjct: 59 Y-YSFQGKKNLYLVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSN--- 112
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAK-------LTTDNNTHVSTRVMGTFGYLAPEY 519
IIHRD+K NIL+D K+ DFGL+K + +++ R++GT Y+APE
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 520 ASSGKLTEKSDVFSFGVMLLELITGRRP 547
++ D +S G +L E + G P
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 8e-21
Identities = 62/200 (31%), Positives = 98/200 (49%), Gaps = 12/200 (6%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA 413
LG G FG VH G +VA+K++ G+ E +F E +++ ++ H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 414 GGKRLLVYEYVPNNNLEFHL---HGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIH 470
+V E++ N L +L GK M L + +G+ YL + IH
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDM----LLSMCQDVCEGMEYLERN---SFIH 123
Query: 471 RDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSD 530
RD+ + N L+ T KV+DFG+ + D+ S+ + PE + K + KSD
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183
Query: 531 VFSFGVMLLELIT-GRRPID 549
V+SFGV++ E+ T G+ P +
Sbjct: 184 VWSFGVLMWEVFTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 9e-21
Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 25/216 (11%)
Query: 354 LGQGGFGYVH----KGVLPNGKE--VAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSL 407
LG+G FG V + P + VAVK+L+ + ++F+ E E+++ + H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHL--HG-------KGRPV-----MDWPTRLKIAMGS 453
G C G ++V+EY+ + +L L HG G+P + L IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 454 AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK-LTTDNNTHVSTRVMGTF 512
A G+ YL +HRD+ + N L+ K+ DFG+++ + + + V M
Sbjct: 133 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 513 GYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
++ PE K T +SDV+SFGV+L E+ T G++P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 22/211 (10%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKS--LRSGSGQGEREFKA-------EVEIISRVHHR 402
L+G G FG V+ G+ +G+ +AVK L S S + ++ E+ ++ + H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 403 HLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHE 462
++V +G + + EYVP ++ L+ G + KGL YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHN 124
Query: 463 DCHPRIIHRDIKSSNILLDYTFETKVADFGLAK------LTTDNNTHVSTRVMGTFGYLA 516
IIHRDIK +NIL+D K++DFG++K L+T N + + G+ ++A
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS-LQGSVFWMA 180
Query: 517 PEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
PE T K+D++S G +++E++TG+ P
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 1e-20
Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 16/215 (7%)
Query: 350 QSNLLGQGGFGYVHKG-VLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLV 408
+ N++ +G G +KG + NG + VK + + E + ++ H ++V L+
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLI 749
Query: 409 GYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRI 468
G C + L++EY+ NL L + W R KIA+G AK L +LH C P +
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 469 IHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEK 528
+ ++ I++D E + L TD +S+ Y+APE + +TEK
Sbjct: 805 VVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISS------AYVAPETRETKDITEK 858
Query: 529 SDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWAR 563
SD++ FG++L+EL+TG+ P D + +V+WAR
Sbjct: 859 SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWAR 893
|
Length = 968 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 14/214 (6%)
Query: 346 GGFSQSNLLGQGGFGYVHKGVLPNGKEV-AVKS-LRSGSGQGEREFKAEVEIISRVHHRH 403
+ + LG+G G V K L N + A+K+ + +++ E+EI +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 404 LVSLVGYCI--AGGKRLLVYEYVPNNNLEF---HLHGKGRPVMDWPTRLKIAMGSAKGLA 458
+V G + + + EY +L+ + +G + + KIA KGL+
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL-GKIAESVLKGLS 119
Query: 459 YLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE 518
YLH +IIHRDIK SNILL + K+ DFG++ N+ T GT Y+APE
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGTFT-GTSFYMAPE 173
Query: 519 YASSGKLTEKSDVFSFGVMLLELITGRRPIDPTG 552
+ SDV+S G+ LLE+ R P P G
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEG 207
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 75/233 (32%), Positives = 122/233 (52%), Gaps = 29/233 (12%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEV----AVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVS 406
+LG G FG V+KG+ +P G+ V A+K L +G + EF E I++ + H HLV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGK-----GRPVMDWPTRLKIAMGSAKGLAYLH 461
L+G C++ +L V + +P+ L ++H + +++W ++ AKG+ YL
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126
Query: 462 EDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT-DNNTHVSTRVMGTFGYLAPEYA 520
E R++HRD+ + N+L+ K+ DFGLA+L D + + ++A E
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 521 SSGKLTEKSDVFSFGVMLLELIT-GRRPID--PTGAMEDCLVDWAR----PLC 566
K T +SDV+S+GV + EL+T G +P D PT + D L R P+C
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPIC 236
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 70/205 (34%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 348 FSQSNLLGQGGFGYVHK-GVLPNGKEVAVKSL---RSGSGQGEREFKAEVEIISRVHHRH 403
F +LG+GGFG V V GK A K L R +GE E +I+ +V+ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 404 LVSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHE 462
+VSL Y L LV + +L+FH++ G P D + A GL LH
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR 120
Query: 463 DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS 522
+ RI++RD+K NILLD +++D GLA + T + RV GT GY+APE +
Sbjct: 121 E---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEVVKN 175
Query: 523 GKLTEKSDVFSFGVMLLELITGRRP 547
+ T D + G ++ E+I G+ P
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVK--SLRSGSGQGEREFKAEVEIISRVHHRHL 404
F+ +G+G FG V+K + + VA+K L + E + + E++ +S+ ++
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIE-DIQQEIQFLSQCRSPYI 61
Query: 405 VSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC 464
G + G K ++ EY + L G+ +D I GL YLHE+
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGSC-LDLLKPGK--LDETYIAFILREVLLGLEYLHEE- 117
Query: 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGK 524
IHRDIK++NILL + K+ADFG++ T + +T V GT ++APE
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSG 174
Query: 525 LTEKSDVFSFGVMLLELITGRRP---IDPTGAM 554
EK+D++S G+ +EL G P + P +
Sbjct: 175 YDEKADIWSLGITAIELAKGEPPLSDLHPMRVL 207
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 3e-20
Identities = 65/202 (32%), Positives = 105/202 (51%), Gaps = 18/202 (8%)
Query: 354 LGQGGFGYVH------KGVLPNGKEVAVKSLRSGSGQGE-REFKAEVEIISRVHHRHLVS 406
LG+G FG V +G G++VAVKSL+ SG + K E+EI+ ++H ++V
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 407 LVGYCIAGGKR--LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC 464
G C G L+ E++P+ +L+ +L + + ++ +LK A+ KG+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYLGSR- 128
Query: 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST---RVMGTFGYLAPEYAS 521
+ +HRD+ + N+L++ + K+ DFGL K + + + F Y APE
Sbjct: 129 --QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLI 185
Query: 522 SGKLTEKSDVFSFGVMLLELIT 543
K SDV+SFGV L EL+T
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 4e-20
Identities = 62/228 (27%), Positives = 97/228 (42%), Gaps = 47/228 (20%)
Query: 353 LLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREF----------KAEVEIISRV-H 400
++G+G F V KE A+K L ++ K E E+++R+
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKIL-------DKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 401 HRHLVSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIA-MGSAKGLA 458
H ++ L Y + L V EY PN L ++ G TR A + A L
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC-TRFYAAEILLA--LE 116
Query: 459 YLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM--------- 509
YLH IIHRD+K NILLD K+ DFG AK+ N++ S +
Sbjct: 117 YLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 510 ----------GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
GT Y++PE + + SD+++ G ++ +++TG+ P
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 6e-20
Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 33/220 (15%)
Query: 354 LGQGGFGYVHKGV------LPNGKEVAVKSLRSGSGQGE-REFKAEVEIISRVHHRHLVS 406
LG+G FG V K VAVK L+ + E R+ +E ++ +V+H H++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLH--------------GKGRPVMDWPTRLKIAMG 452
L G C G LL+ EY +L L + +D P + MG
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 453 S--------AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504
++G+ YL E +++HRD+ + N+L+ + K++DFGL++ + +++V
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 505 S-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 543
++ ++A E T +SDV+SFGV+L E++T
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 7e-20
Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 12/202 (5%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGE-REFKAEVEIISRVHHRHLVSLVGYC 411
+G G V+ + LPN ++VA+K + Q E + EV+ +S+ +H ++V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 412 IAGGKRLLVYEYVPNNNLEFHL--HGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRII 469
+ G + LV Y+ +L + R +D + KGL YLH + I
Sbjct: 69 VVGDELWLVMPYLSGGSL-LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---I 124
Query: 470 HRDIKSSNILLDYTFETKVADFGLAKL---TTDNNTHVSTRVMGTFGYLAPEYASSGK-L 525
HRDIK+ NILL K+ADFG++ D V +GT ++APE
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY 184
Query: 526 TEKSDVFSFGVMLLELITGRRP 547
K+D++SFG+ +EL TG P
Sbjct: 185 DFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 13/211 (6%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
+LG+G +G V+ L +A+K + + + E+ + S + HR++V +G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMD-WPTRLKIAMGSAKGLAYLHEDCHPRIIH 470
G + E VP +L L K P+ D T + +GL YLH++ +I+H
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVH 131
Query: 471 RDIKSSNILLD-YTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGK--LTE 527
RDIK N+L++ Y+ K++DFG +K N T GT Y+APE G
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPEVIDKGPRGYGA 190
Query: 528 KSDVFSFGVMLLELITGRRPI----DPTGAM 554
+D++S G ++E+ TG+ P +P AM
Sbjct: 191 PADIWSLGCTIVEMATGKPPFIELGEPQAAM 221
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 71/205 (34%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 348 FSQSNLLGQGGFGYVHK-GVLPNGKEVAVKSL---RSGSGQGEREFKAEVEIISRVHHRH 403
F +LG+GGFG V V GK A K L R +GE E I+ +V+ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 404 LVSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHE 462
+VSL Y L LV + +L+FH++ G P D + A GL L
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 463 DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS 522
+ RI++RD+K NILLD +++D GLA + T V RV GT GY+APE ++
Sbjct: 121 E---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVINN 175
Query: 523 GKLTEKSDVFSFGVMLLELITGRRP 547
K T D + G ++ E+I G+ P
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 57/212 (26%), Positives = 88/212 (41%), Gaps = 39/212 (18%)
Query: 353 LLGQGGFGYVHKG-VLPNGKEVAVKSLRSGSGQGEREFKA-------------EVEIISR 398
++G+G +G V K G+ VA+K +FK EV+++ +
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIK-----------KFKESEDDEDVKKTALREVKVLRQ 56
Query: 399 VHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLE-FHLHGKGRPVMDWPTRLKIAMGSAKGL 457
+ H ++V+L G+ LV+EYV LE G + + +
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGG---LPPDAVRSYIWQLLQAI 113
Query: 458 AYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAP 517
AY H IIHRDIK NIL+ + K+ DFG A+ T + T Y AP
Sbjct: 114 AYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170
Query: 518 E----YASSGKLTEKSDVFSFGVMLLELITGR 545
E + GK DV++ G ++ EL+ G
Sbjct: 171 ELLVGDTNYGK---PVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 66/208 (31%), Positives = 111/208 (53%), Gaps = 17/208 (8%)
Query: 350 QSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSG--SGQGEREFKA---EVEIISRVHHRH 403
+ LLGQG FG V+ + G+E+AVK + S + ++E A E++++ + H
Sbjct: 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHER 65
Query: 404 LVSLVGYCIAGGKRLLVY-EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHE 462
+V G C+ + L ++ EY+P +++ L G + + TR K +G+ YLH
Sbjct: 66 IVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG-ALTETVTR-KYTRQILEGVEYLHS 122
Query: 463 DCHPRIIHRDIKSSNILLDYTFETKVADFGLAK-LTT--DNNTHVSTRVMGTFGYLAPEY 519
+ I+HRDIK +NIL D K+ DFG +K L T + T + + V GT +++PE
Sbjct: 123 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWMSPEV 178
Query: 520 ASSGKLTEKSDVFSFGVMLLELITGRRP 547
S K+DV+S G ++E++T + P
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 65/211 (30%), Positives = 111/211 (52%), Gaps = 13/211 (6%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQG-EREFKAEVEIISRVHHRHLVSLVGYC 411
LG G G V K +P G +A K + G+ ++ E++I+ ++VS G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRL--KIAMGSAKGLAYLHEDCHPRII 469
+ + E++ +L+ ++ KG P+ P + KIA+ +GL YL+ + H RI+
Sbjct: 73 LNENNICMCMEFMDCGSLD-RIYKKGGPI---PVEILGKIAVAVVEGLTYLY-NVH-RIM 126
Query: 470 HRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKS 529
HRDIK SNIL++ + K+ DFG++ ++ ++ +GT Y++PE GK T KS
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELINS---IADTFVGTSTYMSPERIQGGKYTVKS 183
Query: 530 DVFSFGVMLLELITGRRPIDPTGAMEDCLVD 560
DV+S G+ ++EL G+ P + +D D
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDDDGQDD 214
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 30/217 (13%)
Query: 354 LGQGGFGYVHK----------GVLPNGKE-----VAVKSLRSGSGQGER-EFKAEVEIIS 397
LG+G FG VH G + VAVK LR+ + R +F E++I+S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 398 RVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHL----------HGKGRPVMDWPTRL 447
R+ + +++ L+G C++ ++ EY+ N +L L H P + L
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 448 KIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK-LTTDNNTHVST 506
+A+ A G+ YL +HRD+ + N L+ + K+ADFG+++ L + + +
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 507 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 543
R + ++A E GK T SDV++FGV L E+ T
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 66/224 (29%), Positives = 112/224 (50%), Gaps = 29/224 (12%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKE----VAVKSLRSG-SGQGEREFKAEVEIISRVHH 401
F + +LG G FG V+KG+ +P G++ VA+K LR S + +E E +++ V +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 402 RHLVSLVGYCIAGGKRLL--------VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGS 453
H+ L+G C+ +L+ + +YV + + +++W ++
Sbjct: 69 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQI------ 118
Query: 454 AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK-LTTDNNTHVSTRVMGTF 512
AKG+ YL E R++HRD+ + N+L+ K+ DFGLAK L D + +
Sbjct: 119 AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI 175
Query: 513 GYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAME 555
++A E T +SDV+S+GV + EL+T G +P D A E
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 219
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 60/190 (31%), Positives = 99/190 (52%), Gaps = 7/190 (3%)
Query: 353 LLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVSLVGYC 411
LLG+G FG V KG L + VAVK+ + Q + +F +E I+ + H ++V L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLH-EDCHPRIIH 470
+V E VP + L K + + +K A+ +A G+AYL ++C IH
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKNC----IH 116
Query: 471 RDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSD 530
RD+ + N L+ K++DFG+++ D S + APE + G+ + +SD
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 531 VFSFGVMLLE 540
V+S+G++L E
Sbjct: 177 VWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 68/209 (32%), Positives = 89/209 (42%), Gaps = 35/209 (16%)
Query: 354 LGQGGFGYV----HKGVLPNGKEVAVKSLRSG----SGQGEREFKAEVEIISRVHHRHLV 405
LG G FG V HK +GK A+K L Q E E I+ + H LV
Sbjct: 9 LGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQVE-HVLNEKRILQSIRHPFLV 64
Query: 406 SLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRL---KIAMGSAKGLAYLH 461
+L G L LV EYVP L HL GR R ++ + L YLH
Sbjct: 65 NLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPV-ARFYAAQVVLA----LEYLH 118
Query: 462 EDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM---GTFGYLAPE 518
I++RD+K N+LLD K+ DFG AK V R GT YLAPE
Sbjct: 119 -SLD--IVYRDLKPENLLLDSDGYIKITDFGFAK-------RVKGRTYTLCGTPEYLAPE 168
Query: 519 YASSGKLTEKSDVFSFGVMLLELITGRRP 547
S + D ++ G+++ E++ G P
Sbjct: 169 IILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 64/214 (29%), Positives = 105/214 (49%), Gaps = 19/214 (8%)
Query: 348 FSQSNL-----LGQGGFGYVHKGVLPN-GKEVAVKSLRSGSGQGE-REFKAEVEIISRVH 400
F+ +L +G+G FG V+K + G +AVK +RS + E + +++++ R
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60
Query: 401 H-RHLVSLVGYCIAGGKRLLVYEYVPN--NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGL 457
++V G G + E + + +++ + V+ KIA+ + K L
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKAL 120
Query: 458 AYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLA-KLTTDNNTHVSTRVMGTFGYLA 516
YL E+ IIHRD+K SNILLD K+ DFG++ +L ++ TR G Y+A
Sbjct: 121 NYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMA 175
Query: 517 PE-YASSG--KLTEKSDVFSFGVMLLELITGRRP 547
PE S +SDV+S G+ L E+ TG+ P
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 38/228 (16%)
Query: 338 YEELSAATGGFSQSNLLGQGGFGYVHKGV--LPNGKEVAVKSLRSGS-GQGERE-FKAEV 393
YE L +G+G FG V K V +GK + K + G+ + E++ +EV
Sbjct: 2 YEVL----------ETIGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEV 50
Query: 394 EIISRVHHRHLVSLVGYC--IAGGKRLLVYEYVPNNNLEFHLHG----------KGRPVM 441
I+ + H ++V Y I +Y +E+ G K R +
Sbjct: 51 NILRELKHPNIV---RYYDRIIDRSNQTLYIV-----MEYCEGGDLAQLIQKCKKERKYI 102
Query: 442 DWPTRLKIAMGSAKGLAYLH--EDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499
+ +I L H D ++HRD+K +NI LD K+ DFGLAK+
Sbjct: 103 EEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162
Query: 500 NNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
+++ T V GT Y++PE + EKSD++S G ++ EL P
Sbjct: 163 DSSFAKTYV-GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 79/300 (26%), Positives = 132/300 (44%), Gaps = 59/300 (19%)
Query: 347 GFSQSNLLGQGGFGYVHKGVL-----PNGKEVAVKSLRSGSGQGERE-FKAEVEIISRVH 400
+ S+LL +G FG + G+L +EV VK+++ + + + E ++ +
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS 66
Query: 401 HRHLVSLVGYCIA-GGKRLLVYEYVPNNNLEFHL----HGKGRPVMDWPTRLKIAMGS-- 453
H++++ ++ CI G ++Y Y+ NL+ L G+ T+ + M
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 454 AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK---------LTTDNNTHV 504
A G++YLH+ +IH+DI + N ++D + K+ D L++ L + N V
Sbjct: 127 ACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 505 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP---IDPTGAMEDCLVD 560
++A E + + + SDV+SFGV+L EL+T G+ P IDP M L D
Sbjct: 184 K--------WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF-EMAAYLKD 234
Query: 561 WARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRAL 620
R +A P N P E A M C A RP SQ+V+ L
Sbjct: 235 GYR--------------LAQPI---NCPDELFAVMACCWAL----DPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 85/302 (28%), Positives = 128/302 (42%), Gaps = 64/302 (21%)
Query: 353 LLGQGGFGYVHKGV---LPNGKE---VAVKSLRSGSGQGEREFK---AEVEIISRV-HHR 402
LG+G FG V K L N E VAVK L+ + E++ +E+E++ + H+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHK 76
Query: 403 HLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVM-------DWPTRLKI------ 449
++++L+G C G +V EY + NL L + RP P +
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR-RPPGEYASPDDPRPPEETLTQKDLV 135
Query: 450 --AMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTR 507
A A+G+ +L + IHRD+ + N+L+ K+ADFGLA+ + + T
Sbjct: 136 SFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT- 191
Query: 508 VMGTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDW 561
T G L APE T +SDV+SFGV+L E+ T G P P +E+ L
Sbjct: 192 ---TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY-PGIPVEE-LFKL 246
Query: 562 ARPLCLRALDDGNFNEIADPYLEK--NYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619
L +G +EK N E M C +RP Q+V
Sbjct: 247 --------LKEGY-------RMEKPQNCTQELYHLMRDCW----HEVPSQRPTFKQLVED 287
Query: 620 LE 621
L+
Sbjct: 288 LD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 59/212 (27%), Positives = 106/212 (50%), Gaps = 25/212 (11%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE----------FKAEVEIISRVHH 401
L+G+G +G V+ + + G+ +AVK + + R ++E+E + + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 402 RHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGR---PVMDWPTRLKIAMGSAKGLA 458
++V +G+ + EYVP ++ L GR ++ + T + +GLA
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL-----EGLA 122
Query: 459 YLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM-GTFGYLAP 517
YLH I+HRD+K+ N+L+D K++DFG++K + D + M G+ ++AP
Sbjct: 123 YLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 518 EYASSGK--LTEKSDVFSFGVMLLELITGRRP 547
E S + K D++S G ++LE+ GRRP
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 9/204 (4%)
Query: 348 FSQSNLLGQGGFGYVHK-GVLPNGKEVAVKSL---RSGSGQGEREFKAEVEIISRVHHRH 403
F Q +LG+GGFG V V GK A K L R +GE E +I+ +V+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 404 LVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHED 463
+V+L LV + +L+FH++ G P + L A GL LH +
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 464 CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSG 523
++RD+K NILLD +++D GLA + + + RV GT GY+APE ++
Sbjct: 122 ---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IRGRV-GTVGYMAPEVLNNQ 176
Query: 524 KLTEKSDVFSFGVMLLELITGRRP 547
+ T D + G ++ E+I G+ P
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCI 412
+G G +G V+K + G+ VA+K ++ G + E+ ++ H ++V+ G +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 413 AGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAM---GSAKGLAYLHEDCHPRII 469
K +V EY +L+ P+ + L+IA + KGLAYLHE I
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRGPL----SELQIAYVCRETLKGLAYLHET---GKI 123
Query: 470 HRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTR--VMGTFGYLAPEYA---SSGK 524
HRDIK +NILL + K+ADFG++ T T ++ R +GT ++APE A G
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVSAQLT--AT-IAKRKSFIGTPYWMAPEVAAVERKGG 180
Query: 525 LTEKSDVFSFGVMLLELITGRRP 547
K D+++ G+ +EL + P
Sbjct: 181 YDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 61/195 (31%), Positives = 99/195 (50%), Gaps = 6/195 (3%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA 413
LG G FG V +VAVK+++ GS E F AE ++ + H LV L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHA-VVT 71
Query: 414 GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDI 473
++ E++ +L L P + + A+G+A++ + + IHRD+
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY---IHRDL 128
Query: 474 KSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 533
+++NIL+ + K+ADFGLA++ DN + APE + G T KSDV+S
Sbjct: 129 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 188
Query: 534 FGVMLLELIT-GRRP 547
FG++L+E++T GR P
Sbjct: 189 FGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 59/213 (27%), Positives = 108/213 (50%), Gaps = 28/213 (13%)
Query: 352 NLLGQGGFGYVHKG-VLPNG--KEVAVKSLRSGSGQGE-REFKAEVEIISRV-HHRHLVS 406
+++G+G FG V K + +G + A+K ++ + + + R+F E+E++ ++ HH ++++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 407 LVGYCIAGGKRLLVYEYVPNNNL--------------EFHLHGKGRPVMDWPTRLKIAMG 452
L+G C G L EY P+ NL F + + L A
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 453 SAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTF 512
A+G+ YL + + IHRD+ + NIL+ + K+ADFGL++ +V + MG
Sbjct: 133 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVK-KTMGRL 185
Query: 513 G--YLAPEYASSGKLTEKSDVFSFGVMLLELIT 543
++A E + T SDV+S+GV+L E+++
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 348 FSQSNL-----LGQGGFGYVHKGVLPNGKE------VAVKSLRSGSGQG-EREFKAEVEI 395
F +SNL LG+G FG V +E V VK+L+ + + EF+ E+++
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 396 ISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNL-EFHLHGKGR------PVMDWPTRLK 448
++ H+++V L+G C ++ EY +L +F K + P + ++
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 449 IAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRV 508
+ A G+ +L R +HRD+ + N L+ E KV+ L+K ++ +
Sbjct: 122 LCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNA 178
Query: 509 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 543
+ +LAPE + KSDV+SFGV++ E+ T
Sbjct: 179 LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 30/214 (14%)
Query: 352 NLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE---FKA--EVEIISRVHHRHLV 405
LG+G + V+K G+ VA+K ++ G + ++ F A E++++ + H +++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 406 SLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSA-KGLAYLHED 463
L+ + LV+E++ + LE + K + P +K M +GL YLH +
Sbjct: 66 GLLD-VFGHKSNINLVFEFMETD-LEKVIKDKSIVLT--PADIKSYMLMTLRGLEYLHSN 121
Query: 464 CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE----- 518
I+HRD+K +N+L+ K+ADFGLA+ N ++ +V+ T Y APE
Sbjct: 122 ---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFGA 177
Query: 519 --YASSGKLTEKSDVFSFGVMLLELITGRRPIDP 550
Y D++S G + EL+ R P P
Sbjct: 178 RHYGVG------VDMWSVGCIFAELLL-RVPFLP 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 64/205 (31%), Positives = 110/205 (53%), Gaps = 16/205 (7%)
Query: 353 LLGQGGFGYVHKGVL--PNGKE--VAVKSLRSG-SGQGEREFKAEVEIISRVHHRHLVSL 407
++G G FG V G L P +E VA+K+L++G + + R+F +E I+ + H +++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHL--HGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCH 465
G ++V EY+ N +L+ L H V+ L+ G A G+ YL + +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMKYLSDMGY 127
Query: 466 PRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFG--YLAPEYASSG 523
+HRD+ + NIL++ KV+DFGL+++ D+ T G + APE +
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 524 KLTEKSDVFSFGVMLLELIT-GRRP 547
K T SDV+S+G+++ E+++ G RP
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 64/207 (30%), Positives = 113/207 (54%), Gaps = 18/207 (8%)
Query: 353 LLGQGGFGYVHKGVL--PNGKE--VAVKSLRSG-SGQGEREFKAEVEIISRVHHRHLVSL 407
++G G FG V +G L P +E VA+K+L+SG + + R+F +E I+ + H +++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 408 VGYCIAGGKRLLVYEYVPNNNLE-FHLHGKGR-PVMDWPTRLKIAMGSAKGLAYLHEDCH 465
G +++ E++ N L+ F G+ V+ L+ G A G+ YL E +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSEMNY 127
Query: 466 PRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVS-TRVMG---TFGYLAPEYAS 521
+HRD+ + NIL++ KV+DFGL++ D+ + + T +G + APE +
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 522 SGKLTEKSDVFSFGVMLLELIT-GRRP 547
K T SDV+S+G+++ E+++ G RP
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 30/214 (14%)
Query: 352 NLLGQGGFGYVHKGVLP---NGKEVAVKSLRS-GSGQGEREFKAEVEIISRV-HHRHLVS 406
+++G+G FG V + ++ A+K L+ S R+F E+E++ ++ HH ++++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPT---------------RLKIAM 451
L+G C G + EY P NL L K R + P L+ A
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLR-KSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 452 GSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGT 511
A G+ YL E + IHRD+ + N+L+ +K+ADFGL++ +V + MG
Sbjct: 127 DVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVK-KTMGR 179
Query: 512 FG--YLAPEYASSGKLTEKSDVFSFGVMLLELIT 543
++A E + T KSDV+SFGV+L E+++
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 348 FSQSNLLGQGGFGYVHKGVLPNGKEV-AVKSLRSGSGQGERE-FKAEVEIISRVHHRHLV 405
F++ +G+G FG V KG+ ++V A+K + + E E + E+ ++S+ ++
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 406 SLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCH 465
G + G K ++ EY+ + L T LK + KGL YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSE-- 120
Query: 466 PRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKL 525
+ IHRDIK++N+LL + K+ADFG+A TD +T V GT ++APE
Sbjct: 121 -KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAY 178
Query: 526 TEKSDVFSFGVMLLELITGRRP 547
K+D++S G+ +EL G P
Sbjct: 179 DSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 353 LLGQGGFGYVHKGV--LPNGKE--VAVKSLRSGSGQGERE-FKAEVEIISRVHHRHLVSL 407
+G+G FG V++GV P ++ VAVK+ ++ + RE F E I+ + H H+V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR 467
+G +V E P L +L + +D + + + + LAYL R
Sbjct: 73 IGVITEN-PVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALAYLESK---R 127
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTE 527
+HRDI + N+L+ K+ DFGL++ D + + +++ ++APE + + T
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTS 187
Query: 528 KSDVFSFGVMLLE-LITGRRP 547
SDV+ FGV + E L+ G +P
Sbjct: 188 ASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 60/206 (29%), Positives = 106/206 (51%), Gaps = 19/206 (9%)
Query: 354 LGQGGFGYVH----KGVLPNGKE--VAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVS 406
LGQG FG V+ KGV+ + E VA+K++ + ER EF E ++ + H+V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHG-----KGRPVMDWPT---RLKIAMGSAKGLA 458
L+G G L++ E + +L+ +L + PV P+ +++A A G+A
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 459 YLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH-VSTRVMGTFGYLAP 517
YL+ + + +HRD+ + N ++ F K+ DFG+ + + + + + + +++P
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 518 EYASSGKLTEKSDVFSFGVMLLELIT 543
E G T SDV+SFGV+L E+ T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 8e-18
Identities = 61/206 (29%), Positives = 110/206 (53%), Gaps = 13/206 (6%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGE-REFKAEVEIISRVHHRHLV 405
+ + L+G+G +G V++G +P G+ VA+K + + + + + EV ++S++
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 406 SLVGY--CIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHE 462
++ Y G RL ++ EY ++ + K P+ + + I L Y+H+
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM--KAGPIAEKYISV-IIREVLVALKYIHK 119
Query: 463 DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS 522
+IHRDIK++NIL+ T K+ DFG+A L N++ ST V GT ++APE +
Sbjct: 120 V---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITE 175
Query: 523 GKLTE-KSDVFSFGVMLLELITGRRP 547
GK + K+D++S G+ + E+ TG P
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 9e-18
Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 354 LGQGGFGYVHKGVLPNGK---EVAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVSLVG 409
LG G FG V KGV K +VA+K L++ + + R E E EI+ ++ + ++V ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 410 YCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAM---GSAKGLAYLHEDCHP 466
C A +LV E L L GK D T + + G+ YL
Sbjct: 63 VCEAEA-LMLVMEMASGGPLNKFLSGK----KDEITVSNVVELMHQVSMGMKYLEGK--- 114
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTF--GYLAPEYASSGK 524
+HRD+ + N+LL K++DFGL+K ++++ R G + + APE + K
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174
Query: 525 LTEKSDVFSFGVMLLELIT-GRRP 547
+ +SDV+S+G+ + E + G++P
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 9e-18
Identities = 63/275 (22%), Positives = 129/275 (46%), Gaps = 30/275 (10%)
Query: 348 FSQSNLLGQGGFGYVH--KGVLPNGKEVAVKSLR-SGSGQGERE-FKAEVEIISRVHHRH 403
+ + ++G+G FG VH + + K V +K + + ER + E +++ + H +
Sbjct: 2 YEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 404 LVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHED 463
++ + ++V EY P L ++ + ++D T L + L ++H
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 464 CHPRIIHRDIKSSNILLD-YTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS 522
I+HRD+K+ NILLD + K+ DFG++K+ + + + V+GT Y++PE
Sbjct: 121 ---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK--AYTVVGTPCYISPELCEG 175
Query: 523 GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582
+KSD+++ G +L EL + +R + P + + G F I+D Y
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFEAANL----------PALVLKIMSGTFAPISDRY 225
Query: 583 LEKNYPTEEMARMVACAAASIRHSARRRPKISQIV 617
+ ++ +++ + + +RP++SQI+
Sbjct: 226 ------SPDLRQLI---LSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 71/221 (32%), Positives = 94/221 (42%), Gaps = 29/221 (13%)
Query: 353 LLGQGGFGYVHKGVLPNGKEV-AVKSLRSG---------SGQGEREFKAEVEIISRVHHR 402
+LG+G FG V L E+ AVK L+ E+ A H
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-----KHP 56
Query: 403 HLVSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLH 461
L L C RL V EYV +L FH+ GR D P A GL +LH
Sbjct: 57 FLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGR--FDEPRARFYAAEIVLGLQFLH 113
Query: 462 EDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK--LTTDNNTHVSTRVMGTFGYLAPEY 519
E II+RD+K N+LLD K+ADFG+ K + T + GT Y+APE
Sbjct: 114 ER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPEI 167
Query: 520 ASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVD 560
S D ++ GV+L E++ G+ P + G ED L
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQSPFE--GDDEDELFQ 206
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 58/214 (27%), Positives = 106/214 (49%), Gaps = 30/214 (14%)
Query: 352 NLLGQGGFGYVHKGVLPNG---KEVAVKSLRSGSGQGE-REFKAEVEIISRV-HHRHLVS 406
+++G+G FG V K + + A+K ++ + + + R+F E+E++ ++ HH ++++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHL---------------HGKGRPVMDWPTRLKIAM 451
L+G C G L EY P+ NL L + + L A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS-TLSSQQLLHFAA 119
Query: 452 GSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGT 511
A+G+ YL + + IHRD+ + NIL+ + K+ADFGL++ +V + MG
Sbjct: 120 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVK-KTMGR 172
Query: 512 FG--YLAPEYASSGKLTEKSDVFSFGVMLLELIT 543
++A E + T SDV+S+GV+L E+++
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 66/216 (30%), Positives = 113/216 (52%), Gaps = 23/216 (10%)
Query: 353 LLGQGGFGYVHKGV-LPNGKE----VAVKSLRSG-SGQGEREFKAEVEIISRVHHRHLVS 406
+LG G FG V+KG+ +P+G+ VA+K LR S + +E E +++ V ++
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHL-HGKGR----PVMDWPTRLKIAMGSAKGLAYLH 461
L+G C+ +L V + +P L ++ K R +++W ++ AKG++YL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 462 EDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK-LTTDNNTHVSTRVMGTFGYLAPEYA 520
E R++HRD+ + N+L+ K+ DFGLA+ L D + + ++A E
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 521 SSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAME 555
+ T +SDV+S+GV + EL+T G +P D A E
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE 219
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 11/200 (5%)
Query: 354 LGQGGFGYVHKGVLPN-GKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCI 412
LG G FG V+K G A K ++ S + +F E++I+S H ++V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 413 AGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRD 472
K ++ E+ L+ + R + P + + L +LH ++IHRD
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLHSH---KVIHRD 128
Query: 473 IKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYA-----SSGKLTE 527
+K+ NILL + K+ADFG++ T + GT ++APE
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPYDY 187
Query: 528 KSDVFSFGVMLLELITGRRP 547
K+D++S G+ L+EL P
Sbjct: 188 KADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 81/302 (26%), Positives = 126/302 (41%), Gaps = 61/302 (20%)
Query: 354 LGQGGFGYVHK----GVLPNGKE--VAVKSLRSG-SGQGEREFKAEVEIISRVHHRHLVS 406
+GQG FG V + G+LP VAVK L+ S + +F+ E +++ H ++V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 407 LVGYCIAGGKRLLVYEYVPNNNL-EFHLH-------------------GKGRPVMDWPTR 446
L+G C G L++EY+ +L EF H G + +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 447 LKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK-------LTTD 499
L IA A G+AYL E + +HRD+ + N L+ K+ADFGL++
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 500 NNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLV 559
N + R M PE + T +SDV+++GV+L E+ + + P M
Sbjct: 190 ENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS--YGMQPYYGM----- 236
Query: 560 DWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619
A + + DGN D N P E M C + + + RP + I R
Sbjct: 237 --AHEEVIYYVRDGNVLSCPD-----NCPLELYNLMRLCWS---KLPS-DRPSFASINRI 285
Query: 620 LE 621
L+
Sbjct: 286 LQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 11/203 (5%)
Query: 348 FSQSNLLGQGGFGYVHKGVLPNGKEV-AVKSLRSGSGQGERE-FKAEVEIISRVHHRHLV 405
F++ +G+G FG V+KG+ KEV A+K + + E E + E+ ++S+ ++
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 406 SLVGYCIAGGKRLLVYEYVPNNN-LEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC 464
G + G K ++ EY+ + L+ G ++ I KGL YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYLHSE- 120
Query: 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGK 524
R IHRDIK++N+LL + K+ADFG+A TD +T V GT ++APE
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSA 177
Query: 525 LTEKSDVFSFGVMLLELITGRRP 547
K+D++S G+ +EL G P
Sbjct: 178 YDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 66/205 (32%), Positives = 93/205 (45%), Gaps = 22/205 (10%)
Query: 354 LGQGGFGYV----HKGVLPNGKEVAVKSLRSGS--GQGERE-FKAE---VEIISRVHHRH 403
LG+G FG V +K G+ A+K+L+ G + E E E E + H
Sbjct: 7 LGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 404 LVSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHE 462
LV+L C + V EY +L H+H V P + A GL YLHE
Sbjct: 64 LVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHE 119
Query: 463 DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS 522
+ +I++RD+K N+LLD K+ADFGL K ST GT +LAPE +
Sbjct: 120 N---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEFLAPEVLTE 175
Query: 523 GKLTEKSDVFSFGVMLLELITGRRP 547
T D + GV++ E++ G P
Sbjct: 176 TSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 5e-17
Identities = 65/239 (27%), Positives = 109/239 (45%), Gaps = 40/239 (16%)
Query: 354 LGQGGFGYVHKGVLPNGKE-----------------VAVKSLRSGSGQGER-EFKAEVEI 395
LG+G FG VH + N ++ VAVK LR + + R +F EV+I
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 396 ISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLH--------GKGR--------- 438
+SR+ +++ L+G C+ ++ EY+ N +L L G
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 439 PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK-LT 497
P + + + L +A+ A G+ YL +HRD+ + N L+ K+ADFG+++ L
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 498 TDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMED 556
+ + R + ++A E GK T SDV++FGV L E++ + P G + D
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE-QPYGELTD 247
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 5e-17
Identities = 56/190 (29%), Positives = 90/190 (47%), Gaps = 18/190 (9%)
Query: 370 GKEVAVKSLRSGSGQGERE---FKAEVEIISRVHHRHLVSLVGYCIAGGKRLL-VYEYVP 425
G EVA+K LR+ + + E + F+ E + +R++H ++V+L+ A L V+EYVP
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 426 NNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILL---DY 482
L L G + ++ + LA H I+HRD+K NI++
Sbjct: 63 GRTLREVLAADG--ALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGV 117
Query: 483 TFETKVADFGLAKLTTDNNTHVSTR------VMGTFGYLAPEYASSGKLTEKSDVFSFGV 536
KV DFG+ L V+GT Y APE +T SD++++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 537 MLLELITGRR 546
+ LE +TG+R
Sbjct: 178 IFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 6e-17
Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 353 LLGQGGFG--YVHKGVLPNGKEVAVKSL---RSGSGQGER---EFKAEVEIISRVHHRHL 404
LG G F Y + V G +AVK + R+ S + E + E+ +++R++H H+
Sbjct: 7 QLGTGAFSSCYQARDVK-TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 405 VSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC 464
+ ++G L E++ ++ L G + + +GL+YLHE+
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG-AFKEAVI-INYTEQLLRGLSYLHEN- 122
Query: 465 HPRIIHRDIKSSNILLDYTFE-TKVADFGLA-KLTTD--NNTHVSTRVMGTFGYLAPEYA 520
+IIHRD+K +N+L+D T + ++ADFG A +L +++GT ++APE
Sbjct: 123 --QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 521 SSGKLTEKSDVFSFGVMLLELITGRRP 547
+ DV+S G +++E+ T + P
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 74/243 (30%), Positives = 111/243 (45%), Gaps = 45/243 (18%)
Query: 341 LSAATGGFSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV 399
L TG F ++G+G +G V+K G+ VA+K + E E K E I+ +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI-IEDEEEEIKEEYNILRKY 59
Query: 400 -HHRHLVSLVG------YCIAGGKRLLVYEYVPNN---NLEFHLHGKGRPVMDWPTRLK- 448
+H ++ + G + LV E +L L KG+ RLK
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK-------RLKE 112
Query: 449 -----IAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGL-AKLTTDN-- 500
I + +GLAYLHE+ ++IHRDIK NILL E K+ DFG+ A+L +
Sbjct: 113 EWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR 169
Query: 501 -NTHVSTRVMGTFGYLAPEY-ASSGKLTE----KSDVFSFGVMLLELITGRRP---IDPT 551
NT + GT ++APE A + +SDV+S G+ +EL G+ P + P
Sbjct: 170 RNTFI-----GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM 224
Query: 552 GAM 554
A+
Sbjct: 225 RAL 227
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 66/222 (29%), Positives = 108/222 (48%), Gaps = 30/222 (13%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKA-------EVEIISRV 399
F + N +G+G +G V++ +G+ VA+K +R + E E+ ++ +
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRM-----DNERDGIPISSLREITLLLNL 63
Query: 400 HHRHLVSLVGYCIAGGKRL----LVYEYVPNNNLEFHLHGKGRPVMDWPTRLK-IAMGSA 454
H ++V L + GK L LV EY +L L P + +++K + +
Sbjct: 64 RHPNIVELKE--VVVGKHLDSIFLVMEYC-EQDLASLLDNMPTPFSE--SQVKCLMLQLL 118
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGY 514
+GL YLHE+ IIHRD+K SN+LL K+ADFGLA+ ++ +V+ T Y
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWY 174
Query: 515 LAPEYA-SSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAME 555
APE T D+++ G +L EL+ +P+ P G E
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAH-KPLLP-GKSE 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 61/216 (28%), Positives = 90/216 (41%), Gaps = 31/216 (14%)
Query: 354 LGQGGFGYVHKGVLPNGKEVA---VKSLR-SGSGQGEREFKAEVEIISRVHHRHLVSLVG 409
+G G FG V G G A VK LR S + + F EV+ ++H +++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 410 YCIAGGKRLLVYEYVPNNNLEFHLHG-KGRPVMDWPTRLKIAMGS--AKGLAYLHEDCHP 466
CI LLV E+ P +L+ +L +G + M A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLA-------KLTTDNNTHVSTRVMGTFGYLAPEY 519
IH D+ N L K+ D+GLA T + V R +LAPE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR------WLAPEL 173
Query: 520 ASS-------GKLTEKSDVFSFGVMLLELIT-GRRP 547
T+KS+++S GV + EL T +P
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 43/217 (19%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKA--------EVEIISRV-HHRH 403
LG G FG V+ G+ VA+K ++ ++F + EV+ + ++ H +
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 404 LVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHED 463
+V L + V+EY+ N + KG+P I +GLA++H+
Sbjct: 60 IVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKP-FSESVIRSIIYQILQGLAHIHK- 117
Query: 464 CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH---VSTRVMGTFGYLAPE-- 518
H HRD+K N+L+ K+ADFGLA+ + VSTR Y APE
Sbjct: 118 -H-GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WYRAPEIL 170
Query: 519 -----YASSGKLTEKSDVFSFGVMLLELITGRRPIDP 550
Y+S D+++ G ++ EL T RP+ P
Sbjct: 171 LRSTSYSS------PVDIWALGCIMAELYTL-RPLFP 200
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 71/224 (31%), Positives = 100/224 (44%), Gaps = 35/224 (15%)
Query: 353 LLGQGGFGYVHKGVLPNGKEV-AVKSLRSGSGQGEREFKAEV-----EIISRVHHRHLVS 406
+LG+G FG V L E A+K+L K +V ++ + R +++
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKAL-----------KKDVVLEDDDVECTMVERRVLA 50
Query: 407 LVG--------YCIAGGKRLL--VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKG 456
L +C K L V EY+ +L FH+ GR D A G
Sbjct: 51 LAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR--FDEARARFYAAEIICG 108
Query: 457 LAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLA 516
L +LH+ II+RD+K N+LLD K+ADFG+ K + ST GT Y+A
Sbjct: 109 LQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIA 164
Query: 517 PEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVD 560
PE K E D +SFGV+L E++ G+ P G ED L D
Sbjct: 165 PEILKGQKYNESVDWWSFGVLLYEMLIGQSPF--HGEDEDELFD 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 64/206 (31%), Positives = 92/206 (44%), Gaps = 12/206 (5%)
Query: 354 LGQGGFGYVHKGVL-PNGKEVAVKSL---RSGSGQGEREFKAEVEIISRVHHRHLVSLVG 409
LG+GGFG V + GK A K L R +G E I+++VH R +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 410 YCIAGGKRLLVYEYVPNNNLEFHLHG--KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR 467
LV + +L +H++ + P P GL +LH+ R
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTR-VMGTFGYLAPEYASSGKLT 526
II+RD+K N+LLD +++D GLA D + T+ GT G++APE +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGFMAPELLQGEEYD 175
Query: 527 EKSDVFSFGVMLLELITGRRPIDPTG 552
D F+ GV L E+I R P G
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFRARG 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 66/223 (29%), Positives = 100/223 (44%), Gaps = 32/223 (14%)
Query: 354 LGQGGFGYVH------------KGVLPNGKE-----VAVKSLRSGSGQGER-EFKAEVEI 395
LG+G FG VH K N VAVK LR + R +F EV+I
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 396 ISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLH---------GKGRPVMDWPTR 446
+SR+ ++ L+G C ++ EY+ N +L L + + T
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 447 LKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK-LTTDNNTHVS 505
L +A A G+ YL +HRD+ + N L+ + K+ADFG+++ L + + V
Sbjct: 133 LYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 506 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
R ++A E GK T KSDV++FGV L E++T R
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 21/218 (9%)
Query: 348 FSQSNLLGQGGFGYVHKGVL--PNGK--EVAVKSLR-SGSGQGE-REFKAEVEIISRVHH 401
+LG+G FG V +G L +G +VAVK+++ E EF +E + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 402 RHLVSLVGYCIAGGKR------LLVYEYVPNNNLE---FHLHGKGRPV-MDWPTRLKIAM 451
+++ L+G C +++ ++ + +L + G P + T LK +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 452 GSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGT 511
A G+ YL IHRD+ + N +L VADFGL+K + + R+
Sbjct: 121 DIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 512 -FGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
++A E + T KSDV++FGV + E+ T G+ P
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 6e-16
Identities = 66/217 (30%), Positives = 109/217 (50%), Gaps = 15/217 (6%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLR--SGSGQGEREFKA---EVEIISRVHH 401
+ + LLGQG FG V+ + G+E+A K ++ S + +E A E++++ + H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 402 RHLVSLVGYCIAGGKRLLV--YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAY 459
+V G ++ L EY+P +++ L G + + TR K +G++Y
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG-ALTESVTR-KYTRQILEGMSY 121
Query: 460 LHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK-LTTDNNTHVSTR-VMGTFGYLAP 517
LH + I+HRDIK +NIL D K+ DFG +K L T + R V GT +++P
Sbjct: 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
Query: 518 EYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAM 554
E S K+DV+S G ++E++T + P AM
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 68/215 (31%), Positives = 101/215 (46%), Gaps = 31/215 (14%)
Query: 354 LGQGGFGYV-HKGVLPNGKEVAVKSLRSGSGQGERE----FKAEVEIISRVHHRHLVSLV 408
+G G FG V + + VA+K + S SG+ E EV + ++ H + +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKM-SYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 409 GYCIAGGKRLLVYEYV---PNNNLEFHLHGKGRPVMDWPTRLKIA---MGSAKGLAYLHE 462
G + LV EY ++ LE H +P+ + ++IA G+ +GLAYLH
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDILEVH----KKPLQE----VEIAAICHGALQGLAYLHS 133
Query: 463 DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEY--- 519
IHRDIK+ NILL K+ADFG A L + N+ V GT ++APE
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILA 185
Query: 520 ASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAM 554
G+ K DV+S G+ +EL + P+ AM
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 44/110 (40%), Positives = 65/110 (59%), Gaps = 9/110 (8%)
Query: 448 KIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN--NTHVS 505
KI++ +GL YL E H +I+HRD+K SNIL++ E K+ DFG++ D+ N+ V
Sbjct: 103 KISIAVLRGLTYLREK-H-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 160
Query: 506 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAME 555
TR Y++PE T +SD++S G+ L+E+ GR PI P A E
Sbjct: 161 TR-----SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE 205
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 7e-16
Identities = 62/236 (26%), Positives = 115/236 (48%), Gaps = 29/236 (12%)
Query: 354 LGQGGFGYVHKG-VLPNGKEVAVKSLRSG-SGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
LG G G V+K L + +AVK + + + +++ +E+EI+ + +++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHR 471
+ + E++ +L+ ++ K + +IA+ KGL YL +I+HR
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRK----IPEHVLGRIAVAVVKGLTYLWS---LKILHR 119
Query: 472 DIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 531
D+K SN+L++ + K+ DFG++ ++ ++ +GT Y+APE S + SDV
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGEQYGIHSDV 176
Query: 532 FSFGVMLLELITGRRP----------IDPTGAMEDCLVDWARPLCLRALDDGNFNE 577
+S G+ +EL GR P + P ++ C+VD P+ L G F+E
Sbjct: 177 WSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ-CIVDEDPPV----LPVGQFSE 227
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 8e-16
Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 58/232 (25%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE-FKA----EVEIISRVHHRHLVSL 407
LG+G FG V+K + G+ VA+K + + E++ F E++I+ ++ H ++V L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHN---EKDGFPITALREIKILKKLKHPNVVPL 72
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKG-----RPVMDWP-------TRLKIAMGSAK 455
+ + E +G P MD +K+ K
Sbjct: 73 ID---------MAVERPDK-----SKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK 118
Query: 456 --------GLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN------- 500
G+ YLHE+ I+HRDIK++NIL+D K+ADFGLA+
Sbjct: 119 CYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 501 ---NTHVSTRVMGTFGYLAPEY-ASSGKLTEKSDVFSFGVMLLELITGRRPI 548
T T ++ T Y PE + T D++ G + E+ T RRPI
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 8e-16
Identities = 54/204 (26%), Positives = 69/204 (33%), Gaps = 16/204 (7%)
Query: 8 PGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPD----------RSP 57
P + AA PP+ S A PPP++ PPP PPP S P R P
Sbjct: 2807 PPAAVLAPAAALPPAASPAGPLPPPTSAQPTAPPPPPGPPPPSLPLGGSVAPGGDVRRRP 2866
Query: 58 PPSSPPPSPESPPP------SSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPP 111
P SP P +P + P S + + PP + PPQ PP P PQ PP
Sbjct: 2867 PSRSPAAKPAAPARPPVRRLARPAVSRSTESFALPPDQPERPPQPQAPPPPQPQPQPPPP 2926
Query: 112 PSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNK 171
P PPP + P P D P G G ++
Sbjct: 2927 PQPQPPPPPPPRPQPPLAPTTDPAGAGEPSGAVPQPWLGALVPGRVAVPRFRVPQPAPSR 2986
Query: 172 NWHPPPPPSSSSNSPNGNRSGALS 195
P + +S + S A S
Sbjct: 2987 EAPASSTPPLTGHSLSRVSSWASS 3010
|
Length = 3151 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 9e-16
Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKA--EVEIISRVHHRHLVSLVGY 410
+G+G +G V+K G+ VA+K ++ A E++++ ++H +++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 411 CIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAM-GSAKGLAYLHEDCHPRII 469
G LV+E++ + + + + R + + +K + +GLA+ H I+
Sbjct: 67 FRHKGDLYLVFEFMDTDLYKL-IKDRQRGLP--ESLIKSYLYQLLQGLAFCHSH---GIL 120
Query: 470 HRDIKSSNILLDYTFETKVADFGLAK-LTTDNN--TH-VSTRVMGTFGYLAPE--YASSG 523
HRD+K N+L++ K+ADFGLA+ + TH V TR Y APE G
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDKG 175
Query: 524 KLTEKSDVFSFGVMLLELITGRRPIDP 550
+ D++S G + EL++ RRP+ P
Sbjct: 176 -YSTPVDIWSVGCIFAELLS-RRPLFP 200
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 353 LLGQGGFGYVHKG-VLPNGKEVAVKSL-RSGSGQGEREFKAEVEIISRVHH-RHLVSLVG 409
+G G G V+K G +AVK + R+G+ + + +++++ + H ++V G
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81
Query: 410 YCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRL--KIAMGSAKGLAYLHEDCHPR 467
Y I + E + + L+ L P+ P + K+ + K L YL E H
Sbjct: 82 YFITDSDVFICMELM-STCLDKLLKRIQGPI---PEDILGKMTVAIVKALHYLKEK-H-G 135
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTE 527
+IHRD+K SNILLD + K+ DFG++ D+ TR G Y+APE
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERIDPPDPNP 193
Query: 528 K----SDVFSFGVMLLELITGRRP 547
K +DV+S G+ L+EL TG+ P
Sbjct: 194 KYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 69/222 (31%), Positives = 110/222 (49%), Gaps = 38/222 (17%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLR-SGSGQGE-----REFKAEVEIISRVH 400
+ + +G+G +G V+K L G+ VA+K +R S +G RE A ++ +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI-ALLKQLESFE 59
Query: 401 HRHLVSLVGYCIAGGKRL-------LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGS 453
H ++V L+ C G R LV+E+V + +L +L +P + P +K M
Sbjct: 60 HPNIVRLLDVCH--GPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLP-PETIKDLMRQ 115
Query: 454 -AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTF 512
+G+ +LH H RI+HRD+K NIL+ + K+ADFGLA++ + T V+ T
Sbjct: 116 LLRGVDFLH--SH-RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTL 170
Query: 513 GYLAPE------YASSGKLTEKSDVFSFGVMLLELITGRRPI 548
Y APE YA+ D++S G + EL RRP+
Sbjct: 171 WYRAPEVLLQSSYATP------VDMWSVGCIFAELFR-RRPL 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-15
Identities = 52/226 (23%), Positives = 77/226 (34%), Gaps = 10/226 (4%)
Query: 1 MEDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPS 60
SP PP+P AS PPPS P P PP P
Sbjct: 99 SPAREGSPTPPGPSSPDPPPPTPPPAS--PPPSPAPDLSEMLRPVGSPGPPPAASPPAAG 156
Query: 61 SPPPSPESPPPSSPPPS--SQSPPQS--PPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSN 116
+ P + S SS + SP ++ P PP S+PP +P P P +++
Sbjct: 157 ASPAAVASDAASSRQAALPLSSPEETARAPSSPPAEPPPSTPPAAASPRPPRRSSPISAS 216
Query: 117 ASPPPSQ--DNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWH 174
AS P + +D S++ SS + + W+
Sbjct: 217 ASSPAPAPGRSAADDAGASSSDSSSSESSGCGWGPENECPLPRPAPITLPTRIWEASGWN 276
Query: 175 PPP--PPSSSSNSPNGNRSGALSPPNKSNGSSSSPSSNNGSMLSIP 218
P P +SS+S RS + SP + +G + S + S S
Sbjct: 277 GPSSRPGPASSSSSPRERSPSPSPSSPGSGPAPSSPRASSSSSSSR 322
|
Length = 1352 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 30/127 (23%), Positives = 42/127 (33%), Gaps = 3/127 (2%)
Query: 2 EDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSS 61
++ ++ V+ + P + +S+ P P S P PP P
Sbjct: 155 DEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPSDSSLPP 214
Query: 62 PPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPP 121
P S +S P P S +P P P PP PP + P PPS S P
Sbjct: 215 APSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPT---PPSASATPAPI 271
Query: 122 SQDNPSD 128
D
Sbjct: 272 GGITLDD 278
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 35/129 (27%), Positives = 46/129 (35%)
Query: 12 NSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPP 71
P E A+++ S P D P +SP P SPP P SP
Sbjct: 150 PGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPSD 209
Query: 72 SSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPP 131
SS PP+ S PPP+ +SP SPPP PP ++ P+ + S P
Sbjct: 210 SSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSASATPA 269
Query: 132 GDSNNGSSP 140
Sbjct: 270 PIGGITLDD 278
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 19/206 (9%)
Query: 354 LGQGGFGYVHKGVLPN------GKEVAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVS 406
LGQG FG V++G + VAVK++ + ER EF E ++ H+V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHL--------HGKGRPVMDWPTRLKIAMGSAKGLA 458
L+G G L+V E + + +L+ +L + GRP +++A A G+A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 459 YLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH-VSTRVMGTFGYLAP 517
YL+ + +HRD+ + N ++ + F K+ DFG+ + + + + + + ++AP
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 518 EYASSGKLTEKSDVFSFGVMLLELIT 543
E G T SD++SFGV+L E+ +
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 354 LGQGGFGYVHKGVLPN-GKEVAVKSL---RSGSGQGEREFKAEVEIISRVHHRHLVSLVG 409
LG+GGFG V + N GK A K L R GE+ E EI+ +V+ +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 410 YCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRI 468
Y L LV + +L++H++ G ++ + + G+ +LH I
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDI 116
Query: 469 IHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEK 528
++RD+K N+LLD +++D GLA D T T+ GT GY+APE +
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSYP 174
Query: 529 SDVFSFGVMLLELITGRRP 547
D F+ G + E++ GR P
Sbjct: 175 VDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 31/218 (14%)
Query: 354 LGQGGFGYVH----KGVLPNGKE-------------VAVKSLRSGSGQGER-EFKAEVEI 395
LG+G FG VH +G+ + VAVK LR + + R +F E++I
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 396 ISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHL---------HGKGRPVMDWPTR 446
+SR+ +++ L+ CI ++ EY+ N +L L + + T
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 447 LKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK-LTTDNNTHVS 505
+ +A A G+ YL +HRD+ + N L+ + K+ADFG+++ L + + +
Sbjct: 133 IFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 506 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 543
R + +++ E GK T SDV++FGV L E++T
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 53/211 (25%), Positives = 97/211 (45%), Gaps = 14/211 (6%)
Query: 345 TGGFSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLR----SGSGQGEREFKAEVEIISRV 399
G F +G+G F V+K + L +G+ VA+K ++ + + K E++++ ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL 59
Query: 400 HHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEF---HLHGKGRPVMDWPTRLKIAMGSAKG 456
H +++ + I + +V E +L H + R + T K +
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLI-PERTIWKYFVQLCSA 118
Query: 457 LAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLA 516
L ++H RI+HRDIK +N+ + T K+ D GL + + T + V GT Y++
Sbjct: 119 LEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMS 174
Query: 517 PEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
PE KSD++S G +L E+ + P
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 66/205 (32%), Positives = 91/205 (44%), Gaps = 25/205 (12%)
Query: 354 LGQGGFGYVHK-GVLPNGKEVAVKSLRSGS----GQGEREFKAEVEIISRVHHRHLVSLV 408
LG GGFG V V + A+K ++ GQ + +E EI+ +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECNHPFIVKLY 59
Query: 409 GYCIAGGKRLLVY---EYVPNNNLEFHLHGKGRPVMD-WPTRLKIA-MGSAKGLAYLHED 463
+ +Y EY L L +G D + R IA + A YLH
Sbjct: 60 RTF---KDKKYIYMLMEYCLGGELWTILRDRGL--FDEYTARFYIACVVLA--FEYLHNR 112
Query: 464 CHPRIIHRDIKSSNILLDYTFETKVADFGLAK-LTTDNNTHVSTRVMGTFGYLAPEYASS 522
II+RD+K N+LLD K+ DFG AK L + T T GT Y+APE +
Sbjct: 113 ---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEIILN 166
Query: 523 GKLTEKSDVFSFGVMLLELITGRRP 547
D +S G++L EL+TGR P
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 59/217 (27%), Positives = 109/217 (50%), Gaps = 26/217 (11%)
Query: 354 LGQGGFGYVHKG--VLP---NGKEVAVKSLRS-GSGQGEREFKAEVEIISRVHHRHLVSL 407
LG+ FG ++KG LP + + VA+K+L+ + Q EF+ E +++ +HH ++V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 408 VGYCIAGGKRLLVYEYVPNNNL-EFHL--------------HGKGRPVMDWPTRLKIAMG 452
+G +++EY+ +L EF + G + +D L IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 453 SAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK-LTTDNNTHVSTRVMGT 511
A G+ YL +H+D+ + NIL+ K++D GL++ + + + V + +
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 512 FGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
++ PE GK + SD++SFGV+L E+ + G +P
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 14/202 (6%)
Query: 354 LGQGGFGYVHKGVL---PNGKEVAVKSLRSGSGQG--EREFKAEVEIISRVHHRHLVSLV 408
LG G FG V KG+ + K VAVK L++ + + E E ++ ++ + ++V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 409 GYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRI 468
G C +LV E L L K + V + ++ + G+ YL E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQ-KNKHVTE-KNITELVHQVSMGMKYLEET---NF 116
Query: 469 IHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTF--GYLAPEYASSGKLT 526
+HRD+ + N+LL K++DFGL+K + + + G + + APE + K +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 527 EKSDVFSFGVMLLELIT-GRRP 547
KSDV+SFGV++ E + G++P
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 75/275 (27%), Positives = 120/275 (43%), Gaps = 33/275 (12%)
Query: 353 LLGQGGFGYV----HKGVLPNGKEVAVKSLRSGSGQGEREFKA--EVEIISRVHHRHLVS 406
L+G+G +G V HK G+ VA+K + A E+ ++ ++ H +LV+
Sbjct: 8 LVGEGSYGMVMKCKHK---ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVN 64
Query: 407 LVGYCIAGGKRLLVYEYVPN---NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHED 463
L+ + LV+E+V + ++LE + +G +D K +G+ + H
Sbjct: 65 LIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-----LDESRVRKYLFQILRGIEFCHSH 119
Query: 464 CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEY-ASS 522
IIHRDIK NIL+ + K+ DFG A+ T V T + T Y APE
Sbjct: 120 ---NIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLVGD 175
Query: 523 GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582
K D+++ G ++ E++TG P+ P + D L + CL GN
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTG-EPLFPGDSDIDQLYHIIK--CL-----GNLIPRHQEI 227
Query: 583 LEKNYPTEEMARMVACAAASIRHSARRRPKISQIV 617
+KN A M I +R PK+S +V
Sbjct: 228 FQKNPL---FAGMRLPEVKEIEPLEKRFPKLSGLV 259
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 7e-15
Identities = 57/210 (27%), Positives = 104/210 (49%), Gaps = 40/210 (19%)
Query: 354 LGQGGFGYV----HKGVLPNGKEVAVK--SLRSGSGQGEREFKAEVEIISRVHHRHLVS- 406
+G+G +G V H+ +GK+ +K +LR+ S + + + E +++S++ H ++V+
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 407 -------------LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGS 453
++G+C G +Y + + V++W ++IAM
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGD----LYHKLKEQKGKLLPE---NQVVEW--FVQIAMA- 114
Query: 454 AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFG 513
L YLHE I+HRD+K+ N+ L T KV D G+A++ + ST ++GT
Sbjct: 115 ---LQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPY 167
Query: 514 YLAPEYASSGKLTEKSDVFSFGVMLLELIT 543
Y++PE S+ KSDV++ G + E+ T
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 8e-15
Identities = 33/118 (27%), Positives = 41/118 (34%), Gaps = 3/118 (2%)
Query: 25 RASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPP-PSSQSPPQ 83
+ P P P +E +S SP PP SSP PS SPP+
Sbjct: 143 KEGEDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPE 202
Query: 84 SPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPP 141
P P+ S P P + P S +N SPPP P PP S+
Sbjct: 203 DPSSPSDSSLP--PAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAK 258
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 8e-15
Identities = 65/230 (28%), Positives = 107/230 (46%), Gaps = 50/230 (21%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE-FKA----EVEIISRVHH 401
F +G+G +G V+K G+ VA+K +R E+E F E++I+ +++H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL---DNEKEGFPITAIREIKILRQLNH 65
Query: 402 RHLVSL----------VGYCIAGGKRLLVYEYVPNNNL-----------EFHLHGKGRPV 440
R++V+L + + G LV+EY+ ++ + E H+ + +
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL 125
Query: 441 MDWPTRLKIAMGSAKGLAYLHEDCHPR-IIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499
++ GL Y CH + +HRDIK SNILL+ + K+ADFGLA+L
Sbjct: 126 LE-------------GLNY----CHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168
Query: 500 NNTHVSTRVMGTFGYLAPE-YASSGKLTEKSDVFSFGVMLLELITGRRPI 548
+ T + T Y PE + DV+S G +L EL T ++PI
Sbjct: 169 EESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-15
Identities = 57/191 (29%), Positives = 93/191 (48%), Gaps = 9/191 (4%)
Query: 354 LGQGGFGYVHKGVL-PNGKEVAVKSLRSG-SGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
+G+G FG V G L + VAVKS R + +F E I+ + H ++V L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHR 471
+V E V + L +G P + +++ +A G+ YL IHR
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH---CIHR 118
Query: 472 DIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTF--GYLAPEYASSGKLTEKS 529
D+ + N L+ K++DFG+++ D + ST M + APE + G+ + +S
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDG-VYASTGGMKQIPVKWTAPEALNYGRYSSES 177
Query: 530 DVFSFGVMLLE 540
DV+SFG++L E
Sbjct: 178 DVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 84/292 (28%), Positives = 128/292 (43%), Gaps = 28/292 (9%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE-FKAEVEIISRVHHRHLV 405
F++ +G+G FG V KG+ K VA+K + + E E + E+ ++S+ ++
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 406 SLVGYCIAGGKRLLVYEYVPNNN-LEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC 464
G + K ++ EY+ + L+ G +D I KGL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSE- 120
Query: 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGK 524
+ IHRDIK++N+LL E K+ADFG+A TD +T V GT ++APE
Sbjct: 121 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSA 177
Query: 525 LTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLE 584
K+D++S G+ +EL G P M+ L + N P LE
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHSELHPMK----------VLFLIPKNN-----PPTLE 222
Query: 585 KNY--PTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSLEDLNDGIK 634
NY P +E S R +A+ K IVR + L +L D K
Sbjct: 223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKTSYLTELIDRYK 274
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 23/211 (10%)
Query: 354 LGQGGFGYVHKGVLPNGKE-VAVKSLRSGSGQGEREFK---AEVEIISRVHHRHLVSLVG 409
+G G FG V+ + E VAVK + Q +++ EV+ + ++ H + + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 410 YCIAGGKRLLVYEYV---PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHP 466
+ LV EY ++ LE H +P+ + I G+ +GLAYLH
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIA-AITHGALQGLAYLHSHN-- 141
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEY---ASSG 523
+IHRDIK+ NILL + K+ADFG A ++ N+ V GT ++APE G
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEG 195
Query: 524 KLTEKSDVFSFGVMLLELITGRRPIDPTGAM 554
+ K DV+S G+ +EL + P+ AM
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNAM 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 20/218 (9%)
Query: 353 LLGQGGFGYVHKGVL--PNGKE--VAVKSLRSG-SGQGEREFKAEVEIISRVHHRHLVSL 407
+LG G FG + +G L P+ +E VA+ +LR+G S + R F AE + + H ++V L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR 467
G G ++V EY+ N L+ L K + + + G A G+ YL E +
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLR-KHEGQLVAGQLMGMLPGLASGMKYLSEMGY-- 128
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYL--APEYASSGKL 525
+H+ + + +L++ K++ F +L D + + T + G L APE
Sbjct: 129 -VHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHF 185
Query: 526 TEKSDVFSFGVMLLELIT-GRRPI------DPTGAMED 556
+ SDV+SFG+++ E+++ G RP D A+ED
Sbjct: 186 SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVED 223
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 27/203 (13%)
Query: 354 LGQGGFGYVHKGVL----PNGKEVAVKSLR-SGSGQGER-EFKAEVEIISRVHHRHLVSL 407
+G+G FG K +L +GK+ +K + S ER E + EV ++S + H ++V
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHG-KG-----RPVMDWPTRLKIAMGSAKGLAYLH 461
G +V +Y +L ++ +G ++DW ++ +A L ++H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVH 118
Query: 462 EDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRV-MGTFGYLAPEYA 520
+ +I+HRDIKS NI L K+ DFG+A++ N+T R +GT YL+PE
Sbjct: 119 DR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTVELARTCIGTPYYLSPEIC 173
Query: 521 SSGKLTEKSDVFSFGVMLLELIT 543
+ KSD+++ G +L E+ T
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 61/202 (30%), Positives = 92/202 (45%), Gaps = 11/202 (5%)
Query: 353 LLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKA---EVEIISRVHHRHLVSLV 408
+LG+G FG V L +G+ AVK L+ + + + E I+S + ++ +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 409 GYCIAGGKRLL-VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR 467
C RL V E+V +L FH+ R D A L +LH+
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEITSALMFLHDK---G 116
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTE 527
II+RD+K N+LLD+ K+ADFG+ K N ST GT Y+APE
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEILQEMLYGP 175
Query: 528 KSDVFSFGVMLLELITGRRPID 549
D ++ GV+L E++ G P +
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 37/130 (28%), Positives = 47/130 (36%), Gaps = 2/130 (1%)
Query: 2 EDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSS 61
ED N P + + A+ + S S + P S P S P P P S
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPS 205
Query: 62 PPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPP 121
P PP S S PP P N PP + PP PP Q PP S + +PP
Sbjct: 206 SPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPP--PPPVQQVPPLSTAKPTPPS 263
Query: 122 SQDNPSDPPP 131
+ P+
Sbjct: 264 ASATPAPIGG 273
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 57/224 (25%), Positives = 97/224 (43%), Gaps = 47/224 (20%)
Query: 355 GQGGFGYVHKGVLPN---GKEVAVKSLRSGSGQGE-------REFKAEVEIISRVHHRHL 404
G+G +G V+K N GKE A+K + Q RE + ++ + H ++
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALLRELKHENV 64
Query: 405 VSLVGYCIAGGKRL--LVYEYVPNNNLE---FHLHGKGRPVMDWPTR-LKIAMGSA-KGL 457
VSLV + + L+++Y ++ + FH K + P +K + G+
Sbjct: 65 VSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSI---PPSMVKSLLWQILNGV 121
Query: 458 AYLHEDCHPRIIHRDIKSSNILL----DYTFETKVADFGLAK--------LTTDNNTHVS 505
YLH + ++HRD+K +NIL+ K+ D GLA+ L +
Sbjct: 122 HYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD----- 173
Query: 506 TRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGRRPI 548
V+ T Y APE + T+ D+++ G + EL+T PI
Sbjct: 174 -PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 58/234 (24%), Positives = 97/234 (41%), Gaps = 66/234 (28%)
Query: 352 NLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKA---------EVEIISRVHH 401
+G G +G V V G++VA+K + F E++++ + H
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRH 58
Query: 402 RHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDW-PTRLK--IAMGSA---- 454
+++ L +L + N + ++ V + T L I
Sbjct: 59 ENIIGL--------LDILRPPSPEDFN-DVYI------VTELMETDLHKVIKSPQPLTDD 103
Query: 455 ----------KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT-- 502
+GL YLH + +IHRD+K SNIL++ + K+ DFGLA+ +
Sbjct: 104 HIQYFLYQILRGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160
Query: 503 -----HVSTRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELITGRRPIDP 550
+V TR Y APE SS + T+ D++S G + EL+T R+P+ P
Sbjct: 161 GFLTEYVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLT-RKPLFP 208
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 353 LLGQGGFGYVHKGVL----PNGKEVAVKSLRSG----SGQGEREFKAEVEIISRVHHRHL 404
+LG+GG+G V + GK A+K L+ + + KAE I+ V H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 405 VSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMD----WPTRLKIAMGSAKGLAYL 460
V L+ GGK L+ EY+ L HL +G + D + + + +A+ +L
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALE------HL 116
Query: 461 HEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYA 520
H II+RD+K NILLD K+ DFGL K + T V+ GT Y+APE
Sbjct: 117 H---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEIL 172
Query: 521 SSGKLTEKSDVFSFGVMLLELITGRRP 547
+ D +S G ++ +++TG P
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-14
Identities = 50/224 (22%), Positives = 68/224 (30%), Gaps = 26/224 (11%)
Query: 8 PGVSNSPDAAETP----PSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPP 63
S S P P+ A+ P + P SP PPP+S P PPP PP
Sbjct: 2787 AVASLSESRESLPSPWDPADPPAAVLAPAAALPPAASPAGPLPPPTSAQPTAPPPPPGPP 2846
Query: 64 PSPES--------------PPPSSPPPSSQSP--------PQSPPPPNSKSPPQSSPPPN 101
P PP SP +P + +++S P
Sbjct: 2847 PPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRRLARPAVSRSTESFALPPDQPE 2906
Query: 102 TNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNH 161
P PQ+ PPP PPP Q P PPP +P +
Sbjct: 2907 RPPQPQAPPPPQPQPQPPPPPQPQPPPPPPPRPQPPLAPTTDPAGAGEPSGAVPQPWLGA 2966
Query: 162 NNNNNNNNNKNWHPPPPPSSSSNSPNGNRSGALSPPNKSNGSSS 205
+ P P PS + + + S S+ +SS
Sbjct: 2967 LVPGRVAVPRFRVPQPAPSREAPASSTPPLTGHSLSRVSSWASS 3010
|
Length = 3151 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSG-SGQGEREFKAEVEIISR-VHHRHLVSLVGY 410
LG+G +G V K +P G +AVK +R+ + Q ++ +++I R V + V+ G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 411 CIAGGKRLLVYEYVPNNNLEF--HLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRI 468
G + E + + +F ++ KG + + KIA+ K L YLH +
Sbjct: 69 LFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPE-DILGKIAVSIVKALEYLHSKLS--V 125
Query: 469 IHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEY----ASSGK 524
IHRD+K SN+L++ + K+ DFG++ D + T G Y+APE +
Sbjct: 126 IHRDVKPSNVLINRNGQVKLCDFGISGYLVD--SVAKTIDAGCKPYMAPERINPELNQKG 183
Query: 525 LTEKSDVFSFGVMLLELITGRRPID 549
KSDV+S G+ ++EL TGR P D
Sbjct: 184 YDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 15/196 (7%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCI 412
LG G FG V+K G A K + + S + ++ E+EI++ +H ++V L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 413 AGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRD 472
GK ++ E+ P ++ + R + + P I + L YLH +IIHRD
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTE-PQIQVICRQMLEALQYLHSM---KIIHRD 135
Query: 473 IKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTR--VMGTFGYLAPEYASSGKLTE--- 527
+K+ N+LL + K+ADFG ++ N + R +GT ++APE + +
Sbjct: 136 LKAGNVLLTLDGDIKLADFG---VSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPY 192
Query: 528 --KSDVFSFGVMLLEL 541
K+D++S G+ L+E+
Sbjct: 193 DYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 52/201 (25%), Positives = 99/201 (49%), Gaps = 10/201 (4%)
Query: 354 LGQGGFG--YVHKGVLPNGKEVAVK--SLRSGSGQGEREFKAEVEIISRVHHRHLVSLVG 409
+G+G FG Y+ K + + +K L + + K EV +++++ H ++V+
Sbjct: 8 IGEGSFGKIYLAKAKSDS-EHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 410 YCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRII 469
G+ +V EY +L ++ + + L + + GL ++H+ +I+
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KIL 123
Query: 470 HRDIKSSNILLDYT-FETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEK 528
HRDIKS NI L K+ DFG+A+ +++ ++ +GT YL+PE + K
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYTCVGTPYYLSPEICQNRPYNNK 182
Query: 529 SDVFSFGVMLLELITGRRPID 549
+D++S G +L EL T + P +
Sbjct: 183 TDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 3e-14
Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 23/217 (10%)
Query: 348 FSQSNLLGQGGFGYVHKGVLPNGKEV-AVKSLRSGSGQGEREFK---AEVEIISRVHHRH 403
F+ +G G FG V+ EV A+K + Q +++ EV+ + R+ H +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 404 LVSLVGYCIAGGKRLLVYEYV---PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYL 460
+ G + LV EY ++ LE H +P+ + I G+ +GLAYL
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIA-AITHGALQGLAYL 141
Query: 461 HEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEY- 519
H +IHRDIK+ NILL + K+ADFG A + + N+ V GT ++APE
Sbjct: 142 HSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVI 193
Query: 520 --ASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAM 554
G+ K DV+S G+ +EL + P+ AM
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 230
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 60/209 (28%), Positives = 106/209 (50%), Gaps = 26/209 (12%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKA-----EVEIISRVHHRHLVSL 407
+G+G +G V+K G+ VA+K +R + E E E+ ++ ++H ++V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRL---ETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGS-AKGLAYLHEDCHP 466
+ + K LV+E++ + +L+ ++ +D P +K + +G+AY CH
Sbjct: 64 LDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLD-PPLIKSYLYQLLQGIAY----CHS 117
Query: 467 -RIIHRDIKSSNILLDYTFETKVADFGLAK---LTTDNNTHVSTRVMGTFGYLAPEYASS 522
R++HRD+K N+L+D K+ADFGLA+ + TH V+ T Y APE
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWYRAPEILLG 173
Query: 523 GKLTEKS-DVFSFGVMLLELITGRRPIDP 550
+ D++S G + E++ RRP+ P
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVN-RRPLFP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 64/202 (31%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 353 LLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFK---AEVEIISRV-HHRHLVSL 407
+LG+G FG V L + A+K+L+ + + + E ++S H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 408 VGYCIAGGKRLL--VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCH 465
YC K L V EY+ +L FH+ + D P A GL +LH
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHSK-- 115
Query: 466 PRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKL 525
I++RD+K NILLD K+ADFG+ K + T GT Y+APE K
Sbjct: 116 -GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLGQKY 173
Query: 526 TEKSDVFSFGVMLLELITGRRP 547
D +SFGV+L E++ G+ P
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 6e-14
Identities = 72/385 (18%), Positives = 107/385 (27%), Gaps = 60/385 (15%)
Query: 8 PGVSNSPDAAETPPSPSRASSSPPPSTPP-------------------SDES---PPPSS 45
PG PD + PP+PSR + + P P SD++ PPP
Sbjct: 2498 PGGGGPPDP-DAPPAPSRLAPAILPDEPVGEPVHPRMLTWIRGLEELASDDAGDPPPPLP 2556
Query: 46 PPPSSPPPDRSPPPSSPPPSPESPP-------PSSPPPSSQSPPQSPPPPNSKSPPQSSP 98
P PDRS PP P P P P P +PP S++ + + P SP
Sbjct: 2557 PAAPPAAPDRSVPPPRPAPRPSEPAVTSRARRPDAPPQSARPRAPVDDRGDPRGPAPPSP 2616
Query: 99 PPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGN 158
P P PP + A+ P P+ PPP + +P + G
Sbjct: 2617 LPPDTHAPDPPPPSPSPAANEPDPHPPPTVPPPERPRDDPAPGRVSRPRRARRLGRAAQA 2676
Query: 159 GNHNNNNNNNNNKN--------WHPPPPPSSSSNSPNGNRSGALSPPNKSNGSSSSPSSN 210
+ + PPPPP + +P+ S PP + +SP+
Sbjct: 2677 SSPPQRPRRRAARPTVGSLTSLADPPPPPPTPEPAPHALVSATPLPPGPAAARQASPALP 2736
Query: 211 NGSMLSIPLVAAVAAGAAFLIIVMLLVFFACRRKKNRERNDQMPYYNNNHTTATDYYNSA 270
G R
Sbjct: 2737 AAPAPPAVPAGPATPGG-----------------PARPARPPTTAGPPAPAPPAAPAAGP 2779
Query: 271 ATPSPPPRANWQQQTDHGWPTPPPSQRGAVTVTSSDMSHNSSSGPYGPVLPPP-----PP 325
P ++ P+P V + + ++ P GP+ PP P
Sbjct: 2780 PRRLTRPAVASLSESRESLPSPWDPADPPAAVLAPAAALPPAASPAGPLPPPTSAQPTAP 2839
Query: 326 IVALGFSQSAFTYEELSAATGGFSQ 350
G + A G +
Sbjct: 2840 PPPPGPPPPSLPLGGSVAPGGDVRR 2864
|
Length = 3151 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 65/219 (29%), Positives = 108/219 (49%), Gaps = 36/219 (16%)
Query: 354 LGQGGFGYVHKGVL-------PNG-KEVAVKSLRSGSGQGE-REFKAEVEIISRV-HHRH 403
LG+G FG V PN +VAVK L+S + + + + +E+E++ + H++
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 404 LVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDW---PTRLKIAMGS------- 453
+++L+G C G ++ EY NL +L + P M++ PT++ S
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 454 ----AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM 509
A+G+ YL + IHRD+ + N+L+ K+ADFGLA+ + H+
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKK 198
Query: 510 GTFG-----YLAPEYASSGKLTEKSDVFSFGVMLLELIT 543
T G ++APE T +SDV+SFGV+L E+ T
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 69/217 (31%), Positives = 102/217 (47%), Gaps = 15/217 (6%)
Query: 353 LLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFK---AEVEIISRVHHRHLVSLV 408
+LG+G FG V L G+ AVK+L+ + + + E +++ ++ +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 409 GYCIAGGKRLL--VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHP 466
YC K L V E++ +L FH+ KGR D A GL +LH
Sbjct: 62 -YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR--FDLYRATFYAAEIVCGLQFLHSK--- 115
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLT 526
II+RD+K N++LD K+ADFG+ K + ST GT Y+APE K T
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLKYT 174
Query: 527 EKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWAR 563
D +SFGV+L E++ G+ P G ED L + R
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSPFH--GDDEDELFESIR 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 6e-14
Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 353 LLGQGGFG---YVHKGVLPN-GKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVS 406
+LGQG FG V K P+ G+ A+K L+ + + K E +I++ V+H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGS-AKGLAYLHEDCH 465
L GK L+ +++ +L L + VM +K + A L +LH
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLHS--- 116
Query: 466 PRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKL 525
II+RD+K NILLD K+ DFGL+K + D+ + GT Y+APE +
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVNRRGH 175
Query: 526 TEKSDVFSFGVMLLELITGRRP 547
T+ +D +SFGV++ E++TG P
Sbjct: 176 TQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 6e-14
Identities = 32/141 (22%), Positives = 49/141 (34%), Gaps = 6/141 (4%)
Query: 7 SPGVSNSPDAAETPPSPSRASSSPPPSTPPS------DESPPPSSPPPSSPPPDRSPPPS 60
+P +P A +P+ AS++P P P S P P+
Sbjct: 620 APAAPAAPAPAGAAAAPAEASAAPAPGVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPA 679
Query: 61 SPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPP 120
+PPP+P P++P ++ + P P + P Q + PS + P
Sbjct: 680 APPPAPAPAAPAAPAGAAPAQPAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAADDPV 739
Query: 121 PSQDNPSDPPPGDSNNGSSPP 141
P P DPP PP
Sbjct: 740 PLPPEPDDPPDPAGAPAQPPP 760
|
Length = 824 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 6e-14
Identities = 57/196 (29%), Positives = 96/196 (48%), Gaps = 10/196 (5%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKA-EVEIISRVHHRHLVSLVGYC 411
+GQG G V+ + + G+EVA+K + Q ++E E+ ++ H ++V+ +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHR 471
+ G + +V EY+ +L + MD + + L +LH + ++IHR
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN---QVIHR 139
Query: 472 DIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 531
DIKS NILL K+ DFG T + ST V GT ++APE + K D+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 532 FSFGVMLLELITGRRP 547
+S G+M +E++ G P
Sbjct: 199 WSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 57/198 (28%), Positives = 85/198 (42%), Gaps = 17/198 (8%)
Query: 356 QGGFG--YVHKGVLPNGKEVAVKSLRSGSGQGERE---FKAEVEIISRVHHRHLVSLVGY 410
+G FG Y+ K G A+K L+ + + KAE I+ V+ + Y
Sbjct: 6 KGAFGSVYLAKKRS-TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYY 64
Query: 411 CIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRII 469
L LV EY+ + + G DW + G+ LH+ II
Sbjct: 65 SFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK--QYIAEVVLGVEDLHQR---GII 119
Query: 470 HRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKS 529
HRDIK N+L+D T K+ DFGL++ N + + +GT YLAPE + S
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYLAPETILGVGDDKMS 174
Query: 530 DVFSFGVMLLELITGRRP 547
D +S G ++ E + G P
Sbjct: 175 DWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 9e-14
Identities = 35/99 (35%), Positives = 57/99 (57%), Gaps = 7/99 (7%)
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVS--TRVMGTF 512
+GL Y+H ++HRD+K SN+LL+ + K+ DFGLA++ + H T + T
Sbjct: 117 RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 513 GYLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPIDP 550
Y APE + K K+ D++S G +L E+++ RP+ P
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLFP 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 67/217 (30%), Positives = 111/217 (51%), Gaps = 12/217 (5%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKA-EVEIISRVHHRHLV 405
F Q LG+G + V+KG G+ VA+K + + +G E+ ++ + H ++V
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 406 SLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSA-KGLAYLHEDC 464
L K +LV+EY+ + +L+ ++ G P +K KG+A+ HE+
Sbjct: 62 RLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN- 119
Query: 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAK-LTTDNNTHVSTRVMGTFGYLAPEYASSG 523
R++HRD+K N+L++ E K+ADFGLA+ NT + V T Y AP+
Sbjct: 120 --RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGS 175
Query: 524 KLTEKS-DVFSFGVMLLELITGRRPIDPTGAMEDCLV 559
+ S D++S G ++ E+ITG RP+ P ED L+
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITG-RPLFPGTNNEDQLL 211
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 9e-14
Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 26/212 (12%)
Query: 354 LGQGGFGYVHKGVL--PNGKEVAVKSLRSGSGQGE-REFKAEVEIISRVHHRHLVSLVGY 410
LG+G +G V+K VL P G +A+K +R + + + E++I+ + ++V G
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 411 CIAGGKRLLVYEYVPNNNLE-FHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRII 469
G + EY+ +L+ + G + +I KGL +L E+ + II
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125
Query: 470 HRDIKSSNILLDYTFETKVADFGL-----AKLTTDNNTHVSTRVMGTFGYLAPEYASSGK 524
HRD+K +N+L++ + K+ DFG+ A L N +G Y+APE SG
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN--------IGCQSYMAPERIKSGG 177
Query: 525 LTE------KSDVFSFGVMLLELITGRRPIDP 550
+ +SDV+S G+ +LE+ GR P P
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 354 LGQGGFGYV--------HKGVLPNGKEVAVKSLRSGSGQGE-REFKAEVEIISRV-HHRH 403
LG+G FG V K VAVK L+ + + + + +E+E++ + H++
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 404 LVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDW----------PTRLKIAMGS 453
+++L+G C G ++ EY NL +L + P M++ K +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 454 ----AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM 509
A+G+ YL + IHRD+ + N+L+ K+ADFGLA+ +N +
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR-DVNNIDYYKKTTN 198
Query: 510 GTF--GYLAPEYASSGKLTEKSDVFSFGVMLLELIT 543
G ++APE T +SDV+SFGV++ E+ T
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 59/196 (30%), Positives = 97/196 (49%), Gaps = 26/196 (13%)
Query: 370 GKEVAVK--SLRSGSGQGERE--FKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVP 425
G++VAVK LR Q RE F EV I+ H ++V + + G + +V E++
Sbjct: 44 GRQVAVKKMDLRK---QQRRELLFN-EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99
Query: 426 NNNL-EFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF 484
L + H + M+ + + K L++LH +IHRDIKS +ILL
Sbjct: 100 GGALTDIVTHTR----MNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDG 152
Query: 485 ETKVADFGL-AKLTTDNNTHVSTR--VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLEL 541
K++DFG A+++ + V R ++GT ++APE S + D++S G+M++E+
Sbjct: 153 RVKLSDFGFCAQVSKE----VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 208
Query: 542 ITGRRPI---DPTGAM 554
+ G P P AM
Sbjct: 209 VDGEPPYFNEPPLQAM 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 15/205 (7%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLR--SGSGQGEREFKA---EVEIISRVHHRHLVS 406
LLGQG FG V+ G+E+AVK ++ S + +E A E++++ + H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 407 LVGYCIAGGKRLL--VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC 464
G +R L E++P +++ L G + + TR K +G++YLH +
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG-ALTENVTR-KYTRQILEGVSYLHSN- 125
Query: 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAK-LTTDNNTHVSTR-VMGTFGYLAPEYASS 522
I+HRDIK +NIL D K+ DFG +K L T + + V GT +++PE S
Sbjct: 126 --MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 523 GKLTEKSDVFSFGVMLLELITGRRP 547
K+D++S G ++E++T + P
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 32/217 (14%)
Query: 354 LGQGGFGYVHK----GVLPNGKE----VAVKSLR-SGSGQGEREFKAEVEIISRV-HHRH 403
LG+G FG V + G+ + + VAVK L+ + + + + +E+E++ + H++
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 404 LVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMD--------------WPTRLKI 449
+++L+G C G ++ EY NL L + P D + +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 450 AMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST--- 506
A A+G+ YL R IHRD+ + N+L+ K+ADFGLA+ D + + T
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 507 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 543
R+ ++APE T +SDV+SFG+++ E+ T
Sbjct: 197 RL--PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 2e-13
Identities = 53/201 (26%), Positives = 96/201 (47%), Gaps = 8/201 (3%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVS 406
+++ +GQG G V + + G+EVA+K + + E+ ++ + + ++V+
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHP 466
+ + G + +V EY+ +L + MD + + L +LH +
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFLHAN--- 134
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLT 526
++IHRDIKS N+LL K+ DFG T + ST V GT ++APE +
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 193
Query: 527 EKSDVFSFGVMLLELITGRRP 547
K D++S G+M +E++ G P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 60/198 (30%), Positives = 93/198 (46%), Gaps = 10/198 (5%)
Query: 354 LGQGGFGYVHKGVLPNGKEV-AVKSLRSGSGQGEREFK---AEVEIISRVHHRHLVSLVG 409
+G+G FG V + + + + A+K++R E AE ++++V+ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 410 YCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRII 469
+ K LV ++ L HL +GR R A L LH+ +I
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGR-FDLSRARFYTAE-LLCALENLHK---FNVI 115
Query: 470 HRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKS 529
+RD+K NILLDY + DFGL KL ++ +T GT YLAPE T+
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLGHGYTKAV 174
Query: 530 DVFSFGVMLLELITGRRP 547
D ++ GV+L E++TG P
Sbjct: 175 DWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 8/201 (3%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVS 406
+++ +GQG G V+ + + G+EVA+K + + E+ ++ + ++V+
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHP 466
+ + G + +V EY+ +L + MD + + L +LH +
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALDFLHSN--- 134
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLT 526
++IHRDIKS NILL K+ DFG T + ST V GT ++APE +
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 193
Query: 527 EKSDVFSFGVMLLELITGRRP 547
K D++S G+M +E++ G P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 353 LLGQGGFGYVHKGVLPNG-------KEVAVKSLRSGSGQGERE-----FKAEVEII-SRV 399
LG G FG V+K N KE+ V + G + ER+ +EV II ++
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 400 HHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFH---LHGKGRPVMD---WPTRLKIAMGS 453
H ++V + + +V + + L H L K + + W +++ +
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA- 125
Query: 454 AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFG 513
L YLH++ RI+HRD+ +NI+L + + DFGLAK + S V+GT
Sbjct: 126 ---LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS--VVGTIL 178
Query: 514 YLAPEYASSGKLTEKSDVFSFGVMLLELIT 543
Y PE + EK+DV++FG +L ++ T
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 64/209 (30%), Positives = 90/209 (43%), Gaps = 23/209 (11%)
Query: 348 FSQSNLLGQGGFGYV----HKGVLPNGKEVAVKSLRSGS---GQGEREFKAEVEIISRVH 400
F LG G FG V HKG G+ A+K L+ + + E I+ +
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 401 HRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLA-- 458
H +V+++ + + E+V L HL GR +P + + LA
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR----FPNDVAKFYHAELVLAFE 132
Query: 459 YLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE 518
YLH II+RD+K N+LLD KV DFG AK D + + GT YLAPE
Sbjct: 133 YLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYLAPE 185
Query: 519 YASSGKLTEKSDVFSFGVMLLELITGRRP 547
S + D ++ GV+L E I G P
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 4e-13
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFK---AEVEIISRVHHRH 403
FS +G G FG V+ + N + VA+K + Q +++ EV + ++ H +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 404 LVSLVGYCIAGGKRLLVYEYV---PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYL 460
+ G + LV EY ++ LE H +P+ + + G+ +GLAYL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIA-AVTHGALQGLAYL 131
Query: 461 HEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEY- 519
H +IHRD+K+ NILL K+ DFG A + N V GT ++APE
Sbjct: 132 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183
Query: 520 --ASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAM 554
G+ K DV+S G+ +EL + P+ AM
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 68/236 (28%), Positives = 101/236 (42%), Gaps = 23/236 (9%)
Query: 348 FSQSNLLGQGGFGYVHKGVLPNGKE-VAVKSL---RSGSGQGEREFKAEVEIISRVHHRH 403
+ +G G FG VH + A+K + + E+ E ++ V H
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 404 LVSLVGYCIAGGKRLL--VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLH 461
++ L + +R L + EYVP L +L GR T L A L YLH
Sbjct: 63 IIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEYLH 118
Query: 462 EDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYAS 521
I++RD+K NILLD K+ DFG AK D + + GT YLAPE
Sbjct: 119 SK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGTPEYLAPEVIQ 171
Query: 522 SGKLTEKSDVFSFGVMLLELITGRRPI---DPTGAMEDCL---VDWARPLCLRALD 571
S + D ++ G+++ E++ G P +P G E L +++ R L L A D
Sbjct: 172 SKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKD 227
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 64/217 (29%), Positives = 109/217 (50%), Gaps = 19/217 (8%)
Query: 350 QSNLLGQGGFGYVHKGV-LPNGKEVAVKSL--RSGSGQGEREFKA---EVEIISRVHHRH 403
LLG+G FG V+ G+E+AVK + S + +E A E++++ + H
Sbjct: 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDR 65
Query: 404 LVSLVGYCIAG--GKRLLVY-EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYL 460
+V G C+ K+L ++ EY+P +++ L G + + TR + +G++YL
Sbjct: 66 IVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTR-RYTRQILQGVSYL 122
Query: 461 HEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD---NNTHVSTRVMGTFGYLAP 517
H + I+HRDIK +NIL D K+ DFG +K + T + + V GT +++P
Sbjct: 123 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMSP 178
Query: 518 EYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAM 554
E S K+DV+S ++E++T + P AM
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 73/257 (28%), Positives = 118/257 (45%), Gaps = 25/257 (9%)
Query: 320 LPPPPPIVALGFSQSAFTYEELSAATGGFSQ---SNLLGQGGFGYVHKGV-LPNGKEVAV 375
LP PPP + S S+ +A S+ N +G G G V+K + P G+ A+
Sbjct: 45 LPLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYAL 104
Query: 376 KSLRSGSGQG-EREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLH 434
K + R+ E+EI+ V+H ++V G+ ++ E++ +LE
Sbjct: 105 KVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE---- 160
Query: 435 GKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLA 494
G + D +A G+AYLH I+HRDIK SN+L++ K+ADFG++
Sbjct: 161 --GTHIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVS 215
Query: 495 KLTTDNNTHVSTRVMGTFGYLAPEYASS----GKLTEKS-DVFSFGVMLLELITGRRPID 549
++ ++ V GT Y++PE ++ G + D++S GV +LE GR P
Sbjct: 216 RILAQTMDPCNSSV-GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF- 273
Query: 550 PTGAMEDCLVDWARPLC 566
G DWA +C
Sbjct: 274 GVGRQG----DWASLMC 286
|
Length = 353 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 41/108 (37%), Positives = 65/108 (60%), Gaps = 5/108 (4%)
Query: 448 KIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTR 507
K+++ +GLAYL E +I+HRD+K SNIL++ E K+ DFG++ D+ ++
Sbjct: 107 KVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 161
Query: 508 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAME 555
+GT Y++PE + +SD++S G+ L+EL GR PI P A E
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 20/211 (9%)
Query: 354 LGQGGFGYVHKGVLPNGK---EVAVKSLRSG-SGQGERE-FKAEVEIISRVHHRHLVSLV 408
LG+G FG V +G L +VAVK+++ + E E F +E + H +++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 409 GYCIAGGKR------LLVYEYVPNNNLE-FHLHGK-GRPVMDWPTRL--KIAMGSAKGLA 458
G C+ + +++ ++ + +L F L+ + G PT++ K A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 459 YLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGT-FGYLAP 517
YL IHRD+ + N +L+ VADFGL+K + + + R+ ++A
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 518 EYASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
E + T KSDV+SFGV + E+ T G+ P
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 354 LGQGGFGYV--------HKGVLPNGKEVAVKSLRS-GSGQGEREFKAEVEIISRV-HHRH 403
LG+G FG V K VAVK L+ + + + +E+E++ + H++
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 404 LVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDW-------PTR-------LKI 449
+++L+G C G ++ EY NL +L + P MD+ P +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 450 AMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM 509
A A+G+ YL + IHRD+ + N+L+ K+ADFGLA+ N +
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLAR-DVHNIDYYKKTTN 195
Query: 510 GTF--GYLAPEYASSGKLTEKSDVFSFGVMLLELIT 543
G ++APE T +SDV+SFGV+L E+ T
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-13
Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 15/217 (6%)
Query: 348 FSQSNLLGQGGFGYVHKGVLPNGKEV-AVKSLRSGSGQGEREFK---AEVEIISRVHHRH 403
F+ +LG+G FG V E+ A+K L+ + + + E +++
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 404 LVSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHE 462
++ + C RL V EYV +L +H+ G+ P + A + GL +LH
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLHR 119
Query: 463 DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM-GTFGYLAPEYAS 521
II+RD+K N++LD K+ADFG+ K + V+TR GT Y+APE +
Sbjct: 120 R---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAPEIIA 174
Query: 522 SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCL 558
+ D +++GV+L E++ G+ P D G ED L
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFD--GEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 9e-13
Identities = 39/106 (36%), Positives = 56/106 (52%), Gaps = 19/106 (17%)
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK-LTTDNNTH--------VS 505
K L Y+H +IHRD+K SNILL+ K+ADFGLA+ L+ V+
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 506 TRVMGTFGYLAPE-YASSGKLTEKSDVFSFGVMLLELITGRRPIDP 550
TR Y APE S + T+ D++S G +L E++ G +P+ P
Sbjct: 175 TR-----WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPLFP 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 1e-12
Identities = 21/139 (15%), Positives = 43/139 (30%), Gaps = 2/139 (1%)
Query: 5 NQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSP-PPSSPP 63
+ P + P A P +P+ + + + P + P P P +S
Sbjct: 606 SGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVAAPEHHPKHVAVPDASDG 665
Query: 64 PSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQ 123
P++ P +P P + + + P P ++ A+ PP
Sbjct: 666 GDGWPAKAGGAAPAAPPPAPAPAAPAAPA-GAAPAQPAPAPAATPPAGQADDPAAQPPQA 724
Query: 124 DNPSDPPPGDSNNGSSPPG 142
+ P +++ P
Sbjct: 725 AQGASAPSPAADDPVPLPP 743
|
Length = 824 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 60/213 (28%), Positives = 89/213 (41%), Gaps = 20/213 (9%)
Query: 354 LGQGGFGYV----HKGVLPNGKEVAVKSLRSGS----GQGEREFKAEVEIISRVHHR-HL 404
LG G +G V G GK A+K L+ + + + E +++ V L
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 405 VSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGS-AKGLAYLHE 462
V+L Y +L L+ +YV L HL+ + +++ + L +LH+
Sbjct: 68 VTL-HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVRVYIAEIVLALDHLHQ 123
Query: 463 DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS 522
II+RDIK NILLD + DFGL+K + GT Y+APE
Sbjct: 124 ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRG 180
Query: 523 GKLTEKS--DVFSFGVMLLELITGRRPIDPTGA 553
G D +S GV+ EL+TG P G
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE 213
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-12
Identities = 39/87 (44%), Positives = 52/87 (59%), Gaps = 7/87 (8%)
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFG----YLAPEYASS 522
+IHRDIKS+NILL K+ DFG +K+ T VS V TF Y+APE
Sbjct: 163 HMIHRDIKSANILLCSNGLVKLGDFGFSKMYA--AT-VSDDVGRTFCGTPYYVAPEIWRR 219
Query: 523 GKLTEKSDVFSFGVMLLELITGRRPID 549
++K+D+FS GV+L EL+T +RP D
Sbjct: 220 KPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 1e-12
Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 8/201 (3%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVS 406
+++ +GQG G V+ + + G+EVA++ + + E+ ++ + ++V+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHP 466
+ + G + +V EY+ +L + MD + + L +LH +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN--- 135
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLT 526
++IHRDIKS NILL K+ DFG T + ST V GT ++APE +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194
Query: 527 EKSDVFSFGVMLLELITGRRP 547
K D++S G+M +E+I G P
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 24/206 (11%)
Query: 353 LLGQGGFGYV----HKGVLPNGKEVAVKSLR-SGSGQGEREFKAEVEIISRVHHRHLVSL 407
++G+G FG H + ++ A+K +R S + + E +++++ H ++V+
Sbjct: 7 VVGEGSFGRALLVQHVN---SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHL---HGKGRP---VMDWPTRLKIAMGSAKGLAYLH 461
A G +V EY +L + GK P ++ W ++ + G+ ++H
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIH 117
Query: 462 EDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYAS 521
E R++HRDIKS NI L + K+ DFG A+L T + T V GT Y+ PE
Sbjct: 118 EK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWE 173
Query: 522 SGKLTEKSDVFSFGVMLLELITGRRP 547
+ KSD++S G +L EL T + P
Sbjct: 174 NMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 64/204 (31%), Positives = 89/204 (43%), Gaps = 20/204 (9%)
Query: 353 LLGQGGFGYVHKGVL----PNGKEVAVKSLRSGSGQGEREFK---AEVEIISRVHHRHLV 405
LLG+G FG V +L GK A+K L+ + E E ++ H L
Sbjct: 2 LLGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 406 SLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIA-MGSAKGLAYLHED 463
+L Y RL V EY L FHL + R + R A + SA L YLH
Sbjct: 59 AL-KYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVSA--LGYLHSC 114
Query: 464 CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSG 523
+++RD+K N++LD K+ DFGL K + + T GT YLAPE
Sbjct: 115 ---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDN 170
Query: 524 KLTEKSDVFSFGVMLLELITGRRP 547
D + GV++ E++ GR P
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 35/105 (33%), Positives = 57/105 (54%), Gaps = 18/105 (17%)
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT--------HVST 506
+GL Y+H +IHRD+K SN+L++ E ++ DFG+A+ + + T +V+T
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 507 RVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELITGRRPIDP 550
R Y APE S + T D++S G + E++ GRR + P
Sbjct: 175 R-----WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFP 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 2e-12
Identities = 38/99 (38%), Positives = 54/99 (54%), Gaps = 22/99 (22%)
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT-HVSTRVMGTFG 513
+GL Y+H IIHRD+K SNI ++ E K+ DFGLA+ T D T +V+TR
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180
Query: 514 YLAPE-------YASSGKLTEKSDVFSFGVMLLELITGR 545
Y APE Y + D++S G ++ EL+TG+
Sbjct: 181 YRAPEIMLNWMHY------NQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 50/166 (30%), Positives = 90/166 (54%), Gaps = 11/166 (6%)
Query: 392 EVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRL--KI 449
E++++ + ++V G + G+ + E++ +L+ L GR P ++ K+
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKV 108
Query: 450 AMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM 509
++ KGL YL E +I+HRD+K SNIL++ E K+ DFG++ D+ ++ +
Sbjct: 109 SIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFV 163
Query: 510 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAME 555
GT Y++PE + +SD++S G+ L+E+ GR PI P A E
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 52/143 (36%), Positives = 73/143 (51%), Gaps = 16/143 (11%)
Query: 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNIL 479
V EYV +L +H+ G+ P + A A GL +LH II+RD+K N++
Sbjct: 79 VMEYVNGGDLMYHIQQVGK--FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVM 133
Query: 480 LDYTFETKVADFGLAKLTTDNNTHVSTRVM-GTFGYLAPE---YASSGKLTEKSDVFSFG 535
LD K+ADFG+ K + +TR GT Y+APE Y GK D ++FG
Sbjct: 134 LDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGK---SVDWWAFG 188
Query: 536 VMLLELITGRRPIDPTGAMEDCL 558
V+L E++ G+ P D G ED L
Sbjct: 189 VLLYEMLAGQPPFD--GEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 3e-12
Identities = 23/124 (18%), Positives = 51/124 (41%), Gaps = 6/124 (4%)
Query: 14 PDAAETPPSPSRASSSPPPSTPPSDESPPPSSPP---PSSPPPDRSPPPSSPPPSPESPP 70
P AA +P+ + P +P + P++ P + P++PP + P
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAP 425
Query: 71 PSSPPPSSQSPPQSPPP---PNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPS 127
++P ++ + + P + +PP + P P + +P P+ ++A+P P+ +
Sbjct: 426 VAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAPAAAPAA 485
Query: 128 DPPP 131
Sbjct: 486 ARLT 489
|
Length = 618 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 20/222 (9%)
Query: 341 LSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV- 399
L G F L+G G +G V+KG ++A + +G E E K E+ ++ +
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS 60
Query: 400 HHRHLVSLVGYCIAGG------KRLLVYEYVPNNNL-EFHLHGKGRPVMD-WPTRLKIAM 451
HHR++ + G I + LV E+ ++ + + KG + + W I
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICR 118
Query: 452 GSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGT 511
+GL++LH+ ++IHRDIK N+LL E K+ DFG++ D +GT
Sbjct: 119 EILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGT 174
Query: 512 FGYLAPEYASSGKLTE-----KSDVFSFGVMLLELITGRRPI 548
++APE + + + KSD++S G+ +E+ G P+
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 53/182 (29%), Positives = 87/182 (47%), Gaps = 13/182 (7%)
Query: 369 NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNN 428
GK+VAVK + Q EV I+ HH ++V + + G + +V E++
Sbjct: 46 TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 429 L-EFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETK 487
L + H + M+ + + + L+YLH +IHRDIKS +ILL K
Sbjct: 106 LTDIVTHTR----MNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIK 158
Query: 488 VADFGLAKLTTDNNTHVSTR--VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR 545
++DFG + V R ++GT ++APE S + D++S G+M++E+I G
Sbjct: 159 LSDFGFCAQVS---KEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215
Query: 546 RP 547
P
Sbjct: 216 PP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-12
Identities = 55/228 (24%), Positives = 85/228 (37%), Gaps = 29/228 (12%)
Query: 11 SNSPDAAETPPSPSRASSSPPPS---TPPSDES--PPPSSPPPSSPPPD---------RS 56
+N + T + A +SP TPP S PPP +PPP+SPPP R
Sbjct: 81 ANESRSTPTWSLSTLAPASPAREGSPTPPGPSSPDPPPPTPPPASPPPSPAPDLSEMLRP 140
Query: 57 PPPSSPPPSPESPPPSSPPPSSQSPPQSPPPP-----------NSKSPPQSSPPPNTNPP 105
PPP+ P + P + S S + S P + PPP+T P
Sbjct: 141 VGSPGPPPAASPPAAGASPAAVASDAASSRQAALPLSSPEETARAPSSPPAEPPPSTPPA 200
Query: 106 PQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNN 165
S PP P + S P P + + G +++++++ + +G G G N
Sbjct: 201 AASPRPP----RRSSPISASASSPAPAPGRSAADDAGASSSDSSSSESSGCGWGPENECP 256
Query: 166 NNNNNKNWHPPPPPSSSSNSPNGNRSGALSPPNKSNGSSSSPSSNNGS 213
P +S + +R G S + S SPS ++
Sbjct: 257 LPRPAPITLPTRIWEASGWNGPSSRPGPASSSSSPRERSPSPSPSSPG 304
|
Length = 1352 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 5e-12
Identities = 27/137 (19%), Positives = 48/137 (35%), Gaps = 6/137 (4%)
Query: 1 MEDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPS 60
+E G + +P AA + + +++P P+ + +P + P P
Sbjct: 381 LERRLGVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAP-AAAAAPAPAAAPQPAPAPAPAP 439
Query: 61 SPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPP 120
+PP + P P + S P P ++P P P P P+ + A
Sbjct: 440 APPSPAGNAPAGGAPSPPPAAAPSAQP---APAPAAAPEPTAAPAPAPPAAPAPAAAPAA 496
Query: 121 PSQDNPSDPPPGDSNNG 137
P+ P+ P D
Sbjct: 497 PAA--PAAPAGADDAAT 511
|
Length = 824 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 31/208 (14%)
Query: 354 LGQGGFGYVHKGVL-------PNGKEVAVKSLRSGSGQGER---EFKAEVEIISRVHHRH 403
LGQG F ++KGVL G V + G R F ++S++ H+H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 404 LVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPV-MDWPTRLKIAMGSAKGLAYLHE 462
LV L G C+ ++V EYV L+ LH + V + W +L +A A L YL +
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 463 DCHPRIIHRDIKSSNILL-------DYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYL 515
+++H ++ NIL+ Y K++D G+ V ++
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE-----RIPWI 171
Query: 516 APEYASSG--KLTEKSDVFSFGVMLLEL 541
APE +G LT +D +SFG LLE+
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 6e-12
Identities = 26/132 (19%), Positives = 52/132 (39%), Gaps = 7/132 (5%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSS----PPPSTPPSDESPPPSSPPPSSPPPDRSPPPSS 61
+ + +P +TP P A+ + + P+ + P ++ + PP +PP
Sbjct: 367 AAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAPV 426
Query: 62 PPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPP 121
P+ +P +P + + +P PP +P + P P P + A+P
Sbjct: 427 AAPAAAAPAA-APAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAPAAAPAA 485
Query: 122 SQDNPSDPPPGD 133
++ P+ GD
Sbjct: 486 ARLTPT--EEGD 495
|
Length = 618 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 7e-12
Identities = 30/130 (23%), Positives = 47/130 (36%), Gaps = 3/130 (2%)
Query: 7 SPGVSNSPDAA---ETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPP 63
P S+ D +P+ +P P+ P + P+ P P+ + P
Sbjct: 659 VPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAPAPAATPPAGQADDPA 718
Query: 64 PSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQ 123
P + PS + P PP PP + P PPP + P + A+PPPS
Sbjct: 719 AQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPPPPAPAPAAAPAAAPPPSP 778
Query: 124 DNPSDPPPGD 133
+ + D
Sbjct: 779 PSEEEEMAED 788
|
Length = 824 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 55/229 (24%), Positives = 91/229 (39%), Gaps = 47/229 (20%)
Query: 352 NLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKA--------------EVEII 396
LG+G +G V K GK VA+K ++ + E++I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 397 SRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLK------IA 450
+ + H +++ LV + G LV + + + V+D RL I
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDI---------MASDLKKVVDRKIRLTESQVKCIL 125
Query: 451 MGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK---------LTTDNN 501
+ GL LH+ +HRD+ +NI ++ K+ADFGLA+ + +
Sbjct: 126 LQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 502 THVSTRVMG----TFGYLAPE-YASSGKLTEKSDVFSFGVMLLELITGR 545
T M T Y APE + K D++S G + EL+TG+
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 8e-12
Identities = 59/208 (28%), Positives = 105/208 (50%), Gaps = 27/208 (12%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKA--EVEIISRVHHRHLVSLVGY 410
+G+G +G V+KG G+ VA+K +R S + A E+ ++ + H ++V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 411 CIAGGKRLLVYEYVPNNNLEFHLH--GKGRPVMDWPTRLKIAMGSAKGLAYLHED----- 463
+ + L++E++ + +L+ +L KG+ MD +K +YL++
Sbjct: 68 LMQESRLYLIFEFL-SMDLKKYLDSLPKGQ-YMD-AELVK---------SYLYQILQGIL 115
Query: 464 -CHP-RIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE-YA 520
CH R++HRD+K N+L+D K+ADFGLA+ V T + T Y APE
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPVRVYTHEVVTLWYRAPEVLL 174
Query: 521 SSGKLTEKSDVFSFGVMLLELITGRRPI 548
S + + D++S G + E+ T ++P+
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-11
Identities = 47/220 (21%), Positives = 62/220 (28%), Gaps = 40/220 (18%)
Query: 2 EDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSS 61
D + P E P + SR++ + ST SP P P PPP+
Sbjct: 62 CDRFEPPTGPPPGPGTEAPANESRSTPTWSLSTLAPASPAREGSPTPPGPSSPDPPPPTP 121
Query: 62 PPPSPESPPPS--------SPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPS 113
PP SP P P P S + S + S P
Sbjct: 122 PPASPPPSPAPDLSEMLRPVGSPGPPPAASPPAAGASPAAVASDAASSRQAALPLSSPEE 181
Query: 114 NSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNW 173
+ A P + P PP ++
Sbjct: 182 TARAPSSPPAEPPPSTPPAAASPRPPRR-------------------------------- 209
Query: 174 HPPPPPSSSSNSPNGNRSGALSPPNKSNGSSSSPSSNNGS 213
P S+SS +P RS A S+ SSSS SS G
Sbjct: 210 SSPISASASSPAPAPGRSAADDAGASSSDSSSSESSGCGW 249
|
Length = 1352 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 12/210 (5%)
Query: 354 LGQGGFGYVHKGVLPNGKE-VAVKSLR---SGSGQGEREFKAEVEIISRVHHRHLVSLVG 409
+G+G +G V K E VA+K +R G + E+ ++ + H+++V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLYD 66
Query: 410 YCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRII 469
+ K LV+EY + ++ G +D KGLA+ H ++
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGD--IDPEIVKSFMFQLLKGLAFCHSH---NVL 121
Query: 470 HRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKS 529
HRD+K N+L++ E K+ADFGLA+ S V+ T Y P+ KL S
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTS 180
Query: 530 -DVFSFGVMLLELITGRRPIDPTGAMEDCL 558
D++S G + EL RP+ P ++D L
Sbjct: 181 IDMWSAGCIFAELANAGRPLFPGNDVDDQL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-11
Identities = 35/161 (21%), Positives = 37/161 (22%), Gaps = 6/161 (3%)
Query: 13 SPDAAETPPSPSRASSSPPPSTPPSDESPPPS----SPPPSSPPPDRSPPPSSPPPSPES 68
PP PP + PP PP P P P PS
Sbjct: 168 QAPQLPQPPQQVLPQGMPPRQAAFPQQGPPEQPPGYPQPPQGHPEQVQPQQFLPAPSQAP 227
Query: 69 PPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSD 128
P PP Q PP P Q PP PPQ P A PPP
Sbjct: 228 AQPPLPPQLPQQPPPLQQPQFPGLSQQ--MPPPPPQPPQQQQQPPQPQAQPPPQNQPTPH 285
Query: 129 PPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNN 169
P N PP +
Sbjct: 286 PGLPQGQNAPLPPPQQPQLLPLVQQPQGQQRGPQFREQLVQ 326
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 354 LGQGGFGYVHKGVLPN-GKEVAVKSLRSGSGQGEREFKA--EVEIISRVH---HRHLVSL 407
+G G +G V+K P+ G VA+KS+R + + EV ++ R+ H ++V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 408 VGYCIAG-----GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHE 462
+ C K LV+E+V + +L +L P + T + +GL +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 463 DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVS-TRVMGTFGYLAPEYAS 521
+C I+HRD+K NIL+ + K+ADFGLA++ + ++ T V+ T Y APE
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLWYRAPEVLL 180
Query: 522 SGKLTEKSDVFSFGVMLLELITGRRPI 548
D++S G + E+ R+P+
Sbjct: 181 QSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 1e-11
Identities = 66/203 (32%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 353 LLGQGGFGYVHKGVL----PNGKEVAVKSLRSGSGQGEREFK---AEVEIISRVHHRHLV 405
LLG+G FG V +L +GK A+K L+ + E E ++ H L
Sbjct: 2 LLGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58
Query: 406 SLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC 464
SL Y RL V EYV L FHL + R + TR A L YLH
Sbjct: 59 SL-KYSFQTKDRLCFVMEYVNGGELFFHL-SRERVFSEDRTRFYGAE-IVSALDYLHSG- 114
Query: 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGK 524
+I++RD+K N++LD K+ DFGL K + + T GT YLAPE
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDND 171
Query: 525 LTEKSDVFSFGVMLLELITGRRP 547
D + GV++ E++ GR P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 22/205 (10%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCI 412
+G G +G V+K L G+ AVK ++ G + E+ ++ H ++V+ G +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 413 AGGKRLLVYEYVPNNNLE--FHLHGKGRPVMDWPTRLKIAM---GSAKGLAYLHEDCHPR 467
+ K + EY +L+ +H+ G P+ + L+IA + +GLAYLH
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTG---PL----SELQIAYVCRETLQGLAYLHSKGK-- 127
Query: 468 IIHRDIKSSNILLDYTFETKVADFGL-AKLTTDNNTHVSTRVMGTFGYLAPEYAS---SG 523
+HRDIK +NILL + K+ADFG+ AK+T S +GT ++APE A+ +G
Sbjct: 128 -MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVAAVEKNG 184
Query: 524 KLTEKSDVFSFGVMLLELITGRRPI 548
+ D+++ G+ +EL + P+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 68/233 (29%), Positives = 95/233 (40%), Gaps = 49/233 (21%)
Query: 353 LLGQGGFGYV----HKGVLPNGKEVAVKSLRSG----SGQGEREFKAEVEIISRVHHRHL 404
++G+G FG V K G+ A+K LR Q +AE +I++ +
Sbjct: 8 VIGRGAFGEVWLVRDK---DTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWI 63
Query: 405 VSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIA-MGSAKGLAYLHE 462
V L Y + L LV EY+P +L L K + R IA + A L +H+
Sbjct: 64 VKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIAELVLA--LDSVHK 119
Query: 463 DCHPRIIHRDIKSSNILLDYTFETKVADFGLAK-----------------LTTDNNTHVS 505
IHRDIK NIL+D K+ADFGL K L +N V
Sbjct: 120 LGF---IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 506 TR-----------VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
R +GT Y+APE + D +S GV+L E++ G P
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-11
Identities = 23/137 (16%), Positives = 36/137 (26%), Gaps = 1/137 (0%)
Query: 5 NQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPP 64
+PGV+ + P + +P P P+ P + P
Sbjct: 642 APAPGVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQP 701
Query: 65 SPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQD 124
+P + Q P S P + PP+ PP + A P
Sbjct: 702 APAPAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGA-PAQPPP 760
Query: 125 NPSDPPPGDSNNGSSPP 141
P+ P P
Sbjct: 761 PPAPAPAAAPAAAPPPS 777
|
Length = 824 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 51/150 (34%), Positives = 75/150 (50%), Gaps = 11/150 (7%)
Query: 411 CIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRII 469
C RL V EYV +L + + GR P + A A GL +LH II
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSK---GII 123
Query: 470 HRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM-GTFGYLAPEYASSGKLTEK 528
+RD+K N++LD K+ADFG+ K + V+T+ GT Y+APE + +
Sbjct: 124 YRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKS 181
Query: 529 SDVFSFGVMLLELITGRRPIDPTGAMEDCL 558
D ++FGV+L E++ G+ P + G ED L
Sbjct: 182 VDWWAFGVLLYEMLAGQAPFE--GEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 23/200 (11%)
Query: 354 LGQGGFGYVHKGVLPNGKEV----AVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVG 409
LG G FG V+K KE A K + + S + ++ E++I++ H ++V L+
Sbjct: 13 LGDGAFGKVYKA---QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 69
Query: 410 YCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRII 469
++ E+ ++ + RP+ + R+ + + + L YLHE+ +II
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-VCKQTLEALNYLHEN---KII 125
Query: 470 HRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTR---VMGTFGYLAPEYASSGKLT 526
HRD+K+ NIL + K+ADFG++ NT R +GT ++APE
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSA----KNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 527 E-----KSDVFSFGVMLLEL 541
+ K+DV+S G+ L+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 62/203 (30%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 353 LLGQGGFGYVHKGVLPN-GKEVAVKSL---RSGSGQGEREFKAEVEIISRVHHRHLVSLV 408
++G+GGFG V+ + GK A+K L R QGE E ++S V +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 409 GYCIA---GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCH 465
A K + + + +L +HL G V A GL ++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRF- 117
Query: 466 PRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKL 525
+++RD+K +NILLD +++D GLA + H S +GT GY+APE G
Sbjct: 118 --VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVLQKGTA 172
Query: 526 TEKS-DVFSFGVMLLELITGRRP 547
+ S D FS G ML +L+ G P
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 354 LGQGGFGYVH-KGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCI 412
+G+G G V V +GK VAVK + Q EV I+ H ++V + +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 413 AGGKRLLVYEYVPNNNL-EFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHR 471
G + +V E++ L + H + M+ + + K L+ LH +IHR
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLKALSVLHAQ---GVIHR 140
Query: 472 DIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTR--VMGTFGYLAPEYASSGKLTEKS 529
DIKS +ILL + K++DFG + V R ++GT ++APE S +
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 530 DVFSFGVMLLELITGRRP 547
D++S G+M++E++ G P
Sbjct: 198 DIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 22/104 (21%), Positives = 33/104 (31%), Gaps = 3/104 (2%)
Query: 15 DAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSP 74
+A P + + + P +P PS+ P + PP P +PPP P
Sbjct: 357 EALLVPVPAPQPAKPTAAAPSPVRPTPAPSTRPK--AAAAANIPPKEPVRETATPPPVPP 414
Query: 75 PPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNAS 118
P + P P K + P +PP A
Sbjct: 415 RPVAPPVP-HTPESAPKLTRAAIPVDEKPKYTPPAPPKEEEKAL 457
|
Length = 585 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 34/101 (33%), Positives = 56/101 (55%), Gaps = 11/101 (10%)
Query: 456 GLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYL 515
G+A+LH++ I+HRD+K+SN+LL+ K+ DFGLA+ T+++ T Y
Sbjct: 118 GVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS-PLKPYTQLVVTLWYR 173
Query: 516 APE-YASSGKLTEKSDVFSFGVMLLELIT------GRRPID 549
APE + + + D++S G + EL+T G+ ID
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 24/197 (12%)
Query: 369 NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNN 428
+G++VAVK + Q EV I+ H+++V + + G + ++ E+
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF----- 99
Query: 429 LEFHLHGKGRPVMDWPTRLK------IAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY 482
L G + TRL + + L YLH +IHRDIKS +ILL
Sbjct: 100 ----LQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTL 152
Query: 483 TFETKVADFGL-AKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLEL 541
K++DFG A+++ D S ++GT ++APE S + D++S G+M++E+
Sbjct: 153 DGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEM 210
Query: 542 ITGRRPI---DPTGAME 555
+ G P P AM+
Sbjct: 211 VDGEPPYFSDSPVQAMK 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-11
Identities = 20/123 (16%), Positives = 46/123 (37%), Gaps = 4/123 (3%)
Query: 20 PPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQ 79
P + + A++ TP E+ P++ P + +P + P+ + P++PP ++
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAP---AAAPAAAASAPAAPPAAAP 422
Query: 80 SPPQSPPPPNSK-SPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGS 138
P + P + + P ++P P + + A P P+ + +
Sbjct: 423 PAPVAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAPAAA 482
Query: 139 SPP 141
Sbjct: 483 PAA 485
|
Length = 618 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 3e-11
Identities = 29/86 (33%), Positives = 41/86 (47%), Gaps = 3/86 (3%)
Query: 26 ASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSP 85
+ S +T + P S PPP+ PP P ++PPP+P PPP++ SS +P Q P
Sbjct: 512 SQSGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIP 571
Query: 86 PPPNSKSPPQSSPPPNTNPPPQSSPP 111
+ PP P T P + S P
Sbjct: 572 ADSS---PPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 50/153 (32%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 407 LVGY--CIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHED 463
LVG C RL V E+V +L FH+ + R + + R A S L +LHE
Sbjct: 58 LVGLHSCFQTESRLFFVIEFVSGGDLMFHMQ-RQRKLPEEHARFYSAEISL-ALNFLHER 115
Query: 464 CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSG 523
II+RD+K N+LLD K+ D+G+ K ST GT Y+APE
Sbjct: 116 ---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYIAPEILRGE 171
Query: 524 KLTEKSDVFSFGVMLLELITGRRPIDPTGAMED 556
D ++ GV++ E++ GR P D G ++
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 354 LGQGGFGYVHKGVLPNG---KEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVG 409
+G G FG V G + +G +V VK LR + Q + +F E + + H +L+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 410 YCIAGGKRLLVYEYVPNNNLEFHLHG--KGRPVMDWPTRL-KIAMGSAKGLAYLHEDCHP 466
C LLV E+ P +L+ +L K + PT L ++A A GL +LH++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV-STRVMGTFGYLAPEYASS--G 523
IH D+ N LL K+ D+GL+ + +V ++ ++APE G
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 524 KL-----TEKSDVFSFGVMLLELIT-GRRP 547
L T++S+V+S GV + EL G +P
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 5e-11
Identities = 26/128 (20%), Positives = 53/128 (41%), Gaps = 1/128 (0%)
Query: 15 DAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSP 74
+ E + + +P + P + + P ++P P++ P + +P +P+ P +P
Sbjct: 379 ERLERRLGVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAP-AAAAAPAPAAAPQPAPAPAP 437
Query: 75 PPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDS 134
P+ SP + P + SPP ++ P P ++ P + +P P P
Sbjct: 438 APAPPSPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAP 497
Query: 135 NNGSSPPG 142
++P G
Sbjct: 498 AAPAAPAG 505
|
Length = 824 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 13/203 (6%)
Query: 353 LLGQGGFGYVHKGVLPNGKEV-AVKSLRSGSGQGEREFK---AEVEIIS-RVHHRHLVSL 407
+LG+G FG V L EV A+K L+ + + E I++ H L +L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 408 VGYCIAGGKRLL-VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHP 466
C RL V EYV +L F + + R D P A L +LH
Sbjct: 62 HC-CFQTKDRLFFVMEYVNGGDLMFQIQ-RSRK-FDEPRSRFYAAEVTLALMFLHRH--- 115
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLT 526
+I+RD+K NILLD K+ADFG+ K N +T GT Y+APE +
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT-FCGTPDYIAPEILQELEYG 174
Query: 527 EKSDVFSFGVMLLELITGRRPID 549
D ++ GV++ E++ G+ P +
Sbjct: 175 PSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 36/97 (37%), Positives = 58/97 (59%), Gaps = 6/97 (6%)
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGY 514
+GL Y+H ++HRD+K SN+LL+ + K+ DFGLA+ T++ ++ V+ T Y
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174
Query: 515 LAPE-YASSGKLTEKSDVFSFGVMLLELITGRRPIDP 550
APE + + T DV+S G + EL+ GR+P+ P
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFP 210
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 74/225 (32%), Positives = 101/225 (44%), Gaps = 21/225 (9%)
Query: 354 LGQGGFGYV----HKGVLPNGKEVAVKSLRSGSGQGEREFK---AEVEI-ISRVHHRHLV 405
+G+G FG V HK +GK AVK L+ + ++E K AE + + V H LV
Sbjct: 3 IGKGSFGKVLLAKHK---ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 406 SLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCH 465
L K V +YV L FHL + R + R A A L YLH
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGELFFHLQ-RERSFPEPRARF-YAAEIASALGYLHS--- 114
Query: 466 PRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKL 525
II+RD+K NILLD + DFGL K +++ ST GT YLAPE
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPEVLRKQPY 173
Query: 526 TEKSDVFSFGVMLLELITGRRPI--DPTGAMEDCLVDWARPLCLR 568
D + G +L E++ G P T M D +++ +PL L+
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN--KPLRLK 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 57/228 (25%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKA-------EVEIISRVHHRHLV 405
+GQG FG V K + VA+K + E E + E++I+ + H ++V
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLM-----ENEKEGFPITALREIKILQLLKHENVV 74
Query: 406 SLVGYCIAGGKR--------LLVYEY--------VPNNNLEFHLHGKGRPVMDWPTRLKI 449
+L+ C LV+E+ + N N++F L + + VM K+
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL-SEIKKVM------KM 127
Query: 450 AMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKL----TTDNNTHVS 505
+ GL Y+H + +I+HRD+K++NIL+ K+ADFGLA+ +
Sbjct: 128 LL---NGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 506 TRVMGTFGYLAPEYASSGKLTEKS-----DVFSFGVMLLELITGRRPI 548
RV+ T Y PE L E+ D++ G ++ E+ T R PI
Sbjct: 182 NRVV-TLWYRPPELL----LGERDYGPPIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 331 FSQSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREF 389
++ S E L T + +G+G +G V+K +G AVK L S E E
Sbjct: 7 YNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE-EI 65
Query: 390 KAEVEIISRV-HHRHLVSLVGYC-----IAGGKRLLVYEYVPNNNLEFHLHG--KGRPVM 441
+AE I+ + +H ++V G + GG+ LV E ++ + G +
Sbjct: 66 EAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRL 125
Query: 442 DWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501
D I G+ GL +LH + RIIHRD+K +NILL K+ DFG++ T
Sbjct: 126 DEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182
Query: 502 THVSTRVMGTFGYLAPEYASSGKLTEKS-----DVFSFGVMLLELITGRRPI 548
+T V GT ++APE + + + S DV+S G+ +EL G P+
Sbjct: 183 LRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 34/219 (15%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKA--EVEIISRVHHRHL 404
F + +G+G +G V+K G+ VA+K +R + A E+ ++ ++H ++
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 405 VSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAK--------G 456
V L+ K LV+E+ LH + MD I + K G
Sbjct: 62 VKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQG 112
Query: 457 LAYLHEDCHP-RIIHRDIKSSNILLDYTFETKVADFGLAK---LTTDNNTHVSTRVMGTF 512
LA+ CH R++HRD+K N+L++ K+ADFGLA+ + TH V+ T
Sbjct: 113 LAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---EVV-TL 164
Query: 513 GYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPIDP 550
Y APE K + D++S G + E++T RR + P
Sbjct: 165 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 61/223 (27%), Positives = 105/223 (47%), Gaps = 22/223 (9%)
Query: 341 LSAATGGFSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV 399
L G F ++G G +G V+KG + G+ A+K + + E E K E+ ++ +
Sbjct: 11 LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKY 69
Query: 400 -HHRHLVSLVGYCIAGG------KRLLVYEYVPNNNL-EFHLHGKGRPVM-DWPTRLKIA 450
HHR++ + G I + LV E+ ++ + + KG + DW I
Sbjct: 70 SHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--IC 127
Query: 451 MGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMG 510
+GLA+LH ++IHRDIK N+LL E K+ DFG++ D +G
Sbjct: 128 REILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIG 183
Query: 511 TFGYLAPEYASSGKLTE-----KSDVFSFGVMLLELITGRRPI 548
T ++APE + + + +SD++S G+ +E+ G P+
Sbjct: 184 TPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 33/207 (15%)
Query: 354 LGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKA--EVEIISRVHHRHLVSLVGY 410
LG+G + V+KG G+ VA+K +R +G F A E ++ + H ++V+L +
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTL--H 69
Query: 411 CIAGGKRLL--VYEYVPNNNLEFHL--HGKGRPVMDWPTRLKIAMGS-AKGLAYLHEDCH 465
I K+ L V+EY+ + +L+ ++ G G + +++ + +GLAY H
Sbjct: 70 DIIHTKKTLTLVFEYL-DTDLKQYMDDCGGG---LS-MHNVRLFLFQLLRGLAYCH---Q 121
Query: 466 PRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAP-------E 518
R++HRD+K N+L+ E K+ADFGLA+ + + S V+ T Y P E
Sbjct: 122 RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDVLLGSTE 180
Query: 519 YASSGKLTEKSDVFSFGVMLLELITGR 545
Y++S D++ G + E+ TGR
Sbjct: 181 YSTS------LDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 7e-11
Identities = 35/88 (39%), Positives = 49/88 (55%), Gaps = 5/88 (5%)
Query: 462 EDCHPR-IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYA 520
E H R +++RD+K +NILLD +++D GLA + H S +GT GY+APE
Sbjct: 111 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVL 167
Query: 521 SSGKLTEKS-DVFSFGVMLLELITGRRP 547
G + S D FS G ML +L+ G P
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 63/214 (29%), Positives = 107/214 (50%), Gaps = 22/214 (10%)
Query: 354 LGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVSL---- 407
LG+G + V KG VA+K +R +G EV ++ + H ++V+L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 408 -VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSA-KGLAYLHEDCH 465
C+ LV+EY+ +++L+ +L G +M +KI M +GL+Y H
Sbjct: 73 HTERCLT-----LVFEYL-DSDLKQYLDNCGN-LMSM-HNVKIFMFQLLRGLSYCH---K 121
Query: 466 PRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE-YASSGK 524
+I+HRD+K N+L++ E K+ADFGLA+ + S V+ T Y P+ S +
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTE 180
Query: 525 LTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCL 558
+ D++ G +L E+ TG RP+ P +++ L
Sbjct: 181 YSTPIDMWGVGCILYEMATG-RPMFPGSTVKEEL 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 9e-11
Identities = 22/121 (18%), Positives = 39/121 (32%), Gaps = 6/121 (4%)
Query: 14 PDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSS 73
P A P S++P S + +PP + P PPP+S P + P
Sbjct: 361 PAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVP---PPPASAPQQAPAVPLPE 417
Query: 74 PPPS-SQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPP--SNSNASPPPSQDNPSDPP 130
+ Q + +S P + P +S ++ +P + P+
Sbjct: 418 TTSQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAPAKKE 477
Query: 131 P 131
Sbjct: 478 A 478
|
Length = 647 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 9e-11
Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 25/220 (11%)
Query: 348 FSQSNLLGQGGFGYVHKGVLP----NGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHH 401
F+ +LG+G FG V + L + ++VAVK L++ S EF E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 402 RHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGK----------GRPVMDWP--TRLKI 449
+++ L+G + R +P L F HG G P T ++
Sbjct: 61 PNVIKLIGVSLR--SRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 450 AMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM 509
+ A G+ YL IHRD+ + N +L+ VADFGL+K + +
Sbjct: 119 MIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 510 G-TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
+LA E + T SDV++FGV + E++T G+ P
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-10
Identities = 41/156 (26%), Positives = 48/156 (30%), Gaps = 17/156 (10%)
Query: 3 DNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSP 62
+SP S S + PS RASSS S S S SS P PS
Sbjct: 291 PRERSPSPSPSSPGSGPAPSSPRASSSSSSSRESSSSSTSSSSESSRGAAVSPGPSPSRS 350
Query: 63 PPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPN--------------TNPPPQS 108
P PPP+ P + P S P + + T P
Sbjct: 351 PSPSRPPPPADPSSPRKRPRPSRAPSSPAASAGRPTRRRARAAVAGRARRRDATGRFPAG 410
Query: 109 SPPPS---NSNASPPPSQDNPSDPPPGDSNNGSSPP 141
P PS AS P P G+ GS PP
Sbjct: 411 RPRPSPLDAGAASGAFYARYPLLTPSGEPWPGSPPP 446
|
Length = 1352 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 1e-10
Identities = 24/118 (20%), Positives = 40/118 (33%), Gaps = 1/118 (0%)
Query: 16 AAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPP 75
A R + P + ++ P ++P P + P ++ P+P + P +P
Sbjct: 375 LARLERLERRLGVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPA 434
Query: 76 PSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGD 133
P+ P SP S PP P Q +P P+ + P P
Sbjct: 435 PAPAPAPPSPAGNAPAGGAPSPPPA-AAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPA 491
|
Length = 824 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 1e-10
Identities = 32/194 (16%), Positives = 66/194 (34%), Gaps = 9/194 (4%)
Query: 16 AAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPP 75
P + P S+ P +E+ P++P + P +P ++ P+ S P+
Sbjct: 588 VGPAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGV 647
Query: 76 PSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSN 135
+ + P+ P++ P P + PP A P+ P+ P P +
Sbjct: 648 AAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAPAPAA 707
Query: 136 NGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSSSSNSPNGNRSGALS 195
+ ++ G + P P P + P+ + A
Sbjct: 708 TPPAGQADDPAAQPPQAAQGASAPSP---------AADDPVPLPPEPDDPPDPAGAPAQP 758
Query: 196 PPNKSNGSSSSPSS 209
PP + +++P++
Sbjct: 759 PPPPAPAPAAAPAA 772
|
Length = 824 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-10
Identities = 25/126 (19%), Positives = 50/126 (39%), Gaps = 7/126 (5%)
Query: 8 PGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPE 67
+ +P A P + + A+++P P+ PP+ P ++P ++ + P+ P+PE
Sbjct: 375 ATAAAAPVAQPAPAAAAPAAAAPAPAAPPA---APAAAPAAAAAARAVAAAPARRSPAPE 431
Query: 68 SPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPS 127
+ + + P P P ++P P P + + A+ P +
Sbjct: 432 ALAAARQASARGPGGAPAPAPA----PAAAPAAAARPAAAGPRPVAAAAAAAPARAAPAA 487
Query: 128 DPPPGD 133
P P D
Sbjct: 488 APAPAD 493
|
Length = 700 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 29/204 (14%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRS------GSGQGEREFKAEVE--IISRVHHRHLV 405
LG+G FG V+ ++ + K VA + L+ G +A E ++S++ H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 406 SLVGYCIAGGKRLLVYEYVPNNNLEFHLH-----GKGRP---VMDWPTRLKIAMGSAKGL 457
+ ++ EY +L+ L GK V +W +L + G+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GV 119
Query: 458 AYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAP 517
Y+H+ RI+HRD+K+ NI L K+ DFG+++L + ++T GT Y++P
Sbjct: 120 HYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM-GSCDLATTFTGTPYYMSP 174
Query: 518 EYASSGKLTEKSDVFSFGVMLLEL 541
E KSD++S G +L E+
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 56/234 (23%), Positives = 109/234 (46%), Gaps = 34/234 (14%)
Query: 340 ELSAATGGFSQSNLLGQGGFGYVHKGVL------PNGKEVAVKSLR-SGSGQGEREFKAE 392
E++ +T F + LG+ FG V+KG L + VA+K+L+ G EFK E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 393 VEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKG--------------R 438
+ SR+ H ++V L+G +++ Y +++L L + +
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 439 PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498
++ + I A G+ +L ++H+D+ + N+L+ K++D GL +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 499 DNNTHVSTRVMGT----FGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
+ + ++MG +++PE GK + SD++S+GV+L E+ + G +P
Sbjct: 176 AADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 34/82 (41%), Positives = 54/82 (65%), Gaps = 1/82 (1%)
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN-NTHVSTRVMGTFGYLAPEYASSGKL 525
+++HRD+KS+NI L T K+ DFG +K +D+ + V++ GT YLAPE +
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 526 TEKSDVFSFGVMLLELITGRRP 547
++K+D++S GV+L EL+T RP
Sbjct: 249 SKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 53/160 (33%), Positives = 77/160 (48%), Gaps = 12/160 (7%)
Query: 400 HHRHLVSLVGYCIAGGKRLL-VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLA 458
+H LV L C RL V EYV +L FH+ + R + + R A S L
Sbjct: 54 NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISL-ALN 110
Query: 459 YLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK--LTTDNNTHVSTRVMGTFGYLA 516
YLHE II+RD+K N+LLD K+ D+G+ K L + T + GT Y+A
Sbjct: 111 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIA 164
Query: 517 PEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMED 556
PE D ++ GV++ E++ GR P D G+ ++
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 63/217 (29%), Positives = 92/217 (42%), Gaps = 28/217 (12%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE---FKAEVEIISRVHHRH 403
F +L+G+G FG V G A+K ++ + F+ E +I+S +
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 404 LVSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMD------WPTRLKIAMGSAKG 456
+ L Y L LV EY P +L L + D + L +A+ S
Sbjct: 63 IPQLQ-YAFQDKDNLYLVMEYQPGGDL-LSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 457 LAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLA 516
+ Y +HRDIK N+L+D T K+ADFG A T N S +GT Y+A
Sbjct: 121 MGY---------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIA 171
Query: 517 PEYASSGKLTEKS------DVFSFGVMLLELITGRRP 547
PE ++ K D +S GV+ E+I GR P
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 348 FSQSNLLGQGGFGYVHKGVLPNGKE-VAVKSLRSGSGQGEREFKA--EVEIISRVHHRHL 404
F ++G+G +G V K KE VA+K + E + E++++ + ++
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 405 VSLVGYCIAGGKRLLVYEYVPNNNLEF-HLHGKGRPVMDWPTRLKIAMGS-AKGLAYLHE 462
V L GK LV+EYV N LE G P P +++ + K + + H+
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVP----PEKVRSYIYQLIKAIHWCHK 118
Query: 463 DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS 522
+ I+HRDIK N+L+ + K+ DFG A+ ++ + T + T Y +PE
Sbjct: 119 N---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG 175
Query: 523 GKLTEKSDVFSFGVMLLELITGRRPIDP 550
+ D++S G +L EL G +P+ P
Sbjct: 176 APYGKAVDMWSVGCILGELSDG-QPLFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 63/203 (31%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 353 LLGQGGFGYVHKGVL----PNGKEVAVKSLRSGSGQGEREFK---AEVEIISRVHHRHLV 405
LLG+G FG V +L G+ A+K LR + E E ++ H L
Sbjct: 2 LLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 406 SLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC 464
+L Y RL V EY L FHL + R + R A L YLH
Sbjct: 59 AL-KYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAE-IVSALEYLHSR- 114
Query: 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGK 524
+++RDIK N++LD K+ DFGL K + + T GT YLAPE
Sbjct: 115 --DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDND 171
Query: 525 LTEKSDVFSFGVMLLELITGRRP 547
D + GV++ E++ GR P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-10
Identities = 54/323 (16%), Positives = 84/323 (26%), Gaps = 42/323 (13%)
Query: 14 PDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSS 73
P P SR + SPP ++ P S + PP P P +
Sbjct: 2652 PRDDPAPGRVSRPRRARRLGRAAQASSPPQRPRRRAARPTVGSLTSLADPPPPPPTPEPA 2711
Query: 74 PPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSP-----------PPSNSNASPPPS 122
P +P PP + Q+SP P P + P P + PP+
Sbjct: 2712 PHALV---SATPLPPGPAAARQASPALPAAPAPPAVPAGPATPGGPARPARPPTTAGPPA 2768
Query: 123 QDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSSS 182
P+ P G + P + + + + + P + +
Sbjct: 2769 PAPPAAPAAGPPRRLTRPAVASLSESRESLPSPWDPAD-------------PPAAVLAPA 2815
Query: 183 SNSPNGNRSGALSPPNKSNGSSSSPSSNNGSMLSIPLVAAVAAGAAFLIIVMLLVFFACR 242
+ P PP S ++ P S+PL +VA G
Sbjct: 2816 AALPPAASPAGPLPPPTSAQPTAPPPPPGPPPPSLPLGGSVAPGGDV------------- 2862
Query: 243 RKKNRERNDQMPYYNNNHTTATDYYNSAATPSPPPRANWQQQTDHGWPTPPPSQRGAVTV 302
R++ R+ A + S A P P +
Sbjct: 2863 RRRPPSRSPAAKPAAPARPPVRRLARPAVSRSTESFA--LPPDQPERPPQPQAPPPPQPQ 2920
Query: 303 TSSDMSHNSSSGPYGPVLPPPPP 325
P P P PP
Sbjct: 2921 PQPPPPPQPQPPPPPPPRPQPPL 2943
|
Length = 3151 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 60/202 (29%), Positives = 88/202 (43%), Gaps = 17/202 (8%)
Query: 354 LGQGGFGYVHKGVLPNGKE-VAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVG 409
+GQGG+G V + E VA+K ++ R E +I++ LV L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 410 YCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIA-MGSAKGLAYLHEDCHPR 467
Y + L L EYVP + L+ G + + R +A M A + LHE
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEA--VDALHE---LG 121
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTE 527
IHRD+K N L+D + K+ DFGL+K + V+G+ Y+APE
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLRGKGYDF 177
Query: 528 KSDVFSFGVMLLELITGRRPID 549
D +S G ML E + G P
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 50/146 (34%), Positives = 70/146 (47%), Gaps = 9/146 (6%)
Query: 407 LVGY--CIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHED 463
LVG C RL LV EYV +L FH+ + R + + R A L +LHE
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQ-RQRKLPEEHARF-YAAEICIALNFLHER 115
Query: 464 CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSG 523
II+RD+K N+LLD K+ D+G+ K ST GT Y+APE
Sbjct: 116 ---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYIAPEILRGE 171
Query: 524 KLTEKSDVFSFGVMLLELITGRRPID 549
+ D ++ GV++ E++ GR P D
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 59/278 (21%), Positives = 119/278 (42%), Gaps = 52/278 (18%)
Query: 361 YVHKGVLPNGKEVAVKSLR---SGSGQGEREFKAEVEIISRVHHRHLVSLVGYCI---AG 414
++KG+ N KEV +++ + G + E++ + R+ +++ + G+ I
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 415 GKRLLVYEYVPNNNLEFHLHGKGRPVMD------WPTRLKIAMGSAKGLAYLHE-DCHPR 467
RL + LE+ G R V+D + T+L +A+ KGL L++ P
Sbjct: 94 LPRLSLI-------LEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP- 145
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS--GKL 525
++++ S + L+ ++ K+ GL K+ + + + Y + + + +
Sbjct: 146 --YKNLTSVSFLVTENYKLKIICHGLEKILSSP----PFKNVNFMVYFSYKMLNDIFSEY 199
Query: 526 TEKSDVFSFGVMLLELITGRRPID--PTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583
T K D++S GV+L E+ TG+ P + T + D ++ N+ L
Sbjct: 200 TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLII----------------NKNNSLKL 243
Query: 584 EKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
+ P E + AC + H + +RP I +I+ L
Sbjct: 244 PLDCPLEIKCIVEACTS----HDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 12/209 (5%)
Query: 354 LGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVSLVGYC 411
LG+G + V+KG VA+K +R +G EV ++ + H ++V+L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR-IIH 470
LV+EY+ + +L+ +L G + +L + +GL Y CH R ++H
Sbjct: 74 HTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFL-FQLLRGLNY----CHRRKVLH 127
Query: 471 RDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE-YASSGKLTEKS 529
RD+K N+L++ E K+ADFGLA+ + S V+ T Y P+ S + +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQI 186
Query: 530 DVFSFGVMLLELITGRRPIDPTGAMEDCL 558
D++ G + E+ TG RP+ P +E+ L
Sbjct: 187 DMWGVGCIFYEMSTG-RPLFPGSTVEEQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 354 LGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKA--EVEIISRVHHRHLVSLVGY 410
LG+G + V+KG NGK VA+K +R +G F A E ++ + H ++V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKHANIVLLHDI 71
Query: 411 CIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSA-KGLAYLHEDCHPRII 469
LV+EYV + ++ P P +K+ + +GL+Y+H+ I+
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYM---DKHPGGLHPENVKLFLFQLLRGLSYIHQR---YIL 125
Query: 470 HRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE-YASSGKLTEK 528
HRD+K N+L+ T E K+ADFGLA+ + + S V+ T Y P+ S + +
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGSTEYSTC 184
Query: 529 SDVFSFGVMLLELITG 544
D++ G + +E+I G
Sbjct: 185 LDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-10
Identities = 34/112 (30%), Positives = 39/112 (34%), Gaps = 5/112 (4%)
Query: 7 SPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPP----SSPPPDRSPPPSSP 62
S S S S SP PS P PSSP SS S SS
Sbjct: 273 SGWNGPSSRPGPASSSSSPRERSPSPSPSSPGSGPAPSSPRASSSSSSSRESSSSSTSSS 332
Query: 63 PPSPESPPPSSPPPSSQSP-PQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPS 113
S S P S+SP P PPPP S P+ P P+ P ++
Sbjct: 333 SESSRGAAVSPGPSPSRSPSPSRPPPPADPSSPRKRPRPSRAPSSPAASAGR 384
|
Length = 1352 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-10
Identities = 19/116 (16%), Positives = 43/116 (37%), Gaps = 8/116 (6%)
Query: 35 PPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPP 94
P + + + P+ + P ++P + P + P++ + + PP + P
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAP 425
Query: 95 QSSPPPNTNPPPQSSPPPSNSNASPPPSQDNP--------SDPPPGDSNNGSSPPG 142
++P ++ P + + A PP+Q P P P ++ +P
Sbjct: 426 VAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAPAA 481
|
Length = 618 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 3e-10
Identities = 12/86 (13%), Positives = 31/86 (36%), Gaps = 1/86 (1%)
Query: 26 ASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSP 85
A P + P+ + ++ + + P++P P+P + + PP + +
Sbjct: 34 ADYGPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAA 93
Query: 86 PPPNSKSPPQSSPPPN-TNPPPQSSP 110
P + ++ P + +P
Sbjct: 94 AAPAAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-10
Identities = 38/148 (25%), Positives = 54/148 (36%), Gaps = 16/148 (10%)
Query: 7 SPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSP---- 62
+P P TP P+R + P + PP+ P P + P + PP + P +
Sbjct: 2738 APAPPAVPAGPATPGGPARPARPPTTAGPPA---PAPPAAPAAGPPRRLTRPAVASLSES 2794
Query: 63 ------PPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSP--PPNTNPPPQSSPPPSN 114
P P PP + P++ PP + P P + P PP PP S P
Sbjct: 2795 RESLPSPWDPADPPAAVLAPAAALPPAASPAGPLPPPTSAQPTAPPPPPGPPPPSLPLGG 2854
Query: 115 SNASPPP-SQDNPSDPPPGDSNNGSSPP 141
S A + PS P + PP
Sbjct: 2855 SVAPGGDVRRRPPSRSPAAKPAAPARPP 2882
|
Length = 3151 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-10
Identities = 21/128 (16%), Positives = 43/128 (33%)
Query: 13 SPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPS 72
+ A +P+ A+++ + P+ SP P + + R P + P + P+
Sbjct: 400 AAPPAAPAAAPAAAAAARAVAAAPARRSPAPEALAAARQASARGPGGAPAPAPAPAAAPA 459
Query: 73 SPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPG 132
+ + + P+ + +P +++P P PP D P
Sbjct: 460 AAARPAAAGPRPVAAAAAAAPARAAPAAAPAPADDDPPPWEELPPEFASPAPAQPDAAPA 519
Query: 133 DSNNGSSP 140
S P
Sbjct: 520 GWVAESIP 527
|
Length = 700 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 35/168 (20%)
Query: 392 EVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPN---NNLEFHLHGKGRPVMDWPTRLK 448
E+ ++ ++ H +LV+L+ K LV+EY + N LE + G + K
Sbjct: 50 EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-----VPEHLIKK 104
Query: 449 IAMGSAKGLAYLHE-DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT---DNNT-H 503
I + + + + H+ +C IHRD+K NIL+ + K+ DFG A++ T D+ T +
Sbjct: 105 IIWQTLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY 160
Query: 504 VSTRVMGTFGYLAPE-------YASSGKLTEKSDVFSFGVMLLELITG 544
V+TR Y APE Y DV++ G + EL+TG
Sbjct: 161 VATR-----WYRAPELLVGDTQYGPP------VDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 46/200 (23%), Positives = 94/200 (47%), Gaps = 10/200 (5%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLR---SGSGQGEREFKAEVEIISRVHHRHLVSLVG 409
+G+G F V++ L + K VA+K ++ + ++ E++++ +++H +++ +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 410 YCIAGGKRLLVYEYVPNNNLE--FHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR 467
I + +V E +L K + ++ T K + + ++H R
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---R 126
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTE 527
++HRDIK +N+ + T K+ D GL + + T + V GT Y++PE
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNF 185
Query: 528 KSDVFSFGVMLLELITGRRP 547
KSD++S G +L E+ + P
Sbjct: 186 KSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 51/206 (24%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 354 LGQGGFGYVHKGVLPNGK--------EVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLV 405
LGQG F + KG+ EV +K L F ++S++ H+HLV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 406 SLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCH 465
G C+ G + ++V EYV +L+ +L K + +++ +L++A A L +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLK-KNKNLINISWKLEVAKQLAWALHFLEDK-- 119
Query: 466 PRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGT------FGYLAPEY 519
+ H ++ + N+LL + K + KL ++ +S V+ ++ PE
Sbjct: 120 -GLTHGNVCAKNVLLIREEDRKTGNPPFIKL---SDPGISITVLPKEILLERIPWVPPEC 175
Query: 520 ASSGK-LTEKSDVFSFGVMLLELITG 544
+ + L+ +D +SFG L E+ +G
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 6e-10
Identities = 32/122 (26%), Positives = 44/122 (36%)
Query: 20 PPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQ 79
P+P + ++ + S P SS P +RSP PS P P S SS
Sbjct: 259 RPAPITLPTRIWEASGWNGPSSRPGPASSSSSPRERSPSPSPSSPGSGPAPSSPRASSSS 318
Query: 80 SPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSS 139
S + ++ S +SS +P P S PS S PP +P P S
Sbjct: 319 SSSRESSSSSTSSSSESSRGAAVSPGPSPSRSPSPSRPPPPADPSSPRKRPRPSRAPSSP 378
Query: 140 PP 141
Sbjct: 379 AA 380
|
Length = 1352 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 7e-10
Identities = 45/218 (20%), Positives = 74/218 (33%), Gaps = 22/218 (10%)
Query: 13 SPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPP---SPESP 69
A + + SSP + S PP+ PPPS+PP SP P + S
Sbjct: 162 VASDAASSRQAALPLSSPEETARAP--SSPPAEPPPSTPPAAASPRPPRRSSPISASASS 219
Query: 70 PPSSPPPSSQSPPQSPPPPNSKSP------------PQSSPPPNTNPPPQSSPPPSNSNA 117
P +P S+ + +S S P P P T P N +
Sbjct: 220 PAPAPGRSAADDAGASSSDSSSSESSGCGWGPENECPLPRPAPITLPTRIWEASGWNGPS 279
Query: 118 SPPPSQ-----DNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKN 172
S P P P S+ GS P ++ +++ + + + ++++ ++
Sbjct: 280 SRPGPASSSSSPRERSPSPSPSSPGSGPAPSSPRASSSSSSSRESSSSSTSSSSESSRGA 339
Query: 173 WHPPPPPSSSSNSPNGNRSGALSPPNKSNGSSSSPSSN 210
P P S S SP+ A + S S+
Sbjct: 340 AVSPGPSPSRSPSPSRPPPPADPSSPRKRPRPSRAPSS 377
|
Length = 1352 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 12/209 (5%)
Query: 354 LGQGGFGYVHKGVLPNGKE-VAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVSLVGYC 411
LG+G + V KG + VA+K +R +G EV ++ + H ++V+L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR-IIH 470
LV+EY+ + +L+ ++ G +M +GLAY CH R ++H
Sbjct: 74 HTDKSLTLVFEYL-DKDLKQYMDDCGN-IMSMHNVKIFLYQILRGLAY----CHRRKVLH 127
Query: 471 RDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE-YASSGKLTEKS 529
RD+K N+L++ E K+ADFGLA+ + S V+ T Y P+ S + + +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYSTQI 186
Query: 530 DVFSFGVMLLELITGRRPIDPTGAMEDCL 558
D++ G + E+ +G RP+ P +ED L
Sbjct: 187 DMWGVGCIFFEMASG-RPLFPGSTVEDEL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 54/197 (27%), Positives = 99/197 (50%), Gaps = 13/197 (6%)
Query: 354 LGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKA--EVEIISRVHHRHLVSLVGY 410
LG+G + V+KG+ NG+ VA+K + + +G F A E ++ + H ++V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHDI 71
Query: 411 CIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSA-KGLAYLHEDCHPRII 469
V+EY+ + ++ + P P +++ M +GLAY+H I+
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIH---GQHIL 125
Query: 470 HRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE-YASSGKLTEK 528
HRD+K N+L+ Y E K+ADFGLA+ + + S+ V+ T Y P+ + +
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSA 184
Query: 529 SDVFSFGVMLLELITGR 545
D++ G + +E++ G+
Sbjct: 185 LDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 26/221 (11%)
Query: 348 FSQSNLLGQGGFGYV--------HKGVLPNGKEVAVKSLRSGS----GQGEREFKAEVEI 395
F +LG G +G V H +GK A+K L+ + + + E ++
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHD----SGKLYAMKVLKKATIVQKAKTTEHTRTERQV 57
Query: 396 ISRVHHRHLVSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGS- 453
+ + + + Y +L L+ +Y+ L HL + R ++I G
Sbjct: 58 LEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEI 114
Query: 454 AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFG 513
L +LH+ II+RDIK NILLD + DFGL+K ++ + GT
Sbjct: 115 VLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIE 171
Query: 514 YLAPEYASSGKLTEKS--DVFSFGVMLLELITGRRPIDPTG 552
Y+AP+ G D +S GV++ EL+TG P G
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-09
Identities = 55/230 (23%), Positives = 96/230 (41%), Gaps = 43/230 (18%)
Query: 353 LLGQGGFGYVHKGVLPN-GKEVAVKSLR---SGSGQGEREFKAEVEIISRVHHRHLVSLV 408
L+G+GG G V+ P + VA+K +R S + ++ F E +I + + H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV- 67
Query: 409 GYCIAGGKRLLVYE--YVPNNNLEFHL------------HGKGRPVMDWPTRLKIAMGSA 454
Y I + Y Y+ L+ L + V L I
Sbjct: 68 -YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSV---GAFLSIFHKIC 123
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK---------LTTD------ 499
+ Y+H ++HRD+K NILL E + D+G A L D
Sbjct: 124 ATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 500 --NNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
++ + +++GT Y+APE +E +D+++ GV+L +++T P
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 48/133 (36%), Positives = 67/133 (50%), Gaps = 13/133 (9%)
Query: 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGS-AKGLAYLHEDCHPRIIHRDIKSSN 477
LV +Y+ L +HL +GR D R K + L +LH+ I++RD+K N
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSED---RAKFYIAELVLALEHLHKY---DIVYRDLKPEN 126
Query: 478 ILLDYTFETKVADFGLAK--LTTDNNTHVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSF 534
ILLD T + DFGL+K LT + T+ GT YLAPE K T+ D +S
Sbjct: 127 ILLDATGHIALCDFGLSKANLTDNKTTNT---FCGTTEYLAPEVLLDEKGYTKHVDFWSL 183
Query: 535 GVMLLELITGRRP 547
GV++ E+ G P
Sbjct: 184 GVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-09
Identities = 33/111 (29%), Positives = 49/111 (44%), Gaps = 10/111 (9%)
Query: 24 SRASSSPPPSTPPSDESPPPSSPPPSSPP-PDRSPPPSSPPPSPESPPPSSPPPSSQSPP 82
+R +++P P D+ P++P P+S P P +P P+S PP P +P PS+ P S P
Sbjct: 388 ARHAATPFARGPGGDDQTRPAAPVPASVPTPAPTPVPASAPPPPATPLPSAEPGSDDGPA 447
Query: 83 QSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGD 133
PP+ PP P P + A + P +PP D
Sbjct: 448 ---------PPPERQPPAPATEPAPDDPDDATRKALDALRERRPPEPPGAD 489
|
Length = 3151 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 24/93 (25%), Positives = 30/93 (32%), Gaps = 7/93 (7%)
Query: 57 PPPSSPP-----PSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPP 111
P PP + +S S P S P+ PP+
Sbjct: 147 DPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSS 206
Query: 112 PSNSNASPPPSQDNPSDPP--PGDSNNGSSPPG 142
PS+S+ P PS PP P N S PPG
Sbjct: 207 PSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPG 239
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 22/102 (21%), Positives = 35/102 (34%), Gaps = 11/102 (10%)
Query: 32 PSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSK 91
P P P ++P P P P PS+ P + + P ++ P PP
Sbjct: 362 PVPAPQPAKPTAAAPSPVRPTPA----PSTRPKAAAAANIPPKEPVRETATPPPVPPRPV 417
Query: 92 SPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGD 133
+PP P + +++ P PP PP +
Sbjct: 418 APPVPHTPESAPKLTRAAIPVDEKPKYTPP-------APPKE 452
|
Length = 585 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 2e-09
Identities = 13/89 (14%), Positives = 34/89 (38%), Gaps = 4/89 (4%)
Query: 11 SNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPP 70
P + P + + A+++ + + + P++P P+ P + PP P +
Sbjct: 35 DYGPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAA----AAPAAPPKPAAAA 90
Query: 71 PSSPPPSSQSPPQSPPPPNSKSPPQSSPP 99
++ P++ + P + + P
Sbjct: 91 AAAAAPAAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 61/203 (30%), Positives = 87/203 (42%), Gaps = 17/203 (8%)
Query: 353 LLGQGGFGYVHKGVL----PNGKEVAVKSLRSGSGQGEREFK---AEVEIISRVHHRHLV 405
LLG+G FG V +L G+ A+K L+ + E E ++ H L
Sbjct: 2 LLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 406 SLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC 464
+L Y RL V EY L FHL + R + R A L YLH +
Sbjct: 59 AL-KYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGAE-IVSALDYLHSE- 114
Query: 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGK 524
+++RD+K N++LD K+ DFGL K + + T GT YLAPE
Sbjct: 115 -KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDND 172
Query: 525 LTEKSDVFSFGVMLLELITGRRP 547
D + GV++ E++ GR P
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 354 LGQGGFGYVHKGV-LPNG-KEVAVKSLRSGSGQGEREFKA--EVEIISRVH---HRHLVS 406
+G+G +G V K L NG + VA+K +R +G+ EV ++ + H ++V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 407 LVGYCIAG-----GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLH 461
L C K LV+E+V + +L +L P + T + +GL +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 462 EDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYAS 521
R++HRD+K NIL+ + + K+ADFGLA++ + T V+ T Y APE
Sbjct: 128 SH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLL 182
Query: 522 SGKLTEKSDVFSFGVMLLELITGRRPI 548
D++S G + E+ R+P+
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 35/98 (35%), Positives = 56/98 (57%), Gaps = 11/98 (11%)
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT-HVSTRVMGTFG 513
+GL Y+H ++HRD+K SNIL++ + K+ DFGLA++ T +VSTR
Sbjct: 119 RGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY----- 170
Query: 514 YLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDP 550
Y APE + K + D++S G + E++ G +P+ P
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLFP 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 3e-09
Identities = 24/121 (19%), Positives = 40/121 (33%)
Query: 12 NSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPP 71
A P +S P + P+ + P + P+ +P +S P+P P
Sbjct: 591 APGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVAAP 650
Query: 72 SSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPP 131
P P S + + P P P + P + + A+P P+ PP
Sbjct: 651 EHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAPAPAATPP 710
Query: 132 G 132
Sbjct: 711 A 711
|
Length = 824 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 3e-09
Identities = 26/119 (21%), Positives = 41/119 (34%), Gaps = 8/119 (6%)
Query: 20 PPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQ 79
P +P PP S P+ + ++P + PP P+ PPP +P + P +
Sbjct: 361 PAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPP---QAPAVPPPPASAPQQAPAVPLPE 417
Query: 80 SPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPP-PSNSN----ASPPPSQDNPSDPPPGD 133
+ Q Q + + P +S P NS AS P+ P
Sbjct: 418 TTSQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAPAKK 476
|
Length = 647 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-09
Identities = 24/125 (19%), Positives = 44/125 (35%), Gaps = 11/125 (8%)
Query: 13 SPDAAETPPSPSRASSSPPPSTPP-------SDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
+P AA + + A + P+ S P + P +P +P ++ P +
Sbjct: 409 APAAAAAARAVAAAPARRSPAPEALAAARQASARGPGGAPAPAPAPAA--APAAAARPAA 466
Query: 66 PESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDN 125
P ++ +P ++ P PP PP +SP P+ +A+P
Sbjct: 467 AGPRPV--AAAAAAAPARAAPAAAPAPADDDPPPWEELPPEFASPAPAQPDAAPAGWVAE 524
Query: 126 PSDPP 130
P
Sbjct: 525 SIPDP 529
|
Length = 700 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 39/216 (18%)
Query: 354 LGQGGFGYVHKGVLPNGKE-VAVKSLRSGSGQGEREFKA-------EVEIISRVHHRHLV 405
+G+G +G V+K E +A+K +R E+E + E+ ++ + H ++V
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRL-----EQEDEGVPSTAIREISLLKEMQHGNIV 64
Query: 406 SL--VGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRL-KIAMGSA-KGLAYL 460
L V + KRL LV+EY+ +L+ H P RL K + +G+AY
Sbjct: 65 RLQDVVHS---EKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY- 117
Query: 461 HEDCHP-RIIHRDIKSSNILLD-YTFETKVADFGLAK---LTTDNNTHVSTRVMGTFGYL 515
CH R++HRD+K N+L+D T K+ADFGLA+ + TH T Y
Sbjct: 118 ---CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWYR 170
Query: 516 APE-YASSGKLTEKSDVFSFGVMLLELITGRRPIDP 550
APE S + D++S G + E++ ++P+ P
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPLFP 205
|
Length = 294 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT-DNNTHVSTRVMGTFG 513
+GL YLH I+HRDIK N+L++ K+ DFGLA++ D + H++ V+ +
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 514 YLAPE-YASSGKLTEKSDVFSFGVMLLELITGR 545
Y APE S T D++S G + EL+ R
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-09
Identities = 21/117 (17%), Positives = 40/117 (34%), Gaps = 1/117 (0%)
Query: 5 NQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSP-PPSSPPPDRSPPPSSPP 63
+P + D + + + +D PP+ +P +PP
Sbjct: 427 PAAPAPPATADRGDDAADGDAPVPAKANARASADSRCDERDAQPPADSGSASAPASDAPP 486
Query: 64 PSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPP 120
+ P P + PS+ +P P + + P PP + PP+ + A+P
Sbjct: 487 DAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPAAAAPPAPEARPPTPAAAAPA 543
|
Length = 830 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-09
Identities = 48/223 (21%), Positives = 75/223 (33%), Gaps = 29/223 (13%)
Query: 8 PGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPE 67
P V A + + S A P PP ++PPP P P PPP + PP PPP P
Sbjct: 2881 PPVRRLARPAVSRSTESFALPPDQPERPPQPQAPPPPQPQPQPPPPPQPQPP--PPPPPR 2938
Query: 68 SPPPSSPPPSSQSPPQSPPPPNSKSP--------------PQSSPPPNTNPPPQSSPPPS 113
PP P++ P P + P + P SS PP
Sbjct: 2939 PQPP--LAPTTDPAGAGEPSGAVPQPWLGALVPGRVAVPRFRVPQPAPSREAPASSTPPL 2996
Query: 114 NSNASPPPSQ-------DNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGN----GNHN 162
++ S +DPPP PP + +++ + + + +
Sbjct: 2997 TGHSLSRVSSWASSLALHEETDPPPVSLKQTLWPPDDTEDSDADSLFDSDSERSDLEALD 3056
Query: 163 NNNNNNNNKNWHPPPPPSSSSNSPNGNRSGALSPPNKSNGSSS 205
++ H P P + + + S PP +N + S
Sbjct: 3057 PLPPEPHDPFAHEPDPATPEAGARESPSSQFGPPPLSANAALS 3099
|
Length = 3151 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 354 LGQGGFGYVHKGVL---PNGKEVAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVSLVG 409
+G G FG V + V VK L++ + E+ EF + + + H +++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 410 YCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRL--KIAMGSAKGLAYLHEDCHPR 467
C+ LLV+EY +L+ +L + + L ++A A G+ ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---N 119
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLA-------KLTTDNNTHVSTRVMGTFGYLAPEYA 520
+H D+ N L KV D+G+ + T+++ V R +LAPE
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR------WLAPELV 173
Query: 521 SS--GKL-----TEKSDVFSFGVMLLEL 541
G L T+ S+V++ GV L EL
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 74/243 (30%), Positives = 103/243 (42%), Gaps = 17/243 (6%)
Query: 353 LLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFK---AEVEIISR-VHHRHLVSL 407
++G+G FG V +GK AVK L+ +E K AE ++ + V H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIA-MGSAKGLAYLHEDCHP 466
K V ++V L FHL + R + R A + SA L YLH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQ-RERSFPEPRARFYAAEIASA--LGYLHS---I 115
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLT 526
I++RD+K NILLD + DFGL K + +T GT YLAPE
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGI-AQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 527 EKSDVFSFGVMLLELITGRRPI--DPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLE 584
D + G +L E++ G P M D ++ +PL LR I + LE
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH--KPLVLRPGASLTAWSILEELLE 232
Query: 585 KNY 587
K+
Sbjct: 233 KDR 235
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 35/93 (37%), Positives = 52/93 (55%), Gaps = 10/93 (10%)
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT-HVSTRVMGTFG 513
KGL Y+H IIHRD+K N+ ++ E K+ DFGLA+ T T +V TR
Sbjct: 129 KGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180
Query: 514 YLAPEYASSG-KLTEKSDVFSFGVMLLELITGR 545
Y APE + T+ D++S G ++ E++TG+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 6e-09
Identities = 30/140 (21%), Positives = 39/140 (27%), Gaps = 1/140 (0%)
Query: 3 DNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSP 62
++ S S E R + P+ S P SP SP
Sbjct: 237 SDSSSSESSGCGWGPENECPLPRPAPITLPTRIWEASGWNGPSSRPGPASSSSSPRERSP 296
Query: 63 PPSPESPP-PSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPP 121
PSP SP +P S S +S S SS + P PS S + P
Sbjct: 297 SPSPSSPGSGPAPSSPRASSSSSSSRESSSSSTSSSSESSRGAAVSPGPSPSRSPSPSRP 356
Query: 122 SQDNPSDPPPGDSNNGSSPP 141
P +P
Sbjct: 357 PPPADPSSPRKRPRPSRAPS 376
|
Length = 1352 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 6e-09
Identities = 39/166 (23%), Positives = 48/166 (28%), Gaps = 15/166 (9%)
Query: 14 PDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSS 73
P + PP P + P P P S P+ PP P+ P
Sbjct: 183 GMPPRQAAFPQQGPPEQPPGYPQPPQGHPEQVQPQQFLPAP-SQAPAQPPLPPQLPQQPP 241
Query: 74 PPPSSQSPPQS--PPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPP--PSQDNPSDP 129
P Q P S PPP + P Q P P PQ+ PPP N P P N P
Sbjct: 242 PLQQPQFPGLSQQMPPPPPQPPQQQQQP----PQPQAQPPPQNQPTPHPGLPQGQNAPLP 297
Query: 130 PPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHP 175
PP P G+ G + +
Sbjct: 298 PPQQ------PQLLPLVQQPQGQQRGPQFREQLVQLSQQQREALSQ 337
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 6e-09
Identities = 17/78 (21%), Positives = 30/78 (38%)
Query: 39 ESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSP 98
S S +S P + +P P+ PP P + + + P PP S P +
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 99 PPNTNPPPQSSPPPSNSN 116
P +P P ++ + +
Sbjct: 421 PTEPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 6e-09
Identities = 21/90 (23%), Positives = 32/90 (35%), Gaps = 2/90 (2%)
Query: 39 ESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSP 98
ES S+ + PP P S PPP+P P P + P PPP +++ +
Sbjct: 511 ESQSGSASNTAKTPP--PPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPA 568
Query: 99 PPNTNPPPQSSPPPSNSNASPPPSQDNPSD 128
+ P P + + S D
Sbjct: 569 QIPADSSPPPPIPEEPTPSPTKDSSPEEID 598
|
Length = 620 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 6e-09
Identities = 20/114 (17%), Positives = 42/114 (36%)
Query: 13 SPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPS 72
P+ P S + A+S+ + P + +PP + P P P+ P P S +
Sbjct: 365 LPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPETTSQLLA 424
Query: 73 SPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNP 126
+ ++ + + + + P N+ +S P+ S P++
Sbjct: 425 ARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAPAKKEA 478
|
Length = 647 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 7e-09
Identities = 23/105 (21%), Positives = 35/105 (33%), Gaps = 4/105 (3%)
Query: 14 PDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSS 73
P A P P +++P P P S P + ++ PP P P PP
Sbjct: 362 PVPAPQPAKP--TAAAPSPVRPTPAPSTRPKAAAAANIPP--KEPVRETATPPPVPPRPV 417
Query: 74 PPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNAS 118
PP +P +P + P P PP+ ++
Sbjct: 418 APPVPHTPESAPKLTRAAIPVDEKPKYTPPAPPKEEEKALIADGD 462
|
Length = 585 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 7e-09
Identities = 28/141 (19%), Positives = 49/141 (34%), Gaps = 15/141 (10%)
Query: 16 AAETPPSPSRASSSPPPSTP---PSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPS 72
AA + + P P P+ + P ++ P + P + P + +P
Sbjct: 435 AARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAAAPARAAPAAAPAPADD 494
Query: 73 SPPPSSQSPPQSPPPPNSKSPP-------QSSPPPNTNPP----PQSSPPPSNSNASPPP 121
PPP + PP+ P ++ +S P P T P +P P+ + A
Sbjct: 495 DPPPWEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPDDAFETLAPAPAAAPAPRAA 554
Query: 122 SQDNPSDPP-PGDSNNGSSPP 141
+ P P P ++ P
Sbjct: 555 AATEPVVAPRPPRASASGLPD 575
|
Length = 700 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 37/93 (39%), Positives = 54/93 (58%), Gaps = 10/93 (10%)
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT-HVSTRVMGTFG 513
+GL Y+H IIHRD+K SN+ ++ E K+ DFGLA+ T D T +V+TR
Sbjct: 131 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182
Query: 514 YLAPEYASSG-KLTEKSDVFSFGVMLLELITGR 545
Y APE + + D++S G ++ EL+TGR
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 7e-09
Identities = 34/92 (36%), Positives = 56/92 (60%), Gaps = 6/92 (6%)
Query: 454 AKGLAYL-HEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK-LTTDNNTHVSTRVMGT 511
AKG+++L ++C IHRD+ + NILL + TK+ DFGLA+ + D+N V
Sbjct: 224 AKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 512 FGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 543
++APE + T +SDV+S+G++L E+ +
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 69/226 (30%), Positives = 100/226 (44%), Gaps = 21/226 (9%)
Query: 353 LLGQGGFGYV----HKGVLPNGKEVAVKSLRSGSGQGEREFKAEVE----IISRVHHRHL 404
++G+G FG V HK K AVK L+ + ++E K + ++ V H L
Sbjct: 2 VIGKGSFGKVLLARHKA---EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 58
Query: 405 VSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC 464
V L K V +Y+ L +HL + R ++ R A A L YLH
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARF-YAAEIASALGYLHS-- 114
Query: 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGK 524
I++RD+K NILLD + DFGL K ++N ST GT YLAPE
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLHKQP 172
Query: 525 LTEKSDVFSFGVMLLELITGRRPI--DPTGAMEDCLVDWARPLCLR 568
D + G +L E++ G P T M D +++ +PL L+
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--KPLQLK 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-08
Identities = 25/119 (21%), Positives = 45/119 (37%), Gaps = 3/119 (2%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
+P +P A +++PP + PP + +S P + P PP
Sbjct: 685 PAPAAPAAPAGAAPAQPAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPE 744
Query: 66 PESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQD 124
P+ PP + P+ PP +P P + P ++PPP+ + + +D
Sbjct: 745 PDDPPDPAGAPAQPPPPPAPAPA---AAPAAAPPPSPPSEEEEMAEDDAPSMDDEDRRD 800
|
Length = 824 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-08
Identities = 26/90 (28%), Positives = 38/90 (42%), Gaps = 7/90 (7%)
Query: 10 VSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESP 69
+ + P S PPP+ P P ++PPP+ PPP PP++ S +P
Sbjct: 512 SQSGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPP----PPTATQASSNAP 567
Query: 70 PPSSPPPSSQSPPQSPPPPNSKSPPQSSPP 99
P+ SPP P + SP + S P
Sbjct: 568 AQ---IPADSSPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 23/79 (29%), Positives = 32/79 (40%), Gaps = 1/79 (1%)
Query: 47 PPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPP 106
S + S P + P SPPP+ PS+ Q+ P+ S P P P
Sbjct: 363 AFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPT 422
Query: 107 QSSPPPSNSNASPPPSQDN 125
+ SP P +NA+ P N
Sbjct: 423 EPSPTPP-ANAANAPPSLN 440
|
Length = 620 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 48/206 (23%), Positives = 94/206 (45%), Gaps = 10/206 (4%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRS---GSGQGEREFKAEVEIISRVHHRH 403
F +G+G F V++ L +G VA+K ++ + + E++++ +++H +
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 404 LVSLVGYCIAGGKRLLVYEYVPNNNLEFHLH--GKGRPVMDWPTRLKIAMGSAKGLAYLH 461
++ I + +V E +L + K + ++ T K + L ++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 462 EDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYAS 521
R++HRDIK +N+ + T K+ D GL + + T + V GT Y++PE
Sbjct: 124 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179
Query: 522 SGKLTEKSDVFSFGVMLLELITGRRP 547
KSD++S G +L E+ + P
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 31/211 (14%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKA--EVEIISRVHHR-HLVSLVG 409
+G+G +G V+K GK VA+K R + A E+ ++ + ++V L+
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL- 67
Query: 410 YCI-----AGGKRLL--VYEYVPNNNLEF---HLHGKGRPVMDWPTRLKIAMGSAKGLAY 459
+ GK L V+EY+ ++ +F + G GRP + T KG+A+
Sbjct: 68 -DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP-LPAKTIKSFMYQLLKGVAH 125
Query: 460 LHEDCHPR-IIHRDIKSSNILLDYTFET-KVADFGLAKLTT---DNNTHVSTRVMGTFGY 514
CH ++HRD+K N+L+D K+AD GL + + + TH + T Y
Sbjct: 126 ----CHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----EIVTLWY 177
Query: 515 LAPE-YASSGKLTEKSDVFSFGVMLLELITG 544
APE S + D++S G + E+
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 24/100 (24%), Positives = 34/100 (34%), Gaps = 12/100 (12%)
Query: 8 PGVSNSPDA--AETPPSPS----------RASSSPPPSTPPSDESPPPSSPPPSSPPPDR 55
PG + PD A T P+ RA + PS P+ +PP + P P +
Sbjct: 47 PGDRDEPDMMPAATQALPTQPPEGAAEAVRAGDAAAPSLDPATVAPPNTPVEPEPAPVEP 106
Query: 56 SPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQ 95
P P P+ P P+ P K+ P
Sbjct: 107 PKPKPVEKPKPKPKPQQKVEAPPAPKPEPKPVVEEKAAPT 146
|
Length = 226 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 63/203 (31%), Positives = 88/203 (43%), Gaps = 17/203 (8%)
Query: 353 LLGQGGFGYV----HKGVLPNGKEVAVKSLRSGSGQGEREFK---AEVEIISR-VHHRHL 404
++G+G FG V K +G AVK L+ + ++E AE ++ + + H L
Sbjct: 2 VIGKGSFGKVLLAKRKS---DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFL 58
Query: 405 VSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC 464
V L K V +YV L FHL + R ++ R A A + YLH
Sbjct: 59 VGLHYSFQTAEKLYFVLDYVNGGELFFHLQ-RERCFLEPRARF-YAAEVASAIGYLHS-- 114
Query: 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGK 524
II+RD+K NILLD + DFGL K + ST GT YLAPE
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKEP 172
Query: 525 LTEKSDVFSFGVMLLELITGRRP 547
D + G +L E++ G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCI 412
+G G +G V+K + G+ A+K ++ G+ + E+ ++ H ++V+ G +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 413 AGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSA---KGLAYLHEDCHPRII 469
K + E+ +L+ H G P+ + +IA S +GL YLH +
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTG-PL----SESQIAYVSRETLQGLYYLHSKGK---M 128
Query: 470 HRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYAS---SGKLT 526
HRDIK +NILL K+ADFG++ T + +GT ++APE A+ G
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS-FIGTPYWMAPEVAAVERKGGYN 187
Query: 527 EKSDVFSFGVMLLELITGRRPI 548
+ D+++ G+ +EL + P+
Sbjct: 188 QLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-08
Identities = 29/131 (22%), Positives = 41/131 (31%), Gaps = 4/131 (3%)
Query: 5 NQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPP 64
N+ P +P T + + P P+ S P PS P P+ P
Sbjct: 253 NECPLPRPAPITLPTRIWEASGWNGPSSRPGPASSSSSPRERSPSPSPSSPGSGPAPSSP 312
Query: 65 SP----ESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPP 120
S SS +S S S S P S P + PPP + P P
Sbjct: 313 RASSSSSSSRESSSSSTSSSSESSRGAAVSPGPSPSRSPSPSRPPPPADPSSPRKRPRPS 372
Query: 121 PSQDNPSDPPP 131
+ +P+
Sbjct: 373 RAPSSPAASAG 383
|
Length = 1352 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 2e-08
Identities = 31/124 (25%), Positives = 54/124 (43%), Gaps = 3/124 (2%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
P + + AA +P++ + +P TPP+ ++ P++ PP + +P P++ P
Sbjct: 681 PPPAPAPAAPAAPAGAAPAQPAPAPAA-TPPAGQADDPAAQPPQAAQGASAPSPAADDPV 739
Query: 66 PESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDN 125
P P P PP + +P Q PPPP + P P P S + +P ++
Sbjct: 740 PLPPEPDDPPDPAGAPAQPPPPPAPAPAAAPAAAP--PPSPPSEEEEMAEDDAPSMDDED 797
Query: 126 PSDP 129
D
Sbjct: 798 RRDA 801
|
Length = 824 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 37/97 (38%), Positives = 56/97 (57%), Gaps = 8/97 (8%)
Query: 456 GLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN---NTHVSTRVMGTF 512
GL Y+H ++HRD+K N+L++ E K+ DFGLA+ ++N N T + T
Sbjct: 117 GLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 513 GYLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPI 548
Y APE S + K+ DV+S G +L EL+ GR+P+
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 47/179 (26%), Positives = 78/179 (43%), Gaps = 12/179 (6%)
Query: 371 KEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLE 430
K+V VK++ G G E++I+ + HR +++L+ A + V +P +
Sbjct: 120 KKVIVKAVTGGKTPG-----REIDILKTISHRAIINLIH---AYRWKSTVCMVMPKYKCD 171
Query: 431 FHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVAD 490
+ + + I + LAYLH IIHRD+K+ NI LD + D
Sbjct: 172 LFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGD 228
Query: 491 FGLA-KLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPI 548
FG A KL +T GT +PE + K+D++S G++L E+ +
Sbjct: 229 FGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 19/93 (20%), Positives = 29/93 (31%)
Query: 31 PPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNS 90
P P + P ++P P + S P + S P S+ P +PP +
Sbjct: 370 SGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTPPTVSV 429
Query: 91 KSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQ 123
P P + P P P S+
Sbjct: 430 DPPAAVPVNPPSTAPQAVRPAQFKEEKKIPVSK 462
|
Length = 614 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 29/88 (32%), Positives = 47/88 (53%), Gaps = 5/88 (5%)
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGY 514
+GL YLH RIIHRD+K+ NI ++ + + D G A+ + + GT
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--LAGTVET 222
Query: 515 LAPEYASSGKLTEKSDVFSFGVMLLELI 542
APE + K K+D++S G++L E++
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-08
Identities = 28/121 (23%), Positives = 34/121 (28%), Gaps = 5/121 (4%)
Query: 5 NQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPP 64
Q P PS + A PP P PPP P + PPP PP
Sbjct: 207 PQGHPEQVQPQQFLPAPSQAPAQPPLPPQLPQQ---PPPLQQPQFPGLSQQMPPPPPQPP 263
Query: 65 --SPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPS 122
+ P P + PP P P P ++ P P P P
Sbjct: 264 QQQQQPPQPQAQPPPQNQPTPHPGLPQGQNAPLPPPQQPQLLPLVQQPQGQQRGPQFREQ 323
Query: 123 Q 123
Sbjct: 324 L 324
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-08
Identities = 28/199 (14%), Positives = 42/199 (21%), Gaps = 22/199 (11%)
Query: 15 DAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSP 74
+A P P T + P P P P P + P
Sbjct: 90 PSAGEPAPPPP----HARRTSEPELPRPGRRPYEGYGGPRADDRPPGLPRQDQLPTARPA 145
Query: 75 PPSSQSPPQS---PPPPNSKSPPQ--SSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDP 129
P+ Q P+ P + Q PP +S P P P
Sbjct: 146 YPAYQQRPEPGAWPRAADDYGWQQQRLGFPPRAPYASPASYAPEQERDREPYDAGRPEYD 205
Query: 130 PPGDSNNGSSP------------PGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPP 177
+ P P + +G + P
Sbjct: 206 QRRRDYDHPRPDWDRPRRDRTDRPEPPPGAGHVHRGGPGPPERDDAPVVPIRPS-APGPL 264
Query: 178 PPSSSSNSPNGNRSGALSP 196
+ G + L+P
Sbjct: 265 AAQPAPAPGPGEPTARLNP 283
|
Length = 617 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 29/86 (33%), Positives = 44/86 (51%), Gaps = 5/86 (5%)
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS---- 522
+HRDIK N+LLD ++ADFG + T S+ +GT Y++PE +
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 523 -GKLTEKSDVFSFGVMLLELITGRRP 547
GK + D +S GV + E++ G P
Sbjct: 182 MGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 25/163 (15%), Positives = 42/163 (25%), Gaps = 17/163 (10%)
Query: 52 PPDRSPPPSSPP-PSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSP 110
P D SP P P+ P P + Q+ P ++ + P NPP +
Sbjct: 48 PWDPSPQAPPPVAQLPQPLPQPPPTQALQALPAGDQQQHN----TPTGSPAANPPATFAL 103
Query: 111 PPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNG----NHNNNNN 166
P PG P N N+
Sbjct: 104 PAG--------PAGPTIQTEPGQLYPVQVPVMVTQNPANSPLDQPAQQRALQQLQQRYGA 155
Query: 167 NNNNKNWHPPPPPSSSSNSPNGNRSGALSPPNKSNGSSSSPSS 209
+ + + S + +PP +++G+ S
Sbjct: 156 PASGQLPSQQQSAQKNDESQLQQQPNGETPPQQTDGAGDDESE 198
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 4e-08
Identities = 20/116 (17%), Positives = 36/116 (31%), Gaps = 3/116 (2%)
Query: 26 ASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSP 85
A+ P P PP +P S+ ++P P+ PP S+P + P
Sbjct: 362 AAPLPEPEVPPQSAAPAASAQATAAPTA---AVAPPQAPAVPPPPASAPQQAPAVPLPET 418
Query: 86 PPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPP 141
+ Q +S P ++ + + + P S +P
Sbjct: 419 TSQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAPA 474
|
Length = 647 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-08
Identities = 27/129 (20%), Positives = 44/129 (34%), Gaps = 1/129 (0%)
Query: 8 PGVSNSPDAAETPP-SPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSP 66
P + +P AA P + R ++ + P +P PPP PP P+P
Sbjct: 452 PAPAAAPAAAARPAAAGPRPVAAAAAAAPARAAPAAAPAPADDDPPPWEELPPEFASPAP 511
Query: 67 ESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNP 126
P + ++S P + +P P P P+++ A PP
Sbjct: 512 AQPDAAPAGWVAESIPDPATADPDDAFETLAPAPAAAPAPRAAAATEPVVAPRPPRASAS 571
Query: 127 SDPPPGDSN 135
P D +
Sbjct: 572 GLPDMFDGD 580
|
Length = 700 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 4e-08
Identities = 26/139 (18%), Positives = 47/139 (33%), Gaps = 14/139 (10%)
Query: 7 SPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSS----------PPPSSPPPDRS 56
V+ + AA P + + A+++ PP+ +PP ++ P + R+
Sbjct: 399 VTAVTGAAGAALAPKAAAAAAATRAE-APPAAPAPPATADRGDDAADGDAPVPAKANARA 457
Query: 57 PPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPP---S 113
S PP S S+ + P +P ++P T + P S
Sbjct: 458 SADSRCDERDAQPPADSGSASAPASDAPPDAAFEPAPRAAAPSAATPAAVPDARAPAAAS 517
Query: 114 NSNASPPPSQDNPSDPPPG 132
+A + P PP
Sbjct: 518 REDAPAAAAPPAPEARPPT 536
|
Length = 830 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 28/124 (22%), Positives = 38/124 (30%), Gaps = 5/124 (4%)
Query: 20 PPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQ 79
+P+ A P + PP + P + P PP P +P P Q
Sbjct: 72 NHAPANAQEHEAARPSPQHQYQPPYASAQPRQPVQQPPEAQVPPQHAPRPAQPAPQPVQQ 131
Query: 80 SP--PQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNG 137
PQ P PQ +P P P S+P P+ P P P +
Sbjct: 132 PAYQPQPEQPLQQPVSPQVAPAP---QPVHSAPQPAQQAFQPAEPVAAPQPEPVAEPAPV 188
Query: 138 SSPP 141
P
Sbjct: 189 MDKP 192
|
Length = 333 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 19/119 (15%), Positives = 30/119 (25%)
Query: 5 NQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPP 64
+ + + + P AS+ P E+ P P P P
Sbjct: 76 ANAQEHEAARPSPQHQYQPPYASAQPRQPVQQPPEAQVPPQHAPRPAQPAPQPVQQPAYQ 135
Query: 65 SPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQ 123
P P +P P + Q+ P PQ P + P +
Sbjct: 136 PQPEQPLQQPVSPQVAPAPQPVHSAPQPAQQAFQPAEPVAAPQPEPVAEPAPVMDKPKR 194
|
Length = 333 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 25/107 (23%), Positives = 36/107 (33%), Gaps = 5/107 (4%)
Query: 27 SSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQS-- 84
+ P+ E+ PS PP + P PE+ PP + P Q
Sbjct: 70 RVNHAPANAQEHEAARPSPQHQYQPPYASAQPRQPVQQPPEAQ---VPPQHAPRPAQPAP 126
Query: 85 PPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPP 131
P PQ P PQ +P P +++P P+Q P
Sbjct: 127 QPVQQPAYQPQPEQPLQQPVSPQVAPAPQPVHSAPQPAQQAFQPAEP 173
|
Length = 333 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 32/84 (38%), Positives = 44/84 (52%), Gaps = 6/84 (7%)
Query: 469 IHRDIKSSNILLDYTFETKVADFGLA-KLTTDNNTHVSTRVMGTFGYLAPEYASS----G 523
IHRD+K N+LLD + K+ADFG K+ + T V GT Y++PE S G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDG 222
Query: 524 KLTEKSDVFSFGVMLLELITGRRP 547
+ D +S GV L E++ G P
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 17/94 (18%), Positives = 32/94 (34%), Gaps = 1/94 (1%)
Query: 33 STPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKS 92
S P + + P+ P + P +S P+ + P+ Q+ +P N +
Sbjct: 161 SVPLDTSTTTDPATTPAPAAPVDTTPTNSQTPAV-ATAPAPAVDPQQNAVVAPSQANVDT 219
Query: 93 PPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNP 126
+P P + P + S P + N
Sbjct: 220 AATPAPAAPATPDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 5e-08
Identities = 24/82 (29%), Positives = 32/82 (39%), Gaps = 4/82 (4%)
Query: 35 PPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPP 94
E S+P +P P+ SPPP+ PS ++ PS SPP P P
Sbjct: 363 AFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPT 422
Query: 95 QSSPPPNTNPPPQSSPPPSNSN 116
+ SP P N P + N
Sbjct: 423 EPSPTPPANAA----NAPPSLN 440
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 5e-08
Identities = 14/78 (17%), Positives = 32/78 (41%)
Query: 42 PPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPN 101
P S+ P++ + S+P +P + P++P P+ + PP + ++ P
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 102 TNPPPQSSPPPSNSNASP 119
P ++ P+ +
Sbjct: 98 APPAAAAAAAPAAAAVED 115
|
Length = 1228 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 33/99 (33%), Positives = 49/99 (49%), Gaps = 3/99 (3%)
Query: 447 LKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST 506
L I + + YLHE+ RIIHRDIK+ NI +++ + + DFG A D N +
Sbjct: 185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 507 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR 545
GT APE + D++S G++L E+ T
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 6e-08
Identities = 27/131 (20%), Positives = 43/131 (32%), Gaps = 2/131 (1%)
Query: 13 SPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPS 72
+ A P R+ + ++ + + S + S P P + PP
Sbjct: 792 AEAAFRRPGRLRRSGPAADAASRTASKRK--SRSHTPDGGSESSGPARPPGAAARPPPAR 849
Query: 73 SPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPG 132
S S P + K+ + PP P ++ PP + A+PP P P
Sbjct: 850 SSESSKSKPAAAGGRARGKNGRRRPRPPEPRARPGAAAPPKAAAAAPPAGAPAPRPRPAP 909
Query: 133 DSNNGSSPPGN 143
G PPG
Sbjct: 910 RVKLGPMPPGG 920
|
Length = 1352 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 6e-08
Identities = 22/87 (25%), Positives = 32/87 (36%), Gaps = 6/87 (6%)
Query: 8 PGVSNSPDAAETPPS-PSRASSSPPP-----STPPSDESPPPSSPPPSSPPPDRSPPPSS 61
P AA P P+ A S+ P + PP + ++PPP P P P P +
Sbjct: 365 APQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRPVAPPVPHT 424
Query: 62 PPPSPESPPPSSPPPSSQSPPQSPPPP 88
P +P+ + P PP
Sbjct: 425 PESAPKLTRAAIPVDEKPKYTPPAPPK 451
|
Length = 585 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 6e-08
Identities = 23/78 (29%), Positives = 34/78 (43%)
Query: 17 AETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPP 76
S +S+P TP + SPPP+ PS+P ++ SPPP+ SPP P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 77 SSQSPPQSPPPPNSKSPP 94
++ P P + P
Sbjct: 421 PTEPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 6e-08
Identities = 16/86 (18%), Positives = 37/86 (43%), Gaps = 1/86 (1%)
Query: 2 EDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPP-PDRSPPPS 60
D + + AA + S +++P P + PP++ P++PP P + +
Sbjct: 34 ADYGPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAA 93
Query: 61 SPPPSPESPPPSSPPPSSQSPPQSPP 86
+ P +P + ++ P ++ + P
Sbjct: 94 AAPAAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT-DNNTHVS-TRVMGTF 512
+ L Y+H + HRD+K NIL + + K+ DFGLA++ D T + T + T
Sbjct: 114 RALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 513 GYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPIDP 550
Y APE S K T D++S G + E++TG +P+ P
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFP 209
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 7e-08
Identities = 19/82 (23%), Positives = 30/82 (36%), Gaps = 2/82 (2%)
Query: 11 SNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPP 70
+ +P P+PS + + P E ++ PP PP +PP P S
Sbjct: 373 AAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRPVAPPVPHTPESAPKLT 432
Query: 71 PSSPPPSSQSPPQSPPPPNSKS 92
++ P P+ PP K
Sbjct: 433 RAAIP--VDEKPKYTPPAPPKE 452
|
Length = 585 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 7e-08
Identities = 27/82 (32%), Positives = 41/82 (50%)
Query: 48 PSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQ 107
S+ ++PPP P P +P P P P++ +PP +PPPP + SS P P
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 108 SSPPPSNSNASPPPSQDNPSDP 129
S PPP +P P++D+ +
Sbjct: 575 SPPPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 8e-08
Identities = 10/78 (12%), Positives = 26/78 (33%), Gaps = 1/78 (1%)
Query: 35 PPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSP-PQSPPPPNSKSP 93
P S +P ++ ++ + P++ P+ +P P + + P P + +
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 94 PQSSPPPNTNPPPQSSPP 111
+ P +
Sbjct: 98 APPAAAAAAAPAAAAVED 115
|
Length = 1228 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 8e-08
Identities = 38/132 (28%), Positives = 58/132 (43%), Gaps = 9/132 (6%)
Query: 1 MEDNNQSPGVSNSPDAAETPPSPSRASSSP--PPSTPPSDESPPPSSPPPSSPP---PDR 55
M+ ++P P A A++ PP+ P PP ++P + PP P R
Sbjct: 694 MQPPPRAPTPMRPPAAPPGRAQRPAAATGRARPPAAAPGRARPPAAAPGRARPPAAAPGR 753
Query: 56 SPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNS 115
+ PP++ P P + P+ Q PPQ+PP P + P+ +P P PPPQ+ P
Sbjct: 754 ARPPAAAPGRARPPAAAPGAPTPQPPPQAPPAPQQR--PRGAPTPQ--PPPQAGPTSMQL 809
Query: 116 NASPPPSQDNPS 127
P Q P+
Sbjct: 810 MPRAAPGQQGPT 821
|
Length = 991 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 9e-08
Identities = 21/136 (15%), Positives = 43/136 (31%), Gaps = 6/136 (4%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
+ P S +P A+ + A+ +PP + PPP+S P +P P ++
Sbjct: 369 EVPPQSAAPAASAQATAAPTAAVAPPQAPAVP---PPPASAPQQAPAV--PLPETTSQLL 423
Query: 66 PESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDN 125
++++ P + P S+ + P S
Sbjct: 424 AARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAPAKKEAYRWK- 482
Query: 126 PSDPPPGDSNNGSSPP 141
++P ++P
Sbjct: 483 ATNPVEVKKEPVATPK 498
|
Length = 647 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 9e-08
Identities = 32/151 (21%), Positives = 40/151 (26%), Gaps = 14/151 (9%)
Query: 2 EDNNQSPGVSNSPDAAETPPSPSRASSS-----PPPSTPPSDESPPPSSPPPSSPPPDRS 56
E + + D S S A+S PP S +S + P P R
Sbjct: 22 EGSRDENFDAERDDFLTPLGSTSEATSEDDDDLYPPRETGS-GGGVATSTIYTVPRPPRG 80
Query: 57 PP-----PSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSP---PQSSPPPNTNPPPQS 108
P P S P S E PP +P P S P + S P
Sbjct: 81 PEQTLDKPDSLPASRELPPGPTPVPPGGFRGASSPRLGADSTSPRFLYQVNFPVILAPIG 140
Query: 109 SPPPSNSNASPPPSQDNPSDPPPGDSNNGSS 139
S+ S P NG
Sbjct: 141 ESNSSSEELSEEEEHSRPPPSESLKVKNGGK 171
|
Length = 580 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-07
Identities = 27/132 (20%), Positives = 43/132 (32%), Gaps = 8/132 (6%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPS---SPPPSSPPPDRSPPPSSP 62
S+S ++ + S P PS PS PPP S P P P R+P +
Sbjct: 321 SRESSSSSTSSSSESSRGAAVSPGPSPSRSPSPSRPPPPADPSSPRKRPRPSRAPSSPAA 380
Query: 63 PPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPN--TNPPPQSSPPPSNSNASPP 120
+ + + ++ + P+ SP + + P + P
Sbjct: 381 SAGRPTRRRARAAVAGRARRRDATGRFPAGRPRPSPLDAGAASGAFYARYPLLTPSGEPW 440
Query: 121 PSQDNPSDPPPG 132
P PPPG
Sbjct: 441 PGSP---PPPPG 449
|
Length = 1352 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 1e-07
Identities = 22/79 (27%), Positives = 31/79 (39%), Gaps = 1/79 (1%)
Query: 28 SSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPP 87
S S + +P +P P+ PP PS+P + PS PPP+ SPP P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPS-PPPAKASPPIPVPA 419
Query: 88 PNSKSPPQSSPPPNTNPPP 106
++ P PP
Sbjct: 420 EPTEPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 20/102 (19%), Positives = 33/102 (32%), Gaps = 7/102 (6%)
Query: 32 PSTPPSDESPPPSSPPPSSPPPDRSPPP-------SSPPPSPESPPPSSPPPSSQSPPQS 84
P P + P P ++ PP + +P P + PP++ P+
Sbjct: 42 PLVPKPGDRDEPDMMPAATQALPTQPPEGAAEAVRAGDAAAPSLDPATVAPPNTPVEPEP 101
Query: 85 PPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNP 126
P K P P P P + PP+ P ++
Sbjct: 102 APVEPPKPKPVEKPKPKPKPQQKVEAPPAPKPEPKPVVEEKA 143
|
Length = 226 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 28/180 (15%), Positives = 43/180 (23%), Gaps = 5/180 (2%)
Query: 32 PSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSK 91
P + E PP + P+ P P P PP Q P +
Sbjct: 87 TVDPSAGEPAPPPPHARRTSEPELPRPGRRPYEGYGGPRADDRPPGLPRQDQLPTARPAY 146
Query: 92 SPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQD--NPSDPPPGDSNNGSSPPGNNNNNNN 149
Q P P P PP +P+ P + P +
Sbjct: 147 PAYQQRPEPGAWPRAADDYGWQQQRLGFPPRAPYASPASYAPEQERD-REPYDAGRPEYD 205
Query: 150 NGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSSSSNSPNGNRSGALSPPNKSNGSSSSPSS 209
+ + + + + P PPP + G S+P
Sbjct: 206 QRRRDYDHPRPDWDRPRRDRTDR--PEPPPGAGHVHRGGPGPPERDDAPVVPIRPSAPGP 263
|
Length = 617 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 26/155 (16%), Positives = 41/155 (26%), Gaps = 23/155 (14%)
Query: 2 EDNNQSPGVSNSPDAAETPPS------PSRASSSPPPST-----------PPSDESPPPS 44
+++ PG+ P+ + P + PP P+
Sbjct: 125 RADDRPPGLPRQDQLPTARPAYPAYQQRPEPGAWPRAADDYGWQQQRLGFPPRAPYASPA 184
Query: 45 SPPPSS----PPPDRSPPPSSPP-PSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPP 99
S P P D P + P P P + PPP + + P
Sbjct: 185 SYAPEQERDREPYDAGRPEYDQRRRDYDHPRPDWDRPRRDRTDRPEPPPGAGHVHRGGPG 244
Query: 100 PNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDS 134
P P S P +Q P+ P +
Sbjct: 245 P-PERDDAPVVPIRPSAPGPLAAQPAPAPGPGEPT 278
|
Length = 617 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 26/124 (20%), Positives = 33/124 (26%), Gaps = 6/124 (4%)
Query: 10 VSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESP 69
V A A SP P S P P P P + P P
Sbjct: 68 VHRVNHAPANAQEHEAARPSPQHQYQPPYASAQPRQPVQQPPEAQVPPQHAPRPAQPAPQ 127
Query: 70 PPSSPP--PSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPS 127
P P P + P Q P P PQ P + + P + +
Sbjct: 128 PVQQPAYQPQPEQPLQQPVSPQVAPAPQPVHS----APQPAQQAFQPAEPVAAPQPEPVA 183
Query: 128 DPPP 131
+P P
Sbjct: 184 EPAP 187
|
Length = 333 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 29/95 (30%), Positives = 38/95 (40%), Gaps = 7/95 (7%)
Query: 1 MEDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPS 60
+E GV+ SP A +P +A P P P D P P+ P P P P+
Sbjct: 371 IELVRNDGGVAPSP--AGSPDVKKKA---PEPDLPQPDRHPGPAKPEAPGARPAELPSPA 425
Query: 61 SPPPSPESPPPSSPPPSSQ-SPPQSPPPPNSKSPP 94
S P +PE PP + SP S P + P
Sbjct: 426 SAP-TPEQQPPVARSAPLPPSPQASAPRNVASGKP 459
|
Length = 620 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 354 LGQGGFGYVHKGVL--PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVH-HRHLVSLVGY 410
+G+G +G V K VL NG + AVK L E E +AE I+ + H ++V G
Sbjct: 26 IGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDE-EIEAEYNILKALSDHPNVVKFYGM 83
Query: 411 -----CIAGGKRLLVYEYVPNNNLEFHLHG--KGRPVMDWPTRLKIAMGSAKGLAYLHED 463
G + LV E ++ + G K M+ P I + GL +LH +
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN 143
Query: 464 CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYAS-- 521
+ IHRD+K +NILL K+ DFG++ T +T V GT ++APE +
Sbjct: 144 ---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACE 199
Query: 522 ---SGKLTEKSDVFSFGVMLLELITGRRPI 548
+ DV+S G+ +EL G P+
Sbjct: 200 QQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|240420 PTZ00441, PTZ00441, sporozoite surface protein 2 (SSP2); Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 48/214 (22%), Positives = 64/214 (29%), Gaps = 36/214 (16%)
Query: 2 EDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSS 61
+D P + D + P P PP D +P + P P D P S+
Sbjct: 308 DDEFAVPNFNEGLDVPDNPQDPV------PPPNEGKDGNPNEENLFP--PGDDEVPDESN 359
Query: 62 PPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPP 121
PP+P + P S S P PPN P Q P + P P
Sbjct: 360 VPPNPPNVPGGSNSEFSSDVENPPNPPNPDIPEQEPNIPEDSNKEVPEDVPME----PED 415
Query: 122 SQDNPSDPPPGDSNNGSSPPGN---------------NNNNNNNGKGNG-------NGNG 159
+DN + P N G N N + N +G
Sbjct: 416 DRDNNFNEPKKPENKGDGQNEPVIPKPLDNERDQSNKNKQVNPGNRHNSEDRYTRPHGRN 475
Query: 160 NHNNNNNNNNNKNWHPPPPPSSSSNSPNGNRSGA 193
N N N NN N+ P P S P + +
Sbjct: 476 NENRNYNNKNSDI--PKHPERSEHEQPEDKKKKS 507
|
Length = 576 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-07
Identities = 39/204 (19%), Positives = 63/204 (30%), Gaps = 12/204 (5%)
Query: 13 SPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPS 72
S AE PPS A++SP P S S SSP P+ +S S S
Sbjct: 187 SSPPAEPPPSTPPAAASPRPPRRSSPISASASSPAPAPGRSAADDAGASSSDSSSSESSG 246
Query: 73 SP-------PPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDN 125
P +P P S SSP + + SP
Sbjct: 247 CGWGPENECPLPRPAPITLPTRIWEASGWNGPSSRPGPASSSSSPRERSPSPSPSSPGSG 306
Query: 126 PSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSSSSNS 185
P+ P S++ SS +++ + + + + + + P P
Sbjct: 307 PAPSSPRASSSSSSSR-----ESSSSSTSSSSESSRGAAVSPGPSPSRSPSPSRPPPPAD 361
Query: 186 PNGNRSGALSPPNKSNGSSSSPSS 209
P+ R S+ ++S+
Sbjct: 362 PSSPRKRPRPSRAPSSPAASAGRP 385
|
Length = 1352 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-07
Identities = 40/152 (26%), Positives = 51/152 (33%), Gaps = 18/152 (11%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTP----PSDESPPPSSPPPSSP---------- 51
S +A S + SS S+ P +E P P P + P
Sbjct: 217 ASSPAPAPGRSAADDAGASSSDSSSSESSGCGWGPENECPLPRPAPITLPTRIWEASGWN 276
Query: 52 PPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPP 111
P P P+S SP PS P S S P P S S SS +++ SS
Sbjct: 277 GPSSRPGPASSSSSPRERSPSPSPSSPGSGPAPSSPRASSS--SSSSRESSSSSTSSSSE 334
Query: 112 PSNSNASP--PPSQDNPSDPPPGDSNNGSSPP 141
S A P +PS P + SSP
Sbjct: 335 SSRGAAVSPGPSPSRSPSPSRPPPPADPSSPR 366
|
Length = 1352 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 21/146 (14%), Positives = 37/146 (25%), Gaps = 21/146 (14%)
Query: 66 PESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDN 125
PP + + + ++PP S PS + PS +
Sbjct: 149 NPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPS 208
Query: 126 PSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSSSSNS 185
S PP S+ S P + + N PP P +
Sbjct: 209 DSSLPPAPSSFQSDTPPPSPESPTN---------------------PSPPPGPAAPPPPP 247
Query: 186 PNGNRSGALSPPNKSNGSSSSPSSNN 211
+ + P + S++
Sbjct: 248 VQQVPPLSTAKPTPPSASATPAPIGG 273
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 2e-07
Identities = 22/77 (28%), Positives = 29/77 (37%), Gaps = 1/77 (1%)
Query: 42 PPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPN 101
S ++ P P +P P P PS+P + SPPP SPP P
Sbjct: 363 AFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPA-KASPPIPVPAEP 421
Query: 102 TNPPPQSSPPPSNSNAS 118
T P P +N+ S
Sbjct: 422 TEPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 2e-07
Identities = 16/73 (21%), Positives = 29/73 (39%)
Query: 56 SPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNS 115
S ++ P+ +P P+ PP + P +P + + P P + P P + P S
Sbjct: 366 SEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPTEPS 425
Query: 116 NASPPPSQDNPSD 128
P + + P
Sbjct: 426 PTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 25/149 (16%), Positives = 47/149 (31%), Gaps = 26/149 (17%)
Query: 11 SNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPP 70
S++P A P+P A+ S D P ++ +P P P + PP+P +
Sbjct: 482 SDAPPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPAAAAPPAPEARPPTPAAAA 541
Query: 71 PSS--------------------------PPPSSQSPPQSPPPPNSKSPPQSSPPPNTNP 104
P++ +++ P +P + P
Sbjct: 542 PAARAGGAAAALDVLRNAGMRVSSDRGARAAAAAKPAAAPAAAPKPAAPRVAVQVPTPRA 601
Query: 105 PPQSSPPPSNSNASPPPSQDNPSDPPPGD 133
+ P N A + ++ PPP +
Sbjct: 602 RAATGDAPPNGAARAEQAAESRGAPPPWE 630
|
Length = 830 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 18/129 (13%), Positives = 35/129 (27%), Gaps = 9/129 (6%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
+ A P + + + S +R P + S
Sbjct: 417 AAAATRAEAPPAAPAPPATADRGDDAADGDAPVPAKANARASADSRCDERDAQPPADSGS 476
Query: 66 PESPPPSSPP-------PSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNAS 118
+P +PP P + +P + P + ++ P + P P
Sbjct: 477 ASAPASDAPPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPAAAAPPAP--EARP 534
Query: 119 PPPSQDNPS 127
P P+ P+
Sbjct: 535 PTPAAAAPA 543
|
Length = 830 |
| >gnl|CDD|237171 PRK12678, PRK12678, transcription termination factor Rho; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 2e-07
Identities = 15/198 (7%), Positives = 42/198 (21%), Gaps = 12/198 (6%)
Query: 7 SPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSP 66
+ +P AA + + A++ + + P + + +S P +
Sbjct: 66 AAATPAAPAAAARRAARAAAAARQAEQPAAEAAAAKAEAAPAARAAAAAAAEAASAPEAA 125
Query: 67 ESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQD-- 124
++ +++ + P + + Q
Sbjct: 126 QARERRERGEAARRGAARKAGEGGEQPATEARADAAERTEEEERDERRRRGDREDRQAEA 185
Query: 125 ------NPSDPPPGDSNNGSSPPGNNNNNNNNGK----GNGNGNGNHNNNNNNNNNKNWH 174
+ + + G+ G + + + N
Sbjct: 186 ERGERGRREERGRDGDDRDRRDRREQGDRREERGRRDGGDRRGRRRRRDRRDARGDDNRE 245
Query: 175 PPPPPSSSSNSPNGNRSG 192
G R G
Sbjct: 246 DRGDRDGDDGEGRGGRRG 263
|
Length = 672 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 32/90 (35%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 456 GLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYL 515
G+ +LH IIHRD+K SNI++ K+ DFGLA+ T + ++ V+ T Y
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVV-TRYYR 184
Query: 516 APEYASSGKLTEKSDVFSFGVMLLELITGR 545
APE E D++S G ++ E+I G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 34/137 (24%), Positives = 41/137 (29%), Gaps = 15/137 (10%)
Query: 20 PPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSP---PPSPESPPPSSPPP 76
P PPS PPP+ P + P P P + +PPP
Sbjct: 109 SVPQQPTPQQEPYYPPPSQPQPPPAQQPQAQQPQPPPQVPQQQQYQSPPQQPQYQQNPPP 168
Query: 77 SSQSPPQSPP--PPNSKSPPQSSPPPNTNPPPQSSPPPS----------NSNASPPPSQD 124
+QS PQ P S PQS PP P + PP P
Sbjct: 169 QAQSAPQVSGLYPEESPYQPQSYPPNEPLPSSMAMQPPYSGAPPSQQFYGPPQPSPYMYG 228
Query: 125 NPSDPPPGDSNNGSSPP 141
P P +G PP
Sbjct: 229 GPGGRPNSGFPSGQQPP 245
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 46/212 (21%)
Query: 354 LGQGGFGYVHKG-VLPNGKEVAVKSLRSGSGQGEREFK--------AEVEIISRV-HHRH 403
+G+G F V K GK A+K ++ FK E++ + R+ H +
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKK-------HFKSLEQVNNLREIQALRRLSPHPN 59
Query: 404 LVSL--VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRP-----VMDWPTRLKIAMGSAKG 456
++ L V + G+ LV+E + N E + G+ RP V + +L K
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELMDMNLYEL-IKGRKRPLPEKRVKSYMYQL------LKS 112
Query: 457 LAYLHEDCHPRIIHRDIKSSNILLDYTFET-KVADFGLAKLTTDNNTH---VSTRVMGTF 512
L ++H I HRDIK NIL+ + K+ADFG + + +STR
Sbjct: 113 LDHMH---RNGIFHRDIKPENILIK--DDILKLADFGSCRGIYSKPPYTEYISTR----- 162
Query: 513 GYLAPE-YASSGKLTEKSDVFSFGVMLLELIT 543
Y APE + G K D+++ G + E+++
Sbjct: 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 17/211 (8%)
Query: 348 FSQSNLLGQGGFG---YVHKGVLPN-GKEVAVKSLRSGS----GQGEREFKAEVEIISRV 399
F +LG G +G V K + GK A+K L+ + + + E ++ V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 400 HHRHLVSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSA-KGL 457
+ + Y +L L+ +YV + HL+ + D ++ G L
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED---EVRFYSGEIILAL 118
Query: 458 AYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAP 517
+LH+ I++RDIK NILLD + DFGL+K + GT Y+AP
Sbjct: 119 EHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175
Query: 518 EYA-SSGKLTEKSDVFSFGVMLLELITGRRP 547
E G + D +S G+++ EL+TG P
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 44/157 (28%), Positives = 69/157 (43%), Gaps = 27/157 (17%)
Query: 400 HHRHLVSLVGYCIAGGKR-LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLA 458
+ + + L Y + K +L+ +Y+ + +L F L K + + + KI + L
Sbjct: 67 DNPNFIKLY-YSVTTLKGHVLIMDYIKDGDL-FDLLKKEGKLSEAEVK-KIIRQLVEALN 123
Query: 459 YLHEDCHPRIIHRDIKSSNILLD-YTFETKVADFGLAKLTTDNNTHVSTRVM--GTFGYL 515
LH+ H IIH DIK N+L D + D+GL K + T GT Y
Sbjct: 124 DLHK--H-NIIHNDIKLENVLYDRAKDRIYLCDYGLCK-------IIGTPSCYDGTLDYF 173
Query: 516 APEYASSGKLTEKSDVFSF-----GVMLLELITGRRP 547
+PE K+ + SF GV+ EL+TG+ P
Sbjct: 174 SPE-----KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 17/70 (24%), Positives = 28/70 (40%), Gaps = 1/70 (1%)
Query: 55 RSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSN 114
+P P S +P + PP + +PP P P + + +P P P + P S
Sbjct: 380 GAPAPPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAP-APPAAAAPPARSA 438
Query: 115 SNASPPPSQD 124
A+ + D
Sbjct: 439 DPAAAASAGD 448
|
Length = 576 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 26/82 (31%), Positives = 38/82 (46%), Gaps = 2/82 (2%)
Query: 26 ASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSP 85
A + P+T +D +PPP P ++ P + PP PPP+ P P + +PP P
Sbjct: 28 AVAIALPATANADPAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNA--APPPPP 85
Query: 86 PPPNSKSPPQSSPPPNTNPPPQ 107
PN+ PP P P P+
Sbjct: 86 ADPNAPPPPPVDPNAPPPPAPE 107
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 53/209 (25%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQG-EREFKAEVEIISRVHHRHLVSLVGYCI 412
+G+G +G+V+K +GK+ +L+ G G E+ ++ + H +++SL +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 413 AGGKR--LLVYEYVPNN---NLEFHLHGKGRPVMDWPTRLKIAMGSA------KGLAYLH 461
+ R L+++Y ++ ++FH K P +L M + G+ YLH
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKK---PVQLPRGMVKSLLYQILDGIHYLH 125
Query: 462 EDCHPRIIHRDIKSSNILL----DYTFETKVADFGLAKLTTDNNTHVS--TRVMGTFGYL 515
+ ++HRD+K +NIL+ K+AD G A+L ++ V+ TF Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 516 APEYASSGK-LTEKSDVFSFGVMLLELIT 543
APE + T+ D+++ G + EL+T
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 3e-07
Identities = 35/134 (26%), Positives = 42/134 (31%), Gaps = 8/134 (5%)
Query: 3 DNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPP-----PDRSP 57
D P + P T P P PP + + P+ S R
Sbjct: 112 DPEYIPDLQPDPSLWGTAPKPE---PQPPQAPESQPQPQTPAQKMLSLEEVEAQLQQRQQ 168
Query: 58 PPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNA 117
P P P + P PP + P Q PP P P P Q P PS + A
Sbjct: 169 APQLPQPPQQVLPQGMPPRQAAFPQQGPPEQPPGYPQPPQGHPEQVQPQQFLPAPSQAPA 228
Query: 118 SPPPSQDNPSDPPP 131
PP P PPP
Sbjct: 229 QPPLPPQLPQQPPP 242
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 3e-07
Identities = 14/75 (18%), Positives = 23/75 (30%)
Query: 55 RSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSN 114
++ P +P P S P + S PP +PP P+
Sbjct: 364 FISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPTE 423
Query: 115 SNASPPPSQDNPSDP 129
+ +PP + N
Sbjct: 424 PSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 3e-07
Identities = 15/114 (13%), Positives = 36/114 (31%), Gaps = 5/114 (4%)
Query: 4 NNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSP-----PPDRSPP 58
+ + + A +P +A + PPP ++P P +S +
Sbjct: 374 SAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPETTSQLLAARQQLQRAQ 433
Query: 59 PSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPP 112
++ E S P + + + + S + +P +++ P
Sbjct: 434 GATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAPAKKEAYRWKATNPV 487
|
Length = 647 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 3e-07
Identities = 17/86 (19%), Positives = 25/86 (29%)
Query: 27 SSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPP 86
P P P + P ++ SP SS P +P ++ P + P
Sbjct: 372 GRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTPPTVSVDP 431
Query: 87 PPNSKSPPQSSPPPNTNPPPQSSPPP 112
P P S+ P P
Sbjct: 432 PAAVPVNPPSTAPQAVRPAQFKEEKK 457
|
Length = 614 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-07
Identities = 22/71 (30%), Positives = 28/71 (39%), Gaps = 1/71 (1%)
Query: 29 SPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPP 88
SP S ++P P P P P P P+ P S+P P Q PP + P
Sbjct: 383 SPAGSPDVKKKAPEPDLPQPDRHPGPAKPEAPGARPAELPSPASAPTPE-QQPPVARSAP 441
Query: 89 NSKSPPQSSPP 99
SP S+P
Sbjct: 442 LPPSPQASAPR 452
|
Length = 620 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 26/85 (30%), Positives = 38/85 (44%)
Query: 10 VSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESP 69
V+ + A P+ + A +PPP P + + P + PP PPP P P P+ P
Sbjct: 23 VAGASAVAIALPATANADPAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPP 82
Query: 70 PPSSPPPSSQSPPQSPPPPNSKSPP 94
PP + P + PP P P +P
Sbjct: 83 PPPADPNAPPPPPVDPNAPPPPAPE 107
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 5/86 (5%)
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS---- 522
+HRDIK N+LLD ++ADFG + T S +GT Y++PE +
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDG 181
Query: 523 -GKLTEKSDVFSFGVMLLELITGRRP 547
G+ + D +S GV + E++ G P
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 30/209 (14%)
Query: 354 LGQGGFGYVHKGVL-----------PNGKEVAV--KSLRSGSGQGEREFKAEVEIISRVH 400
LG+G ++ G+L KE+ V K L F ++ +V
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 401 HRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYL 460
H+H+V L G C+ + ++V E+V L+ +H K + P + K+A A L+YL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTT-PWKFKVAKQLASALSYL 121
Query: 461 HEDCHPRIIHRDIKSSNILL-------DYTFETKVADFGLAKLTTDNNTHVSTRVMGTFG 513
ED ++H ++ + NILL + K++D G+ +T + R+
Sbjct: 122 -ED--KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP-ITVLSRQECVERI----P 173
Query: 514 YLAPEYASSGK-LTEKSDVFSFGVMLLEL 541
++APE K L+ +D +SFG L E+
Sbjct: 174 WIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|236333 PRK08691, PRK08691, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 3e-07
Identities = 31/148 (20%), Positives = 58/148 (39%), Gaps = 11/148 (7%)
Query: 2 EDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSS 61
++NN P ++PD A+T ++ S+ S + E +PP + +++ +
Sbjct: 428 QENNDVPPWEDAPDEAQTAAGTAQTSAK---SIQTASE---AETPPENQVSKNKAADNET 481
Query: 62 PPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPP 121
P E P S P +P + + + P P + PP + PPP
Sbjct: 482 DAPLSEVP---SENPIQATPNDEAVETETFAHEAPAEPFYGYGFPDNDCPPEDGAEIPPP 538
Query: 122 SQDN--PSDPPPGDSNNGSSPPGNNNNN 147
++ P+D G ++ + G NN
Sbjct: 539 DWEHAAPADTAGGGADEEAEAGGIGGNN 566
|
Length = 709 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 54/213 (25%), Positives = 80/213 (37%), Gaps = 6/213 (2%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
P A+ + S+ P PP ++ PP+ P PP +P P P S
Sbjct: 302 SQVPPLPLPSQAQPHSHTPPSQSALQPQQPPREQPLPPAPSMPHIKPPPTTPIPQLPNQS 361
Query: 66 PESPP-PSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQD 124
+ PP P P Q P PPPP K P SS P T+ PP + PPP P Q
Sbjct: 362 HKHPPHLQGPSPFPQMPSNLPPPPALK--PLSSLP--THHPPSAHPPPLQLMPQSQPLQS 417
Query: 125 NPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSSSSN 184
P+ PP + + S PP + + ++ + + + PPP +S+
Sbjct: 418 VPAQ-PPVLTQSQSLPPKASTHPHSGLHSGPPQSPFAQHPFTSGGLPAIGPPPSLPTSTP 476
Query: 185 SPNGNRSGALSPPNKSNGSSSSPSSNNGSMLSI 217
+ S PP + SS + + I
Sbjct: 477 AAPPRASSGSQPPGSALPSSGGCAGPGPPLPPI 509
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 32/84 (38%), Positives = 44/84 (52%), Gaps = 6/84 (7%)
Query: 469 IHRDIKSSNILLDYTFETKVADFGLA-KLTTDNNTHVSTRVMGTFGYLAPEYASS----G 523
IHRD+K N+LLD + K+ADFG K+ + T V GT Y++PE S G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDG 222
Query: 524 KLTEKSDVFSFGVMLLELITGRRP 547
+ D +S GV L E++ G P
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 4e-07
Identities = 20/109 (18%), Positives = 42/109 (38%), Gaps = 11/109 (10%)
Query: 44 SSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQS--PPPPNSKSPPQSSPPPN 101
+ P ++ P P P++ P+ +P P++PP + + P + + +P + SP P
Sbjct: 372 AGPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAPAAAAAARAVAAAPARRSPAPE 431
Query: 102 TNP---------PPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPP 141
P + P A+P + + P + ++ P
Sbjct: 432 ALAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAAAP 480
|
Length = 700 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-07
Identities = 27/164 (16%), Positives = 50/164 (30%), Gaps = 25/164 (15%)
Query: 3 DNNQSPGVSNSPDAAETPPSPSRASSSP-PPSTPPSDESPPPS---SPPPSSPPPDRSPP 58
+ + P + +A +P A+ P P + PS +P P ++ D
Sbjct: 465 ERDAQPPADSGSASAPASDAPPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPAA 524
Query: 59 PSSPPPSPESPPPSSPPP---------------------SSQSPPQSPPPPNSKSPPQSS 97
+ P P P P++ P SS ++ + P ++
Sbjct: 525 AAPPAPEARPPTPAAAAPAARAGGAAAALDVLRNAGMRVSSDRGARAAAAAKPAAAPAAA 584
Query: 98 PPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPP 141
P P P P A+ + + + G+ PP
Sbjct: 585 PKPAAPRVAVQVPTPRARAATGDAPPNGAARAEQAAESRGAPPP 628
|
Length = 830 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 4e-07
Identities = 20/83 (24%), Positives = 33/83 (39%), Gaps = 5/83 (6%)
Query: 13 SPDAA-----ETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPE 67
+PD A E PPSP PP ++P ++ P P ++ P+
Sbjct: 379 TPDEALRRLQEGPPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPD 438
Query: 68 SPPPSSPPPSSQSPPQSPPPPNS 90
+ ++ PP+ + PQ NS
Sbjct: 439 AAAAAAAPPAPAAAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 36/113 (31%), Positives = 60/113 (53%), Gaps = 11/113 (9%)
Query: 442 DWPTR----LKIAMGSAKGLAYL-HEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK- 495
WP L+ + A+G+ +L ++C IHRD+ + N+LL K+ DFGLA+
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARD 261
Query: 496 LTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
+ D+N V ++APE T +SDV+S+G++L E+ + G+ P
Sbjct: 262 IMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|219404 pfam07415, Herpes_LMP2, Gammaherpesvirus latent membrane protein (LMP2) protein | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 23/93 (24%), Positives = 28/93 (30%), Gaps = 8/93 (8%)
Query: 53 PDRSPPPSSP--PPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSP 110
P + P S P E P S S P PP P+ P+ PPP
Sbjct: 8 PLGAGGPRSHGGPDGDEGDSNPYYPSSFGSSWDRPGPPV----PEDYDAPSHRPPPYGGS 63
Query: 111 PPSNSNASPPPSQDNPS--DPPPGDSNNGSSPP 141
P Q +PS + G PP
Sbjct: 64 NGDRHGGYQPLGQQDPSLYAGLGQNGGGGLPPP 96
|
This family consists of several Gammaherpesvirus latent membrane protein (LMP2) proteins. Epstein-Barr virus is a human Gammaherpesvirus that infects and establishes latency in B lymphocytes in vivo. The latent membrane protein 2 (LMP2) gene is expressed in latently infected B cells and encodes two protein isoforms, LMP2A and LMP2B, that are identical except for an additional N-terminal 119 aa cytoplasmic domain which is present in the LMP2A isoform. LMP2A is thought to play a key role in either the establishment or the maintenance of latency and/or the reactivation of productive infection from the latent state. The significance of LMP2B and its role in pathogenesis remain unclear. Length = 489 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 52/176 (29%), Positives = 80/176 (45%), Gaps = 30/176 (17%)
Query: 454 AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV---STRVMG 510
A+G+ +L + IHRD+ + NILL K+ DFGLA+ + +V R+
Sbjct: 183 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 237
Query: 511 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRA 569
++APE T +SDV+SFGV+L E+ + G P E+ C R
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--------FC-RR 288
Query: 570 LDDGNFNEIADPYLEKNYPTEEMAR-MVACAAASIRHSARRRPKISQIVRALEGDV 624
L +G + P Y T E+ M+ C ++ RP S++V L GD+
Sbjct: 289 LKEG--TRMRAP----EYATPEIYSIMLDCW----HNNPEDRPTFSELVEIL-GDL 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 5e-07
Identities = 14/118 (11%), Positives = 30/118 (25%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
Q+ + A P+ +S P P S + R+ + S
Sbjct: 382 QATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPETTSQLLAARQQLQRAQGATKAKKS 441
Query: 66 PESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQ 123
+ + P +S + P + ++ ++P P
Sbjct: 442 EPAAASRARPVNSALERLASVRPAPSALEKAPAKKEAYRWKATNPVEVKKEPVATPKA 499
|
Length = 647 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-07
Identities = 26/115 (22%), Positives = 40/115 (34%), Gaps = 5/115 (4%)
Query: 12 NSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSP-ESPP 70
P AA P + + AS SP S+ PS+P ++ P P S PP+ P
Sbjct: 384 TQPAAAPQPSAAAAASPSPSQSSAA----AQPSAPQSATQPAGTPPTVSVDPPAAVPVNP 439
Query: 71 PSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDN 125
PS+ P + + S S P P + + + + P
Sbjct: 440 PSTAPQAVRPAQFKEEKKIPVSKVSSLGPSTLRPIQEKAEQATGNIKEAPTGTQK 494
|
Length = 614 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-07
Identities = 20/95 (21%), Positives = 34/95 (35%), Gaps = 3/95 (3%)
Query: 38 DESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSS 97
D++ P P P ++ P + S P S + Q P ++ P +
Sbjct: 367 DDASGGRGPKQHIKPVFTQP--AAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTP 424
Query: 98 PPPNTNPP-PQSSPPPSNSNASPPPSQDNPSDPPP 131
P + +PP PPS + + P+Q P
Sbjct: 425 PTVSVDPPAAVPVNPPSTAPQAVRPAQFKEEKKIP 459
|
Length = 614 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 5e-07
Identities = 38/129 (29%), Positives = 52/129 (40%), Gaps = 19/129 (14%)
Query: 21 PSPSRASSSPPPSTPPSDESPPPSSPPPSSPP-------------PDRSPPPSSPPPSPE 67
PSP+ A++ P P PPP +P P PP R+ PP++ P
Sbjct: 676 PSPTGANTMLPIQWAPGTMQPPPRAPTPMRPPAAPPGRAQRPAAATGRARPPAAAPGRAR 735
Query: 68 SP--PPSSPPPSSQSPPQSPPP---PNSKSPPQSSP-PPNTNPPPQSSPPPSNSNASPPP 121
P P P + +P ++ PP P PP ++P P PPPQ+ P P P
Sbjct: 736 PPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPGAPTPQPPPQAPPAPQQRPRGAPT 795
Query: 122 SQDNPSDPP 130
Q P P
Sbjct: 796 PQPPPQAGP 804
|
Length = 991 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 5e-07
Identities = 25/87 (28%), Positives = 33/87 (37%), Gaps = 11/87 (12%)
Query: 35 PPSDESPP--PSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKS 92
P SP +P P P PDR P P+ P P P S+ +P Q PP
Sbjct: 382 PSPAGSPDVKKKAPEPDLPQPDRHPGPAKPEAPGARPAELPSPASAPTPEQQPPVA---- 437
Query: 93 PPQSSPPPNTNPPPQSSPPPSNSNASP 119
P PQ+S P + ++ P
Sbjct: 438 -----RSAPLPPSPQASAPRNVASGKP 459
|
Length = 620 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 53/180 (29%), Positives = 82/180 (45%), Gaps = 24/180 (13%)
Query: 384 QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL--VYEYVPNNNLEFHLHGKGRPVM 441
Q ++ F E +I++ + +VS+ +C KR L V EYV + L G +
Sbjct: 44 QIQQVF-VERDILTFAENPFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPV 100
Query: 442 DWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK-----L 496
D R+ A + L YLH + I+HRD+K N+L+ K+ DFGL+K L
Sbjct: 101 DM-ARMYFAE-TVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155
Query: 497 TT---------DNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
TT D + +V GT Y+APE + D ++ G++L E + G P
Sbjct: 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-07
Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 10/93 (10%)
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT-HVSTRVMGTFG 513
+GL Y+H IIHRD+K SN+ ++ E ++ DFGLA+ D T +V+TR
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 514 YLAPEYASSG-KLTEKSDVFSFGVMLLELITGR 545
Y APE + + D++S G ++ EL+ G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 45/225 (20%)
Query: 348 FSQSNLLGQGGFGYVHKGVLPNGKEV-AVKSLRSGSGQGERE---FKAEVEI-------- 395
F ++G+G FG V L N +V A+K L E F+ E ++
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 396 ISRVHH-----RHLVSLVGYCIAGGKRLLVYEY---VPNNNLEFHLHGKGRPVMDWPTRL 447
I+ +H+ +L ++ Y + G L+ ++ +P + F+L +
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL-----------AEM 111
Query: 448 KIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTR 507
IA+ S L Y +HRDIK NIL+D ++ADFG ++ T S+
Sbjct: 112 VIAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV 162
Query: 508 VMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRP 547
+GT Y++PE + GK + D +S GV + E++ G P
Sbjct: 163 AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165468 PHA03201, PHA03201, uracil DNA glycosylase; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 28/86 (32%), Positives = 37/86 (43%), Gaps = 6/86 (6%)
Query: 52 PPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQ-SSPPPNTNPPPQSSP 110
RSP P P P PP SP S + P SPP P ++ PP ++ P P+ P
Sbjct: 4 ARSRSPSPPRRPSPPRPTPPRSPDASPEETPPSPPGPGAEPPPGRAAGPAAPRRRPRGCP 63
Query: 111 PPSNSNASPPPSQ-----DNPSDPPP 131
++S PP D P+ PP
Sbjct: 64 AGVTFSSSAPPRPPLGLDDAPAATPP 89
|
Length = 318 |
| >gnl|CDD|223880 COG0810, TonB, Periplasmic protein TonB, links inner and outer membranes [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 27/102 (26%), Positives = 36/102 (35%), Gaps = 7/102 (6%)
Query: 28 SSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPP 87
P+ P E PP P P+ P P+ P P + P P P P P
Sbjct: 48 VLEAPTEEPQPEPEPPEEQPKPPTEPETPPEPTPPKPKEKPKPEKKPKKPKPKPKPKPKP 107
Query: 88 -------PNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPS 122
P K PP + P Q + PPS ++AS +
Sbjct: 108 KPKVKPQPKPKKPPSKTAAKAPAAPNQPARPPSAASASGAAT 149
|
Length = 244 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 33/92 (35%), Positives = 46/92 (50%), Gaps = 11/92 (11%)
Query: 456 GLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN---NTHVSTRVMGTF 512
G+ +LH IIHRD+K SNI++ K+ DFGLA+ N +V TR
Sbjct: 135 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY---- 187
Query: 513 GYLAPEYASSGKLTEKSDVFSFGVMLLELITG 544
Y APE E D++S G ++ EL+ G
Sbjct: 188 -YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 6e-07
Identities = 25/137 (18%), Positives = 41/137 (29%), Gaps = 1/137 (0%)
Query: 1 MEDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPS 60
+ + + SR +S + D S P R PP
Sbjct: 790 VRAEAAFRRPGRLRRSGPAADAASRTASKRKSRSHTPDGGSESSGPARPPGAAARPPPAR 849
Query: 61 SPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPP 120
S S P + ++ + P PP ++ P ++ PP + P+ P
Sbjct: 850 SSESSKSKPAAAGGRARGKNGRRRPRPPEPRARPGAAAPPKAAAAAPPAGAPAPRPRPAP 909
Query: 121 PSQDNPSDPPPGDSNNG 137
+ P PP G G
Sbjct: 910 RVKLGPM-PPGGPDPRG 925
|
Length = 1352 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 6e-07
Identities = 26/157 (16%), Positives = 45/157 (28%), Gaps = 39/157 (24%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPS----DESPPPSSPPPSSPPP-------- 53
P + P PS + ++ P P + D + P P + PP
Sbjct: 484 APPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPAAAAPPAPEARPPTPAAAAPA 543
Query: 54 ----------------------DRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSK 91
DR ++ +P + P + + Q P P
Sbjct: 544 ARAGGAAAALDVLRNAGMRVSSDRGARAAAAAKPAAAPAAAPKPAAPRVAVQVPTPRARA 603
Query: 92 SPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSD 128
+ + P + + S +PPP +D P D
Sbjct: 604 ATGDAPPNG-----AARAEQAAESRGAPPPWEDIPPD 635
|
Length = 830 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 46/158 (29%), Positives = 68/158 (43%), Gaps = 28/158 (17%)
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLA-KLTTDNNTHVSTRVMGTFGYLAPEYASS---- 522
+IHRD+K N+LLD K+ADFG K+ T V GT Y++PE S
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGD 221
Query: 523 GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582
G + D +S GV L E++ G P D LV G +++I D
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTPF-----YADSLV-------------GTYSKIMDHK 263
Query: 583 LEKNYPTE----EMARMVACAAASIRHSARRRPKISQI 616
N+P + + A+ + CA + R R + +I
Sbjct: 264 NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEI 301
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 51/206 (24%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQG-EREFKAEVEIISRVHHRHLVSLVGYCI 412
+G+G +G+V+K +GK+ +L+ G G E+ ++ + H ++++L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 413 AGGKR--LLVYEYVPNN---NLEFHLHGKG-RPVMDWPTRL--KIAMGSAKGLAYLHEDC 464
+ R L+++Y ++ ++FH K + M P + + G+ YLH +
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128
Query: 465 HPRIIHRDIKSSNILL----DYTFETKVADFGLAKLTTDNNTHVS--TRVMGTFGYLAPE 518
++HRD+K +NIL+ K+AD G A+L ++ V+ TF Y APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 519 YASSGK-LTEKSDVFSFGVMLLELIT 543
+ T+ D+++ G + EL+T
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 7e-07
Identities = 19/82 (23%), Positives = 32/82 (39%)
Query: 9 GVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPES 68
G+ S +E + + A+ +P P+ P PS+P SPPP+ P
Sbjct: 358 GLLPSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPV 417
Query: 69 PPPSSPPPSSQSPPQSPPPPNS 90
P + P + + PP+
Sbjct: 418 PAEPTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 7e-07
Identities = 10/78 (12%), Positives = 27/78 (34%)
Query: 47 PPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPP 106
P S+ P + ++ S + P++ P++ +P + P ++ P
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 107 QSSPPPSNSNASPPPSQD 124
+ + + +D
Sbjct: 98 APPAAAAAAAPAAAAVED 115
|
Length = 1228 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 27/88 (30%), Positives = 37/88 (42%), Gaps = 1/88 (1%)
Query: 17 AETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPP 76
A P+ A++ P P PP + +P PPP + PP+ P P + P PP
Sbjct: 28 AVAIALPATANADPAPPPPPPSTAAAAPAPAAPPPPPPPAAPPA-PQPDDPNAAPPPPPA 86
Query: 77 SSQSPPQSPPPPNSKSPPQSSPPPNTNP 104
+PP P PN+ PP P N
Sbjct: 87 DPNAPPPPPVDPNAPPPPAPEPGRIDNA 114
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 8e-07
Identities = 30/118 (25%), Positives = 39/118 (33%), Gaps = 13/118 (11%)
Query: 11 SNSPDAAETPPSPSRASS-SPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPP----- 64
S S A P PS + S SP PP+D S P P PS P + P
Sbjct: 333 SESSRGAAVSPGPSPSRSPSPSRPPPPADPSSPRKRPRPSRAPSSPAASAGRPTRRRARA 392
Query: 65 --SPESPPPSSPPPSSQSPPQSPPPPN---SKSPPQSSPP--PNTNPPPQSSPPPSNS 115
+ + + P+ P S + P P+ P P S PPP
Sbjct: 393 AVAGRARRRDATGRFPAGRPRPSPLDAGAASGAFYARYPLLTPSGEPWPGSPPPPPGR 450
|
Length = 1352 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 8e-07
Identities = 13/82 (15%), Positives = 32/82 (39%), Gaps = 3/82 (3%)
Query: 45 SPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNP 104
P ++ P + ++ +P + P + P + P + P +PP+ +
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAP--AAPPKPAAAA-AAA 93
Query: 105 PPQSSPPPSNSNASPPPSQDNP 126
++PP + + A+P +
Sbjct: 94 AAPAAPPAAAAAAAPAAAAVED 115
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 8e-07
Identities = 14/83 (16%), Positives = 33/83 (39%), Gaps = 1/83 (1%)
Query: 58 PPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNA 117
P S+ P+ + ++ + + P + P P ++ P P P ++ + + A
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 118 SPPPSQDNPSDPPPGDSNNGSSP 140
+PP + + P + +P
Sbjct: 98 APPAAAA-AAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 23/150 (15%), Positives = 34/150 (22%), Gaps = 13/150 (8%)
Query: 2 EDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSS 61
P V+ P PP + P P+ P ++PP + P
Sbjct: 51 PSPQAPPPVAQLPQPLPQPPPTQALQALPAGDQQQH---NTPTGSPAANPPATFALPAGP 107
Query: 62 ------PPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQ----SSPPPNTNPPPQSSPP 111
P P + P + Q P + P
Sbjct: 108 AGPTIQTEPGQLYPVQVPVMVTQNPANSPLDQPAQQRALQQLQQRYGAPASGQLPSQQQS 167
Query: 112 PSNSNASPPPSQDNPSDPPPGDSNNGSSPP 141
++ S Q N PP G
Sbjct: 168 AQKNDESQLQQQPNGETPPQQTDGAGDDES 197
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 51/222 (22%), Positives = 69/222 (31%), Gaps = 34/222 (15%)
Query: 17 AETPPSPSRASSSPPPSTPPSDESPPPSSPP----PSSPPPDRSPPP---SSPPPSPESP 69
A + +P P +P D+ +PP PS PP + +P P P
Sbjct: 64 APLQQVNAALPPAPAPQSPQPDQQQQSQAPPSHQYPSQLPPQQVQSVPQQPTPQQEPYYP 123
Query: 70 PPSSP---------PPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSN---- 116
PPS P Q PPQ P +SPPQ PP S P +
Sbjct: 124 PPSQPQPPPAQQPQAQQPQPPPQVPQQQQYQSPPQQPQYQQNPPPQAQSAPQVSGLYPEE 183
Query: 117 -----ASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNK 171
S PP++ PS +G+ P G N+
Sbjct: 184 SPYQPQSYPPNEPLPSSMAMQPPYSGAPPSQQFYGPPQPSPY---MYGGPGGRPNSGFPS 240
Query: 172 NWHPPPPPSSSSNSPNGNRSGALSPPNKSNGSSSSPSSNNGS 213
PPP +G PP+K N S + + GS
Sbjct: 241 GQQPPPSQGQEGYGYSG------PPPSKGNHGSVASYAPQGS 276
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 10/93 (10%)
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT-HVSTRVMGTFG 513
GL Y+H IIHRD+K N+ ++ E K+ DFGLA+ T +V TR
Sbjct: 128 CGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 179
Query: 514 YLAPEYASSG-KLTEKSDVFSFGVMLLELITGR 545
Y APE + + D++S G ++ E++TG+
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 8e-07
Identities = 67/262 (25%), Positives = 99/262 (37%), Gaps = 68/262 (25%)
Query: 353 LLGQGGFGYV----HKGVLPNGKEVAVKSLRSGSGQGERE----FKAEVEIISRVHHRHL 404
++G+G FG V K G A+K LR S E+E +AE +I++ + +
Sbjct: 8 VIGRGAFGEVRLVQKKD---TGHIYAMKKLRK-SEMLEKEQVAHVRAERDILAEADNPWV 63
Query: 405 VSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKI-----AMGSAKGLA 458
V L Y L L+ EY+P ++ L K + TR I A+ S L
Sbjct: 64 VKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE-ETRFYIAETILAIDSIHKLG 121
Query: 459 YLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGL----------------------AKL 496
Y IHRDIK N+LLD K++DFGL L
Sbjct: 122 Y---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172
Query: 497 TTDNNTHVSTR---------------VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLEL 541
+ S R +GT Y+APE ++ D +S GV++ E+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
Query: 542 ITGRRPIDPTGAMEDCL--VDW 561
+ G P E ++W
Sbjct: 233 LVGYPPFCSDNPQETYRKIINW 254
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 9e-07
Identities = 16/123 (13%), Positives = 30/123 (24%), Gaps = 16/123 (13%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSS---------PPPDRS 56
+ + P + PPP++ P P S +
Sbjct: 377 PAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPETTSQLLAARQQLQRAQGAT 436
Query: 57 PPPSSPPPSPESPPPSSP-----PPSSQSPPQSPPPPNSKSPPQ--SSPPPNTNPPPQSS 109
S P + P + +P P K + ++ P P ++
Sbjct: 437 KAKKSEPAAASRARPVNSALERLASVRPAPSALEKAPAKKEAYRWKATNPVEVKKEPVAT 496
Query: 110 PPP 112
P
Sbjct: 497 PKA 499
|
Length = 647 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 9e-07
Identities = 21/83 (25%), Positives = 32/83 (38%)
Query: 59 PSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNAS 118
P++P P PE PP S+ P +S +P + + PPP + P Q+ P S
Sbjct: 361 PAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPETTS 420
Query: 119 PPPSQDNPSDPPPGDSNNGSSPP 141
+ G + S P
Sbjct: 421 QLLAARQQLQRAQGATKAKKSEP 443
|
Length = 647 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 9e-07
Identities = 26/98 (26%), Positives = 34/98 (34%), Gaps = 4/98 (4%)
Query: 5 NQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSP--PPSSP 62
Q AA PSPS++S++ PS P S P + P S PP P PPS+
Sbjct: 384 TQPAAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTPPTVSVDPPAAVPVNPPSTA 443
Query: 63 PPS--PESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSP 98
P + P P S+ P
Sbjct: 444 PQAVRPAQFKEEKKIPVSKVSSLGPSTLRPIQEKAEQA 481
|
Length = 614 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 9e-07
Identities = 21/85 (24%), Positives = 29/85 (34%), Gaps = 3/85 (3%)
Query: 26 ASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSS-QSPPQS 84
+ P + PS + SP SS S P S+ P+ P S PP++ P S
Sbjct: 382 VFTQPAAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTPPTVSVDPPAAVPVNPPS 441
Query: 85 PPPPNSKSPPQSSPPPNTNPPPQSS 109
P P P + S
Sbjct: 442 TAPQ--AVRPAQFKEEKKIPVSKVS 464
|
Length = 614 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 36/209 (17%), Positives = 52/209 (24%), Gaps = 16/209 (7%)
Query: 16 AAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPP 75
AE P PS + P P PPP+ + P D+ + +PP +
Sbjct: 44 VAEFPWDPSPQAPPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPATFAL 103
Query: 76 PSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASP--------PPSQDNPS 127
P+ + P P P Q NP P+ A P S PS
Sbjct: 104 PAGPAGPTIQTEPGQLYPVQVPVMVTQNPANSPLDQPAQQRALQQLQQRYGAPASGQLPS 163
Query: 128 DPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSSSSNSPN 187
N+ S N + +G G+ +
Sbjct: 164 QQQSAQKNDESQLQQQPNGETPPQQTDGAGDDESEALVRLR--------EADGTLEQRIK 215
Query: 188 GNRSGALSPPNKSNGSSSSPSSNNGSMLS 216
G G K + S
Sbjct: 216 GAEGGGAMKVLKQPKKQAKSSKRRTIAQI 244
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 1e-06
Identities = 21/81 (25%), Positives = 30/81 (37%)
Query: 56 SPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNS 115
S S+ +P P S PPP+ P P P PP T +
Sbjct: 514 SGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPAD 573
Query: 116 NASPPPSQDNPSDPPPGDSNN 136
++ PPP + P+ P DS+
Sbjct: 574 SSPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 1e-06
Identities = 16/95 (16%), Positives = 34/95 (35%), Gaps = 9/95 (9%)
Query: 43 PSSPPPS--------SPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPP 94
P+S PS P +P ++ + + P++ P + +P PP + + P
Sbjct: 22 PNSVDPSWREFFADYGPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPP-AAAAP 80
Query: 95 QSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDP 129
+ P P ++P + A+ +
Sbjct: 81 AAPPKPAAAAAAAAAPAAPPAAAAAAAPAAAAVED 115
|
Length = 1228 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 26/201 (12%), Positives = 64/201 (31%), Gaps = 27/201 (13%)
Query: 8 PGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPP--S 65
G +P A + A + T + + P + ++ +PP + PP +
Sbjct: 377 AGAVPAPGARAAAAVGASAVPAVTAVTGAAGAALAPKAAAAAAATRAEAPPAAPAPPATA 436
Query: 66 PESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDN 125
+ + + +S+ + + PP + S+P +PP +
Sbjct: 437 DRGDDAADGDAPVPAKANARASADSRCDERDAQPP-ADSGSASAPASD----APPDAAFE 491
Query: 126 PSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSSSSNS 185
P+ P + + ++P + + PP+ +
Sbjct: 492 PA--PRAAAPSAATPAAVPDARAPAAA---------------SREDAPAAAAPPAPEARP 534
Query: 186 PNGNRSGALSPPNKSNGSSSS 206
P A +P ++ G++++
Sbjct: 535 PT---PAAAAPAARAGGAAAA 552
|
Length = 830 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 39/149 (26%), Positives = 54/149 (36%), Gaps = 7/149 (4%)
Query: 2 EDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPP-PSSPPPSSPPPDRSPPPS 60
E+ S S D+ + PP+P + + P + P +P P SP PD+
Sbjct: 32 EEAQSSEAHSFHVDSTKQPPAPEQVAKHELADAPLQQVNAALPPAPAPQSPQPDQQQQSQ 91
Query: 61 SPP----PSPESPPPSSPPPSSQSPPQSP--PPPNSKSPPQSSPPPNTNPPPQSSPPPSN 114
+PP PS P P +P Q P PPP+ PP + P P P P
Sbjct: 92 APPSHQYPSQLPPQQVQSVPQQPTPQQEPYYPPPSQPQPPPAQQPQAQQPQPPPQVPQQQ 151
Query: 115 SNASPPPSQDNPSDPPPGDSNNGSSPPGN 143
SPP +PPP +
Sbjct: 152 QYQSPPQQPQYQQNPPPQAQSAPQVSGLY 180
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 15/71 (21%), Positives = 25/71 (35%), Gaps = 3/71 (4%)
Query: 16 AAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPP 75
A P + A + P+ PP +PP P+ P R P+ P P + P +
Sbjct: 381 APAPPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAAR---PAPAPAPPAAAAPPARS 437
Query: 76 PSSQSPPQSPP 86
+ +
Sbjct: 438 ADPAAAASAGD 448
|
Length = 576 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 18/70 (25%), Positives = 30/70 (42%), Gaps = 3/70 (4%)
Query: 9 GVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPES 68
G P AA P+P+ ++ PP + PP PP + P++ P +P P + P
Sbjct: 380 GAPAPPSAAWGAPTPAAPAAPPPAAAPPV---PPAAPARPAAARPAPAPAPPAAAAPPAR 436
Query: 69 PPPSSPPPSS 78
+ S+
Sbjct: 437 SADPAAAASA 446
|
Length = 576 |
| >gnl|CDD|165468 PHA03201, PHA03201, uracil DNA glycosylase; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 30/89 (33%), Positives = 40/89 (44%), Gaps = 4/89 (4%)
Query: 43 PSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQ-SPPPPNSKSPPQSSPPPN 101
S PP P P R PP SP SPE PPS P P ++ PP + P + P+ P
Sbjct: 7 RSPSPPRRPSPPRPTPPRSPDASPEETPPSPPGPGAEPPPGRAAGPAAPRRRPRGCPAGV 66
Query: 102 T---NPPPQSSPPPSNSNASPPPSQDNPS 127
T + PP+ ++ A+ PP D
Sbjct: 67 TFSSSAPPRPPLGLDDAPAATPPPLDWTE 95
|
Length = 318 |
| >gnl|CDD|111345 pfam02439, Adeno_E3_CR2, Adenovirus E3 region protein CR2 | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 1e-06
Identities = 13/36 (36%), Positives = 20/36 (55%), Gaps = 4/36 (11%)
Query: 212 GSMLSIPLVAAVAAGAAFLIIVMLLVFFACRRKKNR 247
S ++I + AV G A +II M +AC +K+R
Sbjct: 3 SSTIAI--IVAVVVGMAIIIICMFY--YACCYRKHR 34
|
Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host. This region called CR2 (conserved region 1) is found in Adenovirus type 19 (a subgroup D virus) 49 Kd protein in the E3 region. CR2 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 50 amino acid region is unknown. Length = 38 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 354 LGQGGFGYVHKGVLPN-GKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCI 412
LG G G V V + K VAVK + Q + E++II R+ H ++V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 413 AGGKRL--------------LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLA 458
G L +V EY+ + G P+ + RL +GL
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQG---PLSEEHARL-FMYQLLRGLK 128
Query: 459 YLHEDCHPRIIHRDIKSSNILLDY-TFETKVADFGLAKLTTDNNTHVSTRVMG--TFGYL 515
Y+H ++HRD+K +N+ ++ K+ DFGLA++ + +H G T Y
Sbjct: 129 YIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR 185
Query: 516 APEYA-SSGKLTEKSDVFSFGVMLLELITGR 545
+P S T+ D+++ G + E++TG+
Sbjct: 186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 54/176 (30%), Positives = 79/176 (44%), Gaps = 30/176 (17%)
Query: 454 AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV---STRVMG 510
A+G+ +L + IHRD+ + NILL K+ DFGLA+ + +V S R+
Sbjct: 184 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL-- 238
Query: 511 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRA 569
++APE T +SDV+SFGV+L E+ + G P E+ C R
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--------FCQR- 289
Query: 570 LDDGNFNEIADPYLEKNYPTEEMAR-MVACAAASIRHSARRRPKISQIVRALEGDV 624
L DG + T E+ R M+AC + RP S +V L GD+
Sbjct: 290 LKDGTRMRAPE------NATPEIYRIMLACWQG----DPKERPTFSALVEIL-GDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 51.7 bits (123), Expect = 1e-06
Identities = 52/236 (22%), Positives = 94/236 (39%), Gaps = 21/236 (8%)
Query: 9 GVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPES 68
G ++S +T P+ SR +S+ P +T P+ P++ P++ S P++ P+P
Sbjct: 476 GTTSSTLPEDTSPT-SRTTSATPNATSPTPAVTTPNATSPTTQ--KTSDTPNATSPTPIV 532
Query: 69 PPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSD 128
++ S + S P S + SP NTN P +S PS ++ Q
Sbjct: 533 IGVTTTATSPPTGTTSVPNATSPQVTEESPVNNTNTPVVTS-APSVLTSAVTTGQHGTGS 591
Query: 129 PP----PGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNN------NNNNNKNWHPPPP 178
P PG ++ S P +N+ + + + G N + + P P
Sbjct: 592 SPTSQQPGIPSSSHSTPRSNSTSTTPLLTSAHPTGGENITEETPSVPSTTHVSTLSPGPG 651
Query: 179 PSSSSNSPNGNRSGALSPPNKS-------NGSSSSPSSNNGSMLSIPLVAAVAAGA 227
P ++S S P + N +++SPS+ +G ++P V + A
Sbjct: 652 PGTTSQVSGPGNSSTSRYPGEVHVTEGMPNPNATSPSAPSGQKTAVPTVTSTGGKA 707
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 2e-06
Identities = 22/84 (26%), Positives = 36/84 (42%)
Query: 56 SPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNS 115
S +PPP +SPPP +P P P + PPP PP ++ ++N P Q S
Sbjct: 518 SNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSSPP 577
Query: 116 NASPPPSQDNPSDPPPGDSNNGSS 139
P +P+ + + ++
Sbjct: 578 PPIPEEPTPSPTKDSSPEEIDKAA 601
|
Length = 620 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 29/128 (22%), Positives = 49/128 (38%), Gaps = 5/128 (3%)
Query: 7 SPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPP-PSSPPPS 65
+P + P AA P + A+++P + P + +P PPP + PP +SP P+
Sbjct: 457 APAAAARPAAAGPRPVAAAAAAAPARAAPAAAPAPADDDPPP----WEELPPEFASPAPA 512
Query: 66 PESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDN 125
P+ S P + P ++ +P P ++ P + P S
Sbjct: 513 QPDAAPAGWVAESIPDPATADPDDAFETLAPAPAAAPAPRAAAATEPVVAPRPPRASASG 572
Query: 126 PSDPPPGD 133
D GD
Sbjct: 573 LPDMFDGD 580
|
Length = 700 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 21/68 (30%), Positives = 31/68 (45%), Gaps = 9/68 (13%)
Query: 33 STPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKS 92
PPS P+ P++PPP +PP PP + P++ P +P PP + +
Sbjct: 382 PAPPSAAWGAPTPAAPAAPPPAAAPPV---------PPAAPARPAAARPAPAPAPPAAAA 432
Query: 93 PPQSSPPP 100
PP S P
Sbjct: 433 PPARSADP 440
|
Length = 576 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 30/80 (37%), Positives = 37/80 (46%), Gaps = 7/80 (8%)
Query: 57 PPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSN 116
P P PPPS + P+ P PP +PP P P ++PPP P PPP + N
Sbjct: 41 PAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAP-QPDDPNAAPPPPPADPNAPPPPPVDPN 99
Query: 117 ASPPPSQDNPSDPPPGDSNN 136
A PPP P PG +N
Sbjct: 100 APPPP------APEPGRIDN 113
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 2e-06
Identities = 16/122 (13%), Positives = 39/122 (31%), Gaps = 9/122 (7%)
Query: 1 MEDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPP-----PDR 55
++ + +++S AA PP+ + +++ PP P++P P R
Sbjct: 34 VDGGVEIVALADSDLAALAPPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKR 93
Query: 56 SPPPSSPPPS----PESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPP 111
+ P +P +P ++ ++P P ++
Sbjct: 94 LTAQREQLVARAAAPAAPEAQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAAAVA 153
Query: 112 PS 113
+
Sbjct: 154 DA 155
|
Length = 484 |
| >gnl|CDD|218332 pfam04929, Herpes_DNAp_acc, Herpes DNA replication accessory factor | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 22/94 (23%), Positives = 33/94 (35%), Gaps = 7/94 (7%)
Query: 10 VSNSPDAAETPPSPSRASSSPPPSTP-PSDESPPPSSPPPSSPPPDRSPPPSSPPPSPES 68
+S +A P P+ + S P S SPP + S P +PPP+S SP +
Sbjct: 289 ADSSVEANGVEPEPTGSVSDRPRHLSSDSSPSPPDT---SDSDPSTETPPPASLSHSPPA 345
Query: 69 PPPSSPPPSSQSPPQSPPP---PNSKSPPQSSPP 99
S + + SK + P
Sbjct: 346 AFERPLALSPKRKREGDKKQKKKKSKKLKLTFNP 379
|
Replicative DNA polymerases are capable of polymerising tens of thousands of nucleotides without dissociating from their DNA templates. The high processivity of these polymerases is dependent upon accessory proteins that bind to the catalytic subunit of the polymerase or to the substrate. The Epstein-Barr virus (EBV) BMRF1 protein is an essential component of the viral DNA polymerase and is absolutely required for lytic virus replication. BMRF1 is also a transactivator. This family is predicted to have a UL42 like structure. Length = 381 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-06
Identities = 36/213 (16%), Positives = 57/213 (26%), Gaps = 8/213 (3%)
Query: 2 EDNNQSPGVSNSPDAAETPPSPSRASSSPP---PSTPPSDESPPPSSPPPSSPPPDRSPP 58
E + P A + S S + + + P
Sbjct: 12 EAAAEGGEFFPRPPATPGDAADDLLSGSQGQLVSDSAELAAVTVVAGAAACDRFEPPTGP 71
Query: 59 PSSPPPSPESPPPSSPPPSSQSP--PQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSN 116
P P + S P S S P SP S +PP S P PPP + PP S
Sbjct: 72 PPGPGTEAPANESRSTPTWSLSTLAPASPAREGSPTPPGPSSPD---PPPPTPPPASPPP 128
Query: 117 ASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPP 176
+ P + +SPP + + ++
Sbjct: 129 SPAPDLSEMLRPVGSPGPPPAASPPAAGASPAAVASDAASSRQAALPLSSPEETARAPSS 188
Query: 177 PPPSSSSNSPNGNRSGALSPPNKSNGSSSSPSS 209
PP ++P S + +S+S +
Sbjct: 189 PPAEPPPSTPPAAASPRPPRRSSPISASASSPA 221
|
Length = 1352 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 3e-06
Identities = 21/111 (18%), Positives = 31/111 (27%), Gaps = 3/111 (2%)
Query: 8 PGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPE 67
+P A TPP+ + P S P + P P P P PP
Sbjct: 697 APAQPAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLP---PEPDDPPDPAG 753
Query: 68 SPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNAS 118
+P PPP+ P P + + P ++
Sbjct: 754 APAQPPPPPAPAPAAAPAAAPPPSPPSEEEEMAEDDAPSMDDEDRRDAEEV 804
|
Length = 824 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 3e-06
Identities = 21/84 (25%), Positives = 28/84 (33%), Gaps = 6/84 (7%)
Query: 65 SPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQD 124
S + + PP Q P P P PP P PP PPP+ + AS
Sbjct: 514 SGSASNTAKTPPPPQKSPPPPAPT----PPLPQPTATAPPPTPPPPPPTATQASSNAPAQ 569
Query: 125 NPSDPPPGDSNNGSSPPGNNNNNN 148
P+D P P + +
Sbjct: 570 IPADSSP--PPPIPEEPTPSPTKD 591
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 3e-06
Identities = 19/77 (24%), Positives = 31/77 (40%)
Query: 20 PPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQ 79
A++S P + P+ PP +P S P + + PP ++ PP P
Sbjct: 363 AFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPT 422
Query: 80 SPPQSPPPPNSKSPPQS 96
P +PP + +PP
Sbjct: 423 EPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 3e-06
Identities = 41/145 (28%), Positives = 46/145 (31%), Gaps = 20/145 (13%)
Query: 7 SPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSP----PPSSP 62
S S PP P P PS P P S PP P P S
Sbjct: 260 SSRHPQSSHHGPGPPMPHALQQGPVFLQHPSSNPPQPFGLAQSQVPPLPLPSQAQPHSHT 319
Query: 63 PPSPESPPPSSPPPSSQSPPQSP----PPPNSKSPPQSSPPPNTNPPPQSSPPP---SNS 115
PPS + P PP PP PP + PQ + +PP P P S
Sbjct: 320 PPSQSALQPQQPPREQPLPPAPSMPHIKPPPTTPIPQLPNQSHKHPPHLQGPSPFPQMPS 379
Query: 116 NASPPP---------SQDNPSDPPP 131
N PPP + PS PP
Sbjct: 380 NLPPPPALKPLSSLPTHHPPSAHPP 404
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 3e-06
Identities = 37/144 (25%), Positives = 48/144 (33%), Gaps = 18/144 (12%)
Query: 16 AAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSP---PPSSPPPSP------ 66
A + P P+ ++ + PP P P P PS +P P P P P
Sbjct: 189 LAPSAPPPTPSAQAVPPQGSPIAAQPAPQPQQPSPLSLISAPSLHPQRLPSPHPPLQPQT 248
Query: 67 ---ESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSP----PPNTNPPPQSSPPPSNSNASP 119
+SP P +P P P Q P P++NPP S P
Sbjct: 249 ASQQSPQPPAPSSRHPQSSHHGPGPPMPHALQQGPVFLQHPSSNPPQPFGLAQSQVPPLP 308
Query: 120 PPSQDNP--SDPPPGDSNNGSSPP 141
PSQ P PP + PP
Sbjct: 309 LPSQAQPHSHTPPSQSALQPQQPP 332
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 8/93 (8%)
Query: 454 AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV---STRVMG 510
AKG+ +L + IHRD+ + NILL K+ DFGLA+ + +V R+
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 243
Query: 511 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 543
++APE T +SDV+SFGV+L E+ +
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 45/216 (20%), Positives = 69/216 (31%), Gaps = 28/216 (12%)
Query: 14 PDAAETPPSPSRASSSPPPSTPPSDESPPPS---SPPPSSPPP---DRSPPPSSPPPSPE 67
DAA+ P +P +PP +E PP P P SP D PP S P P
Sbjct: 333 SDAADGPKPVPTKPVTPEAPSPPIEEEPPQPKAVVPRPLSPYTAYEDLKPPTSPIPTPPS 392
Query: 68 SPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSS--------------PPPS 113
S P SS + + P P S + P PP S
Sbjct: 393 SSPASSKSVDAVAKPAEPDVVPSPGSASNVPEVEPAQVEAKKTRPLSPYARYEDLKPPTS 452
Query: 114 NSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNW 173
S +P + S + ++P + N + ++
Sbjct: 453 PSPTAPTGVSPSVSSTSSVPAVPDTAPATAATDAAAPPPANMRPLSPYAVYDD------- 505
Query: 174 HPPPPPSSSSNSPNGNRSGALSPPNKSNGSSSSPSS 209
PP S S +P G + + + G+S+ P++
Sbjct: 506 -LKPPTSPSPAAPVGKVAPSSTNEVVKVGNSAPPTA 540
|
Length = 576 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 4e-06
Identities = 29/118 (24%), Positives = 40/118 (33%), Gaps = 11/118 (9%)
Query: 31 PPSTPPSD-------ESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQ 83
P TPPS P + P+ R + P P + P
Sbjct: 357 PTWTPPSSLEDLSAGRHHPKRASLPTRK---RRSARHAATPFARGPGGDDQTRPAAPVPA 413
Query: 84 SPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQD-NPSDPPPGDSNNGSSP 140
S P P P S+PPP P P + P + A PP Q P+ P D + ++
Sbjct: 414 SVPTPAPTPVPASAPPPPATPLPSAEPGSDDGPAPPPERQPPAPATEPAPDDPDDATR 471
|
Length = 3151 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-06
Identities = 44/238 (18%), Positives = 57/238 (23%), Gaps = 27/238 (11%)
Query: 3 DNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSP 62
+ + + S+ +S+ P + S P P P P P
Sbjct: 73 AAVRYNQNAPGAPSVGPDSDLSQKTSTFSPCQSGYEASTDPEYIPDLQPDPSLWGTAPKP 132
Query: 63 PPSPESPPPSSPPP------------------SSQSPPQSPPPPNSKSPPQSSPPPNTNP 104
P P P S P P Q PQ P PP + PQ PP
Sbjct: 133 EPQPPQAPESQPQPQTPAQKMLSLEEVEAQLQQRQQAPQLPQPPQ-QVLPQGMPPRQAAF 191
Query: 105 PPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNN 164
P Q P PP P +P
Sbjct: 192 PQQGPPEQPPGYPQPPQGHPEQVQPQQFLPAPSQAPAQPPLPPQ---LPQQPPPLQQPQF 248
Query: 165 NNNNNNKNWHPPPPPSSSSNSPNGNRSGALSPPNKSNGSSSSPSSNNGSMLSIPLVAA 222
+ PPPPP + A PP N + P G +P
Sbjct: 249 PGLSQQM---PPPPPQPPQQQQQPPQPQAQPPP--QNQPTPHPGLPQGQNAPLPPPQQ 301
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 4e-06
Identities = 15/78 (19%), Positives = 22/78 (28%)
Query: 56 SPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNS 115
S S + P+ P S P P ++P P P P+
Sbjct: 362 SAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEP 421
Query: 116 NASPPPSQDNPSDPPPGD 133
P N ++ PP
Sbjct: 422 TEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 4e-06
Identities = 14/79 (17%), Positives = 24/79 (30%)
Query: 2 EDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSS 61
S + S A TP +P + P + + PP + P P+
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 62 PPPSPESPPPSSPPPSSQS 80
P +PP ++
Sbjct: 421 PTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 4e-06
Identities = 16/93 (17%), Positives = 34/93 (36%), Gaps = 10/93 (10%)
Query: 48 PSSPPP-------DRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPP 100
P+S P D P ++ P + + ++ + +P P + +PP ++ P
Sbjct: 22 PNSVDPSWREFFADYGPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPA 81
Query: 101 NTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGD 133
PP+ + + + A P + P
Sbjct: 82 ---APPKPAAAAAAAAAPAAPPAAAAAAAPAAA 111
|
Length = 1228 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 19/100 (19%), Positives = 36/100 (36%), Gaps = 3/100 (3%)
Query: 1 MEDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSP--P 58
N V T P+ + A ++P +TP + ++P ++ P + P ++
Sbjct: 153 ELSQNSGQSVPLDTSTT-TDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVA 211
Query: 59 PSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSP 98
PS + P + P + P S P + P
Sbjct: 212 PSQANVDTAATPAPAAPATPDGAAPLPTDQAGVSTPAADP 251
|
Length = 331 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 4e-06
Identities = 31/111 (27%), Positives = 47/111 (42%), Gaps = 3/111 (2%)
Query: 22 SPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSP 81
S S++ P++ + P P + P P PSS P+ +P PS+ P
Sbjct: 379 SAPSGSAAEGPASGGAATIPTPGTQGPQGTAPAAGMTPSSAAPA--TPAPSAAPSPRVPW 436
Query: 82 PQSPP-PPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPP 131
+PP PP S PP+ +P P +P S + PP+ +PSD
Sbjct: 437 DDAPPAPPRSGIPPRPAPRMPEASPVPGAPDSVASASDAPPTLGDPSDTAE 487
|
Length = 624 |
| >gnl|CDD|220749 pfam10428, SOG2, RAM signalling pathway protein | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 28/122 (22%), Positives = 40/122 (32%), Gaps = 6/122 (4%)
Query: 19 TPPSPSRASSSPPPSTPPSDESPPPSSP--PPSSPPPDRSPPPSSPPPSPESPPPSSPPP 76
PP R + S P S P S P R PSS P S +P P
Sbjct: 149 GPPLQHRKRDAVTASPSSMIARNTPISDRLRPRSVTPTRGRRPSSSPRSLSNPTTLESPS 208
Query: 77 SSQSPPQSPPPP---NSKSPPQSSPPPNTNPPPQSSP-PPSNSNASPPPSQDNPSDPPPG 132
+ Q PPP S+S SS + ++P + ++P + +
Sbjct: 209 NLQVTTDVPPPYSNGTSRSSTMSSSANLSIISSLATPRSGESFRSTPTSGSSSINPVSGL 268
Query: 133 DS 134
D
Sbjct: 269 DE 270
|
SOG2 proteins in Saccharomyces cerevisiae are involved in cell separation and cytokinesis. Length = 419 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 5e-06
Identities = 19/74 (25%), Positives = 35/74 (47%), Gaps = 4/74 (5%)
Query: 25 RASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQS 84
R + +PP + + P++PPP++ PP PP + P+ P P+ PP++ +PP
Sbjct: 379 RGAPAPPSAAWGAPTPAAPAAPPPAAAPP--VPPAAPARPAAARPAPAPAPPAAAAPPAR 436
Query: 85 PPPPNSKSPPQSSP 98
P + +
Sbjct: 437 SADP--AAAASAGD 448
|
Length = 576 |
| >gnl|CDD|218107 pfam04484, DUF566, Family of unknown function (DUF566) | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 26/127 (20%), Positives = 39/127 (30%), Gaps = 4/127 (3%)
Query: 17 AETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPP 76
A + S S + + P + +S P R P+SPP S + SS
Sbjct: 2 AASVSSGSTSGDASSPRSSSRRRLSSSFLSTSASSRPRRLNAPASPPSSSPARNTSSSSS 61
Query: 77 SSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPS----DPPPG 132
S + + + P +P +S S + AS S
Sbjct: 62 FGLSKQRPSSLSRGRLSSRFVSPSRGSPSAAASLNGSLATASTSGSSSPSRSRRTTSSDL 121
Query: 133 DSNNGSS 139
S NG S
Sbjct: 122 SSGNGPS 128
|
Family of related proteins that is plant specific. Length = 313 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 6e-06
Identities = 19/81 (23%), Positives = 31/81 (38%), Gaps = 3/81 (3%)
Query: 7 SPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSP 66
+ + +P + P P + P T + PP PP ++ +P P+
Sbjct: 517 ASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPA---QIPAD 573
Query: 67 ESPPPSSPPPSSQSPPQSPPP 87
SPPP P + SP + P
Sbjct: 574 SSPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 6e-06
Identities = 14/101 (13%), Positives = 31/101 (30%), Gaps = 8/101 (7%)
Query: 36 PSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSP-------PQSPPPP 88
P + P ++ PP + P P++P P +P + +P P
Sbjct: 53 PPAAAAPAAAQPPPAAAPAAVSRPAAPAAEP-APWLVEHAKRLTAQREQLVARAAAPAAP 111
Query: 89 NSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDP 129
+++P + + + + P D +
Sbjct: 112 EAQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAAAV 152
|
Length = 484 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 7e-06
Identities = 25/119 (21%), Positives = 43/119 (36%), Gaps = 8/119 (6%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
V+ + AA +P+ A + PP +E P P +SP P + + +
Sbjct: 468 GPRPVAAAAAAAPARAAPAAAPAPADDDPPPWEELP----PEFASPAPAQPDAAPAGWVA 523
Query: 66 PESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQD 124
P P++ P +P P + +P ++ P PP S + P D
Sbjct: 524 ESIPDPATADPDDAFETLAPAPAAAPAPRAAAATEPVVAP----RPPRASASGLPDMFD 578
|
Length = 700 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 7e-06
Identities = 20/150 (13%), Positives = 40/150 (26%), Gaps = 14/150 (9%)
Query: 7 SPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPP------DRSPPPS 60
+ + A ++ P + + +PP + PP D +
Sbjct: 387 AAAAVGASAVPAVTAVTGAAGAALAPKAAAAAAATRAEAPPAAPAPPATADRGDDAADGD 446
Query: 61 SPPPSPE--------SPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPP 112
+P P+ P + S S P ++ P P P ++P
Sbjct: 447 APVPAKANARASADSRCDERDAQPPADSGSASAPASDAPPDAAFEPAPRAAAPSAATPAA 506
Query: 113 SNSNASPPPSQDNPSDPPPGDSNNGSSPPG 142
+P + + + PP
Sbjct: 507 VPDARAPAAASREDAPAAAAPPAPEARPPT 536
|
Length = 830 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 7e-06
Identities = 58/210 (27%), Positives = 73/210 (34%), Gaps = 36/210 (17%)
Query: 11 SNSPDAAETPPSPSRASSSPPPSTP------PSDESPP--------PSSPPPSSPPPDRS 56
P PP+PS PPP+TP S + PP P P PPP
Sbjct: 329 QQPPREQPLPPAPSMPHIKPPPTTPIPQLPNQSHKHPPHLQGPSPFPQMPSNLPPPPALK 388
Query: 57 P--------PPSSPPP--------SPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPP 100
P PPS+ PP P P+ PP +QS QS PP S P
Sbjct: 389 PLSSLPTHHPPSAHPPPLQLMPQSQPLQSVPAQPPVLTQS--QSLPPKASTHPHSGLHSG 446
Query: 101 NTNPPPQSSP--PPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGN 158
P P PPPS + P +++GS PPG+ ++ G G
Sbjct: 447 PPQSPFAQHPFTSGGLPAIGPPPSLPTSTPAAPPRASSGSQPPGSALPSSGGCAGPGPPL 506
Query: 159 GNHNNNNN--NNNNKNWHPPPPPSSSSNSP 186
+ + PPPPP S S P
Sbjct: 507 PPIQIKEEPLDEAEEPESPPPPPRSPSPEP 536
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 43/176 (24%), Positives = 74/176 (42%), Gaps = 26/176 (14%)
Query: 403 HLVSLVGYCIAGGKRLLVYEYVPNNNLEFH----LHGKGRPVMDWPTRLKIAMGSAKGLA 458
++V L Y ++ LV ++ L H L+ V W + +A+ +
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 459 YLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE 518
LH + I+ RD+ +NILLD ++ F D+ + M Y APE
Sbjct: 101 -LHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPE 152
Query: 519 YASSGKLTEKSDVFSFGVMLLELITGRRPID--PTG-------AMEDCLVDWARPL 565
+ TE D +S G +L EL+TG+ ++ P+G + + + + AR L
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSL 208
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 7e-06
Identities = 26/84 (30%), Positives = 32/84 (38%), Gaps = 5/84 (5%)
Query: 21 PSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQS 80
S S +S S S SSPP S+ P R PS+ S PS P S
Sbjct: 1 SSSSNPTSRSQSHASSSSSSSSQSSPPSSTSPRPRRRKPSA---SSLLHTPSILPLPKLS 57
Query: 81 PPQSPPPPNSKSPPQSSPPPNTNP 104
P PP + P ++ P NP
Sbjct: 58 SP--SPPSVTLPPAATTQTPQLNP 79
|
Length = 590 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 7e-06
Identities = 32/112 (28%), Positives = 41/112 (36%), Gaps = 6/112 (5%)
Query: 21 PSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESP--PPSSPPPSS 78
P P++ PS P+ P P P P P S + P P S P
Sbjct: 561 PGPAKEHK---PSKIPTLSKKPEFPKDPKHPKDPEEPKKPKRPRSAQRPTRPKSPKLPEL 617
Query: 79 QSPPQSPPPPNSKSPPQSSPPPN-TNPPPQSSPPPSNSNASPPPSQDNPSDP 129
P+SP P S P+ PPP + P + P + PP S P DP
Sbjct: 618 LDIPKSPKRPESPKSPKRPPPPQRPSSPERPEGPKIIKSPKPPKSPKPPFDP 669
|
Length = 943 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-06
Identities = 29/104 (27%), Positives = 37/104 (35%), Gaps = 11/104 (10%)
Query: 20 PPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESP--------PP 71
P + S P S P P P P + P + P P+SP P
Sbjct: 563 PAKEHKPSKIPTLSKKPEFPKDPKHPKDPEEPKKPKRPRSAQRPTRPKSPKLPELLDIPK 622
Query: 72 SSPPPSSQSPPQSPPPPN---SKSPPQSSPPPNTNPPPQSSPPP 112
S P S P+ PPPP S P+ + PP+S PP
Sbjct: 623 SPKRPESPKSPKRPPPPQRPSSPERPEGPKIIKSPKPPKSPKPP 666
|
Length = 943 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 8e-06
Identities = 21/76 (27%), Positives = 32/76 (42%), Gaps = 4/76 (5%)
Query: 19 TPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSS--PPPSPESPPPSSPPP 76
+ P +PP +TP S +P P+ PP+SP S P+S SP ++ P
Sbjct: 75 SKPKTGTGKVAPPAATPTS--APTPTPSPPASPASGMSAAPASAVEEKSPSEESATATAP 132
Query: 77 SSQSPPQSPPPPNSKS 92
S S ++ S
Sbjct: 133 ESPSTSVPSSGSDAAS 148
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 9e-06
Identities = 22/81 (27%), Positives = 29/81 (35%), Gaps = 4/81 (4%)
Query: 7 SPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSP 66
+P A T P + A++ PP +PPP P P +PP P S P
Sbjct: 375 APSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRPVAPPVP--HTPESAPKLT 432
Query: 67 ESPPPSSPPPSSQSPPQSPPP 87
+ P P P PP
Sbjct: 433 RAAIPVDEKPKYTPPA--PPK 451
|
Length = 585 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 9e-06
Identities = 16/78 (20%), Positives = 22/78 (28%), Gaps = 2/78 (2%)
Query: 64 PSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASP--PP 121
PS ++ + P P P S+P S PP S P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 122 SQDNPSDPPPGDSNNGSS 139
+ PP +N S
Sbjct: 421 PTEPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|184927 PRK14963, PRK14963, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 9e-06
Identities = 14/88 (15%), Positives = 22/88 (25%), Gaps = 4/88 (4%)
Query: 9 GVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPES 68
A P+P+ + + +P P P P
Sbjct: 346 PSEGVAAVAPPAPAPADLTQRLNRLEKEVRSLRSAPTAAA---TAAGAPLP-DFDPRPRG 401
Query: 69 PPPSSPPPSSQSPPQSPPPPNSKSPPQS 96
PP P S+++PP P
Sbjct: 402 PPAPEPARSAEAPPLVAPAAAPAGLALR 429
|
Length = 504 |
| >gnl|CDD|218549 pfam05308, Mito_fiss_reg, Mitochondrial fission regulator | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 21/89 (23%), Positives = 29/89 (32%), Gaps = 3/89 (3%)
Query: 23 PSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPP 82
+++S+ + P S+ PP P PPP P PP PPP S
Sbjct: 145 QEQSNSTTSDLLSSDESVPSSSTTSFPISPPTEEPVLEVPPPPP---PPPPPPPPSLQQS 201
Query: 83 QSPPPPNSKSPPQSSPPPNTNPPPQSSPP 111
S + Q S T + P
Sbjct: 202 TSAIDLIKERKGQRSAAGKTLVLSKPKSP 230
|
In eukaryotes, this family of proteins induces mitochondrial fission. Length = 248 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 25/76 (32%), Positives = 35/76 (46%)
Query: 62 PPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPP 121
P + P P PPPS+ + +P P PP + P P + P + PPP +PPP
Sbjct: 34 PATANADPAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPPPPADPNAPPP 93
Query: 122 SQDNPSDPPPGDSNNG 137
+P+ PPP G
Sbjct: 94 PPVDPNAPPPPAPEPG 109
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 44/204 (21%), Positives = 65/204 (31%), Gaps = 1/204 (0%)
Query: 16 AAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPP 75
A + P S P S PP +P + PP SP + P P P+ P P S
Sbjct: 168 AQQQLLQPQGPPSIQVPPGAALAPSAPPPTPSAQAVPPQGSPIAAQPAPQPQQPSPLSLI 227
Query: 76 PS-SQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDS 134
+ S P + P P P +S P P S P S+ + PP P
Sbjct: 228 SAPSLHPQRLPSPHPPLQPQTASQQSPQPPAPSSRHPQSSHHGPGPPMPHALQQGPVFLQ 287
Query: 135 NNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSSSSNSPNGNRSGAL 194
+ S+PP + + +++ + P PP P +
Sbjct: 288 HPSSNPPQPFGLAQSQVPPLPLPSQAQPHSHTPPSQSALQPQQPPREQPLPPAPSMPHIK 347
Query: 195 SPPNKSNGSSSSPSSNNGSMLSIP 218
PP + S + L P
Sbjct: 348 PPPTTPIPQLPNQSHKHPPHLQGP 371
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 1e-05
Identities = 12/71 (16%), Positives = 23/71 (32%)
Query: 32 PSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSK 91
P +P PP P + P ++ P ++ + + PP
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 92 SPPQSSPPPNT 102
+ PQ + N+
Sbjct: 451 AAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 1e-05
Identities = 12/103 (11%), Positives = 32/103 (31%), Gaps = 6/103 (5%)
Query: 24 SRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESP--PPSSPPPSSQSP 81
A+++P + PP + P + P++P + +P + + + +P
Sbjct: 53 PPAAAAPAAAQPPP-AAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAP 111
Query: 82 PQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQD 124
P ++ + ++P P +
Sbjct: 112 EAQAPAAPAERAAAENAARRLARAAAAAPRP---RVPADAAAA 151
|
Length = 484 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 29/85 (34%), Positives = 34/85 (40%), Gaps = 4/85 (4%)
Query: 8 PGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSP-PPS- 65
P P E P P R S+ P+ P S + P P S P+ P P PP
Sbjct: 582 PKDPKHPKDPEEPKKPKRPRSAQRPTRPKSPKLPELLDIPKSPKRPESPKSPKRPPPPQR 641
Query: 66 PESP--PPSSPPPSSQSPPQSPPPP 88
P SP P S PP+SP PP
Sbjct: 642 PSSPERPEGPKIIKSPKPPKSPKPP 666
|
Length = 943 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 31/94 (32%), Positives = 53/94 (56%), Gaps = 10/94 (10%)
Query: 454 AKGLAYL-HEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTF 512
A+G+ +L ++C +HRD+ + N+LL K+ DFGLA+ ++ +VS TF
Sbjct: 247 ARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG--STF 300
Query: 513 ---GYLAPEYASSGKLTEKSDVFSFGVMLLELIT 543
++APE T SDV+S+G++L E+ +
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|234229 TIGR03490, Mycoplas_LppA, mycoides cluster lipoprotein, LppA/P72 family | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 23/102 (22%), Positives = 32/102 (31%), Gaps = 6/102 (5%)
Query: 54 DRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNP---PPQSSP 110
S P PE P + P + P P N+ + + NP P+ P
Sbjct: 26 TTSSNSKQPEKKPEIKPNENTPKIPKKPDNKEPSENNNNKSNNENKDEENPSSTNPEKKP 85
Query: 111 PPSNSNASPPPSQDN---PSDPPPGDSNNGSSPPGNNNNNNN 149
PS + +D P P D N NNN +
Sbjct: 86 DPSKNKEEIEKPKDEPKKPDKKPQADQPNNVHADQPNNNKVD 127
|
Members of this protein family occur in Mycoplasma mycoides, Mycoplasma hyopneumoniae, and related Mycoplasmas in small paralogous families that may also include truncated forms and/or pseudogenes. Members are predicted lipoproteins with a conserved signal peptidase II processing and lipid attachment site. Note that the name for certain characterized members, p72, reflects an anomalous apparent molecular weight, given a theoretical MW of about 61 kDa. Length = 541 |
| >gnl|CDD|114270 pfam05539, Pneumo_att_G, Pneumovirinae attachment membrane glycoprotein G | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 30/130 (23%), Positives = 44/130 (33%), Gaps = 5/130 (3%)
Query: 11 SNSPDAAETPPSPSRASSSPPP----STPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSP 66
S + ++ SS P T S P + PPPS P SP S
Sbjct: 197 SQPATQGHQTATANQRLSSTEPVGTQGTTTSSNPEPQTEPPPSQRGPSGSPQHPPSTTSQ 256
Query: 67 ESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQS-SPPPSNSNASPPPSQDN 125
+ +Q P N +SP ++ PP T ++ P P + + S
Sbjct: 257 DQSTTGDGQEHTQRRKTPPATSNRRSPHSTATPPPTTKRQETGRPTPRPTATTQSGSSPP 316
Query: 126 PSDPPPGDSN 135
S PP +N
Sbjct: 317 HSSPPGVQAN 326
|
Length = 408 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 31/107 (28%), Positives = 55/107 (51%), Gaps = 6/107 (5%)
Query: 439 PVMDWPTRLKIAMGSAKGLAYL-HEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK-L 496
P + + + + A G+ +L ++C +HRD+ + N+L+ K+ DFGLA+ +
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDI 289
Query: 497 TTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 543
D+N ++APE + T SDV+SFG++L E+ T
Sbjct: 290 MRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-05
Identities = 67/320 (20%), Positives = 94/320 (29%), Gaps = 43/320 (13%)
Query: 20 PPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPP-PSSPPPS- 77
P S S P P P + PD P PP P++PP PS P+
Sbjct: 2463 PFSLSLLLGELFPGAPVYRRPAEARFPFAAGAAPD---PGGGGPPDPDAPPAPSRLAPAI 2519
Query: 78 -SQSPPQSPPPPNS----------KSPPQSSPPPNTNPPPQSSPPPSNSNASPPPS-QDN 125
P P P S PPP P P ++PP + + PPP
Sbjct: 2520 LPDEPVGEPVHPRMLTWIRGLEELASDDAGDPPP---PLPPAAPPAAPDRSVPPPRPAPR 2576
Query: 126 PSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPP-PSSSSN 184
PS+P P + G+ G + + PPPP PS ++N
Sbjct: 2577 PSEPAVTSRARRPDAPPQSARPRAPVDDRGDPRGPAPPSPLPPDTHAPDPPPPSPSPAAN 2636
Query: 185 SPNGNRSGALSPPNKSNGSSSSPSSNNGSMLSIPLVAAVAAGAAFLIIVMLLVFFACRRK 244
P+ + + PP + + + AA A+
Sbjct: 2637 EPDPHPPPTVPPPERPRDDPAPGRVSRPRRARRLGRAAQASSPP---------------- 2680
Query: 245 KNRERNDQMPYYNNNHTTATDYYNSAATPSPPPRANWQQQTDHGWPTPPPSQRGAVTVTS 304
R R + T+ D TP P P A P PP +
Sbjct: 2681 -QRPRRRAARPTVGSLTSLADPPPPPPTPEPAPHA-----LVSATPLPPGPAAARQASPA 2734
Query: 305 SDMSHNSSSGPYGPVLPPPP 324
+ + P GP P P
Sbjct: 2735 LPAAPAPPAVPAGPATPGGP 2754
|
Length = 3151 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 2e-05
Identities = 28/74 (37%), Positives = 36/74 (48%), Gaps = 4/74 (5%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
P + P A TPP P +++PPP+ PP PPP++ SS P + P SSPPP
Sbjct: 524 PPPPQKSPPPPAPTPPLPQPTATAPPPTPPP----PPPTATQASSNAPAQIPADSSPPPP 579
Query: 66 PESPPPSSPPPSSQ 79
P SP S
Sbjct: 580 IPEEPTPSPTKDSS 593
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 20/85 (23%), Positives = 29/85 (34%), Gaps = 2/85 (2%)
Query: 60 SSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASP 119
S S + P P S P +PP P + PP PPP ++ SN+ A
Sbjct: 513 QSGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPP--PPPPTATQASSNAPAQI 570
Query: 120 PPSQDNPSDPPPGDSNNGSSPPGNN 144
P P P + + +
Sbjct: 571 PADSSPPPPIPEEPTPSPTKDSSPE 595
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 2e-05
Identities = 9/79 (11%), Positives = 27/79 (34%)
Query: 55 RSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSN 114
++P + + ++ P++ ++P P P ++P P ++ +
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAP 96
Query: 115 SNASPPPSQDNPSDPPPGD 133
+ + P+ D
Sbjct: 97 AAPPAAAAAAAPAAAAVED 115
|
Length = 1228 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 21/92 (22%), Positives = 34/92 (36%)
Query: 44 SSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTN 103
S P +S D + P+ P +P S P + +P + P + S +T
Sbjct: 161 SVPLDTSTTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPSQANVDTA 220
Query: 104 PPPQSSPPPSNSNASPPPSQDNPSDPPPGDSN 135
P + P + A+P P+ P D N
Sbjct: 221 ATPAPAAPATPDGAAPLPTDQAGVSTPAADPN 252
|
Length = 331 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 22/71 (30%), Positives = 31/71 (43%), Gaps = 5/71 (7%)
Query: 58 PPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKS----PPQSSPPPNTNPP-PQSSPPP 112
P SP ++P P P P P P P ++ P S+P P PP +S+P P
Sbjct: 384 PAGSPDVKKKAPEPDLPQPDRHPGPAKPEAPGARPAELPSPASAPTPEQQPPVARSAPLP 443
Query: 113 SNSNASPPPSQ 123
+ AS P +
Sbjct: 444 PSPQASAPRNV 454
|
Length = 620 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-05
Identities = 15/68 (22%), Positives = 27/68 (39%), Gaps = 7/68 (10%)
Query: 24 SRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPP----PSPESPPPSSP-PPSS 78
A + P + +P + PP + P P + P P+P PP++ PP+
Sbjct: 379 RGAPAPPSAAWGAP--TPAAPAAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAAAPPAR 436
Query: 79 QSPPQSPP 86
+ P +
Sbjct: 437 SADPAAAA 444
|
Length = 576 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 2e-05
Identities = 12/77 (15%), Positives = 24/77 (31%), Gaps = 3/77 (3%)
Query: 38 DESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSS 97
E PP PP P + + ++P + + P + ++
Sbjct: 388 QEGPPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPD---AAAAAA 444
Query: 98 PPPNTNPPPQSSPPPSN 114
PP PQ + ++
Sbjct: 445 APPAPAAAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|223880 COG0810, TonB, Periplasmic protein TonB, links inner and outer membranes [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 32/114 (28%), Positives = 40/114 (35%), Gaps = 10/114 (8%)
Query: 31 PPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNS 90
P++E P PP P P P PP P P P P P + P P
Sbjct: 47 KVLEAPTEEPQPEPEPPEEQPKP---PTEPETPPEPTPPKPKEKPK----PEKKPKKPKP 99
Query: 91 KSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNN 144
K P+ P P P P+ PPS + A P P+ P S +S
Sbjct: 100 KPKPKPKPKPKVKPQPKPKKPPSKTAAKAPA---APNQPARPPSAASASGAATG 150
|
Length = 244 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-05
Identities = 53/223 (23%), Positives = 71/223 (31%), Gaps = 48/223 (21%)
Query: 13 SPDAAETPPSPSRASSSP-PPSTPPSDESPP-------PSSPPPSSPPPDRSPPPSSPPP 64
SP E PP P P P T D PP PSS P SS D P+ P
Sbjct: 353 SPPIEEEPPQPKAVVPRPLSPYTAYEDLKPPTSPIPTPPSSSPASSKSVDAVAKPAEPDV 412
Query: 65 SPESPPPSSPPPSSQS--------------------PPQSPPP--PNSKSPPQSSPPPNT 102
P S+ P + PP SP P P SP SS
Sbjct: 413 VPSPGSASNVPEVEPAQVEAKKTRPLSPYARYEDLKPPTSPSPTAPTGVSPSVSSTSSVP 472
Query: 103 NPPPQSSPPPSNSNASPPPSQDNP-------SDPPPGDSNNGSSPPGNNNNNNNNGKGNG 155
P + + A+PPP+ P D P S + ++P G ++ N
Sbjct: 473 AVPDTAPATAATDAAAPPPANMRPLSPYAVYDDLKPPTSPSPAAPVGKVAPSSTNEVVKV 532
Query: 156 NGNGNHNNNNNNNNNKNWHPPP-----------PPSSSSNSPN 187
+ + ++ P P PP+S + SP
Sbjct: 533 GNSAPPTALADEQHHAQPKPRPLSPYTMYEDLKPPTSPTPSPV 575
|
Length = 576 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 19/71 (26%), Positives = 25/71 (35%), Gaps = 2/71 (2%)
Query: 56 SPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNS 115
+ S S S S PPSS + P+ S S +P P SSP P +
Sbjct: 7 TSRSQSHASSSSSSSSQSSPPSS-TSPRPRRRKPSASSLLHTPSI-LPLPKLSSPSPPSV 64
Query: 116 NASPPPSQDNP 126
P + P
Sbjct: 65 TLPPAATTQTP 75
|
Length = 590 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 23/73 (31%), Positives = 28/73 (38%)
Query: 40 SPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPP 99
S P+S S S S PPS SP P PS+ S +P SPP
Sbjct: 3 SSNPTSRSQSHASSSSSSSSQSSPPSSTSPRPRRRKPSASSLLHTPSILPLPKLSSPSPP 62
Query: 100 PNTNPPPQSSPPP 112
T PP ++ P
Sbjct: 63 SVTLPPAATTQTP 75
|
Length = 590 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 17/62 (27%), Positives = 24/62 (38%)
Query: 17 AETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPP 76
A TP S + SPP S + P S+ SP + + + PS P S
Sbjct: 88 AATPTSAPTPTPSPPASPASGMSAAPASAVEEKSPSEESATATAPESPSTSVPSSGSDAA 147
Query: 77 SS 78
S+
Sbjct: 148 ST 149
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|114270 pfam05539, Pneumo_att_G, Pneumovirinae attachment membrane glycoprotein G | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 37/171 (21%), Positives = 57/171 (33%), Gaps = 7/171 (4%)
Query: 17 AETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRS---PPPSSPPPSPESPPPSS 73
++T P+ S PS P ++ S P + + +P P +
Sbjct: 175 SKTTSWPTEVSHPTYPSQVTPQSQPATQGHQTATANQRLSSTEPVGTQGTTTSSNPEPQT 234
Query: 74 PPPSSQSPPQSPP--PPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPP 131
PP SQ P P PP++ S QS+ + PP+ SN P S P
Sbjct: 235 EPPPSQRGPSGSPQHPPSTTSQDQSTTGDGQEHTQRRKTPPATSNRRSPHSTATPPPTTK 294
Query: 132 GDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNN--NNNNNNNKNWHPPPPPS 180
+P + + + + G N N + K PP P S
Sbjct: 295 RQETGRPTPRPTATTQSGSSPPHSSPPGVQANPTTQNLVDCKELDPPKPNS 345
|
Length = 408 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 47/165 (28%), Positives = 80/165 (48%), Gaps = 25/165 (15%)
Query: 389 FKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHG-KGRPVMDWPTRL 447
F ++S+V H HL + G C+ G + ++V E+V + L+ L KGR + W ++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 448 KIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD----NNTH 503
+A A L+YL + ++H ++ + NILL A GLA+ T+ ++
Sbjct: 121 TVAQQLASALSYLEDK---NLVHGNVCAKNILL--------ARLGLAEGTSPFIKLSDPG 169
Query: 504 VSTRVMGT------FGYLAPEYASSG-KLTEKSDVFSFGVMLLEL 541
VS + ++APE G L+ +D +SFG LLE+
Sbjct: 170 VSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 456 GLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYL 515
G+ +LH IIHRD+K SNI++ K+ DFGLA+ T + + T + T Y
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 192
Query: 516 APEYASSGKLTEKSDVFSFGVMLLELITGR 545
APE E D++S G ++ E+I G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 52/200 (26%), Positives = 85/200 (42%), Gaps = 16/200 (8%)
Query: 354 LGQGGFGYVHKGVLPNGK--EVAVKSLRSGSGQGEREFK---AEVEIISRVHHRHLVSLV 408
LG G FG V N VA+K +++ +E +I++ ++H V+L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 409 GYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHP-R 467
G LV E+V L R D + A + + E
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPND------VGCFYAAQIVLIFEYLQSLN 151
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTE 527
I++RD+K N+LLD K+ DFG AK+ D T+ + GT Y+APE + +
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKV-VDTRTYT---LCGTPEYIAPEILLNVGHGK 207
Query: 528 KSDVFSFGVMLLELITGRRP 547
+D ++ G+ + E++ G P
Sbjct: 208 AADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-05
Identities = 30/127 (23%), Positives = 43/127 (33%), Gaps = 4/127 (3%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
Q + P +P P P + P P P + P +P P
Sbjct: 757 QPVAPQQQYQQPQQPVAPQPQYQQPQQPVAPQPQYQQPQQPVAPQPQYQQPQQPVAPQPQ 816
Query: 66 PESP-PPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPP---QSSPPPSNSNASPPP 121
+ P P +P P Q P Q P + N + P ++P PS +PPP
Sbjct: 817 YQQPQQPVAPQPQYQQPQQPVAPQPQDTLLHPLLMRNGDSRPLHKPTTPLPSLDLLTPPP 876
Query: 122 SQDNPSD 128
S+ P D
Sbjct: 877 SEVEPVD 883
|
Length = 1355 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 13/75 (17%), Positives = 27/75 (36%)
Query: 7 SPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSP 66
G + A + ++P + PP++ P+ P + P P+ P
Sbjct: 119 DTGGAPPAAAPAAAAAAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAKPPEPAPAAKPP 178
Query: 67 ESPPPSSPPPSSQSP 81
+P + P ++ P
Sbjct: 179 PTPVARADPRETRVP 193
|
Length = 418 |
| >gnl|CDD|223003 PHA03169, PHA03169, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 42/131 (32%), Positives = 53/131 (40%), Gaps = 4/131 (3%)
Query: 13 SPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSP----PPSSPPPSPES 68
SP + + + AS P +T S P S PP SPP P PP S PSP
Sbjct: 102 SPTPSPSGSAEELASGLSPENTSGSSPESPASHSPPPSPPSHPGPHEPAPPESHNPSPNQ 161
Query: 69 PPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSD 128
P S PS + P+ P PP S+ P S PP + P S PP S + P P
Sbjct: 162 QPSSFLQPSHEDSPEEPEPPTSEPEPDSPGPPQSETPTSSPPPQSPPDEPGEPQSPTPQQ 221
Query: 129 PPPGDSNNGSS 139
P ++
Sbjct: 222 APSPNTQQAVE 232
|
Length = 413 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 3e-05
Identities = 19/81 (23%), Positives = 28/81 (34%), Gaps = 4/81 (4%)
Query: 70 PPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDP 129
+S + PPQ PPP + +PP P PP PP + S + P+
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPP----TPPPPPPTATQASSNAPAQI 570
Query: 130 PPGDSNNGSSPPGNNNNNNNN 150
P S P + +
Sbjct: 571 PADSSPPPPIPEEPTPSPTKD 591
|
Length = 620 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 3e-05
Identities = 37/146 (25%), Positives = 53/146 (36%), Gaps = 6/146 (4%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
G S+ D + S S + SP + SD S P PP + PP ++ PS
Sbjct: 133 NEEGSSDPKDIDQDNRSSSPSIPSPQDNESDSDSSAQQQLLQPQGPPSIQVPPGAALAPS 192
Query: 66 PESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSP---PPNTNPPPQSSPPPS---NSNASP 119
P PS+ Q P + P P P+ +P SP P + +
Sbjct: 193 APPPTPSAQAVPPQGSPIAAQPAPQPQQPSPLSLISAPSLHPQRLPSPHPPLQPQTASQQ 252
Query: 120 PPSQDNPSDPPPGDSNNGSSPPGNNN 145
P PS P S++G PP +
Sbjct: 253 SPQPPAPSSRHPQSSHHGPGPPMPHA 278
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 3e-05
Identities = 16/96 (16%), Positives = 30/96 (31%), Gaps = 3/96 (3%)
Query: 40 SPPPSSPPPSSPPPDRSPPPSSPP--PSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSS 97
P ++P + PPP +P S P P+ E P + + + +P
Sbjct: 53 PPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAPE 112
Query: 98 PPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGD 133
P +++ + + P P D
Sbjct: 113 AQAPAAPAERAAAENAARRLARAA-AAAPRPRVPAD 147
|
Length = 484 |
| >gnl|CDD|219355 pfam07267, Nucleo_P87, Nucleopolyhedrovirus capsid protein P87 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 24/91 (26%), Positives = 34/91 (37%), Gaps = 3/91 (3%)
Query: 47 PPSSPPPDRS-PPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNT--N 103
P +P P+RS P+ P S P + S Q+P Q+P +S P T
Sbjct: 267 PAQTPMPERSWQTPAQTPARRISTPMTEEIKSWQTPLQTPAMYSSDYQAPKPEPIYTWEE 326
Query: 104 PPPQSSPPPSNSNASPPPSQDNPSDPPPGDS 134
+ P + +S P S SD P
Sbjct: 327 LLRERFPSDLFAISSLPDSDSEASDSGPTRK 357
|
This family consists of several Nucleopolyhedrovirus capsid protein P87 sequences. P87 is expressed late in infection and concentrated in infected cell nuclei. Length = 606 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-05
Identities = 25/138 (18%), Positives = 40/138 (28%), Gaps = 14/138 (10%)
Query: 13 SPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSP--PPDRSPPPSSPPPSPESPP 70
+P + P S S+ +SSP S + P + P S+P P P P
Sbjct: 647 TPPSRAPPASLSKPASSPDASQTSASFDLDPDFELATHQSVPEAALASGSAPAPPPVPDP 706
Query: 71 PSSPP---PSSQSPPQSPPPPNSKSPPQSSPPPNTNPP-----PQSSPPPSNSNASPPPS 122
PP + P ++ S +N Q++ P + P+
Sbjct: 707 YDRPPWEEAPEVASANDGPNNAAEGNLSESVEDASNSELQAVEQQATHQPQVQAEAQSPA 766
Query: 123 QD----NPSDPPPGDSNN 136
S N
Sbjct: 767 STTALTQTSSEVQDTELN 784
|
Length = 944 |
| >gnl|CDD|223079 PHA03419, PHA03419, E4 protein; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 27/110 (24%), Positives = 32/110 (29%), Gaps = 12/110 (10%)
Query: 31 PPSTPPSDESPPPSSPPPSSPPPDR---------SPPPSSPPPSPESPPPSSPPPSSQSP 81
PP+TP PPP P P PP PPP + P + P
Sbjct: 53 PPTTPHPSSQPPPCPPSPGHPPQTNDTHEKDLALQPPPGGKKKEKKKKETEKPAQGGEKP 112
Query: 82 PQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPP 131
Q P + PP + PP PP PS P
Sbjct: 113 DQGPEAKGEGEGHEPEDPPPEDTPP---PPGGEGEVEGGPSPGPGPGPLD 159
|
Length = 200 |
| >gnl|CDD|227430 COG5099, COG5099, RNA-binding protein of the Puf family, translational repressor [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-05
Identities = 39/193 (20%), Positives = 62/193 (32%), Gaps = 22/193 (11%)
Query: 36 PSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQ 95
S +S S P +S S + SS S+ + SP
Sbjct: 257 SSSSINELTSIYGSVPSIRNLRGLNSALVSFLNVSSSSLAFSA---LNGKEVSPTGSPST 313
Query: 96 SS---PPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGK 152
S P ++P + + +PP S + +P ++ G S N
Sbjct: 314 RSFARVLPKSSPNNLLTEILTTGV-NPPQSLPSLLNPVFLSTSTGFSLT--------NLS 364
Query: 153 GNGNGNGNHNNNNNNNNNKNWHPPPPPSSSSNSPNGNRSGALSPPNK-------SNGSSS 205
G N N N N ++ + + PS SS+ N G +SP K N
Sbjct: 365 GYLNPNKNLKKNTLSSLSNLGYSSNVPSPSSSESTRNILGNISPNFKTSSNLTNLNSLLK 424
Query: 206 SPSSNNGSMLSIP 218
SN+ S+ +
Sbjct: 425 EKLSNSSSVSATD 437
|
Length = 777 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 24/94 (25%), Positives = 33/94 (35%), Gaps = 9/94 (9%)
Query: 47 PPSSPPPDRSPPPSSPPPSPES-------PPPSSPPPSSQSPPQSPPPPNSKSPPQSSPP 99
PP+ PP +P P P S P + P+ Q+P Q P N PQ P
Sbjct: 173 PPN--PPREAPAPGLPKTFTSSHGHRHRHAPKPTQQPTVQNPAQQPTVQNPAQQPQQQPQ 230
Query: 100 PNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGD 133
P Q P + + P Q + G+
Sbjct: 231 QQPVQPAQQPTPQNPAQQPPQTEQGHKRSREQGN 264
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-05
Identities = 43/199 (21%), Positives = 61/199 (30%), Gaps = 59/199 (29%)
Query: 2 EDNNQSPGVSNSPDAAETPPSPSRASSSPPP--STPPSDESPPPS---------SPPPSS 50
+ +P A P + A+ PPP + P+ + PP +P
Sbjct: 251 DIAAPAPPPVVGEGADRAPETARGATGPPPPPEAAAPNGAAAPPDGVWGAALAGAPLALP 310
Query: 51 PPPDRSPPPS-----------------SPPPSPES---------PPPSSPPPSS------ 78
PPD PP SP P P P+ PPSS
Sbjct: 311 APPDPPPPAPAGDAEEEDDEDGAMEVVSPLPRPRQHYPLGFPKRRRPTWTPPSSLEDLSA 370
Query: 79 --QSPPQSPPP------------PNSKSPPQSSPPPNTNPPPQSSPPPSNSN--ASPPPS 122
P ++ P P ++ P P P S P P+ + AS PP
Sbjct: 371 GRHHPKRASLPTRKRRSARHAATPFARGPGGDDQTRPAAPVPASVPTPAPTPVPASAPPP 430
Query: 123 QDNPSDPPPGDSNNGSSPP 141
P S++G +PP
Sbjct: 431 PATPLPSAEPGSDDGPAPP 449
|
Length = 3151 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 4e-05
Identities = 35/205 (17%), Positives = 64/205 (31%), Gaps = 11/205 (5%)
Query: 7 SPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSP 66
SP P SP R P + + SP P+ ++ S SS S
Sbjct: 188 SPPAEPPPSTPPAAASP-RPPRRSSPISASAS-SPAPAPGRSAADDAGASSSDSSSSESS 245
Query: 67 ESP--PPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQD 124
P + P +P P S SSP + + SP
Sbjct: 246 GCGWGPENECPLPRPAPITLPTRIWEASGWNGPSSRPGPASSSSSPRERSPSPSPSSPGS 305
Query: 125 NPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSSSSN 184
P+ P S++ SS +++++ ++ + G + P PS
Sbjct: 306 GPAPSSPRASSSSSSSRESSSSSTSSSSESSRGAAVS-------PGPSPSRSPSPSRPPP 358
Query: 185 SPNGNRSGALSPPNKSNGSSSSPSS 209
+ + P+++ S ++ +
Sbjct: 359 PADPSSPRKRPRPSRAPSSPAASAG 383
|
Length = 1352 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 4e-05
Identities = 16/80 (20%), Positives = 33/80 (41%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
+P + +P + A S PP + P + +P P++ P + P +PP + P +
Sbjct: 433 PAPAPAPAPPSPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAA 492
Query: 66 PESPPPSSPPPSSQSPPQSP 85
+ P + P+ +
Sbjct: 493 APAAPAAPAAPAGADDAATL 512
|
Length = 824 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 34/131 (25%), Positives = 48/131 (36%), Gaps = 13/131 (9%)
Query: 8 PGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSS-PPPDRSPPPSSPPPSP 66
P S SP T P+ S S S P ++ P ++ ++ PPP P S
Sbjct: 449 PPTSPSP----TAPTGVSPSVSSTSSVPAVPDTAPATAATDAAAPPPANMRPLSPYAVYD 504
Query: 67 ESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASP------- 119
+ PP+SP P++ +P N +S PP Q P SP
Sbjct: 505 DLKPPTSPSPAAPVGKVAPSSTNEVVKVGNSAPPTALADEQHHAQPKPRPLSPYTMYEDL 564
Query: 120 -PPSQDNPSDP 129
PP+ PS
Sbjct: 565 KPPTSPTPSPV 575
|
Length = 576 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 22/87 (25%), Positives = 33/87 (37%), Gaps = 13/87 (14%)
Query: 20 PPSPSRASSSPPPSTPPSDES--------PPPSSPPPSSPPPDRSPPPSSPPPSPESPPP 71
PP+P R +P P P + S P + P+ P + P +P P+ P
Sbjct: 173 PPNPPR--EAPAPGLPKTFTSSHGHRHRHAPKPTQQPTVQNPAQQPTVQNPAQQPQQQPQ 230
Query: 72 SSPPPSSQSPPQSPPPPNSKSPPQSSP 98
P Q Q P ++ PPQ+
Sbjct: 231 QQPV---QPAQQPTPQNPAQQPPQTEQ 254
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 25/207 (12%)
Query: 352 NLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGY 410
N++G G FG V++ + + ++VA+K + RE I+ ++H +++ L Y
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINIIFLKDY 127
Query: 411 ----CIAGGKRLL----VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGS---AKGLAY 459
C ++ + V E++P ++ H R P L + + S + LAY
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKH-YARNNHALPLFL-VKLYSYQLCRALAY 185
Query: 460 LHEDCHPRIIHRDIKSSNILLD-YTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE 518
+H I HRD+K N+L+D T K+ DFG AK VS + F Y APE
Sbjct: 186 IHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY-ICSRF-YRAPE 240
Query: 519 YA-SSGKLTEKSDVFSFGVMLLELITG 544
+ T D++S G ++ E+I G
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|227709 COG5422, ROM1, RhoGEF, Guanine nucleotide exchange factor for Rho/Rac/Cdc42-like GTPases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 4e-05
Identities = 42/194 (21%), Positives = 64/194 (32%), Gaps = 13/194 (6%)
Query: 22 SPSRASSSP-PPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPE---SPPPSSPPPS 77
S + S PP +P + + S + SS P
Sbjct: 23 SDAFVSKQLLPPRRLQRKLNPISIRNGADNDIINSESKESFGKYALGHQIFSSFSSSPKL 82
Query: 78 SQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNG 137
Q + P +S S S+ N+N Q SP + + +P +Q DS G
Sbjct: 83 FQRRNSAGPITHSPSATSSTSSLNSNDGDQFSPASDSLSFNPSSTQSR------KDSGPG 136
Query: 138 SSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSSSSNSP-NGNRSGALSP 196
P N + + +G H +NN + P S P G++S L
Sbjct: 137 DGSP--VQKRKNPLLPSSSTHGTHPPIVFTDNNGSHAGAPNARSRKEIPSLGSQSMQLPS 194
Query: 197 PNKSNGSSSSPSSN 210
P+ SSS +SN
Sbjct: 195 PHFRQKFSSSDTSN 208
|
Length = 1175 |
| >gnl|CDD|223061 PHA03369, PHA03369, capsid maturational protease; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 22/104 (21%), Positives = 30/104 (28%), Gaps = 6/104 (5%)
Query: 27 SSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPP 86
++S + + + P P P+ P S P S + PP
Sbjct: 350 TASLTAPSRVLAAAAKVAVIAAPQTHT--GPADRQRPQRPDGIPYSVPARSPMTAY--PP 405
Query: 87 PPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPP 130
P P P N P S P P P+ NP P
Sbjct: 406 VPQFCGDPGLVSPYNPQSPGTSYGPEPVGPVPPQPT--NPYVMP 447
|
Length = 663 |
| >gnl|CDD|200219 TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogenase, E2 component, dihydrolipoamide succinyltransferase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 19/70 (27%), Positives = 30/70 (42%), Gaps = 2/70 (2%)
Query: 17 AETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPP 76
A P+ +P PS S+ +P P++ P + P P P+ P +P ++P
Sbjct: 203 ANAAPAEPAEEEAPAPSEAGSEPAPDPAARAPHAAPDP--PAPAPAPAKTAAPAAAAPVS 260
Query: 77 SSQSPPQSPP 86
S S P P
Sbjct: 261 SGDSGPYVTP 270
|
This model represents an Actinobacterial clade of E2 enzyme, a component of the 2-oxoglutarate dehydrogenase complex involved in the TCA cycle. These proteins have multiple domains including the catalytic domain (pfam00198), one or two biotin domains (pfam00364) and an E3-component binding domain (pfam02817). Length = 579 |
| >gnl|CDD|236768 PRK10819, PRK10819, transport protein TonB; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 28/123 (22%), Positives = 39/123 (31%), Gaps = 9/123 (7%)
Query: 13 SPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSP-----PPSSPPPSPE 67
+P E P + P P P E P PP +P P P P P P
Sbjct: 54 APADLEPPQAVQPP---PEPVVEPEPEPEPIPEPPKEAPVVIPKPEPKPKPKPKPKPKPV 110
Query: 68 SPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPS 127
P + P P ++ + P +T S P S S+ S++ P
Sbjct: 111 KKVEEQPKREVKPVEPRPASPF-ENTAPARPTSSTATAAASKPVTSVSSGPRALSRNQPQ 169
Query: 128 DPP 130
P
Sbjct: 170 YPA 172
|
Length = 246 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 5e-05
Identities = 36/168 (21%), Positives = 48/168 (28%), Gaps = 15/168 (8%)
Query: 2 EDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSS 61
++ P S + + T D+ P S S +
Sbjct: 20 SPEGSRDENFDAERDDFLTPLGSTSEA-----TSEDDDDLYPPRETGSGGGVATSTIYTV 74
Query: 62 P--PPSPESPP--PSSPPPSSQSPPQSPPPPNSKSPPQSSP---PPNTNPPPQSSPPPSN 114
P P PE P S P S + PP P P SSP +T+P
Sbjct: 75 PRPPRGPEQTLDKPDSLPASRELPPGPTPVPPGGFRGASSPRLGADSTSPRFLYQVNFPV 134
Query: 115 SNASPPPSQDNPSDPPPGDSNNGS-SPPGNNNNNNNNGKGNGNGNGNH 161
A P + N S + S PP + N GK G H
Sbjct: 135 ILA--PIGESNSSSEELSEEEEHSRPPPSESLKVKNGGKVYPKGFSKH 180
|
Length = 580 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 17/63 (26%), Positives = 27/63 (42%)
Query: 16 AAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPP 75
PP+ + S+ P +PP+ + S+ P S+ S+ +PESP S P
Sbjct: 82 GKVAPPAATPTSAPTPTPSPPASPASGMSAAPASAVEEKSPSEESATATAPESPSTSVPS 141
Query: 76 PSS 78
S
Sbjct: 142 SGS 144
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 5e-05
Identities = 25/116 (21%), Positives = 35/116 (30%), Gaps = 5/116 (4%)
Query: 21 PSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSP--PPSS 78
+P AS PP+ P P P P + P +P P P + P+ P
Sbjct: 342 QTPPVASVDVPPAQPTVAWQPVPG---PQTGEPVIAPAPEGYPQQSQYAQPAVQYNEPLQ 398
Query: 79 QSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDS 134
Q P + + P P Q + P + A P N S
Sbjct: 399 QPVQPQQPYYAPAAEQPAQQPYYAPAPEQPAQQPYYAPAPEQPVAGNAWQAEEQQS 454
|
Length = 1355 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 5e-05
Identities = 35/156 (22%), Positives = 50/156 (32%), Gaps = 37/156 (23%)
Query: 3 DNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPS------------------ 44
+ S + +A++ +S S P + + + +
Sbjct: 566 ALSDDEQHSANVQSAQSAAEAQPSSQSLSPISAVTTAAASLADDDILDAVLAARDSLLSD 625
Query: 45 ----SPPPSS---PPPDRSP--PPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQ 95
SP DR P PPS PP+ S P SSP S S P + Q
Sbjct: 626 LDALSPKEGDGKKSSADRKPKTPPSRAPPASLSKPASSPDASQTSASFDLDPDFELATHQ 685
Query: 96 SSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPP 131
S P + S S +PPP +P D PP
Sbjct: 686 SVPE---------AALASGSAPAPPP-VPDPYDRPP 711
|
Length = 944 |
| >gnl|CDD|218440 pfam05110, AF-4, AF-4 proto-oncoprotein | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 5e-05
Identities = 35/185 (18%), Positives = 62/185 (33%), Gaps = 7/185 (3%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
GV P ++ +P + +S S + + + S
Sbjct: 715 YKKGVPPKPAEKDSLSAPKKQTSKTASEKSSSKGKRKHKNDEEADKIESKKQRLEEKSSS 774
Query: 66 PESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDN 125
SS SS + N + P ++P SSP P + + P Q++
Sbjct: 775 CSPSSSSSHHHSSSNKESRKSSRNKEEEML---PSPSSPLSSSSPKPEHPSRKRPRRQED 831
Query: 126 P--SDPPPGDSNNGSSP--PGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSS 181
S P S+ SS + + GKG+ + ++ + N + P PP S+
Sbjct: 832 TSSSSGPFSASSTKSSSKSSSTSKHRKTEGKGSSTSKEHKGSSGDTPNKASSFPVPPLSN 891
Query: 182 SSNSP 186
S+ P
Sbjct: 892 GSSKP 896
|
This family consists of AF4 (Proto-oncogene AF4) and FMR2 (Fragile X E mental retardation syndrome) nuclear proteins. These proteins have been linked to human diseases such as acute lymphoblastic leukaemia and mental retardation. The family also contains a Drosophila AF4 protein homologue Lilliputian which contains an AT-hook domain. Lilliputian represents a novel pair-rule gene that acts in cytoskeleton regulation, segmentation and morphogenesis in Drosophila. Length = 1154 |
| >gnl|CDD|215533 PLN02983, PLN02983, biotin carboxyl carrier protein of acetyl-CoA carboxylase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 24/59 (40%), Positives = 31/59 (52%), Gaps = 3/59 (5%)
Query: 41 PPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPP 99
PPP +P PP PP + PP SP + P+ P+S PP PP +K+P S PP
Sbjct: 144 PPPPAPVVMMQPP---PPHAMPPASPPAAQPAPSAPASSPPPTPASPPPAKAPKSSHPP 199
|
Length = 274 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 13/61 (21%), Positives = 25/61 (40%), Gaps = 4/61 (6%)
Query: 37 SDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSP----PQSPPPPNSKS 92
+ P +PP + P PP + P+ ++ P++ P ++ P P+ P S
Sbjct: 12 GEAEQPAPAPPSPAAAPAPPPPAKTAAPATKAAAPAAAAPRAEKPKKDKPRRERKPKPAS 71
Query: 93 P 93
Sbjct: 72 L 72
|
Length = 475 |
| >gnl|CDD|220401 pfam09786, CytochromB561_N, Cytochrome B561, N terminal | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 28/106 (26%), Positives = 38/106 (35%), Gaps = 6/106 (5%)
Query: 17 AETPPSPSRASSSPPPSTPPSDES--PPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSP 74
++ SP + +S P +T S P S P R PSS PS+
Sbjct: 114 SQAKKSPPASKTSTPMNTSEPLVPGHSSFSDSPSRSASPSRKFSPSSTIQQSPQLTPSNK 173
Query: 75 PPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPP 120
P S S QSP +S P SS N S P + ++
Sbjct: 174 PASPSSSYQSPSYSSSLGPVNSSG----NRSNLRSSPWALRSSGDK 215
|
Members of this family are found in the N terminal region of cytochrome B561, as well as in various other putative uncharacterized proteins. Length = 559 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 20/117 (17%), Positives = 35/117 (29%), Gaps = 9/117 (7%)
Query: 1 MEDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPS 60
M D + + NS + S + ++ P P D +P S P + P + P
Sbjct: 146 MADQSSAELSQNSGQSVPLDTSTTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQ 205
Query: 61 SPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNA 117
S + + P + P + S P ++ NA
Sbjct: 206 QNAVVAPSQANVDTAATPAPAAPATPDGAAPLPTDQAGV---------STPAADPNA 253
|
Length = 331 |
| >gnl|CDD|234229 TIGR03490, Mycoplas_LppA, mycoides cluster lipoprotein, LppA/P72 family | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 6e-05
Identities = 18/98 (18%), Positives = 34/98 (34%), Gaps = 4/98 (4%)
Query: 31 PPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNS 90
P P++ +P P + P + + S+ E P S+ P P ++
Sbjct: 37 KPEIKPNENTPKIPKKPDNKEPSENNNNKSNNENKDEENPSSTNPEKKPDPSKNKEEIE- 95
Query: 91 KSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSD 128
P + PQ+ P + P ++ + SD
Sbjct: 96 ---KPKDEPKKPDKKPQADQPNNVHADQPNNNKVDFSD 130
|
Members of this protein family occur in Mycoplasma mycoides, Mycoplasma hyopneumoniae, and related Mycoplasmas in small paralogous families that may also include truncated forms and/or pseudogenes. Members are predicted lipoproteins with a conserved signal peptidase II processing and lipid attachment site. Note that the name for certain characterized members, p72, reflects an anomalous apparent molecular weight, given a theoretical MW of about 61 kDa. Length = 541 |
| >gnl|CDD|236768 PRK10819, PRK10819, transport protein TonB; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 28/118 (23%), Positives = 36/118 (30%), Gaps = 12/118 (10%)
Query: 36 PSDESPPPSSPPPSSPP--PDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSP 93
P+D PP + PP P P+ P P PP P P + P+ P P K
Sbjct: 55 PADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIPKPEPKPKPKPKPKPKPVKKVE 114
Query: 94 PQSSPP----------PNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPP 141
Q P N P + + A+ P S P N P
Sbjct: 115 EQPKREVKPVEPRPASPFENTAPARPTSSTATAAASKPVTSVSSGPRALSRNQPQYPA 172
|
Length = 246 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 6e-05
Identities = 33/105 (31%), Positives = 39/105 (37%), Gaps = 5/105 (4%)
Query: 26 ASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSP 85
A PPPS+ P S P +S P P S P P P+ P S P P
Sbjct: 185 AIQPPPPSSLPGLPPGSSSLAPSASSTPGNRLPRVSFNPFLPGPSPAQPSAPPASIPAPP 244
Query: 86 PPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPP 130
PP + PP PPPQ P + A + NP D P
Sbjct: 245 IPPVIQYVAP--PPV---PPPQPIIPIQHIRAVTGETPANPRDIP 284
|
Length = 582 |
| >gnl|CDD|183558 PRK12495, PRK12495, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 20/93 (21%), Positives = 32/93 (34%), Gaps = 8/93 (8%)
Query: 5 NQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPP--PSSPPPSS-----PPPDRSP 57
G SPD P + + A+ P S + + PP ++ P PD +
Sbjct: 87 PSDAGSQASPDDDAQPAAEAEAADQSAPPEASSTSATDEAATDPPATAAARDGPTPDPTA 146
Query: 58 PPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNS 90
P++P SP P P +P +
Sbjct: 147 QPATPDER-RSPRQRPPVSGEPPTPSTPDAHVA 178
|
Length = 226 |
| >gnl|CDD|152960 pfam12526, DUF3729, Protein of unknown function (DUF3729) | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 6e-05
Identities = 25/77 (32%), Positives = 28/77 (36%)
Query: 37 SDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQS 96
S SPP S+ P PP PP P P S PPPS + P P P P
Sbjct: 27 SCFSPPESAHPDDPPPVGDPRPPVVDTPPPVSAVWVLPPPSEPAAPPPDPEPPVPGPAGP 86
Query: 97 SPPPNTNPPPQSSPPPS 113
P P + P P
Sbjct: 87 PSPLAPPAPARKPPLPP 103
|
This family of proteins is found in viruses. Proteins in this family are typically between 145 and 1707 amino acids in length. The family is found in association with pfam01443, pfam01661, pfam05417, pfam01660, pfam00978. There is a single completely conserved residue L that may be functionally important. Length = 115 |
| >gnl|CDD|225689 COG3147, DedD, Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 23/113 (20%), Positives = 28/113 (24%), Gaps = 5/113 (4%)
Query: 15 DAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPP---PDRSPPPSSPPPSPESPPP 71
A PP P P P+ PP +S P P + PP
Sbjct: 39 AAIPLPPKPQGDRDEPRVLPAVVQVVALPTQPPEGVAQEIQDAGDAAAASVDPQPVAQPP 98
Query: 72 SSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQD 124
P + P + P K P Q P P P P
Sbjct: 99 VESTP-AGVPVAAQTPKPVKPPKQ-PPAGAVPAKPTPKPEPKPVAEPAAAPTG 149
|
Length = 226 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 6e-05
Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 5/87 (5%)
Query: 456 GLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYL 515
G+ +LH IIHRD+K SNI++ K+ DFGLA+ T + + T + T Y
Sbjct: 131 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 185
Query: 516 APEYASSGKLTEKSDVFSFGVMLLELI 542
APE E D++S G ++ E++
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|218107 pfam04484, DUF566, Family of unknown function (DUF566) | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 24/121 (19%), Positives = 37/121 (30%), Gaps = 4/121 (3%)
Query: 2 EDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPP--SSPPPDRSPPP 59
+ S S+S S S+S P + SPP SSP SS
Sbjct: 10 TSGDASSPRSSSRRR--LSSSFLSTSASSRPRRLNAPASPPSSSPARNTSSSSSFGLSKQ 67
Query: 60 SSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASP 119
S PS SP + S + +S + + +++ +S P
Sbjct: 68 RPSSLSRGRLSSRFVSPSRGSPSAAASLNGSLATASTSGSSSPSRSRRTTSSDLSSGNGP 127
Query: 120 P 120
Sbjct: 128 S 128
|
Family of related proteins that is plant specific. Length = 313 |
| >gnl|CDD|200219 TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogenase, E2 component, dihydrolipoamide succinyltransferase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 15/59 (25%), Positives = 25/59 (42%)
Query: 61 SPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASP 119
+ P E+P PS P + P + PP +P P P ++ P S+ ++ P
Sbjct: 208 AEPAEEEAPAPSEAGSEPAPDPAARAPHAAPDPPAPAPAPAKTAAPAAAAPVSSGDSGP 266
|
This model represents an Actinobacterial clade of E2 enzyme, a component of the 2-oxoglutarate dehydrogenase complex involved in the TCA cycle. These proteins have multiple domains including the catalytic domain (pfam00198), one or two biotin domains (pfam00364) and an E3-component binding domain (pfam02817). Length = 579 |
| >gnl|CDD|219916 pfam08580, KAR9, Yeast cortical protein KAR9 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 39/227 (17%), Positives = 62/227 (27%), Gaps = 27/227 (11%)
Query: 10 VSNSPDAAETPPSPSRASSSPPPSTP-------------PSDESPPPSSPPPSSPPPDRS 56
+ PD+ SR +P + P+ S P P S D
Sbjct: 406 IMTPPDSGPGSNVSSRRVGTPGSKSDRVGAVLLRRMNIKPTLASIPDEKPSNISVFEDSE 465
Query: 57 PPPSSPPPSPESPPPSSP--PPSSQSPP--QSPPPPNSKSPPQSSPPPNTNPPPQSSPPP 112
P+S + PP + P S PP S P S P
Sbjct: 466 TSPNSSTLLRDPPPKKCGEESGHLPNNPFFNKLKLTLSSIPPLSPRQSIITLPTPSRPAS 525
Query: 113 SNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKN 172
S+ S + S P P + + N + +
Sbjct: 526 RISSLSLRLGSYSGSIVSP-------PPYPTLVSRKGAAGLSFNRSVSDIEGERIGRYNL 578
Query: 173 WHP--PPPPSSSSNSPNGNRSGAL-SPPNKSNGSSSSPSSNNGSMLS 216
P P + ++ + RS +L SP S P ++ ++L
Sbjct: 579 LPTRIPALPFKAESTTSSRRSSSLPSPTGVIGFPGSVPRFDHENLLP 625
|
The KAR9 protein in Saccharomyces cerevisiae is a cytoskeletal protein required for karyogamy, correct positioning of the mitotic spindle and for orientation of cytoplasmic microtubules. KAR9 localises at the shmoo tip in mating cells and at the tip of the growing bud in anaphase. Length = 626 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 8e-05
Identities = 15/80 (18%), Positives = 23/80 (28%), Gaps = 2/80 (2%)
Query: 70 PPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDP 129
S ++ +P P PN PP P ++ P + PP
Sbjct: 363 AFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPT 422
Query: 130 PPGDSNNGSSPPGNNNNNNN 149
P S + N + N
Sbjct: 423 EP--SPTPPANAANAPPSLN 440
|
Length = 620 |
| >gnl|CDD|200219 TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogenase, E2 component, dihydrolipoamide succinyltransferase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 19/65 (29%), Positives = 29/65 (44%), Gaps = 4/65 (6%)
Query: 35 PPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPP-PNSKSP 93
P++E P S S P PD P + P + PP +P P+ + P + P + S
Sbjct: 209 EPAEEEAPAPSEAGSEPAPD---PAARAPHAAPDPPAPAPAPAKTAAPAAAAPVSSGDSG 265
Query: 94 PQSSP 98
P +P
Sbjct: 266 PYVTP 270
|
This model represents an Actinobacterial clade of E2 enzyme, a component of the 2-oxoglutarate dehydrogenase complex involved in the TCA cycle. These proteins have multiple domains including the catalytic domain (pfam00198), one or two biotin domains (pfam00364) and an E3-component binding domain (pfam02817). Length = 579 |
| >gnl|CDD|215533 PLN02983, PLN02983, biotin carboxyl carrier protein of acetyl-CoA carboxylase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 29/72 (40%), Positives = 37/72 (51%), Gaps = 8/72 (11%)
Query: 15 DAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSS-PPPSPESPPPSS 73
+A PP P+ PP PP+SPP + P P P+S PPP+P SPPP+
Sbjct: 139 EALPQPPPPAPVVMMQPPPPHAM----PPASPPAAQPAP---SAPASSPPPTPASPPPAK 191
Query: 74 PPPSSQSPPQSP 85
P SS P +SP
Sbjct: 192 APKSSHPPLKSP 203
|
Length = 274 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 14/60 (23%), Positives = 25/60 (41%)
Query: 15 DAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSP 74
+A + P+P +++P P P +P + P++ P P P P P+S
Sbjct: 13 EAEQPAPAPPSPAAAPAPPPPAKTAAPATKAAAPAAAAPRAEKPKKDKPRRERKPKPASL 72
|
Length = 475 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 8e-05
Identities = 24/83 (28%), Positives = 29/83 (34%)
Query: 31 PPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNS 90
+ P + + PPPSS P P P +S P P S P P P P +
Sbjct: 179 GGNIPGAIQPPPPSSLPGLPPGSSSLAPSASSTPGNRLPRVSFNPFLPGPSPAQPSAPPA 238
Query: 91 KSPPQSSPPPNTNPPPQSSPPPS 113
P PP P PPP
Sbjct: 239 SIPAPPIPPVIQYVAPPPVPPPQ 261
|
Length = 582 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 26/122 (21%), Positives = 41/122 (33%), Gaps = 9/122 (7%)
Query: 10 VSNSPDAAETPPSPSRASSSPPPSTPPSDESPP--------PSSPPPSSPPPDRSPPPSS 61
V + +A+ P + + + PP E P S P P P
Sbjct: 150 VEGATNASLFPLGLAAFPAEGTLAAPPLGEGSADGSCDPALPLSAPRLGPADVFVPATPR 209
Query: 62 PPPSPESPPPSSPPPSS-QSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPP 120
P P + P ++P PS+ SPP + P S + +PP +PP
Sbjct: 210 PTPRTTASPETTPTPSTTTSPPSTTIPAPSTTIAAPQAGTTPEAEGTPAPPTPGGGEAPP 269
Query: 121 PS 122
+
Sbjct: 270 AN 271
|
Length = 401 |
| >gnl|CDD|237015 PRK11901, PRK11901, hypothetical protein; Reviewed | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 8e-05
Identities = 26/162 (16%), Positives = 46/162 (28%), Gaps = 44/162 (27%)
Query: 1 MEDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSP--------- 51
+ NQS + + + S + ++ P + P P + PP +P
Sbjct: 87 LSSGNQSSPSAANNTSDGHDASGVKNTAPPQDISAPPISPTPTQAAPPQTPNGQQRIELP 146
Query: 52 -------------------------------PPDRSPPPSSPPPSPESPPPSSPPPSSQS 80
P +P + P+ P+ P
Sbjct: 147 GNISDALSQQQGQVNAASQNAQGNTSTLPTAPATVAPSKGAKVPATAETHPTPPQK---- 202
Query: 81 PPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPS 122
P P N + PP T+ P+S + + +S P S
Sbjct: 203 PATKKPAVNHHKTATVAVPPATSGKPKSGAASARALSSAPAS 244
|
Length = 327 |
| >gnl|CDD|215130 PLN02217, PLN02217, probable pectinesterase/pectinesterase inhibitor | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 8e-05
Identities = 32/112 (28%), Positives = 50/112 (44%), Gaps = 9/112 (8%)
Query: 8 PGV-SNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSP 66
PG+ + +P + + P+ S ASS+ T S +SP P +SPP P + P
Sbjct: 559 PGLFAGNPGSTNSTPTGSAASSN----TTFSSDSPSTVVAPSTSPPAGHLGSPPATPSKI 614
Query: 67 ESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNAS 118
SP S P SP +P P S S+ + P+SS +++ +S
Sbjct: 615 VSPSTSPPASHLGSPSTTPSSPESSIKVASTETAS----PESSIKVASTESS 662
|
Length = 670 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 9e-05
Identities = 37/133 (27%), Positives = 47/133 (35%), Gaps = 8/133 (6%)
Query: 1 MEDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPS 60
M + V P S +S+ P S S PP SP P P
Sbjct: 409 MPQSQPLQSVPAQPPVLTQSQSLPPKASTHPHSGLH---SGPPQSPFAQHPFTSGGLPAI 465
Query: 61 SPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPP---SNSNA 117
PPPS + P++PP + S PP S + P PP Q P +
Sbjct: 466 GPPPSLPTSTPAAPPRA--SSGSQPPGSALPSSGGCAGPGPPLPPIQIKEEPLDEAEEPE 523
Query: 118 SPPPSQDNPSDPP 130
SPPP +PS P
Sbjct: 524 SPPPPPRSPSPEP 536
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|219404 pfam07415, Herpes_LMP2, Gammaherpesvirus latent membrane protein (LMP2) protein | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 9e-05
Identities = 28/118 (23%), Positives = 37/118 (31%), Gaps = 22/118 (18%)
Query: 65 SPESPPPSSPPPSSQSPPQSPPPPNSKSPPQS-SPPPNTNPPPQSSPPPSNSNASPPPSQ 123
S E P + P S P ++ P S + PP + S+ PP
Sbjct: 3 SLEMQPLGAGGPRSHGGPDGDEGDSNPYYPSSFGSSWDRPGPPVPEDYDAPSH--RPP-- 58
Query: 124 DNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSS 181
P GD + G P G + + G G G G PPPP S
Sbjct: 59 --PYGGSNGDRHGGYQPLGQQDPSLYAGLGQNGGGGL---------------PPPPYS 99
|
This family consists of several Gammaherpesvirus latent membrane protein (LMP2) proteins. Epstein-Barr virus is a human Gammaherpesvirus that infects and establishes latency in B lymphocytes in vivo. The latent membrane protein 2 (LMP2) gene is expressed in latently infected B cells and encodes two protein isoforms, LMP2A and LMP2B, that are identical except for an additional N-terminal 119 aa cytoplasmic domain which is present in the LMP2A isoform. LMP2A is thought to play a key role in either the establishment or the maintenance of latency and/or the reactivation of productive infection from the latent state. The significance of LMP2B and its role in pathogenesis remain unclear. Length = 489 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 1e-04
Identities = 13/127 (10%), Positives = 26/127 (20%), Gaps = 7/127 (5%)
Query: 5 NQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSD-------ESPPPSSPPPSSPPPDRSP 57
+P +A + P P T + ++ S P S
Sbjct: 389 AAVAPPQAPAVPPPPASAPQQAPAVPLPETTSQLLAARQQLQRAQGATKAKKSEPAAASR 448
Query: 58 PPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNA 117
P + + P K+ P++
Sbjct: 449 ARPVNSALERLASVRPAPSALEKAPAKKEAYRWKATNPVEVKKEPVATPKALKKALEHEK 508
Query: 118 SPPPSQD 124
+P +
Sbjct: 509 TPELAAK 515
|
Length = 647 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 32/89 (35%), Positives = 49/89 (55%), Gaps = 13/89 (14%)
Query: 348 FSQSNL-----LGQGGFGYVHK------GVLPNGKEVAVKSLRSGSGQGERE-FKAEVEI 395
F + NL LG G FG V + G N VAVK L++ + ERE +E++I
Sbjct: 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKI 94
Query: 396 ISRV-HHRHLVSLVGYCIAGGKRLLVYEY 423
+S + H+++V+L+G C GG L++ EY
Sbjct: 95 LSHLGQHKNIVNLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 1e-04
Identities = 67/343 (19%), Positives = 108/343 (31%), Gaps = 40/343 (11%)
Query: 22 SPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSP 81
+P S T E ++ P + P S P+ P S P+ S+
Sbjct: 425 APDTTKSVIFVYTLVHVEPHKTTAVPTTPSLPPASTGPTVSTADPTSGTPTGTTSSTLPE 484
Query: 82 PQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPP 141
SP + + P ++ P P ++ P + S P+ +P+ G + +SPP
Sbjct: 485 DTSPTSRTTSATPNATSPTPAVTTPNATSPTTQK-TSDTPNATSPTPIVIGVTTTATSPP 543
Query: 142 GNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSSSSNSPNGNRSGALSPPNKS- 200
+ N NN N PS +++ + G S P
Sbjct: 544 TGTTSVPNATSPQVTEESPVNNTNTPVVTS------APSVLTSAVTTGQHGTGSSPTSQQ 597
Query: 201 ----NGSSSSPSSNNGSMLSIPLVAAVAAGAAFLIIVMLLVFFACRRKKNRERNDQMPYY 256
+ S S+P SN+ S L +A G + E +P
Sbjct: 598 PGIPSSSHSTPRSNSTSTTP-LLTSAHPTGG----------------ENITEETPSVP-- 638
Query: 257 NNNHTTATDYYNSAATPSPPPRANWQQQTDHGWPTPPPSQRGAVTVTSSDMSHNSSSGPY 316
+ H + T SP P Q + G V VT + N++S
Sbjct: 639 STTHVS---------TLSPGPGPGTTSQVSGPGNSSTSRYPGEVHVTEGMPNPNATSPSA 689
Query: 317 GPVLPPPPPIVALGFSQSAFTYEELSAATGGFSQSNLLGQGGF 359
P V ++ T +E S +T S S +G F
Sbjct: 690 PSGQKTAVPTVTSTGGKANSTTKETSGSTLMASTSPHTNEGAF 732
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|223061 PHA03369, PHA03369, capsid maturational protease; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 19/105 (18%), Positives = 29/105 (27%)
Query: 9 GVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPES 68
G+ + +T + + + +P + P P R P+
Sbjct: 340 GLKAHNEILKTASLTAPSRVLAAAAKVAVIAAPQTHTGPADRQRPQRPDGIPYSVPARSP 399
Query: 69 PPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPS 113
P P P P N +SP S P P P P
Sbjct: 400 MTAYPPVPQFCGDPGLVSPYNPQSPGTSYGPEPVGPVPPQPTNPY 444
|
Length = 663 |
| >gnl|CDD|220401 pfam09786, CytochromB561_N, Cytochrome B561, N terminal | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 31/112 (27%), Positives = 43/112 (38%), Gaps = 12/112 (10%)
Query: 22 SPSRASSSPPPSTPPSDESPPPSSPPPSSPP--PDRSPPPSSPPPSPESPPPSSPPPSSQ 79
S+A SPP S S+P +S P P S SP S SP + Q
Sbjct: 112 VVSQAKKSPPAS--------KTSTPMNTSEPLVPGHSSFSDSPSRSASPSRKFSPSSTIQ 163
Query: 80 SPPQSPP--PPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDP 129
PQ P P S S SP +++ P +S ++ S P + + D
Sbjct: 164 QSPQLTPSNKPASPSSSYQSPSYSSSLGPVNSSGNRSNLRSSPWALRSSGDK 215
|
Members of this family are found in the N terminal region of cytochrome B561, as well as in various other putative uncharacterized proteins. Length = 559 |
| >gnl|CDD|183558 PRK12495, PRK12495, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 21/114 (18%), Positives = 35/114 (30%), Gaps = 11/114 (9%)
Query: 2 EDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSS 61
+D A P +S + P ++ S PP S +
Sbjct: 76 DDAGDGA-------EATAPSDAGSQASPDDDAQPAAEAEAADQSAPPE--ASSTSATDEA 126
Query: 62 PPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNS 115
P + P + P P P+ + P+ PP + PP S+P +
Sbjct: 127 ATDPPATAAARDGP--TPDPTAQPATPDERRSPRQRPPVSGEPPTPSTPDAHVA 178
|
Length = 226 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 22/93 (23%), Positives = 40/93 (43%), Gaps = 2/93 (2%)
Query: 42 PPSSPPPSSPPPDRSPPPSSPPPSPESPPPSS-PPPSSQSPPQSPPPPNSKSPPQSS-PP 99
++PP D S P+ P +P P P + + P++ P + P ++ P
Sbjct: 171 TLAAPPLGEGSADGSCDPALPLSAPRLGPADVFVPATPRPTPRTTASPETTPTPSTTTSP 230
Query: 100 PNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPG 132
P+T P S+ + + P ++ P+ P PG
Sbjct: 231 PSTTIPAPSTTIAAPQAGTTPEAEGTPAPPTPG 263
|
Length = 401 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 19/70 (27%), Positives = 31/70 (44%)
Query: 19 TPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSS 78
TP R ++SP + PS + PPS+ P+ +P + P + +P P +P
Sbjct: 207 TPRPTPRTTASPETTPTPSTTTSPPSTTIPAPSTTIAAPQAGTTPEAEGTPAPPTPGGGE 266
Query: 79 QSPPQSPPPP 88
P + P P
Sbjct: 267 APPANATPAP 276
|
Length = 401 |
| >gnl|CDD|183854 PRK13042, PRK13042, superantigen-like protein; Reviewed | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 22/70 (31%), Positives = 34/70 (48%), Gaps = 2/70 (2%)
Query: 58 PPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSK-SPPQSSPPPNTNPPPQSSPPPSNSN 116
P S+ +P+S PPS+ + QS P + PP++K PQ +P T P P +
Sbjct: 33 PSSTKVEAPQSTPPSTKVEAPQSKPNATTPPSTKVEAPQQTPNA-TTPSSTKVETPQSPT 91
Query: 117 ASPPPSQDNP 126
P++ NP
Sbjct: 92 TKQVPTEINP 101
|
Length = 291 |
| >gnl|CDD|220309 pfam09606, Med15, ARC105 or Med15 subunit of Mediator complex non-fungal | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 29/97 (29%), Positives = 34/97 (35%), Gaps = 1/97 (1%)
Query: 21 PSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQS 80
+S SP P + P P P SP S PP S PP+ P S
Sbjct: 407 QPGMMSSPSPVPQVQTNQSMPQPPQPSVPSPGGPGSQPPQSVSGGMIPSPPALMPSPSPQ 466
Query: 81 PPQSPPPPNSKSPPQSSPPPNTNPPPQSS-PPPSNSN 116
QSP + SP N P QSS P+N
Sbjct: 467 MSQSPASQRTIQQDMVSPGGPLNTPGQSSVNSPANPQ 503
|
The approx. 70 residue Med15 domain of the ARC-Mediator co-activator is a three-helix bundle with marked similarity to the KIX domain. The sterol regulatory element binding protein (SREBP) family of transcription activators use the ARC105 subunit to activate target genes in the regulation of cholesterol and fatty acid homeostasis. In addition, Med15 is a critical transducer of gene activation signals that control early metazoan development. Length = 768 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 63/234 (26%), Positives = 92/234 (39%), Gaps = 49/234 (20%)
Query: 353 LLGQGGFGYVH----KGVLPNGKEVAVKSLRSGSGQGEREFK---AEVEIISRVHHRHLV 405
LLG+G G V KG GK A+K L + K E EI++ + H L
Sbjct: 8 LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 406 SLVGYC-IAGGKRL-LVYEYVPNNNLEFHLHGK--GRPVMDWPTRLKIAMGSAKGLAYLH 461
+L Y L LV +Y P L F L + G+ + + R A L YLH
Sbjct: 65 TL--YASFQTETYLCLVMDYCPGGEL-FRLLQRQPGKCLSEEVARFYAAEVLL-ALEYLH 120
Query: 462 EDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRV------------- 508
I++RD+K NILL + ++DF L+K + VS +
Sbjct: 121 LL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 509 ---------------MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
+GT Y+APE S D ++ G++L E++ G P
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 33/126 (26%), Positives = 45/126 (35%), Gaps = 43/126 (34%)
Query: 469 IHRDIKSSNILLDYTFETKVADFGL----------------------------------- 493
IHRDIK NIL+D K+ DFGL
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 494 AKLTTDNNTHV--STRVM-----GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRR 546
+L R + GT Y+APE T+ D +S GV+L E++ G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 547 P-IDPT 551
P + T
Sbjct: 243 PFLADT 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|218621 pfam05518, Totivirus_coat, Totivirus coat protein | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 22/123 (17%), Positives = 34/123 (27%), Gaps = 6/123 (4%)
Query: 25 RASSSPPPSTPPS---DESPPPSSPPPSSPPPDRS--PPPSSPPPSPESPPPSSPPPSSQ 79
S PP D + + P P P P ++ P P P
Sbjct: 631 IISGFPPVFKTALPRPDYNRGGEAGGPGVPGPVPVGMPAHTARPSRVARGDPVRPTAHHA 690
Query: 80 SPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSS 139
+ +P P PP P ++ P+ +S S P +P P +
Sbjct: 691 ALR-APQAPRPGGPPGGGGGLPPPPDLPAAAGPAPCGSSLIASPTAPPEPEPPGAEQADG 749
Query: 140 PPG 142
Sbjct: 750 AEN 752
|
Length = 753 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-04
Identities = 17/80 (21%), Positives = 28/80 (35%), Gaps = 6/80 (7%)
Query: 62 PPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPP 121
P P P P ++P P +P S P ++ P P +++ PP P
Sbjct: 364 PAPQPAKPTAAAPSPVRPTPAPSTRPK----AAAAANIPPKEPVRETATPP--PVPPRPV 417
Query: 122 SQDNPSDPPPGDSNNGSSPP 141
+ P P ++ P
Sbjct: 418 APPVPHTPESAPKLTRAAIP 437
|
Length = 585 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 25/154 (16%), Positives = 39/154 (25%), Gaps = 26/154 (16%)
Query: 14 PDAAETPPSPSRASSSP--PPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPP 71
P A + PP R P P+ P + P P + P ++ PP
Sbjct: 124 PRADDRPPGLPRQDQLPTARPAYPAYQQRPEPGAWPRAADDYGWQQQRLGFPP-RAPYAS 182
Query: 72 SSPPPSSQSPPQSPP----------------------PPNSKSPPQSSPPPNTNPPPQSS 109
+ Q + P P + PPP +
Sbjct: 183 PASYAPEQERDREPYDAGRPEYDQRRRDYDHPRPDWDRPRRDRTDRPEPPPGAGHVHRGG 242
Query: 110 PPPSNSNASP-PPSQDNPSDPPPGDSNNGSSPPG 142
P P + +P P + + P P
Sbjct: 243 PGPPERDDAPVVPIRPSAPGPLAAQPAPAPGPGE 276
|
Length = 617 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 19/100 (19%), Positives = 26/100 (26%), Gaps = 2/100 (2%)
Query: 1 MEDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPS 60
V P+A P R + P P P P P +P P
Sbjct: 96 YASAQPRQPVQQPPEAQVPPQHAPRPAQPAPQPVQQPAYQPQPEQPLQQPVSPQVAPAPQ 155
Query: 61 SPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPP 100
+P+ + P + PQ P P P
Sbjct: 156 PVHSAPQPAQQAFQPAEPVAAPQPEPVAE--PAPVMDKPK 193
|
Length = 333 |
| >gnl|CDD|218332 pfam04929, Herpes_DNAp_acc, Herpes DNA replication accessory factor | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 29/99 (29%), Positives = 36/99 (36%), Gaps = 8/99 (8%)
Query: 18 ETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPS 77
S P P+ SD SS SSP P P S PS E+PPP+S
Sbjct: 288 NADSSVEANGVEPEPTGSVSDRPRHLSSD--SSPSP---PDTSDSDPSTETPPPASL--- 339
Query: 78 SQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSN 116
S SPP + P + SP + +S N
Sbjct: 340 SHSPPAAFERPLALSPKRKREGDKKQKKKKSKKLKLTFN 378
|
Replicative DNA polymerases are capable of polymerising tens of thousands of nucleotides without dissociating from their DNA templates. The high processivity of these polymerases is dependent upon accessory proteins that bind to the catalytic subunit of the polymerase or to the substrate. The Epstein-Barr virus (EBV) BMRF1 protein is an essential component of the viral DNA polymerase and is absolutely required for lytic virus replication. BMRF1 is also a transactivator. This family is predicted to have a UL42 like structure. Length = 381 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 38/163 (23%), Positives = 54/163 (33%), Gaps = 28/163 (17%)
Query: 7 SPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPP-------PSSP--------PPSSP 51
SP S S DA P P S S P E P SP PP+SP
Sbjct: 394 SPASSKSVDAVAKPAEPDVVPSPGSASNVPEVEPAQVEAKKTRPLSPYARYEDLKPPTSP 453
Query: 52 PPDRSPPPSSPPPSPESPPPS------SPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPP 105
SP + S S + P ++ + +PPP N + P S +
Sbjct: 454 ----SPTAPTGVSPSVSSTSSVPAVPDTAPATAATDAAAPPPANMR--PLSPYAVYDDLK 507
Query: 106 PQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNN 148
P +SP P+ PS G+S ++ ++
Sbjct: 508 PPTSPSPAAPVGKVAPSS-TNEVVKVGNSAPPTALADEQHHAQ 549
|
Length = 576 |
| >gnl|CDD|220749 pfam10428, SOG2, RAM signalling pathway protein | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 28/127 (22%), Positives = 42/127 (33%), Gaps = 9/127 (7%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
+ V+ SP + +P P TP P SS P S P + PS
Sbjct: 156 KRDAVTASPSSMIARNTPISDRLRPRSVTPTRGRRP-------SSSPRSLSNPTTLESPS 208
Query: 66 PESPPPSSPPPSSQSPPQSPP--PPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQ 123
PPP S +S + S S P + +S+P +S+ +P
Sbjct: 209 NLQVTTDVPPPYSNGTSRSSTMSSSANLSIISSLATPRSGESFRSTPTSGSSSINPVSGL 268
Query: 124 DNPSDPP 130
D +
Sbjct: 269 DEAEEDR 275
|
SOG2 proteins in Saccharomyces cerevisiae are involved in cell separation and cytokinesis. Length = 419 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 16/63 (25%), Positives = 26/63 (41%), Gaps = 5/63 (7%)
Query: 62 PPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPP 121
P +P S P +P SPP SP S +P + + + ++ P + + S P
Sbjct: 87 PAATPTSAPTPTP-----SPPASPASGMSAAPASAVEEKSPSEESATATAPESPSTSVPS 141
Query: 122 SQD 124
S
Sbjct: 142 SGS 144
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 15/71 (21%), Positives = 29/71 (40%), Gaps = 1/71 (1%)
Query: 35 PPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPP 94
PP+ ++ P+ P ++P P P + +PP +++ P +P +P
Sbjct: 124 PPAAAPAAAAAAKAEKTTPE-KPKAAAPTPEPPAASKPTPPAAAKPPEPAPAAKPPPTPV 182
Query: 95 QSSPPPNTNPP 105
+ P T P
Sbjct: 183 ARADPRETRVP 193
|
Length = 418 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 13/65 (20%), Positives = 20/65 (30%)
Query: 58 PPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNA 117
PP++ P + + P P P + S P P ++ PP A
Sbjct: 124 PPAAAPAAAAAAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAKPPEPAPAAKPPPTPVA 183
Query: 118 SPPPS 122
P
Sbjct: 184 RADPR 188
|
Length = 418 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 24/96 (25%), Positives = 31/96 (32%), Gaps = 6/96 (6%)
Query: 26 ASSSPPPSTPPSDESPPPSSPP---PSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPP 82
AS + P PP E+P P P S R P + P+ ++P + P
Sbjct: 167 ASGTYIPPNPPR-EAPAPGLPKTFTSSHGHRHRHAPKPTQQPTVQNPAQQPTVQNPAQQP 225
Query: 83 QSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNAS 118
Q P P Q P NP Q S
Sbjct: 226 QQQPQQQPVQPAQQPTPQ--NPAQQPPQTEQGHKRS 259
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|200219 TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogenase, E2 component, dihydrolipoamide succinyltransferase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 12/54 (22%), Positives = 25/54 (46%)
Query: 50 SPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTN 103
+ P + P S S +P P++ P + P +P P +K+ ++ P ++
Sbjct: 208 AEPAEEEAPAPSEAGSEPAPDPAARAPHAAPDPPAPAPAPAKTAAPAAAAPVSS 261
|
This model represents an Actinobacterial clade of E2 enzyme, a component of the 2-oxoglutarate dehydrogenase complex involved in the TCA cycle. These proteins have multiple domains including the catalytic domain (pfam00198), one or two biotin domains (pfam00364) and an E3-component binding domain (pfam02817). Length = 579 |
| >gnl|CDD|227665 COG5373, COG5373, Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-04
Identities = 15/73 (20%), Positives = 24/73 (32%), Gaps = 2/73 (2%)
Query: 18 ETPPSPSRASSSPPPSTPPSDESP--PPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPP 75
+ + + E+ P S PPP P P+ E P++
Sbjct: 37 SLVAEGAAGPVAKAAEQMAAPEAAEAAPLPAAAESIASPEVPPPVPPAPAQEGEAPAAEQ 96
Query: 76 PSSQSPPQSPPPP 88
PS+ P + P P
Sbjct: 97 PSAVPAPSAAPAP 109
|
Length = 931 |
| >gnl|CDD|227665 COG5373, COG5373, Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-04
Identities = 24/73 (32%), Positives = 33/73 (45%), Gaps = 6/73 (8%)
Query: 14 PDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSS 73
P+AAE P P+ A S P PP P P +P P + PS+ P +P P+
Sbjct: 57 PEAAEAAPLPAAAESIASPEVPP----PVPPAPAQEGEAPA-AEQPSAVPAPSAAPAPAE 111
Query: 74 PP-PSSQSPPQSP 85
P PS + P +
Sbjct: 112 PVEPSLAANPFAA 124
|
Length = 931 |
| >gnl|CDD|177464 PHA02682, PHA02682, ORF080 virion core protein; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (103), Expect = 2e-04
Identities = 34/114 (29%), Positives = 56/114 (49%), Gaps = 8/114 (7%)
Query: 16 AAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPP 75
+ ++P +PS A ++P P+ P + P++P P+ P +P P+ PP + + PP +
Sbjct: 77 SGQSPLAPSPACAAPAPACP----ACAPAAPAPAVTCP--APAPACPPATAPTCPPPAVC 130
Query: 76 PSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDP 129
P+ P + PP + PP +PP T P ++ P N PPP S P
Sbjct: 131 PAPARPAPACPPSTRQCPP--APPLPTPKPAPAAKPIFLHNQLPPPDYPAASCP 182
|
Length = 280 |
| >gnl|CDD|218181 pfam04621, ETS_PEA3_N, PEA3 subfamily ETS-domain transcription factor N terminal domain | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 31/125 (24%), Positives = 43/125 (34%), Gaps = 12/125 (9%)
Query: 32 PSTPPSDESPPPSSPPPSSP----------PPDRSPPPSSPPPSPESPP--PSSPPPSSQ 79
P +P + + S P P DR P PP+P S P P +P + +
Sbjct: 91 PQSPSKELNSSCSQKQPPYPYGEKCLYSYSAYDRKPASGFKPPTPPSTPCSPVNPQETVR 150
Query: 80 SPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSS 139
S P NS P +P PN +P P P +S S Q S+P
Sbjct: 151 QLQPSGPLSNSSPPSPHTPLPNQSPLPPPMSSPDSSYPSEHRFQRQLSEPCLPFPPPPGR 210
Query: 140 PPGNN 144
+
Sbjct: 211 GSRDG 215
|
The N terminus of the PEA3 transcription factors is implicated in transactivation and in inhibition of DNA binding. Transactivation is potentiated by activation of the Ras/MAP kinase and protein kinase A signalling cascades. The N terminal region contains conserved MAP kinase phosphorylation sites. Length = 336 |
| >gnl|CDD|218181 pfam04621, ETS_PEA3_N, PEA3 subfamily ETS-domain transcription factor N terminal domain | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 32/107 (29%), Positives = 39/107 (36%), Gaps = 5/107 (4%)
Query: 24 SRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESP-PPSSPPPSSQSPP 82
+ +S P TPPS P + P +S PPSP +P P SP P S P
Sbjct: 124 RKPASGFKPPTPPSTPCSPVNPQETVRQLQPSGPLSNSSPPSPHTPLPNQSPLPPPMSSP 183
Query: 83 QSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDP 129
S P + Q S P PPP PP S+P
Sbjct: 184 DSSYPSEHRFQRQLSEPCLPFPPPPGRGSRDG----RPPYHRQMSEP 226
|
The N terminus of the PEA3 transcription factors is implicated in transactivation and in inhibition of DNA binding. Transactivation is potentiated by activation of the Ras/MAP kinase and protein kinase A signalling cascades. The N terminal region contains conserved MAP kinase phosphorylation sites. Length = 336 |
| >gnl|CDD|234706 PRK00269, zipA, cell division protein ZipA; Reviewed | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 12/79 (15%), Positives = 20/79 (25%)
Query: 3 DNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSP 62
D + P +S P ++ S P + + DR +
Sbjct: 72 DEHDLPSMSARPRERRRDTKTAKQQKRGRGSEPQQGDLNLDLDEVEPALFSDRDDDFTPD 131
Query: 63 PPSPESPPPSSPPPSSQSP 81
+ P PP P
Sbjct: 132 KRKSKGREPRIEPPKELPP 150
|
Length = 293 |
| >gnl|CDD|233728 TIGR02102, pullulan_Gpos, pullulanase, extracellular, Gram-positive | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-04
Identities = 19/84 (22%), Positives = 25/84 (29%), Gaps = 4/84 (4%)
Query: 77 SSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSN----ASPPPSQDNPSDPPPG 132
P+ PPP P PP + + +PP S D + P G
Sbjct: 1005 GGIEAPEKTPPPPEHEPQAPKPPTQDPDGSKPKDKVDPKDNKDPLTPPGSDDENGETPKG 1064
Query: 133 DSNNGSSPPGNNNNNNNNGKGNGN 156
+ P N N G N N
Sbjct: 1065 NEEKKEEQPDKGANLPNTGTKNSN 1088
|
Pullulan is an unusual, industrially important polysaccharide in which short alpha-1,4 chains (maltotriose) are connected in alpha-1,6 linkages. Enzymes that cleave alpha-1,6 linkages in pullulan and release maltotriose are called pullulanases although pullulan itself may not be the natural substrate. In contrast, a glycogen debranching enzyme such GlgX, homologous to this family, can release glucose at alpha,1-6 linkages from glycogen first subjected to limit degradation by phosphorylase. Characterized members of this family include a surface-located pullulanase from Streptococcus pneumoniae (PMID:11083842) and an extracellular bifunctional amylase/pullulanase with C-terminal pullulanase activity (PMID:8798645). Length = 1111 |
| >gnl|CDD|222010 pfam13254, DUF4045, Domain of unknown function (DUF4045) | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 26/136 (19%), Positives = 43/136 (31%), Gaps = 4/136 (2%)
Query: 2 EDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSS 61
E + P + PS S P + P S S P
Sbjct: 200 EVTPVGLMRTPPPGSHSKSPSKSGIPDLPSSRDSEKTKPEKPQQETSSMDTEKSSAPKPR 259
Query: 62 PPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSP---PPNTNPPPQSSPPPSNSNAS 118
P+SP + P +++ +SP +S S+ P +P P++ P + +
Sbjct: 260 ETLDPKSPEKAPPIDTTEEELKSPEASPKESEEASARKRSPSLLSPSPKAESPKPLA-SP 318
Query: 119 PPPSQDNPSDPPPGDS 134
+D S P S
Sbjct: 319 GKSPRDPLSPRPKPQS 334
|
This presumed domain is functionally uncharacterized. This domain family is found in bacteria and eukaryotes, and is typically between 384 and 430 amino acids in length. Length = 414 |
| >gnl|CDD|140276 PTZ00249, PTZ00249, variable surface protein Vir28; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 33/122 (27%), Positives = 49/122 (40%), Gaps = 7/122 (5%)
Query: 20 PPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQ 79
PP + + + S E+ PP SSP PP + PP+P S SSP +
Sbjct: 217 PPREEQKAVTAHAHRRISGEARPPKHISFSSPHAHGRPPVETRPPNPVS--VSSPQAHGR 274
Query: 80 SPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSS 139
P ++ PP P SS + NP +P + +S + + G+S SS
Sbjct: 275 HPGETHTPPLVTVP--SSKAHDRNPVQTPTPTSVSGYSSQAKGLEKQAG---GESERTSS 329
Query: 140 PP 141
P
Sbjct: 330 VP 331
|
Length = 516 |
| >gnl|CDD|177614 PHA03377, PHA03377, EBNA-3C; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 28/80 (35%), Positives = 37/80 (46%), Gaps = 3/80 (3%)
Query: 22 SPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSP 81
S R + PP PSD PP +SPP +PP ++P P P S P Q+
Sbjct: 543 SGRRQKRATPPKVSPSDRGPPKASPPVMAPPSTGPRVMATPSTGPRDMAPPSTGPRQQAK 602
Query: 82 PQSPPP---PNSKSPPQSSP 98
+ PP P+ K PP S+P
Sbjct: 603 CKDGPPASGPHEKQPPSSAP 622
|
Length = 1000 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 3e-04
Identities = 14/69 (20%), Positives = 18/69 (26%)
Query: 77 SSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNN 136
SQS S P +S PPP PP + PPP +
Sbjct: 511 ESQSGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQI 570
Query: 137 GSSPPGNNN 145
+
Sbjct: 571 PADSSPPPP 579
|
Length = 620 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 18/88 (20%), Positives = 28/88 (31%), Gaps = 7/88 (7%)
Query: 58 PPSSPPPSPESP----PPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPS 113
P P P ++P PS+ + P +S + S+P T P +PP
Sbjct: 370 SGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPSAPQSAT--QPAGTPPTV 427
Query: 114 NSNASPPPSQDNPSDPPPGDSNNGSSPP 141
+ + P NP P
Sbjct: 428 SVDP-PAAVPVNPPSTAPQAVRPAQFKE 454
|
Length = 614 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 29/120 (24%), Positives = 42/120 (35%), Gaps = 6/120 (5%)
Query: 14 PDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSS 73
P TP P+ P P + + P P PPP +P P PP++
Sbjct: 655 PQVEITPYKPTWTQIGHIPYQPSP--TGANTMLPIQWAPGTMQPPPRAPTPMR---PPAA 709
Query: 74 PPPSSQSPPQSP-PPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPG 132
PP +Q P + + P + PP P P + A PP + + PP
Sbjct: 710 PPGRAQRPAAATGRARPPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPGRARPPAA 769
|
Length = 991 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 31/136 (22%), Positives = 41/136 (30%), Gaps = 20/136 (14%)
Query: 58 PPSSPPPSPESPPPS---SPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSN 114
PSP P +P P P + P P P P P P S+P P
Sbjct: 376 NDGGVAPSPAGSPDVKKKAPEPDLPQPDRHPGP---AKPEAPGARPAELPSPASAPTPEQ 432
Query: 115 SNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWH 174
PP + PP + S+P N +GK + N N +
Sbjct: 433 Q----PPVARSAPLPPSPQA---SAPR-----NVASGKPGVDLGSWQGKFMNFTRNGSRK 480
Query: 175 PPPPPSSSS--NSPNG 188
P SSS +
Sbjct: 481 QPVQASSSDAAQTGVF 496
|
Length = 620 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 34/147 (23%), Positives = 43/147 (29%), Gaps = 14/147 (9%)
Query: 11 SNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS----P 66
S + P S PP+ P S P +PP + P P P P
Sbjct: 172 SAPQVSGLYPEESPYQPQSYPPNEPLP-SSMAMQPPYSGAPPSQQFYGPPQPSPYMYGGP 230
Query: 67 ESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPP---------QSSPPPSNSNA 117
P S P Q PP S P S + + S+ PS A
Sbjct: 231 GGRPNSGFPSGQQPPPSQGQEGYGYSGPPPSKGNHGSVASYAPQGSSQSYSTAYPSLPAA 290
Query: 118 SPPPSQDNPSDPPPGDSNNGSSPPGNN 144
+ P S P +GS GN
Sbjct: 291 TVLPQALPMSSAPMSGGGSGSPQSGNR 317
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 3e-04
Identities = 13/79 (16%), Positives = 26/79 (32%), Gaps = 8/79 (10%)
Query: 51 PPPDR--------SPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNT 102
P PD P P P + P++ + P + + P ++
Sbjct: 378 PTPDEALRRLQEGPPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVP 437
Query: 103 NPPPQSSPPPSNSNASPPP 121
+ ++ PP+ + A P
Sbjct: 438 DAAAAAAAPPAPAAAPQPA 456
|
Length = 598 |
| >gnl|CDD|165468 PHA03201, PHA03201, uracil DNA glycosylase; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 28/91 (30%), Positives = 36/91 (39%), Gaps = 6/91 (6%)
Query: 24 SRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQ--SP 81
+R+ S PP P PP SP S PPS P P E PP + P++ P
Sbjct: 4 ARSRSPSPPRRPSPPRPTPPRSPDASP----EETPPSPPGPGAEPPPGRAAGPAAPRRRP 59
Query: 82 PQSPPPPNSKSPPQSSPPPNTNPPPQSSPPP 112
P S PP + P ++PPP
Sbjct: 60 RGCPAGVTFSSSAPPRPPLGLDDAPAATPPP 90
|
Length = 318 |
| >gnl|CDD|218107 pfam04484, DUF566, Family of unknown function (DUF566) | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 29/130 (22%), Positives = 39/130 (30%), Gaps = 6/130 (4%)
Query: 19 TPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPP-- 76
S S S+S S+P S SS + +P SPP SSP
Sbjct: 1 RAASVSSGSTSGDASSPRS----SSRRRLSSSFLSTSASSRPRRLNAPASPPSSSPARNT 56
Query: 77 SSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNN 136
SS S S +P S ++ N S + + S P
Sbjct: 57 SSSSSFGLSKQRPSSLSRGRLSSRFVSPSRGSPSAAASLNGSLATASTSGSSSPSRSRRT 116
Query: 137 GSSPPGNNNN 146
SS + N
Sbjct: 117 TSSDLSSGNG 126
|
Family of related proteins that is plant specific. Length = 313 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 17/72 (23%), Positives = 25/72 (34%), Gaps = 4/72 (5%)
Query: 29 SPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPP 88
S P + P + +P P PP+SP + P S+ S +S
Sbjct: 75 SKPKTGTGKVAPPAATPTSAPTPTPS---PPASPASGMSAAPASAVEEKSP-SEESATAT 130
Query: 89 NSKSPPQSSPPP 100
+SP S P
Sbjct: 131 APESPSTSVPSS 142
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|184927 PRK14963, PRK14963, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 14/65 (21%), Positives = 20/65 (30%), Gaps = 3/65 (4%)
Query: 4 NNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPP 63
N V + A + + A P P P PP P S+ P P ++P
Sbjct: 368 NRLEKEVRSLRSAPTAAATAAGA---PLPDFDPRPRGPPAPEPARSAEAPPLVAPAAAPA 424
Query: 64 PSPES 68
Sbjct: 425 GLALR 429
|
Length = 504 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 3e-04
Identities = 24/139 (17%), Positives = 35/139 (25%), Gaps = 14/139 (10%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTP---PSDESPPPSSPPPSSPP------PDRS 56
Q+ +P P A + + P P P +P P P
Sbjct: 367 QTGEPVIAPAPEGYPQQSQYAQPAVQYNEPLQQPVQPQQPYYAPAAEQPAQQPYYAPAPE 426
Query: 57 PPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSS-----PPPNTNPPPQSSPP 111
P P +P P + QS P S + + PQ
Sbjct: 427 QPAQQPYYAPAPEQPVAGNAWQAEEQQSTFAPQSTYQTEQTYQQPAAQEPLYQQPQPVEQ 486
Query: 112 PSNSNASPPPSQDNPSDPP 130
P + P+ PP
Sbjct: 487 QPVVEPEPVVEETKPARPP 505
|
Length = 1355 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-04
Identities = 14/65 (21%), Positives = 27/65 (41%)
Query: 57 PPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSN 116
PP ++P + + + P ++ +P PP + P + P P + PPP+
Sbjct: 124 PPAAAPAAAAAAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAKPPEPAPAAKPPPTPVA 183
Query: 117 ASPPP 121
+ P
Sbjct: 184 RADPR 188
|
Length = 418 |
| >gnl|CDD|227430 COG5099, COG5099, RNA-binding protein of the Puf family, translational repressor [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 30/182 (16%), Positives = 60/182 (32%), Gaps = 5/182 (2%)
Query: 24 SRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPP--PSSQSP 81
S +S + S S S S+ + SS S + SP PS++S
Sbjct: 257 SSSSINELTSIYGSVPSIRNLRGLNSALVSFLNVSSSSLAFSALNGKEVSPTGSPSTRSF 316
Query: 82 PQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPP 141
+ P + + NPP QS P N + + ++ + N +
Sbjct: 317 ARVLPKSSPNNLLTEILTTGVNPP-QSLPSLLNPVFLSTSTGFSLTNLSGYLNPNKNLKK 375
Query: 142 GNNNNNNNNGKGNG--NGNGNHNNNNNNNNNKNWHPPPPPSSSSNSPNGNRSGALSPPNK 199
++ +N G + + + + + N N ++ NS + S +
Sbjct: 376 NTLSSLSNLGYSSNVPSPSSSESTRNILGNISPNFKTSSNLTNLNSLLKEKLSNSSSVSA 435
Query: 200 SN 201
++
Sbjct: 436 TD 437
|
Length = 777 |
| >gnl|CDD|200219 TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogenase, E2 component, dihydrolipoamide succinyltransferase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 14/52 (26%), Positives = 23/52 (44%)
Query: 48 PSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPP 99
P+ P + +P PS P P + P ++ PP P P + P ++ P
Sbjct: 207 PAEPAEEEAPAPSEAGSEPAPDPAARAPHAAPDPPAPAPAPAKTAAPAAAAP 258
|
This model represents an Actinobacterial clade of E2 enzyme, a component of the 2-oxoglutarate dehydrogenase complex involved in the TCA cycle. These proteins have multiple domains including the catalytic domain (pfam00198), one or two biotin domains (pfam00364) and an E3-component binding domain (pfam02817). Length = 579 |
| >gnl|CDD|219916 pfam08580, KAR9, Yeast cortical protein KAR9 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 3e-04
Identities = 23/117 (19%), Positives = 38/117 (32%), Gaps = 3/117 (2%)
Query: 8 PGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPE 67
P +++ PD + S S + P S+ + PP S P+ P + +
Sbjct: 445 PTLASIPDEKPSNISVFEDSETSPNSSTLLRDPPPKKCGEESGHLPNN-PFFNKLKLTLS 503
Query: 68 SPPPSSP--PPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPS 122
S PP SP + P P S + + P P + + S
Sbjct: 504 SIPPLSPRQSIITLPTPSRPASRISSLSLRLGSYSGSIVSPPPYPTLVSRKGAAGLS 560
|
The KAR9 protein in Saccharomyces cerevisiae is a cytoskeletal protein required for karyogamy, correct positioning of the mitotic spindle and for orientation of cytoplasmic microtubules. KAR9 localises at the shmoo tip in mating cells and at the tip of the growing bud in anaphase. Length = 626 |
| >gnl|CDD|218621 pfam05518, Totivirus_coat, Totivirus coat protein | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 18/89 (20%), Positives = 28/89 (31%)
Query: 8 PGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPE 67
P P P +R P + + +P P PPP P +
Sbjct: 662 PVPVGMPAHTARPSRVARGDPVRPTAHHAALRAPQAPRPGGPPGGGGGLPPPPDLPAAAG 721
Query: 68 SPPPSSPPPSSQSPPQSPPPPNSKSPPQS 96
P S +S + P P PP ++ +
Sbjct: 722 PAPCGSSLIASPTAPPEPEPPGAEQADGA 750
|
Length = 753 |
| >gnl|CDD|220271 pfam09507, CDC27, DNA polymerase subunit Cdc27 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 17/101 (16%), Positives = 25/101 (24%), Gaps = 2/101 (1%)
Query: 32 PSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSK 91
T P++ P P + P S PP S SP
Sbjct: 137 RRTGVGLPPVAPAASPALKPTANGKRPSSKPPKSIMSPEVKVKSAKKTQDTSKETTTEKT 196
Query: 92 SPPQSSPPPNT--NPPPQSSPPPSNSNASPPPSQDNPSDPP 130
S + NPP +S+ S ++
Sbjct: 197 EGKTSVKAASLKRNPPKKSNIMSSFFKKKTKEKKEKKEASE 237
|
This protein forms the C subunit of DNA polymerase delta. It carries the essential residues for binding to the Pol1 subunit of polymerase alpha, from residues 293-332, which are characterized by the motif D--G--VT, referred to as the DPIM motif. The first 160 residues of the protein form the minimal domain for binding to the B subunit, Cdc1, of polymerase delta, the final 10 C-terminal residues, 362-372, being the DNA sliding clamp, PCNA, binding motif. Length = 427 |
| >gnl|CDD|185594 PTZ00395, PTZ00395, Sec24-related protein; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 3e-04
Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 12/110 (10%)
Query: 65 SPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPP----PQSSPPPSN---SNA 117
S P + P+S +P +PP NS +P S PPN+NPP P S+ P SN SNA
Sbjct: 417 PGNSNPGYNNAPNSNTPYNNPP--NSNTP--YSNPPNSNPPYSNLPYSNTPYSNAPLSNA 472
Query: 118 SPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNN 167
P ++D+ S + ++ P N N N N +G N+ N
Sbjct: 473 PPSSAKDHHSAYHAAYQHRAANQPAANLPTANQPAAN-NFHGAAGNSVGN 521
|
Length = 1560 |
| >gnl|CDD|185594 PTZ00395, PTZ00395, Sec24-related protein; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 44/188 (23%), Positives = 73/188 (38%), Gaps = 11/188 (5%)
Query: 15 DAAETPPSPSRASSSPPPSTPPSDESPPPSSPP----PSSPPPDRSPPPSSPPPS--PES 68
+AA++ + S A S + P + +P ++ P P + PP+ + P S+PP S P S
Sbjct: 396 NAAQSNAAQSNAGFSNAGYSNPGNSNPGYNNAPNSNTPYNNPPNSNTPYSNPPNSNPPYS 455
Query: 69 PPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPP----NTNPPPQSSPPPSNSNASP-PPSQ 123
P S P S +P + PP ++K + N P + P + A+ +
Sbjct: 456 NLPYSNTPYSNAPLSNAPPSSAKDHHSAYHAAYQHRAANQPAANLPTANQPAANNFHGAA 515
Query: 124 DNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSSSS 183
N P GS+P G N + G + N + SSSS
Sbjct: 516 GNSVGNPFASRPFGSAPYGGNAATTADPNGIAKREDHPEGGTNRQKYEQSDEESVESSSS 575
Query: 184 NSPNGNRS 191
+ + N +
Sbjct: 576 ENSSENEN 583
|
Length = 1560 |
| >gnl|CDD|217835 pfam03999, MAP65_ASE1, Microtubule associated protein (MAP65/ASE1 family) | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 26/151 (17%), Positives = 45/151 (29%), Gaps = 8/151 (5%)
Query: 62 PPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPP 121
P S ES PS+P + P+ K P + + S N++ P
Sbjct: 460 PYGSTESSVPSTPSTRRNDRNITSNTPSLKRTPNLTKSSLSQEASLISKSTGNTHKHSTP 519
Query: 122 SQDNPSDPPPGDSNNGSS---PPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPP 178
+ P S + G N N +++ G+ N ++
Sbjct: 520 RRLTTLPKLPAASRSSKGNLIRSGANGNASSDLSSPGSINSKSPEHSVPLVR-----VFD 574
Query: 179 PSSSSNSPNGNRSGALSPPNKSNGSSSSPSS 209
+++ G S + K SP S
Sbjct: 575 IHLRASTTKGRHSTPSTNEKKKRLLKRSPLS 605
|
Length = 619 |
| >gnl|CDD|166942 PRK00404, tatB, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 22/59 (37%), Positives = 29/59 (49%), Gaps = 4/59 (6%)
Query: 42 PPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPP 100
PP+ P P +PP +SP P+ P P P S P P P++ P + PP P PP
Sbjct: 84 PPAPPEPVTPPTAQSPAPAVPTPPPTSTPAVPPAPAAAVPAPAAAPP----PSDPPQPP 138
|
Length = 141 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 25/143 (17%), Positives = 48/143 (33%), Gaps = 23/143 (16%)
Query: 2 EDNNQSPGVSNSPDAAETP--PSPSRASSSPPPSTPP---------------------SD 38
+ ++P ++ DA P+P +P + P SD
Sbjct: 507 VPDARAPAAASREDAPAAAAPPAPEARPPTPAAAAPAARAGGAAAALDVLRNAGMRVSSD 566
Query: 39 ESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSP 98
++ + P +P P++P + + P P + + +PP + + +P
Sbjct: 567 RGARAAAAAKPAAAPAAAPKPAAPRVAVQVPTPRARAATGDAPPNGAARAEQAAESRGAP 626
Query: 99 PPNTNPPPQSSPPPSNSNASPPP 121
PP + PP P S P
Sbjct: 627 PPWEDIPPDDYVPLSADEGFGGP 649
|
Length = 830 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 23/114 (20%), Positives = 31/114 (27%), Gaps = 8/114 (7%)
Query: 14 PDAAETPPSPSRASSSPPPST-----PPSDESP--PPSSPPPSSPPPDRSPPPSSPPPSP 66
P +P + +S P P P P PD P P
Sbjct: 170 QRLGFPPRAPYASPASYAPEQERDREPYDAGRPEYDQRRRDYDHPRPDWDRPRRDRTDRP 229
Query: 67 ESPPPS-SPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASP 119
E PP + PP+ P P + P P P P + +P
Sbjct: 230 EPPPGAGHVHRGGPGPPERDDAPVVPIRPSAPGPLAAQPAPAPGPGEPTARLNP 283
|
Length = 617 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 14/66 (21%), Positives = 25/66 (37%)
Query: 68 SPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPS 127
+P P S + +P PP + +PP P + +P P+ A+ PP++
Sbjct: 381 APAPPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAAAPPARSADP 440
Query: 128 DPPPGD 133
Sbjct: 441 AAAASA 446
|
Length = 576 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 4e-04
Identities = 19/69 (27%), Positives = 25/69 (36%), Gaps = 8/69 (11%)
Query: 19 TPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSS 78
+ S S + SSPP ST P PS+ P S P P+ PS P +
Sbjct: 15 SSSSSSSSQSSPPSSTSPRPRRRKPSASSLLHTP--------SILPLPKLSSPSPPSVTL 66
Query: 79 QSPPQSPPP 87
+ P
Sbjct: 67 PPAATTQTP 75
|
Length = 590 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 21/73 (28%), Positives = 25/73 (34%), Gaps = 5/73 (6%)
Query: 10 VSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPP-SPES 68
VS P+ +S P TP SPP S S P + SP S +
Sbjct: 74 VSKPKTGTGKVAPPAATPTSAPTPTP----SPPASPASGMSAAPASAVEEKSPSEESATA 129
Query: 69 PPPSSPPPSSQSP 81
P SP S S
Sbjct: 130 TAPESPSTSVPSS 142
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|220603 pfam10152, DUF2360, Predicted coiled-coil domain-containing protein (DUF2360) | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 14/63 (22%), Positives = 22/63 (34%)
Query: 27 SSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPP 86
+S P +PPP + ++ P PP + SP P + PP+ P
Sbjct: 45 ASIPGLEDVTVQTTPPPPASAITNGGPPPPPPARAEAASPPPPEAPAEPPAEPEPEAPAE 104
Query: 87 PPN 89
Sbjct: 105 NTV 107
|
This is the conserved 140 amino acid region of a family of proteins conserved from nematodes to humans. One C. elegans member is annotated as a Daf-16-dependent longevity protein 1 but this could not be confirmed. The function is unknown. Length = 147 |
| >gnl|CDD|220603 pfam10152, DUF2360, Predicted coiled-coil domain-containing protein (DUF2360) | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 17/64 (26%), Positives = 24/64 (37%), Gaps = 7/64 (10%)
Query: 8 PGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPE 67
PG+ + PP S ++ PP PP+ PPP +P P PE
Sbjct: 48 PGLEDVTVQTTPPPPASAITNGGPPPPPPARAEAAS-------PPPPEAPAEPPAEPEPE 100
Query: 68 SPPP 71
+P
Sbjct: 101 APAE 104
|
This is the conserved 140 amino acid region of a family of proteins conserved from nematodes to humans. One C. elegans member is annotated as a Daf-16-dependent longevity protein 1 but this could not be confirmed. The function is unknown. Length = 147 |
| >gnl|CDD|130689 TIGR01628, PABP-1234, polyadenylate binding protein, human types 1, 2, 3, 4 family | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 20/89 (22%), Positives = 29/89 (32%), Gaps = 3/89 (3%)
Query: 42 PPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPN 101
P S P+ P P+ P +P ++Q+ Q PP PP P
Sbjct: 417 PRMSMMPTPMGPGGPLRPNGLAPMN---AVRAPSRNAQNAAQKPPMQPVMYPPNYQSLPL 473
Query: 102 TNPPPQSSPPPSNSNASPPPSQDNPSDPP 130
+ PQ S + +Q S P
Sbjct: 474 SQDLPQPQSTASQGGQNKKLAQVLASATP 502
|
These eukaryotic proteins recognize the poly-A of mRNA and consists of four tandem RNA recognition domains at the N-terminus (rrm: pfam00076) followed by a PABP-specific domain (pfam00658) at the C-terminus. The protein is involved in the transport of mRNA's from the nucleus to the cytoplasm. There are four paralogs in Homo sapiens which are expressed in testis (GP:11610605_PABP3 ), platelets (SP:Q13310_PABP4 ), broadly expressed (SP:P11940_PABP1) and of unknown tissue range (SP:Q15097_PABP2). Length = 562 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (100), Expect = 4e-04
Identities = 27/130 (20%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 22 SPSRASSSPPPS-TPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPP---SSPPPS 77
+P++A+++P + PP+ + P+ + P ++ PP+ + PP ++PP
Sbjct: 221 APAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAK 280
Query: 78 SQSPP---QSPPPPNSKSPPQSSPPP--NTNPPPQSSPPPSNSNASPPPSQDNPSDPPPG 132
+ +PP +PP + +P +++ P P +++ PP+ + A P + P+
Sbjct: 281 AAAPPAKAAAPPAKAAAAPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKAATPPAKAAAP 340
Query: 133 DSNNGSSPPG 142
+ ++P G
Sbjct: 341 PAKAAAAPVG 350
|
Length = 357 |
| >gnl|CDD|225987 COG3456, COG3456, Predicted component of the type VI protein secretion system, contains a FHA domain [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 25/113 (22%), Positives = 33/113 (29%), Gaps = 13/113 (11%)
Query: 24 SRASSSPPPSTPPSDESPPPSSPPPSSPP--------PDRSPPPSSPPPSPESPPPSSPP 75
S SS+ +D P P PP + P S P S S P
Sbjct: 121 SAVSSTDMDDDFLADIEPEPRLPPGLTDPLQLADPVPNGFSADPLSALQSESLIAQPDPA 180
Query: 76 PSSQSPPQSPPPPNSKSPP-----QSSPPPNTNPPPQSSPPPSNSNASPPPSQ 123
+ S ++ P S P PP +SPP + SQ
Sbjct: 181 GGAPSISRNSEAPLSDPASAGGIDTPFPDDLDVPPIAASPPGPQEGPTISASQ 233
|
Length = 430 |
| >gnl|CDD|223044 PHA03325, PHA03325, nuclear-egress-membrane-like protein; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 28/132 (21%), Positives = 38/132 (28%), Gaps = 17/132 (12%)
Query: 10 VSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESP 69
+ D A+ S P S PP PP P P + P + + E+
Sbjct: 287 AGETADLADDDGSEHSDPEPLPASLPP----PPVRRPRVKHPEAGKEEPDGAR--NAEAK 340
Query: 70 PPSSPPPSSQSPPQSPPP--------PNSKSPPQSSPP--PNTNPPPQSSPPPSNSNASP 119
P+ P S+ S S P S SS + PP SP
Sbjct: 341 EPAQPATSTSSKGSSSAQNKDSGSTGPGSSLAAASSFLEDDDFGSPPLDLTTSLRHMPSP 400
Query: 120 PPSQDNPSDPPP 131
+ P P
Sbjct: 401 SVTS-APEPPSI 411
|
Length = 418 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 5e-04
Identities = 8/73 (10%), Positives = 23/73 (31%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
+ P + + + + + +P P + + ++ PP+
Sbjct: 389 EGPPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPA 448
Query: 66 PESPPPSSPPPSS 78
P + P + +S
Sbjct: 449 PAAAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|223079 PHA03419, PHA03419, E4 protein; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 23/94 (24%), Positives = 34/94 (36%), Gaps = 9/94 (9%)
Query: 42 PPSSPPPSSPPPDRSPPPSSPPPSPESPPPS---SPPPSSQSPPQSPPPPNSKSPPQSSP 98
PP++P PSS PP P P PP + ++ PPP + + + P
Sbjct: 53 PPTTPHPSSQPPPCPPSPGHPPQTNDTHEKDLALQPPPGGKKKEKKKKETEKPAQGGEKP 112
Query: 99 PPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPG 132
+ + PPP + PPPG
Sbjct: 113 DQGPEAKGEGE---GHEPEDPPP---EDTPPPPG 140
|
Length = 200 |
| >gnl|CDD|223044 PHA03325, PHA03325, nuclear-egress-membrane-like protein; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 25/124 (20%), Positives = 38/124 (30%), Gaps = 9/124 (7%)
Query: 2 EDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSS 61
D++ S P A PP P R P P + + P + + P + +S
Sbjct: 294 ADDDGSEHSDPEPLPASLPPPPVR---RPRVKHPEAGKEEPDGARNAEAKEPAQPATSTS 350
Query: 62 PPPSPESPPP---SSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNAS 118
S + S+ P SS + S + P + P P S
Sbjct: 351 SKGSSSAQNKDSGSTGPGSSLAAASSFLEDDDFGSPPLDLTTSLRHMP---SPSVTSAPE 407
Query: 119 PPPS 122
PP
Sbjct: 408 PPSI 411
|
Length = 418 |
| >gnl|CDD|217310 pfam02993, MCPVI, Minor capsid protein VI | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 22/102 (21%), Positives = 29/102 (28%), Gaps = 4/102 (3%)
Query: 8 PGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPE 67
G ET P +A P P PP P P P
Sbjct: 110 LGEEEPAPQEETVADPIQALQPRPRPDVEEVLVPAAPEPPSYEETIKPGPAPVEEP---- 165
Query: 68 SPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSS 109
+ P+ +P PP + PP P P+T + S
Sbjct: 166 VDSMAIAVPAIDTPVTLELPPAPQPPPPVVPQPSTMVVHRRS 207
|
This minor capsid protein may act as a link between the external capsid and the internal DNA-protein core. The C-terminal 11 residues may function as a protease cofactor leading to enzyme activation. Length = 238 |
| >gnl|CDD|177328 PHA01929, PHA01929, putative scaffolding protein | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 24/92 (26%), Positives = 38/92 (41%), Gaps = 4/92 (4%)
Query: 10 VSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPP--PSSPPPSPE 67
V+N P AA P P+ P P +P + P P P + P +P
Sbjct: 16 VANVPPAAAPTPQPNPVIQPQAPVQPGQPGAPQQLAIPTQQPQPVPTSAMTPHVVQQAPA 75
Query: 68 SPPPSSPPPSSQSPPQS--PPPPNSKSPPQSS 97
P P++PP + + P++ PPP + +P
Sbjct: 76 QPAPAAPPAAGAALPEALEVPPPPAFTPNGEI 107
|
Length = 306 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 6e-04
Identities = 17/73 (23%), Positives = 28/73 (38%)
Query: 1 MEDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPS 60
N +P PP+P + S+ + PP + PP P + + P
Sbjct: 367 EIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPTEPSP 426
Query: 61 SPPPSPESPPPSS 73
+PP + + PPS
Sbjct: 427 TPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 27/114 (23%), Positives = 35/114 (30%), Gaps = 3/114 (2%)
Query: 21 PSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQS 80
S A SS S PP+ + +P P +P P SP P Q
Sbjct: 29 LSHEEAQSSEAHSFHVDSTKQPPAPEQVAKHELADAPLQQVNAALPPAPAPQSPQPDQQQ 88
Query: 81 PPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPP---SNSNASPPPSQDNPSDPPP 131
Q+PP S + P P S PPP+Q + P
Sbjct: 89 QSQAPPSHQYPSQLPPQQVQSVPQQPTPQQEPYYPPPSQPQPPPAQQPQAQQPQ 142
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 18/64 (28%), Positives = 26/64 (40%), Gaps = 3/64 (4%)
Query: 57 PPPSSP--PPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSN 114
PP ++P P+P PP+SP + P S S +S+ P S P +
Sbjct: 86 PPAATPTSAPTPTPSPPASPASGMSAAPASAVEEKS-PSEESATATAPESPSTSVPSSGS 144
Query: 115 SNAS 118
AS
Sbjct: 145 DAAS 148
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|234229 TIGR03490, Mycoplas_LppA, mycoides cluster lipoprotein, LppA/P72 family | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 19/89 (21%), Positives = 31/89 (34%), Gaps = 6/89 (6%)
Query: 114 NSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNW 173
+SN+ P + P P ++ P N + NN + N N + N ++ N K
Sbjct: 28 SSNSKQP--EKKPEIKPNENTPKIPKKPDNKEPSENNNNKSNNENKDEENPSSTNPEKK- 84
Query: 174 HPPPPPSSSSNSPNGNRSGALSPPNKSNG 202
P PS + + P K
Sbjct: 85 ---PDPSKNKEEIEKPKDEPKKPDKKPQA 110
|
Members of this protein family occur in Mycoplasma mycoides, Mycoplasma hyopneumoniae, and related Mycoplasmas in small paralogous families that may also include truncated forms and/or pseudogenes. Members are predicted lipoproteins with a conserved signal peptidase II processing and lipid attachment site. Note that the name for certain characterized members, p72, reflects an anomalous apparent molecular weight, given a theoretical MW of about 61 kDa. Length = 541 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 6e-04
Identities = 23/115 (20%), Positives = 40/115 (34%)
Query: 15 DAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSP 74
+ S R +PP PP+ S P SSP S P + +S P ++
Sbjct: 633 EGDGKKSSADRKPKTPPSRAPPASLSKPASSPDASQTSASFDLDPDFELATHQSVPEAAL 692
Query: 75 PPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDP 129
S P P P + P + +P + ++ N + S + ++
Sbjct: 693 ASGSAPAPPPVPDPYDRPPWEEAPEVASANDGPNNAAEGNLSESVEDASNSELQA 747
|
Length = 944 |
| >gnl|CDD|240427 PTZ00470, PTZ00470, glycoside hydrolase family 47 protein; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 6e-04
Identities = 17/46 (36%), Positives = 20/46 (43%)
Query: 143 NNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSSSSNSPNG 188
NN ++N N N N N NN NNN NN+ P N N
Sbjct: 12 NNADDNYNNNNNNNNQINSNNPNNNGNNQASKLPRGKKKQENPFNK 57
|
Length = 522 |
| >gnl|CDD|233870 TIGR02442, Cob-chelat-sub, cobaltochelatase subunit | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 6e-04
Identities = 17/97 (17%), Positives = 24/97 (24%), Gaps = 13/97 (13%)
Query: 50 SPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSS 109
P ++ + P P P +S P+ P P +
Sbjct: 311 RKPFEQPQGKDEKDLEEKPEEPGPDPE----KPDEGEDDAEQSGPRGHPTPG--NDDEKE 364
Query: 110 PPPSNSNASPPPSQDNPSDP-------PPGDSNNGSS 139
P P S D D PP G+S
Sbjct: 365 PDPQEEADGQGSSTDPAGDIFRIRVLAPPQARARGAS 401
|
Cobaltochelatase is responsible for the insertion of cobalt into the corrin ring of coenzyme B12 during its biosynthesis. Two versions have been well described. CbiK/CbiX is a monomeric, anaerobic version which acts early in the biosynthesis (pfam06180). CobNST is a trimeric, ATP-dependent, aerobic version which acts late in the biosynthesis (TIGR02257/TIGR01650/TIGR01651). A number of genomes (actinobacteria, cyanobacteria, betaproteobacteria and pseudomonads) which apparently biosynthesize B12, encode a cobN gene but are demonstrably lacking cobS and cobT. These genomes do, however contain a homolog (modelled here) of the magnesium chelatase subunits BchI/BchD family. Aside from the cyanobacteria (which have a separate magnesium chelatase trimer), these species do not make chlorins, so do not have any use for a magnesium chelatase. Furthermore, in nearly all cases the members of this family are proximal to either CobN itself or other genes involved in cobalt transport or B12 biosynthesis. Length = 633 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 44/215 (20%), Positives = 80/215 (37%), Gaps = 36/215 (16%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVK--SLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
++ K P VAVK +L S S + + + E+ ++ H +++ V
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMD--WPTRLK------IAMGSAKGLAYLHED 463
I + +V + +G ++ +P L I L Y+H
Sbjct: 69 IVDSELYVVSPLMA--------YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH-- 118
Query: 464 CHPRIIHRDIKSSNILLDYTFETKVADF---------GLAKLTTDNNTHVSTRVMGTFGY 514
IHR +K+S+ILL + ++ G + + S + + +
Sbjct: 119 -SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL---PW 174
Query: 515 LAPE--YASSGKLTEKSDVFSFGVMLLELITGRRP 547
L+PE + EKSD++S G+ EL G P
Sbjct: 175 LSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 6e-04
Identities = 29/81 (35%), Positives = 41/81 (50%), Gaps = 5/81 (6%)
Query: 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNI 478
LV EY+ +++ LH G D +K A L YLH IIHRD+K N+
Sbjct: 81 LVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNM 135
Query: 479 LLDYTFETKVADFGLAKLTTD 499
L+ K+ DFGL+K+T +
Sbjct: 136 LISNEGHIKLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|237081 PRK12372, PRK12372, ribonuclease III; Reviewed | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 14/84 (16%), Positives = 32/84 (38%), Gaps = 4/84 (4%)
Query: 13 SPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPS 72
+ A+ P + +A+ P + P + + P + P+S D+ + P+
Sbjct: 327 ADKPADRPDAAEKAAEKPAEAAPRAADKPAGQAADPASSSADK----PGASADAAARTPA 382
Query: 73 SPPPSSQSPPQSPPPPNSKSPPQS 96
++ +PP S + Q+
Sbjct: 383 RARDAAAPDADTPPGGASLAAAQA 406
|
Length = 413 |
| >gnl|CDD|215187 PLN02328, PLN02328, lysine-specific histone demethylase 1 homolog | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 33/120 (27%), Positives = 41/120 (34%), Gaps = 19/120 (15%)
Query: 1 MEDNNQSP--GVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPP 58
ME + P N D SP S P + + E+ +SP SP + P
Sbjct: 1 METETKEPEDPADNVNDVVSEASSPETDLSLSPSQSEQNIENDGQNSPETQSPLTELQPS 60
Query: 59 PSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPP-------------NTNPP 105
P PP + P S S Q P PNS P +PPP N NP
Sbjct: 61 PL-PPNTTLDAPVSDSQGDESSSEQQPQNPNSTEP---APPPKKRRRRKRFFTEINANPA 116
|
Length = 808 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 7e-04
Identities = 13/61 (21%), Positives = 20/61 (32%), Gaps = 4/61 (6%)
Query: 13 SPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSP----PPSSPPPSPES 68
P PS A++ PP + ++ P ++ P P P P P S
Sbjct: 12 GEAEQPAPAPPSPAAAPAPPPPAKTAAPATKAAAPAAAAPRAEKPKKDKPRRERKPKPAS 71
Query: 69 P 69
Sbjct: 72 L 72
|
Length = 475 |
| >gnl|CDD|183854 PRK13042, PRK13042, superantigen-like protein; Reviewed | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 24/77 (31%), Positives = 34/77 (44%), Gaps = 5/77 (6%)
Query: 9 GVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPES 68
GV + A +PS P STPPS + P S P ++ PP S +P +P
Sbjct: 19 GVITTTTQAANATTPSSTKVEAPQSTPPSTKVEAPQSKPNATTPP--STKVEAPQQTPN- 75
Query: 69 PPPSSPPPSSQSPPQSP 85
++P + PQSP
Sbjct: 76 --ATTPSSTKVETPQSP 90
|
Length = 291 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 7e-04
Identities = 41/184 (22%), Positives = 85/184 (46%), Gaps = 18/184 (9%)
Query: 368 PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSL--------VGYCIAGGKRLL 419
P + + K +++GS + + + E+ + R++H +++ + Y I
Sbjct: 190 PKCERLIAKRVKAGS-RAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFD 248
Query: 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNIL 479
+Y ++ + ++ K RP++ TR I + Y+H+ ++IHRDIK NI
Sbjct: 249 LYSFMYDEAFDW----KDRPLL-KQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIF 299
Query: 480 LDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLL 539
L+ + + DFG A +GT +PE + E +D++S G++LL
Sbjct: 300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILL 359
Query: 540 ELIT 543
++++
Sbjct: 360 DMLS 363
|
Length = 501 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 7e-04
Identities = 31/113 (27%), Positives = 45/113 (39%), Gaps = 34/113 (30%)
Query: 469 IHRDIKSSNILLDYTFETKVADFGLA-----------------KLTTD------------ 499
IHRDIK N+LLD K++DFGL L +D
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 500 -----NNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
N ++ +GT Y+APE + D +S GV++ E++ G P
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 30/95 (31%), Positives = 38/95 (40%), Gaps = 12/95 (12%)
Query: 59 PSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNAS 118
P++ P PPP ++ P +PPPP PPP P PQ P + A
Sbjct: 34 PATANADPAPPPPPPSTAAAAPAPAAPPPP---------PPPAAPPAPQPDDPNA---AP 81
Query: 119 PPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKG 153
PPP D + PPP N PP +N G
Sbjct: 82 PPPPADPNAPPPPPVDPNAPPPPAPEPGRIDNAVG 116
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 29/82 (35%), Positives = 39/82 (47%), Gaps = 9/82 (10%)
Query: 8 PGVSNSPDAAETPPSPSRASSSPPPSTPPSDESP-PPSSPPPSSPPPDRSPPPSSPPPSP 66
P +N+ D A PP PS A+++P P+ PP P P +P P P ++PPP P
Sbjct: 34 PATANA-DPAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQP-------DDPNAAPPPPP 85
Query: 67 ESPPPSSPPPSSQSPPQSPPPP 88
P PPP + P P P
Sbjct: 86 ADPNAPPPPPVDPNAPPPPAPE 107
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 8e-04
Identities = 17/79 (21%), Positives = 31/79 (39%), Gaps = 6/79 (7%)
Query: 38 DESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSS 97
D P + P++ + P P++ P+ PP++ P PP + PP+ +
Sbjct: 119 DTGGAPPAAAPAAAAAA--KAEKTTPEKPKAAAPTPEPPAASKPT----PPAAAKPPEPA 172
Query: 98 PPPNTNPPPQSSPPPSNSN 116
P P P + P +
Sbjct: 173 PAAKPPPTPVARADPRETR 191
|
Length = 418 |
| >gnl|CDD|234706 PRK00269, zipA, cell division protein ZipA; Reviewed | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 8e-04
Identities = 14/104 (13%), Positives = 21/104 (20%), Gaps = 1/104 (0%)
Query: 2 EDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSS 61
++ S + +T P P + E + S P
Sbjct: 48 DEEEGSAELLGPARVLDTHKEPQLDEHDLPSMSARPRERRRDTKTAKQQKRGRGSEPQQG 107
Query: 62 PPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPP 105
+ P SK PP PP
Sbjct: 108 DLNLDLDEVEPALFSDRDDDFT-PDKRKSKGREPRIEPPKELPP 150
|
Length = 293 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 9e-04
Identities = 25/112 (22%), Positives = 31/112 (27%), Gaps = 6/112 (5%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
Q P + P + PPP PP + PP P + PPP P P P
Sbjct: 235 QLPQQPPPLQQPQFPGLSQQMP--PPPPQPPQQQQQPP--QPQAQPPPQNQPTP--HPGL 288
Query: 66 PESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNA 117
P+ PPP P + Q S A
Sbjct: 289 PQGQNAPLPPPQQPQLLPLVQQPQGQQRGPQFREQLVQLSQQQREALSQEEA 340
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|184927 PRK14963, PRK14963, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 9e-04
Identities = 12/79 (15%), Positives = 22/79 (27%)
Query: 39 ESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSP 98
E +PP +P + ++ P P + PP P
Sbjct: 348 EGVAAVAPPAPAPADLTQRLNRLEKEVRSLRSAPTAAATAAGAPLPDFDPRPRGPPAPEP 407
Query: 99 PPNTNPPPQSSPPPSNSNA 117
+ PP +P + +
Sbjct: 408 ARSAEAPPLVAPAAAPAGL 426
|
Length = 504 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 9e-04
Identities = 14/74 (18%), Positives = 23/74 (31%)
Query: 26 ASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSP 85
+PP + P + + P P P P P + PP + + P
Sbjct: 120 TGGAPPAAAPAAAAAAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAKPPEPAPAAKPPP 179
Query: 86 PPPNSKSPPQSSPP 99
P P ++ P
Sbjct: 180 TPVARADPRETRVP 193
|
Length = 418 |
| >gnl|CDD|215533 PLN02983, PLN02983, biotin carboxyl carrier protein of acetyl-CoA carboxylase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 9e-04
Identities = 27/62 (43%), Positives = 33/62 (53%), Gaps = 3/62 (4%)
Query: 39 ESPPPSSPPPSSPPPDRSPPPSSPPPSPE--SPPPSSPPPSSQSPPQSPPPPNSKSPPQS 96
+ PPP+ PPP + PP+SPP + S P SSPPP+ SPP P S PP
Sbjct: 143 QPPPPAPVVMMQPPPPHAMPPASPPAAQPAPSAPASSPPPTPASPP-PAKAPKSSHPPLK 201
Query: 97 SP 98
SP
Sbjct: 202 SP 203
|
Length = 274 |
| >gnl|CDD|237782 PRK14666, uvrC, excinuclease ABC subunit C; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 9e-04
Identities = 11/74 (14%), Positives = 20/74 (27%), Gaps = 2/74 (2%)
Query: 15 DAAETPPSPSRASSSPPPSTPPSDESPPPSSPP--PSSPPPDRSPPPSSPPPSPESPPPS 72
+ P P P ++ P S P P+S + P
Sbjct: 332 VCTDAGLLPDTPLLPDAPEGSSDPVVPVAAATPVDASLPDVRTGTAPTSLANVSHADPAV 391
Query: 73 SPPPSSQSPPQSPP 86
+ P + + + P
Sbjct: 392 AQPTQAATLAGAAP 405
|
Length = 694 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 24/93 (25%), Positives = 29/93 (31%), Gaps = 7/93 (7%)
Query: 4 NNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPP 63
Q PG+S PP P + P PPP + P P + PP
Sbjct: 245 QPQFPGLSQQM-----PPPPPQPPQQQQQPPQPQA-QPPPQNQPTPHPGLPQGQNAPLPP 298
Query: 64 PS-PESPPPSSPPPSSQSPPQSPPPPNSKSPPQ 95
P P+ P P Q PQ S Q
Sbjct: 299 PQQPQLLPLVQQPQGQQRGPQFREQLVQLSQQQ 331
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 0.001
Identities = 12/80 (15%), Positives = 22/80 (27%)
Query: 72 SSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPP 131
S S + +P P P P P P++ + + P + P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 132 GDSNNGSSPPGNNNNNNNNG 151
+ + P N +
Sbjct: 421 PTEPSPTPPANAANAPPSLN 440
|
Length = 620 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 17/66 (25%), Positives = 28/66 (42%)
Query: 69 PPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSD 128
PP ++ + + P +PPP + P ++P P +P P + A P S D +
Sbjct: 384 PPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAAAPPARSADPAAA 443
Query: 129 PPPGDS 134
GD
Sbjct: 444 ASAGDR 449
|
Length = 576 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 0.001
Identities = 10/71 (14%), Positives = 19/71 (26%)
Query: 52 PPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPP 111
PP PP +P + + + +P + + P +P
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 112 PSNSNASPPPS 122
+ A S
Sbjct: 451 AAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|220749 pfam10428, SOG2, RAM signalling pathway protein | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 33/133 (24%), Positives = 48/133 (36%), Gaps = 8/133 (6%)
Query: 26 ASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSP 85
A SS P + PSS +P P +P P SS +P
Sbjct: 144 AWSSLGPPLQ--HRKRDAVTASPSSMIARNTPISDRLRPRSVTPTRGRRPSSSPRSLSNP 201
Query: 86 PPPNSKSPPQS---SPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPG 142
S S Q PPP +N +SS S++N S S + P G+S + G
Sbjct: 202 TTLESPSNLQVTTDVPPPYSNGTSRSSTMSSSANLSIISS---LATPRSGESFRSTPTSG 258
Query: 143 NNNNNNNNGKGNG 155
+++ N +G
Sbjct: 259 SSSINPVSGLDEA 271
|
SOG2 proteins in Saccharomyces cerevisiae are involved in cell separation and cytokinesis. Length = 419 |
| >gnl|CDD|234229 TIGR03490, Mycoplas_LppA, mycoides cluster lipoprotein, LppA/P72 family | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 20/111 (18%), Positives = 36/111 (32%), Gaps = 14/111 (12%)
Query: 65 SPESPPPSSPP---PSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPP 121
S S P P P+ +P P N + ++ N + +P +N P P
Sbjct: 28 SSNSKQPEKKPEIKPNENTPKIPKKPDNKEPSENNNNKSNNENKDEENPSSTNPEKKPDP 87
Query: 122 SQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKN 172
S++ P + + K + N + + NNN +
Sbjct: 88 SKNKEEIEKP-----------KDEPKKPDKKPQADQPNNVHADQPNNNKVD 127
|
Members of this protein family occur in Mycoplasma mycoides, Mycoplasma hyopneumoniae, and related Mycoplasmas in small paralogous families that may also include truncated forms and/or pseudogenes. Members are predicted lipoproteins with a conserved signal peptidase II processing and lipid attachment site. Note that the name for certain characterized members, p72, reflects an anomalous apparent molecular weight, given a theoretical MW of about 61 kDa. Length = 541 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 0.001
Identities = 26/119 (21%), Positives = 33/119 (27%), Gaps = 2/119 (1%)
Query: 18 ETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSP--PPDRSPPPSSPPPSPESPPPSSPP 75
+ P P P P +P P P P + P P P
Sbjct: 738 DGPHEPLFTPIVEPVQQPQQPVAPQQQYQQPQQPVAPQPQYQQPQQPVAPQPQYQQPQQP 797
Query: 76 PSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDS 134
+ Q Q P P + P P P PQ P P + +P GDS
Sbjct: 798 VAPQPQYQQPQQPVAPQPQYQQPQQPVAPQPQYQQPQQPVAPQPQDTLLHPLLMRNGDS 856
|
Length = 1355 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 30/121 (24%), Positives = 35/121 (28%), Gaps = 11/121 (9%)
Query: 29 SPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPP 88
P TP + P P + P +P P + P P PQ P P
Sbjct: 741 HEPLFTPIVEPVQQPQQPVAPQQQYQQPQQPVAPQPQYQQPQQPVAPQPQYQQPQQPVAP 800
Query: 89 NSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQ-DNPSDPPPGDS-------NNGSSP 140
P P P PQ P P Q P P P D+ NG S
Sbjct: 801 ---QPQYQQPQQPVAPQPQYQQPQQPVAPQPQYQQPQQPVAPQPQDTLLHPLLMRNGDSR 857
Query: 141 P 141
P
Sbjct: 858 P 858
|
Length = 1355 |
| >gnl|CDD|223061 PHA03369, PHA03369, capsid maturational protease; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 19/83 (22%), Positives = 26/83 (31%), Gaps = 5/83 (6%)
Query: 13 SPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPS 72
A +T P + P P P+ P ++ PP SP +P
Sbjct: 368 VIAAPQTHTGP---ADRQRPQRPDGIPYSVPARSPMTAYPPVPQFCGDPGLVSPYNPQS- 423
Query: 73 SPPPSSQSPPQSPPPPNSKSPPQ 95
P S P P PP +P
Sbjct: 424 -PGTSYGPEPVGPVPPQPTNPYV 445
|
Length = 663 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 10/55 (18%), Positives = 19/55 (34%)
Query: 77 SSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPP 131
P PP + +P P P +++ P + + + P +D P
Sbjct: 12 GEAEQPAPAPPSPAAAPAPPPPAKTAAPATKAAAPAAAAPRAEKPKKDKPRRERK 66
|
Length = 475 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 13/59 (22%), Positives = 24/59 (40%), Gaps = 2/59 (3%)
Query: 47 PPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPP 105
P+ PP + P+ PPP+ + P + + + P++ P K P+ P
Sbjct: 16 QPAPAPPSPAAAPAPPPPAKTAAPATKAAAPAAAAPRAEKPKKDK--PRRERKPKPASL 72
|
Length = 475 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 10/59 (16%), Positives = 20/59 (33%)
Query: 46 PPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNP 104
P P+ P P +P P P + ++ P ++ + P + + P
Sbjct: 17 PAPAPPSPAAAPAPPPPAKTAAPATKAAAPAAAAPRAEKPKKDKPRRERKPKPASLWKL 75
|
Length = 475 |
| >gnl|CDD|220401 pfam09786, CytochromB561_N, Cytochrome B561, N terminal | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 26/97 (26%), Positives = 33/97 (34%), Gaps = 12/97 (12%)
Query: 34 TPPSDESPPPSSPPPSSPPPDRSP-----------PPSSPPPSPESPPPSSPPPSSQSPP 82
T S P + S+P P P S PS + P S+ S Q P
Sbjct: 111 TVVSQAKKSPPASKTSTPMNTSEPLVPGHSSFSDSPSRSASPSRKFSPSSTIQQSPQLTP 170
Query: 83 QSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASP 119
+ P S S S + P SS SN +SP
Sbjct: 171 SNKPASPSSSYQSPSYSSSL-GPVNSSGNRSNLRSSP 206
|
Members of this family are found in the N terminal region of cytochrome B561, as well as in various other putative uncharacterized proteins. Length = 559 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 28/88 (31%), Positives = 32/88 (36%), Gaps = 1/88 (1%)
Query: 42 PPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPN 101
+ P PPP S P P S +P SS P + P SP Q S PP
Sbjct: 179 GGNIPGAIQPPPPSSLPGLPPGSSSLAPSASSTPGNRLPRVSFNPFLPGPSPAQPSAPPA 238
Query: 102 TNPPPQSSPPPSNSNASPPPSQDNPSDP 129
+ P P PP A PP P P
Sbjct: 239 SIPAP-PIPPVIQYVAPPPVPPPQPIIP 265
|
Length = 582 |
| >gnl|CDD|183558 PRK12495, PRK12495, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 20/96 (20%), Positives = 37/96 (38%), Gaps = 3/96 (3%)
Query: 43 PSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNT 102
PS + P D + P + + +S PP S+ + ++ P + + + P P+
Sbjct: 87 PSDAGSQASPDDDAQPAAEAEAADQSAPPE--ASSTSATDEAATDPPATAAARDGPTPDP 144
Query: 103 NPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGS 138
P ++P S PP P P D++
Sbjct: 145 TAQP-ATPDERRSPRQRPPVSGEPPTPSTPDAHVAG 179
|
Length = 226 |
| >gnl|CDD|152960 pfam12526, DUF3729, Protein of unknown function (DUF3729) | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.001
Identities = 26/80 (32%), Positives = 28/80 (35%), Gaps = 4/80 (5%)
Query: 7 SPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPP-PSSPPPDRSPPPSSPPPS 65
SP S PD P PP PPPS P P P P P+ PP
Sbjct: 30 SPPESAHPDDPPPVGDPRPPVVDTPPPVSAVWVLPPPSEPAAPPPDPEPPVPGPAGPPSP 89
Query: 66 PESPPPSSPPPSSQSPPQSP 85
P P+ PP PP P
Sbjct: 90 LAPPAPARKPP---LPPPRP 106
|
This family of proteins is found in viruses. Proteins in this family are typically between 145 and 1707 amino acids in length. The family is found in association with pfam01443, pfam01661, pfam05417, pfam01660, pfam00978. There is a single completely conserved residue L that may be functionally important. Length = 115 |
| >gnl|CDD|183854 PRK13042, PRK13042, superantigen-like protein; Reviewed | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 19/60 (31%), Positives = 25/60 (41%), Gaps = 2/60 (3%)
Query: 72 SSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQ--DNPSDP 129
++P + PQS PP PQS P T P + P NA+ P S + P P
Sbjct: 31 TTPSSTKVEAPQSTPPSTKVEAPQSKPNATTPPSTKVEAPQQTPNATTPSSTKVETPQSP 90
|
Length = 291 |
| >gnl|CDD|218621 pfam05518, Totivirus_coat, Totivirus coat protein | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 23/113 (20%), Positives = 30/113 (26%), Gaps = 4/113 (3%)
Query: 9 GVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSP--PPSSPPPDRSPPPSSPPPSP 66
PD + P P P+ + P P P + + P P
Sbjct: 641 TALPRPDYNRGGEAGGPGVPGPVPVGMPAHTARPSRVARGDPVRPTAHHAALRAPQAPRP 700
Query: 67 ESPP--PSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNA 117
PP PP P + P P S S P PP + N
Sbjct: 701 GGPPGGGGGLPPPPDLPAAAGPAPCGSSLIASPTAPPEPEPPGAEQADGAENQ 753
|
Length = 753 |
| >gnl|CDD|166942 PRK00404, tatB, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 20/62 (32%), Positives = 26/62 (41%), Gaps = 2/62 (3%)
Query: 26 ASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQS--PPQ 83
A +PP P S P PP S P P P+ P P++ PP S PP+
Sbjct: 80 APLTPPAPPEPVTPPTAQSPAPAVPTPPPTSTPAVPPAPAAAVPAPAAAPPPSDPPQPPR 139
Query: 84 SP 85
+P
Sbjct: 140 AP 141
|
Length = 141 |
| >gnl|CDD|166942 PRK00404, tatB, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 16/56 (28%), Positives = 24/56 (42%), Gaps = 2/56 (3%)
Query: 20 PPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPP 75
P P + S P+ +PPP+S P + PP + +P +P P PP
Sbjct: 85 PAPPEPVTPPTAQSPAPAVPTPPPTSTP--AVPPAPAAAVPAPAAAPPPSDPPQPP 138
|
Length = 141 |
| >gnl|CDD|220603 pfam10152, DUF2360, Predicted coiled-coil domain-containing protein (DUF2360) | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 16/61 (26%), Positives = 23/61 (37%), Gaps = 3/61 (4%)
Query: 36 PSDESPPPSSPPPSSPP-PDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPP 94
P E + PP PP PP E+ P PPP + + P + P P + +
Sbjct: 48 PGLEDVTVQTTPPPPASAITNGGPPPPPPARAEAASP--PPPEAPAEPPAEPEPEAPAEN 105
Query: 95 Q 95
Sbjct: 106 T 106
|
This is the conserved 140 amino acid region of a family of proteins conserved from nematodes to humans. One C. elegans member is annotated as a Daf-16-dependent longevity protein 1 but this could not be confirmed. The function is unknown. Length = 147 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (96), Expect = 0.001
Identities = 25/119 (21%), Positives = 59/119 (49%), Gaps = 9/119 (7%)
Query: 17 AETPPSPSRASSSPP-PSTPPSDESPPP----SSPPPSSPPPDRSPPPSSPPPSPESPPP 71
A+ P++A+++P + P+ + PP + P ++ PP ++ P + +P +
Sbjct: 230 AKAAAPPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKAA 289
Query: 72 SSPPPSSQSPPQSPPPP--NSKSPPQSSPPP--NTNPPPQSSPPPSNSNASPPPSQDNP 126
+ P ++ +P ++ P + +P +++ PP PP +++ PP+ + A P + P
Sbjct: 290 APPAKAAAAPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKAATPPAKAAAPPAKAAAAP 348
|
Length = 357 |
| >gnl|CDD|225987 COG3456, COG3456, Predicted component of the type VI protein secretion system, contains a FHA domain [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 29/120 (24%), Positives = 36/120 (30%), Gaps = 10/120 (8%)
Query: 8 PGVSNSPDAAETPPSPSRASSSPPPSTPPS---DESPPPSSPPPSSPPPDRS--PPPSS- 61
VS++ + PP T P D P S P S S P
Sbjct: 121 SAVSSTDMDDDFLADIEPEPRLPPGLTDPLQLADPVPNGFSADPLSALQSESLIAQPDPA 180
Query: 62 ---PPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPP-PQSSPPPSNSNA 117
P S S P S P S+ P P +SPP P +S P +A
Sbjct: 181 GGAPSISRNSEAPLSDPASAGGIDTPFPDDLDVPPIAASPPGPQEGPTISASQPAQRDHA 240
|
Length = 430 |
| >gnl|CDD|217310 pfam02993, MCPVI, Minor capsid protein VI | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 21/101 (20%), Positives = 24/101 (23%), Gaps = 4/101 (3%)
Query: 20 PPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQ 79
A + P P P P PPS P P P
Sbjct: 110 LGEEEPAPQEETVADPIQALQPRPRPDVEEVLVPAAPEPPSYEETIKPGPAPVEEP---- 165
Query: 80 SPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPP 120
+ P +P PP PPP P PS
Sbjct: 166 VDSMAIAVPAIDTPVTLELPPAPQPPPPVVPQPSTMVVHRR 206
|
This minor capsid protein may act as a link between the external capsid and the internal DNA-protein core. The C-terminal 11 residues may function as a protease cofactor leading to enzyme activation. Length = 238 |
| >gnl|CDD|237081 PRK12372, PRK12372, ribonuclease III; Reviewed | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 23/162 (14%), Positives = 48/162 (29%), Gaps = 34/162 (20%)
Query: 8 PGVSNSPDAAE--TPPSPSRASSSPPPSTPPSDESPPPSSPPPSSP-------------- 51
PGV +A + +P RA++ + + + ++ P P
Sbjct: 249 PGVKGVQEALDLRSPERKERAAAREARAAAAAPAATAAAAAPAEEPAVAPMAAIRAAHVE 308
Query: 52 -----------PPDRSPPPSSPPPSPESP--PPSSPPPSSQSPPQSPPPPNSKSPPQSSP 98
P P P++ P ++ P + S+
Sbjct: 309 TAADKGERAAKPAAADKAADKPADRPDAAEKAAEKPAEAAPRAADKPAGQAADPASSSAD 368
Query: 99 PPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSP 140
P + + P +A+ P +D PPG ++ ++
Sbjct: 369 KPGASADAAARTPARARDAAAPD-----ADTPPGGASLAAAQ 405
|
Length = 413 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 32/125 (25%), Positives = 47/125 (37%), Gaps = 46/125 (36%)
Query: 469 IHRDIKSSNILLDYTFETKVADFGLA---------------------------------- 494
IHRDIK NIL+D K++DFGL+
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182
Query: 495 --KLTTDNNTHVST-----RVM-----GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI 542
LT + ++T R+M GT Y+APE ++ D +S G ++ E +
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECL 242
Query: 543 TGRRP 547
G P
Sbjct: 243 IGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|235899 PRK06975, PRK06975, bifunctional uroporphyrinogen-III synthetase/uroporphyrin-III C-methyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 10/56 (17%), Positives = 19/56 (33%), Gaps = 1/56 (1%)
Query: 38 DESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQS-PPQSPPPPNSKS 92
D + P++ P+ + S P + + PP + P PP +
Sbjct: 267 DAAAQPATAAPAPSRMTDTNDSKSVTSQPAAAAAAPAPPPNPPATPPEPPARRGRG 322
|
Length = 656 |
| >gnl|CDD|235899 PRK06975, PRK06975, bifunctional uroporphyrinogen-III synthetase/uroporphyrin-III C-methyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 14/59 (23%), Positives = 23/59 (38%), Gaps = 3/59 (5%)
Query: 15 DAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSS 73
DAA P + + A S + + P++ + PP P P + PP P +
Sbjct: 267 DAAAQPATAAPAPSRMTDTNDSKSVTSQPAAAAAAPAPP---PNPPATPPEPPARRGRG 322
|
Length = 656 |
| >gnl|CDD|215397 PLN02744, PLN02744, dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 14/51 (27%), Positives = 20/51 (39%)
Query: 35 PPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSP 85
S P + P PP + + P P++ PS+PP S SP
Sbjct: 203 SSSAAPAAPKAKPSPPPPKEEEVEKPASSPEPKASKPSAPPSSGDRIFASP 253
|
Length = 539 |
| >gnl|CDD|220708 pfam10349, WWbp, WW-domain ligand protein | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.001
Identities = 25/74 (33%), Positives = 31/74 (41%)
Query: 15 DAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSP 74
+ A+ SR S PP P P+ ++PPP PPP P P P P P
Sbjct: 32 ERAQRAQPVSRESGYYPPPGAYVHLEPLPAYGQYAAPPPYGPPPPYYPAPPGVYPTPPPP 91
Query: 75 PPSSQSPPQSPPPP 88
+ PQ PPPP
Sbjct: 92 NSGYMADPQEPPPP 105
|
The WWbp domain is characterized by several short PY and PT-like motifs of the PPPPY form. These appear to bind directly to the WW domains of WWP1 and WWP2 and other such diverse proteins as dystrophin and YAP (Yes-associated protein). This is the WW-domain binding protein WWbp via PY and PY_like motifs. The presence of a phosphotyrosine residue in the pWBP-1 peptide abolishes WW domain binding which suggests a potential regulatory role for tyrosine phosphorylation in modulating WW domain-ligand interactions. Given the likelihood that WWP1 and WWP2 function as E3 ubiquitin-protein ligases, it is possible that initial substrate-specific recognition occurs via WW domain-substrate protein interaction followed by ubiquitin transfer and subsequent proteolysis. This domain lies just downstream of the GRAM (pfam02893) in many members. Length = 111 |
| >gnl|CDD|114045 pfam05297, Herpes_LMP1, Herpesvirus latent membrane protein 1 (LMP1) | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 27/105 (25%), Positives = 42/105 (40%), Gaps = 9/105 (8%)
Query: 112 PSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNK 171
P N P + DN P +NG P N ++N N NG + +N ++N
Sbjct: 249 PDNGPQDPDNTDDNGPQDPDNTDDNGPQDPDNTDDNGPQDPDNTADNGPQDPDNTDDNGP 308
Query: 172 NWHPPPPPSSSSNSPNG---------NRSGALSPPNKSNGSSSSP 207
+ P PS S+ + G N+ G PP+ ++G P
Sbjct: 309 HDPLPHNPSDSAGNDGGPPKLTEEVENKGGDRGPPSMTDGGGGDP 353
|
This family consists of several latent membrane protein 1 or LMP1s mostly from Epstein-Barr virus. LMP1 of EBV is a 62-65 kDa plasma membrane protein possessing six membrane spanning regions, a short cytoplasmic N-terminus and a long cytoplasmic carboxy tail of 200 amino acids. EBV latent membrane protein 1 (LMP1) is essential for EBV-mediated transformation and has been associated with several cases of malignancies. EBV-like viruses in Cynomolgus monkeys (Macaca fascicularis) have been associated with high lymphoma rates in immunosuppressed monkeys. Length = 382 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 30/113 (26%), Positives = 44/113 (38%), Gaps = 34/113 (30%)
Query: 469 IHRDIKSSNILLDYTFETKVADFGL----------------------------------A 494
IHRDIK N+LLD K++DFGL A
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 495 KLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
+ N ++ +GT Y+APE + D +S GV++ E++ G P
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132858 cd07219, Pat_PNPLA1, Patatin-like phospholipase domain containing protein 1 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 26/96 (27%), Positives = 32/96 (33%), Gaps = 7/96 (7%)
Query: 14 PDAAETPPSPSRASSSPPPSTPPSD---ESPPPSSPPPSSPPPDRSPPPSSPPPSPESPP 70
P + S + P D PP SPP ++P SP SP SP
Sbjct: 291 PSLQDGQASLEESWQPHLARAPKGDGRGLHDPPLSPPLAAPESTAEWVVESPVSSPASPL 350
Query: 71 PSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPP 106
SSP S + P S P S P +T
Sbjct: 351 ESSP---SLPGSLTDLSPASL-PAVHSLPSSTPGLS 382
|
Members of this family share a patatin domain, initially discovered in potato tubers. Some members of PNPLA1 subfamily do not have the lipase consensus sequence Gly-X-Ser-X-Gly which is essential for hydrolase activity. This family includes PNPLA1 from Homo sapiens and Gallus gallus. Currently, there is no literature available on the physiological role, structure, or enzymatic activity of PNPLA1. It is expressed in various human tissues in low mRNA levels. Length = 382 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 27/93 (29%), Positives = 43/93 (46%), Gaps = 3/93 (3%)
Query: 4 NNQSPGVSNSPDAAETP-PSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSP 62
++Q+ + P + TP P+P AS+ PPP+TP P P PPP+R PP +
Sbjct: 402 DDQTRPAAPVPASVPTPAPTPVPASAPPPPATPLPSAEPGSDDGPA--PPPERQPPAPAT 459
Query: 63 PPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQ 95
P+P+ P ++ + PP P +
Sbjct: 460 EPAPDDPDDATRKALDALRERRPPEPPGADLAE 492
|
Length = 3151 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.002
Identities = 14/84 (16%), Positives = 21/84 (25%), Gaps = 4/84 (4%)
Query: 67 ESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNP 126
S S +S +P P P P + P + S S P
Sbjct: 361 PSAFISEIANASAPANPTPAPN----PSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIP 416
Query: 127 SDPPPGDSNNGSSPPGNNNNNNNN 150
P + + N + N
Sbjct: 417 VPAEPTEPSPTPPANAANAPPSLN 440
|
Length = 620 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 20/130 (15%), Positives = 33/130 (25%), Gaps = 2/130 (1%)
Query: 1 MEDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSS--PPPDRSPP 58
D Q + SP A A + P + P P + P
Sbjct: 80 AGDQQQHNTPTGSPAANPPATFALPAGPAGPTIQTEPGQLYPVQVPVMVTQNPANSPLDQ 139
Query: 59 PSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNAS 118
P+ + P S Q P Q + P PP Q+ + + +
Sbjct: 140 PAQQRALQQLQQRYGAPASGQLPSQQQSAQKNDESQLQQQPNGETPPQQTDGAGDDESEA 199
Query: 119 PPPSQDNPSD 128
++
Sbjct: 200 LVRLREADGT 209
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 32/108 (29%), Positives = 48/108 (44%), Gaps = 11/108 (10%)
Query: 7 SPGVSNSPDAAET---PPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPP 63
+ G + P AA PP+ + + PP + P + PP++ P + PP +P +P
Sbjct: 720 ATGRARPPAAAPGRARPPAAAPGRARPPAAAPGR--ARPPAAAPGRARPPAAAPGAPTPQ 777
Query: 64 PSPESPP-PSSPP---PSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQ 107
P P++PP P P P+ Q PPQ+ P P P P Q
Sbjct: 778 PPPQAPPAPQQRPRGAPTPQPPPQAGPTSMQLMPRA--APGQQGPTKQ 823
|
Length = 991 |
| >gnl|CDD|219404 pfam07415, Herpes_LMP2, Gammaherpesvirus latent membrane protein (LMP2) protein | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 23/103 (22%), Positives = 25/103 (24%), Gaps = 21/103 (20%)
Query: 23 PSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSP-PPSPESPPPSS-PPPSSQS 80
P A P DE P S P PP PE S PP
Sbjct: 8 PLGAGGPRSHGGPDGDEGDSNPYYPSSF-----GSSWDRPGPPVPEDYDAPSHRPPPYGG 62
Query: 81 P---PQSPPPPNSKSPPQ-----------SSPPPNTNPPPQSS 109
P + P PPP +P Q S
Sbjct: 63 SNGDRHGGYQPLGQQDPSLYAGLGQNGGGGLPPPPYSPRDQGS 105
|
This family consists of several Gammaherpesvirus latent membrane protein (LMP2) proteins. Epstein-Barr virus is a human Gammaherpesvirus that infects and establishes latency in B lymphocytes in vivo. The latent membrane protein 2 (LMP2) gene is expressed in latently infected B cells and encodes two protein isoforms, LMP2A and LMP2B, that are identical except for an additional N-terminal 119 aa cytoplasmic domain which is present in the LMP2A isoform. LMP2A is thought to play a key role in either the establishment or the maintenance of latency and/or the reactivation of productive infection from the latent state. The significance of LMP2B and its role in pathogenesis remain unclear. Length = 489 |
| >gnl|CDD|165468 PHA03201, PHA03201, uracil DNA glycosylase; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 26/90 (28%), Positives = 37/90 (41%), Gaps = 5/90 (5%)
Query: 11 SNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPP 70
S SP P P P ++P +E+PP P + PPP R+ P++P P P
Sbjct: 6 SRSPSPPRRPSPPRPTPPRSPDASP--EETPPSPPGPGAEPPPGRAAGPAAPRRRPRGCP 63
Query: 71 PSSPPPSSQSPPQSPPPPNSKSPPQSSPPP 100
+ S PP P ++PPP
Sbjct: 64 AGV---TFSSSAPPRPPLGLDDAPAATPPP 90
|
Length = 318 |
| >gnl|CDD|223880 COG0810, TonB, Periplasmic protein TonB, links inner and outer membranes [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 24/103 (23%), Positives = 35/103 (33%), Gaps = 3/103 (2%)
Query: 18 ETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPS 77
E P + P TPP P P P P P P P P+ P P P
Sbjct: 59 EPEPPEEQPKPPTEPETPPEPTPPKPKEKPK--PEKKPKKPKPKPKPKPKPKPKVKPQPK 116
Query: 78 SQSPPQSPPPPNSKSPPQ-SSPPPNTNPPPQSSPPPSNSNASP 119
+ PP +P Q + PP + ++ P ++ +
Sbjct: 117 PKKPPSKTAAKAPAAPNQPARPPSAASASGAATGPSASYLSGL 159
|
Length = 244 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 30/92 (32%), Positives = 40/92 (43%), Gaps = 6/92 (6%)
Query: 19 TPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPP-PDRSPPPSSPPPS-PESPPPSSPPP 76
T P+ SS P+TP +P P P +PP P RS P P P PE+ P P
Sbjct: 408 TAPAAGMTPSSAAPATPAPSAAPSPRVPWDDAPPAPPRSGIPPRPAPRMPEASPVPGAPD 467
Query: 77 SSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQS 108
S S +PP + P S +T P++
Sbjct: 468 SVASASDAPP---TLGDP-SDTAEHTPSGPRT 495
|
Length = 624 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.002
Identities = 17/66 (25%), Positives = 24/66 (36%), Gaps = 3/66 (4%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
+ S+S + P S S PS +P P S P SPP + PP+
Sbjct: 13 HASSSSSSSSQSSPPSSTSPRPRRRKPSASSLLHTPSILPLPKLSSP---SPPSVTLPPA 69
Query: 66 PESPPP 71
+ P
Sbjct: 70 ATTQTP 75
|
Length = 590 |
| >gnl|CDD|223003 PHA03169, PHA03169, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 47/132 (35%), Positives = 55/132 (41%), Gaps = 3/132 (2%)
Query: 13 SPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPS 72
SP+ S AS SPPPS PPS P +PP S P P S PS E P
Sbjct: 119 SPENTSGSSPESPASHSPPPS-PPSHPGPHEPAPPESHNPSPNQQPSSFLQPSHEDSPEE 177
Query: 73 SPPPSSQSPPQSPPPPNSKSPPQSSPP--PNTNPPPQSSPPPSNSNASPPPSQDNPSDPP 130
PP+S+ P SP PP S++P S PP P P SP P + + D P
Sbjct: 178 PEPPTSEPEPDSPGPPQSETPTSSPPPQSPPDEPGEPQSPTPQQAPSPNTQQAVEHEDEP 237
Query: 131 PGDSNNGSSPPG 142
G PG
Sbjct: 238 TEPEREGPPFPG 249
|
Length = 413 |
| >gnl|CDD|200219 TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogenase, E2 component, dihydrolipoamide succinyltransferase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 13/58 (22%), Positives = 22/58 (37%)
Query: 63 PPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPP 120
P+ E P S S +P + P++ P + P ++ P +S S P
Sbjct: 209 EPAEEEAPAPSEAGSEPAPDPAARAPHAAPDPPAPAPAPAKTAAPAAAAPVSSGDSGP 266
|
This model represents an Actinobacterial clade of E2 enzyme, a component of the 2-oxoglutarate dehydrogenase complex involved in the TCA cycle. These proteins have multiple domains including the catalytic domain (pfam00198), one or two biotin domains (pfam00364) and an E3-component binding domain (pfam02817). Length = 579 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 17/81 (20%), Positives = 31/81 (38%), Gaps = 6/81 (7%)
Query: 54 DRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPS 113
+ P +PP +P P P ++ ++ P + P++ P P + P P
Sbjct: 13 EAEQPAPAPPSPAAAPAPPPPAKTAAPATKAAAPA--AAAPRAEKPKKDKPRRERKPKP- 69
Query: 114 NSNASPPPSQDNPSDPPPGDS 134
AS +D +P G +
Sbjct: 70 ---ASLWKLEDFVVEPQEGKT 87
|
Length = 475 |
| >gnl|CDD|152960 pfam12526, DUF3729, Protein of unknown function (DUF3729) | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.002
Identities = 24/78 (30%), Positives = 26/78 (33%), Gaps = 2/78 (2%)
Query: 21 PSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQS 80
P S PPP P P +PPP S PP P P+ PP P S
Sbjct: 31 PPESAHPDDPPPVGDPR--PPVVDTPPPVSAVWVLPPPSEPAAPPPDPEPPVPGPAGPPS 88
Query: 81 PPQSPPPPNSKSPPQSSP 98
P P P P P
Sbjct: 89 PLAPPAPARKPPLPPPRP 106
|
This family of proteins is found in viruses. Proteins in this family are typically between 145 and 1707 amino acids in length. The family is found in association with pfam01443, pfam01661, pfam05417, pfam01660, pfam00978. There is a single completely conserved residue L that may be functionally important. Length = 115 |
| >gnl|CDD|183854 PRK13042, PRK13042, superantigen-like protein; Reviewed | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 22/74 (29%), Positives = 31/74 (41%), Gaps = 6/74 (8%)
Query: 17 AETPPSPS-RASSSPPPSTPPSDESPPPSSPPPSSP---PPDRSPPPSSPPPSPESPPPS 72
A TP S A S PPST P++ P S P ++P ++P + P S
Sbjct: 30 ATTPSSTKVEAPQSTPPSTKVEAPQSKPNATTPPSTKVEAPQQTPNATTPSSTKVETPQS 89
Query: 73 SPPPSSQSPPQSPP 86
P + Q P + P
Sbjct: 90 --PTTKQVPTEINP 101
|
Length = 291 |
| >gnl|CDD|183854 PRK13042, PRK13042, superantigen-like protein; Reviewed | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 21/76 (27%), Positives = 40/76 (52%), Gaps = 4/76 (5%)
Query: 26 ASSSPPPSTP-PSDESPPPSSPPPS-SPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQ 83
A+++ P ST + +S PPS+ + P+ + PPS+ +P+ P ++ P S++ +
Sbjct: 28 ANATTPSSTKVEAPQSTPPSTKVEAPQSKPNATTPPSTKVEAPQQTPNATTPSSTKV--E 85
Query: 84 SPPPPNSKSPPQSSPP 99
+P P +K P P
Sbjct: 86 TPQSPTTKQVPTEINP 101
|
Length = 291 |
| >gnl|CDD|166942 PRK00404, tatB, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 19/60 (31%), Positives = 24/60 (40%), Gaps = 5/60 (8%)
Query: 32 PSTPPSDESPPPSSPPPSSPPPDRS---PPPSSPPPSPESPPPSSPPPSSQSPPQSPPPP 88
P TPP P P +PP + P PP S+P P P ++ P P PP
Sbjct: 81 PLTPP--APPEPVTPPTAQSPAPAVPTPPPTSTPAVPPAPAAAVPAPAAAPPPSDPPQPP 138
|
Length = 141 |
| >gnl|CDD|236154 PRK08119, PRK08119, flagellar motor switch protein; Validated | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 0.002
Identities = 14/77 (18%), Positives = 22/77 (28%), Gaps = 4/77 (5%)
Query: 40 SPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPP 99
+ + P+ P+ Q+PPQ P P P
Sbjct: 225 GEEEEEEEEVEEEE--AQASPAAEPATAQAAPAPKQEQQQAPPQRQEPEKEAQPVNVQPA 282
Query: 100 PNTN--PPPQSSPPPSN 114
+ PPP ++ P N
Sbjct: 283 QFQSFDPPPLATTEPRN 299
|
Length = 382 |
| >gnl|CDD|234818 PRK00708, PRK00708, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 15/101 (14%), Positives = 35/101 (34%)
Query: 22 SPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSP 81
+ S + P +P P +PP P P+ + + ++P ++
Sbjct: 98 KATSMSEPATENKPAEVTTPVEPMGLPETPPAVPVPAPAPAVAAAAAQAAAAPKAPAKPR 157
Query: 82 PQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPS 122
+SP P +P + ++ P ++ + P+
Sbjct: 158 AKSPRPAAKAAPKPTETITAKKAKKTAAAPKPTADKTATPA 198
|
Length = 209 |
| >gnl|CDD|227505 COG5178, PRP8, U5 snRNP spliceosome subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 20/45 (44%), Positives = 22/45 (48%), Gaps = 16/45 (35%)
Query: 44 SSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPP 88
+S PP +PPP PPP P PPS PPP PPPP
Sbjct: 2 ASLPPGNPPP--------PPPPPGFEPPSQPPP--------PPPP 30
|
Length = 2365 |
| >gnl|CDD|197891 smart00818, Amelogenin, Amelogenins, cell adhesion proteins, play a role in the biomineralisation of teeth | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 22/82 (26%), Positives = 27/82 (32%)
Query: 31 PPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNS 90
P P + P P S P + P+ P P+ + P P P P PP
Sbjct: 62 PAQQPVVPQQPLMPVPGQHSMTPTQHHQPNLPQPAQQPFQPQPLQPPQPQQPMQPQPPVH 121
Query: 91 KSPPQSSPPPNTNPPPQSSPPP 112
PP PP P PP
Sbjct: 122 PIPPLPPQPPLPPMFPMQPLPP 143
|
They seem to regulate formation of crystallites during the secretory stage of tooth enamel development and are thought to play a major role in the structural organisation and mineralisation of developing enamel. The extracellular matrix of the developing enamel comprises two major classes of protein: the hydrophobic amelogenins and the acidic enamelins. Circular dichroism studies of porcine amelogenin have shown that the protein consists of 3 discrete folding units: the N-terminal region appears to contain beta-strand structures, while the C-terminal region displays characteristics of a random coil conformation. Subsequent studies on the bovine protein have indicated the amelogenin structure to contain a repetitive beta-turn segment and a "beta-spiral" between Gln112 and Leu138, which sequester a (Pro, Leu, Gln) rich region. The beta-spiral offers a probable site for interactions with Ca2+ ions. Muatations in the human amelogenin gene (AMGX) cause X-linked hypoplastic amelogenesis imperfecta, a disease characterised by defective enamel. A 9bp deletion in exon 2 of AMGX results in the loss of codons for Ile5, Leu6, Phe7 and Ala8, and replacement by a new threonine codon, disrupting the 16-residue (Met1-Ala16) amelogenin signal peptide. Length = 165 |
| >gnl|CDD|237011 PRK11892, PRK11892, pyruvate dehydrogenase subunit beta; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.002
Identities = 12/61 (19%), Positives = 24/61 (39%), Gaps = 2/61 (3%)
Query: 12 NSPDA--AETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESP 69
N+P A E S S A ++P + + +P ++ + P++P +
Sbjct: 71 NTPIAVLLEEGESASDAGAAPAAAAEAAAAAPAAAAAAAAKKAAPAPAAPAAPAAEVAAD 130
Query: 70 P 70
P
Sbjct: 131 P 131
|
Length = 464 |
| >gnl|CDD|177618 PHA03381, PHA03381, tegument protein VP22; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 26/129 (20%), Positives = 38/129 (29%), Gaps = 1/129 (0%)
Query: 14 PDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSS 73
D A +R S DE+ S D P P P + P +S
Sbjct: 41 ADRARRGAGQARGRSQAERRFHHYDEARADYPYYTGSSSEDERPADPRPSRRPHAQPEAS 100
Query: 74 PPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGD 133
P ++ P + SP P P P+ + P ++ S P P
Sbjct: 101 GPGPARGAR-GPAGSRGRGRRAESPSPRDPPNPKGASAPRGRKSACADSAALLDAPAPAA 159
Query: 134 SNNGSSPPG 142
+P G
Sbjct: 160 PKRQKTPAG 168
|
Length = 290 |
| >gnl|CDD|220633 pfam10214, Rrn6, RNA polymerase I-specific transcription-initiation factor | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 23/92 (25%), Positives = 30/92 (32%), Gaps = 12/92 (13%)
Query: 8 PGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPE 67
P V++S P+ SS T S PS+P P + P
Sbjct: 654 PDVTDSSQLESQSQIPTIRSSQQVSQTRKGGSSVVPSAPAP----------RLAQSSQPP 703
Query: 68 SPPPSSPPPSSQSPP--QSPPPPNSKSPPQSS 97
+ SS P S S S P S+S S
Sbjct: 704 TSQSSSDLPPSSSQAFSLSDLPMQSQSESGLS 735
|
RNA polymerase I-specific transcription-initiation factor Rrn6 and Rrn7 represent components of a multisubunit transcription factor essential for the initiation of rDNA transcription by Pol I. These proteins are found in fungi. Length = 753 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 21/85 (24%), Positives = 30/85 (35%), Gaps = 4/85 (4%)
Query: 2 EDNNQSPGVSNSPDAAETPPSPSRASSSPPP-STPPSDESPPPSSPPPSSPPPDRSPPPS 60
+ SP S++ P S ++ + +PP S P P PPS+ P P
Sbjct: 396 AAASPSPSQSSAAAQPSAPQSATQPAGTPPTVSVDPPAAVP---VNPPSTAPQAVRPAQF 452
Query: 61 SPPPSPESPPPSSPPPSSQSPPQSP 85
SS PS+ P Q
Sbjct: 453 KEEKKIPVSKVSSLGPSTLRPIQEK 477
|
Length = 614 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 24/121 (19%), Positives = 39/121 (32%), Gaps = 3/121 (2%)
Query: 21 PSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQS 80
P+P + P+ PS + P P + + PPP +P P
Sbjct: 649 PTPHQPPQVEITPYKPTWTQIGHIPYQPSPTGANTMLPIQWAPGTMQ-PPPRAPTPMR-- 705
Query: 81 PPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSP 140
PP +PP + + P + PP+ + P P P + G +
Sbjct: 706 PPAAPPGRAQRPAAATGRARPPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPGRAR 765
Query: 141 P 141
P
Sbjct: 766 P 766
|
Length = 991 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 13/57 (22%), Positives = 24/57 (42%), Gaps = 1/57 (1%)
Query: 7 SPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPP 63
+P +P A PP A+ + P + P+ PP++ P + D + S+
Sbjct: 393 TPAAPAAPPPAAAPP-VPPAAPARPAAARPAPAPAPPAAAAPPARSADPAAAASAGD 448
|
Length = 576 |
| >gnl|CDD|218332 pfam04929, Herpes_DNAp_acc, Herpes DNA replication accessory factor | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.003
Identities = 16/94 (17%), Positives = 28/94 (29%), Gaps = 2/94 (2%)
Query: 33 STPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKS 92
+ S E+ P S S PSP P S PS+++PP + + +
Sbjct: 288 NADSSVEANGVEPEPTGSVSDRPRHLSSDSSPSP--PDTSDSDPSTETPPPASLSHSPPA 345
Query: 93 PPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNP 126
+ + + + NP
Sbjct: 346 AFERPLALSPKRKREGDKKQKKKKSKKLKLTFNP 379
|
Replicative DNA polymerases are capable of polymerising tens of thousands of nucleotides without dissociating from their DNA templates. The high processivity of these polymerases is dependent upon accessory proteins that bind to the catalytic subunit of the polymerase or to the substrate. The Epstein-Barr virus (EBV) BMRF1 protein is an essential component of the viral DNA polymerase and is absolutely required for lytic virus replication. BMRF1 is also a transactivator. This family is predicted to have a UL42 like structure. Length = 381 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 35/143 (24%), Positives = 49/143 (34%), Gaps = 13/143 (9%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
+ + SP E+P SP R PPP PS P SP P +SP P P
Sbjct: 616 ELLDIPKSPKRPESPKSPKR----PPPPQRPSSPERPEGPKIIKSPKPPKSPKPPFDPKF 671
Query: 66 PESPPPSSPPPSSQS--------PPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNA 117
E +++S +S ++ P++ P T P P P +
Sbjct: 672 KEKFYDDYLDAAAKSKETKTTVVLDESFESILKETLPETPGTPFTTPRPLPPKLPRDEEF 731
Query: 118 SPPPSQDNPSDPPPGDSNNGSSP 140
P D P P D + P
Sbjct: 732 PFEPIGD-PDAEQPDDIEFFTPP 753
|
Length = 943 |
| >gnl|CDD|223061 PHA03369, PHA03369, capsid maturational protease; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 18/89 (20%), Positives = 24/89 (26%), Gaps = 1/89 (1%)
Query: 44 SSPPPSSP-PPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNT 102
S PS + P + P P P S P + + P
Sbjct: 352 SLTAPSRVLAAAAKVAVIAAPQTHTGPADRQRPQRPDGIPYSVPARSPMTAYPPVPQFCG 411
Query: 103 NPPPQSSPPPSNSNASPPPSQDNPSDPPP 131
+P S P + S P P P P
Sbjct: 412 DPGLVSPYNPQSPGTSYGPEPVGPVPPQP 440
|
Length = 663 |
| >gnl|CDD|220401 pfam09786, CytochromB561_N, Cytochrome B561, N terminal | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 25/99 (25%), Positives = 32/99 (32%), Gaps = 5/99 (5%)
Query: 42 PPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPN 101
+ +P +S P P S P S SP + S Q S P
Sbjct: 113 VSQAKKSPPASKTSTPMNTSEPLVPGHSSFSDSPSRSASP---SRKFSPSSTIQQS-PQL 168
Query: 102 TNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSP 140
T +SP S + S S P + SN SSP
Sbjct: 169 TPSNKPASPSSSYQSPS-YSSSLGPVNSSGNRSNLRSSP 206
|
Members of this family are found in the N terminal region of cytochrome B561, as well as in various other putative uncharacterized proteins. Length = 559 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 28/115 (24%), Positives = 45/115 (39%), Gaps = 14/115 (12%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPP--SSPPPDRSPPPSS-- 61
P S D + P P A P P+D P + P ++ P+ +P PS+
Sbjct: 174 APPLGEGSADGSCDPALPLSA-----PRLGPADVFVPATPRPTPRTTASPETTPTPSTTT 228
Query: 62 -PPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNS 115
PP + P S ++ +P + +PP +P PP ++P P S
Sbjct: 229 SPPSTT--IPAPSTTIAAPQAGTTPEAEGTPAPP--TPGGGEAPPANATPAPEAS 279
|
Length = 401 |
| >gnl|CDD|220271 pfam09507, CDC27, DNA polymerase subunit Cdc27 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 19/86 (22%), Positives = 23/86 (26%), Gaps = 8/86 (9%)
Query: 42 PPSSPPPSSPPPDRSPPPSSPPPSPESPP------PSSPPPSSQSPPQSPPPPNSKSPPQ 95
P + P PP +P SP P PSS PP S P+ K+
Sbjct: 128 GPITNPNVKRRTGVGLPPVAPAASPALKPTANGKRPSSKPPKSIMSPEVKVKSAKKTQDT 187
Query: 96 SSP--PPNTNPPPQSSPPPSNSNASP 119
S T N
Sbjct: 188 SKETTTEKTEGKTSVKAASLKRNPPK 213
|
This protein forms the C subunit of DNA polymerase delta. It carries the essential residues for binding to the Pol1 subunit of polymerase alpha, from residues 293-332, which are characterized by the motif D--G--VT, referred to as the DPIM motif. The first 160 residues of the protein form the minimal domain for binding to the B subunit, Cdc1, of polymerase delta, the final 10 C-terminal residues, 362-372, being the DNA sliding clamp, PCNA, binding motif. Length = 427 |
| >gnl|CDD|235899 PRK06975, PRK06975, bifunctional uroporphyrinogen-III synthetase/uroporphyrin-III C-methyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 16/64 (25%), Positives = 27/64 (42%), Gaps = 7/64 (10%)
Query: 17 AETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPP 76
A+ P+ A+ +P T +D S P ++ P +PPP+P + PP P
Sbjct: 266 ADAAAQPATAAPAPSRMTDTNDSKSVTSQPAAAAAAP-------APPPNPPATPPEPPAR 318
Query: 77 SSQS 80
+
Sbjct: 319 RGRG 322
|
Length = 656 |
| >gnl|CDD|220708 pfam10349, WWbp, WW-domain ligand protein | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.003
Identities = 18/71 (25%), Positives = 24/71 (33%), Gaps = 3/71 (4%)
Query: 51 PPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSP 110
P R PP + P +PP PPP + P PPP +S
Sbjct: 38 QPVSRESGYYPPPGAYVHLEPLPAYGQYAAPPPYGPPPPY---YPAPPGVYPTPPPPNSG 94
Query: 111 PPSNSNASPPP 121
++ PPP
Sbjct: 95 YMADPQEPPPP 105
|
The WWbp domain is characterized by several short PY and PT-like motifs of the PPPPY form. These appear to bind directly to the WW domains of WWP1 and WWP2 and other such diverse proteins as dystrophin and YAP (Yes-associated protein). This is the WW-domain binding protein WWbp via PY and PY_like motifs. The presence of a phosphotyrosine residue in the pWBP-1 peptide abolishes WW domain binding which suggests a potential regulatory role for tyrosine phosphorylation in modulating WW domain-ligand interactions. Given the likelihood that WWP1 and WWP2 function as E3 ubiquitin-protein ligases, it is possible that initial substrate-specific recognition occurs via WW domain-substrate protein interaction followed by ubiquitin transfer and subsequent proteolysis. This domain lies just downstream of the GRAM (pfam02893) in many members. Length = 111 |
| >gnl|CDD|227505 COG5178, PRP8, U5 snRNP spliceosome subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.003
Identities = 16/30 (53%), Positives = 17/30 (56%), Gaps = 4/30 (13%)
Query: 42 PPSSPPPSSPPPDRSPPPSSPPPSPESPPP 71
PP +PPP PPP PP PPP PPP
Sbjct: 5 PPGNPPPPPPPPGFEPPSQPPPP----PPP 30
|
Length = 2365 |
| >gnl|CDD|221818 pfam12868, DUF3824, Domain of unknwon function (DUF3824) | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 27/81 (33%), Positives = 35/81 (43%), Gaps = 3/81 (3%)
Query: 36 PSDESPPPSSPPPSSPPPDRSPPPSS---PPPSPESPPPSSPPPSSQSPPQSPPPPNSKS 92
+E P+ PPS P D P+S PPP +P P P +P PPPP +
Sbjct: 49 SYEEPYDPTPYPPSPPVSDPRYYPNSNYFPPPPGSTPVPPPGPQPGYNPADYPPPPGAVP 108
Query: 93 PPQSSPPPNTNPPPQSSPPPS 113
PPQ+ P P +P P
Sbjct: 109 PPQNYPYPPGPGQDPYAPRPR 129
|
This is a repeating domain found in fungal proteins. It is proline-rich, and the function is not known. Length = 135 |
| >gnl|CDD|219133 pfam06682, DUF1183, Protein of unknown function (DUF1183) | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 20/80 (25%), Positives = 24/80 (30%), Gaps = 9/80 (11%)
Query: 134 SNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSSSSNSPNGNRSGA 193
S G G G G G G + PPPP S+ P GA
Sbjct: 179 SCGGVRGGPRPERAGYGGGGGGGGGGGGGGGSGP-------GPPPPGFKSSFPPPYGPGA 231
Query: 194 LSPPNKSNGSSSSPSSNNGS 213
P+ GS + S G
Sbjct: 232 --GPSSGYGSGGTRSGQGGW 249
|
This family consists of several eukaryotic proteins of around 360 residues in length. The function of this family is unknown. Length = 317 |
| >gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.003
Identities = 21/65 (32%), Positives = 33/65 (50%), Gaps = 13/65 (20%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA 413
+ Q VH+ VL +G+EVAVK R G +A+++++ R L L+
Sbjct: 138 IAQ-----VHRAVLKSGEEVAVKVQRPGI---RERIEADLKLL-----RRLARLIKRLPP 184
Query: 414 GGKRL 418
GG+RL
Sbjct: 185 GGRRL 189
|
Length = 517 |
| >gnl|CDD|217509 pfam03353, Lin-8, Ras-mediated vulval-induction antagonist | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 22/82 (26%), Positives = 33/82 (40%), Gaps = 9/82 (10%)
Query: 36 PSDESPPPSSPPPSSP-PPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPP 94
+ P S P +S P PP+P+ P PS+ S+ S S S
Sbjct: 180 ANLAVDEPEQSTMSRPQEVKQSVPAQQAPPNPQQPMPSASSESATS--------KSASTS 231
Query: 95 QSSPPPNTNPPPQSSPPPSNSN 116
+ S P +PPP+ P P+ +
Sbjct: 232 RESSPQPQSPPPRRVPAPTVDS 253
|
LIN-8 is a nuclear protein, present at the sites of transcriptional repressor complexes, which interacts with LIN-35 Rb.Lin35 Rb is a product of the class B synMuv gene lin-35 which silences genes required for vulval specification through chromatin modification and remodelling. The biological role of the interaction has not yet been determined however predictions have been made. The interaction shows that class A synMuv genes control vulval induction through the transcriptional regulation of gene expression. LIN-8 normally functions as part of a protein complex however when the complex is absent, other family members can partially replace LIN-8 activity. Length = 316 |
| >gnl|CDD|223041 PHA03321, PHA03321, tegument protein VP11/12; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.003
Identities = 30/138 (21%), Positives = 48/138 (34%), Gaps = 8/138 (5%)
Query: 8 PGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPP----DRSPPPSSPP 63
P + +P PP P RA P+ + P P R P ++PP
Sbjct: 430 PPGAPAPRRDNDPPPPPRARPGSTPACARRARAQRARDAGPEYVDPLGALRRLPAGAAPP 489
Query: 64 PSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQ 123
P P + P + + PP +++ P PP ++PP + P
Sbjct: 490 PEPAAAPSPATYYTRMGGGPPRLPPRNRATETLRPDWG---PPAAAPPEQMEDPYLEP-D 545
Query: 124 DNPSDPPPGDSNNGSSPP 141
D+ D G + +S P
Sbjct: 546 DDRFDRRDGAAAAATSHP 563
|
Length = 694 |
| >gnl|CDD|111949 pfam03109, ABC1, ABC1 family | Back alignment and domain information |
|---|
Score = 38.0 bits (89), Expect = 0.003
Identities = 13/28 (46%), Positives = 17/28 (60%), Gaps = 5/28 (17%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSG 381
+ Q VH+ VL +G+EVAVK R G
Sbjct: 24 IAQ-----VHRAVLKDGEEVAVKVQRPG 46
|
This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117 |
| >gnl|CDD|221745 pfam12737, Mating_C, C-terminal domain of homeodomain 1 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 29/128 (22%), Positives = 37/128 (28%), Gaps = 1/128 (0%)
Query: 4 NNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPP 63
S AA PSP R+ + S SP +SP + SSP
Sbjct: 55 RQTPRQSRRSKRAAHAYPSPERSPALSSERLLSPSPSVLDLSPVLASPQTGKRRRSSSPS 114
Query: 64 PSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQ 123
+ S P S S S P SP +T + S P
Sbjct: 115 DDEDEAERPSKRPRSDSISSSSSPAKPPEACLPSPAASTQDELSEASAAPLPTPSLSPPH 174
Query: 124 DNPSDPPP 131
P+D P
Sbjct: 175 -TPTDTAP 181
|
Mating in fungi is controlled by the loci that determine the mating type of an individual, and only individuals with differing mating types can mate. Basidiomycete fungi have evolved a unique mating system, termed tetrapolar or bifactorial incompatibility, in which mating type is determined by two unlinked loci; compatibility at both loci is required for mating to occur. The multi-allelic tetrapolar mating system is considered to be a novel innovation that could have only evolved once, and is thus unique to the mushroom fungi. This domain is C-terminal to the homeodomain transcription factor region. Length = 418 |
| >gnl|CDD|218115 pfam04502, DUF572, Family of unknown function (DUF572) | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.003
Identities = 23/89 (25%), Positives = 28/89 (31%), Gaps = 9/89 (10%)
Query: 19 TPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS---------PESP 69
PSP SSSP T +S S PSS ++ P +P
Sbjct: 225 NTPSPKSGSSSPAKPTSILKKSAAKRSEAPSSSKAKKNSRGIPKPRDALSSLVVRKKAAP 284
Query: 70 PPSSPPPSSQSPPQSPPPPNSKSPPQSSP 98
+S PSS P P S S
Sbjct: 285 ESTSQSPSSAEPTSESPQTAGNSSLSSLG 313
|
Family of eukaryotic proteins with undetermined function. Length = 321 |
| >gnl|CDD|220648 pfam10243, MIP-T3, Microtubule-binding protein MIP-T3 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 23/139 (16%), Positives = 37/139 (26%), Gaps = 13/139 (9%)
Query: 7 SPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPP---PSSPPPDRSPP----- 58
G S P AA+T P+ + S ++ P P DR P
Sbjct: 81 EKGGSKGP-AAKTKPAKEPKNESGKEEEKEKEQVKEEKKKKKEKPKEEPKDRKPKEEAKE 139
Query: 59 PSSPPPSPESPPPSSPPPSSQSPPQS----PPPPNSKSPPQSSPPPNTNPPPQSSPPPSN 114
P + P + + K PP+ PP PP+
Sbjct: 140 KRPPKEKEKEKEKKVEEPRDREEEKKRERVRAKSRPKKPPKKKPPNKKKEPPEEEKQRQA 199
Query: 115 SNASPPPSQDNPSDPPPGD 133
+ + + P +
Sbjct: 200 AREAVKGKPEEPDVNEERE 218
|
This protein, which interacts with both microtubules and TRAF3 (tumour necrosis factor receptor-associated factor 3), is conserved from worms to humans. The N-terminal region is the microtubule binding domain and is well-conserved; the C-terminal 100 residues, also well-conserved, constitute the coiled-coil region which binds to TRAF3. The central region of the protein is rich in lysine and glutamic acid and carries KKE motifs which may also be necessary for tubulin-binding, but this region is the least well-conserved. Length = 506 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 24/101 (23%), Positives = 41/101 (40%), Gaps = 6/101 (5%)
Query: 7 SPGVSNSPDAAETPPSPSRASSSPPPSTP--PSDESPPPSSPPPSS-PPPDRSPPPSSPP 63
+P +T P+ +S P P+ P+ PPP++P PS+ P D P PP
Sbjct: 393 TPFARGPGGDDQTRPAAPVPASVPTPAPTPVPASAPPPPATPLPSAEPGSDDGPA---PP 449
Query: 64 PSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNP 104
P + P P++ P + ++ + PP +
Sbjct: 450 PERQPPAPATEPAPDDPDDATRKALDALRERRPPEPPGADL 490
|
Length = 3151 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.004
Identities = 26/123 (21%), Positives = 35/123 (28%), Gaps = 4/123 (3%)
Query: 21 PSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQS 80
P P P PP E P P P+ P P + Q
Sbjct: 640 PITFNVLVFPTPHQPPQVEITPYKPTWTQIGHIPYQPSPTGAN---TMLPIQWAPGTMQP 696
Query: 81 PPQSPPP-PNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSS 139
PP++P P +PP + P P + A PP + + PP
Sbjct: 697 PPRAPTPMRPPAAPPGRAQRPAAATGRARPPAAAPGRARPPAAAPGRARPPAAAPGRARP 756
Query: 140 PPG 142
P
Sbjct: 757 PAA 759
|
Length = 991 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.004
Identities = 11/102 (10%), Positives = 30/102 (29%), Gaps = 10/102 (9%)
Query: 16 AAETPPSPSRASSSPPPSTPPSDESPPPSSPP-----PSSPPPDRSP-PPSSPPPSPESP 69
AA PP + ++ P+ P ++ +P R+ P + +P
Sbjct: 60 AAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAPEAQAP--A 117
Query: 70 PPSSPPPSSQSPPQSPPPPNS--KSPPQSSPPPNTNPPPQSS 109
P+ + + + + + + ++
Sbjct: 118 APAERAAAENAARRLARAAAAAPRPRVPADAAAAVADAVKAR 159
|
Length = 484 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 14/73 (19%), Positives = 30/73 (41%)
Query: 76 PSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSN 135
P + + +PP S P +P P +P S P+++ PS+++ + P +
Sbjct: 77 PKTGTGKVAPPAATPTSAPTPTPSPPASPASGMSAAPASAVEEKSPSEESATATAPESPS 136
Query: 136 NGSSPPGNNNNNN 148
G++ +
Sbjct: 137 TSVPSSGSDAAST 149
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 16/70 (22%), Positives = 28/70 (40%), Gaps = 2/70 (2%)
Query: 61 SPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPP 120
P +P ++ + ++ P+ P P ++ P PP + PP A PP
Sbjct: 121 GGAPPAAAPAAAAAAKAEKTTPEKPKAAAPTPEPPAASKP--TPPAAAKPPEPAPAAKPP 178
Query: 121 PSQDNPSDPP 130
P+ +DP
Sbjct: 179 PTPVARADPR 188
|
Length = 418 |
| >gnl|CDD|200219 TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogenase, E2 component, dihydrolipoamide succinyltransferase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.004
Identities = 18/67 (26%), Positives = 25/67 (37%)
Query: 9 GVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPES 68
+ + A E P+PS A S P P P P P+ P + P ++ P S
Sbjct: 204 NAAPAEPAEEEAPAPSEAGSEPAPDPAARAPHAAPDPPAPAPAPAKTAAPAAAAPVSSGD 263
Query: 69 PPPSSPP 75
P P
Sbjct: 264 SGPYVTP 270
|
This model represents an Actinobacterial clade of E2 enzyme, a component of the 2-oxoglutarate dehydrogenase complex involved in the TCA cycle. These proteins have multiple domains including the catalytic domain (pfam00198), one or two biotin domains (pfam00364) and an E3-component binding domain (pfam02817). Length = 579 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 13/59 (22%), Positives = 22/59 (37%), Gaps = 3/59 (5%)
Query: 30 PPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPP 88
P P+ P +P P P ++ P ++ P++ P E P P + P
Sbjct: 17 PAPAPPSPAAAPAPPPPAKTAAPATKAAAPAAAAPRAEKPKKDKP---RRERKPKPASL 72
|
Length = 475 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 22/84 (26%), Positives = 29/84 (34%), Gaps = 2/84 (2%)
Query: 7 SPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPP--PDRSPPPSSPPP 64
PG P + P P +SS P ++ P S P P P + P + P
Sbjct: 182 IPGAIQPPPPSSLPGLPPGSSSLAPSASSTPGNRLPRVSFNPFLPGPSPAQPSAPPASIP 241
Query: 65 SPESPPPSSPPPSSQSPPQSPPPP 88
+P PP PP P P
Sbjct: 242 APPIPPVIQYVAPPPVPPPQPIIP 265
|
Length = 582 |
| >gnl|CDD|215130 PLN02217, PLN02217, probable pectinesterase/pectinesterase inhibitor | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.004
Identities = 24/94 (25%), Positives = 36/94 (38%)
Query: 20 PPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQ 79
P P + +P + S S+ SS P PS+ PP+ P + P
Sbjct: 556 PYIPGLFAGNPGSTNSTPTGSAASSNTTFSSDSPSTVVAPSTSPPAGHLGSPPATPSKIV 615
Query: 80 SPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPS 113
SP SPP + SP + P ++ S+ S
Sbjct: 616 SPSTSPPASHLGSPSTTPSSPESSIKVASTETAS 649
|
Length = 670 |
| >gnl|CDD|177464 PHA02682, PHA02682, ORF080 virion core protein; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (91), Expect = 0.004
Identities = 25/101 (24%), Positives = 39/101 (38%), Gaps = 2/101 (1%)
Query: 31 PPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNS 90
P P SP ++P P+ P +P +P + +P P+ PP ++ + P P
Sbjct: 76 PSGQSPLAPSPACAAPAPACPAC--APAAPAPAVTCPAPAPACPPATAPTCPPPAVCPAP 133
Query: 91 KSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPP 131
P + PP PP P + P + PPP
Sbjct: 134 ARPAPACPPSTRQCPPAPPLPTPKPAPAAKPIFLHNQLPPP 174
|
Length = 280 |
| >gnl|CDD|166942 PRK00404, tatB, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 19/59 (32%), Positives = 27/59 (45%)
Query: 61 SPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASP 119
+P P P P +PP + P P PP + +P P P P ++PPPS+ P
Sbjct: 80 APLTPPAPPEPVTPPTAQSPAPAVPTPPPTSTPAVPPAPAAAVPAPAAAPPPSDPPQPP 138
|
Length = 141 |
| >gnl|CDD|166942 PRK00404, tatB, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 12/55 (21%), Positives = 20/55 (36%)
Query: 57 PPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPP 111
PP P +P + +P + P +P P + + +P P PP
Sbjct: 84 PPAPPEPVTPPTAQSPAPAVPTPPPTSTPAVPPAPAAAVPAPAAAPPPSDPPQPP 138
|
Length = 141 |
| >gnl|CDD|237011 PRK11892, PRK11892, pyruvate dehydrogenase subunit beta; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.004
Identities = 11/54 (20%), Positives = 23/54 (42%)
Query: 9 GVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSP 62
G S S A + A+++P + + + P+ P++P + + P P
Sbjct: 81 GESASDAGAAPAAAAEAAAAAPAAAAAAAAKKAAPAPAAPAAPAAEVAADPDIP 134
|
Length = 464 |
| >gnl|CDD|171499 PRK12438, PRK12438, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 20/55 (36%), Positives = 28/55 (50%), Gaps = 8/55 (14%)
Query: 16 AAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPP 70
T P AS+ PP + PP+ PP + PPP + PP++PP P+ PP
Sbjct: 901 RVATAPGGDAASAPPPGAGPPA--------PPQAVPPPRTTQPPAAPPRGPDVPP 947
|
Length = 991 |
| >gnl|CDD|147601 pfam05505, Ebola_NP, Ebola nucleoprotein | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 39/214 (18%), Positives = 62/214 (28%), Gaps = 16/214 (7%)
Query: 10 VSNSPDAAETPPSPSRASSSPPPSTPPSD----ESPPPSSPPPSSPPP------DRSPPP 59
P + P SR ++ PP P D E S + D
Sbjct: 417 DDVQPRPMDDDPDDSRDTTIPPGVVDPIDGESTEYSSYSDSFVGTNDDLVLFNLDEDDDD 476
Query: 60 SSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASP 119
S P P + Q P+ PP + S N N + S
Sbjct: 477 SKPIPEQAASTYGQTSRERQGIPEPPPGSHQPGNRASQDLNNNNQKQEDESTNPIGKTSL 536
Query: 120 -----PPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNG-NGNGNHNNNNNNNNNKNW 173
P Q+ D ++ S PP ++++ + G + + K
Sbjct: 537 RYQELTPVQEEDEPEDQTDDDDSSLPPLESDDDPGSDNEQGVDLTEVAPPAPVYRDEKEQ 596
Query: 174 HPPPPPSSSSNSPNGNRSGALSPPNKSNGSSSSP 207
P P+ + P G+ S +SN S+P
Sbjct: 597 DEIPHPAQNPQDPTGSIGNVDSDILRSNSKPSAP 630
|
This family consists of Ebola and Marburg virus nucleoproteins. These proteins are responsible for encapsidation of genomic RNA. It has been found that nucleoprotein DNA vaccines can offer protection from the virus. Length = 717 |
| >gnl|CDD|221143 pfam11593, Med3, Mediator complex subunit 3 fungal | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 25/192 (13%), Positives = 51/192 (26%), Gaps = 11/192 (5%)
Query: 20 PPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSP-------PPSPESPPPS 72
+ ++S S + ++ P++ ++ S+P + + +
Sbjct: 122 LGNAGASASITKTSNGSDAATTSSTANTPAAAKVLKANAASAPNTTTGVGSAATTAAISA 181
Query: 73 SPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPG 132
+ + + + P P + Q+ S N +
Sbjct: 182 TTATTPTTTQKKPRKPRQTKKTGPAAAAKAQASAQAQAQASAYNQMGSLGVPQNTSMLAQ 241
Query: 133 DSNNGSSPPGNNNNNNNNGKGNGNGN----GNHNNNNNNNNNKNWHPPPPPSSSSNSPNG 188
N N + NN + N N N N NN P + +N
Sbjct: 242 IPNPTPLMQLLNGVSPNNAMASPLNNMSPMRNLNQMGNQNNGGQMTPSANNGNMNNQSRE 301
Query: 189 NRSGALSPPNKS 200
N P+ S
Sbjct: 302 NSMNQGMTPSAS 313
|
Mediator is a large complex of up to 33 proteins that is conserved from plants to fungi to humans - the number and representation of individual subunits varying with species. It is arranged into four different sections, a core, a head, a tail and a kinase-activity part, and the number of subunits within each of these is what varies with species. Overall, Mediator regulates the transcriptional activity of RNA polymerase II but it would appear that each of the four different sections has a slightly different function. Mediator subunit Hrs1/Med3 is a physical target for Cyc8-Tup1, a yeast transcriptional co-repressor. Length = 381 |
| >gnl|CDD|218881 pfam06070, Herpes_UL32, Herpesvirus large structural phosphoprotein UL32 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 25/160 (15%), Positives = 39/160 (24%), Gaps = 8/160 (5%)
Query: 31 PPSTPPSDESPPPSSPPPSSP--PPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPP 88
P ++SPPP SPP S S S SP P P
Sbjct: 527 RPRIGFINKSPPPKSPPKSRRTLIVALSLASPSTAGSPRPKPSLGKFVIGTDPFAFANTV 586
Query: 89 NSKSPPQSSPP--PNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNN 146
+ + P +S P P S P+ ++ N
Sbjct: 587 RLTDNMRGGNGVGSSVKPKGSASSKPLTG----PGSDLKPATLNGKTPSSSLVGAARNAG 642
Query: 147 NNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSSSSNSP 186
++ K G + + + S+
Sbjct: 643 ASSKVKIPSGLGGFTSPISLLESALEDVLTSATSTPVKKN 682
|
The large phosphorylated protein (UL32-like) of herpes viruses is the polypeptide most frequently reactive in immuno-blotting analyses with antisera when compared with other viral proteins. Length = 777 |
| >gnl|CDD|215621 PLN03188, PLN03188, kinesin-12 family protein; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 20/59 (33%), Positives = 25/59 (42%), Gaps = 3/59 (5%)
Query: 21 PSPSRASSSPPP-STPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSS 78
P+PS S P S E+ PP P +S D P S +SP P PP S+
Sbjct: 23 PNPSSHKSKPSSRKLKSSKENAPP--PDLNSLTSDLKPDHRSASAKLKSPLPPRPPSSN 79
|
Length = 1320 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.004
Identities = 28/117 (23%), Positives = 42/117 (35%), Gaps = 8/117 (6%)
Query: 14 PDAAETPPSPSRASSSPPPS---TPPSDESPPPSSPPPSSP--PPDRSPPPSSPPPSPES 68
P AA TP S SS+ PS P P + ++ + + PS +
Sbjct: 300 PVAAVTPSSAVTQSSAITPSSAAIPSPAVIPSSVTTQSATTTQASAVALSSAGVLPSDVT 359
Query: 69 PPPSSPPPSSQSPPQSPPPPNSKSPPQSSP---PPNTNPPPQSSPPPSNSNASPPPS 122
P + P+++ P P ++ QSS N P S P SN P+
Sbjct: 360 LPGTVALPAAEPVNMQPQPMSTTETQQSSTGNITSTANGPTTSLPAAPASNIPVSPT 416
|
Length = 421 |
| >gnl|CDD|217298 pfam02948, Amelogenin, Amelogenin | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 24/90 (26%), Positives = 27/90 (30%), Gaps = 1/90 (1%)
Query: 31 PPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPES-PPPSSPPPSSQSPPQSPPPPN 89
P P +S P P P P P P + P Q P Q P P
Sbjct: 54 SPQMPQQQQSAHPKLTPHHQLLILPPQQPMMPVPGHHPMVPMTGQQPHLQPPAQHPLQPT 113
Query: 90 SKSPPQSSPPPNTNPPPQSSPPPSNSNASP 119
PQ P +T PP Q P P
Sbjct: 114 YGQNPQPQQPTHTQPPVQPQQPADPQPGQP 143
|
Amelogenins play a role in biomineralisation. They seem to regulate the formation of crystallites during the secretory stage of tooth enamel development. thought to play a major role in the structural organisation and mineralisation of developing enamel. They are found in the extracellular matrix. Mutations in X-chromosomal amelogenin can cause Amelogenesis imperfecta. Length = 174 |
| >gnl|CDD|217453 pfam03251, Tymo_45kd_70kd, Tymovirus 45/70Kd protein | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 31/105 (29%), Positives = 36/105 (34%), Gaps = 10/105 (9%)
Query: 20 PPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPS---SPPP 76
PP+ R P P P + P ++ P PS P P P S PS +
Sbjct: 361 PPTKRRLRLLPVPP-------PKVQALPLTALAPLVRHSPSIPLPHPPSALPSHVGASSS 413
Query: 77 SSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPP 121
P S P S P SP T P PP S SPP
Sbjct: 414 KHHRLPPSVLPGPRLSSPSPSPSLPTRRPGTPPPPASPPTPSPPS 458
|
Tymoviruses are single stranded RNA viruses. This family includes a protein of unknown function that has been named based on its molecular weight. Tymoviruses such as the ononis yellow mosaic tymovirus encode only three proteins. Of these two are overlapping this protein overlaps a larger ORF that is thought to be the polymerase. Length = 458 |
| >gnl|CDD|234977 PRK01741, PRK01741, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 25/150 (16%), Positives = 39/150 (26%), Gaps = 11/150 (7%)
Query: 3 DNNQSPGVSNSPDAAETPPSPSRASSS---PPPSTPPSDESPPPSSPPPSSPPPDRSPP- 58
+ P S + A+ P + + S PPP P E + ++S
Sbjct: 41 TRTRPPSRPISNEEADQPNTLNPQSYVETTPPPFQQPQTEESESENEVQIQQEVEQSVDE 100
Query: 59 -----PSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQ--SSPP 111
P+ P S P +Q QSP N S P SS
Sbjct: 101 IKITLPNQEPAYYMQNHRSEPIQPTQPQYQSPTQTNVASMTIEETQSPNVPIEGINSSSE 160
Query: 112 PSNSNASPPPSQDNPSDPPPGDSNNGSSPP 141
+ ++ + P
Sbjct: 161 QLRVELAELAAEIYSDASHRVELAKNFMEP 190
|
Length = 332 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 724 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.56 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.44 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.43 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.43 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.41 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.41 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.35 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.29 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.26 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.21 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.15 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.14 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.07 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.05 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.04 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.88 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.84 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.84 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.8 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.76 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.74 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.71 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.66 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.62 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.53 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.51 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.49 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.43 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.38 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.33 | |
| KOG1924 | 1102 | consensus RhoA GTPase effector DIA/Diaphanous [Sig | 98.33 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.31 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.28 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.28 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.19 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.18 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.13 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.1 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.06 | |
| KOG1924 | 1102 | consensus RhoA GTPase effector DIA/Diaphanous [Sig | 97.97 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.95 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.92 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.86 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.8 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.77 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.76 | |
| PHA03247 | 3151 | large tegument protein UL36; Provisional | 97.74 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.73 | |
| KOG3671 | 569 | consensus Actin regulatory protein (Wiskott-Aldric | 97.68 | |
| PF04478 | 154 | Mid2: Mid2 like cell wall stress sensor; InterPro: | 97.66 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.66 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.54 | |
| PLN02236 | 344 | choline kinase | 97.46 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 97.44 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.25 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.22 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 97.18 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.11 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.07 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.05 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.93 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.89 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.87 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.8 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.79 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-57 Score=490.95 Aligned_cols=289 Identities=61% Similarity=1.014 Sum_probs=255.8
Q ss_pred ccccCHHHHHHhhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEE
Q 040832 333 QSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCI 412 (724)
Q Consensus 333 ~~~f~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 412 (724)
...|+|+||..+|++|...++||+|+||.||+|.+.+|+.||||++.....+..++|.+|+++|.+++|+|||+|+|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 45799999999999999999999999999999999999999999888765432566999999999999999999999999
Q ss_pred eCC-eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEe
Q 040832 413 AGG-KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADF 491 (724)
Q Consensus 413 ~~~-~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DF 491 (724)
+.+ +++||||||.+|+|+++|+......|+|.+|++||.++|+||+|||+.|.+.|||||||++|||||+++++||+||
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDF 221 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDF 221 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCc
Confidence 999 5999999999999999999865436899999999999999999999999889999999999999999999999999
Q ss_pred ccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCC-chhhhHHhhhhhhhhhcc
Q 040832 492 GLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTG-AMEDCLVDWARPLCLRAL 570 (724)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~-~~~~~l~~w~~~~~~~~~ 570 (724)
|||+.......+......||++|++|||+..+.+++|+|||||||+|+||+||+.+++... ..+..+++|.++++
T Consensus 222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~---- 297 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL---- 297 (361)
T ss_pred cCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH----
Confidence 9997665422222221179999999999999999999999999999999999999998754 34556999986664
Q ss_pred cCCChhhhcchhhh-cCCCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 571 DDGNFNEIADPYLE-KNYPT-EEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 571 ~~~~~~~~vd~~l~-~~~~~-~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
.++.+.+++|+.|. ..+.. +++.++..++.+|++.+++.||+|.||+++|+....
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 45589999999987 66665 799999999999999999999999999999965443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=410.36 Aligned_cols=256 Identities=34% Similarity=0.532 Sum_probs=212.1
Q ss_pred CcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchh--HHHHHHHHHHHHhcCCCCeeEEeeEEEeCC-eEEEEEEec
Q 040832 348 FSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQG--EREFKAEVEIISRVHHRHLVSLVGYCIAGG-KRLLVYEYV 424 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~--~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~-~~~lV~E~~ 424 (724)
+.+.+.||+|+||+||+|.|.....||||++....... .++|.+|+.+|.+|+|||||+|+|+|.+.. ..+|||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 34455699999999999999554449999998654333 458999999999999999999999999987 789999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCccEEEcCCC-CEEEEEeccccccCCCCC
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR-IIHRDIKSSNILLDYTF-ETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~-iiHrDIkp~NILl~~~~-~vkL~DFGla~~~~~~~~ 502 (724)
++|+|.++|+.+....+++..+++|+++||+||.|||++ + |||||||++||||+.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999999985445699999999999999999999998 7 99999999999999997 99999999999876543
Q ss_pred ccccccccCCCcCCcchhc--CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 503 HVSTRVMGTFGYLAPEYAS--SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~--~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
...+...||+.|||||++. ...|++|+|||||||+||||+||+.||......+.... ++.
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~------------------v~~ 260 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASA------------------VVV 260 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHH------------------HHh
Confidence 2223367999999999999 66999999999999999999999999987654221111 111
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
.......+......|..++.+||+.+|++||++.+|+..|+....
T Consensus 261 ~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 261 GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 111122233366778889999999999999999999999986543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-47 Score=407.17 Aligned_cols=255 Identities=32% Similarity=0.474 Sum_probs=221.6
Q ss_pred CcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCC
Q 040832 348 FSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNN 427 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 427 (724)
+++++.||+|.||+||+|.++....||||.++... .....|.+|+++|++|+|+|||+|+|+|..++.++||||||..|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 35678899999999999999777799999998763 34568999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccccc
Q 040832 428 NLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTR 507 (724)
Q Consensus 428 sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 507 (724)
+|.++|...++..+...+.+.|+.|||+||+||+++ ++|||||.++||||+++..|||+|||||+...++.......
T Consensus 287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 999999986677799999999999999999999999 99999999999999999999999999999777776666565
Q ss_pred cccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcC
Q 040832 508 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKN 586 (724)
Q Consensus 508 ~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~ 586 (724)
..-...|.|||.+..++++.|+|||||||+||||+| |+.||......+. . +.++.-..-.
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev----------~---------~~le~GyRlp 424 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV----------L---------ELLERGYRLP 424 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH----------H---------HHHhccCcCC
Confidence 667789999999999999999999999999999999 9999987643331 1 1111112223
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 587 YPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
.+..+...+.+++..||+.+|++||++..+...|+....
T Consensus 425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 456677889999999999999999999999999886543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=385.21 Aligned_cols=246 Identities=30% Similarity=0.469 Sum_probs=207.5
Q ss_pred cccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC-eEEEEEEecC
Q 040832 349 SQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGG-KRLLVYEYVP 425 (724)
Q Consensus 349 ~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~-~~~lV~E~~~ 425 (724)
...+.||+|..|.|||++++ +++.+|+|++..+.. ...+++.+|++++++.+|++||++||.|.+++ .+.|+||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 44678999999999999965 578899999965433 34568999999999999999999999999999 5999999999
Q ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 426 NNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHE-DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 426 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs-~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
+|+|+.++...++ +++..+-+|+.+|++||.|||+ + +||||||||+||||+..|+|||||||.++.+.+. .
T Consensus 162 gGSLd~~~k~~g~--i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~ 233 (364)
T KOG0581|consen 162 GGSLDDILKRVGR--IPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---I 233 (364)
T ss_pred CCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---h
Confidence 9999999987655 8999999999999999999996 5 8999999999999999999999999999988664 4
Q ss_pred ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhh
Q 040832 505 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLE 584 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~ 584 (724)
....+||..|||||.+.+..|+.++||||||+.|+||++|+.||-.... ...+| .++++..+.
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~---~~~~~--------------~~Ll~~Iv~ 296 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP---PYLDI--------------FELLCAIVD 296 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC---CCCCH--------------HHHHHHHhc
Confidence 4667899999999999999999999999999999999999999965310 01112 222222222
Q ss_pred c---CCCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 585 K---NYPT-EEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 585 ~---~~~~-~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+ ..+. ....++..++..||+.||.+|+++.|++++
T Consensus 297 ~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 297 EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1 2223 366779999999999999999999999874
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=383.79 Aligned_cols=204 Identities=31% Similarity=0.493 Sum_probs=182.7
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
.++|.+.+.||+|.||.||+|+++ ++..||||.+... ..+..+-+..|+.+|+.|+|+|||+|++++..++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467888888999999999999954 5789999999765 3334455889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCC------CCEEEEEecccc
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYT------FETKVADFGLAK 495 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~------~~vkL~DFGla~ 495 (724)
|||.||+|.++|+.++. +++..+..++.|||.||++||++ +||||||||.||||+.. -.+||+|||+|+
T Consensus 89 EyC~gGDLs~yi~~~~~--l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGR--LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999998875 99999999999999999999999 99999999999999764 468999999999
Q ss_pred ccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchh
Q 040832 496 LTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAME 555 (724)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~ 555 (724)
.+... .+...++|++.|||||+++..+|+.|+|+||+|+|||+|++|+.||+.....+
T Consensus 164 ~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 164 FLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred hCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 88743 34566889999999999999999999999999999999999999998654433
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=415.46 Aligned_cols=258 Identities=26% Similarity=0.470 Sum_probs=218.7
Q ss_pred hCCCcccceeeccCcEEEEEEEcC------CCcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP------NGKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKR 417 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 417 (724)
..+....+.||+|.||+||+|... +...||||.|+..... ...+|++|+++|..|+|+|||+|+|+|.+++-+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 344566678999999999999843 3467999999987665 567899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcC--------CC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCC
Q 040832 418 LLVYEYVPNNNLEFHLHGK--------GR----PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFE 485 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~--------~~----~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~ 485 (724)
++|+|||..|||.+||... .. ..|+..+.+.||.|||.||+||-++ .+|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceE
Confidence 9999999999999999632 12 2378899999999999999999999 9999999999999999999
Q ss_pred EEEEEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhh
Q 040832 486 TKVADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWAR 563 (724)
Q Consensus 486 vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~ 563 (724)
|||+||||++.....+++ ...+-+-..+||+||.|+.++|+.++|||||||+|||+++ |+.||.+..+.+.
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV------- 714 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV------- 714 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH-------
Confidence 999999999977554444 3445667889999999999999999999999999999999 9999987654432
Q ss_pred hhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 564 PLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 564 ~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
.+.+..+++ -.++.++..++..|+..||+..|++||+++||-..|+...
T Consensus 715 ---Ie~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 715 ---IECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred ---HHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 111222222 3467778889999999999999999999999999998543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=395.43 Aligned_cols=248 Identities=23% Similarity=0.396 Sum_probs=209.9
Q ss_pred CCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
..|..+++||+|||+.||+++. ..|+.||+|++... .....+.+.+||+|.+.|+|+|||+++++|++...+|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4689999999999999999997 78999999999653 2223456899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
|+|.+++|.++++.. ..+++.++..+++||+.||.|||++ +|||||||..||||+++.+|||+|||||..+..+.
T Consensus 98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 999999999998844 3599999999999999999999999 99999999999999999999999999999887543
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
.. ....+||+.|+|||++....++..+||||+|||||-||.|+.||+.....+. +.+ +...+
T Consensus 173 Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket----y~~------Ik~~~------- 234 (592)
T KOG0575|consen 173 ER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET----YNK------IKLNE------- 234 (592)
T ss_pred cc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH----HHH------HHhcC-------
Confidence 22 2447899999999999998999999999999999999999999976432211 100 11111
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
...+........+++..+|+.+|.+||++++|+++
T Consensus 235 ---Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 235 ---YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ---cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 12334555667888999999999999999999973
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=368.52 Aligned_cols=256 Identities=23% Similarity=0.386 Sum_probs=208.5
Q ss_pred CCcccceeeccCcEEEEEEE-cCCCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEee-EEEeCCe-EEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVG-YCIAGGK-RLLVY 421 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~-~~~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g-~~~~~~~-~~lV~ 421 (724)
+|++.+.||+|.||+|||+. +.+|..||.|.++-+. .+..+++..|+.+|++|+|||||++++ .+.++.. ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 46677889999999999998 5689999999987442 233456899999999999999999998 4444444 78999
Q ss_pred EecCCCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 422 EYVPNNNLEFHLHG--KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR--IIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 422 E~~~~gsL~~~L~~--~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~--iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
|||++|+|..+++. +.+..+.+..+|+++.|+++||.++|.+.. + |+||||||.||+|+.+|.|||+||||++++
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~-r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP-RGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc-ccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999998863 455679999999999999999999999433 4 899999999999999999999999999988
Q ss_pred CCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 498 TDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 498 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
....+ .....+||+.||+||.+....|+.|+||||+||+||||+.-+.||.+....+ +.+.+..+++..
T Consensus 179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~----------L~~KI~qgd~~~ 247 (375)
T KOG0591|consen 179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS----------LCKKIEQGDYPP 247 (375)
T ss_pred cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH----------HHHHHHcCCCCC
Confidence 76544 3455789999999999999999999999999999999999999997653222 222334443332
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
+.+ .-....+..++..|+..|++.||+...++..+..
T Consensus 248 ~p~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 248 LPD--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CcH--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 222 3345678899999999999999996666655544
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=382.07 Aligned_cols=265 Identities=27% Similarity=0.423 Sum_probs=220.5
Q ss_pred hhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhH-HHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGE-REFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~-~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
......+.+.||+|-||+|.++....+..||||+++.+..... ++|..|+++|.+|+||||++|+|+|..++.+++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 4456778899999999999999998889999999998876666 689999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC-C
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN-N 501 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~-~ 501 (724)
||++|+|..+|.....+.+.....++|+.||+.||+||.+. ++|||||.++|||+|.++++||+|||+++-+... .
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCc
Confidence 99999999999887665567778889999999999999998 9999999999999999999999999999965444 4
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh--CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT--GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt--G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
.+...+.+-..+|||+|.+.-++++.++|||+|||.|||+++ ...||....+. ..++-...++ ..+-. ..+
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--~vven~~~~~----~~~~~-~~~ 765 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--QVVENAGEFF----RDQGR-QVV 765 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH--HHHHhhhhhc----CCCCc-cee
Confidence 445567778899999999999999999999999999999877 78888754322 2222221111 11100 111
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
...+.-+...+.+++.+||+.+-++||++++|...|..+
T Consensus 766 -----l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 -----LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -----ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 122344566788999999999999999999999999754
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=376.35 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=205.9
Q ss_pred hhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCc-------hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSG-------QGEREFKAEVEIISRVHHRHLVSLVGYCIAGG 415 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~-------~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 415 (724)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||+++.... .....+++|++||++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456788899999999999999984 5799999999964311 12334689999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCC---CCEEEEEec
Q 040832 416 KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYT---FETKVADFG 492 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~---~~vkL~DFG 492 (724)
..||||||++||+|.+++-.++. +.+.....+++|++.||.|||++ ||+||||||+||||..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999999877665 77778889999999999999999 99999999999999665 789999999
Q ss_pred cccccCCCCCccccccccCCCcCCcchhcCCC---CChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhc
Q 040832 493 LAKLTTDNNTHVSTRVMGTFGYLAPEYASSGK---LTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRA 569 (724)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~ 569 (724)
+|+..+. ...+...+||+.|.|||++.+.. +..|.|||||||+||-+|+|..||...... +-+.++
T Consensus 325 lAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~---------~sl~eQ 393 (475)
T KOG0615|consen 325 LAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD---------PSLKEQ 393 (475)
T ss_pred hhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC---------ccHHHH
Confidence 9998873 33446688999999999997653 345899999999999999999999754111 111222
Q ss_pred ccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 570 LDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 570 ~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+..|.+... ..+..+...+.+.++.+||..||++|+++.|++++
T Consensus 394 I~~G~y~f~------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 394 ILKGRYAFG------PLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred HhcCccccc------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 233322111 11223455678899999999999999999999863
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=356.08 Aligned_cols=267 Identities=22% Similarity=0.304 Sum_probs=211.2
Q ss_pred CCCcccceeeccCcEEEEEEEcCC-CcEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPN-GKEVAVKSLRSGSGQ--GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vaVK~l~~~~~~--~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
+.|+...++|+|+||.|||++.++ |+.||||++.....+ -.+-.++|+++|++|+|+|+|.|+++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 457777889999999999999764 899999998754332 23457899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
||+..-|.++-+...+ ++...+.+++.|+++|+.|+|++ +||||||||+||||+.++.+||||||+|+.+.. ..
T Consensus 82 ~~dhTvL~eLe~~p~G--~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNG--VPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG 155 (396)
T ss_pred ecchHHHHHHHhccCC--CCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence 9998877766554444 88999999999999999999999 999999999999999999999999999998875 33
Q ss_pred ccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhh--hhhhhh---hcc-cCCCh
Q 040832 503 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDW--ARPLCL---RAL-DDGNF 575 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w--~~~~~~---~~~-~~~~~ 575 (724)
...+..+.|.||.|||.+.+ ..|....|||++||++.||++|..-|-+.++.++....- .-.++. ..+ .+..|
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 45577889999999999987 689999999999999999999999998876665532111 001111 111 12222
Q ss_pred hhhcchh------hhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 576 NEIADPY------LEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 576 ~~~vd~~------l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+.-+. |+..|+ ....-+++++..|++.||++|.+-+|++.+
T Consensus 236 ~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 2222222 122222 233468899999999999999999999853
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=365.06 Aligned_cols=243 Identities=28% Similarity=0.382 Sum_probs=201.2
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
-++|.+.++||+|+||+||.++.+ .++.+|+|+++... ..+.+...+|..||.+++||+||+++..|.+.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 357899999999999999999854 58899999997642 22345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
+||+.||.|..+|++.+. +.+..+.-++.+|+.||.|||++ +||||||||+|||||++|+++|+||||++.....
T Consensus 104 ld~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EeccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 999999999999998776 88998999999999999999999 9999999999999999999999999999966544
Q ss_pred CCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
... ...++||..|||||++.+..|+..+|.|||||+||||++|..||...+..+ |.+.. ..+.
T Consensus 179 ~~~-t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~-----~~~~I-----~~~k------ 241 (357)
T KOG0598|consen 179 GDA-TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK-----MYDKI-----LKGK------ 241 (357)
T ss_pred CCc-cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH-----HHHHH-----hcCc------
Confidence 332 234789999999999999999999999999999999999999997653221 11111 1111
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCC
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPK 612 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs 612 (724)
...++.-...+..+++...+..+|++|-.
T Consensus 242 ---~~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 242 ---LPLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred ---CCCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 01112223455778888889999999964
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=394.86 Aligned_cols=258 Identities=27% Similarity=0.447 Sum_probs=216.9
Q ss_pred CCCcccceeeccCcEEEEEEEcCC----CcEEEEEEeccCCchh-HHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPN----GKEVAVKSLRSGSGQG-EREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~----g~~vaVK~l~~~~~~~-~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
...++.++||.|.||+||+|+++- ...||||.||.+..+. .++|+.|+.||.+++||||++|.|+.....-.+||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 345788999999999999999752 3469999999875544 56899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
.|||++|.|+.||+.+++. +.+.+++.|+++||.|+.||-+. ++|||||.++||||+.|..+||+||||++.+.++
T Consensus 709 TEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 9999999999999987764 89999999999999999999999 9999999999999999999999999999988766
Q ss_pred CCccccc--cccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 501 NTHVSTR--VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 501 ~~~~~~~--~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
.....+. ..-..+|.|||.+..++++.++|||||||+|||.++ |.+||-++.+.+. .+.++.+
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV----------IkaIe~g---- 850 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV----------IKAIEQG---- 850 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH----------HHHHHhc----
Confidence 5322222 223478999999999999999999999999999998 9999855432221 1111111
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCCc
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSL 626 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~~ 626 (724)
+.--.+.++..-|.+|++.||++|-.+||++.|||.+|.+.+-.
T Consensus 851 -----yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 851 -----YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred -----cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 11123557788899999999999999999999999999987653
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=370.23 Aligned_cols=264 Identities=26% Similarity=0.350 Sum_probs=206.2
Q ss_pred CCcccceeeccCcEEEEEEE-cCCCcEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCeeEEeeEEEeC--CeEEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQ--GEREFKAEVEIISRVHHRHLVSLVGYCIAG--GKRLLVY 421 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~-~~~g~~vaVK~l~~~~~~--~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV~ 421 (724)
.|..++.||+|.||.||||+ ..+|+.||+|+++.+..+ ..+...+||.||++|+|+||++|.+...+. +.+|||+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 34455679999999999999 457999999999876432 335678999999999999999999998876 7899999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
|||++ +|.-++...+ ..|++.++..|+.||+.||+|||.+ +|+|||||.+|||||++|.+||+|||||+++....
T Consensus 198 eYMdh-DL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred ecccc-hhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 99966 4555665433 3589999999999999999999999 99999999999999999999999999999888777
Q ss_pred CccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhccc-CC---Ch-
Q 040832 502 THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALD-DG---NF- 575 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~-~~---~~- 575 (724)
....+..+-|+||.+||.+.+. .|+.+.|+||.||||.||++|+..|.+..++++....+. +|..--+ .+ ++
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfk--lcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFK--LCGSPTEDYWPVSKLP 350 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHH--HhCCCChhccccccCC
Confidence 6667777889999999999874 799999999999999999999999998877766433221 0110000 00 00
Q ss_pred -hhhc------chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 576 -NEIA------DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 576 -~~~v------d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
...+ ..++.+. -.......++|+..+|..||.+|.++.++++
T Consensus 351 ~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0011 1111111 1112244677888889999999999999886
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=355.11 Aligned_cols=261 Identities=22% Similarity=0.316 Sum_probs=214.6
Q ss_pred hCCCcccceeeccCcEEEEEEE-cCCCcEEEEEEeccC-CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSG-SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~-~~~g~~vaVK~l~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
.+.|++.++||.|..+.||+|+ ...++.||||++.-+ +..+...+++|+..|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4678999999999999999998 556799999999754 44446789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
||.+|++.+++...-...|++..+..|++++++||.|||.+ |.||||||+.||||+.+|.|||+|||.+..+.+...
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999875555599999999999999999999999 999999999999999999999999999877655443
Q ss_pred ccc---cccccCCCcCCcchhcC--CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 503 HVS---TRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 503 ~~~---~~~~gt~~y~APE~~~~--~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
... ...+|++.|||||+++. ..|+.|+||||||+..+||.+|..||.....++..+...... ...
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~----------pp~ 251 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQND----------PPT 251 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC----------CCC
Confidence 322 44689999999999654 479999999999999999999999999887776544432211 110
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
++-..+..+-....-..|.+++..|+..||++||+++++++
T Consensus 252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11111111112222347889999999999999999999885
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=360.27 Aligned_cols=254 Identities=28% Similarity=0.425 Sum_probs=206.6
Q ss_pred CCCcccceeeccCcEEEEEEEcCC-CcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC--eEEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPN-GKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGG--KRLLVYE 422 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~--~~~lV~E 422 (724)
.+|..+++||+|.||.||++...+ |+..|||.+........+.+.+|+.+|++|+|+|||+++|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 457778899999999999999754 8999999987653333567899999999999999999999855444 6889999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC-CCCEEEEEeccccccCC--
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY-TFETKVADFGLAKLTTD-- 499 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~-~~~vkL~DFGla~~~~~-- 499 (724)
|+.+|+|.+++.+.+. .|++..++++++||++||+|||++ +|||||||++||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999998776 699999999999999999999999 9999999999999999 79999999999987764
Q ss_pred CCCccccccccCCCcCCcchhcCCC-CChhHHHHHHHHHHHHHHhCCCCCCCC-CchhhhHHhhhhhhhhhcccCCChhh
Q 040832 500 NNTHVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGRRPIDPT-GAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 500 ~~~~~~~~~~gt~~y~APE~~~~~~-~t~ksDV~SlGvlL~eLltG~~P~~~~-~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
........+.||+.|||||++..+. ...++|||||||+++||+||+.||... ...+..+..+.. .
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~---------~---- 239 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE---------D---- 239 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc---------C----
Confidence 2222234578999999999999643 345999999999999999999999753 222211111110 0
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
....++........+++..|+..+|++||++.+++++.-
T Consensus 240 -----~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 240 -----SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred -----CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 111334445566888999999999999999999998754
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=366.52 Aligned_cols=269 Identities=22% Similarity=0.301 Sum_probs=212.7
Q ss_pred hhCCCcccceeeccCcEEEEEEE-cCCCcEEEEEEeccCCchhHH-HHHHHHHHHHhcC-CCCeeEEeeEEEeCC-eEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGER-EFKAEVEIISRVH-HRHLVSLVGYCIAGG-KRLL 419 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~-~~~g~~vaVK~l~~~~~~~~~-~f~~Ei~il~~l~-HpnIv~l~g~~~~~~-~~~l 419 (724)
..++|...+.||.|.||.||+|. ...++.||||+++..-...++ --++|+..|++|+ |+||++|.+++.+.+ .+|+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 45678999999999999999999 456889999999765333222 3578999999998 999999999999888 9999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
||||| ..+|++++.++ +..+.+..+..|+.||++||+|+|.+ |+.||||||+||||..+..+||+||||||....
T Consensus 88 VfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccccc
Confidence 99999 57899999887 56799999999999999999999999 999999999999999888999999999998865
Q ss_pred CCCccccccccCCCcCCcchhc-CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHH-----------hhhhhhhh
Q 040832 500 NNTHVSTRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLV-----------DWARPLCL 567 (724)
Q Consensus 500 ~~~~~~~~~~gt~~y~APE~~~-~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~-----------~w~~~~~~ 567 (724)
... .+..+-|.||.|||++. .+.|+.+.|||++|||++||++-+.-|-+.++.++... +|.....+
T Consensus 163 kpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 163 KPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred CCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 443 36678899999999875 67899999999999999999999999988876655321 11111000
Q ss_pred hcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 040832 568 RALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRAL 620 (724)
Q Consensus 568 ~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L 620 (724)
.....-.|..+.--.+..-. .......++++.+|+++||++||++.|.+++-
T Consensus 241 a~~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 00000111111111111111 23667789999999999999999999999853
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=367.12 Aligned_cols=259 Identities=26% Similarity=0.424 Sum_probs=204.1
Q ss_pred hCCCcccceeeccCcEEEEEEEc------CCCcEEEEEEeccCCch-hHHHHHHHHHHHHhc-CCCCeeEEeeEEEeC-C
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL------PNGKEVAVKSLRSGSGQ-GEREFKAEVEIISRV-HHRHLVSLVGYCIAG-G 415 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~-~ 415 (724)
.++|.+.++||+|+||.||+|.+ ..++.||||+++..... ..+.+.+|+++|.++ +|+||++++++|... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46789999999999999999974 23467999999754332 345689999999999 899999999988764 4
Q ss_pred eEEEEEEecCCCCHHHHHhcCC----------------------------------------------------------
Q 040832 416 KRLLVYEYVPNNNLEFHLHGKG---------------------------------------------------------- 437 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~~---------------------------------------------------------- 437 (724)
..++||||+++|+|.++|....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 5789999999999999987532
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc-cccccccCCCc
Q 040832 438 --RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH-VSTRVMGTFGY 514 (724)
Q Consensus 438 --~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y 514 (724)
...+.+..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++........ ......++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 12377888999999999999999998 9999999999999999999999999999866433222 12234466789
Q ss_pred CCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHH
Q 040832 515 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMA 593 (724)
Q Consensus 515 ~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~ 593 (724)
+|||++.+..++.++|||||||+||||++ |+.||......+.... .+..+... ..+.....
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~---------~~~~~~~~---------~~~~~~~~ 304 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ---------RLKDGTRM---------RAPENATP 304 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH---------HHhcCCCC---------CCCCCCCH
Confidence 99999999999999999999999999997 9999976432221111 01111100 01112334
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 594 RMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 594 ~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
.+.+++.+||+.+|++||++.||++.|+...
T Consensus 305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 305 EIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 6889999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=371.78 Aligned_cols=265 Identities=27% Similarity=0.448 Sum_probs=210.6
Q ss_pred HHHHHhhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCe
Q 040832 339 EELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGK 416 (724)
Q Consensus 339 ~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 416 (724)
++.+...+.+.+++.||+|.||+||+|+|. ..||||+|+.+.. +..+.|++|+.+|++-+|.||+-++|||...+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 444555566678899999999999999983 3599999986633 345679999999999999999999999999887
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
.||..||+|.+|+.+||... ..|+..+.+.|+.|||+|+.|||.+ +|||||||..||||+++++|||+||||+..
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred -eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceee
Confidence 99999999999999999755 3589999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCCc-cccccccCCCcCCcchhcC---CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccC
Q 040832 497 TTDNNTH-VSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDD 572 (724)
Q Consensus 497 ~~~~~~~-~~~~~~gt~~y~APE~~~~---~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~ 572 (724)
....... ....-.|...|||||+++. ..|++.+|||+||+++|||++|..||... ..+..+ |. +-.
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dqIi--fm-------VGr 607 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQII--FM-------VGR 607 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-ChhheE--EE-------ecc
Confidence 5432211 1222347788999999964 46899999999999999999999999832 222222 11 111
Q ss_pred CChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 573 GNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 573 ~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
|.+. .|.. ....++.+.|.+|+..||..++++||.+.+|+..|+...-
T Consensus 608 G~l~--pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 608 GYLM--PDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cccC--ccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 2110 1111 0122455678888999999999999999999998876543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=395.31 Aligned_cols=258 Identities=31% Similarity=0.482 Sum_probs=214.1
Q ss_pred CCCcccceeeccCcEEEEEEEcCC--Cc----EEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPN--GK----EVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRL 418 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~--g~----~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 418 (724)
...++.+.||+|.||+||+|...+ +. .||||.++.... ++..+|++|..+|++++|+|||+++|+|.+.+..+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 344667889999999999999543 33 499999987644 44568999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecc
Q 040832 419 LVYEYVPNNNLEFHLHGK-----GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGL 493 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~-----~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGl 493 (724)
||+|||++|+|..+|++. ....|...+++.|+.+||+|+.||+++ ++|||||..+|+||+....|||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999865 234588999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhccc
Q 040832 494 AKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALD 571 (724)
Q Consensus 494 a~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~ 571 (724)
|+.+.+.... ...+.+-...|||||.++.+.++.|+|||||||+|||++| |..||....+.+.. ..|. .
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~-~~~~--------~ 919 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL-LDVL--------E 919 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH-HHHH--------h
Confidence 9965544433 3333456689999999999999999999999999999999 99999765443321 1121 1
Q ss_pred CCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 572 DGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 572 ~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
.+ + -..+..+...+.+++..||+.+|++||++..|++.+...+.
T Consensus 920 gg--------R--L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 920 GG--------R--LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred CC--------c--cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 22 1 13455667788899999999999999999999997765543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=331.05 Aligned_cols=267 Identities=22% Similarity=0.340 Sum_probs=209.7
Q ss_pred CCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchh--HHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQG--EREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~--~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
++|...+.||+|.||.||+|++ ..|+.||||+++.....+ ....++|+++|+.++|+||+.|+++|.+.+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4577778899999999999994 579999999998764332 3568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|| ..+|+..++++.. .+...++..|+.++++||+|||++ .|+||||||.|+||+.+|.+||+|||||+.+.....
T Consensus 82 fm-~tdLe~vIkd~~i-~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FM-PTDLEVVIKDKNI-ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred ec-cccHHHHhccccc-ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 99 5678888887654 588899999999999999999999 899999999999999999999999999999876554
Q ss_pred ccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhh---------hhhhhcccC
Q 040832 503 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWAR---------PLCLRALDD 572 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~---------~~~~~~~~~ 572 (724)
.... .+.|.||.|||.+.+ ..|+...||||.|||+.||+-|..-|.+..+.++....+.. +.+....+.
T Consensus 157 ~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 157 IQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 4333 357899999998876 57999999999999999999988878777666654332211 111111111
Q ss_pred CChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 573 GNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 573 ~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.++...-.+.+.. +-..+....++++..+|..+|.+|.+++|++++
T Consensus 236 ~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 236 VKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1111111111111 223344556899999999999999999999874
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=404.27 Aligned_cols=267 Identities=27% Similarity=0.507 Sum_probs=219.5
Q ss_pred cCHHHHHHhhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC
Q 040832 336 FTYEELSAATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAG 414 (724)
Q Consensus 336 f~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 414 (724)
++++++. ..|...++||+|+||.||+|.+ .+++.||||+++..... ...|+++|++++|+|||+++|+|.+.
T Consensus 683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 4555554 4577888999999999999996 57899999998754322 23468899999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccc
Q 040832 415 GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLA 494 (724)
Q Consensus 415 ~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla 494 (724)
+..++||||+++|+|.++++. ++|..+++|+.||++||+|||..|.++|+|||||++|||++.++..++. ||+.
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~ 829 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP 829 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccc
Confidence 999999999999999999963 7899999999999999999997777799999999999999999888876 7766
Q ss_pred cccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCC
Q 040832 495 KLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGN 574 (724)
Q Consensus 495 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~ 574 (724)
...... ....|+..|||||++.+..++.|+|||||||+||||++|+.||+........++.|.+.. .....
T Consensus 830 ~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~ 900 (968)
T PLN00113 830 GLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYC----YSDCH 900 (968)
T ss_pred cccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHh----cCccc
Confidence 543221 223578999999999999999999999999999999999999976544445567776543 23334
Q ss_pred hhhhcchhhhc--CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 575 FNEIADPYLEK--NYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 575 ~~~~vd~~l~~--~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
...++++.+.. ..+.+++.++.+++.+||+.+|++||+|.||+++|+...
T Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred hhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 55566666533 345677888999999999999999999999999998654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=359.66 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=209.5
Q ss_pred HhhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCch---hHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeE
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQ---GEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKR 417 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~---~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 417 (724)
..-.+|..++.||+|.|.+||+|+. ..+++||||++...... ..+-+..|-++|.+| +||.|++|+..|.++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3446789999999999999999995 46899999998643211 123467799999999 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
|+|+||+++|+|.++|+..+. |++.-...++.+|+.||+|||++ |||||||||+|||||+|+++||+|||.|+.+
T Consensus 150 YFvLe~A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999999999999998876 89999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCc----------cc--cccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhh
Q 040832 498 TDNNTH----------VS--TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPL 565 (724)
Q Consensus 498 ~~~~~~----------~~--~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~ 565 (724)
...... .. ..++||..|.+||++..+..+..+|||+||||||+||.|..||....+.-. +.+
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli----Fqk-- 298 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI----FQK-- 298 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH----HHH--
Confidence 543221 11 348999999999999999999999999999999999999999976532211 111
Q ss_pred hhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 566 CLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 566 ~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+++ +.-.++........+|+.+.|..||.+|.+..||-++
T Consensus 299 ------------I~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 299 ------------IQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ------------HHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 111 1123344444678889999999999999999999875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=364.83 Aligned_cols=249 Identities=23% Similarity=0.384 Sum_probs=209.7
Q ss_pred CCcccceeeccCcEEEEEEE-cCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecC
Q 040832 347 GFSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVP 425 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~-~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 425 (724)
.|..-+.||+|..|.||.+. ...++.||||++.......++-+.+|+.+|+.++|+|||++++.|..++++|+|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 45666779999999999998 45688999999987665666678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccc
Q 040832 426 NNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVS 505 (724)
Q Consensus 426 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 505 (724)
+|+|.+++.... |++.++..|+++++.||+|||.+ +|||||||.+||||+.+|.+||+|||++..+..... ..
T Consensus 354 ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR 426 (550)
T KOG0578|consen 354 GGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KR 426 (550)
T ss_pred CCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cc
Confidence 999999886543 89999999999999999999999 999999999999999999999999999988876554 34
Q ss_pred cccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhc
Q 040832 506 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEK 585 (724)
Q Consensus 506 ~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~ 585 (724)
...+||+.|||||++....|+.|.||||||++++||+-|+.||-........... ..+|. + .-
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI---------a~ng~------P--~l 489 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---------ATNGT------P--KL 489 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH---------hhcCC------C--Cc
Confidence 5678999999999999999999999999999999999999999654322211100 00110 1 11
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 586 NYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.........|.+++.+||..|+++|+++.|+|++
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 2233445678999999999999999999999974
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=362.62 Aligned_cols=244 Identities=27% Similarity=0.428 Sum_probs=210.3
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
++|.+.+.||+|.||.||||+.+ +.+.||||.+.+... ++.+.+++|++|++.|+|+||+.++++|+...++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 56778889999999999999965 578899998865422 334568999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|+.| +|..+|...+. |.++.+..|+.+++.||.|||+. +|+|||+||.||||+.++.+|+||||+|+.... ++
T Consensus 82 ~a~g-~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK--LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NT 154 (808)
T ss_pred hhhh-hHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-Cc
Confidence 9977 99999986554 99999999999999999999999 999999999999999999999999999997765 55
Q ss_pred ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchh
Q 040832 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~ 582 (724)
.+.+.+.||+.|||||.+.++.|+..+|+||||||||||+.|+.||.... +.++++..
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s----------------------i~~Lv~~I 212 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS----------------------ITQLVKSI 212 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH----------------------HHHHHHHH
Confidence 66778899999999999999999999999999999999999999995431 12222222
Q ss_pred hhc--CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 583 LEK--NYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 583 l~~--~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
+.+ .++......++.++...+..||.+|-+..+++.
T Consensus 213 ~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 213 LKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred hcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 221 245566777899999999999999999999875
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=363.93 Aligned_cols=241 Identities=28% Similarity=0.465 Sum_probs=206.5
Q ss_pred ccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCCCH
Q 040832 350 QSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNL 429 (724)
Q Consensus 350 ~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 429 (724)
..+-||.|+-|.||+|++ .++.||||+++.- -..+|+-|++|+|+||+.|.|+|...-.++||||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeec-cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 346799999999999999 5688999988631 23478889999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccccccc
Q 040832 430 EFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM 509 (724)
Q Consensus 430 ~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 509 (724)
..+|+.... +.....+.|..+||.||.|||.+ +|||||||.-||||..+..|||+|||-++.+.+..+++ .+.
T Consensus 200 ~~VLka~~~--itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkM--SFa 272 (904)
T KOG4721|consen 200 YEVLKAGRP--ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKM--SFA 272 (904)
T ss_pred HHHHhccCc--cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhhhh--hhh
Confidence 999987554 78889999999999999999999 99999999999999999999999999999888765543 367
Q ss_pred cCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCH
Q 040832 510 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPT 589 (724)
Q Consensus 510 gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~ 589 (724)
||..|||||+++.....+|+|||||||||||||||..||.+.+.+. ..| .+-...|.--.+.
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA---IIw---------------GVGsNsL~LpvPs 334 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA---IIW---------------GVGSNSLHLPVPS 334 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe---eEE---------------eccCCcccccCcc
Confidence 9999999999999999999999999999999999999997653332 222 1222233334556
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 590 EEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 590 ~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
.+...|.-|++.||+..|..||+++||+.+|+-.
T Consensus 335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 6777888999999999999999999999998743
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=348.13 Aligned_cols=257 Identities=20% Similarity=0.298 Sum_probs=204.1
Q ss_pred ccCHHHHHHhhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchh---HHHHHHHHHHHHhcCCCCeeEEeeEE
Q 040832 335 AFTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQG---EREFKAEVEIISRVHHRHLVSLVGYC 411 (724)
Q Consensus 335 ~f~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~---~~~f~~Ei~il~~l~HpnIv~l~g~~ 411 (724)
.+.+++| ++.....||+|++|.||+|.+ +|+.||||+++...... .+.|.+|+.+|++++|+||++++|++
T Consensus 14 ~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~ 87 (283)
T PHA02988 14 CIESDDI-----DKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFI 87 (283)
T ss_pred ecCHHHc-----CCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeE
Confidence 3455555 233346799999999999998 78899999997653332 35688999999999999999999998
Q ss_pred Ee----CCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEE
Q 040832 412 IA----GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETK 487 (724)
Q Consensus 412 ~~----~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vk 487 (724)
.+ ....++||||+.+|+|.+++.... .+++...++|+.+++.||.|||+.. +++|||||++|||+++++.+|
T Consensus 88 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~k 163 (283)
T PHA02988 88 IDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLK 163 (283)
T ss_pred EecccCCCceEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEE
Confidence 77 346789999999999999998654 4889999999999999999999742 688999999999999999999
Q ss_pred EEEeccccccCCCCCccccccccCCCcCCcchhcC--CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhh
Q 040832 488 VADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPL 565 (724)
Q Consensus 488 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~ 565 (724)
|+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||+.....+. ...+
T Consensus 164 l~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~-~~~i---- 234 (283)
T PHA02988 164 IICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI-YDLI---- 234 (283)
T ss_pred EcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH-HHHH----
Confidence 99999998664422 23457889999999976 6899999999999999999999999986532221 1100
Q ss_pred hhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 566 CLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 566 ~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
.. +.. . ...+......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 235 ~~-----~~~----~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 235 IN-----KNN----S----LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred Hh-----cCC----C----CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 00 000 0 011112345688999999999999999999999999753
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=369.75 Aligned_cols=258 Identities=26% Similarity=0.395 Sum_probs=208.5
Q ss_pred CCCcccceeeccCcEEEEEEEcCC--C--cE-EEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPN--G--KE-VAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKR 417 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~--g--~~-vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 417 (724)
++..+.+.||+|+||+||+|.+.. + .. ||||..+.. ......+|.+|+++|++++|+|||+|+|++.+..-+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 445566899999999999999653 2 23 899999852 344556899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
+||||+|.||+|+++|...+. .++..++++++.+.|+||+|||++ ++|||||..+|||++.++.+||+||||++..
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 999999999999999988664 589999999999999999999999 9999999999999999999999999998866
Q ss_pred CCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChh
Q 040832 498 TDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 498 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
....... ....-...|+|||.+..+.|+.++|||||||++||+++ |..||.+....+ +..|. .
T Consensus 313 ~~~~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~--v~~kI--------~----- 376 (474)
T KOG0194|consen 313 SQYVMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE--VKAKI--------V----- 376 (474)
T ss_pred cceeecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH--HHHHH--------H-----
Confidence 5222111 11134678999999999999999999999999999999 899997764332 11111 0
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCCc
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSL 626 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~~ 626 (724)
........+......+..++.+||..+|++|++|.+|.+.|+.....
T Consensus 377 ---~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 377 ---KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred ---hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 00111122234456677788899999999999999999999866543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=358.37 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=206.1
Q ss_pred HhhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccC----Cc-hhHHHHHHHHHHHHhcC-CCCeeEEeeEEEeCC
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSG----SG-QGEREFKAEVEIISRVH-HRHLVSLVGYCIAGG 415 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~----~~-~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~ 415 (724)
...++|.+++.||+|.||.||+|.. ..++.||||++... .. ...+.+.+|+.+|++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4567899999999999999999974 46799999977553 11 23445778999999998 999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCC-CCEEEEEeccc
Q 040832 416 KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYT-FETKVADFGLA 494 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~-~~vkL~DFGla 494 (724)
..++|||||.+|+|.+++.+.+. +.+..+.++++||+.||+|||++ +|+|||||++||||+.+ +.+||+|||++
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~--l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGR--LKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999999999999988554 88899999999999999999999 99999999999999999 99999999999
Q ss_pred cccCCCCCccccccccCCCcCCcchhcCCC-CC-hhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccC
Q 040832 495 KLTTDNNTHVSTRVMGTFGYLAPEYASSGK-LT-EKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDD 572 (724)
Q Consensus 495 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~t-~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~ 572 (724)
.... .........+|++.|+|||++.+.. |+ .++|||||||+||.|++|+.||+......... .+..
T Consensus 169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~----------ki~~ 237 (370)
T KOG0583|consen 169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYR----------KIRK 237 (370)
T ss_pred cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHH----------HHhc
Confidence 9874 1222335578999999999998866 76 89999999999999999999998743221111 1111
Q ss_pred CChhhhcchhhhcCCCHHH-HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 573 GNFNEIADPYLEKNYPTEE-MARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 573 ~~~~~~vd~~l~~~~~~~~-~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
+.+ .++... ...+..++.+|+..+|.+|+++.+|+.
T Consensus 238 ~~~----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 238 GEF----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred CCc----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 111 111112 567889999999999999999999993
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=345.89 Aligned_cols=248 Identities=27% Similarity=0.434 Sum_probs=215.0
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHH---HHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGER---EFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~---~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
..+|.+.+.||+|.||+|-+|+. ..|++||||.++.+...++. .+++||+||..|+||||+.++++|.+.+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45788888999999999999985 67999999999877555444 578999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||..+|.|++++..++. |++.+...|++||..|+.|+|.+ +++|||||.+|||||.|+.+||+||||+.++.+.
T Consensus 132 MEYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999999998876 99999999999999999999999 9999999999999999999999999999988765
Q ss_pred CCccccccccCCCcCCcchhcCCCCC-hhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~t-~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
.. ...++|.+.|.+||++.+..|. ...|.|||||+||-|+.|..|||+.+.. .+.+++..|.+.+--
T Consensus 207 kf--LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk----------~lvrQIs~GaYrEP~ 274 (668)
T KOG0611|consen 207 KF--LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK----------RLVRQISRGAYREPE 274 (668)
T ss_pred cH--HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH----------HHHHHhhcccccCCC
Confidence 43 3568899999999999988775 7899999999999999999999986421 133445556555433
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRAL 620 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L 620 (724)
.+ ....-+|.|||..+|++|.++.+|..+.
T Consensus 275 ~P-----------SdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 275 TP-----------SDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred CC-----------chHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 32 2355688999999999999999998765
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=363.41 Aligned_cols=268 Identities=26% Similarity=0.367 Sum_probs=228.9
Q ss_pred HHHHHhhCCCcccceeeccCcEEEEEEEcCC-CcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeE
Q 040832 339 EELSAATGGFSQSNLLGQGGFGYVHKGVLPN-GKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKR 417 (724)
Q Consensus 339 ~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 417 (724)
++.+....++...+.||-|-||+||.|.|+. .-.||||.|+.+. ...++|+.|+.+|+.++|+|+|+|+|+|..+-..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 5555666677888999999999999999875 5579999998764 3467899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
|||.|||.+|+|.++|.++++..+..-.++.|+.||..||.||..+ ++|||||..+|+||.++..|||+||||++++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 9999999999999999999888888889999999999999999999 9999999999999999999999999999999
Q ss_pred CCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChh
Q 040832 498 TDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 498 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
..+...........+.|.|||.+....++.|+|||+|||+|||+.| |-.||-+.+..+ ..
T Consensus 416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-------------------VY 476 (1157)
T KOG4278|consen 416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------------------VY 476 (1157)
T ss_pred cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-------------------HH
Confidence 7766544444456788999999999999999999999999999999 888886543221 12
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCCcccc
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSLEDL 629 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~~~~l 629 (724)
++++.-+.-+-+..+...+.+|+.+||+++|.+||++.||-++||..+.-..+
T Consensus 477 ~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSi 529 (1157)
T KOG4278|consen 477 GLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSI 529 (1157)
T ss_pred HHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccc
Confidence 22222222334566778899999999999999999999999999987765444
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=347.72 Aligned_cols=263 Identities=26% Similarity=0.413 Sum_probs=203.7
Q ss_pred hCCCcccceeeccCcEEEEEEEcCC-----------------CcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPN-----------------GKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVS 406 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~-----------------g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~ 406 (724)
.++|.+.+.||+|+||.||++.+.+ +..||||.++..... ...+|.+|+++|++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578889999999999999997532 236999999765333 3457999999999999999999
Q ss_pred EeeEEEeCCeEEEEEEecCCCCHHHHHhcCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 040832 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKG-----------------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRII 469 (724)
Q Consensus 407 l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~-----------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ii 469 (724)
+++++.+.+..+|||||+.+++|.+++.... ...+.+..+++|+.||+.||.|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 9999999999999999999999999886432 12467889999999999999999998 999
Q ss_pred ecCCCCccEEEcCCCCEEEEEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh--CCC
Q 040832 470 HRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT--GRR 546 (724)
Q Consensus 470 HrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt--G~~ 546 (724)
||||||+||||+.++.+||+|||+++........ ......++..|+|||++..+.++.++|||||||+||||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999866433221 2233456788999999998999999999999999999987 566
Q ss_pred CCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 547 PIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 547 P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
||......+ +..+.......... .. ....+......+.+++.+||..+|++||++.+|++.|+.
T Consensus 241 p~~~~~~~~--~~~~~~~~~~~~~~-----~~-----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTDEQ--VIENAGEFFRDQGR-----QV-----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCHHH--HHHHHHHHhhhccc-----cc-----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 776543211 11111111100000 00 000112234568999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=345.95 Aligned_cols=252 Identities=27% Similarity=0.391 Sum_probs=202.9
Q ss_pred CCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSG---QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~---~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
.|+..+.||+|+||.||++.+ .+++.||||.+..... .....+.+|+++|++++|+||+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999985 4689999999864321 223457899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|+.+|+|..++.......+++..++.++.||+.||+|||+. +|+||||||+||||++++.+||+|||++........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 99999999888765544689999999999999999999999 999999999999999999999999999987643322
Q ss_pred ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchh
Q 040832 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~ 582 (724)
.....|+..|+|||++.+..++.++|||||||+||||++|+.||......... ..... .+...
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~~~~-----~~~~~--------- 220 (285)
T cd05631 158 --VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR-EEVDR-----RVKED--------- 220 (285)
T ss_pred --ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH-HHHHH-----Hhhcc---------
Confidence 23456899999999999999999999999999999999999999764321110 00000 00000
Q ss_pred hhcCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 040832 583 LEKNYPTEEMARMVACAAASIRHSARRRPK-----ISQIVRA 619 (724)
Q Consensus 583 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evv~~ 619 (724)
...+.......+..++.+||+.+|++|++ +.+|+++
T Consensus 221 -~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 221 -QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred -cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 01122233456788999999999999997 7888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=362.86 Aligned_cols=258 Identities=28% Similarity=0.406 Sum_probs=204.2
Q ss_pred hCCCcccceeeccCcEEEEEEEc------CCCcEEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL------PNGKEVAVKSLRSGS-GQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGK 416 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 416 (724)
.++|++++.||+|+||.||+|.+ ..+..||||+++... ....+.+.+|+++|+.+ +|+||++++++|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34678889999999999999963 235679999997543 23345688999999999 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCC-----------------------------------------------------------
Q 040832 417 RLLVYEYVPNNNLEFHLHGKG----------------------------------------------------------- 437 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~----------------------------------------------------------- 437 (724)
.++||||+++|+|.++++...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999886432
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 438 --------------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 438 --------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
...+++..+++|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 12478889999999999999999998 9999999999999999999999999999876543322
Q ss_pred -cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 504 -VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 504 -~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
......++..|+|||++.+..++.++|||||||+||||++ |..||........ +..+. ..+..
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-~~~~~--------~~~~~------ 335 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-FYKMI--------KEGYR------ 335 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-HHHHH--------HhCcc------
Confidence 1122335677999999999999999999999999999998 8889865432221 11111 11100
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
...+......+.+++.+||+.+|++||++.||+++|+..
T Consensus 336 ---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 ---MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 000111234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=345.42 Aligned_cols=268 Identities=25% Similarity=0.356 Sum_probs=210.1
Q ss_pred hhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhc--CCCCeeEEeeEEEeCC----eE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV--HHRHLVSLVGYCIAGG----KR 417 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l--~HpnIv~l~g~~~~~~----~~ 417 (724)
......+.+.||+|.||+||+|.| .|+.||||++.. .+++.+.+|.+|++.+ +|+||+.|++....+. ++
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeeccc-cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 345678889999999999999999 789999999975 5677899999998865 8999999998876543 77
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCccEEEcCCCCEEEEEec
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHED-----CHPRIIHRDIKSSNILLDYTFETKVADFG 492 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~-----~~~~iiHrDIkp~NILl~~~~~vkL~DFG 492 (724)
|||.||.++|+|.++|.+. .++....+++++.+|.||+|||.. +++.|.|||||.+||||..|+.+.|+|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 9999999999999999874 489999999999999999999965 58899999999999999999999999999
Q ss_pred cccccCCCCCc---cccccccCCCcCCcchhcCCC----C--ChhHHHHHHHHHHHHHHhC----------CCCCCCCCc
Q 040832 493 LAKLTTDNNTH---VSTRVMGTFGYLAPEYASSGK----L--TEKSDVFSFGVMLLELITG----------RRPIDPTGA 553 (724)
Q Consensus 493 la~~~~~~~~~---~~~~~~gt~~y~APE~~~~~~----~--t~ksDV~SlGvlL~eLltG----------~~P~~~~~~ 553 (724)
||......... .....+||-+|||||++.... + -..+||||||++|||+.-+ +.||.+.-.
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 99877654332 234467999999999986432 1 2469999999999999763 344544332
Q ss_pred hhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCCc
Q 040832 554 MEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSL 626 (724)
Q Consensus 554 ~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~~ 626 (724)
.+-.+.+..+..+.+.+. -.+. ......+.+..|.++++.||..+|..|-++-.|-+.|.+..+.
T Consensus 442 ~DPs~eeMrkVVCv~~~R-----P~ip---nrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLR-----PNIP---NRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CCCCHHHHhcceeecccC-----CCCC---cccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 222232222222221111 1111 1234568899999999999999999999999999988876644
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=342.47 Aligned_cols=256 Identities=23% Similarity=0.366 Sum_probs=205.5
Q ss_pred hCCCcccceeeccCcEEEEEEEcC----CCcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP----NGKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
.++|++.+.||+|+||.||+|.++ .+..||+|+++..... ..+.|.+|+.+|++++|+||+++++++..++..+|
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356889999999999999999753 3568999999865433 34578999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
||||+.+++|++++.... ..+.+..++.++.||+.||+|||++ +++|||||++||||+.++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999997643 2488999999999999999999998 999999999999999999999999998865433
Q ss_pred CCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhh
Q 040832 500 NNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEI 578 (724)
Q Consensus 500 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 578 (724)
..........++..|+|||++..+.++.++|||||||++|||++ |+.||......+ +... +..+..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~~~~--------~~~~~~--- 226 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--VIKA--------VEDGFR--- 226 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHH--------HHCCCC---
Confidence 22211122335678999999999999999999999999999875 999997543221 1111 111100
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 579 ADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 579 vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
...+......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 227 ------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 ------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 011222345688899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=340.12 Aligned_cols=256 Identities=29% Similarity=0.452 Sum_probs=209.8
Q ss_pred hhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
..++|++.+.||+|+||.||+|.+.+++.||||.++... ...++|.+|+.++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 346789999999999999999998888899999997643 3356799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+.+++|.+++.......+++..+++++.||+.||.|||+. +|+|||||++|||++.++.+||+|||+++........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999999776545689999999999999999999998 9999999999999999999999999999877643222
Q ss_pred cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchh
Q 040832 504 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~ 582 (724)
......+...|+|||++....++.++||||||++||||++ |+.||....... .+... ... +
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~---------~~~-~------- 221 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-VLQQV---------DQG-Y------- 221 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHH---------HcC-C-------
Confidence 1222223457999999998899999999999999999999 999997543221 11100 000 0
Q ss_pred hhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 583 LEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 583 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
...........+.+++.+|++.+|++||++.+|++.|+.
T Consensus 222 -~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 222 -RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 001112234568899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=343.82 Aligned_cols=269 Identities=22% Similarity=0.287 Sum_probs=205.6
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
++|++.+.||+|+||.||++++. +++.||||+++.... ...+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47899999999999999999975 578899999875422 234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|+.++.|..+..... .+++..++.++.||+.||.|||+. +|+|||||++||||+.++.+||+|||+++.......
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEEMPN--GVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 999988876654332 488999999999999999999998 999999999999999999999999999987654333
Q ss_pred ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhH--Hhhhhhhhh----hcccCCChh
Q 040832 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCL--VDWARPLCL----RALDDGNFN 576 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l--~~w~~~~~~----~~~~~~~~~ 576 (724)
.......|+..|+|||++.+..++.++|||||||+||||++|+.||......+... .....++.. ....+..+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 33344578999999999998889999999999999999999999997654332211 110000000 000000110
Q ss_pred hhcchh------hhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 577 EIADPY------LEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 577 ~~vd~~------l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
....+. +...+.......+.+++.+||+.+|++|+++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000 0111111234568999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=354.19 Aligned_cols=248 Identities=26% Similarity=0.394 Sum_probs=209.9
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchh-HHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQG-EREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~-~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
..|+..++||+|.||.||||.+. .++.||||++..+...+ ..++++|+.+|.+++++||.++||.+..+..+|++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 35677788999999999999954 58899999998765444 46799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
|.+|++.++|....- +++..+.-|+++++.||.|||.+ +.||||||+.||||..+|.|||+|||++..+......
T Consensus 93 ~~gGsv~~lL~~~~~--~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNI--LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred hcCcchhhhhccCCC--CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 999999999976543 57888888999999999999999 9999999999999999999999999999988766554
Q ss_pred cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 504 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
. ..++||+.|||||+++...|+.|+||||||++.+||++|..|+.....|...+. +.+..-+.|
T Consensus 168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl---------------Ipk~~PP~L 231 (467)
T KOG0201|consen 168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL---------------IPKSAPPRL 231 (467)
T ss_pred c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe---------------ccCCCCCcc
Confidence 4 568899999999999988999999999999999999999999987655432110 111112222
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
.+ ....-|.+++..||+.+|+.||++.++++
T Consensus 232 ~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 232 DG----DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cc----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 22 33455888999999999999999999986
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.64 Aligned_cols=255 Identities=26% Similarity=0.424 Sum_probs=209.1
Q ss_pred hCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
.++|++.+.||+|+||.||+|.+.+++.||+|.+.... ...+.|.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35788999999999999999998888899999987543 23567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
.+++|.++++......+.+..++.++.||++||+|||+. +++||||||+|||++.++.+||+|||+++.........
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 999999999765555688999999999999999999998 99999999999999999999999999998765433322
Q ss_pred ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 505 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
.....++..|+|||++..+.++.++|||||||++|||++ |+.||......+ +..+.. .+.. .+.
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~--------~~~~----~~~- 225 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSALQ--------RGYR----MPR- 225 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHHHH--------cCCC----CCC-
Confidence 233346678999999998899999999999999999998 999996543221 111110 0000 000
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
.......+.+++.+|++.+|++||++++|+++|+.
T Consensus 226 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 226 ----MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01123457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=361.19 Aligned_cols=258 Identities=26% Similarity=0.403 Sum_probs=203.0
Q ss_pred hCCCcccceeeccCcEEEEEEEcC------CCcEEEEEEeccCCch-hHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP------NGKEVAVKSLRSGSGQ-GEREFKAEVEIISRV-HHRHLVSLVGYCIAGGK 416 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 416 (724)
.++|.+++.||+|+||.||+|.+. +++.||||+++..... ....+.+|+++|+.+ +|+||++++++|...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 346788999999999999998742 3457999999764333 345688999999999 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCC-----------------------------------------------------------
Q 040832 417 RLLVYEYVPNNNLEFHLHGKG----------------------------------------------------------- 437 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~----------------------------------------------------------- 437 (724)
.+|||||+.+|+|.++++.+.
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885421
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc-cccc
Q 040832 438 ---------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH-VSTR 507 (724)
Q Consensus 438 ---------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~ 507 (724)
...+++.++++|+.||++||+|||++ +|+|||||++|||+++++.+||+|||+++........ ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 12378889999999999999999998 9999999999999999999999999999865433221 1122
Q ss_pred cccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcC
Q 040832 508 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKN 586 (724)
Q Consensus 508 ~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~ 586 (724)
..++..|||||++....++.++|||||||+||||++ |+.||............ +..+ ....
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~---------~~~~---------~~~~ 335 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM---------VKRG---------YQMS 335 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHH---------HHcc---------cCcc
Confidence 335678999999998999999999999999999997 99999754221111000 0000 0000
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 587 YPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
.+......+.+++.+||+.+|++||++.+|+++|++.
T Consensus 336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111235688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=343.84 Aligned_cols=250 Identities=32% Similarity=0.551 Sum_probs=196.5
Q ss_pred cccceeeccCcEEEEEEEcC-----CCcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 349 SQSNLLGQGGFGYVHKGVLP-----NGKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 349 ~~~~~LG~G~fG~Vyk~~~~-----~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
++.+.||.|.||.||+|.+. .+..|+||.++..... ..+.|.+|+++|++++|+||++++|+|...+..++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35678999999999999976 2567999999764333 36789999999999999999999999998888999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|+.+|+|.++|+......+++..+++|+.||++||.|||++ +|+||||+++||||+.++.+||+|||++........
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 99999999999987555699999999999999999999998 999999999999999999999999999987733222
Q ss_pred -ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 503 -HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 503 -~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
.......+...|+|||.+....++.++||||||++||||++ |+.||......+ .+... ..+..
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~-~~~~~---------~~~~~----- 223 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE-IIEKL---------KQGQR----- 223 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH-HHHHH---------HTTEE-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccc---------ccccc-----
Confidence 22233456788999999999999999999999999999999 788886553221 11111 00100
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRAL 620 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L 620 (724)
...+......+..++.+||+.+|++||++.+|++.|
T Consensus 224 ----~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 ----LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111222345688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=353.19 Aligned_cols=251 Identities=25% Similarity=0.335 Sum_probs=205.4
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|++.+.||+|+||.||+|.+. +++.||||+++... ....+.+..|+++|..++|+||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47899999999999999999975 58899999997532 223456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+++++|.+++...+. +.+..++.|+.||+.||.|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGV--LSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 99999999999976543 88999999999999999999998 999999999999999999999999999986644
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhh--hHHhhhhhhhhhcccCCChhhhc
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMED--CLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~--~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
......|+..|+|||++.+..++.++|||||||+||||++|+.||......+. .+..|...+ ..
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----~~------- 219 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL-----QR------- 219 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc-----cC-------
Confidence 22345689999999999999999999999999999999999999976543221 122221110 00
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+.. ..........+.+++.+||..++++|+++.+|+++
T Consensus 220 -~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 -PVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -CCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000 00001234567888999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=342.50 Aligned_cols=269 Identities=27% Similarity=0.404 Sum_probs=199.7
Q ss_pred cccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhc--CCCCeeEEeeEEEeCC----eEEEEEE
Q 040832 349 SQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV--HHRHLVSLVGYCIAGG----KRLLVYE 422 (724)
Q Consensus 349 ~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l--~HpnIv~l~g~~~~~~----~~~lV~E 422 (724)
++.++||+|.||.||||.+ +++.||||++.. ++...|++|-+|++.. +|+||++++++-.... .++||+|
T Consensus 213 ~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 3446699999999999999 459999999975 4566799999988765 7999999999876655 8899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC------HPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~------~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
|.+.|+|.++|..+- ++|....+|+..+++||+|||+.. ++.|+|||||.+||||..|+++.|+|||||..
T Consensus 289 fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 289 FHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred eccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 999999999998754 899999999999999999999873 66899999999999999999999999999988
Q ss_pred cCCCCCc-cccccccCCCcCCcchhcCCC------CChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhc
Q 040832 497 TTDNNTH-VSTRVMGTFGYLAPEYASSGK------LTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRA 569 (724)
Q Consensus 497 ~~~~~~~-~~~~~~gt~~y~APE~~~~~~------~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~ 569 (724)
+...... .....+||.+|||||++.+.. .-.+.||||+|+|||||+++-..++.. ........+...+ ...
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~-~vp~Yqlpfe~ev-G~h 443 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPG-PVPEYQLPFEAEV-GNH 443 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCC-CCCcccCchhHHh-cCC
Confidence 7644332 112367999999999997642 224799999999999999976655321 1111000000000 000
Q ss_pred ccCCChhhhc-----chhhhcC-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCCc
Q 040832 570 LDDGNFNEIA-----DPYLEKN-YPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSL 626 (724)
Q Consensus 570 ~~~~~~~~~v-----d~~l~~~-~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~~ 626 (724)
..-+.+.++| ++.+... .....+..+.+.+..||++|++.|-++.-|-+.+....-+
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 0001111111 1111110 1125677899999999999999999999998887765443
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=337.33 Aligned_cols=252 Identities=27% Similarity=0.433 Sum_probs=204.7
Q ss_pred CCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecC
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVP 425 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 425 (724)
++|++.+.||+|+||.||++.++++..+|+|.++... .....|.+|+++|++++|+||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4578889999999999999999888899999887543 235678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccc
Q 040832 426 NNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVS 505 (724)
Q Consensus 426 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 505 (724)
+++|.++++.... .+++..++.++.||+.||+|||+. +|+|||||++||||+.++.+||+|||+++..........
T Consensus 83 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 9999999875432 488999999999999999999998 999999999999999999999999999986643332222
Q ss_pred cccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhh
Q 040832 506 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLE 584 (724)
Q Consensus 506 ~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~ 584 (724)
....++..|+|||++....++.++||||||++||||++ |+.||......+. ..+. ..+.. ..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~--~~~i--------~~~~~--~~----- 221 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV--VEMI--------SRGFR--LY----- 221 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH--HHHH--------HCCCC--CC-----
Confidence 22335668999999988889999999999999999999 8999975432211 1111 00100 00
Q ss_pred cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 585 KNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
.+......+.+++.+||+.+|++||++.+|++.|.
T Consensus 222 --~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 222 --RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred --CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01112346899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=348.63 Aligned_cols=268 Identities=24% Similarity=0.334 Sum_probs=207.1
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
.++|++.+.||+|+||.||++.+. ++..||+|.++.... .....|.+|+++|++++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999965 578899999876432 234579999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|+++++|.+++..... +.+..+.+++.||+.||.|||+.+ +|+|||||++||||+.++.+||+|||+++......
T Consensus 84 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 84 HMDGGSLDQVLKEAKR--IPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred cCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 9999999999976543 889999999999999999999852 59999999999999999999999999998664322
Q ss_pred ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcc------------
Q 040832 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRAL------------ 570 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~------------ 570 (724)
.....|+..|+|||++.+..++.++|||||||+||||++|+.||......+.. .....+......
T Consensus 159 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE-AIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred --cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHhcccccccccCCccccCccccc
Confidence 23356899999999999989999999999999999999999999754322110 000000000000
Q ss_pred ----------c---CCChhhhcchhhhcCC----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 040832 571 ----------D---DGNFNEIADPYLEKNY----PTEEMARMVACAAASIRHSARRRPKISQIVRAL 620 (724)
Q Consensus 571 ----------~---~~~~~~~vd~~l~~~~----~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L 620 (724)
. ...+.++.+....... .......+.+++.+||+.+|++||++.+|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0 0000111111111100 112345689999999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=346.13 Aligned_cols=245 Identities=25% Similarity=0.321 Sum_probs=201.5
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+|++++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999965 58899999986432 123456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+.+++|.+++...+. +.+..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred eCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 99999999999976553 88999999999999999999999 99999999999999999999999999998764422
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
....|+..|+|||++.+..++.++|||||||+||||++|+.||......+. . .. +..+.+
T Consensus 156 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~--~---~~-----i~~~~~------ 215 (291)
T cd05612 156 ----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI--Y---EK-----ILAGKL------ 215 (291)
T ss_pred ----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H---HH-----HHhCCc------
Confidence 234689999999999988899999999999999999999999976432211 0 00 000100
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPK-----ISQIVRA 619 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evv~~ 619 (724)
.++......+.+++.+||+.||.+|++ +.+++++
T Consensus 216 ----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 ----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 111122346788999999999999995 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=339.66 Aligned_cols=256 Identities=30% Similarity=0.471 Sum_probs=213.1
Q ss_pred hhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
...+|++.++||+|+||.||+|.+.+++.|++|.++.........+.+|+.+|+.++|+||+++++++.+....++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 44568888999999999999999888999999999876655567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+++++|.+++.......+++..+++|+.||+.||.|||+. +|+|||||++||||++++.+||+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999999876556689999999999999999999998 9999999999999999999999999999876543322
Q ss_pred cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchh
Q 040832 504 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~ 582 (724)
. ....++..|++||++..+.++.++|||+||++||+|++ |+.||......+. ..+.. .+
T Consensus 161 ~-~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~--~~~~~--------~~--------- 220 (261)
T cd05148 161 S-SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV--YDQIT--------AG--------- 220 (261)
T ss_pred c-cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH--HHHHH--------hC---------
Confidence 1 23345678999999998899999999999999999998 8999975432211 11110 00
Q ss_pred hhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 583 LEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 583 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
........+...+.+++.+||+.+|++||++.+|++.|+.
T Consensus 221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 221 YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 0001122334568899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=351.79 Aligned_cols=242 Identities=24% Similarity=0.333 Sum_probs=197.0
Q ss_pred ceeeccCcEEEEEEEc-CCCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCC
Q 040832 352 NLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNN 427 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 427 (724)
++||+|+||.||++.. .+|+.||||+++... ......+.+|+++|++++|+||+++++++..++..+|||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 468899999997532 223346788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccccc
Q 040832 428 NLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTR 507 (724)
Q Consensus 428 sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 507 (724)
+|..++...+ .+.+..+..|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~ 154 (323)
T cd05571 81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKT 154 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cccc
Confidence 9999887654 489999999999999999999998 999999999999999999999999999975432222 1234
Q ss_pred cccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCC
Q 040832 508 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNY 587 (724)
Q Consensus 508 ~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~ 587 (724)
..|+..|+|||++.+..++.++|||||||+||||++|+.||........ ... +..+.+ .+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~--~~~--------~~~~~~----------~~ 214 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FEL--------ILMEEI----------RF 214 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH--HHH--------HHcCCC----------CC
Confidence 5699999999999999999999999999999999999999975432211 110 000000 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 040832 588 PTEEMARMVACAAASIRHSARRRP-----KISQIVRA 619 (724)
Q Consensus 588 ~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evv~~ 619 (724)
+......+.+++.+||+.||++|+ ++.+|+++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 222345678899999999999999 78888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=340.96 Aligned_cols=255 Identities=28% Similarity=0.491 Sum_probs=206.4
Q ss_pred CCCcccceeeccCcEEEEEEEcCC------CcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPN------GKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRL 418 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~------g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 418 (724)
++|++.+.||+|+||.||+|.+.. .+.|++|.++.... ....+|.+|+.+|++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357888999999999999998543 25799999875433 23456899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC
Q 040832 419 LVYEYVPNNNLEFHLHGKGR--------------PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF 484 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~--------------~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~ 484 (724)
++|||+++++|.++|..... ..+++..++.++.||++||.|||+. +|+||||||+||||++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999999875321 3478899999999999999999999 999999999999999999
Q ss_pred CEEEEEeccccccCCCCC-ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhh
Q 040832 485 ETKVADFGLAKLTTDNNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWA 562 (724)
Q Consensus 485 ~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~ 562 (724)
.+||+|||+++....... .......++..|+|||++..+.++.++|||||||+||||++ |..||......+ +..+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--~~~~i 239 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--VIEMI 239 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH
Confidence 999999999986543322 22233456788999999998999999999999999999998 999997643221 11111
Q ss_pred hhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 563 RPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 563 ~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
..+.. ...+......+.+++.+||+.+|++||++.||+++|+.
T Consensus 240 --------~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 --------RSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --------HcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111 11123345678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=337.31 Aligned_cols=255 Identities=27% Similarity=0.407 Sum_probs=208.1
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
.+|.+.+.||+|+||.||+|.+. .++.||+|.+..+. ....++.+|+++|++++|+||+++++++..+...++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45788899999999999999965 47889999987542 34567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
.+++|.+++.......+++..++.++.|+++||+|||++ +++||||||+|||+++++.+||+|||++..........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999999999876656689999999999999999999998 99999999999999999999999999998765433222
Q ss_pred ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 505 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
.....++..|+|||++.+..++.++|||||||+||||++ |..||......+. |.. + ..+ +
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~----~~~-~-----~~~---------~ 222 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----YEL-L-----EKG---------Y 222 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH----HHH-H-----HCC---------C
Confidence 222334668999999998899999999999999999998 9999865432111 100 0 000 0
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
....+......+.+++.+||+.+|++||++.+|+++|+..
T Consensus 223 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0111122345688899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=351.74 Aligned_cols=245 Identities=25% Similarity=0.358 Sum_probs=201.1
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|.+.+.||+|+||.||+|.+. +++.||||.++... ....+.+.+|+.+|++++|+||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57899999999999999999965 57899999986532 123356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+.+++|.++|...+. +.+..+..|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGR--FPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred cCCCCChHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 99999999999986553 78889999999999999999998 99999999999999999999999999998765432
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
....|+..|+|||++.+..++.++|||||||+||||++|+.||......+... .+..+.+
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~----------~i~~~~~------ 232 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYE----------KILAGRL------ 232 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHH----------HHhcCCc------
Confidence 23568999999999999899999999999999999999999997543221110 0111111
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPK-----ISQIVRA 619 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evv~~ 619 (724)
.++.....++.+++.+||+.||++|++ +.+|+.+
T Consensus 233 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 ----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011112245788999999999999997 6777654
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=367.74 Aligned_cols=259 Identities=24% Similarity=0.340 Sum_probs=210.2
Q ss_pred hhCCCcccceeeccCcEEEEEEEcCCC-cEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCeeEEee-EEEe---C---
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLPNG-KEVAVKSLRSGSGQGEREFKAEVEIISRVH-HRHLVSLVG-YCIA---G--- 414 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g-~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g-~~~~---~--- 414 (724)
...++++.++|.+|||+.||+|.+..+ ..||+|++-..+....+.+.+||++|++|. |+|||.+++ .... +
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 344678899999999999999997666 999999998877777888999999999996 999999999 3322 1
Q ss_pred CeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccc
Q 040832 415 GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLA 494 (724)
Q Consensus 415 ~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla 494 (724)
-+++|+||||.+|.|-++|..+....|.+.++++|+.++++||++||. |.+.|||||||-+||||..++.+||||||.|
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 267899999999999999987655569999999999999999999998 5778999999999999999999999999999
Q ss_pred cccCCCCCcc--------ccccccCCCcCCcchh---cCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhh
Q 040832 495 KLTTDNNTHV--------STRVMGTFGYLAPEYA---SSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWAR 563 (724)
Q Consensus 495 ~~~~~~~~~~--------~~~~~gt~~y~APE~~---~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~ 563 (724)
.-........ .-...-|+-|.+||.+ .+...++|+|||+|||+||.|+....||+......
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-------- 265 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-------- 265 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee--------
Confidence 7543322110 0113468899999987 45679999999999999999999999998654332
Q ss_pred hhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 564 PLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 564 ~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
+-.++|.- -.......+|..||..||+.+|++||.+.||+..+..+..
T Consensus 266 ------Ilng~Y~~--------P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 266 ------ILNGNYSF--------PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred ------EEeccccC--------CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 12222211 1113567889999999999999999999999887765544
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=335.79 Aligned_cols=252 Identities=29% Similarity=0.440 Sum_probs=205.5
Q ss_pred CCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecC
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVP 425 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 425 (724)
++|.+.+.||+|+||.||+|.+.++..||||.++... ....+|.+|+.++++++|+||+++++++.+....++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4578889999999999999998777789999987543 234679999999999999999999999999888999999999
Q ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccc
Q 040832 426 NNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVS 505 (724)
Q Consensus 426 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 505 (724)
+++|.+++..... .+.+..+++++.||+.||+|||+. +++|||||++|||++.++.+||+|||+++..........
T Consensus 83 ~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 83 NGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 9999999876443 589999999999999999999998 999999999999999999999999999987654332222
Q ss_pred cccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhh
Q 040832 506 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLE 584 (724)
Q Consensus 506 ~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~ 584 (724)
....++..|++||++....++.++|||||||+||||++ |+.||......+ +.... ..+...
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~--------~~~~~~-------- 220 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEKV--------SQGLRL-------- 220 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHH--------hcCCCC--------
Confidence 22345678999999998889999999999999999999 999997543221 11110 001000
Q ss_pred cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 585 KNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
.........+.+++.+||+.+|.+||++.+|++.|+
T Consensus 221 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 -YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 001112467899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=348.52 Aligned_cols=242 Identities=24% Similarity=0.327 Sum_probs=196.4
Q ss_pred ceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCC
Q 040832 352 NLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNN 427 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 427 (724)
++||+|+||.||++... +|+.||+|+++... ......+.+|+++|++++|+||+++++++...+..+|||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999854 68899999997532 223346788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccccc
Q 040832 428 NLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTR 507 (724)
Q Consensus 428 sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 507 (724)
+|..++...+ .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 154 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKT 154 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cccc
Confidence 9998887654 489999999999999999999998 999999999999999999999999999875432221 1233
Q ss_pred cccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCC
Q 040832 508 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNY 587 (724)
Q Consensus 508 ~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~ 587 (724)
..|+..|+|||++.++.++.++|||||||+||||++|+.||......+.....+ ...+ .+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~----------~~~~----------~~ 214 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL----------MEEI----------RF 214 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh----------cCCC----------CC
Confidence 568999999999999999999999999999999999999997543222111000 0000 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 040832 588 PTEEMARMVACAAASIRHSARRRP-----KISQIVRA 619 (724)
Q Consensus 588 ~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evv~~ 619 (724)
+......+.+++.+||+.+|++|+ ++.+++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 122335678899999999999998 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=321.26 Aligned_cols=248 Identities=27% Similarity=0.393 Sum_probs=210.4
Q ss_pred CCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|.+++.||+|.||.||.|+. +++..||+|++.... .+-++++.+|++|-..|+||||++++++|.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 5688999999999999999995 457789999986532 223467999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||..+|.|...|.......+++.....++.|+|.||.|+|.+ +||||||||+|+|++.++.+||+|||-+......
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~- 177 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN- 177 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCCC-
Confidence 999999999999977666799999999999999999999998 9999999999999999999999999999766532
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
.....+||+.|++||...+..++.+.|+|++|++.||++.|..||......+. . .++..
T Consensus 178 --kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et-Y-----------------krI~k- 236 (281)
T KOG0580|consen 178 --KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET-Y-----------------KRIRK- 236 (281)
T ss_pred --CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH-H-----------------HHHHH-
Confidence 23457899999999999999999999999999999999999999976542211 1 11111
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+.-.++........+++.+|+..+|.+|....||+++
T Consensus 237 -~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 237 -VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -ccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1112334455668899999999999999999999875
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=355.95 Aligned_cols=259 Identities=23% Similarity=0.375 Sum_probs=205.7
Q ss_pred hCCCcccceeeccCcEEEEEEEcC------CCcEEEEEEeccCCch-hHHHHHHHHHHHHhcC-CCCeeEEeeEEEeCCe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP------NGKEVAVKSLRSGSGQ-GEREFKAEVEIISRVH-HRHLVSLVGYCIAGGK 416 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~ 416 (724)
.++|.++++||+|+||.||+|.+. .+..||||+++..... ..+.|.+|+++|++++ |+||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 567889999999999999999852 1346999999765333 3456999999999996 9999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCC-----------------------------------------------------------
Q 040832 417 RLLVYEYVPNNNLEFHLHGKG----------------------------------------------------------- 437 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~----------------------------------------------------------- 437 (724)
.+||||||++|+|.++|+...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999998886431
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC
Q 040832 438 -----------------------------------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY 482 (724)
Q Consensus 438 -----------------------------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~ 482 (724)
...+++..+++++.||++||+|||+. +|+|||||++|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 12477888999999999999999998 9999999999999999
Q ss_pred CCCEEEEEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHh
Q 040832 483 TFETKVADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVD 560 (724)
Q Consensus 483 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~ 560 (724)
++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |+.||.......... .
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~-~ 351 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY-N 351 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH-H
Confidence 999999999999876443322 1223456788999999998899999999999999999997 999987542211111 0
Q ss_pred hhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 561 WARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 561 w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
. +..+. ....+......+.+++.+||+.+|++||++.+|+++|+..+
T Consensus 352 ~--------~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 352 K--------IKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred H--------HhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 0 01110 00111223456889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=335.10 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=206.1
Q ss_pred CCCcccceeeccCcEEEEEEEcCC----CcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPN----GKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~----g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
++|++.+.||+|+||.||+|.+.. ...||||.++..... ...+|.+|+.++++++|+||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568899999999999999998743 357999998765333 345789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+.+++|++++..... .+++..+++++.|++.||+|||+. +|+|||||++||||++++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 999999999999976443 589999999999999999999998 9999999999999999999999999999987522
Q ss_pred CCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhh
Q 040832 501 NTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEI 578 (724)
Q Consensus 501 ~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 578 (724)
... ......++..|++||++....++.++||||||+++|||++ |..||......+ +..+. ..+..
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~--------~~~~~--- 226 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VIKAV--------EDGYR--- 226 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HHHHH--------HcCCC---
Confidence 221 1122335678999999998899999999999999999998 999986543211 11111 00000
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 579 ADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 579 vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
..........+.+++.+|++.+|++||++.+|+++|+..
T Consensus 227 ------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 ------LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001112345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=356.29 Aligned_cols=242 Identities=29% Similarity=0.424 Sum_probs=204.9
Q ss_pred HhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcC-CCCeeEEeeEEEeCCeE
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVH-HRHLVSLVGYCIAGGKR 417 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~ 417 (724)
...++|.+.++||+|.||+|+++.++ +++.+|||+|+++. .++.+..+.|.+|+.... ||+|++|+.+|...+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34568999999999999999999975 47889999998773 334456788999998885 99999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
|+||||+.||++..+.+. ..+++..+.-++..|+.||+|||++ +|||||||.+|||||.+|++||+||||++..
T Consensus 445 ~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999995444332 3489999999999999999999999 9999999999999999999999999999976
Q ss_pred CCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 498 TDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 498 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
..... ....++||+.|||||++.+..|+...|.|+|||+|||||.|+.||.+.++.+
T Consensus 519 m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee---------------------- 575 (694)
T KOG0694|consen 519 MGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE---------------------- 575 (694)
T ss_pred CCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH----------------------
Confidence 53332 3356899999999999999999999999999999999999999998654333
Q ss_pred hcchhhh--cCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 040832 578 IADPYLE--KNYPTEEMARMVACAAASIRHSARRRPKI 613 (724)
Q Consensus 578 ~vd~~l~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 613 (724)
+.|..+. -.|+.-...+.+.++.++|+.+|++|.-+
T Consensus 576 ~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 576 VFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1222222 23666777888999999999999999988
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=354.77 Aligned_cols=248 Identities=27% Similarity=0.387 Sum_probs=209.8
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSG---QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~---~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
.+-|++++-||+|+-|.|.+|+. ..|+.+|||++..... .....+.+||-||+.|.|+||++||+++.+..++|||
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 35688899999999999999984 4799999999865411 1234588999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
.||+++|-|.++|-.++. +.+.+..+++.||+.||.|+|.. +|+||||||+|+|||..+.+||+|||+|.+...+
T Consensus 91 lEyv~gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EEecCCchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999999988876 88999999999999999999998 9999999999999999999999999999876554
Q ss_pred CCccccccccCCCcCCcchhcCCCCC-hhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~t-~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
. .-..-+|.+.|.+||++++..|+ .++||||+|||||.||+|+.|||+.+ ... ++..+..|.|
T Consensus 166 k--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-ir~---------LLlKV~~G~f---- 229 (786)
T KOG0588|consen 166 K--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-IRV---------LLLKVQRGVF---- 229 (786)
T ss_pred c--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-HHH---------HHHHHHcCcc----
Confidence 3 33456799999999999999886 79999999999999999999998432 221 1122233333
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+.+.+.......|+.+|+..||.+|-++.||+++
T Consensus 230 ------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 ------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 2334555678889999999999999999999984
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=347.82 Aligned_cols=242 Identities=26% Similarity=0.341 Sum_probs=197.1
Q ss_pred ceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCC
Q 040832 352 NLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNN 427 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 427 (724)
++||+|+||.||++... +++.||||+++... ......+.+|+++|+.++|+||+++++++..++..+|||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999854 68899999997542 223456889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccccc
Q 040832 428 NLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTR 507 (724)
Q Consensus 428 sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 507 (724)
+|..++.... .+.+.+++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~ 154 (328)
T cd05593 81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMKT 154 (328)
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-cccc
Confidence 9998887654 389999999999999999999999 999999999999999999999999999986433222 1234
Q ss_pred cccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCC
Q 040832 508 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNY 587 (724)
Q Consensus 508 ~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~ 587 (724)
..|+..|+|||++.+..++.++|||||||+||||++|+.||......+.... +....+ .+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~----------~~~~~~----------~~ 214 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----------ILMEDI----------KF 214 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH----------hccCCc----------cC
Confidence 5699999999999988999999999999999999999999975432211100 000000 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 040832 588 PTEEMARMVACAAASIRHSARRRP-----KISQIVRA 619 (724)
Q Consensus 588 ~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evv~~ 619 (724)
+......+.+++.+||+.+|++|+ ++.||+++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 122334678899999999999997 88888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=332.48 Aligned_cols=250 Identities=26% Similarity=0.405 Sum_probs=203.2
Q ss_pred CCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCC
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPN 426 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 426 (724)
+|++.+.||+|+||.||++.+++++.+|||.+..... ....|.+|++++++++|+||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4778889999999999999987778899999865432 345788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcccc
Q 040832 427 NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST 506 (724)
Q Consensus 427 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 506 (724)
++|.+++..... .+++..+++|+.||++||+|||+. +|+|||||++|||+++++.+||+|||+++...+.......
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 84 GCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 999999876443 589999999999999999999999 9999999999999999999999999999876543222212
Q ss_pred ccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhc
Q 040832 507 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEK 585 (724)
Q Consensus 507 ~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~ 585 (724)
...++..|+|||++.+..++.++||||||++||||++ |+.||+.....+... . +..+ .. .
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~--~--------~~~~-----~~----~ 220 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE--S--------VSAG-----YR----L 220 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH--H--------HHcC-----Cc----C
Confidence 2224457999999998999999999999999999999 899997543222110 0 0000 00 0
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 040832 586 NYPTEEMARMVACAAASIRHSARRRPKISQIVRAL 620 (724)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L 620 (724)
..+......+.+++.+||+.+|++||++.||++.|
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11112345789999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=347.57 Aligned_cols=252 Identities=25% Similarity=0.323 Sum_probs=198.8
Q ss_pred CCcccceeeccCcEEEEEEEc----CCCcEEEEEEeccCC----chhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVL----PNGKEVAVKSLRSGS----GQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKR 417 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~----~~g~~vaVK~l~~~~----~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 417 (724)
+|++.+.||+|+||.||++.. .+++.||||+++... ....+.+..|+.+|+++ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488899999999999999874 357899999986431 12234678899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
++||||+.+|+|..++..... +.+..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 999999999999999876543 88999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChh
Q 040832 498 TDNNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 498 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
............|+..|||||++.+. .++.++|||||||+||||++|+.||......... ..+..... .
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~-----~---- 225 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ-SEVSRRIL-----K---- 225 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH-HHHHHHHh-----c----
Confidence 44333333346799999999999765 4788999999999999999999999654221110 00000000 0
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRP-----KISQIVRA 619 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evv~~ 619 (724)
.+ ..++......+.+++.+||+.+|++|+ ++.+++++
T Consensus 226 --~~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 --CD----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --CC----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 00 011222334578899999999999999 67777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=344.60 Aligned_cols=245 Identities=22% Similarity=0.316 Sum_probs=202.4
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch---hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ---GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~---~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
..++|.++.+||+|+||+||+++.+ .|+.+|+|+|+..... ..+.++.|-++|...++++||+|+..|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999954 5899999999865322 33468899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
||||++||++..+|...+- |.+..+..++.+++.||..||+. |+|||||||+|+|||..|++||+||||+.-+..
T Consensus 219 iMEylPGGD~mTLL~~~~~--L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDT--LTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEecCCccHHHHHHhcCc--CchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhh
Confidence 9999999999999988765 89999999999999999999999 999999999999999999999999999952211
Q ss_pred -----------------------CCC------c-----------------cccccccCCCcCCcchhcCCCCChhHHHHH
Q 040832 500 -----------------------NNT------H-----------------VSTRVMGTFGYLAPEYASSGKLTEKSDVFS 533 (724)
Q Consensus 500 -----------------------~~~------~-----------------~~~~~~gt~~y~APE~~~~~~~t~ksDV~S 533 (724)
+.. . .....+||+.|||||++.+..|+..+|.||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 000 0 001257999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCchhhh--HHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCC
Q 040832 534 FGVMLLELITGRRPIDPTGAMEDC--LVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRP 611 (724)
Q Consensus 534 lGvlL~eLltG~~P~~~~~~~~~~--l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP 611 (724)
|||||||||.|-.||......+.+ ++.|..-+... . ......+..++|.+|+. |+++|-
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP--~----------------~~~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP--E----------------EVDLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC--C----------------cCcccHHHHHHHHHHhc-CHHHhc
Confidence 999999999999999887766653 66665433111 0 11112566778888888 999997
Q ss_pred C
Q 040832 612 K 612 (724)
Q Consensus 612 s 612 (724)
.
T Consensus 435 G 435 (550)
T KOG0605|consen 435 G 435 (550)
T ss_pred C
Confidence 6
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=339.28 Aligned_cols=268 Identities=22% Similarity=0.285 Sum_probs=199.5
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
.++|.+.+.||+|+||.||+|... +++.||||+++.... .....+.+|+.++++++|+||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999965 688999999875432 223467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|+. ++|.+++.... ..+.+..+..++.||++||+|||++ +|+||||||+||||+.++.+||+|||+++.......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 84 YVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH 158 (303)
T ss_pred CCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence 996 56666665432 2478899999999999999999999 999999999999999999999999999976543222
Q ss_pred ccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhh------------hc
Q 040832 503 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCL------------RA 569 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~------------~~ 569 (724)
......|+..|+|||++.+ ..++.++|||||||+||||++|+.||.........+......+.. ..
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 159 -TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred -cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 2233568899999998865 468899999999999999999999998654433222211110000 00
Q ss_pred ccCCChhhhcchhhhcCCC-HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 570 LDDGNFNEIADPYLEKNYP-TEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 570 ~~~~~~~~~vd~~l~~~~~-~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
.....+.......+...+. ......+.+++.+||+.+|++|+++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000000000000 011245778999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.02 Aligned_cols=254 Identities=30% Similarity=0.446 Sum_probs=206.8
Q ss_pred hCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
.++|++.+.||+|+||.||+|.+.++..||+|.++.... ..+.|.+|+.++++++|+||+++++++. ....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 356888899999999999999988888899999976433 3457999999999999999999999875 45679999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
.+++|.++++......+++..++.|+.||+.||+|||+. +|+|||||++|||+++++.+||+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999999875555689999999999999999999998 99999999999999999999999999998765433222
Q ss_pred ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 505 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
.....++..|+|||++....++.++||||||++||||++ |+.||......+ .+..+. .+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-~~~~~~---------~~~--------- 220 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-VLEQVE---------RGY--------- 220 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHHH---------cCC---------
Confidence 223345678999999988899999999999999999999 889996543221 111110 000
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
....+......+.+++.+|+..+|++||++.++++.|++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 001122334568999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=360.86 Aligned_cols=250 Identities=23% Similarity=0.311 Sum_probs=203.3
Q ss_pred CCcccceeeccCcEEEEEEEcC-C-CcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-N-GKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~-g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
.|.+.++||+|+||.||+|... + ++.||+|++..........+++|+.+|+.++|+||++++++|..++..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888999999999999999854 3 5678888876655455567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 425 PNNNLEFHLHGK--GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 425 ~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
++|+|.++|+.. ....+++..+..|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999888642 233578999999999999999999998 999999999999999999999999999987654322
Q ss_pred -ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 503 -HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 503 -~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
.......|+.+|+|||++.+..++.++|||||||+||||++|+.||......+. . ... ..+.+.
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~--~---~~~-----~~~~~~----- 289 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI--M---QQV-----LYGKYD----- 289 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH--H---HHH-----HhCCCC-----
Confidence 223446699999999999999999999999999999999999999975432211 0 000 001110
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
.++......+.+++.+||..+|++||++.+++.
T Consensus 290 ----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 ----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 011223356889999999999999999999875
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=344.08 Aligned_cols=200 Identities=29% Similarity=0.441 Sum_probs=175.6
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
.++|++.+.||+|+||.||++.+. +++.||+|.++.... .....|.+|+++|++++|+||++++++|.+++..+||||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999965 578899998875432 234568999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|+.+++|.+++...+. +++..++.++.||++||.|||+.+ +|+|||||++||||+.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 84 HMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred cCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 9999999999976543 788999999999999999999742 69999999999999999999999999997654321
Q ss_pred ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCC
Q 040832 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPT 551 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~ 551 (724)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred --cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 23346899999999999888999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=350.17 Aligned_cols=246 Identities=25% Similarity=0.406 Sum_probs=192.4
Q ss_pred CcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecC
Q 040832 348 FSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVP 425 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 425 (724)
|...+.||+|+||.||+|.+. +++.||||++...... ..+.|.+|+++|++++|+||+++++++.+++..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 445678999999999999864 6899999999754332 34578999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccc
Q 040832 426 NNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVS 505 (724)
Q Consensus 426 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 505 (724)
+++|.... .+.+..++.|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++....... ..
T Consensus 156 ~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 225 (353)
T PLN00034 156 GGSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PC 225 (353)
T ss_pred CCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-cc
Confidence 99986532 256778889999999999999998 999999999999999999999999999987653321 12
Q ss_pred cccccCCCcCCcchhcC-----CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 506 TRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 506 ~~~~gt~~y~APE~~~~-----~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
....|+..|+|||++.. ...+.++|||||||+||||++|+.||...... +|...... +....
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-----~~~~~~~~--~~~~~------ 292 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-----DWASLMCA--ICMSQ------ 292 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-----cHHHHHHH--HhccC------
Confidence 33568999999998743 23346899999999999999999999743211 12111100 00000
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
...........+.+++.+||+.+|++||++.||+++
T Consensus 293 ---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 ---PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011122334568899999999999999999999974
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=336.49 Aligned_cols=266 Identities=24% Similarity=0.327 Sum_probs=197.5
Q ss_pred CCCcccceeeccCcEEEEEEEcC--CCcEEEEEEeccCCch--hHHHHHHHHHHHHhc---CCCCeeEEeeEEEe-----
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP--NGKEVAVKSLRSGSGQ--GEREFKAEVEIISRV---HHRHLVSLVGYCIA----- 413 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~--~g~~vaVK~l~~~~~~--~~~~f~~Ei~il~~l---~HpnIv~l~g~~~~----- 413 (724)
.+|++.+.||+|+||.||+|.+. +++.||||.++..... ....+.+|+.+++++ +|+||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999853 4678999998754322 234566788777766 69999999999863
Q ss_pred CCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecc
Q 040832 414 GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGL 493 (724)
Q Consensus 414 ~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGl 493 (724)
....++||||+. ++|..++.......+++..++.|+.||++||.|||++ +|+||||||+||||+.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 346799999996 6888888765555689999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhh--HHhhhhhhhhhc--
Q 040832 494 AKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC--LVDWARPLCLRA-- 569 (724)
Q Consensus 494 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~--l~~w~~~~~~~~-- 569 (724)
++..... .......|+..|+|||++....++.++|||||||+||||++|+.||......+.. +.+.........
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 9876543 2223456899999999998889999999999999999999999999876433221 111100000000
Q ss_pred ----ccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 570 ----LDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 570 ----~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
+....+.......+.. ...+....+.+++.+||+.+|++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhcccchhccCCCCCCHHH-HccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000000000000000 00112345678999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=332.51 Aligned_cols=255 Identities=30% Similarity=0.432 Sum_probs=206.5
Q ss_pred hCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
.++|++.+.||+|+||.||+|.+.++..||||+++.... ...+|.+|++++++++|+||+++++++.. ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 356899999999999999999987777899999975332 34578999999999999999999998754 5679999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
.+++|.+++.......+++..++.++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999999865444589999999999999999999998 99999999999999999999999999998765443322
Q ss_pred ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 505 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
.....++..|++||++..+.++.++|||||||++|||++ |+.||......+.. . .+..+.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~-~---------~~~~~~--------- 220 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-D---------QVERGY--------- 220 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH-H---------HHhcCC---------
Confidence 223446778999999998899999999999999999999 88888654321110 0 000000
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
......+....+.+++.+|++.+|++||++.++++.|+..
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0011223445688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=335.11 Aligned_cols=268 Identities=22% Similarity=0.318 Sum_probs=201.0
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
++|.+.+.||+|+||.||+|... +++.||||.++.... .....+.+|+.++++++|+||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56899999999999999999864 678999999875432 2344688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+.+ +|..++...+. .+.+..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 85 ~~~-~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 85 LDS-DLKQYLDNCGN-LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159 (288)
T ss_pred CCc-CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence 975 88888865432 478899999999999999999998 9999999999999999999999999999865432221
Q ss_pred cccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhh---hh--hhhhcc-cCCChh
Q 040832 504 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWA---RP--LCLRAL-DDGNFN 576 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~---~~--~~~~~~-~~~~~~ 576 (724)
.....++..|+|||++.+ ..++.++|||||||+||||++|+.||......+.....+. .+ .....+ ....+.
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 160 -YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred -ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 233467899999998865 5689999999999999999999999976543332111110 00 000000 001111
Q ss_pred hhcchhhhcC----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 577 EIADPYLEKN----YPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 577 ~~vd~~l~~~----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
....+..... ........+++++.+|++.+|++|+++.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 1111100000 001122457789999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=335.99 Aligned_cols=254 Identities=27% Similarity=0.490 Sum_probs=206.5
Q ss_pred CCCcccceeeccCcEEEEEEEcCC------CcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPN------GKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRL 418 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~------g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 418 (724)
+.|.+.+.||+|+||.||+|.+.+ ++.||||.++..... ..+.|.+|+++|++++|+||+++++++..+...+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457788899999999999998643 478999999866444 4568999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCE
Q 040832 419 LVYEYVPNNNLEFHLHGKG------------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFET 486 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~v 486 (724)
+||||+.+++|.++|...+ ...+.+..++.++.||+.||.|||++ +++|||||++||||+.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999997543 23478889999999999999999998 99999999999999999999
Q ss_pred EEEEeccccccCCCCC-ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhh
Q 040832 487 KVADFGLAKLTTDNNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARP 564 (724)
Q Consensus 487 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~ 564 (724)
||+|||+++....... .......++..|+|||++..+.++.++|||||||+||||++ |..||......+ +..+.
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~~~-- 237 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIECI-- 237 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHH--
Confidence 9999999986533221 12233446788999999999999999999999999999998 999986543222 11111
Q ss_pred hhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 565 LCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 565 ~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
..+.+. ..+......+.+++.+||..+|++||++.||++.|+
T Consensus 238 ------~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 ------TQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ------HcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 111111 111223456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=321.97 Aligned_cols=200 Identities=32% Similarity=0.433 Sum_probs=180.5
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhH---HHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGE---REFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~---~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|+..+.||.|.||+|.+++.+ +|..+|+|+|........ +...+|..+|+.+.||+++++++.|.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 35777889999999999999965 578899999976533332 34678999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||++||-|..+|++.++ +++..+..++.||+.||+|||++ +||+|||||+|||||.+|.+||+|||+|+...+.
T Consensus 124 eyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred eccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 99999999999998776 99999999999999999999999 9999999999999999999999999999988764
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCch
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAM 554 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~ 554 (724)
....+||+.|+|||++....|..++|.|+|||++|||+.|..||.....+
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~ 247 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI 247 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH
Confidence 23478999999999999999999999999999999999999999876543
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=343.47 Aligned_cols=255 Identities=27% Similarity=0.425 Sum_probs=202.6
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCc----EEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGK----EVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~----~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
.+|++.+.||+|+||.||+|.+. +++ .||||+++.... ...++|.+|+.+++.++|+||++++|+|..+ ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46899999999999999999854 333 389999875432 3456799999999999999999999999875 5689
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
|+||+.+|+|.+++.... ..+.+..+++++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999988643 2478999999999999999999998 999999999999999999999999999987754
Q ss_pred CCCcc-ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 500 NNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 500 ~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
..... .....++..|++||++.+..++.++|||||||+||||++ |+.||+.....+ +..+. ..+..
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~~~~--------~~~~~-- 229 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSIL--------EKGER-- 229 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH--------hCCCC--
Confidence 33321 122334678999999999999999999999999999998 999997643221 11110 00000
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
+ ..+......+.+++.+||..+|.+||++.+|+..|....
T Consensus 230 ~-------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 230 L-------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred C-------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 001112345788999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=327.99 Aligned_cols=267 Identities=22% Similarity=0.271 Sum_probs=205.9
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchh--HHHHHHHHHHHHhcCCCCeeEEeeEEEe--CCeEEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQG--EREFKAEVEIISRVHHRHLVSLVGYCIA--GGKRLLVY 421 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~--~~~f~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~lV~ 421 (724)
+|.+.+.|++|.||.||+|+++ +++.||+|+++.+.... -..-++||.+|.+++|+|||.+-++.+. -+.+||||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 4666788999999999999965 57889999998653221 1246899999999999999999887664 35789999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
|||+ .+|..+|+... ..+...++..++.|+++||+|||.+ .|+|||||++|+|+.+.|.+||+|||||+.++...
T Consensus 157 e~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 157 EYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred HHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 9995 57889998876 3578889999999999999999999 89999999999999999999999999999988653
Q ss_pred CccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHh-----------hhhhhhhhc
Q 040832 502 THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVD-----------WARPLCLRA 569 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~-----------w~~~~~~~~ 569 (724)
...+..+-|.||.|||.+.+. .|+...||||+|||+.||++++.-|.+..++++.-.. |..-.....
T Consensus 232 -k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 232 -KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred -ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence 335667789999999998874 6999999999999999999999999888766553221 111111111
Q ss_pred ccCCChhhhcchhhhcCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 570 LDDGNFNEIADPYLEKNYPTE-EMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 570 ~~~~~~~~~vd~~l~~~~~~~-~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+..-.+.+.-...|.+.+... ....-.+++..+|..||.+|-++.|.+++
T Consensus 311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 111111111222233333332 33455677888899999999999998763
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=342.59 Aligned_cols=267 Identities=19% Similarity=0.346 Sum_probs=198.0
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC-----CeEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAG-----GKRL 418 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~-----~~~~ 418 (724)
+|++.++||+|+||.||+|... +++.||||+++.. .......+.+|+++|++++|+||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4888999999999999999954 6889999998743 223345688999999999999999999988643 2579
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
+||||+. ++|..++..... +++..++.|+.||++||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKANDD--LTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhccc--CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 688888876543 89999999999999999999999 99999999999999999999999999998653
Q ss_pred CCCC--ccccccccCCCcCCcchhcC--CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhh--HHhhhh---hhhhhc
Q 040832 499 DNNT--HVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC--LVDWAR---PLCLRA 569 (724)
Q Consensus 499 ~~~~--~~~~~~~gt~~y~APE~~~~--~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~--l~~w~~---~~~~~~ 569 (724)
.... ......+|+..|+|||++.+ ..++.++|||||||+||||++|+.||......... +.+... ......
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 3221 12234579999999999876 67899999999999999999999999765432211 000000 000000
Q ss_pred ccCCChhhhcchhhhcC-CC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 570 LDDGNFNEIADPYLEKN-YP-----TEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 570 ~~~~~~~~~vd~~l~~~-~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+......+.+....... .. ......+.+++.+||+.+|++||++.||+++
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 11111111111000000 00 0112457889999999999999999999974
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=331.11 Aligned_cols=255 Identities=29% Similarity=0.428 Sum_probs=208.3
Q ss_pred hhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
..++|++.++||+|+||.||+|.+++++.||||.+..... ....|.+|+.++++++|+||+++++++. .+..++||||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 3467899999999999999999998999999999976543 3467899999999999999999999874 4568999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+.+++|.+++.......+++.+++.|+.||+.||+|||+. +++|||||++||+++.++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999998776555689999999999999999999998 9999999999999999999999999999876533332
Q ss_pred cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchh
Q 040832 504 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~ 582 (724)
......++..|++||++..+.++.++||||||+++|||++ |+.||......+ +... +..+..
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~--------~~~~~~------- 221 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQN--------LERGYR------- 221 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHHH--------HHcCCC-------
Confidence 2233446778999999998899999999999999999999 999997543221 1111 000000
Q ss_pred hhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 583 LEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 583 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
..........+.+++.+|++.+|++||++++|++.|+.
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 --MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 00111223468999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=343.38 Aligned_cols=242 Identities=26% Similarity=0.342 Sum_probs=194.1
Q ss_pred eeccCcEEEEEEEcC-CCcEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCCCH
Q 040832 354 LGQGGFGYVHKGVLP-NGKEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNL 429 (724)
Q Consensus 354 LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 429 (724)
||+|+||.||++... +++.||||+++.. .......+.+|+.+|++++|+||+++++++...+..++||||+.+|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999965 5788999998643 223345688999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccccccc
Q 040832 430 EFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM 509 (724)
Q Consensus 430 ~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 509 (724)
.+++...+. +++..++.|+.||++||.|||++ +|+||||||+||||+.++.+||+|||+++....... ......
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~ 154 (312)
T cd05585 81 FHHLQREGR--FDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTFC 154 (312)
T ss_pred HHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-cccccc
Confidence 999976543 89999999999999999999998 999999999999999999999999999986433222 223456
Q ss_pred cCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCH
Q 040832 510 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPT 589 (724)
Q Consensus 510 gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~ 589 (724)
|+..|+|||++.+..++.++|||||||+||||++|+.||......+. ..... .+.+ .++.
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~-----~~~~~-----~~~~----------~~~~ 214 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM-----YRKIL-----QEPL----------RFPD 214 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH-----HHHHH-----cCCC----------CCCC
Confidence 99999999999999999999999999999999999999975432211 11010 0000 1122
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 590 EEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 590 ~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
.....+.+++.+||+.+|++|+++..+.+.|+
T Consensus 215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 23356788999999999999986544444433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=351.31 Aligned_cols=264 Identities=22% Similarity=0.273 Sum_probs=199.2
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
..++|.+.+.||+|+||.||++.+. .++.||||... ...+.+|+++|++|+|+||+++++++..+...++|||
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 3468999999999999999999854 57889999754 2357889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
++. ++|..++.... .+.+..++.|+.||++||+|||++ +||||||||+||||+.++.+||+|||+++.......
T Consensus 164 ~~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 164 RYK-TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred cCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 995 67877776554 388999999999999999999998 999999999999999999999999999976543332
Q ss_pred ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCch------hhhHHhhhhhhhh--hccc---
Q 040832 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAM------EDCLVDWARPLCL--RALD--- 571 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~------~~~l~~w~~~~~~--~~~~--- 571 (724)
.......||..|+|||++.+..++.++|||||||+||||++|+.||...... ...+......+.. ..+.
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 3334467999999999999999999999999999999999999887533211 1111100000000 0000
Q ss_pred CCChhhhcchhhhc-------CC----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 572 DGNFNEIADPYLEK-------NY----PTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 572 ~~~~~~~vd~~l~~-------~~----~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
...+.++....... .. ..+....+..++.+||+.+|++||++.|++++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00011111000000 00 01233468889999999999999999999863
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=335.47 Aligned_cols=255 Identities=25% Similarity=0.447 Sum_probs=203.6
Q ss_pred CCCcccceeeccCcEEEEEEEc-----CCCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-----PNGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-----~~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
++|++.+.||+|+||.||+|.+ ..++.|++|.++.... +...+|.+|++++++++|+||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999984 2467899999975433 334678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC
Q 040832 420 VYEYVPNNNLEFHLHGKG---------------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF 484 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~---------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~ 484 (724)
||||+.+++|.+++.... ...+++.+++.++.||+.||+|||++ +|+||||||+||||++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 999999999999985321 23478889999999999999999998 999999999999999999
Q ss_pred CEEEEEeccccccCCCCC-ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhh
Q 040832 485 ETKVADFGLAKLTTDNNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWA 562 (724)
Q Consensus 485 ~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~ 562 (724)
.+||+|||+++....... .......++..|+|||++.++.++.++|||||||+||||++ |..||......+ +....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~--~~~~~ 239 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE--VIEMV 239 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH
Confidence 999999999987643322 12233445678999999988889999999999999999998 999986543211 11111
Q ss_pred hhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 563 RPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 563 ~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
. ..... ..+.....++.+++.+|++.+|++||++.+|+++|.+
T Consensus 240 ~--------~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 R--------KRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H--------cCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 01000 0111223568889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=349.83 Aligned_cols=250 Identities=26% Similarity=0.347 Sum_probs=204.5
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|.+.+.||+|+||.||+|... +++.||||+++... ......+.+|+++|..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999965 68899999997532 133456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+.+++|..++...+ .+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 9999999999998763 489999999999999999999998 99999999999999999999999999998765443
Q ss_pred ----------------------------CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCc
Q 040832 502 ----------------------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGA 553 (724)
Q Consensus 502 ----------------------------~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~ 553 (724)
........|+..|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 1122345699999999999999999999999999999999999999976543
Q ss_pred hhhh--HHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 040832 554 MEDC--LVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPK-ISQIVRA 619 (724)
Q Consensus 554 ~~~~--l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~evv~~ 619 (724)
.+.. +..|...+ .+ +. .......+..++.+|++ +|.+|++ +.+|+++
T Consensus 236 ~~~~~~i~~~~~~~--------~~-----p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 QETYNKIINWKESL--------RF-----PP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHHHhccCCcc--------cC-----CC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 2211 11111100 00 00 00124557788889997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=340.19 Aligned_cols=256 Identities=25% Similarity=0.343 Sum_probs=201.1
Q ss_pred HHhhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCch--------------hHHHHHHHHHHHHhcCCCCeeE
Q 040832 342 SAATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQ--------------GEREFKAEVEIISRVHHRHLVS 406 (724)
Q Consensus 342 ~~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~--------------~~~~f~~Ei~il~~l~HpnIv~ 406 (724)
....+.|++++.||+|.||+|-+|+. .+++.||||+|...... ..+..++||.||++|+|+|||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34457899999999999999999995 46899999998543111 1246889999999999999999
Q ss_pred EeeEEEe--CCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC
Q 040832 407 LVGYCIA--GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF 484 (724)
Q Consensus 407 l~g~~~~--~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~ 484 (724)
|+++..+ .+.+|||+|||..|.+...= .....+.+.++++|+++++.||+|||.+ +||||||||+|+||+++|
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence 9999876 46889999999988765432 2223389999999999999999999999 999999999999999999
Q ss_pred CEEEEEeccccccCCCCC----ccccccccCCCcCCcchhcCCC----CChhHHHHHHHHHHHHHHhCCCCCCCCCchhh
Q 040832 485 ETKVADFGLAKLTTDNNT----HVSTRVMGTFGYLAPEYASSGK----LTEKSDVFSFGVMLLELITGRRPIDPTGAMED 556 (724)
Q Consensus 485 ~vkL~DFGla~~~~~~~~----~~~~~~~gt~~y~APE~~~~~~----~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~ 556 (724)
+|||+|||.+........ ....+.+||+.|||||.+..+. ...+.|||++||+||.|+.|+.||.....++.
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 999999999987633221 1223467999999999987642 34789999999999999999999976433222
Q ss_pred hHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 040832 557 CLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRAL 620 (724)
Q Consensus 557 ~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L 620 (724)
. +.++...|.--...++-..+..++.++|..||++|-++.+|..+.
T Consensus 328 ~------------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 328 F------------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred H------------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 1 122222221111224566788999999999999999999998654
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=347.53 Aligned_cols=245 Identities=22% Similarity=0.291 Sum_probs=200.0
Q ss_pred CCCcccceeeccCcEEEEEEEcCC--CcEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPN--GKEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~--g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
++|.+.+.||+|+||.||+|.+.+ +..||||++... .......+.+|+.+|+.++|+||+++++++.+++..+||
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468899999999999999998543 368999998643 122345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+.+|+|.+++..... +++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKR--FPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 999999999999976553 88999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
. ....|+..|||||++.+..++.++|||||||+||||++|+.||........ +.. +..+.+
T Consensus 185 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~----~~~------i~~~~~----- 245 (340)
T PTZ00426 185 T----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI----YQK------ILEGII----- 245 (340)
T ss_pred c----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH----HHH------HhcCCC-----
Confidence 1 235689999999999988899999999999999999999999976432211 100 011110
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRP-----KISQIVRA 619 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evv~~ 619 (724)
.++......+.+++.+|++.+|++|+ ++++|+++
T Consensus 246 -----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 -----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 01112224467899999999999995 78888764
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=334.53 Aligned_cols=256 Identities=23% Similarity=0.425 Sum_probs=203.9
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC------CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCe
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP------NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGK 416 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 416 (724)
..++|++.+.||+|+||.||+|.+. .+..||||+++.... ....+|.+|+.+++.++|+||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999998753 246799999865432 334568999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEE
Q 040832 417 RLLVYEYVPNNNLEFHLHGKG--------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKV 488 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL 488 (724)
.++||||+.+++|.+++.... ...+.+..++.++.|+++||+|||+. +++||||||+||||++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 999999999999999986532 12357888999999999999999998 9999999999999999999999
Q ss_pred EEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhh
Q 040832 489 ADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLC 566 (724)
Q Consensus 489 ~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~ 566 (724)
+|||+++........ ......++..|+|||++.++.++.++|||||||+||||++ |..||......+ ...+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~--~~~~~---- 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ--VLRFV---- 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH----
Confidence 999999865433222 1222345788999999998899999999999999999999 788886543221 11110
Q ss_pred hhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 567 LRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 567 ~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
..+.+. ..+......+.+++.+||+.+|++||++.|++++|+
T Consensus 235 ----~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 235 ----MEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ----HcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 001110 111223356889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=328.79 Aligned_cols=253 Identities=30% Similarity=0.442 Sum_probs=205.6
Q ss_pred CCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecC
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVP 425 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 425 (724)
++|.+.+.||+|+||.||++.+.++..||+|.+.... ...+.|.+|++++++++|+||+++++++.. +..++||||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 5688889999999999999998777789999887543 234678999999999999999999998754 56789999999
Q ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccc
Q 040832 426 NNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVS 505 (724)
Q Consensus 426 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 505 (724)
+++|.++++......+++..++.++.||+.||.|||+. +|+|||||++||||++++.+||+|||+++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 99999999875555689999999999999999999998 999999999999999999999999999987654332222
Q ss_pred cccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhh
Q 040832 506 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLE 584 (724)
Q Consensus 506 ~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~ 584 (724)
....++..|++||++..+.++.++|||||||+||||++ |+.||......+ ...+.. .+ +.
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~--------~~-~~-------- 221 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVE--------RG-YR-------- 221 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH--------cC-CC--------
Confidence 23346778999999998999999999999999999999 899997543221 111110 00 00
Q ss_pred cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 585 KNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
..........+.+++.+||+.+|++||++.+|++.|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01112334568899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=343.51 Aligned_cols=264 Identities=20% Similarity=0.291 Sum_probs=196.9
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
..+|.+.+.||+|+||.||++.+. .++.||||.... ..+.+|+++|++|+|+||+++++++..++..+||||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999965 478899996432 3467899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+. ++|..++..... .+++.+++.|+.||++||.|||++ +|||||||++||||+.++.+||+|||+++........
T Consensus 242 ~~-~~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 242 YR-SDLYTYLGARLR-PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred cC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 95 677777765332 489999999999999999999998 9999999999999999999999999999876443222
Q ss_pred -cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCc------hhhhHHhhhhhhhhh--cccCCC
Q 040832 504 -VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGA------MEDCLVDWARPLCLR--ALDDGN 574 (724)
Q Consensus 504 -~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~------~~~~l~~w~~~~~~~--~~~~~~ 574 (724)
......||..|+|||++.+..++.++|||||||+||||++|..++..... ....+....+..... .+....
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 22345799999999999999999999999999999999998876533211 111111111110000 000000
Q ss_pred hhhhcchhh-------hcCCCH-------HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 575 FNEIADPYL-------EKNYPT-------EEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 575 ~~~~vd~~l-------~~~~~~-------~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
...++..+. ...+.. .....+.+++.+||+.||++||++.||+++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000000 000000 111357789999999999999999999985
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=343.14 Aligned_cols=242 Identities=28% Similarity=0.408 Sum_probs=195.6
Q ss_pred ceeeccCcEEEEEEEc----CCCcEEEEEEeccCC----chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 352 NLLGQGGFGYVHKGVL----PNGKEVAVKSLRSGS----GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~----~~g~~vaVK~l~~~~----~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
++||+|+||.||++.. ..++.||||+++... ......+.+|+++|++++|+||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 357889999987531 12234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+.+++|..++...+. +.+..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (323)
T cd05584 82 LSGGELFMHLEREGI--FMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT- 155 (323)
T ss_pred CCCchHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence 999999999876543 78888999999999999999998 999999999999999999999999999975433222
Q ss_pred cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 504 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
......|+..|+|||++.+..++.++|||||||+||||++|+.||......... .. +..+.+
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~-~~---------~~~~~~-------- 217 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI-DK---------ILKGKL-------- 217 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH-HH---------HHcCCC--------
Confidence 223456999999999999888999999999999999999999999765322111 00 001110
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRP-----KISQIVRA 619 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evv~~ 619 (724)
.++......+.+++.+||+.+|++|+ ++.+++++
T Consensus 218 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 218 --NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred --CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 11122234678999999999999999 78887764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=329.20 Aligned_cols=256 Identities=30% Similarity=0.465 Sum_probs=209.9
Q ss_pred hhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
..++|.+.+.||+|+||.||+|.+++++.|+||.+.... ....++.+|+.++++++|+||+++++++..+...++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 456889999999999999999998888899999997543 3356799999999999999999999999998899999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+++++|.+++.......+++..++.|+.+|+.||.|||++ +|+|||||++||||+.++.+||+|||+++........
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999999876555689999999999999999999999 9999999999999999999999999999876543222
Q ss_pred cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchh
Q 040832 504 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~ 582 (724)
......++..|++||.+.+..++.++|||||||++|||++ |+.||....... .+..+.. + +.
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~~~~~---------~-~~------ 222 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLEQVER---------G-YR------ 222 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHc---------C-CC------
Confidence 2222334568999999998899999999999999999999 999996543211 1111100 0 00
Q ss_pred hhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 583 LEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 583 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
...+......+.+++.+|++.+|++||++++|++.|+.
T Consensus 223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 --MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00111224568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=332.86 Aligned_cols=266 Identities=27% Similarity=0.373 Sum_probs=204.7
Q ss_pred CcccceeeccCcEEEEEEEc-----CCCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC--CeEEE
Q 040832 348 FSQSNLLGQGGFGYVHKGVL-----PNGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAG--GKRLL 419 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~-----~~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~l 419 (724)
|++.+.||+|+||.||++.. .+++.||+|.++.... .....|.+|+++|++++|+||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 48889999999999988652 3577899999976533 3456788999999999999999999988754 36789
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
||||+.+++|.+++.... +++.+++.|+.|+++||.|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 86 v~e~~~~~~l~~~~~~~~---l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPKHK---LNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHHcC---CCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 999999999999987643 89999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCc--cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 500 NNTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 500 ~~~~--~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
.... ......++..|++||++....++.++||||||++||||++|..||.........+..+... ......+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~ 235 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQG----QMTVVRLIE 235 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccc----ccchhhhhh
Confidence 3221 1122335667999999998899999999999999999999999986542211111111110 011111222
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
+++.......+......+.+++.+||+.+|++||++++|++.|+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 2222221122334456799999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=336.41 Aligned_cols=256 Identities=27% Similarity=0.460 Sum_probs=208.2
Q ss_pred CCCcccceeeccCcEEEEEEEcC------CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP------NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
++|.+.+.||+|+||.||++.+. ++..|++|.++.......+.|.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45788899999999999999742 345689999887665556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCC
Q 040832 420 VYEYVPNNNLEFHLHGKG--------------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFE 485 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~ 485 (724)
||||+.+++|.+++.... ...+++..+++|+.||+.||+|||++ +|+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999999986532 23478999999999999999999999 9999999999999999999
Q ss_pred EEEEEeccccccCCCCC-ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhh
Q 040832 486 TKVADFGLAKLTTDNNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWAR 563 (724)
Q Consensus 486 vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~ 563 (724)
+||+|||+++....... .......++..|+|||++....++.++|||||||+||||++ |+.||......+ ..++
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~-- 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VIEC-- 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH--
Confidence 99999999986644322 12233456788999999999999999999999999999999 999986543221 1111
Q ss_pred hhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 564 PLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 564 ~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
+..+.+.. ........+.+++.+||+.+|++||++.+|++.|+..
T Consensus 238 ------~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 238 ------ITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred ------HhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 11111111 1112345688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=345.48 Aligned_cols=242 Identities=23% Similarity=0.324 Sum_probs=195.8
Q ss_pred ceeeccCcEEEEEEEc-CCCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCC
Q 040832 352 NLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNN 427 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 427 (724)
++||+|+||.||++.. .+++.||||+++... ......+..|+++++.++|+||+++++++...+..+|||||+.++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 468899999997532 223356788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcccc
Q 040832 428 NLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHE-DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST 506 (724)
Q Consensus 428 sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs-~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 506 (724)
+|..++.... .+++..++.|+.||+.||+|||+ . +|+||||||+||||+.++.+||+|||+++........ ..
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~ 154 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-MK 154 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc-cc
Confidence 9998887654 38999999999999999999997 6 8999999999999999999999999999764332222 23
Q ss_pred ccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcC
Q 040832 507 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKN 586 (724)
Q Consensus 507 ~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~ 586 (724)
...|+..|+|||++.++.++.++|||||||+||||++|+.||......+.....+ ...+ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~----------~~~~----------~ 214 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL----------MEEI----------R 214 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh----------cCCC----------C
Confidence 3569999999999999999999999999999999999999997543221111100 0000 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 040832 587 YPTEEMARMVACAAASIRHSARRRP-----KISQIVRA 619 (724)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evv~~ 619 (724)
++......+.+++.+||+.+|++|+ ++.+|+++
T Consensus 215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1122234578899999999999997 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=335.21 Aligned_cols=256 Identities=26% Similarity=0.429 Sum_probs=203.8
Q ss_pred CCcccceeeccCcEEEEEEEcC------CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP------NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~------~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
+|++.+.||+|+||.||+|.+. ....|++|.+..... ...+.+.+|+.+|+.++|+||++++++|..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999853 235788998875543 334578999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcC----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCcc
Q 040832 420 VYEYVPNNNLEFHLHGK----------------------GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSN 477 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~----------------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~N 477 (724)
||||+.+++|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 99999999999987642 112478899999999999999999998 99999999999
Q ss_pred EEEcCCCCEEEEEeccccccCCCCCcc-ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchh
Q 040832 478 ILLDYTFETKVADFGLAKLTTDNNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAME 555 (724)
Q Consensus 478 ILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~ 555 (724)
|||++++.+||+|||+++......... .....++..|++||++.+..++.++||||||++||||++ |+.||......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 999999999999999998664333221 222345678999999988889999999999999999999 99999654321
Q ss_pred hhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 556 DCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 556 ~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
.+..+.. .+ +....+......+.+++.+|++.+|++||++.+|++.|++.+
T Consensus 237 -~~~~~~~--------~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 237 -RLFNLLK--------TG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred -HHHHHHh--------CC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 1111111 00 000111223356889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=345.55 Aligned_cols=259 Identities=27% Similarity=0.422 Sum_probs=203.5
Q ss_pred hCCCcccceeeccCcEEEEEEEcC------CCcEEEEEEeccCCch-hHHHHHHHHHHHHhc-CCCCeeEEeeEEEeC-C
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP------NGKEVAVKSLRSGSGQ-GEREFKAEVEIISRV-HHRHLVSLVGYCIAG-G 415 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~-~ 415 (724)
.++|++.++||+|+||.||+|.+. .++.||+|+++..... ..+.+..|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 356888999999999999999742 2478999999754333 335688899999999 899999999988654 5
Q ss_pred eEEEEEEecCCCCHHHHHhcCCC---------------------------------------------------------
Q 040832 416 KRLLVYEYVPNNNLEFHLHGKGR--------------------------------------------------------- 438 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~~~--------------------------------------------------------- 438 (724)
..++||||+.+++|.++|.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999998864321
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc-ccccccCCCcC
Q 040832 439 --PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV-STRVMGTFGYL 515 (724)
Q Consensus 439 --~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~ 515 (724)
..+++..+++++.||++||+|||++ +|+||||||+||||+.++.+||+|||+++.+....... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 2578999999999999999999998 99999999999999999999999999998764433221 22344677899
Q ss_pred CcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHH
Q 040832 516 APEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMAR 594 (724)
Q Consensus 516 APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~ 594 (724)
|||++.+..++.++|||||||+||||++ |..||......+. +... +..+.. ...+......
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~~~--------~~~~~~---------~~~~~~~~~~ 304 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FCRR--------LKEGTR---------MRAPEYATPE 304 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HHHH--------HhccCC---------CCCCccCCHH
Confidence 9999999999999999999999999998 9999965422111 1100 011100 0011223456
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 595 MVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 595 l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
+.+++.+||+.+|++||++.||+++|+..+
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=348.96 Aligned_cols=258 Identities=26% Similarity=0.433 Sum_probs=215.5
Q ss_pred hhCCCcccceeeccCcEEEEEEEcCC---Cc--EEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLPN---GK--EVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKR 417 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~~---g~--~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 417 (724)
......+.++||+|-||.||+|.+.+ |+ .||||.-+.++. ++.+.|+.|+-+|++++||||++|+|+|.+. ..
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ce
Confidence 33445666779999999999999533 33 488998887544 3456799999999999999999999999875 56
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
|||||.+..|.|..+|+.+.. .|+......++.||+.+|+|||+. ++|||||..+||||....-|||+||||++++
T Consensus 466 WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred eEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhc
Confidence 999999999999999987543 488899999999999999999999 9999999999999999999999999999999
Q ss_pred CCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChh
Q 040832 498 TDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 498 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
.++......+..-...|||||.+.-.+++.++|||.|||++||++. |..||.+..+.+. ...+++|.-
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV----------I~~iEnGeR- 610 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV----------IGHIENGER- 610 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce----------EEEecCCCC-
Confidence 9888776666667889999999999999999999999999999998 9999976533221 111222211
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
--++..+...|..++.+||..+|.+||++.||...|.....
T Consensus 611 --------lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 611 --------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred --------CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 13456777889999999999999999999999887776544
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=349.52 Aligned_cols=250 Identities=23% Similarity=0.336 Sum_probs=198.8
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|++.++||+|+||.||++... +++.||||+++... ......+.+|+++|+.++|+||+++++++.++...+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999964 58899999997431 223346889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+.+|+|.+++...+. +++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKKDT--FTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 99999999999976553 89999999999999999999999 99999999999999999999999999997543221
Q ss_pred Cc-------------------------------------cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhC
Q 040832 502 TH-------------------------------------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITG 544 (724)
Q Consensus 502 ~~-------------------------------------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG 544 (724)
.. .....+||..|+|||++....++.++|||||||+||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 10 01124699999999999999999999999999999999999
Q ss_pred CCCCCCCCchhhh--HHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 040832 545 RRPIDPTGAMEDC--LVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPK---ISQIVRA 619 (724)
Q Consensus 545 ~~P~~~~~~~~~~--l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs---~~evv~~ 619 (724)
+.||......+.. +..|...+ .+ .........+.+++.+|+. +|.+|++ +.|++++
T Consensus 236 ~~Pf~~~~~~~~~~~i~~~~~~~-----------~~-------~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 236 YPPFCSDNPQETYRKIINWKETL-----------QF-------PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCHHHHHHHHHcCCCcc-----------CC-------CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999765433221 11121100 00 0000112345677777886 8999998 8887764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=324.45 Aligned_cols=247 Identities=28% Similarity=0.424 Sum_probs=200.6
Q ss_pred ceeeccCcEEEEEEEcCCCcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCCCHH
Q 040832 352 NLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLE 430 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 430 (724)
++||+|+||.||+|...+++.||+|.++..... ....|.+|++++++++|+||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 369999999999999888899999998765433 3346899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcccccccc
Q 040832 431 FHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMG 510 (724)
Q Consensus 431 ~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~g 510 (724)
+++.... ..+++..++.++.|++.+|.|||++ +++|||||++|||++.++.+||+|||++...............+
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9887644 3478999999999999999999998 99999999999999999999999999997654432222222334
Q ss_pred CCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCH
Q 040832 511 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPT 589 (724)
Q Consensus 511 t~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~ 589 (724)
+..|+|||++..+.++.++||||||++||||++ |..||........ .... ..+. ......
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~-~~~~---------~~~~---------~~~~~~ 217 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA-REQV---------EKGY---------RMSCPQ 217 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH-HHHH---------HcCC---------CCCCCC
Confidence 678999999998999999999999999999998 9999965432211 0000 0000 001112
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 590 EEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 590 ~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
.....+.+++.+|+..+|++||++.+|++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 23457899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=332.25 Aligned_cols=255 Identities=28% Similarity=0.439 Sum_probs=203.1
Q ss_pred hCCCcccceeeccCcEEEEEEEcCC------CcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPN------GKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKR 417 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~------g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 417 (724)
.++|.+.+.||+|+||.||+|.+.+ +..|++|.+...... .+..|..|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678999999999999999998753 467899988754333 345799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC---CEEEE
Q 040832 418 LLVYEYVPNNNLEFHLHGKGR-----PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF---ETKVA 489 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~-----~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~---~vkL~ 489 (724)
++||||+.+++|.++++.... ..+++..+++++.||++||+|||++ +++|||||++|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 999999999999999876431 2589999999999999999999998 999999999999998654 59999
Q ss_pred EeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhh
Q 040832 490 DFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCL 567 (724)
Q Consensus 490 DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~ 567 (724)
|||+++........ .......+..|+|||++.++.++.++|||||||+||||++ |+.||......+. ...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~--~~~------ 233 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV--MEF------ 233 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--HHH------
Confidence 99999876432221 1122234568999999999999999999999999999997 9999975432211 110
Q ss_pred hcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 568 RALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 568 ~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
+.... ...++......+.+++.+|++.+|++||++.+|+++|+
T Consensus 234 --~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 --VTGGG---------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --HHcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 00000 00112223456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=347.41 Aligned_cols=250 Identities=24% Similarity=0.314 Sum_probs=195.5
Q ss_pred CCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
.|.+++.||+|+||.||+|.+ .+++.||||++.... ......+.+|+++|++++|+||+++++++.+.+.++||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999985 457899999996532 2234568999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|+++|+|.+++...+. +++..+..++.||+.||+|||+. +|+||||||+||||+.++++||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRMEV--FPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 9999999999976543 88889999999999999999998 999999999999999999999999999864311000
Q ss_pred ----------------------------------------------ccccccccCCCcCCcchhcCCCCChhHHHHHHHH
Q 040832 503 ----------------------------------------------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV 536 (724)
Q Consensus 503 ----------------------------------------------~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGv 536 (724)
......+||..|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0012357999999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCCchhhh--HHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHH--hhccCCCCCCC
Q 040832 537 MLLELITGRRPIDPTGAMEDC--LVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAA--SIRHSARRRPK 612 (724)
Q Consensus 537 lL~eLltG~~P~~~~~~~~~~--l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~--cl~~~P~~RPs 612 (724)
+||||++|+.||......+.. +..|...+ .+. . ...+. ..+.+++.+ |+..++..|++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------~~~----~--~~~~s----~~~~dli~~ll~~~~~~~~R~~ 298 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVINWENTL--------HIP----P--QVKLS----PEAVDLITKLCCSAEERLGRNG 298 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHcccccc--------CCC----C--CCCCC----HHHHHHHHHHccCcccccCCCC
Confidence 999999999999765433221 11221110 000 0 00122 234455544 55666777999
Q ss_pred HHHHHHH
Q 040832 613 ISQIVRA 619 (724)
Q Consensus 613 ~~evv~~ 619 (724)
+.+|+++
T Consensus 299 ~~~~l~h 305 (381)
T cd05626 299 ADDIKAH 305 (381)
T ss_pred HHHHhcC
Confidence 9999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=346.57 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=212.2
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCe-EEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGK-RLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~-~~lV~ 421 (724)
+.|..+++||+|+||.++..+.+ +++.|++|.+.-. .....+....|+.++++++|||||.+++.|++++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56788899999999999988754 5778999988654 22333467899999999999999999999999988 89999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
+||+||+|.+.+.+..+..+.++.+++|+.||+.||.|||++ +|+|||||+.|||++.++.|||.|||+|+.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 999999999999987777899999999999999999999998 99999999999999999999999999999987665
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
. ....++||+.||.||.+.+..|..|+|||||||++|||++-+++|+..+... .+....+ ..
T Consensus 161 ~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~-Li~ki~~-------------~~--- 222 (426)
T KOG0589|consen 161 S-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE-LILKINR-------------GL--- 222 (426)
T ss_pred h-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH-HHHHHhh-------------cc---
Confidence 2 3455789999999999999999999999999999999999999997653221 1111110 00
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..-.+......+..++..|++.+|+.||++.+++++
T Consensus 223 --~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 --YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 112334556778899999999999999999999975
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=336.93 Aligned_cols=260 Identities=26% Similarity=0.412 Sum_probs=207.2
Q ss_pred HhhCCCcccceeeccCcEEEEEEEcCC------CcEEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeC
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVLPN------GKEVAVKSLRSGS-GQGEREFKAEVEIISRV-HHRHLVSLVGYCIAG 414 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~~~------g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~ 414 (724)
...++|++.+.||+|+||.||++.+.+ ...||+|.++... .....++.+|+++++++ +|+||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 344578889999999999999998642 3679999987543 23345688999999999 799999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEE
Q 040832 415 GKRLLVYEYVPNNNLEFHLHGK--------------GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILL 480 (724)
Q Consensus 415 ~~~~lV~E~~~~gsL~~~L~~~--------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl 480 (724)
+..++||||+.+++|..+++.. ....+++..+++|+.||+.||+|||+. +|+|||||++|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEE
Confidence 9999999999999999998642 234588999999999999999999998 99999999999999
Q ss_pred cCCCCEEEEEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhH
Q 040832 481 DYTFETKVADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCL 558 (724)
Q Consensus 481 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l 558 (724)
++++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||......+...
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 99999999999999876543221 1122335678999999998899999999999999999998 999986543222110
Q ss_pred HhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 559 VDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 559 ~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
. +..+. ....+......+.+++.+|++.+|++||++.+|++.|+..+
T Consensus 246 ~----------~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 246 L----------LKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred H----------HHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 0 00000 00112233456889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=344.70 Aligned_cols=202 Identities=24% Similarity=0.353 Sum_probs=175.6
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|++.+.||+|+||.||++... +++.||||+++... ......+.+|+.++.+++|+||+++++++.+....+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999854 58899999996532 122346888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+++|+|.+++...+. +++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKKDT--LTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 99999999999986543 89999999999999999999998 99999999999999999999999999997543211
Q ss_pred C----------------------------------ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCC
Q 040832 502 T----------------------------------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547 (724)
Q Consensus 502 ~----------------------------------~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P 547 (724)
. .......||..|+|||++.+..++.++|||||||+||||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 001235799999999999999999999999999999999999999
Q ss_pred CCCCC
Q 040832 548 IDPTG 552 (724)
Q Consensus 548 ~~~~~ 552 (724)
|....
T Consensus 236 f~~~~ 240 (363)
T cd05628 236 FCSET 240 (363)
T ss_pred CCCCC
Confidence 97654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.41 Aligned_cols=258 Identities=21% Similarity=0.253 Sum_probs=200.1
Q ss_pred HHHHhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC
Q 040832 340 ELSAATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGG 415 (724)
Q Consensus 340 el~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 415 (724)
++....++|++.++||+|+||.||++... +++.||+|++... .......+.+|+.+++.++|+||+++++++.++.
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34445678999999999999999999965 5788999998642 1223446889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 416 KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
..++||||+.+|+|.+++... .+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccce
Confidence 999999999999999998754 378889999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCccccccccCCCcCCcchhcCC----CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhccc
Q 040832 496 LTTDNNTHVSTRVMGTFGYLAPEYASSG----KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALD 571 (724)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~ 571 (724)
..............||..|||||++... .++.++|||||||+||||++|+.||........ +..... .
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~-~~~i~~----~--- 262 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT-YSKIMD----H--- 262 (370)
T ss_pred ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH-HHHHHh----C---
Confidence 7654333223456799999999998653 378899999999999999999999976532221 111000 0
Q ss_pred CCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 040832 572 DGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARR--RPKISQIVRA 619 (724)
Q Consensus 572 ~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evv~~ 619 (724)
...+ .-.........+..++..|+...+.+ |+++.|++++
T Consensus 263 ~~~~--------~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 263 KNSL--------NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred Cccc--------CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0000 00001122344666777788755544 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=332.45 Aligned_cols=252 Identities=27% Similarity=0.378 Sum_probs=202.5
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG---QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~---~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
.|++.++||+|+||.||++.+. +++.||||++..... .....+.+|+.+|++++|+||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999864 688999999975322 123457889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|+.+++|.+++.......+++..++.++.||++||.|||+. +|+|||||++|||+++++.++|+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999888765445689999999999999999999998 999999999999999999999999999987643322
Q ss_pred ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchh
Q 040832 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~ 582 (724)
. ....|+..|+|||++.+..++.++|||||||+||||++|+.||........ ...+.. .+..
T Consensus 158 ~--~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~-~~~~~~-----~~~~---------- 219 (285)
T cd05605 158 I--RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK-REEVER-----RVKE---------- 219 (285)
T ss_pred c--ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH-HHHHHH-----Hhhh----------
Confidence 1 234689999999999988999999999999999999999999975432111 000000 0000
Q ss_pred hhcCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 040832 583 LEKNYPTEEMARMVACAAASIRHSARRRP-----KISQIVRA 619 (724)
Q Consensus 583 l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evv~~ 619 (724)
....+.......+.+++.+||+.+|++|+ ++.+++++
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 220 DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 00112233445678999999999999999 77787664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=351.74 Aligned_cols=256 Identities=22% Similarity=0.243 Sum_probs=202.3
Q ss_pred HHhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeE
Q 040832 342 SAATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKR 417 (724)
Q Consensus 342 ~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 417 (724)
....++|.+.++||+|+||.||++... +++.||||++... .......+.+|+.+|+.++|+||+++++++.++...
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 344568999999999999999999864 5889999998642 122334578899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
+|||||+.+|+|..++.+. .+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 9999999999999998754 278888999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCccccccccCCCcCCcchhcCC----CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCC
Q 040832 498 TDNNTHVSTRVMGTFGYLAPEYASSG----KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDG 573 (724)
Q Consensus 498 ~~~~~~~~~~~~gt~~y~APE~~~~~----~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~ 573 (724)
............|+..|+|||++... .++.++|||||||+||||++|+.||......... ... ...
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-~~i---------~~~ 262 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY-SKI---------MDH 262 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH-HHH---------HcC
Confidence 54333223345799999999998653 4789999999999999999999999765322111 000 000
Q ss_pred ChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 040832 574 NFNEIADPYLEKNYPTEEMARMVACAAASIRHSARR--RPKISQIVRA 619 (724)
Q Consensus 574 ~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evv~~ 619 (724)
.. . +.-.........+.+++..||+.+|++ |+++.+|+++
T Consensus 263 ~~-~-----~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 263 KN-S-----LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CC-c-----CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00 0 000000122356778889999999988 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=330.72 Aligned_cols=271 Identities=27% Similarity=0.351 Sum_probs=203.7
Q ss_pred CCCcccceeeccCcEEEEEEEc-----CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC--CeEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-----PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAG--GKRL 418 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-----~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~ 418 (724)
..|++.+.||+|+||.||++.. .+++.||||.++.......+.|.+|+++|++++|+||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4688899999999999999974 35788999999876655667899999999999999999999987543 4678
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
+||||+.+++|.+++.... ..+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999997543 2489999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCcc--ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChh
Q 040832 499 DNNTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 499 ~~~~~~--~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
...... .....+...|+|||++.+..++.++|||||||+||||++|..++...... .. ...............+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE--FM-RMMGNDKQGQMIVYHLI 236 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh--hh-hhcccccccccchHHHH
Confidence 433221 11222345699999999889999999999999999999988765432110 00 00000000000000001
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
+++...............+.+++.+||..+|++||++.+|++.|+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11111000011223345689999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=335.67 Aligned_cols=257 Identities=27% Similarity=0.411 Sum_probs=206.5
Q ss_pred CCCcccceeeccCcEEEEEEEcC------CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP------NGKEVAVKSLRSGSG-QGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKR 417 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 417 (724)
++|.+.+.||+|+||.||++.+. .+..||||+++.... ...+.|.+|+++++++ +|+||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 46888999999999999999742 345799999875432 3345689999999999 799999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
++||||+.+++|..+++......+++.++++|+.||+.||+|||++ +|+|||||++|||++.++.+||+|||+++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 9999999999999999865544589999999999999999999998 9999999999999999999999999999866
Q ss_pred CCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCCh
Q 040832 498 TDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 498 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~ 575 (724)
...... ......++..|+|||++..+.++.++|||||||+||||++ |..||......+... .+. ..+.
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~-~~~--------~~~~- 261 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY-KLI--------KEGY- 261 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHH-HHH--------HcCC-
Confidence 543221 1222345678999999999999999999999999999998 999987653322111 110 0000
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 576 NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 576 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
...........+.+++.+|++.+|++||++.||++.|+..
T Consensus 262 --------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 --------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0001111234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=333.25 Aligned_cols=258 Identities=26% Similarity=0.437 Sum_probs=207.6
Q ss_pred hCCCcccceeeccCcEEEEEEEcC------CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP------NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRL 418 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 418 (724)
.++|.+.+.||+|+||.||++... ++..||||.++.........|.+|+++|++++|+||+++++++..++..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357889999999999999999742 34568999997665555667999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEE
Q 040832 419 LVYEYVPNNNLEFHLHGKG-----------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETK 487 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~-----------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vk 487 (724)
+||||+.+++|.+++...+ ...+++..+++++.||+.||+|||++ +++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 9999999999999987432 12489999999999999999999998 999999999999999999999
Q ss_pred EEEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhh
Q 040832 488 VADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPL 565 (724)
Q Consensus 488 L~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~ 565 (724)
|+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||......+ .+..
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-~~~~----- 234 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-VIEC----- 234 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHH-----
Confidence 9999999866433221 2223445778999999998899999999999999999998 899986543221 1111
Q ss_pred hhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 566 CLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 566 ~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
+..+.+... .......+.+++.+||+.+|.+||++.+|+..|+...
T Consensus 235 ----i~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 235 ----ITQGRVLQR---------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred ----HHcCCcCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 111111110 1112345899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=345.36 Aligned_cols=253 Identities=24% Similarity=0.280 Sum_probs=201.7
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|.+.+.||+|+||.||++... +++.||||+++... ....+.+.+|+.+++.++|+||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47899999999999999999854 68899999997532 223456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+++++|.+++.... ..+++..+..|+.||++||.|||+. +|+|||||++||||+.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999997652 2489999999999999999999999 99999999999999999999999999998775544
Q ss_pred CccccccccCCCcCCcchhc------CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCCh
Q 040832 502 THVSTRVMGTFGYLAPEYAS------SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~------~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~ 575 (724)
........|+..|+|||++. ...++.++|||||||+||||++|+.||......... . . ++ ....+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~-~---~-i~----~~~~~ 227 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY-N---N-IM----NFQRF 227 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH-H---H-HH----cCCCc
Confidence 33333456899999999986 456789999999999999999999999765322211 0 0 00 00000
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 576 NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 576 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+ .........+..++..|++ +|++|+++.+++.+
T Consensus 228 ~~~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 228 LKF-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred cCC-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 000 0001123457778888997 99999999998863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=324.50 Aligned_cols=250 Identities=29% Similarity=0.477 Sum_probs=207.2
Q ss_pred hCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
.++|.+.+.||+|+||.||+|.. .++.||||.++.... ..+++.+|+.++++++|+||+++++++.++...++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 35678889999999999999987 478899999986644 4567999999999999999999999999989999999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
.+++|.+++.......+.+..++.++.|++.||.|||++ +|+|||||++|||++.++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 999999999876655689999999999999999999998 999999999999999999999999999987743222
Q ss_pred ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 505 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
...++..|+|||++..+.++.++||||||+++|||++ |+.||......+ +.... ..+..
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~--------~~~~~-------- 217 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPHV--------EKGYR-------- 217 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHH--------hcCCC--------
Confidence 2335678999999998899999999999999999997 999986543211 11100 00000
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
...+......+.+++.+|++.+|++||++.+|+.+|+.
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 218 -MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred -CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 01112234568889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=324.93 Aligned_cols=247 Identities=25% Similarity=0.401 Sum_probs=197.3
Q ss_pred ceeeccCcEEEEEEEcC-CCcEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCCCH
Q 040832 352 NLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNL 429 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 429 (724)
+.||+|+||.||+|.+. +++.||+|.+.... .+....|.+|+++|++++|+||++++++|......++||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999864 68889999886543 23345799999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc-cccc
Q 040832 430 EFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV-STRV 508 (724)
Q Consensus 430 ~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~ 508 (724)
.+++...+ ..+++..++.++.|++.||.|||++ +|+|||||++|||++.++.+||+|||++.......... ....
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99987543 3488999999999999999999998 99999999999999999999999999998654321111 1111
Q ss_pred ccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCC
Q 040832 509 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNY 587 (724)
Q Consensus 509 ~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~ 587 (724)
.++..|+|||++..+.++.++|||||||+||||++ |..||+....... ... + ... .....
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~--~~~----~----~~~---------~~~~~ 217 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT--REA----I----EQG---------VRLPC 217 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH--HHH----H----HcC---------CCCCC
Confidence 23457999999999999999999999999999998 8888865432111 000 0 000 00011
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 588 PTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 588 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
+......+.+++.+|++.+|++||++.+|+++|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1223456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=339.46 Aligned_cols=244 Identities=27% Similarity=0.415 Sum_probs=193.8
Q ss_pred CcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHH---HhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 348 FSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEII---SRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il---~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
|++.++||+|+||.||+|.+. +++.||||+++... ....+.+..|++++ ++++|+||+++++++...+..+||
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999864 58899999997432 22234566676665 466799999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+.+++|..+++.. .+++..++.|+.||+.||.|||+. +|+|||||++||||+.++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999999888653 489999999999999999999998 9999999999999999999999999998754332
Q ss_pred CCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
.. ......|+..|||||++.+..++.++|||||||+||||++|+.||......+. +... ..+..
T Consensus 155 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~-~~~i---------~~~~~----- 218 (324)
T cd05589 155 GD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV-FDSI---------VNDEV----- 218 (324)
T ss_pred CC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH-HHHH---------HhCCC-----
Confidence 22 12345689999999999999999999999999999999999999976532221 1100 00000
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPK-----ISQIVR 618 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evv~ 618 (724)
.++......+.+++.+||+.+|++|++ +.++++
T Consensus 219 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 -----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 111223355788999999999999994 566655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=324.13 Aligned_cols=258 Identities=19% Similarity=0.309 Sum_probs=206.6
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|.+.+.||+|+||.||+|... +++.||||.++.. .......|.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999964 6889999987642 2233456899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 422 EYVPNNNLEFHLHG--KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 422 E~~~~gsL~~~L~~--~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
||+++++|..++.. .....+++..++.++.||++||.|||++ +|+|||||++||||+.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988753 2234578899999999999999999998 999999999999999999999999999987654
Q ss_pred CCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 500 NNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 500 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
.... .....|+..|+|||++.+..++.++||||||+++|||++|+.||.........+... + ....+..
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~---~-----~~~~~~~-- 227 (267)
T cd08228 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK---I-----EQCDYPP-- 227 (267)
T ss_pred hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHH---H-----hcCCCCC--
Confidence 3221 123458889999999988889999999999999999999999986532211111111 0 0001100
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
.........+.+++.+||+.+|++||++.+|++.|++.
T Consensus 228 ------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 ------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 01122345688999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=338.33 Aligned_cols=241 Identities=26% Similarity=0.362 Sum_probs=193.9
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCC-CCeeEEeeEEEeCCeEEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHH-RHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~lV~ 421 (724)
+|++.+.||+|+||.||+|.+. +++.||||+++... ....+.+..|++++..++| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5788999999999999999865 46789999987532 2334568889999999965 56888999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+.+|+|..++..... +.+..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVGK--FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 99999999999876543 88999999999999999999998 99999999999999999999999999987543221
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
. ......|+..|+|||++.+..++.++|||||||+||||++|+.||......+.... . ....
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~-i---------~~~~------- 217 (324)
T cd05587 156 K-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS-I---------MEHN------- 217 (324)
T ss_pred C-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH-H---------HcCC-------
Confidence 1 12345689999999999999999999999999999999999999976542221110 0 0000
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKI 613 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 613 (724)
..++......+.+++.+||+.+|.+|++.
T Consensus 218 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 ---VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ---CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 01112223467889999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=326.34 Aligned_cols=255 Identities=26% Similarity=0.425 Sum_probs=207.7
Q ss_pred hhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
..++|++.+.||+|+||.||++.+.++..|++|.++... .....|.+|++++++++|+||+++++++.. ...++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 356889999999999999999998778889999887542 234578999999999999999999999887 778999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+.+++|.+++.......+++..++.++.||+.||.|||+. +++|||||++||+|+.++.+||+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999999876555688999999999999999999998 9999999999999999999999999999876543322
Q ss_pred cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchh
Q 040832 504 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~ 582 (724)
......++..|++||++..+.++.++|||||||++|||++ |+.||......+ +..+. ..+...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~--------~~~~~~------ 222 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRAL--------ERGYRM------ 222 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH--HHHHH--------hCCCCC------
Confidence 2223345678999999998889999999999999999999 999997543211 11111 111000
Q ss_pred hhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 583 LEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 583 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
.........+.+++.+|++.+|++||++.+|++.|+.
T Consensus 223 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 ---PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111233568899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=323.66 Aligned_cols=250 Identities=28% Similarity=0.413 Sum_probs=206.3
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
+|.+.+.||+|+||.||++.+. +++.|++|.+... .....+++.+|++++++++|+||+++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4788899999999999999864 5889999988643 233456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+.+++|.++++......+++..+++++.||++||.|||+. +|+|||||++|||++.++.+||+|||+++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999999876445689999999999999999999998 9999999999999999999999999999876543322
Q ss_pred cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 504 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
.....|+..|+|||++.++.++.++|||||||++|||++|+.||......+ ...+. ..+.+.
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~--------~~~~~~------- 219 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--LILKI--------IRGVFP------- 219 (256)
T ss_pred -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH--------HcCCCC-------
Confidence 233468889999999999999999999999999999999999997654211 11110 011111
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.........+.+++.+||+.+|++||++.+|+++
T Consensus 220 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 --PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1111234568999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=323.37 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=202.7
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc-----hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG-----QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~-----~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
++|.+.++||+|+||.||++... +++.|+||.++.... ...+.+.+|++++++++|+||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57899999999999999999854 688999998864321 123468899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
||||+.+++|.+++...+ .+++..+++++.||+.||.|||+. +|+|||||++||||+.++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999999987654 378899999999999999999998 999999999999999999999999999976543
Q ss_pred CCCccc--cccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 500 NNTHVS--TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 500 ~~~~~~--~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
...... ....|+..|+|||++.+..++.++||||||++||||++|+.||........... .. ...
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~~--------~~~---- 223 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK-IA--------TQP---- 223 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHH-Hh--------ccC----
Confidence 222111 234578899999999988899999999999999999999999975433222110 00 000
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
....++......+.+++.+||+.+|++||++.+|+++
T Consensus 224 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 -----TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -----CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0011122233457889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=330.07 Aligned_cols=254 Identities=26% Similarity=0.417 Sum_probs=199.5
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCc----EEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGK----EVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~----~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
++|++.+.||+|+||.||+|.+. +++ .|++|.+...... ..+++..|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46788899999999999999864 344 4778887644322 33568889999999999999999998764 55789
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
|+||+.+|+|.+++..+.. .+++..++.|+.||+.||+|||++ +++|||||++|||+++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 9999999999999976433 489999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 500 NNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 500 ~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
.... ......++..|++||++.++.++.++|||||||+||||++ |+.||....... +.++. ..+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~~--------~~~~~~~ 231 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VPDLL--------EKGERLA 231 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH--------HCCCcCC
Confidence 3322 2234557789999999998999999999999999999998 999997643211 11111 1111000
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
.+ .. ....+..++.+||..+|++||++.||++.|+..
T Consensus 232 --~~---~~----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 232 --QP---QI----CTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred --CC---CC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 00 01 123467788999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=346.84 Aligned_cols=250 Identities=23% Similarity=0.312 Sum_probs=195.9
Q ss_pred CCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|.+.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+++|++++|+||+++++++.+....||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4788999999999999999985 468899999986431 223456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+++|+|.+++...+ .+.+..+..|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999997654 388899999999999999999998 99999999999999999999999999996432110
Q ss_pred Cc----------------------------------------------cccccccCCCcCCcchhcCCCCChhHHHHHHH
Q 040832 502 TH----------------------------------------------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFG 535 (724)
Q Consensus 502 ~~----------------------------------------------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlG 535 (724)
.. .....+||..|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 00124699999999999988999999999999
Q ss_pred HHHHHHHhCCCCCCCCCchhh--hHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCC---
Q 040832 536 VMLLELITGRRPIDPTGAMED--CLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRR--- 610 (724)
Q Consensus 536 vlL~eLltG~~P~~~~~~~~~--~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~R--- 610 (724)
|+||||++|+.||......+. .+..|...+ .+. . .......+.+++.+|+. ++.+|
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------~~p--------~--~~~~s~~~~dli~~lL~-~~~~r~~r 296 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHETYRKIINWRETL--------YFP--------D--DIHLSVEAEDLIRRLIT-NAENRLGR 296 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHHHHHHHccCCcc--------CCC--------C--CCCCCHHHHHHHHHHhc-CHhhcCCC
Confidence 999999999999976543221 111221100 000 0 00112456778888887 56654
Q ss_pred CCHHHHHHH
Q 040832 611 PKISQIVRA 619 (724)
Q Consensus 611 Ps~~evv~~ 619 (724)
+++.|++++
T Consensus 297 ~~~~~~l~h 305 (377)
T cd05629 297 GGAHEIKSH 305 (377)
T ss_pred CCHHHHhcC
Confidence 588888874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=326.15 Aligned_cols=255 Identities=25% Similarity=0.375 Sum_probs=203.5
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
.++|++.+.||+|+||.||+|.+ .+++.||||+++.........+.+|+.++++++|+||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35789999999999999999996 46788999999765555556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+.+++|.++++..+ .+++..++.++.|+++||.|||+. +|+|||||++|||++.++.+||+|||+++.......
T Consensus 88 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 88 CGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 99999999987654 378999999999999999999998 999999999999999999999999999986643221
Q ss_pred cccccccCCCcCCcchhc---CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 504 VSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~---~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
......|+..|+|||.+. ...++.++|||||||+||||++|+.||......+.. ..+ ....+. .
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~~~---------~~~~~~---~ 228 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLM---------SKSNFQ---P 228 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-eee---------ecCCCC---C
Confidence 112345888999999884 345788999999999999999999998644322111 000 000000 0
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRAL 620 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L 620 (724)
..+.. .......+.+++.+||+.+|++||++.+|+++|
T Consensus 229 ~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 229 PKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00000 112235688999999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=349.79 Aligned_cols=247 Identities=29% Similarity=0.455 Sum_probs=207.0
Q ss_pred CcccceeeccCcEEEEEEEcCC--Cc--EEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 348 FSQSNLLGQGGFGYVHKGVLPN--GK--EVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~~--g~--~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
.++.++||+|.||.|++|.|.. |+ .||||.|+.+... ...+|++|+.+|.+|+|+|+++|||+..+ ...+||||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 4566789999999999999863 44 4899999987544 55789999999999999999999999887 67789999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
+++.|+|.+.|+......|-...+..++.|||.||.||.++ ++|||||..+||||-....||||||||.+-+.....
T Consensus 191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 99999999999985566678888999999999999999999 999999999999999888999999999998876554
Q ss_pred cc--ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 503 HV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 503 ~~--~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
+. .....-.+.|+|||.+..++++.++|||+|||.||||++ |+.||-+....+ +++.++.+
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q----------IL~~iD~~------ 331 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ----------ILKNIDAG------ 331 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH----------HHHhcccc------
Confidence 42 223445788999999999999999999999999999999 899997653222 11112211
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIV 617 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv 617 (724)
-.-..+..+...+.+++..||.++|.+||++..|+
T Consensus 332 ---erLpRPk~csedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 332 ---ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred ---ccCCCCCCChHHHHHHHHHhccCCccccccHHHHH
Confidence 11233556788899999999999999999999997
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=331.73 Aligned_cols=254 Identities=22% Similarity=0.382 Sum_probs=202.2
Q ss_pred CCcccceeeccCcEEEEEEEcCC------CcEEEEEEeccCCchh-HHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLPN------GKEVAVKSLRSGSGQG-EREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~~------g~~vaVK~l~~~~~~~-~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
+|.+.+.||+|+||.||+|.+.+ ++.||||+++...... .+.|.+|+.++++++|+||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46677889999999999998532 4679999998654332 3568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCC
Q 040832 420 VYEYVPNNNLEFHLHGK--------------GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFE 485 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~--------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~ 485 (724)
++||+.+++|..++... ....+.+..+++++.|+++||+|||++ +|+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 99999999999988532 122478889999999999999999998 9999999999999999999
Q ss_pred EEEEEeccccccCCCCC-ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhh
Q 040832 486 TKVADFGLAKLTTDNNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWAR 563 (724)
Q Consensus 486 vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~ 563 (724)
+||+|||+++....... .......++..|+|||++..+.++.++|||||||+||||++ |..||......+ +...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~-- 238 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--VIEM-- 238 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH--
Confidence 99999999986643322 12233446778999999998899999999999999999998 888886543221 1111
Q ss_pred hhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 564 PLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 564 ~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
+..+... .++.+....+..++..|++.+|++||++++|++.|+.
T Consensus 239 ------i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 ------IRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ------HHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111110 1122334558899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=356.72 Aligned_cols=258 Identities=25% Similarity=0.323 Sum_probs=205.7
Q ss_pred HHHHhhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC-
Q 040832 340 ELSAATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGG- 415 (724)
Q Consensus 340 el~~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~- 415 (724)
++....++|.+.++||+|+||.||++.+ .+++.||||++.... ......+++|+.+|..++|+||+++++.+....
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 4445567999999999999999999985 468999999986542 233456889999999999999999988765432
Q ss_pred -------eEEEEEEecCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCE
Q 040832 416 -------KRLLVYEYVPNNNLEFHLHGK--GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFET 486 (724)
Q Consensus 416 -------~~~lV~E~~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~v 486 (724)
.+++||||+.+|+|.++|+.. ....+.+..++.|+.||+.||.|||+. +|+||||||+||||+.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCE
Confidence 367999999999999998653 234588999999999999999999998 99999999999999999999
Q ss_pred EEEEeccccccCCCCC-ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhh
Q 040832 487 KVADFGLAKLTTDNNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPL 565 (724)
Q Consensus 487 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~ 565 (724)
||+|||+++....... .......|+..|+|||++.+..++.++|||||||+||||++|+.||......+ +....
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~-----~~~~~ 257 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE-----VMHKT 257 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHH
Confidence 9999999987654322 12334679999999999999999999999999999999999999997543211 10000
Q ss_pred hhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 566 CLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 566 ~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+.+. ..+......+..++.+||+.+|++||++.+|+++
T Consensus 258 -----~~~~~~---------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 -----LAGRYD---------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -----hcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 011111 1122234568899999999999999999999875
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=336.72 Aligned_cols=240 Identities=27% Similarity=0.403 Sum_probs=190.9
Q ss_pred ceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEEEEecCC
Q 040832 352 NLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLVYEYVPN 426 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 426 (724)
++||+|+||.||+|.+. +++.||||.++... ....+.+..|..++..+ +|+||+++++++..++..++||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 57889999997532 22234456677777654 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcccc
Q 040832 427 NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST 506 (724)
Q Consensus 427 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 506 (724)
|+|..++...+. +++..++.|+.||+.||.|||++ +|+|||||++||||+.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSGR--FDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS 154 (316)
T ss_pred CcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence 999999876543 88999999999999999999998 99999999999999999999999999998654322 2223
Q ss_pred ccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcC
Q 040832 507 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKN 586 (724)
Q Consensus 507 ~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~ 586 (724)
...|+..|+|||++.+..++.++|||||||+||||++|+.||......+. +... ... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~-~~~i---------~~~----------~~~ 214 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL-FDSI---------LND----------RPH 214 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH-HHHH---------HcC----------CCC
Confidence 45699999999999988999999999999999999999999976542211 1000 000 001
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 040832 587 YPTEEMARMVACAAASIRHSARRRPKISQIV 617 (724)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv 617 (724)
++......+.+++.+||+.+|++|+++.+.+
T Consensus 215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l 245 (316)
T cd05592 215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDI 245 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHH
Confidence 1222234577899999999999999986433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=348.48 Aligned_cols=250 Identities=24% Similarity=0.304 Sum_probs=195.0
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
.+|++.+.||+|+||.||++... +++.||||++.... ......+.+|+++|++++|+||+++++++.+++..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999854 58899999986431 122356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+++|+|.+++...+ .+.+..+..|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999997654 378889999999999999999998 99999999999999999999999999985321000
Q ss_pred ------------------------------------------CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHH
Q 040832 502 ------------------------------------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLL 539 (724)
Q Consensus 502 ------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~ 539 (724)
.......+|+..|||||++.+..++.++|||||||+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00011356999999999999989999999999999999
Q ss_pred HHHhCCCCCCCCCchhhh--HHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCC---CHH
Q 040832 540 ELITGRRPIDPTGAMEDC--LVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRP---KIS 614 (724)
Q Consensus 540 eLltG~~P~~~~~~~~~~--l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP---s~~ 614 (724)
||++|+.||......+.. +..|...+ .+ .........+.+++.+|+ .+|.+|+ ++.
T Consensus 236 ell~G~~Pf~~~~~~~~~~~i~~~~~~~-----------~~-------~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ 296 (376)
T cd05598 236 EMLVGQPPFLADTPAETQLKVINWETTL-----------HI-------PSQAKLSREASDLILRLC-CGAEDRLGKNGAD 296 (376)
T ss_pred ehhhCCCCCCCCCHHHHHHHHhccCccc-----------cC-------CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHH
Confidence 999999999765433221 11111100 00 000111233455555555 4999999 788
Q ss_pred HHHHH
Q 040832 615 QIVRA 619 (724)
Q Consensus 615 evv~~ 619 (724)
+++++
T Consensus 297 ell~h 301 (376)
T cd05598 297 EIKAH 301 (376)
T ss_pred HHhCC
Confidence 88764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=337.43 Aligned_cols=241 Identities=26% Similarity=0.366 Sum_probs=194.9
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
+|.+.+.||+|+||.||+|... +++.||||.++... ....+.+..|..++..+ +|++|+++++++...+..+|||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5788999999999999999865 56789999987542 12234567788888887 5899999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+.+|+|..++...+. +++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 99999999998876543 88999999999999999999998 99999999999999999999999999997543222
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
. ......|+..|+|||++....++.++|||||||+||||++|+.||......+. +..+ ....
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~-~~~i---------~~~~------- 217 (323)
T cd05616 156 V-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-FQSI---------MEHN------- 217 (323)
T ss_pred C-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH-HHHH---------HhCC-------
Confidence 1 22345689999999999999999999999999999999999999976542221 1100 0000
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKI 613 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 613 (724)
..++......+.+++.+|++.+|++|++.
T Consensus 218 ---~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 ---VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 01222334567889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=326.39 Aligned_cols=254 Identities=26% Similarity=0.413 Sum_probs=201.3
Q ss_pred CcccceeeccCcEEEEEEEcCC----CcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCe-----
Q 040832 348 FSQSNLLGQGGFGYVHKGVLPN----GKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGK----- 416 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~~----g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~----- 416 (724)
|.+++.||+|+||.||+|.+.. +..||||+++.... .....+.+|+++|+.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998642 36799999875432 234578999999999999999999999876554
Q ss_pred -EEEEEEecCCCCHHHHHhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEe
Q 040832 417 -RLLVYEYVPNNNLEFHLHGK----GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADF 491 (724)
Q Consensus 417 -~~lV~E~~~~gsL~~~L~~~----~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DF 491 (724)
.++||||+.+++|..++... ....+++..++.++.||+.||+|||+. +|+|||||++|||+++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 68999999999999888542 233588999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCcc-ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhc
Q 040832 492 GLAKLTTDNNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRA 569 (724)
Q Consensus 492 Gla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~ 569 (724)
|+++......... .....++..|++||++....++.++|||||||++|||++ |..||......+ +.++..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--~~~~~~------ 229 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--IYDYLR------ 229 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH------
Confidence 9998765433221 122235678999999988889999999999999999999 889886543222 111110
Q ss_pred ccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 570 LDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 570 ~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
.+... ..+......+.+++.+||+.+|++||++.||++.|+..
T Consensus 230 --~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 --HGNRL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --cCCCC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11000 11223345789999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.23 Aligned_cols=248 Identities=24% Similarity=0.319 Sum_probs=196.2
Q ss_pred eeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCCCH
Q 040832 354 LGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNL 429 (724)
Q Consensus 354 LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 429 (724)
||+|+||.||++..+ +|+.||+|.+.... ....+.+..|+++|++++|+||+++++++.++...++||||+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999864 58999999986431 12234566799999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccccccc
Q 040832 430 EFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM 509 (724)
Q Consensus 430 ~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 509 (724)
.+++.......+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........ .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eeccC
Confidence 9988766655689999999999999999999998 999999999999999999999999999987654322 23346
Q ss_pred cCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCH
Q 040832 510 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPT 589 (724)
Q Consensus 510 gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~ 589 (724)
|+..|+|||++.+..++.++|||||||+||||++|+.||........ ...+.+.. ....+ . ... .
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~-----~~~~~----~-~~~----~ 220 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRRT-----LEDEV----K-FEH----Q 220 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHHh-----hcccc----c-ccc----c
Confidence 89999999999988899999999999999999999999975422111 01111100 00000 0 000 1
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 590 EEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 590 ~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
.....+.+++.+||+.+|++|+++.|+++.+.
T Consensus 221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 221 NFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred cCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 12345789999999999999999987765444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=345.00 Aligned_cols=266 Identities=20% Similarity=0.251 Sum_probs=199.8
Q ss_pred CCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC-----eEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGG-----KRL 418 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~-----~~~ 418 (724)
+|++++.||+|+||.||++.. .+++.||||++... .....+.+.+|+++|+.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999995 46899999998643 2233467889999999999999999999998776 789
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
+||||+. ++|..++.... .+++..++.|+.||++||.|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 56777775543 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhh---hcccC--
Q 040832 499 DNNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCL---RALDD-- 572 (724)
Q Consensus 499 ~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~---~~~~~-- 572 (724)
...........++..|+|||++.+. .++.++|||||||+||||++|+.||......+.. ......+.. ..+..
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL-DLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHH-HHHHHHcCCCCHHHHHHhh
Confidence 4433333445688999999998764 5789999999999999999999999766433221 100000000 00000
Q ss_pred CChhhhcch------hhh--cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 573 GNFNEIADP------YLE--KNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 573 ~~~~~~vd~------~l~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
......+.. .+. ..........+.+++.+||+.||++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000 000 00111224567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=347.44 Aligned_cols=259 Identities=25% Similarity=0.403 Sum_probs=204.7
Q ss_pred hCCCcccceeeccCcEEEEEEEcC------CCcEEEEEEeccCCchh-HHHHHHHHHHHHhcC-CCCeeEEeeEEEeCCe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP------NGKEVAVKSLRSGSGQG-EREFKAEVEIISRVH-HRHLVSLVGYCIAGGK 416 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vaVK~l~~~~~~~-~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~ 416 (724)
.++|.+++.||+|+||.||+|++. .++.||||+++...... .+.|..|+++|.++. |+||++++++|...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 345677889999999999999853 34579999998653333 346889999999997 9999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCCC----------------------------------------------------------
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGR---------------------------------------------------------- 438 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~---------------------------------------------------------- 438 (724)
.++||||+.+|+|.++|+....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999975321
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEE
Q 040832 439 --------------------------------------PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILL 480 (724)
Q Consensus 439 --------------------------------------~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl 480 (724)
..+++..+++|+.||++||+|||+. +|+|||||++||||
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEE
Confidence 2467788899999999999999998 99999999999999
Q ss_pred cCCCCEEEEEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhH
Q 040832 481 DYTFETKVADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCL 558 (724)
Q Consensus 481 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l 558 (724)
++++.+||+|||+++........ ......++..|+|||++....++.++|||||||+||||++ |+.||......+...
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 99999999999999865432221 1223456788999999998889999999999999999998 899986543222110
Q ss_pred HhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 559 VDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 559 ~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
.. +..+. ....+......+.+++.+||+.+|++||++++|++.|+..+
T Consensus 353 ~~---------~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 353 NA---------IKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HH---------HHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 00 00000 00011122356889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=325.97 Aligned_cols=255 Identities=27% Similarity=0.458 Sum_probs=203.9
Q ss_pred CCCcccceeeccCcEEEEEEEcCC-C---cEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPN-G---KEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~-g---~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
++|+..++||+|+||.||+|.+.. + ..|+||.++... ....++|..|++++++++|+||+++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467888999999999999999653 3 368999987653 33345799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+.+++|.+++..+. ..+++.+++.++.|++.||+|||+. +++|||||++|||++.++.+||+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 85 TEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999997643 3489999999999999999999998 9999999999999999999999999999866543
Q ss_pred CCcccc--ccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 501 NTHVST--RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 501 ~~~~~~--~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
...... ....+..|++||++....++.++|||||||+||||++ |+.||......+ +... +..+.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-----~~~~-----i~~~~--- 227 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-----VMKA-----INDGF--- 227 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-----HHHH-----HhcCC---
Confidence 222111 1223457999999998899999999999999999998 999996543211 1110 00000
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
......+....+.+++.+||+.+|++||++.+|++.|++.
T Consensus 228 ------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 ------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0001112335688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=334.03 Aligned_cols=255 Identities=28% Similarity=0.446 Sum_probs=200.8
Q ss_pred CCCcccceeeccCcEEEEEEEcCC-Cc--EEEEEEeccC-CchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPN-GK--EVAVKSLRSG-SGQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~-g~--~vaVK~l~~~-~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 420 (724)
++|++.++||+|+||.||+|.+.+ +. .+++|.++.. .....+.|.+|+++++++ +|+||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578899999999999999998754 32 4788888753 233456789999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCE
Q 040832 421 YEYVPNNNLEFHLHGKG--------------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFET 486 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~v 486 (724)
|||+++++|.++++... ...+.+..+++|+.||+.||+|||++ +|+||||||+||||+.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 99999999999996532 12478899999999999999999998 99999999999999999999
Q ss_pred EEEEeccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhh
Q 040832 487 KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPL 565 (724)
Q Consensus 487 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~ 565 (724)
||+|||++......... .....+..|+|||++....++.++|||||||+||||++ |+.||......+ +...
T Consensus 159 kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--~~~~---- 230 (297)
T cd05089 159 KIADFGLSRGEEVYVKK--TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--LYEK---- 230 (297)
T ss_pred EECCcCCCccccceecc--CCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH----
Confidence 99999998743221111 11123567999999998889999999999999999998 999996543211 1100
Q ss_pred hhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 566 CLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 566 ~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
+..+. ....+......+.+++.+||+.+|.+||++.+|++.|+..+
T Consensus 231 ----~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 231 ----LPQGY---------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred ----HhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00000 00111122346788999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=326.43 Aligned_cols=254 Identities=24% Similarity=0.371 Sum_probs=202.5
Q ss_pred HhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeC------
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGYCIAG------ 414 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~------ 414 (724)
.+.+.|.+.+.||+|+||.||+|.+. +++.||||.+.... .....+..|+.+++++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45677888999999999999999864 57889999986543 3456788999999999 799999999998753
Q ss_pred CeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccc
Q 040832 415 GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLA 494 (724)
Q Consensus 415 ~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla 494 (724)
...++||||+.+++|..++.......+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 4678999999999999999875555689999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCccccccccCCCcCCcchhc-----CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhc
Q 040832 495 KLTTDNNTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRA 569 (724)
Q Consensus 495 ~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~ 569 (724)
+....... ......|+..|+|||++. ...++.++|||||||+||||++|+.||+...........+..
T Consensus 159 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~------ 231 (272)
T cd06637 159 AQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN------ 231 (272)
T ss_pred eecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC------
Confidence 86543222 223456899999999986 346888999999999999999999999754332221111100
Q ss_pred ccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 570 LDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 570 ~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..... ........+.+++.+||..+|.+||++.+|+++
T Consensus 232 ----~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 232 ----PAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred ----CCCCC--------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00000 011123457899999999999999999999863
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=323.95 Aligned_cols=245 Identities=26% Similarity=0.403 Sum_probs=196.2
Q ss_pred eeeccCcEEEEEEEc---CCCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCC
Q 040832 353 LLGQGGFGYVHKGVL---PNGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNN 427 (724)
Q Consensus 353 ~LG~G~fG~Vyk~~~---~~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 427 (724)
.||+|+||.||+|.+ .+++.||||+++.... ...++|.+|+.++++++|+||+++++++.. +..++||||+.++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999974 3578899999875432 234579999999999999999999998854 5668999999999
Q ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc--c
Q 040832 428 NLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV--S 505 (724)
Q Consensus 428 sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~--~ 505 (724)
+|.+++.... .+++..+++|+.||+.||+|||++ +|+||||||.|||++.++.+||+|||+++......... .
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 9999997654 488999999999999999999998 99999999999999999999999999998765443221 1
Q ss_pred cccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhh
Q 040832 506 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLE 584 (724)
Q Consensus 506 ~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~ 584 (724)
....++..|+|||.+....++.++|||||||+||||++ |+.||......+ +... +..+..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~--------i~~~~~--------- 216 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--VTQM--------IESGER--------- 216 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH--------HHCCCC---------
Confidence 12234578999999988889999999999999999998 999997653221 1111 111110
Q ss_pred cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 585 KNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
...+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 01112234567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=323.28 Aligned_cols=248 Identities=28% Similarity=0.454 Sum_probs=201.9
Q ss_pred CCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEE-eCCeEEEEEEec
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCI-AGGKRLLVYEYV 424 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~-~~~~~~lV~E~~ 424 (724)
.+|.+.+.||+|+||.||++.. .++.|++|.++... ..+.|.+|+.++++++|+||+++++++. .++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4788899999999999999987 47789999987542 3457999999999999999999999765 456789999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
++++|.+++.......+++..+++++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 999999999876665689999999999999999999998 99999999999999999999999999998654322
Q ss_pred ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 505 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
....++..|+|||++....++.++|||||||++|||++ |+.||......+ +..+. ..+.
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~--~~~~~--------~~~~--------- 216 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRV--------EKGY--------- 216 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH--------hcCC---------
Confidence 12334568999999998889999999999999999998 999986432111 11110 0000
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
...........+.+++.+|++.+|++||++.+|+++|+.
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 217 KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 001112234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=337.60 Aligned_cols=242 Identities=26% Similarity=0.366 Sum_probs=194.3
Q ss_pred ceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEEEEecCC
Q 040832 352 NLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLVYEYVPN 426 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 426 (724)
++||+|+||.||+|.+. +++.||||+++... ....+.+..|++++..+ +|+||+++++++...+..+|||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 47899999987532 22334577899999876 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcccc
Q 040832 427 NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST 506 (724)
Q Consensus 427 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 506 (724)
++|..++..... +++..++.|+.||++||.|||++ +|+||||||+||||+.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (321)
T cd05591 81 GDLMFQIQRSRK--FDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTT 154 (321)
T ss_pred CcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-ccc
Confidence 999988876543 88999999999999999999999 999999999999999999999999999976433222 223
Q ss_pred ccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcC
Q 040832 507 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKN 586 (724)
Q Consensus 507 ~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~ 586 (724)
...|+..|+|||++.+..++.++|||||||+||||++|+.||......+. +.. +..+.. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~-~~~---------i~~~~~----------~ 214 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL-FES---------ILHDDV----------L 214 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH-HHH---------HHcCCC----------C
Confidence 45689999999999988999999999999999999999999976542221 110 000000 0
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCC-------CHHHHHHH
Q 040832 587 YPTEEMARMVACAAASIRHSARRRP-------KISQIVRA 619 (724)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RP-------s~~evv~~ 619 (724)
++......+.+++..||+.+|++|+ ++.+++++
T Consensus 215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1111234578899999999999999 77777754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=328.45 Aligned_cols=255 Identities=25% Similarity=0.436 Sum_probs=205.6
Q ss_pred hCCCcccceeeccCcEEEEEEEcCC------CcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPN------GKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKR 417 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~------g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 417 (724)
.++|.+.+.||+|+||.||+|.+.+ ++.||+|.+..... .....|.+|+.+|+.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4578889999999999999998643 36799999875533 3345789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEE
Q 040832 418 LLVYEYVPNNNLEFHLHGKG--------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVA 489 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~ 489 (724)
++||||+.+++|..++.... ...+.+..++.|+.||+.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 99999999999999986532 22478899999999999999999998 99999999999999999999999
Q ss_pred EeccccccCCCCC-ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhh
Q 040832 490 DFGLAKLTTDNNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCL 567 (724)
Q Consensus 490 DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~ 567 (724)
|||+++....... .......++..|+|||.+..+.++.++|||||||++|||++ |+.||......+ +..+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~~---- 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--VLKFVI---- 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--HHHHHh----
Confidence 9999986644322 12233456788999999998899999999999999999998 999986543221 111110
Q ss_pred hcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 568 RALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 568 ~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
.+... ..+......+.+++.+||+.+|++||++.+|+..|+
T Consensus 236 ----~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 ----DGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ----cCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11000 111222457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=330.78 Aligned_cols=259 Identities=25% Similarity=0.445 Sum_probs=205.3
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC------CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCe
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP------NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGK 416 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 416 (724)
..++|++.+.||+|+||.||+|... .+..||||.++.... .....+.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999753 245799998875432 234568899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEE
Q 040832 417 RLLVYEYVPNNNLEFHLHGKG--------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKV 488 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL 488 (724)
.++||||+.+|+|.+++.... ...+.+..+++++.||+.||.|||++ +|+||||||+|||++.++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999997532 23456778899999999999999998 9999999999999999999999
Q ss_pred EEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhh
Q 040832 489 ADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLC 566 (724)
Q Consensus 489 ~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~ 566 (724)
+|||+++........ ......++..|++||++.++.++.++|||||||+||||++ |..||......+ +..+.
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--~~~~~---- 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--VLKFV---- 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH----
Confidence 999999865432221 1223345778999999999999999999999999999999 788886543211 11110
Q ss_pred hhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 567 LRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 567 ~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
..+.+.. ........+.+++.+|++.+|++||++.++++.|+..+
T Consensus 235 ----~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 ----MDGGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ----HcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 0111100 11122357999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=320.90 Aligned_cols=258 Identities=21% Similarity=0.369 Sum_probs=207.8
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|++.+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+||+++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 67999999999999999999976 7899999988642 2223457899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 422 EYVPNNNLEFHLHG--KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 422 E~~~~gsL~~~L~~--~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
||+++++|..++.. .....+.+.+++.++.+|++||.|||+. +|+|||||++|||++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998864 2234578999999999999999999998 999999999999999999999999999986644
Q ss_pred CCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 500 NNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 500 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
.... .....++..|+|||++.+..++.++|||||||++|||++|+.||...... +.++.. .+..+.+..+
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~-----~~~~~~~~~~- 228 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCK-----KIEKCDYPPL- 228 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc---HHHHHh-----hhhcCCCCCC-
Confidence 3221 22345888999999999888999999999999999999999998643211 111110 0111111110
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
........+.+++.+||..+|++||++.+|+++|++.
T Consensus 229 -------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 229 -------PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 0113345688999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=322.66 Aligned_cols=252 Identities=27% Similarity=0.469 Sum_probs=204.2
Q ss_pred CCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecC
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVP 425 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 425 (724)
.+|++.+.||+|+||.||++.+.+++.+|||.++.... ....|.+|++++++++|+||+++++++......++||||+.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46788899999999999999987788999999875432 34578999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccc
Q 040832 426 NNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVS 505 (724)
Q Consensus 426 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 505 (724)
+++|.+++..+.. .+.+..++.++.+++.+|+|||+. +++|||||++|||++.++.+||+|||+++..........
T Consensus 83 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 83 HGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 9999999876543 478999999999999999999998 999999999999999999999999999986654332222
Q ss_pred cccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhh
Q 040832 506 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLE 584 (724)
Q Consensus 506 ~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~ 584 (724)
....++.+|+|||++.++.++.++||||||+++|||++ |+.||......+ +... +..+. ....
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~--------~~~~~--~~~~---- 222 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVET--------INAGF--RLYK---- 222 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--HHHH--------HhCCC--CCCC----
Confidence 22335678999999998899999999999999999998 999997543211 1110 00000 0000
Q ss_pred cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 585 KNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
+......+.+++.+||+.+|++||++.+|++.|.
T Consensus 223 ---~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 ---PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1112356899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=331.52 Aligned_cols=262 Identities=24% Similarity=0.382 Sum_probs=202.6
Q ss_pred hCCCcccceeeccCcEEEEEEEcCC---------------CcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPN---------------GKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLV 408 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~---------------g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~ 408 (724)
.++|.+.+.||+|+||.||++...+ ...||||+++..... ....|.+|+++|++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578889999999999999987532 234899999765333 345699999999999999999999
Q ss_pred eEEEeCCeEEEEEEecCCCCHHHHHhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccE
Q 040832 409 GYCIAGGKRLLVYEYVPNNNLEFHLHGKG----------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNI 478 (724)
Q Consensus 409 g~~~~~~~~~lV~E~~~~gsL~~~L~~~~----------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NI 478 (724)
+++......++||||+.+++|.+++.... ...+.+..+++++.||++||+|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 99999999999999999999999986532 12368899999999999999999998 999999999999
Q ss_pred EEcCCCCEEEEEeccccccCCCCC-ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh--CCCCCCCCCchh
Q 040832 479 LLDYTFETKVADFGLAKLTTDNNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT--GRRPIDPTGAME 555 (724)
Q Consensus 479 Ll~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt--G~~P~~~~~~~~ 555 (724)
||++++.+||+|||++........ .......++..|+|||++..+.++.++|||||||+||||++ |..||......+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999986543322 12233445778999999999999999999999999999998 667776543222
Q ss_pred hhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 556 DCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 556 ~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
.+..+.... ... ........+......+.+++.+|+..+|++||+|.+|++.|+
T Consensus 241 -~~~~~~~~~-----~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 -VIENTGEFF-----RNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred -HHHHHHHhh-----hhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111111000 000 000000011112357999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=325.08 Aligned_cols=254 Identities=25% Similarity=0.404 Sum_probs=197.5
Q ss_pred CcccceeeccCcEEEEEEEcCCCc---EEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC------Ce
Q 040832 348 FSQSNLLGQGGFGYVHKGVLPNGK---EVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAG------GK 416 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~~g~---~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~------~~ 416 (724)
|.++++||+|+||.||+|.+.+.. .||||.++.. .....+.|..|+++|++++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 456788999999999999975433 5899988754 223345789999999999999999999987542 24
Q ss_pred EEEEEEecCCCCHHHHHhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEec
Q 040832 417 RLLVYEYVPNNNLEFHLHGK----GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFG 492 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~----~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFG 492 (724)
.++||||+.+++|..++... ....+++..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999887421 223478999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCcc-ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcc
Q 040832 493 LAKLTTDNNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRAL 570 (724)
Q Consensus 493 la~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~ 570 (724)
+++......... .....++..|++||++....++.++|||||||+||||++ |+.||......+ +... +
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~--------~ 227 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE--IYDY--------L 227 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH--------H
Confidence 998765432211 122345678999999999999999999999999999999 888886543211 1110 1
Q ss_pred cCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 571 DDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 571 ~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
..+... .........+.+++.+||+.+|++||++.+|++.|+..
T Consensus 228 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 228 RQGNRL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111100 01112334578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=328.93 Aligned_cols=255 Identities=27% Similarity=0.446 Sum_probs=204.6
Q ss_pred CCCcccceeeccCcEEEEEEEcC------CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP------NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
.+|...+.||+|+||.||++... ++..|++|.++.........|.+|++++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45677889999999999999632 356789999887665666789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCE
Q 040832 420 VYEYVPNNNLEFHLHGKGR-------------PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFET 486 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~-------------~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~v 486 (724)
||||+.+++|.+++..... ..+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999999875431 2478999999999999999999998 99999999999999999999
Q ss_pred EEEEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhh
Q 040832 487 KVADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARP 564 (724)
Q Consensus 487 kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~ 564 (724)
||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |..||......+.. ..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--~~--- 236 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI--EC--- 236 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH--HH---
Confidence 99999999765432221 1223345678999999998999999999999999999998 99998654322211 00
Q ss_pred hhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 565 LCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 565 ~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
+..+.. ...+......+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 237 -----~~~~~~---------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 237 -----ITQGRE---------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred -----HHcCcc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 000000 01111223568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=329.53 Aligned_cols=259 Identities=24% Similarity=0.404 Sum_probs=207.5
Q ss_pred hhCCCcccceeeccCcEEEEEEEcCC-----CcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEe-CCe
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLPN-----GKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIA-GGK 416 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~~-----g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~-~~~ 416 (724)
..++|.+.++||+|+||.||+|.+.+ ++.|++|+++.... .....+.+|+.+|++++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35678899999999999999999765 68899999875533 334568999999999999999999999876 467
Q ss_pred EEEEEEecCCCCHHHHHhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEE
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGR------PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVAD 490 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~------~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~D 490 (724)
.++++||+.+++|..+|..... ..+.+..++.++.||+.||+|||+. +++|||||++|||+++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 7899999999999999875422 4589999999999999999999998 999999999999999999999999
Q ss_pred eccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhh
Q 040832 491 FGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLR 568 (724)
Q Consensus 491 FGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~ 568 (724)
||+++.+.....+ ......++..|+|||++....++.++|||||||+||||++ |+.||+.....+ +..+...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~---- 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE--MAAYLKD---- 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH--HHHHHHc----
Confidence 9999866443322 1223346778999999988889999999999999999999 999997643222 2222110
Q ss_pred cccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 569 ALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 569 ~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
...+. ........+.+++.+||+.+|++||++.+|++.|+...
T Consensus 235 ---~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 235 ---GYRLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred ---CCCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00000 01112346789999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=334.43 Aligned_cols=261 Identities=26% Similarity=0.414 Sum_probs=206.9
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC--------CCcEEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCeeEEeeEEEe
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP--------NGKEVAVKSLRSGS-GQGEREFKAEVEIISRV-HHRHLVSLVGYCIA 413 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~--------~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~ 413 (724)
..++|.+.+.||+|+||.||++.+. ++..||+|.++... ....+++.+|+.+++.+ +|+||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3457888999999999999999731 24579999987543 33456799999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEE
Q 040832 414 GGKRLLVYEYVPNNNLEFHLHGKG--------------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNIL 479 (724)
Q Consensus 414 ~~~~~lV~E~~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NIL 479 (724)
....++||||+.+++|.++|.... ...+++..++.++.||++||.|||++ +|+|||||++|||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 999999999999999999987532 23478889999999999999999998 9999999999999
Q ss_pred EcCCCCEEEEEeccccccCCCCCcc-ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhh
Q 040832 480 LDYTFETKVADFGLAKLTTDNNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDC 557 (724)
Q Consensus 480 l~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~ 557 (724)
|+.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||++||||++ |..||......+
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-- 247 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 247 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--
Confidence 9999999999999998765433221 222345678999999998899999999999999999998 788886543211
Q ss_pred HHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCCc
Q 040832 558 LVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSL 626 (724)
Q Consensus 558 l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~~ 626 (724)
+... +..+.. ..........+..++.+||+.+|++||++.+|++.|+..+.+
T Consensus 248 ---~~~~-----~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 248 ---LFKL-----LKEGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred ---HHHH-----HHcCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1110 000000 011123345688899999999999999999999999876554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.83 Aligned_cols=246 Identities=27% Similarity=0.387 Sum_probs=194.7
Q ss_pred eeccCcEEEEEEEcC-CCcEEEEEEeccCCch---hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCCCH
Q 040832 354 LGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ---GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNL 429 (724)
Q Consensus 354 LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~---~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 429 (724)
||+|+||+||++.+. +++.||||++...... ..+.+..|+++|++++|+||+++++++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999864 6889999998653222 234678899999999999999999999999999999999999999
Q ss_pred HHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccccc
Q 040832 430 EFHLHGK--GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTR 507 (724)
Q Consensus 430 ~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 507 (724)
..++... ....+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||++......... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 9887542 234589999999999999999999998 9999999999999999999999999999866543222 233
Q ss_pred cccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCC
Q 040832 508 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNY 587 (724)
Q Consensus 508 ~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~ 587 (724)
..|+..|+|||++.+..++.++|||||||+||||++|+.||.......... ..... +... . ..+
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~-----~~~~--------~--~~~ 220 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK-ELKQR-----ILND--------S--VTY 220 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH-HHHHh-----hccc--------C--CCC
Confidence 568999999999999999999999999999999999999997543211100 00000 0000 0 012
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 040832 588 PTEEMARMVACAAASIRHSARRRP-----KISQIVRA 619 (724)
Q Consensus 588 ~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evv~~ 619 (724)
+......+.+++.+||+.+|++|+ ++.+++++
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 221 PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 223445688899999999999999 66777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=346.47 Aligned_cols=202 Identities=26% Similarity=0.335 Sum_probs=173.3
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
.|.+.++||+|+||.||+|... +++.||||++.... ......+.+|+++|++++|+||+++++++.+++..+||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999854 57889999987532 1233568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC-
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN- 501 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~- 501 (724)
||++|+|..++...+ .+.+..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999987654 378889999999999999999998 99999999999999999999999999975321000
Q ss_pred ---------------------------------------------CccccccccCCCcCCcchhcCCCCChhHHHHHHHH
Q 040832 502 ---------------------------------------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV 536 (724)
Q Consensus 502 ---------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGv 536 (724)
........||..|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012346999999999999989999999999999
Q ss_pred HHHHHHhCCCCCCCCCc
Q 040832 537 MLLELITGRRPIDPTGA 553 (724)
Q Consensus 537 lL~eLltG~~P~~~~~~ 553 (724)
+||||++|+.||.....
T Consensus 237 il~elltG~~Pf~~~~~ 253 (382)
T cd05625 237 ILYEMLVGQPPFLAQTP 253 (382)
T ss_pred HHHHHHhCCCCCCCCCH
Confidence 99999999999976543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=338.12 Aligned_cols=247 Identities=22% Similarity=0.351 Sum_probs=194.1
Q ss_pred ceeeccCcEEEEEEEcC-CCcEEEEEEeccC---CchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEEEEecCC
Q 040832 352 NLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG---SGQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLVYEYVPN 426 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 426 (724)
++||+|+||.||++.+. +++.||+|+++.. .....+.+..|+.++.++ +|+||+++++++...+..+|||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 5788999999753 222344678899998877 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcccc
Q 040832 427 NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST 506 (724)
Q Consensus 427 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 506 (724)
++|..++.... .+.+..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTS 154 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-ccc
Confidence 99998887654 389999999999999999999998 999999999999999999999999999975432221 123
Q ss_pred ccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchh---hhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 507 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAME---DCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 507 ~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~---~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
...|+..|+|||++.+..++.++|||||||+||||++|+.||+...... .....|..... ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i----~~~~--------- 221 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI----LEKQ--------- 221 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH----hcCC---------
Confidence 4578999999999999999999999999999999999999996422111 11111111000 0000
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCC------HHHHHH
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPK------ISQIVR 618 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs------~~evv~ 618 (724)
..++......+..++.+||+.+|++|++ +.+|++
T Consensus 222 -~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 222 -IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 0122333456789999999999999998 456654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=322.49 Aligned_cols=258 Identities=20% Similarity=0.324 Sum_probs=206.3
Q ss_pred CCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|++.+.||+|+||.||++.. .+++.|+||.+.... .....+|.+|+.+++.++|+||+++++++..++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999995 478899999886432 223457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 422 EYVPNNNLEFHLHG--KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 422 E~~~~gsL~~~L~~--~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
||+.+++|.+++.. .....+++..++.|+.||++||.|||++ +++|+|||++|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998864 2234589999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 500 NNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 500 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
.... .....|+..|+|||++.+..++.++||||||+++|||++|..||......... +... +....+
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~~~-----~~~~~~---- 225 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS---LCKK-----IEQCDY---- 225 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHH---Hhhh-----hhcCCC----
Confidence 3322 12345888999999998888999999999999999999999999643211111 1110 000000
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
+. .........+.+++.+||+.+|++||+|.+|++.++..
T Consensus 226 -~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 226 -PP---LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred -CC---CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 00 01112345688999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=342.85 Aligned_cols=261 Identities=22% Similarity=0.253 Sum_probs=203.3
Q ss_pred HHHHHHhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEe
Q 040832 338 YEELSAATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIA 413 (724)
Q Consensus 338 ~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 413 (724)
+.++....++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.+++.++|+||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4556666789999999999999999999965 5788999998642 12233457899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecc
Q 040832 414 GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGL 493 (724)
Q Consensus 414 ~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGl 493 (724)
+...++||||+++|+|..++.... +++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~~---~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 999999999999999999987543 78888999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCCcCCcchhcCC----CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhc
Q 040832 494 AKLTTDNNTHVSTRVMGTFGYLAPEYASSG----KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRA 569 (724)
Q Consensus 494 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~ 569 (724)
++..............||..|||||++... .++.++|||||||+||||++|+.||......... ..+.
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-~~i~------- 260 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY-SKIM------- 260 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH-HHHH-------
Confidence 987754433333456799999999998653 3789999999999999999999999765432211 1000
Q ss_pred ccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHH
Q 040832 570 LDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARR--RPKISQIVRAL 620 (724)
Q Consensus 570 ~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evv~~L 620 (724)
.......+ .........+..++.+|+...+.+ |+++.+|+++.
T Consensus 261 -~~~~~~~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 261 -NHKNSLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -cCCCcccC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 00000000 001123445677888888744433 77888888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=336.31 Aligned_cols=236 Identities=28% Similarity=0.373 Sum_probs=190.7
Q ss_pred ceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEEEEecCC
Q 040832 352 NLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLVYEYVPN 426 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 426 (724)
++||+|+||.||+|.++ +++.||||+++... ....+.+..|+.++..+ +|+||+++++++...+..+|||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 57899999987531 22345677888888877 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcccc
Q 040832 427 NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST 506 (724)
Q Consensus 427 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 506 (724)
++|..++..... +++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++....... ...
T Consensus 81 g~L~~~i~~~~~--l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~~ 154 (320)
T cd05590 81 GDLMFHIQKSRR--FDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTS 154 (320)
T ss_pred chHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-ccc
Confidence 999998876543 89999999999999999999998 999999999999999999999999999876432222 223
Q ss_pred ccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcC
Q 040832 507 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKN 586 (724)
Q Consensus 507 ~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~ 586 (724)
...|+..|+|||++.+..++.++|||||||+||||++|+.||......+. +.. +..+.. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-~~~---------i~~~~~----------~ 214 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL-FEA---------ILNDEV----------V 214 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-HHH---------HhcCCC----------C
Confidence 45699999999999988999999999999999999999999976532211 100 001100 0
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCH
Q 040832 587 YPTEEMARMVACAAASIRHSARRRPKI 613 (724)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPs~ 613 (724)
++......+.+++.+||+.+|++|+++
T Consensus 215 ~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 215 YPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 111123457889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=337.94 Aligned_cols=247 Identities=21% Similarity=0.340 Sum_probs=194.7
Q ss_pred ceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEEEEecCC
Q 040832 352 NLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLVYEYVPN 426 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 426 (724)
++||+|+||.||++.+. +++.||||+++... ....+.++.|+.++.++ +|+||+++++++.+....+|||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999864 57899999997532 22334588999999998 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcccc
Q 040832 427 NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST 506 (724)
Q Consensus 427 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 506 (724)
++|..++...+ .+.+..++.|+.||+.||.|||++ +|+|||||++||||+.++.+||+|||+++....... ...
T Consensus 81 g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (329)
T cd05588 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TTS 154 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCC-ccc
Confidence 99998887654 389999999999999999999998 999999999999999999999999999975322111 223
Q ss_pred ccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchh---hhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 507 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAME---DCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 507 ~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~---~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
...|+..|+|||++.+..++.++|||||||+||||++|+.||+.....+ ....+|....+ ....+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~-------- 222 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI----LEKQI-------- 222 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH----HcCCC--------
Confidence 4579999999999999999999999999999999999999997432111 11111111100 00000
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCC------HHHHHH
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPK------ISQIVR 618 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs------~~evv~ 618 (724)
.++......+.+++.+||+.+|.+|++ +.+|++
T Consensus 223 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 223 --RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred --CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 112223456788999999999999997 566664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=339.69 Aligned_cols=238 Identities=27% Similarity=0.350 Sum_probs=193.1
Q ss_pred ceeeccCcEEEEEEEc----CCCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecC
Q 040832 352 NLLGQGGFGYVHKGVL----PNGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVP 425 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~----~~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 425 (724)
+.||+|+||.||++.. .+|+.||||+++.... .....+..|+++|++++|+||+++++++.+++..+|||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3578999999975321 223457789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccc
Q 040832 426 NNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVS 505 (724)
Q Consensus 426 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 505 (724)
+++|..++.... .+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++........ .
T Consensus 82 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~-~ 155 (318)
T cd05582 82 GGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-A 155 (318)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc-e
Confidence 999999987654 389999999999999999999998 9999999999999999999999999999866443222 2
Q ss_pred cccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhc
Q 040832 506 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEK 585 (724)
Q Consensus 506 ~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~ 585 (724)
....|+..|+|||++....++.++|||||||+||||++|+.||......+.... +....+
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~----------i~~~~~---------- 215 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM----------ILKAKL---------- 215 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHH----------HHcCCC----------
Confidence 345689999999999988899999999999999999999999976532221110 000000
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 040832 586 NYPTEEMARMVACAAASIRHSARRRPKISQ 615 (724)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~e 615 (724)
.++......+..++.+||+.+|++|+++.+
T Consensus 216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 111122345778999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=326.76 Aligned_cols=250 Identities=26% Similarity=0.377 Sum_probs=200.1
Q ss_pred CcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch---hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 348 FSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ---GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~---~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
|+..++||+|+||+||+|.+. +++.||||.+...... ....+.+|+++|++++|+||+.+++++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 677889999999999999864 6889999998654222 234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+.+++|.+++...+...+++..++.++.||++||.|||+. +|+|||||++|||++.++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 9999999988765555689999999999999999999998 999999999999999999999999999976543222
Q ss_pred cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 504 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
.....|+..|+|||++.+..++.++|||||||+||||++|+.||........ ...+... +....
T Consensus 158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~~-----~~~~~--------- 221 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDRR-----VLETE--------- 221 (285)
T ss_pred -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHh-----hhccc---------
Confidence 1335689999999999988999999999999999999999999976432211 1111110 00000
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPK-----ISQIVR 618 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evv~ 618 (724)
..+.......+.+++..|++.+|++|++ +.+++.
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 222 -EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred -cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 0112223345788999999999999999 556555
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=325.92 Aligned_cols=255 Identities=26% Similarity=0.442 Sum_probs=202.8
Q ss_pred CCCcccceeeccCcEEEEEEEcCC-C---cEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPN-G---KEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~-g---~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
+.|++.+.||+|+||.||+|.+.. + ..||||.++... .....+|..|+.++++++|+||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357889999999999999998653 3 359999987653 33346799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+.+++|++++..+.. .+++.+++.++.|++.||.|||++ +++|||||++||||+.++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 84 TEFMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EecCCCCcHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999999876533 489999999999999999999998 9999999999999999999999999999866443
Q ss_pred CCcc--ccccc--cCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCCh
Q 040832 501 NTHV--STRVM--GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 501 ~~~~--~~~~~--gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~ 575 (724)
.... ..... .+..|++||++..+.++.++|||||||++|||++ |..||......+ ...+... ...+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~--~~~~i~~-------~~~~ 230 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--VINAIEQ-------DYRL 230 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH--HHHHHHc-------CCcC
Confidence 2211 11111 2457999999999999999999999999999887 999996543221 1111110 0000
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 576 NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 576 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
....+....+.+++.+||+.+|++||++.+|+.+|+..
T Consensus 231 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 ----------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01112234578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=348.81 Aligned_cols=266 Identities=20% Similarity=0.299 Sum_probs=194.4
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC--------
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAG-------- 414 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~-------- 414 (724)
..++|.++++||+|+||.||+|... .++.||||++.... ....+|+.+|++++|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999864 57899999886432 2345799999999999999999886532
Q ss_pred CeEEEEEEecCCCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC-CEEEEEe
Q 040832 415 GKRLLVYEYVPNNNLEFHLHG--KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF-ETKVADF 491 (724)
Q Consensus 415 ~~~~lV~E~~~~gsL~~~L~~--~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~-~vkL~DF 491 (724)
..+++||||+.+ +|..++.. .....+.+..++.|+.||++||+|||++ +||||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 245689999975 56555542 2334588999999999999999999998 999999999999998654 7999999
Q ss_pred ccccccCCCCCccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhh---hhhhh
Q 040832 492 GLAKLTTDNNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWA---RPLCL 567 (724)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~---~~~~~ 567 (724)
|+++........ ....|+..|+|||++.+. .++.++|||||||+||||++|..||......+.....+. .+...
T Consensus 216 Gla~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 216 GSAKNLLAGQRS--VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred ccchhccCCCCc--ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 999876543222 235689999999998764 689999999999999999999999976543332111110 00000
Q ss_pred ------hcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 568 ------RALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 568 ------~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+..-.+..+....+...++......+.+++.+||+.+|.+|+++.|++++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000000111111111122222334578899999999999999999999864
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=332.19 Aligned_cols=259 Identities=26% Similarity=0.413 Sum_probs=204.6
Q ss_pred hCCCcccceeeccCcEEEEEEEcC--------CCcEEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeC
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP--------NGKEVAVKSLRSGS-GQGEREFKAEVEIISRV-HHRHLVSLVGYCIAG 414 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~--------~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~ 414 (724)
.++|.+++.||+|+||.||++.+. +...||+|.++... .....++.+|+++++++ +|+||++++++|..+
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357899999999999999999742 23569999998653 23345688999999999 799999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEE
Q 040832 415 GKRLLVYEYVPNNNLEFHLHGKG--------------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILL 480 (724)
Q Consensus 415 ~~~~lV~E~~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl 480 (724)
+..++||||+.+++|.+++.... ...+++.++++|+.||+.||+|||++ +++|||||++|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 99999999999999999997542 13488999999999999999999998 99999999999999
Q ss_pred cCCCCEEEEEeccccccCCCCCcc-ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhH
Q 040832 481 DYTFETKVADFGLAKLTTDNNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCL 558 (724)
Q Consensus 481 ~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l 558 (724)
+.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||+||||++ |..||......+ ..
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~-~~ 252 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-LF 252 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-HH
Confidence 999999999999998664322111 112234568999999998899999999999999999998 888886543211 10
Q ss_pred HhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 559 VDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 559 ~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
.. +..+.. ...+......+.+++.+|++.+|++||+|.+|++.|+..+.
T Consensus 253 ----~~-----~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 253 ----KL-----LKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred ----HH-----HHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 00 000100 01112234567889999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=327.61 Aligned_cols=262 Identities=27% Similarity=0.403 Sum_probs=205.0
Q ss_pred hCCCcccceeeccCcEEEEEEEcCC-----------------CcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPN-----------------GKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVS 406 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~-----------------g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~ 406 (724)
.++|.+.+.||+|+||.||++.+.+ +..||+|++...... ...+|.+|+++|++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578899999999999999988542 245899998765433 4557899999999999999999
Q ss_pred EeeEEEeCCeEEEEEEecCCCCHHHHHhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCcc
Q 040832 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKG---------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSN 477 (724)
Q Consensus 407 l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~---------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~N 477 (724)
+++++..++..++||||+.+++|..+|.... ...+++..++.++.||++||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 9999999999999999999999999987643 12588999999999999999999998 99999999999
Q ss_pred EEEcCCCCEEEEEeccccccCCCCC-ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh--CCCCCCCCCch
Q 040832 478 ILLDYTFETKVADFGLAKLTTDNNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT--GRRPIDPTGAM 554 (724)
Q Consensus 478 ILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt--G~~P~~~~~~~ 554 (724)
|||+.++.++|+|||+++....... .......++..|+|||++..+.++.++|||||||+||||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999986543322 12234456788999999998899999999999999999998 67777654322
Q ss_pred hhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 555 EDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 555 ~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
+ ...+.... +........ ..........+.+++.+|++.+|++||++.||++.|+
T Consensus 241 ~--~~~~~~~~----~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 Q--VIENAGHF----FRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred H--HHHHHHhc----ccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1 11111100 000000000 0111122357899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=335.04 Aligned_cols=203 Identities=24% Similarity=0.317 Sum_probs=175.0
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|++.+.||+|+||.||++... +++.||||++... .....+.|.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999954 5889999998642 1223345889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+.+++|..++.... ..+.+..+..|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 9999999999997533 2488999999999999999999999 99999999999999999999999999997765443
Q ss_pred CccccccccCCCcCCcchhcC-----CCCChhHHHHHHHHHHHHHHhCCCCCCCCC
Q 040832 502 THVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRPIDPTG 552 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~-----~~~t~ksDV~SlGvlL~eLltG~~P~~~~~ 552 (724)
.......+|+..|||||++.. +.++.++|||||||+||||++|+.||....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 212 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence 333334569999999999863 457889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=334.33 Aligned_cols=242 Identities=27% Similarity=0.388 Sum_probs=195.3
Q ss_pred ceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEEEEecCC
Q 040832 352 NLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLVYEYVPN 426 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 426 (724)
++||+|+||.||++.+. +++.||||.++... ......+..|++++..+ +|+||+++++++...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 47889999997532 22344577899999888 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcccc
Q 040832 427 NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST 506 (724)
Q Consensus 427 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 506 (724)
++|..++...+. +++..++.|+.||++||.|||+. +|+|||||++||||+.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~~--l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (318)
T cd05570 81 GDLMFHIQRSGR--FDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTS 154 (318)
T ss_pred CCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-ccc
Confidence 999998876643 89999999999999999999998 999999999999999999999999999975332221 123
Q ss_pred ccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcC
Q 040832 507 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKN 586 (724)
Q Consensus 507 ~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~ 586 (724)
...|+..|+|||++.+..++.++|||||||+||||++|+.||......+. ... +..... .
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~--~~~--------i~~~~~----------~ 214 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL--FQS--------ILEDEV----------R 214 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH--HHH--------HHcCCC----------C
Confidence 35689999999999999999999999999999999999999976532211 100 000000 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 040832 587 YPTEEMARMVACAAASIRHSARRRPKI-----SQIVRA 619 (724)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evv~~ 619 (724)
++......+.+++.+||+.+|++|+++ .+++++
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 112223467899999999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=318.57 Aligned_cols=247 Identities=29% Similarity=0.438 Sum_probs=200.2
Q ss_pred ceeeccCcEEEEEEEcCCCcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCCCHH
Q 040832 352 NLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLE 430 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 430 (724)
++||+|+||.||++.+.+++.|++|.++..... ....|.+|++++++++|+||+++++++.+....++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998765443 4567999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccc-cccc
Q 040832 431 FHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVS-TRVM 509 (724)
Q Consensus 431 ~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~-~~~~ 509 (724)
+++..... .+++..++.++.+++.+|+|||++ +++|||||++||||+.++.+||+|||+++.......... ....
T Consensus 81 ~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 99876433 478999999999999999999999 999999999999999999999999999986653222211 1122
Q ss_pred cCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCC
Q 040832 510 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYP 588 (724)
Q Consensus 510 gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~ 588 (724)
++..|+|||++.++.++.++|||||||++|||++ |..||....... ..... ... .....+
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~~~~--------~~~---------~~~~~~ 217 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TRERI--------ESG---------YRMPAP 217 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HHHHH--------hcC---------CCCCCC
Confidence 3567999999998899999999999999999999 888886543211 11110 000 000112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 589 TEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 589 ~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
......+.+++.+|++.+|++||++.||++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 223456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=351.30 Aligned_cols=269 Identities=21% Similarity=0.309 Sum_probs=195.0
Q ss_pred HHHHhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCC------CCeeEEeeEEE
Q 040832 340 ELSAATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHH------RHLVSLVGYCI 412 (724)
Q Consensus 340 el~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~H------pnIv~l~g~~~ 412 (724)
++....++|++.++||+|+||.||+|.+. .++.||||+++... ...+++..|+.++++++| .+|+++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 44456789999999999999999999864 57889999996432 233456677777777754 45889999887
Q ss_pred eC-CeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC-------
Q 040832 413 AG-GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF------- 484 (724)
Q Consensus 413 ~~-~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~------- 484 (724)
.+ +..+||||++ +++|.+++...+ .+.+..++.|+.||+.||+|||+++ +||||||||+||||+.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCccccccc
Confidence 65 4778999988 677877776554 3899999999999999999999732 899999999999998765
Q ss_pred ---------CEEEEEeccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchh
Q 040832 485 ---------ETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAME 555 (724)
Q Consensus 485 ---------~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~ 555 (724)
.+||+|||++..... ......||..|+|||++.+..++.++|||||||+||||++|+.||+.....+
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred ccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 499999998864332 2234679999999999999999999999999999999999999998765433
Q ss_pred hhH-H---------hhhhhhhhh----cc-cCCChhhhcchh-h----hcC--CCHHHHHHHHHHHHHhhccCCCCCCCH
Q 040832 556 DCL-V---------DWARPLCLR----AL-DDGNFNEIADPY-L----EKN--YPTEEMARMVACAAASIRHSARRRPKI 613 (724)
Q Consensus 556 ~~l-~---------~w~~~~~~~----~~-~~~~~~~~vd~~-l----~~~--~~~~~~~~l~~l~~~cl~~~P~~RPs~ 613 (724)
... . .|....... .+ ..+.+....++. + ... ........+.+|+.+||+.||++|+++
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 211 0 011000000 00 000000000000 0 000 000112457799999999999999999
Q ss_pred HHHHH
Q 040832 614 SQIVR 618 (724)
Q Consensus 614 ~evv~ 618 (724)
.|+++
T Consensus 433 ~e~L~ 437 (467)
T PTZ00284 433 RQMTT 437 (467)
T ss_pred HHHhc
Confidence 99997
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=320.37 Aligned_cols=247 Identities=29% Similarity=0.460 Sum_probs=198.2
Q ss_pred ceeeccCcEEEEEEEcCC----CcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCC
Q 040832 352 NLLGQGGFGYVHKGVLPN----GKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPN 426 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~~----g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 426 (724)
++||+|+||.||+|.+.. +..||+|.++..... ..+++.+|+.+|++++|+||+++++++. ....++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997432 268999999865443 4567999999999999999999999876 4567999999999
Q ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccc-
Q 040832 427 NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVS- 505 (724)
Q Consensus 427 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~- 505 (724)
++|.++|.... .+++..+++|+.||+.||+|||+. +++|||||++||||+.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999998655 489999999999999999999998 999999999999999999999999999987754433221
Q ss_pred -cccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 506 -TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 506 -~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
....++..|+|||.+....++.++|||||||+||||++ |+.||+.....+ +..+.. .+..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~--~~~~~~--------~~~~-------- 216 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE--VIAMLE--------SGER-------- 216 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHH--------cCCc--------
Confidence 11223467999999998899999999999999999998 999997653321 111111 0000
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
...+......+.+++.+|+..+|++||++.+|++.|++.
T Consensus 217 -~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 217 -LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 011122335688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=321.59 Aligned_cols=266 Identities=23% Similarity=0.299 Sum_probs=202.4
Q ss_pred CCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCC-eeEEeeEEEeCC------e
Q 040832 347 GFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQ--GEREFKAEVEIISRVHHRH-LVSLVGYCIAGG------K 416 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~--~~~~f~~Ei~il~~l~Hpn-Iv~l~g~~~~~~------~ 416 (724)
.|...+.||+|.||.||+|+. .+|+.||+|+++....+ --....+|+.+|++|+|.| |++|++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 344556799999999999995 46889999999865432 1234689999999999999 999999999877 7
Q ss_pred EEEEEEecCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccc
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGR--PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLA 494 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~--~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla 494 (724)
++|||||+ .-+|..++..... ..++...++.++.||++||+|||++ +|+||||||.||||+++|.+||+|||+|
T Consensus 92 l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence 88999999 5678888876543 3477789999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhccc--
Q 040832 495 KLTTDNNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALD-- 571 (724)
Q Consensus 495 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~-- 571 (724)
+...-... ..+..++|.+|.|||++.+. .|+...||||+|||+.||++++.-|.+..+.++....+ +-+.....+
T Consensus 168 ra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If-~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIF-RLLGTPNEKDW 245 (323)
T ss_pred HHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHH-HHcCCCCccCC
Confidence 96653222 23556789999999999875 79999999999999999999999998776544432222 111111000
Q ss_pred -------CC--Chhhhcchh-hhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 572 -------DG--NFNEIADPY-LEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 572 -------~~--~~~~~vd~~-l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+. .+...-.+. +.. .-........+++.+|++.+|.+|.+++.++.+
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~-~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSS-ILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHH-hccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00 111111000 000 001112468889999999999999999999986
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=338.73 Aligned_cols=266 Identities=23% Similarity=0.281 Sum_probs=197.9
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC-----
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGG----- 415 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~----- 415 (724)
..++|++.+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++|+||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999864 5889999999653 2233456889999999999999999999986543
Q ss_pred -eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccc
Q 040832 416 -KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLA 494 (724)
Q Consensus 416 -~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla 494 (724)
..++||||++++ |...++. .+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 568999999764 5555543 278889999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhh------------
Q 040832 495 KLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWA------------ 562 (724)
Q Consensus 495 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~------------ 562 (724)
+...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||...+..+.....+.
T Consensus 171 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 171 RTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred cccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 8654322 22345689999999999999999999999999999999999999976543221100000
Q ss_pred -hhhhhh------cccCCChhhhcchhhh---cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 563 -RPLCLR------ALDDGNFNEIADPYLE---KNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 563 -~~~~~~------~~~~~~~~~~vd~~l~---~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
...... ......+.++....+. ..........+.+++.+||+.+|++||++.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 0000001111110000 00111123567899999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=323.68 Aligned_cols=255 Identities=26% Similarity=0.430 Sum_probs=204.2
Q ss_pred CCCcccceeeccCcEEEEEEEcC----CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP----NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
++|++.+.||+|+||.||+|.+. .+..||+|.++.... ...+.|.+|+.++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888999999999999999863 233699999875432 3345789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+++++|.+++..... .+++.+++.|+.||+.||+|||+. +++|||||++|||++.++.+||+|||++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 999999999999976543 479999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCccc--cccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 501 NTHVS--TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 501 ~~~~~--~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
..... ....++..|++||++.++.++.++|||+|||++|||++ |+.||......+ +..+.. .+. .
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~~~--------~~~--~ 227 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKAIE--------EGY--R 227 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHHHh--------CCC--c
Confidence 32221 11223567999999998899999999999999999887 999986543221 111110 000 0
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
..........+.+++.+|++.+|++||+|.+|++.|+..
T Consensus 228 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 -------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 000112235678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=334.05 Aligned_cols=240 Identities=28% Similarity=0.397 Sum_probs=191.3
Q ss_pred ceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEEEEecCC
Q 040832 352 NLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLVYEYVPN 426 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 426 (724)
++||+|+||.||+|.+. +++.||||.++... ......+..|..++..+ +|+||+++++++.+++..+|||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 57899999997532 22334567788888765 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcccc
Q 040832 427 NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST 506 (724)
Q Consensus 427 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 506 (724)
++|..++..++. +++..++.++.||++||+|||++ +|+||||||+||||+.++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKGR--FDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAS 154 (316)
T ss_pred CcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Ccee
Confidence 999998876543 88999999999999999999999 99999999999999999999999999987542221 1223
Q ss_pred ccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcC
Q 040832 507 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKN 586 (724)
Q Consensus 507 ~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~ 586 (724)
...|+..|+|||++.+..++.++|||||||+||||++|+.||......+ +... +.... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~--~~~~--------~~~~~----------~~ 214 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE--LFES--------IRVDT----------PH 214 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHH--------HHhCC----------CC
Confidence 4668999999999999999999999999999999999999997543221 1100 00000 01
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 040832 587 YPTEEMARMVACAAASIRHSARRRPKIS-QIV 617 (724)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evv 617 (724)
++......+.+++.+||+.+|++|+++. +|.
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 215 YPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1111234577899999999999999985 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=333.30 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=200.4
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCc--EEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGK--EVAVKSLRSGS-GQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~--~vaVK~l~~~~-~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 420 (724)
++|++.+.||+|+||.||+|.+. ++. .+++|.++... ....+.|.+|+++|.++ +|+||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 56888899999999999999864 344 45788776543 23446789999999999 899999999999999999999
Q ss_pred EEecCCCCHHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCE
Q 040832 421 YEYVPNNNLEFHLHGKG--------------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFET 486 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~v 486 (724)
|||+++++|.++++..+ ...+++.+++.++.||++||+|||++ +|+||||||+||||+.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 99999999999997542 23578999999999999999999998 99999999999999999999
Q ss_pred EEEEeccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhh
Q 040832 487 KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPL 565 (724)
Q Consensus 487 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~ 565 (724)
||+|||+++....... .....++..|+|||++....++.++|||||||+||||++ |..||......+. ....
T Consensus 164 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~--- 236 (303)
T cd05088 164 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--YEKL--- 236 (303)
T ss_pred EeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH--HHHH---
Confidence 9999999864321111 111224567999999988889999999999999999998 9999965432211 1100
Q ss_pred hhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 566 CLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 566 ~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
..+. ...........+.+++.+||+.+|++||++.+++++|+..+
T Consensus 237 -----~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 237 -----PQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred -----hcCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0000 00011112345788999999999999999999999988543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=324.73 Aligned_cols=266 Identities=24% Similarity=0.314 Sum_probs=196.4
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch--hHHHHHHHHHHHHhc---CCCCeeEEeeEEEe-----CC
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ--GEREFKAEVEIISRV---HHRHLVSLVGYCIA-----GG 415 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~--~~~~f~~Ei~il~~l---~HpnIv~l~g~~~~-----~~ 415 (724)
+|.+.+.||+|+||.||+|.+. +++.||||.++..... ....+.+|+++++++ +|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999865 5889999998753222 234566777777665 79999999998864 24
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 416 KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
..++||||+.+ +|..++.......+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 57899999974 788888765555689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhh--HHhhhhhhhhhc----
Q 040832 496 LTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC--LVDWARPLCLRA---- 569 (724)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~--l~~w~~~~~~~~---- 569 (724)
....... .....|+..|+|||++.+..++.++|||||||+||||++|+.+|......+.. +..+........
T Consensus 157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 157 IYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 7653322 23456889999999999889999999999999999999999999765332211 111100000000
Q ss_pred --ccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 570 --LDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 570 --~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.....+.......+ .....+....+.+++.+||+.||++||++.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 235 VTLPRGAFSPRGPRPV-QSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccCCCCCCch-HHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000000000 00111233457899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=325.28 Aligned_cols=255 Identities=26% Similarity=0.401 Sum_probs=201.8
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCc----EEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGK----EVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRL 418 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~----~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 418 (724)
..+|.+.++||+|+||.||+|.+. +++ .||||+++.... ...+++.+|+.+++.++|+||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 357888999999999999999853 444 389999875433 3356789999999999999999999999764 468
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
++|||+++|+|.++++... ..+.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++...
T Consensus 85 l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 9999999999999987643 2489999999999999999999998 99999999999999999999999999998775
Q ss_pred CCCCcc-ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChh
Q 040832 499 DNNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 499 ~~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
...... .....++..|++||.+.+..++.++|||||||+||||++ |..||+..... .+..+.. .+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~--------~~~~~ 230 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIPDLLE--------KGERL 230 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH--------CCCcC
Confidence 433221 112234678999999998899999999999999999998 99998754321 1111111 01000
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
.........+.+++.+||+.+|++||++.+|++.|+..
T Consensus 231 ---------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 231 ---------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred ---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 01112234678899999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=335.45 Aligned_cols=237 Identities=27% Similarity=0.363 Sum_probs=188.6
Q ss_pred ceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHH-HHHhcCCCCeeEEeeEEEeCCeEEEEEEecCC
Q 040832 352 NLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVE-IISRVHHRHLVSLVGYCIAGGKRLLVYEYVPN 426 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 426 (724)
++||+|+||.||+|.+. +|+.||||++.... ....+++..|.. +++.++|+||+++++++.+.+..+|||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999964 68899999986431 122334555544 56789999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcccc
Q 040832 427 NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST 506 (724)
Q Consensus 427 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 506 (724)
++|..++...+ .+.+..++.|+.||++||.|||++ +|+|||||++||||+.++.+||+|||+++....... ...
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (323)
T cd05575 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TTS 154 (323)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-ccc
Confidence 99999887654 388999999999999999999998 999999999999999999999999999975432221 223
Q ss_pred ccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcC
Q 040832 507 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKN 586 (724)
Q Consensus 507 ~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~ 586 (724)
...|+..|+|||++.+..++.++|||||||+||||++|+.||......+. ... .. .+.+ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~----i~-----~~~~----------~ 214 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM-YDN----IL-----NKPL----------R 214 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH-HHH----HH-----cCCC----------C
Confidence 45689999999999999999999999999999999999999975432211 100 00 0000 0
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 040832 587 YPTEEMARMVACAAASIRHSARRRPKIS 614 (724)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~ 614 (724)
........+.+++.+||+.+|++|+++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 215 LKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1112245678899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=325.75 Aligned_cols=251 Identities=27% Similarity=0.389 Sum_probs=200.8
Q ss_pred CcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 348 FSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG---QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~---~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
|+..++||+|+||.||++.+. +++.||||.+..... ...+.+.+|+.+|++++|+||+.+++.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677889999999999999864 588999999865422 2234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+.+++|.+++.......+.+.+++.++.|++.||.|||+. +|+|||||++|||++.++.++|+|||++.........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 158 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence 9999999998765555689999999999999999999998 9999999999999999999999999999765433221
Q ss_pred cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 504 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
...+|+..|+|||++.+..++.++|||||||++|||++|+.||........ ...+.. +++. .
T Consensus 159 --~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~~~~~--------------~~~~-~ 220 (285)
T cd05630 159 --KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVER--------------LVKE-V 220 (285)
T ss_pred --cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-HHHHHh--------------hhhh-h
Confidence 234689999999999999999999999999999999999999975422110 000000 0000 0
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPK-----ISQIVRA 619 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evv~~ 619 (724)
...+.......+.+++..||+.+|++|++ +.|++++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 221 QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 00111222345788999999999999999 7888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=335.87 Aligned_cols=246 Identities=25% Similarity=0.324 Sum_probs=192.5
Q ss_pred ceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHH-HHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCC
Q 040832 352 NLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEV-EIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPN 426 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei-~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 426 (724)
+.||+|+||.||++.+. +++.||+|++.... ......+..|. .+++.++|+||+++++++...+..++||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 56789999986432 12233444444 456788999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcccc
Q 040832 427 NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST 506 (724)
Q Consensus 427 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 506 (724)
++|.+++..... +.+..++.|+.||++||.|||++ +|+|||||++||||+.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~~--~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~ 154 (325)
T cd05602 81 GELFYHLQRERC--FLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTS 154 (325)
T ss_pred CcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Ccc
Confidence 999999976543 77888899999999999999998 999999999999999999999999999975433222 223
Q ss_pred ccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcC
Q 040832 507 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKN 586 (724)
Q Consensus 507 ~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~ 586 (724)
...|+..|+|||++.+..++.++|||||||+||||++|+.||......+. ..+ .. ... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~---i~-----~~~----------~~ 214 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM--YDN---IL-----NKP----------LQ 214 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH--HHH---HH-----hCC----------cC
Confidence 45799999999999999999999999999999999999999975432221 110 00 000 01
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 587 YPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
+.......+.+++.+|++.+|.+|+++.+.++.+...
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~ 251 (325)
T cd05602 215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNH 251 (325)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcC
Confidence 1122345678899999999999999988655544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=320.50 Aligned_cols=258 Identities=23% Similarity=0.355 Sum_probs=204.6
Q ss_pred HHHhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 341 LSAATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 341 l~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
++.+++.+....+||+|+||.||+|.+. ++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 4556677777789999999999999854 577899999887666667789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC-CCCEEEEEecccccc
Q 040832 420 VYEYVPNNNLEFHLHGKGRP-VMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY-TFETKVADFGLAKLT 497 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~-~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~-~~~vkL~DFGla~~~ 497 (724)
||||+.+++|.+++...... ..++..++.++.||++||+|||++ +|+|||||++||||+. ++.+||+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 99999999999999764221 127888899999999999999998 9999999999999976 679999999999766
Q ss_pred CCCCCccccccccCCCcCCcchhcCCC--CChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCCh
Q 040832 498 TDNNTHVSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 498 ~~~~~~~~~~~~gt~~y~APE~~~~~~--~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~ 575 (724)
...... .....|+..|+|||++.... ++.++|||||||+||||++|+.||........ ..|.....
T Consensus 160 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~~~~~~~--------- 227 (268)
T cd06624 160 AGINPC-TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AMFKVGMF--------- 227 (268)
T ss_pred ccCCCc-cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hHhhhhhh---------
Confidence 432221 22345788999999986643 78899999999999999999999965322111 11111000
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 576 NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 576 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.....++......+..++.+||+.+|++||++.||+++
T Consensus 228 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 ------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00111222334568889999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=320.24 Aligned_cols=246 Identities=26% Similarity=0.433 Sum_probs=195.5
Q ss_pred eeccCcEEEEEEEcC---CCcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCCCH
Q 040832 354 LGQGGFGYVHKGVLP---NGKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNL 429 (724)
Q Consensus 354 LG~G~fG~Vyk~~~~---~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 429 (724)
||+|+||.||+|.+. .+..||||++...... ..+.|.+|+.++++++|+||+++++++.. ...++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence 899999999999753 3556999999765432 34569999999999999999999998864 567999999999999
Q ss_pred HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcccc--c
Q 040832 430 EFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST--R 507 (724)
Q Consensus 430 ~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~--~ 507 (724)
.+++.... ..+++..+++++.||++||+|||++ +++|||||++|||++.++.+||+|||+++........... .
T Consensus 82 ~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 82 NKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99987543 2489999999999999999999998 9999999999999999999999999999866443322111 1
Q ss_pred cccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcC
Q 040832 508 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKN 586 (724)
Q Consensus 508 ~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~ 586 (724)
..++..|+|||++....++.++|||||||+||||++ |+.||......+. ..+. ..+. ...
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~--------~~~~---------~~~ 218 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV--MSFI--------EQGK---------RLD 218 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH--HHHH--------HCCC---------CCC
Confidence 223578999999988889999999999999999996 9999976532221 1110 0110 011
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 587 YPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
.+......+.+++.+||..++++||++.+|++.|+..
T Consensus 219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 2223346678899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=331.55 Aligned_cols=241 Identities=28% Similarity=0.396 Sum_probs=191.5
Q ss_pred ceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEEEEecCC
Q 040832 352 NLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLVYEYVPN 426 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 426 (724)
+.||+|+||.||+|.+. +++.||||+++... ....+.+..|..++..+ +|+||+++++++.+.+..+|||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 47889999997532 22334566788888764 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcccc
Q 040832 427 NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST 506 (724)
Q Consensus 427 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 506 (724)
|+|..++.... .+++.+++.++.||++||.|||++ +|+|||||++||||+.++.+||+|||+++....... ...
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (316)
T cd05619 81 GDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTC 154 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-cee
Confidence 99999987654 388999999999999999999998 999999999999999999999999999975432221 123
Q ss_pred ccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcC
Q 040832 507 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKN 586 (724)
Q Consensus 507 ~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~ 586 (724)
...|+..|+|||++.+..++.++|||||||+||||++|+.||......+ +.... .... . .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~~~i--------~~~~------~----~ 214 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--LFQSI--------RMDN------P----C 214 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--HHHHH--------HhCC------C----C
Confidence 4568999999999998899999999999999999999999997643221 11110 0000 0 0
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 040832 587 YPTEEMARMVACAAASIRHSARRRPKIS-QIVR 618 (724)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evv~ 618 (724)
++......+.+++.+||+.+|++|+++. ++.+
T Consensus 215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 215 YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1111234577889999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=327.29 Aligned_cols=265 Identities=24% Similarity=0.352 Sum_probs=203.2
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
++|++.+.||+|+||.||++.+. +++.||+|.++..... ...++.+|++++++++|+||++++++|.+++..+|||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46899999999999999999854 5788999988754332 335688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+++++|.++++..+ .+++..+..++.||++||.|||+.+ +|+|||||++|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 81 MDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 99999999997654 3889999999999999999999732 89999999999999999999999999997654322
Q ss_pred cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcc-------------
Q 040832 504 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRAL------------- 570 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~------------- 570 (724)
.....|+..|+|||++.+..++.++|||||||+||||++|+.||....... +..+.........
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE--LEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh--HHHhhcCccccccccCCcccccCCCC
Confidence 233568899999999988889999999999999999999999996543211 1111100000000
Q ss_pred c---CCChhhhcchhhhcC---C-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 571 D---DGNFNEIADPYLEKN---Y-PTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 571 ~---~~~~~~~vd~~l~~~---~-~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
. .....++.+..+... . .......+.+++.+||+.+|++||++.||+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000011111111000 0 00123458899999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=337.60 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=200.9
Q ss_pred hCCCcccceeeccCcEEEEEEEc------CCCcEEEEEEeccCCch-hHHHHHHHHHHHHhc-CCCCeeEEeeEEEeC-C
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL------PNGKEVAVKSLRSGSGQ-GEREFKAEVEIISRV-HHRHLVSLVGYCIAG-G 415 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~-~ 415 (724)
.++|+++++||+|+||.||+|.+ .+++.||||+++..... ..+.+.+|+.+|.++ +|+||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788999999999999999973 34678999999765332 345688999999999 789999999988654 4
Q ss_pred eEEEEEEecCCCCHHHHHhcCCC---------------------------------------------------------
Q 040832 416 KRLLVYEYVPNNNLEFHLHGKGR--------------------------------------------------------- 438 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~~~--------------------------------------------------------- 438 (724)
..++||||+++|+|.++++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999864321
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc-cccccc
Q 040832 439 --------PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH-VSTRVM 509 (724)
Q Consensus 439 --------~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~ 509 (724)
..+++..+++++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++........ ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 2367888899999999999999998 9999999999999999999999999999875433221 112234
Q ss_pred cCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCC
Q 040832 510 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYP 588 (724)
Q Consensus 510 gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~ 588 (724)
++..|+|||++.+..++.++||||||++||||++ |..||............ +..+.... . +
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---------~~~~~~~~-----~----~ 304 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR---------LKEGTRMR-----A----P 304 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH---------HhccCCCC-----C----C
Confidence 5678999999998899999999999999999997 99998654322111100 01110000 0 0
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 589 TEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 589 ~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
......+.+++..||+.+|++||++.+|+++|+..+
T Consensus 305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 011235788899999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=318.51 Aligned_cols=248 Identities=30% Similarity=0.492 Sum_probs=203.6
Q ss_pred ceeeccCcEEEEEEEcCC----CcEEEEEEeccCCchh-HHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCC
Q 040832 352 NLLGQGGFGYVHKGVLPN----GKEVAVKSLRSGSGQG-EREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPN 426 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~~----g~~vaVK~l~~~~~~~-~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 426 (724)
++||+|+||.||+|.+.. +..|+||.++...... .+.+.+|+++++.++|+||+++++++.++...++||||+.+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999754 7789999998664443 56799999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 427 NNLEFHLHGKG-------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 427 gsL~~~L~~~~-------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
++|.+++.... ...+++..+++++.||++||+|||++ +|+|||||++||||+.++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999998752 24589999999999999999999998 999999999999999999999999999987765
Q ss_pred CCC-ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 500 NNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 500 ~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
... .......++..|+|||.+....++.++|||||||+||||++ |+.||......+ +... +..+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~--------~~~~~~-- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE--VLEY--------LRKGYR-- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH--HHHH--------HHcCCC--
Confidence 432 12233457889999999988899999999999999999999 699997652211 1111 011100
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
..........+.+++.+||+.+|++||++.||+++|+
T Consensus 226 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 -------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0112222467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=326.84 Aligned_cols=262 Identities=25% Similarity=0.390 Sum_probs=202.4
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-----------------CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-----------------NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVS 406 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-----------------~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~ 406 (724)
.++|++.+.||+|+||.||++.+. +...||||+++.... ....+|.+|+++|++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356899999999999999998532 234689999976533 33467999999999999999999
Q ss_pred EeeEEEeCCeEEEEEEecCCCCHHHHHhcCCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCcc
Q 040832 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGR---------PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSN 477 (724)
Q Consensus 407 l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~---------~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~N 477 (724)
+++++..++..++||||+.+++|.+++..... ..+++.++++++.||+.||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 99999999999999999999999999875421 2367889999999999999999998 99999999999
Q ss_pred EEEcCCCCEEEEEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh--CCCCCCCCCch
Q 040832 478 ILLDYTFETKVADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT--GRRPIDPTGAM 554 (724)
Q Consensus 478 ILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt--G~~P~~~~~~~ 554 (724)
|||+.++.+||+|||+++........ ......++..|++||....+.++.++|||||||+||||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999999865433221 1223345678999999988899999999999999999998 77888654322
Q ss_pred hhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 555 EDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 555 ~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
+. +. ......... ... .. + ..+..+...+.+++.+||+.+|++||++.+|++.|+
T Consensus 241 ~~-~~-~~~~~~~~~-~~~----~~---~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QV-IE-NTGEFFRDQ-GRQ----VY---L--PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HH-HH-HHHHHHhhc-ccc----cc---C--CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 21 10 000000000 000 00 0 011123367889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=332.81 Aligned_cols=241 Identities=25% Similarity=0.385 Sum_probs=193.7
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcC-CCCeeEEeeEEEeCCeEEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVH-HRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~ 421 (724)
+|+..++||+|+||.||++... +++.||||+++... ....+.+..|+.+++.+. |++|+++++++.+.+..+|||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999854 68899999987532 223345788999998885 677888999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+++|+|..++...+. +++.+++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 99999999999876543 89999999999999999999998 99999999999999999999999999998643322
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
. ......|+..|+|||++.+..++.++|||||||+||||++|+.||....... +... .. ...
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~~~---i~-----~~~------- 217 (323)
T cd05615 156 V-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE--LFQS---IM-----EHN------- 217 (323)
T ss_pred c-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHH---HH-----hCC-------
Confidence 1 1233568999999999998899999999999999999999999997653221 1110 00 000
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKI 613 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 613 (724)
..++......+.+++.+||+.+|.+|++.
T Consensus 218 ---~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 ---VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 01122233467889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=337.58 Aligned_cols=266 Identities=19% Similarity=0.245 Sum_probs=199.0
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC------
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIAG------ 414 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~------ 414 (724)
..++|.+.+.||+|+||.||++... .++.||||++.... ....+.+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999854 57889999997542 22345688999999999999999999988654
Q ss_pred CeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccc
Q 040832 415 GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLA 494 (724)
Q Consensus 415 ~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla 494 (724)
...++||||+++ +|...+.. .+++..++.++.||++||+|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccc
Confidence 356899999976 55555543 278899999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhh-----------
Q 040832 495 KLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWAR----------- 563 (724)
Q Consensus 495 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~----------- 563 (724)
+....... .....|+..|+|||++.+..++.++|||||||+||||++|+.||......+........
T Consensus 167 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 167 RTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred ccCCCccc--cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 86544322 23456899999999999889999999999999999999999999765433221100000
Q ss_pred --hhhhhcccC-CChhhhcchh------h--hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 564 --PLCLRALDD-GNFNEIADPY------L--EKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 564 --~~~~~~~~~-~~~~~~vd~~------l--~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+.....+.. ..+..+..+. + ...........+.+++.+||+.+|++||++.||+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 0000000000 0 001111234567899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=317.13 Aligned_cols=250 Identities=24% Similarity=0.372 Sum_probs=203.9
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
+|++.+.||+|+||.||++.+. +++.||+|.++... ....+.+.+|+.++++++|+||+++++++.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999864 58889999986432 334457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
++++|..++.......+++..++.|+.||+.||.|||++ +|+|+|||++|||++.++.++|+|||++........ .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 999999988765555688999999999999999999998 999999999999999999999999999986654322 2
Q ss_pred ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhh
Q 040832 505 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLE 584 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~ 584 (724)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||+.......... +..+.+..
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~----------~~~~~~~~------- 219 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK----------VCQGSYKP------- 219 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH----------HhcCCCCC-------
Confidence 2335688899999999988899999999999999999999999975432211110 01111111
Q ss_pred cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 585 KNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+......+.+++.+||+.+|++||++.+|+..
T Consensus 220 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 --LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111223457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=334.46 Aligned_cols=237 Identities=26% Similarity=0.351 Sum_probs=188.1
Q ss_pred ceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc---hhHHHHHHHHH-HHHhcCCCCeeEEeeEEEeCCeEEEEEEecCC
Q 040832 352 NLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG---QGEREFKAEVE-IISRVHHRHLVSLVGYCIAGGKRLLVYEYVPN 426 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~---~~~~~f~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 426 (724)
++||+|+||.||+|.+. +++.||||++..... .....+..|.. +++.++|+||+++++++.+.+..+|||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 578899999864321 22334555554 67889999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcccc
Q 040832 427 NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST 506 (724)
Q Consensus 427 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 506 (724)
++|..++.... .+.+..+..|+.||++||+|||+. +|+|||||++||||+.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (321)
T cd05603 81 GELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TTS 154 (321)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-ccc
Confidence 99998887644 378889999999999999999998 999999999999999999999999999975432221 223
Q ss_pred ccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcC
Q 040832 507 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKN 586 (724)
Q Consensus 507 ~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~ 586 (724)
...|+..|+|||++.+..++.++|||||||+||||++|+.||...+..+. .. ... ... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~----~i~-----~~~----------~~ 214 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM-YD----NIL-----HKP----------LQ 214 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH-HH----HHh-----cCC----------CC
Confidence 45689999999999988999999999999999999999999976532111 00 000 000 01
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 040832 587 YPTEEMARMVACAAASIRHSARRRPKIS 614 (724)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~ 614 (724)
++......+.+++.+||+.+|++|++..
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1223345688999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=321.30 Aligned_cols=252 Identities=25% Similarity=0.338 Sum_probs=192.8
Q ss_pred ceeeccCcEEEEEEEcCC---CcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCC
Q 040832 352 NLLGQGGFGYVHKGVLPN---GKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNN 427 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~~---g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 427 (724)
+.||+|+||.||+|.+.+ +..+++|.++.... .....|.+|+.++++++|+||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998643 35689999876543 33457899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 428 NLEFHLHGKG---RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 428 sL~~~L~~~~---~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
+|.++|+... ...+++..++.++.|+++||+|||+. +|+|||||++|||++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999987532 22456778889999999999999998 99999999999999999999999999997654433221
Q ss_pred -ccccccCCCcCCcchhcCC-------CCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCCh
Q 040832 505 -STRVMGTFGYLAPEYASSG-------KLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 505 -~~~~~gt~~y~APE~~~~~-------~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~ 575 (724)
.....++..|+|||++... .++.++||||||+++|||++ |+.||......+.....+. +..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~----------~~~ 227 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR----------EQQ 227 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh----------ccc
Confidence 2234577889999998642 35789999999999999996 9999976543322111110 000
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 576 NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 576 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
..+.++.+.. .....+.+++..|+ .+|++||++.+|++.|+
T Consensus 228 ~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 228 LKLPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111111111 12234677888898 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=322.93 Aligned_cols=249 Identities=28% Similarity=0.458 Sum_probs=195.3
Q ss_pred ceeeccCcEEEEEEEcCC-Cc--EEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEEEEecCC
Q 040832 352 NLLGQGGFGYVHKGVLPN-GK--EVAVKSLRSGS-GQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLVYEYVPN 426 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~~-g~--~vaVK~l~~~~-~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 426 (724)
++||+|+||.||+|.+.+ +. .+++|.++... ....+.|.+|++++.++ +|+||+++++++...+..++||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 469999999999999754 33 46888887543 33456789999999999 899999999999999999999999999
Q ss_pred CCHHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEec
Q 040832 427 NNLEFHLHGKG--------------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFG 492 (724)
Q Consensus 427 gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFG 492 (724)
++|.+++.... ...+.+.+++.++.||+.||+|||+. +++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999987532 12478999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhccc
Q 040832 493 LAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALD 571 (724)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~ 571 (724)
++......... .....+..|+|||++....++.++|||||||+||||++ |+.||......+ +... +.
T Consensus 158 l~~~~~~~~~~--~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~--------~~ 225 (270)
T cd05047 158 LSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEK--------LP 225 (270)
T ss_pred Cccccchhhhc--cCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--HHHH--------Hh
Confidence 98643211111 11223567999999988899999999999999999997 999996543211 1100 00
Q ss_pred CCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 572 DGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 572 ~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
.+... .........+.+++.+|++.+|.+||++.+|+..|+..+
T Consensus 226 ~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 226 QGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCC---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00000 011122345789999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=323.29 Aligned_cols=256 Identities=23% Similarity=0.371 Sum_probs=204.9
Q ss_pred hCCCcccceeeccCcEEEEEEEcCCC----cEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPNG----KEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~g----~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
.++|.+.++||+|+||.||+|.+.+. ..|+||...... ....+.|.+|+.++++++|+||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 34678889999999999999986432 468999887654 3445679999999999999999999999876 45689
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
||||+.+++|.+++..... .+++..++.++.+|+.||+|||+. +++|||||++|||++.++.+||+|||+++....
T Consensus 84 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 84 VMELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999999976443 489999999999999999999998 999999999999999999999999999987655
Q ss_pred CCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhh
Q 040832 500 NNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEI 578 (724)
Q Consensus 500 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 578 (724)
..........+...|+|||.+....++.++|||||||++|||++ |+.||......+.. .+. ..+...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~--~~~--------~~~~~~-- 227 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI--GRI--------ENGERL-- 227 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHH--------HcCCcC--
Confidence 43333333345568999999988889999999999999999996 99999765432211 111 001000
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 579 ADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 579 vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
.........+.+++.+|+..+|++||++.++++.|+...
T Consensus 228 -------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 228 -------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 011123356888999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=319.44 Aligned_cols=253 Identities=30% Similarity=0.455 Sum_probs=200.5
Q ss_pred CcccceeeccCcEEEEEEEcCC-CcEEEEEEeccCCchhHH--HHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 348 FSQSNLLGQGGFGYVHKGVLPN-GKEVAVKSLRSGSGQGER--EFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~~-g~~vaVK~l~~~~~~~~~--~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
|++++.||+|+||.||++.... ++.||+|.+......... ....|+.++++++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6778999999999999999654 568999999876544333 3456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
.+++|.++|.... .+++..++.++.||++||+|||+. +|+|||||++|||++.++.++|+|||++...... ...
T Consensus 81 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-NEN 154 (260)
T ss_dssp TTEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTST-TSE
T ss_pred ccccccccccccc--cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-ccc
Confidence 9999999998333 389999999999999999999999 9999999999999999999999999999865222 223
Q ss_pred ccccccCCCcCCcchhc-CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 505 STRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~-~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
.....++..|+|||++. ...++.++||||||+++|+|++|+.||........ ........ . . .+....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~-~-----~---~~~~~~- 223 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ-LEIIEKIL-K-----R---PLPSSS- 223 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH-HHHHHHHH-H-----T---HHHHHT-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhh-hhhhhhcc-c-----c---cccccc-
Confidence 34466889999999998 78899999999999999999999999986521111 11000000 0 0 000000
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.........+.+++..||+.+|++||++.+|+++
T Consensus 224 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 224 --QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp --TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred --cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000112789999999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=319.59 Aligned_cols=248 Identities=28% Similarity=0.436 Sum_probs=201.1
Q ss_pred ceeeccCcEEEEEEEcCC--C--cEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCC
Q 040832 352 NLLGQGGFGYVHKGVLPN--G--KEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPN 426 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~~--g--~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 426 (724)
++||+|+||.||+|.+.+ + ..||||.+..... ...+.|.+|+.++++++|+||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 2589999987665 556689999999999999999999999988 888999999999
Q ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc--c
Q 040832 427 NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH--V 504 (724)
Q Consensus 427 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~--~ 504 (724)
++|..++.......+++..++.++.||++||+|||+. +++|||||++|||++.++.+||+|||+++........ .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9999999775434589999999999999999999999 9999999999999999999999999999877543222 1
Q ss_pred ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 505 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
.....++..|++||++....++.++|||||||++|||++ |+.||+.....+ .+..+.. ... .+
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~~--------~~~--~~----- 220 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-ILKKIDK--------EGE--RL----- 220 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHh--------cCC--cC-----
Confidence 123457789999999998899999999999999999999 999997543222 1111110 000 00
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
..+......+.+++.+|++.+|++||++.+|++.|.
T Consensus 221 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 --ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011123456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=335.62 Aligned_cols=243 Identities=26% Similarity=0.332 Sum_probs=191.0
Q ss_pred ceeeccCcEEEEEEEcC-CCcEEEEEEeccC---CchhHHHHHHHHH-HHHhcCCCCeeEEeeEEEeCCeEEEEEEecCC
Q 040832 352 NLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG---SGQGEREFKAEVE-IISRVHHRHLVSLVGYCIAGGKRLLVYEYVPN 426 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~---~~~~~~~f~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 426 (724)
++||+|+||+||++... +|+.||||++... .......+..|.. +++.++|+||+++++++..++..+|||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999854 6889999998643 1122344555554 56778999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcccc
Q 040832 427 NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST 506 (724)
Q Consensus 427 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 506 (724)
++|..++.... .+.+..++.++.||++||+|||+. +|+|||||++||||+.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~ 154 (325)
T cd05604 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TTT 154 (325)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Ccc
Confidence 99998887654 388999999999999999999998 999999999999999999999999999975432221 223
Q ss_pred ccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcC
Q 040832 507 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKN 586 (724)
Q Consensus 507 ~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~ 586 (724)
...|+..|+|||++.+..++.++|||||||+||||++|+.||......+. ... . ..+.+ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~-~~~----~-----~~~~~----------~ 214 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM-YDN----I-----LHKPL----------V 214 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH-HHH----H-----HcCCc----------c
Confidence 45699999999999999999999999999999999999999975432211 000 0 00000 0
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 040832 587 YPTEEMARMVACAAASIRHSARRRPKISQIVRAL 620 (724)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L 620 (724)
........+.+++.+|++.+|.+|+++.+.++.+
T Consensus 215 ~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 215 LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 1112334577889999999999999987544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=328.28 Aligned_cols=265 Identities=20% Similarity=0.344 Sum_probs=198.6
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
++|.+.+.||+|+||.||+|... +++.||||.++.... .....+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57899999999999999999865 578899999875432 2334678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+.+ +|..++...+ ..+++..++.++.||++||+|||++ +|+||||||+||||+.++.+||+|||+++........
T Consensus 86 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 86 LDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 975 7777776543 2478899999999999999999998 9999999999999999999999999999765432221
Q ss_pred cccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHH-----------hhhhhhhhhccc
Q 040832 504 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLV-----------DWARPLCLRALD 571 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~-----------~w~~~~~~~~~~ 571 (724)
.....++..|+|||++.+ ..++.++|||||||+||||++|+.||......+.... .|..........
T Consensus 161 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 161 -YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred -cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 223457899999998865 4688999999999999999999999976543222110 010000000000
Q ss_pred CCChhhhc-chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 572 DGNFNEIA-DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 572 ~~~~~~~v-d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
...+.... ...+. ........+.+++.+||+.+|++|+++.|+++
T Consensus 240 ~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 240 NYNFPKYKPQPLIN--HAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhcCccCCCchhh--hccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000 00000 00112345678999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=325.70 Aligned_cols=250 Identities=23% Similarity=0.377 Sum_probs=204.6
Q ss_pred CCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
.+|++.+.||+|+||.||+|.. .+++.|+||.+..........+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5788889999999999999985 468899999997665555677999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
.+++|.+++... .+.+.+++.++.||+.||+|||+. +|+|||||++||||+.++.+||+|||++.........
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~- 172 (296)
T cd06654 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (296)
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc-
Confidence 999999998653 378999999999999999999999 9999999999999999999999999998865433221
Q ss_pred ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhh
Q 040832 505 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLE 584 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~ 584 (724)
.....|+..|+|||++.+..++.++|||||||+||||++|+.||............+.. +. .. +
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~---------~~-~~-----~- 236 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN---------GT-PE-----L- 236 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC---------CC-CC-----C-
Confidence 22346888999999999888999999999999999999999999755332211111100 00 00 0
Q ss_pred cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 585 KNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.........+.+++.+||..+|++||++.+|+++
T Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0112233557889999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=325.89 Aligned_cols=256 Identities=27% Similarity=0.436 Sum_probs=204.3
Q ss_pred hCCCcccceeeccCcEEEEEEEcC------CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP------NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKR 417 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 417 (724)
.++|++.+.||+|+||.||++.+. +++.||||+++.... ...++|.+|+.++++++|+||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999853 467899999876533 3346799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCcc
Q 040832 418 LLVYEYVPNNNLEFHLHGKG--------------------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSN 477 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~--------------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~N 477 (724)
++||||+.+++|.+++.... ...+++.+++.++.||+.||+|||+. +++|||||++|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999999986421 12467889999999999999999998 99999999999
Q ss_pred EEEcCCCCEEEEEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchh
Q 040832 478 ILLDYTFETKVADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAME 555 (724)
Q Consensus 478 ILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~ 555 (724)
||++.++.+||+|||++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999765432211 1122334667999999998899999999999999999998 888886543211
Q ss_pred hhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 556 DCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 556 ~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
+..+ +..+.+. ..+......+.+++.+|++.+|++||++.||++.|+.
T Consensus 241 --~~~~--------~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 --VIYY--------VRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --HHHH--------HhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111 1111111 0112234578899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=323.61 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=198.0
Q ss_pred CCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
++|++.++||+|+||.||+|.+ .+++.||||.+..+. ....++|.+|+++|++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999985 468889999986543 33346799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+++++|..+. .+++..+..++.||+.||.|||+. +|+|+|||++|||++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 9999997652 267888999999999999999998 99999999999999999999999999998664332
Q ss_pred cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhH--HhhhhhhhhhcccCCChhhhcch
Q 040832 504 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCL--VDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l--~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.......... ..+.. .+.... ..
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-----~~~~~~-----~~ 218 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ-----CIVDED-----PP 218 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH-----HHhccC-----CC
Confidence 223568899999999998899999999999999999999999996532111110 00000 000000 00
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+ ........+.+++.+|++.+|++||++.+|+++
T Consensus 219 ~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 219 VL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00 011123457889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=319.66 Aligned_cols=247 Identities=28% Similarity=0.494 Sum_probs=201.3
Q ss_pred CCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecC
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVP 425 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 425 (724)
++|++.+.||+|+||.||++.. +++.||+|.++... ....|.+|+.++++++|+||+++++++..++ .++||||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCC
Confidence 4588899999999999999975 67889999987542 3457899999999999999999999987654 699999999
Q ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccc
Q 040832 426 NNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVS 505 (724)
Q Consensus 426 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 505 (724)
+++|..++.......+.+..+++++.||++||.|||+. +++|||||++|||++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 99999999876655689999999999999999999998 99999999999999999999999999997654321
Q ss_pred cccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhh
Q 040832 506 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLE 584 (724)
Q Consensus 506 ~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~ 584 (724)
........|++||++.++.++.++|||||||++|||++ |+.||......+. ... +..+..
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~~~--------~~~~~~--------- 215 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV--KEC--------VEKGYR--------- 215 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH--HHH--------HhCCCC---------
Confidence 12234567999999998899999999999999999998 9999975432211 000 011100
Q ss_pred cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 585 KNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
..........+.+++.+|++.+|++||++.+|+..|+.
T Consensus 216 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 216 MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 01112234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=322.72 Aligned_cols=270 Identities=19% Similarity=0.295 Sum_probs=207.2
Q ss_pred HhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEec--cCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEe-----C
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLR--SGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA-----G 414 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~--~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~-----~ 414 (724)
.....|...+.||+|+||.|+.+.+. +|+.||||++. -......++..+|+.+|++++|+||+.+++++.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34456666789999999999999854 68999999987 2344456778899999999999999999998765 3
Q ss_pred CeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccc
Q 040832 415 GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLA 494 (724)
Q Consensus 415 ~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla 494 (724)
..+|+|+|+| +.+|..+++.... |....+..+++||++||.|+|+. +|+||||||.|+|++.+..+||||||||
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~~--L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQD--LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCcc--ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence 5789999999 7788888876554 88999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCC-CccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhh-h----hhhhh
Q 040832 495 KLTTDNN-THVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDW-A----RPLCL 567 (724)
Q Consensus 495 ~~~~~~~-~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w-~----~~~~~ 567 (724)
+...... ....+..+.|.||.|||++.. ..|+.+.||||.||||.|||+|+.-|-+.+...+..... . .....
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 9885431 123466788999999998754 689999999999999999999999998876554421100 0 01111
Q ss_pred hcccCCChhhhcchhh-------hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 568 RALDDGNFNEIADPYL-------EKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 568 ~~~~~~~~~~~vd~~l-------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+...+....+...- ...++ ..-...++++.+||..||++|.+++|.+++
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111111111111110 00011 233457889999999999999999999874
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=316.38 Aligned_cols=250 Identities=25% Similarity=0.367 Sum_probs=205.1
Q ss_pred hCCCcccceeeccCcEEEEEEEcCC-CcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPN-GKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
.++|++.+.||+|+||.||+|.+.+ ++.|++|.+..... ..+|.+|++++++++|+||+++++++.++...+++|||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3678889999999999999999765 78999999875432 56899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+.+++|.+++...+ ..+++..++.++.||++||.|||+. +|+||||+++||+++.++.+||+|||++........
T Consensus 80 ~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 80 CGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999999987543 3589999999999999999999998 999999999999999999999999999987654332
Q ss_pred cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 504 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
......++..|++||++.+..++.++|||||||++|||++|+.||.............. ... ..+
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~----------~~~-----~~~ 219 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN----------KPP-----PTL 219 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc----------CCC-----CCC
Confidence 22334578899999999988999999999999999999999999976433221111000 000 000
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
..+......+.+++.+||+.+|++||++.||++
T Consensus 220 --~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 --SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred --CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 011122356888999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=319.08 Aligned_cols=240 Identities=24% Similarity=0.401 Sum_probs=190.1
Q ss_pred ceeeccCcEEEEEEEcCC-------------CcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEE
Q 040832 352 NLLGQGGFGYVHKGVLPN-------------GKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRL 418 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~~-------------g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 418 (724)
+.||+|+||.||+|.+.. ...|++|.+..........|.+|+.+++.++|+||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2258899887654445567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCC-------EEEEEe
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFE-------TKVADF 491 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~-------vkL~DF 491 (724)
+||||+++++|+.++..+.. .+++..+++|+.||++||+|||++ +|+||||||+||||+.++. +||+||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSD-VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 99999999999998875433 489999999999999999999998 9999999999999987654 899999
Q ss_pred ccccccCCCCCccccccccCCCcCCcchhc-CCCCChhHHHHHHHHHHHHHH-hCCCCCCCCCchhhhHHhhhhhhhhhc
Q 040832 492 GLAKLTTDNNTHVSTRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVMLLELI-TGRRPIDPTGAMEDCLVDWARPLCLRA 569 (724)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~t~ksDV~SlGvlL~eLl-tG~~P~~~~~~~~~~l~~w~~~~~~~~ 569 (724)
|++...... ....++..|+|||++. ...++.++|||||||+||||+ .|+.||......+. ...+
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~-------- 222 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERFY-------- 222 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HHHH--------
Confidence 998765332 2245788899999887 467899999999999999998 58888764321111 0000
Q ss_pred ccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 570 LDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 570 ~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
.+.+ .. .......+.+++.+||+.+|++||++.+|++.|+
T Consensus 223 --~~~~-~~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 --EGQC-ML---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred --hcCc-cC---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0000 00 0111245788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=319.06 Aligned_cols=253 Identities=23% Similarity=0.376 Sum_probs=201.3
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
++|.+.+.||+|+||.||+|.+. +++.||+|.++.........+++|+.+++.++|+||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777888999999999999854 58899999997665455567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
++++|.+++...+. +++.+++.++.||+.||.|||+. +|+|||||++|||++.++.+||+|||++........ .
T Consensus 89 ~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06645 89 GGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-K 162 (267)
T ss_pred CCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-c
Confidence 99999999876553 89999999999999999999999 999999999999999999999999999976643221 1
Q ss_pred ccccccCCCcCCcchhc---CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 505 STRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~---~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
.....|+..|+|||++. .+.++.++|||||||+||||++|+.||........... . ....+. ..
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~-~---------~~~~~~---~~ 229 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-M---------TKSNFQ---PP 229 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh-h---------hccCCC---CC
Confidence 23346899999999874 45688999999999999999999999865432221110 0 000000 00
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+... ......+.+++.+|+..+|++||++.+|+++
T Consensus 230 ~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 230 KLKDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00000 0112357889999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=330.21 Aligned_cols=257 Identities=26% Similarity=0.413 Sum_probs=202.8
Q ss_pred hCCCcccceeeccCcEEEEEEEcC--------CCcEEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeC
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP--------NGKEVAVKSLRSGS-GQGEREFKAEVEIISRV-HHRHLVSLVGYCIAG 414 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~--------~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~ 414 (724)
.++|.+++.||+|+||.||++... ....||+|.++... .....++..|+++++++ +|+||++++++|.++
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357888999999999999999742 24568999987543 23445789999999999 699999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEE
Q 040832 415 GKRLLVYEYVPNNNLEFHLHGKG--------------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILL 480 (724)
Q Consensus 415 ~~~~lV~E~~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl 480 (724)
+..++||||+.+++|..++.... ...+.+.++++|+.||+.||.|||++ +|+|||||++||||
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 99999999999999999986532 23488999999999999999999998 99999999999999
Q ss_pred cCCCCEEEEEeccccccCCCCCcc-ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhH
Q 040832 481 DYTFETKVADFGLAKLTTDNNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCL 558 (724)
Q Consensus 481 ~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l 558 (724)
+.++.+||+|||+++......... .....++..|||||++.++.++.++|||||||++|||++ |..||......+.
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-- 245 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL-- 245 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 999999999999998765322211 112234467999999998899999999999999999999 8888865432211
Q ss_pred HhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 559 VDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 559 ~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
.... ..+.. ..........+.+++.+|++.+|++||++.+|++.|++.
T Consensus 246 ~~~~--------~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 246 FKLL--------REGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred HHHH--------HcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1100 00000 011122234677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=335.42 Aligned_cols=203 Identities=23% Similarity=0.308 Sum_probs=175.5
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|.+.+.||+|+||.||++.+. +++.||||.+... .......+.+|+.++..++|+||+++++++.+++..||||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999965 5788999998642 1122345888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+.+|+|..++..... .+.+..+..|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFED-RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 99999999999976432 478999999999999999999998 99999999999999999999999999998765543
Q ss_pred CccccccccCCCcCCcchhcC-----CCCChhHHHHHHHHHHHHHHhCCCCCCCCC
Q 040832 502 THVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRPIDPTG 552 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~-----~~~t~ksDV~SlGvlL~eLltG~~P~~~~~ 552 (724)
........|+..|+|||++.. +.++.++|||||||+||||++|+.||....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 333334569999999999875 567889999999999999999999997643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=317.04 Aligned_cols=251 Identities=29% Similarity=0.475 Sum_probs=203.5
Q ss_pred CcccceeeccCcEEEEEEEcCC-----CcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 348 FSQSNLLGQGGFGYVHKGVLPN-----GKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~~-----g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
|++.+.||+|+||.||++.+.+ +..||+|+++..... ..+.+..|++++++++|+||+++++++.+.+..++||
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567889999999999999754 378999999766444 4568999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+.+++|.+++.......+++.+++.++.||+.||+|||+. +++|||||++|||++.++.++|+|||+++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999865543389999999999999999999999 99999999999999999999999999998776543
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
........++..|++||.+....++.++|||+||+++|||++ |+.||......+ +..+. ..+...
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~--~~~~~--------~~~~~~---- 223 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE--VLEYL--------KKGYRL---- 223 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH--------hcCCCC----
Confidence 322222336789999999988889999999999999999998 788886532211 11110 011100
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRAL 620 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L 620 (724)
.........+.+++.+|++.+|++||++.|+++.|
T Consensus 224 -----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 -----PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 01111345688899999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=314.48 Aligned_cols=250 Identities=22% Similarity=0.378 Sum_probs=202.2
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEe-CCeEEEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIA-GGKRLLVYE 422 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~lV~E 422 (724)
+|++.+.||+|+||.||++... +++.||||.+.... ....+.+.+|++++++++|+||+++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5888999999999999999864 47889999986542 2334568899999999999999999998764 446789999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|+.+++|.+++.......+++.+++.++.+|+.||+|||+. +|+|||||++|||++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999999765445689999999999999999999999 999999999999999999999999999987643322
Q ss_pred ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchh
Q 040832 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~ 582 (724)
......++..|+|||++.+..++.++||||||+++|||++|+.||+....... ...+ ..+.+
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-~~~~---------~~~~~------- 219 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-VYRI---------IEGKL------- 219 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-HHHH---------HhcCC-------
Confidence 22345688999999999999999999999999999999999999975432111 1100 00111
Q ss_pred hhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 583 LEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 583 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..........+.+++.+|++.+|++||++.+|+++
T Consensus 220 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 --PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 01122334568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=318.07 Aligned_cols=250 Identities=25% Similarity=0.453 Sum_probs=201.9
Q ss_pred CCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCc------hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSG------QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~------~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
+|..++.||+|+||.||+|...+++.||||.++.... .....+.+|+++|++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4788899999999999999988899999998864321 1224588999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+.+++|++++...+ .+.+..+..++.||+.||+|||+. +|+|+|||++|||++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999997654 378999999999999999999998 9999999999999999999999999999865321
Q ss_pred C-----CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCCh
Q 040832 501 N-----THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 501 ~-----~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~ 575 (724)
. ........|+..|++||++.+..++.++|||||||++|||++|+.||........... ... ....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~-~~~-------~~~~~ 227 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY-IGA-------HRGLM 227 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH-hhh-------ccCCC
Confidence 1 1112335688999999999988899999999999999999999999975433222110 000 00000
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 576 NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 576 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
+ ..+......+..++.+||+.+|++||++.+|++
T Consensus 228 -----~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 -----P----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -----C----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 111223455788999999999999999999986
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=321.37 Aligned_cols=255 Identities=24% Similarity=0.402 Sum_probs=204.5
Q ss_pred CCCcccceeeccCcEEEEEEEcC------CCcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP------NGKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRL 418 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 418 (724)
.+|.+.+.||+|+||.||+|+.+ +.+.|++|.+...... ...+|.+|+++|++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888899999999999999854 3467999988765433 3467999999999999999999999999989999
Q ss_pred EEEEecCCCCHHHHHhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEe
Q 040832 419 LVYEYVPNNNLEFHLHGKGR-------PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADF 491 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~-------~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DF 491 (724)
+||||+++++|.+++..... ..+.+..++.++.||++||+|||+. +|+||||||+||||+.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999976541 2489999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcc
Q 040832 492 GLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRAL 570 (724)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~ 570 (724)
|+++..............++..|++||.+.+..++.++||||||+++|||++ |..||...... .+..+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~~~-------- 231 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNRL-------- 231 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHHHH--------
Confidence 9987654332222233456778999999988888999999999999999999 88888643221 111111
Q ss_pred cCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 571 DDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 571 ~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
..+.+.. .........+.+++.+||+.+|++||++.||+.+|.
T Consensus 232 ~~~~~~~--------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 232 QAGKLEL--------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HcCCcCC--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111100 011122346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.90 Aligned_cols=266 Identities=18% Similarity=0.232 Sum_probs=196.4
Q ss_pred ccceeecc--CcEEEEEEEc-CCCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 350 QSNLLGQG--GFGYVHKGVL-PNGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 350 ~~~~LG~G--~fG~Vyk~~~-~~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
++++||+| +|++||++.. .+|+.||||+++... ....+.+.+|+++++.++|+||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45679999 7889999985 468899999997542 223456888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc-
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH- 503 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~- 503 (724)
++++|.+++.......+++..+++|+.||++||+|||++ +|+|||||++||||+.++.++|+||+...........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999998764444589999999999999999999998 9999999999999999999999999876543221110
Q ss_pred -----cccccccCCCcCCcchhcC--CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccC----
Q 040832 504 -----VSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDD---- 572 (724)
Q Consensus 504 -----~~~~~~gt~~y~APE~~~~--~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~---- 572 (724)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||+............. ......++.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN-GTVPCLLDTTTIP 237 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc-CCccccccccchh
Confidence 0112346778999999976 4588999999999999999999999975432221111110 000000000
Q ss_pred --------------CChhhhcc---------hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 573 --------------GNFNEIAD---------PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 573 --------------~~~~~~vd---------~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+.+... ......+.......+.+++.+||+.||++||++.||+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00000000 000001122334578899999999999999999999873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=331.75 Aligned_cols=242 Identities=23% Similarity=0.309 Sum_probs=190.5
Q ss_pred ceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc---hhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEEEEecCC
Q 040832 352 NLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG---QGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLVYEYVPN 426 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~---~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 426 (724)
++||+|+||.||++.+. +++.||||+++.... ...+.+..|+.++.++ +|+||+++++++...+..+|||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 578899999975422 2334588999999988 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcccc
Q 040832 427 NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST 506 (724)
Q Consensus 427 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 506 (724)
++|..++...+ .+++..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TTS 154 (327)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-cee
Confidence 99998887654 389999999999999999999998 999999999999999999999999999975432211 123
Q ss_pred ccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhh-hHHhhhhhhhhhcccCCChhhhcchhhhc
Q 040832 507 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMED-CLVDWARPLCLRALDDGNFNEIADPYLEK 585 (724)
Q Consensus 507 ~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~-~l~~w~~~~~~~~~~~~~~~~~vd~~l~~ 585 (724)
...|+..|+|||++.+..++.++|||||||+||||++|+.||+....... ...++..... ... . .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~----~~~--------~--~ 220 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI----LEK--------P--I 220 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH----HhC--------C--C
Confidence 45699999999999999999999999999999999999999964321110 0111110000 000 0 0
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 040832 586 NYPTEEMARMVACAAASIRHSARRRPKI 613 (724)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 613 (724)
.++......+.+++.+||+.+|++|+++
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 1122233457889999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.08 Aligned_cols=249 Identities=25% Similarity=0.456 Sum_probs=200.9
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch---------hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCe
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ---------GEREFKAEVEIISRVHHRHLVSLVGYCIAGGK 416 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~---------~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 416 (724)
+|.+++.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.++++++|+||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999864 5788999988654221 12458889999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
.++||||+++++|..++...+ .+++..++.++.||+.||+|||+. +++||||+|+||||+.++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999997654 378899999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCc-----cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhccc
Q 040832 497 TTDNNTH-----VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALD 571 (724)
Q Consensus 497 ~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~ 571 (724)
....... ......|+..|+|||++.+..++.++|||+|||++|||++|+.||.......... .. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~---------~ 225 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF-KI---------G 225 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH-HH---------h
Confidence 7532211 1123457889999999998889999999999999999999999997643222110 00 0
Q ss_pred CCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 572 DGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 572 ~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.. .. ...+......+.+++.+||+.+|++||++.||+++
T Consensus 226 ~~-----~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 226 EN-----AS----PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred cc-----CC----CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 00 00 11122334567889999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=324.10 Aligned_cols=265 Identities=25% Similarity=0.366 Sum_probs=202.2
Q ss_pred CCcccceeeccCcEEEEEEEc-----CCCcEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC--CeEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVL-----PNGKEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAG--GKRL 418 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~-----~~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~ 418 (724)
.|++.+.||+|+||.||++.+ .+++.||+|.++... ......|.+|+.+|++++|+||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467889999999999999973 357889999987553 33345799999999999999999999998875 5678
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
+||||+++++|..++..... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 85 lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKN-KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEccCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccc
Confidence 99999999999999875432 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc--cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchh-hhHHhhhhhhhhhcccCCCh
Q 040832 499 DNNTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAME-DCLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 499 ~~~~~--~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~-~~l~~w~~~~~~~~~~~~~~ 575 (724)
..... ......++..|+|||++.+..++.++|||||||+||||++++.++....... .....+. ....+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~--------~~~~~ 232 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTH--------GQMTV 232 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccc--------ccccH
Confidence 43321 1123446778999999988889999999999999999999877643211000 0000000 00000
Q ss_pred hhhcchh---hhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 576 NEIADPY---LEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 576 ~~~vd~~---l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
...++.. ............+.+++.+||+.+|++||++.+|++.|+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 233 TRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000000 00011223456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=315.00 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=206.4
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
++|.+.+.||+|+||.||++... +++.+++|.+........+.+.+|++++++++|+||+++++++.++...+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57889999999999999999864 57889999998765556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
.+++|.+++.... ..+++.+++.++.|++.||+|||++ +|+|||||++||+|+.++.+||+|||++........ .
T Consensus 83 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 157 (262)
T cd06613 83 GGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-K 157 (262)
T ss_pred CCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-c
Confidence 9999999887642 2488999999999999999999998 999999999999999999999999999986643221 1
Q ss_pred ccccccCCCcCCcchhcCC---CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 505 STRVMGTFGYLAPEYASSG---KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~---~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
.....++..|++||++... .++.++|||||||+||||++|+.||......+....... ..+. ..
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~----------~~~~---~~ 224 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK----------SNFP---PP 224 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------ccCC---Cc
Confidence 2335688899999999776 889999999999999999999999976543322111100 0000 00
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+ .........+.+++.+||..+|.+||++.+|+.+
T Consensus 225 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 225 KL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred cc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 1112334568899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=316.51 Aligned_cols=238 Identities=27% Similarity=0.437 Sum_probs=191.4
Q ss_pred ceeeccCcEEEEEEEcCCCc-----------EEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 352 NLLGQGGFGYVHKGVLPNGK-----------EVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~~g~-----------~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
+.||+|+||.||+|.+.+.. .|++|.+...... ...|.+|+.+|++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999976433 4788887655433 6789999999999999999999999988 778999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC-------CEEEEEecc
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF-------ETKVADFGL 493 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~-------~vkL~DFGl 493 (724)
|||+.+++|++++..... .+++..++.++.||+.||+|||++ +|+|||||++|||++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999986543 589999999999999999999998 999999999999999887 799999999
Q ss_pred ccccCCCCCccccccccCCCcCCcchhcCC--CCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcc
Q 040832 494 AKLTTDNNTHVSTRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRAL 570 (724)
Q Consensus 494 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~ 570 (724)
+...... ....+...|+|||++... .++.++|||||||++|||++ |..||......+ ....|..
T Consensus 155 a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-~~~~~~~------- 221 (259)
T cd05037 155 PITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-KERFYQD------- 221 (259)
T ss_pred ccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-HHHHHhc-------
Confidence 9865431 223466789999999876 78999999999999999999 577776543111 1111100
Q ss_pred cCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 571 DDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 571 ~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
.. .........+.+++.+||..+|.+||++.+|++.|+
T Consensus 222 --~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 --QH-----------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --CC-----------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 000011167889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=335.92 Aligned_cols=266 Identities=20% Similarity=0.240 Sum_probs=198.7
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC------
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIAG------ 414 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~------ 414 (724)
..++|.+.+.||+|+||.||++... .++.||||++.... ....+.+.+|+.+++.++|+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3568999999999999999999854 57889999997532 23345688999999999999999999987543
Q ss_pred CeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccc
Q 040832 415 GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLA 494 (724)
Q Consensus 415 ~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla 494 (724)
...++||||+++ +|..++.. .+++..++.++.||++||+|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 357999999975 56666643 278889999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhh----------h-
Q 040832 495 KLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWA----------R- 563 (724)
Q Consensus 495 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~----------~- 563 (724)
+....... .....|+..|+|||++.+..++.++|||||||+||||++|+.||...+..+....... .
T Consensus 174 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 174 RTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred cccCCCCc--ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 87644322 2335689999999999999999999999999999999999999976543322110000 0
Q ss_pred --hhhhhcc------cCCChhhhcchhhh---cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 564 --PLCLRAL------DDGNFNEIADPYLE---KNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 564 --~~~~~~~------~~~~~~~~vd~~l~---~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+.... ....+..+....+. ..........+.+++.+|++.||++||++.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 00000111110000 01111223567899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=318.25 Aligned_cols=267 Identities=22% Similarity=0.311 Sum_probs=202.9
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
++|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|++++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999975 588999998864321 233568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|+++++|..++.... .+++..++.++.||++||+|||+. +|+|||||++||||+.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999999988876544 389999999999999999999998 999999999999999999999999999987654332
Q ss_pred ccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhh---hhhhh---cccCCCh
Q 040832 503 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWAR---PLCLR---ALDDGNF 575 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~---~~~~~---~~~~~~~ 575 (724)
. .....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+. +..+.. .+... .+....+
T Consensus 156 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 156 D-YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred c-ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChHHhhhcccccc
Confidence 1 123457889999999876 4678999999999999999999999976543322 111111 00000 0000000
Q ss_pred -hhhcchhhhcCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 576 -NEIADPYLEKNYP-----TEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 576 -~~~vd~~l~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+..+......+ ......+.+++.+||+.+|++||++.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000000000000 1123568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=327.14 Aligned_cols=195 Identities=23% Similarity=0.350 Sum_probs=160.5
Q ss_pred cceeeccCcEEEEEEEcC---CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEe--CCeEEEEEEecC
Q 040832 351 SNLLGQGGFGYVHKGVLP---NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA--GGKRLLVYEYVP 425 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~---~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~lV~E~~~ 425 (724)
++.||+|+||.||+|... +++.||||.++... ....+.+|+++|++++|+||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 467999999999999864 45789999987542 23457889999999999999999998864 456789999996
Q ss_pred CCCHHHHHhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEE----cCCCCEEEEEeccc
Q 040832 426 NNNLEFHLHGK-------GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILL----DYTFETKVADFGLA 494 (724)
Q Consensus 426 ~gsL~~~L~~~-------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl----~~~~~vkL~DFGla 494 (724)
++|.+++... ....+++..++.|+.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4777766421 122478899999999999999999999 99999999999999 45678999999999
Q ss_pred cccCCCCCc--cccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCC
Q 040832 495 KLTTDNNTH--VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPT 551 (724)
Q Consensus 495 ~~~~~~~~~--~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~ 551 (724)
+........ ......|+..|+|||++.+ ..++.++|||||||+||||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876543221 2234678999999999876 45899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=331.62 Aligned_cols=260 Identities=26% Similarity=0.411 Sum_probs=205.4
Q ss_pred CCCcccceeeccCcEEEEEEEcC--------CCcEEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCC
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP--------NGKEVAVKSLRSGS-GQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGG 415 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~--------~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~ 415 (724)
.+|.+++.||+|+||.||++.+. .+..||+|.++... ....+++.+|+++++++ +|+||++++++|..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46889999999999999999742 12368999887543 23346799999999999 7999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEc
Q 040832 416 KRLLVYEYVPNNNLEFHLHGKG--------------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLD 481 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~ 481 (724)
..++||||+.+++|.++|.... ...+.+.+++.++.||++||+|||++ +|+|||||++||||+
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 9999999999999999987532 23478899999999999999999998 999999999999999
Q ss_pred CCCCEEEEEeccccccCCCCCcc-ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHH
Q 040832 482 YTFETKVADFGLAKLTTDNNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLV 559 (724)
Q Consensus 482 ~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~ 559 (724)
.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||+||||++ |+.||......+
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---- 244 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----
Confidence 99999999999998665432221 122234567999999999999999999999999999998 888886543211
Q ss_pred hhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCCcc
Q 040832 560 DWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSLE 627 (724)
Q Consensus 560 ~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~~~ 627 (724)
+...+ ..+.. ..........+.+++.+||+.+|++||++.||++.|+..+...
T Consensus 245 -~~~~~-----~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 245 -LFKLL-----KEGHR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred -HHHHH-----HcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 11100 00100 0111223456889999999999999999999999998776443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=339.78 Aligned_cols=202 Identities=24% Similarity=0.361 Sum_probs=175.4
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|++.+.||+|+||.||++... +++.||||+++... ......+.+|+.++.+++|+||+++++++.+++..+|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999864 58899999997431 223456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+.+|+|.+++...+. +++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKKDT--LSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 99999999999976543 88999999999999999999998 99999999999999999999999999987543211
Q ss_pred C----------------------------------ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCC
Q 040832 502 T----------------------------------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547 (724)
Q Consensus 502 ~----------------------------------~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P 547 (724)
. ......+||..|+|||++.+..++.++|||||||+||||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 011235699999999999999999999999999999999999999
Q ss_pred CCCCC
Q 040832 548 IDPTG 552 (724)
Q Consensus 548 ~~~~~ 552 (724)
|....
T Consensus 236 f~~~~ 240 (360)
T cd05627 236 FCSET 240 (360)
T ss_pred CCCCC
Confidence 97654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.64 Aligned_cols=250 Identities=23% Similarity=0.372 Sum_probs=204.9
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
.++|++.+.||+|+||.||++.. .+++.||||.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36789999999999999999995 47899999999766555566789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+++++|.+++... .+++.+++.++.|++.||.|||+. +|+|||||++||||+.++.+||+|||++.........
T Consensus 98 ~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 98 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred cCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 9999999998653 378899999999999999999998 9999999999999999999999999999866443222
Q ss_pred cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 504 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
.....++..|++||++.+..++.++|||||||+||+|++|+.||............+. .+ ...
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~---------~~-~~~------ 234 (297)
T cd06656 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---------NG-TPE------ 234 (297)
T ss_pred -cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc---------CC-CCC------
Confidence 2334688899999999988899999999999999999999999975432221111000 00 000
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
..........+.+++.+||+.+|++||++.+|++
T Consensus 235 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 -LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred -CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011223345778999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=322.85 Aligned_cols=268 Identities=23% Similarity=0.347 Sum_probs=202.4
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ--GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~--~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
++|++.+.||+|+||.||+|.++ +++.||+|++...... ..+.+.+|+++|++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999975 4889999988643222 34568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|+.+++|+.++..... +++.+++.++.||++||+|||+. +|+||||+++||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 81 FVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred cCCccHHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 9999999887765433 89999999999999999999998 999999999999999999999999999987644332
Q ss_pred ccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhh--HHhhhhhhhhh---cccCCCh-
Q 040832 503 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC--LVDWARPLCLR---ALDDGNF- 575 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~--l~~w~~~~~~~---~~~~~~~- 575 (724)
......++..|+|||++.+ ..++.++|||||||+||||++|+.+|......+.. +..+...+... .+....+
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 156 -VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred -ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 2233557889999999875 45788999999999999999999999754432211 11111000000 0000000
Q ss_pred hhhcchhhh-----cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 576 NEIADPYLE-----KNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 576 ~~~vd~~l~-----~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+..+... ..........+.+++.+||+.+|++||++.+|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000000 00011234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=321.37 Aligned_cols=252 Identities=24% Similarity=0.375 Sum_probs=202.4
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
+.|++.+.||+|+||.||+|.+. +++.|++|.+........+.+.+|+.++++++|+||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888999999999999999965 48899999998766566678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
++++|..++.... ..+++..++.++.||+++|.|||+. +|+|||||++|||++.++.+||+|||++.........
T Consensus 92 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~- 166 (292)
T cd06644 92 PGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR- 166 (292)
T ss_pred CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccccc-
Confidence 9999988876543 2489999999999999999999998 9999999999999999999999999998765332221
Q ss_pred ccccccCCCcCCcchhc-----CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 505 STRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~-----~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
.....++..|+|||++. ...++.++|||||||++|||++|+.||......+. +..+.. .....+
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~~~~~---------~~~~~~- 235 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LLKIAK---------SEPPTL- 235 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH-HHHHhc---------CCCccC-
Confidence 23345788999999884 34568899999999999999999999965432211 111110 000000
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+......+.+++.+||+.+|++||++.+|+++
T Consensus 236 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 236 ------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0112233467889999999999999999999863
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=333.45 Aligned_cols=203 Identities=24% Similarity=0.320 Sum_probs=174.2
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|++.++||+|+||.||++.++ .++.||+|++... .......|.+|+.++..++|+||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999965 4678999998642 1122345888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+.+|+|.++|..... .+.+..++.|+.||+.||.|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 81 ey~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 99999999999976432 488999999999999999999998 99999999999999999999999999997654433
Q ss_pred CccccccccCCCcCCcchhc-----CCCCChhHHHHHHHHHHHHHHhCCCCCCCCC
Q 040832 502 THVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPIDPTG 552 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~-----~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~ 552 (724)
........|+..|+|||++. .+.++.++|||||||+||||++|+.||....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 33333457999999999986 3468899999999999999999999997654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=307.06 Aligned_cols=264 Identities=22% Similarity=0.307 Sum_probs=209.3
Q ss_pred HhhCCCcccceeeccCcEEEEEEE-cCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC-----e
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGG-----K 416 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~-~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~-----~ 416 (724)
...++|.+.++||+|||..||++. +.+++.||+|++.....++.+..++|+++.++++|+||+++++++..+. .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345689999999999999999998 6678999999999888777888999999999999999999998876544 4
Q ss_pred EEEEEEecCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccc
Q 040832 417 RLLVYEYVPNNNLEFHLHGK--GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLA 494 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla 494 (724)
.||++.|+..|+|.+.+... ++..+++.++++|+.+|++||.+||+. .+.++||||||.|||+.+.+.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence 89999999999999888653 344689999999999999999999997 224999999999999999999999999999
Q ss_pred cccCCCCC--c------cccccccCCCcCCcchhc---CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhh
Q 040832 495 KLTTDNNT--H------VSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWAR 563 (724)
Q Consensus 495 ~~~~~~~~--~------~~~~~~gt~~y~APE~~~---~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~ 563 (724)
....-... + .......|.-|.|||.+. +...++++|||||||+||+|+.|..||+..-....++
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl----- 251 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL----- 251 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE-----
Confidence 75432111 0 111234688899999885 3467899999999999999999999997532111000
Q ss_pred hhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 564 PLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 564 ~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
.-++..+++.-.-+. .....|.+++.+|++.||.+||++.+++..++..
T Consensus 252 ---aLAv~n~q~s~P~~~--------~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 252 ---ALAVQNAQISIPNSS--------RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ---EEeeeccccccCCCC--------CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 011112222111111 2456789999999999999999999999988754
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.65 Aligned_cols=269 Identities=24% Similarity=0.363 Sum_probs=206.9
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
++|++.+.||+|+||.||+|.+. +++.|+||.++.... .....+.+|+++|++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46889999999999999999965 578999999875422 234578999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|++++.|..++.... .+++..++.++.||++||.|||+. +|+||||+++||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEASPG--GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 999888877665443 389999999999999999999999 999999999999999999999999999987765543
Q ss_pred ccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhH--Hhhhhhhhh----hcccCCC-
Q 040832 503 HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCL--VDWARPLCL----RALDDGN- 574 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l--~~w~~~~~~----~~~~~~~- 574 (724)
.......++..|+|||++... .++.++||||||++||||++|+.+|......+... ..+...+.. .......
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 333446688899999999888 88999999999999999999999997653322110 000000000 0000000
Q ss_pred ----hhhhcch-hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 575 ----FNEIADP-YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 575 ----~~~~vd~-~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+.+..+. .+...++......+.+++.+||..+|++||++++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0011110 11112233346779999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=313.49 Aligned_cols=251 Identities=23% Similarity=0.370 Sum_probs=205.4
Q ss_pred CCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 347 GFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
+|+..++||+|+||.||.+.. .+++.|++|.+... .....+++.+|+++|++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999998884 45888999987643 233456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+.+++|.+++.......+++.+++.++.|++++|.|||+. +++|||||++|||+++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999876455689999999999999999999998 999999999999999999999999999987654432
Q ss_pred cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 504 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
......|+..|+|||++.+..++.++||||||+++|||++|+.||+.....+.. ... ..+.+...
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~-~~~---------~~~~~~~~----- 221 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV-VKI---------VQGNYTPV----- 221 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHH-HHH---------HcCCCCCC-----
Confidence 223456899999999998888899999999999999999999999754322111 110 11111111
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPKISQIVRAL 620 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L 620 (724)
.......+.+++.+||+.+|++||++.++++++
T Consensus 222 ----~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 ----VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ----ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 122345688899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.22 Aligned_cols=252 Identities=23% Similarity=0.260 Sum_probs=203.2
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch---hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ---GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~---~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|++.+.||+|+||.||++... +++.||||.+...... ..+.+.+|+++|++++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46888999999999999999965 4889999999754322 3456899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+.+++|.+++.......+++..++.++.||++||+|||+. +++|||||++||||+.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999999865555689999999999999999999998 99999999999999999999999999987653221
Q ss_pred Cc----------------------------cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCc
Q 040832 502 TH----------------------------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGA 553 (724)
Q Consensus 502 ~~----------------------------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~ 553 (724)
.. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 11 11234688899999999988899999999999999999999999976543
Q ss_pred hhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 040832 554 MEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPK----ISQIVR 618 (724)
Q Consensus 554 ~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs----~~evv~ 618 (724)
.......+.. .. .-.........+.+++.+||..+|++||+ +.||++
T Consensus 238 ~~~~~~~~~~----------~~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DETFSNILKK----------EV--------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHHHHhcC----------Cc--------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 2211111100 00 00001114567899999999999999999 555555
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=338.83 Aligned_cols=264 Identities=21% Similarity=0.255 Sum_probs=198.5
Q ss_pred hCCCcccceeeccCcEEEEEEEcC---CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP---NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~---~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
..+|.+.+.||+|+||.||++... .++.||||.+... +.+.+|+++|++|+|+||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999753 3567999988643 34568999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+. ++|..++.... .+.+..++.|+.||++||.|||++ +|||||||++||||+.++.+||+|||+++......
T Consensus 166 e~~~-~~l~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYK-CDLFTYVDRSG--PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9995 67777775433 489999999999999999999998 99999999999999999999999999998665433
Q ss_pred Cc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCch--hhhHHhhhhhhhhhc--ccCCC--
Q 040832 502 TH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAM--EDCLVDWARPLCLRA--LDDGN-- 574 (724)
Q Consensus 502 ~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~--~~~l~~w~~~~~~~~--~~~~~-- 574 (724)
.. ......|+..|+|||++....++.++|||||||+||||++|+.||...... ...+....+.+-... +....
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 22 223467999999999999999999999999999999999999999654321 111111111000000 00000
Q ss_pred -hhhhcchh---hhcCCC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 575 -FNEIADPY---LEKNYP-------TEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 575 -~~~~vd~~---l~~~~~-------~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+...+... ....+. ......+..++.+||+.+|++||++.||+.+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 000000 0112356788999999999999999999975
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=320.95 Aligned_cols=240 Identities=23% Similarity=0.417 Sum_probs=191.4
Q ss_pred ceeeccCcEEEEEEEcCC--------CcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 352 NLLGQGGFGYVHKGVLPN--------GKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~~--------g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
+.||+|+||.||+|.... ...|++|.+........+.|.+|+.+|+.++|+||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998532 234888888655444556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCC--------EEEEEecccc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFE--------TKVADFGLAK 495 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~--------vkL~DFGla~ 495 (724)
+.+|+|..+++.++. .+++..+++++.||+.||+|||++ +|+|||||++|||++.++. ++|+|||++.
T Consensus 81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999986543 589999999999999999999998 9999999999999987765 6999999987
Q ss_pred ccCCCCCccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCC-CCCCCCCchhhhHHhhhhhhhhhcccCC
Q 040832 496 LTTDNNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGR-RPIDPTGAMEDCLVDWARPLCLRALDDG 573 (724)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~-~P~~~~~~~~~~l~~w~~~~~~~~~~~~ 573 (724)
..... ....++..|+|||++.+ ..++.++|||||||++|||++|. .||.......... ... .
T Consensus 157 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~--~~~-------~-- 220 (258)
T cd05078 157 TVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ--FYE-------D-- 220 (258)
T ss_pred ccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH--HHH-------c--
Confidence 55432 22457889999999976 45789999999999999999985 5554332221110 000 0
Q ss_pred ChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 574 NFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 574 ~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
...++......+.+++.+||+.+|++||++.+|++.|+
T Consensus 221 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 ----------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ----------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00122223356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=321.35 Aligned_cols=270 Identities=26% Similarity=0.355 Sum_probs=205.9
Q ss_pred CCCcccceeeccCcEEEEEEEcC-----CCcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEe--CCeE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-----NGKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIA--GGKR 417 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-----~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~--~~~~ 417 (724)
+.|++.+.||+|+||.||++.+. .++.||||.++..... ..+.|.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777899999999999999853 3678999999865443 45679999999999999999999999887 5578
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
++||||+++++|.+++..... .+++..++.++.||+.||+|||+. +|+|||||++|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 999999999999999976543 489999999999999999999998 9999999999999999999999999999877
Q ss_pred CCCCCc--cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCCh
Q 040832 498 TDNNTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 498 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~ 575 (724)
...... ......+...|++||++....++.++||||||+++|||++|+.|+........ .+..... .......+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~---~~~~~~~-~~~~~~~~ 235 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL---RMIGIAQ-GQMIVTRL 235 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhc---ccccccc-ccccHHHH
Confidence 633221 11123355679999999888999999999999999999999999864321110 0000000 00000000
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 576 NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 576 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
.+.+...............+.+++.+||+.+|++||+|.||+++|+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 011111111111122336788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.72 Aligned_cols=268 Identities=20% Similarity=0.284 Sum_probs=198.8
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
+|++.+.||+|+||.||+|... +++.||||+++.... ...+.+.+|+.++++++|+||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999964 688999999865322 2345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 424 VPNNNLEFHLHGKG-RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 424 ~~~gsL~~~L~~~~-~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
+. ++|..++.... ...+++..++.|+.||++||+|||++ +|+|||||++|||++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 57877776432 24589999999999999999999998 999999999999999999999999999986543321
Q ss_pred ccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHH---hhhhhhh--hhcc-cCCCh
Q 040832 503 HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLV---DWARPLC--LRAL-DDGNF 575 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~---~w~~~~~--~~~~-~~~~~ 575 (724)
......++..|+|||++.+. .++.++|||||||++|||++|+.||........... .+..... .... ....+
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 22234578899999988654 578999999999999999999999976533221110 0000000 0000 00001
Q ss_pred hhhcchhhhc---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 576 NEIADPYLEK---NYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 576 ~~~vd~~l~~---~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
...+...... ........++.+++.+||..+|++||++.+|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 1100000000 0011123456789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.29 Aligned_cols=239 Identities=23% Similarity=0.381 Sum_probs=188.4
Q ss_pred eeeccCcEEEEEEEcCC-------------------------CcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEE
Q 040832 353 LLGQGGFGYVHKGVLPN-------------------------GKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSL 407 (724)
Q Consensus 353 ~LG~G~fG~Vyk~~~~~-------------------------g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l 407 (724)
+||+|+||.||+|.+.. ...|+||++.........+|.+|+.++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997421 13488999876544455678999999999999999999
Q ss_pred eeEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC---
Q 040832 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF--- 484 (724)
Q Consensus 408 ~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~--- 484 (724)
+++|..+...+|||||+++++|+.++.... ..+++..+++|+.||++||+|||++ +|+|||||++||||+.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCccc
Confidence 999999999999999999999999886533 2488999999999999999999998 999999999999997643
Q ss_pred ----CEEEEEeccccccCCCCCccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHH-hCCCCCCCCCchhhhH
Q 040832 485 ----ETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELI-TGRRPIDPTGAMEDCL 558 (724)
Q Consensus 485 ----~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLl-tG~~P~~~~~~~~~~l 558 (724)
.+||+|||++...... ....++..|+|||++.+ ..++.++|||||||++|||+ +|+.||......+.
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-- 230 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-- 230 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--
Confidence 3899999998654322 12346788999998865 56899999999999999995 69999865432211
Q ss_pred HhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 559 VDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 559 ~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
..+.. . .. ..+......+.+++.+||+.+|++||++.+|++.|.
T Consensus 231 ~~~~~----~---~~------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ERFYE----K---KH------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHH----h---cc------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11100 0 00 001111235888999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=319.95 Aligned_cols=251 Identities=24% Similarity=0.249 Sum_probs=206.4
Q ss_pred CCcccceeeccCcEEEEEEEcCC-CcEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLPN-GKEVAVKSLRSGSG---QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~~-g~~vaVK~l~~~~~---~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
.|++.+.||+|.-|.||++.+.+ +..+|+|++..... +...+.+.|-+||+.++||+|..||..+..+...+||||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 45667889999999999999765 58899999976532 233467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC---
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD--- 499 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~--- 499 (724)
||.||+|..+++.+....+.+..+..++.+|+-||+|||.. |||+|||||+||||.++|++.|+||.|+.....
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 99999999999999888999999999999999999999999 999999999999999999999999998853211
Q ss_pred ------------------------------CCC----------------------ccccccccCCCcCCcchhcCCCCCh
Q 040832 500 ------------------------------NNT----------------------HVSTRVMGTFGYLAPEYASSGKLTE 527 (724)
Q Consensus 500 ------------------------------~~~----------------------~~~~~~~gt~~y~APE~~~~~~~t~ 527 (724)
... .....++||-.|+|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 000 0011257999999999999999999
Q ss_pred hHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCC
Q 040832 528 KSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSA 607 (724)
Q Consensus 528 ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P 607 (724)
++|.|.|||+|||||.|..||.+.+..+.......++ +.---..+.+..+.+||.+.|..||
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~------------------l~Fp~~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQP------------------LKFPEEPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCC------------------CcCCCCCcchhHHHHHHHHHhccCh
Confidence 9999999999999999999998876555432211111 1101111445678899999999999
Q ss_pred CCCCC----HHHHHH
Q 040832 608 RRRPK----ISQIVR 618 (724)
Q Consensus 608 ~~RPs----~~evv~ 618 (724)
++|-- +.||-+
T Consensus 377 ~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIKR 391 (459)
T ss_pred hhhhccccchHHhhc
Confidence 99998 666654
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.55 Aligned_cols=255 Identities=25% Similarity=0.350 Sum_probs=203.7
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
++|++.+.||+|+||.||++.+. +++.||+|++.... ....+.|.+|+++++.++|+||+++++++.....++|||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56778889999999999999864 58889999886543 23356799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+++++|.+++...+ .+.+..+..++.+++.+|.|||+.+ +|+|||||++|||++.++.++|+|||++........
T Consensus 85 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~- 159 (284)
T cd06620 85 MDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA- 159 (284)
T ss_pred CCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc-
Confidence 99999999887654 3899999999999999999999732 799999999999999999999999999875533221
Q ss_pred cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhh------hHHhhhhhhhhhcccCCChhh
Q 040832 504 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMED------CLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~------~l~~w~~~~~~~~~~~~~~~~ 577 (724)
....|+..|++||++.++.++.++|||||||++|||++|+.||+.....++ .+.++.....
T Consensus 160 --~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------- 226 (284)
T cd06620 160 --DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV----------- 226 (284)
T ss_pred --CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-----------
Confidence 235689999999999888999999999999999999999999976532211 1111111110
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRAL 620 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L 620 (724)
..........+....+.+++.+|++.+|++||++.||+++.
T Consensus 227 --~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 227 --QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred --hccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 00000000112345688999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=314.56 Aligned_cols=250 Identities=22% Similarity=0.364 Sum_probs=204.2
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
+|++.+.||+|+||.||++... +++.|+||.+... .....+++.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4888999999999999999854 6889999998643 223345789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+.+++|.+++.......+++.++++|+.||+.||.|||++ +++|+||+++||||+.++.++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 9999999998765544578999999999999999999998 9999999999999999999999999999866443221
Q ss_pred cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 504 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||......+. ...+. .+.+.
T Consensus 158 -~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~-~~~~~---------~~~~~------- 219 (256)
T cd08218 158 -ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL-VLKII---------RGSYP------- 219 (256)
T ss_pred -hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH-HHHHh---------cCCCC-------
Confidence 2234588899999999988999999999999999999999999965432111 11110 01110
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.........+.+++.+||+.+|++||+|.+|+++
T Consensus 220 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 --PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0112234568899999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=331.77 Aligned_cols=252 Identities=25% Similarity=0.325 Sum_probs=210.6
Q ss_pred hhCCCcccceeeccCcEEEEEEEcCC-CcEEEEEEeccCCch---hHHHHHHHHHHHHhcC-CCCeeEEeeEEEeCCeEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLPN-GKEVAVKSLRSGSGQ---GEREFKAEVEIISRVH-HRHLVSLVGYCIAGGKRL 418 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vaVK~l~~~~~~---~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~ 418 (724)
....|.+.+.||+|.||.||++..+. |+.+|+|.+...... ....+.+|+.+|++|. |+|||.++++|.+...++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 35678888999999999999999765 999999999754332 3357999999999998 999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC----CCCEEEEEeccc
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY----TFETKVADFGLA 494 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~----~~~vkL~DFGla 494 (724)
+|||+|.||.|.+.+... .+.+..+..++.||+.++.|||+. +|+||||||+|||+.. ++.+|++|||++
T Consensus 113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999999999988776 289999999999999999999998 9999999999999953 357999999999
Q ss_pred cccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCC
Q 040832 495 KLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGN 574 (724)
Q Consensus 495 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~ 574 (724)
..... ......++||+.|+|||++....|+...||||+||++|.|++|..||.........+ .+..++
T Consensus 187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~----------~i~~~~ 254 (382)
T KOG0032|consen 187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL----------AILRGD 254 (382)
T ss_pred eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH----------HHHcCC
Confidence 98877 334466889999999999999999999999999999999999999998765433322 122222
Q ss_pred hhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 575 FNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 575 ~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+ .+...+-......+.+++..|+..||.+|.++.+++++
T Consensus 255 ~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 255 F------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred C------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 2 11112222335667888999999999999999999984
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=317.96 Aligned_cols=267 Identities=23% Similarity=0.317 Sum_probs=203.2
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
+|++.+.||+|+||.||+|.+. +++.|+||++.... ......+.+|+.++++++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788999999999999999964 68899999987543 22345799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+ +++|..++.... ..+++.+++.++.||++||+|||+. +|+|+|||++||+++.++.++|+|||++.........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 9 999999987644 3589999999999999999999998 9999999999999999999999999999877554322
Q ss_pred cccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhH--Hh-hhhhh--hhhccc-CCChh
Q 040832 504 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCL--VD-WARPL--CLRALD-DGNFN 576 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l--~~-w~~~~--~~~~~~-~~~~~ 576 (724)
......|+..|+|||++.+. .++.++|||||||++|||++|+.+|.......... .. +..+. ....+. ...+.
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence 23345688999999988654 46899999999999999999988886544322110 00 00000 000000 00000
Q ss_pred hhcc-----hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 577 EIAD-----PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 577 ~~vd-----~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+.. ..+. ....+....+.+++.+|++.+|++||++++|+++
T Consensus 236 ~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 236 KITFPESKPIPLE-EIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cccCCCCCcchHH-HhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 0000 0111223778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=314.77 Aligned_cols=248 Identities=25% Similarity=0.409 Sum_probs=201.8
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC-----chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS-----GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~-----~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
+|+..+.||+|+||.||+|.+. +++.|++|.+.... .+..+.|.+|++++++++|+||+++++++.++...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999976 78899999886532 22346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+++++|..++.... .+++..++.++.||++||+|||+. +|+||||+++||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999997654 378999999999999999999998 9999999999999999999999999999876443
Q ss_pred CCccccccccCCCcCCcchhcCCC-CChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~-~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
. ......|+..|++||.+.... ++.++|||||||++|+|++|+.||+.....+. +..+.. .....
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~--------~~~~~--- 221 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA-VFKIGR--------SKELP--- 221 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH-HHHHHh--------cccCC---
Confidence 3 123456889999999987766 89999999999999999999999976542111 111110 00000
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+......+.+++.+||..+|++||++.+++++
T Consensus 222 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 222 ------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 1111223557788999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=319.39 Aligned_cols=248 Identities=29% Similarity=0.491 Sum_probs=197.2
Q ss_pred ceeeccCcEEEEEEEcCC-------CcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 352 NLLGQGGFGYVHKGVLPN-------GKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~~-------g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
+.||+|+||.||+|.+.+ ++.|+||.+..... .....|.+|+.+|+.++|+||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998643 25789998865432 3355789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC-----CEEEEEecc
Q 040832 424 VPNNNLEFHLHGK-----GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF-----ETKVADFGL 493 (724)
Q Consensus 424 ~~~gsL~~~L~~~-----~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~-----~vkL~DFGl 493 (724)
+.+++|.+++... ....+.+.+++.++.||+.||.|||+. +++|+|||++||||+.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999998753 223478899999999999999999998 999999999999999877 899999999
Q ss_pred ccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhccc
Q 040832 494 AKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALD 571 (724)
Q Consensus 494 a~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~ 571 (724)
++........ ......++..|+|||++.++.++.++|||||||+||||++ |+.||......+. ..+. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~--~~~~--------~ 227 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV--LQHV--------T 227 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH--HHHH--------h
Confidence 9765432221 1222345678999999999999999999999999999998 9999965432221 1110 0
Q ss_pred CCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 572 DGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 572 ~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
.+.. ..........+.+++.+||..+|.+||++.+|+++|+
T Consensus 228 ~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 228 AGGR---------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cCCc---------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0000 0111223456789999999999999999999999986
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=318.63 Aligned_cols=250 Identities=23% Similarity=0.354 Sum_probs=199.9
Q ss_pred CcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCC
Q 040832 348 FSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPN 426 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 426 (724)
|++.+.||+|+||.||+|.+. ++..+++|.+........+.+.+|+++++.++|+||+++++++..++..++||||+.+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567788999999999999965 4677889988765555566789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcccc
Q 040832 427 NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST 506 (724)
Q Consensus 427 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 506 (724)
++|..++.... ..+++..++.++.||++||.|||+. +|+|||||++|||++.++++||+|||++........ ...
T Consensus 87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~ 161 (282)
T cd06643 87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRD 161 (282)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-ccc
Confidence 99998887533 2489999999999999999999998 999999999999999999999999999976543322 123
Q ss_pred ccccCCCcCCcchhc-----CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 507 RVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 507 ~~~gt~~y~APE~~~-----~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
...++..|+|||++. ...++.++|||||||++|||++|+.||......+. ...+.. .....+.
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~---------~~~~~~~-- 229 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-LLKIAK---------SEPPTLA-- 229 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-HHHHhh---------cCCCCCC--
Confidence 346889999999984 34577899999999999999999999976432221 111110 0000000
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+......+.+++.+||+.+|.+||++.+|+++
T Consensus 230 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 230 -----QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111123467889999999999999999998864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=321.44 Aligned_cols=249 Identities=21% Similarity=0.382 Sum_probs=204.7
Q ss_pred CCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
.+|+..+.||.|+||.||+|.. .+++.|+||.+........+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 3588999999999999999985 468899999997655555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
.+++|..++... .+++.+++.++.||++||+|||+. +++|||||++|||++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~- 171 (296)
T cd06655 99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK- 171 (296)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc-
Confidence 999999988653 389999999999999999999999 9999999999999999999999999998866543222
Q ss_pred ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhh
Q 040832 505 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLE 584 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~ 584 (724)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||............+.. ....+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~----------~~~~~------ 235 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN----------GTPEL------ 235 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------CCccc------
Confidence 22345888999999999888999999999999999999999999765433221111100 00000
Q ss_pred cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 585 KNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
.........+.+++.+||..+|++||++.+|+.
T Consensus 236 -~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 -QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 011122345778899999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=315.62 Aligned_cols=251 Identities=25% Similarity=0.340 Sum_probs=188.6
Q ss_pred eeeccCcEEEEEEEcCC---CcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCCC
Q 040832 353 LLGQGGFGYVHKGVLPN---GKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNN 428 (724)
Q Consensus 353 ~LG~G~fG~Vyk~~~~~---g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 428 (724)
.||+|+||.||+|...+ ...+++|.+..... .....|.+|+.+++.++|+||+++++++......++||||+.+|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 34688888765433 234568999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc-c
Q 040832 429 LEFHLHGKGR---PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH-V 504 (724)
Q Consensus 429 L~~~L~~~~~---~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~ 504 (724)
|.++|..... ....+..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++........ .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999976432 2346788899999999999999998 9999999999999999999999999999765332221 1
Q ss_pred ccccccCCCcCCcchhcC-------CCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChh
Q 040832 505 STRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~-------~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
.....++..|+|||++.. ..++.++|||||||+||||++ |+.||......+. +... +... ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~--------~~~~-~~ 228 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-LKQV--------VREQ-DI 228 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH-HHHH--------hhcc-Cc
Confidence 223346678999998743 356789999999999999999 7888865432221 1100 0000 01
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
.+.++.+ .......+..++..|+ .+|++||++++|++.|.
T Consensus 229 ~~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 229 KLPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1111111 1222344566677787 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=316.21 Aligned_cols=253 Identities=24% Similarity=0.369 Sum_probs=200.6
Q ss_pred CCcccceeeccCcEEEEEEEcCC--CcEEEEEEeccC----------CchhHHHHHHHHHHHHh-cCCCCeeEEeeEEEe
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLPN--GKEVAVKSLRSG----------SGQGEREFKAEVEIISR-VHHRHLVSLVGYCIA 413 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~~--g~~vaVK~l~~~----------~~~~~~~f~~Ei~il~~-l~HpnIv~l~g~~~~ 413 (724)
+|++.+.||+|+||.||+|.+.. ++.+|||.+... ......++..|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999999765 678999987532 11223457788888875 799999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEe
Q 040832 414 GGKRLLVYEYVPNNNLEFHLHG--KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADF 491 (724)
Q Consensus 414 ~~~~~lV~E~~~~gsL~~~L~~--~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DF 491 (724)
++..++||||+.+++|.+++.. .....+++..+++++.|++.||.|||+.. +|+|||||++|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999988753 22345889999999999999999999631 7999999999999999999999999
Q ss_pred ccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhccc
Q 040832 492 GLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALD 571 (724)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~ 571 (724)
|++....... ......|+..|++||++.++.++.++||||||+++|||++|+.||......... .. +.
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~-~~---------~~ 226 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA-TK---------IV 226 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH-HH---------Hh
Confidence 9998765543 223456889999999999888999999999999999999999999654322110 00 01
Q ss_pred CCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 572 DGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 572 ~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
.+.+... . .......+.+++.+||+.+|++||++.||..+|+
T Consensus 227 ~~~~~~~----~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 227 EAVYEPL----P----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hccCCcC----C----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111100 0 0112356888999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.34 Aligned_cols=249 Identities=25% Similarity=0.376 Sum_probs=203.5
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
++|++.+.||.|+||.||+|.+. +++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46788889999999999999965 58899999987543 33445789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+.+++|.+++... .+++..++.++.||+.||.|||++ +|+||||+++|||+++++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 9999999998764 489999999999999999999998 999999999999999999999999999987764422
Q ss_pred cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 504 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
......++..|++||++.+..++.++|||||||+||||++|+.||........... +....... +
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~----------~~~~~~~~-----~ 218 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL----------IPKNNPPS-----L 218 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH----------hhhcCCCC-----C
Confidence 22334688899999999988899999999999999999999999975432221110 00010001 1
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
... .....+.+++.+||..+|++||++.+|+++
T Consensus 219 ~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 219 EGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 001 023357788999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=354.67 Aligned_cols=258 Identities=23% Similarity=0.330 Sum_probs=201.6
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG---QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~---~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|.+.++||+|+||.||+|.+. .++.||||+++.... ...++|.+|++++++++|+||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 67999999999999999999965 588999999975432 22457999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEec
Q 040832 422 EYVPNNNLEFHLHGKG---------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFG 492 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~---------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFG 492 (724)
||+++++|.+++.... ...+++..+++|+.||++||+|||++ +|+||||||+||||+.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886421 12356778899999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCC-----------------ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchh
Q 040832 493 LAKLTTDNNT-----------------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAME 555 (724)
Q Consensus 493 la~~~~~~~~-----------------~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~ 555 (724)
+++....... ......+||..|||||++.+..++.++|||||||+||||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 11123579999999999999999999999999999999999999997532211
Q ss_pred hhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHhCC
Q 040832 556 DCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRP-KISQIVRALEGD 623 (724)
Q Consensus 556 ~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evv~~L~~~ 623 (724)
...... +.++. ......+....+.+++.+|++.+|++|+ ++.++++.|+..
T Consensus 239 i~~~~~----------------i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 ISYRDV----------------ILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred hhhhhh----------------ccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 100000 00000 0000012234578899999999999995 566677766654
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=315.38 Aligned_cols=250 Identities=26% Similarity=0.395 Sum_probs=194.4
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC-----chhHHHHHHHHHHHHhcCCCCeeEEeeEEEe--CCeE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS-----GQGEREFKAEVEIISRVHHRHLVSLVGYCIA--GGKR 417 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~-----~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~--~~~~ 417 (724)
.+|...++||+|+||.||+|... .++.|++|++.... .+....+.+|+.++++++|+||+++++++.+ +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888999999999999999864 58899999886432 1223468899999999999999999998875 3577
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
+++|||+.+++|.+++...+. +++..++.++.||++||+|||+. +|+|||||++|||++.++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGA--LTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 899999999999999976543 78999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCC--ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCCh
Q 040832 498 TDNNT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 498 ~~~~~--~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~ 575 (724)
..... .......++..|+|||++.+..++.++|||||||++|||++|+.||......+.... . ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~-----~----~~~~-- 225 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK-----I----ATQP-- 225 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHH-----H----hcCC--
Confidence 32111 111234588999999999988899999999999999999999999975432221110 0 0000
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 576 NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 576 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.. ..++......+..++ .||..+|++||+++||+++
T Consensus 226 ---~~----~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 226 ---TN----PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred ---CC----CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 00 111112223344444 6888999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=345.60 Aligned_cols=251 Identities=28% Similarity=0.407 Sum_probs=206.1
Q ss_pred CcccceeeccCcEEEEEEEc-CCCc----EEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 348 FSQSNLLGQGGFGYVHKGVL-PNGK----EVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~-~~g~----~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++.+++||.|+||.||||.| ..|+ .||||++...... ..++|++|+-+|.+|+|+||++|+|+|.... +.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 35568899999999999995 3343 5899998766443 4578999999999999999999999998876 78999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
+|++.|+|.++++.... .+-....+.|..|||+||.|||++ +++||||..+||||..-..+||.|||+++.+..+.
T Consensus 777 q~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999999987543 478889999999999999999999 99999999999999999999999999999987665
Q ss_pred Ccccc-ccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 502 THVST-RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 502 ~~~~~-~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
..... ...-.+.|||-|.+....|+.++|||+|||.+|||+| |..|++.....+. .+++
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI-------------------~dll 913 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI-------------------PDLL 913 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-------------------hHHH
Confidence 54322 2334578999999999999999999999999999999 9999987643221 1111
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
+.-..-..+......+..++.+||..|++.||+++++...+..
T Consensus 914 e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 914 EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 1111123455566778888899999999999999998876654
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=322.14 Aligned_cols=266 Identities=21% Similarity=0.332 Sum_probs=199.0
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
++|.+.+.||+|+||.||+|.+. +++.||+|.++... ......+.+|+.++++|+|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56889999999999999999864 57889999987542 22344678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+. ++|..++..... .+++..++.++.||++||+|||+. +|+|||||++||||+.++.+||+|||++.........
T Consensus 86 ~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 86 LD-KDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred cc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 97 588888765432 478999999999999999999998 9999999999999999999999999999765432221
Q ss_pred cccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhh--HHh---------hhhhhhhhccc
Q 040832 504 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC--LVD---------WARPLCLRALD 571 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~--l~~---------w~~~~~~~~~~ 571 (724)
.....++..|+|||++.+ ..++.++|||||||+||||++|+.||......+.. +.. |...+......
T Consensus 161 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 161 -YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred -ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 123457889999998865 45788999999999999999999999765432211 000 10000000000
Q ss_pred CCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 572 DGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 572 ~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
...+......++. .........+.+++.+||+.+|++|+++.||++
T Consensus 240 ~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 240 SYNYPKYRADCLH-NHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccCccccccHH-hhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0001111111110 001122345788999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=319.16 Aligned_cols=254 Identities=28% Similarity=0.435 Sum_probs=202.9
Q ss_pred CCCcccceeeccCcEEEEEEEcCC-Cc----EEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPN-GK----EVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~-g~----~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
++|++.+.||+|+||.||+|.+.+ |+ .||+|.+..... ....++.+|+.+|++++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 567888999999999999998643 33 589998876543 334678999999999999999999999987 78899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
||||+.+++|.++++.... .+++..++.++.||+.||+|||++ +|+|||||++|||++.++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 9999999999999986543 389999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCccc-cccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 500 NNTHVS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 500 ~~~~~~-~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
...... ....++..|++||.+..+.++.++|||||||++|||++ |+.||+.....+ +..+. ..+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~--------~~~~~-- 229 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--IPDLL--------EKGER-- 229 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHH--------hCCCC--
Confidence 332211 11223567999999988899999999999999999999 999997653211 11111 00100
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
...+......+..++.+||..+|++||++.+|++.|+..
T Consensus 230 -------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 230 -------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 001111234578889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=316.02 Aligned_cols=250 Identities=28% Similarity=0.420 Sum_probs=192.9
Q ss_pred ceeeccCcEEEEEEEcCC----CcEEEEEEeccC-CchhHHHHHHHHHHHHhcCCCCeeEEeeEEE-eCCeEEEEEEecC
Q 040832 352 NLLGQGGFGYVHKGVLPN----GKEVAVKSLRSG-SGQGEREFKAEVEIISRVHHRHLVSLVGYCI-AGGKRLLVYEYVP 425 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~~----g~~vaVK~l~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~-~~~~~~lV~E~~~ 425 (724)
++||+|+||.||+|.+.+ ...||||.+... .....+.|.+|+.+++.++|+||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 469999999999998532 356999988643 2334567889999999999999999999876 4556789999999
Q ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc--
Q 040832 426 NNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH-- 503 (724)
Q Consensus 426 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~-- 503 (724)
+++|.+++..... .+.+..++.++.||++||.|||+. +|+|||||++||||+.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 9999999976433 367888899999999999999998 9999999999999999999999999999865432211
Q ss_pred -cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhC-CCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 504 -VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITG-RRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 504 -~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG-~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
......++..|+|||++....++.++|||||||++|||++| ..+|......+ +..+. ..+...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~--~~~~~--------~~~~~~----- 221 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD--ITVYL--------LQGRRL----- 221 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH--------hcCCCC-----
Confidence 11234467789999999888999999999999999999995 45554332111 11110 001000
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
..+......+.+++..||+.+|++||++.+|++.|+..+
T Consensus 222 ----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 ----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 001112346889999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.03 Aligned_cols=247 Identities=25% Similarity=0.372 Sum_probs=200.6
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
.|+..+.||+|+||.||+|.+. +++.||||.+.... ....+.+.+|++++++++|+||+++++++..+...++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4666778999999999999864 57789999987543 233457899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
.+++|.+++... .+.+..++.++.||++||.|||++ +++|+||+++||++++++.+||+|||++........ .
T Consensus 85 ~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06642 85 GGGSALDLLKPG---PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence 999999988643 378999999999999999999998 999999999999999999999999999987654322 1
Q ss_pred ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhh
Q 040832 505 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLE 584 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~ 584 (724)
.....|+..|++||++.+..++.++|||||||+||||++|+.||........ ..+ +..+. .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~--------~~~~~-----~---- 218 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LFL--------IPKNS-----P---- 218 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--Hhh--------hhcCC-----C----
Confidence 2234578899999999988999999999999999999999999864322111 000 00000 0
Q ss_pred cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 585 KNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..........+.+++.+||+.+|++||+|.+|+++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 01112334568899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=330.06 Aligned_cols=193 Identities=25% Similarity=0.368 Sum_probs=164.9
Q ss_pred HhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
....+|.+.+.||+|+||.||+|.+. .++.||+|..... .+..|+.+|++++|+||+++++++......++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34468999999999999999999965 4678999975432 2456899999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+. ++|..++.... ..+++..++.|+.||+.||.|||++ +|||||||++||||+.++.+||+|||+++......
T Consensus 137 e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 137 PHYS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred EccC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 9995 57777776533 3489999999999999999999998 99999999999999999999999999997543322
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCC
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPI 548 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~ 548 (724)
. .....|+..|+|||++.+..++.++|||||||+||||+++..++
T Consensus 212 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 A--FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred c--cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1 23356899999999999999999999999999999999965554
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=320.10 Aligned_cols=267 Identities=21% Similarity=0.261 Sum_probs=197.7
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ--GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~--~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
+|++.+.||+|+||.||+|.+. +|+.||+|.++..... ....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999964 6889999998754222 234678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+.+ +|..++.... ..+++..++.++.||++||.|||++ +|+|||||++|||++.++.+||+|||+++........
T Consensus 81 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 81 CDQ-DLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155 (284)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence 974 6777665433 2489999999999999999999998 9999999999999999999999999999865433221
Q ss_pred cccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhh----------hhhcccC
Q 040832 504 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPL----------CLRALDD 572 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~----------~~~~~~~ 572 (724)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||......+..+....+.+ .......
T Consensus 156 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 156 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred -cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 2234578899999998764 478999999999999999999999754433222211110000 0000000
Q ss_pred CChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 573 GNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 573 ~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+...................+.+++.+||+.+|.+||++.+|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000000000001111234567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=312.60 Aligned_cols=256 Identities=25% Similarity=0.358 Sum_probs=206.4
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
++|++.+.||.|+||.||+|... ++..|++|++.... ....+.+.+|+++|+.++|+||+++++.+..++..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999954 57889999986542 33456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 424 VPNNNLEFHLHGKGR-PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~-~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
+.+++|.+++..... ..+++..+..++.||+.||+|||+. +|+|||||++||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976432 4589999999999999999999998 999999999999999999999999999987655433
Q ss_pred c---cccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhh
Q 040832 503 H---VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEI 578 (724)
Q Consensus 503 ~---~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 578 (724)
. ......|+..|++||++... .++.++|||||||++|||++|+.||......+. +..+... ...
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~------~~~----- 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-LMLTLQN------DPP----- 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-HHHHhcC------CCC-----
Confidence 2 22345688999999999877 788999999999999999999999976543221 1111100 000
Q ss_pred cchhhhcCC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 579 ADPYLEKNY-PTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 579 vd~~l~~~~-~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+.... .......+.+++.+||+.+|++||++.+|+++
T Consensus 226 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 226 ---SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ---CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 010000 11234567899999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=315.89 Aligned_cols=248 Identities=25% Similarity=0.376 Sum_probs=203.8
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
..|+..+.||+|+||.||+|.+. +++.||||.+.... ......|.+|+.++++++|+||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35777788999999999999865 57889999987543 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+++++|.+++... .+.+.+++.++.|+++||+|||+. +++|+||+++|||++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 84 LGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 9999999988753 378899999999999999999998 999999999999999999999999999987654332
Q ss_pred cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 504 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
......++..|+|||++.+..++.++|||||||+||||++|..||.......... .+..+.
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~----------~~~~~~--------- 217 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF----------LIPKNN--------- 217 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh----------hhhcCC---------
Confidence 2233467889999999988889999999999999999999999997543221100 000000
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
...........+.+++.+||+.+|++||++.+|+++
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 112233455678899999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=319.59 Aligned_cols=263 Identities=24% Similarity=0.367 Sum_probs=205.0
Q ss_pred cCHHHHHHhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCeeEEeeEEE-
Q 040832 336 FTYEELSAATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGYCI- 412 (724)
Q Consensus 336 f~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~- 412 (724)
+.++.+..+.++|++.+.||+|+||.||++.+. +++.||||+++... ....++.+|+.+++++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 455677778899999999999999999999864 57889999886532 2245688999999999 7999999999884
Q ss_pred ----eCCeEEEEEEecCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCE
Q 040832 413 ----AGGKRLLVYEYVPNNNLEFHLHGK--GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFET 486 (724)
Q Consensus 413 ----~~~~~~lV~E~~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~v 486 (724)
.++..++||||+++++|.++++.. ....+++..++.++.||++||.|||+. +|+|||||++|||++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence 345689999999999999887632 233578899999999999999999998 99999999999999999999
Q ss_pred EEEEeccccccCCCCCccccccccCCCcCCcchhcC-----CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhh
Q 040832 487 KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDW 561 (724)
Q Consensus 487 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w 561 (724)
||+|||+++........ .....|+..|+|||++.. ..++.++|||||||++|||++|+.||........ +..+
T Consensus 164 kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~~~~ 241 (286)
T cd06638 164 KLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-LFKI 241 (286)
T ss_pred EEccCCceeecccCCCc-cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-Hhhc
Confidence 99999999876443222 223458999999998853 4578899999999999999999999975432221 1111
Q ss_pred hhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 040832 562 ARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRAL 620 (724)
Q Consensus 562 ~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L 620 (724)
. ......+.+ +......+..++.+||+.+|++||++.||++++
T Consensus 242 ~---------~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 242 P---------RNPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred c---------ccCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0 000000000 011123588899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.52 Aligned_cols=260 Identities=24% Similarity=0.382 Sum_probs=205.3
Q ss_pred cCHHHHHHhhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEe
Q 040832 336 FTYEELSAATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGYCIA 413 (724)
Q Consensus 336 f~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~ 413 (724)
.++.++....+.|++.+.||+|+||.||+|.+ .+++.||+|.+.... ....++..|+.+++++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 35667777788999999999999999999996 457889999886543 2345688899999999 79999999999863
Q ss_pred ------CCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEE
Q 040832 414 ------GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETK 487 (724)
Q Consensus 414 ------~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vk 487 (724)
....++||||+.+++|..++.......+.+..++.++.||++||+|||+. +|+|||||++||||++++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 45789999999999999998765555688889999999999999999998 999999999999999999999
Q ss_pred EEEeccccccCCCCCccccccccCCCcCCcchhc-----CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhh
Q 040832 488 VADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWA 562 (724)
Q Consensus 488 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~ 562 (724)
|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||............
T Consensus 162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~-- 238 (282)
T cd06636 162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI-- 238 (282)
T ss_pred EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH--
Confidence 999999876543221 123356889999999875 346788999999999999999999999654322211110
Q ss_pred hhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 563 RPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 563 ~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
. ......+ ........+.+++.+||+.+|.+||++.||++
T Consensus 239 --------~-----~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 239 --------P-----RNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --------h-----hCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 0000000 01122346888999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=313.87 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=196.8
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC-----chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC--CeE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS-----GQGEREFKAEVEIISRVHHRHLVSLVGYCIAG--GKR 417 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~-----~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--~~~ 417 (724)
.+|++.++||+|+||.||+|.+. +++.|+||.+.... ....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47889999999999999999864 58899999886431 12234688899999999999999999988763 467
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
++||||+++++|.+++..... +++..+++++.||+.||.|||+. +|+|||||++|||++.++.+||+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGA--LTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 899999999999999876543 78889999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCCc--cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCCh
Q 040832 498 TDNNTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 498 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~ 575 (724)
...... ......|+..|+|||++.+..++.++|||||||++|||++|+.||.......... .. . ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-~~----~----~~~-- 225 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF-KI----A----TQP-- 225 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH-HH----h----cCC--
Confidence 432111 1223468899999999988889999999999999999999999996542221110 00 0 000
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 576 NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 576 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.....+......+..++.+|+. +|++||++.+|+++
T Consensus 226 -------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 -------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0111233444567778888884 89999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=319.80 Aligned_cols=266 Identities=20% Similarity=0.256 Sum_probs=201.8
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ-----GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~-----~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
+|.+.+.||+|+||.||+|.+. +++.|+||.++..... ....+..|++++++++|+||+++++++.++...++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999964 6889999999765322 234578899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+ +++|..++.... ..+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 999999997655 3589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhh---c-ccCCCh
Q 040832 501 NTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLR---A-LDDGNF 575 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~---~-~~~~~~ 575 (724)
... .....++..|+|||++.+ ..++.++|||||||+||||++|..+|......+.. ......+... . .....+
T Consensus 156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 156 NRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL-GKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred Ccc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH-HHHHHHcCCCchhhhhhcccc
Confidence 222 122346788999998865 46789999999999999999998777654433221 1110000000 0 000000
Q ss_pred hhhcchhhhcC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 576 NEIADPYLEKN-----YPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 576 ~~~vd~~l~~~-----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
........... ........+.+++.+||+.+|++||++.||+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000001 112234678899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=322.53 Aligned_cols=195 Identities=24% Similarity=0.352 Sum_probs=159.8
Q ss_pred cceeeccCcEEEEEEEcC---CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEe--CCeEEEEEEecC
Q 040832 351 SNLLGQGGFGYVHKGVLP---NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA--GGKRLLVYEYVP 425 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~---~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~lV~E~~~ 425 (724)
+..||+|+||.||+|... .++.||+|.++... ....+.+|+++|++++|+||+++++++.. +...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 467999999999999864 34689999987542 23468899999999999999999998854 457789999997
Q ss_pred CCCHHHHHhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEE----cCCCCEEEEEeccc
Q 040832 426 NNNLEFHLHGK-------GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILL----DYTFETKVADFGLA 494 (724)
Q Consensus 426 ~gsL~~~L~~~-------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl----~~~~~vkL~DFGla 494 (724)
+ +|.+++... ....+.+..++.|+.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 666665321 223478889999999999999999998 99999999999999 56679999999999
Q ss_pred cccCCCCCc--cccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCC
Q 040832 495 KLTTDNNTH--VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPT 551 (724)
Q Consensus 495 ~~~~~~~~~--~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~ 551 (724)
+........ ......|+..|+|||++.+ ..++.++|||||||+||||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876543221 1234568999999999876 45889999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=357.69 Aligned_cols=256 Identities=20% Similarity=0.328 Sum_probs=199.2
Q ss_pred HHhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC--Ce
Q 040832 342 SAATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIAG--GK 416 (724)
Q Consensus 342 ~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--~~ 416 (724)
....++|.+++.||+|+||.||++.+. .++.||+|.+.... ......|..|+.+|++|+|+|||+++++|.+. ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 345578999999999999999999965 46788999886432 22345689999999999999999999988653 56
Q ss_pred EEEEEEecCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCeEecCCCCccEEEcC--------
Q 040832 417 RLLVYEYVPNNNLEFHLHGK--GRPVMDWPTRLKIAMGSAKGLAYLHEDC----HPRIIHRDIKSSNILLDY-------- 482 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLHs~~----~~~iiHrDIkp~NILl~~-------- 482 (724)
+||||||+.+++|..+|... ....+++..++.|+.||+.||+|||+.+ ..+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999998752 1235899999999999999999999852 125999999999999964
Q ss_pred ---------CCCEEEEEeccccccCCCCCccccccccCCCcCCcchhcC--CCCChhHHHHHHHHHHHHHHhCCCCCCCC
Q 040832 483 ---------TFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPIDPT 551 (724)
Q Consensus 483 ---------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~t~ksDV~SlGvlL~eLltG~~P~~~~ 551 (724)
.+.+||+|||+++....... .....|+..|+|||++.. ..++.++||||||||||||++|+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 23489999999987644322 234568999999999864 45889999999999999999999999765
Q ss_pred CchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 552 GAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 552 ~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
......+..... +. .+ .+ ......|..|+..||+.+|.+||++.|++.
T Consensus 247 ~~~~qli~~lk~---------~p--~l---pi-----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NNFSQLISELKR---------GP--DL---PI-----KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcHHHHHHHHhc---------CC--CC---Cc-----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 433322211110 00 00 00 112346888999999999999999999985
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=315.70 Aligned_cols=251 Identities=23% Similarity=0.335 Sum_probs=188.5
Q ss_pred eeeccCcEEEEEEEcCCCc---EEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCCC
Q 040832 353 LLGQGGFGYVHKGVLPNGK---EVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNN 428 (724)
Q Consensus 353 ~LG~G~fG~Vyk~~~~~g~---~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 428 (724)
.||+|+||.||+|.+.++. .+++|.++.... ...+.|.+|+.+++.++|+||++++++|......++||||+.+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5999999999999754433 466777665432 345679999999999999999999999999999999999999999
Q ss_pred HHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC-Cccc
Q 040832 429 LEFHLHGKG--RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN-THVS 505 (724)
Q Consensus 429 L~~~L~~~~--~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~ 505 (724)
|.++++... ...+.+..++.++.||++||+|||+. +|+|||||++|||++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999997642 23456778889999999999999998 99999999999999999999999999986532221 1122
Q ss_pred cccccCCCcCCcchhcC-------CCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 506 TRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 506 ~~~~gt~~y~APE~~~~-------~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
....++..|+|||++.. ..++.++|||||||++|||++ |..||......+.....+ .+....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~----------~~~~~~ 228 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVI----------KDQQVK 228 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----------hhcccc
Confidence 34567889999998753 245789999999999999997 567886543322111100 011112
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
+.++.+...+ ..++.+++..|| .+|++||++.+|++.|.
T Consensus 229 ~~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 229 LFKPQLELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCccCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2222222222 245677888898 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=310.87 Aligned_cols=249 Identities=23% Similarity=0.393 Sum_probs=202.8
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
+|...+.||+|+||.||++... +++.||||.+... .....+.+.+|+++|++++|+||+++++++..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999864 6788999998654 223456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCC-CCEEEEEeccccccCCCCC
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYT-FETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~-~~vkL~DFGla~~~~~~~~ 502 (724)
+++++|.+++.......+++..+++++.+++++|.|||++ +|+|||||++|||++.+ +.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999999876555689999999999999999999998 99999999999999865 4579999999987754322
Q ss_pred ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchh
Q 040832 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~ 582 (724)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.+|+....... ..+. ..+....
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~--~~~~--------~~~~~~~----- 220 (256)
T cd08220 158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL--VLKI--------MSGTFAP----- 220 (256)
T ss_pred --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH--HHHH--------HhcCCCC-----
Confidence 2235688899999999988899999999999999999999999976432211 1110 0011111
Q ss_pred hhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 583 LEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 583 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
........+.+++.+||+.+|++||++.||+++
T Consensus 221 ----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 221 ----ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ----CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=315.25 Aligned_cols=254 Identities=23% Similarity=0.384 Sum_probs=200.1
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch----------hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ----------GEREFKAEVEIISRVHHRHLVSLVGYCIAGG 415 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~----------~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 415 (724)
+|.+.+.||+|+||.||+|... +++.||||.++..... ..+.+..|+.++++++|+||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999854 6889999988632110 1235788999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 416 KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
..++||||+.+++|.+++...+ .+++..+..++.||+.||.|||++ +++||||+++||+++.++.++|+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 9999999999999999998764 488999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCc-cccccccCCCcCCcchhcCCC--CChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccC
Q 040832 496 LTTDNNTH-VSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDD 572 (724)
Q Consensus 496 ~~~~~~~~-~~~~~~gt~~y~APE~~~~~~--~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~ 572 (724)
........ ......|+..|++||++.... ++.++||||||+++|||++|..||......+... +.. .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~---------~ 226 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF-KLG---------N 226 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH-Hhh---------c
Confidence 65433221 123356888999999987654 7899999999999999999999996543322111 100 0
Q ss_pred CChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 573 GNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 573 ~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
......+. .....+....+.+++.+|++.+|++||++.+|+++
T Consensus 227 ~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 227 KRSAPPIP----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cccCCcCC----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00000000 11111234568889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=313.14 Aligned_cols=251 Identities=28% Similarity=0.426 Sum_probs=202.5
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ--GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~--~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
+|++.+.||+|+||.||+|.+. +++.|+||.++..... ..+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4788899999999999999854 6889999999765443 456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+++++|.+++.... .+.+..++.|+.+|++||.|||+. +|+||||+++|||+++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999998654 378899999999999999999998 9999999999999999999999999999877654433
Q ss_pred ccc---ccccCCCcCCcchhcCCC---CChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 504 VST---RVMGTFGYLAPEYASSGK---LTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 504 ~~~---~~~gt~~y~APE~~~~~~---~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
... ...++..|++||++.... ++.++|||+||++||||++|+.||......... ..+.. .+..
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~-~~~~~--------~~~~-- 224 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI-MFHVG--------AGHK-- 224 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH-HHHHh--------cCCC--
Confidence 222 345788999999998766 889999999999999999999999754321111 10000 0000
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
..+.. .......+.+++.+||+.+|++||++.+|+.
T Consensus 225 ---~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 ---PPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---CCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 0112445678999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=329.45 Aligned_cols=264 Identities=20% Similarity=0.295 Sum_probs=198.0
Q ss_pred HHhhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC----
Q 040832 342 SAATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAG---- 414 (724)
Q Consensus 342 ~~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~---- 414 (724)
....++|.+.+.||+|+||.||+|.+ .+++.||||++..... ...+.+.+|+++|++++|+||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 34567899999999999999999985 4678899999875322 2345678899999999999999999987543
Q ss_pred --CeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEec
Q 040832 415 --GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFG 492 (724)
Q Consensus 415 --~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFG 492 (724)
...+++||++ +++|..++... .+++..++.|+.||++||.|||++ +|+||||||+||||+.++.+||+|||
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence 3568999988 78888877643 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhh------h
Q 040832 493 LAKLTTDNNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARP------L 565 (724)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~------~ 565 (724)
+++...... ....|+..|+|||++.+ ..++.++|||||||+||||++|+.||......+. +..+... .
T Consensus 164 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~ 238 (343)
T cd07878 164 LARQADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ-LKRIMEVVGTPSPE 238 (343)
T ss_pred cceecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCCHH
Confidence 998764422 23468999999999876 5788999999999999999999999976543221 1111100 0
Q ss_pred hhhcccCCChhhhcchhhhcCCCH--------HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 566 CLRALDDGNFNEIADPYLEKNYPT--------EEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 566 ~~~~~~~~~~~~~vd~~l~~~~~~--------~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
....+........+.. +. .... .....+.+++.+|++.+|++||++.|++.+
T Consensus 239 ~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQS-LP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhhc-cc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000110000000000 00 0000 012346789999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.36 Aligned_cols=243 Identities=28% Similarity=0.393 Sum_probs=199.2
Q ss_pred CcccceeeccCcEEEEEEEc-CCCcEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 348 FSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
|...+.||.|.||.||.|++ .+.+.||||++.-. ....+.+++.|+.+|++|+|||++.+.|||..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 56667899999999999995 46788999998644 334456899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
| -|+..++|.-... .|.+.++..|+.+.+.||+|||+. +.||||||..||||.+.|.|||+|||.|.+....+
T Consensus 108 C-lGSAsDlleVhkK-plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn-- 180 (948)
T KOG0577|consen 108 C-LGSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN-- 180 (948)
T ss_pred H-hccHHHHHHHHhc-cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh--
Confidence 9 5666777654332 378889999999999999999999 99999999999999999999999999998776543
Q ss_pred cccccccCCCcCCcchhc---CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 504 VSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~---~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
.++||+.|||||++. .|.|+-|+||||||+++.||...+.|+...+.|... ...+. .-.
T Consensus 181 ---sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL-YHIAQ--------------Nes 242 (948)
T KOG0577|consen 181 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQ--------------NES 242 (948)
T ss_pred ---cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH-HHHHh--------------cCC
Confidence 467999999999885 578999999999999999999999998766555321 11111 111
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
+-|. ..+....++.++..||+.-|.+||+..++++
T Consensus 243 PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 243 PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 1121 2244556888999999999999999998765
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=320.38 Aligned_cols=262 Identities=24% Similarity=0.337 Sum_probs=198.3
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC-----eEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGG-----KRLLV 420 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~-----~~~lV 420 (724)
.|...++||.|.||.||+|.+. .++.||||++..+.. .-.+|+++|++++|+|||+|+-+|.... ...||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4566789999999999999954 578999999976432 3356899999999999999998876532 23489
Q ss_pred EEecCCCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCC-CCEEEEEecccccc
Q 040832 421 YEYVPNNNLEFHLHG--KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYT-FETKVADFGLAKLT 497 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~--~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~-~~vkL~DFGla~~~ 497 (724)
||||+. +|.++++. ..+..++...+.-+..||++||+|||+. +|+||||||.|||||.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999965 67766653 1233477778888999999999999998 99999999999999976 99999999999988
Q ss_pred CCCCCccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhh---hcc---
Q 040832 498 TDNNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCL---RAL--- 570 (724)
Q Consensus 498 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~---~~~--- 570 (724)
..+.... ....+..|.|||.+.+ ..|+.+.||||.||++.||+-|+.-|.+.+. .++++...+-+.. +.+
T Consensus 177 ~~~epni--SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~-~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VKGEPNI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS-VDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred ccCCCce--eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH-HHHHHHHHHHhCCCCHHHHhhc
Confidence 7655443 3446788999999876 5799999999999999999999999987543 3344444332211 111
Q ss_pred ----cCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 571 ----DDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 571 ----~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..-.+.++....+.+-+.......+++++.+++..+|.+|-+..|++.+
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 1112222222222222344556678999999999999999999998863
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=335.81 Aligned_cols=264 Identities=24% Similarity=0.319 Sum_probs=204.8
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcC-C-----CCeeEEeeEEEeCCeEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVH-H-----RHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~-H-----pnIv~l~g~~~~~~~~~l 419 (724)
+|.+.++||+|.||.|.||.+. .++.||||+++... ...++-+.|+.+|..|+ | -|||++++||...++++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7899999999999999999954 58999999998642 33456678999999996 3 689999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC--CCCEEEEEecccccc
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY--TFETKVADFGLAKLT 497 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~--~~~vkL~DFGla~~~ 497 (724)
|+|.+ .-+|+++|+.+....++...+..|+.||+.||.+||+. +|||+||||+||||.+ ..+|||+|||.+...
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999 67899999987777799999999999999999999999 9999999999999965 347999999999977
Q ss_pred CCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhh--HHhhh---hhhhhh----
Q 040832 498 TDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC--LVDWA---RPLCLR---- 568 (724)
Q Consensus 498 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~--l~~w~---~~~~~~---- 568 (724)
..... ..+-+..|.|||++.+..|+.+.|||||||||.||++|...|-+.++.++. +++.. ...++.
T Consensus 342 ~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~ 417 (586)
T KOG0667|consen 342 SQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK 417 (586)
T ss_pred CCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 65432 345677899999999999999999999999999999998778666544431 11110 000000
Q ss_pred ---cccC--CChh-----h--------hcch-----hhhc-----------CCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 040832 569 ---ALDD--GNFN-----E--------IADP-----YLEK-----------NYPTEEMARMVACAAASIRHSARRRPKIS 614 (724)
Q Consensus 569 ---~~~~--~~~~-----~--------~vd~-----~l~~-----------~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ 614 (724)
.++. +.+. + .++. .... .....+-..+++++++||.+||.+|++..
T Consensus 418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~ 497 (586)
T KOG0667|consen 418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA 497 (586)
T ss_pred cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence 0000 0000 0 0000 0110 11123456689999999999999999999
Q ss_pred HHHHH
Q 040832 615 QIVRA 619 (724)
Q Consensus 615 evv~~ 619 (724)
|.+++
T Consensus 498 qal~H 502 (586)
T KOG0667|consen 498 QALNH 502 (586)
T ss_pred HHhcC
Confidence 99874
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=317.41 Aligned_cols=268 Identities=21% Similarity=0.295 Sum_probs=203.0
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCeeEEeeEEEeC--CeEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ--GEREFKAEVEIISRVHHRHLVSLVGYCIAG--GKRLLV 420 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~--~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV 420 (724)
++|++.+.||+|+||.||+|.+. +++.|+||.++..... ....+.+|++++++++|+||+++++++... ...+||
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999975 5788999999754322 233577899999999999999999999887 889999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+. ++|..++..... .+++..+++|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99997 488888876443 589999999999999999999998 9999999999999999999999999999876554
Q ss_pred CCccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHH-----------hhhhhhhhh
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLV-----------DWARPLCLR 568 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~-----------~w~~~~~~~ 568 (724)
... .....++..|+|||++.+. .++.++||||||+++|||++|+.+|.....++.... .|.......
T Consensus 160 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 LKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred ccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 222 2234578899999998754 468999999999999999999999976544322110 011100000
Q ss_pred cccCCChhhhcchhhhcCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 569 ALDDGNFNEIADPYLEKNYPTE-EMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 569 ~~~~~~~~~~vd~~l~~~~~~~-~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
......+.......+...+... ....+.+++..||+.+|++||++.||+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0011111111111222222222 35567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=309.41 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=199.8
Q ss_pred hhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
.++.|++.+.||+|.|+.||+... ..|+.+|+|++... ...+.+++.+|+.|.+.|+||||++|++.+..++.+|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 356788888999999999999874 46888888877432 334567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEc---CCCCEEEEEecccccc
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLD---YTFETKVADFGLAKLT 497 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~---~~~~vkL~DFGla~~~ 497 (724)
+|+|+|++|.+-+-.+ ...++..+-.+++||+++|.|+|.+ +|||||+||+|+||- ..--+||+|||+|..+
T Consensus 89 Fe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999997655433 3467788889999999999999999 999999999999993 3446899999999988
Q ss_pred CCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 498 TDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 498 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
.+ .......+||++|||||+++...|+..+|||+.|||||-||.|+.||-+.+... + .+.+..+.++-
T Consensus 164 ~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r--l--------ye~I~~g~yd~ 231 (355)
T KOG0033|consen 164 ND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--L--------YEQIKAGAYDY 231 (355)
T ss_pred CC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH--H--------HHHHhccccCC
Confidence 83 234455779999999999999999999999999999999999999996632211 1 11112222110
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
+ ..+-.........++.+||..||.+|-++.|.+.
T Consensus 232 --~----~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 232 --P----SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred --C----CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 0 0011122345678889999999999999998765
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=322.50 Aligned_cols=255 Identities=28% Similarity=0.438 Sum_probs=200.5
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCc----EEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGK----EVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRL 418 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~----~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 418 (724)
.++|+..+.||+|+||.||+|.+. +++ .||+|.+...... ...+|.+|+.++++++|+||++++++|... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356788899999999999999854 343 4788988765332 234689999999999999999999998764 467
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
+|+||+.+|+|.+++..... .+.+..++.|+.||+.||.|||++ +|+|||||++||||+.++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeehhcCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999999876432 478999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCcc-ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChh
Q 040832 499 DNNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 499 ~~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
...... .....++..|++||++.+..++.++|||||||+||||++ |+.||...... .+..+... ...+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--~~~~~~~~-------~~~~~ 231 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--EIPDLLEK-------GERLP 231 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHC-------CCCCC
Confidence 433221 122345678999999998899999999999999999998 99999654311 11111110 00000
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
........+..++..||..+|++||++.+|++.|+..
T Consensus 232 ----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 232 ----------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0111234678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=317.39 Aligned_cols=253 Identities=26% Similarity=0.395 Sum_probs=200.1
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
++|++.+.||+|+||.||++.+. +++.||+|.++.... .....+.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999975 689999998875422 2345789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 424 VPNNNLEFHLHGKG-RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 424 ~~~gsL~~~L~~~~-~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
+++++|..++.... ...+++..++.++.||+.||.|||+.+ +|+|||||++|||++.++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA 158 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc
Confidence 99999999887631 235899999999999999999999643 899999999999999999999999999976643222
Q ss_pred ccccccccCCCcCCcchhcCC------CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChh
Q 040832 503 HVSTRVMGTFGYLAPEYASSG------KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~------~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
....++..|+|||++.+. .++.++|||||||+||||++|+.||........ .... ..+..+..
T Consensus 159 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~------~~~~~~~~- 227 (286)
T cd06622 159 ---KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI-FAQL------SAIVDGDP- 227 (286)
T ss_pred ---ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH-HHHH------HHHhhcCC-
Confidence 223578899999998554 357899999999999999999999965422111 0000 00000000
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
...+.+....+..++.+||+.+|++||++.+++.+
T Consensus 228 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 228 --------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred --------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11223345667889999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=310.93 Aligned_cols=253 Identities=23% Similarity=0.397 Sum_probs=202.0
Q ss_pred CCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEe--CCeEEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIA--GGKRLLVY 421 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~lV~ 421 (724)
+|++.+.||.|+||.||++.. .+++.||+|.+.... ....+.+..|++++++++|+||+++++++.. +...++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999985 467889999986432 2334568899999999999999999998764 45678999
Q ss_pred EecCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 422 EYVPNNNLEFHLHGK--GRPVMDWPTRLKIAMGSAKGLAYLHEDC--HPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 422 E~~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLHs~~--~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
||+.+++|..++... ....+++..++.++.||++||.|||..+ ..+|+|||||++|||++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 2345899999999999999999999322 229999999999999999999999999999877
Q ss_pred CCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 498 TDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 498 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
...... .....++..|++||++....++.++|||+||+++|+|++|+.||...... .+... +..+.+
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~--------~~~~~~-- 227 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL--QLASK--------IKEGKF-- 227 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH--HHHHH--------HhcCCC--
Confidence 654322 23346889999999999888999999999999999999999999765311 11111 111111
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
...+......+.+++.+|++.+|++||++.+|+++
T Consensus 228 -------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 -------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11223345678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=313.31 Aligned_cols=252 Identities=22% Similarity=0.390 Sum_probs=201.8
Q ss_pred CCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCc------hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSG------QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~------~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
+|+.+++||+|+||.||++.. .+++.||+|.+..... ...+.+.+|+++|++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999985 5688999999864321 123568999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC-CEEEEEeccccccC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF-ETKVADFGLAKLTT 498 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~-~vkL~DFGla~~~~ 498 (724)
||||+.+++|.++|...+ .+++..++.|+.||+.||.|||++ +++|||||++|||++.++ .+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999997654 378999999999999999999998 999999999999998775 59999999998765
Q ss_pred CCCCc---cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCCh
Q 040832 499 DNNTH---VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 499 ~~~~~---~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~ 575 (724)
..... ......|+..|+|||++.+..++.++|||+||+++|||++|+.||.......... .+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~------------ 222 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA-LIFK------------ 222 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH-HHHH------------
Confidence 43221 1223568899999999988889999999999999999999999996432211111 0000
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 576 NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 576 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
..........+......+.+++.+|++.+|++||++.+++.
T Consensus 223 --~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 223 --IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00000011233344567888999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=315.22 Aligned_cols=248 Identities=25% Similarity=0.389 Sum_probs=209.5
Q ss_pred CcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCC
Q 040832 348 FSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPN 426 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 426 (724)
|.+.+.||+|.||.|||+..+ .|+.||||++..+ .+.+++..|+.||++.+.+++|++||.|.....+|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 667788999999999999954 6899999999765 4567899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcccc
Q 040832 427 NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST 506 (724)
Q Consensus 427 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 506 (724)
|++.+++..+. ..|.+.++..+++..++||+|||.. +-||||||..||||+-+|.+||+|||.|..+.+.-.. ..
T Consensus 113 GSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK-RN 187 (502)
T KOG0574|consen 113 GSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK-RN 187 (502)
T ss_pred CcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHh-hC
Confidence 99999987654 3589999999999999999999998 8999999999999999999999999999988764333 34
Q ss_pred ccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcC
Q 040832 507 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKN 586 (724)
Q Consensus 507 ~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~ 586 (724)
.+.||+.|||||++..-.|+.++||||||+...||..|+.||.+...|...+..-..+- + .-.
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PP---------------P--TF~ 250 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPP---------------P--TFK 250 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCC---------------C--CCC
Confidence 57899999999999999999999999999999999999999987765543221111100 0 011
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 587 YPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+......+.++++.||-..|++|-++.+++++
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 233445668889999999999999999988764
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=316.28 Aligned_cols=253 Identities=24% Similarity=0.370 Sum_probs=203.8
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
.++|.+.+.||+|+||.||++.+. +++.||+|.++.......+.|..|++++++++|+||+++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888899999999999999964 5889999999876555567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+++++|..++...+. .+++..+++++.|++.||.|||+. +|+|||||++|||++.++.++|+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 84 CDGGALDSIMLELER-GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred cCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 999999999876433 489999999999999999999999 9999999999999999999999999998765433221
Q ss_pred cccccccCCCcCCcchhc-----CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhh
Q 040832 504 VSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEI 578 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~-----~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 578 (724)
.....++..|++||++. ...++.++|||||||++|||++|+.||......+. +..+.. +..
T Consensus 160 -~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~---------~~~--- 225 (280)
T cd06611 160 -RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV-LLKILK---------SEP--- 225 (280)
T ss_pred -cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH-HHHHhc---------CCC---
Confidence 23356889999999875 34567899999999999999999999976533221 111111 000
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 579 ADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 579 vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+.+ ..+......+.+++.+||+.+|++||++.+|+++
T Consensus 226 --~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 --PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred --CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 0111223457789999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=313.25 Aligned_cols=253 Identities=28% Similarity=0.420 Sum_probs=204.0
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
++|...+.||+|+||.||++.+. +++.|++|.+..... ...+++.+|++++++++|+||+++++++..+...++||||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46778889999999999999975 588899999876533 3456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHE-DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs-~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
+.+++|.+++.... ..+++..+++++.||++||+|||+ . +++|||||++||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 99999999997653 358899999999999999999999 7 999999999999999999999999999876643322
Q ss_pred ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchh
Q 040832 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~ 582 (724)
. ...++..|++||++.+..++.++||||||++||+|++|+.||...........+....... .. ..
T Consensus 157 ~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~-----~~- 222 (265)
T cd06605 157 K---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN-----EP-----PP- 222 (265)
T ss_pred h---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc-----CC-----CC-
Confidence 2 2568889999999998899999999999999999999999997543211111111111100 00 00
Q ss_pred hhcCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 583 LEKNYPTE-EMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 583 l~~~~~~~-~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..... ....+.+++.+||..+|++||++.+|+++
T Consensus 223 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 223 ---RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ---CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 01111 34558899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=316.90 Aligned_cols=267 Identities=21% Similarity=0.288 Sum_probs=200.0
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
+|++.+.||+|+||.||+|.+. +++.||||+++.... .....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999864 688999999875432 2235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+. ++|..++.......+++..++.++.||++||+|||+. +++||||+++|||++.++.+||+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 95 6888888765555689999999999999999999998 9999999999999999999999999999866433221
Q ss_pred cccccccCCCcCCcchhcCCC-CChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhH--Hhhhhhhhhhc------c--cC
Q 040832 504 VSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCL--VDWARPLCLRA------L--DD 572 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~~-~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l--~~w~~~~~~~~------~--~~ 572 (724)
.....++..|+|||++.+.. ++.++|||||||+||||+||+.||.......... ..+........ + ..
T Consensus 157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 157 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred -cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 22334688999999886644 6889999999999999999999997654322211 11110000000 0 00
Q ss_pred CChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 573 GNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 573 ~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+..+....+... .......+.+++.+|++.+|++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 236 PSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00001111111000 01122456789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=315.24 Aligned_cols=269 Identities=21% Similarity=0.284 Sum_probs=197.8
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchh-HHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQG-EREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~-~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
+.++|.+.+.||+|+||.||+|... +++.|+||.+....... ...+.+|+++|+.++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999854 68899999987543322 346788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+. ++|..++.... ..+.+..+..++.||++||.|||+. +|+|||||++||||+.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9996 56665554432 2377888999999999999999998 99999999999999999999999999997654322
Q ss_pred CccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhH-Hhhhhhhhhh-----ccc--C
Q 040832 502 THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCL-VDWARPLCLR-----ALD--D 572 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l-~~w~~~~~~~-----~~~--~ 572 (724)
.. .....++..|+|||++.+. .++.++|||||||+||||++|+.||+........+ ..|....... .+. .
T Consensus 158 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 158 QT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred CC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 21 2234578899999998753 57889999999999999999999997654322221 1121100000 000 0
Q ss_pred CChhhhcch----hhhcC-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 573 GNFNEIADP----YLEKN-YPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 573 ~~~~~~vd~----~l~~~-~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
....++... .+... ........+.+++.+|++.+|++||++.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000 00000 00012356778899999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=315.45 Aligned_cols=267 Identities=22% Similarity=0.317 Sum_probs=198.9
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
++|.+.+.||+|+||.||+|... +++.||||.+...... ....+.+|++++++++|+||+++++++.++...++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67899999999999999999965 6789999998754322 234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+.+ +|..++..... .+.+..++.++.||++||.|||+. +|+|||||++|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 85 LDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred CCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 985 89888876543 578999999999999999999998 999999999999999999999999999875432211
Q ss_pred cccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhh------h------cc
Q 040832 504 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCL------R------AL 570 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~------~------~~ 570 (724)
......++..|+|||++.+ ..++.++|||||||+||||++|+.+|.........+....+.+.. . ..
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 1122346788999998875 458899999999999999999999997554222221111000000 0 00
Q ss_pred cCCChhhhcchhhhcCC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 571 DDGNFNEIADPYLEKNY-PTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 571 ~~~~~~~~vd~~l~~~~-~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
....+.......+.... .......+.+++.+|++.+|++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000000010000 1111256788999999999999999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=315.77 Aligned_cols=263 Identities=25% Similarity=0.364 Sum_probs=206.9
Q ss_pred ccCHHHHHHhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCeeEEeeEEE
Q 040832 335 AFTYEELSAATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGYCI 412 (724)
Q Consensus 335 ~f~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~ 412 (724)
.++++++..+.++|.+.+.||+|+||.||++... +++.||+|.+.... .....+.+|+.+++++ +|+||+++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 4666788888999999999999999999999964 68889999986532 2345678899999999 8999999999987
Q ss_pred eC-----CeEEEEEEecCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCC
Q 040832 413 AG-----GKRLLVYEYVPNNNLEFHLHGK--GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFE 485 (724)
Q Consensus 413 ~~-----~~~~lV~E~~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~ 485 (724)
.. +..++||||+.+++|.++++.. ....+.+..++.++.||+.||.|||+. +|+|||||++|||++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence 53 3579999999999999988641 233588999999999999999999998 9999999999999999999
Q ss_pred EEEEEeccccccCCCCCccccccccCCCcCCcchhcCC-----CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHh
Q 040832 486 TKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSG-----KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVD 560 (724)
Q Consensus 486 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~ 560 (724)
+||+|||++......... .....|+..|++||++..+ .++.++|||||||++|||++|+.||........ +..
T Consensus 167 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-~~~ 244 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-LFK 244 (291)
T ss_pred EEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-HHH
Confidence 999999999866433221 1234578899999998643 367899999999999999999999975432221 111
Q ss_pred hhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 561 WARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 561 w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+.+. ....+.+ ..+....+.+++.+||+.+|++||++.+|+++
T Consensus 245 ~~~~---------~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 IPRN---------PPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HhcC---------CCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1110 0000100 11223468899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=314.27 Aligned_cols=254 Identities=23% Similarity=0.381 Sum_probs=198.3
Q ss_pred CcccceeeccCcEEEEEEEcC----CCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC------
Q 040832 348 FSQSNLLGQGGFGYVHKGVLP----NGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGG------ 415 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~----~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~------ 415 (724)
|.+.++||+|+||.||+|.+. .++.||||+++... ....+++.+|+++|++++|+||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999853 36789999987642 233557899999999999999999999886542
Q ss_pred eEEEEEEecCCCCHHHHHhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEe
Q 040832 416 KRLLVYEYVPNNNLEFHLHGK----GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADF 491 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~----~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DF 491 (724)
..++++||+.+++|..++... ....+++..+++++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 247899999999998877432 222478899999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhc
Q 040832 492 GLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRA 569 (724)
Q Consensus 492 Gla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~ 569 (724)
|+++........ ......+...|++||.+....++.++|||||||++|||++ |+.||......+ +..+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~--~~~~~~------ 229 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE--IYNYLI------ 229 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH--HHHHHH------
Confidence 999876433221 1122335577999999998889999999999999999999 888886543221 111111
Q ss_pred ccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 570 LDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 570 ~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
....+ .........+.+++.+|++.+|++||++.+|++.|++.
T Consensus 230 -~~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 -KGNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -cCCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00000 01112345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=303.88 Aligned_cols=250 Identities=26% Similarity=0.424 Sum_probs=206.4
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecC
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVP 425 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 425 (724)
+|...+.||+|+||.||++.+. +++.|++|++..........+.+|++++++++|+||+++++++..+...+++|||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999975 688899999987655566789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccc
Q 040832 426 NNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVS 505 (724)
Q Consensus 426 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 505 (724)
+++|.+++.... ..+++..++.++.|++++|.|||+. +++||||+++||++++++.++|+|||++........ .
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999999987653 3489999999999999999999998 999999999999999999999999999987765432 2
Q ss_pred cccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhc
Q 040832 506 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEK 585 (724)
Q Consensus 506 ~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~ 585 (724)
....++..|++||++....++.++|||+||++||+|++|+.||............. . .....+..
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~---------~~~~~~~~----- 219 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA-T---------NGPPGLRN----- 219 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH-h---------cCCCCcCc-----
Confidence 34568899999999988889999999999999999999999997653222211100 0 00000000
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 586 NYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.......+.+++.+||+.+|++||++.+|+++
T Consensus 220 --~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 --PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred --ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01113568899999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=309.39 Aligned_cols=251 Identities=28% Similarity=0.415 Sum_probs=207.1
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
++|.+.++||+|+||.||++.+. +++.|+||++..... ...+.|.+|+.++.+++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888999999999999999976 489999999876544 3456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHE-DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs-~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
+++++|.+++.... .+++..+++++.||++||+|||+ . +++||||+++||+|+.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 99999999997653 48999999999999999999999 8 999999999999999999999999999987654332
Q ss_pred ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCch-hhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAM-EDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~-~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
. .....++..|++||.+....++.++|||+||+++|||++|+.||...... ...+..+.. ....
T Consensus 156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--------~~~~------ 220 (264)
T cd06623 156 Q-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC--------DGPP------ 220 (264)
T ss_pred c-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh--------cCCC------
Confidence 2 22456788999999999989999999999999999999999999765321 001111110 0000
Q ss_pred hhhcCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 582 YLEKNYPTE-EMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 582 ~l~~~~~~~-~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
...... ....+.+++.+||+.+|++||++.+|+++
T Consensus 221 ---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 ---PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ---CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011122 44678999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=315.74 Aligned_cols=244 Identities=27% Similarity=0.376 Sum_probs=200.8
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|++.+.||+|+||.||++.+. +++.||||++.... ......+.+|+++|++++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47889999999999999999865 58899999986432 223456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+.+++|.+++...+ .+++..++.++.||++||.|||+. +|+||||+++||||+.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999999999987664 489999999999999999999998 9999999999999999999999999999876544
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
.....|+..|++||.+.+...+.++||||||+++|+|++|+.||......+. +.. +..+..
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~------~~~~~~------ 215 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI----YEK------ILEGKV------ 215 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH----HHH------HhcCCc------
Confidence 2334688999999999888889999999999999999999999976542110 000 001100
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRP-----KISQIVR 618 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evv~ 618 (724)
.++......+.+++.+||..+|.+|+ +++++++
T Consensus 216 ----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 ----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 11112245678899999999999999 6677765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=328.87 Aligned_cols=240 Identities=24% Similarity=0.305 Sum_probs=185.8
Q ss_pred eeccCcEEEEEEEcC-CCcEEEEEEeccCCc---hhHHHHHHHHHHHHhc---CCCCeeEEeeEEEeCCeEEEEEEecCC
Q 040832 354 LGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG---QGEREFKAEVEIISRV---HHRHLVSLVGYCIAGGKRLLVYEYVPN 426 (724)
Q Consensus 354 LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~---~~~~~f~~Ei~il~~l---~HpnIv~l~g~~~~~~~~~lV~E~~~~ 426 (724)
||+|+||.||+|... +++.||||++..... .....+..|..++.++ +|+||+++++++.+....++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999864 588999999864321 1223455677777665 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcccc
Q 040832 427 NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST 506 (724)
Q Consensus 427 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 506 (724)
++|..++...+. +++..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++....... ...
T Consensus 81 g~L~~~l~~~~~--~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~ 154 (330)
T cd05586 81 GELFWHLQKEGR--FSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTN 154 (330)
T ss_pred ChHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Ccc
Confidence 999998876543 89999999999999999999998 999999999999999999999999999976433222 123
Q ss_pred ccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhc
Q 040832 507 RVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEK 585 (724)
Q Consensus 507 ~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~ 585 (724)
...|+..|+|||++.+. .++.++|||||||+||||++|+.||......+. +.. +..+.+ .+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~-~~~---------i~~~~~------~~~~ 218 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM-YRN---------IAFGKV------RFPK 218 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH-HHH---------HHcCCC------CCCC
Confidence 45699999999998764 478999999999999999999999976432211 100 011110 0000
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 040832 586 NYPTEEMARMVACAAASIRHSARRRPK----ISQIVR 618 (724)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPs----~~evv~ 618 (724)
......+.+++.+||+.+|++|++ +.++++
T Consensus 219 ---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 ---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 012345678999999999999984 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=317.73 Aligned_cols=257 Identities=21% Similarity=0.248 Sum_probs=202.7
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG---QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~---~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|.+.+.||+|+||.||++... .++.|+||.+..... .....+.+|+++++.++|+||+++++++..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46889999999999999999864 478899999875432 23346889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+++++|.+++...+ .+.+..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999997654 388999999999999999999998 99999999999999999999999999987421110
Q ss_pred C--------------ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhh
Q 040832 502 T--------------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCL 567 (724)
Q Consensus 502 ~--------------~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~ 567 (724)
. .......++..|+|||++....++.++|||||||+||||++|+.||......+ .+..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-~~~~~~~---- 230 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LFGQVIS---- 230 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHh----
Confidence 0 01122457889999999998889999999999999999999999996542211 1111000
Q ss_pred hcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 568 RALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 568 ~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
+.+ ..+.. .......+..++.+||+.+|++||++.++.+.|+..+
T Consensus 231 -----~~~---~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~ 275 (305)
T cd05609 231 -----DDI---EWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275 (305)
T ss_pred -----ccc---CCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence 000 00000 0122345789999999999999999877777777654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=309.33 Aligned_cols=250 Identities=24% Similarity=0.401 Sum_probs=202.7
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
+|.+.+.||+|+||.||++.+. +|+.||+|.+.... ....+.+.+|++++++++|+||+++++++..+...++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788899999999999999965 57889999986531 23345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC-CEEEEEeccccccCCCCC
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF-ETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~-~vkL~DFGla~~~~~~~~ 502 (724)
+.+++|.+++.......+++..++.|+.||++||.|||+. +|+|+|||++|||+++++ .+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999999776555689999999999999999999998 999999999999998875 469999999987654332
Q ss_pred ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchh
Q 040832 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~ 582 (724)
. .....|+..|+|||++....++.++|||||||++|||++|+.||......+.. .... .+.+..
T Consensus 158 ~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~-----~~~~~~----- 221 (257)
T cd08225 158 L-AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV-----LKIC-----QGYFAP----- 221 (257)
T ss_pred c-ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH-----HHHh-----cccCCC-----
Confidence 2 22345888999999998888999999999999999999999999754322211 1110 011111
Q ss_pred hhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 583 LEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 583 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
........+.+++.+|+..+|++||++.+|+++
T Consensus 222 ----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 ----ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111223468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=319.92 Aligned_cols=245 Identities=23% Similarity=0.352 Sum_probs=197.9
Q ss_pred cceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCCCH
Q 040832 351 SNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNL 429 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 429 (724)
...||+|+||.||++... +++.||||.+........+.+.+|+.++++++|+||+++++++..++..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 356999999999999864 5889999998765545556789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccccccc
Q 040832 430 EFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM 509 (724)
Q Consensus 430 ~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 509 (724)
.+++... .+++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||++......... .....
T Consensus 107 ~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~~ 179 (292)
T cd06658 107 TDIVTHT---RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSLV 179 (292)
T ss_pred HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-Cceee
Confidence 9988643 378999999999999999999998 9999999999999999999999999999765433222 23356
Q ss_pred cCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCH
Q 040832 510 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPT 589 (724)
Q Consensus 510 gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~ 589 (724)
|+..|+|||++.+..++.++|||||||+||||++|+.||......... ..+. ..+...+.. ..
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~-~~~~--------------~~~~~~~~~--~~ 242 (292)
T cd06658 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM-RRIR--------------DNLPPRVKD--SH 242 (292)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHH--------------hcCCCcccc--cc
Confidence 889999999998888999999999999999999999999754322211 1000 000111101 01
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 590 EEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 590 ~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.....+..++.+|+..+|.+||++.+|+++
T Consensus 243 ~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 243 KVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 123357788899999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.64 Aligned_cols=267 Identities=22% Similarity=0.287 Sum_probs=201.1
Q ss_pred CcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC--CeEEEEEE
Q 040832 348 FSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIAG--GKRLLVYE 422 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV~E 422 (724)
|++.+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|++++++++|+||+++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999965 47899999998653 23345688999999999999999999999988 88999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|+++ +|..++.... ..+++..++.++.||++||+|||+. +++|+|||++|||+++++.+||+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9975 7888776543 3589999999999999999999998 999999999999999999999999999987765442
Q ss_pred ccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhH--Hhhhhhhhh---hcccC----
Q 040832 503 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCL--VDWARPLCL---RALDD---- 572 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l--~~w~~~~~~---~~~~~---- 572 (724)
.......++..|+|||.+.+ ..++.++|||+||+++|||++|+.||.......... ......... ..+..
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 22233456788999998764 467899999999999999999999997654322111 110000000 00000
Q ss_pred --CChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 573 --GNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 573 --~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..........+...+...+...+.+++.+||+.+|++||++.+|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000001111111111135678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=313.12 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=201.6
Q ss_pred HhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCC-----
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGG----- 415 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~----- 415 (724)
...++|++.+.||+|+||.||+|.+. +++.|++|.+..... ....|.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35688999999999999999999974 578899999876543 346799999999999 7999999999997644
Q ss_pred -eEEEEEEecCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEec
Q 040832 416 -KRLLVYEYVPNNNLEFHLHGKG--RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFG 492 (724)
Q Consensus 416 -~~~lV~E~~~~gsL~~~L~~~~--~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFG 492 (724)
..++||||+++++|.+++.... ...+++..++.++.|+++||.|||+. +|+||||+++||+|+.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999999887533 34589999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccCCCcCCcchhcC-----CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhh
Q 040832 493 LAKLTTDNNTHVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCL 567 (724)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~ 567 (724)
++......... .....|+..|+|||++.. ..++.++|||||||+||||++|+.||......... ...
T Consensus 159 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~------ 230 (275)
T cd06608 159 VSAQLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL-FKI------ 230 (275)
T ss_pred cceecccchhh-hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH-HHh------
Confidence 99765433222 233458889999998753 34678999999999999999999999754322211 111
Q ss_pred hcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 568 RALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 568 ~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
.......+ .........+.+++.+||..+|++||++.||++
T Consensus 231 ---~~~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 ---PRNPPPTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ---hccCCCCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00100000 111223456889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=310.94 Aligned_cols=257 Identities=26% Similarity=0.325 Sum_probs=201.3
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC--CeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAG--GKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV~ 421 (724)
++|...+.||.|+||.||++.+. +++.||+|.+..... .....+.+|++++++++|+||++++++|.+. ...+|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999974 578899999875433 3456799999999999999999999998654 4689999
Q ss_pred EecCCCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 422 EYVPNNNLEFHLHG--KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 422 E~~~~gsL~~~L~~--~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
||+++++|.+++.. .....+.+..++.|+.||+.||+|||+. +++|+||+++||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988753 2234578899999999999999999998 999999999999999999999999999876543
Q ss_pred CCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCc---hhhhHHhhhhhhhhhcccCCChh
Q 040832 500 NNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGA---MEDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 500 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~---~~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
... ....++..|++||.+.+..++.++|||+|||++|||++|+.||+.... ....+..|... ....
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~~ 226 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN--------MPNP 226 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc--------CCch
Confidence 221 234578899999999999999999999999999999999999976522 11112222111 0000
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+.+.. .........+.+++.+||+.+|.+||++.||+++
T Consensus 227 ~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 227 ELKDEP---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred hhccCC---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 000000 0011234568899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.79 Aligned_cols=247 Identities=20% Similarity=0.329 Sum_probs=199.0
Q ss_pred cccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCC
Q 040832 349 SQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNN 427 (724)
Q Consensus 349 ~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 427 (724)
.....||+|+||.||++... +++.||||.+........+.+.+|+.+++.++|+||+++++++..++..++||||++++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 33456999999999999864 68899999987654445567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccccc
Q 040832 428 NLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTR 507 (724)
Q Consensus 428 sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 507 (724)
+|..++... .+++..++.++.||+.||.|||+. +|+|||||++||||+.++.+||+|||++......... ...
T Consensus 104 ~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~ 176 (297)
T cd06659 104 ALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKS 176 (297)
T ss_pred CHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-ccc
Confidence 999887653 378999999999999999999998 9999999999999999999999999999765433221 233
Q ss_pred cccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCC
Q 040832 508 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNY 587 (724)
Q Consensus 508 ~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~ 587 (724)
..|+..|+|||++.+..++.++|||||||+||||++|+.||......+. +..+.. .....+ . .
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~~~~~---------~~~~~~-~------~ 239 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-MKRLRD---------SPPPKL-K------N 239 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhc---------cCCCCc-c------c
Confidence 5688999999999988999999999999999999999999975432221 111100 000000 0 0
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 588 PTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 588 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.......+.+++.+||+.+|++||++.+|+++
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 01122347789999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=324.33 Aligned_cols=252 Identities=23% Similarity=0.392 Sum_probs=201.9
Q ss_pred hCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccC--CchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSG--SGQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
...|+++++||+||..+||++...+.+.||+|++... ..+...-|..|+.+|.+| .|.+|++|++|-..++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 3467888999999999999999888889999877543 333456799999999999 4999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||= ..+|..+|..+......| .++.+..|++.++.++|++ ||||.||||.|+|+-. |.+||+|||+|.....+.
T Consensus 440 E~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred ecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 975 788999999877655556 6778899999999999999 9999999999999854 589999999999887666
Q ss_pred Cc-cccccccCCCcCCcchhcCC-----------CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhc
Q 040832 502 TH-VSTRVMGTFGYLAPEYASSG-----------KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRA 569 (724)
Q Consensus 502 ~~-~~~~~~gt~~y~APE~~~~~-----------~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~ 569 (724)
+. .....+||+.||+||.+... +...++||||||||||+|+.|+.||... ...|++
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~------~n~~aK------ 581 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI------INQIAK------ 581 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH------HHHHHH------
Confidence 55 34557899999999988643 2557899999999999999999999643 222333
Q ss_pred ccCCChhhhcchhhhcCCCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 570 LDDGNFNEIADPYLEKNYPT-EEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 570 ~~~~~~~~~vd~~l~~~~~~-~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+..+.++..+-.|+. ..-..++++++.||..||++||++.+|+++
T Consensus 582 -----l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 -----LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -----HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 222333322112211 111228999999999999999999999974
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=311.02 Aligned_cols=247 Identities=25% Similarity=0.429 Sum_probs=199.9
Q ss_pred CCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCC-chhHHHHHHHHHHHHhcC---CCCeeEEeeEEEeCCeEEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGS-GQGEREFKAEVEIISRVH---HRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~lV~ 421 (724)
.|++.+.||+|+||.||+|.+ .+++.|+||.++... .....++.+|+.++++++ |+||+++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999995 568899999987542 334457889999999997 999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+.+++|.+++... .+++..++.++.||++||.|||+. +|+||||+++||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999988653 488999999999999999999998 99999999999999999999999999998775543
Q ss_pred CccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 502 THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
.. .....|+..|+|||++..+ .++.++|||||||+||+|++|+.||+........ .+ +.....
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~~--------~~~~~~----- 219 (277)
T cd06917 156 SK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM--ML--------IPKSKP----- 219 (277)
T ss_pred cc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh--hc--------cccCCC-----
Confidence 22 2334688899999998765 4688999999999999999999999764322111 00 000000
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
+.+... .....+.+++.+||+.+|++||++.++++
T Consensus 220 ~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 220 PRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 111110 13456888999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=311.12 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=193.7
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC-chhHHHHHHHHHH-HHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS-GQGEREFKAEVEI-ISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~-~~~~~~f~~Ei~i-l~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
++|++.+.||+|+||.||++.+. +|+.||||+++... .....++..|+.+ ++.++|+||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47889999999999999999965 58999999987643 2334456666665 666789999999999999999999999
Q ss_pred ecCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 423 YVPNNNLEFHLHGK--GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 423 ~~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|++ ++|..++... ....+++..++.++.||+.||+|||+++ +++|||||++|||++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 6787776542 2345899999999999999999999854 7999999999999999999999999999876433
Q ss_pred CCccccccccCCCcCCcchhcC----CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChh
Q 040832 501 NTHVSTRVMGTFGYLAPEYASS----GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~----~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
.. .....|+..|+|||++.+ ..++.++|||+|||+||||++|+.||+........+..... +..
T Consensus 158 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------~~~- 225 (283)
T cd06617 158 VA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE---------EPS- 225 (283)
T ss_pred cc--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh---------cCC-
Confidence 22 133458889999998864 34688999999999999999999999653221111111100 000
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
..+ ........+.+++.+||..+|++||++.+|+.
T Consensus 226 ----~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 ----PQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ----CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00112345888999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=309.98 Aligned_cols=247 Identities=26% Similarity=0.378 Sum_probs=200.5
Q ss_pred CCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 347 GFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
-|++.+.||+|+||.||+|.+ .+++.||||.+.... ......|.+|+.++++++|+||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 367788999999999999985 467899999886433 233457899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
.+++|..++... .+++..++.++.||+.+|.|||+. +++|+|||++|||++.++.++|+|||++........ .
T Consensus 85 ~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06641 85 GGGSALDLLEPG---PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-h
Confidence 999999988753 378999999999999999999998 999999999999999999999999999976644322 1
Q ss_pred ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhh
Q 040832 505 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLE 584 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~ 584 (724)
.....++..|++||++....++.++|||||||+||||++|..||....... .... +..+..
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~--------~~~~~~--------- 218 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--VLFL--------IPKNNP--------- 218 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--HHHH--------HhcCCC---------
Confidence 223467889999999988889999999999999999999999996532211 1100 000100
Q ss_pred cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 585 KNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..........+.+++.+|++.+|++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 01112233557889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.48 Aligned_cols=250 Identities=23% Similarity=0.380 Sum_probs=203.9
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
++|.+.+.||+|+||.||++... +++.|++|.+........+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 67888999999999999999853 67889999987554445567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
++++|.+++... .+.+..++.++.||+.||.|||++ +++|||||++||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~- 171 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 171 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccccc-
Confidence 999999998754 378899999999999999999999 9999999999999999999999999998766543322
Q ss_pred ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhh
Q 040832 505 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLE 584 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~ 584 (724)
.....|+..|++||++..+.++.++|||||||++|||++|+.||......+.....+ ..+. +.
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~---------~~~~------~~-- 234 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---------TNGT------PE-- 234 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh---------cCCC------CC--
Confidence 223468889999999988889999999999999999999999997643222111000 0000 00
Q ss_pred cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 585 KNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..........+.+++.+||..+|++||++.+|+.+
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111233457889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=316.82 Aligned_cols=248 Identities=22% Similarity=0.297 Sum_probs=207.8
Q ss_pred hCCCcccceeeccCcEEEEEEE-cCCCcEEEEEEeccCCchh--HHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQG--EREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~-~~~g~~vaVK~l~~~~~~~--~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
.+-|.+.+.||+|.|+.|-+|+ .-.|..||||++....-+. .-.+..|++.|+.++|+|||+||++......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 4567788889999999999988 3479999999997653333 346889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEc-CCCCEEEEEeccccccCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLD-YTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~-~~~~vkL~DFGla~~~~~~ 500 (724)
|+-++|+|.+++..... .+.+....+++.||+.|+.|+|+. .+|||||||+||++. .-|-|||.|||++-.+...
T Consensus 97 ELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 99999999999875433 389999999999999999999998 899999999998774 5788999999999766554
Q ss_pred CCccccccccCCCcCCcchhcCCCCC-hhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~t-~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
.. .+..+|.+.|-|||++.+..|+ .+.||||||||||-|++|+.||....+.+.. ..++
T Consensus 173 ~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL------------------TmIm 232 (864)
T KOG4717|consen 173 KK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL------------------TMIM 232 (864)
T ss_pred ch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh------------------hhhh
Confidence 33 3557899999999999999888 6899999999999999999999876544331 2222
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
|.. ...+.-...++.++|..||..||++|.+.++|+.
T Consensus 233 DCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 233 DCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 221 1345566778999999999999999999999985
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=332.19 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=206.2
Q ss_pred CCCcccceeeccCcEEEEEEEcCCCcE-EEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPNGKE-VAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~-vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
+.|.++..||.|+||+||||..++-.. .|.|++...+.....+|+-||+||..++||+||+|++.|..++.+|++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 346777889999999999999776444 4568887777777788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
.||-++.++..-++ .|.+.++..+++|++.||.|||++ +|||||||..|||++-+|.++|+|||.+...... ...
T Consensus 112 ~GGAVDaimlEL~r-~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qk 186 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGR-VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQK 186 (1187)
T ss_pred CCchHhHHHHHhcc-ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH-Hhh
Confidence 99999988876554 589999999999999999999999 9999999999999999999999999998644322 223
Q ss_pred ccccccCCCcCCcchhcC-----CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 505 STRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~-----~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
...+.||++|||||+.++ ..|+.++||||||+.|.||..+..|......|...+..- ...-.-++
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKia----------KSePPTLl 256 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA----------KSEPPTLL 256 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHh----------hcCCCccc
Confidence 455889999999998764 579999999999999999999999987766665433211 01111111
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
. +......+.+++.+||..+|+.||++.||++
T Consensus 257 q-------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 Q-------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred C-------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1 2233456888999999999999999999875
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=311.83 Aligned_cols=265 Identities=21% Similarity=0.293 Sum_probs=199.8
Q ss_pred CcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 348 FSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
|++.+.||+|++|.||+|.+. +|+.||||++..... .....+.+|++++++++|+||+++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999864 689999999875432 22356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
. ++|..++.......+++..+++++.||++||+|||+. +++||||+++|||++.++.++|+|||+++........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 5 6899888776544689999999999999999999998 9999999999999999999999999999765432211
Q ss_pred ccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhh---c----ccCCCh-
Q 040832 505 STRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLR---A----LDDGNF- 575 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~---~----~~~~~~- 575 (724)
.....++..|+|||++.+. .++.++|||||||+||||++|+.||......... ....+..... . .....+
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQL-FRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCChHHhhhhhhchhhh
Confidence 1223468899999988664 5789999999999999999999999765433221 1111100000 0 000000
Q ss_pred ---hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 576 ---NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 576 ---~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.......+ ..........+.+++.+|++.+|++||++.||+++
T Consensus 235 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 235 PTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000 01111223568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=301.93 Aligned_cols=251 Identities=28% Similarity=0.424 Sum_probs=207.1
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC--CeEEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAG--GKRLLVY 421 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV~ 421 (724)
+|.+.+.||+|+||.||+|... +++.|+||++..... ...+.+.+|++++++++|+||+++++++... ...++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999976 688999999876543 3456799999999999999999999999988 8899999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+.+++|.+++.... .+++..++.++.|++++|.|||+. +++|+||+++||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999998765 589999999999999999999998 99999999999999999999999999998776544
Q ss_pred Cc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 502 TH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 502 ~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
.. ......++..|++||.+....++.++|||+||++||+|++|+.||.........+.... ....
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~------ 221 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIG--------SSGE------ 221 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcc--------ccCC------
Confidence 31 12335688899999999888899999999999999999999999976541111111100 0000
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
...++......+.+++.+|+..+|++||++.+++++
T Consensus 222 ---~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 222 ---PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ---CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 011222335678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=310.71 Aligned_cols=268 Identities=20% Similarity=0.234 Sum_probs=196.7
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch--hHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCe-----
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ--GEREFKAEVEIISRV-HHRHLVSLVGYCIAGGK----- 416 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~--~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~----- 416 (724)
++|++.+.||+|+||.||+|.+. +++.||||.++..... ....+.+|+.+++++ +|+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999964 6889999988654222 235688899999999 46999999999887665
Q ss_pred EEEEEEecCCCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC-CCCEEEEEec
Q 040832 417 RLLVYEYVPNNNLEFHLHGKG---RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY-TFETKVADFG 492 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~---~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~-~~~vkL~DFG 492 (724)
.++||||+++ +|..++.... ...+++..++.++.||++||.|||++ +|+|||||++|||++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 7877776432 23579999999999999999999999 9999999999999998 8899999999
Q ss_pred cccccCCCCCccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhh---hhhhhh
Q 040832 493 LAKLTTDNNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWA---RPLCLR 568 (724)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~---~~~~~~ 568 (724)
+++........ .....++..|+|||++.+ ..++.++|||||||+||||++|..||......+....... .+....
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 99865432211 122346788999998865 4578999999999999999999999976544332211000 000000
Q ss_pred cccCCChhhh------cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 569 ALDDGNFNEI------ADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 569 ~~~~~~~~~~------vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
......+... ....+ ..........+.+++.+||+.+|.+||++.||+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDL-SRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CcchhhccchhhcCcccchhH-HHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000 00000 00011234557889999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.80 Aligned_cols=269 Identities=22% Similarity=0.291 Sum_probs=197.6
Q ss_pred CCcccceeeccCcEEEEEEEcCC---CcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC--CeEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLPN---GKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAG--GKRL 418 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~~---g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~ 418 (724)
+|.+.+.||+|+||.||+|.+.. ++.||||.+.... ....+.+.+|+.++++++|+||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47888999999999999999654 7899999998642 23345678899999999999999999999988 7899
Q ss_pred EEEEecCCCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC----CCCEEEEEe
Q 040832 419 LVYEYVPNNNLEFHLHGK---GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY----TFETKVADF 491 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~---~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~----~~~vkL~DF 491 (724)
|||||+++ +|..++... ....+.+..++.|+.||+.||.|||+. +|+|||||++||||+. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 555555321 223578999999999999999999999 9999999999999999 999999999
Q ss_pred ccccccCCCCC--ccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchh--------hhHHh
Q 040832 492 GLAKLTTDNNT--HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAME--------DCLVD 560 (724)
Q Consensus 492 Gla~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~--------~~l~~ 560 (724)
|+++....... .......++..|+|||++.+. .++.++|||||||+||||++|+.||....... ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987654332 122335678999999988764 57899999999999999999999997553221 01111
Q ss_pred hhhhhhhh-------cccCCChhhhcchhhhcCCC---------H--HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 561 WARPLCLR-------ALDDGNFNEIADPYLEKNYP---------T--EEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 561 w~~~~~~~-------~~~~~~~~~~vd~~l~~~~~---------~--~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+...+... ......+..+.+......+. . ....++.+++.+||+.+|++||++.||+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 10000000 00000111100000000111 1 233568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=308.45 Aligned_cols=267 Identities=24% Similarity=0.344 Sum_probs=200.1
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
+|++.+.||+|+||.||+|.+. +|+.||||.++..... ....+.+|+.++++++|+||+++++++.+.+..+|||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788999999999999999975 5888999998765332 2456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 425 PNNNLEFHLHGKG-RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 425 ~~gsL~~~L~~~~-~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
.+ +|.+++.... ...+++..+++++.||++||+|||+. +|+|||||++|||+++++.+||+|||+++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 85 7777776533 23589999999999999999999998 9999999999999999999999999999765432221
Q ss_pred cccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhH--Hhh-hhhhh--hhccc-----C
Q 040832 504 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCL--VDW-ARPLC--LRALD-----D 572 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l--~~w-~~~~~--~~~~~-----~ 572 (724)
.....++..|++||++.+. .++.++|||+|||++|||++|+.||......+... ..+ ..+.. ...+. .
T Consensus 157 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 157 -FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred -cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 1234578899999988654 57889999999999999999999997654332211 111 00000 00000 0
Q ss_pred CChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 573 GNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 573 ~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+....+..+ ..+.......+.+++.+|++.+|.+||++.||+++
T Consensus 236 ~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 236 PTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred ccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000000000 01111234567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=311.32 Aligned_cols=267 Identities=20% Similarity=0.287 Sum_probs=198.7
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
++|++.+.||+|+||.||+|.+. +++.||||.++.... ...+.+.+|++++++++|+||+++++++.++...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999965 688999999865422 223568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC-CCCEEEEEeccccccCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY-TFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~-~~~vkL~DFGla~~~~~~~ 501 (724)
|+. ++|..++.......+++..++.++.||+.||+|||++ +|+|||||++||||+. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 5777777655444568888999999999999999998 9999999999999985 5679999999998654322
Q ss_pred CccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhh---hhhhhhhcccC-CChh
Q 040832 502 THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDW---ARPLCLRALDD-GNFN 576 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w---~~~~~~~~~~~-~~~~ 576 (724)
. ......++..|++||++.+. .++.++|||||||++|+|++|+.||......+.....+ ..+. ...+.. ..+.
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 235 (294)
T PLN00009 158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPN-EETWPGVTSLP 235 (294)
T ss_pred c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC-hhhccccccch
Confidence 1 12234578899999988664 57899999999999999999999997654433221110 0000 000000 0000
Q ss_pred hh-------cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 577 EI-------ADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 577 ~~-------vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.. ....+. .........+.+++.+|++.+|++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 236 DYKSAFPKWPPKDLA-TVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhcccCCCCCHH-HhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 000000 0111233457889999999999999999999873
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=298.90 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=204.7
Q ss_pred HHhhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCc----hhH----HHHHHHHHHHHhc-CCCCeeEEeeEE
Q 040832 342 SAATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSG----QGE----REFKAEVEIISRV-HHRHLVSLVGYC 411 (724)
Q Consensus 342 ~~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~----~~~----~~f~~Ei~il~~l-~HpnIv~l~g~~ 411 (724)
......|...+.||+|..+.|.++.. ..|+++|+|++..... ... +.-..|+.||+++ .||+|+.|.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 34456777788899999999998875 4688999998854311 112 2356799999999 699999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEe
Q 040832 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADF 491 (724)
Q Consensus 412 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DF 491 (724)
..+...++|+|.|+.|.|.++|...- .+++....+|++||++|+.|||.+ +||||||||+|||+|+|.++||+||
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence 99999999999999999999998654 489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCccccccccCCCcCCcchhcC------CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhh-
Q 040832 492 GLAKLTTDNNTHVSTRVMGTFGYLAPEYASS------GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARP- 564 (724)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~- 564 (724)
|+++.+...... ..++||++|+|||.+.. ..|+...|+|++|||||-||.|..|| |.+.
T Consensus 168 GFa~~l~~GekL--relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPF------------wHRkQ 233 (411)
T KOG0599|consen 168 GFACQLEPGEKL--RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPF------------WHRKQ 233 (411)
T ss_pred ceeeccCCchhH--HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCch------------hHHHH
Confidence 999988765443 56889999999998864 35788999999999999999999999 3322
Q ss_pred -hhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 565 -LCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 565 -~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
++++.+..|++.---. ++ .+......+++.+||+.||.+|-+++|++++
T Consensus 234 mlMLR~ImeGkyqF~sp-----eW-adis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 234 MLMLRMIMEGKYQFRSP-----EW-ADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHHHHHHhcccccCCc-----ch-hhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 2333344444321100 00 2334557889999999999999999998863
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=338.25 Aligned_cols=272 Identities=17% Similarity=0.232 Sum_probs=189.6
Q ss_pred HhhCCCcccceeeccCcEEEEEEEcCC--CcEEEEE------------------EeccCCchhHHHHHHHHHHHHhcCCC
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVLPN--GKEVAVK------------------SLRSGSGQGEREFKAEVEIISRVHHR 402 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~~~--g~~vaVK------------------~l~~~~~~~~~~f~~Ei~il~~l~Hp 402 (724)
...++|.+++.||+|+||+||++.++. +..+++| .++. .....+.|.+|+.+|++|+|+
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCC
Confidence 345789999999999999999987532 2222222 1111 112345688999999999999
Q ss_pred CeeEEeeEEEeCCeEEEEEEecCCCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEE
Q 040832 403 HLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKG---RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNIL 479 (724)
Q Consensus 403 nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~---~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NIL 479 (724)
||+++++++...+..|+|+|++.+ +|..++.... .......++++|+.||++||+|||++ +||||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 999999999999999999999965 5555554321 11233566788999999999999998 9999999999999
Q ss_pred EcCCCCEEEEEeccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCC-CCCCC-chhhh
Q 040832 480 LDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP-IDPTG-AMEDC 557 (724)
Q Consensus 480 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P-~~~~~-~~~~~ 557 (724)
|+.++.+||+|||+++.+............|+..|+|||++.+..++.++|||||||+||||++|+.+ |.... .....
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 99999999999999987765444334456799999999999999999999999999999999998754 43321 11112
Q ss_pred HHhhhhhh--hhhcccC--CChhhhcchhhhcCC---------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 558 LVDWARPL--CLRALDD--GNFNEIADPYLEKNY---------PTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 558 l~~w~~~~--~~~~~~~--~~~~~~vd~~l~~~~---------~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+......+ +...+.+ ..+.+.++....... .......+.+++.+||+.||++||++.|++.+
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 21111100 0000000 000111110000000 00112346677899999999999999999874
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=309.62 Aligned_cols=253 Identities=25% Similarity=0.371 Sum_probs=206.1
Q ss_pred HhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
...+.|...+.||+|+||.||+|.+. +++.|++|++..... ....+.+|++++++++|+||+++++++......++||
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 34567888889999999999999976 588899999976544 4567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+++++|.+++.... ..+++..++.++.||++||.|||+. +|+|+||+++||+|+.++.++|+|||++.......
T Consensus 95 e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 95 EYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 9999999999998764 3589999999999999999999998 99999999999999999999999999987654332
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
. ......++..|++||++.+..++.++|||+|||+||+|++|+.||.......... .+.. .....+.
T Consensus 171 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~-~~~~---------~~~~~~~-- 237 (286)
T cd06614 171 S-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF-LITT---------KGIPPLK-- 237 (286)
T ss_pred h-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHh---------cCCCCCc--
Confidence 2 1233457889999999988889999999999999999999999997543322111 1100 0000000
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
........+.+++.+|++.+|.+||++.+|++
T Consensus 238 -----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 238 -----NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -----chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 01112346888999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=321.03 Aligned_cols=266 Identities=21% Similarity=0.264 Sum_probs=199.7
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC------
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAG------ 414 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~------ 414 (724)
..++|++.+.||+|+||.||+|... +++.||||.+... .......+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3578999999999999999999954 6889999998643 223345678899999999999999999988644
Q ss_pred CeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccc
Q 040832 415 GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLA 494 (724)
Q Consensus 415 ~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla 494 (724)
...++||||+. ++|...+... +++..+..++.||++||+|||++ +|+|||||++|||++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35689999996 4777777543 78889999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHH---hhhhh-------
Q 040832 495 KLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLV---DWARP------- 564 (724)
Q Consensus 495 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~---~w~~~------- 564 (724)
+....... .....++..|+|||++.+..++.++|||||||+||+|++|+.||...+....... .+..+
T Consensus 166 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 166 RTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 87654322 2334578899999999999999999999999999999999999976543221100 00000
Q ss_pred ---hhhhcc------cCCChhhhcchhhh----cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 565 ---LCLRAL------DDGNFNEIADPYLE----KNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 565 ---~~~~~~------~~~~~~~~vd~~l~----~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.....+ ....+.++....+. ..........+.+++.+||+.+|++||++.||+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 00011111111110 01122345568899999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=329.22 Aligned_cols=243 Identities=23% Similarity=0.379 Sum_probs=194.1
Q ss_pred cceeeccCcEEEEEEEcC-CCcEEEEEEec--cC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCe--EEEEEEe
Q 040832 351 SNLLGQGGFGYVHKGVLP-NGKEVAVKSLR--SG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGK--RLLVYEY 423 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~--~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~--~~lV~E~ 423 (724)
..+||+|+|-+||||.+. .|.+||--.++ .. .....++|..|+++|+.|+|+||++++.++.+... +.+|.|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 455999999999999974 46677743332 11 22334679999999999999999999999987665 7799999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC-CCCEEEEEeccccccCCCCC
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY-TFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~-~~~vkL~DFGla~~~~~~~~ 502 (724)
+..|+|+.++.+.++ ++...++.|++||++||.|||++ ++.|||||||.+||||+. -|+|||+|+|||........
T Consensus 125 ~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a 201 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA 201 (632)
T ss_pred ccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence 999999999988766 88889999999999999999996 778999999999999976 58999999999998765432
Q ss_pred ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchh
Q 040832 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~ 582 (724)
..++||+.|||||.+. ..|++..||||||++|+||+|+..||..-..-.+.... +...+.-..|..+-|
T Consensus 202 ---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKK-----V~SGiKP~sl~kV~d-- 270 (632)
T KOG0584|consen 202 ---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKK-----VTSGIKPAALSKVKD-- 270 (632)
T ss_pred ---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHH-----HHcCCCHHHhhccCC--
Confidence 3488999999999887 78999999999999999999999999754333221110 111111222222222
Q ss_pred hhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 583 LEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 583 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
.++.++|.+|+.. ...|+++.|++.
T Consensus 271 ----------Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 271 ----------PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ----------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 3478899999999 999999999986
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=312.17 Aligned_cols=254 Identities=28% Similarity=0.410 Sum_probs=194.3
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcC-CCCeeEEeeEEEeCCeEEEEEEe
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVH-HRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
+|...+.||+|+||.||++.+. +++.||||.+..... .....+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4455678999999999999854 578999999875432 34457899999999996 99999999999999999999999
Q ss_pred cCCCCHHHH---HhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 424 VPNNNLEFH---LHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 424 ~~~gsL~~~---L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
+.. +|..+ +.......+.+..+.+++.++++||+|||+.+ +|+|||||++|||++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 44433 33333345899999999999999999999743 8999999999999999999999999999866443
Q ss_pred CCccccccccCCCcCCcchhcCC---CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSG---KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~---~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
... ....|+..|+|||++... .++.++|||||||++|||++|+.||.........+... ..+..
T Consensus 162 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---------~~~~~-- 228 (288)
T cd06616 162 IAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQV---------VKGDP-- 228 (288)
T ss_pred Ccc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhh---------cCCCC--
Confidence 222 233588899999998766 68899999999999999999999996543111111000 00100
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+.+...........+.+++.+||+.+|++||++.+|+++
T Consensus 229 ---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 ---PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ---CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111112344568899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=309.18 Aligned_cols=265 Identities=23% Similarity=0.311 Sum_probs=200.0
Q ss_pred CcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcC-CCCeeEEeeEEEeCCeEEEEEEec
Q 040832 348 FSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVH-HRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
|.+.+.||+|+||.||+|.+. +++.|+||++..... .....+.+|+..+++++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 667889999999999999975 478899999875432 22334567999999998 999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
+++|.+++.......+.+.+++.++.||+++|.|||++ +++|+||+++||||+.++.++|+|||++.........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY- 155 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc-
Confidence 88898888776545689999999999999999999998 9999999999999999999999999999866543221
Q ss_pred ccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhH--Hh---------hhhhhhhhcccC
Q 040832 505 STRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCL--VD---------WARPLCLRALDD 572 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l--~~---------w~~~~~~~~~~~ 572 (724)
....++..|+|||++.. ..++.++||||||++||||++|+.+|......+... .. |...........
T Consensus 156 -~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 156 -TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred -CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 33457889999998754 457899999999999999999999996654322210 01 111000000000
Q ss_pred CChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 573 GNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 573 ~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+.......+.... ......+.+++.+|++.+|++||++.||+.+
T Consensus 235 ~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000101111101 1124678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.09 Aligned_cols=264 Identities=24% Similarity=0.330 Sum_probs=213.9
Q ss_pred CHHHHHHhhCCCcccceeeccCcEEEEEEEcC------CCcEEEEEEeccCCchh-HHHHHHHHHHHHhcCCCCeeEEee
Q 040832 337 TYEELSAATGGFSQSNLLGQGGFGYVHKGVLP------NGKEVAVKSLRSGSGQG-EREFKAEVEIISRVHHRHLVSLVG 409 (724)
Q Consensus 337 ~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vaVK~l~~~~~~~-~~~f~~Ei~il~~l~HpnIv~l~g 409 (724)
..++|.....+|+..-++-+|.||+||+|+|. +.+.|.||.++....+. ...|+.|.-+|..+.|+|+..+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 35677777788999999999999999999764 34567889988764443 346889999999999999999999
Q ss_pred EEEeC-CeEEEEEEecCCCCHHHHHhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC
Q 040832 410 YCIAG-GKRLLVYEYVPNNNLEFHLHG------KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY 482 (724)
Q Consensus 410 ~~~~~-~~~~lV~E~~~~gsL~~~L~~------~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~ 482 (724)
++.++ ...+++|.++.-|+|+.||.- +....+...+.+.++.|++.|++|||++ +|||.||..+|++||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence 98765 467899999999999999972 2334567778899999999999999999 9999999999999999
Q ss_pred CCCEEEEEeccccccCCCCCcc-ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHh
Q 040832 483 TFETKVADFGLAKLTTDNNTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVD 560 (724)
Q Consensus 483 ~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~ 560 (724)
..++||+|-.|++.+-..+.+. .........||++|.+.+..|+.++|||||||+||||+| |+.|+...+..+-.
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~--- 508 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME--- 508 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH---
Confidence 9999999999999876655552 233445678999999999999999999999999999999 99998765433211
Q ss_pred hhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 561 WARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 561 w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
..+.+|. .-..+.++..+|..++.-||+..|++||+++|++..|.+
T Consensus 509 -------~ylkdGy---------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 509 -------HYLKDGY---------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred -------HHHhccc---------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 1111111 112234566788899999999999999999999998864
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=309.11 Aligned_cols=247 Identities=23% Similarity=0.354 Sum_probs=200.3
Q ss_pred CcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCC
Q 040832 348 FSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPN 426 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 426 (724)
|...+.||+|+||.||++.. .+++.|+||+++.......+.+.+|+.++++++|+||+++++++...+..++|+||+.+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44557899999999999985 46888999998765545556789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcccc
Q 040832 427 NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST 506 (724)
Q Consensus 427 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 506 (724)
++|.+++... .+++..++.|+.||+.||+|||++ +|+||||+++|||++.++.++|+|||++......... ..
T Consensus 101 ~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-~~ 173 (285)
T cd06648 101 GALTDIVTHT---RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-RK 173 (285)
T ss_pred CCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-cc
Confidence 9999998762 388999999999999999999998 9999999999999999999999999998765443221 23
Q ss_pred ccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcC
Q 040832 507 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKN 586 (724)
Q Consensus 507 ~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~ 586 (724)
...|+..|++||.+.+..++.++|||||||+||||++|+.||.......... .. ..... ..+.
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~-----~~-----~~~~~-----~~~~-- 236 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK-----RI-----RDNLP-----PKLK-- 236 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH-----HH-----HhcCC-----CCCc--
Confidence 3458899999999988889999999999999999999999997543221110 00 00000 0000
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 587 YPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
........+.+++.+||+.+|++||++.+|++
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 01112356899999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=316.71 Aligned_cols=248 Identities=28% Similarity=0.379 Sum_probs=207.9
Q ss_pred HhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEE
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRL 418 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 418 (724)
...+.|+.-++||+||||+||-+... .|+-||+|.|... ..+.+.-.++|-.||.+++.++||.|--.|...+.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 34567899999999999999998854 5899999988543 2233445788999999999999999998899999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
|||..|.||+|..+|.+.+...+++..++.++.+|+.||++||+. +||+|||||+|||||+.|+|+|+|+|||..+.
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 999999999999999998888899999999999999999999999 99999999999999999999999999999887
Q ss_pred CCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhh
Q 040832 499 DNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEI 578 (724)
Q Consensus 499 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 578 (724)
..... ...+||.+|||||++.++.|+...|.|+|||+||||+.|+.||...... +.| +.
T Consensus 339 ~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK----vk~---------------eE 397 (591)
T KOG0986|consen 339 EGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK----VKR---------------EE 397 (591)
T ss_pred CCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh----hhH---------------HH
Confidence 76554 3347999999999999999999999999999999999999999643111 111 12
Q ss_pred cchhh---hcCCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 040832 579 ADPYL---EKNYPTEEMARMVACAAASIRHSARRRPKIS 614 (724)
Q Consensus 579 vd~~l---~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ 614 (724)
+|.+. ...|+.........+....|..||.+|.-..
T Consensus 398 vdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 398 VDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 22221 1245566667778888888999999997554
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=326.72 Aligned_cols=245 Identities=27% Similarity=0.441 Sum_probs=204.2
Q ss_pred eeeccCcEEEEEEEcCC-CcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCCCHHH
Q 040832 353 LLGQGGFGYVHKGVLPN-GKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEF 431 (724)
Q Consensus 353 ~LG~G~fG~Vyk~~~~~-g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 431 (724)
+||+|.||.||-|++.+ ...+|||.+.....+..+-+.+||.+.++|+|.|||+++|.|.+++..-|.||.++||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 59999999999999765 44689999977666666779999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEc-CCCCEEEEEeccccccCCCCCccccccc
Q 040832 432 HLHGKGRPV-MDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLD-YTFETKVADFGLAKLTTDNNTHVSTRVM 509 (724)
Q Consensus 432 ~L~~~~~~~-l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~ 509 (724)
+|..+=++. -++..+-.+.+||++||.|||++ .|||||||-+||||+ ..|.+||+|||-++.+..-+. ....+-
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TETFT 737 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTETFT 737 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCc-cccccc
Confidence 998753321 26677888999999999999999 999999999999995 689999999999998765433 334577
Q ss_pred cCCCcCCcchhcCC--CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCC
Q 040832 510 GTFGYLAPEYASSG--KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNY 587 (724)
Q Consensus 510 gt~~y~APE~~~~~--~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~ 587 (724)
||..|||||++..| .|..++|||||||.+.||.||+.||-....-+.... .-|-| ..+...
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF-----------kVGmy------KvHP~i 800 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF-----------KVGMY------KVHPPI 800 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh-----------hhcce------ecCCCC
Confidence 99999999999876 588999999999999999999999965533221110 00111 123456
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 588 PTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 588 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
+.+...+...++.+|+..+|.+||+++++++
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 7788899999999999999999999999985
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=312.68 Aligned_cols=246 Identities=25% Similarity=0.346 Sum_probs=195.3
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG---QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~---~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
..|.+.+.||+|+||.||+|.+. +++.||+|.+..... ...+++.+|+++++.++|+||++++++|.+++..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999864 688999998864322 23356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+. |+|.+++..... .+.+..++.++.||+.||.|||+. +|+||||+++||+++.++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~-~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKK-PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HhhC-CCHHHHHHHccc-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 9997 566666554322 489999999999999999999998 9999999999999999999999999999765432
Q ss_pred CccccccccCCCcCCcchhc---CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhh
Q 040832 502 THVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEI 578 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~---~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 578 (724)
....++..|+|||++. .+.++.++||||||+++|||++|+.||.......... .. .......
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~-~~---------~~~~~~~- 233 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HI---------AQNDSPT- 233 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH-HH---------hcCCCCC-
Confidence 2345788999999874 4568899999999999999999999997543222110 00 0000000
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 579 ADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 579 vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.........+.+++.+||..+|++||++.+|+++
T Consensus 234 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 -------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0011234568999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=299.64 Aligned_cols=247 Identities=26% Similarity=0.415 Sum_probs=203.9
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
+|++.+.||+|+||.||++.+. +++.|+||.+..... .....+.+|++++++++|+||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999865 578899999976643 3446799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+.+++|.+++...+ .+++..++.++.|++.+|.|||+. +|+|||||++||+++.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999999987653 489999999999999999999998 9999999999999999999999999999877654332
Q ss_pred cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 504 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
.....++..|++||++....++.++|||+||+++|+|++|+.||........ .|... ....
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~---~~~~~-------~~~~-------- 216 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA---LFRIV-------QDDH-------- 216 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHh-------ccCC--------
Confidence 2335688899999999888889999999999999999999999975432211 11100 0000
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
...+......+..++.+||..+|++||++.+++.
T Consensus 217 -~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 -PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0111222456789999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=309.58 Aligned_cols=270 Identities=23% Similarity=0.277 Sum_probs=200.4
Q ss_pred HhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC----
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAGG---- 415 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~---- 415 (724)
...++|++.+.||+|+||.||+|.++ +++.||||+++.... .....+.+|++++++++|+||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999975 578999999975432 22356788999999999999999999987654
Q ss_pred ------eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEE
Q 040832 416 ------KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVA 489 (724)
Q Consensus 416 ------~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~ 489 (724)
..++||||+++ +|..++... ...+++..++.|+.||+.||+|||+. +|+|||||++|||+++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence 78999999986 666666554 23589999999999999999999998 99999999999999999999999
Q ss_pred EeccccccCCCCCccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhh-
Q 040832 490 DFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCL- 567 (724)
Q Consensus 490 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~- 567 (724)
|||++...............++..|++||++.+ ..++.++|||+|||++|||++|+.||......+.... .......
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~-~~~~~~~~ 237 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL-ISRLCGSP 237 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHhCCC
Confidence 999998765443322233446788999998865 4578899999999999999999999976543322111 1110000
Q ss_pred -----hcccCC-Chh-----hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 568 -----RALDDG-NFN-----EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 568 -----~~~~~~-~~~-----~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+... .+. ......+...+. .....+.+++.+||+.+|.+||++.+|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000 000 000000000000 123568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=305.59 Aligned_cols=261 Identities=21% Similarity=0.269 Sum_probs=194.7
Q ss_pred CcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcC-CCCeeEEeeEEEeC--CeEEEEEE
Q 040832 348 FSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVH-HRHLVSLVGYCIAG--GKRLLVYE 422 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~--~~~~lV~E 422 (724)
|++.+.||+|+||.||+|... +++.||||+++.... .......+|+.+++++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999854 688999999875422 22334567899999995 99999999999987 88999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|+.+ +|.+++.... ..+++..++.++.||+.||.|||+. +|+|||||++|||++. +.+||+|||+++.......
T Consensus 81 ~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMDM-NLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCCc-cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 9974 6777666533 3589999999999999999999998 9999999999999999 9999999999987654322
Q ss_pred ccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhh-------hcccCC-
Q 040832 503 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCL-------RALDDG- 573 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~-------~~~~~~- 573 (724)
. ....++..|+|||++.. +.++.++|||||||+||||++|..||...+..+. +.+...... ..+...
T Consensus 155 ~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 155 Y--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ--IAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred c--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH--HHHHHHHcCCCCHHHHHhhcccc
Confidence 2 23457889999997654 5678899999999999999999999976543221 111111000 000000
Q ss_pred ----ChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 574 ----NFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 574 ----~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+.......+ ..........+.+++.+||+.+|++||++.+|+++
T Consensus 231 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 231 HMNYNFPSKKGTGL-RKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccCcccccccH-HHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000000 00011335778999999999999999999999874
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=306.35 Aligned_cols=247 Identities=26% Similarity=0.324 Sum_probs=201.5
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
+|.+.+.||+|+||.||++.+. +++.||+|.+.... ....+.+.+|++++++++|+||+++++++..+...++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5888999999999999999975 58899999986532 2345679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|+.+++|..++... ..+.+..++.|+.||++||.|||+. +++|+||+++|||+++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence 99999999999765 3488999999999999999999998 999999999999999999999999999987654321
Q ss_pred ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchh
Q 040832 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~ 582 (724)
.....|+..|++||++....++.++||||||+++|+|++|+.||....... ..+.... ...
T Consensus 156 --~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~----~~~---------- 216 (258)
T cd05578 156 --TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI---RDQIRAK----QET---------- 216 (258)
T ss_pred --ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH---HHHHHHH----hcc----------
Confidence 233457889999999988889999999999999999999999997653211 0110000 000
Q ss_pred hhcCCCHHHHHHHHHHHHHhhccCCCCCCCH--HHHH
Q 040832 583 LEKNYPTEEMARMVACAAASIRHSARRRPKI--SQIV 617 (724)
Q Consensus 583 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~--~evv 617 (724)
.....+......+.+++.+||+.+|++|+++ +|++
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0011222233678899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=304.01 Aligned_cols=264 Identities=24% Similarity=0.330 Sum_probs=198.5
Q ss_pred CcccceeeccCcEEEEEEEcCC-CcEEEEEEeccCCch--hHHHHHHHHHHHHhc---CCCCeeEEeeEEEeCCe-----
Q 040832 348 FSQSNLLGQGGFGYVHKGVLPN-GKEVAVKSLRSGSGQ--GEREFKAEVEIISRV---HHRHLVSLVGYCIAGGK----- 416 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~~-g~~vaVK~l~~~~~~--~~~~f~~Ei~il~~l---~HpnIv~l~g~~~~~~~----- 416 (724)
|++.+.||+|+||.||+|.+.. ++.||||.++..... ....+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6778899999999999999764 899999999743222 234577788887776 59999999999988776
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
.+++|||+.+ +|..++.......+++..++.++.||++||.|||+. +++|+||+++|||++.++.+||+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999974 788888765544689999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhc---cc--
Q 040832 497 TTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRA---LD-- 571 (724)
Q Consensus 497 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~---~~-- 571 (724)
....... ....++..|++||++.+..++.++|||||||++|||++|+.+|......+. +..+........ ..
T Consensus 157 ~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 157 YSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ-LDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred ccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH-HHHHHHHcCCCChHhcCCC
Confidence 6443221 233478899999999988999999999999999999999999876543221 111111000000 00
Q ss_pred ----CCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 572 ----DGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 572 ----~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
...+.......+ .....+....+.+++.+||+.+|++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 234 VSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000000000000 01112334667889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.52 Aligned_cols=267 Identities=18% Similarity=0.203 Sum_probs=198.9
Q ss_pred CcccceeeccCcEEEEEEEcCCCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecC
Q 040832 348 FSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVP 425 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 425 (724)
|.+++.+|.|+++.||++.. +++.||||+++.. .....+.+..|+++|++++|+||+++++++.+.+..+++|||+.
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 34455667777777777766 7899999998754 33345679999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc--
Q 040832 426 NNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH-- 503 (724)
Q Consensus 426 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~-- 503 (724)
+++|++++.......+++..+..++.||++||+|||++ +|+|||||++||||+.++.+||+|||++.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999999865444588999999999999999999999 9999999999999999999999999998755332211
Q ss_pred ----cccccccCCCcCCcchhcCC--CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCC---
Q 040832 504 ----VSTRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGN--- 574 (724)
Q Consensus 504 ----~~~~~~gt~~y~APE~~~~~--~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~--- 574 (724)
......++..|+|||++... .++.++|||||||++|||++|+.||.........+.... ......+....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 238 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR-GTVPCLLDKSTYPL 238 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-ccCccccccCchhh
Confidence 11224567789999998763 578899999999999999999999976543222111110 00000000000
Q ss_pred ----hhh----hcch----hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 575 ----FNE----IADP----YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 575 ----~~~----~vd~----~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
... ..+. .....+.......+.+++.+||+.+|++||++.||+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 0000 01111223344678889999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=301.64 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=198.5
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC-----CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC--CeE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG-----SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAG--GKR 417 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~-----~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--~~~ 417 (724)
.+|.+.++||+|+||.||+|.+. +++.|++|.+... .......|.+|++++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46889999999999999999864 5889999987532 122335788999999999999999999998764 467
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
++||||+.+++|.+++...+. +.+..+++|+.||+.||.|||+. +|+|||||++|||++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGA--LTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 899999999999999876543 78999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCC--ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCCh
Q 040832 498 TDNNT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 498 ~~~~~--~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~ 575 (724)
..... .......|+..|+|||++.+..++.++|||||||+||||++|+.||......+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------ 224 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQ------------ 224 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcC------------
Confidence 32111 1112356889999999998888999999999999999999999999754332221110000
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 576 NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 576 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
......+......+.+++.+|++. +.+||+..+++++
T Consensus 225 ------~~~~~~p~~~~~~~~~~i~~~l~~-~~~r~~~~~~~~~ 261 (264)
T cd06653 225 ------PTKPMLPDGVSDACRDFLKQIFVE-EKRRPTAEFLLRH 261 (264)
T ss_pred ------CCCCCCCcccCHHHHHHHHHHhcC-cccCccHHHHhcC
Confidence 000112333446688899999995 6999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=307.08 Aligned_cols=259 Identities=18% Similarity=0.218 Sum_probs=185.0
Q ss_pred hCCCcccceeeccCcEEEEEEEcCCC----cEEEEEEeccCCchh--H---------HHHHHHHHHHHhcCCCCeeEEee
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPNG----KEVAVKSLRSGSGQG--E---------REFKAEVEIISRVHHRHLVSLVG 409 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~g----~~vaVK~l~~~~~~~--~---------~~f~~Ei~il~~l~HpnIv~l~g 409 (724)
.++|.+.++||+|+||.||+|.+.++ ..+|+|+........ + .....++..+..++|.||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46899999999999999999996543 456666543222111 1 11223344556678999999999
Q ss_pred EEEeCC----eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCC
Q 040832 410 YCIAGG----KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFE 485 (724)
Q Consensus 410 ~~~~~~----~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~ 485 (724)
++.... ..+++||++. .++.+++.... ...+..++.|+.||++||+|||+. +|+||||||+||||+.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCc
Confidence 776543 3467888774 35655555432 256788999999999999999998 9999999999999999999
Q ss_pred EEEEEeccccccCCCCCc------cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHH
Q 040832 486 TKVADFGLAKLTTDNNTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLV 559 (724)
Q Consensus 486 vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~ 559 (724)
+||+|||+++........ ......||..|+|||++.+..++.++|||||||+||||++|+.||.........+.
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 999999999876432211 11224599999999999999999999999999999999999999976532221111
Q ss_pred hhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 560 DWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 560 ~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
.-...+ ...+..+.+ . .......+.+++..|++.++++||++.+|++.|+
T Consensus 245 ~~~~~~-~~~~~~~~~--------~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 245 AAKCDF-IKRLHEGKI--------K---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HhHHHH-HHHhhhhhh--------c---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 000000 011111110 0 0112356889999999999999999999998763
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.61 Aligned_cols=248 Identities=26% Similarity=0.356 Sum_probs=196.0
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG---QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~---~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
.|...+.||+|+||.||++.+. +++.||||.+..... .....+..|++++++++|+||+++++++.++...+||||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3677788999999999999954 678999999864322 233568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|+.+ +|.+++.... ..+++.+++.++.||+.||.|||+. +|+||||+++||+++.++.+||+|||++......
T Consensus 106 ~~~g-~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 106 YCLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CCCC-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 9975 6666665432 2489999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccCCCcCCcchhc---CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 503 HVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~---~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
....|+..|+|||++. .+.++.++|||||||++|||++|+.||....... .+..+... . ..
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~--------~-~~--- 242 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQN--------E-SP--- 242 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHhc--------c-CC---
Confidence 2345788999999974 4578899999999999999999999986542211 11111110 0 00
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
..........+.+++.+||+.+|.+||++.+|++++-.
T Consensus 243 -----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 243 -----TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred -----CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 00011233458889999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=304.72 Aligned_cols=246 Identities=24% Similarity=0.350 Sum_probs=199.5
Q ss_pred eeccCcEEEEEEEcCC-CcEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCCCH
Q 040832 354 LGQGGFGYVHKGVLPN-GKEVAVKSLRSGSG---QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNL 429 (724)
Q Consensus 354 LG~G~fG~Vyk~~~~~-g~~vaVK~l~~~~~---~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 429 (724)
||+|+||.||++.+.+ ++.|++|.+..... ...+.+.+|++++++++|+||+++++++..+...++||||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999764 89999999875433 3345688999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC-------
Q 040832 430 EFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT------- 502 (724)
Q Consensus 430 ~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~------- 502 (724)
..++...+ .+++..++.|+.||++||+|||+. +++||||+++|||++.++.+||+|||++........
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99998755 489999999999999999999998 999999999999999999999999999976543321
Q ss_pred ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchh
Q 040832 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~ 582 (724)
.......++..|++||.+....++.++|||+||+++|||++|+.||+.....+. ... . ..+.+
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~~---~-----~~~~~------- 218 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI--FQN---I-----LNGKI------- 218 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHH---H-----hcCCc-------
Confidence 122335678899999999888899999999999999999999999975532211 110 0 00110
Q ss_pred hhcCCCHH--HHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 583 LEKNYPTE--EMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 583 l~~~~~~~--~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
..... ....+..++.+|++.+|++||++.+|.+.|+..+
T Consensus 219 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~ 259 (265)
T cd05579 219 ---EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPF 259 (265)
T ss_pred ---CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcc
Confidence 00111 2466889999999999999999977777776543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=299.37 Aligned_cols=250 Identities=25% Similarity=0.404 Sum_probs=205.3
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
+|.+.+.||+|+||.||++.+. +++.|++|++..... ...+.+.+|++++++++|+|++++++.+..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999965 588999999976533 4456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 424 VPNNNLEFHLHGKG--RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 424 ~~~gsL~~~L~~~~--~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
+++++|..++.... ...+++..++.|+.+|++||.|||+. +++|+||+++|||++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999987642 34589999999999999999999998 99999999999999999999999999998765543
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
.......|+..|++||.+....++.++|||+||+++|+|++|+.||+.....+ ....+. ...+..
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~~~---------~~~~~~---- 222 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-LALKIL---------KGQYPP---- 222 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH-HHHHHh---------cCCCCC----
Confidence 22233568889999999988889999999999999999999999997543211 111110 011111
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+......+.+++.+||..+|++||++.+|+++
T Consensus 223 -----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 223 -----IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111233567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.86 Aligned_cols=265 Identities=20% Similarity=0.279 Sum_probs=201.6
Q ss_pred CcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 348 FSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ--GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~--~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
|.+.+.||+|+||.||++... +++.+++|+++..... ....+.+|+++|++++|+||+++++++..+...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566788999999999999864 6888999998754332 3457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
.+ +|.+++..+. ..+++..++.++.||++||.|||+. +|+|+|||++|||++.++.+||+|||++....... ..
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 75 7877776643 3589999999999999999999998 99999999999999999999999999998776543 12
Q ss_pred ccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHh---hhhh--hhhhcccC----C-
Q 040832 505 STRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVD---WARP--LCLRALDD----G- 573 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~---w~~~--~~~~~~~~----~- 573 (724)
.....++..|++||.+.+. .++.++||||||++||+|++|+.+|...+..+..... +..+ .....+.. .
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 2334578899999998776 7899999999999999999999999765543321110 0000 00000000 0
Q ss_pred -ChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 574 -NFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 574 -~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+.......+ .....+....+.+++..||+.+|.+||++.+|+.+
T Consensus 235 ~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 235 FSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000000000 00112345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=302.04 Aligned_cols=248 Identities=26% Similarity=0.405 Sum_probs=203.5
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
+|++.+.||+|+||.||++... +++.++||.+.... .....++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999854 67889999987532 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 424 VPNNNLEFHLHGK--GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 424 ~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
+.+++|..++... ....+++..++.++.||++||+|||+. +++||||+++||+++.++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999999988652 234589999999999999999999998 99999999999999999999999999998776542
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
.....++..|++||++.+..++.++|+||||+++|||++|+.||...+..+. ... +..+.+.
T Consensus 158 ---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~-~~~---------~~~~~~~----- 219 (256)
T cd08530 158 ---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL-RYK---------VQRGKYP----- 219 (256)
T ss_pred ---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH---------HhcCCCC-----
Confidence 1224578899999999988899999999999999999999999976542211 110 1111111
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.........+..++.+|+..+|++||++.+|+++
T Consensus 220 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 ----PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ----CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1122344568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=316.11 Aligned_cols=269 Identities=22% Similarity=0.345 Sum_probs=198.9
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC--CchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeC--CeE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG--SGQGEREFKAEVEIISRV-HHRHLVSLVGYCIAG--GKR 417 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~--~~~ 417 (724)
..++|.+.+.||+|+||.||+|.+. +++.||||++... .......+.+|+.+++++ +|+||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888899999999999999965 5788999988543 222344677899999999 999999999998654 367
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
++||||+. ++|..++... .+++..++.++.||+.||+|||+. +|+|||||++||||+.++.+||+|||+++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999997 5888888654 478999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCc----cccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhh--HHhhhhhhh---h
Q 040832 498 TDNNTH----VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC--LVDWARPLC---L 567 (724)
Q Consensus 498 ~~~~~~----~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~--l~~w~~~~~---~ 567 (724)
...... ......|+..|++||++.. ..++.++|||||||++|||++|+.||......+.. +..+..... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 543321 2234568899999998765 46788999999999999999999999765433221 111100000 0
Q ss_pred hcccCCChhhhcchhhhc------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 568 RALDDGNFNEIADPYLEK------NYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 568 ~~~~~~~~~~~vd~~l~~------~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+.......+++..... .........+.+++.+||+.+|++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000000000000 0001134568899999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=316.89 Aligned_cols=265 Identities=20% Similarity=0.316 Sum_probs=197.9
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC-----eE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGG-----KR 417 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~-----~~ 417 (724)
.++|++.++||+|+||.||+|.+ .+++.||||++.... ......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 47899999999999999999985 468899999986432 233456889999999999999999999876543 57
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
++||||+.+ +|..++..+ .+.+..++.++.||++||+|||+. +|+|||||++||||+.++.+||+|||+++..
T Consensus 84 ~lv~e~~~~-~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhccc-CHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 999999964 777777543 389999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc--cccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCC
Q 040832 498 TDNNTH--VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGN 574 (724)
Q Consensus 498 ~~~~~~--~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~ 574 (724)
...... ......|+..|+|||.+.+ ..++.++|||||||+||||++|+.||........ +..+...+ . ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~-~~~~~~~~-~-~~~~~~ 233 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ-LNLILGVL-G-TPSQED 233 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHc-C-CCCHHH
Confidence 443221 1233568899999998754 4688999999999999999999999976432221 11111000 0 000001
Q ss_pred hhhhcchh----hh---c--C-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 575 FNEIADPY----LE---K--N-----YPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 575 ~~~~vd~~----l~---~--~-----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+..+.+.. +. . . ........+.+++.+||+.+|++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11111000 00 0 0 001124568899999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.38 Aligned_cols=242 Identities=24% Similarity=0.331 Sum_probs=187.6
Q ss_pred eeeccCcEEEEEEEcC-CCcEEEEEEeccCCc---hhHHHHHHHHHHHHh---cCCCCeeEEeeEEEeCCeEEEEEEecC
Q 040832 353 LLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG---QGEREFKAEVEIISR---VHHRHLVSLVGYCIAGGKRLLVYEYVP 425 (724)
Q Consensus 353 ~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~---~~~~~f~~Ei~il~~---l~HpnIv~l~g~~~~~~~~~lV~E~~~ 425 (724)
+||+|+||.||++.+. +++.||||.+..... .....+.+|..+++. .+|+||+.+++++..++..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 588999998865422 122334555544444 479999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccc
Q 040832 426 NNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVS 505 (724)
Q Consensus 426 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 505 (724)
+++|.+++...+. +.+..+..|+.||+.||+|||+. +|+|||||++|||+++++.+||+|||++........
T Consensus 81 ~~~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~--- 152 (279)
T cd05633 81 GGDLHYHLSQHGV--FSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 152 (279)
T ss_pred CCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---
Confidence 9999998876543 89999999999999999999998 999999999999999999999999999976543222
Q ss_pred cccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhh
Q 040832 506 TRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLE 584 (724)
Q Consensus 506 ~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~ 584 (724)
....|+..|+|||.+.. ..++.++|||||||+||||++|+.||........... ..... ...
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~--~~~~~---------------~~~ 215 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--DRMTL---------------TVN 215 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH--HHHhh---------------cCC
Confidence 23458999999999864 4588999999999999999999999975422111100 00000 000
Q ss_pred cCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 040832 585 KNYPTEEMARMVACAAASIRHSARRRP-----KISQIVRA 619 (724)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evv~~ 619 (724)
...+......+.+++.+||+.+|++|+ ++++++++
T Consensus 216 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 216 VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 112223345788899999999999999 59888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=305.38 Aligned_cols=241 Identities=27% Similarity=0.377 Sum_probs=191.2
Q ss_pred eeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCCCH
Q 040832 354 LGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNL 429 (724)
Q Consensus 354 LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 429 (724)
||+|+||.||++... +|+.||+|.+.... ....+.+..|+++|++++|+||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 68899999986432 12344578899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccccccc
Q 040832 430 EFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM 509 (724)
Q Consensus 430 ~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 509 (724)
.+++.......+.+..++.++.||+.||.|||+. +++||||+++|||++.++.+||+|||++........ .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--ccccc
Confidence 9999876655689999999999999999999998 999999999999999999999999999986654221 12345
Q ss_pred cCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCH
Q 040832 510 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPT 589 (724)
Q Consensus 510 gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~ 589 (724)
++..|++||++.++.++.++|||||||++|+|++|+.||.......... .... .... ....+..
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~-----~~~~----------~~~~~~~ 219 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE-ELKR-----RTLE----------MAVEYPD 219 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH-HHHh-----cccc----------ccccCCc
Confidence 7889999999988889999999999999999999999997543211000 0000 0000 0001122
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHH
Q 040832 590 EEMARMVACAAASIRHSARRRPKISQ 615 (724)
Q Consensus 590 ~~~~~l~~l~~~cl~~~P~~RPs~~e 615 (724)
.....+.+++.+||+.+|++||+..+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 220 KFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred cCCHHHHHHHHHHccCChhHccCCCc
Confidence 23456789999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.99 Aligned_cols=268 Identities=23% Similarity=0.308 Sum_probs=197.5
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchh--HHHHHHHHHHHHhcCCCCeeEEeeEEEeC--CeEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQG--EREFKAEVEIISRVHHRHLVSLVGYCIAG--GKRLL 419 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~--~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~l 419 (724)
.++|++.+.||+|+||.||+|.+. +|+.||+|.++...... ...+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999964 58899999987543222 23567899999999999999999998765 46899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
||||+.+ +|.+++.... ..+.+.+++.++.||++||+|||+. +++|||||++|||+++++.+||+|||++.....
T Consensus 86 v~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 9999965 7877776533 3589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhh--HHhhhhh---hhhhcccC-
Q 040832 500 NNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC--LVDWARP---LCLRALDD- 572 (724)
Q Consensus 500 ~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~--l~~w~~~---~~~~~~~~- 572 (724)
.... .....++..|+|||.+.+ ..++.++|||||||+||||++|+.||......+.. +..+... .....+..
T Consensus 161 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 161 PAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred ccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 3221 222345788999999865 45789999999999999999999999765433221 1111000 00000000
Q ss_pred ---CChh--hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 573 ---GNFN--EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 573 ---~~~~--~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+. ......+... .......+.+++.+||+.||++||++.+|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccCCCCCchHHh-ccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 0000000000 00123456789999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=312.13 Aligned_cols=264 Identities=19% Similarity=0.238 Sum_probs=194.5
Q ss_pred ceeecc--CcEEEEEEEcC-CCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCC
Q 040832 352 NLLGQG--GFGYVHKGVLP-NGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPN 426 (724)
Q Consensus 352 ~~LG~G--~fG~Vyk~~~~-~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 426 (724)
+.||+| +||.||++.+. +|+.||||++..... ...+.|.+|+.+++.++|+||++++++|..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 99999999864 789999999875422 2235688999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc--
Q 040832 427 NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV-- 504 (724)
Q Consensus 427 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-- 504 (724)
++|.+++.......+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999998875545589999999999999999999998 99999999999999999999999998664332211110
Q ss_pred ----ccccccCCCcCCcchhcCC--CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhh----hhhh------
Q 040832 505 ----STRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARP----LCLR------ 568 (724)
Q Consensus 505 ----~~~~~gt~~y~APE~~~~~--~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~----~~~~------ 568 (724)
.....++..|++||++.++ .++.++|||||||+||||++|+.||......+......... +...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 0112345679999999764 47899999999999999999999997654322211110000 0000
Q ss_pred -c-------ccC----CChh-----hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 569 -A-------LDD----GNFN-----EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 569 -~-------~~~----~~~~-----~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
. ... ..+. .+.+..+.......+...+.+++.+||+.+|++||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 000 0000 000111111122345567899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=301.51 Aligned_cols=242 Identities=26% Similarity=0.318 Sum_probs=195.7
Q ss_pred eeccCcEEEEEEEcC-CCcEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCCCH
Q 040832 354 LGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG---QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNL 429 (724)
Q Consensus 354 LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~---~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 429 (724)
||+|+||.||++.+. +++.|+||.+..... ...+.+.+|+.++++++|+||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 488999999865322 2345799999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccccccc
Q 040832 430 EFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM 509 (724)
Q Consensus 430 ~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 509 (724)
.+++..... +.+..++.++.||+.||.|||++ +++|+|||++||||+.++.+||+|||+++...... ......
T Consensus 81 ~~~l~~~~~--l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~ 153 (262)
T cd05572 81 WTILRDRGL--FDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC 153 (262)
T ss_pred HHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence 999976543 88999999999999999999998 99999999999999999999999999998775442 123346
Q ss_pred cCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCH
Q 040832 510 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPT 589 (724)
Q Consensus 510 gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~ 589 (724)
|+..|++||++....++.++|||+||++||||++|..||.........+. . .+.+......++.
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~-------------~~~~~~~~~~~~~ 217 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY---N-------------DILKGNGKLEFPN 217 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHH---H-------------HHhccCCCCCCCc
Confidence 78899999999888899999999999999999999999976532111110 0 0000000111222
Q ss_pred HHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 040832 590 EEMARMVACAAASIRHSARRRPK-----ISQIVR 618 (724)
Q Consensus 590 ~~~~~l~~l~~~cl~~~P~~RPs-----~~evv~ 618 (724)
.....+..++.+||+.+|++|++ +.|+++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 23457899999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.21 Aligned_cols=251 Identities=25% Similarity=0.360 Sum_probs=197.2
Q ss_pred CCcccceeeccCcEEEEEEEc----CCCcEEEEEEeccCC----chhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVL----PNGKEVAVKSLRSGS----GQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKR 417 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~----~~g~~vaVK~l~~~~----~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 417 (724)
+|++.+.||+|+||.||++.. .+|+.||+|+++... ....+.+.+|+++|+++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999985 368899999987532 12345688899999999 699999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
++||||+++++|.++|.... .+.+..+..++.||++||.|||+. +++|||||++||||+.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999987654 378899999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCccccccccCCCcCCcchhcCC--CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCCh
Q 040832 498 TDNNTHVSTRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 498 ~~~~~~~~~~~~gt~~y~APE~~~~~--~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~ 575 (724)
............|+..|++||++... .++.++||||||++||+|++|+.||...... .....+...... .
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~-----~-- 227 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISRRILK-----S-- 227 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHHHHhhc-----c--
Confidence 54333222345688999999998753 4678999999999999999999999643211 111111111100 0
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 040832 576 NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRP-----KISQIVR 618 (724)
Q Consensus 576 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evv~ 618 (724)
...++......+..++.+|++.+|++|+ .+.+++.
T Consensus 228 --------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 --------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred --------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0112223345678999999999999997 5566654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=295.05 Aligned_cols=249 Identities=27% Similarity=0.395 Sum_probs=197.0
Q ss_pred cccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcC-CCCeeEEeeEEEeCCeEEEEEEecC
Q 040832 349 SQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVH-HRHLVSLVGYCIAGGKRLLVYEYVP 425 (724)
Q Consensus 349 ~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~ 425 (724)
.++..||.|..|.||+++.. .|..+|||.+..... ++.++++..++++.+-+ +|+||+.+|||..+...++.||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 34567999999999999964 588999999976544 44567888899887775 9999999999999999999999984
Q ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccc
Q 040832 426 NNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVS 505 (724)
Q Consensus 426 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 505 (724)
..++.+|..-.. .+.+..+=++...+++||.||.+++ +|||||+||+|||||+.|.+||||||++..+-+...+
T Consensus 175 -~C~ekLlkrik~-piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh-- 248 (391)
T KOG0983|consen 175 -TCAEKLLKRIKG-PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH-- 248 (391)
T ss_pred -HHHHHHHHHhcC-CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc--
Confidence 345566654333 3777778899999999999999986 8999999999999999999999999999988776554
Q ss_pred cccccCCCcCCcchhcC---CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchh
Q 040832 506 TRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582 (724)
Q Consensus 506 ~~~~gt~~y~APE~~~~---~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~ 582 (724)
++..|...|||||.+.- .+|+.++||||||+.|+||.||+.||....-.-+.+-.. .+ ..-++
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv---------ln-----~ePP~ 314 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV---------LN-----EEPPL 314 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH---------Hh-----cCCCC
Confidence 56679999999999853 479999999999999999999999998753221111100 00 00122
Q ss_pred hhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 583 LEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 583 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
|... ......+++++..||+.|..+||...+++++
T Consensus 315 L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 315 LPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 2221 1245678899999999999999999998864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=341.71 Aligned_cols=251 Identities=28% Similarity=0.432 Sum_probs=193.9
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC---------
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAG--------- 414 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--------- 414 (724)
.+|...++||+||||.|||++.+ ||+.||||++.... ....+.+.+|+.+|++|+|||||+++..+++.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 44555578999999999999965 89999999997653 23345789999999999999999987533211
Q ss_pred --------------------------------------------------------------------------------
Q 040832 415 -------------------------------------------------------------------------------- 414 (724)
Q Consensus 415 -------------------------------------------------------------------------------- 414 (724)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred ------------------------------CeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 040832 415 ------------------------------GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC 464 (724)
Q Consensus 415 ------------------------------~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~ 464 (724)
..+||-||||+..+|+++++.+.... .....++++++|++||+|+|++
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~~- 716 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHDQ- 716 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHhC-
Confidence 12378899999999999888754311 4678899999999999999999
Q ss_pred CCCeEecCCCCccEEEcCCCCEEEEEeccccccC------C-----------CCCccccccccCCCcCCcchhcCC---C
Q 040832 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT------D-----------NNTHVSTRVMGTFGYLAPEYASSG---K 524 (724)
Q Consensus 465 ~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~------~-----------~~~~~~~~~~gt~~y~APE~~~~~---~ 524 (724)
+||||||||.||+||.+..|||+|||+|+... + ......+..+||..|+|||++.+. .
T Consensus 717 --giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 717 --GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred --ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 99999999999999999999999999998721 0 001123457899999999999764 5
Q ss_pred CChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhc
Q 040832 525 LTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIR 604 (724)
Q Consensus 525 ~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~ 604 (724)
|+.|+|||||||||+||+. ||... |+... .+..+..+.+..- ..+..+.+..=..++.++++
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~-------iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~ 856 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTS--MERAS-------ILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLS 856 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCch--HHHHH-------HHHhcccCCCCCC------cccccccchHHHHHHHHHhc
Confidence 9999999999999999986 56543 33321 2223334444332 23445566667889999999
Q ss_pred cCCCCCCCHHHHHH
Q 040832 605 HSARRRPKISQIVR 618 (724)
Q Consensus 605 ~~P~~RPs~~evv~ 618 (724)
+||.+||++.|++.
T Consensus 857 hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 857 HDPSKRPTATELLN 870 (1351)
T ss_pred CCCccCCCHHHHhh
Confidence 99999999999985
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=305.12 Aligned_cols=257 Identities=25% Similarity=0.306 Sum_probs=201.7
Q ss_pred CCcccceeeccCcEEEEEEEc----CCCcEEEEEEeccCCc----hhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVL----PNGKEVAVKSLRSGSG----QGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKR 417 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~----~~g~~vaVK~l~~~~~----~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 417 (724)
+|++.+.||+|+||.||++.. .+++.||||.++.... ...+.+.+|++++.++ +|+||+++++++..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478889999999999999874 3567899999874321 2234688999999999 699999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
++||||+.+++|..++.... .+.+..++.++.|++++|.|||+. +++|||||++|||++.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999999987643 388999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCccccccccCCCcCCcchhcCCC--CChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCCh
Q 040832 498 TDNNTHVSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 498 ~~~~~~~~~~~~gt~~y~APE~~~~~~--~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~ 575 (724)
............|+..|++||.+.+.. .+.++|||+||++||||++|+.||........ ...+..... ..
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~~~~~~-----~~-- 227 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS-QSEISRRIL-----KS-- 227 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch-HHHHHHHHH-----cc--
Confidence 544332233356889999999987655 78899999999999999999999964321110 111111100 00
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 576 NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 576 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
....+......+.+++.+||+.+|++||++.++.+.|+..+
T Consensus 228 --------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 228 --------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268 (288)
T ss_pred --------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence 00111222345788999999999999999999988887653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=314.99 Aligned_cols=268 Identities=19% Similarity=0.290 Sum_probs=201.1
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEe----CCeE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIA----GGKR 417 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~----~~~~ 417 (724)
.++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+|++++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999954 58899999987542 2234567889999999999999999988753 3467
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
++||||+. ++|..++..... +++..++.++.||++||.|||+. +|+|||||++|||++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQP--LTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccCCC--CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 689888876543 89999999999999999999998 9999999999999999999999999999866
Q ss_pred CCCCCc---cccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhh------hh
Q 040832 498 TDNNTH---VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPL------CL 567 (724)
Q Consensus 498 ~~~~~~---~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~------~~ 567 (724)
...... ......|+..|++||++.. ..++.++|||||||++|||++|+.||...+..... ..+...+ ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~-~~~~~~~g~~~~~~~ 236 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL-KLILSVLGSPSEEVL 236 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH-HHHHHHhCCChhHhh
Confidence 433221 1234568899999999865 46889999999999999999999999765433221 1000000 00
Q ss_pred hcccCCChhhhcchhh-hcCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 568 RALDDGNFNEIADPYL-EKNY-----PTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 568 ~~~~~~~~~~~vd~~l-~~~~-----~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.......+.+.++..- .... .......+..++.+||+.+|++||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000111111111000 0001 11235678999999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=304.45 Aligned_cols=248 Identities=25% Similarity=0.373 Sum_probs=203.2
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC---CchhHHHHHHHHHHHHhcC-CCCeeEEeeEEEeCCeEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG---SGQGEREFKAEVEIISRVH-HRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV 420 (724)
++|.+.+.||+|+||.||++.+. +++.|++|++... .....+.+.+|++++++++ |+||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47889999999999999999965 6889999998653 1223457889999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+.+++|.+++...+ .+.+..++.|+.||+.||.|||+. +++|+|||++||+|+.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999998654 489999999999999999999998 9999999999999999999999999999876543
Q ss_pred CC-------------------ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhh
Q 040832 501 NT-------------------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDW 561 (724)
Q Consensus 501 ~~-------------------~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w 561 (724)
.. .......++..|++||.+....++.++|||+||+++|+|++|+.||........ ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~ 233 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT--FQK 233 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH--HHH
Confidence 32 112234678899999999888899999999999999999999999976532111 000
Q ss_pred hhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCH----HHHHH
Q 040832 562 ARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKI----SQIVR 618 (724)
Q Consensus 562 ~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~----~evv~ 618 (724)
.. .....++......+..++.+||+.+|++||++ .+|++
T Consensus 234 ~~------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 234 IL------------------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HH------------------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00 00011222235668999999999999999999 77665
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.00 Aligned_cols=269 Identities=22% Similarity=0.282 Sum_probs=196.7
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC------
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ--GEREFKAEVEIISRVHHRHLVSLVGYCIAGG------ 415 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~--~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~------ 415 (724)
.++|++.+.||+|+||.||+|.+. +++.||||++...... ....+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999964 5889999988654322 2346788999999999999999999875433
Q ss_pred --eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecc
Q 040832 416 --KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGL 493 (724)
Q Consensus 416 --~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGl 493 (724)
..++||||+.+ +|...+.... ..+++..++.|+.||++||+|||++ +|+|||||++|||+++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence 46899999975 5666665432 3489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc----------cccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhh
Q 040832 494 AKLTTDNNTH----------VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWA 562 (724)
Q Consensus 494 a~~~~~~~~~----------~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~ 562 (724)
++........ ......++..|+|||++.+. .++.++|||||||+||||++|+.+|............|.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9865432211 11234678889999988654 578999999999999999999999976544332211111
Q ss_pred h---hhh--------hhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 563 R---PLC--------LRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 563 ~---~~~--------~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
. +.. ................+...+ ......+.+++.+||+.+|++||++.+++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 0 000 000000000000001111100 1122568899999999999999999998863
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=306.18 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=194.7
Q ss_pred hCCCcccceeeccCcEEEEEEEcCC-CcEEEEEEeccCCc-hhHHHHHHHHHHHHhcC-CCCeeEEeeEEEeCCeEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPN-GKEVAVKSLRSGSG-QGEREFKAEVEIISRVH-HRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~ 421 (724)
.++|.+.+.||+|+||.||+|.+.+ ++.||||.++.... ....++..|+.++.++. |+||++++++|.++...++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3567889999999999999999765 88999999975432 23456777888777775 999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+. ++|..++..... .+++..+.+++.||++||+|||+.+ +|+||||+++|||+++++.+||+|||++.......
T Consensus 94 e~~~-~~l~~l~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 94 ELMS-TCLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred eccC-cCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 9985 467666654332 5899999999999999999999732 89999999999999999999999999998664432
Q ss_pred CccccccccCCCcCCcchhcCCC----CChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 502 THVSTRVMGTFGYLAPEYASSGK----LTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~----~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
.. ....++..|+|||++.... ++.++||||||++||||++|+.||.........+..+.. .....
T Consensus 170 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---------~~~~~ 238 (296)
T cd06618 170 AK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ---------EEPPS 238 (296)
T ss_pred cc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc---------CCCCC
Confidence 22 2335788999999987553 788999999999999999999999653221111111110 00000
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+. ........+.+++.+||+.+|++||++.+|+++
T Consensus 239 -----~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 -----LP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -----CC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 000123468889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=304.76 Aligned_cols=267 Identities=21% Similarity=0.278 Sum_probs=195.7
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC------
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAGG------ 415 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~------ 415 (724)
.++|++.+.||+|+||.||+|... +++.||||.+..... .....+.+|+.++++++|+||++++++|...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457999999999999999999964 588999998865422 22345678999999999999999999987654
Q ss_pred --eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecc
Q 040832 416 --KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGL 493 (724)
Q Consensus 416 --~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGl 493 (724)
..++||||+.+ +|..++.... ..+++.+++.++.||++||.|||++ +|+|||||++||||+.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCC
Confidence 44999999964 7777776543 2489999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCc---cccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhh-HHhhhh----h
Q 040832 494 AKLTTDNNTH---VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC-LVDWAR----P 564 (724)
Q Consensus 494 a~~~~~~~~~---~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~-l~~w~~----~ 564 (724)
+......... ......++..|+|||++.+. .++.++||||||++||||++|+.+|......... ...... +
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9866433221 12234578899999988664 4788999999999999999999999765432211 000000 0
Q ss_pred hhhhcccC----------CChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 565 LCLRALDD----------GNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 565 ~~~~~~~~----------~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
........ ......+...+. ...+...+.+++.+||+.+|.+||++.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~---~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLK---PYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcc---cccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00000000 000000000000 00112456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=313.06 Aligned_cols=273 Identities=21% Similarity=0.284 Sum_probs=203.3
Q ss_pred cCHHHHHHhhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEE
Q 040832 336 FTYEELSAATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCI 412 (724)
Q Consensus 336 f~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 412 (724)
...+++..+.++|.+.+.||+|+||.||+|.+ .+++.||||+++... ....+.+.+|++++++++|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 45677888899999999999999999999985 468899999987532 223456888999999999999999999886
Q ss_pred eC------CeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCE
Q 040832 413 AG------GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFET 486 (724)
Q Consensus 413 ~~------~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~v 486 (724)
.. ...+++++++ +++|..++... .+.+..++.++.||++||+|||+. +|+|||||++||+++.++.+
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence 43 3467888877 78898887643 389999999999999999999999 99999999999999999999
Q ss_pred EEEEeccccccCCCCCccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhh--HHhhh-
Q 040832 487 KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC--LVDWA- 562 (724)
Q Consensus 487 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~--l~~w~- 562 (724)
||+|||+++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||......... +..+.
T Consensus 160 kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (345)
T cd07877 160 KILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235 (345)
T ss_pred EEecccccccccccc----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999998654321 23457889999998866 56888999999999999999999999654332211 11100
Q ss_pred --hhhhhhcccCCChhhhc---chhhhcCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 563 --RPLCLRALDDGNFNEIA---DPYLEKNY---PTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 563 --~~~~~~~~~~~~~~~~v---d~~l~~~~---~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+.....+........+ .......+ .......+.+++.+|++.+|++|+++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00011111111000000 00000000 00123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=306.26 Aligned_cols=243 Identities=23% Similarity=0.350 Sum_probs=196.2
Q ss_pred ceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCCCHH
Q 040832 352 NLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLE 430 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 430 (724)
..||+|+||.||++.. .+++.||||++..........+.+|+.++++++|+||+++++++..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 4699999999999986 468899999986554445567999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcccccccc
Q 040832 431 FHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMG 510 (724)
Q Consensus 431 ~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~g 510 (724)
+++... .+.+..++.++.||+.+|+|||+. +++|||||++||||+.++.++|+|||++........ ......|
T Consensus 106 ~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~ 178 (292)
T cd06657 106 DIVTHT---RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVG 178 (292)
T ss_pred HHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccccc
Confidence 987543 378999999999999999999998 999999999999999999999999999876644322 1233458
Q ss_pred CCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHH
Q 040832 511 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTE 590 (724)
Q Consensus 511 t~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~ 590 (724)
+..|++||++....++.++|||||||++|||++|..||......+. +. .... .+...+.. ...
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-~~-~~~~-------------~~~~~~~~--~~~ 241 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-MK-MIRD-------------NLPPKLKN--LHK 241 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HH-HHHh-------------hCCcccCC--ccc
Confidence 8999999999888899999999999999999999999975432211 10 0000 00000000 011
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 591 EMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 591 ~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
....+..++.+||+.+|.+||++.+|++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 2345778899999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=312.94 Aligned_cols=270 Identities=18% Similarity=0.297 Sum_probs=201.4
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC-----Ce
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAG-----GK 416 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~-----~~ 416 (724)
.++|.+.+.||+|+||.||++... +++.||||.++.. .......+.+|+.+|+.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999854 6889999998753 223345678899999999999999999987654 34
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
.+|||||+. ++|..++...+ .+.+..++.|+.||+.||.|||++ +++|||||++|||++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999996 67888886554 389999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhh--HHhhhhh---hhhhcc
Q 040832 497 TTDNNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC--LVDWARP---LCLRAL 570 (724)
Q Consensus 497 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~--l~~w~~~---~~~~~~ 570 (724)
...... ......++..|+|||.+.. ..++.++|||||||+||+|++|+.||......... +...... -....+
T Consensus 158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 158 TSEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred cCCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 654321 2233457889999998865 46889999999999999999999999765322211 1100000 000001
Q ss_pred cCCChhhhcch-------hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HhC
Q 040832 571 DDGNFNEIADP-------YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA--LEG 622 (724)
Q Consensus 571 ~~~~~~~~vd~-------~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~--L~~ 622 (724)
........++. .+. ....+....+.+++.+||+.+|++||++.+|+++ |+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred CchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 11111111110 000 0011234668899999999999999999999986 554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=312.77 Aligned_cols=268 Identities=20% Similarity=0.308 Sum_probs=197.6
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC------
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGG------ 415 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~------ 415 (724)
.++|.+.+.||+|+||.||+|.+. +++.||||+++... ......+.+|+.++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999954 68999999986532 222356889999999999999999999987542
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 416 KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
..++||||+.. +|..++. ..+.+..++.++.||++||+|||+. +|+|||||++|||++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 46899999964 6766552 2378999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhh-----hhhhhc
Q 040832 496 LTTDNNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWAR-----PLCLRA 569 (724)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~-----~~~~~~ 569 (724)
...... ....++..|+|||++.+ ..++.++|||||||+||||++|+.||.....+......+.. +.....
T Consensus 166 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 166 HADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 653321 23457889999999876 46889999999999999999999999865433322111110 000000
Q ss_pred ccCCChhhhcch---hhhcCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HhCCC
Q 040832 570 LDDGNFNEIADP---YLEKNY---PTEEMARMVACAAASIRHSARRRPKISQIVRA--LEGDV 624 (724)
Q Consensus 570 ~~~~~~~~~vd~---~l~~~~---~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~--L~~~~ 624 (724)
+........++. ...... .......+.+++.+||+.+|++||++.+|+++ +++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 011000000000 000000 00123457899999999999999999999965 55443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=311.26 Aligned_cols=267 Identities=19% Similarity=0.291 Sum_probs=203.8
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC-----eEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGG-----KRL 418 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~-----~~~ 418 (724)
+|.+.+.||+|+||.||+|... +++.|+||++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999965 48899999987643 334567999999999999999999999988775 789
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
+||||+. ++|..++.... .+++..++.|+.||++||+|||+. +|+|||||++||||+.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 57888887654 589999999999999999999998 99999999999999999999999999998776
Q ss_pred CCCC--ccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhh--HHhhhhhhhhhc---c
Q 040832 499 DNNT--HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC--LVDWARPLCLRA---L 570 (724)
Q Consensus 499 ~~~~--~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~--l~~w~~~~~~~~---~ 570 (724)
.... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+.. +..+........ .
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 5431 122345678899999999887 7899999999999999999999999766433211 111100000000 0
Q ss_pred cCCChhhhcchhhh-c-----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 571 DDGNFNEIADPYLE-K-----NYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 571 ~~~~~~~~vd~~l~-~-----~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
......+.+..... . ....+....+.+++.+||+.+|++||++.+|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11111111110000 0 0011234568899999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=318.08 Aligned_cols=249 Identities=26% Similarity=0.376 Sum_probs=207.1
Q ss_pred HHhhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEE
Q 040832 342 SAATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQ--GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRL 418 (724)
Q Consensus 342 ~~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~--~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 418 (724)
..-.+.|.+.+.||+|.|+.|.+|+. ..+..||||.+...... ..+.+.+|+++|+.|+|||||+|+.+.+....+|
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 34567899999999999999999984 35899999999765333 2345899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
+||||+.+|.|+++|...++ +.+..+..++.|+..+++|||++ .|+|||||.+||||+.+..+||+|||++..+.
T Consensus 132 lV~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence 99999999999999998776 66788889999999999999999 89999999999999999999999999998886
Q ss_pred CCCCccccccccCCCcCCcchhcCCCCC-hhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 499 DNNTHVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 499 ~~~~~~~~~~~gt~~y~APE~~~~~~~t-~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
. .......+|++.|.|||++.+..|+ .++|+|++|++||-|+.|.+||++.. +.+
T Consensus 207 ~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~----------------------lk~ 262 (596)
T KOG0586|consen 207 Y--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN----------------------LKE 262 (596)
T ss_pred c--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc----------------------ccc
Confidence 3 3344668899999999999987665 89999999999999999999998642 222
Q ss_pred hcchhhhcCC--CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 578 IADPYLEKNY--PTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 578 ~vd~~l~~~~--~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+-+..+.+.| +.-....+.+++++++-.+|.+|.++++|.+.
T Consensus 263 Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 263 LRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 2222222222 11222346677788888999999999998763
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=336.46 Aligned_cols=260 Identities=26% Similarity=0.425 Sum_probs=209.4
Q ss_pred HhhCCCcccceeeccCcEEEEEEEcC----C----CcEEEEEEeccCCch-hHHHHHHHHHHHHhc-CCCCeeEEeeEEE
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVLP----N----GKEVAVKSLRSGSGQ-GEREFKAEVEIISRV-HHRHLVSLVGYCI 412 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~~----~----g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l-~HpnIv~l~g~~~ 412 (724)
...+++.+.+.||+|.||.||+|... . ...||||+++..... +.+.|..|+++|+.+ +|+||+.++|+|.
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 33444566679999999999999843 1 346999999876444 456799999999999 6999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHhcCC------------C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccE
Q 040832 413 AGGKRLLVYEYVPNNNLEFHLHGKG------------R--PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNI 478 (724)
Q Consensus 413 ~~~~~~lV~E~~~~gsL~~~L~~~~------------~--~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NI 478 (724)
..+..++|+||+..|+|..+|..+. . ..+...+++.++.|||+|++||++. ++|||||..+||
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNV 449 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNV 449 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhE
Confidence 9999999999999999999998655 0 1378889999999999999999999 999999999999
Q ss_pred EEcCCCCEEEEEeccccccCCCCCccccccc--cCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchh
Q 040832 479 LLDYTFETKVADFGLAKLTTDNNTHVSTRVM--GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAME 555 (724)
Q Consensus 479 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~--gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~ 555 (724)
||.++..+||+|||||+............-. -...|||||.+....|+.|+|||||||+||||++ |..||.+....+
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~ 529 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE 529 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence 9999999999999999976655444322222 3567999999999999999999999999999999 999986532122
Q ss_pred hhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 556 DCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 556 ~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
+. ..+. ..|. .-..+..+..++..++..||+.+|++||++.++++.|+..
T Consensus 530 ~l-~~~l--------~~G~---------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 530 EL-LEFL--------KEGN---------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HH-HHHH--------hcCC---------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 11 2121 1111 1123344466788999999999999999999999999974
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=298.93 Aligned_cols=248 Identities=25% Similarity=0.331 Sum_probs=201.2
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHH---HHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGER---EFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~---~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
.++|...++||+|.||+|.+++-+ .++.+|||+|+........ .-+.|-++|+..+||++..|.-.|...+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467888899999999999999854 6899999999876333333 356799999999999999998889999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+.||.|..+|.++.. +++.....+...|+.||.|||++ +||+||||.+|.|||.+|++||+||||++.-...
T Consensus 247 MeyanGGeLf~HLsrer~--FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERV--FSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEEccCceEeeehhhhhc--ccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 999999999999987554 88888888999999999999998 9999999999999999999999999999865433
Q ss_pred CCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
.. ....++||+.|+|||++....|..+.|.|.+||++|||++||.||...+... +.+++-
T Consensus 322 g~-t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k-------------------LFeLIl 381 (516)
T KOG0690|consen 322 GD-TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK-------------------LFELIL 381 (516)
T ss_pred cc-eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH-------------------HHHHHH
Confidence 22 2345889999999999999999999999999999999999999997543222 111111
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRP-----KISQIVR 618 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evv~ 618 (724)
-. .-.++.....+...++...|..||++|. .++||.+
T Consensus 382 ~e-d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 382 ME-DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred hh-hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 00 1123444455566777788889999996 3555554
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=299.59 Aligned_cols=241 Identities=25% Similarity=0.352 Sum_probs=187.3
Q ss_pred eeeccCcEEEEEEEcC-CCcEEEEEEeccCCc---hhHHHHHHHHHH---HHhcCCCCeeEEeeEEEeCCeEEEEEEecC
Q 040832 353 LLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG---QGEREFKAEVEI---ISRVHHRHLVSLVGYCIAGGKRLLVYEYVP 425 (724)
Q Consensus 353 ~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~---~~~~~f~~Ei~i---l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 425 (724)
+||+|+||.||++... +++.||||.+..... .....+..|..+ ++..+|+||+++++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 588999998865322 222234445444 444579999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccc
Q 040832 426 NNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVS 505 (724)
Q Consensus 426 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 505 (724)
+++|.+++...+ .+.+..++.|+.|+++||.|||+. +|+|||||++|||++.++.+||+|||++........
T Consensus 81 g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~--- 152 (278)
T cd05606 81 GGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 152 (278)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---
Confidence 999999887554 489999999999999999999998 999999999999999999999999999976543222
Q ss_pred cccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhh
Q 040832 506 TRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLE 584 (724)
Q Consensus 506 ~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~ 584 (724)
....|+..|+|||++.++ .++.++|||||||+||||++|+.||............... . ...
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------~------~~~---- 215 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-------L------TMA---- 215 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh-------h------ccC----
Confidence 234689999999998755 6889999999999999999999999764221111110000 0 000
Q ss_pred cCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 040832 585 KNYPTEEMARMVACAAASIRHSARRRP-----KISQIVR 618 (724)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evv~ 618 (724)
..++......+.+++.+|+..+|.+|+ ++.++++
T Consensus 216 ~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 216 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 011222345788899999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=296.02 Aligned_cols=245 Identities=22% Similarity=0.237 Sum_probs=190.7
Q ss_pred ceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc---hhHHHHHHHHHHH-HhcCCCCeeEEeeEEEeCCeEEEEEEecCC
Q 040832 352 NLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG---QGEREFKAEVEII-SRVHHRHLVSLVGYCIAGGKRLLVYEYVPN 426 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~---~~~~~f~~Ei~il-~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 426 (724)
+.||+|+||.||+|... +++.||||.++.... .....+..|..++ ..++|+||+++++++..++..++||||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999864 588999999865321 1223445555544 445899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcccc
Q 040832 427 NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST 506 (724)
Q Consensus 427 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 506 (724)
++|..++...+ .+++..+..|+.||+.||.|||+. +|+||||+++||||+.++.+||+|||+++.... ..
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~ 151 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK 151 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence 99999997654 378999999999999999999998 999999999999999999999999999976543 12
Q ss_pred ccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcC
Q 040832 507 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKN 586 (724)
Q Consensus 507 ~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~ 586 (724)
...|+..|++||.+.+..++.++||||||++||||++|..||......+. ...+ ..+... ....
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~---------~~~~~~------~~~~ 215 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-FDNI---------LSRRIN------WPEE 215 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-HHHH---------HhcccC------CCCc
Confidence 34578899999999888889999999999999999999999975432211 1110 000000 0000
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 587 YPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
........+.+++.+||+.+|++||++.++.+.|+.
T Consensus 216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 111234568999999999999999988766665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=295.66 Aligned_cols=250 Identities=20% Similarity=0.241 Sum_probs=194.7
Q ss_pred HHHHHHhhCCCccccee--eccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEe
Q 040832 338 YEELSAATGGFSQSNLL--GQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGYCIA 413 (724)
Q Consensus 338 ~~el~~~~~~f~~~~~L--G~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~ 413 (724)
..++....++|.+.+.+ |+|+||.||++..+ +++.+|+|.+....... .|+.+...+ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence 44555566788887777 99999999999854 67889999886432111 123333323 79999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC-CEEEEEec
Q 040832 414 GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF-ETKVADFG 492 (724)
Q Consensus 414 ~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~-~vkL~DFG 492 (724)
.+..++||||+++++|.+++.... .+++.+++.|+.||++||.|||+. +++|||||++|||++.++ .++|+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 999999999999999999997764 589999999999999999999999 999999999999999988 99999999
Q ss_pred cccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccC
Q 040832 493 LAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDD 572 (724)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~ 572 (724)
+++...... ...++..|+|||++.+..++.++|||||||++|||++|+.||.........+..|.... .
T Consensus 156 ~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------~ 224 (267)
T PHA03390 156 LCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ------Q 224 (267)
T ss_pred cceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh------c
Confidence 998665332 23578899999999988899999999999999999999999975432221222222111 0
Q ss_pred CChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 040832 573 GNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPK-ISQIVR 618 (724)
Q Consensus 573 ~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~evv~ 618 (724)
. . ..........+.+++.+||+.+|.+|++ ++|+++
T Consensus 225 ~--------~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 K--------K--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred c--------c--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 0 0111133456888999999999999995 688875
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=312.46 Aligned_cols=267 Identities=20% Similarity=0.295 Sum_probs=196.6
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC---------
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAG--------- 414 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--------- 414 (724)
.++|.+.+.||+|+||.||+|... +++.||||++........+.+.+|+++|++++|+||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999864 5889999998766555567789999999999999999999776543
Q ss_pred -----CeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEc-CCCCEEE
Q 040832 415 -----GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLD-YTFETKV 488 (724)
Q Consensus 415 -----~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~-~~~~vkL 488 (724)
...++||||+. ++|..++... .+.+..++.++.||++||.|||+. +|+|||||++||||+ +++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 5888877543 378999999999999999999998 999999999999997 4567899
Q ss_pred EEeccccccCCCCCcc--ccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhh-hh
Q 040832 489 ADFGLAKLTTDNNTHV--STRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWA-RP 564 (724)
Q Consensus 489 ~DFGla~~~~~~~~~~--~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~-~~ 564 (724)
+|||+++......... .....++..|+|||++.. ..++.++|||||||+||||++|+.||......+....... .+
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999998664322211 122357889999998754 4678899999999999999999999976544333211100 00
Q ss_pred hhhhcccCCChhhhcchhhh-----cCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 565 LCLRALDDGNFNEIADPYLE-----KNY-----PTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 565 ~~~~~~~~~~~~~~vd~~l~-----~~~-----~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..... ....+.......+. ... .......+.+++..||+.+|++||++.+|+++
T Consensus 237 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 237 VVREE-DRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCChH-HhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00000 00000000000000 000 01123567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=307.52 Aligned_cols=267 Identities=21% Similarity=0.256 Sum_probs=196.3
Q ss_pred CCCc-ccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchh--------------HHHHHHHHHHHHhcCCCCeeEEee
Q 040832 346 GGFS-QSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQG--------------EREFKAEVEIISRVHHRHLVSLVG 409 (724)
Q Consensus 346 ~~f~-~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~--------------~~~f~~Ei~il~~l~HpnIv~l~g 409 (724)
++|. +.++||+|+||.||+|.+. +++.||||+++...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3444 4577999999999999964 68899999986542221 125788999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEE
Q 040832 410 YCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVA 489 (724)
Q Consensus 410 ~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~ 489 (724)
++..++..++||||+. ++|.+++..... +++..++.|+.||++||+|||+. +|+|||||++||||+.++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIR--LTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEEC
Confidence 9999999999999996 688888875443 88999999999999999999998 99999999999999999999999
Q ss_pred EeccccccCCCC-------------CccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchh
Q 040832 490 DFGLAKLTTDNN-------------THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAME 555 (724)
Q Consensus 490 DFGla~~~~~~~-------------~~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~ 555 (724)
|||+++...... ........++..|+|||++.+. .++.++|||||||++|||++|+.||......+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999998665111 0111223467889999998764 46899999999999999999999997664433
Q ss_pred hhH--HhhhhhhhhhcccC----C---ChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 556 DCL--VDWARPLCLRALDD----G---NFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 556 ~~l--~~w~~~~~~~~~~~----~---~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
... ..+........+.. . .+.......+... .......+.+++.+||+.+|++||++.||+.+
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 211 11000000000000 0 0000000011000 11223567899999999999999999999973
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=309.39 Aligned_cols=267 Identities=19% Similarity=0.289 Sum_probs=198.4
Q ss_pred HHHhhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC--
Q 040832 341 LSAATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGG-- 415 (724)
Q Consensus 341 l~~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~-- 415 (724)
+....++|++.+.||+|+||.||++.. .+++.||||++.... ......+.+|+++|++++|+||+++++++..+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 344577899999999999999999984 468899999986432 223356889999999999999999999987653
Q ss_pred ----eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEe
Q 040832 416 ----KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADF 491 (724)
Q Consensus 416 ----~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DF 491 (724)
..++||||+ +++|..++... .+++..++.++.||++||+|||+. +|+|||||++|||++.++.+||+||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 458999999 77898887643 388999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHH--hhhh---hh
Q 040832 492 GLAKLTTDNNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLV--DWAR---PL 565 (724)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~--~w~~---~~ 565 (724)
|++....... ....++..|++||++.+ ..++.++|||||||+||+|++|+.||........... .... ..
T Consensus 163 g~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 163 GLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred ccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9998664322 23457889999999876 4688999999999999999999999976543222111 0000 00
Q ss_pred hhhcccCCChhhhcchh--hh----cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 566 CLRALDDGNFNEIADPY--LE----KNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 566 ~~~~~~~~~~~~~vd~~--l~----~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
+...+............ +. ..........+.+++.+|++.+|++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000101000000000 00 0001122345789999999999999999999985
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=345.25 Aligned_cols=257 Identities=28% Similarity=0.388 Sum_probs=205.0
Q ss_pred HHhhCCCcccceeeccCcEEEEEEE-cCCCcEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEE
Q 040832 342 SAATGGFSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQ--GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRL 418 (724)
Q Consensus 342 ~~~~~~f~~~~~LG~G~fG~Vyk~~-~~~g~~vaVK~l~~~~~~--~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 418 (724)
...+-++..+..||.|.||.||-|. ..+|+..|||-++-.... ....+.+|+.+|..|+|+|||+++|+-.+.+..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 3445577888999999999999998 456888999987644322 2346889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
|.||||++|+|.+++...+. +++.....+..|++.||+|||++ +|||||||+.||||+.+|.+|++|||.|....
T Consensus 1311 IFMEyC~~GsLa~ll~~gri--~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRI--EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHHhccCcHHHHHHhcch--hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEec
Confidence 99999999999999875443 56666777889999999999999 99999999999999999999999999998876
Q ss_pred CCCCc---cccccccCCCcCCcchhcCC---CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccC
Q 040832 499 DNNTH---VSTRVMGTFGYLAPEYASSG---KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDD 572 (724)
Q Consensus 499 ~~~~~---~~~~~~gt~~y~APE~~~~~---~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~ 572 (724)
..... .....+||+.|||||++.+. ...-+.||||||||++||+||++||...+. +|+.-.- +..
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn------e~aIMy~---V~~ 1456 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN------EWAIMYH---VAA 1456 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc------hhHHHhH---Hhc
Confidence 54311 12347899999999999753 345689999999999999999999965432 2332111 111
Q ss_pred CChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 573 GNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 573 ~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
|.. ..++......=.+++..||.+||++|.++.||+++--
T Consensus 1457 gh~---------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f 1496 (1509)
T KOG4645|consen 1457 GHK---------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAF 1496 (1509)
T ss_pred cCC---------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhc
Confidence 111 2334445566788999999999999999988887543
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.02 Aligned_cols=244 Identities=26% Similarity=0.372 Sum_probs=192.5
Q ss_pred CcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 348 FSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG---QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~---~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
|...+.||+|+||.||+|.+. +++.|+||++..... ...+.+.+|++++++++|+||+++++++.++...++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666778999999999999864 578899999864322 2335688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+. ++|.+++.... ..+++.+++.++.||+.+|.|||+. +|+||||+++|||++.++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~--- 174 (313)
T cd06633 103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA--- 174 (313)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC---
Confidence 96 56666665433 2489999999999999999999998 9999999999999999999999999998654322
Q ss_pred cccccccCCCcCCcchhc---CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 504 VSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~---~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
....|+..|+|||++. .+.++.++|||||||+||||++|+.||.......... +.. .......
T Consensus 175 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~--~~~--------~~~~~~~-- 240 (313)
T cd06633 175 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIA--------QNDSPTL-- 240 (313)
T ss_pred --CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHH--------hcCCCCC--
Confidence 2356888999999984 4568889999999999999999999987653222111 000 0000000
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
........+.+++.+||+.+|.+||++.+++++
T Consensus 241 ------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 ------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011122357889999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=321.54 Aligned_cols=269 Identities=26% Similarity=0.373 Sum_probs=200.3
Q ss_pred CcccceeeccCcEEEEEEE-cCCCcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC------eEEE
Q 040832 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGG------KRLL 419 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~-~~~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~------~~~l 419 (724)
|...+.||+|+||.||+|+ ...|+.||||.++..... ..+.+.+|+++|++|+|+|||+++++-.... ..++
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4455679999999999999 457999999999875433 3456889999999999999999998755433 4579
Q ss_pred EEEecCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEc--CCC--CEEEEEeccc
Q 040832 420 VYEYVPNNNLEFHLHGK-GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLD--YTF--ETKVADFGLA 494 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~--~~~--~vkL~DFGla 494 (724)
|||||.+|+|+..|... +...|.+.+++.++..++.||.|||++ +|+||||||.||++- .+| -.||+|||+|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999999863 334589999999999999999999998 999999999999993 334 3699999999
Q ss_pred cccCCCCCccccccccCCCcCCcchhc-CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchh-hhHHhhhhhh------h
Q 040832 495 KLTTDNNTHVSTRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAME-DCLVDWARPL------C 566 (724)
Q Consensus 495 ~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~-~~l~~w~~~~------~ 566 (724)
+.+.++. ....++||..|++||.+. .+.|+..+|.|||||++||++||..||-...... ...+.|.... +
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 9988765 457789999999999998 4899999999999999999999999996553221 1112222110 0
Q ss_pred hh--cccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCC--CHHHHHHHHh
Q 040832 567 LR--ALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRP--KISQIVRALE 621 (724)
Q Consensus 567 ~~--~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP--s~~evv~~L~ 621 (724)
.. .-++|.+..-..--...........++-.++..++..++++|. ...+....+.
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~ 308 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVD 308 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHH
Confidence 00 0011111100000001123345667777888888889999998 5555444443
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=305.28 Aligned_cols=268 Identities=20% Similarity=0.308 Sum_probs=199.3
Q ss_pred HHHhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEe-CCe
Q 040832 341 LSAATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIA-GGK 416 (724)
Q Consensus 341 l~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~-~~~ 416 (724)
+..+.++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++|+||+++++++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 4457789999999999999999999854 78899999886432 2234678899999999999999999999876 557
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
.++||||+ +++|..++... .+.+..+..++.||++||+|||+. +|+|||||++|||++.++.+||+|||++..
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 88999999 56888888643 367888899999999999999999 999999999999999999999999999975
Q ss_pred cCCCCCccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhh--HHhhhhhh---hhhcc
Q 040832 497 TTDNNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC--LVDWARPL---CLRAL 570 (724)
Q Consensus 497 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~--l~~w~~~~---~~~~~ 570 (724)
..... ....++..|++||++.+ ..++.++|||+|||++|||++|+.||......... +.++.... ....+
T Consensus 158 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 158 QDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred cCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 43321 22457888999998766 56899999999999999999999999755322111 11110000 00000
Q ss_pred cCCChhhhcchh-hhcCCCH-----HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 571 DDGNFNEIADPY-LEKNYPT-----EEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 571 ~~~~~~~~vd~~-l~~~~~~-----~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+...+++... .....+. .....+.+++.+|++.+|++||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 001101111000 0011111 123578899999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=298.42 Aligned_cols=264 Identities=24% Similarity=0.328 Sum_probs=200.4
Q ss_pred CcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 348 FSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
|+..+.||+|+||.||+|... +++.|++|.+.... ....+.+..|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999965 48899999997653 223456888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
. ++|.+++.... ..+++..+++++.||++||+|||++ +|+||||+++||++++++.+||+|||+++........
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 154 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT- 154 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-
Confidence 7 58999987653 2489999999999999999999998 9999999999999999999999999999876543322
Q ss_pred ccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhH--H---------hhhhhhhhhcccC
Q 040832 505 STRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCL--V---------DWARPLCLRALDD 572 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l--~---------~w~~~~~~~~~~~ 572 (724)
.....++..|+|||++... .++.++|||+|||++|||++|+.+|......+... . .|....... ...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 233 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP-DYK 233 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc-ccc
Confidence 2233467789999998776 88899999999999999999999997654322210 0 010000000 000
Q ss_pred CChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 573 GNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 573 ~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+.......+...+ ......+.+++..||..+|++||++.+|+.+
T Consensus 234 ~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 234 PTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 111111111110000 1124568999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=295.14 Aligned_cols=249 Identities=21% Similarity=0.333 Sum_probs=195.2
Q ss_pred CCcccceeeccCcEEEEEEEcCC-CcEEEEEEeccC-----CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLPN-GKEVAVKSLRSG-----SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~~-g~~vaVK~l~~~-----~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
+|.+.+.||+|+||.||++.+.. +..+++|.++.. .......+..|+.++++++|+||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999998643 344556655432 122334577899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 421 YEYVPNNNLEFHLHG--KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~--~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
|||+.+++|..++.. .....+++..++.++.|+++||.|||+. +++|+|||++|||++. +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998864 2334589999999999999999999998 9999999999999976 469999999998765
Q ss_pred CCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhh
Q 040832 499 DNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEI 578 (724)
Q Consensus 499 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 578 (724)
.... ......|+..|++||++....++.++||||||+++|+|++|+.+|......... ..+ ..+..
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~-~~~---------~~~~~--- 222 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV-LRI---------VEGPT--- 222 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH-HHH---------HcCCC---
Confidence 4322 223345788999999998888899999999999999999999999654321111 000 00111
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 579 ADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 579 vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
...+......+.+++.+|++.+|++||++.+|+++
T Consensus 223 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 223 ------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 01122334578889999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=303.45 Aligned_cols=246 Identities=26% Similarity=0.359 Sum_probs=194.1
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
.|...+.||+|+||.||+|.+. +++.|+||.+... .....+++.+|+++++.++|+||+++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999964 5788999988642 22234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|+. ++|.+++..... .+++..++.++.|++.||.|||+. +++|||||++|||++.++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~~-~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 96 YCL-GSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred ccC-CCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 996 577776654332 478999999999999999999998 9999999999999999999999999999765432
Q ss_pred ccccccccCCCcCCcchhc---CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 503 HVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~---~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
....++..|+|||++. .+.++.++|||||||++|||++|+.||......+. +..+.. +..
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~---------~~~---- 231 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQ---------NES---- 231 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH-HHHHhh---------cCC----
Confidence 2345788999999974 35678899999999999999999999865422111 111111 000
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRAL 620 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L 620 (724)
+. .........+.+++.+||+.+|++||++.+|+++.
T Consensus 232 -~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 232 -PA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred -CC---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 00 01112345578899999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=330.83 Aligned_cols=146 Identities=29% Similarity=0.371 Sum_probs=131.5
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG---QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~---~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
.++|.+.+.||+|+||.||+|.+. +++.||||+++.... .....+..|+.+++.++|+||+++++++......|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367999999999999999999965 688999999975422 2235688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
|||+.+++|..++...+. +.+..+++|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~--l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999976543 78899999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=319.98 Aligned_cols=262 Identities=23% Similarity=0.371 Sum_probs=215.8
Q ss_pred cCHHHHHHhhCCCcccceeeccCcEEEEEEE-cCCCcEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEe
Q 040832 336 FTYEELSAATGGFSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGYCIA 413 (724)
Q Consensus 336 f~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~-~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~ 413 (724)
..++.+..-++.|.+.+.||+|.+|+||+++ .++++.+|||++..+. +.++++..|.+||+.+ +|+|++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3455555667889999999999999999998 5578899999887654 3455788899999988 79999999999864
Q ss_pred -----CCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEE
Q 040832 414 -----GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKV 488 (724)
Q Consensus 414 -----~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL 488 (724)
++++|||||||.+|+.-+++++-....|.|..+..|++.+++||.+||.. .+||||||-.||||+.++.|||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence 56899999999999999999876677899999999999999999999999 9999999999999999999999
Q ss_pred EEeccccccCCCCCccccccccCCCcCCcchhcCC-----CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhh
Q 040832 489 ADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSG-----KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWAR 563 (724)
Q Consensus 489 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~ 563 (724)
+|||++..+...... ....+||+.|||||++... .|+..+|+||||++..||.-|..|+.+...+...+..-
T Consensus 165 vDFGvSaQldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip-- 241 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-- 241 (953)
T ss_pred eeeeeeeeeeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC--
Confidence 999999877654333 3446799999999998653 47789999999999999999999997765554322110
Q ss_pred hhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 564 PLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 564 ~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
. .+...-..+..-.+++.++|..||..|.++||.+.+++++
T Consensus 242 --------R-------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 242 --------R-------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred --------C-------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 0 1111112244566789999999999999999999998863
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=301.61 Aligned_cols=265 Identities=20% Similarity=0.259 Sum_probs=192.6
Q ss_pred CCcccceeeccCcEEEEEEEcC-C--CcEEEEEEeccCC--chhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeC----Ce
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-N--GKEVAVKSLRSGS--GQGEREFKAEVEIISRV-HHRHLVSLVGYCIAG----GK 416 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~--g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~----~~ 416 (724)
+|++.++||+|+||.||++... . ++.||||++.... ....+.+.+|+++++++ +|+||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999964 3 6789999987432 22345688899999999 599999999876533 45
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
.+++|||+. ++|..++.... .+++..++.++.||++||.|||+. +|+|||||++|||++.++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 688899886 68888886543 389999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCc---cccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhh--HHhhhhhh---hh
Q 040832 497 TTDNNTH---VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC--LVDWARPL---CL 567 (724)
Q Consensus 497 ~~~~~~~---~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~--l~~w~~~~---~~ 567 (724)
....... ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||......... +....... ..
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 6433221 1233568999999998865 46889999999999999999999999765422110 00000000 00
Q ss_pred hcccCCChhhhcc-------hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 568 RALDDGNFNEIAD-------PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 568 ~~~~~~~~~~~vd-------~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
..+........+. ..+.. ........+.+++.+|++.+|++||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000000 00000 00112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=306.18 Aligned_cols=266 Identities=20% Similarity=0.320 Sum_probs=199.3
Q ss_pred HhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCe---
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGK--- 416 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~--- 416 (724)
...++|.+.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++++++|+||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999975 57889999986532 2234567889999999999999999988776554
Q ss_pred ---EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecc
Q 040832 417 ---RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGL 493 (724)
Q Consensus 417 ---~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGl 493 (724)
.++|+||+ +++|.+++... .+++..++.++.||++||+|||+. +|+|||||++|||++.++.+||+|||+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999999 67898888653 389999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhh--HHhhhh---hhhh
Q 040832 494 AKLTTDNNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC--LVDWAR---PLCL 567 (724)
Q Consensus 494 a~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~--l~~w~~---~~~~ 567 (724)
+...... .....++..|+|||.+.+ ..++.++|||||||+||||++|+.||......+.. +..... ..+.
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 9876433 223457889999999865 36789999999999999999999999765432211 111000 0000
Q ss_pred hcccCCChhhhcchhhh---cCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 568 RALDDGNFNEIADPYLE---KNY---PTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 568 ~~~~~~~~~~~vd~~l~---~~~---~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+.......++..... ..+ .......+.+++.+||+.+|++||++.+|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00111111111110000 000 01124578899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=293.52 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=194.5
Q ss_pred cceeeccCcEEEEEEEc-CCCcEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEEEEecCCC
Q 040832 351 SNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSG-QGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLVYEYVPNN 427 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~g 427 (724)
...||.|.||.|+|-.. ..|+..|||+++.... .+.++|+.|.+...+- +.+|||+++|.+..++..|+.||.|+ .
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence 45799999999999885 4689999999998755 4455788888876555 79999999999999999999999994 4
Q ss_pred CHHHH---HhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 428 NLEFH---LHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 428 sL~~~---L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
+|+.+ ++......+++..+-+|...+++||.||.+.. +||||||||+||||+..|.+||||||++..+-+....
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAk- 224 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAK- 224 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHHHh-
Confidence 55443 33334445888888899999999999999876 7999999999999999999999999999877654322
Q ss_pred ccccccCCCcCCcchhcC--CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchh
Q 040832 505 STRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~--~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~ 582 (724)
+.-.|..-|||||.+.. ..|+-++||||||+.|||+.||+.|+..++..-+++.. +-.|....++..
T Consensus 225 -T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~---------Vv~gdpp~l~~~- 293 (361)
T KOG1006|consen 225 -TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQ---------VVIGDPPILLFD- 293 (361)
T ss_pred -hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHH---------HHcCCCCeecCc-
Confidence 33458889999999854 34899999999999999999999999876443222211 111222111111
Q ss_pred hhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 583 LEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 583 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
.-..+....|+.++..|+..|-..||+..++..
T Consensus 294 ---~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 294 ---KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ---ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 111234567899999999999999999998875
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.11 Aligned_cols=255 Identities=29% Similarity=0.396 Sum_probs=194.8
Q ss_pred CCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchh-------HHHHHHHHHHHHhcCCCCeeEEeeEEEeCC-e
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQG-------EREFKAEVEIISRVHHRHLVSLVGYCIAGG-K 416 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~-------~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~-~ 416 (724)
++|-+.++||+|||.+||||.+ ...+.||||+-..+.... .+...+|.+|.+.|+|+.||++|+|+..+. .
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 3567788999999999999984 456778899754332111 123568999999999999999999987654 5
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEc---CCCCEEEEEecc
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLD---YTFETKVADFGL 493 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~---~~~~vkL~DFGl 493 (724)
.+-|+|||+|.+|+++|..... +++.++..|+.||+.||.||.+. .+.|||-||||.||||. .-|++||.||||
T Consensus 543 FCTVLEYceGNDLDFYLKQhkl--mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKL--MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhh--hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 6789999999999999986654 89999999999999999999995 67899999999999994 357899999999
Q ss_pred ccccCCCCCc------cccccccCCCcCCcchhcCC----CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhh
Q 040832 494 AKLTTDNNTH------VSTRVMGTFGYLAPEYASSG----KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWAR 563 (724)
Q Consensus 494 a~~~~~~~~~------~~~~~~gt~~y~APE~~~~~----~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~ 563 (724)
++++.++... ......||+||++||.+.-+ +.+.|.||||+|||+|.+|.|+.||+......+.|. ...
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq-eNT 698 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ-ENT 698 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh-hhc
Confidence 9988765433 23456799999999988644 678999999999999999999999987643333222 111
Q ss_pred hhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 040832 564 PLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIV 617 (724)
Q Consensus 564 ~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv 617 (724)
.+ ......--..+ ........+|.+||..--++|-.+.|+.
T Consensus 699 Il-----kAtEVqFP~KP--------vVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 699 IL-----KATEVQFPPKP--------VVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hh-----cceeccCCCCC--------ccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 11 00111111111 1223466788999999988888776665
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=288.22 Aligned_cols=202 Identities=26% Similarity=0.360 Sum_probs=168.1
Q ss_pred CCCcccceeeccCcEEEEEEEcCC-----CcEEEEEEeccCCchh--HHHHHHHHHHHHhcCCCCeeEEeeEEEe-CCeE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPN-----GKEVAVKSLRSGSGQG--EREFKAEVEIISRVHHRHLVSLVGYCIA-GGKR 417 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~-----g~~vaVK~l~~~~~~~--~~~f~~Ei~il~~l~HpnIv~l~g~~~~-~~~~ 417 (724)
..|+....||+|.||.||||...+ .+.+|||+++...... .....+|+.+++.|+|+||+.|+.++.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 568889999999999999996332 3479999997642221 2457889999999999999999999887 7889
Q ss_pred EEEEEecCCCCHHHHHhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCC----CCEEEEE
Q 040832 418 LLVYEYVPNNNLEFHLHG---KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYT----FETKVAD 490 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~---~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~----~~vkL~D 490 (724)
+|++||.+.. |.++++- .....+....+..|+.||+.|+.|||++ -|+||||||.||||..+ |.|||+|
T Consensus 104 ~l~fdYAEhD-L~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEHD-LWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhhh-HHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 9999999764 5555542 2224688889999999999999999999 79999999999999877 8999999
Q ss_pred eccccccCCCCCc--cccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCC
Q 040832 491 FGLAKLTTDNNTH--VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPT 551 (724)
Q Consensus 491 FGla~~~~~~~~~--~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~ 551 (724)
||+++++...... ....++-|++|.|||.+.+ ..|+.+.|||++|||+.||||-+.-|...
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 9999988765433 2456888999999999887 47999999999999999999998888644
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=286.95 Aligned_cols=236 Identities=29% Similarity=0.345 Sum_probs=193.0
Q ss_pred eeccCcEEEEEEEcC-CCcEEEEEEeccCCch---hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCCCH
Q 040832 354 LGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ---GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNL 429 (724)
Q Consensus 354 LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~---~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 429 (724)
||+|+||.||++.+. +++.|++|.++..... ....+..|++++++++|+||+++++++..+...++||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 4889999998754322 345789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccccccc
Q 040832 430 EFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM 509 (724)
Q Consensus 430 ~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 509 (724)
.+++.... .+++..++.++.||++||.|||+. +++|+||+++||+++.++.++|+|||++........ ......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTFC 154 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCCc
Confidence 99997654 389999999999999999999998 999999999999999999999999999987654321 123355
Q ss_pred cCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCH
Q 040832 510 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPT 589 (724)
Q Consensus 510 gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~ 589 (724)
++..|++||.+.+...+.++|+|+||+++|||++|+.||+.....+ +.... .... ..++.
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~~~~~--------~~~~----------~~~~~ 214 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE--IYEKI--------LKDP----------LRFPE 214 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHH--------hcCC----------CCCCC
Confidence 7889999999988888999999999999999999999997553211 11110 0000 01122
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHH
Q 040832 590 EEMARMVACAAASIRHSARRRPKISQ 615 (724)
Q Consensus 590 ~~~~~l~~l~~~cl~~~P~~RPs~~e 615 (724)
.....+.+++.+||..+|++||++.+
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 22456788999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=262.85 Aligned_cols=267 Identities=21% Similarity=0.294 Sum_probs=197.3
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchh--HHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQG--EREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~--~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
+|...+.||+|.||+||||+.. .++.||+|.++-+..++ -...++|+-+|+.|+|.|||+++++...+..+-||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4566678999999999999954 57889999998654332 24688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
| ..+|..++...++ .++...+..++.|+++||.|+|++ +++||||||.|.||+.||++||+|||+++.++-....
T Consensus 83 c-dqdlkkyfdslng-~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred h-hHHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 9 4567777766443 388999999999999999999999 9999999999999999999999999999987654433
Q ss_pred cccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCC-Chhhhcch
Q 040832 504 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDG-NFNEIADP 581 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~-~~~~~vd~ 581 (724)
. ...+-|.+|.+|+++.+. -|+...|+||-|||+.||....+|.......++++....+.+....-+.+ .+..+-|-
T Consensus 158 y-saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 158 Y-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred e-eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 3 334569999999999875 57889999999999999999555544444455555544433221111110 11111111
Q ss_pred hhhcCCCH---------HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 582 YLEKNYPT---------EEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 582 ~l~~~~~~---------~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.....|+. ..-.+=.+++...+.-+|.+|-++++.+++
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 11111211 111222456666777789999988887764
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=282.21 Aligned_cols=250 Identities=25% Similarity=0.339 Sum_probs=198.3
Q ss_pred HhhCCCccc-ceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEe----CC
Q 040832 343 AATGGFSQS-NLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGYCIA----GG 415 (724)
Q Consensus 343 ~~~~~f~~~-~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~----~~ 415 (724)
..+++|++. ++||-|-.|+|-.+..+ .++.+|+|+|.. ....++|+++.-.. .|+|||+++++|.+ ..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 345666654 78999999999988854 588899999964 24467788776555 59999999998764 34
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC---CCCEEEEEec
Q 040832 416 KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY---TFETKVADFG 492 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~---~~~vkL~DFG 492 (724)
.+++|||+|+||.|...++.++...+.+.++-.|++||+.||.|||+. +|.||||||+|+|... |..+||+|||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence 678999999999999999999988999999999999999999999999 9999999999999954 5678999999
Q ss_pred cccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccC
Q 040832 493 LAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDD 572 (724)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~ 572 (724)
+|+........ ..-+.|+.|.|||++...+|+...|+||+||++|-||+|..||........ .+-+...+..
T Consensus 210 FAK~t~~~~~L--~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai------spgMk~rI~~ 281 (400)
T KOG0604|consen 210 FAKETQEPGDL--MTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------SPGMKRRIRT 281 (400)
T ss_pred cccccCCCccc--cCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC------ChhHHhHhhc
Confidence 99977643332 234579999999999999999999999999999999999999976532211 1112222233
Q ss_pred CChhhhcchhhhcCCCHHHH----HHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 573 GNFNEIADPYLEKNYPTEEM----ARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 573 ~~~~~~vd~~l~~~~~~~~~----~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
|.+ .|+..|+ ....++++.+|+.+|.+|.++.+++.
T Consensus 282 gqy----------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 282 GQY----------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred cCc----------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 322 3344443 33456788889999999999999986
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=284.28 Aligned_cols=267 Identities=25% Similarity=0.423 Sum_probs=201.3
Q ss_pred CHHHHHHhhCCCcccceeeccCcEEEEEEE-cCCCcEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeC
Q 040832 337 TYEELSAATGGFSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGYCIAG 414 (724)
Q Consensus 337 ~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~-~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~ 414 (724)
+++++...+ .++||+|+|+.|-.+. +.+|.+||||++.+.......++.+|++++.+. .|+||+.|+++|+++
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 456665554 4679999999999887 678999999999887666677899999999999 599999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC---CEEEEEe
Q 040832 415 GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF---ETKVADF 491 (724)
Q Consensus 415 ~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~---~vkL~DF 491 (724)
+..|||||.|.||.|..+++.+.. +++.++.+++.+|+.||.|||.+ +|.||||||+|||-..-. -||||||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRKH--FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecc
Confidence 999999999999999999987654 89999999999999999999999 999999999999996543 4799999
Q ss_pred ccccccCCCC--Cc----cccccccCCCcCCcchhc-----CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHh
Q 040832 492 GLAKLTTDNN--TH----VSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVD 560 (724)
Q Consensus 492 Gla~~~~~~~--~~----~~~~~~gt~~y~APE~~~-----~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~ 560 (724)
.|..-..... .- ....-+|...|||||+.. ...|+.+.|.||||||||-||.|..||.+.-. ++ --
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg-~d--CG 300 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG-AD--CG 300 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC-Cc--CC
Confidence 9986432211 11 112346889999999763 34689999999999999999999999965411 11 12
Q ss_pred hhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHH----HHHHHHhhccCCCCCCCHHHHHH
Q 040832 561 WARPLCLRALDDGNFNEIADPYLEKNYPTEEMARM----VACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 561 w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l----~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
|.+...-+.-....|+.+-+. .-++++.++..+ .+++...+-.++.+|-++.++++
T Consensus 301 WdrGe~Cr~CQ~~LFesIQEG--kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 301 WDRGEVCRVCQNKLFESIQEG--KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccCCCccHHHHHHHHHHHhcc--CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 332211110000011111111 114555555543 44556667799999999998886
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=308.52 Aligned_cols=265 Identities=21% Similarity=0.291 Sum_probs=181.9
Q ss_pred hhCCCcccceeeccCcEEEEEEEc-----------------CCCcEEEEEEeccCCchhHHHH--------------HHH
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVL-----------------PNGKEVAVKSLRSGSGQGEREF--------------KAE 392 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~-----------------~~g~~vaVK~l~~~~~~~~~~f--------------~~E 392 (724)
..++|.+.++||+|+||.||+|.+ .+++.||||+++.......++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999964 2356799999875433322333 347
Q ss_pred HHHHHhcCCCCe-----eEEeeEEEe--------CCeEEEEEEecCCCCHHHHHhcCCC---------------------
Q 040832 393 VEIISRVHHRHL-----VSLVGYCIA--------GGKRLLVYEYVPNNNLEFHLHGKGR--------------------- 438 (724)
Q Consensus 393 i~il~~l~HpnI-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~L~~~~~--------------------- 438 (724)
+.++.+++|.++ ++++++|.. .+..+|||||+.+++|.++|+....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888876654 677787753 3567999999999999999875321
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccccccccCCCcCCc
Q 040832 439 -PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAP 517 (724)
Q Consensus 439 -~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~AP 517 (724)
..+++..++.|+.||+++|.|||+. +|+|||||++|||++.++.+||+|||+++..............++..|++|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 1246778899999999999999998 999999999999999999999999999976543322222223457899999
Q ss_pred chhcCCC----------------------CChhHHHHHHHHHHHHHHhCCC-CCCCCCchhhhHHhhhhhhh-hhcccCC
Q 040832 518 EYASSGK----------------------LTEKSDVFSFGVMLLELITGRR-PIDPTGAMEDCLVDWARPLC-LRALDDG 573 (724)
Q Consensus 518 E~~~~~~----------------------~t~ksDV~SlGvlL~eLltG~~-P~~~~~~~~~~l~~w~~~~~-~~~~~~~ 573 (724)
|.+.... ...+.||||+||+||||++|.. +|.........+..+...+. ++.+...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9875422 1135799999999999999876 66532211111111110000 0000001
Q ss_pred ChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCC---CCCCCHHHHHHH
Q 040832 574 NFNEIADPYLEKNYPTEEMARMVACAAASIRHSA---RRRPKISQIVRA 619 (724)
Q Consensus 574 ~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P---~~RPs~~evv~~ 619 (724)
.+ .-...........+++.+++..++ .+|+++.|++++
T Consensus 460 ~~--------~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 460 KY--------DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CC--------CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 00 000111223456677777887655 789999999874
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=290.28 Aligned_cols=242 Identities=26% Similarity=0.374 Sum_probs=198.7
Q ss_pred hCCCcccceeeccCcEEEEEEEcCC-CcEEEEEEeccCCchhH---HHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPN-GKEVAVKSLRSGSGQGE---REFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vaVK~l~~~~~~~~---~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~l 419 (724)
..+|....+||+|.||+|.+|..+. .+.+|||+|+.+-.... +--..|-++|+.. +-|++++|+.+|..-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 3578889999999999999998654 57799999987632222 2234577777776 57899999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
||||+.||+|-.+++..++ +.+..++.++.+||-||-+||++ +||+||||.+|||||.+|++||+|||+++..--
T Consensus 428 VMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc
Confidence 9999999999999988776 88889999999999999999999 999999999999999999999999999986533
Q ss_pred CCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 500 NNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 500 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
... ....++||+.|+|||++....|....|.|+|||+|||||.|+.||++.++.+.. ..+.
T Consensus 503 ~~~-TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF------------------~aI~ 563 (683)
T KOG0696|consen 503 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF------------------QAIM 563 (683)
T ss_pred CCc-ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH------------------HHHH
Confidence 222 224578999999999999999999999999999999999999999987543321 1111
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCC
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPK 612 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs 612 (724)
+.. -.|+.....+.+.++...+...|.+|.-
T Consensus 564 ehn--vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 564 EHN--VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred Hcc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 111 2466677777888888888999998853
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-32 Score=274.57 Aligned_cols=238 Identities=27% Similarity=0.339 Sum_probs=195.0
Q ss_pred CcEEEEEEEcC-CCcEEEEEEeccCCchh-HHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCCCHHHHHhc
Q 040832 358 GFGYVHKGVLP-NGKEVAVKSLRSGSGQG-EREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHG 435 (724)
Q Consensus 358 ~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~-~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~ 435 (724)
+||.||+|.+. +++.|++|++....... .+.|.+|++++++++|+||+++++++......++||||+.+++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48899999998765444 67899999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccccccccCCCcC
Q 040832 436 KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYL 515 (724)
Q Consensus 436 ~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~ 515 (724)
... +++..++.++.+++++|.|||+. +|+|+||+++||+++.++.++|+|||++....... ......++..|+
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM 153 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence 544 88999999999999999999998 99999999999999999999999999998776543 223455788999
Q ss_pred CcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHH
Q 040832 516 APEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARM 595 (724)
Q Consensus 516 APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l 595 (724)
+||.+....++.++|||+||+++|+|++|..||+.....+. +.++.. ....... .........+
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~-~~~~~~--------~~~~~~~-------~~~~~~~~~~ 217 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE-LFKKIG--------KPKPPFP-------PPEWKISPEA 217 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHh--------ccCCCCc-------cccccCCHHH
Confidence 99999988899999999999999999999999976322221 111111 0000000 0000033568
Q ss_pred HHHHHHhhccCCCCCCCHHHHHH
Q 040832 596 VACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 596 ~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
.+++.+|+..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 88999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=321.34 Aligned_cols=209 Identities=26% Similarity=0.313 Sum_probs=186.3
Q ss_pred CHHHHHHhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCeeEEeeEEE
Q 040832 337 TYEELSAATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG---QGEREFKAEVEIISRVHHRHLVSLVGYCI 412 (724)
Q Consensus 337 ~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~---~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 412 (724)
...++....++|.+.++||+|+||+|...+.+ .++.||+|+|..... .+-.-|.+|-++|..-+.+=|++|+-.|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 35677778899999999999999999999965 488999999976321 12235889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEec
Q 040832 413 AGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFG 492 (724)
Q Consensus 413 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFG 492 (724)
++.++|||||||.||+|-.+|.+.+ .+++..+..++..|+-||+-||+. |+|||||||+|||||..|++||+|||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccch
Confidence 9999999999999999999998877 488999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccCCCcCCcchhc----C-CCCChhHHHHHHHHHHHHHHhCCCCCCC
Q 040832 493 LAKLTTDNNTHVSTRVMGTFGYLAPEYAS----S-GKLTEKSDVFSFGVMLLELITGRRPIDP 550 (724)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~APE~~~----~-~~~t~ksDV~SlGvlL~eLltG~~P~~~ 550 (724)
.+..+..+..-.....+||+.|++||++. + +.|+..+|.||+||++||||.|..||..
T Consensus 221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 99888876666666778999999999985 2 6799999999999999999999999964
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=297.34 Aligned_cols=211 Identities=27% Similarity=0.370 Sum_probs=176.1
Q ss_pred CcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCch---hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 348 FSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQ---GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~---~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
|..++.||-|+||+|.+++. +....||+|.|++.... ....++.|-+||+.-+.+-||+||-.|.+++.+|+||||
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 67788899999999999984 44678999999764322 223578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc---CCC
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT---TDN 500 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~---~~~ 500 (724)
++||++-.+|.+.+- +.+..+..++.++..|+++.|.. |+|||||||+|||||.+|++||.||||+.-+ .+.
T Consensus 711 IPGGDmMSLLIrmgI--FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMGI--FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred cCCccHHHHHHHhcc--CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccc
Confidence 999999999988764 88888888999999999999999 9999999999999999999999999999522 111
Q ss_pred C-----Ccc---------------------------------ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHH
Q 040832 501 N-----THV---------------------------------STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI 542 (724)
Q Consensus 501 ~-----~~~---------------------------------~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLl 542 (724)
. .|. ....+||..|+|||++....|+.-+|.|+.|||||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 0 000 01157999999999999999999999999999999999
Q ss_pred hCCCCCCCCCchhh--hHHhhhh
Q 040832 543 TGRRPIDPTGAMED--CLVDWAR 563 (724)
Q Consensus 543 tG~~P~~~~~~~~~--~l~~w~~ 563 (724)
.|+.||-.....+. .+..|..
T Consensus 866 ~g~~pf~~~tp~~tq~kv~nw~~ 888 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVINWRN 888 (1034)
T ss_pred hCCCCccCCCCCcceeeeeehhh
Confidence 99999976644443 3445543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=315.16 Aligned_cols=263 Identities=20% Similarity=0.245 Sum_probs=172.4
Q ss_pred hhCCCcccceeeccCcEEEEEEEcCC-----CcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeE------EE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLPN-----GKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGY------CI 412 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~~-----g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~------~~ 412 (724)
..++|.+.++||+|+||.||+|.+.+ ++.||||++...... +.+..| .+++..+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 56789999999999999999999654 688999988643211 111111 1222222222222211 24
Q ss_pred eCCeEEEEEEecCCCCHHHHHhcCCCC------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 040832 413 AGGKRLLVYEYVPNNNLEFHLHGKGRP------------------VMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIK 474 (724)
Q Consensus 413 ~~~~~~lV~E~~~~gsL~~~L~~~~~~------------------~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIk 474 (724)
.+...+|||||+.+++|.++++..... ......+..|+.||++||+|||++ +|||||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 566889999999999999988754311 112334568999999999999998 99999999
Q ss_pred CccEEEcC-CCCEEEEEeccccccCCCCCccccccccCCCcCCcchhcCC----------------------CCChhHHH
Q 040832 475 SSNILLDY-TFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSG----------------------KLTEKSDV 531 (724)
Q Consensus 475 p~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~----------------------~~t~ksDV 531 (724)
|+||||+. ++.+||+|||+++.+............++..|||||.+... .+..++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 67999999999987654444444557789999999965322 24456799
Q ss_pred HHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchh----hhcCC--CHHHHHHHHHHHHHhhcc
Q 040832 532 FSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY----LEKNY--PTEEMARMVACAAASIRH 605 (724)
Q Consensus 532 ~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~----l~~~~--~~~~~~~l~~l~~~cl~~ 605 (724)
|||||+||||+++..+++.. . ..+.+.+.........+...+... +...+ .........+++.+||+.
T Consensus 363 wSlGviL~el~~~~~~~~~~--~----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN--L----IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH--H----HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 99999999999987765432 1 111110000000000000011100 00000 001122345899999999
Q ss_pred CCCCCCCHHHHHHH
Q 040832 606 SARRRPKISQIVRA 619 (724)
Q Consensus 606 ~P~~RPs~~evv~~ 619 (724)
||++||++.|++++
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999985
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=278.85 Aligned_cols=219 Identities=21% Similarity=0.198 Sum_probs=175.8
Q ss_pred cCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCCCHHHHHhc
Q 040832 357 GGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHG 435 (724)
Q Consensus 357 G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~ 435 (724)
|.||.||++.+. +++.||+|+++... .+..|...+....|+||+++++++.+....++||||+.+++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999964 67899999997532 344455556666799999999999999999999999999999998876
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccccccccCCCcC
Q 040832 436 KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYL 515 (724)
Q Consensus 436 ~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~ 515 (724)
... +++..++.++.||++||+|||+. +|+||||||+|||++.++.++|+|||++....... ....++..|+
T Consensus 79 ~~~--l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~ 149 (237)
T cd05576 79 FLN--IPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYC 149 (237)
T ss_pred hcC--CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCcccc
Confidence 543 89999999999999999999998 99999999999999999999999999887654321 2234567799
Q ss_pred CcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHH
Q 040832 516 APEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARM 595 (724)
Q Consensus 516 APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l 595 (724)
|||++....++.++||||||+++|||++|+.+|+..... +. . ... ...+......+
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~---------~-----~~~----~~~~~~~~~~~ 205 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------IN---------T-----HTT----LNIPEWVSEEA 205 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cc---------c-----ccc----cCCcccCCHHH
Confidence 999998888999999999999999999999877532100 00 0 000 01111223467
Q ss_pred HHHHHHhhccCCCCCCCH
Q 040832 596 VACAAASIRHSARRRPKI 613 (724)
Q Consensus 596 ~~l~~~cl~~~P~~RPs~ 613 (724)
.+++.+|++.+|++|+++
T Consensus 206 ~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 206 RSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHccCCHHHhcCC
Confidence 889999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-33 Score=294.44 Aligned_cols=199 Identities=28% Similarity=0.434 Sum_probs=173.4
Q ss_pred cceeeccCcEEEEEEE-cCCCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCC
Q 040832 351 SNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNN 427 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~-~~~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 427 (724)
.++||.|-||.||-|+ .++|+.||||++.+. ..+.+..+++|+.||++++||.||.|-..|+..+.+++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 5889999999999998 457999999998643 3345678999999999999999999999999999999999999777
Q ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCC---CCEEEEEeccccccCCCCCcc
Q 040832 428 NLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYT---FETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 428 sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~---~~vkL~DFGla~~~~~~~~~~ 504 (724)
-|+-+|.... ..|.+..-..++.||+.||.|||-+ +|+|+||||+||||... -++||||||+|++.+....
T Consensus 649 MLEMILSsEk-gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-- 722 (888)
T KOG4236|consen 649 MLEMILSSEK-GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-- 722 (888)
T ss_pred HHHHHHHhhc-ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh--
Confidence 7777776433 2488888888999999999999999 99999999999999543 3799999999999886543
Q ss_pred ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchh
Q 040832 505 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAME 555 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~ 555 (724)
...++||+.|+|||++....|...-|+||.|||+|--|.|..||....+..
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn 773 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN 773 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh
Confidence 356889999999999999999999999999999999999999997654443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=260.77 Aligned_cols=204 Identities=28% Similarity=0.445 Sum_probs=167.6
Q ss_pred hhCCCcccceeeccCcEEEEEEE-cCCCcEEEEEEeccC-CchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSG-SGQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~-~~~g~~vaVK~l~~~-~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 420 (724)
..+....+..||+|+||.|-+.+ ..+|...|+|.++.. ..+..++++.|+++..+. .+|++|.++|.+..++..|+.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 33445556789999999998877 457999999999865 334456788899987665 799999999999999999999
Q ss_pred EEecCCCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 421 YEYVPNNNLEFHLHG--KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~--~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
||.|+ .+|+.+-.. +.+..+.+..+=+|+..+++||.|||++. .|||||+||+||||+.+|+|||||||++.++.
T Consensus 124 ME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 124 MELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 99994 556554332 22335888899999999999999999986 79999999999999999999999999999887
Q ss_pred CCCCccccccccCCCcCCcchhcC----CCCChhHHHHHHHHHHHHHHhCCCCCCCCC
Q 040832 499 DNNTHVSTRVMGTFGYLAPEYASS----GKLTEKSDVFSFGVMLLELITGRRPIDPTG 552 (724)
Q Consensus 499 ~~~~~~~~~~~gt~~y~APE~~~~----~~~t~ksDV~SlGvlL~eLltG~~P~~~~~ 552 (724)
+.-.. +--.|.--|||||.+.. ..|+-|+||||||+.+.||.+++.||+.+.
T Consensus 201 dSiAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 201 DSIAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred hhhHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 64332 21347788999998854 368899999999999999999999998653
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=301.68 Aligned_cols=239 Identities=24% Similarity=0.373 Sum_probs=187.4
Q ss_pred eeeccCcE-EEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEEEEecCCCCHH
Q 040832 353 LLGQGGFG-YVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLVYEYVPNNNLE 430 (724)
Q Consensus 353 ~LG~G~fG-~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 430 (724)
++|.|.-| .||+|.. +|+.||||++-. ......++||.+|+.- +|+|||++++.-.+...+||+.|.| ..+|.
T Consensus 516 ilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~ 590 (903)
T KOG1027|consen 516 ILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQ 590 (903)
T ss_pred HcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHH
Confidence 38999887 6899998 778999999864 2334568899999988 5999999999999999999999999 78899
Q ss_pred HHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC-----CCCEEEEEeccccccCCCCCc
Q 040832 431 FHLHGK--GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY-----TFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 431 ~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~-----~~~vkL~DFGla~~~~~~~~~ 503 (724)
+++... ..........+.++.|+++||++||+. +||||||||.||||+. ..+++|+|||+++.+..+...
T Consensus 591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS 667 (903)
T KOG1027|consen 591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS 667 (903)
T ss_pred HHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence 999873 222222245578899999999999997 9999999999999965 357899999999988766544
Q ss_pred c--ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 504 V--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 504 ~--~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
. .....||.+|+|||++.....+.+.||||||||+|+.++ |.+||+..-..+..+.. +++. ++
T Consensus 668 ~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~------------~~~~-L~- 733 (903)
T KOG1027|consen 668 FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT------------GNYT-LV- 733 (903)
T ss_pred hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc------------Cccc-ee-
Confidence 2 345679999999999999888889999999999999999 59999865332222211 1110 00
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
.| ....++ +..++|.+|++.+|..||++.+|+.
T Consensus 734 -~L--~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 734 -HL--EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -ee--ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 01 111112 6788999999999999999999974
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=296.83 Aligned_cols=241 Identities=24% Similarity=0.281 Sum_probs=194.9
Q ss_pred hhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++..|.+...||.|.|+.|-++.. ..++..+||++... ..+..+|+.++... +|+||+++++.+.++.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 466788888899999999999884 46788999999753 33456778777666 7999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEE-cCCCCEEEEEeccccccCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILL-DYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl-~~~~~vkL~DFGla~~~~~~ 500 (724)
|++.++-|.+.+..+.. + ...+..|+.+|+.+|.|||++ +||||||||+|||+ +..++++|+|||.++.....
T Consensus 396 e~l~g~ell~ri~~~~~--~-~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPE--F-CSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hhccccHHHHHHHhcch--h-HHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99999988777765543 2 267778999999999999998 99999999999999 58899999999999988765
Q ss_pred CCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
. ..-+-|..|.|||++....|++++|+||||++||+||+|+.||.......+ +...+..+.+.
T Consensus 470 ~----~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e---------i~~~i~~~~~s---- 532 (612)
T KOG0603|consen 470 C----DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE---------IHTRIQMPKFS---- 532 (612)
T ss_pred h----cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH---------HHHhhcCCccc----
Confidence 1 112347889999999999999999999999999999999999976543311 11112222222
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
........+++.+||+.+|.+|++|.++..+
T Consensus 533 --------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 533 --------ECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred --------cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 3334557788999999999999999998763
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-33 Score=272.72 Aligned_cols=266 Identities=22% Similarity=0.344 Sum_probs=191.1
Q ss_pred CcccceeeccCcEEEEEEEcC-CCcEEEEEEecc-CCchh-HHHHHHHHHHHHhcCCCCeeEEeeEEEeC--------Ce
Q 040832 348 FSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRS-GSGQG-EREFKAEVEIISRVHHRHLVSLVGYCIAG--------GK 416 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~-~~~~~-~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--------~~ 416 (724)
|....+||+|.||+||+|+.+ .|+.||+|++.- +.... -...++|+++|..|+|+|++.|++.|... ..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 344467999999999999965 467788876543 22221 24568899999999999999999988642 35
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
.||||+||+. +|.-+|.+.. ..+....+.+++.++.+||.|+|.. .|+|||+|+.|+||+.++.+||+|||+++.
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 7999999954 5677776543 3489999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCc---cccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhh-----
Q 040832 497 TTDNNTH---VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCL----- 567 (724)
Q Consensus 497 ~~~~~~~---~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~----- 567 (724)
+...... ..+..+-|.+|+.||.+.+. .|+.+.|||+-||||.||+||.+-|.++.+..+. ...+.++.
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql--~~Is~LcGs~tke 251 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQL--HLISQLCGSITKE 251 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHH--HHHHHHhccCCcc
Confidence 6432221 23445679999999988764 6899999999999999999999988876544331 11111111
Q ss_pred --hcccCCChhhhc--chhhhcCC--CHHHHH------HHHHHHHHhhccCCCCCCCHHHHHHHH
Q 040832 568 --RALDDGNFNEIA--DPYLEKNY--PTEEMA------RMVACAAASIRHSARRRPKISQIVRAL 620 (724)
Q Consensus 568 --~~~~~~~~~~~v--d~~l~~~~--~~~~~~------~l~~l~~~cl~~~P~~RPs~~evv~~L 620 (724)
..++.-.+.+-+ .+.-++.+ -.+.+. ..++++..++..||.+|+.+.+++.+.
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 111111111111 00000000 011111 456777888999999999999998753
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=288.91 Aligned_cols=241 Identities=24% Similarity=0.315 Sum_probs=197.6
Q ss_pred CCcccceeeccCcEEEEEEEcCCCcE-EEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLPNGKE-VAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~~g~~-vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
+++.+-.||-||||.|-+...++.+. +|+|.++.. .....+.+..|-+||...+.++||+||.-|.++..+|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 34556669999999999988755443 788888654 33344568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
-|-||.|...|.+++. ++......++..+++|++|||++ +||+|||||+|.|||.+|-+||.|||+|+.+.....
T Consensus 501 aClGGElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 501 ACLGGELWTILRDRGS--FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred hhcCchhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 9999999999988776 88899999999999999999999 999999999999999999999999999998876544
Q ss_pred ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchh
Q 040832 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~ 582 (724)
. -.++||+.|.|||++.+...+.++|.|+||+++||||+|..||...+.|...-. +++.++.-
T Consensus 576 T--wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~------ILkGid~i--------- 638 (732)
T KOG0614|consen 576 T--WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL------ILKGIDKI--------- 638 (732)
T ss_pred e--eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH------HHhhhhhh---------
Confidence 3 347899999999999999999999999999999999999999998776654211 11111111
Q ss_pred hhcCCCHHHHHHHHHHHHHhhccCCCCCCC
Q 040832 583 LEKNYPTEEMARMVACAAASIRHSARRRPK 612 (724)
Q Consensus 583 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs 612 (724)
.++....+...+++++.++.+|.+|.-
T Consensus 639 ---~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 639 ---EFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ---hcccccchhHHHHHHHHHhcCcHhhhc
Confidence 233334445667777777888877754
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=277.39 Aligned_cols=269 Identities=20% Similarity=0.276 Sum_probs=207.4
Q ss_pred HHhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCC--C----CeeEEeeEEEeC
Q 040832 342 SAATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHH--R----HLVSLVGYCIAG 414 (724)
Q Consensus 342 ~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~H--p----nIv~l~g~~~~~ 414 (724)
....++|.+..+||+|.||.|-++.+. .+..||||+++.-.. ..+..+-|+++|.+|.+ | -+|.+.++|...
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 334788999999999999999998854 367899999975422 23346779999999942 2 267778889999
Q ss_pred CeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEc-------------
Q 040832 415 GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLD------------- 481 (724)
Q Consensus 415 ~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~------------- 481 (724)
++.+||+|.+ |-++.++|..++...+....+..|+.||+++++|||+. +++|-||||+|||+.
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCc
Confidence 9999999998 66899999988888899999999999999999999999 999999999999993
Q ss_pred -------CCCCEEEEEeccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCch
Q 040832 482 -------YTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAM 554 (724)
Q Consensus 482 -------~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~ 554 (724)
.+..|||+|||.|+...... ..++.|..|.|||++.+-.++..+||||+||||+||++|...|...++.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 13468999999998765433 4466789999999999999999999999999999999999999876543
Q ss_pred hh------hHHhhhhhhhhhc-----ccCC-----------Chhhhcchh----hhcCCCHHHHHHHHHHHHHhhccCCC
Q 040832 555 ED------CLVDWARPLCLRA-----LDDG-----------NFNEIADPY----LEKNYPTEEMARMVACAAASIRHSAR 608 (724)
Q Consensus 555 ~~------~l~~w~~~~~~~~-----~~~~-----------~~~~~vd~~----l~~~~~~~~~~~l~~l~~~cl~~~P~ 608 (724)
+. .+...-..++.+. ...+ +.....+.+ ..-.....+..+|++|+..||..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 32 2211111111111 1111 111111111 11123557788899999999999999
Q ss_pred CCCCHHHHHHH
Q 040832 609 RRPKISQIVRA 619 (724)
Q Consensus 609 ~RPs~~evv~~ 619 (724)
+|.++.|++.+
T Consensus 396 ~RiTl~EAL~H 406 (415)
T KOG0671|consen 396 RRITLREALSH 406 (415)
T ss_pred ccccHHHHhcC
Confidence 99999999864
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=268.37 Aligned_cols=247 Identities=22% Similarity=0.339 Sum_probs=196.1
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC---CchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG---SGQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 420 (724)
.+|.+.++||+|.|++|..++++ ..+.||+|+++.. ..++...++.|-.++.+- +||++|.|+.+|..+..+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 57899999999999999999864 5788999998764 223334578888888877 799999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
.||+.||+|-.+++.+.. |.++.+..+..+|+.||.|||++ +||+||||.+|||||..|++||.|+|+++.-...
T Consensus 330 ieyv~ggdlmfhmqrqrk--lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQRK--LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEecCcceeeehhhhhc--CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 999999999988887654 88899989999999999999999 9999999999999999999999999999865433
Q ss_pred CCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCC--chhhhHHhhhhhhhhhcccCCChhhh
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTG--AMEDCLVDWARPLCLRALDDGNFNEI 578 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~--~~~~~l~~w~~~~~~~~~~~~~~~~~ 578 (724)
.. ....++||+.|+|||++.+..|....|.|+|||+++||+.|+.||+... +.+..-.++.-.. +
T Consensus 405 gd-~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv------------i 471 (593)
T KOG0695|consen 405 GD-TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV------------I 471 (593)
T ss_pred Cc-ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH------------H
Confidence 22 2345889999999999999999999999999999999999999998542 1122222221111 0
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCC
Q 040832 579 ADPYLEKNYPTEEMARMVACAAASIRHSARRRPK 612 (724)
Q Consensus 579 vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs 612 (724)
++.. -..+.....+...+++.-|+.||++|..
T Consensus 472 lekq--iriprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 472 LEKQ--IRIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred hhhc--ccccceeehhhHHHHHHhhcCCcHHhcC
Confidence 1100 1233344455566777778888888753
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=256.13 Aligned_cols=262 Identities=20% Similarity=0.298 Sum_probs=204.2
Q ss_pred hCCCcccceeeccCcEEEEEEE-cCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCeeEEeeEEEeC--CeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVH-HRHLVSLVGYCIAG--GKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~-~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~--~~~~lV 420 (724)
.++|++.+.+|+|.|++||.|+ ..+.+.++||+|+. ...+.+.+|+.||..|. |+||++|+++..+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 3578889999999999999998 45778899999987 45678999999999996 99999999998764 356799
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCC-CCEEEEEeccccccCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYT-FETKVADFGLAKLTTD 499 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~-~~vkL~DFGla~~~~~ 499 (724)
+||+.+.+...+... |....+..++.+|++||.|+|+. ||+|||+||.|++||.. -.++|+|||||.+...
T Consensus 114 FE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 999999988776543 67778899999999999999999 99999999999999864 5799999999988765
Q ss_pred CCCccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhccc-------
Q 040832 500 NNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALD------- 571 (724)
Q Consensus 500 ~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~------- 571 (724)
.... .-.+.+..|--||.+.. ..|+..-|+|||||+|..|+..+.||.......++++..++-+....+.
T Consensus 186 ~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 186 GKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred Ccee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 4332 22345667899998865 4688899999999999999999999987766677777776655443221
Q ss_pred ---CCChhhhcchhhhcCC--------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 572 ---DGNFNEIADPYLEKNY--------PTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 572 ---~~~~~~~vd~~l~~~~--------~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+..+..++...-.+.+ ..-...+.++++...|+.|-.+|++++|...+
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 1122222221111110 01112567888999999999999999998753
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=270.72 Aligned_cols=267 Identities=24% Similarity=0.339 Sum_probs=200.6
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcC--------CCCeeEEeeEEEe--
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVH--------HRHLVSLVGYCIA-- 413 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~--------HpnIv~l~g~~~~-- 413 (724)
.++|.+.++||.|.|.+||++.+ .+.+.||+|+.+... ...+..+.||++|++++ -.+||+|+++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 36888999999999999999985 457789999998642 22345778999999994 2579999999875
Q ss_pred --CCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC---------
Q 040832 414 --GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY--------- 482 (724)
Q Consensus 414 --~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~--------- 482 (724)
+.+++||+|++ |.+|..++.......+....+.+|++||+.||.|||++| +|||-||||+||||..
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhh
Confidence 45889999999 666777777666667999999999999999999999999 9999999999999930
Q ss_pred --------------------------------------------------------------------------------
Q 040832 483 -------------------------------------------------------------------------------- 482 (724)
Q Consensus 483 -------------------------------------------------------------------------------- 482 (724)
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence
Q ss_pred -----------------------------------------------------------------------------CCC
Q 040832 483 -----------------------------------------------------------------------------TFE 485 (724)
Q Consensus 483 -----------------------------------------------------------------------------~~~ 485 (724)
+.+
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence 002
Q ss_pred EEEEEeccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCC-----chhhhHHh
Q 040832 486 TKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTG-----AMEDCLVD 560 (724)
Q Consensus 486 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~-----~~~~~l~~ 560 (724)
|||+|||.|.+.... .+.-..|..|.|||++.+..|...+||||++|++|||+||...|+... ..++.+..
T Consensus 393 vKIaDlGNACW~~kh----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~ 468 (590)
T KOG1290|consen 393 VKIADLGNACWVHKH----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIAL 468 (590)
T ss_pred EEEeeccchhhhhhh----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHH
Confidence 577777777765432 222345778999999999999999999999999999999999996431 12222211
Q ss_pred h-------hhhhhh---------------hcccCCChhhhcchhhh-cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 040832 561 W-------ARPLCL---------------RALDDGNFNEIADPYLE-KNYPTEEMARMVACAAASIRHSARRRPKISQIV 617 (724)
Q Consensus 561 w-------~~~~~~---------------~~~~~~~~~~~vd~~l~-~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv 617 (724)
. -+.+.+ +.+..-++..+.+-..+ ..+..++...|.+++.-||+.+|++|+++.+.+
T Consensus 469 i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl 548 (590)
T KOG1290|consen 469 IMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCL 548 (590)
T ss_pred HHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHh
Confidence 1 111111 11111112222222222 257889999999999999999999999999998
Q ss_pred HH
Q 040832 618 RA 619 (724)
Q Consensus 618 ~~ 619 (724)
++
T Consensus 549 ~h 550 (590)
T KOG1290|consen 549 KH 550 (590)
T ss_pred cC
Confidence 63
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-29 Score=245.71 Aligned_cols=211 Identities=35% Similarity=0.540 Sum_probs=185.4
Q ss_pred eeccCcEEEEEEEcCC-CcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCCCHHH
Q 040832 354 LGQGGFGYVHKGVLPN-GKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEF 431 (724)
Q Consensus 354 LG~G~fG~Vyk~~~~~-g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 431 (724)
||+|.||.||++...+ ++.++||++...... ....+.+|+++++.+.|++|+++++++......+++|||+.+++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 889999999865432 34679999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC-CCCEEEEEeccccccCCCCCcccccccc
Q 040832 432 HLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY-TFETKVADFGLAKLTTDNNTHVSTRVMG 510 (724)
Q Consensus 432 ~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~g 510 (724)
++.... ..+++..++.++.+++++|.|||+. +++|+||++.||+++. +++++|+|||++........ ......+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 987653 2478999999999999999999999 9999999999999999 89999999999987755432 1233457
Q ss_pred CCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCH
Q 040832 511 TFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPT 589 (724)
Q Consensus 511 t~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~ 589 (724)
...|++||.+... .++.+.|+|+||++|++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 8889999999887 888999999999999998
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 040832 590 EEMARMVACAAASIRHSARRRPKISQIVRAL 620 (724)
Q Consensus 590 ~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L 620 (724)
..+.+++..|++.+|++||++.+++++|
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 5688899999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=250.08 Aligned_cols=199 Identities=33% Similarity=0.448 Sum_probs=174.6
Q ss_pred CcccceeeccCcEEEEEEEcCC-CcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecC
Q 040832 348 FSQSNLLGQGGFGYVHKGVLPN-GKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVP 425 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~~-g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 425 (724)
|.+.+.||.|+||.||++...+ ++.++||.+...... ..+.+.+|++.+++++|+|++++++++......++++||+.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5677899999999999999765 889999999876544 56789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccc
Q 040832 426 NNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVS 505 (724)
Q Consensus 426 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 505 (724)
+++|..++...... +++..++.++.+++++|.|||++ +++|+||++.||+++.++.++|+|||++...........
T Consensus 81 ~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 99999998765432 78999999999999999999998 999999999999999999999999999987765431122
Q ss_pred cccccCCCcCCcchh-cCCCCChhHHHHHHHHHHHHHHhCCCCCCC
Q 040832 506 TRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELITGRRPIDP 550 (724)
Q Consensus 506 ~~~~gt~~y~APE~~-~~~~~t~ksDV~SlGvlL~eLltG~~P~~~ 550 (724)
....+...|++||.+ ....++.++|||+||++++||++|+.||+.
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 335678889999998 666778899999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-31 Score=262.95 Aligned_cols=268 Identities=22% Similarity=0.328 Sum_probs=193.5
Q ss_pred CcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC-----CeEEE
Q 040832 348 FSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAG-----GKRLL 419 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~-----~~~~l 419 (724)
.+-.+.||-|+||.||...+. +|+.|++|++... .-..-+.+.+|+++|..++|.|++..++...-. .++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 344677999999999998864 6899999987532 112345788999999999999999988765432 24567
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
|.|.| ..+|..++-... .|+...++-+++||++||.|||+. +|+||||||.|.||+.|..+|||||||++....
T Consensus 135 ~TELm-QSDLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHH-HhhhhheeccCC--CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 77877 344555443332 377788888999999999999999 999999999999999999999999999998877
Q ss_pred CCCccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhh--HHhhhhhhhhhcc---cCC
Q 040832 500 NNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC--LVDWARPLCLRAL---DDG 573 (724)
Q Consensus 500 ~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~--l~~w~~~~~~~~~---~~~ 573 (724)
+....++..+-|..|.|||++++ .+|+.+.||||.|||+.||+..+.-|...+..++. +.+....-..+.+ -.|
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 66666677778999999999987 47999999999999999999998888766544432 1111000000000 001
Q ss_pred Chhhhcch--------hhhc-CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 574 NFNEIADP--------YLEK-NYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 574 ~~~~~vd~--------~l~~-~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
.-..+++. .|.. .-+...-.+-+.|...++..||++|-+..+.+.++.
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11111111 1110 112233345566778889999999999988887653
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=268.48 Aligned_cols=271 Identities=22% Similarity=0.259 Sum_probs=204.9
Q ss_pred HHHhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcC------CCCeeEEeeEEEe
Q 040832 341 LSAATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVH------HRHLVSLVGYCIA 413 (724)
Q Consensus 341 l~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~------HpnIv~l~g~~~~ 413 (724)
-+...+.|.+....|+|-|+.|.+|.+. .|..||||+++.+.. ..+.=+.|++||++|+ --|+++|+-.|..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 3445678888889999999999999964 478999999987543 3445678999999995 4688999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCC-CCEEEEEe
Q 040832 414 GGKRLLVYEYVPNNNLEFHLHGKGR-PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYT-FETKVADF 491 (724)
Q Consensus 414 ~~~~~lV~E~~~~gsL~~~L~~~~~-~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~-~~vkL~DF 491 (724)
..++|||+|-+ .-+|.++|...+. ..|....+..++.|++-||.+|..+ +|+|.||||.||||++. ..+|||||
T Consensus 506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccC
Confidence 99999999988 6678999986543 3478889999999999999999997 99999999999999875 46799999
Q ss_pred ccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCc--hhhhHHhhhhhhhhhc
Q 040832 492 GLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGA--MEDCLVDWARPLCLRA 569 (724)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~--~~~~l~~w~~~~~~~~ 569 (724)
|.|......... .+.-.-.|.|||++.+..|+...|+||.||+||||+||+..|-+..+ |-....+..-++-...
T Consensus 582 GSA~~~~eneit---PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km 658 (752)
T KOG0670|consen 582 GSASFASENEIT---PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM 658 (752)
T ss_pred cccccccccccc---HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence 999988765442 23345679999999999999999999999999999999999976532 2222222221111111
Q ss_pred ccCCChhh------------h---------------cch------hhhc--CCCH---HHHHHHHHHHHHhhccCCCCCC
Q 040832 570 LDDGNFNE------------I---------------ADP------YLEK--NYPT---EEMARMVACAAASIRHSARRRP 611 (724)
Q Consensus 570 ~~~~~~~~------------~---------------vd~------~l~~--~~~~---~~~~~l~~l~~~cl~~~P~~RP 611 (724)
+..+.|.+ . +.+ .|.. .++. .....|..|+..||..||++|-
T Consensus 659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi 738 (752)
T KOG0670|consen 659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI 738 (752)
T ss_pred hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence 11111110 0 111 1111 1233 3456688899999999999999
Q ss_pred CHHHHHHH
Q 040832 612 KISQIVRA 619 (724)
Q Consensus 612 s~~evv~~ 619 (724)
+..|.|.+
T Consensus 739 t~nqAL~H 746 (752)
T KOG0670|consen 739 TVNQALKH 746 (752)
T ss_pred CHHHHhcC
Confidence 99998764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-30 Score=277.84 Aligned_cols=253 Identities=24% Similarity=0.370 Sum_probs=206.8
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
.++|.+...||.|.||.|||+++. .++..|||+++-.-.++..-++.|+.+++..+|+||+.++|.+......|++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 467888899999999999999965 5788999999988777788899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
|.+|+|.+.-+.-+- +++.++..+++..++||+|||+. +-+|||||-.|||+++.|.+||+|||.+..+.....
T Consensus 94 cgggslQdiy~~Tgp--lselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~- 167 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTGP--LSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA- 167 (829)
T ss_pred cCCCcccceeeeccc--chhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhh-
Confidence 999999998876554 88999999999999999999999 899999999999999999999999999987654332
Q ss_pred cccccccCCCcCCcchh---cCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 504 VSTRVMGTFGYLAPEYA---SSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~---~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
....+.||+.|||||+. +.+.|..++|||++|+...||-.-+.|......+.....- ....|.-
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm----------TkS~~qp--- 234 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM----------TKSGFQP--- 234 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh----------hccCCCC---
Confidence 23457899999999976 5678999999999999999998888886555444432210 0000100
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
+.+ +-...-...+.++++.|+..+|++||++..++.
T Consensus 235 p~l--kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PTL--KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred Ccc--cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 001 011223345778889999999999999997664
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-29 Score=245.96 Aligned_cols=256 Identities=18% Similarity=0.314 Sum_probs=192.3
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCeeEEeeE-EEeCCeEEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGY-CIAGGKRLLV 420 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~-~~~~~~~~lV 420 (724)
..+.|.+.+.||+|.||.+-++..+ ....+++|.+.... ...++|.+|...--.| .|.||+.-+++ |...+..+++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 3456999999999999999999865 46778999886542 3467899999876666 59999988764 5566778899
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEc--CCCCEEEEEeccccccC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLD--YTFETKVADFGLAKLTT 498 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~--~~~~vkL~DFGla~~~~ 498 (724)
|||++.|+|...+...+ +-+....+++.|++.||.|+|++ ++||||||.+||||. +..+|||||||+.+..+
T Consensus 101 qE~aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred eccCccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999998887654 67888899999999999999999 999999999999993 33489999999998665
Q ss_pred CCCCccccccccCCCcCCcchhcC---C--CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCC
Q 040832 499 DNNTHVSTRVMGTFGYLAPEYASS---G--KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDG 573 (724)
Q Consensus 499 ~~~~~~~~~~~gt~~y~APE~~~~---~--~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~ 573 (724)
.... .+.-+..|.+||.... + .....+|||.||+|+|.+|||..||.....++....+|...+.....
T Consensus 175 ~tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~--- 247 (378)
T KOG1345|consen 175 TTVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP--- 247 (378)
T ss_pred ceeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc---
Confidence 4322 2234557999997643 2 34568999999999999999999998666666666666543322111
Q ss_pred ChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 574 NFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 574 ~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
.+...+. ....+++.|.++.|.+++++|-...++.++-..
T Consensus 248 ~~P~~F~---------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 248 ALPKKFN---------PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred cCchhhc---------ccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 1111111 123456677778889999999666665554433
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-29 Score=267.76 Aligned_cols=196 Identities=26% Similarity=0.378 Sum_probs=168.2
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchh--------HHHHHHHHHHHHhcC---CCCeeEEeeEEEe
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQG--------EREFKAEVEIISRVH---HRHLVSLVGYCIA 413 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~--------~~~f~~Ei~il~~l~---HpnIv~l~g~~~~ 413 (724)
..|...+.||+|+||.|+.+.++ +..+|+||++.+...-. .-.+-.||.||+.|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46888999999999999999965 46789999986531110 012446999999997 9999999999999
Q ss_pred CCeEEEEEEecC-CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEec
Q 040832 414 GGKRLLVYEYVP-NNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFG 492 (724)
Q Consensus 414 ~~~~~lV~E~~~-~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFG 492 (724)
++.+||+||-.. +-+|.+++..+.+ |++.+...|++||+-|+++||++ +|||||||=+||+|+.+|-+||+|||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeecc
Confidence 999999999764 5578888887665 99999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccCCCcCCcchhcCCCCC-hhHHHHHHHHHHHHHHhCCCCCC
Q 040832 493 LAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVMLLELITGRRPID 549 (724)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t-~ksDV~SlGvlL~eLltG~~P~~ 549 (724)
.+.+...... ..++||.+|.|||++.+.+|- ..-|||+||++||-++....||.
T Consensus 716 saa~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9987765433 456799999999999988764 66899999999999999888874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=243.05 Aligned_cols=258 Identities=23% Similarity=0.284 Sum_probs=192.0
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC------eE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGG------KR 417 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~------~~ 417 (724)
+|...+.+|.|.- .|..+.+. .++.||+|++... .....+...+|+.++..++|+||++++.++.-.. ..
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4555567888877 55555532 5788999987543 2344577889999999999999999999986543 56
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
|+||||| ..+|..+++. .++-..+.+|+.|++.|++|||+. +|+||||||+||+|..+..+||+|||+|+..
T Consensus 97 y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 97 YLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhccc
Confidence 8999999 5567777662 267788999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhccc------
Q 040832 498 TDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALD------ 571 (724)
Q Consensus 498 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~------ 571 (724)
... ...+..+.+..|.|||++.+..|.+.+||||+||++.||++|..-|.+.+. +..|.+..-.-.-.
T Consensus 169 ~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~----idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 169 DTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH----IDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred Ccc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH----HHHHHHHHHHhcCCCHHHHH
Confidence 543 456777889999999999988899999999999999999999999875433 33333211110000
Q ss_pred -----------------CCChhhhcchhh-h--cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 572 -----------------DGNFNEIADPYL-E--KNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 572 -----------------~~~~~~~vd~~l-~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.-.+.+++...+ . -+.+.-.......++.+||-.+|++|-++++++++
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 011111111000 0 01112234556778899999999999999999985
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=247.38 Aligned_cols=269 Identities=23% Similarity=0.302 Sum_probs=200.5
Q ss_pred HHHhhCCCcccceeeccCcEEEEEEEcCC----CcEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCC
Q 040832 341 LSAATGGFSQSNLLGQGGFGYVHKGVLPN----GKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGG 415 (724)
Q Consensus 341 l~~~~~~f~~~~~LG~G~fG~Vyk~~~~~----g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~ 415 (724)
+....+.|..+++||+|.|+.||++.+.. ++.||+|.+...+ .-..+.+|+++|..+ .+.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 44456788999999999999999998543 5789999987643 335689999999999 5999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC-CCCEEEEEeccc
Q 040832 416 KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY-TFETKVADFGLA 494 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~-~~~vkL~DFGla 494 (724)
...+||||+++....+++.. ++...+..+++.+++||.|+|.+ |||||||||.|+|.+. .++-.|+|||||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhH
Confidence 99999999999999888865 66789999999999999999999 9999999999999975 567899999999
Q ss_pred cccCCCC-------------------------------------------CccccccccCCCcCCcchhcC-CCCChhHH
Q 040832 495 KLTTDNN-------------------------------------------THVSTRVMGTFGYLAPEYASS-GKLTEKSD 530 (724)
Q Consensus 495 ~~~~~~~-------------------------------------------~~~~~~~~gt~~y~APE~~~~-~~~t~ksD 530 (724)
....... ........||.||.|||++.. ...+.+.|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7211000 001112579999999998864 57889999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhh-----cccCCC------------------hhhh-cchhhhcC
Q 040832 531 VFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLR-----ALDDGN------------------FNEI-ADPYLEKN 586 (724)
Q Consensus 531 V~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~-----~~~~~~------------------~~~~-vd~~l~~~ 586 (724)
|||.|||++.+++++.||.........+.+.+..+... +...|. |..+ +..+....
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 99999999999999999966543333333322111110 000111 1111 01111101
Q ss_pred C--------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 587 Y--------PTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 587 ~--------~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
. .......++.++.+|+..+|.+|-++++.+++
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 1 11122367889999999999999999998864
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=278.95 Aligned_cols=195 Identities=15% Similarity=0.190 Sum_probs=137.3
Q ss_pred hcCC-CCeeEEeeEE-------EeCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 040832 398 RVHH-RHLVSLVGYC-------IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRII 469 (724)
Q Consensus 398 ~l~H-pnIv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ii 469 (724)
.++| .||++++++| ...+..+++|||+ +++|.++|.... ..+++.+++.|++||++||+|||++ +||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 3444 5777777776 2334567888987 669999997543 3489999999999999999999998 999
Q ss_pred ecCCCCccEEEcCC-------------------CCEEEEEeccccccCCCCC---------------ccccccccCCCcC
Q 040832 470 HRDIKSSNILLDYT-------------------FETKVADFGLAKLTTDNNT---------------HVSTRVMGTFGYL 515 (724)
Q Consensus 470 HrDIkp~NILl~~~-------------------~~vkL~DFGla~~~~~~~~---------------~~~~~~~gt~~y~ 515 (724)
||||||+||||+.. +.+||+|||+++....... ......+||.+||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999654 4455666666553211000 0011246888999
Q ss_pred CcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHH
Q 040832 516 APEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARM 595 (724)
Q Consensus 516 APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l 595 (724)
|||++.+..++.++|||||||+||||++|..++.... ..+..+... .+.... .....++
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~-------------~~~~~~-----~~~~~~~ 241 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHR-------------VLPPQI-----LLNWPKE 241 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHh-------------hcChhh-----hhcCHHH
Confidence 9999999999999999999999999999988764321 111111000 000100 1122345
Q ss_pred HHHHHHhhccCCCCCCCHHHHHH
Q 040832 596 VACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 596 ~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
..++.+||+.+|.+||+|.||++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhh
Confidence 67778999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.4e-25 Score=214.93 Aligned_cols=166 Identities=19% Similarity=0.201 Sum_probs=127.7
Q ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcccc
Q 040832 427 NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST 506 (724)
Q Consensus 427 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 506 (724)
|+|.++|+..+ ..+++.+++.|+.||++||+|||++ + |++|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-----
Confidence 68999997643 2489999999999999999999998 5 999999999999999 99998765432
Q ss_pred ccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcC
Q 040832 507 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKN 586 (724)
Q Consensus 507 ~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~ 586 (724)
..|+..|||||++.+..++.++|||||||+||||++|+.||.........+..+........... ..
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------~~ 130 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD------------RS 130 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc------------cc
Confidence 24889999999999999999999999999999999999999755433333322221111000000 00
Q ss_pred CCHHHH--HHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 587 YPTEEM--ARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 587 ~~~~~~--~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
...... ..+.+++.+||+.+|++||++.||++++..
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 011111 368999999999999999999999998864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=235.80 Aligned_cols=165 Identities=22% Similarity=0.247 Sum_probs=130.5
Q ss_pred HhhCCCcccceeeccCcEEEEEEEcC--CCcEEEEEEeccCC-----chhHHHHHHHHHHHHhcCCCCeeE-EeeEEEeC
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVLP--NGKEVAVKSLRSGS-----GQGEREFKAEVEIISRVHHRHLVS-LVGYCIAG 414 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~~--~g~~vaVK~l~~~~-----~~~~~~f~~Ei~il~~l~HpnIv~-l~g~~~~~ 414 (724)
...++|.+.++||+|+||+||+|.+. +++.||||++.... ....+.|.+|+++|++|+|+||+. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 44678999999999999999999864 57778999875331 122456999999999999999985 4432
Q ss_pred CeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCccEEEcCCCCEEEEEecc
Q 040832 415 GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDI-KSSNILLDYTFETKVADFGL 493 (724)
Q Consensus 415 ~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDI-kp~NILl~~~~~vkL~DFGl 493 (724)
+..+|||||+++++|... ... . ...++.+++++|.|||++ +|+|||| ||+||||+.++++||+|||+
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~~-----~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RPH-----G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Ccc-----c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 457999999999999632 111 1 146789999999999998 9999999 99999999999999999999
Q ss_pred ccccCCCCCcc-------ccccccCCCcCCcchhcCC
Q 040832 494 AKLTTDNNTHV-------STRVMGTFGYLAPEYASSG 523 (724)
Q Consensus 494 a~~~~~~~~~~-------~~~~~gt~~y~APE~~~~~ 523 (724)
|+.+....... ...+++++.|++||++...
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99775543211 1356789999999998643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-24 Score=230.39 Aligned_cols=257 Identities=22% Similarity=0.267 Sum_probs=192.8
Q ss_pred CCcccceeeccCcEEEEEEEcCCC--cEEEEEEeccCCchhHHHHHHHHHHHHhcCC----CCeeEEeeEE-EeCCeEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLPNG--KEVAVKSLRSGSGQGEREFKAEVEIISRVHH----RHLVSLVGYC-IAGGKRLL 419 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~~g--~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~H----pnIv~l~g~~-~~~~~~~l 419 (724)
+|.+.+.||+|+||.||++..... ..+|+|............+..|+.+|..+.. .++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996553 4788888765433333378889999998863 6889999988 47778899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCC-----CCEEEEEeccc
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYT-----FETKVADFGLA 494 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~-----~~vkL~DFGla 494 (724)
||+.+ |.+|.++........++..+.++|+.|++.+|.+||+. ++|||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 88999988665556799999999999999999999999 99999999999999754 46999999999
Q ss_pred c--ccCCCCC----cc---ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhh--hHHhhhh
Q 040832 495 K--LTTDNNT----HV---STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMED--CLVDWAR 563 (724)
Q Consensus 495 ~--~~~~~~~----~~---~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~--~l~~w~~ 563 (724)
+ ....... .. .....||..|+++....+...+.+.|+||++.++.||+.|..||........ .+.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8 3322221 11 1235599999999999999999999999999999999999999965432211 1111100
Q ss_pred hhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 564 PLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 564 ~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
. ..... .......++..+.. .+-..+...+|....+...|.+..
T Consensus 255 ~------------~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 255 K------------LLTDR--FGDLKPEEFAKILE---YIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred h------------hcccc--ccCCChHHHHHHHH---HhhccCCcCCCCHHHHHHHHHHHH
Confidence 0 00000 11222334444444 344478899999999998876544
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-25 Score=221.95 Aligned_cols=248 Identities=21% Similarity=0.326 Sum_probs=195.7
Q ss_pred ccceeeccCcEEEEEEEcCCCcEEEEEEecc--CCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCC
Q 040832 350 QSNLLGQGGFGYVHKGVLPNGKEVAVKSLRS--GSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNN 427 (724)
Q Consensus 350 ~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~--~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 427 (724)
+..+|.+...|+.|+|+|+ |..+++|+|.. ......++|.+|.-.|+.+.||||+.++|.|.....+.+|..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 3446889999999999995 45566777653 23444578999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccccc
Q 040832 428 NLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTR 507 (724)
Q Consensus 428 sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 507 (724)
+|+.+||+......+-.++++++++|++|++|||+. .+-|.---|..+.|+||++.+++|. .+-+++..... .
T Consensus 273 slynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfsfqe~-----g 345 (448)
T KOG0195|consen 273 SLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQEV-----G 345 (448)
T ss_pred HHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceeeeecc-----c
Confidence 999999998888889999999999999999999996 4444455789999999999988774 22222211111 1
Q ss_pred cccCCCcCCcchhcCCC---CChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhh
Q 040832 508 VMGTFGYLAPEYASSGK---LTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLE 584 (724)
Q Consensus 508 ~~gt~~y~APE~~~~~~---~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~ 584 (724)
.+-.+.||+||.+.... .-.++|+|||+++||||.|...||.....++-.... .-.-|.
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki------------------aleglr 407 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI------------------ALEGLR 407 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh------------------hhcccc
Confidence 22357899999987643 346899999999999999999999887766543211 111223
Q ss_pred cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 585 KNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
-..+......|.+++..|++.||.+||.+..|+-.||+.
T Consensus 408 v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 345666777889999999999999999999999999864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.7e-23 Score=214.08 Aligned_cols=258 Identities=30% Similarity=0.374 Sum_probs=198.8
Q ss_pred CcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCch---hHHHHHHHHHHHHhcCCC-CeeEEeeEEEeCCeEEEEEEe
Q 040832 348 FSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQ---GEREFKAEVEIISRVHHR-HLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~---~~~~f~~Ei~il~~l~Hp-nIv~l~g~~~~~~~~~lV~E~ 423 (724)
|.+.+.||.|+||.||++.+. +.+++|.+...... ....|.+|+.+++.+.|+ +|+++++++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667788999999999999976 78999998765333 356799999999999988 799999999877778999999
Q ss_pred cCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC-CEEEEEeccccccCCCC
Q 040832 424 VPNNNLEFHLHGKGR-PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF-ETKVADFGLAKLTTDNN 501 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~-~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~-~vkL~DFGla~~~~~~~ 501 (724)
+.+++|.+++..... ..+.......++.|++.+|.|+|+. +++||||||+|||++..+ .++++|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999976665432 2488899999999999999999999 899999999999999988 79999999998665443
Q ss_pred Cc-----cccccccCCCcCCcchhcC---CCCChhHHHHHHHHHHHHHHhCCCCCCCCCch--hhhHHhhhhhhhhhccc
Q 040832 502 TH-----VSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPIDPTGAM--EDCLVDWARPLCLRALD 571 (724)
Q Consensus 502 ~~-----~~~~~~gt~~y~APE~~~~---~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~--~~~l~~w~~~~~~~~~~ 571 (724)
.. ......|+..|++||.+.. ..+....|+|++|++++++++|..||...... ..............
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--- 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--- 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence 32 2355779999999999987 67889999999999999999999997665431 11111111100000
Q ss_pred CCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 572 DGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 572 ~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.....+...........+.+++..|+..++..|.++.+....
T Consensus 234 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 ------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000002234567888889999999999999987764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.5e-23 Score=207.87 Aligned_cols=199 Identities=23% Similarity=0.321 Sum_probs=171.6
Q ss_pred CCcccceeeccCcEEEEEEE-cCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCeeEEeeEEEeCCeEEEEEEec
Q 040832 347 GFSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVH-HRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~-~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
.|.+++.||+|.||++|.|. +-+++.||||.--.. .+.-++..|.+.++.|. .++|..++-|...+.+-.||||.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 68999999999999999998 558899999975432 23456888999999985 799999888877777778999998
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC-----CCCEEEEEeccccccCC
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY-----TFETKVADFGLAKLTTD 499 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~-----~~~vkL~DFGla~~~~~ 499 (724)
|-+|++++.=+++ .++..+++.||.|++.-++|+|++ .+|.|||||+|+||.. ...+.|+|||+|+.+.+
T Consensus 107 -GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred -CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 8899999987776 489999999999999999999999 9999999999999953 34589999999999877
Q ss_pred CCCcc------ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCC
Q 040832 500 NNTHV------STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTG 552 (724)
Q Consensus 500 ~~~~~------~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~ 552 (724)
..++. .....||.+||+---..+.+.+.+.|+-+||-+++++|-|..||.+..
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 65542 223579999999999999999999999999999999999999998753
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.2e-23 Score=202.14 Aligned_cols=203 Identities=24% Similarity=0.314 Sum_probs=171.8
Q ss_pred HhhCCCcccceeeccCcEEEEEEE-cCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCC-CCeeEEeeEEEeCCeEEEE
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHH-RHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~-~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~lV 420 (724)
...++|.+++.||.|.||.+|.|. ..+|.+||||.-.... ....+..|..+.+.|+| ..|..+..|..+...-.||
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 345789999999999999999998 6789999999876542 23468889999999964 6777788888888888999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC---CCCEEEEEecccccc
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY---TFETKVADFGLAKLT 497 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~---~~~vkL~DFGla~~~ 497 (724)
||.+ |-+|++++.-+.+ .++..+++-++-|++.-|+|+|.+ ++|||||||+|+|..- ..++.|+||||++.+
T Consensus 90 MdLL-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eecc-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence 9998 8899999886654 488899999999999999999999 8999999999999953 346899999999987
Q ss_pred CCCCCc------cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCC
Q 040832 498 TDNNTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTG 552 (724)
Q Consensus 498 ~~~~~~------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~ 552 (724)
-+..+. ......||.+|.+--...+-..+.+.|+-|+|.+|.++.-|..||.+..
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 654432 2345779999999888877788889999999999999999999998753
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=204.20 Aligned_cols=173 Identities=13% Similarity=0.129 Sum_probs=136.6
Q ss_pred HhhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHH---------HHHHHHHHHhcCCCCeeEEeeEEEe
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGERE---------FKAEVEIISRVHHRHLVSLVGYCIA 413 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~---------f~~Ei~il~~l~HpnIv~l~g~~~~ 413 (724)
...++|+..++||.|+||.||+... +++.+|||.++......++. |.+|++.+.+|+|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3468999999999999999999766 57789999997654333332 6789999999999999999888664
Q ss_pred C--------CeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCC
Q 040832 414 G--------GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFE 485 (724)
Q Consensus 414 ~--------~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~ 485 (724)
. +..+|||||++|.+|.++.. ++. ..+.+|+.+|..||+. +++||||||+|||++.++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-
Confidence 3 35789999999999988732 222 2456899999999999 999999999999999988
Q ss_pred EEEEEeccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh
Q 040832 486 TKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 543 (724)
Q Consensus 486 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt 543 (724)
++|+|||..+........ . .+++...+..++|+|+||+.|..+..
T Consensus 173 i~liDfg~~~~~~e~~a~--d-----------~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK--D-----------RIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEEEECCCcccccchhhH--H-----------HHHHHhHhcccccccceeEeehHHHH
Confidence 999999998765322111 0 03444556679999999999877653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.9e-22 Score=197.83 Aligned_cols=140 Identities=14% Similarity=0.155 Sum_probs=109.4
Q ss_pred cceeeccCcEEEEEEEcCCCcEEEEEEeccCCch--h-------HH-----------------HHHHHHHHHHhcCCCCe
Q 040832 351 SNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQ--G-------ER-----------------EFKAEVEIISRVHHRHL 404 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~--~-------~~-----------------~f~~Ei~il~~l~HpnI 404 (724)
.+.||+|+||.||+|.+.+|+.||||+++..... . .. ....|+++|.+|.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999888999999999754211 1 01 12349999999988776
Q ss_pred eEEeeEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCccEEEcCC
Q 040832 405 VSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYL-HEDCHPRIIHRDIKSSNILLDYT 483 (724)
Q Consensus 405 v~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yL-Hs~~~~~iiHrDIkp~NILl~~~ 483 (724)
.....+... ..+|||||+++++|...+.... .+++..+++++.||+.+|.|| |+. +|+||||||+||||+ +
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~--~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKDA--PLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-C
Confidence 443333222 2389999999987765533222 478899999999999999999 687 999999999999998 4
Q ss_pred CCEEEEEeccccccC
Q 040832 484 FETKVADFGLAKLTT 498 (724)
Q Consensus 484 ~~vkL~DFGla~~~~ 498 (724)
+.++|+|||+|....
T Consensus 154 ~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 GKLYIIDVSQSVEHD 168 (190)
T ss_pred CcEEEEEccccccCC
Confidence 789999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.9e-23 Score=236.89 Aligned_cols=253 Identities=22% Similarity=0.272 Sum_probs=186.9
Q ss_pred cccceeeccCcEEEEEEEc-CCCcEEEEEEeccC--CchhHH----HHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 349 SQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSG--SGQGER----EFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 349 ~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~--~~~~~~----~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
...+++|.|.||.|+.... ...+.++.|.++.. ....++ .+..|+-+-..|+|+|++..+..+.+....+.+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999997776653 23333444433210 111222 2667888888899999988888777776667779
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
|||++ +|..++...+. +...++..++.||++||+|||.. +|.|||||++|+|+..+|.+||+|||.+..+.-..
T Consensus 401 E~~~~-Dlf~~~~~~~~--~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGK--LTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHhcccc--cchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99999 99988876533 78888999999999999999999 99999999999999999999999999997664332
Q ss_pred C---ccccccccCCCcCCcchhcCCCCCh-hHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 502 T---HVSTRVMGTFGYLAPEYASSGKLTE-KSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 502 ~---~~~~~~~gt~~y~APE~~~~~~~t~-ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
. .....++|.-.|+|||.+....|+. ..||||.|++++.|++|+.||......++...+- .....+..
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~--------~~~~~~~~ 546 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN--------NYSDQRNI 546 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh--------cccccccc
Confidence 2 4566788999999999999998884 6999999999999999999997654333321000 00000000
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
..- ..........+...++.++|+.+|.+|-++.+|++
T Consensus 547 ~~~---~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 547 FEG---PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccC---hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000 01112345566888999999999999999999985
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.3e-21 Score=190.53 Aligned_cols=141 Identities=15% Similarity=0.124 Sum_probs=112.0
Q ss_pred cceeeccCcEEEEEEEcCCCcEEEEEEeccCCch---------------------h-----HHHHHHHHHHHHhcCCCCe
Q 040832 351 SNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQ---------------------G-----EREFKAEVEIISRVHHRHL 404 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~---------------------~-----~~~f~~Ei~il~~l~HpnI 404 (724)
.+.||+|+||.||+|.+.+|+.||||+++..... . ...+..|++.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5689999999999999878999999999765211 0 1124578999999999987
Q ss_pred eEEeeEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCccEEEcCC
Q 040832 405 VSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHE-DCHPRIIHRDIKSSNILLDYT 483 (724)
Q Consensus 405 v~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs-~~~~~iiHrDIkp~NILl~~~ 483 (724)
.....+... ..+|||||++++++...+.... .++...+++|+.|++.+|.+||. + +|+||||||+||||+ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~--~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV--PLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhc--cCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-C
Confidence 554444333 2489999999886544322222 36788999999999999999999 8 999999999999999 7
Q ss_pred CCEEEEEeccccccCC
Q 040832 484 FETKVADFGLAKLTTD 499 (724)
Q Consensus 484 ~~vkL~DFGla~~~~~ 499 (724)
++++|+|||+++....
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 8999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-20 Score=185.22 Aligned_cols=183 Identities=16% Similarity=0.094 Sum_probs=139.5
Q ss_pred cccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchh----HHHHHHHHHHHHhcC-CCCeeEEeeEEEeCCeEEEEEEe
Q 040832 349 SQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQG----EREFKAEVEIISRVH-HRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 349 ~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~----~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
.....|++|+||+||.+.. .+..++.+.+.....-. ...|.+|+++|++|+ |++|.+++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3456899999999998766 67778888776543211 125889999999995 5889999886 346999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDI-KSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDI-kp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
+.|.+|...+.. ..+.++.|++++|.+||++ +|+|||| |+.|||++.++.++|+|||++........
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999998754321 1245788999999999999 9999999 79999999999999999999986554331
Q ss_pred c----c--------ccccccCCCcCCcchhcC--CCCChhHHHHHHHHHHHHHHhCCCCC
Q 040832 503 H----V--------STRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPI 548 (724)
Q Consensus 503 ~----~--------~~~~~gt~~y~APE~~~~--~~~t~ksDV~SlGvlL~eLltG~~P~ 548 (724)
. . ....+.+..|+.|+...- ..--...+.++.|+.+|.++||+.++
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 0 0 111346777888885432 22225779999999999999998875
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-21 Score=223.82 Aligned_cols=253 Identities=25% Similarity=0.263 Sum_probs=183.2
Q ss_pred CCcccceeeccCcEEEEEEEcCCCcEEEEEEeccC-CchhHHHHHHHHHH--HHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSG-SGQGEREFKAEVEI--ISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~-~~~~~~~f~~Ei~i--l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
+|...+.||.+.|=+|.+|.+.+|. |+||++-.. ..-..+.|.++++- +..++|||++.+..+...+..-|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6777888999999999999987776 888987543 23344555444333 4455899999998877777777888898
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc--CCCC
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT--TDNN 501 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~--~~~~ 501 (724)
+ ..+|++.|..+ +.+...+.+.|+.||++||.-+|+. +|+|||||.+||||+.-.=+.|+||..-+-. ..++
T Consensus 103 v-khnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 V-KHNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred H-hhhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 8 56788887654 4588889999999999999999999 9999999999999999878999999876532 2222
Q ss_pred Cccc----cccccCCCcCCcchhcCC-----------CCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhh
Q 040832 502 THVS----TRVMGTFGYLAPEYASSG-----------KLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPL 565 (724)
Q Consensus 502 ~~~~----~~~~gt~~y~APE~~~~~-----------~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~ 565 (724)
.... ..-..-..|+|||.+..+ .++.+-||||+||++.||++ |+.+|... +|..+
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aY---- 247 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAY---- 247 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhH----
Confidence 1111 111122359999988542 26778999999999999999 78888532 12211
Q ss_pred hhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 566 CLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 566 ~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
+.+. .......|++.-+. .+++++..|++.||.+|-+++++++.-.|.+-
T Consensus 248 -----r~~~-~~~~e~~Le~Ied~----~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~F 297 (1431)
T KOG1240|consen 248 -----RSGN-ADDPEQLLEKIEDV----SLRNLILSMIQRDPSKRLSAEDYLQKYRGLVF 297 (1431)
T ss_pred -----hccC-ccCHHHHHHhCcCc----cHHHHHHHHHccCchhccCHHHHHHhhhcccc
Confidence 1121 11122222222111 57888999999999999999999998777664
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-20 Score=219.84 Aligned_cols=199 Identities=23% Similarity=0.230 Sum_probs=157.8
Q ss_pred HHHHhhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcC---CCCeeEEeeEEEeCCe
Q 040832 340 ELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVH---HRHLVSLVGYCIAGGK 416 (724)
Q Consensus 340 el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~---HpnIv~l~g~~~~~~~ 416 (724)
+++.-...|.+.+.||+|+||.||+|...+|+.||+|+-+..+.-+ |.--.+++.+|+ -+.|+.+...+.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 3444556789999999999999999998889999999887653321 211223344443 2334444444455566
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEc-------CCCCEEEE
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLD-------YTFETKVA 489 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~-------~~~~vkL~ 489 (724)
.+||+||.+.|+|.+++...+ .++|..++.|+.|+++.|++||.. +|||+||||+|+||. ++..++|+
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~--~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNK--VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred ceeeeeccccccHHHhhccCC--CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEE
Confidence 699999999999999998444 599999999999999999999998 999999999999994 34568999
Q ss_pred EeccccccCCCCC-ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCC
Q 040832 490 DFGLAKLTTDNNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRR 546 (724)
Q Consensus 490 DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~ 546 (724)
|||.+..+.-... .....+++|-.+-.+|...+..++...|.|.|+.+++-||.|+.
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9999975532222 24456789999999999999999999999999999999999875
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=182.51 Aligned_cols=136 Identities=18% Similarity=0.208 Sum_probs=107.4
Q ss_pred cccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhc-----CCCCeeEEeeEEEeCC---eEE-E
Q 040832 349 SQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV-----HHRHLVSLVGYCIAGG---KRL-L 419 (724)
Q Consensus 349 ~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l-----~HpnIv~l~g~~~~~~---~~~-l 419 (724)
...++||+|+||.||. ..+....+||++........+.+.+|+.+|+.| +|+||++++|++.++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4457899999999996 333333479988765444567899999999999 5799999999998863 434 7
Q ss_pred EEEe--cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCccEEEcC----CCCEEEEEec
Q 040832 420 VYEY--VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGL-AYLHEDCHPRIIHRDIKSSNILLDY----TFETKVADFG 492 (724)
Q Consensus 420 V~E~--~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL-~yLHs~~~~~iiHrDIkp~NILl~~----~~~vkL~DFG 492 (724)
|||| +.+++|.+++.+.. +++. ..++.+++.+| +|||++ +||||||||+|||++. +++++|+||+
T Consensus 83 I~e~~G~~~~tL~~~l~~~~---~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCR---YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EecCCCCcchhHHHHHHccc---ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 8999 55899999996532 4544 35678888888 999999 9999999999999974 3489999955
Q ss_pred cc
Q 040832 493 LA 494 (724)
Q Consensus 493 la 494 (724)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 44
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.8e-21 Score=211.09 Aligned_cols=186 Identities=31% Similarity=0.365 Sum_probs=157.2
Q ss_pred eeeccCcEEEEEEE----cCCCcEEEEEEeccCCchh--HHHHHHHHHHHHhcC-CCCeeEEeeEEEeCCeEEEEEEecC
Q 040832 353 LLGQGGFGYVHKGV----LPNGKEVAVKSLRSGSGQG--EREFKAEVEIISRVH-HRHLVSLVGYCIAGGKRLLVYEYVP 425 (724)
Q Consensus 353 ~LG~G~fG~Vyk~~----~~~g~~vaVK~l~~~~~~~--~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~ 425 (724)
.+|+|.||.|++.+ .+.|+.+|+|.++...... ......|..++..++ |+++|+++-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999865 3357789999887542221 114566888899997 9999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccc
Q 040832 426 NNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVS 505 (724)
Q Consensus 426 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 505 (724)
+|.|...+.... .+++.....+...++-+|++||+. +|||||+|.+||+++.+|++|+.|||+++..-.....
T Consensus 81 gg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred cchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 999987776544 367777778888999999999999 9999999999999999999999999999987654332
Q ss_pred cccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCC
Q 040832 506 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDP 550 (724)
Q Consensus 506 ~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~ 550 (724)
+|+..|||||++. ......|.|+||++++||+||..||..
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 7999999999998 456789999999999999999999975
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.9e-19 Score=186.12 Aligned_cols=232 Identities=19% Similarity=0.284 Sum_probs=147.1
Q ss_pred CCcccceeeccCcEEEEEEEcCC-CcEEEEEEeccCC---chhHHHHHHHHHHHHhcCC----------CCeeEEeeEE-
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLPN-GKEVAVKSLRSGS---GQGEREFKAEVEIISRVHH----------RHLVSLVGYC- 411 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~~-g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~H----------pnIv~l~g~~- 411 (724)
.+..++.||.|+|+.||.+.+.. ++.+|||++.... ....+++++|.-.+..+.+ -.++--++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 34567889999999999999754 8899999875432 2234556666654444321 1111111111
Q ss_pred --------EeC---C-----eEEEEEEecCCCCHHHHHh---cCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 040832 412 --------IAG---G-----KRLLVYEYVPNNNLEFHLH---GKGR--PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIH 470 (724)
Q Consensus 412 --------~~~---~-----~~~lV~E~~~~gsL~~~L~---~~~~--~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiH 470 (724)
... . ..+++|+-+ .++|..++. .... ..+....++.+..|+++.+++||.. +|+|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence 111 1 226788877 677777653 2211 1234456677889999999999999 9999
Q ss_pred cCCCCccEEEcCCCCEEEEEeccccccCCCCCccccccccCCCcCCcchhcC--------CCCChhHHHHHHHHHHHHHH
Q 040832 471 RDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS--------GKLTEKSDVFSFGVMLLELI 542 (724)
Q Consensus 471 rDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~t~ksDV~SlGvlL~eLl 542 (724)
+||+++|+|++.+|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|+||++||.|.
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999999988766542221 334578999997744 25789999999999999999
Q ss_pred hCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCC
Q 040832 543 TGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRR 610 (724)
Q Consensus 543 tG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~R 610 (724)
+|+.||+...... ..+| .+ ..|. +....+..++..+|+.++++|
T Consensus 245 C~~lPf~~~~~~~--~~~~--------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEA--DPEW--------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGS--TSGG--------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccc--cccc--------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999998652211 1111 11 2334 566778888999999999887
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.6e-19 Score=181.33 Aligned_cols=143 Identities=16% Similarity=0.158 Sum_probs=113.1
Q ss_pred CCcccceeeccCcEEEEEEE--cCCCcEEEEEEeccCCch------------------------hHHHHHHHHHHHHhcC
Q 040832 347 GFSQSNLLGQGGFGYVHKGV--LPNGKEVAVKSLRSGSGQ------------------------GEREFKAEVEIISRVH 400 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~--~~~g~~vaVK~l~~~~~~------------------------~~~~f~~Ei~il~~l~ 400 (724)
.|.+.+.||+|+||.||+|. ..+|+.||||+++..... ....+..|++++.+|.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999998 568999999998754210 0123568999999997
Q ss_pred CC--CeeEEeeEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCcc
Q 040832 401 HR--HLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR-IIHRDIKSSN 477 (724)
Q Consensus 401 Hp--nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~-iiHrDIkp~N 477 (724)
+. .+.+++++ ...+|||||+.+++|..++.... .+...+...++.||+.+|.|||.+ + |+||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhh
Confidence 53 33444443 23589999999988876553322 255667789999999999999999 8 9999999999
Q ss_pred EEEcCCCCEEEEEeccccccCC
Q 040832 478 ILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 478 ILl~~~~~vkL~DFGla~~~~~ 499 (724)
|||+ +++++|+|||++.....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EEEE-CCCEEEEEChhhhccCC
Confidence 9999 88999999999876543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-19 Score=199.06 Aligned_cols=214 Identities=26% Similarity=0.404 Sum_probs=162.8
Q ss_pred HHhcCCCCeeEEeeEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-EecCCC
Q 040832 396 ISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRI-IHRDIK 474 (724)
Q Consensus 396 l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~i-iHrDIk 474 (724)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+... ...++|.-...++++|++||.|||.- .| .|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeec
Confidence 45788999999999999999999999999999999999873 34589999999999999999999986 44 899999
Q ss_pred CccEEEcCCCCEEEEEeccccccCCCCC-ccccccccCCCcCCcchhcCC---C----CChhHHHHHHHHHHHHHHhCCC
Q 040832 475 SSNILLDYTFETKVADFGLAKLTTDNNT-HVSTRVMGTFGYLAPEYASSG---K----LTEKSDVFSFGVMLLELITGRR 546 (724)
Q Consensus 475 p~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~---~----~t~ksDV~SlGvlL~eLltG~~ 546 (724)
..|+++|..+.+||.|||+.....+... .......-..-|.|||.+... . .+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 9999999999999999999987753110 111112234569999998753 1 4678999999999999999999
Q ss_pred CCCCCCchhh--hHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 547 PIDPTGAMED--CLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 547 P~~~~~~~~~--~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
||+....... .++.+.+ . .......+.+.... +....+..++..||..+|..||++.+|-..++...
T Consensus 157 ~~~~~~~~~~~~eii~~~~--------~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVK--------K-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccccccccCChHHHHHHHH--------h-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 9987532222 2222211 1 11122223222111 33336999999999999999999999998887543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.7e-19 Score=176.62 Aligned_cols=134 Identities=22% Similarity=0.328 Sum_probs=114.4
Q ss_pred ceeeccCcEEEEEEEcCCCcEEEEEEeccCCch--------hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 352 NLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQ--------GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~--------~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
+.||+|+||.||+|.+ +|..|+||+....... ....+.+|++++..++|.+|.....++.+.+..+|||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 6778999987643211 123578899999999999988777777777888999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
++|++|.+++.... + .+..++.+|+.+|.+||+. +++||||++.|||++ ++.++|+|||+++.
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986532 2 8889999999999999999 999999999999999 78999999999875
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.5e-19 Score=186.55 Aligned_cols=197 Identities=23% Similarity=0.283 Sum_probs=137.3
Q ss_pred CCCCeeEEeeEEEeC---------------------------CeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHH
Q 040832 400 HHRHLVSLVGYCIAG---------------------------GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMG 452 (724)
Q Consensus 400 ~HpnIv~l~g~~~~~---------------------------~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~q 452 (724)
.|||||++.++|.+. ..+||||..+ ..+|..+|..+. .+.-...-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence 499999999877643 3558999888 567888887654 355566778999
Q ss_pred HHHHHHHHHhcCCCCeEecCCCCccEEE--cCCC--CEEEEEeccccccCCCCCc-----cccccccCCCcCCcchhcC-
Q 040832 453 SAKGLAYLHEDCHPRIIHRDIKSSNILL--DYTF--ETKVADFGLAKLTTDNNTH-----VSTRVMGTFGYLAPEYASS- 522 (724)
Q Consensus 453 ia~gL~yLHs~~~~~iiHrDIkp~NILl--~~~~--~vkL~DFGla~~~~~~~~~-----~~~~~~gt~~y~APE~~~~- 522 (724)
+++|+.|||.+ +|.|||+|.+|||| |+|+ .+.|+|||++--.....-. ..-..-|...-||||++..
T Consensus 350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999999 99999999999999 3333 4688999988532211111 1112346777899998853
Q ss_pred -CC----CChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHH
Q 040832 523 -GK----LTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVA 597 (724)
Q Consensus 523 -~~----~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~ 597 (724)
|. .-.|+|.|+.|.+.||++..+.||.....+.... ..+.+---+.| +......+.+
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~--------------r~Yqe~qLPal----p~~vpp~~rq 488 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT--------------RTYQESQLPAL----PSRVPPVARQ 488 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech--------------hhhhhhhCCCC----cccCChHHHH
Confidence 22 2369999999999999999999997644332111 11222111222 2233345677
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHh
Q 040832 598 CAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 598 l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
++...++.+|.+|++..-....|+
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHH
Confidence 777889999999998775555443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=174.12 Aligned_cols=131 Identities=21% Similarity=0.329 Sum_probs=107.7
Q ss_pred eeeccCcEEEEEEEcCCCcEEEEEEeccCCch--------hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 353 LLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQ--------GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 353 ~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~--------~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
+||+|+||.||+|.+ +++.|+||++...... ...++.+|++++..++|.++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 6788999986543211 1245778999999999887665555566666779999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
+|++|.+++..... .++.+++.+|.+||+. +++||||+++|||++ +++++|+|||+++..
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999988754321 7899999999999999 999999999999999 789999999998763
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=2e-18 Score=173.09 Aligned_cols=146 Identities=19% Similarity=0.140 Sum_probs=115.2
Q ss_pred HHHHHhhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCch----------------------hHHHHHHHHHHH
Q 040832 339 EELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQ----------------------GEREFKAEVEII 396 (724)
Q Consensus 339 ~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~----------------------~~~~f~~Ei~il 396 (724)
+++......|.+.+.||+|+||.||++.+.+|+.||||+++..... ....+..|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 4555555558889999999999999999888999999987643210 012367789999
Q ss_pred HhcCCCC--eeEEeeEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 040832 397 SRVHHRH--LVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIK 474 (724)
Q Consensus 397 ~~l~Hpn--Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIk 474 (724)
.+++|.+ +..+++ ....++||||+++++|..++.. .....++.+|+++|.+||+. +|+|||||
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~ 152 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHGDLS 152 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence 9998874 444443 2345899999999999765431 24567889999999999998 99999999
Q ss_pred CccEEEcCCCCEEEEEeccccccCC
Q 040832 475 SSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 475 p~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
|+||||+++++++|+|||++.....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999999975544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.9e-18 Score=197.51 Aligned_cols=145 Identities=21% Similarity=0.310 Sum_probs=116.1
Q ss_pred HHHHHHhhCCCcccceeeccCcEEEEEEEcCCCcEEEEEE-eccC-Cc------hhHHHHHHHHHHHHhcCCCCeeEEee
Q 040832 338 YEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKS-LRSG-SG------QGEREFKAEVEIISRVHHRHLVSLVG 409 (724)
Q Consensus 338 ~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~-l~~~-~~------~~~~~f~~Ei~il~~l~HpnIv~l~g 409 (724)
+.........|...++||+|+||.||+|.+.+.. +++|+ +... .. ...+.+.+|+++|++++|++|+..+.
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~ 403 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI 403 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence 3333444455677899999999999999875544 44443 2211 11 11245889999999999999998888
Q ss_pred EEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEE
Q 040832 410 YCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVA 489 (724)
Q Consensus 410 ~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~ 489 (724)
++.+....+|||||+++++|.+++. ....++.+|+++|.|||+. +|+||||||+|||| .++.++|+
T Consensus 404 ~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~li 469 (535)
T PRK09605 404 YDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLI 469 (535)
T ss_pred EEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEE
Confidence 8888778899999999999998875 4567999999999999999 99999999999999 67799999
Q ss_pred Eecccccc
Q 040832 490 DFGLAKLT 497 (724)
Q Consensus 490 DFGla~~~ 497 (724)
|||+++..
T Consensus 470 DFGla~~~ 477 (535)
T PRK09605 470 DFGLGKYS 477 (535)
T ss_pred eCcccccC
Confidence 99999754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-18 Score=189.38 Aligned_cols=175 Identities=26% Similarity=0.396 Sum_probs=131.7
Q ss_pred eEEEEEEecCCCCHHHHHhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccc
Q 040832 416 KRLLVYEYVPNNNLEFHLHG-KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLA 494 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~-~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla 494 (724)
..|+.|++|...+|+++|.+ +.....++...+.|+.|++.|++| + +.+|||+|+.||+...+.++||.||||.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 46899999999999999973 444557888999999999999999 5 8999999999999999999999999999
Q ss_pred cccCCCC-----CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhh
Q 040832 495 KLTTDNN-----THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLR 568 (724)
Q Consensus 495 ~~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~ 568 (724)
....... ....+...||.+||+||.+.+..|+.|+|||+||+||+||+. =...|+.. ....
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~-------------~t~~ 470 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI-------------ATLT 470 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-------------Hhhh
Confidence 8776555 223456789999999999999999999999999999999997 22222110 1111
Q ss_pred cccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 040832 569 ALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRAL 620 (724)
Q Consensus 569 ~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L 620 (724)
.+.++.+. +....+|+ .=..++.+++...|.+|| .++...+
T Consensus 471 d~r~g~ip----~~~~~d~p-----~e~~ll~~lls~~p~~RP--~~~~~~~ 511 (516)
T KOG1033|consen 471 DIRDGIIP----PEFLQDYP-----EEYTLLQQLLSPSPEERP--SAIEVAL 511 (516)
T ss_pred hhhcCCCC----hHHhhcCc-----HHHHHHHHhcCCCcccCc--hHHHHhh
Confidence 22333332 11111222 234567788999999999 4444443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=150.45 Aligned_cols=135 Identities=21% Similarity=0.147 Sum_probs=115.3
Q ss_pred ccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCC--CCeeEEeeEEEeCCeEEEEEEecCCC
Q 040832 350 QSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHH--RHLVSLVGYCIAGGKRLLVYEYVPNN 427 (724)
Q Consensus 350 ~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~H--pnIv~l~g~~~~~~~~~lV~E~~~~g 427 (724)
+.+.||+|.++.||++...+ +.++||....... ...+.+|+.+++.++| .++.++++++...+..+++|||+.++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35679999999999999854 7899999876543 4679999999999976 58999999888888899999999988
Q ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 428 NLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 428 sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
.+..+ +......++.+++++|++||.....+++|+||+++|||++.++.++|+|||+++.
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77653 4567778899999999999986445799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.5e-16 Score=157.44 Aligned_cols=137 Identities=18% Similarity=0.219 Sum_probs=101.0
Q ss_pred cceeeccCcEEEEEEEcCCCcEEEEEEeccCCchh--HHH----------------------HHHHHHHHHhcCCCC--e
Q 040832 351 SNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQG--ERE----------------------FKAEVEIISRVHHRH--L 404 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~--~~~----------------------f~~Ei~il~~l~Hpn--I 404 (724)
.+.||+|+||.||+|.+.+++.||||+++...... ... ...|...+.++++.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999987542211 111 135667777775443 4
Q ss_pred eEEeeEEEeCCeEEEEEEecCCCCHHH-HHhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCccEEEcC
Q 040832 405 VSLVGYCIAGGKRLLVYEYVPNNNLEF-HLHGKGRPVMDWPTRLKIAMGSAKGLAYLHE-DCHPRIIHRDIKSSNILLDY 482 (724)
Q Consensus 405 v~l~g~~~~~~~~~lV~E~~~~gsL~~-~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs-~~~~~iiHrDIkp~NILl~~ 482 (724)
.+.+++ ...+|||||+.++.+.. .|.... . .....+++.+++.+|.+||. . +|+||||||+||||+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence 444443 24589999999954432 122111 1 15678899999999999999 7 999999999999999
Q ss_pred CCCEEEEEeccccccCC
Q 040832 483 TFETKVADFGLAKLTTD 499 (724)
Q Consensus 483 ~~~vkL~DFGla~~~~~ 499 (724)
++.++|+|||++.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 88999999999975544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.7e-17 Score=188.45 Aligned_cols=211 Identities=22% Similarity=0.270 Sum_probs=142.4
Q ss_pred hCCCcccceeeccCcEEEEEEEcCC-CcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPN-GKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
..+|..+++|..|+||.||..+++. .+.+|+|+-+.+ .+++- +|.....+++|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee------------------
Confidence 4678999999999999999998653 566788543321 11110 22222333333
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC-
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT- 502 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~- 502 (724)
|+-...+...+. +... ++.+++|||+. +|+|||+|++|.||+.-|++|+.||||.+.......
T Consensus 136 ---gDc~tllk~~g~--lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGP--LPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ---chhhhhcccCCC--Ccch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 333444544333 2211 27789999999 999999999999999999999999999975322111
Q ss_pred -----------c--cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhc
Q 040832 503 -----------H--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRA 569 (724)
Q Consensus 503 -----------~--~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~ 569 (724)
+ ...+++||+.|+|||++....|..-+|.|+||+|+||++-|..||++....+..-+ ...
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~-vis------ 272 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ-VIS------ 272 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhh-hhh------
Confidence 1 12447899999999999999999999999999999999999999987643332110 000
Q ss_pred ccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 040832 570 LDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKIS 614 (724)
Q Consensus 570 ~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ 614 (724)
++..+.| -+.....+...++...|+++|..|--..
T Consensus 273 -d~i~wpE---------~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 273 -DDIEWPE---------EDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred -hhccccc---------cCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 0001111 1223344567777788888888885444
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.8e-15 Score=156.05 Aligned_cols=137 Identities=19% Similarity=0.225 Sum_probs=105.6
Q ss_pred cceee-ccCcEEEEEEEcCCCcEEEEEEeccCC-------------chhHHHHHHHHHHHHhcCCCCe--eEEeeEEEeC
Q 040832 351 SNLLG-QGGFGYVHKGVLPNGKEVAVKSLRSGS-------------GQGEREFKAEVEIISRVHHRHL--VSLVGYCIAG 414 (724)
Q Consensus 351 ~~~LG-~G~fG~Vyk~~~~~g~~vaVK~l~~~~-------------~~~~~~f~~Ei~il~~l~HpnI--v~l~g~~~~~ 414 (724)
+.+|| .||.|.||+... +++.++||.++... ......+.+|++++.+|+|.+| ++.++++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45687 888888998877 46778998875321 1122457889999999998775 6777765443
Q ss_pred C----eEEEEEEecCC-CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEE
Q 040832 415 G----KRLLVYEYVPN-NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVA 489 (724)
Q Consensus 415 ~----~~~lV~E~~~~-gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~ 489 (724)
. ..+|||||+++ .+|.+++... .++.. .+.+|+.+|.+||++ +|+||||||+||||+.+++++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence 2 22599999997 6898888653 23433 357899999999999 99999999999999998899999
Q ss_pred EeccccccC
Q 040832 490 DFGLAKLTT 498 (724)
Q Consensus 490 DFGla~~~~ 498 (724)
|||.+....
T Consensus 185 Dfg~~~~~~ 193 (239)
T PRK01723 185 DFDRGELRT 193 (239)
T ss_pred ECCCcccCC
Confidence 999997644
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.1e-16 Score=182.22 Aligned_cols=254 Identities=23% Similarity=0.298 Sum_probs=185.7
Q ss_pred CCcccceeeccCcEEEEEEEcCC--CcEEEEEEeccCC--chhHHHHHHHHHHHHhcC-CCCeeEEeeEEEeCCeEEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLPN--GKEVAVKSLRSGS--GQGEREFKAEVEIISRVH-HRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~~--g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~ 421 (724)
.|.+.+.||+|.|+.|-.....+ ...+|+|.+.... .........|..+-+.+. |.|++++++...+.+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 34555669999999998877543 3446666664432 222334556888888886 999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCccEEEcCCC-CEEEEEeccccccCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLH-EDCHPRIIHRDIKSSNILLDYTF-ETKVADFGLAKLTTD 499 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH-s~~~~~iiHrDIkp~NILl~~~~-~vkL~DFGla~~~~~ 499 (724)
+|..++++...+...+...+.....-.++.|+..+|.|+| +. ++.||||||+|.+++.++ ..+++|||+|..+..
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999988873223223666777889999999999999 76 899999999999999999 999999999988766
Q ss_pred -CC-Ccccccccc-CCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCCh
Q 040832 500 -NN-THVSTRVMG-TFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 500 -~~-~~~~~~~~g-t~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~ 575 (724)
.. ........| ++.|+|||...+ .......|+||+|+++.-+++|..||+...........|...- +.+
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~-------~~~ 250 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK-------GRF 250 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc-------ccc
Confidence 22 223344567 999999999887 4556789999999999999999999976544433333332211 000
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 576 NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 576 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
. ...-.........+..+++..++..|.+.+++..
T Consensus 251 ~--------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 251 T--------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred c--------cCccccCChhhhhcccccccCCchhccccccccc
Confidence 0 0001112233455666677788999998887653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.56 E-value=2e-14 Score=160.93 Aligned_cols=142 Identities=24% Similarity=0.265 Sum_probs=103.7
Q ss_pred cceeeccCcEEEEEEEcCCCcEEEEEEeccCCchh----------------------------------------HHHHH
Q 040832 351 SNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQG----------------------------------------EREFK 390 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~----------------------------------------~~~f~ 390 (724)
.+.||.|++|.||+|++.+|+.||||+.+.+.... +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999999999999999987642111 01245
Q ss_pred HHHHHHHhcC----CCCeeEEeeEEE-eCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHH-HHHHHHhcC
Q 040832 391 AEVEIISRVH----HRHLVSLVGYCI-AGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAK-GLAYLHEDC 464 (724)
Q Consensus 391 ~Ei~il~~l~----HpnIv~l~g~~~-~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~-gL~yLHs~~ 464 (724)
.|++.+.++. |.+-+.+-.++. ..+..+|||||++|++|.+++..... .+ .+.+++..+++ .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~- 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLRD- 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhC-
Confidence 5666666663 333344333333 24467999999999999887653211 12 34556776666 47888988
Q ss_pred CCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 465 ~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
+++|+|+||.|||++.+++++|+|||++..+..
T Consensus 277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred --CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.8e-13 Score=140.47 Aligned_cols=207 Identities=19% Similarity=0.286 Sum_probs=140.2
Q ss_pred HHHHHHHHhcCCCCeeEEeeEEEeCC-----eEEEEEEecCCCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 040832 390 KAEVEIISRVHHRHLVSLVGYCIAGG-----KRLLVYEYVPNNNLEFHLHG--KGRPVMDWPTRLKIAMGSAKGLAYLHE 462 (724)
Q Consensus 390 ~~Ei~il~~l~HpnIv~l~g~~~~~~-----~~~lV~E~~~~gsL~~~L~~--~~~~~l~~~~~~~i~~qia~gL~yLHs 462 (724)
..-++.|-++.|-|||+++.|+.+.. ...++.|||..|+|..+|++ +....+......+|+.||+.||.|||+
T Consensus 115 ~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs 194 (458)
T KOG1266|consen 115 RAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS 194 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc
Confidence 33455666778999999999886543 46799999999999999975 233457778888999999999999999
Q ss_pred cCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC---CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHH
Q 040832 463 DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN---THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLL 539 (724)
Q Consensus 463 ~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~---~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~ 539 (724)
|.+.|||+++..+-|++..++-+|+.--.-......-+ ......-.+-.+|.+||+-.....+-.+|||+||...+
T Consensus 195 -~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 195 -CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL 273 (458)
T ss_pred -cCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence 78899999999999999999988874211111100000 00111123567899999877777788999999999999
Q ss_pred HHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 540 ELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 540 eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
||.-|..--..........+.... ....++++ +=+.++..|++..|..||+|++++.+
T Consensus 274 emailEiq~tnseS~~~~ee~ia~--~i~~len~--------------------lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 274 EMAILEIQSTNSESKVEVEENIAN--VIIGLENG--------------------LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHHHheeccCCCcceeehhhhhhh--heeeccCc--------------------cccCcCcccccCCCCCCcchhhhhcC
Confidence 998765432111100000000000 00001111 11235668899999999999988764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.8e-13 Score=130.62 Aligned_cols=131 Identities=18% Similarity=0.103 Sum_probs=97.7
Q ss_pred cceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCe-eEEeeEEEeCCeEEEEEEecCCCCH
Q 040832 351 SNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHL-VSLVGYCIAGGKRLLVYEYVPNNNL 429 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~E~~~~gsL 429 (724)
.+.|+.|.++.||++... ++.|+||....... ....+..|+.+++.+.+.++ .+++.++. ...++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 356899999999999874 77899998865432 23356889999999865454 45555433 345899999999887
Q ss_pred HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 430 EFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC--HPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 430 ~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~--~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
... . . ....++.+++++|+.||... ..+++|+|+++.|||++ ++.++|+|||.+..
T Consensus 79 ~~~----~---~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE----D---F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc----c---c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 643 0 1 12345678999999999972 22369999999999999 66899999999863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.2e-13 Score=152.90 Aligned_cols=246 Identities=23% Similarity=0.270 Sum_probs=179.4
Q ss_pred CCcccceeec--cCcEEEEEEEc---CCCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcC-CCCeeEEeeEEEeCCeEE
Q 040832 347 GFSQSNLLGQ--GGFGYVHKGVL---PNGKEVAVKSLRSGSG--QGEREFKAEVEIISRVH-HRHLVSLVGYCIAGGKRL 418 (724)
Q Consensus 347 ~f~~~~~LG~--G~fG~Vyk~~~---~~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~ 418 (724)
.|.+.+.+|. |.+|.||++.. .++..+|+|.-+..-. .....=.+|+...++++ |.|.++.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4667788999 99999999886 3577889987443211 22233456777777775 999999888899999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCccEEEcCC-CCEEEEEecc
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAK----GLAYLHEDCHPRIIHRDIKSSNILLDYT-FETKVADFGL 493 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~----gL~yLHs~~~~~iiHrDIkp~NILl~~~-~~vkL~DFGl 493 (724)
+-.|+|. .+|..+.+.... .+....++.++.+... ||.++|+. .++|-|+|+.||++..+ ..++++|||+
T Consensus 195 iqtE~~~-~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeecccc-chhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcce
Confidence 9999995 777777765432 3677788888888888 99999998 99999999999999998 8899999999
Q ss_pred ccccCCCCCc----cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhc
Q 040832 494 AKLTTDNNTH----VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRA 569 (724)
Q Consensus 494 a~~~~~~~~~----~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~ 569 (724)
...+.+.... ...+..|...|++||.+. +.++.+.|||+||.+++|..+|.+...... ...|..
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~-----~~~W~~------ 337 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGK-----NSSWSQ------ 337 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCC-----CCCccc------
Confidence 9988776532 223336888899999865 577899999999999999999877653321 111321
Q ss_pred ccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 040832 570 LDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIV 617 (724)
Q Consensus 570 ~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv 617 (724)
++.+ ++..++-.....++...+..+++.++..|++.+.+.
T Consensus 338 ~r~~--------~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 338 LRQG--------YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred cccc--------cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 1111 111122222223344477888999999988766554
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.41 E-value=6e-13 Score=150.93 Aligned_cols=145 Identities=21% Similarity=0.266 Sum_probs=97.9
Q ss_pred CCCcccceeeccCcEEEEEEEcCC-CcEEEEEEeccCCchh----------------------------------H----
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPN-GKEVAVKSLRSGSGQG----------------------------------E---- 386 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vaVK~l~~~~~~~----------------------------------~---- 386 (724)
..|.. +.||.|++|.||+|++++ |+.||||+++.+.... .
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 789999999999999987 9999999997642110 0
Q ss_pred --HHHHHHHHHHHhcC----CCCeeEEeeEEEe-CCeEEEEEEecCCCCHHHH--HhcCCCCCCCHHHHHHHHHHHHHH-
Q 040832 387 --REFKAEVEIISRVH----HRHLVSLVGYCIA-GGKRLLVYEYVPNNNLEFH--LHGKGRPVMDWPTRLKIAMGSAKG- 456 (724)
Q Consensus 387 --~~f~~Ei~il~~l~----HpnIv~l~g~~~~-~~~~~lV~E~~~~gsL~~~--L~~~~~~~l~~~~~~~i~~qia~g- 456 (724)
-+|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.|.++ +...+ .+.. .++...++.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g---~d~~---~la~~~v~~~ 272 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG---TDMK---LLAERGVEVF 272 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC---CCHH---HHHHHHHHHH
Confidence 12445665555553 4444544444443 4567899999999999764 33222 2212 222222221
Q ss_pred HHHHHhcCCCCeEecCCCCccEEEcCCC----CEEEEEeccccccCCC
Q 040832 457 LAYLHEDCHPRIIHRDIKSSNILLDYTF----ETKVADFGLAKLTTDN 500 (724)
Q Consensus 457 L~yLHs~~~~~iiHrDIkp~NILl~~~~----~vkL~DFGla~~~~~~ 500 (724)
+.-++.. +++|+|+||.||||+.++ +++++|||++..+...
T Consensus 273 ~~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 273 FTQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 2233345 999999999999999888 9999999999877543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.3e-12 Score=142.85 Aligned_cols=166 Identities=20% Similarity=0.277 Sum_probs=127.5
Q ss_pred cCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHH
Q 040832 367 LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTR 446 (724)
Q Consensus 367 ~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~ 446 (724)
..++..|.|+..+...........+-++.|+.|+||||++++..++.++..|||.|.+. -|..+|.+.+ ...+
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-----~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-----KEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----HHHH
Confidence 34677888888876554334557788999999999999999999999999999999984 4566666533 4566
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccccccccCCCcCCcchhcCCCCC
Q 040832 447 LKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLT 526 (724)
Q Consensus 447 ~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t 526 (724)
...+.||+.||.|||++| +++|++|+-.-|+|+..|+.||++|-++......... .....---.|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~-~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP-AKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc-cccchhhhcccChhhcCccc--
Confidence 677899999999999887 8999999999999999999999999998765543320 01111112356666543322
Q ss_pred hhHHHHHHHHHHHHHHhC
Q 040832 527 EKSDVFSFGVMLLELITG 544 (724)
Q Consensus 527 ~ksDV~SlGvlL~eLltG 544 (724)
-..|.|.|||+++|++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.3e-11 Score=122.70 Aligned_cols=138 Identities=14% Similarity=0.151 Sum_probs=100.5
Q ss_pred cceeeccCcEEEEEEEcCC-------CcEEEEEEeccCCc---------------------hh-HHHHH----HHHHHHH
Q 040832 351 SNLLGQGGFGYVHKGVLPN-------GKEVAVKSLRSGSG---------------------QG-EREFK----AEVEIIS 397 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~~-------g~~vaVK~l~~~~~---------------------~~-~~~f~----~Ei~il~ 397 (724)
...||.|.-+.||.|...+ +..+|||+.+.... .. .+.+. +|++.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999998543 47899998753200 00 11233 7999999
Q ss_pred hcCC--CCeeEEeeEEEeCCeEEEEEEecCCCCHHH-HHhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCC
Q 040832 398 RVHH--RHLVSLVGYCIAGGKRLLVYEYVPNNNLEF-HLHGKGRPVMDWPTRLKIAMGSAKGLAYL-HEDCHPRIIHRDI 473 (724)
Q Consensus 398 ~l~H--pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~-~L~~~~~~~l~~~~~~~i~~qia~gL~yL-Hs~~~~~iiHrDI 473 (724)
++.. -++.+++++ ...+|||||+.++.+.. .|.+. .++..+...+..+++.+|.+| |+. +||||||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 9953 456666654 45589999998764422 23221 244556778889999999999 787 9999999
Q ss_pred CCccEEEcCCCCEEEEEeccccccCC
Q 040832 474 KSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 474 kp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
++.|||+++ +.++|+|||.+.....
T Consensus 152 s~~NIL~~~-~~v~iIDF~qav~~~h 176 (197)
T cd05146 152 SEYNMLWHD-GKVWFIDVSQSVEPTH 176 (197)
T ss_pred CHHHEEEEC-CcEEEEECCCceeCCC
Confidence 999999974 6899999999876643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.32 E-value=1e-11 Score=125.80 Aligned_cols=142 Identities=21% Similarity=0.260 Sum_probs=111.8
Q ss_pred ceeeccCcEEEEEEEcCCCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCC--CCeeEEeeEEEeC---CeEEEEEEecC
Q 040832 352 NLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHH--RHLVSLVGYCIAG---GKRLLVYEYVP 425 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~H--pnIv~l~g~~~~~---~~~~lV~E~~~ 425 (724)
+.|+.|.++.||++...+|+.++||+...... .....+..|+++++.|++ -++.+++.++... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778899999865432 134578999999999975 3457777776654 35689999999
Q ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 040832 426 NNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC----------------------------------------- 464 (724)
Q Consensus 426 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~----------------------------------------- 464 (724)
+.+|...+.. ..++..++..++.++++.|.+||+..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9988776542 23677788889999999999998531
Q ss_pred ------------CCCeEecCCCCccEEEcC--CCCEEEEEeccccc
Q 040832 465 ------------HPRIIHRDIKSSNILLDY--TFETKVADFGLAKL 496 (724)
Q Consensus 465 ------------~~~iiHrDIkp~NILl~~--~~~vkL~DFGla~~ 496 (724)
...++|+|+++.|||++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2e-12 Score=143.38 Aligned_cols=249 Identities=21% Similarity=0.206 Sum_probs=177.8
Q ss_pred HHHhhCCCcccceeeccCcEEEEEEEc--CCCcEEEEEEeccCCchhHHH--HHHHHHHHHhc-CCCCeeEEeeEEEeCC
Q 040832 341 LSAATGGFSQSNLLGQGGFGYVHKGVL--PNGKEVAVKSLRSGSGQGERE--FKAEVEIISRV-HHRHLVSLVGYCIAGG 415 (724)
Q Consensus 341 l~~~~~~f~~~~~LG~G~fG~Vyk~~~--~~g~~vaVK~l~~~~~~~~~~--f~~Ei~il~~l-~HpnIv~l~g~~~~~~ 415 (724)
......+|.++..||.|.|+.||+... .++..|++|.+.........+ -..|+.+...+ -|.++++++..+....
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 344567899999999999999998763 367889999887664443333 35677777777 4889999888888888
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCC-CCEEEEEeccc
Q 040832 416 KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYT-FETKVADFGLA 494 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~-~~vkL~DFGla 494 (724)
..|+=.|||++++++..+.-. ..++...++++..|++.+|.++|+. .++|+|+|++||++..+ +..++.|||++
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cccCchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence 888999999999988766322 2377888999999999999999998 99999999999999886 78899999998
Q ss_pred cccCCCCCccccccccCCCcC--CcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccC
Q 040832 495 KLTTDNNTHVSTRVMGTFGYL--APEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDD 572 (724)
Q Consensus 495 ~~~~~~~~~~~~~~~gt~~y~--APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~ 572 (724)
..+.-.. ......-+++ +++......+..+.|+|+||+-+.|.++|..--. ..+.|... ..
T Consensus 415 t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~-------~~~~~~~i------~~ 477 (524)
T KOG0601|consen 415 TRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE-------SGVQSLTI------RS 477 (524)
T ss_pred cccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCc-------ccccceee------ec
Confidence 7422111 1111233344 4555556678899999999999999998765211 11122110 11
Q ss_pred CChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 573 GNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 573 ~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
+.+ + ..+ .+...+..++..++..++..|+.+.++..+.+
T Consensus 478 ~~~-----p----~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 478 GDT-----P----NLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ccc-----c----CCC-chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 110 0 011 11245666777788899999998888776654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=6.5e-11 Score=113.42 Aligned_cols=144 Identities=19% Similarity=0.239 Sum_probs=106.0
Q ss_pred ccceeeccCcEEEEEEEcCCCcEEEEEEeccC--------CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 350 QSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSG--------SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 350 ~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~--------~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
...+|.||+-+.|+++.+ .|+.++||.-... ..-..++.++|+++|.+++--.|.--.-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567899999999999998 6777777743211 1112346788999999987545544444555555668999
Q ss_pred EecCC-CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC---CEEEEEecccccc
Q 040832 422 EYVPN-NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF---ETKVADFGLAKLT 497 (724)
Q Consensus 422 E~~~~-gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~---~vkL~DFGla~~~ 497 (724)
||+++ .++.+++...............++..|-+.|.-||.. +|||+||..+||||..++ .+.|+||||+...
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99987 5778877654433344444478899999999999999 999999999999995543 3589999998654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.3e-10 Score=112.04 Aligned_cols=132 Identities=21% Similarity=0.287 Sum_probs=99.3
Q ss_pred ceeeccCcEEEEEEEcCCCcEEEEEEeccCC---ch-----hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 352 NLLGQGGFGYVHKGVLPNGKEVAVKSLRSGS---GQ-----GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~---~~-----~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
.+|++|+-+.+|.+.+.+ ..+++|.=.... .. ....-.+|+.+|.+++--.|.--+-|+.+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 358899999999998744 346666432210 01 112467899999999755555444556666677899999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
++|..|.++|... ...++..+-+-+.-||.. +|||+||.++||+|..+. +.++||||+...
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999999888764 245677777888899999 999999999999998774 999999999744
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=9.1e-10 Score=115.23 Aligned_cols=142 Identities=18% Similarity=0.085 Sum_probs=103.9
Q ss_pred cceeeccCcEEEEEEEcCCCcEEEEEEeccCCchh-H----------HHHHHHHHHHHhcCCCC--eeEEeeEEEe----
Q 040832 351 SNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQG-E----------REFKAEVEIISRVHHRH--LVSLVGYCIA---- 413 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~-~----------~~f~~Ei~il~~l~Hpn--Iv~l~g~~~~---- 413 (724)
++++-+-....|++..+ +|+.|.||......... . ..+.+|+..+.+|..-+ ...++++++.
T Consensus 27 ~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 27 GEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred CcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 35566555566778766 67889999775432110 1 13778999999885333 3455566543
Q ss_pred -CCeEEEEEEecCCC-CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC-------CC
Q 040832 414 -GGKRLLVYEYVPNN-NLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY-------TF 484 (724)
Q Consensus 414 -~~~~~lV~E~~~~g-sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~-------~~ 484 (724)
...-+||||++++. +|.+++........+...+..++.+|+..+.-||.. ||+|+||+++||||+. ++
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence 23468999999986 899888542222345667789999999999999999 9999999999999975 56
Q ss_pred CEEEEEeccccc
Q 040832 485 ETKVADFGLAKL 496 (724)
Q Consensus 485 ~vkL~DFGla~~ 496 (724)
.+.|+||+.+..
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999998864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.6e-09 Score=118.04 Aligned_cols=167 Identities=17% Similarity=0.227 Sum_probs=127.5
Q ss_pred EEEEEEE-cCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEE----eCCeEEEEEEecCC-CCHHHHH
Q 040832 360 GYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCI----AGGKRLLVYEYVPN-NNLEFHL 433 (724)
Q Consensus 360 G~Vyk~~-~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~----~~~~~~lV~E~~~~-gsL~~~L 433 (724)
.+.||+. .-||..|++|+++.+..+.-.....-+++++++.|.|||.|.+++. .+..++|||+|+++ ++|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 5788888 3479999999996543333334456688999999999999998876 34567899999987 5565543
Q ss_pred hcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 434 HGK-------------GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 434 ~~~-------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
... ....+.+..+|.++.||..||.++|+. |+.-+-|.+++||++.+.+++|..+|+...+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 221 122356789999999999999999999 9999999999999999999999988887665544
Q ss_pred CCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCC
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P 547 (724)
... -+ .-..+-|.-.||++|+.|.||..-
T Consensus 447 ~~~---------------~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 PTE---------------PL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCc---------------ch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 311 01 012367999999999999999654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.2e-09 Score=112.86 Aligned_cols=260 Identities=18% Similarity=0.220 Sum_probs=156.3
Q ss_pred cccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCeeEEeeE------EEeCC-eEEEE
Q 040832 349 SQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGY------CIAGG-KRLLV 420 (724)
Q Consensus 349 ~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~------~~~~~-~~~lV 420 (724)
..++.||+|+.+.+|-.- .-+..+.|+.+.-..-...+ .+..|... .|+-+..-+.+ .-+.+ ..-++
T Consensus 14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 345679999999999632 22224557665432222211 23334444 45544331111 11222 25677
Q ss_pred EEecCCCCH-HHHHh----cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 421 YEYVPNNNL-EFHLH----GKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 421 ~E~~~~gsL-~~~L~----~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
|..+.+.-= ..++. ++.-+..+|.-.++.++.|+.+.+-||+. |.+-+|++.+||||.+++.|.|+|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 887766522 22221 23345688999999999999999999999 89999999999999999999999865444
Q ss_pred ccCCCCCccccccccCCCcCCcchhc-----CCCCChhHHHHHHHHHHHHHHhC-CCCCCCCCchhhhHHhhhhhhhhhc
Q 040832 496 LTTDNNTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITG-RRPIDPTGAMEDCLVDWARPLCLRA 569 (724)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~ksDV~SlGvlL~eLltG-~~P~~~~~~~~~~l~~w~~~~~~~~ 569 (724)
.... ......-+|...|.+||... +..-+...|.|.|||+|++||.| ++||.+....-.. .+-....
T Consensus 166 i~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~a-----p~p~E~~ 238 (637)
T COG4248 166 INAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDA-----PNPLETD 238 (637)
T ss_pred eccC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCC-----CCcchhh
Confidence 3322 22223346889999999754 34567789999999999999996 9999754211100 0000001
Q ss_pred ccCCChhhhcchhhh-----cCCCHH-HHHHHHHHHHHhhccC--CCCCCCHHHHHHHHhCC
Q 040832 570 LDDGNFNEIADPYLE-----KNYPTE-EMARMVACAAASIRHS--ARRRPKISQIVRALEGD 623 (724)
Q Consensus 570 ~~~~~~~~~vd~~l~-----~~~~~~-~~~~l~~l~~~cl~~~--P~~RPs~~evv~~L~~~ 623 (724)
+..+.|..--+.... ..++-. ....+..+..+|+... +.-||+.+.++.+|...
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 112222211111110 011111 2234556666777644 56899999998877643
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.3e-09 Score=107.86 Aligned_cols=126 Identities=25% Similarity=0.313 Sum_probs=83.8
Q ss_pred EEEEEEcCCCcEEEEEEeccCCc-------------h--------h-----HHHHHHHHHHHHhcCCC--CeeEEeeEEE
Q 040832 361 YVHKGVLPNGKEVAVKSLRSGSG-------------Q--------G-----EREFKAEVEIISRVHHR--HLVSLVGYCI 412 (724)
Q Consensus 361 ~Vyk~~~~~g~~vaVK~l~~~~~-------------~--------~-----~~~f~~Ei~il~~l~Hp--nIv~l~g~~~ 412 (724)
.||.|...+|..+|||+.+.... . . ....++|+++|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999988999999998754210 0 0 12356799999999755 566666542
Q ss_pred eCCeEEEEEEecC--CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEecCCCCccEEEcCCCCEEEE
Q 040832 413 AGGKRLLVYEYVP--NNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAY-LHEDCHPRIIHRDIKSSNILLDYTFETKVA 489 (724)
Q Consensus 413 ~~~~~~lV~E~~~--~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~y-LHs~~~~~iiHrDIkp~NILl~~~~~vkL~ 489 (724)
..+|||||++ |..|..+.... +.......++.++++.+.. ||.. +|||+||...|||++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence 3389999998 55554433321 1134566778888886665 5677 99999999999999988 99999
Q ss_pred EeccccccC
Q 040832 490 DFGLAKLTT 498 (724)
Q Consensus 490 DFGla~~~~ 498 (724)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.9e-11 Score=139.44 Aligned_cols=202 Identities=21% Similarity=0.267 Sum_probs=147.8
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
.++|.+.+-+-.|.|+.++.+.-. .|...++|..... .....+..+.+-.++-..+||.+++..--+......+||
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 355666777889999999886632 3444444443321 111223344444555555677777766555556678999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
++|+.+++|...||..+ ..+.+.....+..+..+++|||.. .++|||+++.|+|+..+++.++.|||+....+.-
T Consensus 883 ~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccc
Confidence 99999999999999766 355555556677788999999997 7999999999999999999999999843221100
Q ss_pred ---------------------CC---------ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCC
Q 040832 501 ---------------------NT---------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDP 550 (724)
Q Consensus 501 ---------------------~~---------~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~ 550 (724)
.. .....+.||..|++||.+.+......+|.|++|++|+|.++|..||+.
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 00 012236799999999999999999999999999999999999999976
Q ss_pred C
Q 040832 551 T 551 (724)
Q Consensus 551 ~ 551 (724)
.
T Consensus 1038 ~ 1038 (1205)
T KOG0606|consen 1038 E 1038 (1205)
T ss_pred c
Confidence 4
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.5e-08 Score=103.27 Aligned_cols=138 Identities=21% Similarity=0.195 Sum_probs=99.5
Q ss_pred CCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCch----------------------hHHHHHHHHHHHHhcCCC--
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQ----------------------GEREFKAEVEIISRVHHR-- 402 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~----------------------~~~~f~~Ei~il~~l~Hp-- 402 (724)
-..+++.||-|.-+.||.|...+|..+|||.=+.+... .....++|+++|.+|.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 45678899999999999999999999999965432110 012346799999999644
Q ss_pred CeeEEeeEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC
Q 040832 403 HLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY 482 (724)
Q Consensus 403 nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~ 482 (724)
.|.+.+++ +...+||||++|--|...-. +....-.|+..|++-+..+-.. ||||+|+..-||||++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 66666554 45689999999877654321 2223334445555555555555 8999999999999999
Q ss_pred CCCEEEEEeccccccC
Q 040832 483 TFETKVADFGLAKLTT 498 (724)
Q Consensus 483 ~~~vkL~DFGla~~~~ 498 (724)
||.++|+||--+....
T Consensus 238 dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 238 DGDIVVIDWPQAVPIS 253 (304)
T ss_pred CCCEEEEeCcccccCC
Confidence 9999999997775443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.1e-08 Score=100.03 Aligned_cols=107 Identities=23% Similarity=0.254 Sum_probs=85.6
Q ss_pred HHHHHHHHHHHhcCC--CCeeEEeeEEEeCC----eEEEEEEecCCC-CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 040832 387 REFKAEVEIISRVHH--RHLVSLVGYCIAGG----KRLLVYEYVPNN-NLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAY 459 (724)
Q Consensus 387 ~~f~~Ei~il~~l~H--pnIv~l~g~~~~~~----~~~lV~E~~~~g-sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~y 459 (724)
....+|...+.+|.. -.+.+.+++..... .-+||+|++++. +|.+++..... ++......++.++++.++-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 457889998888853 33456666665522 348999999884 79998876433 5667788999999999999
Q ss_pred HHhcCCCCeEecCCCCccEEEcCCC---CEEEEEeccccccC
Q 040832 460 LHEDCHPRIIHRDIKSSNILLDYTF---ETKVADFGLAKLTT 498 (724)
Q Consensus 460 LHs~~~~~iiHrDIkp~NILl~~~~---~vkL~DFGla~~~~ 498 (724)
||+. +|+|+|+++.||||+.+. ++.|+||+.++...
T Consensus 134 lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 134 LHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999 999999999999998886 89999999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=9.7e-09 Score=116.10 Aligned_cols=139 Identities=24% Similarity=0.299 Sum_probs=95.4
Q ss_pred ceeeccCcEEEEEEEcCCCcEEEEEEeccCCchh----------------------------------------HHHHHH
Q 040832 352 NLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQG----------------------------------------EREFKA 391 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~----------------------------------------~~~f~~ 391 (724)
+-|+.++-|.||+|++++|+.||||+.+.+-... +-+|..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5789999999999999999999999987642210 112445
Q ss_pred HHHHHHhcC----CCCeeEEeeEEEe-CCeEEEEEEecCCCCHHHHH--hcCCCCCCCHHHHHHHHHHHHHH-HHHHHhc
Q 040832 392 EVEIISRVH----HRHLVSLVGYCIA-GGKRLLVYEYVPNNNLEFHL--HGKGRPVMDWPTRLKIAMGSAKG-LAYLHED 463 (724)
Q Consensus 392 Ei~il~~l~----HpnIv~l~g~~~~-~~~~~lV~E~~~~gsL~~~L--~~~~~~~l~~~~~~~i~~qia~g-L~yLHs~ 463 (724)
|+..+.+++ +..-+++=.+|++ .+...|+|||++|--+.++. ...+ ++...+ +..++++ +..+-.+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g---~d~k~i---a~~~~~~f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG---IDRKEL---AELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC---CCHHHH---HHHHHHHHHHHHHhc
Confidence 666666652 2222333344443 45679999999999998874 4333 443333 3333332 2223334
Q ss_pred CCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 464 CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 464 ~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
+++|.|.+|.||+++.++++.+.|||+......
T Consensus 285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999986654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=1e-07 Score=95.24 Aligned_cols=139 Identities=16% Similarity=0.074 Sum_probs=103.6
Q ss_pred eeccCcEEEEEEEcCCCcEEEEEEeccCC------chhHHHHHHHHHHHHhcCC--CCeeEEeeEEEe--C--CeEEEEE
Q 040832 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSGS------GQGEREFKAEVEIISRVHH--RHLVSLVGYCIA--G--GKRLLVY 421 (724)
Q Consensus 354 LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~------~~~~~~f~~Ei~il~~l~H--pnIv~l~g~~~~--~--~~~~lV~ 421 (724)
-|+||-+-||+-.+ +|+.+-||+-.... ...+..|.+|+..|.+|.. -.+.+++.+... . -.-+||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 56788888999776 45578888765221 2245679999999999963 334555522211 1 1347999
Q ss_pred EecCC-CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCC--EEEEEeccccc
Q 040832 422 EYVPN-NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFE--TKVADFGLAKL 496 (724)
Q Consensus 422 E~~~~-gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~--vkL~DFGla~~ 496 (724)
|-+.+ .+|.+++........+...+..++.+|++.|+-||.. ++.|+|+.++|||++.++. ++++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97754 6888888765544567778889999999999999999 9999999999999986666 99999977654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.8e-09 Score=121.59 Aligned_cols=151 Identities=21% Similarity=0.340 Sum_probs=105.7
Q ss_pred HHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc--------cccccccCCCcCCcchhc
Q 040832 450 AMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH--------VSTRVMGTFGYLAPEYAS 521 (724)
Q Consensus 450 ~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~--------~~~~~~gt~~y~APE~~~ 521 (724)
+.+++.||.|||... ++||++|.|++|.++.++.+||+.|+.+......... ..--..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 344559999999764 8999999999999999999999999988655442111 111123456799999999
Q ss_pred CCCCChhHHHHHHHHHHHHHHhCCC-CCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHH
Q 040832 522 SGKLTEKSDVFSFGVMLLELITGRR-PIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAA 600 (724)
Q Consensus 522 ~~~~t~ksDV~SlGvlL~eLltG~~-P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~ 600 (724)
....+.++|+|||||++|.+..|+. -++....... ..+....+..-...+..+...++.+.+.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~----------------~~~~~~~~~~~~~~~s~~~p~el~~~l~ 246 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS----------------YSFSRNLLNAGAFGYSNNLPSELRESLK 246 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcch----------------hhhhhcccccccccccccCcHHHHHHHH
Confidence 9889999999999999999995444 3433211110 1111111111112334556677888899
Q ss_pred HhhccCCCCCCCHHHHHH
Q 040832 601 ASIRHSARRRPKISQIVR 618 (724)
Q Consensus 601 ~cl~~~P~~RPs~~evv~ 618 (724)
+++..+...||++.++..
T Consensus 247 k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 247 KLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHhcCCcccCcchhhhhc
Confidence 999999999998887653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.5e-07 Score=96.40 Aligned_cols=138 Identities=18% Similarity=0.193 Sum_probs=87.0
Q ss_pred ceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC--eeEEeeEEEeCCeEEEEEEecCCCC-
Q 040832 352 NLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRH--LVSLVGYCIAGGKRLLVYEYVPNNN- 428 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~Hpn--Iv~l~g~~~~~~~~~lV~E~~~~gs- 428 (724)
..||+|..+.||+. .++.+++|...... ......+|+++++.+..-. +.+.++++...+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 56899999999984 24567889887543 3345788999999996433 4677888877778889999999974
Q ss_pred HHHH---------------------HhcCCCCCCCHHHHHH-HHH----------HHHH-HHHHHHhc-CCCCeEecCCC
Q 040832 429 LEFH---------------------LHGKGRPVMDWPTRLK-IAM----------GSAK-GLAYLHED-CHPRIIHRDIK 474 (724)
Q Consensus 429 L~~~---------------------L~~~~~~~l~~~~~~~-i~~----------qia~-gL~yLHs~-~~~~iiHrDIk 474 (724)
+... ||.............. +.. .+.+ ...+|... ....++|+|++
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 2111 1221111111111110 000 0011 12222211 12357899999
Q ss_pred CccEEEcCCCCEEEEEecccc
Q 040832 475 SSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 475 p~NILl~~~~~vkL~DFGla~ 495 (724)
+.||++++++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999887 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.71 E-value=2e-07 Score=94.42 Aligned_cols=154 Identities=19% Similarity=0.207 Sum_probs=106.9
Q ss_pred ccCHHHHHHhhCCCcccceee---ccCcEEEEEEEcCCCcEEEEEEeccCCchhH-------------------H-----
Q 040832 335 AFTYEELSAATGGFSQSNLLG---QGGFGYVHKGVLPNGKEVAVKSLRSGSGQGE-------------------R----- 387 (724)
Q Consensus 335 ~f~~~el~~~~~~f~~~~~LG---~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~-------------------~----- 387 (724)
..+++.|.....+..+.++.| .|.-+.||+|...++..||||+++....... +
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 346777777777777766655 5666699999988899999999865322111 1
Q ss_pred HHHHHHHHHHhcC--CCCeeEEeeEEEeCCeEEEEEEecCCCCH-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 040832 388 EFKAEVEIISRVH--HRHLVSLVGYCIAGGKRLLVYEYVPNNNL-EFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC 464 (724)
Q Consensus 388 ~f~~Ei~il~~l~--HpnIv~l~g~~~~~~~~~lV~E~~~~gsL-~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~ 464 (724)
....|+..|.++. +-.+.+-+++.. -.|||||+...-+ .-.|.+-. +...+...+..++++.+.-|-..+
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~---~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKDVP---LELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcccCC---cCchhHHHHHHHHHHHHHHHHHhc
Confidence 1235888888874 444455555542 3799999966521 11222221 233356777888888888887733
Q ss_pred CCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 465 ~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
++||+||..-|||+. ++.+.|+|||-|....
T Consensus 187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 999999999999999 7799999999987554
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.2e-07 Score=94.45 Aligned_cols=143 Identities=19% Similarity=0.186 Sum_probs=87.4
Q ss_pred cceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCC--CeeEEeeEEEe---CCeEEEEEEecC
Q 040832 351 SNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHR--HLVSLVGYCIA---GGKRLLVYEYVP 425 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~Hp--nIv~l~g~~~~---~~~~~lV~E~~~ 425 (724)
++.|+.|..+.||+....+ +.+++|..... .....+..|+.+++.|... .+.+++.++.. ....+++|+|++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4679999999999999866 68999987654 4456788999999998533 35677765433 345789999999
Q ss_pred CCCHHH----------------HH---hcC--CCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 040832 426 NNNLEF----------------HL---HGK--GRPVMDWPT---------RLKI------------AMGSAK-GLAYLHE 462 (724)
Q Consensus 426 ~gsL~~----------------~L---~~~--~~~~l~~~~---------~~~i------------~~qia~-gL~yLHs 462 (724)
+..+.. +| |.. ....+.+.. .... +..+.+ .+..|++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 998877 11 111 111111110 0000 112222 3334443
Q ss_pred c----CCCCeEecCCCCccEEEc-CCCCEEEEEeccccc
Q 040832 463 D----CHPRIIHRDIKSSNILLD-YTFETKVADFGLAKL 496 (724)
Q Consensus 463 ~----~~~~iiHrDIkp~NILl~-~~~~vkL~DFGla~~ 496 (724)
. ....++|+|+.+.|||++ +++++.|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2 234699999999999999 666778999988753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.6e-07 Score=92.68 Aligned_cols=138 Identities=17% Similarity=0.212 Sum_probs=95.3
Q ss_pred hhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHH---------HHHHHHHhcCC---CCeeEEeeEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFK---------AEVEIISRVHH---RHLVSLVGYC 411 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~---------~Ei~il~~l~H---pnIv~l~g~~ 411 (724)
..++|...+++-......|.+-.. +|+.+++|..+......++.|+ +++..+.++.. -.++.++.++
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 457888888888888888887766 6788999998875544444433 34444444432 2222322222
Q ss_pred E-----eCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCE
Q 040832 412 I-----AGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFET 486 (724)
Q Consensus 412 ~-----~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~v 486 (724)
. -....+|||||++|..|.++.. ++. .++..|.++|.-||+. |++|+|++|.|++|+++ .+
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i 173 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GI 173 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cE
Confidence 2 1234468999999988866532 222 2445677889999999 99999999999999866 59
Q ss_pred EEEEeccccc
Q 040832 487 KVADFGLAKL 496 (724)
Q Consensus 487 kL~DFGla~~ 496 (724)
+++||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999987764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.53 E-value=1e-06 Score=91.08 Aligned_cols=138 Identities=20% Similarity=0.149 Sum_probs=86.2
Q ss_pred eeccCc-EEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCeeEEeeEEEeCCeEEEEEEecCCCCHHH
Q 040832 354 LGQGGF-GYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVH-HRHLVSLVGYCIAGGKRLLVYEYVPNNNLEF 431 (724)
Q Consensus 354 LG~G~f-G~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 431 (724)
|..|.. ..||+.... +..++||+..... ..++.+|+++++.+. +--+.++++++...+..+|||||++|..|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 445555 789998764 4678888876543 345778999999884 4445678888877777899999999988764
Q ss_pred HH-------------------hcCCCC--CCC--HHHHHHHHH--------------------HHHHHHHHHHhc----C
Q 040832 432 HL-------------------HGKGRP--VMD--WPTRLKIAM--------------------GSAKGLAYLHED----C 464 (724)
Q Consensus 432 ~L-------------------~~~~~~--~l~--~~~~~~i~~--------------------qia~gL~yLHs~----~ 464 (724)
.. |..... .+. ....+.... .+...+..|-.. .
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 32 211100 010 000000000 011112222111 1
Q ss_pred CCCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 465 ~~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
.+.++|+|+.+.|||++++..+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 3458999999999999998778899998775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=3.3e-07 Score=103.46 Aligned_cols=142 Identities=25% Similarity=0.317 Sum_probs=94.9
Q ss_pred ceeeccCcEEEEEEEcCCCcEEEEEEeccCCchh-------------------------------------HHHHHHHHH
Q 040832 352 NLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQG-------------------------------------EREFKAEVE 394 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~-------------------------------------~~~f~~Ei~ 394 (724)
+-||....|.||+|++++|+.||||+.+.+-... +-+|..|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5689999999999999999999999987642211 112445665
Q ss_pred HHHhc----CCCCe---eEEeeEEEe-CCeEEEEEEecCCCCHHHH--HhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 040832 395 IISRV----HHRHL---VSLVGYCIA-GGKRLLVYEYVPNNNLEFH--LHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC 464 (724)
Q Consensus 395 il~~l----~HpnI---v~l~g~~~~-~~~~~lV~E~~~~gsL~~~--L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~ 464 (724)
...++ .|-++ |.+=.++++ ...+.|+||||+|.-+.++ |.+.+ ++...+..-+.++ |++...
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~i~~~l~~~-----~~~qIf 318 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG---ISPHDILNKLVEA-----YLEQIF 318 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC---CCHHHHHHHHHHH-----HHHHHH
Confidence 54444 34441 222233333 3577999999999877654 33333 4555444333332 333333
Q ss_pred CCCeEecCCCCccEEEc----CCCCEEEEEeccccccCCCC
Q 040832 465 HPRIIHRDIKSSNILLD----YTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 465 ~~~iiHrDIkp~NILl~----~~~~vkL~DFGla~~~~~~~ 501 (724)
..|++|+|=+|.||||+ .++++.+.|||+........
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~~ 359 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHKT 359 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHHH
Confidence 33899999999999998 47789999999998776543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=1e-08 Score=114.27 Aligned_cols=188 Identities=18% Similarity=0.131 Sum_probs=138.4
Q ss_pred hCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC-eeEEeeEEEeCCeEEEEEEe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRH-LVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~lV~E~ 423 (724)
+..+..-+-+++++++++||.+....+...++.+... ....-++++|.+++||| .+..++-+..+...+++|++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 3344444557999999999988544455556666542 34566899999999999 77777777777888999999
Q ss_pred cCCC-CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 424 VPNN-NLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 424 ~~~g-sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
+.++ +-.... ......+...+...+++.-+++|+|||+. --+||| |||..+ ...|+.||+....+.+..
T Consensus 316 ~s~~rs~~~~~-~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~- 385 (829)
T KOG0576|consen 316 CSTGRSSALEM-TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM- 385 (829)
T ss_pred hcCCccccccC-ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc-
Confidence 9887 221111 11111234445566777778899999987 558999 888766 589999999998776653
Q ss_pred ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCC
Q 040832 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPI 548 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~ 548 (724)
......++..|++||+...+.+..+-|+|++|+--.+|--|..|-
T Consensus 386 -~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 -KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred -ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 234466899999999999999999999999998777777676653
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.2e-06 Score=84.16 Aligned_cols=128 Identities=22% Similarity=0.255 Sum_probs=92.1
Q ss_pred ccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCee-EEeeEEEeCCeEEEEEEecCCCC
Q 040832 350 QSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLV-SLVGYCIAGGKRLLVYEYVPNNN 428 (724)
Q Consensus 350 ~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv-~l~g~~~~~~~~~lV~E~~~~gs 428 (724)
..+.|++|.+|.||+|.+. |..+|+|+-+.+. ..+.+..|+++|..+.-.++. +++.|.. .++.|||++|-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcc
Confidence 3467999999999999994 4578999887653 346799999999999866654 4555533 356699999988
Q ss_pred HHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC--ccEEEcCCCCEEEEEecccccc
Q 040832 429 LEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKS--SNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 429 L~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp--~NILl~~~~~vkL~DFGla~~~ 497 (724)
|..+.... +... +..+++.-.-|... +|-|+.|.- +||++.++ .+.|+||.-|+..
T Consensus 99 L~~~~~~~-----~rk~----l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~-~~~iIDFd~At~k 156 (201)
T COG2112 99 LGKLEIGG-----DRKH----LLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDR-DVYIIDFDSATFK 156 (201)
T ss_pred hhhhhhcc-----cHHH----HHHHHHHHHHHHHh---ccchhhhcCCceeEEecCC-cEEEEEccchhhc
Confidence 87665432 1222 34455665556666 899999873 56666554 8999999998743
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.38 E-value=3.4e-06 Score=102.37 Aligned_cols=147 Identities=17% Similarity=0.261 Sum_probs=93.7
Q ss_pred cceeeccCcEEEEEEEcCCC---cEEEEEEeccCC-chhHHHHHHHHHHHHhcC-CCCe--eEEeeEEEeC---CeEEEE
Q 040832 351 SNLLGQGGFGYVHKGVLPNG---KEVAVKSLRSGS-GQGEREFKAEVEIISRVH-HRHL--VSLVGYCIAG---GKRLLV 420 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~~g---~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~-HpnI--v~l~g~~~~~---~~~~lV 420 (724)
.+.|+.|.+..+|+..+.++ +.+++|+..... ......+.+|+++|+.|. |.+| .+++++|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999876554 367777764432 123457889999999995 6665 7888888764 467899
Q ss_pred EEecCCCCHHH-----------------------HHhcCCCC---------CCCH--HHHHHHHH---------------
Q 040832 421 YEYVPNNNLEF-----------------------HLHGKGRP---------VMDW--PTRLKIAM--------------- 451 (724)
Q Consensus 421 ~E~~~~gsL~~-----------------------~L~~~~~~---------~l~~--~~~~~i~~--------------- 451 (724)
|||++|..+.+ .||..... ...+ .++.+|..
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99999865321 12221110 0011 11111111
Q ss_pred HHHHHHHHHHhcCC--------CCeEecCCCCccEEEcC-CCC-EEEEEecccccc
Q 040832 452 GSAKGLAYLHEDCH--------PRIIHRDIKSSNILLDY-TFE-TKVADFGLAKLT 497 (724)
Q Consensus 452 qia~gL~yLHs~~~--------~~iiHrDIkp~NILl~~-~~~-vkL~DFGla~~~ 497 (724)
.+.+.+++|..+.. +.+||+|+++.|||++. +.+ +-|+||.++.+-
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 12334566755432 35999999999999975 334 579999988643
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.3e-05 Score=80.18 Aligned_cols=129 Identities=21% Similarity=0.281 Sum_probs=94.1
Q ss_pred ccceeeccCcEEEEEEEcCCCcEEEEEEeccCC----------------chhHHHHHHHHHHHHhcC------CCCeeEE
Q 040832 350 QSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGS----------------GQGEREFKAEVEIISRVH------HRHLVSL 407 (724)
Q Consensus 350 ~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~----------------~~~~~~f~~Ei~il~~l~------HpnIv~l 407 (724)
...+||+|+.-.||. ..++...+||+++... ....+++.+|+.-...+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 345799999999997 5566778999987655 112456677777666665 8999999
Q ss_pred eeEEEeCCeEEEEEEecCCC------CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEc
Q 040832 408 VGYCIAGGKRLLVYEYVPNN------NLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLD 481 (724)
Q Consensus 408 ~g~~~~~~~~~lV~E~~~~g------sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~ 481 (724)
+|+...+...-+|+|.+.+. +|++++.... ++. .. ...+-+-..||-+. .|+.+||++.||++.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~---~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-EL---RQALDEFKRYLLDH---HIVIRDLNPHNIVVQ 152 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HH---HHHHHHHHHHHHHc---CCeecCCCcccEEEE
Confidence 99999998889999988542 5777775443 443 33 33344455677777 899999999999995
Q ss_pred CC--C--CEEEEE
Q 040832 482 YT--F--ETKVAD 490 (724)
Q Consensus 482 ~~--~--~vkL~D 490 (724)
.+ + ++.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 32 2 577787
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1924 consensus RhoA GTPase effector DIA/Diaphanous [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.33 E-value=2.2e-06 Score=96.43 Aligned_cols=22 Identities=27% Similarity=0.387 Sum_probs=11.1
Q ss_pred HHHHHhCCCCCCCC-CchhhhHH
Q 040832 538 LLELITGRRPIDPT-GAMEDCLV 559 (724)
Q Consensus 538 L~eLltG~~P~~~~-~~~~~~l~ 559 (724)
|||=|.-...|+.. -.++.++.
T Consensus 958 lye~L~eYyaFd~kkysmEEFFa 980 (1102)
T KOG1924|consen 958 LYESLGEYYAFDPKKYSMEEFFA 980 (1102)
T ss_pred HHHHHHHHeecCcccCcHHHHHH
Confidence 45555555566654 23444443
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.1e-05 Score=86.06 Aligned_cols=80 Identities=13% Similarity=0.078 Sum_probs=59.2
Q ss_pred CCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCC---CCeeEEeeEEEe---CCeEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHH---RHLVSLVGYCIA---GGKRLLV 420 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~H---pnIv~l~g~~~~---~~~~~lV 420 (724)
.....+.||.|..+.||+....+++ ++||..+.. .....|..|++.|+.|.. -.+.+++++|.. .+..+||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQGN-PMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCCC-EEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 3444567999999999998765554 667775431 123578999999999953 367888888754 3668999
Q ss_pred EEecCCCCH
Q 040832 421 YEYVPNNNL 429 (724)
Q Consensus 421 ~E~~~~gsL 429 (724)
||++++.++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998764
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.28 E-value=2.8e-06 Score=84.42 Aligned_cols=102 Identities=21% Similarity=0.171 Sum_probs=82.3
Q ss_pred HHHHHHHHhcCC-CCeeEEeeEEEeCCeEEEEEEecCCCCHHHH---HhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 040832 390 KAEVEIISRVHH-RHLVSLVGYCIAGGKRLLVYEYVPNNNLEFH---LHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCH 465 (724)
Q Consensus 390 ~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~---L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~ 465 (724)
..|.-+|+.|.+ +++.+++|+|-. ++|.||+..+.+... |.. ....+|..|.+||.++++.+.+|+....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 458889999975 699999999943 889999987765421 111 1125899999999999999999998544
Q ss_pred CCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 466 PRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 466 ~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
..+.-.|++++|+-|++++++|++|.+.+...
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 46788999999999999999999999877544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.28 E-value=4.7e-06 Score=85.82 Aligned_cols=73 Identities=14% Similarity=0.206 Sum_probs=47.7
Q ss_pred ceeeccCcE-EEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCC---CeeEEeeEEEeC---CeEEEEEEec
Q 040832 352 NLLGQGGFG-YVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHR---HLVSLVGYCIAG---GKRLLVYEYV 424 (724)
Q Consensus 352 ~~LG~G~fG-~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~Hp---nIv~l~g~~~~~---~~~~lV~E~~ 424 (724)
+.|+.|+.. .||+. +..+++|..+.. .....+.+|+++|+.|... .+.++++.+... +..++||+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457777776 58974 345778876542 2345789999999988532 344444444332 2348899999
Q ss_pred CCCCHH
Q 040832 425 PNNNLE 430 (724)
Q Consensus 425 ~~gsL~ 430 (724)
+|.+|.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.4e-05 Score=77.70 Aligned_cols=125 Identities=26% Similarity=0.406 Sum_probs=91.0
Q ss_pred CCCcccceeeccCc-EEEEEEEcCCCcEEEEEEeccC-----------Cch----------hHHHHHHHHHHHHhcC---
Q 040832 346 GGFSQSNLLGQGGF-GYVHKGVLPNGKEVAVKSLRSG-----------SGQ----------GEREFKAEVEIISRVH--- 400 (724)
Q Consensus 346 ~~f~~~~~LG~G~f-G~Vyk~~~~~g~~vaVK~l~~~-----------~~~----------~~~~f~~Ei~il~~l~--- 400 (724)
..|+..+.||.|.. |.|||+.+ +|+.||+|+++.. ... ...-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78899999999999 99999998 7789999994321 000 0124778888888774
Q ss_pred CCCe--eEEeeEEEeCC------------------eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 040832 401 HRHL--VSLVGYCIAGG------------------KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYL 460 (724)
Q Consensus 401 HpnI--v~l~g~~~~~~------------------~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yL 460 (724)
+.++ |+.+||..-.. .+.||.||+.... .+ ..+-+.+|.+-|..|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~----~~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PL----QIRDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------cc----chhHHHHHHHHHHHH
Confidence 5566 89999875431 2247888776543 11 223356677888899
Q ss_pred HhcCCCCeEecCCCCccEEEcCCCCEEEEEeccc
Q 040832 461 HEDCHPRIIHRDIKSSNILLDYTFETKVADFGLA 494 (724)
Q Consensus 461 Hs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla 494 (724)
|.. +|+-+|++..|.. .-||+|||.+
T Consensus 181 ~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHC---CeeeccCcccccc-----CCEEEecccC
Confidence 998 9999999999985 3589999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.6e-05 Score=81.57 Aligned_cols=139 Identities=21% Similarity=0.200 Sum_probs=82.5
Q ss_pred ceeeccCcEEEEEEEcCC--CcEEEEEEeccCCchhHHHHHHHHHHHHhcCC-CCeeEEeeEEEeCCeEEEEEEecCCCC
Q 040832 352 NLLGQGGFGYVHKGVLPN--GKEVAVKSLRSGSGQGEREFKAEVEIISRVHH-RHLVSLVGYCIAGGKRLLVYEYVPNNN 428 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~~--g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~lV~E~~~~gs 428 (724)
+.|..|-...+|+....+ ++.|++|....... ...+..+|+.+++.+.. -...++++++. + .+||||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence 567788888999988764 67899997764321 11234578889988853 33445554432 2 48999999987
Q ss_pred HHHH-----------------HhcCCC---------CCCC-HHHHHHHHH----------------------HHHHHHHH
Q 040832 429 LEFH-----------------LHGKGR---------PVMD-WPTRLKIAM----------------------GSAKGLAY 459 (724)
Q Consensus 429 L~~~-----------------L~~~~~---------~~l~-~~~~~~i~~----------------------qia~gL~y 459 (724)
|... ||.... .... +..+..+.. .+.+.+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6321 122111 0111 222222211 11111112
Q ss_pred H----Hhc-CCCCeEecCCCCccEEEcC-CCCEEEEEecccc
Q 040832 460 L----HED-CHPRIIHRDIKSSNILLDY-TFETKVADFGLAK 495 (724)
Q Consensus 460 L----Hs~-~~~~iiHrDIkp~NILl~~-~~~vkL~DFGla~ 495 (724)
| ... ....++|+|+++.|||++. ++.+.|+||..|.
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 2 111 2236899999999999998 5789999998875
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.5e-05 Score=84.83 Aligned_cols=141 Identities=18% Similarity=0.146 Sum_probs=87.3
Q ss_pred cceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC--eeEEee------EEEeCCeEEEEEE
Q 040832 351 SNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRH--LVSLVG------YCIAGGKRLLVYE 422 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~Hpn--Iv~l~g------~~~~~~~~~lV~E 422 (724)
.+.|..|....+|+....+ +.+++|+... .....+..|++++..|++.+ +.+++. +...++..++||+
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 5567778778999987644 4688898764 23456777888888885432 445443 1233456789999
Q ss_pred ecCCCCHHH--------------HHhcC----CC-----CCCCHHHHH----------HHHHHHHHHHHHHHh----cCC
Q 040832 423 YVPNNNLEF--------------HLHGK----GR-----PVMDWPTRL----------KIAMGSAKGLAYLHE----DCH 465 (724)
Q Consensus 423 ~~~~gsL~~--------------~L~~~----~~-----~~l~~~~~~----------~i~~qia~gL~yLHs----~~~ 465 (724)
|++|..+.. .||.. .. ....|.... .....+.+.+.+|.+ ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877532 11211 00 011222111 011123344555543 123
Q ss_pred CCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 466 PRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 466 ~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
.+++|+|+.+.|||+++++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999988777899998875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.5e-05 Score=83.19 Aligned_cols=137 Identities=12% Similarity=0.050 Sum_probs=80.1
Q ss_pred eeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCe-eEEeeEEEeCCeEEEEEEecCCCCHHHH
Q 040832 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHL-VSLVGYCIAGGKRLLVYEYVPNNNLEFH 432 (724)
Q Consensus 354 LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~E~~~~gsL~~~ 432 (724)
+..|-...+|+... +++.+++|..............+|+++++.+....+ .++++++. .++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 55677788998874 567788987654322211245778999998864333 34444432 2699999998765321
Q ss_pred -----------------HhcCC--CCCCCHHH-HHHHHHHH---------HHHHHHHHhc-----CCCCeEecCCCCccE
Q 040832 433 -----------------LHGKG--RPVMDWPT-RLKIAMGS---------AKGLAYLHED-----CHPRIIHRDIKSSNI 478 (724)
Q Consensus 433 -----------------L~~~~--~~~l~~~~-~~~i~~qi---------a~gL~yLHs~-----~~~~iiHrDIkp~NI 478 (724)
||... ...++... +..+..++ .+.+..+-.. ....++|+|+.+.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 22221 11122211 11211111 1112222111 123589999999999
Q ss_pred EEcCCCCEEEEEeccccc
Q 040832 479 LLDYTFETKVADFGLAKL 496 (724)
Q Consensus 479 Ll~~~~~vkL~DFGla~~ 496 (724)
|+++++ ++|+||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999876 78999998853
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.06 E-value=8.6e-05 Score=88.80 Aligned_cols=196 Identities=19% Similarity=0.213 Sum_probs=137.5
Q ss_pred HHHHHHHHHhcCCCCeeEEeeEEEeCCeE----EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 040832 389 FKAEVEIISRVHHRHLVSLVGYCIAGGKR----LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC 464 (724)
Q Consensus 389 f~~Ei~il~~l~HpnIv~l~g~~~~~~~~----~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~ 464 (724)
...|+..+.++.|.|++.+++|....... .+..|+|...++..++...+. +.....+.+..++.+||+|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~--i~~~~~r~~~~~~~~GL~~~h~~- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS--IPLETLRILHQKLLEGLAYLHSL- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc--cCHHHHHHHHHHHhhhHHHHHHh-
Confidence 34577788888999999999987765433 245678888888888887665 77888889999999999999998
Q ss_pred CCCeEecCCCCc---cEEEcCCCCEEEE--EeccccccCCCCCccccccccCCCcCCcchhcCCCCC--hhHHHHHHHHH
Q 040832 465 HPRIIHRDIKSS---NILLDYTFETKVA--DFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLT--EKSDVFSFGVM 537 (724)
Q Consensus 465 ~~~iiHrDIkp~---NILl~~~~~vkL~--DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t--~ksDV~SlGvl 537 (724)
...|.-|..+ +..++.++.+.+. ||+..+.+.+....... .-...|.++|......+. ...|+|.+|.+
T Consensus 306 --~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~--~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 306 --SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSD--LLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred --ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhh--cCccccccccccccccchhhhhhHHHHHHHH
Confidence 5666655555 5555667777777 99988877665443221 234457778877655444 44799999999
Q ss_pred HHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 040832 538 LLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIV 617 (724)
Q Consensus 538 L~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv 617 (724)
+..+..|...-... ..+...+.... ...+......|+..+.++|....+++
T Consensus 382 ~~~~~~~~~i~~~~-------------------------~~~~~~l~~~~----~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKS-------------------------AVPVSLLDVLS----TSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HhhhhhcCcccccc-------------------------cchhhhhcccc----chhhhhhhhhhcchhhhhccchhhhh
Confidence 99999876542211 11111111111 11456667789999999999999998
Q ss_pred HHH
Q 040832 618 RAL 620 (724)
Q Consensus 618 ~~L 620 (724)
.+.
T Consensus 433 ~~~ 435 (1351)
T KOG1035|consen 433 THP 435 (1351)
T ss_pred hch
Confidence 754
|
|
| >KOG1924 consensus RhoA GTPase effector DIA/Diaphanous [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.97 E-value=3.3e-05 Score=87.26 Aligned_cols=12 Identities=17% Similarity=0.421 Sum_probs=6.2
Q ss_pred CHHHHHHHHhCC
Q 040832 612 KISQIVRALEGD 623 (724)
Q Consensus 612 s~~evv~~L~~~ 623 (724)
-|..++++|...
T Consensus 1042 VmDslLeaLqsg 1053 (1102)
T KOG1924|consen 1042 VMDSLLEALQSG 1053 (1102)
T ss_pred hHHHHHHHHHhh
Confidence 345555555543
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00014 Score=80.29 Aligned_cols=75 Identities=17% Similarity=0.144 Sum_probs=54.3
Q ss_pred ceeeccCcEEEEEEEcCCC-cEEEEEEeccCC-------chhHHHHHHHHHHHHhcC---CCCeeEEeeEEEeCCeEEEE
Q 040832 352 NLLGQGGFGYVHKGVLPNG-KEVAVKSLRSGS-------GQGEREFKAEVEIISRVH---HRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~~g-~~vaVK~l~~~~-------~~~~~~f~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~lV 420 (724)
+.||.|.+..||+..+.+| +.|+||+-.... ......+..|.+.|+.+. -.++.+++.+. .+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEE
Confidence 5689999999999998777 489999854211 123456777888888873 34577777763 3556899
Q ss_pred EEecCCCC
Q 040832 421 YEYVPNNN 428 (724)
Q Consensus 421 ~E~~~~gs 428 (724)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998743
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.92 E-value=6.1e-05 Score=80.52 Aligned_cols=139 Identities=24% Similarity=0.298 Sum_probs=84.3
Q ss_pred ceeeccCcEEEEEEEcCC-------CcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCe-eEEeeEEEeCCeEEEEEEe
Q 040832 352 NLLGQGGFGYVHKGVLPN-------GKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHL-VSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~~-------g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~E~ 423 (724)
+.|..|-...||+....+ ++.|++|+..... ....+..+|++++..+....+ .++++++. + .+||||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence 456667777999988655 4789999876543 223456788888888853333 45555553 2 368999
Q ss_pred cCCCCHHHH-----------------HhcCCCC-------CCC--HHHHHH--------------------------HHH
Q 040832 424 VPNNNLEFH-----------------LHGKGRP-------VMD--WPTRLK--------------------------IAM 451 (724)
Q Consensus 424 ~~~gsL~~~-----------------L~~~~~~-------~l~--~~~~~~--------------------------i~~ 451 (724)
++|..|... ||..... ... |..+.+ +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998776421 1221111 000 111111 111
Q ss_pred HHHHHHHHHHh------cCCCCeEecCCCCccEEEcCC----CCEEEEEecccc
Q 040832 452 GSAKGLAYLHE------DCHPRIIHRDIKSSNILLDYT----FETKVADFGLAK 495 (724)
Q Consensus 452 qia~gL~yLHs------~~~~~iiHrDIkp~NILl~~~----~~vkL~DFGla~ 495 (724)
.+.+-+.+|.. .....++|+|+.+.|||++.+ +.++|+||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22223334432 234578999999999999875 889999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00027 Score=75.84 Aligned_cols=155 Identities=19% Similarity=0.204 Sum_probs=90.6
Q ss_pred HHHHHHhhCCCcc-----cceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC--eeEEeeE
Q 040832 338 YEELSAATGGFSQ-----SNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRH--LVSLVGY 410 (724)
Q Consensus 338 ~~el~~~~~~f~~-----~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~Hpn--Iv~l~g~ 410 (724)
-++|......|.+ .+.|+.|....+|+....+| .+++|+.+... ...++..|++++..|.... +.+++..
T Consensus 9 ~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t 85 (307)
T TIGR00938 9 DEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKS 85 (307)
T ss_pred HHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccC
Confidence 3455444444544 45577777789999876444 57788775532 2345667788888874222 4444432
Q ss_pred ------EEeCCeEEEEEEecCCCCHH-----------H---HHhcCCC----------CCCCHHHHH------------H
Q 040832 411 ------CIAGGKRLLVYEYVPNNNLE-----------F---HLHGKGR----------PVMDWPTRL------------K 448 (724)
Q Consensus 411 ------~~~~~~~~lV~E~~~~gsL~-----------~---~L~~~~~----------~~l~~~~~~------------~ 448 (724)
...++..++||||++|..+. . .||.... ..-.|.... .
T Consensus 86 ~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~ 165 (307)
T TIGR00938 86 RDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAH 165 (307)
T ss_pred CCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHH
Confidence 12346678999999986532 0 1221100 001121110 0
Q ss_pred HHHHHHHHHHHHHh----cCCCCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 449 IAMGSAKGLAYLHE----DCHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 449 i~~qia~gL~yLHs----~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
....+.+.+++|.. ....+++|+|++..|||++.++.+.|+||+.+.
T Consensus 166 ~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 166 MGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 11123345555543 234589999999999999988767899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00041 Score=74.71 Aligned_cols=155 Identities=17% Similarity=0.165 Sum_probs=86.0
Q ss_pred CHHHHHHhhCCCcc-----cceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC--eeEEee
Q 040832 337 TYEELSAATGGFSQ-----SNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRH--LVSLVG 409 (724)
Q Consensus 337 ~~~el~~~~~~f~~-----~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~Hpn--Iv~l~g 409 (724)
+.+++......|.+ .+.|+.|....+|+....+| .+++|++.. .....+..|+.++..|...+ +.+++.
T Consensus 8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~ 83 (319)
T PRK05231 8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVA 83 (319)
T ss_pred CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCccee
Confidence 34555444445544 34566777778999876555 688898762 22344555667776664222 333332
Q ss_pred ------EEEeCCeEEEEEEecCCCCHH-----------HH---HhcCCC---------CCC-CHHHHHH-----------
Q 040832 410 ------YCIAGGKRLLVYEYVPNNNLE-----------FH---LHGKGR---------PVM-DWPTRLK----------- 448 (724)
Q Consensus 410 ------~~~~~~~~~lV~E~~~~gsL~-----------~~---L~~~~~---------~~l-~~~~~~~----------- 448 (724)
+....+..+++|||++|..+. .. ||.... ..+ .|...+.
T Consensus 84 ~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (319)
T PRK05231 84 RRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQA 163 (319)
T ss_pred CCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHH
Confidence 223356779999999987531 11 121110 011 1111111
Q ss_pred -HHHH-HHHHHHHHHhc----CCCCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 449 -IAMG-SAKGLAYLHED----CHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 449 -i~~q-ia~gL~yLHs~----~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
.+.+ +...++.+... ...++||+|+++.|||++.+...-|+||+.+.
T Consensus 164 ~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 164 ALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 11122333211 34589999999999999876555899999875
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.77 E-value=3.1e-05 Score=81.04 Aligned_cols=138 Identities=20% Similarity=0.118 Sum_probs=95.5
Q ss_pred CCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCc-----hh------------H-----HHHHHHHHHHHhcCC--C
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSG-----QG------------E-----REFKAEVEIISRVHH--R 402 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~-----~~------------~-----~~f~~Ei~il~~l~H--p 402 (724)
-+..++.||-|.-+-||.+.+.+|+..++|.-+.+.. .. + -...+|+..|+.|.. -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 4677899999999999999999999999985322100 00 0 123468888888853 2
Q ss_pred CeeEEeeEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC
Q 040832 403 HLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY 482 (724)
Q Consensus 403 nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~ 482 (724)
-|.+.+++ ...++|||++.+-.|...-+- .+..++..- +..-+.-|-.+ |+||+|++-=||+|++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly~~---lm~~Iv~la~~---GlIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV-----EDPPTLYDD---LMGLIVRLANH---GLIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeec-----CChHHHHHH---HHHHHHHHHHc---CceecccchheeEEec
Confidence 23444443 456899999998887654332 233343333 33334455566 9999999999999999
Q ss_pred CCCEEEEEeccccccCC
Q 040832 483 TFETKVADFGLAKLTTD 499 (724)
Q Consensus 483 ~~~vkL~DFGla~~~~~ 499 (724)
++.++++||--......
T Consensus 238 d~~i~vIDFPQmvS~sh 254 (465)
T KOG2268|consen 238 DDKIVVIDFPQMVSTSH 254 (465)
T ss_pred CCCEEEeechHhhccCC
Confidence 99999999976655443
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00015 Score=77.15 Aligned_cols=142 Identities=15% Similarity=0.215 Sum_probs=98.8
Q ss_pred cccceeeccCcEEEEEEEcCCCcEEEEEEeccC---------------------CchhHH-----HHHHHHHHHHhcCCC
Q 040832 349 SQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSG---------------------SGQGER-----EFKAEVEIISRVHHR 402 (724)
Q Consensus 349 ~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~---------------------~~~~~~-----~f~~Ei~il~~l~Hp 402 (724)
.+...|.-|.-+.||.+.-.+|..+|||+++.. +...-+ ....|++.|++|+.-
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 345678889999999999999999999987531 000001 123588888888754
Q ss_pred CeeEEeeEEEeCCeEEEEEEecCCCCHHH-HHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEc
Q 040832 403 HLVSLVGYCIAGGKRLLVYEYVPNNNLEF-HLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLD 481 (724)
Q Consensus 403 nIv~l~g~~~~~~~~~lV~E~~~~gsL~~-~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~ 481 (724)
.|..---+.. ...+|||+|+....... .|.+ ..+....+..+-++++.-+.-|...| ++||.||.--|+|+.
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence 4322111111 23479999997544322 2222 23666778888899999999998888 899999999999995
Q ss_pred CCCCEEEEEeccccccC
Q 040832 482 YTFETKVADFGLAKLTT 498 (724)
Q Consensus 482 ~~~~vkL~DFGla~~~~ 498 (724)
+ |.+.|+|.+.+....
T Consensus 300 d-G~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 300 D-GKLYIIDVSQSVEHD 315 (520)
T ss_pred C-CEEEEEEccccccCC
Confidence 4 589999998876543
|
|
| >PHA03247 large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.0038 Score=79.45 Aligned_cols=10 Identities=20% Similarity=0.185 Sum_probs=4.3
Q ss_pred HHHHHHHhhc
Q 040832 595 MVACAAASIR 604 (724)
Q Consensus 595 l~~l~~~cl~ 604 (724)
|.-|+..|.+
T Consensus 3111 lAlLi~ACr~ 3120 (3151)
T PHA03247 3111 LAVLIEACRR 3120 (3151)
T ss_pred HHHHHHHHHH
Confidence 3344444433
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00025 Score=74.92 Aligned_cols=31 Identities=29% Similarity=0.476 Sum_probs=25.8
Q ss_pred CCeEecCCCCccEEEcCCCC-EEEEEeccccc
Q 040832 466 PRIIHRDIKSSNILLDYTFE-TKVADFGLAKL 496 (724)
Q Consensus 466 ~~iiHrDIkp~NILl~~~~~-vkL~DFGla~~ 496 (724)
..++|+|+++.|||++++++ .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997565 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG3671 consensus Actin regulatory protein (Wiskott-Aldrich syndrome protein) [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.0013 Score=71.73 Aligned_cols=18 Identities=22% Similarity=0.359 Sum_probs=14.0
Q ss_pred CCCC-CCCCcccC---CCCCCC
Q 040832 1 MEDN-NQSPGVSN---SPDAAE 18 (724)
Q Consensus 1 ~~~~-~~~~~~~~---~~~~~~ 18 (724)
|+++ +++++|+. +++++.
T Consensus 296 i~k~~~~~~Sv~~~~~~lp~q~ 317 (569)
T KOG3671|consen 296 IQKNPNGLPSVGQSAAELPRQK 317 (569)
T ss_pred hhcCCCCCcccccchhhccccc
Confidence 5677 99999998 777764
|
|
| >PF04478 Mid2: Mid2 like cell wall stress sensor; InterPro: IPR007567 This family represents a region near the C terminus of Mid2, which contains a transmembrane region | Back alignment and domain information |
|---|
Probab=97.66 E-value=1.3e-05 Score=74.45 Aligned_cols=32 Identities=31% Similarity=0.589 Sum_probs=17.9
Q ss_pred ceeehhhHHH--HHHHHHHHHHHHHHhhhccccc
Q 040832 218 PLVAAVAAGA--AFLIIVMLLVFFACRRKKNRER 249 (724)
Q Consensus 218 ~~i~~i~~g~--~~~lv~l~~~~~~~~rk~~~~r 249 (724)
-+|||+|||+ +++|++++++||||+|+||+..
T Consensus 49 nIVIGvVVGVGg~ill~il~lvf~~c~r~kktdf 82 (154)
T PF04478_consen 49 NIVIGVVVGVGGPILLGILALVFIFCIRRKKTDF 82 (154)
T ss_pred cEEEEEEecccHHHHHHHHHhheeEEEecccCcc
Confidence 3455555554 4555555666666666666543
|
The remainder of the protein sequence is serine-rich and of low complexity, and is therefore impossible to align accurately. Mid2 is thought to act as a mechanosensor of cell wall stress. The C-terminal cytoplasmic region of Mid2 is known to interact with Rom2, a guanine nucleotide exchange factor (GEF) for Rho1, which is part of the cell wall integrity signalling pathway []. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00041 Score=74.16 Aligned_cols=139 Identities=19% Similarity=0.213 Sum_probs=83.5
Q ss_pred cceeeccCcEEEEEEEcCCCcEEEEEEec-cCCchhHHHHHHHHHHHHhcCC--CCeeEEeeEEEeCC--eEEEEEEecC
Q 040832 351 SNLLGQGGFGYVHKGVLPNGKEVAVKSLR-SGSGQGEREFKAEVEIISRVHH--RHLVSLVGYCIAGG--KRLLVYEYVP 425 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~-~~~~~~~~~f~~Ei~il~~l~H--pnIv~l~g~~~~~~--~~~lV~E~~~ 425 (724)
.+.+..|---.+|..... ++.+++.+-. ...........+|+.+|+.+.- --+.+.+++|.++. ..|.||+|++
T Consensus 30 v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 30 VEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 344433333345554443 7778888221 1233345567889999988853 33445667777665 7799999999
Q ss_pred CCCHHHHHhcCCCCCCCHHHHHHHH-HHHHHH------------------------------------------------
Q 040832 426 NNNLEFHLHGKGRPVMDWPTRLKIA-MGSAKG------------------------------------------------ 456 (724)
Q Consensus 426 ~gsL~~~L~~~~~~~l~~~~~~~i~-~qia~g------------------------------------------------ 456 (724)
|..+...+..... . .+++ ..+++.
T Consensus 109 Ge~~~~~~~~~~~-----~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~ 181 (321)
T COG3173 109 GEVVWSALPPESL-----G--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD 181 (321)
T ss_pred ceeccCcCCcccc-----h--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence 8543322211100 0 0111 133333
Q ss_pred --HHHHHhc-----CCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 457 --LAYLHED-----CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 457 --L~yLHs~-----~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
..+|+.+ ....++|+|+++.||||+.+..+=|+||+++.+-
T Consensus 182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 3344433 2346999999999999999888999999999754
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00041 Score=73.51 Aligned_cols=140 Identities=18% Similarity=0.209 Sum_probs=75.1
Q ss_pred CcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcC---CCCeeEEeeEEEeCCeEEEEEEec
Q 040832 348 FSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVH---HRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
.+..+.|+.|....+|+.. .+++.+.||+-.. .....|..|++-|+.|. --.+.+++++...++..+|||||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3445678999999999977 4778899998762 33456889999999884 455778888888777779999999
Q ss_pred CCCCH--------HH---HHhc-CCCC-------------------CCCHHH-----HHHHHHHHHH-----------HH
Q 040832 425 PNNNL--------EF---HLHG-KGRP-------------------VMDWPT-----RLKIAMGSAK-----------GL 457 (724)
Q Consensus 425 ~~gsL--------~~---~L~~-~~~~-------------------~l~~~~-----~~~i~~qia~-----------gL 457 (724)
+.+.. .. .||. .... .-+|.. |+....+++. .+
T Consensus 95 ~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~ 174 (288)
T PF03881_consen 95 EMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLV 174 (288)
T ss_dssp ------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHH
Confidence 88711 11 1233 1110 112322 1111111111 12
Q ss_pred HHHHhc-----CCCCeEecCCCCccEEEcCCCCEEEEEe
Q 040832 458 AYLHED-----CHPRIIHRDIKSSNILLDYTFETKVADF 491 (724)
Q Consensus 458 ~yLHs~-----~~~~iiHrDIkp~NILl~~~~~vkL~DF 491 (724)
+.|.+. ..+-+||+||...|++++.++++.|.|=
T Consensus 175 ~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DP 213 (288)
T PF03881_consen 175 ERLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDP 213 (288)
T ss_dssp HHHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S-
T ss_pred HHHHHHhcCCCCCceeeEcCccccceeecCCCCceeecc
Confidence 222222 2457999999999999999998999874
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00088 Score=73.14 Aligned_cols=139 Identities=19% Similarity=0.218 Sum_probs=82.7
Q ss_pred ceeeccCcEEEEEEEcCC-----CcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCe-eEEeeEEEeCCeEEEEEEecC
Q 040832 352 NLLGQGGFGYVHKGVLPN-----GKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHL-VSLVGYCIAGGKRLLVYEYVP 425 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~~-----g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~E~~~ 425 (724)
+.|-.|-.-.+|+..+.+ ++.|++|....... ....-.+|+.+++.+..-++ .++++++.. + .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence 345557778999987532 36789998865432 22234678999988864444 356666533 2 5899998
Q ss_pred CCCHHHH-----------------HhcCC---CC-CCCHHHHHHHHHH-----------------HHHHHHHHHh-----
Q 040832 426 NNNLEFH-----------------LHGKG---RP-VMDWPTRLKIAMG-----------------SAKGLAYLHE----- 462 (724)
Q Consensus 426 ~gsL~~~-----------------L~~~~---~~-~l~~~~~~~i~~q-----------------ia~gL~yLHs----- 462 (724)
+.+|... ||... .. ..-+.++.+++.+ +...+..|.+
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 22211 11 1112333333221 1122222222
Q ss_pred cCCCCeEecCCCCccEEEcC-CCCEEEEEecccc
Q 040832 463 DCHPRIIHRDIKSSNILLDY-TFETKVADFGLAK 495 (724)
Q Consensus 463 ~~~~~iiHrDIkp~NILl~~-~~~vkL~DFGla~ 495 (724)
.....++|+||++.|||+++ ++.++|+||..+.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 12336899999999999976 4689999998875
|
|
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00011 Score=66.80 Aligned_cols=36 Identities=19% Similarity=0.262 Sum_probs=19.6
Q ss_pred CCCCccceeehhhHHHHHHHHHHHHHHHH-Hhhhccc
Q 040832 212 GSMLSIPLVAAVAAGAAFLIIVMLLVFFA-CRRKKNR 247 (724)
Q Consensus 212 ~~~~s~~~i~~i~~g~~~~lv~l~~~~~~-~~rk~~~ 247 (724)
...++.++|++|++||++.+|+++++++| +||+|||
T Consensus 58 ~h~fs~~~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk 94 (122)
T PF01102_consen 58 VHRFSEPAIIGIIFGVMAGVIGIILLISYCIRRLRKK 94 (122)
T ss_dssp SSSSS-TCHHHHHHHHHHHHHHHHHHHHHHHHHHS--
T ss_pred ccCccccceeehhHHHHHHHHHHHHHHHHHHHHHhcc
Confidence 34677778888888776555554444444 4444443
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0051 Score=65.81 Aligned_cols=64 Identities=9% Similarity=0.118 Sum_probs=40.7
Q ss_pred EEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCC--CeeEEeeE------EEeCCeEEEEEEecCCCCH
Q 040832 361 YVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHR--HLVSLVGY------CIAGGKRLLVYEYVPNNNL 429 (724)
Q Consensus 361 ~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~Hp--nIv~l~g~------~~~~~~~~lV~E~~~~gsL 429 (724)
.||+....+| .+++|++.. ....+..|+.++..|... .+.+++.. ...++..++|+||++|..+
T Consensus 11 ~v~~v~t~~g-~~~LK~~~~----~~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~ 82 (313)
T TIGR02906 11 NVYKVETDSG-NKCLKKINY----PPERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC 82 (313)
T ss_pred cEEEEEeCCC-CeEEEEcCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence 3888776444 588998753 234466677777777432 33444421 2335678999999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.006 Score=65.92 Aligned_cols=135 Identities=24% Similarity=0.336 Sum_probs=84.5
Q ss_pred CcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC------eeEEeeEE--EeCC--eEEEEEEecCCC
Q 040832 358 GFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRH------LVSLVGYC--IAGG--KRLLVYEYVPNN 427 (724)
Q Consensus 358 ~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~Hpn------Iv~l~g~~--~~~~--~~~lV~E~~~~g 427 (724)
.-..||+....+|+. ++|+.+.. ....++..|+.+|..|.-.. |..+-|-. ...+ ..+-|++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 445789988767665 89988875 44567788888888884222 22222221 1234 778999999998
Q ss_pred CHHH------------H---Hhc--CCC--------CCCCHHH-------------HHHHHHHHHHHHHHHHhcC----C
Q 040832 428 NLEF------------H---LHG--KGR--------PVMDWPT-------------RLKIAMGSAKGLAYLHEDC----H 465 (724)
Q Consensus 428 sL~~------------~---L~~--~~~--------~~l~~~~-------------~~~i~~qia~gL~yLHs~~----~ 465 (724)
.+.. + ||. ++. ....|.. ......++...++.+.+.. .
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 8872 0 111 111 1233331 0123344445555555442 2
Q ss_pred CC---eEecCCCCccEEEcCCCC-EEEEEecccc
Q 040832 466 PR---IIHRDIKSSNILLDYTFE-TKVADFGLAK 495 (724)
Q Consensus 466 ~~---iiHrDIkp~NILl~~~~~-vkL~DFGla~ 495 (724)
.. +||+|+.+.|||++.+.. +.++||+.+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 23 999999999999998875 8999999875
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.012 Score=63.62 Aligned_cols=136 Identities=19% Similarity=0.191 Sum_probs=78.1
Q ss_pred cCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCC--CeeE---Eee--EEEeCCeEEEEEEecCCCCH
Q 040832 357 GGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHR--HLVS---LVG--YCIAGGKRLLVYEYVPNNNL 429 (724)
Q Consensus 357 G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~Hp--nIv~---l~g--~~~~~~~~~lV~E~~~~gsL 429 (724)
+.-..||+....+++.+++|+.+... ....++..|++++..|... .++. .-| +...++..+.|++|++|..+
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 34467999888788889999886432 2455677888888877421 1222 112 22335677899999988653
Q ss_pred H-----------H---HHhc--CC-----CCCCCHHHH----H--------------HHHHHHHHHH-HHHHh-----cC
Q 040832 430 E-----------F---HLHG--KG-----RPVMDWPTR----L--------------KIAMGSAKGL-AYLHE-----DC 464 (724)
Q Consensus 430 ~-----------~---~L~~--~~-----~~~l~~~~~----~--------------~i~~qia~gL-~yLHs-----~~ 464 (724)
. . .||. .. +..++.... + ....++++.+ +.+.+ ..
T Consensus 115 ~~~~~~~~~~lG~~LarlH~~~~~~~~~~r~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 194 (325)
T PRK11768 115 ELDNLDQLEWVGRFLGRIHQVGAKRPFEHRPTLDLQEYGIEPRDWLLASDLIPSDLRPAYLAAADQLLAAVEACWARGDV 194 (325)
T ss_pred CCCCHHHHHHHHHHHHHHHhhccCCCCCCCCcCCHHHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 2 1 1232 10 112221110 0 1111222111 11111 12
Q ss_pred CCCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 465 ~~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
..++||+|+.+.|||++ + .+.|+||+.+.
T Consensus 195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred CccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 34689999999999995 4 57899999875
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0044 Score=67.25 Aligned_cols=79 Identities=14% Similarity=0.083 Sum_probs=50.5
Q ss_pred eeeccCcEEEEEEEcCCC-cEEEEEEeccCC-------chhHHHHHHHHHHHHhcC--CC-CeeEEeeEEEeCCeEEEEE
Q 040832 353 LLGQGGFGYVHKGVLPNG-KEVAVKSLRSGS-------GQGEREFKAEVEIISRVH--HR-HLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 353 ~LG~G~fG~Vyk~~~~~g-~~vaVK~l~~~~-------~~~~~~f~~Ei~il~~l~--Hp-nIv~l~g~~~~~~~~~lV~ 421 (724)
.||.|....||++...+| +.|+||+-.... .-...+..-|.+.|+.++ .| ++.+++.| +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999998655 589999753211 122344556778887663 23 45555444 445667999
Q ss_pred EecCCC-CHHHHH
Q 040832 422 EYVPNN-NLEFHL 433 (724)
Q Consensus 422 E~~~~g-sL~~~L 433 (724)
|++... .|+..|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 999653 343433
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0064 Score=67.18 Aligned_cols=73 Identities=12% Similarity=0.112 Sum_probs=49.3
Q ss_pred cceeeccCcEEEEEEEcCCCcEEEEEEeccCCc-------hhHHHHHHHHHHHHhcC---CCCeeEEeeEEEeCCeEEEE
Q 040832 351 SNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSG-------QGEREFKAEVEIISRVH---HRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~-------~~~~~f~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~lV 420 (724)
.+.||.|....||+... .++.|+||+-..... -...+-..|++.|+.+. ..++.+++.+|.+ ..++|
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEE
Confidence 46789999999999876 456799997652111 01223334466666653 3578888888873 45889
Q ss_pred EEecCC
Q 040832 421 YEYVPN 426 (724)
Q Consensus 421 ~E~~~~ 426 (724)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.00023 Score=86.92 Aligned_cols=159 Identities=13% Similarity=0.022 Sum_probs=112.3
Q ss_pred HHHHHHHHHhcCCCCeeEEeeEEEe--CCeEEEEEEecCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 040832 389 FKAEVEIISRVHHRHLVSLVGYCIA--GGKRLLVYEYVPNNNLEFHLHGK--GRPVMDWPTRLKIAMGSAKGLAYLHEDC 464 (724)
Q Consensus 389 f~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~lV~E~~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLHs~~ 464 (724)
...|.+.++...|.++.....-... ....|.+++|+.+|.+...|-+. ....++..-+.....+.+.+..-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3445555666678887765544332 33558999999999999988653 2223344444433444355555655543
Q ss_pred CC--CeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHH
Q 040832 465 HP--RIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI 542 (724)
Q Consensus 465 ~~--~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLl 542 (724)
+. -.+|++||.-|.+|..+..+|+.++|+.+....... ......++..|+.++....-.++.++|+|..|+.+|++.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s-f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS-FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchHh-hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 22 368999999999999999999999999995443322 233456778899999988889999999999999999998
Q ss_pred hCCCCC
Q 040832 543 TGRRPI 548 (724)
Q Consensus 543 tG~~P~ 548 (724)
.|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 776544
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.015 Score=72.41 Aligned_cols=143 Identities=18% Similarity=0.224 Sum_probs=81.8
Q ss_pred ceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcC-------CCCeeEEe-e----EEEe-CC--e
Q 040832 352 NLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVH-------HRHLVSLV-G----YCIA-GG--K 416 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~-------HpnIv~l~-g----~~~~-~~--~ 416 (724)
+.|+ |.+-.+|+....+|+.+++|+.+... ....+..|.++|..|. -|.++... | .... ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4453 45678899887788899999998653 2334445556666552 22333321 1 1111 22 4
Q ss_pred EEEEEEecCCCCHHHH-----------------Hh----cCC----CCCCCHHH-----------------HHHHHHHHH
Q 040832 417 RLLVYEYVPNNNLEFH-----------------LH----GKG----RPVMDWPT-----------------RLKIAMGSA 454 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~-----------------L~----~~~----~~~l~~~~-----------------~~~i~~qia 454 (724)
.+.+|+|++|..|... || +.. ...+.|.. ...++.+++
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 5779999999877541 11 110 11223321 112223333
Q ss_pred HHHHH----HHhcCCCCeEecCCCCccEEEcCCC--CEE-EEEecccccc
Q 040832 455 KGLAY----LHEDCHPRIIHRDIKSSNILLDYTF--ETK-VADFGLAKLT 497 (724)
Q Consensus 455 ~gL~y----LHs~~~~~iiHrDIkp~NILl~~~~--~vk-L~DFGla~~~ 497 (724)
+.+.- ........+||+|++..|||++.++ ++. |+|||.+...
T Consensus 188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~~ 237 (1013)
T PRK06148 188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVHA 237 (1013)
T ss_pred HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccccc
Confidence 32221 1122345799999999999998875 565 9999988643
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.005 Score=66.82 Aligned_cols=139 Identities=17% Similarity=0.178 Sum_probs=80.4
Q ss_pred ceeeccCcEEEEEEEcCC----CcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCe-eEEeeEEEeCCeEEEEEEecCC
Q 040832 352 NLLGQGGFGYVHKGVLPN----GKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHL-VSLVGYCIAGGKRLLVYEYVPN 426 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~~----g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~E~~~~ 426 (724)
+.|..|-...+|+....+ +..|++|+...... ...+-.+|+.+++.+..-+| .++++++. ++ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 345456777889886533 23788998865432 22234678889998865444 45666653 32 58999987
Q ss_pred CCHHH-----------------HHhcCCC---CCC-CHHHHHHHHHH----------------------HHHHHHHHHhc
Q 040832 427 NNLEF-----------------HLHGKGR---PVM-DWPTRLKIAMG----------------------SAKGLAYLHED 463 (724)
Q Consensus 427 gsL~~-----------------~L~~~~~---~~l-~~~~~~~i~~q----------------------ia~gL~yLHs~ 463 (724)
..|.. .||.... ... -|..+.++..+ +.+-+..|...
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 76531 1122211 001 12332222222 11222222221
Q ss_pred -----CCCCeEecCCCCccEEEcC-CCCEEEEEecccc
Q 040832 464 -----CHPRIIHRDIKSSNILLDY-TFETKVADFGLAK 495 (724)
Q Consensus 464 -----~~~~iiHrDIkp~NILl~~-~~~vkL~DFGla~ 495 (724)
...-++|.||.+.|||+++ ++.++|+||..|.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 1123689999999999974 5789999999885
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0028 Score=64.04 Aligned_cols=122 Identities=19% Similarity=0.157 Sum_probs=60.8
Q ss_pred CcEEEEEEeccCCchhHHHHHHHHHHHHhcCC-CCeeEEeeEEEeCCeEEEEEEecCCCCHHH-------H---------
Q 040832 370 GKEVAVKSLRSGSGQGEREFKAEVEIISRVHH-RHLVSLVGYCIAGGKRLLVYEYVPNNNLEF-------H--------- 432 (724)
Q Consensus 370 g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~-------~--------- 432 (724)
.+.|+||+..... .....-..|+.+++.+.. -.-.++++++.+ .+|+||+++..|.. +
T Consensus 2 ~~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 4578888887652 334556778888888854 333566665433 35779997776532 1
Q ss_pred -Hhc--C---CCCCCCHHHHHHH----------------------HHHHHHHHHHHHhc----C-CCCeEecCCCCccEE
Q 040832 433 -LHG--K---GRPVMDWPTRLKI----------------------AMGSAKGLAYLHED----C-HPRIIHRDIKSSNIL 479 (724)
Q Consensus 433 -L~~--~---~~~~l~~~~~~~i----------------------~~qia~gL~yLHs~----~-~~~iiHrDIkp~NIL 479 (724)
||. . .....-|..+.++ +..+.+-+..+.+. . ...+.|+||.+.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 111 0 0000011222222 11122223333221 1 125789999999999
Q ss_pred E-cCCCCEEEEEeccccc
Q 040832 480 L-DYTFETKVADFGLAKL 496 (724)
Q Consensus 480 l-~~~~~vkL~DFGla~~ 496 (724)
+ +.++.++|+||..|..
T Consensus 157 ~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp ETSSSSCEEE--GTT-EE
T ss_pred eccCCCeEEEecHHHHhh
Confidence 9 8889999999988863
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.0037 Score=69.47 Aligned_cols=71 Identities=13% Similarity=0.134 Sum_probs=48.5
Q ss_pred EEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC-eEEEEEEecCCCCHHHHHhcC
Q 040832 362 VHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGG-KRLLVYEYVPNNNLEFHLHGK 436 (724)
Q Consensus 362 Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~-~~~lV~E~~~~gsL~~~L~~~ 436 (724)
+|.|..+.|+.+ ..=+--. .....++..+.+++.+.|+|+..++.+..... ...+|||++ +-+|++.+..+
T Consensus 5 ~~~a~~~~~~~c-~nglplt--~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 5 TFFAQEKPGDVC-SNGLPLT--PNSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred EEehhcCCCccc-cCCCcCC--CcHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence 566666566544 3222211 22456777889999999999999998876543 457899999 67788877654
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.011 Score=63.41 Aligned_cols=146 Identities=16% Similarity=0.196 Sum_probs=0.0
Q ss_pred CCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEe------eEEEeCCeEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLV------GYCIAGGKRLLV 420 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~------g~~~~~~~~~lV 420 (724)
++.+.++ ++.-+.||+... ++..+++|.+. ........+..-++-|.+-.-++++.++ -+...++..+++
T Consensus 9 ~l~v~~i--~~~~~~v~~v~T-~~G~~~Lk~~~-~~~~~l~~~~~~~~~L~~~G~~~~~~~~~t~~G~~~~~~~~~~~~L 84 (309)
T TIGR02904 9 GLQPEEM--EQVTGKLFKVYT-DQGVFALKKLY-ADRNTIESFVSQIQVLSEKGFSRIVPVYPTKDGSYYLFHGHFLYYL 84 (309)
T ss_pred CCCceee--ecccCcEEEEEe-CCCCEEEEEec-cchHhHHHHHHHHHHHHHcCCCcCCceeecCCCCeeeEECCEEEEE
Q ss_pred EEecCCCCH-----------------------------HHHHhcCCCCCCCHHHH-------------------------
Q 040832 421 YEYVPNNNL-----------------------------EFHLHGKGRPVMDWPTR------------------------- 446 (724)
Q Consensus 421 ~E~~~~gsL-----------------------------~~~L~~~~~~~l~~~~~------------------------- 446 (724)
|+|++|... ..+........-.|..+
T Consensus 85 ~~wi~G~~~~~~~~~~~~~~~~LA~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~fe~~~~ 164 (309)
T TIGR02904 85 MPWLDIERNEERNYQHESMFQELALLHRKTVKTERVTEEELKKHYERTLSRWENIPEGLEEFIVEAEAKWYMSPFELQAC 164 (309)
T ss_pred eCCcccccccCCHHHHHHHHHHHHHHHHhhhCCCcccHhHHHhHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHHHHH
Q ss_pred ---HHHHHHHHHHHHHHH---------hcCCCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 447 ---LKIAMGSAKGLAYLH---------EDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 447 ---~~i~~qia~gL~yLH---------s~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
..+...+..+++.|. .....+++|+|+...|||++.++.+.|+||..+..
T Consensus 165 ~~~~~~~~~~~~a~~~l~~~~~~~~~~~~~~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 165 TYYHEVMQAAEFAQNKLEDWHEATKEKESWRTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHhhcceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 724 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-69 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-68 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-48 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-48 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-40 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-38 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-27 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-26 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-26 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-26 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-25 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-25 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-25 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-24 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-24 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-23 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-23 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-23 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-23 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-23 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-23 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-23 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-23 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-23 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-23 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-23 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-23 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-23 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-23 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-23 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-22 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-22 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-22 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-22 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-22 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-22 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-22 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-22 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-22 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-22 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-21 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-20 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-20 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-20 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-20 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-19 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-19 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-19 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-19 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-19 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-19 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-18 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-18 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-18 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-17 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-16 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-16 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-16 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-15 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-15 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-15 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-15 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-15 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-15 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-15 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-15 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-15 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 7e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 9e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-05 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-05 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-05 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 724 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 0.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 0.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-176 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-90 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-68 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 6e-65 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-64 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 8e-64 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-62 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 7e-62 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-59 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 7e-59 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-57 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-56 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-56 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 3e-55 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-55 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-52 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 7e-45 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-43 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 5e-43 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 8e-43 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 4e-42 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 6e-41 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-40 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-40 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 3e-40 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 3e-40 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 3e-40 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 3e-40 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 4e-40 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 4e-40 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 7e-40 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 1e-39 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 1e-39 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-39 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-39 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 1e-39 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-39 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-39 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-39 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-39 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 5e-39 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 6e-39 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 7e-39 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 8e-39 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 8e-39 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-38 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 3e-38 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 3e-38 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 4e-38 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 4e-38 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 9e-38 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-37 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 3e-37 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 5e-37 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 6e-37 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-36 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-36 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-36 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-36 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-36 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 4e-36 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-35 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 1e-35 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-35 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-35 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-08 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 9e-07 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 9e-06 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-04 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-04 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 6e-04 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-35 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-35 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-35 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 6e-35 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 6e-35 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-34 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-34 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 1e-34 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-34 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 2e-34 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 4e-34 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-33 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-33 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-33 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-33 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-33 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 3e-33 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 3e-33 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 3e-33 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 4e-33 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 5e-33 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 6e-33 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 9e-33 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-32 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-32 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-32 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-31 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-31 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 4e-31 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 9e-31 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 1e-30 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 4e-30 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 5e-30 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-29 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-29 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-28 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-28 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 3e-28 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 3e-28 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 4e-28 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 5e-28 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 7e-28 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 8e-28 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 8e-28 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-27 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-27 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-27 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 3e-27 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 4e-27 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 8e-27 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 8e-27 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 9e-27 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-26 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 2e-26 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 2e-26 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-25 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-25 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-25 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-25 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 3e-25 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 3e-25 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 4e-25 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 4e-25 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 5e-25 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 6e-25 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 7e-25 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 8e-25 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 8e-25 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 1e-24 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-24 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-24 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 3e-24 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 3e-24 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 3e-24 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 4e-24 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 1e-23 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-23 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-23 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 9e-06 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 6e-04 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-23 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 3e-23 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 4e-23 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 4e-23 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 4e-23 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 7e-23 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 8e-23 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-22 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-22 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-22 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 1e-22 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-22 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-22 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-22 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-22 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-22 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-22 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-22 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-22 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 3e-22 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-22 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 4e-22 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 6e-22 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 8e-22 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 9e-22 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-21 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-21 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 1e-21 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-21 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 3e-21 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 7e-04 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 6e-21 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 6e-21 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 8e-21 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 9e-21 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-20 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-20 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-20 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 2e-20 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-20 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-20 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 3e-20 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 3e-20 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 5e-20 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 6e-20 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 6e-20 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-19 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-19 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-19 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 4e-19 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 6e-19 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 7e-19 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 9e-19 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-18 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-18 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-18 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 3e-18 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 3e-15 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 7e-15 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 1e-14 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 8e-12 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 3e-10 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 3e-18 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 4e-18 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 7e-18 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 7e-18 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 9e-18 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 2e-17 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 3e-17 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 3e-17 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 3e-17 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 7e-16 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 4e-15 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 6e-15 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 2e-05 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 4e-17 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 9e-16 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 1e-15 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 8e-15 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 8e-15 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 1e-14 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 3e-14 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 8e-14 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 3e-13 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 2e-10 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 3e-07 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 1e-16 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 6e-16 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 6e-16 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-15 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 6e-15 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 6e-15 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 1e-14 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-14 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-14 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-14 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 3e-14 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 5e-14 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 8e-14 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-13 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 3e-13 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 4e-13 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 4e-13 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 6e-13 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 1e-11 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 3e-11 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 5e-11 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 7e-10 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 4e-08 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 4e-06 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 4e-05 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 7e-13 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 1e-12 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 1e-12 | |
| 3gdb_A | 937 | Endo-D, putative uncharacterized protein SPR0440; | 1e-12 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 2e-12 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 2e-12 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 1e-09 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 7e-09 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 6e-08 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 2e-05 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-11 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 2e-11 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 2e-11 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 2e-11 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 3e-11 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 4e-11 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 4e-10 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 7e-11 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 8e-11 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 5e-10 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 1e-09 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 3e-08 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 1e-07 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 1e-07 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 1e-06 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 2e-05 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-10 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 2e-10 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 2e-10 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 2e-10 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 3e-10 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 1e-09 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 1e-08 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 1e-08 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 6e-08 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 2e-05 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 3e-05 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 4e-05 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 2e-04 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 3e-10 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 8e-10 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 1e-09 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 2e-09 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 5e-07 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 1e-04 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 7e-04 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 1e-09 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 1e-08 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 2e-08 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 2e-08 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 4e-08 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 2e-07 | |
| 3pgw_B | 231 | SM B; protein-RNA complex, U1 snRNA, SM fold, SM c | 1e-09 | |
| 3pgw_B | 231 | SM B; protein-RNA complex, U1 snRNA, SM fold, SM c | 6e-09 | |
| 3pgw_B | 231 | SM B; protein-RNA complex, U1 snRNA, SM fold, SM c | 2e-08 | |
| 3pgw_B | 231 | SM B; protein-RNA complex, U1 snRNA, SM fold, SM c | 3e-08 | |
| 3pgw_B | 231 | SM B; protein-RNA complex, U1 snRNA, SM fold, SM c | 5e-07 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 1e-09 | |
| 3odw_A | 536 | RHO guanine nucleotide exchange factor 1; regulati | 3e-09 | |
| 3odw_A | 536 | RHO guanine nucleotide exchange factor 1; regulati | 3e-08 | |
| 3odw_A | 536 | RHO guanine nucleotide exchange factor 1; regulati | 2e-06 | |
| 3odw_A | 536 | RHO guanine nucleotide exchange factor 1; regulati | 2e-06 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 3e-09 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 2e-08 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 2e-07 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 2e-07 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 3e-07 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 6e-06 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 2e-05 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 4e-05 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 9e-09 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 4e-08 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 5e-08 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 9e-08 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 2e-07 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 3e-07 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 5e-07 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 7e-07 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 1e-06 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 4e-05 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 6e-05 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 4e-04 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 5e-04 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 1e-08 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 1e-08 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 7e-07 | |
| 3ghg_A | 562 | Fibrinogen alpha chain; triple-stranded coiled coi | 6e-08 | |
| 3ghg_A | 562 | Fibrinogen alpha chain; triple-stranded coiled coi | 3e-07 | |
| 1mv3_A | 213 | MYC box dependent interacting protein 1; tumor sup | 3e-07 | |
| 1mv3_A | 213 | MYC box dependent interacting protein 1; tumor sup | 4e-07 | |
| 1mv3_A | 213 | MYC box dependent interacting protein 1; tumor sup | 6e-07 | |
| 1mv3_A | 213 | MYC box dependent interacting protein 1; tumor sup | 2e-06 | |
| 1mv3_A | 213 | MYC box dependent interacting protein 1; tumor sup | 3e-06 | |
| 1mv3_A | 213 | MYC box dependent interacting protein 1; tumor sup | 5e-06 | |
| 1mv3_A | 213 | MYC box dependent interacting protein 1; tumor sup | 2e-05 | |
| 1mv3_A | 213 | MYC box dependent interacting protein 1; tumor sup | 2e-05 | |
| 1mv3_A | 213 | MYC box dependent interacting protein 1; tumor sup | 2e-05 | |
| 1mv3_A | 213 | MYC box dependent interacting protein 1; tumor sup | 5e-05 | |
| 1mv3_A | 213 | MYC box dependent interacting protein 1; tumor sup | 1e-04 | |
| 1mv3_A | 213 | MYC box dependent interacting protein 1; tumor sup | 7e-04 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 4e-07 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 2e-06 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 3e-06 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 4e-05 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 4e-05 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 3e-04 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 4e-04 | |
| 2yew_A | 253 | Capsid protein, coat protein; alphavirus, molecula | 6e-07 | |
| 2yew_A | 253 | Capsid protein, coat protein; alphavirus, molecula | 2e-06 | |
| 2yew_A | 253 | Capsid protein, coat protein; alphavirus, molecula | 1e-05 | |
| 2yew_A | 253 | Capsid protein, coat protein; alphavirus, molecula | 2e-05 | |
| 2yew_A | 253 | Capsid protein, coat protein; alphavirus, molecula | 3e-04 | |
| 1ej6_B | 1275 | Lambda1; icosahedral, non-equivalence, dsRNA virus | 2e-06 | |
| 1ej6_B | 1275 | Lambda1; icosahedral, non-equivalence, dsRNA virus | 1e-04 | |
| 2j63_A | 467 | AP-endonuclease; base excision repair, lyase; 2.48 | 3e-06 | |
| 3u3p_A | 313 | Tumor necrosis factor receptor superfamily member; | 7e-06 | |
| 3i2d_A | 371 | E3 SUMO-protein ligase SIZ1; signal transduction, | 1e-05 | |
| 3i2d_A | 371 | E3 SUMO-protein ligase SIZ1; signal transduction, | 8e-05 | |
| 3i2d_A | 371 | E3 SUMO-protein ligase SIZ1; signal transduction, | 1e-04 | |
| 3i2d_A | 371 | E3 SUMO-protein ligase SIZ1; signal transduction, | 2e-04 | |
| 3i2d_A | 371 | E3 SUMO-protein ligase SIZ1; signal transduction, | 2e-04 | |
| 3i2d_A | 371 | E3 SUMO-protein ligase SIZ1; signal transduction, | 2e-04 | |
| 3i2d_A | 371 | E3 SUMO-protein ligase SIZ1; signal transduction, | 3e-04 | |
| 3sqr_A | 580 | Laccase; multicopper oxidase, glycosylation, oxido | 2e-05 | |
| 2xag_A | 852 | Lysine-specific histone demethylase 1; amine oxida | 3e-05 | |
| 3egg_C | 170 | Spinophilin; PP1, serine/threonine phosphatase, po | 4e-05 | |
| 1kxf_A | 264 | Sindbis virus capsid protein; chymotrypsin-like se | 6e-05 | |
| 1kxf_A | 264 | Sindbis virus capsid protein; chymotrypsin-like se | 2e-04 | |
| 1kxf_A | 264 | Sindbis virus capsid protein; chymotrypsin-like se | 2e-04 | |
| 1kxf_A | 264 | Sindbis virus capsid protein; chymotrypsin-like se | 2e-04 | |
| 3bbn_E | 308 | Ribosomal protein S5; small ribosomal subunit, spi | 6e-05 | |
| 2b5l_C | 222 | Nonstructural protein V; DDB1, SV5-V, beta propell | 6e-05 | |
| 1dx0_A | 219 | Prion protein; brain, repeat; NMR {Bos taurus} SCO | 8e-05 | |
| 2krg_A | 216 | Na(+)/H(+) exchange regulatory cofactor NHE-RF1; a | 8e-05 | |
| 2krg_A | 216 | Na(+)/H(+) exchange regulatory cofactor NHE-RF1; a | 2e-04 | |
| 2krg_A | 216 | Na(+)/H(+) exchange regulatory cofactor NHE-RF1; a | 7e-04 | |
| 2g6z_A | 211 | Dual specificity protein phosphatase 5; alpha/beta | 9e-05 | |
| 1x9d_A | 538 | Endoplasmic reticulum mannosyl-oligosaccharide 1, | 2e-04 | |
| 1x9d_A | 538 | Endoplasmic reticulum mannosyl-oligosaccharide 1, | 2e-04 | |
| 1x9d_A | 538 | Endoplasmic reticulum mannosyl-oligosaccharide 1, | 6e-04 | |
| 1x9d_A | 538 | Endoplasmic reticulum mannosyl-oligosaccharide 1, | 7e-04 | |
| 3dva_I | 428 | Dihydrolipoyllysine-residue acetyltransferase comp | 2e-04 | |
| 3dva_I | 428 | Dihydrolipoyllysine-residue acetyltransferase comp | 7e-04 | |
| 3oun_A | 157 | Putative uncharacterized protein TB39.8; peptidogl | 3e-04 | |
| 3oun_A | 157 | Putative uncharacterized protein TB39.8; peptidogl | 4e-04 | |
| 3oun_A | 157 | Putative uncharacterized protein TB39.8; peptidogl | 8e-04 | |
| 1w7p_D | 566 | VPS36P, YLR417W; ESCRT-II complex, endosomal prote | 5e-04 | |
| 2axn_A | 520 | 6-phosphofructo-2-kinase/fructose-2,6- biphosphata | 6e-04 | |
| 3eiv_A | 199 | Single-stranded DNA-binding protein 2; DNA damage, | 7e-04 | |
| 1t9b_A | 677 | Acetolactate synthase, mitochondrial; acetohydroxy | 7e-04 | |
| 2qlv_B | 252 | Protein SIP2, protein SPM2; heterotrimer, ATP-bind | 8e-04 | |
| 1eys_C | 382 | Photosynthetic reaction center; membrane protein c | 9e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 576 bits (1487), Expect = 0.0
Identities = 146/320 (45%), Positives = 200/320 (62%), Gaps = 11/320 (3%)
Query: 319 VLPPPPPIVALGFSQSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSL 378
V P V LG + F+ EL A+ FS N+LG+GGFG V+KG L +G VAVK L
Sbjct: 4 VPAEEDPEVHLGQLKR-FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL 62
Query: 379 RSGSGQG-EREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGK- 436
+ QG E +F+ EVE+IS HR+L+ L G+C+ +RLLVY Y+ N ++ L +
Sbjct: 63 KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122
Query: 437 -GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495
+P +DWP R +IA+GSA+GLAYLH+ C P+IIHRD+K++NILLD FE V DFGLAK
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
Query: 496 LTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPID---PTG 552
L +THV+T V GT G++APEY S+GK +EK+DVF +GVMLLELITG+R D
Sbjct: 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242
Query: 553 AMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPK 612
+ L+DW + L L + + D L+ NY EE+ +++ A + S RPK
Sbjct: 243 DDDVMLLDWVKGL----LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPK 298
Query: 613 ISQIVRALEGDVSLEDLNDG 632
+S++VR LEGD E +
Sbjct: 299 MSEVVRMLEGDGLAERWEEW 318
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 534 bits (1378), Expect = 0.0
Identities = 122/323 (37%), Positives = 174/323 (53%), Gaps = 11/323 (3%)
Query: 310 NSSSGPYGPVLPPPPPIVALGFSQSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPN 369
+ S + + F +L AT F L+G G FG V+KGVL +
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 370 GKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNL 429
G +VA+K S QG EF+ E+E +S H HLVSL+G+C + +L+Y+Y+ N NL
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 430 EFHLHGKGRPV--MDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETK 487
+ HL+G P M W RL+I +G+A+GL YLH IIHRD+KS NILLD F K
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 488 VADFGLAKL-TTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRR 546
+ DFG++K T + TH+ST V GT GY+ PEY G+LTEKSDV+SFGV+L E++ R
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
Query: 547 PIDPTGAMED-CLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRH 605
I + E L +WA ++G +I DP L E + + A +
Sbjct: 240 AIVQSLPREMVNLAEWAVES----HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLAL 295
Query: 606 SARRRPKISQIVRALEGDVSLED 628
S+ RP + ++ LE + L++
Sbjct: 296 SSEDRPSMGDVLWKLEYALRLQE 318
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 504 bits (1300), Expect = e-176
Identities = 101/303 (33%), Positives = 166/303 (54%), Gaps = 22/303 (7%)
Query: 335 AFTYEELSAATGGFSQ------SNLLGQGGFGYVHKGVLPNGKEVAVKSLRSG----SGQ 384
+F++ EL T F + N +G+GGFG V+KG + N VAVK L + + +
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 385 GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHG-KGRPVMDW 443
+++F E++++++ H +LV L+G+ G LVY Y+PN +L L G P + W
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 444 PTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKL-TTDNNT 502
R KIA G+A G+ +LHE+ IHRDIKS+NILLD F K++DFGLA+ T
Sbjct: 133 HMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWA 562
+++R++GT Y+APE G++T KSD++SFGV+LLE+ITG +D L+D
Sbjct: 190 VMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQLLLDIK 247
Query: 563 RPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622
+ ++ + D + + + + M + A+ + +RP I ++ + L+
Sbjct: 248 EEI-ED--EEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
Query: 623 DVS 625
+
Sbjct: 304 MTA 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 285 bits (730), Expect = 1e-90
Identities = 73/320 (22%), Positives = 120/320 (37%), Gaps = 29/320 (9%)
Query: 332 SQSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKA 391
S E L + + +G FG V K + VAVK Q + +
Sbjct: 10 SGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSW-QNEY 67
Query: 392 EVEIISRVHHRHLVSLVGYCIAGGK----RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRL 447
EV + + H +++ +G G L+ + +L L V+ W
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELC 124
Query: 448 KIAMGSAKGLAYLHED-------CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500
IA A+GLAYLHED P I HRDIKS N+LL +ADFGLA
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 501 NTHV-STRVMGTFGYLAPEYASSG-----KLTEKSDVFSFGVMLLELITGRRPIDPTGAM 554
+ + +GT Y+APE + D+++ G++L EL + D G +
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD--GPV 242
Query: 555 EDCLVDWARPL----CLRALDDGNFNEIADPYLEKNYPTEE-MARMVACAAASIRHSARR 609
++ ++ + + L + + ++ P L + MA + H A
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302
Query: 610 RPKISQIVRALEGDVSLEDL 629
R + + L ++
Sbjct: 303 RLSAGCVGERITQMQRLTNI 322
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 2e-68
Identities = 66/343 (19%), Positives = 123/343 (35%), Gaps = 56/343 (16%)
Query: 336 FTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEI 395
E S L+G+G +G V+KG L + + VAVK + + F E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNI 58
Query: 396 --ISRVHHRHLVSLVGYCIAGG-----KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLK 448
+ + H ++ + + LLV EY PN +L +L DW + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSSCR 115
Query: 449 IAMGSAKGLAYLHED------CHPRIIHRDIKSSNILLDYTFETKVADFGLAKL------ 496
+A +GLAYLH + P I HRD+ S N+L+ ++DFGL+
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 497 -TTDNNTHVSTRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVMLLELITGRRPI 548
+ + +GT Y+APE ++ D+++ G++ E+ +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 549 DPTGAMEDCLVDWARPLCLRALDDGNFNEIAD--------PYLEKNYPTEEMAR------ 594
P ++ + + + F ++ P + + +A
Sbjct: 236 FPGESVPEYQM----AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291
Query: 595 MVACAAASIRHSARRRPKISQIVRALEGDVSLEDLNDGIKPSQ 637
+ C A R + + + + N + P+
Sbjct: 292 IEDC----WDQDAEARLTAQXAEERMAELMMIWERNKSVSPTA 330
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 6e-65
Identities = 87/275 (31%), Positives = 129/275 (46%), Gaps = 32/275 (11%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
+G G FG VH+ +G +VAVK L + EF EV I+ R+ H ++V +G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKG-RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIH 470
+V EY+ +L LH G R +D RL +A AKG+ YLH +P I+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVH 162
Query: 471 RDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSD 530
R++KS N+L+D + KV DFGL++L S GT ++APE EKSD
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEWMAPEVLRDEPSNEKSD 221
Query: 531 VFSFGVMLLELITGRRP---IDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNY 587
V+SFGV+L EL T ++P ++P + R EI P +N
Sbjct: 222 VYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL------------EI--P---RNL 264
Query: 588 PTEEMAR-MVACAAASIRHSARRRPKISQIVRALE 621
++A + C + +RP + I+ L
Sbjct: 265 N-PQVAAIIEGC----WTNEPWKRPSFATIMDLLR 294
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 2e-64
Identities = 85/287 (29%), Positives = 138/287 (48%), Gaps = 47/287 (16%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGE-------REFKAEVEIISRVHHRHLV 405
+G+GGFG VHKG + + VA+KSL G +GE +EF+ EV I+S ++H ++V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 406 SLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCH 465
L G +V E+VP +L L K P + W +L++ + A G+ Y+ + +
Sbjct: 87 KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQ-NQN 142
Query: 466 PRIIHRDIKSSNILLDYTFET-----KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE-- 518
P I+HRD++S NI L E KVADFGL++ + H + ++G F ++APE
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMAPETI 198
Query: 519 YASSGKLTEKSDVFSFGVMLLELITGRRP---IDPTGAMEDCLVDWARPLCLRALDDGNF 575
A TEK+D +SF ++L ++TG P ++ LR
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG---LR------- 248
Query: 576 NEIADPYLEKNYPTEEMAR-MVACAAASIRHSARRRPKISQIVRALE 621
P + ++ P + + C + ++RP S IV+ L
Sbjct: 249 -----PTIPEDCP-PRLRNVIELCWS----GDPKKRPHFSYIVKELS 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 8e-64
Identities = 79/284 (27%), Positives = 120/284 (42%), Gaps = 45/284 (15%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSG----SGQGEREFKAEVEIISRVHHRHLVSLVG 409
+G GGFG V++ G EVAVK+ R Q + E ++ + + H ++++L G
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 410 YCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRII 469
C+ LV E+ L L GK + + A+ A+G+ YLH++ II
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPII 130
Query: 470 HRDIKSSNILLDYTFET--------KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYAS 521
HRD+KSSNIL+ E K+ DFGLA+ G + ++APE
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAPEVIR 187
Query: 522 SGKLTEKSDVFSFGVMLLELITGRRP---IDPTGAMEDCLVDWARPLCLRALDDGNFNEI 578
+ ++ SDV+S+GV+L EL+TG P ID ++ I
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL------------PI 235
Query: 579 ADPYLEKNYPTEEMAR-MVACAAASIRHSARRRPKISQIVRALE 621
P P E A+ M C RP + I+ L
Sbjct: 236 --P---STCP-EPFAKLMEDCWN----PDPHSRPSFTNILDQLT 269
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 1e-62
Identities = 83/271 (30%), Positives = 124/271 (45%), Gaps = 30/271 (11%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA 413
+G+G FG V K K+VA+K + S S + F E+ +SRV+H ++V L G C+
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 414 GGKRLLVYEYVPNNNLEFHLHGKGR-PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRD 472
LV EY +L LHG P + + ++G+AYLH +IHRD
Sbjct: 73 --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 473 IKSSNILLDYTFET-KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 531
+K N+LL K+ DFG A + T G+ ++APE +EK DV
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFEGSNYSEKCDV 186
Query: 532 FSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEE 591
FS+G++L E+IT R+P D G + WA R P L KN P +
Sbjct: 187 FSWGIILWEVITRRKPFDEIGGPAF-RIMWAVHNGTR------------PPLIKNLP-KP 232
Query: 592 MAR-MVACAAASIRHSARRRPKISQIVRALE 621
+ M C + +RP + +IV+ +
Sbjct: 233 IESLMTRCWS----KDPSQRPSMEEIVKIMT 259
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 7e-62
Identities = 60/279 (21%), Positives = 108/279 (38%), Gaps = 41/279 (14%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
L + G + KG G ++ VK L+ S + R+F E + H +++ ++G C
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 412 IA--GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRII 469
+ L+ ++P +L LH V+D +K A+ A+G+A+LH P I
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135
Query: 470 HRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE---YASSGKLT 526
+ S ++++D +++ + S M ++APE
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPEDTNR 189
Query: 527 EKSDVFSFGVMLLELITGRRP---IDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583
+D++SF V+L EL+T P + ++ RP I P
Sbjct: 190 RSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP------------TI--P-- 233
Query: 584 EKNYPTEEMAR-MVACAAASIRHSARRRPKISQIVRALE 621
+++ M C + +RPK IV LE
Sbjct: 234 -PGIS-PHVSKLMKIC----MNEDPAKRPKFDMIVPILE 266
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 2e-59
Identities = 78/278 (28%), Positives = 134/278 (48%), Gaps = 35/278 (12%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
+G G FG V+KG +G +VAVK L + Q + FK EV ++ + H +++ +GY
Sbjct: 32 IGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHR 471
+ +V ++ ++L HLH + + IA +A+G+ YLH IIHR
Sbjct: 90 T-APQLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLHA---KSIIHR 144
Query: 472 DIKSSNILLDYTFETKVADFGLAKLTTD-NNTHVSTRVMGTFGYLAPE---YASSGKLTE 527
D+KS+NI L K+ DFGLA + + +H ++ G+ ++APE S +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 528 KSDVFSFGVMLLELITGRRP---IDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLE 584
+SDV++FG++L EL+TG+ P I+ + + + G+ + +
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNINNRDQI------------IEMVGRGSLSPDL-SKVR 251
Query: 585 KNYPTEEMAR-MVACAAASIRHSARRRPKISQIVRALE 621
N P + M R M C ++ RP +I+ +E
Sbjct: 252 SNCP-KRMKRLMAEC----LKKKRDERPSFPRILAEIE 284
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 7e-59
Identities = 73/282 (25%), Positives = 106/282 (37%), Gaps = 35/282 (12%)
Query: 354 LGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCI 412
LG+G FG K G+ + +K L + +R F EV+++ + H +++ +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 413 AGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRD 472
+ + EY+ L + W R+ A A G+AYLH IIHRD
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLHS---MNIIHRD 133
Query: 473 IKSSNILLDYTFETKVADFGLAKLTTDNNTH-------------VSTRVMGTFGYLAPEY 519
+ S N L+ VADFGLA+L D T V+G ++APE
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 520 ASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579
+ EK DVFSFG++L E+I L N
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNA-------------DPDYLPRTMDFGLNVRGFL 240
Query: 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
D Y N P V C +RP ++ LE
Sbjct: 241 DRYCPPNCPPSFFPITVRCCDL----DPEKRPSFVKLEHWLE 278
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 1e-56
Identities = 66/301 (21%), Positives = 120/301 (39%), Gaps = 62/301 (20%)
Query: 352 NLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEI--ISRVHHRHLVSLVG 409
+G+G +G V +G G+ VAVK S + E+ + E E+ + H +++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 410 YCIAGGKR----LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHED-- 463
+ L+ Y +L +L +D + L+I + A GLA+LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 464 ---CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV---STRVMGTFGYLAP 517
P I HRD+KS NIL+ + +AD GLA + + + + + +GT Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 518 E------YASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALD 571
E ++ D+++FG++L E+ R +
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR------------------------RMVS 222
Query: 572 DGNFNEIADPYLEKNYP---TEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSLED 628
+G + P+ + E+M ++V ++RP I + SL
Sbjct: 223 NGIVEDYKPPFYDVVPNDPSFEDMRKVVC--------VDQQRPNIPNRWFSDPTLTSLAK 274
Query: 629 L 629
L
Sbjct: 275 L 275
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 3e-55
Identities = 68/303 (22%), Positives = 116/303 (38%), Gaps = 51/303 (16%)
Query: 352 NLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEI--ISRVHHRHLVSLVG 409
+G+G +G V G G++VAVK + E + E EI + H +++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 410 YCIAGGKR----LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHED-- 463
I G L+ +Y N +L +L +D + LK+A S GL +LH +
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 464 ---CHPRIIHRDIKSSNILLDYTFETKVADFGLAKL---TTDNNTHVSTRVMGTFGYLAP 517
P I HRD+KS NIL+ +AD GLA T+ +GT Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 518 E------YASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALD 571
E + + +D++SFG++L E+ + D
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS------- 268
Query: 572 DGNFNEIAD--------PYLEKNYPTEEMAR-----MVACAAASIRHSARRRPKISQIVR 618
D ++ ++ + P + ++E R M C H+ R ++ +
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTEC----WAHNPASRLTALRVKK 324
Query: 619 ALE 621
L
Sbjct: 325 TLA 327
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 3e-55
Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 22/211 (10%)
Query: 352 NLLGQGGFGYVHKGVLPNGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVG 409
L+G+G FG V+ G +G EVA++ + + + FK EV + H ++V +G
Sbjct: 39 ELIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 410 YCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRII 469
C++ ++ L + + V+D +IA KG+ YLH I+
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHA---KGIL 152
Query: 470 HRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM----GTFGYLAPEYASSGKL 525
H+D+KS N+ D + + DFGL ++ + G +LAPE
Sbjct: 153 HKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 526 ---------TEKSDVFSFGVMLLELITGRRP 547
++ SDVF+ G + EL P
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-52
Identities = 71/301 (23%), Positives = 118/301 (39%), Gaps = 62/301 (20%)
Query: 352 NLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEI--ISRVHHRHLVSLVG 409
+G+G FG V +G G+EVAVK S + ER + E EI + H +++ +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 410 YCIAGGKR----LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHED-- 463
LV +Y + +L +L+ R + +K+A+ +A GLA+LH +
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 464 ---CHPRIIHRDIKSSNILLDYTFETKVADFGLAKL---TTDNNTHVSTRVMGTFGYLAP 517
P I HRD+KS NIL+ +AD GLA TD +GT Y+AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 518 E------YASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALD 571
E + +++D+++ G++ E+ R
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIAR------------------------RCSI 256
Query: 572 DGNFNEIADPYLEKNYP---TEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSLED 628
G + PY + EEM ++V + RP I ++ E +
Sbjct: 257 GGIHEDYQLPYYDLVPSDPSVEEMRKVVC--------EQKLRPNIPNRWQSCEALRVMAK 308
Query: 629 L 629
+
Sbjct: 309 I 309
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 7e-45
Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 354 LGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVSLVGYC 411
+G+G FG V G L + VAVKS R + +F E I+ + H ++V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHR 471
+V E V + L +G + T L++ +A G+ YL IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARL-RVKTLLQMVGDAAAGMEYLESK---CCIHR 237
Query: 472 DIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGY--LAPEYASSGKLTEKS 529
D+ + N L+ K++DFG+++ D + ++ + APE + G+ + +S
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEAD-GVYAASGGLRQVPVKWTAPEALNYGRYSSES 296
Query: 530 DVFSFGVMLLELIT-GRRP 547
DV+SFG++L E + G P
Sbjct: 297 DVWSFGILLWETFSLGASP 315
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-43
Identities = 74/287 (25%), Positives = 123/287 (42%), Gaps = 36/287 (12%)
Query: 354 LGQGGFGYVHKGVLP-----NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLV 408
LG+G FG V G+ VAVK L+ + + R+F+ E+EI+ + H ++V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 409 GYCIAGGKR--LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHP 466
G C + G+R L+ EY+P +L +L K + +D L+ KG+ YL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 133
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTF--GYLAPEYASSGK 524
R IHRD+ + NIL++ K+ DFGL K+ + + G + APE + K
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 525 LTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCL--VDWARPLCLRALDDGNFNEIADP 581
+ SDV+SFGV+L EL T + P + + + ++
Sbjct: 194 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE---------- 243
Query: 582 YLEKNYPTEEMARMVACAAA--SI-----RHSARRRPKISQIVRALE 621
L+ N + R C I ++ +RP + ++
Sbjct: 244 LLKNNG---RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-43
Identities = 75/288 (26%), Positives = 124/288 (43%), Gaps = 38/288 (13%)
Query: 354 LGQGGFGYVHKGVLP-----NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLV 408
LG+G FG V G+ VAVK L+ + + R+F+ E+EI+ + H ++V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 409 GYCIAGGKR--LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHP 466
G C + G+R L+ EY+P +L +L K + +D L+ KG+ YL
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 164
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTF--GYLAPEYASSGK 524
R IHRD+ + NIL++ K+ DFGL K+ + + + G + APE + K
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 224
Query: 525 LTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCL--VDWARPLCLRALDDGNFNEIADP 581
+ SDV+SFGV+L EL T + P + + + ++
Sbjct: 225 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE---------- 274
Query: 582 YLEKNY--------PTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
L+ N P E M C ++ +RP + ++
Sbjct: 275 LLKNNGRLPRPDGCPDEIYMIMTECWN----NNVNQRPSFRDLALRVD 318
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 8e-43
Identities = 81/286 (28%), Positives = 118/286 (41%), Gaps = 35/286 (12%)
Query: 354 LGQGGFGYVHKGVLP-----NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLV 408
LG+G FG V G VAVK L+ +R+F+ E++I+ +H +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 409 GYCIAGGKR--LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHP 466
G G++ LV EY+P+ L L + R +D L + KG+ YL
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSR--- 146
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTF--GYLAPEYASSGK 524
R +HRD+ + NIL++ K+ADFGLAKL + + R G + APE S
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206
Query: 525 LTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583
+ +SDV+SFGV+L EL T + C + D L
Sbjct: 207 FSRQSDVWSFGVVLYELFTYCDKS---------CSPSAEFLRMMGCERDVPALSRLLELL 257
Query: 584 EKNY--------PTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
E+ P E M C A S + RP S + L+
Sbjct: 258 EEGQRLPAPPACPAEVHELMKLCWA----PSPQDRPSFSALGPQLD 299
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-42
Identities = 68/286 (23%), Positives = 115/286 (40%), Gaps = 34/286 (11%)
Query: 354 LGQGGFGYVHKGVLP-----NGKEVAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVSL 407
LG+G FG V G++VAVKSL+ SG + K E+EI+ ++H ++V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 408 VGYCIAGGKR--LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCH 465
G C G L+ E++P+ +L+ +L K + ++ +LK A+ KG+ YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKYAVQICKGMDYLGSR-- 145
Query: 466 PRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTF--GYLAPEYASSG 523
+ +HRD+ + N+L++ + K+ DFGL K + + + + + APE
Sbjct: 146 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS 204
Query: 524 KLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582
K SDV+SFGV L EL+T P +
Sbjct: 205 KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT---------HGQMTVTRLVNT 255
Query: 583 LEKNYPTEEMARMVACAAA--SI-----RHSARRRPKISQIVRALE 621
L++ + C + R ++ E
Sbjct: 256 LKEGK---RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 6e-41
Identities = 64/195 (32%), Positives = 104/195 (53%), Gaps = 6/195 (3%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA 413
+G G FG VH G N +VA+K++R G+ E +F E E++ ++ H LV L G C+
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 414 GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDI 473
LV E++ + L +L R + T L + + +G+AYL E+ +IHRD+
Sbjct: 75 QAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYL-EEAC--VIHRDL 130
Query: 474 KSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 533
+ N L+ KV+DFG+ + D+ ST + +PE S + + KSDV+S
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 534 FGVMLLELIT-GRRP 547
FGV++ E+ + G+ P
Sbjct: 191 FGVLMWEVFSEGKIP 205
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-40
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA 413
LG G FG V G +VAVK ++ GS E EF E + + ++ H LV G C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 414 GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDI 473
+V EY+ N L +L G+ + + L++ +G+A+L E IHRD+
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHGKGL-EPSQLLEMCYDVCEGMAFL-ESHQ--FIHRDL 130
Query: 474 KSSNILLDYTFETKVADFGLAKLTTDNNTHVST------RVMGTFGYLAPEYASSGKLTE 527
+ N L+D KV+DFG+ + D+ S + APE K +
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS------APEVFHYFKYSS 184
Query: 528 KSDVFSFGVMLLELIT-GRRP 547
KSDV++FG+++ E+ + G+ P
Sbjct: 185 KSDVWAFGILMWEVFSLGKMP 205
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 9/199 (4%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGE---REFKAEVEIISRVHHRHLVSLV 408
LG GG V+ +VA+K++ + E + F+ EV S++ H+++VS++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 409 GYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRI 468
LV EY+ L ++ G + T + G+ + H+ RI
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDM---RI 132
Query: 469 IHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEK 528
+HRDIK NIL+D K+ DFG+AK ++ + + V+GT Y +PE A E
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 529 SDVFSFGVMLLELITGRRP 547
+D++S G++L E++ G P
Sbjct: 193 TDIYSIGIVLYEMLVGEPP 211
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-40
Identities = 59/201 (29%), Positives = 106/201 (52%), Gaps = 12/201 (5%)
Query: 354 LGQGGFGYVHKGVLPNGKE---VAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVSLVG 409
LG G FG V +GV K+ VA+K L+ G+ + + E E +I+ ++ + ++V L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 410 YCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRII 469
C +LV E L L GK + ++ + G+ YL E+ + +
Sbjct: 78 VCQ-AEALMLVMEMAGGGPLHKFLVGKREEI-PVSNVAELLHQVSMGMKYL-EEKN--FV 132
Query: 470 HRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTF--GYLAPEYASSGKLTE 527
HRD+ + N+LL K++DFGL+K ++++ + R G + + APE + K +
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 528 KSDVFSFGVMLLELIT-GRRP 547
+SDV+S+GV + E ++ G++P
Sbjct: 193 RSDVWSYGVTMWEALSYGQKP 213
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-40
Identities = 84/300 (28%), Positives = 124/300 (41%), Gaps = 37/300 (12%)
Query: 354 LGQGGFGYVHKGVLPNGKE-----VAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVSL 407
LG+G FG V + VAVK+L++ +G R +K E++I+ ++H H++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 408 VGYCIAGGKR--LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCH 465
G C G LV EYVP +L +L R + L A +G+AYLH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYLHAQ-- 153
Query: 466 PRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTF--GYLAPEYASSG 523
IHRD+ + N+LLD K+ DFGLAK + + + R G + APE
Sbjct: 154 -HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 212
Query: 524 KLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVD--WARPLC--LRALDDGNFNEI 578
K SDV+SFGV L EL+T P + + + L+ G
Sbjct: 213 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE---- 268
Query: 579 ADPYLEK--NYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSLEDLNDGIKPS 636
L + P E M C A RP ++ L+ ++ + G PS
Sbjct: 269 ---RLPRPDKCPAEVYHLMKNCWE----TEASFRPTFENLIPILK---TVHEKYQGQAPS 318
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-40
Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 16/200 (8%)
Query: 352 NLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
+G+G FG V G G +VAVK +++ + + F AE +++++ H +LV L+G
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 412 IAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIH 470
+ L +V EY+ +L +L +GR V+ LK ++ + + YL + +H
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 140
Query: 471 RDIKSSNILLDYTFETKVADFGLAKL--TTDNNTHVSTRVMGTFGYLAPEYASSGKLTEK 528
RD+ + N+L+ KV+DFGL K +T + + + APE K + K
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------APEALREKKFSTK 194
Query: 529 SDVFSFGVMLLELIT-GRRP 547
SDV+SFG++L E+ + GR P
Sbjct: 195 SDVWSFGILLWEIYSFGRVP 214
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-40
Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 19/205 (9%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVK--SLRSGSGQGEREFKAEVEIISRVHHRHLVSLVG 409
+G+G F V+KG+ EVA R + + FK E E++ + H ++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 410 YCIAGGK---RLLVY-EYVPNNNLEFHL--HGKGRPVMDWPTRLKIAMGSAKGLAYLHED 463
+ K +++ E + + L+ +L M KGL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHT- 147
Query: 464 CHPRIIHRDIKSSNILLDYTF-ETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS 522
P IIHRD+K NI + K+ D GLA L + V+GT ++APE
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEE 204
Query: 523 GKLTEKSDVFSFGVMLLELITGRRP 547
E DV++FG+ +LE+ T P
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYP 228
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-40
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 17/204 (8%)
Query: 354 LGQGGFGYVHKGVLPNGKE-----VAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVSL 407
LG G FG V+KG+ E VA+K LR + E E +++ V + H+ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR 467
+G C+ L+ + +P L ++ + + + L + AKG+ YL + R
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGT---FGYLAPEYASSGK 524
++HRD+ + N+L+ K+ DFGLAKL G ++A E
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALESILHRI 195
Query: 525 LTEKSDVFSFGVMLLELIT-GRRP 547
T +SDV+S+GV + EL+T G +P
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-40
Identities = 87/354 (24%), Positives = 136/354 (38%), Gaps = 52/354 (14%)
Query: 290 PTPPPSQRGAVTVTSSDMSHNSSSGPYGPVLPPPPPIVALGFSQSAFTYEELSAATGGFS 349
P P G ++ S +G + + + + + G S
Sbjct: 28 PRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPS 87
Query: 350 QSNL-----LGQGGFGYVHKGVL--PNGKE--VAVKSLRSGSGQGER-EFKAEVEIISRV 399
+ +G+G FG V+ G L +GK+ AVKSL + GE +F E I+
Sbjct: 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 147
Query: 400 HHRHLVSLVGYCI-AGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLA 458
H +++SL+G C+ + G L+V Y+ + +L + + + AKG+
Sbjct: 148 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMK 206
Query: 459 YLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYL--- 515
+L + +HRD+ + N +LD F KVADFGLA+ D T L
Sbjct: 207 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN--KTGAKLPVK 261
Query: 516 --APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP---IDPTGAMEDCLVDWARPLCLRA 569
A E + K T KSDV+SFGV+L EL+T G P ++
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-------------Y 308
Query: 570 LDDGNFNEIADPYLEK--NYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
L G L + P M+ C A RP S++V +
Sbjct: 309 LLQGR-------RLLQPEYCPDPLYEVMLKCW----HPKAEMRPSFSELVSRIS 351
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 7e-40
Identities = 81/288 (28%), Positives = 121/288 (42%), Gaps = 49/288 (17%)
Query: 352 NLLGQGGFGYVHKGVL--PNGKE--VAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVS 406
++G+G FG V+ G L +GK+ AVKSL + GE +F E I+ H +++S
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 407 LVGYCIAG-GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCH 465
L+G C+ G L+V Y+ + +L + + + AKG+ YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKYLASK-- 147
Query: 466 PRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYL------APEY 519
+ +HRD+ + N +LD F KVADFGLA+ D + V G A E
Sbjct: 148 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTGAKLPVKWMALES 203
Query: 520 ASSGKLTEKSDVFSFGVMLLELIT-GRRP---IDPTGAMEDCLVDWARPLCLRALDDGNF 575
+ K T KSDV+SFGV+L EL+T G P ++ L G
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-------------YLLQGR- 249
Query: 576 NEIADPYLEK--NYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
L + P M+ C A RP S++V +
Sbjct: 250 ------RLLQPEYCPDPLYEVMLKCW----HPKAEMRPSFSELVSRIS 287
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-39
Identities = 69/197 (35%), Positives = 99/197 (50%), Gaps = 6/197 (3%)
Query: 352 NLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
LGQG FG V G VA+K+L+ G+ E F E +++ ++ H LV L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHR 471
+V EY+ +L L G+ + P + +A A G+AY+ +HR
Sbjct: 249 S-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 304
Query: 472 DIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 531
D++++NIL+ KVADFGLA+L DN + APE A G+ T KSDV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 532 FSFGVMLLELIT-GRRP 547
+SFG++L EL T GR P
Sbjct: 365 WSFGILLTELTTKGRVP 381
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-39
Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 354 LGQGGFGYVHKGVLPNGK-EVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCI 412
LG G +G V++GV VAVK+L+ + + E EF E ++ + H +LV L+G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 413 AGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRD 472
++ E++ NL +L R + L +A + + YL + IHRD
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 136
Query: 473 IKSSNILLDYTFETKVADFGLAKLTTDN--NTHVSTRV----MGTFGYLAPEYASSGKLT 526
+ + N L+ KVADFGL++L T + H + APE + K +
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT------APESLAYNKFS 190
Query: 527 EKSDVFSFGVMLLELIT-GRRP 547
KSDV++FGV+L E+ T G P
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSP 212
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-39
Identities = 64/238 (26%), Positives = 104/238 (43%), Gaps = 24/238 (10%)
Query: 317 GPVLPPPPPIVALGFSQSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVK 376
GP+ P A G ++ E+ + LG G FG V G +VA+K
Sbjct: 1 GPLGSKNAPSTA-GLGYGSW---EIDPKD--LTFLKELGTGQFGVVKYGKWRGQYDVAIK 54
Query: 377 SLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGK 436
++ GS E EF E +++ + H LV L G C ++ EY+ N L +L +
Sbjct: 55 MIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-E 112
Query: 437 GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496
R L++ + + YL E +HRD+ + N L++ KV+DFGL++
Sbjct: 113 MRHRFQTQQLLEMCKDVCEAMEYL-ESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRY 169
Query: 497 TTDNNTHVST------RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
D+ S R PE K + KSD+++FGV++ E+ + G+ P
Sbjct: 170 VLDDEYTSSVGSKFPVRWS------PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-39
Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 6/198 (3%)
Query: 352 NLLGQGGFGYVHKGVLPN-GKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGY 410
+ LG G +G V++GV VAVK+L+ + + E EF E ++ + H +LV L+G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 284
Query: 411 CIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIH 470
C ++ E++ NL +L R + L +A + + YL + IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 341
Query: 471 RDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSD 530
R++ + N L+ KVADFGL++L T + + APE + K + KSD
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401
Query: 531 VFSFGVMLLELIT-GRRP 547
V++FGV+L E+ T G P
Sbjct: 402 VWAFGVLLWEIATYGMSP 419
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-39
Identities = 61/198 (30%), Positives = 104/198 (52%), Gaps = 16/198 (8%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA 413
+G+G FG V G G +VAVK +++ + + F AE +++++ H +LV L+G +
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 414 GGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRD 472
L +V EY+ +L +L +GR V+ LK ++ + + YL + +HRD
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRD 314
Query: 473 IKSSNILLDYTFETKVADFGLAK--LTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSD 530
+ + N+L+ KV+DFGL K +T + + + APE K + KSD
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------APEALREKKFSTKSD 368
Query: 531 VFSFGVMLLELIT-GRRP 547
V+SFG++L E+ + GR P
Sbjct: 369 VWSFGILLWEIYSFGRVP 386
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 64/203 (31%), Positives = 108/203 (53%), Gaps = 13/203 (6%)
Query: 354 LGQGGFGYVHKGVL--PNGKE---VAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVSL 407
+G G FG V+KG+L +GK+ VA+K+L++G + +R +F E I+ + H +++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR 467
G +++ EY+ N L+ L + + + G A G+ YL + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYL-ANMN-- 167
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGY--LAPEYASSGKL 525
+HRD+ + NIL++ KV+DFGL+++ D+ T G APE S K
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227
Query: 526 TEKSDVFSFGVMLLELIT-GRRP 547
T SDV+SFG+++ E++T G RP
Sbjct: 228 TSASDVWSFGIVMWEVMTYGERP 250
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 354 LGQGGFGYVHKGVL--PNGKE--VAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVSLV 408
+G+G FG VH+G+ P VA+K+ ++ + R +F E + + H H+V L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 409 GYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRI 468
G ++ E L L + +D + + A + LAYL R
Sbjct: 83 GVIT-ENPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESK---RF 137
Query: 469 IHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEK 528
+HRDI + N+L+ K+ DFGL++ D+ + +++ ++APE + + T
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 197
Query: 529 SDVFSFGVMLLELIT-GRRP 547
SDV+ FGV + E++ G +P
Sbjct: 198 SDVWMFGVCMWEILMHGVKP 217
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 55/200 (27%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 354 LGQGGFGYVHKGVL--PNGKE--VAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVSLV 408
LG+G FG V++GV G++ VAVK+ + + +F +E I+ + H H+V L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 409 GYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRI 468
G ++ E P L +L + + + T + ++ K +AYL E +
Sbjct: 80 GIIE-EEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYL-ESIN--C 134
Query: 469 IHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEK 528
+HRDI NIL+ K+ DFGL++ D + + ++ +++PE + + T
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTA 194
Query: 529 SDVFSFGVMLLELIT-GRRP 547
SDV+ F V + E+++ G++P
Sbjct: 195 SDVWMFAVCMWEILSFGKQP 214
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 14/202 (6%)
Query: 354 LGQGGFGYVHKGVLPNGK---EVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLV 408
LG G FG V KG K VAVK L++ + E AE ++ ++ + ++V ++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 409 GYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRI 468
G C +LV E L +L + +++ + G+ YL E+ +
Sbjct: 85 GIC-EAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYL-EESN--F 138
Query: 469 IHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTF--GYLAPEYASSGKLT 526
+HRD+ + N+LL K++DFGL+K + + + G + + APE + K +
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 527 EKSDVFSFGVMLLELIT-GRRP 547
KSDV+SFGV++ E + G++P
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKP 220
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-39
Identities = 70/287 (24%), Positives = 117/287 (40%), Gaps = 47/287 (16%)
Query: 352 NLLGQGGFGYVHKGVLPNGKE----VAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVS 406
++G+G FG V+ G + + A+KSL + + F E ++ ++H ++++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 407 LVGYCIAG-GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCH 465
L+G + G ++ Y+ + +L + + + + A+G+ YL E
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVARGMEYLAEQ-- 143
Query: 466 PRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYL-----APEYA 520
+ +HRD+ + N +LD +F KVADFGLA+ D + + L A E
Sbjct: 144 -KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ--HRHARLPVKWTALESL 200
Query: 521 SSGKLTEKSDVFSFGVMLLELIT-GRRP---IDPTGAMEDCLVDWARPLCLRALDDGNFN 576
+ + T KSDV+SFGV+L EL+T G P IDP L G
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH-------------FLAQGR-- 245
Query: 577 EIADPYLEK--NYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
L + P M C RP +V +E
Sbjct: 246 -----RLPQPEYCPDSLYQVMQQCW----EADPAVRPTFRVLVGEVE 283
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 6e-39
Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 12/202 (5%)
Query: 354 LGQGGFGYVHKGVL--PNGKE--VAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVSLV 408
+G G G V G L P ++ VA+K+L++G + +R +F +E I+ + H +++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 409 GYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRI 468
G G ++V EY+ N +L+ L + + G G+ YL D
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYL-SDLG--Y 172
Query: 469 IHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYL--APEYASSGKLT 526
+HRD+ + N+L+D KV+DFGL+++ D+ T G APE + +
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS 232
Query: 527 EKSDVFSFGVMLLELIT-GRRP 547
SDV+SFGV++ E++ G RP
Sbjct: 233 SASDVWSFGVVMWEVLAYGERP 254
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 7e-39
Identities = 69/195 (35%), Positives = 101/195 (51%), Gaps = 6/195 (3%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA 413
LG G FG V G +VAVKSL+ GS + F AE ++ ++ H+ LV L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT- 78
Query: 414 GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDI 473
++ EY+ N +L L + L +A A+G+A++ E IHRD+
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 135
Query: 474 KSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 533
+++NIL+ T K+ADFGLA+L DN + APE + G T KSDV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 534 FGVMLLELIT-GRRP 547
FG++L E++T GR P
Sbjct: 196 FGILLTEIVTHGRIP 210
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 8e-39
Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 12/202 (5%)
Query: 354 LGQGGFGYVHKGVL--PNGKE--VAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVSLV 408
+G G FG V G L P+ KE VA+K+L+ G + +R +F E I+ + H +++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 409 GYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRI 468
G ++V EY+ N +L+ L K + + G A G+ YL D
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYL-SDMG--Y 168
Query: 469 IHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYL--APEYASSGKLT 526
+HRD+ + NIL++ KV+DFGL ++ D+ T G +PE + K T
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 527 EKSDVFSFGVMLLELIT-GRRP 547
SDV+S+G++L E+++ G RP
Sbjct: 229 SASDVWSYGIVLWEVMSYGERP 250
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 8e-39
Identities = 74/296 (25%), Positives = 121/296 (40%), Gaps = 56/296 (18%)
Query: 354 LGQGGFGYVHKGVLPNGKE------VAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSL 407
LG+G FG V N VAVK+L+ + ++F+ E E+++ + H H+V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTR--------------LKIAMGS 453
G C G ++V+EY+ + +L L G M L IA
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 454 AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFG 513
A G+ YL +HRD+ + N L+ K+ DFG+++ + + +G
Sbjct: 143 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RVGGHT 195
Query: 514 YL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCL 567
L PE K T +SDV+SFGV+L E+ T G++P + + V +
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW---FQLSNTEV-------I 245
Query: 568 RALDDGNFNEIADPYLEK--NYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
+ G LE+ P E M+ C + ++R I +I + L
Sbjct: 246 ECITQGR-------VLERPRVCPKEVYDVMLGCW----QREPQQRLNIKEIYKILH 290
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-38
Identities = 60/197 (30%), Positives = 96/197 (48%), Gaps = 6/197 (3%)
Query: 352 NLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
LG G FG V +VAVK+++ GS F AE ++ + H LV L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHR 471
++ E++ +L L P + + A+G+A++ + IHR
Sbjct: 253 T-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHR 308
Query: 472 DIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 531
D++++NIL+ + K+ADFGLA++ DN + APE + G T KSDV
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 368
Query: 532 FSFGVMLLELIT-GRRP 547
+SFG++L+E++T GR P
Sbjct: 369 WSFGILLMEIVTYGRIP 385
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-38
Identities = 60/266 (22%), Positives = 110/266 (41%), Gaps = 16/266 (6%)
Query: 293 PPSQRGAVTVTSSDMSHNSSSGPYGPVLPPPPPIVALGFSQSAFTYEELSAATGGFSQSN 352
P + + +++N G + TY S +
Sbjct: 332 PQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRER 391
Query: 353 L-----LGQGGFGYVHKGVL--PNGKE--VAVKSLRSGSGQGER-EFKAEVEIISRVHHR 402
+ +G+G FG VH+G+ P VA+K+ ++ + R +F E + + H
Sbjct: 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 403 HLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHE 462
H+V L+G ++ E L L + +D + + A + LAYL
Sbjct: 452 HIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYLES 509
Query: 463 DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS 522
R +HRDI + N+L+ K+ DFGL++ D+ + +++ ++APE +
Sbjct: 510 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 523 GKLTEKSDVFSFGVMLLELIT-GRRP 547
+ T SDV+ FGV + E++ G +P
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 63/204 (30%), Positives = 93/204 (45%), Gaps = 15/204 (7%)
Query: 354 LGQGGFGYVHKGVL--PNGKE--VAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVS 406
LG G FG V +G P+GK VAVK L+ + +F EV + + HR+L+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHP 466
L G + +V E P +L L K + T + A+ A+G+ YL
Sbjct: 86 LYGVVL-TPPMKMVTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMGYLESK--- 140
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGY--LAPEYASSGK 524
R IHRD+ + N+LL K+ DFGL + N+ H + + APE +
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200
Query: 525 LTEKSDVFSFGVMLLELIT-GRRP 547
+ SD + FGV L E+ T G+ P
Sbjct: 201 FSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-38
Identities = 73/291 (25%), Positives = 129/291 (44%), Gaps = 51/291 (17%)
Query: 354 LGQGGFGYVHKGVLPNGKE------VAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVS 406
LGQG FG V++GV + VA+K++ + ER EF E ++ + H+V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTR--------LKIAMGSAKGLA 458
L+G G L++ E + +L+ +L + + P +++A A G+A
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 459 YLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYL--- 515
YL+ + + +HRD+ + N ++ F K+ DFG+ + + + + G G L
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLPVR 205
Query: 516 --APEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDD 572
+PE G T SDV+SFGV+L E+ T +P + E LR + +
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQ---------VLRFVME 255
Query: 573 GNFNEIADPYLEK--NYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
G L+K N P M C +++ + RP +I+ +++
Sbjct: 256 GG-------LLDKPDNCPDMLFELMRMCW----QYNPKMRPSFLEIISSIK 295
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 354 LGQGGFGYVHKGVL--------PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLV 405
LGQG F + KGV + EV +K L F ++S++ H+HLV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 406 SLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCH 465
G C+ G + +LV E+V +L+ +L K + ++ +L++A A + +L E+
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL-EENT 133
Query: 466 PRIIHRDIKSSNILLDYTFET--------KVADFGLAKLTTDNN-THVSTRVMGTFGYLA 516
+IH ++ + NILL + K++D G++ + +
Sbjct: 134 --LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV------P 185
Query: 517 PEYASSGKL-TEKSDVFSFGVMLLELIT-GRRP 547
PE + K +D +SFG L E+ + G +P
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 9e-38
Identities = 65/204 (31%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 354 LGQGGFGYVHKGVLPNGKE-----VAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVSL 407
LG G FG VHKGV E V +K + SG+ + I + H H+V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR 467
+G C G LV +Y+P +L H+ + R + L + AKG+ YL E
Sbjct: 81 LGLCP-GSSLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYLEEH---G 135
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGT---FGYLAPEYASSGK 524
++HR++ + N+LL + +VADFG+A L ++ + ++A E GK
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS--EAKTPIKWMALESIHFGK 193
Query: 525 LTEKSDVFSFGVMLLELIT-GRRP 547
T +SDV+S+GV + EL+T G P
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 15/205 (7%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGE---REFKAEVEIISRVHHRHLVSL- 407
+LG GG VH L + ++VAVK LR+ + F+ E + + ++H +V++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 408 -VGYCIAGGKRL--LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC 464
G L +V EYV L +H +G M +++ + + L + H++
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQN- 135
Query: 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV--STRVMGTFGYLAPEYASS 522
IIHRD+K +NI++ T KV DFG+A+ D+ V + V+GT YL+PE A
Sbjct: 136 --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 523 GKLTEKSDVFSFGVMLLELITGRRP 547
+ +SDV+S G +L E++TG P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 147 bits (371), Expect = 3e-37
Identities = 70/335 (20%), Positives = 129/335 (38%), Gaps = 28/335 (8%)
Query: 223 VAAGAAFLIIVMLLVFFACRRKKN---RERNDQMPYYNNNHTTATDYYNSAATPSPPPRA 279
+ G F + L+ + + + +N A + + P+
Sbjct: 223 IPEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQR 282
Query: 280 NWQQQTDHGWPTPPPSQRGAVTVTSSDMSHNSSSGPYGPVLPPPPPIVALGFSQSAFTYE 339
G+ P M + P+ + L
Sbjct: 283 RIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADI 342
Query: 340 ELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKE---VAVKSLRSGSGQGER-EFKAEVEI 395
EL G G FG V +GV K+ VA+K L+ G+ + + E E +I
Sbjct: 343 EL-------------GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 389
Query: 396 ISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAK 455
+ ++ + ++V L+G C +LV E L L GK + ++ +
Sbjct: 390 MHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEI-PVSNVAELLHQVSM 447
Query: 456 GLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGY- 514
G+ YL E +HR++ + N+LL K++DFGL+K ++++ + R G +
Sbjct: 448 GMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504
Query: 515 -LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
APE + K + +SDV+S+GV + E ++ G++P
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-37
Identities = 51/202 (25%), Positives = 84/202 (41%), Gaps = 15/202 (7%)
Query: 353 LLGQGGFGYVHKG---VLPNGKEVAVKSLRSGSGQGE---REFKAEVEIISRVHHRHLVS 406
L+G+GG G V++ V + VA+K + + E R+ H+V
Sbjct: 41 LVGRGGMGDVYEAEDTVR--ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHP 466
+ + G+ + + +L L +G + P + I L H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAA--- 153
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN-THVSTRVMGTFGYLAPEYASSGKL 525
HRD+K NIL+ + DFG+A TTD T + +GT Y+APE S
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSESHA 212
Query: 526 TEKSDVFSFGVMLLELITGRRP 547
T ++D+++ +L E +TG P
Sbjct: 213 TYRADIYALTCVLYECLTGSPP 234
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-37
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 17/204 (8%)
Query: 354 LGQGGFGYVHKGVLPNGKE-----VAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVSL 407
LG G FG V+KG+ E VA+K LR + E E +++ V + H+ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR 467
+G C+ L+ + +P L ++ + + + L + AKG+ YL + R
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGT---FGYLAPEYASSGK 524
++HRD+ + N+L+ K+ DFGLAKL G ++A E
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALESILHRI 195
Query: 525 LTEKSDVFSFGVMLLELIT-GRRP 547
T +SDV+S+GV + EL+T G +P
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 69/294 (23%), Positives = 112/294 (38%), Gaps = 57/294 (19%)
Query: 354 LGQGGFGYVHKGVLPNGKE----VAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSL 407
LG+G FG V +G L VAVK+++ S + EF +E + H +++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 408 VGYC-----IAGGKRLLVYEYVPNNNL-EF---HLHGKGRPVMDWPTRLKIAMGSAKGLA 458
+G C K +++ ++ +L + G + T LK + A G+
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 459 YLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYL--- 515
YL +HRD+ + N +L VADFGL+K + + G +
Sbjct: 162 YLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQ----GRIAKMPVK 214
Query: 516 --APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP---IDPTGAMEDCLVDWARPLCLRA 569
A E + T KSDV++FGV + E+ T G P + +
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD-------------Y 261
Query: 570 LDDGNFNEIADPYLEK--NYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
L G+ L++ + E M +C R RP S + LE
Sbjct: 262 LLHGH-------RLKQPEDCLDELYEIMYSCW----RTDPLDRPTFSVLRLQLE 304
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 63/219 (28%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 354 LGQGGFGYVHKGVLPNGKE------VAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSL 407
LG+G FG V N VAVK+L+ S ++F+ E E+++ + H+H+V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTR-------------LKIAMGSA 454
G C G L+V+EY+ + +L L G L +A A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGY 514
G+ YL +HRD+ + N L+ K+ DFG+++ + R +G
Sbjct: 169 AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YR-VGGRTM 221
Query: 515 L-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
L PE K T +SDV+SFGV+L E+ T G++P
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 62/210 (29%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 352 NLLGQGGFGYVHKGV-LPNGKEVAVKSLR----SGSGQGEREFKAEVEIISRVHHRHLVS 406
LG+G FG V+ + +A+K L +G + + EVEI S + H +++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILR 73
Query: 407 LVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCH 465
L GY R+ L+ EY P + L + D A L+Y H
Sbjct: 74 LYGY-FHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSK-- 128
Query: 466 PRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKL 525
R+IHRDIK N+LL E K+ADFG + + + GT YL PE
Sbjct: 129 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPPEMIEGRMH 184
Query: 526 TEKSDVFSFGVMLLELITGRRPIDPTGAME 555
EK D++S GV+ E + G+ P + E
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 75/292 (25%), Positives = 119/292 (40%), Gaps = 53/292 (18%)
Query: 354 LGQGGFGYVHKGVLPNGK------EVAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVS 406
LG G FG V++G + +VAVK+L + + +F E IIS+ +H+++V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRL------KIAMGSAKGLAYL 460
+G + R ++ E + +L+ L + RP P+ L +A A G YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 461 HEDCHPRIIHRDIKSSNILLDYTFET---KVADFGLAKLTTDNNTHVSTRVMGTFGYL-- 515
E+ IHRDI + N LL K+ DFG+A+ + + G L
Sbjct: 157 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY----RKGGCAMLPV 209
Query: 516 ---APEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALD 571
PE G T K+D +SFGV+L E+ + G P + + V L +
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY---PSKSNQEV-------LEFVT 259
Query: 572 DGNFNEIADPYLEK--NYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
G ++ N P M C +H RP + I+ +E
Sbjct: 260 SGG-------RMDPPKNCPGPVYRIMTQCW----QHQPEDRPNFAIILERIE 300
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 65/284 (22%), Positives = 116/284 (40%), Gaps = 50/284 (17%)
Query: 352 NLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGY 410
L+G GGFG V K +GK +K ++ + + EV+ ++++ H ++V G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 411 ---------------CIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSA 454
+ K L + E+ LE + + +D L++
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGY 514
KG+ Y+H ++I+RD+K SNI L T + K+ DFGL ++ TR GT Y
Sbjct: 133 KGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSKGTLRY 187
Query: 515 LAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGN 574
++PE SS ++ D+++ G++L EL+ A E
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFE---------------TSKF 227
Query: 575 FNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618
F ++ D + + +E + + RP S+I+R
Sbjct: 228 FTDLRDGIISDIFDKKEKTLLQKL----LSKKPEDRPNTSEILR 267
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 67/295 (22%), Positives = 110/295 (37%), Gaps = 58/295 (19%)
Query: 354 LGQGGFGYVHKGVLPNGKE----VAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSL 407
LG+G FG V + L VAVK L++ + EF E + H H+ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 408 VGYCIAGGKR------LLVYEYVPNNNL-EF---HLHGKGRPVMDWPTRLKIAMGSAKGL 457
VG + + +++ ++ + +L F G+ + T ++ + A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 458 AYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYL-- 515
YL IHRD+ + N +L VADFGL++ + + G L
Sbjct: 151 EYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ----GCASKLPV 203
Query: 516 ---APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP---IDPTGAMEDCLVDWARPLCLR 568
A E + T SDV++FGV + E++T G+ P I+
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN------------- 250
Query: 569 ALDDGNFNEIADPYLEK--NYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
L GN L++ E M C ++RP + + LE
Sbjct: 251 YLIGGN-------RLKQPPECMEEVYDLMYQCW----SADPKQRPSFTCLRMELE 294
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 63/297 (21%), Positives = 114/297 (38%), Gaps = 57/297 (19%)
Query: 354 LGQGGFGYVHKGVLPNGKE------VAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVS 406
LG+ FG V+KG L VA+K+L+ + R EF+ E + +R+ H ++V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTR--------------LKIAMG 452
L+G +++ Y + +L L + T + +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 453 SAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTF 512
A G+ YL ++H+D+ + N+L+ K++D GL + + + +
Sbjct: 137 IAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY----KLLGN 189
Query: 513 GYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLC 566
L APE GK + SD++S+GV+L E+ + G +P + +D
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY-CGYSNQD---------V 239
Query: 567 LRALDDGNFNEIADPYLEK--NYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
+ + + L + P A M+ C RRP+ I L
Sbjct: 240 VEMIRNRQ-------VLPCPDDCPAWVYALMIECW----NEFPSRRPRFKDIHSRLR 285
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-35
Identities = 75/292 (25%), Positives = 118/292 (40%), Gaps = 53/292 (18%)
Query: 354 LGQGGFGYVHKGVLPNGK------EVAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVS 406
LG G FG V++G + +VAVK+L + + +F E IIS+ +H+++V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRL------KIAMGSAKGLAYL 460
+G + R ++ E + +L+ L + RP P+ L +A A G YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 461 HEDCHPRIIHRDIKSSNILLDYTFET---KVADFGLAKLTTDNNTHVSTRVMGTFGYL-- 515
E+ IHRDI + N LL K+ DFG+A+ + G L
Sbjct: 198 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY----RKGGCAMLPV 250
Query: 516 ---APEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALD 571
PE G T K+D +SFGV+L E+ + G P + + V L +
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY---PSKSNQEV-------LEFVT 300
Query: 572 DGNFNEIADPYLEK--NYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
G ++ N P M C +H RP + I+ +E
Sbjct: 301 SGG-------RMDPPKNCPGPVYRIMTQCW----QHQPEDRPNFAIILERIE 341
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 57/244 (23%), Positives = 102/244 (41%), Gaps = 17/244 (6%)
Query: 310 NSSSGPYGPVLPPPPPIVALGFSQSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGV-LP 368
S G GP +P P Q A + F +G+G F V++ L
Sbjct: 3 EQSQGMQGPPVPQFQP-------QKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLL 55
Query: 369 NGKEVAVK--SLRSGSGQGEREF-KAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVP 425
+G VA+K + R E++++ +++H +++ I + +V E
Sbjct: 56 DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 115
Query: 426 NNNLEFHL--HGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYT 483
+L + K + ++ T K + L ++H R++HRDIK +N+ + T
Sbjct: 116 AGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITAT 172
Query: 484 FETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 543
K+ D GL + + T + V GT Y++PE KSD++S G +L E+
Sbjct: 173 GVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 231
Query: 544 GRRP 547
+ P
Sbjct: 232 LQSP 235
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-35
Identities = 69/197 (35%), Positives = 99/197 (50%), Gaps = 6/197 (3%)
Query: 352 NLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
LGQG FG V G VA+K+L+ G+ E F E +++ ++ H LV L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHR 471
+V EY+ +L L G+ + P + +A A G+AY+ +HR
Sbjct: 332 SEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 387
Query: 472 DIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 531
D++++NIL+ KVADFGLA+L DN + APE A G+ T KSDV
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 532 FSFGVMLLELIT-GRRP 547
+SFG++L EL T GR P
Sbjct: 448 WSFGILLTELTTKGRVP 464
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 14/78 (17%), Positives = 22/78 (28%)
Query: 20 PPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQ 79
S R S P + + P+S PS P S +P + P +
Sbjct: 9 DASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNS 68
Query: 80 SPPQSPPPPNSKSPPQSS 97
S + P +
Sbjct: 69 SDTVTSPQRAGPLAGGVT 86
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 16/86 (18%), Positives = 24/86 (27%), Gaps = 1/86 (1%)
Query: 24 SRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQ 83
S S S P + S PS P + PS+ + + P+
Sbjct: 2 SNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPK 61
Query: 84 SPPPPNSKSPPQSSPPPNTNPPPQSS 109
NS S +SP +
Sbjct: 62 LFGGFNS-SDTVTSPQRAGPLAGGVT 86
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 15/81 (18%), Positives = 26/81 (32%), Gaps = 1/81 (1%)
Query: 40 SPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPP 99
P +S S P + + P S PS P + S + + P+
Sbjct: 6 KPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGG 65
Query: 100 PNTNPPPQSSPPPSNSNASPP 120
N++ +SP + A
Sbjct: 66 FNSSDTV-TSPQRAGPLAGGV 85
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 14/71 (19%), Positives = 20/71 (28%), Gaps = 4/71 (5%)
Query: 11 SNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSS----PPPSSPPPDRSPPPSSPPPSP 66
S P +S PS P S + S P + P S SP
Sbjct: 16 SLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSP 75
Query: 67 ESPPPSSPPPS 77
+ P + +
Sbjct: 76 QRAGPLAGGVT 86
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 15/71 (21%), Positives = 26/71 (36%), Gaps = 1/71 (1%)
Query: 72 SSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPP-PQSSPPPSNSNASPPPSQDNPSDPP 130
S P +SQ P N + P + P P S+ +A+ P+ P
Sbjct: 5 SKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFG 64
Query: 131 PGDSNNGSSPP 141
+S++ + P
Sbjct: 65 GFNSSDTVTSP 75
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 8/81 (9%), Positives = 18/81 (22%)
Query: 60 SSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASP 119
S P + + P + P + +S + P +P +
Sbjct: 5 SKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFG 64
Query: 120 PPSQDNPSDPPPGDSNNGSSP 140
+ + P
Sbjct: 65 GFNSSDTVTSPQRAGPLAGGV 85
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 142 bits (358), Expect = 2e-35
Identities = 69/218 (31%), Positives = 98/218 (44%), Gaps = 17/218 (7%)
Query: 345 TGGFSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE-FKAEVEIISRVHHR 402
G + LG GGFGYV + + G++VA+K R RE + E++I+ +++H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 403 HLVSLV------GYCIAGGKRLLVYEYVPNNNLEFHLHGKGRP-VMDWPTRLKIAMGSAK 455
++VS LL EY +L +L+ + + +
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 456 GLAYLHEDCHPRIIHRDIKSSNILLDYTFET---KVADFGLAKLTTDNNTHVSTRVMGTF 512
L YLHE+ RIIHRD+K NI+L + K+ D G AK D + V GT
Sbjct: 133 ALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK-ELDQGELCTEFV-GTL 187
Query: 513 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDP 550
YLAPE K T D +SFG + E ITG RP P
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 65/301 (21%), Positives = 117/301 (38%), Gaps = 59/301 (19%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVS 406
F + +LGQG FG V K + + A+K +R + +EV +++ ++H+++V
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66
Query: 407 L------------VGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGS 453
+ L + EY N L +H + ++
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN-QQRDEYWRLFRQI 125
Query: 454 AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKL--------------TTD 499
+ L+Y+H IIHRD+K NI +D + K+ DFGLAK
Sbjct: 126 LEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 500 NNTHVSTRVMGTFGYLAPE-YASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCL 558
++ ++++ + GT Y+A E +G EK D++S G++ E+I + ME
Sbjct: 183 SSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-----FSTGMERVN 236
Query: 559 VDWARPLCLRALDDGNFNEIADPYLEKNYPTEE---MARMVACAAASIRHSARRRPKISQ 615
+ L+ L + P + N E + + I H +RP
Sbjct: 237 I-------LKKLRSVSIEF--PPDFDDNKMKVEKKIIRLL-------IDHDPNKRPGART 280
Query: 616 I 616
+
Sbjct: 281 L 281
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 65/294 (22%), Positives = 108/294 (36%), Gaps = 54/294 (18%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLR-SGSGQGEREFKAEVEIISRVHHRHLVSLVGY 410
LG+GGFG V + + A+K +R + EV+ ++++ H +V
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 411 CI---------AGGKRLLVY---EYVPNNNL-EFHLHGKGRPVMDWPTRLKIAMGSAKGL 457
+ ++ +Y + NL ++ + L I + A+ +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 458 AYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK-----------LTTDNNTHVST 506
+LH ++HRD+K SNI KV DFGL LT T
Sbjct: 132 EFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 507 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLC 566
+GT Y++PE + K D+FS G++L EL+ P + ME R
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---P--FSTQME-------RVRT 236
Query: 567 LRALDDGNFNEIADPYLEKNYPTEEM--ARMVACAAASIRHSARRRPKISQIVR 618
L + + F + YP E + M + S RP+ I+
Sbjct: 237 LTDVRNLKFPPLFTQK----YPCEYVMVQDM-------LSPSPMERPEAINIIE 279
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-35
Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 33/222 (14%)
Query: 352 NLLGQGGFGYVHKGVL------PNGKEVAVKSLRSGSGQGER-EFKAEVEIISRV-HHRH 403
LG G FG V + +VAVK L+S + E+ +E++I+S + H +
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 404 LVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTR------------LKIAM 451
+V+L+G C GG L++ EY +L L K R + P L +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 452 GSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGT 511
A+G+A+L IHRD+ + N+LL K+ DFGLA+ +++ ++
Sbjct: 172 QVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK----G 224
Query: 512 FGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
L APE T +SDV+S+G++L E+ + G P
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 53/225 (23%), Positives = 88/225 (39%), Gaps = 21/225 (9%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
LG+GGF YV L +G A+K + Q E + E ++ +H +++ LV YC
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 412 I----AGGKRLLVYEYVPNNNLEFHL--HGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCH 465
+ A + L+ + L + + L + +G +GL +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 466 PRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM--------GTFGYLAP 517
HRD+K +NILL + + D G + + T Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 518 E---YASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLV 559
E S + E++DV+S G +L ++ G P D D +
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 7/198 (3%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLR-SGSGQGEREF-KAEVEIISRVHHRHLVSLVG 409
+G+G FG +G++ +K + S ERE + EV +++ + H ++V
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 410 YCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRII 469
G +V +Y +L ++ + + L + L ++H+ +I+
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKIL 147
Query: 470 HRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKS 529
HRDIKS NI L ++ DFG+A++ + GT YL+PE + KS
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPYNNKS 206
Query: 530 DVFSFGVMLLELITGRRP 547
D+++ G +L EL T +
Sbjct: 207 DIWALGCVLYELCTLKHA 224
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 62/209 (29%), Positives = 90/209 (43%), Gaps = 16/209 (7%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLR----SGSGQGEREFKAEVEIISRVHHRHLVSL 407
LG+G FG V+ N +A+K L G + + E+EI S + H +++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLRHPNILRM 79
Query: 408 VGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHP 466
Y KR+ L+ E+ P L L GR + + + A L Y HE
Sbjct: 80 YNY-FHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATFMEE-LADALHYCHER--- 133
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLT 526
++IHRDIK N+L+ Y E K+ADFG + GT YL PE
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYLPPEMIEGKTHD 190
Query: 527 EKSDVFSFGVMLLELITGRRPIDPTGAME 555
EK D++ GV+ E + G P D E
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 35/221 (15%)
Query: 352 NLLGQGGFGYVHKGVLPNGKE---VAVKSLRSGSGQGER-EFKAEVEIISRV-HHRHLVS 406
+++G+G FG V K + A+K ++ + + + +F E+E++ ++ HH ++++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTR--------------LKIAMG 452
L+G C G L EY P+ NL L D L A
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 453 SAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTF 512
A+G+ YL + + IHRD+ + NIL+ + K+ADFGL++ +V T
Sbjct: 151 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK----TM 200
Query: 513 GYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
G L A E + T SDV+S+GV+L E+++ G P
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 15/210 (7%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVK----SLRSGSGQGEREFKAEVEIISRVHHRHLVSL 407
LLG+G F V++ + G EVA+K +G +R + EV+I ++ H ++ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILEL 76
Query: 408 VGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHP 466
Y + LV E N + +L + +P + R + G+ YLH
Sbjct: 77 YNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ-IITGMLYLHSH--- 131
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLA-KLTTDNNTHVSTRVMGTFGYLAPEYASSGKL 525
I+HRD+ SN+LL K+ADFGLA +L + H T + GT Y++PE A+
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-YT-LCGTPNYISPEIATRSAH 189
Query: 526 TEKSDVFSFGVMLLELITGRRPIDPTGAME 555
+SDV+S G M L+ GR P D
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDTDTVKN 219
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 13/211 (6%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
+LG+G +G V+ G L N +A+K + + + E+ + + H+++V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSA-KGLAYLHEDCHPRIIH 470
G + E VP +L L K P+ D + +GL YLH++ +I+H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 471 RDIKSSNILLD-YTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE--YASSGKLTE 527
RDIK N+L++ Y+ K++DFG +K N T GT Y+APE +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYGK 204
Query: 528 KSDVFSFGVMLLELITGRRP----IDPTGAM 554
+D++S G ++E+ TG+ P +P AM
Sbjct: 205 AADIWSLGCTIIEMATGKPPFYELGEPQAAM 235
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 10/204 (4%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLR-SGSGQGEREF-KAEVEIISRVHHRHLVSLVG 409
+G G +G K +GK + K L + E++ +EV ++ + H ++V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 410 -YCIAGGKRL-LVYEYVPNNNLEFHL--HGKGRPVMDWPTRLKIAMGSAKGLAYLHE--D 463
L +V EY +L + K R +D L++ L H D
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 464 CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSG 523
++HRD+K +N+ LD K+ DFGLA++ + + T V GT Y++PE +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRM 191
Query: 524 KLTEKSDVFSFGVMLLELITGRRP 547
EKSD++S G +L EL P
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPP 215
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 48/221 (21%), Positives = 89/221 (40%), Gaps = 35/221 (15%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSL-----------------RSGSGQGEREFKAEVEII 396
L QG F + + K A+K + +FK E++II
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 397 SRVHHRHLVSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGS-- 453
+ + + + ++ G I + ++YEY+ N+++ ++ + I +
Sbjct: 98 TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 454 ----AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM 509
+Y+H I HRD+K SNIL+D K++DFG ++ D S
Sbjct: 157 IKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---R 211
Query: 510 GTFGYLAPEYASSGKLT---EKSDVFSFGVMLLELITGRRP 547
GT+ ++ PE S + + K D++S G+ L + P
Sbjct: 212 GTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 56/230 (24%), Positives = 96/230 (41%), Gaps = 44/230 (19%)
Query: 354 LGQGGFGYVHKGVLPNGKE------VAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVS 406
+G+G FG V + P VAVK L+ + + +F+ E +++ + ++V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTR-------------------- 446
L+G C G L++EY+ +L L P
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSM-SPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 447 ---LKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503
L IA A G+AYL E + +HRD+ + N L+ K+ADFGL++ + +
Sbjct: 174 AEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 504 VSTRVMGTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
+ PE + T +SDV+++GV+L E+ + G +P
Sbjct: 231 ----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 23/212 (10%)
Query: 352 NLLGQGGFGYVHKGVLPNGKEVAVK--SLRSGSGQGEREFKAEVEIISRV--HHRHLVSL 407
+G GG V + + + A+K +L Q ++ E+ ++++ H ++ L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR 467
Y I +V E N +L L K +D R + + +H+
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQH---G 147
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTR-VMGTFGYLAPE-------- 518
I+H D+K +N L+ K+ DFG+A + T V +GT Y+ PE
Sbjct: 148 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 519 ---YASSGKLTEKSDVFSFGVMLLELITGRRP 547
S K++ KSDV+S G +L + G+ P
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 61/229 (26%), Positives = 102/229 (44%), Gaps = 42/229 (18%)
Query: 354 LGQGGFGYVHKGVLPNGKE------VAVKSLRSGSGQGER-EFKAEVEIISRVHHRHLVS 406
LG+G FG V K + K VAVK L+ + E + +E ++ +V+H H++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 407 LVGYCIAGGKRLLVYEYVPNNNL----------------------EFHLHGKGRPVMDWP 444
L G C G LL+ EY +L L +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 445 TRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504
+ A ++G+ YL E +++HRD+ + NIL+ + K++DFGL++ + +++V
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 505 STRVMGTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
+ G + A E T +SDV+SFGV+L E++T G P
Sbjct: 208 K----RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 52/226 (23%), Positives = 88/226 (38%), Gaps = 22/226 (9%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE-FKAEVEIISRVHHRHLV 405
+ S++LGQG V +G G A+K + S + E E++ +++H+++V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 406 SLVGYCIAGGKRL--LVYEYVPNNNLEFHLHGKGRPV-MDWPTRLKIAMGSAKGLAYLHE 462
L R L+ E+ P +L L + L + G+ +L E
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 463 DCHPRIIHRDIKSSNILLDYTFET----KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE 518
+ I+HR+IK NI+ + K+ DFG A+ +++ + GT YL P+
Sbjct: 131 N---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-ELEDDEQFVSLY-GTEEYLHPD 185
Query: 519 --------YASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMED 556
K D++S GV TG P P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 37/224 (16%)
Query: 354 LGQGGFGYVHKGVLPNGKE--------VAVKSLRSGSGQGER-EFKAEVEIISRV-HHRH 403
LG+G FG V + VAVK L+ + + + + +E+E++ + H++
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 404 LVSLVGYCIAGGKRLLVYEYVPNNNL--------------EFHLHGKGRPVMDWPTRLKI 449
+++L+G C G ++ EY NL + ++ M + +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 450 AMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM 509
A+G+ YL + IHRD+ + N+L+ K+ADFGLA+ + + +
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK---- 215
Query: 510 GTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
T G L APE T +SDV+SFGV++ E+ T G P
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 37/224 (16%)
Query: 354 LGQGGFGYVHKGVLPNGKE------VAVKSLRSGSGQGER-EFKAEVEIISRV-HHRHLV 405
LG G FG V + + VAVK L+ + ER +E++++S + +H ++V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 406 SLVGYCIAGGKRLLVYEYVPNNNL----------------EFHLHGKGRPVMDWPTRLKI 449
+L+G C GG L++ EY +L + +D L
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 450 AMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM 509
+ AKG+A+L IHRD+ + NILL + TK+ DFGLA+ +++ +V
Sbjct: 151 SYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK--- 204
Query: 510 GTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
L APE + T +SDV+S+G+ L EL + G P
Sbjct: 205 -GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 23/216 (10%)
Query: 348 FSQSNLLGQGGFGYVHKGVLPNGKEVAVK--SLRSGSGQGEREFKAEVEIISRV--HHRH 403
+S +G GG V + + + A+K +L Q ++ E+ ++++ H
Sbjct: 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 404 LVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHED 463
++ L Y I +V E N +L L K +D R + + +H+
Sbjct: 71 IIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQH 127
Query: 464 CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTR-VMGTFGYLAPE---- 518
I+H D+K +N L+ K+ DFG+A + T V +GT Y+ PE
Sbjct: 128 ---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 519 -------YASSGKLTEKSDVFSFGVMLLELITGRRP 547
S K++ KSDV+S G +L + G+ P
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-33
Identities = 56/277 (20%), Positives = 98/277 (35%), Gaps = 43/277 (15%)
Query: 353 LLGQGGFGYVHKGV--LPNGKEVAVKSLRSGSGQGERE-FKAEVEIISRVHHRHLVSLVG 409
+ GG G+++ + NG+ V +K L + AE + ++ V H +V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 410 YCIAGGKRL-----LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC 464
+ + +V EYV +L+ K + + + L+YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLHSI- 201
Query: 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGK 524
+++ D+K NI+L + K+ D G + GT G+ APE
Sbjct: 202 --GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY-----LYGTPGFQAPEIVR-TG 252
Query: 525 LTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARP---------LCLRALDDGNF 575
T +D+++ G L L G D L + L RA+D
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPT--RNGRYVDGLPEDDPVLKTYDSYGRLLRRAID---- 306
Query: 576 NEIADPYLEKNYPT-EEMARMVACAAASIRHSARRRP 611
DP + + T EEM+ + + P
Sbjct: 307 ---PDP--RQRFTTAEEMSAQLTGVLREVVAQDTGVP 338
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 42/229 (18%)
Query: 354 LGQGGFGYVHKGVLPNGKE------VAVKSLRSGSGQGER-EFKAEVEIISRV-HHRHLV 405
LG G FG V + VAVK L+ + ER +E+++++++ H ++V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 406 SLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTR------------------- 446
+L+G C G L++EY +L +L K +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 447 --LKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504
L A AKG+ +L +HRD+ + N+L+ + K+ DFGLA+ ++ +V
Sbjct: 173 DLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 505 STRVMGTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
L APE G T KSDV+S+G++L E+ + G P
Sbjct: 230 VR----GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-33
Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 37/224 (16%)
Query: 354 LGQGGFGYVHKGVLPNGKE--------VAVKSLRSGSGQGER-EFKAEVEIISRV-HHRH 403
LG+G FG V + VAVK L+ + + + + +E+E++ + H++
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 404 LVSLVGYCIAGGKRLLVYEYVPNNNL--------------EFHLHGKGRPVMDWPTRLKI 449
+++L+G C G ++ EY NL + ++ M + +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 450 AMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM 509
A+G+ YL + IHRD+ + N+L+ K+ADFGLA+ + + +
Sbjct: 209 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK---- 261
Query: 510 GTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
T G L APE T +SDV+SFGV++ E+ T G P
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-33
Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 36/223 (16%)
Query: 354 LGQGGFGYVHKGVLPNGKE------VAVKSLRSGSGQGER-EFKAEVEIISRV-HHRHLV 405
LG+G FG V + + VAVK L+ G+ E +E++I+ + HH ++V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 406 SLVGYC-IAGGKRLLVYEYVPNNNL--------------EFHLHGKGRPVMDWPTRLKIA 450
+L+G C GG +++ E+ NL + + + + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 451 MGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMG 510
AKG+ +L + IHRD+ + NILL K+ DFGLA+ + +V
Sbjct: 155 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK---- 207
Query: 511 TFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
L APE T +SDV+SFGV+L E+ + G P
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-32
Identities = 56/260 (21%), Positives = 100/260 (38%), Gaps = 23/260 (8%)
Query: 304 SSDMSHNSSSGPYGPVLPPPPPIVALGFSQSAFTYEELSAATGGFSQSNLLGQGGFGYVH 363
S M +++ + P S+ E +S +S +G GG V
Sbjct: 14 GSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVF 73
Query: 364 KGVLPNGKEVAVK--SLRSGSGQGEREFKAEVEIISRVHH--RHLVSLVGYCIAGGKRLL 419
+ + + A+K +L Q ++ E+ ++++ ++ L Y I +
Sbjct: 74 QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133
Query: 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNIL 479
V E N +L L K +D R + + +H+ I+H D+K +N L
Sbjct: 134 VMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFL 187
Query: 480 LDYTFETKVADFGLAKLTTDNNTHVSTR-VMGTFGYLAPE-----------YASSGKLTE 527
+ K+ DFG+A + T V +G Y+ PE S K++
Sbjct: 188 IV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISP 246
Query: 528 KSDVFSFGVMLLELITGRRP 547
KSDV+S G +L + G+ P
Sbjct: 247 KSDVWSLGCILYYMTYGKTP 266
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 52/226 (23%), Positives = 88/226 (38%), Gaps = 22/226 (9%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE-FKAEVEIISRVHHRHLV 405
+ S++LGQG V +G G A+K + S + E E++ +++H+++V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 406 SLVGYCIAGGKRL--LVYEYVPNNNLEFHLHGKGRPV-MDWPTRLKIAMGSAKGLAYLHE 462
L R L+ E+ P +L L + L + G+ +L E
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 463 DCHPRIIHRDIKSSNILLDYTFET----KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE 518
+ I+HR+IK NI+ + K+ DFG A+ +++ + GT YL P+
Sbjct: 131 N---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-ELEDDEQFVSLY-GTEEYLHPD 185
Query: 519 --------YASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMED 556
K D++S GV TG P P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 37/224 (16%)
Query: 354 LGQGGFGYVHKGVLPNGK--------EVAVKSLRSGSGQGER-EFKAEVEIISRV-HHRH 403
LG+G FG V +VAVK L+S + + + + +E+E++ + H++
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 404 LVSLVGYCIAGGKRLLVYEYVPNNNL--------------EFHLHGKGRPVMDWPTRLKI 449
+++L+G C G ++ EY NL ++ + +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 450 AMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM 509
A A+G+ YL + IHRD+ + N+L+ K+ADFGLA+ + +
Sbjct: 197 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK---- 249
Query: 510 GTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
T G L APE T +SDV+SFGV+L E+ T G P
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 59/205 (28%), Positives = 83/205 (40%), Gaps = 14/205 (6%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVK-SLRSGSGQGERE-FKAEVEIISRV-HHRH 403
F + + LG G +G V K +G+ AVK S+ G +R AEV +V H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 404 LVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHED 463
V L GG L E +L+ H G + + + LA+LH
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPE-AQVWGYLRDTLLALAHLHSQ 176
Query: 464 CHPRIIHRDIKSSNILLDYTFETKVADFGLAK-LTTDNNTHVSTRVMGTFGYLAPEYASS 522
++H D+K +NI L K+ DFGL L T V G Y+APE
Sbjct: 177 ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAPE-LLQ 229
Query: 523 GKLTEKSDVFSFGVMLLELITGRRP 547
G +DVFS G+ +LE+
Sbjct: 230 GSYGTAADVFSLGLTILEVACNMEL 254
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVK----SLRSGSGQGEREFKAEVEIISRVHHRHLVSL 407
LG+GGF + + A K SL Q E+ E+ I + H+H+V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 80
Query: 408 VGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHP 466
G+ + +V E +L LH + + + + R G YLH +
Sbjct: 81 HGF-FEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN--- 134
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLA-KLTTDNNTHVSTRVM-GTFGYLAPEYASSGK 524
R+IHRD+K N+ L+ E K+ DFGLA K+ D +V+ GT Y+APE S
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLSKKG 191
Query: 525 LTEKSDVFSFGVMLLELITGRRPIDPTGAME 555
+ + DV+S G ++ L+ G+ P + + E
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 222
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 64/274 (23%), Positives = 111/274 (40%), Gaps = 35/274 (12%)
Query: 290 PTPPPSQRGAVTVTSSDMSHNSSSGPYGPVLPPPPPIVALGFSQSAFTYEELSAATGGFS 349
P P + V ++ + ++ P P ++ S+ +
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAA-----PPAKEIPEVLVDPRSR------------RRYV 44
Query: 350 QSNLLGQGGFGYVHKGV-LPNGKEVAVKSLR----SGSGQGEREFKAEVEIISRVHHRHL 404
+ LG+GGF + + A K + Q E+ E+ I + H+H+
Sbjct: 45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHV 103
Query: 405 VSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHED 463
V G+ + +V E +L LH + + + + R G YLH +
Sbjct: 104 VGFHGF-FEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN 160
Query: 464 CHPRIIHRDIKSSNILLDYTFETKVADFGLA-KLTTDNNTHVSTRVM-GTFGYLAPEYAS 521
R+IHRD+K N+ L+ E K+ DFGLA K+ D +V+ GT Y+APE S
Sbjct: 161 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLS 214
Query: 522 SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAME 555
+ + DV+S G ++ L+ G+ P + + E
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 248
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-31
Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 13/207 (6%)
Query: 354 LGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREF-KAEVEIISRVHHRHLVSLVGYC 411
LG G G V K P+G +A K + R E++++ + ++V G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHR 471
+ G+ + E++ +L+ L GR + K+++ KGL YL E I+HR
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHK--IMHR 156
Query: 472 DIKSSNILLDYTFETKVADFGLAKLTTDN--NTHVSTRVMGTFGYLAPEYASSGKLTEKS 529
D+K SNIL++ E K+ DFG++ D+ N+ V GT Y++PE + +S
Sbjct: 157 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQGTHYSVQS 211
Query: 530 DVFSFGVMLLELITGRRPIDPTGAMED 556
D++S G+ L+E+ GR PI P A E
Sbjct: 212 DIWSMGLSLVEMAVGRYPIPPPDAKEL 238
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 51/216 (23%), Positives = 83/216 (38%), Gaps = 19/216 (8%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVS 406
+ +G+G FG VH+ G + AVK +R + E E+ + + +V
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVP 114
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHP 466
L G G + E + +L + G + L + +GL YLH
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTR--- 169
Query: 467 RIIHRDIKSSNILLDYT-FETKVADFGLAKLTTDNNTHVSTR----VMGTFGYLAPEYAS 521
RI+H D+K+ N+LL + DFG A + S + GT ++APE
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 522 SGKLTEKSDVFSFGVMLLELITGRRP---IDPTGAM 554
K D++S M+L ++ G P
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC 265
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 4e-30
Identities = 55/226 (24%), Positives = 95/226 (42%), Gaps = 25/226 (11%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGY 410
+L +GGF +V++ + +G+E A+K L S + R EV + ++ H ++V
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 411 CIAGGKR--------LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHE 462
G + LL+ E +EF + R + T LKI + + + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 463 DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM-----------GT 511
P IIHRD+K N+LL K+ DFG A + + + T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 512 FGYLAPE---YASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAM 554
Y PE S+ + EK D+++ G +L L + P + +
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 15/215 (6%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE-FKAEVEIISR-VHHRHLVSLVGY 410
+G+G +G V+K V P+G+ +AVK +RS + E++ +++++ R ++V G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 411 CIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRL--KIAMGSAKGLAYLHEDCHPRI 468
G + E + + +F+ + P + KI + + K L +L E+ I
Sbjct: 90 LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--I 147
Query: 469 IHRDIKSSNILLDYTFETKVADFGL-AKLTTDNNTHVSTRVMGTFGYLAPE----YASSG 523
IHRDIK SNILLD + K+ DFG+ +L ++ TR G Y+APE AS
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMAPERIDPSASRQ 204
Query: 524 KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCL 558
+SDV+S G+ L EL TGR P ++ D L
Sbjct: 205 GYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL 239
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 42/232 (18%), Positives = 72/232 (31%), Gaps = 46/232 (19%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVK--SLRSGSGQGEREFKAEVEIISRV-HHRH 403
F + +G G FG V K V +G A+K E+ EV + + H H
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 404 LVSLVGYCIAGGKRLLVYEYVPNNNLEFHL--HGKGRPVMDWPTRLKIAMGSAKGLAYLH 461
+V L+ EY +L + + + + + +GL Y+H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 462 EDCHPRIIHRDIKSSNILLD-------------------YTFETKVADFGLAKLTTDNNT 502
++H DIK SNI + K+ D G +
Sbjct: 133 SM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189
Query: 503 HVSTRVMGTFGYLAPE-------YASSGKLTEKSDVFSFGVMLLELITGRRP 547
G +LA E + K+D+F+ + ++
Sbjct: 190 EE-----GDSRFLANEVLQENYTH------LPKADIFALALTVVCAAGAEPL 230
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE-FKAEVEIISR-VHHRHLVSLVGY 410
LG+G +G V K +P+G+ +AVK +R+ E++ +++I R V V+ G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 411 CIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRL------KIAMGSAKGLAYLHEDC 464
G + E ++ L + V+D + KIA+ K L +LH
Sbjct: 75 LFREGDVWICMEL-----MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 465 HPRIIHRDIKSSNILLDYTFETKVADFGL-AKLTTDNNTHVSTRVMGTFGYLAPE----Y 519
+IHRD+K SN+L++ + K+ DFG+ L + G Y+APE
Sbjct: 130 S--VIHRDVKPSNVLINALGQVKMCDFGISGYLV---DDVAKDIDAGCKPYMAPERINPE 184
Query: 520 ASSGKLTEKSDVFSFGVMLLELITGRRPIDP 550
+ + KSD++S G+ ++EL R P D
Sbjct: 185 LNQKGYSVKSDIWSLGITMIELAILRFPYDS 215
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 59/251 (23%), Positives = 98/251 (39%), Gaps = 27/251 (10%)
Query: 309 HNSSSGPYGPVLPPPPPIVALGFSQSAFTYEELSAA---TGGFSQSNLLGQGGFGYVHKG 365
H+ SSG + Q + +G+G G V
Sbjct: 5 HHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLA 64
Query: 366 V-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424
+G++VAVK + Q EV I+ H ++V + + G + ++ E++
Sbjct: 65 REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124
Query: 425 PNNNLEFHLHGKGRPVMD--WPTRLK------IAMGSAKGLAYLHEDCHPRIIHRDIKSS 476
G + D RL + + LAYLH +IHRDIKS
Sbjct: 125 Q-----------GGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSD 170
Query: 477 NILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV 536
+ILL K++DFG + + + V GT ++APE S + D++S G+
Sbjct: 171 SILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVDIWSLGI 229
Query: 537 MLLELITGRRP 547
M++E++ G P
Sbjct: 230 MVIEMVDGEPP 240
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 51/251 (20%), Positives = 85/251 (33%), Gaps = 40/251 (15%)
Query: 382 SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNL-EFHLHGKGRPV 440
S ++ + ++ V + + + NL ++
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 441 MDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK----- 495
+ L I + A+ + +LH ++HRD+K SNI KV DFGL
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 496 ------LTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPID 549
LT T +GT Y++PE + K D+FS G++L EL+
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST-- 275
Query: 550 PTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEM--ARMVACAAASIRHSA 607
ME R + + + F + YP E M M + S
Sbjct: 276 ---QME-------RVRIITDVRNLKFPLLFTQK----YPQEHMMVQDM-------LSPSP 314
Query: 608 RRRPKISQIVR 618
RP+ + I+
Sbjct: 315 TERPEATDIIE 325
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-28
Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 28/207 (13%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSL--RSGSGQGEREFKAEVEIISRVHHRHLVSLVGY 410
LG G +G V E A+K + S S + EV ++ + H +++ L +
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 411 CIAGGKRLLVYEYVPNNNLEFHLHGKGR-------PVMDWPTRLKIAMGSAKGLAYLHED 463
LV E L + + + ++ ++ G+ YLH+
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVII-----KQVL----SGVTYLHKH 155
Query: 464 CHPRIIHRDIKSSNILLDYTFET---KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYA 520
I+HRD+K N+LL+ + K+ DFGL+ + + +GT Y+APE
Sbjct: 156 ---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYIAPE-V 209
Query: 521 SSGKLTEKSDVFSFGVMLLELITGRRP 547
K EK DV+S GV+L L+ G P
Sbjct: 210 LRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 24/218 (11%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE-FKAEVEIISRVHHRHLV 405
F++ +G+G FG V KG+ K VA+K + + E E + E+ ++S+ ++
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 406 SLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLK------IAMGSAKGLAY 459
G + K ++ EY+ G +++ P L I KGL Y
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGG--------GSALDLLE-PGPLDETQIATILREILKGLDY 134
Query: 460 LHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEY 519
LH + + IHRDIK++N+LL E K+ADFG+A TD +T +GT ++APE
Sbjct: 135 LHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEV 190
Query: 520 ASSGKLTEKSDVFSFGVMLLELITGRRP---IDPTGAM 554
K+D++S G+ +EL G P + P +
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL 228
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVS 406
+++ +GQG G V+ + + G+EVA++ + + E+ ++ + ++V+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMD--WPTRLK------IAMGSAKGLA 458
+ + G + +V EY+ G + D T + + + L
Sbjct: 82 YLDSYLVGDELWVVMEYLA-----------GGSLTDVVTETCMDEGQIAAVCRECLQALE 130
Query: 459 YLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE 518
+LH + ++IHRDIKS NILL K+ DFG T + ST V GT ++APE
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPE 186
Query: 519 YASSGKLTEKSDVFSFGVMLLELITGRRP 547
+ K D++S G+M +E+I G P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-28
Identities = 68/209 (32%), Positives = 100/209 (47%), Gaps = 19/209 (9%)
Query: 348 FSQSNLLGQGGFGYV----HKGVLPNGKEVAVKSLRSG---SGQGEREFKAEVEIISRVH 400
F Q +LG+GGFG V + GK A K L +GE E +I+ +V+
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242
Query: 401 HRHLVSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWP-TRLKIAMGSAKGLA 458
R +VSL Y L LV + +L+FH++ G+ A GL
Sbjct: 243 SRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLE 300
Query: 459 YLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE 518
LH + RI++RD+K NILLD +++D GLA + T + RV GT GY+APE
Sbjct: 301 DLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPE 355
Query: 519 YASSGKLTEKSDVFSFGVMLLELITGRRP 547
+ + T D ++ G +L E+I G+ P
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 8e-28
Identities = 21/231 (9%), Positives = 44/231 (19%), Gaps = 43/231 (18%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLR---SGSGQGEREFKAEVEIISRVHHRHLVSLV 408
L G V + ++ A+K S +R+
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 409 GYC--------------------------IAGGKRLLVYEYVPNNNLE----FHLHGKGR 438
A LL+ + R
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 439 PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498
+ + A L ++H N+ + + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 499 DNNTHVSTRVMGTFGYLAPEYASSGKL--TEKSDVFSFGVMLLELITGRRP 547
Y E+ ++ T + + G+ + + P
Sbjct: 246 TR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-28
Identities = 58/219 (26%), Positives = 91/219 (41%), Gaps = 52/219 (23%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSL--RSGSGQGEREFKAEVEIISRVHHRHLVSLVGY 410
LG+G FG V K +E AVK + S + EVE++ ++ H +++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE- 88
Query: 411 CIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPT------RLKIAMGS----------- 453
+ E ++ F++ V + T + I
Sbjct: 89 ---------ILE----DSSSFYI------VGELYTGGELFDEI-IKRKRFSEHDAARIIK 128
Query: 454 --AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFET---KVADFGLAKLTTDNNTHVSTRV 508
G+ Y+H+ I+HRD+K NILL+ + K+ DFGL+ N
Sbjct: 129 QVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDR 183
Query: 509 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
+GT Y+APE G EK DV+S GV+L L++G P
Sbjct: 184 IGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-27
Identities = 64/211 (30%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 348 FSQSNLLGQGGFGYV----HKGVLPNGKEVAVKSLRSG---SGQGEREFKAEVEIISRVH 400
F +LG+GGFG V K GK A K L +G + E +I+++VH
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 401 HRHLVSLVGYCIAGGKRL-LVYEYVPNNNLEFHLH--GKGRPVMDWP-TRLKIAMGSAKG 456
R +VSL Y L LV + ++ +H++ + P P A G
Sbjct: 244 SRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSG 301
Query: 457 LAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLA 516
L +LH+ II+RD+K N+LLD +++D GLA T GT G++A
Sbjct: 302 LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMA 357
Query: 517 PEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
PE + D F+ GV L E+I R P
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVS 406
+ LG G FG V+K G A K + + S + ++ E+EI++ H ++V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAM---GSAKGLAYLHED 463
L+G GK ++ E+ P ++ + R + T +I + + L +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGL----TEPQIQVVCRQMLEALNFLHSK 136
Query: 464 CHPRIIHRDIKSSNILLDYTFETKVADFGL-AKLTTDN---NTHVSTRVMGTFGYLAPEY 519
RIIHRD+K+ N+L+ + ++ADFG+ AK ++ + GT ++APE
Sbjct: 137 ---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEV 188
Query: 520 ASSGKLTE-----KSDVFSFGVMLLELITGRRP 547
+ + K+D++S G+ L+E+ P
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-27
Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 53/220 (24%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSL---RSGSGQGEREFKAEVEIISRVHHRHLVSLVG 409
LG+G FG V G+E AVK + + + EV+++ ++ H +++ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 410 YCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPT------RLKIAMGS---------- 453
+E + F+L V + T + I+
Sbjct: 94 ----------FFE----DKGYFYL------VGEVYTGGELFDEI-ISRKRFSEVDAARII 132
Query: 454 ---AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFET---KVADFGLAKLTTDNNTHVSTR 507
G+ Y+H++ +I+HRD+K N+LL+ + ++ DFGL+ +
Sbjct: 133 RQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KD 187
Query: 508 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
+GT Y+APE G EK DV+S GV+L L++G P
Sbjct: 188 KIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 16/206 (7%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE-FKAEVEIISR-VHHRHLVSLVGY 410
+G G G V K G +AVK +R + E + +++++ + ++V G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 411 CIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIH 470
I + E + + +G + K+ + K L YL E +IH
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGP--IPERILGKMTVAIVKALYYLKEKHG--VIH 148
Query: 471 RDIKSSNILLDYTFETKVADFGL-AKLTTDNNTHVSTRVMGTFGYLAPE-----YASSGK 524
RD+K SNILLD + K+ DFG+ +L + R G Y+APE +
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRLV---DDKAKDRSAGCAAYMAPERIDPPDPTKPD 205
Query: 525 LTEKSDVFSFGVMLLELITGRRPIDP 550
++DV+S G+ L+EL TG+ P
Sbjct: 206 YDIRADVWSLGISLVELATGQFPYKN 231
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 37/222 (16%), Positives = 68/222 (30%), Gaps = 26/222 (11%)
Query: 348 FSQSNLLGQGGFGYVHKGV------LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHH 401
+LLG+G F V++ N ++ +K + + +E +
Sbjct: 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQ 126
Query: 402 RHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRP---VMDWPTRLKIAMGSAKGLA 458
+ + +LV E L ++ VM + AM +
Sbjct: 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIE 186
Query: 459 YLHEDCHPRIIHRDIKSSNILLDYTFET-----------KVADFGLAKLTT--DNNTHVS 505
+H+ IIH DIK N +L F + D G + T +
Sbjct: 187 QVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT 243
Query: 506 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
+ T G+ E S+ + D F + ++ G
Sbjct: 244 AKC-ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-27
Identities = 48/211 (22%), Positives = 83/211 (39%), Gaps = 19/211 (9%)
Query: 348 FSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVS 406
F ++LG G G + + + ++VAVK + + EV+++ H +++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVIR 82
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHP 466
+ + E L+ ++ K + + + GLA+LH
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLHSL--- 137
Query: 467 RIIHRDIKSSNILLDYTFET-----KVADFGLAKLTTDNNTHVSTR--VMGTFGYLAPEY 519
I+HRD+K NIL+ ++DFGL K S R V GT G++APE
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 520 ---ASSGKLTEKSDVFSFGVMLLELITGRRP 547
T D+FS G + +I+
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVS 406
F LG+G +G V+K + G+ VA+K + +E E+ I+ + H+V
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK 88
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAM---GSAKGLAYLHED 463
G +V EY ++ + + + + T +IA + KGL YLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL----TEDEIATILQSTLKGLEYLHFM 144
Query: 464 CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSG 523
R IHRDIK+ NILL+ K+ADFG+A TD +T + GT ++APE
Sbjct: 145 ---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEI 200
Query: 524 KLTEKSDVFSFGVMLLELITGRRP 547
+D++S G+ +E+ G+ P
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPP 224
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 50/218 (22%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
+LG G F V GK A+K ++ + + E+ ++ ++ H ++V+L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED-- 73
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPT------RLKIAMGS------------ 453
+YE + ++L VM + R+ + G
Sbjct: 74 --------IYE----STTHYYL------VMQLVSGGELFDRI-LERGVYTEKDASLVIQQ 114
Query: 454 -AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFET---KVADFGLAKLTTDNNTHVSTRVM 509
+ YLHE+ I+HRD+K N+L E + DFGL+K+ + ST
Sbjct: 115 VLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--STAC- 168
Query: 510 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
GT GY+APE + ++ D +S GV+ L+ G P
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-26
Identities = 54/251 (21%), Positives = 94/251 (37%), Gaps = 39/251 (15%)
Query: 321 PPPPPIVALGFSQSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLR 379
+ + + ++ + + LG G +G V E A+K ++
Sbjct: 11 RENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIK 70
Query: 380 -------------SGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPN 426
+ E E+ ++ + H +++ L LV E+
Sbjct: 71 KSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEG 130
Query: 427 NNLEFHLHGKGR-------PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNIL 479
L + + + +M +I G+ YLH+ I+HRDIK NIL
Sbjct: 131 GELFEQIINRHKFDECDAANIM-----KQIL----SGICYLHKH---NIVHRDIKPENIL 178
Query: 480 LDYTFET---KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV 536
L+ K+ DFGL+ + + + +GT Y+APE K EK DV+S GV
Sbjct: 179 LENKNSLLNIKIVDFGLSSFFSKD--YKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGV 235
Query: 537 MLLELITGRRP 547
++ L+ G P
Sbjct: 236 IMYILLCGYPP 246
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-26
Identities = 63/212 (29%), Positives = 92/212 (43%), Gaps = 24/212 (11%)
Query: 348 FSQSNLLGQGGFGYV----HKGVLPNGKEVAVKSLRSG---SGQGEREFKAEVEIISRVH 400
FS ++G+GGFG V GK A+K L QGE E ++S V
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 401 ---HRHLVSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKG 456
+V + Y +L + + + +L +HL G R A G
Sbjct: 248 TGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD-MRFYAAE-IILG 304
Query: 457 LAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLA 516
L ++H +++RD+K +NILLD +++D GLA + H V GT GY+A
Sbjct: 305 LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMA 358
Query: 517 PEYASSGKLTEKS-DVFSFGVMLLELITGRRP 547
PE G + S D FS G ML +L+ G P
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKS-----LRSGSGQGEREFKAEVEIISRVHHRHLVSL 407
+G+G F V + + G++ AVK S G + K E I + H H+V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTR-----LKIAMGSAKGLAYLHE 462
+ + G +V+E++ +L F + + + ++ + + L Y H+
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL---EALRYCHD 148
Query: 463 DCHPRIIHRDIKSSNILLDYTFET---KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEY 519
+ IIHRD+K +LL + K+ FG+A ++ RV GT ++APE
Sbjct: 149 N---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEV 204
Query: 520 ASSGKLTEKSDVFSFGVMLLELITGRRP 547
+ DV+ GV+L L++G P
Sbjct: 205 VKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 19/217 (8%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE-FKAEVEIISRVHHRHLVSLVGYC 411
+G G V P ++VA+K + Q + E++ +S+ HH ++VS
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLK---IAM---GSAKGLAYLHEDCH 465
+ + LV + + ++ + L IA +GL YLH++
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-- 140
Query: 466 PRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTF-G---YLAPEYAS 521
IHRD+K+ NILL ++ADFG++ +V TF G ++APE
Sbjct: 141 -GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 522 SGKL-TEKSDVFSFGVMLLELITGRRP---IDPTGAM 554
+ K+D++SFG+ +EL TG P P +
Sbjct: 200 QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL 236
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 62/244 (25%), Positives = 98/244 (40%), Gaps = 28/244 (11%)
Query: 317 GPVLPPPPPIVALGFSQSAFTYEELSAATGGFSQSNLLGQGGFGYV----HKGVLPNGKE 372
G P P +L +Q + F +LG+G F V +E
Sbjct: 3 GTAAEPRPGAGSLQHAQPPPQPRKKRPE--DFKFGKILGEGSFSTVVLARELA---TSRE 57
Query: 373 VAVKSLRSGSGQGEREF---KAEVEIISRVHHRHLVSLVGYCIAGGKRL-LVYEYVPNNN 428
A+K L E + E +++SR+ H V L + ++L Y N
Sbjct: 58 YAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGE 116
Query: 429 LEFHLHGKGR---PVMDWPTRLKIA-MGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF 484
L ++ G TR A + SA L YLH IIHRD+K NILL+
Sbjct: 117 LLKYIRKIGSFDETC----TRFYTAEIVSA--LEYLHGK---GIIHRDLKPENILLNEDM 167
Query: 485 ETKVADFGLAKLTTDNNTHVSTRVM-GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 543
++ DFG AK+ + + GT Y++PE + + SD+++ G ++ +L+
Sbjct: 168 HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227
Query: 544 GRRP 547
G P
Sbjct: 228 GLPP 231
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-25
Identities = 48/229 (20%), Positives = 86/229 (37%), Gaps = 35/229 (15%)
Query: 348 FSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVS 406
+LG G G V G+ VAVK + E+++++ H +++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIR 73
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEF----HLHGKGRPVMDWPTRLKIAMGSAKGLAYLHE 462
+ E N + ++ + + + + A G+A+LH
Sbjct: 74 YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 463 DCHPRIIHRDIKSSNILLDYTFET-------------KVADFGLAKLTTDNNTHVSTRVM 509
+IIHRD+K NIL+ + ++DFGL K + T +
Sbjct: 134 L---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 510 ---GTFGYLAPE-------YASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
GT G+ APE + +LT D+FS G + +++ G+ P
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 60/247 (24%), Positives = 101/247 (40%), Gaps = 19/247 (7%)
Query: 310 NSSSGPYGPVLPPPPPIVALGFSQSAFTYEELSAA--TGGFSQSNLLGQGGFGYVHKGV- 366
+ + + + P P G + E FS +G G FG V+
Sbjct: 16 TTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARD 75
Query: 367 LPNGKEVAVKSLRSGSGQGEREFK---AEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423
+ N + VA+K + Q +++ EV + ++ H + + G + LV EY
Sbjct: 76 VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135
Query: 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYT 483
+ + K + + G+ +GLAYLH +IHRD+K+ NILL
Sbjct: 136 CLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEP 190
Query: 484 FETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTE---KSDVFSFGVMLLE 540
K+ DFG A + N+ +GT ++APE + + K DV+S G+ +E
Sbjct: 191 GLVKLGDFGSASIMAPANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 245
Query: 541 LITGRRP 547
L + P
Sbjct: 246 LAERKPP 252
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 30/241 (12%), Positives = 66/241 (27%), Gaps = 54/241 (22%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE----------------------- 388
+LGQ + G+ V
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 389 -----FKAEVEIISRVHHRHLVSLVGYC--IAGGKRLLVYEYVPNNNLEF----HLHGKG 437
F +++ + ++ + + R +Y + +N F H
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 438 RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497
+ RL++ + + LA LH H ++H ++ +I+LD + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 498 TDNNTHVSTRVMGTFGYLAPEYASS-----------GKLTEKSDVFSFGVMLLELITGRR 546
+ G+ PE + +T D ++ G+++ +
Sbjct: 257 GARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 547 P 547
P
Sbjct: 312 P 312
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 54/245 (22%), Positives = 82/245 (33%), Gaps = 54/245 (22%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKS-----LRSGSGQGEREFKAEVEIISRVHHRHLVSL 407
+GQG +G V + A+K +R + + K EV ++ ++HH ++ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAK------------ 455
LV E +L L+ +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 456 --------------------------GLAYLHEDCHPRIIHRDIKSSNILL--DYTFETK 487
L YLH I HRDIK N L + +FE K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 488 VADFGLAKLTTDNNTHVSTRVM---GTFGYLAPE--YASSGKLTEKSDVFSFGVMLLELI 542
+ DFGL+K N + GT ++APE ++ K D +S GV+L L+
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 543 TGRRP 547
G P
Sbjct: 271 MGAVP 275
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 61/240 (25%), Positives = 103/240 (42%), Gaps = 55/240 (22%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLV 405
F L+G G +G V+KG + G+ A+K + +G E E K E+ ++ + HHR++
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 406 SLVG-------------------YCIAGGKRLLVYEYVPNNNL-EFHLHGKGRPVMDWPT 445
+ G +C G + + N L E
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFC-GAGSVTDLIKNTKGNTLKEEW------------- 130
Query: 446 RLKIAM---GSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502
IA +GL++LH+ ++IHRDIK N+LL E K+ DFG++
Sbjct: 131 ---IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 184
Query: 503 HVSTRVMGTFGYLAPEYASSGKLTE-----KSDVFSFGVMLLELITGRRP---IDPTGAM 554
+T +GT ++APE + + + KSD++S G+ +E+ G P + P A+
Sbjct: 185 RRNT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 33/235 (14%), Positives = 65/235 (27%), Gaps = 43/235 (18%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGE---REFKAEVEIISRV--------- 399
+LGQ + G+ V ++ K EV + +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 400 --HHRHLVSLVGYCIAGGKRL----------------LVYEYVPNNNLEF----HLHGKG 437
H R + K++ +Y + +N F H
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 438 RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497
+ RL++ + + LA LH H ++H ++ +I+LD + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 498 TDNNTHVSTRVMGTFGYLAPE-----YASSGKLTEKSDVFSFGVMLLELITGRRP 547
+ R A +T D ++ G+ + + P
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 40/214 (18%), Positives = 77/214 (35%), Gaps = 17/214 (7%)
Query: 355 GQGGFGYVHKGV-LPNGKEVAVK--SLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
G V+ P G+ V V+ +L + S + + E+ + +H ++V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHR 471
IA + +V ++ + + + M+ I G K L Y+H +HR
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHR 152
Query: 472 DIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM------GTFGYLAPEYASSGKL 525
+K+S+IL+ + ++ + +L+PE
Sbjct: 153 SVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQ 212
Query: 526 --TEKSDVFSFGVMLLELITGRRP---IDPTGAM 554
KSD++S G+ EL G P + T +
Sbjct: 213 GYDAKSDIYSVGITACELANGHVPFKDMPATQML 246
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-25
Identities = 60/210 (28%), Positives = 88/210 (41%), Gaps = 30/210 (14%)
Query: 353 LLGQGGFGYV----HKGVLPNGKEVAVKSLRSGSGQGEREF---KAEVEIISRVHHRHLV 405
+G+G FG V K A+K + E E++I+ + H LV
Sbjct: 22 AIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLV 78
Query: 406 SLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGR---PVMDWPTRLKIA-MGSAKGLAYL 460
+L Y + + +V + + +L +HL +L I + A L YL
Sbjct: 79 NLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET----VKLFICELVMA--LDYL 131
Query: 461 HEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYA 520
RIIHRD+K NILLD + DF +A + + + GT Y+APE
Sbjct: 132 QNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMF 186
Query: 521 SSGKLTE--KS-DVFSFGVMLLELITGRRP 547
SS K + D +S GV EL+ GRRP
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 59/219 (26%), Positives = 92/219 (42%), Gaps = 52/219 (23%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSL--RSGSGQGEREFKAEVEIISRVHHRHLVSLVGY 410
LG+G FG V K +E AVK + S + EVE++ ++ H +++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE- 88
Query: 411 CIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPT------RLKIAMGS----------- 453
+ E ++ F++ V + T + I
Sbjct: 89 ---------ILE----DSSSFYI------VGELYTGGELFDEI-IKRKRFSEHDAARIIK 128
Query: 454 --AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFET---KVADFGLAKLTTDNNTHVSTRV 508
G+ Y+H+ I+HRD+K NILL+ + K+ DFGL+ N R+
Sbjct: 129 QVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-KDRI 184
Query: 509 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
GT Y+APE G EK DV+S GV+L L++G P
Sbjct: 185 -GTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 54/221 (24%), Positives = 89/221 (40%), Gaps = 53/221 (23%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE-FKAEVEIISRVHHRHLVSLVGYC 411
LG G FG VH +G E +K++ Q E +AE+E++ + H +++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE-- 87
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVM---------DWPTRLKIAMGS--------- 453
V+E + ++ VM + + +
Sbjct: 88 --------VFE----DYHNMYI------VMETCEGGELLERIVSAQARGKALSEGYVAEL 129
Query: 454 ----AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFET---KVADFGLAKLTTDNNTHVST 506
LAY H ++H+D+K NIL T K+ DFGLA+L + +
Sbjct: 130 MKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS-TN 185
Query: 507 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
GT Y+APE +T K D++S GV++ L+TG P
Sbjct: 186 AA-GTALYMAPEVF-KRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-25
Identities = 66/326 (20%), Positives = 124/326 (38%), Gaps = 70/326 (21%)
Query: 253 MPYYNNNHTTATD------YYNSAATPSPPPRANWQQQTDHGWPTPPPSQRGAVTVTSSD 306
M +++++H++ D Y+ S + + W ++R V +
Sbjct: 1 MGHHHHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTS 60
Query: 307 MSHNSSSGPYGPVLPPPPPIVALGFSQSAFT--YEELSAATGGFSQSNLLGQGGFGYVHK 364
P P P + Q A Y S++ +LG G FG VHK
Sbjct: 61 ALAVDIPAP-----PAPFDHRIVTAKQGAVNSFYT--------VSKTEILGGGRFGQVHK 107
Query: 365 GV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423
G ++A K +++ + + E K E+ +++++ H +L+ L +E
Sbjct: 108 CEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYD----------AFE- 156
Query: 424 VPNNNLEFHLHGKGRPVMDWPT------RLKIAMGSA--------------KGLAYLHED 463
+ + L VM++ R+ I +G+ ++H+
Sbjct: 157 ---SKNDIVL------VMEYVDGGELFDRI-IDESYNLTELDTILFMKQICEGIRHMHQM 206
Query: 464 CHPRIIHRDIKSSNILLDYTFET--KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYAS 521
I+H D+K NIL K+ DFGLA+ + GT +LAPE +
Sbjct: 207 ---YILHLDLKPENILCVNRDAKQIKIIDFGLARR-YKPREKLKVNF-GTPEFLAPEVVN 261
Query: 522 SGKLTEKSDVFSFGVMLLELITGRRP 547
++ +D++S GV+ L++G P
Sbjct: 262 YDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSL--RSGSGQGEREFKAEVEIISRVHHRHLVSLVGY 410
+G+G F V + G+EVA+K + + ++ EV I+ ++H ++V L +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80
Query: 411 -CIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRI 468
I K L L+ EY + +L GR M + Y H+ I
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQKR---I 135
Query: 469 IHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTE- 527
+HRD+K+ N+LLD K+ADFG + T + G Y APE GK +
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAFC-GAPPYAAPELF-QGKKYDG 192
Query: 528 -KSDVFSFGVMLLELITGRRPID 549
+ DV+S GV+L L++G P D
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFD 215
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 39/213 (18%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSL--RSGSGQGEREFKAEVEIISRVHHRHLVSLVGY 410
LG+G F V + V G E A K + + S + ++ + E I ++ H ++V L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 411 CIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGS-------------AKGL 457
LV++ V L F + +A + +
Sbjct: 74 IQEESFHYLVFDLVTGGEL-FE-------------DI-VAREFYSEADASHCIQQILESI 118
Query: 458 AYLHEDCHPRIIHRDIKSSNILLDYTFET---KVADFGLAKLTTDNNTHVSTRVMGTFGY 514
AY H + I+HR++K N+LL + K+ADFGLA D+ GT GY
Sbjct: 119 AYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFA-GTPGY 173
Query: 515 LAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
L+PE ++ D+++ GV+L L+ G P
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 49/213 (23%), Positives = 85/213 (39%), Gaps = 38/213 (17%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSL--RSGSGQGEREFKAEVEIISRVHHRHLVSLVGY 410
LG+G F V + V + G+E A + + S + ++ + E I + H ++V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 411 CIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGS-------------AKGL 457
G L+++ V L F + +A + +
Sbjct: 79 ISEEGHHYLIFDLVTGGEL-FE-------------DI-VAREYYSEADASHCIQQILEAV 123
Query: 458 AYLHEDCHPRIIHRDIKSSNILLDYTFET---KVADFGLAKLTTDNNTHVSTRVMGTFGY 514
+ H+ ++HR++K N+LL + K+ADFGLA GT GY
Sbjct: 124 LHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGY 179
Query: 515 LAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
L+PE + D+++ GV+L L+ G P
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 69/265 (26%), Positives = 108/265 (40%), Gaps = 45/265 (16%)
Query: 308 SHNSSSGPYGPVLPPPPPIVALGFSQSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGVL 367
S S+ P V P A + ++ ++G G FG V + L
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKL 61
Query: 368 PNGKEVAVKSLRSGSGQGEREFKA-EVEIISRVHHRHLVSLVGYCIAGGKRL------LV 420
EVA+K + ++ FK E++I+ V H ++V L + + G + LV
Sbjct: 62 VESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116
Query: 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSA----------KGLAYLHEDCHPRIIH 470
EYVP ++ +LK M + LAY+H I H
Sbjct: 117 LEYVPET-----VY----RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICH 164
Query: 471 RDIKSSNILLD-YTFETKVADFGLAKLT--TDNNTH-VSTRVMGTFGYLAPE-YASSGKL 525
RDIK N+LLD + K+ DFG AK+ + N + +R Y APE +
Sbjct: 165 RDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPELIFGATNY 219
Query: 526 TEKSDVFSFGVMLLELITGRRPIDP 550
T D++S G ++ EL+ G +P+ P
Sbjct: 220 TTNIDIWSTGCVMAELMQG-QPLFP 243
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 51/217 (23%), Positives = 82/217 (37%), Gaps = 50/217 (23%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCI 412
+G+G +G V V A K + + FK E+EI+ + H +++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE--- 73
Query: 413 AGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPT------RLKIAMGS------------- 453
+E +N + +L VM+ T R+ +
Sbjct: 74 -------TFE----DNTDIYL------VMELCTGGELFERV-VHKRVFRESDAARIMKDV 115
Query: 454 AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFET---KVADFGLAKLTTDNNTHVSTRVMG 510
+AY H+ + HRD+K N L K+ DFGLA T+V G
Sbjct: 116 LSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-RTKV-G 170
Query: 511 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
T Y++P+ G + D +S GVM+ L+ G P
Sbjct: 171 TPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 58/239 (24%), Positives = 95/239 (39%), Gaps = 59/239 (24%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVK------------SLRSGSGQGEREFKA-------- 391
+G+G +G V + A+K R +G R
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 392 ------EVEIISRVHHRHLVSLVGYCI---AGGKRL-LVYEYVPNNNLEFHLHGKGRPVM 441
E+ I+ ++ H ++V L + L +V+E V PVM
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELV-----------NQGPVM 126
Query: 442 DWPTRLKIAMGSAK--------GLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGL 493
+ PT ++ A+ G+ YLH +IIHRDIK SN+L+ K+ADFG+
Sbjct: 127 EVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 494 AKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLT---EKSDVFSFGVMLLELITGRRPID 549
+ ++ +S V GT ++APE S + + DV++ GV L + G+ P
Sbjct: 184 SNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 55/215 (25%), Positives = 87/215 (40%), Gaps = 30/215 (13%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLR----SGSGQGEREFKAEVEIISRVHHRHLVSL 407
LLG+G +G V + + AVK L+ GE K E++++ R+ H++++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 408 --VGYCIAGGKRLLVYEYVPNNNLE-FHLHGKGRPVMDWPTRLKIAMGSAK------GLA 458
V Y K +V EY E + R + GL
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR--------FPVCQAHGYFCQLIDGLE 123
Query: 459 YLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD--NNTHVSTRVMGTFGYLA 516
YLH I+H+DIK N+LL K++ G+A+ + T G+ +
Sbjct: 124 YLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAFQP 179
Query: 517 PEYASSGKLTE--KSDVFSFGVMLLELITGRRPID 549
PE A+ K D++S GV L + TG P +
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 57/244 (23%), Positives = 95/244 (38%), Gaps = 43/244 (17%)
Query: 331 FSQSAFTYEELSAATGGFSQ----SNLLGQGGFGYVHKGV-LPNGKEVAVKSL--RSGSG 383
F T ++ S S LG G G V K+VA++ + R +
Sbjct: 116 FVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAI 175
Query: 384 QGERE------FKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHL---H 434
RE + E+EI+ +++H ++ + + +V E + L F +
Sbjct: 176 GSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL-FDKVVGN 233
Query: 435 GK-----GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFET--- 486
+ + ++ + YLHE+ IIHRD+K N+LL E
Sbjct: 234 KRLKEATCKLYF-----YQML----LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLI 281
Query: 487 KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE---YASSGKLTEKSDVFSFGVMLLELIT 543
K+ DFG +K+ + + T GT YLAPE + D +S GV+L ++
Sbjct: 282 KITDFGHSKI-LGETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 339
Query: 544 GRRP 547
G P
Sbjct: 340 GYPP 343
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 24/207 (11%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSL--RSGSGQGEREFKAEVEIISRV-HHRHLVSLVG 409
LG+G F V + + G+E A K L R E E+ ++ +++L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 410 YCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRL--KIAMGSAK----GLAYLHED 463
+ +L+ EY + F + + + + K G+ YLH++
Sbjct: 97 VYENTSEIILILEYAAGGEI-FS-----LCLPELAEMVSENDVIRLIKQILEGVYYLHQN 150
Query: 464 CHPRIIHRDIKSSNILLDYTFET---KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYA 520
I+H D+K NILL + K+ DFG+++ + + + GT YLAPE
Sbjct: 151 ---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACELREIM-GTPEYLAPEIL 205
Query: 521 SSGKLTEKSDVFSFGVMLLELITGRRP 547
+ +T +D+++ G++ L+T P
Sbjct: 206 NYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 59/323 (18%), Positives = 119/323 (36%), Gaps = 50/323 (15%)
Query: 255 YYNNNHTTATDY-YNSAATPSPPPRANWQQQTDHGWPTPPPSQRGAVTVTSSDMSHNSSS 313
+++++H++ D +N + + S R + +++ ++
Sbjct: 2 HHHHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKL 61
Query: 314 GPYGPVLPPPPPIVALGFSQSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGV-LPNGKE 372
P ++G + + +++G+G V + V G E
Sbjct: 62 NDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHE 121
Query: 373 VAVKSLR-------SGSGQGERE-FKAEVEIISRVH-HRHLVSLVGYCIAGGKRLLVYEY 423
AVK + + RE + E I+ +V H H+++L+ + LV++
Sbjct: 122 FAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDL 181
Query: 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGS-------------AKGLAYLHEDCHPRIIH 470
+ L F L + + +++LH + I+H
Sbjct: 182 MRKGEL-FD-------------YL-TEKVALSEKETRSIMRSLLEAVSFLHAN---NIVH 223
Query: 471 RDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE------YASSGK 524
RD+K NILLD + +++DFG + + GT GYLAPE +
Sbjct: 224 RDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELC-GTPGYLAPEILKCSMDETHPG 281
Query: 525 LTEKSDVFSFGVMLLELITGRRP 547
++ D+++ GV+L L+ G P
Sbjct: 282 YGKEVDLWACGVILFTLLAGSPP 304
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 10/83 (12%), Positives = 21/83 (25%)
Query: 28 SSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPP 87
S + E P +R + + P S+ + P
Sbjct: 7 HSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQP 66
Query: 88 PNSKSPPQSSPPPNTNPPPQSSP 110
+++ S P P ++
Sbjct: 67 KGTENLYFQSMGPEDELPDWAAA 89
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 6/83 (7%), Positives = 11/83 (13%)
Query: 19 TPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSS 78
+ + R P S E+ + P
Sbjct: 9 SGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKG 68
Query: 79 QSPPQSPPPPNSKSPPQSSPPPN 101
P +
Sbjct: 69 TENLYFQSMGPEDELPDWAAAKE 91
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 51/224 (22%), Positives = 82/224 (36%), Gaps = 50/224 (22%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSL---------RSGSGQGEREFKAEVEIISRV-HHR 402
LG+G V + + P KE AVK + + EV+I+ +V H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 403 HLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGS--------- 453
+++ L LV++ + L F L +
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGEL-FD-------------YL-TEKVTLSEKETRKI 129
Query: 454 ----AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM 509
+ + LH+ I+HRD+K NILLD K+ DFG + +
Sbjct: 130 MRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVC- 184
Query: 510 GTFGYLAPE------YASSGKLTEKSDVFSFGVMLLELITGRRP 547
GT YLAPE + ++ D++S GV++ L+ G P
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 60/252 (23%), Positives = 102/252 (40%), Gaps = 38/252 (15%)
Query: 350 QSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSL 407
Q ++LG+G V + L +E AVK + G EVE++ + HR+++ L
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKG-------RPVMDWPTRLKIAMGSAKGLAYL 460
+ + + LV+E + ++ H+H + V+ +A L +L
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVV-----QDVA----SALDFL 127
Query: 461 HEDCHPRIIHRDIKSSNILLDYTFET---KVADFGLAKLTTDNNTH--VSTRVM----GT 511
H I HRD+K NIL ++ + K+ DF L N +ST + G+
Sbjct: 128 HN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 512 FGYLAPE-----YASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLC 566
Y+APE + ++ D++S GV+L L++G P W R
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV---GRCGSDCGWDRGEA 241
Query: 567 LRALDDGNFNEI 578
A + F I
Sbjct: 242 CPACQNMLFESI 253
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 55/224 (24%), Positives = 86/224 (38%), Gaps = 56/224 (25%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLR------SGSGQGEREFKAEVEIISRVHHRHLVS 406
LG G F V K G + A K ++ S G + + EV I+ + H ++++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPT------RLKIAMGS------- 453
L VYE N + L +++ L S
Sbjct: 79 LHE----------VYE----NKTDVIL------ILELVAGGELFDFL-AEKESLTEEEAT 117
Query: 454 ------AKGLAYLHEDCHPRIIHRDIKSSNILL-DYTFET---KVADFGLAKLTTDNNTH 503
G+ YLH +I H D+K NI+L D K+ DFGLA N
Sbjct: 118 EFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 504 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
+ GT ++APE + L ++D++S GV+ L++G P
Sbjct: 175 --KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 99.1 bits (248), Expect = 4e-23
Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 30/215 (13%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE---FKA--EVEIISRVHH 401
+ + +G+G +G V K + VA+K +R + E A E+ ++ + H
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKELKH 60
Query: 402 RHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGS-AKGLAYL 460
+++V L + K LV+E+ + L+ + + P +K + KGL +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQD-LKKYFDSCNGDLD--PEIVKSFLFQLLKGLGFC 117
Query: 461 HEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE-- 518
H ++HRD+K N+L++ E K+A+FGLA+ S V+ T Y P+
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVL 173
Query: 519 -----YASSGKLTEKSDVFSFGVMLLELITGRRPI 548
Y++S D++S G + EL RP+
Sbjct: 174 FGAKLYSTS------IDMWSAGCIFAELANAGRPL 202
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 49/206 (23%), Positives = 85/206 (41%), Gaps = 28/206 (13%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGYC 411
LG+G F K V + + AVK + + E + E+ + H ++V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKG-------RPVMDWPTRLKIAMGSAKGLAYLHEDC 464
LV E + L + K +M K+ ++++H+
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIM-----RKLV----SAVSHMHDV- 125
Query: 465 HPRIIHRDIKSSNILLDYTFET---KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYAS 521
++HRD+K N+L + K+ DFG A+L +N + T T Y APE +
Sbjct: 126 --GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLN 182
Query: 522 SGKLTEKSDVFSFGVMLLELITGRRP 547
E D++S GV+L +++G+ P
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 61/254 (24%), Positives = 100/254 (39%), Gaps = 48/254 (18%)
Query: 317 GPVLPPPPPIVALGFSQSAFTYEELSAATGGFSQS----NLLGQGGFGYVHKGV-LPNGK 371
GP + +G E + A+ FS + LG+G F V + V G
Sbjct: 1 GPHMASMTGGQQMGRGS-----EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGL 55
Query: 372 EVAVKSL--RSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNL 429
E A K + + S + ++ + E I ++ H ++V L LV++ V L
Sbjct: 56 EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 115
Query: 430 EFHLHGKGRPVMDWPTRLKIAMGS-------------AKGLAYLHEDCHPRIIHRDIKSS 476
F + +A + +AY H + I+HR++K
Sbjct: 116 -FE-------------DI-VAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPE 157
Query: 477 NILLDYTFET---KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 533
N+LL + K+ADFGLA D+ GT GYL+PE ++ D+++
Sbjct: 158 NLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFA-GTPGYLSPEVLKKDPYSKPVDIWA 215
Query: 534 FGVMLLELITGRRP 547
GV+L L+ G P
Sbjct: 216 CGVILYILLVGYPP 229
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 8e-23
Identities = 56/224 (25%), Positives = 86/224 (38%), Gaps = 56/224 (25%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKS-----LRSGSGQGERE-FKAEVEIISRVHHRHLVS 406
LG G F V K GKE A K L S RE + EV I+ + H ++++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPT------RLKIAMGS------- 453
L ++E N + L +++ + L S
Sbjct: 73 LHD----------IFE----NKTDVVL------ILELVSGGELFDFL-AEKESLTEDEAT 111
Query: 454 ------AKGLAYLHEDCHPRIIHRDIKSSNILL-DYTFET---KVADFGLAKLTTDNNTH 503
G+ YLH RI H D+K NI+L D K+ DFG+A +
Sbjct: 112 QFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-EAGNE 167
Query: 504 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
GT ++APE + L ++D++S GV+ L++G P
Sbjct: 168 FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 49/217 (22%), Positives = 88/217 (40%), Gaps = 49/217 (22%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCI 412
LG G FG VH+ V G+ K + + + K E+ I++++HH L++L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHD--- 115
Query: 413 AGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPT------RLKIAMGSA------------ 454
+E + E L ++++ + R+ A
Sbjct: 116 -------AFE----DKYEMVL------ILEFLSGGELFDRI-AAEDYKMSEAEVINYMRQ 157
Query: 455 --KGLAYLHEDCHPRIIHRDIKSSNILLDYTFET--KVADFGLAKLTTDNNTHVSTRVMG 510
+GL ++HE I+H DIK NI+ + + K+ DFGLA + +
Sbjct: 158 ACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTA 212
Query: 511 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
T + APE + +D+++ GV+ L++G P
Sbjct: 213 TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 51/227 (22%), Positives = 85/227 (37%), Gaps = 36/227 (15%)
Query: 339 EELSAATGGFSQ----SNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEV 393
++L + F+ +G G + + + E AVK + E +
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----I 66
Query: 394 EIISR-VHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEF-HLHGKG-------RPVMDWP 444
EI+ R H ++++L G +V E + L + + V+
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL-LDKILRQKFFSEREASAVL--- 122
Query: 445 TRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFET----KVADFGLAKLTTDN 500
I K + YLH ++HRD+K SNIL ++ DFG AK
Sbjct: 123 --FTIT----KTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173
Query: 501 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
N + T T ++APE D++S GV+L ++TG P
Sbjct: 174 NGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 45/210 (21%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCI 412
LG+G FG VH+ V + K K ++ G + K E+ I++ HR+++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 413 AGGKRLLVYEYVPNNNL-------EFHLHGKG-----RPVMDWPTRLKIAMGSAKGLAYL 460
+ + ++++E++ ++ F L+ + V + L +L
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE-------------ALQFL 118
Query: 461 HEDCHPRIIHRDIKSSNILLDYTFET---KVADFGLAKLTTDNNTHVSTRVMGTFGYLAP 517
H I H DI+ NI+ T + K+ +FG A+ + + Y AP
Sbjct: 119 HSH---NIGHFDIRPENIIY-QTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAP 172
Query: 518 EYASSGKLTEKSDVFSFGVMLLELITGRRP 547
E ++ +D++S G ++ L++G P
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 54/222 (24%), Positives = 88/222 (39%), Gaps = 49/222 (22%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSL--RSGSGQGERE------FKAEVEIISRVHHRHL 404
LG G G V K+VA+K + R + RE + E+EI+ +++H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 405 VSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGS----------- 453
+ + + +V E + L F ++ +
Sbjct: 78 IKIKNF-FDAEDYYIVLELMEGGEL-FD-------------KV-VGNKRLKEATCKLYFY 121
Query: 454 --AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFET---KVADFGLAKLTTDNNTHVSTRV 508
+ YLHE+ IIHRD+K N+LL E K+ DFG +K+ + + + T
Sbjct: 122 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLC 177
Query: 509 MGTFGYLAPE---YASSGKLTEKSDVFSFGVMLLELITGRRP 547
GT YLAPE + D +S GV+L ++G P
Sbjct: 178 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 353 LLGQGGFGYV----HKGVLPNGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVS 406
+LGQG FG V + A+K L+ + + K E +I+ V+H +V
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 407 LVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIA-MGSAKGLAYLHEDC 464
L Y +L L+ +++ +L L + + + +A + A L +LH
Sbjct: 91 LH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED-VKFYLAELALA--LDHLHSL- 145
Query: 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGK 524
II+RD+K NILLD K+ DFGL+K + D+ + GT Y+APE +
Sbjct: 146 --GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVNRRG 202
Query: 525 LTEKSDVFSFGVMLLELITGRRP 547
T+ +D +SFGV++ E++TG P
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLP 225
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 58/218 (26%), Positives = 84/218 (38%), Gaps = 44/218 (20%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKS-----LRSGSGQGERE-FKAEVEIISRVHHRHLVS 406
LG G F V K G E A K R+ RE + EV I+ +V H ++++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGS------------- 453
L +L+ E V L F L S
Sbjct: 80 LHDVYENRTDVVLILELVSGGEL-FD-------------FL-AQKESLSEEEATSFIKQI 124
Query: 454 AKGLAYLHEDCHPRIIHRDIKSSNILL-DYTFET---KVADFGLAKLTTDNNTHVSTRVM 509
G+ YLH +I H D+K NI+L D K+ DFGLA D +
Sbjct: 125 LDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIF 179
Query: 510 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
GT ++APE + L ++D++S GV+ L++G P
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 62/286 (21%), Positives = 106/286 (37%), Gaps = 64/286 (22%)
Query: 287 HGWPTPPPSQRGAVTVTSSDMSHNSSSGPYGPVLPPPPPIVALGFSQSAFT--YEELSAA 344
H G + MS ++S G P + G ++ A + +E
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWI-DGSNRDALSDFFE----- 56
Query: 345 TGGFSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRH 403
LG+G V++ K A+K L+ ++ + E+ ++ R+ H +
Sbjct: 57 ---VES--ELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPN 109
Query: 404 LVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPT------RLKIAMGS---- 453
++ L ++E E L V++ T R+ + G
Sbjct: 110 IIKLKE----------IFE----TPTEISL------VLELVTGGELFDRI-VEKGYYSER 148
Query: 454 ---------AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFET---KVADFGLAKLTTDNN 501
+ +AYLHE+ I+HRD+K N+L K+ADFGL+K+
Sbjct: 149 DAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205
Query: 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
V GT GY APE + D++S G++ L+ G P
Sbjct: 206 LM--KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 60/210 (28%), Positives = 87/210 (41%), Gaps = 27/210 (12%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSL-RSGSGQGEREFKAEVEIISRVHHRHLVSLVGY 410
LG+G +G V V + VAVK + + K E+ I ++H ++V G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG- 72
Query: 411 CIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLK-----IAMGSAKGLAYLHEDC 464
G L EY L + M P + +A G+ Y
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA-----GVVY----L 121
Query: 465 HPR-IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT--HVSTRVMGTFGYLAPEYAS 521
H I HRDIK N+LLD K++DFGLA + NN ++ GT Y+APE
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL- 179
Query: 522 SGKL--TEKSDVFSFGVMLLELITGRRPID 549
+ E DV+S G++L ++ G P D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-22
Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 23/214 (10%)
Query: 348 FSQSNLLGQGGFGYV----HKGVLPNGKEVAVKSLRSGS--GQGERE-FKAEVEIISRVH 400
F ++G+G FG V K K A+K L + E F+ E +++
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGD 132
Query: 401 HRHLVSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIA-MGSAKGLA 458
+ + +L Y L LV +Y +L L + + R +A M A +
Sbjct: 133 SKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA--ID 189
Query: 459 YLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE 518
+H+ +HRDIK NIL+D ++ADFG ++ T S+ +GT Y++PE
Sbjct: 190 SVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246
Query: 519 -----YASSGKLTEKSDVFSFGVMLLELITGRRP 547
G+ + D +S GV + E++ G P
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 64/212 (30%), Positives = 95/212 (44%), Gaps = 32/212 (15%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSL---RSGSGQGEREFKAEVEIISRVHHRHLVSLV 408
LG G FG V G G +VAVK L + S + K E++ + H H++ L
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL- 76
Query: 409 GY-CIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAK------GLAYL 460
Y I+ +V EYV L ++ GR ++ + Y
Sbjct: 77 -YQVISTPTDFFMVMEYVSGGELFDYICKHGR--------VEEMEARRLFQQILSAVDY- 126
Query: 461 HEDCHPR-IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEY 519
CH ++HRD+K N+LLD K+ADFGL+ + +D + T G+ Y APE
Sbjct: 127 ---CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSC-GSPNYAAPEV 181
Query: 520 ASSGKLTE--KSDVFSFGVMLLELITGRRPID 549
SG+L + D++S GV+L L+ G P D
Sbjct: 182 I-SGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 51/221 (23%), Positives = 83/221 (37%), Gaps = 54/221 (24%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGY 410
+LG G G V + G++ A+K L + + EV+ + H+V ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVCILD- 89
Query: 411 CIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPT------RLKIAMGS----------- 453
VYE + + + +M+ R+ G
Sbjct: 90 ---------VYENMHHGKRCLLI------IMECMEGGELFSRI-QERGDQAFTEREAAEI 133
Query: 454 ----AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFET---KVADFGLAKLTTDNNTHVST 506
+ +LH I HRD+K N+L + K+ DFG AK TT N + T
Sbjct: 134 MRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQT 188
Query: 507 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
T Y+APE K + D++S GV++ L+ G P
Sbjct: 189 PC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 58/211 (27%), Positives = 107/211 (50%), Gaps = 29/211 (13%)
Query: 348 FSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGERE---FKA--EVEIISRVHHR 402
+ + +G+G +G V+K G+ VA+K +R + E E A E+ ++ +HH
Sbjct: 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIPSTAIREISLLKELHHP 79
Query: 403 HLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGS-AKGLAYLH 461
++VSL+ + LV+E++ + L+ L + +++KI + +G+A+ H
Sbjct: 80 NIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQ--DSQIKIYLYQLLRGVAHCH 136
Query: 462 EDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE--- 518
+ RI+HRD+K N+L++ K+ADFGLA+ + V+ T Y AP+
Sbjct: 137 QH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLM 192
Query: 519 ----YASSGKLTEKSDVFSFGVMLLELITGR 545
Y++S D++S G + E+ITG+
Sbjct: 193 GSKKYSTS------VDIWSIGCIFAEMITGK 217
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 56/216 (25%), Positives = 87/216 (40%), Gaps = 25/216 (11%)
Query: 348 FSQSNLLGQGGFGYV----HKGVLPNGKEVAVKSLRSGS--GQGERE-FKAEVEIISRVH 400
F ++G+G F V K G+ A+K + +GE F+ E +++
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD 119
Query: 401 HRHLVSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIA-MGSAKGLA 458
R + L + L LV EY +L L G + R +A + A +
Sbjct: 120 RRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA--ID 176
Query: 459 YLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE 518
+H +HRDIK NILLD ++ADFG + T S +GT YL+PE
Sbjct: 177 SVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPE 233
Query: 519 -------YASSGKLTEKSDVFSFGVMLLELITGRRP 547
+G + D ++ GV E+ G+ P
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 58/260 (22%), Positives = 101/260 (38%), Gaps = 26/260 (10%)
Query: 303 TSSDMSHNSSSGPYGPVLPPPPPIVALGFSQSAFTYEELSAATGGFSQSNLLGQGGFGYV 362
+ H+S P G + P + A + +E + LLG GGFG V
Sbjct: 4 SHHHHHHSSGLVPRGSHMAPCNDLHATKLAPG----KEKEPLESQYQVGPLLGSGGFGSV 59
Query: 363 HKGV-LPNGKEVAVKSL------RSGSGQGEREFKAEVEIISRVHHR--HLVSLVGYCIA 413
+ G+ + + VA+K + G EV ++ +V ++ L+ +
Sbjct: 60 YSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119
Query: 414 GGKRLLVYEYV-PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR-IIHR 471
+L+ E P +L + +G + + + + CH ++HR
Sbjct: 120 PDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRH----CHNCGVLHR 173
Query: 472 DIKSSNILLDY-TFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLT-EKS 529
DIK NIL+D E K+ DFG L D GT Y PE+ + +
Sbjct: 174 DIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPEWIRYHRYHGRSA 230
Query: 530 DVFSFGVMLLELITGRRPID 549
V+S G++L +++ G P +
Sbjct: 231 AVWSLGILLYDMVCGDIPFE 250
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-22
Identities = 58/218 (26%), Positives = 84/218 (38%), Gaps = 44/218 (20%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKS-----LRSGSGQGERE-FKAEVEIISRVHHRHLVS 406
LG G F V K G E A K R+ RE + EV I+ +V H ++++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGS------------- 453
L +L+ E V L F L S
Sbjct: 80 LHDVYENRTDVVLILELVSGGEL-FD-------------FL-AQKESLSEEEATSFIKQI 124
Query: 454 AKGLAYLHEDCHPRIIHRDIKSSNILL-DYTFET---KVADFGLAKLTTDNNTHVSTRVM 509
G+ YLH +I H D+K NI+L D K+ DFGLA D +
Sbjct: 125 LDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIF 179
Query: 510 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
GT ++APE + L ++D++S GV+ L++G P
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 8e-22
Identities = 58/290 (20%), Positives = 98/290 (33%), Gaps = 46/290 (15%)
Query: 273 PSPPPRANWQQQTDHGWPTPPPSQRGAVTVTSSDMSHNSSSGPYGPVLPPPPPIVALGFS 332
+P +++ G+ + T S N + P P I
Sbjct: 97 TAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVL 156
Query: 333 QSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKA 391
+ LG G FG VH+ G A K + + + +
Sbjct: 157 DH-------------YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK 203
Query: 392 EVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNL-------EFHLHGKG-----RP 439
E++ +S + H LV+L + +++YE++ L + R
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 263
Query: 440 VMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFET--KVADFGLAKLT 497
V GL ++HE+ +H D+K NI+ K+ DFGL
Sbjct: 264 VCK-------------GLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307
Query: 498 TDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
D V GT + APE A + +D++S GV+ L++G P
Sbjct: 308 -DPKQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 9e-22
Identities = 59/226 (26%), Positives = 92/226 (40%), Gaps = 40/226 (17%)
Query: 348 FSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVS 406
F + GQG FG V G G VA+K + RE + ++ ++ +HH ++V
Sbjct: 25 FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPNIVQ 83
Query: 407 LVGYCIAGGKR-------LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSA----- 454
L Y G+R +V EYVP+ LH R ++A
Sbjct: 84 LQSYFYTLGERDRRDIYLNVVMEYVPDT-----LH----RCCRNYYRRQVAPPPILIKVF 134
Query: 455 -----KGLAYLHEDCHPRIIHRDIKSSNILLDY-TFETKVADFGLAKLT--TDNNTH-VS 505
+ + LH + HRDIK N+L++ K+ DFG AK ++ N +
Sbjct: 135 LFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC 193
Query: 506 TRVMGTFGYLAPEY-ASSGKLTEKSDVFSFGVMLLELITGRRPIDP 550
+R Y APE + T D++S G + E++ G PI
Sbjct: 194 SRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPIFR 233
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 348 FSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGERE---FKA--EVEIISRVHHR 402
+ +G+G +G V+K G+ A+K +R E E E+ I+ + H
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK---EDEGIPSTTIREISILKELKHS 60
Query: 403 HLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGS-AKGLAYLH 461
++V L + +LV+E++ + L+ L + K + G+AY H
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLE--SVTAKSFLLQLLNGIAYCH 117
Query: 462 EDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE--- 518
+ R++HRD+K N+L++ E K+ADFGLA+ + ++ T Y AP+
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLM 173
Query: 519 ----YASSGKLTEKSDVFSFGVMLLELITGR 545
Y+++ D++S G + E++ G
Sbjct: 174 GSKKYSTT------IDIWSVGCIFAEMVNGT 198
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 55/266 (20%), Positives = 100/266 (37%), Gaps = 56/266 (21%)
Query: 304 SSDMSHNSSSGPYGPVLPPPPPIVALGFSQSAFTYEELSAATGGFSQSNLLGQGGFGYVH 363
+ H+ + P + A + S Y + LG+G +G V+
Sbjct: 2 AHHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRI----------TKLGEGTYGEVY 51
Query: 364 KGV-LPNGKEVAVKSLRSGSGQGERE---FKA--EVEIISRVHHRHLVSLVGYCIAGGKR 417
K + + VA+K +R E E A EV ++ + HR+++ L +
Sbjct: 52 KAIDTVTNETVAIKRIRLEH---EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108
Query: 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSA------KGLAYLHEDCHPRIIHR 471
L++EY E L MD + + + + G+ + H R +HR
Sbjct: 109 HLIFEY-----AENDLKK----YMDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHR 156
Query: 472 DIKSSNILLDYTFET-----KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE-------Y 519
D+K N+LL + + K+ DFGLA+ + ++ T Y PE Y
Sbjct: 157 DLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEILLGSRHY 215
Query: 520 ASSGKLTEKSDVFSFGVMLLELITGR 545
++S D++S + E++
Sbjct: 216 STS------VDIWSIACIWAEMLMKT 235
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 60/210 (28%), Positives = 87/210 (41%), Gaps = 27/210 (12%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSL-RSGSGQGEREFKAEVEIISRVHHRHLVSLVGY 410
LG+G +G V V + VAVK + + K E+ I ++H ++V G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG- 72
Query: 411 CIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLK-----IAMGSAKGLAYLHEDC 464
G L EY L + M P + +A G+ Y
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA-----GVVY----L 121
Query: 465 HPR-IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT--HVSTRVMGTFGYLAPEYAS 521
H I HRDIK N+LLD K++DFGLA + NN ++ GT Y+APE
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL- 179
Query: 522 SGKL--TEKSDVFSFGVMLLELITGRRPID 549
+ E DV+S G++L ++ G P D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 61/203 (30%), Positives = 86/203 (42%), Gaps = 17/203 (8%)
Query: 353 LLGQGGFGYV----HKGVLPNGKEVAVKSLRSGSGQGEREF---KAEVEIISRVHHRHLV 405
LLG+G FG V K G+ A+K L+ + E E ++ H L
Sbjct: 155 LLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 406 SLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC 464
+L Y RL V EY L FHL + D R A L YLH +
Sbjct: 212 ALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR-ARFYGAEI-VSALDYLHSEK 268
Query: 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGK 524
+ +++RD+K N++LD K+ DFGL K + + T GT YLAPE
Sbjct: 269 N--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDND 325
Query: 525 LTEKSDVFSFGVMLLELITGRRP 547
D + GV++ E++ GR P
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGRLP 348
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 3e-21
Identities = 67/288 (23%), Positives = 105/288 (36%), Gaps = 66/288 (22%)
Query: 290 PTPPPSQRGAVTVTSSDMSHNSSSGPYGPVLPPPPPIV--ALGFSQSAFT--YEELSAAT 345
P P P+ + + H + P P P V L ++A Y+ S
Sbjct: 11 PVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTS--- 67
Query: 346 GGFSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRH 403
+LG G G V + ++ A+K L+ + + EVE+ R H
Sbjct: 68 ------QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPH 116
Query: 404 LVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPT------RLKIAMGS---- 453
+V +V VYE + + VM+ R+ G
Sbjct: 117 IVRIVD----------VYENLYAGRKCLLI------VMECLDGGELFSRI-QDRGDQAFT 159
Query: 454 -----------AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFET---KVADFGLAKLTTD 499
+ + YLH I HRD+K N+L K+ DFG AK TT
Sbjct: 160 EREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
Query: 500 NNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
+N+ ++T T Y+APE K + D++S GV++ L+ G P
Sbjct: 217 HNS-LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 17/54 (31%), Positives = 23/54 (42%), Gaps = 1/54 (1%)
Query: 55 RSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQS 108
+ P P P+P +PPP P P+ PP PPPP + PQ +
Sbjct: 6 QGQSPPVPFPAP-APPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNA 58
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 6e-21
Identities = 57/221 (25%), Positives = 78/221 (35%), Gaps = 46/221 (20%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSL--------RSGSGQGEREFKAEVEIISRVHHRHL 404
LG G FG+V V KEV VK + + E+ I+SRV H ++
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 405 VSLVGYCIAGGKRLLVYEYVPNNN-----LEFHLHG---------KGRPVMDWPTRLKIA 450
+ + + N +E H G R +D P I
Sbjct: 92 IKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIF 136
Query: 451 MGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMG 510
+ YL IIHRDIK NI++ F K+ DFG A T G
Sbjct: 137 RQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYTFC-G 191
Query: 511 TFGYLAPEYASSGKLTE--KSDVFSFGVMLLELITGRRPID 549
T Y APE G + +++S GV L L+ P
Sbjct: 192 TIEYCAPEVL-MGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 6e-21
Identities = 65/226 (28%), Positives = 105/226 (46%), Gaps = 46/226 (20%)
Query: 348 FSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKA-EVEIISRVHHRHLV 405
++ + ++G G FG V++ L +G+ VA+K + ++ FK E++I+ ++ H ++V
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 110
Query: 406 SLVGYCIAGGKRL------LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSA----- 454
L + + G++ LV +YVP ++ V +R K +
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPET-----VY----RVARHYSRAKQTLPVIYVKLY 161
Query: 455 -----KGLAYLHEDCHPRIIHRDIKSSNILLD-YTFETKVADFGLAKLTTDN--NTH-VS 505
+ LAY+H I HRDIK N+LLD T K+ DFG AK N +
Sbjct: 162 MYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218
Query: 506 TRVMGTFGYLAPEY-ASSGKLTEKSDVFSFGVMLLELITGRRPIDP 550
+R Y APE + T DV+S G +L EL+ G +PI P
Sbjct: 219 SRY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 258
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 8e-21
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 18/205 (8%)
Query: 353 LLGQGGFGYV----HKGVLPNGKEVAVKSLRSGS---GQGEREF-KAEVEIISRVHHRHL 404
+LG+GG+G V GK A+K L+ + KAE I+ V H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 405 VSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIA-MGSAKGLAYLHE 462
V L+ Y G +L L+ EY+ L L +G + D +A + A L +LH+
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT-ACFYLAEISMA--LGHLHQ 139
Query: 463 DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS 522
II+RD+K NI+L++ K+ DFGL K + + T T GT Y+APE
Sbjct: 140 K---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYMAPEILMR 195
Query: 523 GKLTEKSDVFSFGVMLLELITGRRP 547
D +S G ++ +++TG P
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 9e-21
Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 28/217 (12%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE---FKA--EVEIISRVHH 401
+ + + LG+G F V+K + VA+K ++ G ++ A E++++ + H
Sbjct: 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 402 RHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSA-KGLAYL 460
+++ L+ LV++++ + LE + + P+ +K M +GL YL
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLT--PSHIKAYMLMTLQGLEYL 128
Query: 461 HEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE-- 518
H+ I+HRD+K +N+LLD K+ADFGLAK N + +V+ T Y APE
Sbjct: 129 HQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAPELL 184
Query: 519 -----YASSGKLTEKSDVFSFGVMLLELITGRRPIDP 550
Y D+++ G +L EL+ R P P
Sbjct: 185 FGARMYGVG------VDMWAVGCILAELLL-RVPFLP 214
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-20
Identities = 58/214 (27%), Positives = 86/214 (40%), Gaps = 26/214 (12%)
Query: 348 FSQSNLLGQGGFGYV----HKGVLPNGKEVAVKSLRSGS----GQGEREFKAEVEIISRV 399
+ ++G+G FG V HK K A+K L F E +I++
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFA 126
Query: 400 HHRHLVSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIA-MGSAKGL 457
+ +V L Y + L +V EY+P +L +L W R A + A L
Sbjct: 127 NSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKW-ARFYTAEVVLA--L 181
Query: 458 AYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAP 517
+H IHRD+K N+LLD + K+ADFG +GT Y++P
Sbjct: 182 DAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238
Query: 518 E----YASSGKLTEKSDVFSFGVMLLELITGRRP 547
E G + D +S GV L E++ G P
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 65/209 (31%), Positives = 89/209 (42%), Gaps = 30/209 (14%)
Query: 353 LLGQGGFGYV----HKGVLPNGKEVAVKSLRSGSGQGEREF---KAEVEIISRVHHRHLV 405
LLG+G FG V K G+ A+K LR + E E ++ H L
Sbjct: 12 LLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 406 SLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIA-MGSAKGLAYLHED 463
+L Y RL V EY L FHL + + R A + SA L YLH
Sbjct: 69 ALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER-ARFYGAEIVSA--LEYLHSR 124
Query: 464 CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSG 523
+++RDIK N++LD K+ DFGL K + + T GT YLAPE
Sbjct: 125 ---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEV---- 176
Query: 524 KLTEKS-----DVFSFGVMLLELITGRRP 547
L + D + GV++ E++ GR P
Sbjct: 177 -LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 56/215 (26%), Positives = 84/215 (39%), Gaps = 40/215 (18%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGY- 410
+G G FG + VAVK + G+ E + E+ + H ++V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRF--KE 83
Query: 411 CIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAK------GLAYLHED 463
I L ++ EY L + GR G++Y
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNAGR--------FSEDEARFFFQQLLSGVSY---- 131
Query: 464 CHPR-IIHRDIKSSNILLDYTFET--KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE-- 518
CH I HRD+K N LLD + K+ DFG +K + ++ + V GT Y+APE
Sbjct: 132 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV-GTPAYIAPEVL 189
Query: 519 ----YASSGKLTEKSDVFSFGVMLLELITGRRPID 549
Y GK +DV+S GV L ++ G P +
Sbjct: 190 LRQEYD--GK---IADVWSCGVTLYVMLVGAYPFE 219
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 31/212 (14%)
Query: 348 FSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGE-----REFKAEVEIISRVHH 401
+ + + LG+G + V+KG VA+K +R +G RE ++ + H
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDLKH 59
Query: 402 RHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGS-AKGLAYL 460
++V+L LV+EY+ + +L+ +L G + +K+ + +GLAY
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIIN--MHNVKLFLFQLLRGLAYC 116
Query: 461 HEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE-- 518
H +++HRD+K N+L++ E K+ADFGLA+ + V+ T Y P+
Sbjct: 117 H---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDIL 172
Query: 519 -----YASSGKLTEKSDVFSFGVMLLELITGR 545
Y++ D++ G + E+ TGR
Sbjct: 173 LGSTDYSTQ------IDMWGVGCIFYEMATGR 198
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 63/260 (24%), Positives = 102/260 (39%), Gaps = 35/260 (13%)
Query: 305 SDMSHNSSSGPYGPVLPPPPPIVALGFSQSAFTYEELSAATGGFSQSNLLGQGGFGYVHK 364
S ++ P P P PPP ++ A + LLG+GGFG V
Sbjct: 1 SMLTKPLQGPPAPPGTPTPPP-----------GGKDREAFEAEYRLGPLLGKGGFGTVFA 49
Query: 365 GV-LPNGKEVAVKSL------RSGSGQGEREFKAEVEIISRVH----HRHLVSLVGYCIA 413
G L + +VA+K + EV ++ +V H ++ L+ +
Sbjct: 50 GHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109
Query: 414 GGKRLLVYEY-VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR-IIHR 471
+LV E +P +L ++ KG + + + CH R ++HR
Sbjct: 110 QEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQH----CHSRGVVHR 163
Query: 472 DIKSSNILLDY-TFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLT-EKS 529
DIK NIL+D K+ DFG L D GT Y PE+ S + +
Sbjct: 164 DIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---GTRVYSPPEWISRHQYHALPA 220
Query: 530 DVFSFGVMLLELITGRRPID 549
V+S G++L +++ G P +
Sbjct: 221 TVWSLGILLYDMVCGDIPFE 240
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 38/210 (18%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE-FKA----EVEIISRVHHRHLVSL 407
+G+G +G V K G+ VA+K + K E+ ++ ++ H +LV+L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESE---DDPVIKKIALREIRMLKQLKHPNLVNL 67
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGS-AKGLAYLHEDCHP 466
+ + LV+EY ++ + L R V +K + + + H+ H
Sbjct: 68 LEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVP--EHLVKSITWQTLQAVNFCHK--H- 121
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN---TH-VSTRVMGTFGYLAPE---- 518
IHRD+K NIL+ K+ DFG A+L T + V+TR Y +PE
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYRSPELLVG 176
Query: 519 ---YASSGKLTEKSDVFSFGVMLLELITGR 545
Y DV++ G + EL++G
Sbjct: 177 DTQYGPP------VDVWAIGCVFAELLSGV 200
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 57/225 (25%), Positives = 98/225 (43%), Gaps = 41/225 (18%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEV------EI----- 395
+ +G G +G V+K +G VA+KS+R + + E+
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN---GGGGGGGLPISTVREVALLRR 67
Query: 396 ISRVHHRHLVSL----VGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIA 450
+ H ++V L ++ LV+E+V + +L +L P + +K
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLP-AETIKDL 125
Query: 451 MGS-AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM 509
M +GL +LH + I+HRD+K NIL+ K+ADFGLA++ + + V+
Sbjct: 126 MRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-TPVVV 181
Query: 510 GTFGYLAPE------YASSGKLTEKSDVFSFGVMLLELITGRRPI 548
T Y APE YA+ D++S G + E+ R+P+
Sbjct: 182 -TLWYRAPEVLLQSTYATP------VDMWSVGCIFAEMFR-RKPL 218
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSL-RSGSGQGEREFKA--EVEIISRVHHRHLVSLV 408
LG+G FG V ++VA+K + R + + + E+ + + H H++ L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL- 74
Query: 409 GY-CIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAK------GLAYL 460
Y I + +V EY L ++ K R + G + Y
Sbjct: 75 -YDVITTPTDIVMVIEYA-GGELFDYIVEKKR--------MTEDEGRRFFQQIICAIEY- 123
Query: 461 HEDCHPR-IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEY 519
CH I+HRD+K N+LLD K+ADFGL+ + TD N + T G+ Y APE
Sbjct: 124 ---CHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTSC-GSPNYAAPEV 178
Query: 520 ASSGKLTE--KSDVFSFGVMLLELITGRRPID 549
+GKL + DV+S G++L ++ GR P D
Sbjct: 179 I-NGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 5e-20
Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 32/212 (15%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSL---RSGSGQGEREFKAEVEIISRVHHRHLVSLV 408
LG G FG V G G +VAVK L + S + + E++ + H H++ L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL- 81
Query: 409 GY-CIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAK------GLAYL 460
Y I+ + +V EYV L ++ GR L G+ Y
Sbjct: 82 -YQVISTPSDIFMVMEYVSGGELFDYICKNGR--------LDEKESRRLFQQILSGVDY- 131
Query: 461 HEDCHPR-IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEY 519
CH ++HRD+K N+LLD K+ADFGL+ + +D + T G+ Y APE
Sbjct: 132 ---CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSC-GSPNYAAPEV 186
Query: 520 ASSGKLTE--KSDVFSFGVMLLELITGRRPID 549
SG+L + D++S GV+L L+ G P D
Sbjct: 187 I-SGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 6e-20
Identities = 53/212 (25%), Positives = 92/212 (43%), Gaps = 38/212 (17%)
Query: 352 NLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE-FKA----EVEIISRVHHRHLV 405
L+G+G +G V K G+ VA+K + + K E++++ ++ H +LV
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD---DDKMVKKIAMREIKLLKQLRHENLV 87
Query: 406 SLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGS-AKGLAYLHEDC 464
+L+ C + LV+E+V ++ + L + ++ + G+ + H
Sbjct: 88 NLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLD--YQVVQKYLFQIINGIGFCHS-- 142
Query: 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN---TH-VSTRVMGTFGYLAPE-- 518
H IIHRDIK NIL+ + K+ DFG A+ V+TR Y APE
Sbjct: 143 H-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-----WYRAPELL 196
Query: 519 -----YASSGKLTEKSDVFSFGVMLLELITGR 545
Y + DV++ G ++ E+ G
Sbjct: 197 VGDVKYGKA------VDVWAIGCLVTEMFMGE 222
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 6e-20
Identities = 32/275 (11%), Positives = 70/275 (25%), Gaps = 53/275 (19%)
Query: 353 LLGQGGFGYVHKG---VLPNGKEVAVKSLRSGSGQGE---REFKAEVEIISRVHHRHLVS 406
G + L ++VA+ + + +E + +SR+ +
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHP 466
++ L+V E++ +L+ P ++ A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSP----VGAIRAMQSLAAAADAAHRA--- 148
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLT 526
+ S + V+ G L +
Sbjct: 149 GVALSIDHPSRVR--------VSIDGDVVL-------------AYPATMPDA-------N 180
Query: 527 EKSDVFSFGVMLLELITGRRPIDPTG-------AMEDCLVDWARPLCLRALDDGNFNEIA 579
+ D+ G L L+ R P+ G A D P + + +A
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVA 240
Query: 580 DPYLEKN---YPTEEMARMVACAAASIRHSARRRP 611
++ + + ++ A A + P
Sbjct: 241 ARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGP 275
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 2e-19
Identities = 58/270 (21%), Positives = 99/270 (36%), Gaps = 80/270 (29%)
Query: 354 LGQGGFGYVHKGVL------PNGKEVAVKSLRSGSGQGER-EFKAEVEIISRV-HHRHLV 405
LG+G FG V + + VAVK L+ G+ E +E++I+ + HH ++V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 406 SLVGYCI-AGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC 464
+L+G C GG +++ E+ NL +L K + + T+ + + D
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149
Query: 465 HPRI-------------------------------IHRDIKSSNILLDYTFE-------- 485
R+ +++D + L+ Y+F+
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209
Query: 486 ----------------------TKVADFGLAKLTTDNNTHVSTRVMGTFGYL-----APE 518
K+ DFGLA+ + +V L APE
Sbjct: 210 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD----ARLPLKWMAPE 265
Query: 519 YASSGKLTEKSDVFSFGVMLLELIT-GRRP 547
T +SDV+SFGV+L E+ + G P
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 32/215 (14%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGE-----REFKAEVEIISRVHH 401
F Q LG G + V+KG+ G VA+K ++ S +G RE + ++ + H
Sbjct: 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMKELKH 62
Query: 402 RHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDW---PTRLKIAMGSA-KGL 457
++V L K LV+E++ N+ L+ ++ + +K +GL
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 458 AYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAP 517
A+ HE+ +I+HRD+K N+L++ + K+ DFGLA+ S+ V+ T Y AP
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAP 177
Query: 518 E-------YASSGKLTEKSDVFSFGVMLLELITGR 545
+ Y++S D++S G +L E+ITG+
Sbjct: 178 DVLMGSRTYSTS------IDIWSCGCILAEMITGK 206
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 61/241 (25%), Positives = 106/241 (43%), Gaps = 49/241 (20%)
Query: 330 GFSQSAFTYEELSAATGGFSQSNLLGQGGFGYVHKG--VLPNGKEVAVKSLRSGSGQGER 387
G ++ YE + +G+G +G V K + G+ VA+K +R +
Sbjct: 5 GLCRADQQYECV----------AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---GE 51
Query: 388 E---FKAEVEI-----ISRVHHRHLVSL----VGYCIAGGKRL-LVYEYVPNNNLEFHLH 434
E E+ + H ++V L +L LV+E+V + +L +L
Sbjct: 52 EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLD 110
Query: 435 GKGRPVMDWPTRLKIAMGS-AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGL 493
P + +K M +GL +LH R++HRD+K NIL+ + + K+ADFGL
Sbjct: 111 KVPEPGVP-TETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 166
Query: 494 AKLTTDNNTHVSTRVMGTFGYLAPE------YASSGKLTEKSDVFSFGVMLLELITGRRP 547
A++ + ++ V+ T Y APE YA+ D++S G + E+ R+P
Sbjct: 167 ARIYSFQMAL-TSVVV-TLWYRAPEVLLQSSYATP------VDLWSVGCIFAEMFR-RKP 217
Query: 548 I 548
+
Sbjct: 218 L 218
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 60/204 (29%), Positives = 89/204 (43%), Gaps = 19/204 (9%)
Query: 353 LLGQGGFGYV----HKGVLPNGKEVAVKSLRSGSGQGEREF---KAEVEIISRV-HHRHL 404
+LG+G FG V KG + AVK L+ + + E +++ L
Sbjct: 27 VLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 83
Query: 405 VSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHED 463
L C RL V EYV +L +H+ GR A A GL +L
Sbjct: 84 TQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH-AVFYAAE-IAIGLFFLQSK 140
Query: 464 CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSG 523
II+RD+K N++LD K+ADFG+ K + T GT Y+APE +
Sbjct: 141 ---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQ 196
Query: 524 KLTEKSDVFSFGVMLLELITGRRP 547
+ D ++FGV+L E++ G+ P
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-19
Identities = 60/210 (28%), Positives = 84/210 (40%), Gaps = 25/210 (11%)
Query: 348 FSQSNLLGQGGFGYV----HKGVLPNGKEVAVKSLRSGSGQGEREF---KAEVEIISRVH 400
F + LG G FG V HK +G A+K L ++ E I+ V+
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 401 HRHLVSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIA-MGSAKGLA 458
LV L + L +V EYV + HL GR R A +
Sbjct: 100 FPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYAAQIVLT--FE 155
Query: 459 YLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM-GTFGYLAP 517
YLH +I+RD+K N+L+D +V DFG AK T + GT LAP
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAP 207
Query: 518 EYASSGKLTEKSDVFSFGVMLLELITGRRP 547
E S + D ++ GV++ E+ G P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 9e-19
Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 31/213 (14%)
Query: 348 FSQSNLLGQGGFGYV----HKGVLPNGKEVAVKSLRSGSGQGEREF---KAEVEIISRVH 400
F LG G FG V + NG+ A+K L+ ++ E ++S V
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 401 HRHLVSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGR---PVMDWPTRLKIA-MGSAK 455
H ++ + +++ ++ +Y+ L L R PV + A + A
Sbjct: 65 HPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV----AKFYAAEVCLA- 118
Query: 456 GLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVM-GTFGY 514
L YLH II+RD+K NILLD K+ DFG AK D T + GT Y
Sbjct: 119 -LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDY 169
Query: 515 LAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
+APE S+ + D +SFG+++ E++ G P
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 31/210 (14%)
Query: 353 LLGQGGFGYV----HKGVLPNGKEVAVKSLRSGSGQGEREF---KAEVEIISRV-HHRHL 404
++G+G + V K + A+K ++ + + + E + + +H L
Sbjct: 16 VIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 72
Query: 405 VSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIA-MGSAKGLAYLHE 462
V L C RL V EYV +L FH+ + + + R A + A L YLHE
Sbjct: 73 VGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYSAEISLA--LNYLHE 128
Query: 463 DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS 522
II+RD+K N+LLD K+ D+G+ K ST GT Y+APE
Sbjct: 129 R---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEI--- 181
Query: 523 GKLTEKS-----DVFSFGVMLLELITGRRP 547
L + D ++ GV++ E++ GR P
Sbjct: 182 --LRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 353 LLGQGGFGYV----HKGVLPNGKEVAVKSLRSGSGQGEREF----KAEVEIISRV-HHRH 403
+LG G +G V GK A+K L+ + + + + E +++ +
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 404 LVSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIA-MGSAKGLAYLH 461
LV+L Y +L L+ +Y+ L HL + R ++ + + A L +LH
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-VQIYVGEIVLA--LEHLH 176
Query: 462 EDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE--- 518
+ II+RDIK NILLD + DFGL+K + T + GT Y+AP+
Sbjct: 177 KL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 233
Query: 519 YASSGKLTEKS-DVFSFGVMLLELITGRRP 547
SG +K+ D +S GV++ EL+TG P
Sbjct: 234 GGDSGH--DKAVDWWSLGVLMYELLTGASP 261
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 88.9 bits (220), Expect = 2e-18
Identities = 78/417 (18%), Positives = 136/417 (32%), Gaps = 51/417 (12%)
Query: 140 PPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSSSSNSPNGNRSGALSPPNK 199
+ + N N ++ K P P S S +S N+
Sbjct: 167 AHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNE 226
Query: 200 SNGSSSSPSSNNGSMLSIPLVAAVAAGAAFLIIVMLLVFFACRRKKNRERNDQMPYYNNN 259
+ S + + + + F+ + + ++ ++
Sbjct: 227 TFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISE-------LQKAGVDGWFKLL 279
Query: 260 HTTATDYYNSAATPSPPPRANWQQQTDHGWPTPPPSQRGAVTVTSSDMSHNSSSGPYGPV 319
+Y+N P PP + ++ + Q + +
Sbjct: 280 SQEEGEYFN---VPVPPEGSEGNEELRQKFERAKIGQ--------GTKAPEEKTANTISK 328
Query: 320 LPPPPPIVALGFSQSAFTYEELSAATGGFSQSNLLGQGGFGYV----HKGVLPNGKEVAV 375
+ + F+ +LG+G FG V KG + AV
Sbjct: 329 FDNNGNRDRMKLTD--------------FNFLMVLGKGSFGKVMLSERKG---TDELYAV 371
Query: 376 KSLRSGSGQGEREF---KAEVEIISRV-HHRHLVSLVGYCIAGGKRL-LVYEYVPNNNLE 430
K L+ + + E +++ L L C RL V EYV +L
Sbjct: 372 KILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLM 430
Query: 431 FHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVAD 490
+H+ GR A A GL +L II+RD+K N++LD K+AD
Sbjct: 431 YHIQQVGRFKEPH-AVFYAAE-IAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIAD 485
Query: 491 FGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
FG+ K + T GT Y+APE + + D ++FGV+L E++ G+ P
Sbjct: 486 FGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 89.0 bits (220), Expect = 3e-18
Identities = 45/221 (20%), Positives = 80/221 (36%), Gaps = 11/221 (4%)
Query: 1 MEDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPS 60
+D +P + S SP + +D + + + + P
Sbjct: 1465 GQDGGVTPYSNESGLVNADLDVKDELMFSPLVDSGSNDAMAGGFTAYGGADYGEATSPFG 1524
Query: 61 SPPPSPESP--PPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNAS 118
+ +P SP SSP S SP SP + P SP + P S P++ + S
Sbjct: 1525 AYGEAPTSPGFGVSSPGFSPTSPTYSP------TSPAYSPTSPSYSPTSPSYSPTSPSYS 1578
Query: 119 PPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPP 178
P +P+ P ++ SP + + + + + + + + + + ++ P P
Sbjct: 1579 PTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP 1638
Query: 179 ---PSSSSNSPNGNRSGALSPPNKSNGSSSSPSSNNGSMLS 216
P+S S SP SP S SP+S + S S
Sbjct: 1639 SYSPTSPSYSPTSPSYSPTSPAYSPTSPSYSPTSPSYSPTS 1679
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 79.4 bits (195), Expect = 3e-15
Identities = 53/233 (22%), Positives = 82/233 (35%), Gaps = 26/233 (11%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPD--RSP--PPSS 61
+ + + +P S ++ + + + P + SP SS
Sbjct: 1480 VNADLDVKDELMFSPLVDSGSNDAMAGGFTAYGGADYGEATSPFGAYGEAPTSPGFGVSS 1539
Query: 62 P---PPSPESPPPSSPPPSSQSPPQSPPPPN--SKSPPQS---------SPPPNTNPPPQ 107
P P SP P+SP S SP SP P+ SP S SP + P
Sbjct: 1540 PGFSPTSPTY-SPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSY 1598
Query: 108 SSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNG----NGNHNN 163
S PS S SP S +PS P S + +SP + + + + + + +
Sbjct: 1599 SPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS 1658
Query: 164 NNNNNNNKNWHPPPP---PSSSSNSPNGNRSGALSPPNKSNGSSSSPSSNNGS 213
+ + ++ P P P+S S SP SP S SP+S S
Sbjct: 1659 PAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPNYSPTSPSYSPTSPGYS 1711
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 78.2 bits (192), Expect = 7e-15
Identities = 39/202 (19%), Positives = 69/202 (34%), Gaps = 5/202 (2%)
Query: 15 DAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSP 74
TP S+ES ++ SP S + ++
Sbjct: 1452 KYMPEQKITEIEDGQDGGVTPYSNESGLVNADLDVKDELMFSPLVDSGSNDAMAGGFTAY 1511
Query: 75 PPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDS 134
+ SP ++P +SP + P S P+ S SP S +PS P S
Sbjct: 1512 GGADYGEATSPFGAYGEAP--TSPGFGVSSPGFSPTSPTYSPTSPAYSPTSPSYSPTSPS 1569
Query: 135 NNGSSP---PGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSSSSNSPNGNRS 191
+ +SP P + + + + + + + + + P PS S SP+ + +
Sbjct: 1570 YSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPT 1629
Query: 192 GALSPPNKSNGSSSSPSSNNGS 213
P + S +SPS + S
Sbjct: 1630 SPSYSPTSPSYSPTSPSYSPTS 1651
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 77.4 bits (190), Expect = 1e-14
Identities = 59/196 (30%), Positives = 79/196 (40%), Gaps = 8/196 (4%)
Query: 4 NNQSPGVS-NSPDAAETPPSPSRASSSPPPSTP-PSDESPPPSSPPPSSPPPDRSPPPSS 61
SPG S SP + T P+ S S S P++P S SP S PS P S P+S
Sbjct: 1536 GVSSPGFSPTSPTYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS 1595
Query: 62 PPPSPESP--PPSSPPPSSQSPPQSP----PPPNSKSPPQSSPPPNTNPPPQSSPPPSNS 115
P SP SP P+SP S SP SP P S S +SP + P S PS S
Sbjct: 1596 PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS 1655
Query: 116 NASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHP 175
SP S +PS P S + +SP + + + + + + + + P
Sbjct: 1656 PTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPNYSPTSPSYSPTSPGYSPGSP 1715
Query: 176 PPPPSSSSNSPNGNRS 191
P N N +
Sbjct: 1716 AYSPKQDEQKHNENEN 1731
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 68.2 bits (166), Expect = 8e-12
Identities = 51/139 (36%), Positives = 63/139 (45%), Gaps = 9/139 (6%)
Query: 12 NSPDAAETPPSPSRASSSPPPSTPP-SDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPP 70
SP + T PS S S S P++P S SP S PS P S P+SP SP SP
Sbjct: 1594 TSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPS 1653
Query: 71 --PSSPPPSSQSPPQSPPPPN-SKSPPQSSPPPNTNPP--PQSSPP-PSNSNASPPPSQD 124
P+SP S SP SP P+ S + P SP + P P SP PS S SP S
Sbjct: 1654 YSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPNYSPTSPSYSPTSPGYSPG 1713
Query: 125 NPSDPP--PGDSNNGSSPP 141
+P+ P +N +
Sbjct: 1714 SPAYSPKQDEQKHNENENS 1732
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 62.8 bits (152), Expect = 3e-10
Identities = 43/128 (33%), Positives = 55/128 (42%), Gaps = 8/128 (6%)
Query: 4 NNQSPGVS-NSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSP-PPSSPPPDRSPPPSS 61
+ SP S SP + T PS S S S P++P + P SP PS P + P+S
Sbjct: 1606 SPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPAYSPTS 1665
Query: 62 PPPSPESPP--PSSPPPSSQSPPQSPPPPN----SKSPPQSSPPPNTNPPPQSSPPPSNS 115
P SP SP P+SP S SP SP PN S S +SP + P S
Sbjct: 1666 PSYSPTSPSYSPTSPSYSPTSPSYSPTSPNYSPTSPSYSPTSPGYSPGSPAYSPKQDEQK 1725
Query: 116 NASPPPSQ 123
+ S+
Sbjct: 1726 HNENENSR 1733
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 62/205 (30%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 353 LLGQGGFGYV----HKGVLPNGKEVAVKSLRSGSGQGEREF---KAEVEIISR-VHHRHL 404
++G+G FG V HK AVK L+ + ++E +E ++ + V H L
Sbjct: 45 VIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 101
Query: 405 VSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIA-MGSAKGLAYLHE 462
V L + +L V +Y+ L +HL + + R A + SA L YLH
Sbjct: 102 VGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR-ARFYAAEIASA--LGYLHS 157
Query: 463 DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS 522
I++RD+K NILLD + DFGL K ++N+ ST GT YLAPE
Sbjct: 158 L---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEYLAPEVLHK 213
Query: 523 GKLTEKSDVFSFGVMLLELITGRRP 547
D + G +L E++ G P
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 4e-18
Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 19/204 (9%)
Query: 353 LLGQGGFGYV----HKGVLPNGKEVAVKSLRSGSGQGEREF---KAEVEIISRV-HHRHL 404
+LG+G FG V K + A+K+L+ + + E ++S H L
Sbjct: 24 MLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 80
Query: 405 VSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHED 463
+ + L V EY+ +L +H+ + + A GL +LH
Sbjct: 81 THMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSR-ATFYAAE-IILGLQFLHSK 137
Query: 464 CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSG 523
I++RD+K NILLD K+ADFG+ K + +T GT Y+APE
Sbjct: 138 ---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLGQ 193
Query: 524 KLTEKSDVFSFGVMLLELITGRRP 547
K D +SFGV+L E++ G+ P
Sbjct: 194 KYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 7e-18
Identities = 64/253 (25%), Positives = 106/253 (41%), Gaps = 59/253 (23%)
Query: 325 PIVALGFSQSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSG 383
V F YE+L +GQG FG V K G++VA+K + +
Sbjct: 6 DSVECPFCDEVSKYEKL----------AKIGQGTFGEVFKARHRKTGQKVALKKVLMEN- 54
Query: 384 QGERE---FKA--EVEIISRVHHRHLVSLVGYCIAGGKRL--------LVYEYVPNNNLE 430
E+E A E++I+ + H ++V+L+ C LV+++ ++L
Sbjct: 55 --EKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLA 111
Query: 431 FHLHGKGRPVMDWPTRLKIAMGS-AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVA 489
L + +K M GL Y+H + +I+HRD+K++N+L+ K+A
Sbjct: 112 GLLSNVLVKFT--LSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA 166
Query: 490 DFGLAKLTTDNN-------THVSTRVMGTFGYLAPE-------YASSGKLTEKSDVFSFG 535
DFGLA+ + T+ RV+ T Y PE Y D++ G
Sbjct: 167 DFGLARAFSLAKNSQPNRYTN---RVV-TLWYRPPELLLGERDY------GPPIDLWGAG 216
Query: 536 VMLLELITGRRPI 548
++ E+ T R PI
Sbjct: 217 CIMAEMWT-RSPI 228
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 7e-18
Identities = 67/210 (31%), Positives = 93/210 (44%), Gaps = 31/210 (14%)
Query: 353 LLGQGGFGYV----HKGVLPNGKEVAVKSLRSGSGQGEREF---KAEVEIISRV-HHRHL 404
+LG+G FG V K G AVK L+ + + E I+S +H L
Sbjct: 30 VLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 405 VSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIA-MGSAKGLAYLHE 462
L C RL V E+V +L FH+ R R A + SA L +LH+
Sbjct: 87 TQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEAR-ARFYAAEIISA--LMFLHD 142
Query: 463 DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS 522
II+RD+K N+LLD+ K+ADFG+ K N +T GT Y+APE
Sbjct: 143 K---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPEI--- 195
Query: 523 GKLTEKS-----DVFSFGVMLLELITGRRP 547
L E D ++ GV+L E++ G P
Sbjct: 196 --LQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 9e-18
Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 353 LLGQGGFGYV----HKGVLPNGKEVAVKSLRSGSGQGEREF---KAEVEIISRV-HHRHL 404
++G+G + V K + A++ ++ + + + E + + +H L
Sbjct: 59 VIGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 115
Query: 405 VSLVGYCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIA-MGSAKGLAYLHE 462
V L C RL V EYV +L FH+ + + + R A + A L YLHE
Sbjct: 116 VGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYSAEISLA--LNYLHE 171
Query: 463 DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS 522
II+RD+K N+LLD K+ D+G+ K ST GT Y+APE
Sbjct: 172 R---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEILRG 227
Query: 523 GKLTEKSDVFSFGVMLLELITGRRP 547
D ++ GV++ E++ GR P
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 54/221 (24%), Positives = 91/221 (41%), Gaps = 42/221 (19%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKA---EVEIISRVH-------- 400
LG G F V + N VA+K +R + +A E++++ RV+
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 401 ---HRHLVSLVG---YCIAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRL--KIAM 451
H++ L+ + G + +V+E + N L + R + P +I+
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI---PLIYVKQISK 138
Query: 452 GSAKGLAYLHEDCHPRIIHRDIKSSNILLDY------TFETKVADFGLAKLTTDN-NTHV 504
GL Y+H C IIH DIK N+L++ + K+AD G A ++ +
Sbjct: 139 QLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 196
Query: 505 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR 545
TR Y +PE +D++S ++ ELITG
Sbjct: 197 QTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 52/212 (24%), Positives = 98/212 (46%), Gaps = 41/212 (19%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGYC 411
LG+G + V + + + N ++V VK L+ +++ K E++I+ + ++++L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITL--AD 98
Query: 412 I----AGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTR------LKIAMGSAKGLAYLH 461
I LV+E+V NN +F + + D+ R LK L Y H
Sbjct: 99 IVKDPVSRTPALVFEHV--NNTDFKQLYQ--TLTDYDIRFYMYEILK-------ALDYCH 147
Query: 462 EDCHPRIIHRDIKSSNILLDY-TFETKVADFGLAKLTTDN---NTHVSTRVMGTFGYLAP 517
I+HRD+K N+++D+ + ++ D+GLA+ N V++R + P
Sbjct: 148 SM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGP 199
Query: 518 EYASSGKLTEKS-DVFSFGVMLLELITGRRPI 548
E ++ + S D++S G ML +I + P
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 58/276 (21%), Positives = 99/276 (35%), Gaps = 88/276 (31%)
Query: 330 GFSQSAFTYEELSAATGGFSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE 388
G S+ Y LG G FG V + + +GK A+K + +
Sbjct: 1 GLETSSKKYSLGK----------TLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPR 45
Query: 389 FKA-EVEIISRVHHRHLVSLVGYCIAGGKRL----------------------------- 418
+K E++I+ + H +++ LV Y G
Sbjct: 46 YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIV 105
Query: 419 ---------LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSA----------KGLAY 459
++ EYVP+ LH V+ R ++ + + +
Sbjct: 106 NPSQNKYLNVIMEYVPDT-----LH----KVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156
Query: 460 LHEDCHPRIIHRDIKSSNILLD-YTFETKVADFGLAKLT--TDNNTH-VSTRVMGTFGYL 515
+H I HRDIK N+L++ K+ DFG AK ++ + + +R Y
Sbjct: 157 IH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YR 208
Query: 516 APE-YASSGKLTEKSDVFSFGVMLLELITGRRPIDP 550
APE + + T D++S G + ELI G +P+
Sbjct: 209 APELMLGATEYTPSIDLWSIGCVFGELILG-KPLFS 243
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 85.5 bits (211), Expect = 3e-17
Identities = 65/236 (27%), Positives = 90/236 (38%), Gaps = 23/236 (9%)
Query: 1 MEDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPP---PSSPP--PSSPPPDR 55
+ SP + SP ++P S P +SP PSSP
Sbjct: 1508 LVQGGSEGREGFGDYGLLGAASPYKGVQSPGYTSPFSSAMSPGYGLTSPSYSPSSPGYST 1567
Query: 56 SPP--PSSPPPSPESPP--PSSPPPSSQSPPQSP---------PPPNSKSPPQSSPPPNT 102
SP PSSP SP SP P+SP S SP SP P + SP S P+
Sbjct: 1568 SPAYMPSSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSATSPSYSPTSPSYSPTSPSY 1627
Query: 103 NP--PPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGN 160
+P P S PS S SP S +PS P S + +SP + + + + +
Sbjct: 1628 SPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS 1687
Query: 161 HNNNNNNNNNKNWHPPPPPSSSSNSPNGNRSGALSP---PNKSNGSSSSPSSNNGS 213
+ + + + P P+S S SP SP P + S +SPS + S
Sbjct: 1688 PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS 1743
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 81.3 bits (200), Expect = 7e-16
Identities = 59/240 (24%), Positives = 83/240 (34%), Gaps = 31/240 (12%)
Query: 1 MEDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESP-----PPSSPPPSSPPPDR 55
G SPDAA P S SP +SP
Sbjct: 1487 ERSPMVDSGFVGSPDAAAFSPLVQGGSEGREGFGDYGLLGAASPYKGVQSPGYTSPFSSA 1546
Query: 56 SPP---PSSPPPSPESPP---------------PSSPPPSSQSPPQSP--PPPNSKSPPQ 95
P +SP SP SP P+SP S SP SP P + SP
Sbjct: 1547 MSPGYGLTSPSYSPSSPGYSTSPAYMPSSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSY 1606
Query: 96 SSPPPNTNP--PPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKG 153
S+ P+ +P P S PS S SP S +PS P S + +SP + + +
Sbjct: 1607 SATSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP----SYSPTSPSY 1662
Query: 154 NGNGNGNHNNNNNNNNNKNWHPPPPPSSSSNSPNGNRSGALSPPNKSNGSSSSPSSNNGS 213
+ + + + + P PS S SP+ + + P + S +SPS + S
Sbjct: 1663 SPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS 1722
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 78.6 bits (193), Expect = 4e-15
Identities = 62/214 (28%), Positives = 89/214 (41%), Gaps = 33/214 (15%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTP---PSDESPPPSSPPPSSPPPDRSP----- 57
SPG S SP + PS S S S P++P P+ S P+SP S+ P SP
Sbjct: 1561 SSPGYSTSPAYMPSSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSATSPSYSPTSPSY 1620
Query: 58 PPSSPPPSPESPP--PSSPPPSSQSPPQSPPPPN-SKSPPQSSPPPNTNPPPQSSPPPSN 114
P+SP SP SP P+SP S SP SP P+ S + P SP + P S P++
Sbjct: 1621 SPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS 1680
Query: 115 SNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWH 174
+ SP +P+ P ++ SP + + + +
Sbjct: 1681 PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPS----------------------Y 1718
Query: 175 PPPPPSSSSNSPNGNRSGALSPPNKSNGSSSSPS 208
P PS S SP+ + + P + S +SPS
Sbjct: 1719 SPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPS 1752
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 78.2 bits (192), Expect = 6e-15
Identities = 51/224 (22%), Positives = 71/224 (31%), Gaps = 20/224 (8%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTP------PSDESPPPSSPPPSSPPPDRSPPP 59
G S P+ A TP S S +P P + + P
Sbjct: 1471 SGMGTSQLPEGAGTPYERSPMVDSGFVGSPDAAAFSPLVQGGSEGREGFGDYGLLGAASP 1530
Query: 60 SSPPPSPESPPPSSPPPSSQSPPQSP-----PPPNSKSPPQSSPPPNTNP--PPQSSPPP 112
SP P S S SP P S SP P+ +P P S P
Sbjct: 1531 YKGVQSPGYTSPFSSAMSPGYGLTSPSYSPSSPGYSTSPAYMPSSPSYSPTSPSYSPTSP 1590
Query: 113 SNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKN 172
S S SP S +PS S + +SP + + + + + + + +
Sbjct: 1591 SYSPTSPSYSPTSPSYSATSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS----- 1645
Query: 173 WHPPPPPSSSSNSPNGNRSGALSPPNKSNGSSSSPSSNNGSMLS 216
P P+S S SP SP S SP+S + S S
Sbjct: 1646 --PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS 1687
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 33/88 (37%), Positives = 40/88 (45%), Gaps = 14/88 (15%)
Query: 4 NNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPP 63
+ SP S P SPS + +SP S SP S P+SP S P+SP
Sbjct: 1677 SPTSPSYS--------PTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP----SYSPTSPS 1724
Query: 64 PSPESP--PPSSPPPSSQSPPQSPPPPN 89
SP SP P+SP S SP SP P+
Sbjct: 1725 YSPTSPSYSPTSPSYSPTSPSYSPTSPS 1752
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 84.9 bits (209), Expect = 4e-17
Identities = 27/179 (15%), Positives = 39/179 (21%), Gaps = 1/179 (0%)
Query: 20 PPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQ 79
P + + + P P+ PP PP PS +P Q
Sbjct: 10 PQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQ-EQ 68
Query: 80 SPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSS 139
Q S + P +P P +P Q P P + +
Sbjct: 69 LHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAM 128
Query: 140 PPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSSSSNSPNGNRSGALSPPN 198
N + PP S N + S N
Sbjct: 129 GQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNASPDYIRSTLN 187
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 80.6 bits (198), Expect = 9e-16
Identities = 23/166 (13%), Positives = 34/166 (20%), Gaps = 2/166 (1%)
Query: 22 SPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSP 81
S + P + P P PP P + PP PS
Sbjct: 2 SHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQ--DPAAAGMSYGQMGMPPQGAVPSMGQQ 59
Query: 82 PQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPP 141
P + N + P + NA P P + P
Sbjct: 60 QFLTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAP 119
Query: 142 GNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSSSSNSPN 187
+ G+ N + + P P
Sbjct: 120 AYGQPSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPP 165
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 79.9 bits (196), Expect = 1e-15
Identities = 21/145 (14%), Positives = 25/145 (17%), Gaps = 1/145 (0%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
Q P P PP PS +P +S
Sbjct: 24 QQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQLHQQIDQATTSMNDM 83
Query: 66 PESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSP-PPNTNPPPQSSPPPSNSNASPPPSQD 124
P P + P Q P P + P
Sbjct: 84 HLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAMGQNMRPMNQLYPIDL 143
Query: 125 NPSDPPPGDSNNGSSPPGNNNNNNN 149
PPP PP
Sbjct: 144 LTELPPPITDLTLPPPPLVIPPERM 168
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 77.6 bits (190), Expect = 8e-15
Identities = 19/143 (13%), Positives = 35/143 (24%), Gaps = 2/143 (1%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
Q N+ + + + PP + P +P
Sbjct: 13 QLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQLHQQ 72
Query: 66 PESPPPSSPPPSSQSPPQSPPPP--NSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQ 123
+ S + P P + P Q P P ++P +A+ +
Sbjct: 73 IDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAMGQNM 132
Query: 124 DNPSDPPPGDSNNGSSPPGNNNN 146
+ P D PP +
Sbjct: 133 RPMNQLYPIDLLTELPPPITDLT 155
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 77.6 bits (190), Expect = 8e-15
Identities = 18/139 (12%), Positives = 26/139 (18%), Gaps = 2/139 (1%)
Query: 14 PDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSS 73
P A + P PP D + S PP + P
Sbjct: 10 PQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQL 69
Query: 74 PPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASP--PPSQDNPSDPPP 131
Q+ P P P P P+ PS
Sbjct: 70 HQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAMG 129
Query: 132 GDSNNGSSPPGNNNNNNNN 150
+ + +
Sbjct: 130 QNMRPMNQLYPIDLLTELP 148
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 77.2 bits (189), Expect = 1e-14
Identities = 15/129 (11%), Positives = 28/129 (21%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
Q+ P+ P + + P S + P+
Sbjct: 11 QAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQLH 70
Query: 66 PESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDN 125
+ ++ PN+ PQ T Q P + + P +
Sbjct: 71 QQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAMGQ 130
Query: 126 PSDPPPGDS 134
P
Sbjct: 131 NMRPMNQLY 139
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 76.0 bits (186), Expect = 3e-14
Identities = 18/140 (12%), Positives = 26/140 (18%), Gaps = 1/140 (0%)
Query: 11 SNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPP 70
+ P A PP + S PP P P +
Sbjct: 12 AQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQLHQ 71
Query: 71 PSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPP 130
+S + P P P A+P Q + +
Sbjct: 72 QIDQATTSMNDMHLHNVPLV-DPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAMGQ 130
Query: 131 PGDSNNGSSPPGNNNNNNNN 150
N P
Sbjct: 131 NMRPMNQLYPIDLLTELPPP 150
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 74.1 bits (181), Expect = 8e-14
Identities = 22/147 (14%), Positives = 35/147 (23%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
S PP + S P+ E ++ D
Sbjct: 34 DPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQLHQQIDQATTSMNDMHLHNVPLVDP 93
Query: 66 PESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDN 125
P P Q P + + Q S N P + P + PP +
Sbjct: 94 NAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAMGQNMRPMNQLYPIDLLTELPPPITD 153
Query: 126 PSDPPPGDSNNGSSPPGNNNNNNNNGK 152
+ PPP + +N +
Sbjct: 154 LTLPPPPLVIPPERMLVPSELSNASPD 180
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 72.6 bits (177), Expect = 3e-13
Identities = 22/145 (15%), Positives = 33/145 (22%), Gaps = 4/145 (2%)
Query: 4 NNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPP 63
S G P P + +P S P P
Sbjct: 38 AGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQLH----QQIDQATTSMNDMHLHNVPLVDP 93
Query: 64 PSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQ 123
+ P + Q P + P ++ N P Q P + PP +
Sbjct: 94 NAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAMGQNMRPMNQLYPIDLLTELPPPITD 153
Query: 124 DNPSDPPPGDSNNGSSPPGNNNNNN 148
PP P +N +
Sbjct: 154 LTLPPPPLVIPPERMLVPSELSNAS 178
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 63.3 bits (153), Expect = 2e-10
Identities = 16/137 (11%), Positives = 30/137 (21%), Gaps = 1/137 (0%)
Query: 4 NNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPP 63
P + + +P++ + + P P P P
Sbjct: 45 MGMPPQGAVPSMGQQQFLTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPN-AYMQPQVPV 103
Query: 64 PSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQ 123
P ++ + Q P + P P + PP
Sbjct: 104 QMGTPLQQQQQPMAAPAYGQPSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVI 163
Query: 124 DNPSDPPPGDSNNGSSP 140
P + +N S
Sbjct: 164 PPERMLVPSELSNASPD 180
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 3e-07
Identities = 17/156 (10%), Positives = 36/156 (23%), Gaps = 10/156 (6%)
Query: 68 SPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPS 127
S P +Q P P PP P + P + +
Sbjct: 2 SHHKKRVYPQAQLQYGQNATPLQ--QPAQFMPPQ--DPAAAGMSYGQMGMPPQGAVPSMG 57
Query: 128 DPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSSSSNSPN 187
+P + + + + +N + N P P +
Sbjct: 58 QQQFL------TPAQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQ 111
Query: 188 GNRSGALSPPNKSNGSSSSPSSNNGSMLSIPLVAAV 223
+ A + + + + I L+ +
Sbjct: 112 QQQPMAAPAYGQPSAAMGQNMRPMNQLYPIDLLTEL 147
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 53/226 (23%), Positives = 98/226 (43%), Gaps = 50/226 (22%)
Query: 354 LGQGGFGYVHKGV---LPNGKEVAVKSLR----SGSGQGEREFKAEVEIISRVHHRHLVS 406
+G+G +G+V+K + K+ A+K + S S E + ++ + H +++S
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE------IALLRELKHPNVIS 82
Query: 407 LVGYCIAGGKRL--LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAK--------G 456
L ++ R L+++Y ++L + + +++ G K G
Sbjct: 83 LQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKP-VQLPRGMVKSLLYQILDG 140
Query: 457 LAYLHEDCHPRIIHRDIKSSNILLDYTFET----KVADFGLAKLTTDNN---THVSTRVM 509
+ YLH + ++HRD+K +NIL+ K+AD G A+L + V+
Sbjct: 141 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 510 GTFGYLAPE-------YASSGKLTEKSDVFSFGVMLLELITGRRPI 548
TF Y APE Y T+ D+++ G + EL+T PI
Sbjct: 198 -TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLT-SEPI 235
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 43/228 (18%), Positives = 90/228 (39%), Gaps = 44/228 (19%)
Query: 354 LGQGGFGYVHKGV---------LPNGKEVAVKSLRSGSGQGEREFK--------AEVEII 396
+ G +++ P ++ ++K L + G+ E +V
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 397 SRVHHRHLV---SLVGYCIAGGK-RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMG 452
+++ L+ + +G+ + K R LV + +L+ L + V+ + L++A
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 453 SAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKV--ADFGLAKLTTDNNTHVSTR--- 507
L +LHE+ +H ++ + NI +D +++V A +G A + HV+
Sbjct: 168 LLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGS 224
Query: 508 ---VMGTFGYLAPEYAS----SGK-LTEKSDVFSFGVMLLELITGRRP 547
G E+ S G + +SD+ S G +L+ + G P
Sbjct: 225 RSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 46/220 (20%), Positives = 72/220 (32%), Gaps = 74/220 (33%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGYC 411
LG G G V + ++ A+K L+ + + EVE+ R H+V +V
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVD-- 78
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPT------RLKIAMGS------------ 453
VYE + + VM+ R+ G
Sbjct: 79 --------VYENLYAGRKCLLI------VMECLDGGELFSRI-QDRGDQAFTEREASEIM 123
Query: 454 ---AKGLAYLHEDCHPRIIHRDIKSSNILLDYTFET---KVADFGLAKLTTDNNTHVSTR 507
+ + YLH I HRD+K N+L K+ DFG AK +
Sbjct: 124 KSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-------ETTGE 173
Query: 508 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
Y + D++S GV++ L+ G P
Sbjct: 174 -----KY-----------DKSCDMWSLGVIMYILLCGYPP 197
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 48/218 (22%), Positives = 83/218 (38%), Gaps = 42/218 (19%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVK--SLRSGSGQGEREFKA---------EVEIISRVHHR 402
+ G +G V GV G VA+K G+ E+ +++ HH
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 403 HLVSLVGYCIAGGKRL-----LVYEYVPNNNLEFHLHGKGRPVMDWPTR------LKIAM 451
+++ L + + LV E + + L +H + + + L
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVIHDQRIVISPQHIQYFMYHILL--- 145
Query: 452 GSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT---HVSTRV 508
GL LHE ++HRD+ NILL + + DF LA+ T + +V+ R
Sbjct: 146 ----GLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW 198
Query: 509 MGTFGYLAPEY-ASSGKLTEKSDVFSFGVMLLELITGR 545
Y APE T+ D++S G ++ E+ +
Sbjct: 199 -----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 53/229 (23%), Positives = 88/229 (38%), Gaps = 47/229 (20%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSL---RSGSGQGEREFK-----AEVEIISRVHHRH 403
+G GGFG ++ ++ A + +G E K A+ + I + R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 404 LVSLVG---------YCIAGGK-RLLVYEYVPNNNLE--FHLHGKGRPVMDWPTRLKIAM 451
+ +G G R +V E + +L+ +G T L++ +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGT----FKKSTVLQLGI 158
Query: 452 GSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKV--ADFGLAKLTTDNNTHV----- 504
L Y+HE+ +H DIK++N+LL Y +V AD+GL+ N H
Sbjct: 159 RMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215
Query: 505 -STRVMGTFGYLAPEYAS----SGK-LTEKSDVFSFGVMLLELITGRRP 547
GT E+ S G L+ +SDV G +L + G+ P
Sbjct: 216 PRKGHNGT-----IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 10/93 (10%)
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH-VSTRVMGTFG 513
KGL Y+H ++HRD+K N+ ++ E K+ DFGLA+ T V TR
Sbjct: 137 KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW----- 188
Query: 514 YLAPEYA-SSGKLTEKSDVFSFGVMLLELITGR 545
Y APE S + D++S G ++ E++TG+
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 49/230 (21%), Positives = 86/230 (37%), Gaps = 46/230 (20%)
Query: 353 LLGQGGFGYVHKGVLPNGK------EVAVKSLRSGSGQGEREFK-----AEVEIISRVHH 401
+GQGGFG ++ + + + VK S +G E K A+ E I +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 402 RHLVSLVG----------YCIAGGKRLLVYEYV-PNNNLEFHLHGKGRPVMDWPTRLKIA 450
+ +G R ++ + + L+ + T L+++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSD--LQKIYEANAKR-FSRKTVLQLS 158
Query: 451 MGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKV--ADFGLAKLTTDNNTHV---- 504
+ L Y+HE +H DIK+SN+LL+Y +V D+GLA H
Sbjct: 159 LRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAA 215
Query: 505 --STRVMGTFGYLAPEYAS----SGK-LTEKSDVFSFGVMLLELITGRRP 547
GT E+ S +G + + D+ G +++ +TG P
Sbjct: 216 DPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 37/93 (39%), Positives = 54/93 (58%), Gaps = 10/93 (10%)
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT-HVSTRVMGTFG 513
+GL Y+H IIHRD+K SN+ ++ E K+ DFGLA+ T D T +V+TR
Sbjct: 143 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW----- 194
Query: 514 YLAPEYA-SSGKLTEKSDVFSFGVMLLELITGR 545
Y APE + + D++S G ++ EL+TGR
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 35/93 (37%), Positives = 52/93 (55%), Gaps = 10/93 (10%)
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT-HVSTRVMGTFG 513
KGL Y+H IIHRD+K N+ ++ E K+ DFGLA+ T +V TR
Sbjct: 139 KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW----- 190
Query: 514 YLAPEYA-SSGKLTEKSDVFSFGVMLLELITGR 545
Y APE + + T+ D++S G ++ E+ITG+
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 32/94 (34%), Positives = 46/94 (48%), Gaps = 11/94 (11%)
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT---HVSTRVMGT 511
G+ +LH IIHRD+K SNI++ K+ DFGLA+ + +V TR
Sbjct: 138 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--- 191
Query: 512 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR 545
Y APE E D++S G ++ E+I G
Sbjct: 192 --YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 51/214 (23%), Positives = 86/214 (40%), Gaps = 34/214 (15%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVK--SLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGY 410
+G+G FG + +G L N ++VA+K RS + Q E++ + ++ +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT---YKLLAGCTGIPNVYYF 74
Query: 411 CIAGGKRLLVYEYV-PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRII 469
G +LV + + P+ LE L GR T A + +HE ++
Sbjct: 75 GQEGLHNVLVIDLLGPS--LEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKS---LV 128
Query: 470 HRDIKSSNILLDYTFETK-----VADFGLAKLTTDNNT--HVSTR----VMGTFGYLAPE 518
+RDIK N L+ V DFG+ K D T H+ R + GT
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT-----AR 183
Query: 519 YAS----SGK-LTEKSDVFSFGVMLLELITGRRP 547
Y S G+ + + D+ + G + + + G P
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 51/219 (23%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGE-----REFKAEVEIISRVHHRHLVSL 407
+G+G +G V N VA+K + Q RE K I+ R H +++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK----ILLRFRHENIIGI 90
Query: 408 VGYCIAGGKRL-----LVYEYVPNNNLEFHLHG--KGRPVMDWPTR------LKIAMGSA 454
A +V + +E L+ K + + + L+
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQHLSNDHICYFLYQILR------ 139
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH-------VSTR 507
GL Y+H ++HRD+K SN+LL+ T + K+ DFGLA++ ++ H V+TR
Sbjct: 140 -GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 508 VMGTFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELITGR 545
Y APE +S T+ D++S G +L E+++ R
Sbjct: 196 -----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 8e-14
Identities = 74/328 (22%), Positives = 119/328 (36%), Gaps = 67/328 (20%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKA---EVEIISRVHHR------ 402
++G+G FG V K + VA+K +R+ +R + E+ I+ + +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 403 HLVSLVGY-------CIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRL--KIAMGS 453
+++ ++ C+ +E + N E K + L K A
Sbjct: 160 NVIHMLENFTFRNHICM-------TFELLSMNLYELIKKNKFQGF---SLPLVRKFAHSI 209
Query: 454 AKGLAYLHEDCHPRIIHRDIKSSNILL--DYTFETKVADFGLAKLTTDNNTH---VSTRV 508
+ L LH+ RIIH D+K NILL KV DFG + ++ + +R
Sbjct: 210 LQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTYIQSR- 263
Query: 509 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPT-------GAMEDCLVDW 561
F Y APE + D++S G +L EL+TG P+ P M + L
Sbjct: 264 ---F-YRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLPGEDEGDQLACMIELLGMP 318
Query: 562 ARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
++ L + NF T +V S R R P+ + AL+
Sbjct: 319 SQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALK 378
Query: 622 G--DVSLEDLNDG---------IKPSQA 638
G D D + P QA
Sbjct: 379 GCDDPLFLDFLKQCLEWDPAVRMTPGQA 406
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 51/231 (22%), Positives = 86/231 (37%), Gaps = 47/231 (20%)
Query: 345 TGGFSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKA---EVEIISRVH 400
+ +L+G+G FG V K + VA+K +++ + EV ++ ++
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMN 108
Query: 401 HR------HLVSLVGY-------CIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRL 447
++V L + C+ V+E + N + + R V L
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCL-------VFEMLSYNLYDLLRNTNFRGV---SLNL 158
Query: 448 --KIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILL--DYTFETKVADFGLAKLTTDNNTH 503
K A L +L IIH D+K NILL K+ DFG +
Sbjct: 159 TRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRI 215
Query: 504 ---VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPT 551
+ +R F Y +PE D++S G +L+E+ TG P+
Sbjct: 216 YQYIQSR----F-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTG-EPLFSG 260
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 54/213 (25%), Positives = 83/213 (38%), Gaps = 34/213 (15%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVK--SLRSGSGQGEREFK-----AEVEIISRVHHRHLV 405
+G G FG ++ G + G+EVA+K +++ Q E K I +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRW---- 72
Query: 406 SLVGYCIAGGKRLLVYEYV-PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC 464
G ++V E + P+ LE + R T L +A + Y+H
Sbjct: 73 ----CGAEGDYNVMVMELLGPS--LEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKN 125
Query: 465 HPRIIHRDIKSSNILLDYTFETK---VADFGLAKLTTDNNT--HVSTR----VMGTFGYL 515
IHRD+K N L+ + + DFGLAK D T H+ R + GT Y
Sbjct: 126 ---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY- 181
Query: 516 APEYASSGK-LTEKSDVFSFGVMLLELITGRRP 547
A G + + D+ S G +L+ G P
Sbjct: 182 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 50/230 (21%), Positives = 89/230 (38%), Gaps = 64/230 (27%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVK------------SLRSGSGQGEREFKAEVEIISRVH 400
LG GG G V V K VA+K +LR E++II R+
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR------------EIKIIRRLD 66
Query: 401 HRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDW-PTRLKIAMGSA----- 454
H ++V + G +L ++ V ++ T L +
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYI------VQEYMETDLANVLEQGPLLEE 120
Query: 455 ----------KGLAYLHEDCHPRIIHRDIKSSNILLDYTF-ETKVADFGLAKLTTDNNTH 503
+GL Y+H ++HRD+K +N+ ++ K+ DFGLA++ + +H
Sbjct: 121 HARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
Query: 504 -------VSTRVMGTFGYLAPE-YASSGKLTEKSDVFSFGVMLLELITGR 545
+ T+ Y +P S T+ D+++ G + E++TG+
Sbjct: 178 KGHLSEGLVTK-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 51/214 (23%), Positives = 82/214 (38%), Gaps = 34/214 (15%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVK--SLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGY 410
+G G FG + G L + VA+K ++S + Q E++ + + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYR---FYKQLGSGDGIPQVYYF 73
Query: 411 CIAGGKRLLVYEYV-PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRII 469
G +V E + P+ LE R T L IA+ + Y+H +I
Sbjct: 74 GPCGKYNAMVLELLGPS--LEDLFDLCDR-TFSLKTVLMIAIQLISRMEYVHSKN---LI 127
Query: 470 HRDIKSSNILLDYTFETK-----VADFGLAKLTTDNNT--HVSTR----VMGTFGYLAPE 518
+RD+K N L+ + DF LAK D T H+ R + GT
Sbjct: 128 YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT-----AR 182
Query: 519 YAS----SGK-LTEKSDVFSFGVMLLELITGRRP 547
Y S GK + + D+ + G M + + G P
Sbjct: 183 YMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 70.5 bits (172), Expect = 6e-13
Identities = 25/133 (18%), Positives = 36/133 (27%), Gaps = 3/133 (2%)
Query: 12 NSPDAAETPPSPSRASSSPPPSTPPSDESP---PPSSPPPSSPPPDRSPPPSSPPPSPES 68
+ D + S SS P+ S +P P P SP SP + P
Sbjct: 7 HHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPINGM 66
Query: 69 PPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSD 128
PP S S P P + P ++P S
Sbjct: 67 GPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVPA 126
Query: 129 PPPGDSNNGSSPP 141
P G+ + +
Sbjct: 127 HPSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 66.3 bits (161), Expect = 1e-11
Identities = 25/134 (18%), Positives = 36/134 (26%), Gaps = 1/134 (0%)
Query: 20 PPSPSRASSSPPPSTPPSDESPPPSSP-PPSSPPPDRSPPPSSPPPSPESPPPSSPPPSS 78
ST + P+ ++P S P P P S+
Sbjct: 4 HHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPI 63
Query: 79 QSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGS 138
+S P S P T S+ P S+ P S PP G +
Sbjct: 64 NGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLK 123
Query: 139 SPPGNNNNNNNNGK 152
P + N + K
Sbjct: 124 VPAHPSGNMASFTK 137
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 3e-11
Identities = 31/130 (23%), Positives = 44/130 (33%), Gaps = 5/130 (3%)
Query: 5 NQSPGVSNSPDAAETPPS--PSRASSSPPPSTPPSDESPPPSSPPPS--SPPPDRSPPPS 60
+ S +++ T P+ S A+ S PS P SP P S S P + PP
Sbjct: 11 DDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPINGMGPPF 70
Query: 61 SPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPP 120
S SP P S P++ + S P SP PP A P
Sbjct: 71 SVISSP-MGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVPAHPS 129
Query: 121 PSQDNPSDPP 130
+ + +
Sbjct: 130 GNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 26/136 (19%), Positives = 35/136 (25%), Gaps = 1/136 (0%)
Query: 28 SSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPP 87
+ D+ + S P ++P P P P SP +
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSS 61
Query: 88 P-NSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNN 146
P N PP S P S P S Q + P S + P G N
Sbjct: 62 PINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGV 121
Query: 147 NNNNGKGNGNGNGNHN 162
+GN
Sbjct: 122 LKVPAHPSGNMASFTK 137
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 7e-10
Identities = 25/122 (20%), Positives = 33/122 (27%), Gaps = 2/122 (1%)
Query: 4 NNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPP 63
+ Q SP + +PS S P P P S+ S P
Sbjct: 17 STQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPINGMGPPFSVISSP 76
Query: 64 PSPESPPPSSPPPSSQSP--PQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPP 121
P S + P S PQ P N S + PP P + N +
Sbjct: 77 MGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVPAHPSGNMASFT 136
Query: 122 SQ 123
Sbjct: 137 KH 138
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 19/133 (14%), Positives = 34/133 (25%)
Query: 47 PPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPP 106
D S+ S + P ++ S S P SP + P
Sbjct: 4 HHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPI 63
Query: 107 QSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNN 166
PP + +SP P + SP ++ N + + N
Sbjct: 64 NGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLK 123
Query: 167 NNNNKNWHPPPPP 179
+ + +
Sbjct: 124 VPAHPSGNMASFT 136
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 19/133 (14%), Positives = 35/133 (26%)
Query: 76 PSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSN 135
+++ + P S PS P Q +
Sbjct: 4 HHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPI 63
Query: 136 NGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSSSSNSPNGNRSGALS 195
NG PP + ++ + + + P SS P +G L
Sbjct: 64 NGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLK 123
Query: 196 PPNKSNGSSSSPS 208
P +G+ +S +
Sbjct: 124 VPAHPSGNMASFT 136
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 4e-05
Identities = 24/142 (16%), Positives = 40/142 (28%), Gaps = 6/142 (4%)
Query: 60 SSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASP 119
+ S SP S + P P P SP +S S
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSL---GPGIGSPGQLHSPIST 58
Query: 120 PPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPPP 179
S N PP + SSP G ++ + G G+ ++ N + PP
Sbjct: 59 LSSPINGMGPPF---SVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPP 115
Query: 180 SSSSNSPNGNRSGALSPPNKSN 201
+ + + + +
Sbjct: 116 LGLNGVLKVPAHPSGNMASFTK 137
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 7e-13
Identities = 58/231 (25%), Positives = 93/231 (40%), Gaps = 59/231 (25%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGE-----REFKAEVEIISRVHHRHLVSL 407
LG+G +G V P G+ VA+K + RE K I+ H +++++
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK----ILKHFKHENIITI 74
Query: 408 VGYCIAGGKRL-----LVYEYVPNNNLEFHLHG--KGRPVMDWPTR------LKIAMGSA 454
++ E ++ LH + + D + L+
Sbjct: 75 FNIQRPDSFENFNEVYIIQEL-----MQTDLHRVISTQMLSDDHIQYFIYQTLR------ 123
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT------------ 502
+ LH +IHRD+K SN+L++ + KV DFGLA++ ++
Sbjct: 124 -AVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 503 --HVSTRVMGTFGYLAPEY-ASSGKLTEKSDVFSFGVMLLELITGRRPIDP 550
V+TR Y APE +S K + DV+S G +L EL RRPI P
Sbjct: 180 VEFVATR-----WYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFP 224
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 30/94 (31%), Positives = 46/94 (48%), Gaps = 11/94 (11%)
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT---HVSTRVMGT 511
G+ +LH IIHRD+K SNI++ K+ DFGLA+ + +V TR
Sbjct: 175 CGIKHLH-SAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--- 228
Query: 512 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR 545
Y APE E D++S G ++ E++ +
Sbjct: 229 --YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.1 bits (168), Expect = 1e-12
Identities = 41/248 (16%), Positives = 67/248 (27%), Gaps = 59/248 (23%)
Query: 344 ATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLR--------SGSGQGEREFKAEVEI 395
T + +G+G FG V + + + VA+K + + E E+ I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 396 ISRVH---------HRHLVSLVGYCIAGGKR----LLVYEYVPNNN-------------- 428
+ + L G L +++ +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 429 ----LEFHLHGK-----GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNIL 479
LEF G + T I LA HRD+ N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVL 194
Query: 480 LDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAP--EYASSGKLTEKSDVFSFGVM 537
L T K+ K + + + G +Y S + VF M
Sbjct: 195 LKKTSLKKLHYTLNGK----------SSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSM 244
Query: 538 LLELITGR 545
+L TG
Sbjct: 245 DEDLFTGD 252
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 70.4 bits (171), Expect = 1e-12
Identities = 17/200 (8%), Positives = 51/200 (25%), Gaps = 2/200 (1%)
Query: 10 VSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPP-SSPPPDRSPPPSSPPPSPES 68
+ N E P + ++ + S+ S + + + +
Sbjct: 14 LENLYFQGEETAVPENSGANTELVSGESEHSTNEADKQNEGEHARENKLEKAEGVATASE 73
Query: 69 PPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSD 128
+ ++ + +K ++S P ++ P + P + + +
Sbjct: 74 TASPASNEAATTETAEAASA-AKPEEKASEVVAETPSAEAKPKSDKETEAKPEATNQGDE 132
Query: 129 PPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSSSSNSPNG 188
P N + + N K N+ + + +
Sbjct: 133 SKPAAEANKTEKEVQPDVPKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINRGSVVLA 192
Query: 189 NRSGALSPPNKSNGSSSSPS 208
+R K++ + +
Sbjct: 193 SRRTGHLVNEKASKEAKVQA 212
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 64/253 (25%), Positives = 97/253 (38%), Gaps = 91/253 (35%)
Query: 353 LLGQGGFGYV-----HKGVLPNGKEVAVKSLRSGSGQGEREFKA---EVEIISRVHHR-- 402
LG+G FG V HK G+ VAVK +++ +R +A E++++ ++
Sbjct: 21 TLGEGAFGKVVECIDHKA---GGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDP 73
Query: 403 ----HLVSLVGY-------CIAGGKRLL---VYEYVPNNNLEFHLHGKGRPVMDWPTRL- 447
V ++ + CI LL Y+++ N P
Sbjct: 74 NSTFRCVQMLEWFEHHGHICIV--FELLGLSTYDFIKENGF--------LPF---RLDHI 120
Query: 448 -KIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILL---DYTFET----------------K 487
K+A K + +LH ++ H D+K NIL DYT K
Sbjct: 121 RKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177
Query: 488 VADFGLAKLTTDNNTH---VSTRVMGTFGYLAPE------YASSGKLTEKSDVFSFGVML 538
V DFG A T D+ H VSTR Y APE + ++ DV+S G +L
Sbjct: 178 VVDFGSA--TYDDEHHSTLVSTRH-----YRAPEVILALGW------SQPCDVWSIGCIL 224
Query: 539 LELITGRRPIDPT 551
+E G + PT
Sbjct: 225 IEYYLG-FTVFPT 236
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 29/108 (26%), Positives = 38/108 (35%), Gaps = 5/108 (4%)
Query: 18 ETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPS 77
+ + + + P+ SD +P + PP PP
Sbjct: 341 DKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAM---MQKMQQQQAAYPPQGYAPPP 397
Query: 78 SQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDN 125
PPQ PP PPQ PP PPPQ +PP A+PP DN
Sbjct: 398 QGYPPQGYPPQGY--PPQGYPPQGYPPPPQGAPPQGAPPAAPPQGVDN 443
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 28/107 (26%), Positives = 37/107 (34%), Gaps = 6/107 (5%)
Query: 2 EDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSS 61
+D + S + S+ + PP +PPP
Sbjct: 340 DDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPPQG 399
Query: 62 PPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQS 108
PP + PP PP PPQ PPP +PPQ +PP PPQ
Sbjct: 400 YPP--QGYPPQGYPPQGY-PPQGYPPPPQGAPPQGAPPAA---PPQG 440
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 7e-09
Identities = 27/107 (25%), Positives = 41/107 (38%), Gaps = 3/107 (2%)
Query: 2 EDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSS 61
ED+ + + ++++ PS A + + + PP PP + PP
Sbjct: 345 EDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPPQGYPPQG 404
Query: 62 PPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQS 108
PP PP PP PPQ PP +PP + P N Q+
Sbjct: 405 YPPQGY-PPQGYPPQGYPPPPQGAPP--QGAPPAAPPQGVDNQAYQA 448
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 28/115 (24%), Positives = 36/115 (31%), Gaps = 7/115 (6%)
Query: 23 PSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPP 82
+ ++ SS S + + + + PP PP
Sbjct: 338 QFDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPP 397
Query: 83 QSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNG 137
Q PP PPQ PP PPQ PPP PP P+ PP G N
Sbjct: 398 QGYPPQGY--PPQGYPPQGY--PPQGYPPPPQGA---PPQGAPPAAPPQGVDNQA 445
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 16/106 (15%), Positives = 25/106 (23%)
Query: 41 PPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPP 100
+ P + S + + + P +PPP
Sbjct: 338 QFDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPP 397
Query: 101 NTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNN 146
PP P PP P P ++PP +N
Sbjct: 398 QGYPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPAAPPQGVDN 443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 56/254 (22%), Positives = 90/254 (35%), Gaps = 89/254 (35%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKA---EVEIISRV-----HHRH 403
+G G FG V + N K AVK +R+ ++ ++ E +I+ ++ ++ +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNN 97
Query: 404 LVSLVGY-------CIAGGKRLL---VYEYVPNNNLEFHLHGKGRPVMDWPTRL--KIAM 451
+V G C+ L +YE + NN +
Sbjct: 98 IVKYHGKFMYYDHMCLI--FEPLGPSLYEIITRNNY--------NGF---HIEDIKLYCI 144
Query: 452 GSAKGLAYLHEDCHPRIIHRDIKSSNILL---DYTFET---------------------- 486
K L YL + + H D+K NILL +
Sbjct: 145 EILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 487 KVADFGLAKLTTDNNTH---VSTRVMGTFGYLAPE------YASSGKLTEKSDVFSFGVM 537
K+ DFG A T ++ H ++TR Y APE + SD++SFG +
Sbjct: 202 KLIDFGCA--TFKSDYHGSIINTR----Q-YRAPEVILNLGW------DVSSDMWSFGCV 248
Query: 538 LLELITGRRPIDPT 551
L EL TG + T
Sbjct: 249 LAELYTG-SLLFRT 261
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 55/247 (22%), Positives = 90/247 (36%), Gaps = 79/247 (31%)
Query: 353 LLGQGGFGYVHKGV--LPNGKEVAVKSLRSGSGQGEREFKA---EVEIISRVHHR----- 402
LG+G FG V + + +VA+K +R+ + +A E+ ++ ++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENK 81
Query: 403 -HLVSLVGY-------CIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRL--KIAMG 452
V + + CI +E + N EF +P P +A
Sbjct: 82 FLCVLMSDWFNFHGHMCI-------AFELLGKNTFEFLKENNFQPY---PLPHVRHMAYQ 131
Query: 453 SAKGLAYLHEDCHPRIIHRDIKSSNILL---DYTFET----------------KVADFGL 493
L +LHE ++ H D+K NIL ++ +VADFG
Sbjct: 132 LCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 494 AKLTTDNNTH---VSTRVMGTFGYLAPE------YASSGKLTEKSDVFSFGVMLLELITG 544
A T D+ H V+TR Y PE + + DV+S G +L E G
Sbjct: 189 A--TFDHEHHTTIVATRH-----YRPPEVILELGW------AQPCDVWSIGCILFEYYRG 235
Query: 545 RRPIDPT 551
+ T
Sbjct: 236 -FTLFQT 241
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 25/115 (21%), Positives = 40/115 (34%), Gaps = 5/115 (4%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPP--PSSPP 63
P A+ T + ++ PP T P PPP +P +PP +
Sbjct: 16 PRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPPDTVTGDSVLQRIL 75
Query: 64 PSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSS---PPPNTNPPPQSSPPPSNS 115
P P +S P+ + Q P + +PP + P +P P+ P
Sbjct: 76 RGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPVPEPDPVRVEE 130
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 21/124 (16%), Positives = 31/124 (25%), Gaps = 1/124 (0%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
S + AS + S + PP + P P+ PPP + P
Sbjct: 7 HHHHSSGLVPRG-SHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPPDTV 65
Query: 66 PESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDN 125
P + P + Q P + PP + P P D
Sbjct: 66 TGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPVPEPDP 125
Query: 126 PSDP 129
Sbjct: 126 VRVE 129
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 65.2 bits (158), Expect = 3e-11
Identities = 21/115 (18%), Positives = 28/115 (24%), Gaps = 3/115 (2%)
Query: 28 SSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPP 87
SS S P +S + PP + P P+ PP
Sbjct: 3 SSHHHHHHSS---GLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAG 59
Query: 88 PNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPG 142
+ S P S + A Q P P G + PG
Sbjct: 60 NPPDTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPG 114
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 64.8 bits (157), Expect = 4e-11
Identities = 22/109 (20%), Positives = 29/109 (26%), Gaps = 2/109 (1%)
Query: 24 SRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQ 83
S S P +S S ++ P P P+ PPP + +
Sbjct: 3 SSHHHHHHSSGLVPR--GSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGN 60
Query: 84 SPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPG 132
P S Q T P S P P P + P G
Sbjct: 61 PPDTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAG 109
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 61.7 bits (149), Expect = 4e-10
Identities = 23/117 (19%), Positives = 34/117 (29%), Gaps = 7/117 (5%)
Query: 10 VSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS---P 66
+ +S S P + + S + PP P P+ PPP
Sbjct: 1 MGSSHH--HHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAA 58
Query: 67 ESPPPSSPPPSSQSPPQSPP--PPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPP 121
+PP + S P P + P P +S PP+ A P
Sbjct: 59 GNPPDTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGL 115
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 7e-11
Identities = 58/260 (22%), Positives = 89/260 (34%), Gaps = 72/260 (27%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVH--------HRHL 404
LG G F V + K VA+K ++S E E+ ++ V +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREMV 103
Query: 405 VSLVGY-CIAG--GKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYL 460
V L+ I+G G + +V+E + ++ L++ + + + P KI +GL YL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQG-LPLPCVKKIIQQVLQGLDYL 162
Query: 461 HEDCHPRIIHRDIKSSNILLDYT------------------------------------- 483
H C IIH DIK NILL
Sbjct: 163 HTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNF 220
Query: 484 ------------FETKVADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSD 530
+ K+AD G A + T + TR Y + E +D
Sbjct: 221 LVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPAD 275
Query: 531 VFSFGVMLLELITGRRPIDP 550
++S M EL TG +P
Sbjct: 276 IWSTACMAFELATGDYLFEP 295
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 29/112 (25%), Positives = 46/112 (41%), Gaps = 24/112 (21%)
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGY 514
K + YLH ++HRD+K SNILL+ KVADFGL++ + + +
Sbjct: 120 KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 515 LAPEYASSGKLTE--------------------KS-DVFSFGVMLLELITGR 545
LT+ K D++S G +L E++ G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 2e-10
Identities = 17/116 (14%), Positives = 32/116 (27%)
Query: 19 TPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSS 78
P+P++ S + + PP P+ P P PP P P
Sbjct: 27 ELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKP 86
Query: 79 QSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDS 134
+ P+ + P + P + P+ +S + +
Sbjct: 87 KPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVTSVASG 142
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 2e-10
Identities = 24/121 (19%), Positives = 36/121 (29%)
Query: 10 VSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESP 69
+S + P P P P E P PP +P P P P
Sbjct: 35 ISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVK 94
Query: 70 PPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDP 129
P P +S P ++ + +T S P S ++ S++ P P
Sbjct: 95 KVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVTSVASGPRALSRNQPQYP 154
Query: 130 P 130
Sbjct: 155 A 155
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 26/126 (20%), Positives = 35/126 (27%)
Query: 16 AAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPP 75
A P S + + + P P P P P PP +P + P P
Sbjct: 30 APAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPK 89
Query: 76 PSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSN 135
P Q P + K P N P + + A+ P S P N
Sbjct: 90 PKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVTSVASGPRALSRN 149
Query: 136 NGSSPP 141
P
Sbjct: 150 QPQYPA 155
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 60.1 bits (145), Expect = 3e-10
Identities = 27/128 (21%), Positives = 37/128 (28%), Gaps = 1/128 (0%)
Query: 16 AAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPE-SPPPSSP 74
+ S + P P+ P S P+ P P P P PE P P
Sbjct: 15 PRGSHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKE 74
Query: 75 PPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDS 134
P P+ P P K + P + P S P S + P + +
Sbjct: 75 APVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSK 134
Query: 135 NNGSSPPG 142
S G
Sbjct: 135 PVTSVASG 142
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 1e-09
Identities = 21/115 (18%), Positives = 30/115 (26%)
Query: 16 AAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPP 75
A P + P + + PP P P PP P E P P P
Sbjct: 29 PAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKP 88
Query: 76 PSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPP 130
P P +S P + S + A+ + + P
Sbjct: 89 KPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVTSVASGP 143
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 1e-08
Identities = 24/136 (17%), Positives = 37/136 (27%), Gaps = 1/136 (0%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
S G+ + + P S + PP P P P
Sbjct: 9 HSSGLVPRGSHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPI 68
Query: 66 PESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDN 125
PE PP +P + P+ P P Q P + P P + A +
Sbjct: 69 PE-PPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSST 127
Query: 126 PSDPPPGDSNNGSSPP 141
+ + +S P
Sbjct: 128 ATAATSKPVTSVASGP 143
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 1e-08
Identities = 19/118 (16%), Positives = 27/118 (22%)
Query: 14 PDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSS 73
P + P P P P PP + P P P+ P
Sbjct: 34 PISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPV 93
Query: 74 PPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPP 131
Q P + + P + P ++ S S S P
Sbjct: 94 KKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVTSVASGPRALSRNQP 151
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 6e-08
Identities = 19/133 (14%), Positives = 31/133 (23%)
Query: 27 SSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPP 86
SS P P P+ P P+ P PP P + P+ P
Sbjct: 10 SSGLVPRGSHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIP 69
Query: 87 PPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNN 146
P ++P P P P ++ + +
Sbjct: 70 EPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTAT 129
Query: 147 NNNNGKGNGNGNG 159
+ +G
Sbjct: 130 AATSKPVTSVASG 142
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 2e-05
Identities = 22/103 (21%), Positives = 32/103 (31%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
P V P+ P P A P P P P D P S P
Sbjct: 55 PEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASP 114
Query: 66 PESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQS 108
E+ P+ S+ + S P + S P++ P ++
Sbjct: 115 FENTAPARLTSSTATAATSKPVTSVASGPRALSRNQPQYPARA 157
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 3e-05
Identities = 16/119 (13%), Positives = 32/119 (26%)
Query: 46 PPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPP 105
P P + + P+ PP + PP P P PP+ +P P
Sbjct: 24 QVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPK 83
Query: 106 PQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNN 164
P+ P P + + ++ + ++ + +
Sbjct: 84 PKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVTSVASG 142
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 4e-05
Identities = 18/138 (13%), Positives = 25/138 (18%)
Query: 42 PPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPN 101
S P + P S +P P P P P P P
Sbjct: 18 SHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPV 77
Query: 102 TNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNH 161
P+ P P Q P ++
Sbjct: 78 VIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVT 137
Query: 162 NNNNNNNNNKNWHPPPPP 179
+ + P P
Sbjct: 138 SVASGPRALSRNQPQYPA 155
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 2e-04
Identities = 20/137 (14%), Positives = 26/137 (18%)
Query: 43 PSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNT 102
P S P P+ P P PP + PP P P PP
Sbjct: 15 PRGSHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKE 74
Query: 103 NPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHN 162
P P P P + N +
Sbjct: 75 APVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSK 134
Query: 163 NNNNNNNNKNWHPPPPP 179
+ + P
Sbjct: 135 PVTSVASGPRALSRNQP 151
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 29/119 (24%), Positives = 47/119 (39%), Gaps = 25/119 (21%)
Query: 455 KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLA-KLTTDNNTHVSTRVMGTFG 513
G ++HE IIHRD+K +N LL+ KV DFGLA + ++ +T++ +
Sbjct: 140 LGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 514 YLAPEYASSGKLTE--------------------KS-DVFSFGVMLLELITGRRPIDPT 551
+LT KS D++S G + EL+ +
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 19/102 (18%), Positives = 30/102 (29%)
Query: 20 PPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQ 79
SS + + + P + DRSP +SP P S +
Sbjct: 13 AMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHGSLQGYQTY 72
Query: 80 SPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPP 121
S + P +S P + ++S AS P
Sbjct: 73 GHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPH 114
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 17/142 (11%), Positives = 33/142 (23%), Gaps = 6/142 (4%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
++ ++ S + + P + + P + SP + PP
Sbjct: 5 EAMSQVIQAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHG 64
Query: 66 PESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNS------NASP 119
+ S++ P P + SP + SSP P
Sbjct: 65 SLQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLKCEP 124
Query: 120 PPSQDNPSDPPPGDSNNGSSPP 141
Q +
Sbjct: 125 DEPQVQAKIMAYLQQEQANRSK 146
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 23/137 (16%), Positives = 35/137 (25%), Gaps = 9/137 (6%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSS---PPPDRSPPPSSP 62
P A + S S+ + PP+D P P S PP +
Sbjct: 13 AMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHGSLQGYQTY 72
Query: 63 PPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQS------SPPPSNSN 116
P S P S P+S + Q+S P + P +
Sbjct: 73 GHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLKCEPDEPQVQAK 132
Query: 117 ASPPPSQDNPSDPPPGD 133
Q+ +
Sbjct: 133 IMAYLQQEQANRSKHEK 149
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 16/120 (13%), Positives = 25/120 (20%), Gaps = 7/120 (5%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
+ D +P S S + PP P + P P + P
Sbjct: 36 LNHAALPPTDYDRSPFVTSPISMTMPPHGSLQGYQTYGHFPSRAIKSE--YPDPYTSSPE 93
Query: 66 PESPPPSSPPPSSQSPPQSPPPPNS-----KSPPQSSPPPNTNPPPQSSPPPSNSNASPP 120
+ SP P PQ + + + S
Sbjct: 94 SIMGYSYMDSYQTSSPASIPHLILELLKCEPDEPQVQAKIMAYLQQEQANRSKHEKLSTF 153
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 14/119 (11%), Positives = 25/119 (21%), Gaps = 4/119 (3%)
Query: 1 MEDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPS 60
D ++SP V++ P + + + P +S P
Sbjct: 43 PTDYDRSPFVTSPISMTMPPHGSLQGYQTYGHFPSRA--IKSEYPDPYTSSPESIMGYSY 100
Query: 61 SPPPSPESPPPSSPPPSS--QSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNA 117
SP + P P N + + S
Sbjct: 101 MDSYQTSSPASIPHLILELLKCEPDEPQVQAKIMAYLQQEQANRSKHEKLSTFGLMCKM 159
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 14/93 (15%), Positives = 24/93 (25%), Gaps = 2/93 (2%)
Query: 57 PPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSP--PPNTNPPPQSSPPPSN 114
P SS + S + P ++ PP P T+P + PP +
Sbjct: 6 AMSQVIQAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHGS 65
Query: 115 SNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNN 147
+ +S P +
Sbjct: 66 LQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGY 98
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 60.5 bits (145), Expect = 1e-09
Identities = 19/124 (15%), Positives = 33/124 (26%)
Query: 17 AETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPP 76
A P P R + PS P +P ++ + P + P ++ PP+
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRL 70
Query: 77 SSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNN 136
S P + P P + + + QD S+
Sbjct: 71 RLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRA 130
Query: 137 GSSP 140
Sbjct: 131 RELG 134
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 57.4 bits (137), Expect = 1e-08
Identities = 20/140 (14%), Positives = 34/140 (24%)
Query: 7 SPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSP 66
P ++ A TP A +P +T S + P + P +
Sbjct: 17 PPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDE 76
Query: 67 ESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNP 126
S P + P + P +P PP T+ Q + S
Sbjct: 77 VSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGAR 136
Query: 127 SDPPPGDSNNGSSPPGNNNN 146
+ +
Sbjct: 137 VRALKASAQDAGESCTPEAE 156
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 56.3 bits (134), Expect = 2e-08
Identities = 20/130 (15%), Positives = 36/130 (27%)
Query: 13 SPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPS 72
A +P+ A+S P + PP+ S S P +PE+P
Sbjct: 30 PSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDEVSSPSTPEAPDIP 89
Query: 73 SPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPG 132
+ P Q +S P S+ +T S + + + +
Sbjct: 90 ACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGARVRALKASAQDAGE 149
Query: 133 DSNNGSSPPG 142
+
Sbjct: 150 SCTPEAEGRP 159
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 56.3 bits (134), Expect = 2e-08
Identities = 19/124 (15%), Positives = 32/124 (25%), Gaps = 4/124 (3%)
Query: 11 SNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPES-- 68
+ P A +P P+ P +S P +P P
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRL 70
Query: 69 --PPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNP 126
PS+ P P P+ + S P PP +S ++ +
Sbjct: 71 RLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRA 130
Query: 127 SDPP 130
+
Sbjct: 131 RELG 134
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 55.5 bits (132), Expect = 4e-08
Identities = 22/137 (16%), Positives = 43/137 (31%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
++P + A + + PP+ P D++ PP+ + S P + P
Sbjct: 28 RTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDEVSSPSTPEAPD 87
Query: 66 PESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDN 125
+ P +P PP + + Q + + ++ + A +QD
Sbjct: 88 IPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGARVRALKASAQDA 147
Query: 126 PSDPPPGDSNNGSSPPG 142
P P G
Sbjct: 148 GESCTPEAEGRPEEPCG 164
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 53.2 bits (126), Expect = 2e-07
Identities = 22/197 (11%), Positives = 46/197 (23%)
Query: 40 SPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPP 99
+ PP +PP PS P+ +P ++ ++ P + P + PP
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRL 70
Query: 100 PNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNG 159
+ S P + PS + + + + +
Sbjct: 71 RLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRA 130
Query: 160 NHNNNNNNNNNKNWHPPPPPSSSSNSPNGNRSGALSPPNKSNGSSSSPSSNNGSMLSIPL 219
+ + P + + G +L
Sbjct: 131 RELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLPYKY 190
Query: 220 VAAVAAGAAFLIIVMLL 236
+ IV +L
Sbjct: 191 QVLAEMFRSMDTIVGML 207
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 27/145 (18%), Positives = 39/145 (26%), Gaps = 5/145 (3%)
Query: 3 DNNQSPGVSNSPDAAETPPSPSRASSSPPPST-PPSDESPPPSSPPPSSPPPDRSPPPSS 61
+N S V P A ++ P + P P P +P P
Sbjct: 75 ENLVSMTVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGV 134
Query: 62 PPPSPESPPP----SSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNA 117
PS + P + ++ + P P + PPP
Sbjct: 135 GGPSQQVMTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPG 194
Query: 118 SPPPSQDNPSDPPPGDSNNGSSPPG 142
PP PP + G PPG
Sbjct: 195 MRPPMGPPMGIPPGRGTPMGMPPPG 219
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 29/141 (20%), Positives = 41/141 (29%), Gaps = 4/141 (2%)
Query: 4 NNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPP 63
+ AA P A P P + P P +
Sbjct: 88 KDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGPSQQVMTPQGR 147
Query: 64 PSPESPPPSSPPPSSQSPPQSPPPPNSKSPP--QSSPPPNTNPPPQSSPPPSNSNASPPP 121
+ + ++ + +P Q PP PP + +PPP PP PP PP
Sbjct: 148 GTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPGMRPPMGPPMGIPP 207
Query: 122 SQDNPSDPPPGDSNNGSSPPG 142
+ P PP PPG
Sbjct: 208 GRGTPMGMPPP--GMRPPPPG 226
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 23/134 (17%), Positives = 31/134 (23%), Gaps = 2/134 (1%)
Query: 10 VSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESP 69
VS + + + + P P P P + P P
Sbjct: 78 VSMTVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGP 137
Query: 70 PPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDP 129
P + + + S P P PPP A PP P
Sbjct: 138 SQQVMTPQGRGTVAAAAAAATASIAG--APTQYPPGRGGPPPPMGRGAPPPGMMGPPPGM 195
Query: 130 PPGDSNNGSSPPGN 143
P PPG
Sbjct: 196 RPPMGPPMGIPPGR 209
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 17/91 (18%), Positives = 23/91 (25%)
Query: 20 PPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQ 79
+ + + + P PP PPP +P PP
Sbjct: 138 SQQVMTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPGMRP 197
Query: 80 SPPQSPPPPNSKSPPQSSPPPNTNPPPQSSP 110
P + P PPP PPP
Sbjct: 198 PMGPPMGIPPGRGTPMGMPPPGMRPPPPGMR 228
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 21/142 (14%), Positives = 31/142 (21%)
Query: 18 ETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPS 77
E S + P + + P R P P P +
Sbjct: 75 ENLVSMTVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGV 134
Query: 78 SQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNG 137
Q P + ++ + + P PPP P G
Sbjct: 135 GGPSQQVMTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPG 194
Query: 138 SSPPGNNNNNNNNGKGNGNGNG 159
PP G+G G
Sbjct: 195 MRPPMGPPMGIPPGRGTPMGMP 216
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 38/195 (19%), Positives = 67/195 (34%), Gaps = 34/195 (17%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLR---SGSGQGEREFKAEVEIISRVHHRHLVSLVG 409
+G G +G+V + + VA+K + +R + E+ I++R++H H+V ++
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDHVVKVLD 119
Query: 410 YCIAGGKRL-----LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSA------KGLA 458
I +V E + + P L G+
Sbjct: 120 IVIPKDVEKFDELYVVLEI-----ADSDFKK----LFRTPVYLTELHIKTLLYNLLVGVK 170
Query: 459 YLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLA------KLTTDNNTHVSTRVMGTF 512
Y+H I+HRD+K +N L++ KV DFGLA +
Sbjct: 171 YVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 513 GYLAPEYASSGKLTE 527
+LT
Sbjct: 228 VTFPHTKNLKRQLTG 242
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 20/117 (17%), Positives = 32/117 (27%), Gaps = 4/117 (3%)
Query: 20 PPSPS-RASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSS 78
P P R + + P PS +P +P S SP
Sbjct: 43 PQVPDFRHLKAEVDAEKPGATDRKGGVGMPSRDRNIGAPGQDTPGVSLHPLSLDSPDREP 102
Query: 79 QSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSN 135
+ P S PQ + PP+S+ + + + P + P
Sbjct: 103 GA---DAPLELGDSSPQGPMSLESLAPPESTDEGAETESPEPGDEGEPGRSGLELEP 156
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 19/140 (13%), Positives = 34/140 (24%), Gaps = 4/140 (2%)
Query: 3 DNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSP 62
N +S + + + +R + P + P + S
Sbjct: 15 GNRRSDEPAKTKKGLSSILDAARWNRGEPQVPDFRHLKAEVDAEKPGATDRKGGVGMPSR 74
Query: 63 PPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSP-PPSNSNASPPP 121
+ +P +P S P + P +P + PQ S +
Sbjct: 75 DRNIGAPGQDTPGVSLHPLSLDSP---DREPGADAPLELGDSSPQGPMSLESLAPPESTD 131
Query: 122 SQDNPSDPPPGDSNNGSSPP 141
P PGD
Sbjct: 132 EGAETESPEPGDEGEPGRSG 151
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 17/126 (13%), Positives = 29/126 (23%), Gaps = 5/126 (3%)
Query: 21 PSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPP---PSPESPPPSSPPPS 77
R+ S PD + P PS
Sbjct: 14 MGNRRSDEPAKTKKGLSSILDAARWNRGEPQVPDFRHLKAEVDAEKPGATDRKGGVGMPS 73
Query: 78 SQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASP--PPSQDNPSDPPPGDSN 135
+P + + P + P ++SP P S ++ + P D
Sbjct: 74 RDRNIGAPGQDTPGVSLHPLSLDSPDREPGADAPLELGDSSPQGPMSLESLAPPESTDEG 133
Query: 136 NGSSPP 141
+ P
Sbjct: 134 AETESP 139
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 22/128 (17%), Positives = 35/128 (27%), Gaps = 11/128 (8%)
Query: 4 NNQSPGVSNS---PDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPS 60
Q P + DA + + + P +P +P S P
Sbjct: 42 EPQVPDFRHLKAEVDAEKPGATDRKGGVGMPSR------DRNIGAPGQDTPGV--SLHPL 93
Query: 61 SPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPP 120
S P +P S PQ P S +PP+S+ P+ +
Sbjct: 94 SLDSPDREPGADAPLELGDSSPQGPMSLESLAPPESTDEGAETESPEPGDEGEPGRSGLE 153
Query: 121 PSQDNPSD 128
+ P
Sbjct: 154 LEPEEPPG 161
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 3e-09
Identities = 18/107 (16%), Positives = 29/107 (27%)
Query: 25 RASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQS 84
R S S + P+ P P PPP + P ++P + S +S SP
Sbjct: 8 RLSDSNFMANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAP 67
Query: 85 PPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPP 131
P + SS ++ +
Sbjct: 68 SPGSSGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAA 114
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 2e-08
Identities = 19/115 (16%), Positives = 31/115 (26%)
Query: 22 SPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSP 81
S S ++ P + P P PPPS+ P +P ++ S P++ SP
Sbjct: 10 SDSNFMANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSP 69
Query: 82 PQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNN 136
S S + S + D +
Sbjct: 70 GSSGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPH 124
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 2e-07
Identities = 20/120 (16%), Positives = 30/120 (25%), Gaps = 7/120 (5%)
Query: 11 SNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPP 70
SN PPP P + P + P S+ ++P SP +P
Sbjct: 12 SNFMANLPNGYMTDLQRPQPPPPPPSA---ASPGATPGSAAASAERASTAAPVASPAAPS 68
Query: 71 PSSPPP----SSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNP 126
P S SS S + + + + P D
Sbjct: 69 PGSSGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDWA 128
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 2e-07
Identities = 16/105 (15%), Positives = 27/105 (25%)
Query: 37 SDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQS 96
SD + + P R PP PP + +S + P S + P
Sbjct: 10 SDSNFMANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSP 69
Query: 97 SPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPP 141
S + A+ + G + G +
Sbjct: 70 GSSGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAA 114
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 3e-07
Identities = 16/104 (15%), Positives = 28/104 (26%), Gaps = 2/104 (1%)
Query: 44 SSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTN 103
+ P+ D PPP P S P S + + ++P P ++
Sbjct: 15 MANLPNGYMTD--LQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSS 72
Query: 104 PPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNN 147
SN+ + G + G+ G
Sbjct: 73 GGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARV 116
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 6e-06
Identities = 16/99 (16%), Positives = 22/99 (22%), Gaps = 2/99 (2%)
Query: 44 SSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTN 103
S + P+ P P PP +P + S P
Sbjct: 10 SDSNFMANLPNGYMTDLQRPQPPPPPPS--AASPGATPGSAAASAERASTAAPVASPAAP 67
Query: 104 PPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPG 142
P S S+ S Q + G G
Sbjct: 68 SPGSSGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGG 106
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 2e-05
Identities = 9/96 (9%), Positives = 23/96 (23%)
Query: 3 DNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSP 62
N + P + S ++ + S P++P P S
Sbjct: 19 PNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFF 78
Query: 63 PPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSP 98
+ ++ ++ Q ++
Sbjct: 79 SSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAA 114
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 4e-05
Identities = 16/102 (15%), Positives = 27/102 (26%), Gaps = 4/102 (3%)
Query: 8 PGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPE 67
P + PP P +++SP + + S +S P SP S
Sbjct: 19 PNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVAS----PAAPSPGSSGG 74
Query: 68 SPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSS 109
SS + + + S+ S
Sbjct: 75 GGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARV 116
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 13/95 (13%), Positives = 30/95 (31%)
Query: 30 PPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPN 89
P T P ++ + P +PP P+ + P + P + +PP+
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNA 61
Query: 90 SKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQD 124
+ + ++ + + + PP
Sbjct: 62 TVAAGHATLREHLRDIKAENTDANFYVCPPPTGAT 96
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 12/93 (12%), Positives = 23/93 (24%)
Query: 23 PSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPP 82
P+ +S P + ++ P+ P +P P + P +PP +
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNA 61
Query: 83 QSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNS 115
+ PP
Sbjct: 62 TVAAGHATLREHLRDIKAENTDANFYVCPPPTG 94
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 15/96 (15%), Positives = 33/96 (34%), Gaps = 1/96 (1%)
Query: 14 PDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSS 73
P A +P +P A+++ + P+ PP+ + P P+P P +
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPA-TPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDN 60
Query: 74 PPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSS 109
++ + K+ + PP ++
Sbjct: 61 ATVAAGHATLREHLRDIKAENTDANFYVCPPPTGAT 96
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 15/81 (18%), Positives = 31/81 (38%)
Query: 61 SPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPP 120
+ P SP +P ++ ++ P +P PP + P P P N P++ PP + +
Sbjct: 3 AAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNAT 62
Query: 121 PSQDNPSDPPPGDSNNGSSPP 141
+ + + +
Sbjct: 63 VAAGHATLREHLRDIKAENTD 83
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 14/95 (14%), Positives = 32/95 (33%), Gaps = 2/95 (2%)
Query: 8 PGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPE 67
P SP + +++ P+TP + P + P+ P P+ +
Sbjct: 2 PAAPTSPGTPGVAAATQ--AANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGD 59
Query: 68 SPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNT 102
+ ++ + + + N+ + PPP
Sbjct: 60 NATVAAGHATLREHLRDIKAENTDANFYVCPPPTG 94
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 10/81 (12%), Positives = 20/81 (24%)
Query: 45 SPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNP 104
+ P S P + + P +P P + + P+ K+P P +
Sbjct: 3 AAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNAT 62
Query: 105 PPQSSPPPSNSNASPPPSQDN 125
+
Sbjct: 63 VAAGHATLREHLRDIKAENTD 83
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 11/91 (12%), Positives = 26/91 (28%)
Query: 7 SPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSP 66
+P +P A + + ++P P + + P P P P+ +
Sbjct: 4 APTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNATV 63
Query: 67 ESPPPSSPPPSSQSPPQSPPPPNSKSPPQSS 97
+ + ++ PP +
Sbjct: 64 AAGHATLREHLRDIKAENTDANFYVCPPPTG 94
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 15/96 (15%), Positives = 31/96 (32%), Gaps = 2/96 (2%)
Query: 20 PPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQ 79
P +P+ + + + P + PP+ P P++P P P +
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNA 61
Query: 80 SPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNS 115
+ + + NT+ PPP+ +
Sbjct: 62 TVA--AGHATLREHLRDIKAENTDANFYVCPPPTGA 95
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 14/86 (16%), Positives = 27/86 (31%), Gaps = 3/86 (3%)
Query: 38 DESPPPSSPPPSSPPPDRSP---PPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPP 94
D + P S P ++ P + PP+ + P P P P++P PP
Sbjct: 1 DPAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDN 60
Query: 95 QSSPPPNTNPPPQSSPPPSNSNASPP 120
+ + + + +
Sbjct: 61 ATVAAGHATLREHLRDIKAENTDANF 86
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 12/83 (14%), Positives = 25/83 (30%), Gaps = 2/83 (2%)
Query: 76 PSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSN 135
P++ + P +P + ++ P T PP P+ + PP +
Sbjct: 2 PAAPTSPGTPGVAAA--TQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGD 59
Query: 136 NGSSPPGNNNNNNNNGKGNGNGN 158
N + G+ +
Sbjct: 60 NATVAAGHATLREHLRDIKAENT 82
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 10/79 (12%), Positives = 20/79 (25%)
Query: 71 PSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPP 130
P+SP + +P + P+ N +PP + +
Sbjct: 5 PTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNATVA 64
Query: 131 PGDSNNGSSPPGNNNNNNN 149
G + N +
Sbjct: 65 AGHATLREHLRDIKAENTD 83
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 12/88 (13%), Positives = 24/88 (27%), Gaps = 7/88 (7%)
Query: 63 PPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPS 122
P +P SP ++Q+ P P + + P P + +P P
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAA-------PTGDPKPKKNKKPKNPTPP 54
Query: 123 QDNPSDPPPGDSNNGSSPPGNNNNNNNN 150
+ + + + N
Sbjct: 55 RPAGDNATVAAGHATLREHLRDIKAENT 82
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 17/104 (16%), Positives = 32/104 (30%), Gaps = 9/104 (8%)
Query: 9 GVSNSPDAAETP--PSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSP 66
+ + A P P+P ++P P ++ P +P P P D + +
Sbjct: 13 VAAATQAANGGPATPAPPALGAAPTGDPKPK-KNKKPKNPTPPRPAGDNATVAAGHATLR 71
Query: 67 ESPPPSSPPPSSQSPPQSPPPPNSKS-----PPQSSPPPNTNPP 105
E ++ + PPP + P+ P
Sbjct: 72 EH-LRDIKAENTDANFYVCPPPTGATVVQFEQPRRCPTRPEGQN 114
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 28/160 (17%), Positives = 45/160 (28%), Gaps = 1/160 (0%)
Query: 30 PPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPN 89
S PP + + P +PP + SS ++PPP
Sbjct: 292 ILKYQQSQIASAPPRAVGHGAGPSGLAPPALQNDRQSGVDEGRTSGWSSMDRRRAPPPIA 351
Query: 90 SKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNN 149
S P N S P +++ S S P S+ P + +
Sbjct: 352 SVGTLAKQKAPVGNDASFSKEPVISASNFLGRSS-GSSRRPAVSSSRDVMPIDTSEPSRT 410
Query: 150 NGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSSSSNSPNGN 189
G + ++ N P SS+ +S N
Sbjct: 411 RATDASPGAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVK 450
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 52/212 (24%), Positives = 86/212 (40%), Gaps = 32/212 (15%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVK--SLRSGSGQGEREFK-----AEVEIISRVHHRHLV 405
+G G FG ++ G + +EVA+K ++++ Q E K I V
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRW---- 70
Query: 406 SLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCH 465
+ + G +LV + + +LE + R + T L +A + ++H
Sbjct: 71 ----FGVEGDYNVLVMDLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKS- 123
Query: 466 PRIIHRDIKSSNILLDYTFETK---VADFGLAKLTTDNNT--HVSTR----VMGTFGYLA 516
+HRDIK N L+ + DFGLAK D +T H+ R + GT Y A
Sbjct: 124 --FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-A 180
Query: 517 PEYASSGK-LTEKSDVFSFGVMLLELITGRRP 547
G + + D+ S G +L+ + G P
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 23/174 (13%), Positives = 46/174 (26%), Gaps = 3/174 (1%)
Query: 39 ESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSP 98
+S PP + P PP+ + S + +P
Sbjct: 291 TILKYQQSQIASAPPRAVGHGAGPSGLA---PPALQNDRQSGVDEGRTSGWSSMDRRRAP 347
Query: 99 PPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGN 158
PP + + N + + S ++GSS +++ + + +
Sbjct: 348 PPIASVGTLAKQKAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSRDVMPIDTSEP 407
Query: 159 GNHNNNNNNNNNKNWHPPPPPSSSSNSPNGNRSGALSPPNKSNGSSSSPSSNNG 212
+ + P SS NS S + + S+ G
Sbjct: 408 SRTRATDASPGAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESALKGIEG 461
|
| >3ghg_A Fibrinogen alpha chain; triple-stranded coiled coil, beta sheets, alpha helices, AMY amyloidosis, blood coagulation, disease mutation, glycoprot phosphoprotein; HET: NAG NDG BMA MAN GAL SIA; 2.90A {Homo sapiens} PDB: 3h32_A* 2a45_G* Length = 562 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 6e-08
Identities = 39/312 (12%), Positives = 76/312 (24%), Gaps = 4/312 (1%)
Query: 11 SNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPP 70
+ S S + P P S S S P S + + P
Sbjct: 246 GGNEITRGGSTSYGTGSETESPRNPSSAGSWNSGSSGPGSTGNRNPGSSGTGGTATWKPG 305
Query: 71 PSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPP 130
S P + S ++ + SP P + S
Sbjct: 306 SSGPGSTGSWNSGSSGTGSTGNQNPGSPRPGSTGTWNPGSSERGSAGHWTSESSVSGSTG 365
Query: 131 PGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSSSSNSPNGNR 190
S +GS P + + N G + N + + + G++
Sbjct: 366 QWHSESGSFRPDSPGSGNARPNNPDWGTFEEVSGNVSPGT----RREYHTEKLVTSKGDK 421
Query: 191 SGALSPPNKSNGSSSSPSSNNGSMLSIPLVAAVAAGAAFLIIVMLLVFFACRRKKNRERN 250
++GS+++ + ++ ++ +V C +
Sbjct: 422 ELRTGKEKVTSGSTTTTRRSCSKTVTKTVIGPDGHKEVTKEVVTSEDGSDCPEAMDLGTL 481
Query: 251 DQMPYYNNNHTTATDYYNSAATPSPPPRANWQQQTDHGWPTPPPSQRGAVTVTSSDMSHN 310
+ + D T S G RG+ + ++ +
Sbjct: 482 SGIGTLDGFRHRHPDEAAFFDTASTGKTFPGFFSPMLGEFVSETESRGSESGIFTNTKES 541
Query: 311 SSSGPYGPVLPP 322
SS P P
Sbjct: 542 SSHHPGIAEFPS 553
|
| >3ghg_A Fibrinogen alpha chain; triple-stranded coiled coil, beta sheets, alpha helices, AMY amyloidosis, blood coagulation, disease mutation, glycoprot phosphoprotein; HET: NAG NDG BMA MAN GAL SIA; 2.90A {Homo sapiens} PDB: 3h32_A* 2a45_G* Length = 562 | Back alignment and structure |
|---|
Score = 52.6 bits (125), Expect = 3e-07
Identities = 28/196 (14%), Positives = 51/196 (26%)
Query: 18 ETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPS 77
+ P ++ P + P P + S S S PS
Sbjct: 212 DLVPGNFKSQLQKVPPEWKALTDMPQMRMELERPGGNEITRGGSTSYGTGSETESPRNPS 271
Query: 78 SQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNG 137
S S + ++ T P S ++ + + G+ N G
Sbjct: 272 SAGSWNSGSSGPGSTGNRNPGSSGTGGTATWKPGSSGPGSTGSWNSGSSGTGSTGNQNPG 331
Query: 138 SSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHPPPPPSSSSNSPNGNRSGALSPP 197
S PG+ N G+ + ++ + + WH + +GN
Sbjct: 332 SPRPGSTGTWNPGSSERGSAGHWTSESSVSGSTGQWHSESGSFRPDSPGSGNARPNNPDW 391
Query: 198 NKSNGSSSSPSSNNGS 213
S + S
Sbjct: 392 GTFEEVSGNVSPGTRR 407
|
| >1mv3_A MYC box dependent interacting protein 1; tumor suppressor, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 213 | Back alignment and structure |
|---|
Score = 50.9 bits (120), Expect = 3e-07
Identities = 19/130 (14%), Positives = 32/130 (24%)
Query: 19 TPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSS 78
+ P PP PPP +P S + P
Sbjct: 11 RVNHEPEPAGGATPGATLPKSPSQLRKGPPVPPPPKHTPSKEVKQEQILSLFEDTFVPEI 70
Query: 79 QSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGS 138
S P S+ + P P +++ + S++ P + G GS
Sbjct: 71 SVTTPSQPAEASEVAGGTQPAAGAQEPGETAASEAASSSLPAVVVETFPATVNGTVEGGS 130
Query: 139 SPPGNNNNNN 148
+
Sbjct: 131 GAGRLDLPPG 140
|
| >1mv3_A MYC box dependent interacting protein 1; tumor suppressor, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 213 | Back alignment and structure |
|---|
Score = 50.5 bits (119), Expect = 4e-07
Identities = 19/138 (13%), Positives = 28/138 (20%)
Query: 7 SPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSP 66
SP + P A+ PS P PPP P +
Sbjct: 3 SPAATPEIRVNHEPEPAGGATPGATLPKSPSQLRKGPPVPPPPKHTPSKEVKQEQILSLF 62
Query: 67 ESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNP 126
E ++ S P + P + + S
Sbjct: 63 EDTFVPEISVTTPSQPAEASEVAGGTQPAAGAQEPGETAASEAASSSLPAVVVETFPATV 122
Query: 127 SDPPPGDSNNGSSPPGNN 144
+ G S G
Sbjct: 123 NGTVEGGSGAGRLDLPPG 140
|
| >1mv3_A MYC box dependent interacting protein 1; tumor suppressor, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 213 | Back alignment and structure |
|---|
Score = 49.7 bits (117), Expect = 6e-07
Identities = 18/133 (13%), Positives = 32/133 (24%)
Query: 20 PPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQ 79
P P + P S PP PP +P + S +
Sbjct: 7 TPEIRVNHEPEPAGGATPGATLPKSPSQLRKGPPVPPPPKHTPSKEVKQEQILSLFEDTF 66
Query: 80 SPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSS 139
P S P+ + P + ++ + S + NG+
Sbjct: 67 VPEISVTTPSQPAEASEVAGGTQPAAGAQEPGETAASEAASSSLPAVVVETFPATVNGTV 126
Query: 140 PPGNNNNNNNNGK 152
G+ +
Sbjct: 127 EGGSGAGRLDLPP 139
|
| >1mv3_A MYC box dependent interacting protein 1; tumor suppressor, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 213 | Back alignment and structure |
|---|
Score = 48.2 bits (113), Expect = 2e-06
Identities = 18/132 (13%), Positives = 34/132 (25%)
Query: 27 SSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPP 86
P+ + P ++ P S + PP PP S S P
Sbjct: 9 EIRVNHEPEPAGGATPGATLPKSPSQLRKGPPVPPPPKHTPSKEVKQEQILSLFEDTFVP 68
Query: 87 PPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNN 146
+ +P Q + Q + + + S P ++ G
Sbjct: 69 EISVTTPSQPAEASEVAGGTQPAAGAQEPGETAASEAASSSLPAVVVETFPATVNGTVEG 128
Query: 147 NNNNGKGNGNGN 158
+ G+ +
Sbjct: 129 GSGAGRLDLPPG 140
|
| >1mv3_A MYC box dependent interacting protein 1; tumor suppressor, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 213 | Back alignment and structure |
|---|
Score = 47.8 bits (112), Expect = 3e-06
Identities = 24/142 (16%), Positives = 35/142 (24%), Gaps = 3/142 (2%)
Query: 21 PSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQS 80
SP+ P P + P SP R PP PPP PS Q
Sbjct: 2 GSPAATPEIRVNHEPEPAGGATPGATLPKSPSQLRKGPPVPPPP---KHTPSKEVKQEQI 58
Query: 81 PPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSP 140
+ + P P+ P + + + + +
Sbjct: 59 LSLFEDTFVPEISVTTPSQPAEASEVAGGTQPAAGAQEPGETAASEAASSSLPAVVVETF 118
Query: 141 PGNNNNNNNNGKGNGNGNGNHN 162
P N G G G +
Sbjct: 119 PATVNGTVEGGSGAGRLDLPPG 140
|
| >1mv3_A MYC box dependent interacting protein 1; tumor suppressor, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 213 | Back alignment and structure |
|---|
Score = 47.0 bits (110), Expect = 5e-06
Identities = 14/134 (10%), Positives = 27/134 (20%)
Query: 7 SPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSP 66
V++ P+ A + SP PPP P ++ P
Sbjct: 9 EIRVNHEPEPAGGATPGATLPKSPSQLRKGPPVPPPPKHTPSKEVKQEQILSLFEDTFVP 68
Query: 67 ESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNP 126
E + P+ S P + + + + +
Sbjct: 69 EISVTTPSQPAEASEVAGGTQPAAGAQEPGETAASEAASSSLPAVVVETFPATVNGTVEG 128
Query: 127 SDPPPGDSNNGSSP 140
Sbjct: 129 GSGAGRLDLPPGFM 142
|
| >1mv3_A MYC box dependent interacting protein 1; tumor suppressor, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 213 | Back alignment and structure |
|---|
Score = 45.8 bits (107), Expect = 2e-05
Identities = 20/143 (13%), Positives = 38/143 (26%)
Query: 29 SPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPP 88
P +TP + P ++P PS P PPP PS + +
Sbjct: 2 GSPAATPEIRVNHEPEPAGGATPGATLPKSPSQLRKGPPVPPPPKHTPSKEVKQEQILSL 61
Query: 89 NSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNN 148
+ + P ++S + + + + S++ +
Sbjct: 62 FEDTFVPEISVTTPSQPAEASEVAGGTQPAAGAQEPGETAASEAASSSLPAVVVETFPAT 121
Query: 149 NNGKGNGNGNGNHNNNNNNNNNK 171
NG G + K
Sbjct: 122 VNGTVEGGSGAGRLDLPPGFMFK 144
|
| >1mv3_A MYC box dependent interacting protein 1; tumor suppressor, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 213 | Back alignment and structure |
|---|
Score = 45.8 bits (107), Expect = 2e-05
Identities = 18/129 (13%), Positives = 32/129 (24%)
Query: 5 NQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPP 64
N P + T P PP PP +P
Sbjct: 13 NHEPEPAGGATPGATLPKSPSQLRKGPPVPPPPKHTPSKEVKQEQILSLFEDTFVPEISV 72
Query: 65 SPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQD 124
+ S P + + + P + ++ + + + P + + S
Sbjct: 73 TTPSQPAEASEVAGGTQPAAGAQEPGETAASEAASSSLPAVVVETFPATVNGTVEGGSGA 132
Query: 125 NPSDPPPGD 133
D PPG
Sbjct: 133 GRLDLPPGF 141
|
| >1mv3_A MYC box dependent interacting protein 1; tumor suppressor, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 213 | Back alignment and structure |
|---|
Score = 45.1 bits (105), Expect = 2e-05
Identities = 21/142 (14%), Positives = 39/142 (27%)
Query: 38 DESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSS 97
D SP + + P+ + + P+SP P PP+ P K S
Sbjct: 1 DGSPAATPEIRVNHEPEPAGGATPGATLPKSPSQLRKGPPVPPPPKHTPSKEVKQEQILS 60
Query: 98 PPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNG 157
+T P S PS + + + ++ +++
Sbjct: 61 LFEDTFVPEISVTTPSQPAEASEVAGGTQPAAGAQEPGETAASEAASSSLPAVVVETFPA 120
Query: 158 NGNHNNNNNNNNNKNWHPPPPP 179
N + + PP
Sbjct: 121 TVNGTVEGGSGAGRLDLPPGFM 142
|
| >1mv3_A MYC box dependent interacting protein 1; tumor suppressor, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 213 | Back alignment and structure |
|---|
Score = 44.3 bits (103), Expect = 5e-05
Identities = 16/126 (12%), Positives = 26/126 (20%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
+ G + PS R PP + S P S PS
Sbjct: 17 EPAGGATPGATLPKSPSQLRKGPPVPPPPKHTPSKEVKQEQILSLFEDTFVPEISVTTPS 76
Query: 66 PESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDN 125
+ + + P + S SS P + + +
Sbjct: 77 QPAEASEVAGGTQPAAGAQEPGETAASEAASSSLPAVVVETFPATVNGTVEGGSGAGRLD 136
Query: 126 PSDPPP 131
Sbjct: 137 LPPGFM 142
|
| >1mv3_A MYC box dependent interacting protein 1; tumor suppressor, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 213 | Back alignment and structure |
|---|
Score = 42.8 bits (99), Expect = 1e-04
Identities = 24/141 (17%), Positives = 35/141 (24%), Gaps = 2/141 (1%)
Query: 26 ASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSP 85
S + P + E P P + P PP P PPP P Q
Sbjct: 2 GSPAATPEIRVNHEPEPAGGATPGATLPKSPSQLRKGPPVP--PPPKHTPSKEVKQEQIL 59
Query: 86 PPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNN 145
P+ S + P S A+ + S+ +
Sbjct: 60 SLFEDTFVPEISVTTPSQPAEASEVAGGTQPAAGAQEPGETAASEAASSSLPAVVVETFP 119
Query: 146 NNNNNGKGNGNGNGNHNNNNN 166
N G+G G +
Sbjct: 120 ATVNGTVEGGSGAGRLDLPPG 140
|
| >1mv3_A MYC box dependent interacting protein 1; tumor suppressor, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 213 | Back alignment and structure |
|---|
Score = 40.8 bits (94), Expect = 7e-04
Identities = 17/156 (10%), Positives = 33/156 (21%), Gaps = 2/156 (1%)
Query: 46 PPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPP 105
P++ P P P+ + P ++ P S + PP P S
Sbjct: 2 GSPAATPE--IRVNHEPEPAGGATPGATLPKSPSQLRKGPPVPPPPKHTPSKEVKQEQIL 59
Query: 106 PQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNN 165
+ PSQ + G + + + +
Sbjct: 60 SLFEDTFVPEISVTTPSQPAEASEVAGGTQPAAGAQEPGETAASEAASSSLPAVVVETFP 119
Query: 166 NNNNNKNWHPPPPPSSSSNSPNGNRSGALSPPNKSN 201
N + A ++
Sbjct: 120 ATVNGTVEGGSGAGRLDLPPGFMFKVQAQHDYTATD 155
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 51.5 bits (122), Expect = 4e-07
Identities = 17/83 (20%), Positives = 24/83 (28%)
Query: 43 PSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNT 102
P SP SP S ++ S S P S P ++ S P +
Sbjct: 238 LDERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSETESVNPVS 297
Query: 103 NPPPQSSPPPSNSNASPPPSQDN 125
P S P S ++
Sbjct: 298 TPASVEYHAGMKSLNKAPYSSNS 320
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 49.2 bits (116), Expect = 2e-06
Identities = 13/81 (16%), Positives = 22/81 (27%)
Query: 35 PPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPP 94
S + ++ P S P + + P+ ++ N S P
Sbjct: 240 ERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSETESVNPVSTP 299
Query: 95 QSSPPPNTNPPPQSSPPPSNS 115
S +P SNS
Sbjct: 300 ASVEYHAGMKSLNKAPYSSNS 320
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 48.8 bits (115), Expect = 3e-06
Identities = 8/89 (8%), Positives = 21/89 (23%)
Query: 15 DAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSP 74
D + + + P S + ++ P+ + +
Sbjct: 232 DLSLFYLDERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSETE 291
Query: 75 PPSSQSPPQSPPPPNSKSPPQSSPPPNTN 103
+ S P S +P + +
Sbjct: 292 SVNPVSTPASVEYHAGMKSLNKAPYSSNS 320
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 4e-05
Identities = 10/83 (12%), Positives = 18/83 (21%)
Query: 14 PDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSS 73
D + + ++ P +P + ES P S
Sbjct: 238 LDERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSETESVNPVS 297
Query: 74 PPPSSQSPPQSPPPPNSKSPPQS 96
P S + + S
Sbjct: 298 TPASVEYHAGMKSLNKAPYSSNS 320
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 4e-05
Identities = 15/88 (17%), Positives = 27/88 (30%)
Query: 3 DNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSP 62
D + S A P S P++ + + P S P +R+ +
Sbjct: 232 DLSLFYLDERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSETE 291
Query: 63 PPSPESPPPSSPPPSSQSPPQSPPPPNS 90
+P S P S + P ++
Sbjct: 292 SVNPVSTPASVEYHAGMKSLNKAPYSSN 319
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 3e-04
Identities = 15/89 (16%), Positives = 21/89 (23%), Gaps = 3/89 (3%)
Query: 49 SSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQS 108
P SP S S + + S P S+P T
Sbjct: 232 DLSLFYLDERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSETE 291
Query: 109 SPPPSN---SNASPPPSQDNPSDPPPGDS 134
S P + S + P +S
Sbjct: 292 SVNPVSTPASVEYHAGMKSLNKAPYSSNS 320
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 4e-04
Identities = 11/88 (12%), Positives = 19/88 (21%)
Query: 58 PPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNA 117
P P N + S P S + +
Sbjct: 233 LSLFYLDERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSETES 292
Query: 118 SPPPSQDNPSDPPPGDSNNGSSPPGNNN 145
P S + G + +P +N+
Sbjct: 293 VNPVSTPASVEYHAGMKSLNKAPYSSNS 320
|
| >2yew_A Capsid protein, coat protein; alphavirus, molecular dynamics; 5.00A {Barmah forest virus} Length = 253 | Back alignment and structure |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 15/90 (16%), Positives = 21/90 (23%), Gaps = 2/90 (2%)
Query: 43 PSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNT 102
P+ R P P P+ P P Q + +
Sbjct: 5 PTQTFYGRRW--RPAPVQRYIPQPQPPAPPRRRRGPSQLQQLVAALGALALQPKQKQKRA 62
Query: 103 NPPPQSSPPPSNSNASPPPSQDNPSDPPPG 132
P+ +PPP P PG
Sbjct: 63 QKKPKKTPPPKPKKTQKPKKPTQKKKSKPG 92
|
| >2yew_A Capsid protein, coat protein; alphavirus, molecular dynamics; 5.00A {Barmah forest virus} Length = 253 | Back alignment and structure |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 15/102 (14%), Positives = 24/102 (23%), Gaps = 3/102 (2%)
Query: 30 PPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPN 89
P + P P P P P P P + +
Sbjct: 5 PTQTFYGRRWRPAPVQRYIPQPQP---PAPPRRRRGPSQLQQLVAALGALALQPKQKQKR 61
Query: 90 SKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPP 131
++ P+ +PPP + P + P N
Sbjct: 62 AQKKPKKTPPPKPKKTQKPKKPTQKKKSKPGKRMRNCMKIEN 103
|
| >2yew_A Capsid protein, coat protein; alphavirus, molecular dynamics; 5.00A {Barmah forest virus} Length = 253 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 15/101 (14%), Positives = 26/101 (25%), Gaps = 1/101 (0%)
Query: 23 PSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPP 82
P++ P + P PP+ P R P + P +
Sbjct: 5 PTQTFYGRRWRPAPV-QRYIPQPQPPAPPRRRRGPSQLQQLVAALGALALQPKQKQKRAQ 63
Query: 83 QSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQ 123
+ P P ++ P +S P N +
Sbjct: 64 KKPKKTPPPKPKKTQKPKKPTQKKKSKPGKRMRNCMKIEND 104
|
| >2yew_A Capsid protein, coat protein; alphavirus, molecular dynamics; 5.00A {Barmah forest virus} Length = 253 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 11/93 (11%), Positives = 21/93 (22%)
Query: 15 DAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSP 74
D T R P PP P + + + +
Sbjct: 2 DFIPTQTFYGRRWRPAPVQRYIPQPQPPAPPRRRRGPSQLQQLVAALGALALQPKQKQKR 61
Query: 75 PPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQ 107
P P ++ P + + + P +
Sbjct: 62 AQKKPKKTPPPKPKKTQKPKKPTQKKKSKPGKR 94
|
| >2yew_A Capsid protein, coat protein; alphavirus, molecular dynamics; 5.00A {Barmah forest virus} Length = 253 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 7/93 (7%), Positives = 15/93 (16%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPS 65
A + PP +
Sbjct: 6 TQTFYGRRWRPAPVQRYIPQPQPPAPPRRRRGPSQLQQLVAALGALALQPKQKQKRAQKK 65
Query: 66 PESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSP 98
P+ PP P + + + + +
Sbjct: 66 PKKTPPPKPKKTQKPKKPTQKKKSKPGKRMRNC 98
|
| >1ej6_B Lambda1; icosahedral, non-equivalence, dsRNA virus, methylase, methyltransferase, guanylyltransferase, zinc finger, icosahedral virus; 3.60A {Reovirus SP} SCOP: i.7.1.1 PDB: 2cse_V Length = 1275 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 2e-06
Identities = 18/139 (12%), Positives = 33/139 (23%), Gaps = 4/139 (2%)
Query: 8 PGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPE 67
+N A T P S S + S+ P + +P
Sbjct: 32 DKQNNKAGPATTEPGTSNREQYRARPGIASVQRATESAELPMKNNDEGTPDKKGNTRGDL 91
Query: 68 SPPPSSPPPSSQSPPQSPPPPNSKSP----PQSSPPPNTNPPPQSSPPPSNSNASPPPSQ 123
S + Q KS + N N +S + ++ P
Sbjct: 92 VNEHSEAKDEADEATQKQAKDTDKSKAQVTYSDTGINNANELSRSGNVDNEGGSNQKPMS 151
Query: 124 DNPSDPPPGDSNNGSSPPG 142
++ + + G
Sbjct: 152 TRIAEATSAIVSKHPARVG 170
|
| >1ej6_B Lambda1; icosahedral, non-equivalence, dsRNA virus, methylase, methyltransferase, guanylyltransferase, zinc finger, icosahedral virus; 3.60A {Reovirus SP} SCOP: i.7.1.1 PDB: 2cse_V Length = 1275 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 1e-04
Identities = 9/119 (7%), Positives = 27/119 (22%), Gaps = 4/119 (3%)
Query: 6 QSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSP----PPDRSPPPSS 61
PG+++ A E+ P + + P + + + + +
Sbjct: 55 ARPGIASVQRATESAELPMKNNDEGTPDKKGNTRGDLVNEHSEAKDEADEATQKQAKDTD 114
Query: 62 PPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPP 120
+ + + +++ S + PP
Sbjct: 115 KSKAQVTYSDTGINNANELSRSGNVDNEGGSNQKPMSTRIAEATSAIVSKHPARVGLPP 173
|
| >2j63_A AP-endonuclease; base excision repair, lyase; 2.48A {Leishmania major} Length = 467 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 15/125 (12%), Positives = 27/125 (21%), Gaps = 10/125 (8%)
Query: 22 SPSRASSSPPPSTPPSDESPPPSSPPPS--SPPPDRSPPPSSPPPSPESPPPSSPP---- 75
+ R S S S PS PPS + R P ++
Sbjct: 22 ASKRCRQCSGDSASSSTSSLSPSELPPSKKAAGGQRVTAEVEVAPITTDATSATVTAAGG 81
Query: 76 ----PSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPP 131
++ SP + + + T + +
Sbjct: 82 AKKKATTGSPARRTSSAAKITNGDAGELIRTAEALAALNAKKSEKEIWSDVVPFVRRTTD 141
Query: 132 GDSNN 136
D +
Sbjct: 142 SDFDP 146
|
| >3u3p_A Tumor necrosis factor receptor superfamily member; trigger apoptosis, apoptosis; 2.09A {Homo sapiens} PDB: 3u3q_A 3u3s_A 3u3t_A 3u3v_A 3qo4_A Length = 313 | Back alignment and structure |
|---|
Score = 47.6 bits (112), Expect = 7e-06
Identities = 15/113 (13%), Positives = 30/113 (26%)
Query: 28 SSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPP 87
+ P + + SP + P P S+ P + S+ S + S
Sbjct: 171 GTLPSFSSSTSPSPGTAIFPRPEHMETHEVPSSTYVPKGMNSTESNSSASVRPKVLSSIQ 230
Query: 88 PNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSP 140
+ SS + ++ P + P ++ G
Sbjct: 231 EGTVPDNTSSARGKEDVNKTLPNLQVVNHQQGPHHRHILKLLPSMEATGGEKS 283
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 1e-05
Identities = 19/99 (19%), Positives = 31/99 (31%), Gaps = 3/99 (3%)
Query: 21 PSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQS 80
+P A + PP+ + PS S ++ SS +PPP++P SS S
Sbjct: 2 LTPLSAITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSR---APPPTNPDASSSS 58
Query: 81 PPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASP 119
+ P + K P +
Sbjct: 59 SSFAVPTIHFKESPFYKIQRLIPELVMNVEVTGGRGMCS 97
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 8e-05
Identities = 14/74 (18%), Positives = 19/74 (25%), Gaps = 3/74 (4%)
Query: 40 SPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPP 99
S P S P P S+ S PPP + P +S
Sbjct: 1 SLTPLSAITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRAPPP---TNPDASSS 57
Query: 100 PNTNPPPQSSPPPS 113
++ P S
Sbjct: 58 SSSFAVPTIHFKES 71
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 43.8 bits (102), Expect = 1e-04
Identities = 15/67 (22%), Positives = 20/67 (29%)
Query: 56 SPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNS 115
S P S P + S S + P K+ SS P + S+S
Sbjct: 1 SLTPLSAITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRAPPPTNPDASSSSSS 60
Query: 116 NASPPPS 122
A P
Sbjct: 61 FAVPTIH 67
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 43.8 bits (102), Expect = 2e-04
Identities = 10/72 (13%), Positives = 17/72 (23%)
Query: 29 SPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPP 88
S P + + S P P+ + + S PP + S
Sbjct: 1 SLTPLSAITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRAPPPTNPDASSSSSS 60
Query: 89 NSKSPPQSSPPP 100
+ P
Sbjct: 61 FAVPTIHFKESP 72
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 43.4 bits (101), Expect = 2e-04
Identities = 15/97 (15%), Positives = 18/97 (18%)
Query: 13 SPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPS 72
S S PS P+ +S S P P S S
Sbjct: 1 SLTPLSAITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRAPPPTNPDASSSSSS 60
Query: 73 SPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSS 109
P+ P T S
Sbjct: 61 FAVPTIHFKESPFYKIQRLIPELVMNVEVTGGRGMCS 97
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 43.0 bits (100), Expect = 2e-04
Identities = 17/116 (14%), Positives = 32/116 (27%)
Query: 7 SPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSP 66
S ++ P+ SP + S+ +S P + P +S S
Sbjct: 1 SLTPLSAITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRAPPPTNPDASSSSSS 60
Query: 67 ESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPS 122
+ P S Q P + + + + S N ++P
Sbjct: 61 FAVPTIHFKESPFYKIQRLIPELVMNVEVTGGRGMCSAKFKLSKADYNLLSNPNSK 116
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 43.0 bits (100), Expect = 3e-04
Identities = 13/64 (20%), Positives = 22/64 (34%)
Query: 64 PSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQ 123
+P S + Q P +SP Q T+ ++ PP + +S S
Sbjct: 2 LTPLSAITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRAPPPTNPDASSSSSSF 61
Query: 124 DNPS 127
P+
Sbjct: 62 AVPT 65
|
| >3sqr_A Laccase; multicopper oxidase, glycosylation, oxidoreductase; HET: NAG BMA MAN; 1.67A {Botrytis aclada} Length = 580 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 15/114 (13%), Positives = 24/114 (21%), Gaps = 2/114 (1%)
Query: 64 PSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPP--P 121
S + P S + P + SS + +
Sbjct: 351 SSSIANPTSVGTTPRGTCEDEPVASLVPHLALDVGGYSLVDEQVSSAFTNYFTWTINSSS 410
Query: 122 SQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKNWHP 175
+ S P N + N + N N + WHP
Sbjct: 411 LLLDWSSPTTLKIFNNETIFPTEYNVVALEQTNANEEWVVYVIEDLTGFGIWHP 464
|
| >2xag_A Lysine-specific histone demethylase 1; amine oxidase, chromatin regulator, histone inhibitor binding, methylation, nucleosome core, oxidoreductase; HET: FAD TCF; 3.10A {Homo sapiens} PDB: 2xaf_A* 2xah_A* 2xaj_A* 2xaq_A* 2xas_A* 2com_A Length = 852 | Back alignment and structure |
|---|
Score = 46.5 bits (109), Expect = 3e-05
Identities = 18/131 (13%), Positives = 27/131 (20%), Gaps = 2/131 (1%)
Query: 3 DNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSP 62
++P P A+ S+ P + P + P+
Sbjct: 55 VGERTPRKKEPPRASPPGGLAEPPGSAGPQAGPTVVPGSATPMETGIAETPEGRRTSRRK 114
Query: 63 PPSPESP--PPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPP 120
E S S + PPP PP+ S
Sbjct: 115 RAKVEYREMDESLANLSEDEYYSEEERNAKAEKEKKLPPPPPQAPPEEENESEPEEPSGV 174
Query: 121 PSQDNPSDPPP 131
S P
Sbjct: 175 EGAAFQSRLPH 185
|
| >3egg_C Spinophilin; PP1, serine/threonine phosphatase, post synapti density, glutametergic receptors, carbohydrate metabolism, cycle, cell division; HET: MES; 1.85A {Rattus norvegicus} PDB: 3egh_C* 3hvq_C 2fn5_A Length = 170 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 4e-05
Identities = 11/76 (14%), Positives = 14/76 (18%)
Query: 27 SSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPP 86
PP P S P P P R S+ P S +
Sbjct: 6 EDGEPPYEPESGCVEIPGLSEEEDPAPSRKIHFSTAPIQVFSTYSNEDYDRRNEDVDPMA 65
Query: 87 PPNSKSPPQSSPPPNT 102
+
Sbjct: 66 ASAEYELEKRVERLEL 81
|
| >1kxf_A Sindbis virus capsid protein; chymotrypsin-like serine proteinase, wild type, viral protein; 2.38A {Sindbis virus} SCOP: b.47.1.3 PDB: 1ld4_A 3j0f_A Length = 264 | Back alignment and structure |
|---|
Score = 44.4 bits (104), Expect = 6e-05
Identities = 16/103 (15%), Positives = 26/103 (25%), Gaps = 2/103 (1%)
Query: 21 PSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQS 80
P+P+ + + S P++P P PP +
Sbjct: 15 PAPTAMWRPRRRRQAAPMPARNGLASQIQQLTTAVSALVIGQATRPQNPRPRPPPRQKKQ 74
Query: 81 PPQSPPPPNSKSPPQSSP--PPNTNPPPQSSPPPSNSNASPPP 121
P+ PP P P + P T P +
Sbjct: 75 APKQPPKPKKPKPQEKKKKQPAKTKPGKRQRMALKLEADRLFD 117
|
| >1kxf_A Sindbis virus capsid protein; chymotrypsin-like serine proteinase, wild type, viral protein; 2.38A {Sindbis virus} SCOP: b.47.1.3 PDB: 1ld4_A 3j0f_A Length = 264 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 2e-04
Identities = 13/111 (11%), Positives = 22/111 (19%)
Query: 41 PPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPP 100
P P P + + + + P P Q P
Sbjct: 17 PTAMWRPRRRRQAAPMPARNGLASQIQQLTTAVSALVIGQATRPQNPRPRPPPRQKKQAP 76
Query: 101 NTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNG 151
P P+ P P ++ N + + G
Sbjct: 77 KQPPKPKKPKPQEKKKKQPAKTKPGKRQRMALKLEADRLFDVKNEDGDVIG 127
|
| >1kxf_A Sindbis virus capsid protein; chymotrypsin-like serine proteinase, wild type, viral protein; 2.38A {Sindbis virus} SCOP: b.47.1.3 PDB: 1ld4_A 3j0f_A Length = 264 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 2e-04
Identities = 17/106 (16%), Positives = 29/106 (27%), Gaps = 3/106 (2%)
Query: 14 PDAAETPPSPSRASSSPPPSTPPSDESPPPSS---PPPSSPPPDRSPPPSSPPPSPESPP 70
P A P +A+ P + S ++ ++P P PP + P
Sbjct: 17 PTAMWRPRRRRQAAPMPARNGLASQIQQLTTAVSALVIGQATRPQNPRPRPPPRQKKQAP 76
Query: 71 PSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSN 116
P P P + +K+ P N +
Sbjct: 77 KQPPKPKKPKPQEKKKKQPAKTKPGKRQRMALKLEADRLFDVKNED 122
|
| >1kxf_A Sindbis virus capsid protein; chymotrypsin-like serine proteinase, wild type, viral protein; 2.38A {Sindbis virus} SCOP: b.47.1.3 PDB: 1ld4_A 3j0f_A Length = 264 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 2e-04
Identities = 17/101 (16%), Positives = 24/101 (23%), Gaps = 1/101 (0%)
Query: 31 PPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNS 90
P P + P P + + S Q+P PPP
Sbjct: 13 PFPAPTAMWRPRRRRQAAPMPARNGLASQIQQLTTAVSALVIGQATRPQNPRPRPPPRQK 72
Query: 91 KSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPP 131
K P+ P P P + + P Q
Sbjct: 73 KQAPKQPPKPKKPKPQE-KKKKQPAKTKPGKRQRMALKLEA 112
|
| >3bbn_E Ribosomal protein S5; small ribosomal subunit, spinach chloroplast ribosome, ribonucleoprotein particle, macromolecular complex; 9.40A {Spinacea oleracea} Length = 308 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 21/157 (13%), Positives = 39/157 (24%), Gaps = 10/157 (6%)
Query: 16 AAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPP 75
A +PS S + P ++ S P S + P
Sbjct: 2 ATTATTTPSATSLTT--LHRRIPLFPTTTTLLSLSSSS--KPLFLSLSSTRSFPTHLYCI 57
Query: 76 PSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSN 135
N PP P+ PP + P S++ + +
Sbjct: 58 KKDDIDITFFEQDNPDEEITFDPPE----KPEGYIPPRAVDEPPFESEEEIALAY--EEL 111
Query: 136 NGSSPPGNNNNNNNNGKGNGNGNGNHNNNNNNNNNKN 172
G++ G + N+ + + + K
Sbjct: 112 YGAAYSGESLLGNDVYAMDSKIKKATGFGSKSKKEKI 148
|
| >2b5l_C Nonstructural protein V; DDB1, SV5-V, beta propeller, propeller cluster, zinc finger, protein binding/viral protein complex; 2.85A {Simian virus 5} PDB: 2hye_B* Length = 222 | Back alignment and structure |
|---|
Score = 43.8 bits (102), Expect = 6e-05
Identities = 21/140 (15%), Positives = 31/140 (22%), Gaps = 4/140 (2%)
Query: 16 AAETPPSPSRASSSPPPSTP---PSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPS 72
T S ++ PP T + E+ S P P P P
Sbjct: 30 QQVTGTSSLGKNTIPPGVTGLLTNAAEAKIQESTNHQKGSVGGGAKPKKPRPKIAIVPAD 89
Query: 73 SP-PPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPP 131
P P ++ S P S + + P
Sbjct: 90 DKTVPGKPIPNPLLGLDSTPSTQTVLDLSGKTLPSGSYKGVKLAKFGKENLMTRFIEEPR 149
Query: 132 GDSNNGSSPPGNNNNNNNNG 151
+ SSP + G
Sbjct: 150 ENPIATSSPIDFKRGRDTGG 169
|
| >1dx0_A Prion protein; brain, repeat; NMR {Bos taurus} SCOP: d.6.1.1 PDB: 1dx1_A 1qlx_A 1qlz_A Length = 219 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 8e-05
Identities = 13/146 (8%), Positives = 21/146 (14%)
Query: 30 PPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPN 89
P S P P + P P P
Sbjct: 2 SKKRPKPGGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGG 61
Query: 90 SKSPPQSSPPPNTNPPPQSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNN 149
P P + N + +
Sbjct: 62 WGQPHGGGWGQPHGGGGWGQGGTHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGS 121
Query: 150 NGKGNGNGNGNHNNNNNNNNNKNWHP 175
G+ + N + +P
Sbjct: 122 AMSRPLIHFGSDYEDRYYRENMHRYP 147
|
| >2krg_A Na(+)/H(+) exchange regulatory cofactor NHE-RF1; acetylation, cell projection, disease mutation, membrane, phosphoprotein, polymorphism; NMR {Homo sapiens} Length = 216 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 8e-05
Identities = 11/84 (13%), Positives = 17/84 (20%)
Query: 19 TPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSS 78
P P P T + + P S S +S
Sbjct: 103 IPSQEHLNGPLPVPFTNGEIQKENSREALAEAALESPRPALVRSASSDTSEELNSQDSPP 162
Query: 79 QSPPQSPPPPNSKSPPQSSPPPNT 102
+ +P +S P
Sbjct: 163 KQDSTAPSSTSSSDPILDFNISLA 186
|
| >2krg_A Na(+)/H(+) exchange regulatory cofactor NHE-RF1; acetylation, cell projection, disease mutation, membrane, phosphoprotein, polymorphism; NMR {Homo sapiens} Length = 216 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 2e-04
Identities = 16/95 (16%), Positives = 24/95 (25%), Gaps = 1/95 (1%)
Query: 1 MEDNNQSPGVSNSPDAAETP-PSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPP 59
++ + V S + P P P ++ + SP P+ S
Sbjct: 93 TDEFFKKCRVIPSQEHLNGPLPVPFTNGEIQKENSREALAEAALESPRPALVRSASSDTS 152
Query: 60 SSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPP 94
P S PSS S N
Sbjct: 153 EELNSQDSPPKQDSTAPSSTSSSDPILDFNISLAM 187
|
| >2krg_A Na(+)/H(+) exchange regulatory cofactor NHE-RF1; acetylation, cell projection, disease mutation, membrane, phosphoprotein, polymorphism; NMR {Homo sapiens} Length = 216 | Back alignment and structure |
|---|
Score = 40.9 bits (95), Expect = 7e-04
Identities = 9/95 (9%), Positives = 19/95 (20%)
Query: 47 PPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPP 106
+ + P P S + P +
Sbjct: 90 DRETDEFFKKCRVIPSQEHLNGPLPVPFTNGEIQKENSREALAEAALESPRPALVRSASS 149
Query: 107 QSSPPPSNSNASPPPSQDNPSDPPPGDSNNGSSPP 141
+S ++ ++ P PS D +
Sbjct: 150 DTSEELNSQDSPPKQDSTAPSSTSSSDPILDFNIS 184
|
| >2g6z_A Dual specificity protein phosphatase 5; alpha/beta, hydrolase; 2.70A {Homo sapiens} Length = 211 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 9e-05
Identities = 12/58 (20%), Positives = 18/58 (31%)
Query: 20 PPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPS 77
PPS ++ SP + P +P P+ S S P + S
Sbjct: 153 PPSCQGEAAGSSLIGHLQTLSPDMQGAYCTFPASVLAPVPTHSTVSELSRSPVATATS 210
|
| >1x9d_A Endoplasmic reticulum mannosyl-oligosaccharide 1, 2-alpha-mannosidase; substrate analogue, glycosyl hydrolase; HET: SMD; 1.41A {Homo sapiens} SCOP: a.102.2.1 PDB: 1fo3_A* 1fo2_A* 1fmi_A Length = 538 | Back alignment and structure |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 13/74 (17%), Positives = 16/74 (21%)
Query: 62 PPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPPPQSSPPPSNSNASPPP 121
PP Q P P P S P Q + PS P
Sbjct: 11 PPSQDLKDGTQEEATKRQEAPVDPRPEGDPQRTVISWRGAVIEPEQGTELPSRRAEVPTK 70
Query: 122 SQDNPSDPPPGDSN 135
P+ +
Sbjct: 71 PPLPPARTQGTPVH 84
|
| >1x9d_A Endoplasmic reticulum mannosyl-oligosaccharide 1, 2-alpha-mannosidase; substrate analogue, glycosyl hydrolase; HET: SMD; 1.41A {Homo sapiens} SCOP: a.102.2.1 PDB: 1fo3_A* 1fo2_A* 1fmi_A Length = 538 | Back alignment and structure |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 12/74 (16%), Positives = 22/74 (29%), Gaps = 1/74 (1%)
Query: 25 RASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSP-PQ 83
S + + +P P D S + P + PS ++ P
Sbjct: 10 DPPSQDLKDGTQEEATKRQEAPVDPRPEGDPQRTVISWRGAVIEPEQGTELPSRRAEVPT 69
Query: 84 SPPPPNSKSPPQSS 97
PP P +++
Sbjct: 70 KPPLPPARTQGTPV 83
|
| >1x9d_A Endoplasmic reticulum mannosyl-oligosaccharide 1, 2-alpha-mannosidase; substrate analogue, glycosyl hydrolase; HET: SMD; 1.41A {Homo sapiens} SCOP: a.102.2.1 PDB: 1fo3_A* 1fo2_A* 1fmi_A Length = 538 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 16/88 (18%), Positives = 25/88 (28%), Gaps = 10/88 (11%)
Query: 30 PPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPN 89
PPS D + P P S + P Q P+
Sbjct: 10 DPPSQDLKD-------GTQEEATKRQEAPVDPRPEGDPQRTVISWRGAVIEPEQGTELPS 62
Query: 90 SKSPPQSSPPPNTNPPPQSSPPPSNSNA 117
++ + PP PP ++ P + N
Sbjct: 63 RRAEVPTKPPL---PPARTQGTPVHLNY 87
|
| >1x9d_A Endoplasmic reticulum mannosyl-oligosaccharide 1, 2-alpha-mannosidase; substrate analogue, glycosyl hydrolase; HET: SMD; 1.41A {Homo sapiens} SCOP: a.102.2.1 PDB: 1fo3_A* 1fo2_A* 1fmi_A Length = 538 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 13/80 (16%), Positives = 21/80 (26%), Gaps = 4/80 (5%)
Query: 46 PPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPPNTNPP 105
PP + +P P P P + + P Q + P+
Sbjct: 11 PPSQDLKDGTQEEATKRQEAPVDPRPEGDPQRTVISWRGAVIE----PEQGTELPSRRAE 66
Query: 106 PQSSPPPSNSNASPPPSQDN 125
+ PP + P N
Sbjct: 67 VPTKPPLPPARTQGTPVHLN 86
|
| >3dva_I Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase...; oxidoreductase, multienzyme complex; HET: TPW; 2.35A {Bacillus stearothermophilus} PDB: 3dv0_I* 3duf_I* 1b5s_A 1lab_A 1lac_A 1w3d_A Length = 428 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 11/120 (9%), Positives = 26/120 (21%), Gaps = 33/120 (27%)
Query: 7 SPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSP---- 62
+PG N + + + S ++ P++P + + P
Sbjct: 78 APGYENMTFKGQEQEEAKKEEKTETVSKEEKVDAVAPNAPAAEAEAGPNRRVIAMPSVRK 137
Query: 63 ------------PPS-----------------PESPPPSSPPPSSQSPPQSPPPPNSKSP 93
+ P P++ + P + P
Sbjct: 138 YAREKGVDIRLVQGTGKNGRVLKEDIDAFLAGGAKPAPAAAEEKAAPAAAKPATTEGEFP 197
|
| >3dva_I Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase...; oxidoreductase, multienzyme complex; HET: TPW; 2.35A {Bacillus stearothermophilus} PDB: 3dv0_I* 3duf_I* 1b5s_A 1lab_A 1lac_A 1w3d_A Length = 428 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 2/55 (3%), Positives = 8/55 (14%)
Query: 44 SSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSP 98
+ + + + P + + P
Sbjct: 79 PGYENMTFKGQEQEEAKKEEKTETVSKEEKVDAVAPNAPAAEAEAGPNRRVIAMP 133
|
| >3oun_A Putative uncharacterized protein TB39.8; peptidoglycan, Ser/Thr kinase, pseudokinase, FHA domain, REG phosphorylation; HET: TPO; 2.71A {Mycobacterium tuberculosis} Length = 157 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 11/65 (16%), Positives = 11/65 (16%)
Query: 13 SPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPS 72
S S S P E S PD P
Sbjct: 3 SSQHHHHHSSGLVPRGSHMPQGGGYAEPAGRDYDYGQSGAPDYGQPAPGGYSGYGQGGYG 62
Query: 73 SPPPS 77
S S
Sbjct: 63 SAGTS 67
|
| >3oun_A Putative uncharacterized protein TB39.8; peptidoglycan, Ser/Thr kinase, pseudokinase, FHA domain, REG phosphorylation; HET: TPO; 2.71A {Mycobacterium tuberculosis} Length = 157 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 4e-04
Identities = 9/61 (14%), Positives = 10/61 (16%)
Query: 28 SSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPPP 87
S S P S P +P P P S
Sbjct: 2 GSSQHHHHHSSGLVPRGSHMPQGGGYAEPAGRDYDYGQSGAPDYGQPAPGGYSGYGQGGY 61
Query: 88 P 88
Sbjct: 62 G 62
|
| >3oun_A Putative uncharacterized protein TB39.8; peptidoglycan, Ser/Thr kinase, pseudokinase, FHA domain, REG phosphorylation; HET: TPO; 2.71A {Mycobacterium tuberculosis} Length = 157 | Back alignment and structure |
|---|
Score = 39.9 bits (93), Expect = 8e-04
Identities = 11/65 (16%), Positives = 12/65 (18%)
Query: 24 SRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQ 83
S S S P + P S P P P Q
Sbjct: 3 SSQHHHHHSSGLVPRGSHMPQGGGYAEPAGRDYDYGQSGAPDYGQPAPGGYSGYGQGGYG 62
Query: 84 SPPPP 88
S
Sbjct: 63 SAGTS 67
|
| >1w7p_D VPS36P, YLR417W; ESCRT-II complex, endosomal protein sorting, protein transpo; 3.60A {Saccharomyces cerevisiae} SCOP: a.4.5.54 a.4.5.54 Length = 566 | Back alignment and structure |
|---|
Score = 42.4 bits (98), Expect = 5e-04
Identities = 24/226 (10%), Positives = 48/226 (21%), Gaps = 10/226 (4%)
Query: 2 EDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSS 61
+D + S D T P S+ D P P P S
Sbjct: 100 KDELGKSAETASADVVSTWVCPICMVSNETQGEFTKDTLPTPICINCGVPADYELTKSSI 159
Query: 62 PPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSS-------PPPNTNPPPQSSPPPSN 114
+ P + + P + PQ PN + +
Sbjct: 160 NCSNAIDPNANPQNQFGVNSENICPACTFANHPQIGNCEICGHRLPNASKVRSKLNRLNF 219
Query: 115 SNASPPPSQDNPSDPPPGDSNNGSSPPGNNNNNNNNGKG---NGNGNGNHNNNNNNNNNK 171
++ + S S++ S + ++ + +G N
Sbjct: 220 HDSRVHIELEKNSLARNKSSHSALSSSSSTGSSTEFVQLSFRKSDGVLFSQATERALENI 279
Query: 172 NWHPPPPPSSSSNSPNGNRSGALSPPNKSNGSSSSPSSNNGSMLSI 217
+ + + + S + I
Sbjct: 280 LTEKNKHIFNQNVVSVNGVDMRKGASSHEYNNEVPFIETKLSRIGI 325
|
| >2axn_A 6-phosphofructo-2-kinase/fructose-2,6- biphosphatase 3 (6PF-2-K/FRU- 2,6-P2ASE brain/placenta-type...; bifunctional enzyme, EDTA complex; HET: F6P EDT ADP; 2.10A {Homo sapiens} PDB: 2dwo_A* 2dwp_A* 2i1v_B* 3qpu_A* 3qpv_A* 3qpw_A* Length = 520 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 6e-04
Identities = 15/74 (20%), Positives = 23/74 (31%)
Query: 12 NSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPP 71
+ A+ P+P +S P P P + + PS PP + P
Sbjct: 444 ERSEDAKKGPNPLMRRNSVTPLASPEPTKKPRINSFEEHVASTSAALPSCLPPEVPTQLP 503
Query: 72 SSPPPSSQSPPQSP 85
S+S S
Sbjct: 504 GQNMKGSRSSADSS 517
|
| >3eiv_A Single-stranded DNA-binding protein 2; DNA damage, DNA repair, DNA replication, phosphoprotein; 2.14A {Streptomyces coelicolor} Length = 199 | Back alignment and structure |
|---|
Score = 40.7 bits (95), Expect = 7e-04
Identities = 10/85 (11%), Positives = 13/85 (15%)
Query: 15 DAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSP 74
A T S + P P P + +P
Sbjct: 114 TAKVTKTSGQGRGGQGGYGGGGGGQGGGGWGGGPGGGQQGGGAPADDPWATGGAPAGGQQ 173
Query: 75 PPSSQSPPQSPPPPNSKSPPQSSPP 99
Q PP
Sbjct: 174 GGGGQGGGGWGGGSGGGGGYSDEPP 198
|
| >1t9b_A Acetolactate synthase, mitochondrial; acetohydroxyacid synthase, herbicide, sulfonylurea, thiamin diphosphate, FAD, inhibitor; HET: 1CS P25 FAD NSP P22 YF3; 2.20A {Saccharomyces cerevisiae} SCOP: c.31.1.3 c.36.1.5 c.36.1.9 PDB: 1n0h_A* 1t9a_A* 1t9c_A* 1t9d_A* 1jsc_A* Length = 677 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 9/72 (12%), Positives = 14/72 (19%)
Query: 27 SSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQSPPQSPP 86
SS P E+ PD P P +
Sbjct: 8 SSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKAMGSAPSFNVDPLEQPAEPSKLAK 67
Query: 87 PPNSKSPPQSSP 98
++ +S
Sbjct: 68 KLRAEPDMDTSF 79
|
| >2qlv_B Protein SIP2, protein SPM2; heterotrimer, ATP-binding, carbohydrate metabolism, kinase, membrane, nucleotide-binding, nucleus; 2.60A {Saccharomyces cerevisiae} SCOP: b.1.18.21 d.353.1.1 Length = 252 | Back alignment and structure |
|---|
Score = 40.8 bits (94), Expect = 8e-04
Identities = 23/128 (17%), Positives = 34/128 (26%), Gaps = 6/128 (4%)
Query: 1 MEDNNQSPGVSNSPDAAETPPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPS 60
+ N + S +A P S SS D+ + P +
Sbjct: 87 QPEKNPTNEKIRSKEADSMRPPTSDRSSIALQIGKDPDDFGDGYTRFHEDLSPRPPLEYT 146
Query: 61 SPPPSPESPPPSSPPPSSQSPPQSPPPPNSKSPPQSSPPP------NTNPPPQSSPPPSN 114
+ P+ + P Q S P PP N Q +N
Sbjct: 147 TDIPAVFTDPSVMERYYYTLDRQQSNTDTSWLTPPQLPPQLENVILNKYYATQDQFNENN 206
Query: 115 SNASPPPS 122
S A P P+
Sbjct: 207 SGALPIPN 214
|
| >1eys_C Photosynthetic reaction center; membrane protein complex, electron transport; HET: BGL BCL BPH MQ8 HEM CRT LDA PEF; 2.20A {Thermochromatium tepidum} SCOP: a.138.1.2 Length = 382 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 9e-04
Identities = 11/69 (15%), Positives = 24/69 (34%)
Query: 20 PPSPSRASSSPPPSTPPSDESPPPSSPPPSSPPPDRSPPPSSPPPSPESPPPSSPPPSSQ 79
+ + P + P+ E+ P ++ + P + P + P+ P + S +
Sbjct: 307 GLYKTAVTQEALPGSAPASEAAPAAATEAAPEAPAQEVPAAEAVPAAAEPGAAEAAGSVE 366
Query: 80 SPPQSPPPP 88
P P
Sbjct: 367 PAPVEEVAP 375
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 724 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.48 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.22 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.21 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.98 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.84 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.8 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.77 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.74 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.59 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.43 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.37 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.28 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.24 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.23 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 98.03 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.94 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.85 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.76 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.68 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.61 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.53 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.47 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 97.45 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.43 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 97.24 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.23 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 97.13 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 97.06 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.68 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.67 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.23 | |
| 2l34_A | 33 | TYRO protein tyrosine kinase-binding protein; immu | 93.5 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 93.27 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.33 | |
| 1iij_A | 35 | ERBB-2 receptor protein-tyrosine kinase; alpha-hel | 92.13 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.84 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 89.78 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 87.23 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.45 | |
| 2knc_A | 54 | Integrin alpha-IIB; transmembrane signaling, prote | 84.4 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 84.17 | |
| 2klu_A | 70 | T-cell surface glycoprotein CD4; cell membrane, di | 83.92 | |
| 2x6h_A | 696 | GH13170P, VPS34, phosphotidylinositol 3 kinase 59F | 83.82 | |
| 3ls8_A | 614 | Phosphatidylinositol 3-kinase catalytic subunit ty | 82.48 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=459.76 Aligned_cols=256 Identities=28% Similarity=0.462 Sum_probs=206.7
Q ss_pred CCCcccceeeccCcEEEEEEEcC------CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP------NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
.+|.+.+.||+|+||+||+|.+. +++.||||+++.......++|++|+++|++|+|+|||+++|+|.+.+.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56788899999999999999864 477899999987766667789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCE
Q 040832 420 VYEYVPNNNLEFHLHGKG-------------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFET 486 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~-------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~v 486 (724)
|||||++|+|.++|+... ...++|.++++|+.|||+||+|||++ +|||||||++||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 999999999999997642 23589999999999999999999998 99999999999999999999
Q ss_pred EEEEeccccccCCCCC-ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhh
Q 040832 487 KVADFGLAKLTTDNNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARP 564 (724)
Q Consensus 487 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~ 564 (724)
||+|||+++....... .......||+.|||||++.+..|+.++|||||||+||||+| |+.||......+. ...
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~--~~~--- 272 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA--IDC--- 272 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH--HHH---
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH--HHH---
Confidence 9999999997654432 23455779999999999999999999999999999999999 9999986543321 111
Q ss_pred hhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 565 LCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 565 ~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
+..+. ....+......+.+++.+||+.||++||+|.||+++|+..
T Consensus 273 -----i~~g~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 273 -----ITQGR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp -----HHHTC---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred -----HHcCC---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 00110 0012223345688999999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-54 Score=456.95 Aligned_cols=257 Identities=26% Similarity=0.444 Sum_probs=213.7
Q ss_pred hCCCcccceeeccCcEEEEEEEcC------CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP------NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRL 418 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 418 (724)
.++|.+.+.||+|+||+||+|.+. +++.||||+++.......++|.+|+++|++|+|||||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 356888999999999999999864 46789999998776666778999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEE
Q 040832 419 LVYEYVPNNNLEFHLHGKG-----------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETK 487 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~-----------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vk 487 (724)
||||||++|+|.++|+..+ ...++|.++++|+.||++||+|||++ +|||||||++||||+.++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence 9999999999999997542 34699999999999999999999998 999999999999999999999
Q ss_pred EEEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhh
Q 040832 488 VADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPL 565 (724)
Q Consensus 488 L~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~ 565 (724)
|+|||+|+........ ......||+.|||||++.++.|+.++|||||||+||||+| |+.||......+. ...
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~--~~~---- 242 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV--IEC---- 242 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HHH----
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH--HHH----
Confidence 9999999876544332 3344679999999999999999999999999999999999 9999986543321 111
Q ss_pred hhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 566 CLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 566 ~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
+..+.. ...+......+.+++.+||+.+|++||+|.||++.|+..
T Consensus 243 ----i~~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 243 ----ITQGRV---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp ----HHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111111 012223345688999999999999999999999999853
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-54 Score=457.84 Aligned_cols=257 Identities=23% Similarity=0.399 Sum_probs=212.2
Q ss_pred CCCcccceeeccCcEEEEEEEcC------CCcEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP------NGKEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRL 418 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 418 (724)
..+++.+.||+|+||+||+|.+. +++.||||+++... ....++|++|+.+|++|+|||||+|+|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34677889999999999999863 46789999997553 334578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC
Q 040832 419 LVYEYVPNNNLEFHLHGKG--------------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF 484 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~ 484 (724)
||||||++|+|.++|+.+. ...++|.++++|+.|||+||+|||++ +|||||||++||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 9999999999999997532 23589999999999999999999999 999999999999999999
Q ss_pred CEEEEEeccccccCCCC-CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhh
Q 040832 485 ETKVADFGLAKLTTDNN-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWA 562 (724)
Q Consensus 485 ~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~ 562 (724)
.+||+|||+++...... ........||+.|||||++.++.|+.++|||||||+||||+| |+.||......+ +...
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~--~~~~- 259 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--VVEM- 259 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH--HHHH-
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH--HHHH-
Confidence 99999999998765432 223455679999999999999999999999999999999999 899998654322 1111
Q ss_pred hhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 563 RPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 563 ~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
+..+.. ...+.++...+.+++.+||+.+|++||+|.||++.|+...
T Consensus 260 -------i~~~~~---------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 260 -------IRNRQV---------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp -------HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -------HHcCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 111111 1122334556889999999999999999999999998654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-53 Score=447.63 Aligned_cols=257 Identities=27% Similarity=0.441 Sum_probs=202.9
Q ss_pred hCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
.++|.+++.||+|+||+||+|.+.+ .||||+++.. ..+..+.|.+|+++|++|+|+|||+++|+|.+ +.++||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 4577889999999999999999743 5999999754 23345679999999999999999999999865 56799999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
||++|+|.++|+.... .++|.++++|+.|||+||+|||++ +||||||||+||||++++.+||+|||+|+.......
T Consensus 112 y~~gGsL~~~l~~~~~-~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 112 WCEGSSLYKHLHVQET-KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CCSSCBHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred cCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 9999999999976543 489999999999999999999998 999999999999999999999999999987654322
Q ss_pred -ccccccccCCCcCCcchhcC---CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhh
Q 040832 503 -HVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEI 578 (724)
Q Consensus 503 -~~~~~~~gt~~y~APE~~~~---~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 578 (724)
......+||+.|||||++.. +.|+.++|||||||+||||+||+.||.............. .......+.
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~-----~~~~~p~~~-- 260 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVG-----RGYASPDLS-- 260 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH-----TTCCCCCST--
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHh-----cCCCCCCcc--
Confidence 23345689999999999963 4699999999999999999999999986544332211111 111111111
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 579 ADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 579 vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
....+....+.+++.+||+.+|++||+|.||+++|+.
T Consensus 261 -------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 261 -------KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp -------TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred -------cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1122334568889999999999999999999998874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=451.43 Aligned_cols=251 Identities=21% Similarity=0.363 Sum_probs=204.8
Q ss_pred CCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
++|++++.||+|+||+||+|++ .+|+.||||+++... ....+.|++|+++|++|+|||||++++++.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999995 468999999997542 2334579999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
||++|+|.++|..++...+++.+++.|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+......
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 99999999999877666689999999999999999999999 99999999999999999999999999998765322
Q ss_pred ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchh
Q 040832 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~ 582 (724)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||......+.... +..+.+..
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~----------i~~~~~~~----- 244 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLK----------IISGSFPP----- 244 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----------HHHTCCCC-----
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH----------HHcCCCCC-----
Confidence 123446799999999999999999999999999999999999999986543321110 01111110
Q ss_pred hhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 583 LEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 583 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+......+.+++.+||+.||++||++.||+++
T Consensus 245 ----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 245 ----VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111223467889999999999999999999863
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=444.78 Aligned_cols=250 Identities=21% Similarity=0.314 Sum_probs=208.8
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
..|++.+.||+|+||.||+|++. +|+.||||+++.......+.|.+|+++|++|+|+|||+++++|.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46999999999999999999964 68999999997554445567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
++|+|.+++... .+++.+++.|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+........
T Consensus 154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~- 226 (346)
T 4fih_A 154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR- 226 (346)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-
T ss_pred CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc-
Confidence 999999999764 389999999999999999999999 9999999999999999999999999999987654332
Q ss_pred ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhh
Q 040832 505 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLE 584 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~ 584 (724)
....+||+.|||||++.+..|+.++|||||||+||||++|+.||......+.. .... .... ..+
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~-~~i~-----~~~~-~~~--------- 290 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-KMIR-----DNLP-PRL--------- 290 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHHH-----HSSC-CCC---------
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-HHHH-----cCCC-CCC---------
Confidence 34578999999999999999999999999999999999999999765433221 1000 0000 000
Q ss_pred cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 585 KNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.........+.+++.+||+.||++||++.||+++
T Consensus 291 -~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 291 -KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp -SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0011223467889999999999999999999873
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=445.63 Aligned_cols=268 Identities=25% Similarity=0.387 Sum_probs=217.2
Q ss_pred cCHHHHHHhhCCCcccceeeccCcEEEEEEEcCC------CcEEEEEEeccCCch-hHHHHHHHHHHHHhcC-CCCeeEE
Q 040832 336 FTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPN------GKEVAVKSLRSGSGQ-GEREFKAEVEIISRVH-HRHLVSL 407 (724)
Q Consensus 336 f~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~------g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~-HpnIv~l 407 (724)
+...+.+...++|++++.||+|+||+||+|.+.. ++.||||+++..... ..+.|.+|+++|++|+ |+|||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3445556667889999999999999999998542 367999999876444 3467999999999995 5899999
Q ss_pred eeEEEeC-CeEEEEEEecCCCCHHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 040832 408 VGYCIAG-GKRLLVYEYVPNNNLEFHLHGKG--------------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRD 472 (724)
Q Consensus 408 ~g~~~~~-~~~~lV~E~~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrD 472 (724)
+|+|.+. +.++||||||++|+|.++|+... ...+++..++.|+.|||+||+|||++ +|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9999764 56899999999999999997532 23589999999999999999999999 999999
Q ss_pred CCCccEEEcCCCCEEEEEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCC
Q 040832 473 IKSSNILLDYTFETKVADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDP 550 (724)
Q Consensus 473 Ikp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~ 550 (724)
||++||||++++.+||+|||+|+........ ......||+.|||||++.++.|+.++|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999977554433 3445679999999999999999999999999999999998 9999976
Q ss_pred CCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 551 TGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 551 ~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
....+....... .+. ....+......+.+++.+||+.||++||++.||+++|+..+
T Consensus 291 ~~~~~~~~~~i~---------~g~---------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 291 VKIDEEFCRRLK---------EGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp CCCSHHHHHHHH---------HTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHH---------cCC---------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 543322111111 110 00112223456788999999999999999999999998653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=438.37 Aligned_cols=253 Identities=22% Similarity=0.262 Sum_probs=206.2
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
.+.|.+.+.||+|+||.||+|++. +|+.||||+++... .+.+|+.+|++|+|||||++++++.+++.+||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356888999999999999999964 68999999997542 235799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC-CEEEEEeccccccCCCCC
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF-ETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~-~vkL~DFGla~~~~~~~~ 502 (724)
|++|+|.++|+..+. +++.+++.|+.||+.||+|||++ +||||||||+||||+.++ ++||+|||+|+.......
T Consensus 132 ~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred cCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 999999999987654 89999999999999999999999 999999999999999987 699999999997754322
Q ss_pred c----cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhh
Q 040832 503 H----VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEI 578 (724)
Q Consensus 503 ~----~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 578 (724)
. ....++||+.|||||++.+..|+.++|||||||+||||++|+.||......+........ ...+
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--------~~~~--- 275 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--------PPPI--- 275 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--------CCGG---
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--------CCCc---
Confidence 1 123467999999999999999999999999999999999999999765433211110000 0000
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 579 ADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 579 vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
..++......+.+++.+||+.||++||++.||+++|...+
T Consensus 276 ------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 276 ------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp ------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 0122233456888999999999999999999999887543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=437.61 Aligned_cols=268 Identities=23% Similarity=0.297 Sum_probs=202.6
Q ss_pred CCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHH--HHHHHHHHhcCCCCeeEEeeEEEeCC----eEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREF--KAEVEIISRVHHRHLVSLVGYCIAGG----KRLL 419 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f--~~Ei~il~~l~HpnIv~l~g~~~~~~----~~~l 419 (724)
.+|.+.+.||+|+||.||+|.+ +|+.||||+++.. ..+++ ..|+.++.+|+|+|||+++|+|.+++ .++|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 3578889999999999999998 6899999999753 23333 44666667889999999999998754 5799
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCccEEEcCCCCEEEEEeccc
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC-----HPRIIHRDIKSSNILLDYTFETKVADFGLA 494 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~-----~~~iiHrDIkp~NILl~~~~~vkL~DFGla 494 (724)
|||||++|+|.++|+... ++|..+++|+.|+++||+|||+++ .++||||||||+||||+.++++||+|||+|
T Consensus 79 V~Ey~~~gsL~~~l~~~~---l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EecCCCCCcHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999998753 899999999999999999999863 458999999999999999999999999999
Q ss_pred cccCCCCCc---cccccccCCCcCCcchhcCC------CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhh---
Q 040832 495 KLTTDNNTH---VSTRVMGTFGYLAPEYASSG------KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWA--- 562 (724)
Q Consensus 495 ~~~~~~~~~---~~~~~~gt~~y~APE~~~~~------~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~--- 562 (724)
+........ .....+||++|||||++.+. .++.++|||||||+||||+||+.+|......+.....+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 877554332 12346799999999999754 467899999999999999999888754432221111110
Q ss_pred --hhhhhhcccCCChhhhcchhhhc-CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 563 --RPLCLRALDDGNFNEIADPYLEK-NYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 563 --~~~~~~~~~~~~~~~~vd~~l~~-~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
...+...+..+. .++.+.. ....+....+.+++.+||+.||++||+|.||++.|+...
T Consensus 236 ~~~~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 236 PSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CCHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred chHHHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 000000000111 1111111 123456778999999999999999999999999998643
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-51 Score=447.99 Aligned_cols=250 Identities=22% Similarity=0.327 Sum_probs=209.7
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
+.|++.+.||+|+||.||+|++. +|+.||||++........+.|.+|+.+|++|+|+|||+++++|.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 46899999999999999999964 68999999997665555667999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
++|+|.+++.... +++.++..|+.||++||+|||++ +||||||||+||||+.+|.+||+|||+|+.+......
T Consensus 231 ~gG~L~~~i~~~~---l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~- 303 (423)
T 4fie_A 231 EGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR- 303 (423)
T ss_dssp TTEEHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC-
T ss_pred CCCcHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc-
Confidence 9999999997543 89999999999999999999999 9999999999999999999999999999987654332
Q ss_pred ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhh
Q 040832 505 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLE 584 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~ 584 (724)
....+||+.|||||++.+..|+.++|||||||+||||++|+.||......+... ... ... ...+
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~-~i~-----~~~---------~~~~- 367 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIR-----DNL---------PPRL- 367 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHH-----HSC---------CCCC-
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH-HHH-----cCC---------CCCC-
Confidence 345789999999999999999999999999999999999999997654332211 000 000 0000
Q ss_pred cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 585 KNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.........+.+++.+||..||++|+++.||+++
T Consensus 368 -~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 368 -KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp -SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0011223467889999999999999999999873
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=435.88 Aligned_cols=247 Identities=22% Similarity=0.333 Sum_probs=207.4
Q ss_pred CCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|+++++||+|+||+||+|+. .+++.||||++... .....+.+.+|+++|++|+|||||++++++.+++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4699999999999999999995 46899999999643 1233467999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
|||++|+|.++|...+. +++.++..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.+....
T Consensus 112 Ey~~gG~L~~~i~~~~~--l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 99999999999987654 89999999999999999999999 99999999999999999999999999999875433
Q ss_pred C-ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 502 T-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 502 ~-~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
. ......+||+.|||||++.+..|+.++|||||||+||||++|+.||...+..+. +... ..+.+
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-~~~i---------~~~~~----- 251 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI-FAKI---------IKLEY----- 251 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH---------HHTCC-----
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH---------HcCCC-----
Confidence 2 234557899999999999999999999999999999999999999976543221 1110 01111
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIV 617 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv 617 (724)
.++......+.+++.+||+.||++|+++.|++
T Consensus 252 -----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -----CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11222234678899999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=424.88 Aligned_cols=246 Identities=26% Similarity=0.363 Sum_probs=198.1
Q ss_pred CcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEe----CCeEEEE
Q 040832 348 FSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIA----GGKRLLV 420 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~lV 420 (724)
|++.+.||+|+||.||+|.+. +++.||||++... .....+.|.+|+++|++|+|||||+++++|.+ +..+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 366778999999999999964 5889999999643 23334579999999999999999999999875 3467999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCccEEEcC-CCCEEEEEecccccc
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR--IIHRDIKSSNILLDY-TFETKVADFGLAKLT 497 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~--iiHrDIkp~NILl~~-~~~vkL~DFGla~~~ 497 (724)
||||++|+|.++|...+. +++..++.|+.||++||+|||++ + ||||||||+||||+. ++.+||+|||+|+..
T Consensus 108 mEy~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 999999999999987543 89999999999999999999998 6 999999999999984 799999999999865
Q ss_pred CCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 498 TDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 498 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
... .....+||+.|||||++. +.|+.++|||||||+||||+||+.||............ +..+...
T Consensus 183 ~~~---~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~---------i~~~~~~- 248 (290)
T 3fpq_A 183 RAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR---------VTSGVKP- 248 (290)
T ss_dssp CTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH---------HTTTCCC-
T ss_pred CCC---ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHH---------HHcCCCC-
Confidence 432 234568999999999886 46999999999999999999999999765433221111 1111110
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+...+ ...+.+++.+||+.||++||++.||+++
T Consensus 249 ---~~~~~~~----~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 249 ---ASFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ---GGGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---CCCCccC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111122 2357889999999999999999999873
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=419.55 Aligned_cols=245 Identities=25% Similarity=0.395 Sum_probs=190.7
Q ss_pred CCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|++.+.||+|+||+||+|.. .+|+.||||+++... ....+.|.+|+++|++|+|||||++++++.+++..||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999995 468999999997542 223457999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||| +|+|.++|..++. +++.+++.|+.||+.||+|||++ +||||||||+||||+.++++||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDK--MSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp ECC-CEEHHHHHHHSCS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999 6789888877654 99999999999999999999999 99999999999999999999999999998765433
Q ss_pred CccccccccCCCcCCcchhcCCCC-ChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~-t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
. ....+||+.|||||++.+..+ +.++|||||||+||||++|+.||......+ .+... ..+.+
T Consensus 167 ~--~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~-~~~~i---------~~~~~----- 229 (275)
T 3hyh_A 167 F--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV-LFKNI---------SNGVY----- 229 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH---------HHTCC-----
T ss_pred c--cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHH---------HcCCC-----
Confidence 2 244679999999999988776 589999999999999999999997653221 11110 11110
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
.++......+.+++.+||+.||++||++.|+++
T Consensus 230 -----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 -----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111122345788999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=428.59 Aligned_cols=247 Identities=26% Similarity=0.333 Sum_probs=196.7
Q ss_pred CCCcccceeeccCcEEEEEEEcC----CCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP----NGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
++|++++.||+|+||+||+|+.. .++.||||+++... ......+.+|+++|++|+|||||++++++.+++..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46999999999999999999842 46889999996532 1223468899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
|||||++|+|.++|...+. +++.+++.|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 9999999999999987654 89999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 500 NNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 500 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
.... ....+||+.|||||++.+..|+.++|||||||+||||++|+.||...+..+.... . . .+.+
T Consensus 179 ~~~~-~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~-i----~-----~~~~---- 243 (304)
T 3ubd_A 179 HEKK-AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM-I----L-----KAKL---- 243 (304)
T ss_dssp --CC-CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-H----H-----HCCC----
T ss_pred CCcc-ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHH-H----H-----cCCC----
Confidence 3332 3446799999999999999999999999999999999999999986543322110 0 0 0100
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPK-----ISQIVR 618 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evv~ 618 (724)
.++......+.+++.+||+.||++|++ ++||++
T Consensus 244 ------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 ------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 111222345788999999999999998 466664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=410.85 Aligned_cols=250 Identities=23% Similarity=0.379 Sum_probs=188.8
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC--------
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGG-------- 415 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~-------- 415 (724)
++|++.+.||+|+||+||+|++. +|+.||||+++..... ..+.|.+|+++|++|+|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45899999999999999999954 6899999999755433 3457999999999999999999999987644
Q ss_pred ----eEEEEEEecCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEE
Q 040832 416 ----KRLLVYEYVPNNNLEFHLHGKGR-PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVAD 490 (724)
Q Consensus 416 ----~~~lV~E~~~~gsL~~~L~~~~~-~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~D 490 (724)
.+|||||||.+|+|.++|..+.. ...++..++.|+.||++||+|||++ +||||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999986543 2345677899999999999999999 999999999999999999999999
Q ss_pred eccccccCCCCCc-----------cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHH
Q 040832 491 FGLAKLTTDNNTH-----------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLV 559 (724)
Q Consensus 491 FGla~~~~~~~~~-----------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~ 559 (724)
||+|+........ .....+||+.|||||++.+..|+.++|||||||+||||++ ||.........+.
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 9999877543221 1233579999999999999999999999999999999996 7753211100010
Q ss_pred hhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 560 DWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 560 ~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+....+.... .+....+..++.+||+.||++||++.||+++
T Consensus 239 ---------~~~~~~~p~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 239 ---------DVRNLKFPPLF---------TQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp ---------HHHTTCCCHHH---------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---------HHhcCCCCCCC---------cccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01111111111 1222345679999999999999999999873
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=405.80 Aligned_cols=288 Identities=49% Similarity=0.830 Sum_probs=247.9
Q ss_pred cccCHHHHHHhhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEE
Q 040832 334 SAFTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCI 412 (724)
Q Consensus 334 ~~f~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 412 (724)
..|+++++....++|.+.++||+|+||.||+|.+.+++.||||+++..... ....|.+|++++++++|+||++++++|.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 468899999999999999999999999999999888999999999764322 2336899999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEE
Q 040832 413 AGGKRLLVYEYVPNNNLEFHLHGKG--RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVAD 490 (724)
Q Consensus 413 ~~~~~~lV~E~~~~gsL~~~L~~~~--~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~D 490 (724)
+.+..++||||+.+++|.+++.... ...+++..++.|+.||+.||+|||+++.++|+||||||+||||+.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999998653 33489999999999999999999998777899999999999999999999999
Q ss_pred eccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCC---CchhhhHHhhhhhhhh
Q 040832 491 FGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPT---GAMEDCLVDWARPLCL 567 (724)
Q Consensus 491 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~---~~~~~~l~~w~~~~~~ 567 (724)
||+++..............|+..|+|||++.++.++.++|||||||+||||++|+.||+.. ......+.+|....
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-- 255 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL-- 255 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT--
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH--
Confidence 9999987655555555667999999999999889999999999999999999999999632 11222344554433
Q ss_pred hcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 568 RALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 568 ~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
+....+..+++..+...+..++...+.+++.+||+.+|++||++.||+++|++...
T Consensus 256 --~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 256 --LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp --TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred --hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 34556677777777788889999999999999999999999999999999997543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=416.19 Aligned_cols=269 Identities=19% Similarity=0.288 Sum_probs=202.4
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEe------CC
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIA------GG 415 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~------~~ 415 (724)
.++|.+++.||+|+||.||+|++ .+|+.||||+++.... ...+.+++|+++|++|+|+|||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 35799999999999999999995 4689999999975432 334578899999999999999999998764 36
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 416 KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
.+|||||||+ |+|.++|...+ .+++..+..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceee
Confidence 7899999996 67988887655 499999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCC---CccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHH--hhhhh---hh
Q 040832 496 LTTDNN---THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLV--DWARP---LC 566 (724)
Q Consensus 496 ~~~~~~---~~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~--~w~~~---~~ 566 (724)
.+.... .......+||..|||||++.+. .++.++|||||||+||||++|+.||.+.+..+.... ..... ..
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 764432 1233457899999999998875 579999999999999999999999987654433211 10000 00
Q ss_pred hhcccCCChhhhcchhhh-cCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 567 LRALDDGNFNEIADPYLE-KNYP-----TEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 567 ~~~~~~~~~~~~vd~~l~-~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
...+....+...+...-. ...+ ......+.+++.+||..||++|+++.|++++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000111111100000 0000 0112457889999999999999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=405.60 Aligned_cols=271 Identities=19% Similarity=0.240 Sum_probs=204.8
Q ss_pred HHHHHhhCCCcccceeeccCcEEEEEEEcC----CCcEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEe
Q 040832 339 EELSAATGGFSQSNLLGQGGFGYVHKGVLP----NGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGYCIA 413 (724)
Q Consensus 339 ~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~ 413 (724)
+.+-...+.|++.+.||+|+||.||+|+.+ .++.||||++.... ....+.+|+++|+.+ +|+||+++++++.+
T Consensus 14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 334456688999999999999999999743 46789999987542 345688999999998 69999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCC-CCEEEEEec
Q 040832 414 GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYT-FETKVADFG 492 (724)
Q Consensus 414 ~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~-~~vkL~DFG 492 (724)
.+..|||||||++|+|.+++.. +++.++..|+.||+.||+|||++ +||||||||+||||+.+ +.+||+|||
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~~-----l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILNS-----LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHTT-----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CCEEEEEEeCCCcccHHHHHcC-----CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 9999999999999999999842 88999999999999999999999 99999999999999876 799999999
Q ss_pred cccccCCCCCc---------------------------cccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhC
Q 040832 493 LAKLTTDNNTH---------------------------VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITG 544 (724)
Q Consensus 493 la~~~~~~~~~---------------------------~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG 544 (724)
+|+...+.... .....+||++|||||++.+. .|+.++||||+||+||||++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 99866443211 12235799999999999775 589999999999999999999
Q ss_pred CCCCCCCCchhhhHHhhhhhh------------hh-----hcccCCChhhhcchhhh------------------cCCCH
Q 040832 545 RRPIDPTGAMEDCLVDWARPL------------CL-----RALDDGNFNEIADPYLE------------------KNYPT 589 (724)
Q Consensus 545 ~~P~~~~~~~~~~l~~w~~~~------------~~-----~~~~~~~~~~~vd~~l~------------------~~~~~ 589 (724)
+.||.........+......+ .. ..+....+..+.+.... .....
T Consensus 244 ~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 323 (361)
T 4f9c_A 244 RYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWN 323 (361)
T ss_dssp CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CT
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccc
Confidence 999976543333222111100 00 00001111111110000 00001
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 590 EEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 590 ~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.....+.+++.+||+.||++|+++.|++++
T Consensus 324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 324 EVPDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp TCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 122457889999999999999999999863
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=401.32 Aligned_cols=285 Identities=42% Similarity=0.693 Sum_probs=240.7
Q ss_pred ccCHHHHHHhhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC
Q 040832 335 AFTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAG 414 (724)
Q Consensus 335 ~f~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 414 (724)
.+.+.++....++|.+.++||+|+||.||+|.+.+++.||||++........+.|.+|+++|++++|+||+++++++.+.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 44555667788999999999999999999999888999999999877666677899999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEec
Q 040832 415 GKRLLVYEYVPNNNLEFHLHGKGR--PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFG 492 (724)
Q Consensus 415 ~~~~lV~E~~~~gsL~~~L~~~~~--~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFG 492 (724)
+..++||||+++++|.+++..... ..+++..+++|+.||++||+|||++ +|+|||||++||||+.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999999976432 3489999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCC-CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchh-hhHHhhhhhhhhhcc
Q 040832 493 LAKLTTDNN-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAME-DCLVDWARPLCLRAL 570 (724)
Q Consensus 493 la~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~-~~l~~w~~~~~~~~~ 570 (724)
+++...... ........|+..|+|||++.++.++.++|||||||+||||++|+.||......+ ..+..|.... .
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~----~ 260 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES----H 260 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH----H
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc----c
Confidence 998754322 223344568999999999999999999999999999999999999997653222 2234443322 2
Q ss_pred cCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCCc
Q 040832 571 DDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSL 626 (724)
Q Consensus 571 ~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~~ 626 (724)
..+.+..++++.+......+....+.+++.+||+.+|++||++.||+++|+....+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 34455566666666677888999999999999999999999999999999876543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=420.30 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=209.1
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
.++|.+++.||+|+||.||+|..+ +|+.||||+++.......+.+++|+++|++|+|||||+|+++|.+.+.+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999964 6899999999876655667799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCC--CCEEEEEeccccccCCCC
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYT--FETKVADFGLAKLTTDNN 501 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~--~~vkL~DFGla~~~~~~~ 501 (724)
|++|+|.++|..+.. .+++.++..|+.||++||+|||++ +||||||||+||||+.+ +.+||+|||+|+.+....
T Consensus 236 ~~gg~L~~~i~~~~~-~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 236 MSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCCBHHHHHTCTTS-CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred cCCCcHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 999999998865432 489999999999999999999999 99999999999999754 899999999999876543
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
. ....+||+.|||||++.+..|+.++|||||||+||||++|+.||......+.... . ....+. + ..
T Consensus 312 ~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~-i---------~~~~~~-~-~~ 377 (573)
T 3uto_A 312 S--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN-V---------KSCDWN-M-DD 377 (573)
T ss_dssp E--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH-H---------HTTCCC-C-CS
T ss_pred c--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH-H---------HhCCCC-C-Cc
Confidence 2 2446799999999999999999999999999999999999999987644332111 0 001000 0 00
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..... ....+.+|+.+||+.||++|+++.|++++
T Consensus 378 ~~~~~----~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 378 SAFSG----ISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp GGGTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccccC----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011 12457789999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=417.23 Aligned_cols=248 Identities=23% Similarity=0.329 Sum_probs=199.2
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHH---HHHHHHhcCCCCeeEEeeEEEeCCeE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKA---EVEIISRVHHRHLVSLVGYCIAGGKR 417 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~---Ei~il~~l~HpnIv~l~g~~~~~~~~ 417 (724)
.++|.++++||+|+||+||+|+.. +|+.||||+++... ......+.+ ++.+++.++|||||++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 368999999999999999999954 68999999996421 112233344 45666777899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
|||||||.||+|..+|...+. +++..+..|+.||+.||+|||++ +||||||||+||||+.+|++||+|||+|+..
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~--l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeec
Confidence 999999999999999987654 89999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhh-hHHhhhhhhhhhcccCCCh
Q 040832 498 TDNNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMED-CLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 498 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~-~l~~w~~~~~~~~~~~~~~ 575 (724)
..... ...+||+.|||||++.. ..|+.++||||||||||||++|+.||......+. .+... ... .
T Consensus 343 ~~~~~---~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~---i~~-----~-- 409 (689)
T 3v5w_A 343 SKKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLT-----M-- 409 (689)
T ss_dssp SSCCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH---HHH-----C--
T ss_pred CCCCC---CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---hcC-----C--
Confidence 65432 34679999999999975 4799999999999999999999999975322111 11100 000 0
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 040832 576 NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPK-----ISQIVR 618 (724)
Q Consensus 576 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evv~ 618 (724)
...++......+.+++.+||+.||.+|++ +.||.+
T Consensus 410 --------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 410 --------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred --------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 00122233456789999999999999998 677765
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=378.19 Aligned_cols=258 Identities=26% Similarity=0.389 Sum_probs=212.2
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
.++|.++++||+|+||.||+|.+. +++.||||++........+.|.+|+++|++++|+||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 367899999999999999999964 5889999999776666677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+++++|.+++..... .+++.+++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++........
T Consensus 89 ~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 89 IKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CTTCBHHHHHHHCCT-TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 999999999987433 489999999999999999999999 9999999999999999999999999999876543322
Q ss_pred c-------------ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcc
Q 040832 504 V-------------STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRAL 570 (724)
Q Consensus 504 ~-------------~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~ 570 (724)
. .....||..|+|||++.+..++.++|||||||+||||++|..+|..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~------------ 232 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF------------ 232 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS------------
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH------------
Confidence 1 114579999999999999999999999999999999999999986532211100
Q ss_pred cCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 571 DDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 571 ~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
...+...+...++......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 233 -----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 233 -----GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp -----SBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----hhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000111111122223334688899999999999999999999999854
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=389.42 Aligned_cols=260 Identities=26% Similarity=0.421 Sum_probs=212.6
Q ss_pred hCCCcccceeeccCcEEEEEEEcC--------CCcEEEEEEeccCCch-hHHHHHHHHHHHHhc-CCCCeeEEeeEEEeC
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP--------NGKEVAVKSLRSGSGQ-GEREFKAEVEIISRV-HHRHLVSLVGYCIAG 414 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~--------~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~ 414 (724)
.++|.+++.||+|+||.||+|.+. ++..||||+++..... ..+.|.+|+++|+++ +|+||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467899999999999999999852 3457999999865433 345799999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEE
Q 040832 415 GKRLLVYEYVPNNNLEFHLHGKG--------------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILL 480 (724)
Q Consensus 415 ~~~~lV~E~~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl 480 (724)
+..+|||||+.+|+|.++|.... ...+++.+++.|+.||++||+|||++ +|+|||||++||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 99999999999999999997643 23478999999999999999999999 99999999999999
Q ss_pred cCCCCEEEEEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhH
Q 040832 481 DYTFETKVADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCL 558 (724)
Q Consensus 481 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l 558 (724)
+.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |+.||......+. +
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~-~ 315 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-F 315 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-H
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH-H
Confidence 99999999999999876543322 2234557889999999999999999999999999999999 9999976532221 1
Q ss_pred HhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCCc
Q 040832 559 VDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSL 626 (724)
Q Consensus 559 ~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~~ 626 (724)
.. +..+. ....+......+.+++.+||+.+|++||++.||++.|+..+.+
T Consensus 316 -~~--------~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 316 -KL--------LKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp -HH--------HHTTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HH--------HhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 00 00110 0111223345688999999999999999999999999976543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=372.10 Aligned_cols=251 Identities=22% Similarity=0.357 Sum_probs=210.3
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
.++|++.+.||+|+||.||+|.+ .+++.||||++........+.+.+|+.++++++|+||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999985 56899999999766555667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+.+++|.+++... .+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++........
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence 9999999999865 389999999999999999999999 9999999999999999999999999999877654332
Q ss_pred cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 504 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
.....|+..|+|||++.+..++.++|||||||+||||++|+.||............... ....
T Consensus 173 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-----~~~~----------- 235 (297)
T 3fxz_A 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-----GTPE----------- 235 (297)
T ss_dssp -BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH-----CSCC-----------
T ss_pred -cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----CCCC-----------
Confidence 23457999999999999999999999999999999999999999765433221111100 0000
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
...+......+.+++.+||+.||++||++.|++++
T Consensus 236 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 236 -LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp -CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00112233457889999999999999999999873
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=365.28 Aligned_cols=280 Identities=35% Similarity=0.632 Sum_probs=229.1
Q ss_pred cccCHHHHHHhhCCCccc------ceeeccCcEEEEEEEcCCCcEEEEEEeccCC----chhHHHHHHHHHHHHhcCCCC
Q 040832 334 SAFTYEELSAATGGFSQS------NLLGQGGFGYVHKGVLPNGKEVAVKSLRSGS----GQGEREFKAEVEIISRVHHRH 403 (724)
Q Consensus 334 ~~f~~~el~~~~~~f~~~------~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~----~~~~~~f~~Ei~il~~l~Hpn 403 (724)
..|+++++..++++|... +.||+|+||.||+|.+ +++.||||++.... ....+.|.+|+.+|++++|+|
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 468999999999999887 9999999999999997 67899999986532 233567999999999999999
Q ss_pred eeEEeeEEEeCCeEEEEEEecCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC
Q 040832 404 LVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGK-GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY 482 (724)
Q Consensus 404 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~ 482 (724)
|+++++++.+.+..++||||+++++|.+++... ....+++..++.|+.||++||.|||++ +|+||||||+||||+.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 999999999999999999999999999998743 234589999999999999999999999 9999999999999999
Q ss_pred CCCEEEEEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhh
Q 040832 483 TFETKVADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDW 561 (724)
Q Consensus 483 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w 561 (724)
++.+||+|||+++........ ......|+..|+|||.+.+ .++.++||||||++||||++|+.||+...... .+..+
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~ 246 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLLDI 246 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-BTTHH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH-HHHHH
Confidence 999999999999876543322 2334579999999998864 58899999999999999999999997653221 11122
Q ss_pred hhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 562 ARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 562 ~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
..... .....+.++++..+ ..........+.+++.+||+.+|++||++.+|+++|+..
T Consensus 247 ~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 247 KEEIE---DEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHH---TTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHhh---hhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11110 11223444444433 345667788899999999999999999999999999854
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=378.79 Aligned_cols=266 Identities=30% Similarity=0.439 Sum_probs=205.2
Q ss_pred cCHHHHHHhhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEe
Q 040832 336 FTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIA 413 (724)
Q Consensus 336 f~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 413 (724)
+...++....++|++.+.||+|+||.||+|.+ +++.||||++..... ...+.|.+|+++|++++|+||+++++++.+
T Consensus 27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105 (309)
T ss_dssp -----CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 33444455567899999999999999999987 688899999976532 234579999999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCccEEEcCCCCEEEEE
Q 040832 414 GGKRLLVYEYVPNNNLEFHLHGKGR-PVMDWPTRLKIAMGSAKGLAYLHEDCHPR--IIHRDIKSSNILLDYTFETKVAD 490 (724)
Q Consensus 414 ~~~~~lV~E~~~~gsL~~~L~~~~~-~~l~~~~~~~i~~qia~gL~yLHs~~~~~--iiHrDIkp~NILl~~~~~vkL~D 490 (724)
.+..++||||+.+++|.+++...+. ..+++..++.|+.||++||+|||++ + |+|||||++||||+.++.+||+|
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~D 182 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCD 182 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECC
Confidence 9999999999999999999986432 2388999999999999999999998 8 99999999999999999999999
Q ss_pred eccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcc
Q 040832 491 FGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRAL 570 (724)
Q Consensus 491 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~ 570 (724)
||+++....... ......|+..|+|||++.+..++.++|||||||+||||++|+.||......+... ... ...
T Consensus 183 fg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~--~~~----~~~ 255 (309)
T 3p86_A 183 FGLSRLKASTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA--AVG----FKC 255 (309)
T ss_dssp CC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH--HHH----HSC
T ss_pred CCCCcccccccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHH----hcC
Confidence 999986544322 2234569999999999999999999999999999999999999997654322111 100 000
Q ss_pred cCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 571 DDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 571 ~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
.. ...+......+.+++.+||+.+|++||++.+|++.|+..+
T Consensus 256 ~~------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 256 KR------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp CC------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 0112223346889999999999999999999999998654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=369.24 Aligned_cols=261 Identities=23% Similarity=0.363 Sum_probs=208.3
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG---QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~---~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
.++|++.+.||+|+||.||+|.+. +++.||||.+..... ...+.|.+|+.++++++|+||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999854 688999999864322 2345789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+++++|.+++...+. +++..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 999999999999986543 89999999999999999999999 9999999999999999999999999999877654
Q ss_pred CCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
.........|+..|+|||++.+..++.++|||||||+||||++|+.||.............. .. ...
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~---------~~-~~~--- 231 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ---------DS-VPN--- 231 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS---------SC-CCC---
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh---------cc-CCC---
Confidence 44444456799999999999999999999999999999999999999987543332211111 00 000
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHhCCCC
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRP-KISQIVRALEGDVS 625 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evv~~L~~~~~ 625 (724)
+......+....+.+++.+|++.+|++|| ++.++.+.|+..+.
T Consensus 232 --~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 232 --VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp --HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred --cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 00111122345688999999999999998 99999999987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=378.45 Aligned_cols=257 Identities=26% Similarity=0.415 Sum_probs=208.3
Q ss_pred hCCCcccceeeccCcEEEEEEEcC----CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP----NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
.++|.+.++||+|+||.||+|.+. .+..||||+++.... ...+.|.+|+.+|++|+|+||+++++++.+++..+|
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467899999999999999999974 345699999986533 345679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
||||+++++|.+++..... .+++..++.|+.||++||.|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 128 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 9999999999999976532 489999999999999999999999 999999999999999999999999999987755
Q ss_pred CCCc--cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChh
Q 040832 500 NNTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 500 ~~~~--~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
.... ......++..|+|||++.+..++.++|||||||+||||++ |+.||......+.. .... .+
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-~~~~---------~~--- 270 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI-SSVE---------EG--- 270 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH-HHHH---------TT---
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHH-HHHH---------cC---
Confidence 4322 2223456778999999998999999999999999999999 99999765332211 1000 00
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
.....+......+.+++.+||+.+|++||++.||++.|+..+
T Consensus 271 ------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 271 ------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 001112233456889999999999999999999999998654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=401.59 Aligned_cols=260 Identities=26% Similarity=0.375 Sum_probs=217.3
Q ss_pred HhhCCCcccceeeccCcEEEEEEEcCC-CcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVLPN-GKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
....+|.+.+.||+|+||.||+|.+.. ++.||||+++... ...++|.+|+.+|++|+|+||++++++|.+.+..+|||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 345678999999999999999999764 7889999998653 34678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+.+|+|.++|.......+++..++.|+.||++||+|||++ +|||||||++||||+.++.+||+|||+++......
T Consensus 296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999999876666689999999999999999999999 99999999999999999999999999999876544
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
........++..|+|||++..+.++.++|||||||+||||++ |+.||......+. .... ..
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~--~~~~--------~~-------- 434 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--YELL--------EK-------- 434 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HHHH--------HT--------
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH--HHHH--------Hc--------
Confidence 333334456789999999999999999999999999999999 9999976542221 1110 00
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
......+......+.+++.+||+.+|++||++.+|++.|+..+.
T Consensus 435 -~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 435 -DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred -CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 00011222334568889999999999999999999999997653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=374.85 Aligned_cols=249 Identities=25% Similarity=0.357 Sum_probs=207.6
Q ss_pred hhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
..++|.+.+.||+|+||.||+|.+ .+|+.||||++... .....+.+.+|+++|++++|+||+++++++...+..+||
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 457899999999999999999996 57899999999654 223456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+++++|.+++...+. +++..++.++.||++||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp ECCCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EECCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999999976554 89999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCccccccccCCCcCCcchhcCCCCC-hhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~t-~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
.. .....|+..|+|||++.+..+. .++|||||||+||||++|+.||+.....+... .. ..+.+
T Consensus 168 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-----~i-----~~~~~---- 231 (328)
T 3fe3_A 168 GK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRE-----RV-----LRGKY---- 231 (328)
T ss_dssp CG--GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----HH-----HHCCC----
T ss_pred Cc--cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHH-----HH-----HhCCC----
Confidence 32 3456799999999999888765 89999999999999999999998654222110 00 00110
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+......+.+++.+||..||++||++.||+++
T Consensus 232 ------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 ------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111223457889999999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=365.98 Aligned_cols=255 Identities=29% Similarity=0.471 Sum_probs=212.1
Q ss_pred hCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
.++|++.+.||+|+||.||+|.+.+++.||||+++.... ..++|.+|+++|++++|+||+++++++.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 357899999999999999999988889999999986533 3567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
++++|.+++..... .+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.........
T Consensus 88 ~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 88 EHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp TTCBHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCcHHHHHHhcCc-ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 99999999976443 489999999999999999999999 99999999999999999999999999998765433333
Q ss_pred ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 505 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
.....++..|+|||++....++.++||||||++||||++ |+.||......+. ...+.. + .
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~-~~~~~~---------~---------~ 224 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-VEDIST---------G---------F 224 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HHHHHT---------T---------C
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH-HHHHhc---------C---------c
Confidence 334557788999999999999999999999999999999 9999976543221 111110 0 0
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
....+......+.+++.+||+.+|++||++.||+++|+..
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 225 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 0011111234588899999999999999999999999854
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=370.17 Aligned_cols=262 Identities=21% Similarity=0.328 Sum_probs=216.4
Q ss_pred cccCHHHHHHhhCC----------CcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCC
Q 040832 334 SAFTYEELSAATGG----------FSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHR 402 (724)
Q Consensus 334 ~~f~~~el~~~~~~----------f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~Hp 402 (724)
..|+++++..+++. |...+.||+|+||.||+|.+. +|+.||||++........+.+.+|+.+|++++|+
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45788898887764 777889999999999999975 7999999999876666677899999999999999
Q ss_pred CeeEEeeEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC
Q 040832 403 HLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY 482 (724)
Q Consensus 403 nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~ 482 (724)
||+++++++...+..+|||||+++++|.+++... .+++..++.|+.||++||+|||++ +|+||||||+||||+.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTL 176 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECC
Confidence 9999999999999999999999999999998753 389999999999999999999998 9999999999999999
Q ss_pred CCCEEEEEeccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhh
Q 040832 483 TFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWA 562 (724)
Q Consensus 483 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~ 562 (724)
++.+||+|||+++........ .....|+..|+|||++.+..++.++|||||||+||||++|+.||......+. + ...
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~-~-~~~ 253 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-M-KRL 253 (321)
T ss_dssp TCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-H-HHH
T ss_pred CCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H-HHH
Confidence 999999999999876543322 2345799999999999999999999999999999999999999976543221 1 110
Q ss_pred hhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 563 RPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 563 ~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
. .. ....+. ........+.+++.+||+.+|++||++.||+++
T Consensus 254 ~----~~-~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 254 R----DS-PPPKLK----------NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp H----HS-SCCCCT----------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred h----cC-CCCCcC----------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00 000000 001123457889999999999999999999874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=381.65 Aligned_cols=269 Identities=26% Similarity=0.395 Sum_probs=217.1
Q ss_pred ccCHHHHHHhhCCCcccceeeccCcEEEEEEEc------CCCcEEEEEEeccCCch-hHHHHHHHHHHHHhc-CCCCeeE
Q 040832 335 AFTYEELSAATGGFSQSNLLGQGGFGYVHKGVL------PNGKEVAVKSLRSGSGQ-GEREFKAEVEIISRV-HHRHLVS 406 (724)
Q Consensus 335 ~f~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l-~HpnIv~ 406 (724)
.+...+++...++|.+++.||+|+||.||+|.+ .+++.||||+++..... ..+.|.+|+++|+++ +|+||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 455677777889999999999999999999973 34578999999865433 345799999999999 7999999
Q ss_pred EeeEEEeCC-eEEEEEEecCCCCHHHHHhcCCC-----------------------------------------------
Q 040832 407 LVGYCIAGG-KRLLVYEYVPNNNLEFHLHGKGR----------------------------------------------- 438 (724)
Q Consensus 407 l~g~~~~~~-~~~lV~E~~~~gsL~~~L~~~~~----------------------------------------------- 438 (724)
++++|.+.+ ..++||||+.+|+|.++++....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999998865 48999999999999999986542
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 439 -----------------PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 439 -----------------~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
..+++..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 1288999999999999999999999 99999999999999999999999999998764433
Q ss_pred C-ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 502 T-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 502 ~-~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
. .......|+..|+|||++.+..++.++|||||||+||||++ |+.||......+........ +.
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~---------~~----- 313 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE---------GT----- 313 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH---------TC-----
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc---------CC-----
Confidence 2 23344668999999999999999999999999999999998 99999765433222111110 00
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
....+......+.+++.+||+.+|++||++.||+++|+..+
T Consensus 314 ----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 314 ----RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 00111122345888999999999999999999999998654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=384.26 Aligned_cols=258 Identities=27% Similarity=0.441 Sum_probs=199.6
Q ss_pred hCCCcccceeeccCcEEEEEEEcC----CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP----NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
.++|.+.++||+|+||.||+|.+. ++..||||+++.... ...++|.+|+.+|++++|+||+++++++.+.+..+|
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357899999999999999999865 567899999986533 344679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
||||+++++|.++|+..+ ..+++.+++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 124 v~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999998654 3489999999999999999999999 999999999999999999999999999987755
Q ss_pred CCCcc--ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChh
Q 040832 500 NNTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 500 ~~~~~--~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
..... .....++..|+|||++....++.++|||||||+||||++ |+.||......+. ... +..+
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~--~~~--------i~~~--- 266 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--IKA--------VDEG--- 266 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH--HHH--------HHTT---
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHH--------HHcC---
Confidence 43221 122345778999999999999999999999999999998 9999976532221 110 0000
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
............+.+++.+||+.+|++||++.+|++.|+..+.
T Consensus 267 ------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 267 ------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp ------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 0011122334568899999999999999999999999987643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=361.69 Aligned_cols=258 Identities=27% Similarity=0.405 Sum_probs=214.4
Q ss_pred hhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
..++|++.+.||+|+||.||+|.+.+++.||||+++.... ..+++.+|+++|++++|+||+++++++.+++..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 3567999999999999999999998888999999976543 356799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+++++|.+++...+. .+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++........
T Consensus 85 ~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp CTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred cCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999999976432 489999999999999999999999 9999999999999999999999999999877655444
Q ss_pred cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchh
Q 040832 504 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~ 582 (724)
......++..|+|||.+.+..++.++||||||++||||++ |+.||+.....+.... ... +. .
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-~~~---------~~--~----- 223 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK-VSQ---------GH--R----- 223 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-HHT---------TC--C-----
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH-HHc---------CC--C-----
Confidence 3344456778999999998889999999999999999999 9999976543322111 100 00 0
Q ss_pred hhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 583 LEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 583 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
...+......+.+++.+||+.+|++||++.||+++|+...+
T Consensus 224 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 224 --LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp --CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred --CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 00011122458889999999999999999999999987654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=363.90 Aligned_cols=260 Identities=23% Similarity=0.389 Sum_probs=204.3
Q ss_pred hCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHh--cCCCCeeEEeeEEEeC----CeEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISR--VHHRHLVSLVGYCIAG----GKRL 418 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~--l~HpnIv~l~g~~~~~----~~~~ 418 (724)
.++|++.+.||+|+||.||+|.+ +++.||||++.. .....+..|.+++.. ++|+||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 56899999999999999999998 789999999965 345667778888877 7899999999987653 4578
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCccEEEcCCCCEEEEE
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLH--------EDCHPRIIHRDIKSSNILLDYTFETKVAD 490 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH--------s~~~~~iiHrDIkp~NILl~~~~~vkL~D 490 (724)
|||||+++|+|.++++.. .+++..+++|+.||++||+||| +. +|+||||||+||||+.++.+||+|
T Consensus 83 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECC
T ss_pred EehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEee
Confidence 999999999999999653 4899999999999999999999 76 999999999999999999999999
Q ss_pred eccccccCCCCCcc---ccccccCCCcCCcchhcCC------CCChhHHHHHHHHHHHHHHhC----------CCCCCCC
Q 040832 491 FGLAKLTTDNNTHV---STRVMGTFGYLAPEYASSG------KLTEKSDVFSFGVMLLELITG----------RRPIDPT 551 (724)
Q Consensus 491 FGla~~~~~~~~~~---~~~~~gt~~y~APE~~~~~------~~t~ksDV~SlGvlL~eLltG----------~~P~~~~ 551 (724)
||+++......... .....||..|+|||++.+. .++.++|||||||+||||++| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99998765543332 2234799999999999876 455799999999999999999 7777543
Q ss_pred CchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 552 GAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 552 ~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
.........+...... ......+ ....+.......+.+++.+||+.+|++||++.||++.|+.
T Consensus 237 ~~~~~~~~~~~~~~~~----~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCV----DQQRPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp SCSSCCHHHHHHHHTT----SCCCCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCcchhhhhHHHhc----cCCCCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 2222111111111100 0000000 0111234567889999999999999999999999999974
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=395.51 Aligned_cols=261 Identities=26% Similarity=0.404 Sum_probs=214.6
Q ss_pred HHHhhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 341 LSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 341 l~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
.+...++|.+.+.||+|+||.||+|.+.+++.||||+++... ...+.|.+|+++|++|+|+||+++++++. .+..+||
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 344567889999999999999999999888999999998654 34678999999999999999999999986 5678999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+.+|+|.++|+......+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 9999999999999865433588999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
.........++..|+|||++..+.++.++|||||||+||||++ |+.||......+.. ... ..+.
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~-~~i---------~~~~----- 402 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-RAL---------ERGY----- 402 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-HHH---------HHTC-----
T ss_pred ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH-HHH---------HcCC-----
Confidence 2222233446788999999999999999999999999999999 99999765432211 000 0000
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
....+......+.+++.+||+.+|++||++.+|++.|+....
T Consensus 403 ----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 403 ----RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred ----CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 001122234568899999999999999999999999997654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=369.05 Aligned_cols=257 Identities=25% Similarity=0.389 Sum_probs=209.8
Q ss_pred hhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
..++|++.+.||+|+||.||++.+.+++.||||+++.... ..++|.+|+++|++++|+||+++++++.+.+..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 3467899999999999999999998888999999986533 356799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+.+++|.+++..... .+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++........
T Consensus 101 ~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 101 MANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp CTTCBHHHHHHCGGG-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred cCCCcHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 999999999976322 489999999999999999999999 9999999999999999999999999999876543332
Q ss_pred cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchh
Q 040832 504 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~ 582 (724)
......++..|+|||++.+..++.++||||||++||||++ |+.||......+... .... +
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~-~~~~---------~--------- 237 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE-HIAQ---------G--------- 237 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HHHT---------T---------
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH-HHhc---------c---------
Confidence 2333456788999999999999999999999999999998 999997654322111 0000 0
Q ss_pred hhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 583 LEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 583 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
+....+......+.+++.+||+.+|++||++.||+++|+..+
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 238 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 000111112346889999999999999999999999998654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=376.62 Aligned_cols=266 Identities=25% Similarity=0.409 Sum_probs=215.8
Q ss_pred HHHHHHhhCCCcccceeeccCcEEEEEEEcC------CCcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeE
Q 040832 338 YEELSAATGGFSQSNLLGQGGFGYVHKGVLP------NGKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGY 410 (724)
Q Consensus 338 ~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~ 410 (724)
+.++....++|.+.+.||+|+||.||+|.+. +++.||||+++..... ..+.|.+|+.+|++++|+||++++++
T Consensus 39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3445556789999999999999999999974 3478999999865433 34679999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 040832 411 CIAGGKRLLVYEYVPNNNLEFHLHGKG----------------------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRI 468 (724)
Q Consensus 411 ~~~~~~~~lV~E~~~~gsL~~~L~~~~----------------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~i 468 (724)
+.+++..+|||||+++++|.++|.... ...+++.+++.|+.||++||.|||++ +|
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~i 195 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 195 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 999999999999999999999997642 14589999999999999999999999 99
Q ss_pred EecCCCCccEEEcCCCCEEEEEeccccccCCCCC-ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCC
Q 040832 469 IHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRR 546 (724)
Q Consensus 469 iHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~ 546 (724)
+|||||++||||+.++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||+||||++ |+.
T Consensus 196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999987643322 22234568899999999999999999999999999999999 999
Q ss_pred CCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 547 PIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 547 P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
||......+. ... +..+... .++......+.+++.+||+.+|++||++.+|+++|+....
T Consensus 276 p~~~~~~~~~--~~~--------~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 276 PYYGMAHEEV--IYY--------VRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TTTTSCHHHH--HHH--------HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cCCCCChHHH--HHH--------HhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 9976532221 110 1111110 1112233568899999999999999999999999997654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=371.92 Aligned_cols=253 Identities=26% Similarity=0.377 Sum_probs=205.9
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
.++|++.+.||+|+||.||+|.+. +++.||||++...... ..+.+.+|+.++++++|+||+++++++.+++..+||||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999865 7889999999754322 23568999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|+++++|.+++..... +++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.......
T Consensus 86 ~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 86 YCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CCTTEEGGGGSBTTTB--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 9999999999976543 89999999999999999999998 999999999999999999999999999987643322
Q ss_pred -ccccccccCCCcCCcchhcCCCC-ChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 503 -HVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 503 -~~~~~~~gt~~y~APE~~~~~~~-t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
.......|+..|+|||++.+..+ +.++|||||||+||||++|+.||+...........|..... .. .
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--------~~---~ 229 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--------YL---N 229 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT--------TS---T
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc--------cC---C
Confidence 22345679999999999987765 78999999999999999999999866544333333322110 00 0
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
. .......+.+++.+||+.+|++||++.||+++
T Consensus 230 ~------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 P------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp T------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred c------cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 01123456789999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=369.53 Aligned_cols=272 Identities=25% Similarity=0.350 Sum_probs=206.5
Q ss_pred hCCCcccceeeccCcEEEEEEEc-----CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC--CeE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-----PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAG--GKR 417 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-----~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--~~~ 417 (724)
.++|++.+.||+|+||.||+|.+ .+++.||||+++.......+.|.+|+++|++++|+||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46789999999999999999983 36789999999877666667899999999999999999999998654 457
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
+|||||+++++|.+++..... .+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 999999999999999976542 489999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCc--cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCCh
Q 040832 498 TDNNTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 498 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~ 575 (724)
...... ......++..|+|||.+.+..++.++|||||||+||||++|..||...... ...+.............+
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHCTTCCTHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhhcCccccchhHHHH
Confidence 543322 223345777899999999999999999999999999999999998643110 000000000000000000
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 576 NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 576 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
.+.+........+......+.+++.+||+.+|++||++.||++.|+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 001111111122334456788999999999999999999999999854
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=365.50 Aligned_cols=276 Identities=21% Similarity=0.253 Sum_probs=214.6
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC--eEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGG--KRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~--~~~lV 420 (724)
.++|.+.++||+|+||.||+|.+. +++.||||+++... ....+.+.+|+++|++++|+||+++++++.... ..+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 357999999999999999999965 48899999997543 233567889999999999999999999998765 77999
Q ss_pred EEecCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEE----cCCCCEEEEEecccc
Q 040832 421 YEYVPNNNLEFHLHGKGR-PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILL----DYTFETKVADFGLAK 495 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~-~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl----~~~~~vkL~DFGla~ 495 (724)
|||+++++|.+++..... ..+++..++.|+.||++||+|||++ +|+||||||+|||| +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976432 2389999999999999999999999 99999999999999 788889999999998
Q ss_pred ccCCCCCccccccccCCCcCCcchhc--------CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhh---HHhhhhh
Q 040832 496 LTTDNNTHVSTRVMGTFGYLAPEYAS--------SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC---LVDWARP 564 (724)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~APE~~~--------~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~---l~~w~~~ 564 (724)
........ ....|+..|+|||++. ...++.++|||||||+||||++|+.||......... +......
T Consensus 165 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 165 ELEDDEQF--VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp ECCTTCCB--CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ecCCCCce--eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 77654332 3456999999999986 578899999999999999999999999754332221 1111110
Q ss_pred hhhh------cccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 565 LCLR------ALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 565 ~~~~------~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
.... ......+...-+-.....+.......+..++.+||+.||++||++.|++++...+.-
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 0000 000000000000011124556778889999999999999999999999999985543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=371.71 Aligned_cols=256 Identities=27% Similarity=0.402 Sum_probs=201.7
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcE----EEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKE----VAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRL 418 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~----vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 418 (724)
.++|++.++||+|+||.||+|.+. +++. ||+|.++... ....++|.+|+.+|++++|+||++++++|.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 357899999999999999999954 3443 6888886442 344578999999999999999999999998765 68
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
+||||+.+|+|.+++..... .+++..++.|+.||++||.|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTT-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 99999999999999987543 489999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChh
Q 040832 499 DNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 499 ~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
..... ......++..|+|||++.+..++.++|||||||+||||++ |+.||+.....+. .... ..+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~--------~~~--- 235 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--SSIL--------EKG--- 235 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHH--------HTT---
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH--HHHH--------HcC---
Confidence 54332 2233457889999999999999999999999999999999 9999976543221 1110 000
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
.....+......+..++.+||+.+|++||++.||+++|+...
T Consensus 236 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 236 ------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ------CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 001112223456889999999999999999999999998654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=366.34 Aligned_cols=260 Identities=26% Similarity=0.374 Sum_probs=218.3
Q ss_pred HhhCCCcccceeeccCcEEEEEEEcCC-CcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVLPN-GKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
...++|++.+.||+|+||.||+|.+.+ ++.||||+++... ...+.|.+|++++++++|+||+++++++.+++..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 456789999999999999999999754 7889999997643 34567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+.+++|.+++.......+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999999887666799999999999999999999999 99999999999999999999999999999876655
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
........++..|+|||++.+..++.++||||||++||||++ |+.||........ .....
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~--~~~~~----------------- 226 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--YELLE----------------- 226 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HHHHH-----------------
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHh-----------------
Confidence 444455667889999999999999999999999999999999 9999976532221 11000
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
.......+......+.+++.+||+.+|++||++.||++.|+..+.
T Consensus 227 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 227 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 000011112233568899999999999999999999999986543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=370.97 Aligned_cols=249 Identities=23% Similarity=0.325 Sum_probs=206.2
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
.++|++.++||+|+||.||++... +++.||||+++.. .......+.+|+++|++++|+||+++++++.+.+..+||
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367999999999999999999965 6899999999753 223345788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+.+|+|..++...+. +++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 84 ~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 999999999999976543 89999999999999999999999 9999999999999999999999999999864432
Q ss_pred CCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
.. ......||..|+|||++.+..++.++|||||||+||||++|+.||......+.. . .... +.
T Consensus 159 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-~----~i~~-----~~------ 221 (337)
T 1o6l_A 159 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-E----LILM-----EE------ 221 (337)
T ss_dssp TC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-H----HHHH-----CC------
T ss_pred CC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHH-H----HHHc-----CC------
Confidence 22 224467999999999999999999999999999999999999999765322111 0 0000 00
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRP-----KISQIVRA 619 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evv~~ 619 (724)
..++......+.+++.+||+.+|++|+ ++.||+++
T Consensus 222 ----~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 ----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 011222345678899999999999999 89999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=374.17 Aligned_cols=273 Identities=24% Similarity=0.297 Sum_probs=207.8
Q ss_pred hhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC----eEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGG----KRLL 419 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~----~~~l 419 (724)
..++|++.++||+|+||.||+|.+. ++.||||+++... .....+..|+.+|++++|+||+++++++.... ..+|
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 3468999999999999999999874 7899999997532 23345667999999999999999999998754 4699
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------CCCeEecCCCCccEEEcCCCCEEEEEec
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC-------HPRIIHRDIKSSNILLDYTFETKVADFG 492 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~-------~~~iiHrDIkp~NILl~~~~~vkL~DFG 492 (724)
||||+++|+|.+++.... +++..++.|+.||++||+|||+.+ .++|+||||||+||||+.++.+||+|||
T Consensus 100 v~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEecCCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 999999999999997643 899999999999999999999862 3379999999999999999999999999
Q ss_pred cccccCCCCCc-cccccccCCCcCCcchhcCC-----CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhh-HHhh--hh
Q 040832 493 LAKLTTDNNTH-VSTRVMGTFGYLAPEYASSG-----KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC-LVDW--AR 563 (724)
Q Consensus 493 la~~~~~~~~~-~~~~~~gt~~y~APE~~~~~-----~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~-l~~w--~~ 563 (724)
+++........ ......|+..|+|||++.+. .++.++|||||||+||||++|+.||......... ...+ ..
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 99876544332 22345799999999999863 4567899999999999999999999764321110 0000 00
Q ss_pred ---hhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 564 ---PLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 564 ---~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
..+...+........+.... ........+.+++.+||+.+|++||++.||++.|+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 257 PSLEDMQEVVVHKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CchhhhhhhhhcccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00000000000001111110 12345677999999999999999999999999998643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=378.40 Aligned_cols=261 Identities=27% Similarity=0.420 Sum_probs=213.4
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC--------CCcEEEEEEeccCCch-hHHHHHHHHHHHHhc-CCCCeeEEeeEEEe
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP--------NGKEVAVKSLRSGSGQ-GEREFKAEVEIISRV-HHRHLVSLVGYCIA 413 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~--------~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~ 413 (724)
..++|.+++.||+|+||.||+|.+. .+..||||+++..... ..+.+.+|+++|+++ +|+||++++++|.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3468899999999999999999852 2357999999865433 346799999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEE
Q 040832 414 GGKRLLVYEYVPNNNLEFHLHGKG--------------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNIL 479 (724)
Q Consensus 414 ~~~~~lV~E~~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NIL 479 (724)
++..+|||||+++++|.+++.... ...+++..+++|+.||++||+|||++ +|+|||||++|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEE
Confidence 999999999999999999998654 23589999999999999999999999 9999999999999
Q ss_pred EcCCCCEEEEEeccccccCCCCC-ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhh
Q 040832 480 LDYTFETKVADFGLAKLTTDNNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDC 557 (724)
Q Consensus 480 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~ 557 (724)
|+.++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||+||||++ |+.||......+
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~-- 301 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-- 301 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 99999999999999987754332 22334557889999999999999999999999999999999 999997653221
Q ss_pred HHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCCc
Q 040832 558 LVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSL 626 (724)
Q Consensus 558 l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~~ 626 (724)
+..... .+. ....+......+.+++.+||+.+|++||++.||+++|+..+..
T Consensus 302 ~~~~~~--------~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 302 LFKLLK--------EGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp HHHHHH--------TTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHH--------cCC---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 111110 000 0011122345688999999999999999999999999876543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=385.07 Aligned_cols=251 Identities=27% Similarity=0.423 Sum_probs=208.0
Q ss_pred hhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC-eEEEEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGG-KRLLVYE 422 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~-~~~lV~E 422 (724)
..++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.|.+|+.+|++++|+||+++++++.+.. ..+||||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 4567889999999999999999984 7899999998653 4567999999999999999999999988765 7899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|+.+|+|.++|...+...+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 343 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 343 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence 99999999999876665689999999999999999999999 99999999999999999999999999998654321
Q ss_pred ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
....++..|+|||.+....++.++|||||||+||||++ |+.||......+.. . .+..+.
T Consensus 344 ---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~-~---------~i~~~~------- 403 (450)
T 1k9a_A 344 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-P---------RVEKGY------- 403 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH-H---------HHHTTC-------
T ss_pred ---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-H---------HHHcCC-------
Confidence 22357889999999999999999999999999999998 99999765322211 0 001110
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
....+......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 404 --~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 404 --KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0112223345788999999999999999999999999853
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=391.15 Aligned_cols=259 Identities=30% Similarity=0.444 Sum_probs=207.7
Q ss_pred HhhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
...++|++.+.||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++|+|+||+++++++.+ +..+||||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 3456789999999999999999999888889999998654 345679999999999999999999999876 67899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|+.+|+|.++|.......+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.......
T Consensus 259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 99999999999764434589999999999999999999999 999999999999999999999999999987765433
Q ss_pred ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
.......++..|+|||.+..+.++.++|||||||+||||++ |+.||......+. ... +..+.
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--~~~--------i~~~~------- 398 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--LDQ--------VERGY------- 398 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HHH--------HHTTC-------
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH--HHH--------HHcCC-------
Confidence 33334457789999999999999999999999999999999 9999976533221 100 01110
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
....+......+.+++.+||+.+|++||++.+|++.|+....
T Consensus 399 --~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 399 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred --CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 001122334568899999999999999999999999997654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=401.59 Aligned_cols=260 Identities=30% Similarity=0.442 Sum_probs=213.5
Q ss_pred HHhhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 342 SAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 342 ~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
+...++|++.+.||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++|+|+||+++++++.+ +..+|||
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 34456789999999999999999999888889999998654 345679999999999999999999999876 6789999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+.+|+|.++|.......+++.+++.|+.||++||+|||++ +|||||||++||||+.++.+||+|||+++......
T Consensus 341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 999999999999764334589999999999999999999999 99999999999999999999999999998765432
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
........++..|+|||++..+.++.++|||||||+||||++ |+.||......+. ... +..+.
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~--~~~--------i~~~~------ 481 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--LDQ--------VERGY------ 481 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH--HHH--------HHTTC------
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHH--------HHcCC------
Confidence 222233456788999999999999999999999999999999 9999976532221 110 01110
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
....+......|.+++.+||+.+|++||++.+|++.|+..+.
T Consensus 482 ---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 482 ---RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 001122334568889999999999999999999999997654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=381.03 Aligned_cols=260 Identities=27% Similarity=0.387 Sum_probs=209.6
Q ss_pred hCCCcccceeeccCcEEEEEEEcC------CCcEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP------NGKEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKR 417 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 417 (724)
.++|.+.+.||+|+||.||+|.+. +++.||||+++... ......|.+|+.+|++++|+||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467899999999999999999843 45689999997543 34455799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC---CEEEE
Q 040832 418 LLVYEYVPNNNLEFHLHGKG-----RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF---ETKVA 489 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~-----~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~---~vkL~ 489 (724)
+|||||+.+|+|.+++.... ...+.+..++.|+.||++||+|||++ +|+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997632 23589999999999999999999999 999999999999998554 59999
Q ss_pred EeccccccCCCCC-ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhh
Q 040832 490 DFGLAKLTTDNNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCL 567 (724)
Q Consensus 490 DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~ 567 (724)
|||+++....... .......|+..|+|||++.+..++.++|||||||+||||++ |+.||......+. ....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~--~~~i----- 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--LEFV----- 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--HHHH-----
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHH-----
Confidence 9999986532221 22334568899999999999999999999999999999998 9999976543221 1110
Q ss_pred hcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCCc
Q 040832 568 RALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSL 626 (724)
Q Consensus 568 ~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~~ 626 (724)
..+.. ...+......+.+++.+||+.+|++||++.+|+++|+.....
T Consensus 300 ---~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 300 ---TSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp ---HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---HcCCC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 00000 011122334588999999999999999999999999875543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=382.54 Aligned_cols=257 Identities=25% Similarity=0.382 Sum_probs=209.1
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
..++|.+.+.||+|+||.||+|.+. +++.||||+++..... ..++|.+|+++|++++|+||++++++|.+.+..+|||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3467899999999999999999975 6889999999865333 2346899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+++|+|.++|...+ ..+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 192 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp ECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred EcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 9999999999997643 2488999999999999999999999 99999999999999999999999999998654432
Q ss_pred Cccc-cccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 502 THVS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 502 ~~~~-~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
.... ....++..|+|||.+..+.++.++|||||||+||||++ |+.||......+. ..+. ..+.
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~--~~~~--------~~~~----- 332 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT--REFV--------EKGG----- 332 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH--HHHH--------HTTC-----
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHH--------HcCC-----
Confidence 2111 12235678999999998999999999999999999998 9999976543221 1111 0010
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
....+......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 333 ----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 333 ----RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 0011122334688899999999999999999999999853
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=367.12 Aligned_cols=259 Identities=25% Similarity=0.399 Sum_probs=211.7
Q ss_pred hhCCCcccceeeccCcEEEEEEEc------CCCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCe
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVL------PNGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGK 416 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 416 (724)
..++|.+.+.||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|+++|++|+|+||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 356789999999999999999985 2457899999986543 334679999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGR----------------------PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIK 474 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~----------------------~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIk 474 (724)
.++||||+++++|.+++..... ..+++..+++|+.||++||.|||++ +|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence 9999999999999999976432 3478999999999999999999999 99999999
Q ss_pred CccEEEcCCCCEEEEEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCC
Q 040832 475 SSNILLDYTFETKVADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTG 552 (724)
Q Consensus 475 p~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~ 552 (724)
|+||||+.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||+||||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999877544332 2233457788999999998899999999999999999999 999997654
Q ss_pred chhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 553 AMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 553 ~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
..+. .... ..+.. ...+......+.+++.+||+.+|++||++.+|+++|+..+
T Consensus 258 ~~~~--~~~~--------~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 258 PERL--FNLL--------KTGHR---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp GGGH--HHHH--------HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH--HHHh--------hcCCc---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 3221 1110 00000 0111223456889999999999999999999999998643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=365.14 Aligned_cols=260 Identities=28% Similarity=0.405 Sum_probs=213.2
Q ss_pred hhCCCcccceeeccCcEEEEEEEc------CCCcEEEEEEeccCCch-hHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCC
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVL------PNGKEVAVKSLRSGSGQ-GEREFKAEVEIISRV-HHRHLVSLVGYCIAGG 415 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~ 415 (724)
..++|.+.+.||+|+||.||+|.+ .+++.||||+++..... ..+.|.+|+.+|++| +|+||+++++++.+.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346789999999999999999984 34678999999865433 346799999999999 9999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEE
Q 040832 416 KRLLVYEYVPNNNLEFHLHGKGRP----------------VMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNIL 479 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~~~~----------------~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NIL 479 (724)
..++||||+++++|.+++...... .+++..+++|+.||++||+|||++ +|+||||||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEE
Confidence 999999999999999999865432 489999999999999999999999 9999999999999
Q ss_pred EcCCCCEEEEEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhh
Q 040832 480 LDYTFETKVADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDC 557 (724)
Q Consensus 480 l~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~ 557 (724)
|+.++.+||+|||+++........ ......|+..|+|||++.+..++.++|||||||+||||++ |+.||.........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 999999999999999877654332 2334567889999999999999999999999999999999 99999765432221
Q ss_pred HHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 558 LVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 558 l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
...... ......+......+.+++.+||+.+|++||++.||+++|+..+
T Consensus 258 ~~~~~~------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 258 YKMIKE------------------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp HHHHHH------------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcc------------------CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 111100 0000111223356889999999999999999999999998654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=388.47 Aligned_cols=263 Identities=21% Similarity=0.274 Sum_probs=213.2
Q ss_pred cCHHHHHHhhCCCcccceeeccCcEEEEEEEcCC-CcEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCeeEEeeEE
Q 040832 336 FTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPN-GKEVAVKSLRSGSG---QGEREFKAEVEIISRVHHRHLVSLVGYC 411 (724)
Q Consensus 336 f~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vaVK~l~~~~~---~~~~~f~~Ei~il~~l~HpnIv~l~g~~ 411 (724)
+.++++....++|.+.++||+|+||.||+|.+.+ ++.||||+++.... .....+.+|+.+|..++|+||++++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 4567778888999999999999999999999754 78899999964211 1122388999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEe
Q 040832 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADF 491 (724)
Q Consensus 412 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DF 491 (724)
.+.+..+||||||.+|+|.++|.... ..+++..++.|+.||+.||+|||++ +||||||||+||||+.++.+||+||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence 99999999999999999999998642 2489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCccccccccCCCcCCcchhc-----CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhh--HHhhhhh
Q 040832 492 GLAKLTTDNNTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC--LVDWARP 564 (724)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~--l~~w~~~ 564 (724)
|+++.............+||.+|+|||++. .+.++.++|||||||+||||++|+.||......+.. +..+...
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 299 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 299 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc
Confidence 999877655544445568999999999987 567899999999999999999999999865433321 1111100
Q ss_pred hhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 040832 565 LCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARR--RPKISQIVRA 619 (724)
Q Consensus 565 ~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evv~~ 619 (724)
+ .+.. ........+.+++.+||..++++ |+++.||+++
T Consensus 300 ~--------~~p~---------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 300 F--------QFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp C--------CCCS---------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred c--------cCCc---------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0 0000 00112345778888899888888 9999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=364.98 Aligned_cols=267 Identities=21% Similarity=0.278 Sum_probs=202.7
Q ss_pred hhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQ--GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~--~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
..++|++.+.||+|+||.||+|.+.+++.||||+++..... ..+.+.+|+++|++++|+||+++++++.+++..+|||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 35789999999999999999999988999999999754322 2457899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+++ +|.+++.... ..+++..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 99 e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 99 EFMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp ECCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred cCCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 99985 6777776543 3489999999999999999999999 99999999999999999999999999998765433
Q ss_pred CccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc-
Q 040832 502 THVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA- 579 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v- 579 (724)
.. .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||......+... .....+. ......+..+.
T Consensus 174 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~i~~~~~--~~~~~~~~~~~~ 249 (311)
T 3niz_A 174 RS-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP-KIFSILG--TPNPREWPQVQE 249 (311)
T ss_dssp C----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHH-HHHHHHC--CCCTTTSGGGTT
T ss_pred cc-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHHC--CCChHHhhhhhc
Confidence 22 233568999999999876 568999999999999999999999997654333211 1110000 00000000000
Q ss_pred -----chh---hhc----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 580 -----DPY---LEK----NYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 580 -----d~~---l~~----~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+.. +.. .........+.+++.+||+.||++||++.||+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000 000 0001123467899999999999999999999973
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=371.81 Aligned_cols=261 Identities=25% Similarity=0.413 Sum_probs=210.5
Q ss_pred hhCCCcccceeeccCcEEEEEEEc------CCCcEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCC
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVL------PNGKEVAVKSLRSGSG-QGEREFKAEVEIISRV-HHRHLVSLVGYCIAGG 415 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~ 415 (724)
..++|.+++.||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|+.+|+++ +|+||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 457899999999999999999985 2456799999975432 2345799999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 040832 416 KRLLVYEYVPNNNLEFHLHGKGR---------------------PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIK 474 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~~~---------------------~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIk 474 (724)
..+|||||+++|+|.++|..... ..+++..++.|+.||++||+|||++ +|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 99999999999999999986543 2378999999999999999999999 99999999
Q ss_pred CccEEEcCCCCEEEEEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCC
Q 040832 475 SSNILLDYTFETKVADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTG 552 (724)
Q Consensus 475 p~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~ 552 (724)
|+||||+.++.+||+|||+++........ ......|+..|+|||++.++.++.++|||||||+||||++ |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999999876544332 2344567889999999999999999999999999999998 999997654
Q ss_pred chhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 553 AMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 553 ~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
....... +.. .+ +....+......+..++.+||+.+|++||++.+|+++|+..+.
T Consensus 280 ~~~~~~~-~~~--------~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 280 VDANFYK-LIQ--------NG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CSHHHHH-HHH--------TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cHHHHHH-HHh--------cC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 3322111 110 00 0011112234568889999999999999999999999987654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=358.83 Aligned_cols=266 Identities=21% Similarity=0.280 Sum_probs=203.8
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
++|++.+.||+|+||.||+|.+. +++.||||+++.... ...+.+.+|+.+|++++|+||+++++++.+++..+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999964 588999999975432 234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|++++.+..+....+ .+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.......
T Consensus 82 ~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred cCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 998755544444333 489999999999999999999999 999999999999999999999999999987654332
Q ss_pred ccccccccCCCcCCcchhcCCC-CChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc--
Q 040832 503 HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA-- 579 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~-~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v-- 579 (724)
. .....|+..|+|||++.+.. ++.++|||||||+||||++|+.||.........+....+.+... ....+..+.
T Consensus 157 ~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~~ 233 (292)
T 3o0g_A 157 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP--TEEQWPSMTKL 233 (292)
T ss_dssp C-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCC--CTTTCTTGGGS
T ss_pred c-ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC--Chhhhhhhccc
Confidence 2 23456899999999998765 89999999999999999999998755544433333222211100 000000000
Q ss_pred -c---------hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 580 -D---------PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 580 -d---------~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+ ..............+.+++.+||+.||++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 000001112234567899999999999999999999873
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=369.70 Aligned_cols=253 Identities=24% Similarity=0.318 Sum_probs=207.0
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch------hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCe
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ------GEREFKAEVEIISRVHHRHLVSLVGYCIAGGK 416 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~------~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 416 (724)
..+.|.+++.||+|+||.||++... +|+.||||+++..... ..+.+.+|+.+|++++|+||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3568999999999999999999965 5889999999754322 34679999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC----CEEEEEec
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF----ETKVADFG 492 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~----~vkL~DFG 492 (724)
.+|||||+.+++|.+++...+ .+++..++.|+.||+.||.|||++ +|+||||||+||||+.++ .+||+|||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 999999999999999997654 489999999999999999999999 999999999999998876 79999999
Q ss_pred cccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccC
Q 040832 493 LAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDD 572 (724)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~ 572 (724)
+++....... .....||..|+|||++.+..++.++|||||||+||||++|+.||......+. +..+. .
T Consensus 165 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~-~~~i~---------~ 232 (361)
T 2yab_A 165 LAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANIT---------A 232 (361)
T ss_dssp SCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHH---------T
T ss_pred CceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH---------h
Confidence 9987755322 2345699999999999998999999999999999999999999976533221 11110 0
Q ss_pred CChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 573 GNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 573 ~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+.+. .+...... ....+.+++.+||..+|++||++.|++++
T Consensus 233 ~~~~--~~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 233 VSYD--FDEEFFSQ----TSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp TCCC--CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCC--CCchhccC----CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1000 00000011 12457889999999999999999999863
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=357.11 Aligned_cols=253 Identities=28% Similarity=0.445 Sum_probs=196.4
Q ss_pred hCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCc----hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSG----QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~----~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
.++|++.++||+|+||.||+|.+ .++.||||+++.... ...+.+.+|++++++++|+||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46899999999999999999997 488999999875432 2246789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC--------CCCEEEEEec
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY--------TFETKVADFG 492 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~--------~~~vkL~DFG 492 (724)
|||+++++|.+++... .+++..++.|+.||++||+|||+++..+|+||||||+||||+. ++.+||+|||
T Consensus 85 ~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999998643 4899999999999999999999982112999999999999986 7789999999
Q ss_pred cccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccC
Q 040832 493 LAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDD 572 (724)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~ 572 (724)
+++....... ....|+..|+|||.+.+..++.++||||||+++|||++|+.||..............
T Consensus 162 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---------- 228 (271)
T 3dtc_A 162 LAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM---------- 228 (271)
T ss_dssp C----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT----------
T ss_pred cccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc----------
Confidence 9986654322 235689999999999999999999999999999999999999976543322111000
Q ss_pred CChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 573 GNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 573 ~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
.. +....+......+.+++.+||+.+|++||++.||+++|+.
T Consensus 229 ~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 229 NK--------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp SC--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CC--------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 00 0011122233568899999999999999999999999975
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=373.71 Aligned_cols=272 Identities=17% Similarity=0.228 Sum_probs=207.2
Q ss_pred hCCCcccceeecc--CcEEEEEEEcC-CCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 345 TGGFSQSNLLGQG--GFGYVHKGVLP-NGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 345 ~~~f~~~~~LG~G--~fG~Vyk~~~~-~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
.++|++.++||+| +||.||+|.+. +++.||||+++... ....+.+.+|+.+|++++|+||+++++++.+++..+|
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4679999999999 99999999965 68999999997542 2334568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
|||||++++|.+++.......+++..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||++.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999876555699999999999999999999999 999999999999999999999999999875532
Q ss_pred CCC------ccccccccCCCcCCcchhcC--CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhh--h--
Q 040832 500 NNT------HVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLC--L-- 567 (724)
Q Consensus 500 ~~~------~~~~~~~gt~~y~APE~~~~--~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~--~-- 567 (724)
... .......|+..|+|||++.+ ..++.++|||||||+||||++|+.||......+.....+..... .
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 211 11122468999999999987 57999999999999999999999999775444332221111000 0
Q ss_pred hcccCC-------------Chhhhcch---------hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 568 RALDDG-------------NFNEIADP---------YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 568 ~~~~~~-------------~~~~~vd~---------~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
...... .+.+.+.. .....+.......+.+++.+||+.||++||++.||+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000000 00000000 00001122234568899999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=359.42 Aligned_cols=257 Identities=30% Similarity=0.429 Sum_probs=211.5
Q ss_pred hhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
..++|++.+.||+|+||.||+|.+.+++.||||.++... ...+.|.+|+++|++++|+||+++++++.+ +..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 346789999999999999999998888899999997653 345679999999999999999999999864 457999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+.+++|.+++.......+++..++.|+.||++||.|||++ +|+|||||++||||+.++.+||+|||+++........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 9999999999764333589999999999999999999999 9999999999999999999999999999887654433
Q ss_pred cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchh
Q 040832 504 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~ 582 (724)
......++..|+|||.+..+.++.++||||||++||||++ |+.||......+. +... ..+. .
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~~~~---------~~~~-----~-- 228 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV-IQNL---------ERGY-----R-- 228 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-HHHH---------HTTC-----C--
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH-HHHH---------hccc-----C--
Confidence 3344557889999999998899999999999999999999 9999976532221 1100 0000 0
Q ss_pred hhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 583 LEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 583 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
...+......+.+++.+|++.+|++||++.+|++.|+..+
T Consensus 229 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 229 --MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 0111122356889999999999999999999999998654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=369.55 Aligned_cols=265 Identities=25% Similarity=0.370 Sum_probs=197.4
Q ss_pred HHHHHhhCCCcccceeeccCcEEEEEEEcCCCc----EEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEE
Q 040832 339 EELSAATGGFSQSNLLGQGGFGYVHKGVLPNGK----EVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCI 412 (724)
Q Consensus 339 ~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~----~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 412 (724)
+++....++|.+++.||+|+||.||+|.+.... .||||+++.. .....+.|.+|++++++++|+||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 344455678999999999999999999975433 7999999765 3344567999999999999999999999998
Q ss_pred eCCeE------EEEEEecCCCCHHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC
Q 040832 413 AGGKR------LLVYEYVPNNNLEFHLHGKG----RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY 482 (724)
Q Consensus 413 ~~~~~------~lV~E~~~~gsL~~~L~~~~----~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~ 482 (724)
..... ++||||+.+++|.+++.... ...+++..++.|+.||++||+|||++ +|+||||||+||||+.
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAE 172 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcC
Confidence 87655 89999999999999986422 22489999999999999999999999 9999999999999999
Q ss_pred CCCEEEEEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHh
Q 040832 483 TFETKVADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVD 560 (724)
Q Consensus 483 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~ 560 (724)
++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||+||||++ |+.||......+....
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~- 251 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY- 251 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH-
Confidence 999999999999876543322 2233456788999999999999999999999999999999 9999976543321110
Q ss_pred hhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 561 WARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 561 w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
+. .+.. ..........+.+++.+||+.+|++||++.+|++.|+..+.
T Consensus 252 ~~---------~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 252 LI---------GGNR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp HH---------TTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Hh---------cCCC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00 0000 01122233568899999999999999999999999986543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=358.95 Aligned_cols=257 Identities=23% Similarity=0.383 Sum_probs=197.0
Q ss_pred hhCCCcccceeeccCcEEEEEEEcCC----CcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLPN----GKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRL 418 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~~----g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 418 (724)
..++|++.+.||+|+||.||+|.+.. +..||||+++..... ..+.|.+|+.+|++++|+||+++++++. ++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 45689999999999999999998643 456999998764333 3457999999999999999999999984 45679
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
+||||+.+++|.+++.... ..+++..++.|+.||++||.|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccC
Confidence 9999999999999998653 2489999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 499 DNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 499 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
...........++..|+|||.+....++.++|||||||+||||++ |+.||......+. ... +..+..
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~--~~~--------i~~~~~-- 235 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IGR--------IENGER-- 235 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHH--------HHTTCC--
T ss_pred cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH--HHH--------HHcCCC--
Confidence 544333344557789999999998999999999999999999997 9999976543221 110 000100
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
...+......+.+++.+||+.+|++||++.||++.|+..+
T Consensus 236 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 236 -------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0111223456888999999999999999999999998654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=363.43 Aligned_cols=252 Identities=17% Similarity=0.274 Sum_probs=206.6
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
.++|.+.+.||+|+||.||++.+. +++.||+|.++... .....+.+|+.+|++++|+||+++++++.+.+..+|||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 578999999999999999999965 57889999987543 3455789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC--CCCEEEEEeccccccCCCC
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY--TFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~--~~~vkL~DFGla~~~~~~~ 501 (724)
+++++|.+++.... ..+++..++.|+.||++||.|||++ +|+||||||+||||+. ++.+||+|||+++......
T Consensus 83 ~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999997643 2489999999999999999999999 9999999999999987 7899999999998775433
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
. .....|+..|+|||++.+..++.++|||||||+||||++|+.||......+. +..... +.+. ...
T Consensus 159 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~---------~~~~--~~~ 224 (321)
T 1tki_A 159 N--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-IENIMN---------AEYT--FDE 224 (321)
T ss_dssp E--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHH---------TCCC--CCH
T ss_pred c--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH-HHHHHc---------CCCC--CCh
Confidence 2 2345689999999999988899999999999999999999999976532221 111100 0000 000
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..... ....+.+++.+||..+|++||++.|++++
T Consensus 225 ~~~~~----~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 225 EAFKE----ISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhcc----CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00011 13457889999999999999999999984
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=362.38 Aligned_cols=271 Identities=25% Similarity=0.348 Sum_probs=204.4
Q ss_pred HHHHhhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhc--CCCCeeEEeeEEEeC---
Q 040832 340 ELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV--HHRHLVSLVGYCIAG--- 414 (724)
Q Consensus 340 el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l--~HpnIv~l~g~~~~~--- 414 (724)
.-....++|++.++||+|+||.||+|.+. ++.||||++... ....+..|.+++..+ +|+||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 33445678999999999999999999984 899999999642 344556666666655 899999999999987
Q ss_pred -CeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCccEEEcCCCCEEE
Q 040832 415 -GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC-----HPRIIHRDIKSSNILLDYTFETKV 488 (724)
Q Consensus 415 -~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~-----~~~iiHrDIkp~NILl~~~~~vkL 488 (724)
...+|||||+++++|.++++.. .+++..++.|+.||+.||+|||+++ .++|+||||||+||||+.++.+||
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 7889999999999999999765 3899999999999999999999762 347999999999999999999999
Q ss_pred EEeccccccCCCCCcc---ccccccCCCcCCcchhcCCCCChh------HHHHHHHHHHHHHHhC----------CCCCC
Q 040832 489 ADFGLAKLTTDNNTHV---STRVMGTFGYLAPEYASSGKLTEK------SDVFSFGVMLLELITG----------RRPID 549 (724)
Q Consensus 489 ~DFGla~~~~~~~~~~---~~~~~gt~~y~APE~~~~~~~t~k------sDV~SlGvlL~eLltG----------~~P~~ 549 (724)
+|||+++......... .....|+..|+|||++.+..+..+ +|||||||+||||++| +.||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 9999998765433321 124579999999999987766554 9999999999999999 55554
Q ss_pred CCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 550 PTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 550 ~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
...........+...... ..+....... ....+....+.+++.+||+.+|++||++.||+++|+...+
T Consensus 264 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCI-----KKLRPSFPNR---WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp TTSCSSCCHHHHHHHHTT-----SCCCCCCCGG---GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcCCCCchhhhHHHHhh-----hccCcccccc---chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 322111111111111100 0000000000 1123667789999999999999999999999999987544
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=362.65 Aligned_cols=252 Identities=23% Similarity=0.309 Sum_probs=205.9
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch------hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ------GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKR 417 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~------~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 417 (724)
.+.|.+.+.||+|+||.||++... +++.||||+++..... ..+.|.+|+.+|++|+|+||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356999999999999999999965 5889999998754321 356799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC----CEEEEEecc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF----ETKVADFGL 493 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~----~vkL~DFGl 493 (724)
+|||||+.+++|.+++...+ .+++..++.|+.||+.||.|||++ +|+||||||+||||+.++ .+||+|||+
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 99999999999999997654 489999999999999999999999 999999999999998887 899999999
Q ss_pred ccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCC
Q 040832 494 AKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDG 573 (724)
Q Consensus 494 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~ 573 (724)
++....... .....|+..|+|||++....++.++|||||||+||||++|+.||......+. +..... .. .
T Consensus 165 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~------~~-~ 234 (326)
T 2y0a_A 165 AHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANVSA------VN-Y 234 (326)
T ss_dssp CEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHH------TC-C
T ss_pred CeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHh------cC-C
Confidence 987754322 2345699999999999999999999999999999999999999976532221 111100 00 0
Q ss_pred ChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 574 NFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 574 ~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+ ....... ....+.+++.+||+.+|++||++.||+++
T Consensus 235 ~~----~~~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 235 EF----EDEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CC----CHHHHTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred Cc----Ccccccc----CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0000011 12457889999999999999999999974
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=383.62 Aligned_cols=259 Identities=22% Similarity=0.259 Sum_probs=210.5
Q ss_pred CHHHHHHhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEE
Q 040832 337 TYEELSAATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCI 412 (724)
Q Consensus 337 ~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 412 (724)
.++++....++|.+.++||+|+||.||+|.+. +++.||||+++... ....+.+.+|+.+|+.++|+||++++++|.
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34566677789999999999999999999965 58899999986421 111234889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEec
Q 040832 413 AGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFG 492 (724)
Q Consensus 413 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFG 492 (724)
+.+..+||||||.+|+|.++++... +++..++.|+.||+.||+|||++ +||||||||+||||+.++.+||+|||
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~~---~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccc
Confidence 9999999999999999999997643 89999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccCCCcCCcchhcCCC----CChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhh
Q 040832 493 LAKLTTDNNTHVSTRVMGTFGYLAPEYASSGK----LTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLR 568 (724)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~ 568 (724)
+++.............+||..|+|||++.... ++.++|||||||+||||++|+.||......+.... +..
T Consensus 214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~-i~~----- 287 (410)
T 3v8s_A 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK-IMN----- 287 (410)
T ss_dssp TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-HHT-----
T ss_pred eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHH-HHh-----
Confidence 99877655433344577999999999997654 78999999999999999999999976543322111 100
Q ss_pred cccCCChhhhcchhhhcCCC--HHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 040832 569 ALDDGNFNEIADPYLEKNYP--TEEMARMVACAAASIRHSARR--RPKISQIVRA 619 (724)
Q Consensus 569 ~~~~~~~~~~vd~~l~~~~~--~~~~~~l~~l~~~cl~~~P~~--RPs~~evv~~ 619 (724)
......++ ......+.+++.+||..++++ |+++.||+++
T Consensus 288 ------------~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 288 ------------HKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ------------HHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ------------ccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00000011 112346788899999999998 9999999975
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=370.40 Aligned_cols=270 Identities=28% Similarity=0.338 Sum_probs=213.4
Q ss_pred hCCCcccceeeccCcEEEEEEEc-----CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEE--eCCeE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-----PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCI--AGGKR 417 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-----~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~--~~~~~ 417 (724)
.++|++.+.||+|+||.||++.+ .+++.||||++........+.|.+|+++|++++|+||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35789999999999999999983 467889999998776666678999999999999999999999987 45678
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
+|||||+++++|.+++..... .+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceec
Confidence 999999999999999976332 389999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCc--cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCCh
Q 040832 498 TDNNTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 498 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~ 575 (724)
...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||...... ....+... .....+
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~--~~~~~~~~-----~~~~~~ 250 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE--FLRMMGCE-----RDVPAL 250 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH--HHHHCC---------CCHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch--hhhhcccc-----cccccH
Confidence 544332 223356888899999999989999999999999999999999998643111 11100000 000011
Q ss_pred h---hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 576 N---EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 576 ~---~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
. +.+........+......+.+++.+||+.+|++||++.||+++|+..+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1 1111111122333445678999999999999999999999999997764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=373.20 Aligned_cols=249 Identities=26% Similarity=0.353 Sum_probs=200.5
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC---CchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG---SGQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRL 418 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~ 418 (724)
..++|++.++||+|+||.||+|++. +++.||||+++.. .....+.+.+|+++|+.+ +|+||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3478999999999999999999964 5889999999753 122345688999999998 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
|||||+.+|+|..++...+. +++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 101 lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999999987544 89999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhh
Q 040832 499 DNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEI 578 (724)
Q Consensus 499 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 578 (724)
.... .....+||..|+|||++.+..++.++|||||||+||||++|+.||......+.. ... . .+.
T Consensus 176 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~-~~i----~-----~~~---- 240 (353)
T 3txo_A 176 CNGV-TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF-EAI----L-----NDE---- 240 (353)
T ss_dssp C----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHH----H-----HCC----
T ss_pred cCCc-cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH-HHH----H-----cCC----
Confidence 3222 234467999999999999888999999999999999999999999765432211 100 0 000
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCH------HHHHH
Q 040832 579 ADPYLEKNYPTEEMARMVACAAASIRHSARRRPKI------SQIVR 618 (724)
Q Consensus 579 vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~------~evv~ 618 (724)
..++......+..++.+||+.+|++|+++ .||++
T Consensus 241 ------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 ------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 01122233457889999999999999998 67765
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=369.91 Aligned_cols=253 Identities=22% Similarity=0.343 Sum_probs=205.6
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
..++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+|++|+|+||+++++++.+.+..+||
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4568999999999999999999864 58899999997543 23345789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCC---CCEEEEEecccccc
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYT---FETKVADFGLAKLT 497 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~---~~vkL~DFGla~~~ 497 (724)
|||+.+++|.+++.... .+++..++.|+.||++||.|||++ +|+||||||+||||+.+ +.+||+|||+++..
T Consensus 107 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp ECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999999887654 489999999999999999999999 99999999999999764 45999999999877
Q ss_pred CCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 498 TDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 498 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
..... .....||..|+|||++.+..++.++|||||||+||||++|+.||......+. +... ..+.+..
T Consensus 182 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-~~~i---------~~~~~~~ 249 (362)
T 2bdw_A 182 NDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-YAQI---------KAGAYDY 249 (362)
T ss_dssp TTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH---------HHTCCCC
T ss_pred cCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHH---------HhCCCCC
Confidence 64332 2346799999999999999999999999999999999999999976532211 1100 0010000
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..... ......+.+++.+||+.+|++||++.|++++
T Consensus 250 -~~~~~-----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 -PSPEW-----DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -CTTGG-----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -Ccccc-----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 1123457889999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=361.62 Aligned_cols=258 Identities=19% Similarity=0.218 Sum_probs=208.3
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
.++|.+.+.||+|+||.||+|.. .+++.||||++..... .+.+.+|+++|++| +|+||+++++++..++..+||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999995 5788999999875432 34688999999999 99999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCC-----EEEEEecccccc
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFE-----TKVADFGLAKLT 497 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~-----vkL~DFGla~~~ 497 (724)
|+ +++|.+++.... ..+++..++.|+.||++||+|||++ +|+||||||+||||+.++. +||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 999999998652 3589999999999999999999999 9999999999999998887 999999999876
Q ss_pred CCCCCc------cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchh--hhHHhhhhhhhhhc
Q 040832 498 TDNNTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAME--DCLVDWARPLCLRA 569 (724)
Q Consensus 498 ~~~~~~------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~--~~l~~w~~~~~~~~ 569 (724)
...... ......||..|+|||++.+..++.++|||||||+||||++|+.||......+ ..+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~---- 236 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK---- 236 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH----
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh----
Confidence 543322 1235679999999999999999999999999999999999999998653221 1111111000
Q ss_pred ccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 570 LDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 570 ~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
.. .....+...+ . .+.+++..||+.+|.+||++.+|++.|+...
T Consensus 237 -----~~-~~~~~~~~~~----p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 237 -----RA-TPIEVLCENF----P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp -----HH-SCHHHHTTTC----H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred -----cc-CCHHHHhccC----h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 00 0000011111 1 7899999999999999999999999998544
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=355.49 Aligned_cols=255 Identities=29% Similarity=0.453 Sum_probs=211.1
Q ss_pred hCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
.++|++.+.||+|+||.||++.+.+++.||||+++.... ..+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 357899999999999999999988889999999986543 3467999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
++++|.+++.... ..+++..++.++.||++||.|||++ +|+|||||++||||+.++.+||+|||+++.........
T Consensus 86 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 86 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp TTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 9999999997653 2489999999999999999999999 99999999999999999999999999998765432222
Q ss_pred ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 505 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
.....++..|+|||.+....++.++||||||++||||++ |+.||......+. ..... .+. .
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~~i~---------~~~-----~--- 223 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-VEDIS---------TGF-----R--- 223 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HHHHH---------TTC-----C---
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH-HHHHh---------cCC-----c---
Confidence 233457788999999998899999999999999999999 8999976532221 11110 000 0
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
...+......+.+++.+||+.+|++||++.+|+++|+..
T Consensus 224 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 224 -LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 001112234688899999999999999999999999854
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=357.45 Aligned_cols=265 Identities=22% Similarity=0.313 Sum_probs=201.7
Q ss_pred CCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQ--GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~--~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
++|.+.+.||+|+||.||+|.+.+++.||||+++..... ..+.+.+|+++|++++|+||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 579999999999999999999888999999999754322 235788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+.+ +|.+++.... ..+++..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++........
T Consensus 82 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 156 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (288)
T ss_dssp CSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence 975 8888887543 2489999999999999999999999 9999999999999999999999999999876533222
Q ss_pred cccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhh----
Q 040832 504 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEI---- 578 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~---- 578 (724)
.....|+..|+|||++.+. .++.++|||||||+||||++|+.||......+.....+ +.+.. .....+..+
T Consensus 157 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 157 -YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF-RILGT--PNSKNWPNVTELP 232 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-HHHCC--CCTTTSTTGGGST
T ss_pred -cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-HHHCC--CChhhchhhhccc
Confidence 2335689999999999764 58999999999999999999999998764333221111 10000 000000000
Q ss_pred -cchhh-------hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 579 -ADPYL-------EKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 579 -vd~~l-------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+..+ ...+.......+.+++.+||+.||++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000 001111233567899999999999999999999863
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=371.46 Aligned_cols=268 Identities=17% Similarity=0.215 Sum_probs=207.1
Q ss_pred hhCCCcccceeeccCcEEEEEEEcCC------CcEEEEEEeccCCchhHH-----------HHHHHHHHHHhcCCCCeeE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLPN------GKEVAVKSLRSGSGQGER-----------EFKAEVEIISRVHHRHLVS 406 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~~------g~~vaVK~l~~~~~~~~~-----------~f~~Ei~il~~l~HpnIv~ 406 (724)
..++|.+.++||+|+||.||+|.+.+ ++.||||++........+ .+..|+..++.++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35689999999999999999998754 478999998765432111 2334566677788999999
Q ss_pred EeeEEEeC----CeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEc-
Q 040832 407 LVGYCIAG----GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLD- 481 (724)
Q Consensus 407 l~g~~~~~----~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~- 481 (724)
+++++... ...+|||||+ +++|.+++.... ..+++..++.|+.||+.||+|||++ +|+||||||+||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEec
Confidence 99998875 4579999999 999999998753 3489999999999999999999999 999999999999998
Q ss_pred -CCCCEEEEEeccccccCCCCCcc------ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCch
Q 040832 482 -YTFETKVADFGLAKLTTDNNTHV------STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAM 554 (724)
Q Consensus 482 -~~~~vkL~DFGla~~~~~~~~~~------~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~ 554 (724)
.++.+||+|||+++......... .....||..|+|||++.+..++.++|||||||+||||++|+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 88999999999998765432221 13345999999999999999999999999999999999999999753222
Q ss_pred hhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 555 EDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 555 ~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
... ..+.... ....+.++++.++.. ......+..++..||+.+|++||++.+|++.|+..+.
T Consensus 268 ~~~-~~~~~~~-----~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 268 PKY-VRDSKIR-----YRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp HHH-HHHHHHH-----HHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHH-HHHHHHH-----hhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 211 1111110 012234444444421 1223568889999999999999999999999986554
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=370.46 Aligned_cols=275 Identities=24% Similarity=0.293 Sum_probs=213.2
Q ss_pred ccCHHHHHHhhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcC-----CCCeeEEe
Q 040832 335 AFTYEELSAATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVH-----HRHLVSLV 408 (724)
Q Consensus 335 ~f~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~-----HpnIv~l~ 408 (724)
.|++++.....++|.+.+.||+|+||.||+|.+ .+++.||||+++.. ....+.+..|+++|+++. |+||++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 455556666788999999999999999999996 46889999999743 234556888999999996 99999999
Q ss_pred eEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC------
Q 040832 409 GYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY------ 482 (724)
Q Consensus 409 g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~------ 482 (724)
+++...+..+|||||+ +++|.+++.......+++..++.|+.||+.||+|||++ +|+||||||+||||+.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccccc
Confidence 9999999999999999 99999999877666699999999999999999999999 9999999999999975
Q ss_pred -------------------CCCEEEEEeccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh
Q 040832 483 -------------------TFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 543 (724)
Q Consensus 483 -------------------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt 543 (724)
++.+||+|||+++...... ....|+..|+|||++.+..++.++|||||||+||||++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 7899999999998755432 34568999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhhhH--Hhhhhh----hhhhcccCCChhhhcc-hhhh-----------------cCCCH---HHHHHHH
Q 040832 544 GRRPIDPTGAMEDCL--VDWARP----LCLRALDDGNFNEIAD-PYLE-----------------KNYPT---EEMARMV 596 (724)
Q Consensus 544 G~~P~~~~~~~~~~l--~~w~~~----~~~~~~~~~~~~~~vd-~~l~-----------------~~~~~---~~~~~l~ 596 (724)
|+.||......+... .....+ +....... .....++ ..+. ...+. .+...+.
T Consensus 255 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 333 (360)
T 3llt_A 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKT-NGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC 333 (360)
T ss_dssp SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTS-GGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHH
T ss_pred CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhc-cCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHH
Confidence 999998764332211 110000 00000000 0000000 0000 00000 0115678
Q ss_pred HHHHHhhccCCCCCCCHHHHHHH
Q 040832 597 ACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 597 ~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+++.+||+.||++||++.||+++
T Consensus 334 ~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 334 DFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHhcCChhhCCCHHHHhcC
Confidence 99999999999999999999863
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=368.64 Aligned_cols=252 Identities=22% Similarity=0.331 Sum_probs=199.1
Q ss_pred hhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCC--CCeeEEeeEEEeCCeEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHH--RHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~H--pnIv~l~g~~~~~~~~~l 419 (724)
..+.|++.+.||+|+||.||++.+.+++.||||++.... ....+.|.+|+.+|++|+| +||+++++++.+++..+|
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 346799999999999999999999889999999987543 2334679999999999976 999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
||| +.+++|.+++..... +++.+++.|+.||++||.|||++ +|+||||||+||||+ ++.+||+|||+++....
T Consensus 87 v~e-~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEC-CCSEEHHHHHHHSCC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEe-CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 999 568899999987553 89999999999999999999999 999999999999997 56899999999987754
Q ss_pred CCCc-cccccccCCCcCCcchhcC-----------CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhh
Q 040832 500 NNTH-VSTRVMGTFGYLAPEYASS-----------GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCL 567 (724)
Q Consensus 500 ~~~~-~~~~~~gt~~y~APE~~~~-----------~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~ 567 (724)
.... ......||..|+|||++.+ ..++.++|||||||+||||++|+.||.........+...
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~------ 233 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI------ 233 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH------
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHH------
Confidence 4332 2345679999999999864 678999999999999999999999997643221111111
Q ss_pred hcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 568 RALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 568 ~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
++......++......+.+++.+||+.+|++||++.||+++
T Consensus 234 -----------~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 234 -----------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -----------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----------hcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 11111111222223467899999999999999999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=359.70 Aligned_cols=250 Identities=22% Similarity=0.289 Sum_probs=197.1
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCch--------------------------hHHHHHHHHHHHH
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQ--------------------------GEREFKAEVEIIS 397 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~--------------------------~~~~f~~Ei~il~ 397 (724)
.++|.+.+.||+|+||.||+|.+ .+++.||||++...... ..+.|.+|+++|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999999985 46889999998654211 1246889999999
Q ss_pred hcCCCCeeEEeeEEEe--CCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 040832 398 RVHHRHLVSLVGYCIA--GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKS 475 (724)
Q Consensus 398 ~l~HpnIv~l~g~~~~--~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp 475 (724)
+|+|+||+++++++.+ ++..+|||||+++++|.+++... .+++..++.|+.||++||+|||++ +|+||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK---PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCH
Confidence 9999999999999987 56889999999999998865432 489999999999999999999999 999999999
Q ss_pred ccEEEcCCCCEEEEEeccccccCCCCCccccccccCCCcCCcchhcCCC---CChhHHHHHHHHHHHHHHhCCCCCCCCC
Q 040832 476 SNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGK---LTEKSDVFSFGVMLLELITGRRPIDPTG 552 (724)
Q Consensus 476 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~t~ksDV~SlGvlL~eLltG~~P~~~~~ 552 (724)
+||||+.++.+||+|||+++........ .....|+..|+|||++.+.. ++.++|||||||+||||++|+.||....
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHEEECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999999877544322 23457999999999997665 4789999999999999999999997643
Q ss_pred chhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 553 AMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 553 ~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.... ........+. + .........+.+++.+||+.+|++||++.||+++
T Consensus 245 ~~~~-----~~~~~~~~~~---~----------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 IMCL-----HSKIKSQALE---F----------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHH-----HHHHHHCCCC---C----------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHH-----HHHHhcccCC---C----------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 2211 1100000000 0 0001123458899999999999999999999763
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=364.10 Aligned_cols=249 Identities=26% Similarity=0.370 Sum_probs=195.8
Q ss_pred hCCCcccceeeccCcEEEEEEEc----CCCcEEEEEEeccCC----chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL----PNGKEVAVKSLRSGS----GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGK 416 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~----~~g~~vaVK~l~~~~----~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 416 (724)
.++|++.++||+|+||.||++.. .+++.||||+++... ......+.+|+++|++++|+||+++++++.+++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999986 478999999997642 2233468899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
.+|||||+.+++|.+++...+. +.+..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGI--FMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 9999999999999999976543 88999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChh
Q 040832 497 TTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 497 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||......+.. .. +.. ..
T Consensus 171 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~----i~~-----~~-- 237 (327)
T 3a62_A 171 SIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI-DK----ILK-----CK-- 237 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HH----HHH-----TC--
T ss_pred cccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH-HH----HHh-----CC--
Confidence 543322 223457999999999999999999999999999999999999999765432211 00 000 00
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRP-----KISQIVRA 619 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evv~~ 619 (724)
..++......+.+++.+||+.+|++|| ++.||+++
T Consensus 238 --------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 238 --------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp --------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred --------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 011222335688999999999999999 77788764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=354.83 Aligned_cols=251 Identities=22% Similarity=0.326 Sum_probs=206.2
Q ss_pred hCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC--CeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIAG--GKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV 420 (724)
.++|.+.+.||+|+||.||+|.+ +++.||||+++... ....+.|.+|+.+|++++|+||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 35789999999999999999998 48889999997653 33446799999999999999999999999887 778999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR--IIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~--iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
|||+++++|.+++.......+++..++.|+.||++||+|||++ + |+|||||++||||+.++.++|+|||+.....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 9999999999999887665689999999999999999999998 7 9999999999999999999999999876533
Q ss_pred CCCCccccccccCCCcCCcchhcCCCCC---hhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCCh
Q 040832 499 DNNTHVSTRVMGTFGYLAPEYASSGKLT---EKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 499 ~~~~~~~~~~~gt~~y~APE~~~~~~~t---~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~ 575 (724)
. ....|+..|+|||.+.+..+. .++|||||||+||||++|+.||......+........ +
T Consensus 165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---------~-- 227 (271)
T 3kmu_A 165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE---------G-- 227 (271)
T ss_dssp C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHS---------C--
T ss_pred c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhc---------C--
Confidence 2 234589999999999875444 4899999999999999999999765433221111000 0
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 576 NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 576 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
.....+......+.+++.+||+.+|++||++.||++.|+..
T Consensus 228 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 228 -------LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 00111222334688999999999999999999999999854
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=356.46 Aligned_cols=260 Identities=28% Similarity=0.465 Sum_probs=197.3
Q ss_pred hhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
..++|++.+.||+|+||.||+|.+. ..||||+++... ....+.|.+|+++|++++|+||+++++++ .....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 3568999999999999999999864 359999997543 23346799999999999999999999976 455679999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+.+++|.+++.... ..+++..++.|+.||+.||.|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 99 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 99 QWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred EecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccccc
Confidence 9999999999997543 3489999999999999999999999 99999999999999999999999999998665322
Q ss_pred -CccccccccCCCcCCcchhc---CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 502 -THVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 502 -~~~~~~~~gt~~y~APE~~~---~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
........|+..|+|||++. ...++.++|||||||+||||++|+.||......+.......... ....+.
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~- 248 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS-----LSPDLS- 248 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTS-----CCCCTT-
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccc-----cCcchh-
Confidence 22234457999999999986 56789999999999999999999999977544332221111100 000010
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
.........+.+++.+||+.+|++||++.+|++.|+...
T Consensus 249 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 249 --------KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp --------SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --------hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 111223457889999999999999999999999998654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=362.65 Aligned_cols=246 Identities=26% Similarity=0.360 Sum_probs=205.1
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
.++|++.+.||+|+||.||++... +|+.||||+++... ....+.+.+|+.+|+.++|+||+++++++.+.+..+||
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357899999999999999999964 68999999997531 12345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+.+|+|.++|...+. +++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 999999999999987554 89999999999999999999998 9999999999999999999999999999876542
Q ss_pred CCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
.....||..|+|||++.+..++.++|||||||+||||++|+.||......+.... .+. +.+
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-----i~~-----~~~----- 220 (318)
T 1fot_A 160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK-----ILN-----AEL----- 220 (318)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-----HHH-----CCC-----
T ss_pred ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH-----HHh-----CCC-----
Confidence 2345799999999999999999999999999999999999999976543221110 000 000
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRP-----KISQIVRA 619 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evv~~ 619 (724)
.++......+.+++.+||+.+|++|+ ++.+|+++
T Consensus 221 -----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 221 -----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -----CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 11122234688899999999999999 88888853
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=359.86 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=205.4
Q ss_pred hCCCcccceeeccCcEEEEEEEcCC-C-------cEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPN-G-------KEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGK 416 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~-g-------~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 416 (724)
.++|.+.+.||+|+||.||+|.+.. + +.||+|++........+.|.+|+.+|++++|+||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4678999999999999999998643 2 4699999977666667789999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCC--------EEE
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFE--------TKV 488 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~--------vkL 488 (724)
.++||||+.+++|.+++..... .+++..++.|+.||++||.|||++ +|+|||||++||||+.++. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGG-GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeee
Confidence 9999999999999999986542 389999999999999999999999 9999999999999998887 999
Q ss_pred EEeccccccCCCCCccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhh
Q 040832 489 ADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCL 567 (724)
Q Consensus 489 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~ 567 (724)
+|||++...... ....|+..|+|||++.+ ..++.++|||||||+||||++|..++............+..
T Consensus 163 ~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~---- 233 (289)
T 4fvq_A 163 SDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED---- 233 (289)
T ss_dssp CCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT----
T ss_pred ccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc----
Confidence 999999755332 23458899999999987 77999999999999999999965554333222221111110
Q ss_pred hcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCCc
Q 040832 568 RALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSL 626 (724)
Q Consensus 568 ~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~~ 626 (724)
... .+......+.+++.+||+.+|++||++.||+++|+....-
T Consensus 234 ----~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 234 ----RHQ------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp ----TCC------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred ----cCC------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 000 0111123478899999999999999999999999977653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=363.54 Aligned_cols=267 Identities=28% Similarity=0.373 Sum_probs=209.5
Q ss_pred CcccceeeccCcEEEEEEEcC-----CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC--CeEEE
Q 040832 348 FSQSNLLGQGGFGYVHKGVLP-----NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAG--GKRLL 419 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~-----~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~l 419 (724)
|++.+.||+|+||.||++.+. +++.||||+++.... ...+.|.+|+++|++++|+||+++++++.+. ...+|
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488999999999999988642 578899999986543 3346799999999999999999999999884 57899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
||||+++++|.+++.... +++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 113 v~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 999999999999997654 89999999999999999999999 999999999999999999999999999988765
Q ss_pred CCCc--cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 500 NNTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 500 ~~~~--~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
.... ......|+..|+|||++.+..++.++|||||||+||||++|+.||.........+..|.... .....+.+
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~ 262 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQ----MTVLRLTE 262 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHH----HHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccc----hhHHHHHH
Confidence 4332 22345678889999999998999999999999999999999999864321111111111000 00001111
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
.++.......+......+.+++.+||+.+|++||++.||++.|+...
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 22222122233344567899999999999999999999999998643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=361.01 Aligned_cols=252 Identities=21% Similarity=0.340 Sum_probs=198.4
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC------
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGG------ 415 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~------ 415 (724)
..++|++.+.||+|+||.||+|.+. +++.||||+++.... ...+.+.+|+++|++|+|+||++++++|.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3467999999999999999999975 789999999975433 34567999999999999999999999986643
Q ss_pred ---------------------------------------------------eEEEEEEecCCCCHHHHHhcCCC-CCCCH
Q 040832 416 ---------------------------------------------------KRLLVYEYVPNNNLEFHLHGKGR-PVMDW 443 (724)
Q Consensus 416 ---------------------------------------------------~~~lV~E~~~~gsL~~~L~~~~~-~~l~~ 443 (724)
..++|||||++++|.+++..... ....+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 37999999999999999986432 23566
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC-----------ccccccccCC
Q 040832 444 PTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT-----------HVSTRVMGTF 512 (724)
Q Consensus 444 ~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~-----------~~~~~~~gt~ 512 (724)
..+++|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++....... .......|+.
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 77899999999999999999 999999999999999999999999999987765432 1123356999
Q ss_pred CcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHH
Q 040832 513 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEM 592 (724)
Q Consensus 513 ~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~ 592 (724)
.|+|||++.+..++.++|||||||+||||++|..++... . .+.. .+....+... .....
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~---~-~~~~--------~~~~~~~~~~---------~~~~~ 299 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER---V-RIIT--------DVRNLKFPLL---------FTQKY 299 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH---H-HHHH--------HHHTTCCCHH---------HHHHC
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH---H-HHHH--------HhhccCCCcc---------cccCC
Confidence 999999999999999999999999999999987654210 0 0000 0001111100 11233
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 593 ARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 593 ~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+.+++.+||+.+|++||++.||+++
T Consensus 300 ~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 300 PQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred hhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 456889999999999999999999974
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=361.39 Aligned_cols=270 Identities=25% Similarity=0.352 Sum_probs=206.6
Q ss_pred CCCcccceeeccCcEEEEEEEc-----CCCcEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC--CeE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-----PNGKEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAG--GKR 417 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-----~~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--~~~ 417 (724)
+.|++.+.||+|+||.||+|.+ .+++.||||+++... ....+.+.+|+++|++++|+||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588999999999999999983 468899999997543 23456799999999999999999999999876 568
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
++||||+++++|.+++..... .+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccc
Confidence 999999999999999965432 389999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCc--cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCCh
Q 040832 498 TDNNTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 498 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~ 575 (724)
...... ......|+..|+|||++.+..++.++|||||||+||||++|+.|+..... ....+..+... ......+
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~-~~~~~~~ 252 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA---LFLKMIGPTHG-QMTVTRL 252 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH---HHHHHHCSCCG-GGHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh---HHhhccCCccc-ccCHHHH
Confidence 654332 23345688889999999999999999999999999999999998643210 00000000000 0000000
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 576 NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 576 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
...+........+......+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 011111111122334456789999999999999999999999999853
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=367.92 Aligned_cols=257 Identities=27% Similarity=0.418 Sum_probs=203.1
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcE----EEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKE----VAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRL 418 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~----vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 418 (724)
.++|++.++||+|+||.||+|.+. +++. ||+|.+.... ....+.+.+|+.++++++|+||++++++|. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 357899999999999999999864 3443 7888876443 223356889999999999999999999986 45679
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
+||||+.+++|.+++.... ..+++..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 91 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 9999999999999997653 2488999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChh
Q 040832 499 DNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 499 ~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
..... ......|+..|+|||++.++.++.++|||||||+||||++ |+.||......+.. .... .+.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~--~~~~--------~~~-- 234 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP--DLLE--------KGE-- 234 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH--HHHH--------TTC--
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH--HHHH--------cCC--
Confidence 54332 2344568889999999999999999999999999999999 99999765322211 1100 000
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
....+......+..++.+||+.+|++||++.+|+++|+....
T Consensus 235 -------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 235 -------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp -------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred -------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 000111122347789999999999999999999999987654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=365.17 Aligned_cols=260 Identities=25% Similarity=0.416 Sum_probs=211.1
Q ss_pred hCCCcccceeeccCcEEEEEEEcC--------CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeC
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP--------NGKEVAVKSLRSGSG-QGEREFKAEVEIISRV-HHRHLVSLVGYCIAG 414 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~--------~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~ 414 (724)
.++|.+++.||+|+||.||+|.+. +++.||||+++.... ...+.+.+|+++|+++ +|+||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 468899999999999999999853 467899999986543 3346799999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEE
Q 040832 415 GKRLLVYEYVPNNNLEFHLHGKGR--------------PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILL 480 (724)
Q Consensus 415 ~~~~lV~E~~~~gsL~~~L~~~~~--------------~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl 480 (724)
+..+|||||+++++|.+++..... ..+++..++.|+.||++||.|||++ +|+|||||++||||
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 999999999999999999986532 2488999999999999999999999 99999999999999
Q ss_pred cCCCCEEEEEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhH
Q 040832 481 DYTFETKVADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCL 558 (724)
Q Consensus 481 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l 558 (724)
+.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |+.||......+.
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-- 268 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-- 268 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH--
Confidence 99999999999999877554322 2233457788999999998899999999999999999999 9999976532221
Q ss_pred HhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCCc
Q 040832 559 VDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSL 626 (724)
Q Consensus 559 ~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~~ 626 (724)
..... .+. ....+......+.+++.+||+.+|++||++.||++.|+..+.+
T Consensus 269 ~~~~~--------~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 269 FKLLK--------EGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp HHHHH--------HTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHh--------cCC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 11100 000 0011122335688999999999999999999999999976543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=364.55 Aligned_cols=254 Identities=22% Similarity=0.349 Sum_probs=203.5
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC-----CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG-----SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRL 418 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~-----~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 418 (724)
.+.|++.+.||+|+||.||+|... +++.||||+++.. .....+.|.+|+.+|++|+|+||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 456999999999999999999854 6899999998532 1224567999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCC---EEEEEecc
Q 040832 419 LVYEYVPNNNLEFHLHGK--GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFE---TKVADFGL 493 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~---vkL~DFGl 493 (724)
||||||++++|.+++... ....+++..++.|+.||++||+|||++ +|+||||||+||||+.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998877542 233589999999999999999999999 9999999999999976554 99999999
Q ss_pred ccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCC
Q 040832 494 AKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDG 573 (724)
Q Consensus 494 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~ 573 (724)
++....... ......||..|+|||++.+..++.++|||||||+||||++|+.||.... +..+.... .+
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~i~---------~~ 247 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGII---------KG 247 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--HHHHHHHH---------HT
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--HHHHHHHH---------cC
Confidence 987765432 2334579999999999999999999999999999999999999997642 11111110 01
Q ss_pred ChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 574 NFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 574 ~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+. ........ ....+.+++.+||+.||++||++.|++++
T Consensus 248 ~~~--~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 248 KYK--MNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp CCC--CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCC--CCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 00000011 13467889999999999999999999863
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=372.80 Aligned_cols=250 Identities=22% Similarity=0.339 Sum_probs=199.1
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc---hhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG---QGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~---~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~l 419 (724)
.++|++.++||+|+||.||++++. +++.||||+++.... ...+.+..|+.+|.++ +|+||+++++++.+.+..+|
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999965 578899999975422 2224588999999887 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
||||+.+|+|..++...+. +++..++.|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 9999999999999986543 89999999999999999999999 999999999999999999999999999986433
Q ss_pred CCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 500 NNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 500 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
... .....+||..|+|||++.+..++.++|||||||+||||++|+.||+.....+..... ....+.
T Consensus 206 ~~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~-------------~~~~~~ 271 (396)
T 4dc2_A 206 PGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN-------------TEDYLF 271 (396)
T ss_dssp TTC-CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------C-------------CHHHHH
T ss_pred CCC-ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchh-------------hHHHHH
Confidence 222 234467999999999999999999999999999999999999999653221110000 000000
Q ss_pred chhhh--cCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 040832 580 DPYLE--KNYPTEEMARMVACAAASIRHSARRRPKI 613 (724)
Q Consensus 580 d~~l~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 613 (724)
...+. ..++......+..++.+||+.+|++|+++
T Consensus 272 ~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 272 QVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 00000 11223344568899999999999999985
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=353.69 Aligned_cols=252 Identities=33% Similarity=0.563 Sum_probs=203.6
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhH-------HHHHHHHHHHHhcCCCCeeEEeeEEEeCCe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGE-------REFKAEVEIISRVHHRHLVSLVGYCIAGGK 416 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~-------~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 416 (724)
.++|++.+.||+|+||.||+|.+ .+++.||||++........ +.|.+|++++++++|+||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46799999999999999999996 4788999999865432211 57899999999999999999999987655
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCccEEEcCCCC-----EEEE
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR--IIHRDIKSSNILLDYTFE-----TKVA 489 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~--iiHrDIkp~NILl~~~~~-----vkL~ 489 (724)
++||||+.+++|.+++.... ..+++..++.|+.||++||+|||++ + |+||||||+||||+.++. +||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred -eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 79999999999988887654 3589999999999999999999998 8 999999999999988776 9999
Q ss_pred EeccccccCCCCCccccccccCCCcCCcchh--cCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhh
Q 040832 490 DFGLAKLTTDNNTHVSTRVMGTFGYLAPEYA--SSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCL 567 (724)
Q Consensus 490 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~--~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~ 567 (724)
|||+++..... .....|+..|+|||++ ....++.++|||||||+||||++|+.||.................
T Consensus 172 Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-- 245 (287)
T 4f0f_A 172 DFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE-- 245 (287)
T ss_dssp CCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS--
T ss_pred CCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc--
Confidence 99999855432 2345689999999998 445678999999999999999999999976543332221111100
Q ss_pred hcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 568 RALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 568 ~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
.+....+......+.+++.+||+.+|++||++.||++.|+.
T Consensus 246 --------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 246 --------------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp --------------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred --------------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 00011222334568899999999999999999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=367.00 Aligned_cols=253 Identities=23% Similarity=0.289 Sum_probs=192.0
Q ss_pred HhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
...++|.+.+.||+|+||.||+|.+. +++.||||+++... ..+.+.+|+++|++|+|+||+++++++.+.+..+|||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 34678999999999999999999975 47889999998642 3456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC---CCCEEEEEeccccccC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY---TFETKVADFGLAKLTT 498 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~---~~~vkL~DFGla~~~~ 498 (724)
||+++++|.+++...+. +++.+++.|+.||++||.|||++ +|+|||||++||||+. ++.+||+|||+++...
T Consensus 128 e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKGY--YSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCCSCBHHHHHTTCSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EeCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 99999999999976543 89999999999999999999999 9999999999999975 8899999999998765
Q ss_pred CCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhh
Q 040832 499 DNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEI 578 (724)
Q Consensus 499 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 578 (724)
... ......|+..|+|||++.+..++.++|||||||+||||++|+.||......+..+..+.. ..+. .
T Consensus 203 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~---------~~~~-~ 270 (349)
T 2w4o_A 203 HQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN---------CEYY-F 270 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHT---------TCCC-C
T ss_pred ccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHh---------CCCc-c
Confidence 432 223456999999999999999999999999999999999999999765433222111110 0000 0
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 579 ADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 579 vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.. .+..+....+.+++.+||+.||++||++.|++++
T Consensus 271 ~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 271 IS-----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CT-----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CC-----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0111223467899999999999999999999873
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=351.91 Aligned_cols=259 Identities=18% Similarity=0.208 Sum_probs=209.6
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+.+++++ +|+||+++++++.++...++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999995 578999999987542 234688999999999 79999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCC-----EEEEEecccccc
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFE-----TKVADFGLAKLT 497 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~-----vkL~DFGla~~~ 497 (724)
|+ +++|.+++...+. .+++..++.|+.||++||+|||++ +|+||||||+||||+.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 9999999986543 489999999999999999999998 9999999999999987766 999999999877
Q ss_pred CCCCCc------cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhh--hHHhhhhhhhhhc
Q 040832 498 TDNNTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMED--CLVDWARPLCLRA 569 (724)
Q Consensus 498 ~~~~~~------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~--~l~~w~~~~~~~~ 569 (724)
...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||........ .+.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---- 237 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK---- 237 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH----
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc----
Confidence 654321 22446799999999999999999999999999999999999999976532211 111110000
Q ss_pred ccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 570 LDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 570 ~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
...... .+... ....+.+++.+||+.+|++||++.+|++.|+..+
T Consensus 238 -~~~~~~-----~~~~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 238 -QSTPLR-----ELCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp -HHSCHH-----HHTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred -cCccHH-----HHHhh----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 000000 01111 2356889999999999999999999999998654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=366.26 Aligned_cols=266 Identities=23% Similarity=0.407 Sum_probs=214.9
Q ss_pred HHHHHHhhCCCcccceeeccCcEEEEEEEcC------CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeE
Q 040832 338 YEELSAATGGFSQSNLLGQGGFGYVHKGVLP------NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGY 410 (724)
Q Consensus 338 ~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~ 410 (724)
.++++...++|.+.+.||+|+||.||+|.+. .++.||||++..... .....|.+|+.+|++++|+||++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 3444556788999999999999999999864 367899999976533 334569999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC
Q 040832 411 CIAGGKRLLVYEYVPNNNLEFHLHGKG--------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY 482 (724)
Q Consensus 411 ~~~~~~~~lV~E~~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~ 482 (724)
+.+.+..++||||+.+++|.+++.... ...+++..+++|+.||++||.|||++ +|+|||||++||||+.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 173 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcC
Confidence 999999999999999999999987521 23478999999999999999999999 9999999999999999
Q ss_pred CCCEEEEEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHh
Q 040832 483 TFETKVADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVD 560 (724)
Q Consensus 483 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~ 560 (724)
++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |+.||......+. ..
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~ 251 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV--LR 251 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH--HH
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH--HH
Confidence 999999999999866543222 2234467889999999999999999999999999999999 8999976532221 11
Q ss_pred hhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 561 WARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 561 w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
.. ..+.+. .........+.+++.+||+.+|++||++.||+++|+..+.
T Consensus 252 ~~--------~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 252 FV--------MEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HH--------HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HH--------HcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 10 011110 1112233568889999999999999999999999997654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=361.98 Aligned_cols=269 Identities=26% Similarity=0.390 Sum_probs=217.2
Q ss_pred ccCHHHHHHhhCCCcccceeeccCcEEEEEEEc------CCCcEEEEEEeccCCch-hHHHHHHHHHHHHhc-CCCCeeE
Q 040832 335 AFTYEELSAATGGFSQSNLLGQGGFGYVHKGVL------PNGKEVAVKSLRSGSGQ-GEREFKAEVEIISRV-HHRHLVS 406 (724)
Q Consensus 335 ~f~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l-~HpnIv~ 406 (724)
.+...++....++|.+.+.||+|+||.||+|.+ .+++.||||+++..... ..+.+.+|+.+|+++ +|+||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 345566667788999999999999999999973 35678999999865443 345799999999999 7999999
Q ss_pred EeeEEEeCC-eEEEEEEecCCCCHHHHHhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 040832 407 LVGYCIAGG-KRLLVYEYVPNNNLEFHLHGKGR--------------PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHR 471 (724)
Q Consensus 407 l~g~~~~~~-~~~lV~E~~~~gsL~~~L~~~~~--------------~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHr 471 (724)
+++++...+ ..++||||+.+++|.+++..... ..+++..++.|+.||++||.|||++ +|+||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence 999988755 58999999999999999986543 2278999999999999999999999 99999
Q ss_pred CCCCccEEEcCCCCEEEEEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCC
Q 040832 472 DIKSSNILLDYTFETKVADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPID 549 (724)
Q Consensus 472 DIkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~ 549 (724)
||||+||||+.++.+||+|||+++........ ......|+..|+|||++.+..++.++|||||||+||||++ |+.||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 99999999999999999999999876544332 2334568899999999999999999999999999999998 999997
Q ss_pred CCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 550 PTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 550 ~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
.....+.....+.. +.. ...+......+.+++.+||+.+|.+||++.||+++|+..+
T Consensus 253 ~~~~~~~~~~~~~~---------~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 253 GVKIDEEFCRRLKE---------GTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp TCCCSHHHHHHHHH---------TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchhHHHHHHhcc---------Ccc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 65433222111111 000 0111122346888999999999999999999999998654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=356.73 Aligned_cols=267 Identities=24% Similarity=0.302 Sum_probs=202.9
Q ss_pred hhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCC-----chhHHHHHHHHHHHHhcC---CCCeeEEeeEEEeC
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGS-----GQGEREFKAEVEIISRVH---HRHLVSLVGYCIAG 414 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~-----~~~~~~f~~Ei~il~~l~---HpnIv~l~g~~~~~ 414 (724)
..++|++.+.||+|+||.||+|.+ .+++.||||+++... ......+.+|+++++++. |+||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999995 468899999986422 112346777888777764 99999999999876
Q ss_pred C-----eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEE
Q 040832 415 G-----KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVA 489 (724)
Q Consensus 415 ~-----~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~ 489 (724)
. ..++||||+. ++|.+++.......+++..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence 5 5789999997 5999999877666699999999999999999999999 99999999999999999999999
Q ss_pred EeccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhc
Q 040832 490 DFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRA 569 (724)
Q Consensus 490 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~ 569 (724)
|||+++....... .....||..|+|||++.+..++.++|||||||+||||++|+.||......+... .....+..
T Consensus 163 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~i~~~~~~-- 237 (308)
T 3g33_A 163 DFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG-KIFDLIGL-- 237 (308)
T ss_dssp SCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHH-HHHHHHCC--
T ss_pred eCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCC--
Confidence 9999987654332 244679999999999999999999999999999999999999998764433211 11110000
Q ss_pred ccCCChhh---hcchhhhc-------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 570 LDDGNFNE---IADPYLEK-------NYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 570 ~~~~~~~~---~vd~~l~~-------~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.....+.. +.+..+.. ....+....+.+++.+||+.||++||++.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00000000 00000000 0011223567889999999999999999999873
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=370.65 Aligned_cols=253 Identities=21% Similarity=0.324 Sum_probs=208.0
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
.++|.+.+.||+|+||.||+|.+. +++.||+|++..........+.+|+++|++|+|+||+++++++.+....+|||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999864 6889999999876555566899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC--CCCEEEEEeccccccCCCC
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY--TFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~--~~~vkL~DFGla~~~~~~~ 501 (724)
+.+++|.+++...+ ..+++..++.|+.||++||+|||++ +|+||||||+||||+. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 130 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999987643 2489999999999999999999999 9999999999999974 5789999999998775543
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
. .....||..|+|||++.+..++.++|||||||+||||++|+.||......+. +..... ..+. .+
T Consensus 206 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-~~~i~~---------~~~~--~~- 270 (387)
T 1kob_A 206 I--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-LQNVKR---------CDWE--FD- 270 (387)
T ss_dssp C--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHH---------CCCC--CC-
T ss_pred c--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH-HHHHHh---------CCCC--CC-
Confidence 2 2334699999999999999999999999999999999999999976543221 111100 0000 00
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..........+.+++.+||+.+|++||++.||+++
T Consensus 271 ---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 271 ---EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ---SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00111223467899999999999999999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=359.71 Aligned_cols=267 Identities=23% Similarity=0.323 Sum_probs=211.6
Q ss_pred HHHHhhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHh--cCCCCeeEEeeEEEeCC--
Q 040832 340 ELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISR--VHHRHLVSLVGYCIAGG-- 415 (724)
Q Consensus 340 el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~--l~HpnIv~l~g~~~~~~-- 415 (724)
.-....++|.+.+.||+|+||.||+|.+ +++.||||++.. ...+.+.+|++++.. ++|+||+++++++....
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 3344567899999999999999999998 589999999964 345678899999988 68999999999998876
Q ss_pred --eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCccEEEcCCCC
Q 040832 416 --KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLH--------EDCHPRIIHRDIKSSNILLDYTFE 485 (724)
Q Consensus 416 --~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH--------s~~~~~iiHrDIkp~NILl~~~~~ 485 (724)
..++||||+.+++|.+++... .+++..+++|+.||++||.||| +. +|+||||||+||||+.++.
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSC
T ss_pred cceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCC
Confidence 789999999999999999764 3899999999999999999999 66 9999999999999999999
Q ss_pred EEEEEeccccccCCCCCc---cccccccCCCcCCcchhcCCC------CChhHHHHHHHHHHHHHHhC----------CC
Q 040832 486 TKVADFGLAKLTTDNNTH---VSTRVMGTFGYLAPEYASSGK------LTEKSDVFSFGVMLLELITG----------RR 546 (724)
Q Consensus 486 vkL~DFGla~~~~~~~~~---~~~~~~gt~~y~APE~~~~~~------~t~ksDV~SlGvlL~eLltG----------~~ 546 (724)
+||+|||+++........ ......|+..|+|||++.+.. ++.++|||||||+||||++| +.
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 999999999877654432 123457999999999997652 33789999999999999999 77
Q ss_pred CCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 547 PIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 547 P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
||............+....... .+...+.. .....+....+.+++.+||+.+|++||++.||+++|+...
T Consensus 266 p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 266 PYYDLVPSDPSVEEMRKVVCEQ-----KLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTS-----CCCCCCCG---GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred CccccCcCcccHHHHHHHHHHH-----HhCCCCcc---cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 7765432222222222211111 00000000 0123467788999999999999999999999999998653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=362.11 Aligned_cols=245 Identities=24% Similarity=0.292 Sum_probs=193.5
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc--hhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG--QGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|++.++||+|+||.||+|.+. +++.||||++..... .....+..|+..+.++ +|+||++++++|.+++..+|||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999975 689999999865432 2333456666666665 8999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+ +++|.+++...+ ..+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 137 e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp ECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred ecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 999 678888876643 2489999999999999999999999 99999999999999999999999999998765432
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
. .....||.+|+|||++.+ .++.++|||||||+||||++|..++..... |.. +..+.+ ..
T Consensus 212 ~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-------~~~------~~~~~~----~~ 271 (311)
T 3p1a_A 212 A--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-------WQQ------LRQGYL----PP 271 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-------HHH------HTTTCC----CH
T ss_pred C--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHH------HhccCC----Cc
Confidence 2 234569999999998875 799999999999999999999777643211 110 011111 11
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+.. .....+.+++.+||+.+|++||++.||+++
T Consensus 272 ~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 272 EFTA----GLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccc----CCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 1111 123568899999999999999999999873
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=372.55 Aligned_cols=250 Identities=22% Similarity=0.330 Sum_probs=198.7
Q ss_pred CCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCC--chhHHHHHHHHHHHHhcC--CCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGS--GQGEREFKAEVEIISRVH--HRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~--HpnIv~l~g~~~~~~~~~lV~ 421 (724)
+.|.+.+.||+|+||.||++.+.+++.||||++.... ....+.|.+|+.+|++|. |+||+++++++..++..+|||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4599999999999999999998889999999987543 234467999999999996 599999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
| +.+++|.++|.... .+++..++.|+.||++||.|||++ +|+||||||+||||+ ++.+||+|||+++......
T Consensus 136 E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 56889999998765 488999999999999999999998 999999999999995 5799999999998775433
Q ss_pred Cc-cccccccCCCcCCcchhcC-----------CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhc
Q 040832 502 TH-VSTRVMGTFGYLAPEYASS-----------GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRA 569 (724)
Q Consensus 502 ~~-~~~~~~gt~~y~APE~~~~-----------~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~ 569 (724)
.. ......||..|+|||++.. ..++.++|||||||+||||++|+.||.........+....
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~------- 281 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII------- 281 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH-------
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh-------
Confidence 22 2345679999999999865 4689999999999999999999999976432221111111
Q ss_pred ccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 570 LDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 570 ~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+......++......+.+++.+||+.+|++||++.||+++
T Consensus 282 ----------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 ----------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ----------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----------CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1111111111123467889999999999999999999975
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=362.71 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=195.4
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCch---hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC----e
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQ---GEREFKAEVEIISRVHHRHLVSLVGYCIAGG----K 416 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~---~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~----~ 416 (724)
.++|++.++||+|+||.||+|.+ .+++.||||+++..... ....|.+|++++++++|+||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999995 57889999999765332 2356899999999999999999999987654 3
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
.+|||||+++++|.++++..+. +++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 4999999999999999986543 89999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc--cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCC
Q 040832 497 TTDNNTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGN 574 (724)
Q Consensus 497 ~~~~~~~--~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~ 574 (724)
....... ......|+..|+|||++.+..++.++|||||||+||||++|+.||......+....... ...
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~---------~~~ 236 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR---------EDP 236 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH---------CCC
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc---------CCC
Confidence 6543322 22345699999999999999999999999999999999999999976543322111100 000
Q ss_pred hhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 575 FNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 575 ~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
.. ...... .....+.+++.+||+.+|++||+..++++
T Consensus 237 ~~---~~~~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 237 IP---PSARHE----GLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp CC---HHHHST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CC---cccccC----CCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 00 000001 12345788999999999999998776664
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=378.26 Aligned_cols=262 Identities=21% Similarity=0.250 Sum_probs=211.0
Q ss_pred cCHHHHHHhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCeeEEeeEE
Q 040832 336 FTYEELSAATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG---QGEREFKAEVEIISRVHHRHLVSLVGYC 411 (724)
Q Consensus 336 f~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~---~~~~~f~~Ei~il~~l~HpnIv~l~g~~ 411 (724)
+.++++....++|++.++||+|+||.||+++.+ +++.||||+++.... ...+.+.+|+++|.+++|+||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 456777778899999999999999999999964 689999999964211 1123488999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEe
Q 040832 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADF 491 (724)
Q Consensus 412 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DF 491 (724)
.+.+..||||||+.+|+|..+|...+ ..+++..++.|+.||+.||+|||++ +||||||||+||||+.++++||+||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999997643 2489999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCccccccccCCCcCCcchhc-------CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhh--HHhhh
Q 040832 492 GLAKLTTDNNTHVSTRVMGTFGYLAPEYAS-------SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC--LVDWA 562 (724)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~-------~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~--l~~w~ 562 (724)
|+++.............+||..|+|||++. .+.++.++|||||||+||||++|+.||......+.. +..+.
T Consensus 207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 286 (412)
T 2vd5_A 207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK 286 (412)
T ss_dssp TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 999887655443334567999999999987 457899999999999999999999999765433221 11111
Q ss_pred hhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCC---CCHHHHHHH
Q 040832 563 RPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRR---PKISQIVRA 619 (724)
Q Consensus 563 ~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~R---Ps~~evv~~ 619 (724)
..+ ..+.+ .......+.+++.+||. +|++| +++.||+++
T Consensus 287 ~~~-------------~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 287 EHL-------------SLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHC-------------CCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred cCc-------------CCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 000 00111 11223467889999998 89988 589998764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=364.60 Aligned_cols=265 Identities=18% Similarity=0.241 Sum_probs=201.0
Q ss_pred hCCCcccceeeccCcEEEEEEEcC----CCcEEEEEEeccCCchh-----------HHHHHHHHHHHHhcCCCCeeEEee
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP----NGKEVAVKSLRSGSGQG-----------EREFKAEVEIISRVHHRHLVSLVG 409 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vaVK~l~~~~~~~-----------~~~f~~Ei~il~~l~HpnIv~l~g 409 (724)
.++|.+.+.||+|+||.||+|.+. .+..||||++....... .+.+.+|+.+++.++|+||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999975 56789999987654321 123667889999999999999999
Q ss_pred EEEe----CCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC-
Q 040832 410 YCIA----GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF- 484 (724)
Q Consensus 410 ~~~~----~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~- 484 (724)
++.. ....+|||||+ +++|.+++...+ .+++..++.|+.||++||+|||++ +|+||||||+||||+.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSST
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCC
Confidence 9988 67889999999 999999998655 489999999999999999999999 999999999999998877
Q ss_pred -CEEEEEeccccccCCCCCc------cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhh
Q 040832 485 -ETKVADFGLAKLTTDNNTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC 557 (724)
Q Consensus 485 -~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~ 557 (724)
.+||+|||+++........ ......|+..|+|||++.+..++.++|||||||+||||++|+.||.........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 9999999999876432211 123457999999999999999999999999999999999999999643211111
Q ss_pred HHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 558 LVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 558 l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
+........ ..+...+...+ ........+.+++.+||+.+|++||++.+|++.|+...
T Consensus 270 ~~~~~~~~~------~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 270 VQTAKTNLL------DELPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHH------HTTTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHHhhc------ccccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 111111000 00011111110 01123346889999999999999999999999998643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=359.86 Aligned_cols=265 Identities=22% Similarity=0.304 Sum_probs=191.5
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
.++|++.+.||+|+||.||+|.+. +++.||||+++..... ..+.+.+|+++|++++|+||+++++++.+++..+||||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467899999999999999999864 5889999999755322 34678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 423 YVPNNNLEFHLHGK----GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 423 ~~~~gsL~~~L~~~----~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
|++ ++|.+++... ....+++..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5888887642 223488999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhh------h----
Q 040832 499 DNNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLC------L---- 567 (724)
Q Consensus 499 ~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~------~---- 567 (724)
..... .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||......+.. ......+. .
T Consensus 160 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPVNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL-KLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCCCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCSCCTTTCGGGG
T ss_pred CCccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCChhHhhhhh
Confidence 43222 234568999999999976 46899999999999999999999999876433221 11100000 0
Q ss_pred --hcc-------cCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 568 --RAL-------DDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 568 --~~~-------~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+ ....+.+.+.... .......+.+++.+||+.||++||++.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHT----KEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGC----SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccchhHHHhhcccc----cccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000 0001111111111 11223468899999999999999999999863
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=353.56 Aligned_cols=258 Identities=24% Similarity=0.344 Sum_probs=204.1
Q ss_pred hhCCCcccceeeccCcEEEEEEEcCC----CcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLPN----GKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRL 418 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~~----g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 418 (724)
..++|.+.++||+|+||.||+|.+.+ +..||||.++.... ...+.|.+|+.+|++++|+||+++++++.++ ..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 34678999999999999999998543 23599999986533 3456799999999999999999999998654 568
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
+||||+.+++|.+++.... ..+++..++.|+.||++||.|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 9999999999999997643 2489999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 499 DNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 499 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
...........++..|+|||.+.+..++.++||||||++||||++ |+.||......+.. .... .+..
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~--~~~~--------~~~~-- 232 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI--GVLE--------KGDR-- 232 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH--HHHH--------HTCC--
T ss_pred cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH--HHHh--------cCCC--
Confidence 544333344557889999999998999999999999999999998 99999754332211 0000 0000
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
...+......+.+++.+||+.+|++||++.||+++|+....
T Consensus 233 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 233 -------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 00111223458899999999999999999999999986543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=367.07 Aligned_cols=253 Identities=21% Similarity=0.268 Sum_probs=194.1
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
.++|.+.+.||+|+||.||++... +++.||||++..... ..+.+++|+.++++++|+||+++++++.+.+..+|||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467999999999999999999965 688999999976433 235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCC--EEEEEeccccccCCCC
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFE--TKVADFGLAKLTTDNN 501 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~--vkL~DFGla~~~~~~~ 501 (724)
+.+++|.+++...+. +++..++.|+.||++||+|||++ +|+||||||+||||+.++. +||+|||+++......
T Consensus 98 ~~~~~L~~~l~~~~~--~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 98 ASGGELYERICNAGR--FSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp CCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 999999999976544 89999999999999999999999 9999999999999987765 9999999998543322
Q ss_pred CccccccccCCCcCCcchhcCCCCChh-HHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEK-SDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~k-sDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
......||..|+|||++.+..+..+ +|||||||+||||++|+.||............... ..... ..+
T Consensus 173 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~-~~~~~---~~~----- 241 (361)
T 3uc3_A 173 --QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR-ILSVK---YSI----- 241 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHH-HHTTC---CCC-----
T ss_pred --CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHH-HhcCC---CCC-----
Confidence 1234569999999999988887755 89999999999999999999765332211111110 00000 000
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.........+.+++.+||+.+|++||++.||+++
T Consensus 242 -----~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 242 -----PDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -----CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -----CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0001123567899999999999999999999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=370.63 Aligned_cols=250 Identities=24% Similarity=0.322 Sum_probs=191.9
Q ss_pred CCCccc-ceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHh-cCCCCeeEEeeEEEe----CCeEE
Q 040832 346 GGFSQS-NLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISR-VHHRHLVSLVGYCIA----GGKRL 418 (724)
Q Consensus 346 ~~f~~~-~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~-l~HpnIv~l~g~~~~----~~~~~ 418 (724)
++|.+. ++||+|+||.||++.+. +++.||||+++. ...+.+|++++.+ ++|+||+++++++.. .+..|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 78999999999999864 588999999963 2457788888755 489999999999876 56789
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC---CCCEEEEEecccc
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY---TFETKVADFGLAK 495 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~---~~~vkL~DFGla~ 495 (724)
||||||++|+|.++|...+...+++..++.|+.||++||.|||++ +|||||||++||||+. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 999999999999999887666799999999999999999999998 9999999999999987 7899999999998
Q ss_pred ccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhh--HHhhhhhhhhhcccCC
Q 040832 496 LTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC--LVDWARPLCLRALDDG 573 (724)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~--l~~w~~~~~~~~~~~~ 573 (724)
....... ....+||..|+|||++.+..++.++|||||||+||||++|+.||......... +... +..+
T Consensus 213 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--------i~~~ 282 (400)
T 1nxk_A 213 ETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR--------IRMG 282 (400)
T ss_dssp ECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH--------HHHT
T ss_pred ccCCCCc--cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH--------HHcC
Confidence 7654322 23467899999999999999999999999999999999999999765322110 0000 0001
Q ss_pred ChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 574 NFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 574 ~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+. +... ........+.+++.+||+.+|++||++.||+++
T Consensus 283 ~~~-~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 283 QYE-FPNP-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCC-CCTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccc-CCCc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 0000 001223467899999999999999999999985
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=365.43 Aligned_cols=245 Identities=24% Similarity=0.306 Sum_probs=204.8
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|.+.+.||+|+||.||++... +|+.||||+++... ....+.+.+|+++|++++|+||+++++++.+.+..+|||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 67999999999999999999964 68999999986431 123457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+.+++|.++|...+. +++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 121 e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~ 195 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp ECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred cCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCCc
Confidence 99999999999987543 89999999999999999999999 99999999999999999999999999998765432
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
....||..|+|||++.+..++.++|||||||+||||++|+.||......+. +..+. .+.+
T Consensus 196 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~i~---------~~~~------ 255 (350)
T 1rdq_E 196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-YEKIV---------SGKV------ 255 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHH---------HCCC------
T ss_pred ----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH-HHHHH---------cCCC------
Confidence 345799999999999999999999999999999999999999976532221 11110 0100
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPK-----ISQIVRA 619 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evv~~ 619 (724)
.++......+.+++.+||+.+|++|++ +.+|+++
T Consensus 256 ----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 256 ----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 111223356889999999999999998 8888763
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=374.83 Aligned_cols=254 Identities=20% Similarity=0.269 Sum_probs=205.3
Q ss_pred hhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
..++|.+.+.||+|+||.||++.. .+|+.||+|++..... ...+.+.+|+++|++|+|+||+++++++.+++..+||
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 456799999999999999999985 4688999999976432 2345689999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEc---CCCCEEEEEecccccc
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLD---YTFETKVADFGLAKLT 497 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~---~~~~vkL~DFGla~~~ 497 (724)
||||.+|+|.+++...+. +++..++.|+.||++||.|||++ +|+||||||+||||+ .++.+||+|||+++..
T Consensus 89 ~E~~~gg~L~~~i~~~~~--~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp ECCCBCCBHHHHHHHCSC--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 999999999999887654 89999999999999999999999 999999999999998 4678999999999877
Q ss_pred CCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 498 TDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 498 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
...... .....||..|+|||++.+..++.++|||||||+||||++|+.||......+. +... ..+.+..
T Consensus 164 ~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~-~~~i---------~~~~~~~ 232 (444)
T 3soa_A 164 EGEQQA-WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL-YQQI---------KAGAYDF 232 (444)
T ss_dssp CTTCCB-CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHH---------HHTCCCC
T ss_pred cCCCce-eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH-HHHH---------HhCCCCC
Confidence 554322 2346799999999999999999999999999999999999999976532221 1111 0111000
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+. -......+.+++.+||+.||++||++.|++++
T Consensus 233 -~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 -PSPE-----WDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -CTTT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -Cccc-----cccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000 01123457889999999999999999999874
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=369.50 Aligned_cols=249 Identities=26% Similarity=0.341 Sum_probs=203.5
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
.++|.+.++||+|+||.||++... +++.||||++... .....+.+.+|+++|++++|+||++++++|.+.+..+||
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367899999999999999999854 5788999998643 122346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+.+|+|..++..... +++..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 94 ~e~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVH--FKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp ECCCTTEEHHHHHHTTCC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 999999999999987544 89999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCccccccccCCCcCCcchhcC---CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhh-hHHhhhhhhhhhcccCCChh
Q 040832 501 NTHVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMED-CLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~---~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~-~l~~w~~~~~~~~~~~~~~~ 576 (724)
.. .....||..|+|||++.. ..++.++|||||||+||||++|+.||........ .+...... .
T Consensus 169 ~~--~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--------~--- 235 (384)
T 4fr4_A 169 TQ--ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET--------T--- 235 (384)
T ss_dssp CC--BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH--------C---
T ss_pred Cc--eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh--------c---
Confidence 32 244679999999999864 4589999999999999999999999975432211 11111000 0
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPK-ISQIVR 618 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~evv~ 618 (724)
...++......+..++.+||+.+|++|++ +.+|.+
T Consensus 236 -------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 -------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 01122233456889999999999999998 677664
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=363.38 Aligned_cols=257 Identities=27% Similarity=0.407 Sum_probs=200.6
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcE----EEEEEeccC-CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKE----VAVKSLRSG-SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRL 418 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~----vaVK~l~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 418 (724)
.++|++.++||+|+||.||+|.+. +++. |++|.++.. .....+.|.+|+.+|++++|+||++++++|..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467999999999999999999854 3443 578877644 3345678999999999999999999999998765 78
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
+||||+.+++|.+++..... .+++..++.|+.||++||.|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 99999999999999986543 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChh
Q 040832 499 DNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 499 ~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
..... ......++..|+|||++.+..++.++|||||||+||||++ |+.||+.....+.. ... ..+.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~--~~~--------~~~~-- 236 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--SIL--------EKGE-- 236 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH--HHH--------HTTC--
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH--HHH--------HcCC--
Confidence 43322 2233456788999999999999999999999999999999 99999765433211 110 0000
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
....+......+.+++.+||+.+|++||++.||++.|+....
T Consensus 237 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 237 -------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred -------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 001112233468889999999999999999999999987653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=363.88 Aligned_cols=260 Identities=26% Similarity=0.383 Sum_probs=209.9
Q ss_pred hhCCCcccceeeccCcEEEEEEEcCC------CcEEEEEEeccCCch-hHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCC
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLPN------GKEVAVKSLRSGSGQ-GEREFKAEVEIISRV-HHRHLVSLVGYCIAGG 415 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~~------g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~ 415 (724)
..++|.+.+.||+|+||.||+|.+.. .+.||||.++..... ..+.+.+|+.+|+++ +|+||+++++++.+.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 35789999999999999999998542 247999999865433 345799999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCC
Q 040832 416 KRLLVYEYVPNNNLEFHLHGKG------------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYT 483 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~~------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~ 483 (724)
..+|||||+++|+|.+++.... ...+++..++.|+.||+.||+|||++ +|+||||||+||||+.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCC
Confidence 9999999999999999987532 23478999999999999999999999 99999999999999999
Q ss_pred CCEEEEEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhh
Q 040832 484 FETKVADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDW 561 (724)
Q Consensus 484 ~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w 561 (724)
+.+||+|||+++........ ......|+..|+|||++.+..++.++|||||||+||||++ |+.||.......... ..
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~-~~ 279 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY-KL 279 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH-HH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH-HH
Confidence 99999999999876543322 2334567889999999999999999999999999999999 999997653222111 11
Q ss_pred hhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 562 ARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 562 ~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
.. . ......+......+.+++.+||+.+|.+||++.||+++|+...
T Consensus 280 ~~----~-------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 280 VK----D-------------GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HH----H-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Hh----c-------------CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 00 0 0000111122356888999999999999999999999998643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=367.03 Aligned_cols=251 Identities=25% Similarity=0.343 Sum_probs=204.1
Q ss_pred HHhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCe
Q 040832 342 SAATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGK 416 (724)
Q Consensus 342 ~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 416 (724)
....++|.+.++||+|+||.||+|.++ +++.||||+++... ....+.+..|..+|..+ +|+||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 445688999999999999999999965 58899999997531 22345688899999987 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
.+|||||+.+|+|.+++...+. +++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 9999999999999999986543 89999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChh
Q 040832 497 TTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 497 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
...... .....+||..|+|||++.+..++.++|||||||+||||++|+.||......+.. ... . .+.
T Consensus 168 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-~~i----~-----~~~-- 234 (345)
T 1xjd_A 168 NMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-HSI----R-----MDN-- 234 (345)
T ss_dssp CCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHH----H-----HCC--
T ss_pred cccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHH-HHH----H-----hCC--
Confidence 533222 234467999999999999999999999999999999999999999765432211 000 0 000
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKIS-QIVR 618 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evv~ 618 (724)
..++......+.+++.+||+.+|++|+++. +|++
T Consensus 235 --------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 235 --------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp --------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 011122234678899999999999999997 6653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=362.55 Aligned_cols=251 Identities=22% Similarity=0.340 Sum_probs=199.3
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 420 (724)
++|.+.++||+|+||.||++++. +++.||||+++... ....+.+.+|+.+|+++ +|+||+++++++.+.+..+||
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57899999999999999999965 58899999997542 22345688999999998 899999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+.+|+|..++...+. +++..++.++.||+.||+|||++ +|+||||||+||||+.++++||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 999999999999976543 89999999999999999999999 9999999999999999999999999999864332
Q ss_pred CCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
.. ......||..|+|||++.+..++.++|||||||+||||++|+.||............. ...+...+....
T Consensus 164 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~-~~~~~~~i~~~~------ 235 (345)
T 3a8x_A 164 GD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT-EDYLFQVILEKQ------ 235 (345)
T ss_dssp TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------C-HHHHHHHHHHCC------
T ss_pred CC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccccc-HHHHHHHHHcCC------
Confidence 22 2344679999999999999999999999999999999999999997532111000000 000000000000
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKI 613 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 613 (724)
..++......+.+++.+||+.+|++|+++
T Consensus 236 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 236 ----IRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ----CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 01222334568889999999999999995
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=365.98 Aligned_cols=247 Identities=25% Similarity=0.359 Sum_probs=202.2
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
.++|.+.+.||+|+||.||+|.+ .+++.||||++.... ......+.+|+.+|+.++|+||+++++++...+..+||
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 47899999999999999999995 578899999986431 12235689999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+ +|+|.+++...+. +++..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||++......
T Consensus 88 ~E~~-~g~l~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp ECCC-CEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EECC-CCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 9999 6788888766543 89999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCccccccccCCCcCCcchhcCCCC-ChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~-t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
.. .....|+..|+|||++.+..+ +.++|||||||+||||++|+.||+...... +...+..+.+
T Consensus 162 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~----------~~~~i~~~~~---- 225 (336)
T 3h4j_B 162 NF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN----------LFKKVNSCVY---- 225 (336)
T ss_dssp BT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT----------CBCCCCSSCC----
T ss_pred cc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH----------HHHHHHcCCC----
Confidence 32 234569999999999987765 789999999999999999999997542111 0011111100
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+......+.+++.+||+.||.+||++.||+++
T Consensus 226 ------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 226 ------VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp ------CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred ------CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1122233567889999999999999999999873
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=364.95 Aligned_cols=271 Identities=23% Similarity=0.378 Sum_probs=200.3
Q ss_pred hCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHH--HhcCCCCeeEEeeEEEe-----CCeE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEII--SRVHHRHLVSLVGYCIA-----GGKR 417 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il--~~l~HpnIv~l~g~~~~-----~~~~ 417 (724)
.++|++.++||+|+||.||+|.+ +++.||||++... ....+..|.+++ ..++|+||+++++++.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46899999999999999999987 6899999999753 344555555554 45899999999986543 2256
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCccEEEcCCCCEEEEEe
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC------HPRIIHRDIKSSNILLDYTFETKVADF 491 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~------~~~iiHrDIkp~NILl~~~~~vkL~DF 491 (724)
+|||||+++|+|.+++.... +++..+++|+.||++||+|||+.+ .++|+||||||+||||+.++.+||+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 89999999999999997654 588999999999999999999863 337999999999999999999999999
Q ss_pred ccccccCCCCC-------ccccccccCCCcCCcchhcC-------CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhh
Q 040832 492 GLAKLTTDNNT-------HVSTRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC 557 (724)
Q Consensus 492 Gla~~~~~~~~-------~~~~~~~gt~~y~APE~~~~-------~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~ 557 (724)
|+++....... .......||..|+|||++.+ ..++.++|||||||+||||++|+.||.........
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 99987654321 11224569999999999976 35667999999999999999998887543222111
Q ss_pred HHhhhhhhhhhcccCCChhhh--------cchhhhc--CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCCc
Q 040832 558 LVDWARPLCLRALDDGNFNEI--------ADPYLEK--NYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSL 626 (724)
Q Consensus 558 l~~w~~~~~~~~~~~~~~~~~--------vd~~l~~--~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~~ 626 (724)
...+.... .....+.++ ..+.+.. .........+.+++.+||+.+|++||++.||++.|+..+..
T Consensus 245 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 245 QMAFQTEV----GNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCTTHHHH----CSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHhhhccc----CCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 11110000 000000000 0000101 11234566799999999999999999999999999976543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=362.34 Aligned_cols=260 Identities=23% Similarity=0.256 Sum_probs=202.1
Q ss_pred HHHhhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccC-----CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC
Q 040832 341 LSAATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSG-----SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAG 414 (724)
Q Consensus 341 l~~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~-----~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 414 (724)
+....++|.+.+.||+|+||.||+|.+ .+++.||||++... .....+.|.+|+++|++++|+||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 445577899999999999999999986 46788999998643 233456799999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcCC--------------------------------------CCCCCHHHHHHHHHHHHHH
Q 040832 415 GKRLLVYEYVPNNNLEFHLHGKG--------------------------------------RPVMDWPTRLKIAMGSAKG 456 (724)
Q Consensus 415 ~~~~lV~E~~~~gsL~~~L~~~~--------------------------------------~~~l~~~~~~~i~~qia~g 456 (724)
+..+|||||+++++|.+++.... ...+++..++.|+.||++|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999885210 1123567788999999999
Q ss_pred HHHHHhcCCCCeEecCCCCccEEEcCCC--CEEEEEeccccccCCCCCc---cccccccCCCcCCcchhcC--CCCChhH
Q 040832 457 LAYLHEDCHPRIIHRDIKSSNILLDYTF--ETKVADFGLAKLTTDNNTH---VSTRVMGTFGYLAPEYASS--GKLTEKS 529 (724)
Q Consensus 457 L~yLHs~~~~~iiHrDIkp~NILl~~~~--~vkL~DFGla~~~~~~~~~---~~~~~~gt~~y~APE~~~~--~~~t~ks 529 (724)
|+|||++ +|+||||||+||||+.++ .+||+|||+++........ ......|+..|+|||++.. ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 999999999999998766 8999999999876432221 2344569999999999975 6789999
Q ss_pred HHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCC
Q 040832 530 DVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARR 609 (724)
Q Consensus 530 DV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~ 609 (724)
|||||||+||||++|+.||......+.....+.... .+. .+.. ......+.+++.+||+.+|++
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~--------~~~---~~~~-----~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKL--------CFE---NPNY-----NVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------CTT---SGGG-----GGSCHHHHHHHHHHSCSCTTT
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhccc--------ccC---Cccc-----ccCCHHHHHHHHHHcCCChhH
Confidence 999999999999999999976643332211111000 000 0000 012345788999999999999
Q ss_pred CCCHHHHHHH
Q 040832 610 RPKISQIVRA 619 (724)
Q Consensus 610 RPs~~evv~~ 619 (724)
||++.|++++
T Consensus 322 Rps~~~~l~h 331 (345)
T 3hko_A 322 RFDAMRALQH 331 (345)
T ss_dssp SCCHHHHHHS
T ss_pred CCCHHHHhcC
Confidence 9999999873
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=366.88 Aligned_cols=248 Identities=23% Similarity=0.317 Sum_probs=198.4
Q ss_pred cccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCCC
Q 040832 349 SQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNN 427 (724)
Q Consensus 349 ~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 427 (724)
...++||+|+||.||+|.+ .+|+.||||+++.......+.|.+|+++|++|+|+||+++++++.+.+..+|||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 3367899999999999985 468999999998766566778999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEE--cCCCCEEEEEeccccccCCCCCccc
Q 040832 428 NLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILL--DYTFETKVADFGLAKLTTDNNTHVS 505 (724)
Q Consensus 428 sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl--~~~~~vkL~DFGla~~~~~~~~~~~ 505 (724)
+|.+++.... ..+++..++.|+.||++||+|||++ +|+||||||+|||| +.++.+||+|||+++........
T Consensus 172 ~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~-- 245 (373)
T 2x4f_A 172 ELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL-- 245 (373)
T ss_dssp EEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC--
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc--
Confidence 9998887543 2489999999999999999999999 99999999999999 56789999999999877544322
Q ss_pred cccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhc
Q 040832 506 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEK 585 (724)
Q Consensus 506 ~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~ 585 (724)
....|+..|+|||++....++.++|||||||+||||++|+.||......+. +..+.. ..+ .+ .... ..
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~i~~----~~~---~~---~~~~-~~ 313 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET-LNNILA----CRW---DL---EDEE-FQ 313 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHH----TCC---CS---CSGG-GT
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHh----ccC---CC---Chhh-hc
Confidence 334699999999999999999999999999999999999999976543221 111111 000 00 0000 01
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 586 NYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
. ....+.+++.+||+.+|++||++.|+++
T Consensus 314 ~----~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 314 D----ISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp T----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c----CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1 2346788999999999999999999997
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=365.15 Aligned_cols=250 Identities=26% Similarity=0.351 Sum_probs=204.2
Q ss_pred hhCCCcccceeeccCcEEEEEEEcCC-CcEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLPN-GKEVAVKSLRSGS---GQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRL 418 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~ 418 (724)
..++|.+.++||+|+||.||+|.... ++.||||+++... ....+.+..|..+|..+ +|+||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 45789999999999999999999754 7889999997531 22345688999999988 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
|||||+.+|+|.++|...+. +++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 98 lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 99999999999999986543 89999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhh
Q 040832 499 DNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEI 578 (724)
Q Consensus 499 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 578 (724)
.... ......||..|+|||++.+..++.++|||||||+||||++|+.||......+. +.. ++. +.
T Consensus 173 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-~~~----i~~-----~~---- 237 (353)
T 2i0e_A 173 WDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-FQS----IME-----HN---- 237 (353)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH----HHH-----CC----
T ss_pred cCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH-HHH----HHh-----CC----
Confidence 3222 23446799999999999999999999999999999999999999976532221 100 000 00
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 040832 579 ADPYLEKNYPTEEMARMVACAAASIRHSARRRPK-----ISQIVRA 619 (724)
Q Consensus 579 vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evv~~ 619 (724)
..++......+.+++.+||+.+|++|++ +.+|+++
T Consensus 238 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 238 ------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0122223456889999999999999995 4676653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=360.97 Aligned_cols=258 Identities=28% Similarity=0.437 Sum_probs=202.4
Q ss_pred hCCCcccceeeccCcEEEEEEEcCC-----CcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPN-----GKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRL 418 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~-----g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 418 (724)
.+.|.+.++||+|+||.||+|.+.. +..||||+++..... ....|.+|+.+|++++|+||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4578889999999999999998643 235999999865433 3457999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
|||||+++++|.+++.... ..+++..++.|+.||++||.|||++ +|+|||||++||||+.++.+||+|||+++...
T Consensus 123 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999997653 2489999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCc--cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCCh
Q 040832 499 DNNTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 499 ~~~~~--~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~ 575 (724)
..... ......++..|+|||++....++.++|||||||+||||++ |+.||......+. ... +..+.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~--~~~--------~~~~~- 267 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV--MKA--------INDGF- 267 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHH--------HHTTC-
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH--HHH--------HHCCC-
Confidence 43322 1222346788999999999999999999999999999999 9999976532211 100 00000
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 576 NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 576 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
....+......+.+++.+||+.+|++||++.+|+++|+..+.
T Consensus 268 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 268 --------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp --------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 001112234568899999999999999999999999986553
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=379.76 Aligned_cols=249 Identities=23% Similarity=0.334 Sum_probs=196.3
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
.++|.+.++||+|+||.||+|.. .+++.||||+++.. .......+.+|+.+|++++|+||++++++|.+.+..+||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999985 46889999999743 223345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHE-DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs-~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
|||+++++|.+++.... .+++..++.|+.||++||+|||+ + +||||||||+||||+.++.+||+|||+++....
T Consensus 227 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp ECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 99999999999997654 38999999999999999999998 7 899999999999999999999999999986543
Q ss_pred CCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 500 NNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 500 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
.... .....||..|+|||++.+..++.++|||||||+||||++|+.||......+.. .. ... ..
T Consensus 302 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~---i~~-----~~----- 365 (446)
T 4ejn_A 302 DGAT-MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF--EL---ILM-----EE----- 365 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HH---HHH-----CC-----
T ss_pred CCcc-cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH--HH---HHh-----CC-----
Confidence 3222 34467999999999999999999999999999999999999999765322211 00 000 00
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRP-----KISQIVRA 619 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evv~~ 619 (724)
..++......+.+++.+||+.||++|| ++.||+++
T Consensus 366 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 366 -----IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 011222335688999999999999999 99999873
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=352.55 Aligned_cols=248 Identities=26% Similarity=0.407 Sum_probs=204.8
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEe---------
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA--------- 413 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~--------- 413 (724)
..++|++.++||+|+||.||+|.+. +++.||||+++... ..+.+|+++|++++|+||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3467999999999999999999975 78999999997643 357789999999999999999998864
Q ss_pred -------CCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCE
Q 040832 414 -------GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFET 486 (724)
Q Consensus 414 -------~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~v 486 (724)
....++||||+++++|.+++.......+++..++.|+.||++||.|||++ +|+|||||++||||+.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCE
Confidence 34578999999999999999765445689999999999999999999999 99999999999999999999
Q ss_pred EEEEeccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhh
Q 040832 487 KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLC 566 (724)
Q Consensus 487 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~ 566 (724)
||+|||+++....... .....|+..|+|||++.+..++.++||||||++||||++|..+|... . .+..
T Consensus 162 kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~----~~~~--- 229 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---S----KFFT--- 229 (284)
T ss_dssp EECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---H----HHHH---
T ss_pred EECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---H----HHHH---
Confidence 9999999987765432 23456899999999999999999999999999999999999886321 0 0000
Q ss_pred hhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 567 LRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 567 ~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
.+..+.+ ...+ ...+.+++.+||+.+|++||++.||+++|+...
T Consensus 230 --~~~~~~~--------~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 230 --DLRDGII--------SDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp --HHHTTCC--------CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred --Hhhcccc--------cccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 0111111 1112 234778999999999999999999999998544
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=353.44 Aligned_cols=269 Identities=19% Similarity=0.261 Sum_probs=200.8
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ--GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~--~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
.++|++.+.||+|+||.||+|.+. +++.||||++...... ..+.+.+|+++|++++|+||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 368999999999999999999965 5899999998655332 2456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+++++|..++..... +++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 82 e~~~~~~l~~~~~~~~~--~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRG--VPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp ECCSEEHHHHHHHTSSC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EeCCCchHHHHHhhhcC--CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 99999999998876543 89999999999999999999999 99999999999999999999999999998765433
Q ss_pred CccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhh--hhhhh---hhcccCCCh
Q 040832 502 THVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDW--ARPLC---LRALDDGNF 575 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w--~~~~~---~~~~~~~~~ 575 (724)
.. .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||......+...... ..... ...+....+
T Consensus 157 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 157 DY-YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred cc-cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 22 234568999999999876 678999999999999999999999998765433221100 00000 000000000
Q ss_pred hhhcc-hhhhcCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 576 NEIAD-PYLEKNYP-----TEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 576 ~~~vd-~~l~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..... +....... ......+.+++.+||+.+|++||++.||+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 00000000 1223457889999999999999999999974
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=347.68 Aligned_cols=251 Identities=22% Similarity=0.251 Sum_probs=205.2
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
..++|++.+.||+|+||.||+|.+. +++.||+|++........+.|.+|+++|++++|+||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3467999999999999999999965 467899999987655667789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEE---cCCCCEEEEEeccccccCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILL---DYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl---~~~~~vkL~DFGla~~~~~ 499 (724)
|+.+++|.+++..... +++..++.|+.||++||+|||++ +|+|||||++|||| +.++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 87 LCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred ccCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 9999999998876543 89999999999999999999999 99999999999999 7889999999999987654
Q ss_pred CCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 500 NNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 500 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
... .....|+..|+|||++.+ .++.++||||||++||||++|+.||......+.. ..+.. +.+..
T Consensus 162 ~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~---------~~~~~-- 226 (277)
T 3f3z_A 162 GKM--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM-LKIRE---------GTFTF-- 226 (277)
T ss_dssp TSC--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHH---------CCCCC--
T ss_pred ccc--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH-HHHHh---------CCCCC--
Confidence 332 234568999999998865 4899999999999999999999999765432211 11100 00000
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
...... .....+.+++.+||+.+|++||++.|+++
T Consensus 227 ~~~~~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 227 PEKDWL----NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred Cchhhh----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 12346888999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=368.12 Aligned_cols=255 Identities=26% Similarity=0.348 Sum_probs=205.3
Q ss_pred hCCCcccceeeccCcEEEEEEEc----CCCcEEEEEEeccCC----chhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCC
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL----PNGKEVAVKSLRSGS----GQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGG 415 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~----~~g~~vaVK~l~~~~----~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~ 415 (724)
.++|.+.++||+|+||.||++.. .+++.||||+++... ....+.+.+|+++|+++ +|+||+++++++..++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36799999999999999999986 468999999986432 12335678899999999 6999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 416 KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
..+|||||+++++|.++|..... +++..++.|+.||++||.|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999999986543 89999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccccccCCCcCCcchhcC--CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCC
Q 040832 496 LTTDNNTHVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDG 573 (724)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~ 573 (724)
..............||..|+|||++.+ ..++.++|||||||+||||++|+.||........ ...+.......
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~----- 281 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKS----- 281 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHC-----
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHHHHHhcc-----
Confidence 765544444455679999999999985 3578999999999999999999999975422111 11111111000
Q ss_pred ChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHH
Q 040832 574 NFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRP-----KISQIVRAL 620 (724)
Q Consensus 574 ~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evv~~L 620 (724)
...++.+....+.+++.+||..+|++|| ++.||+++.
T Consensus 282 ----------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 ----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ----------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0112233345688999999999999999 999998865
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=376.92 Aligned_cols=264 Identities=20% Similarity=0.243 Sum_probs=197.5
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC------C
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAG------G 415 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~------~ 415 (724)
.++|++.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.+|++++|+||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999854 6889999999754 233456789999999999999999999999654 4
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 416 KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
..+|||||++++ |..++.. .+++..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCCC-HHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 679999999765 5555543 288999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhh------hhhc
Q 040832 496 LTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPL------CLRA 569 (724)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~------~~~~ 569 (724)
...... .....+||.+|+|||++.+..++.++|||||||+||||++|+.||...+..+... .....+ ....
T Consensus 213 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~-~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 213 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN-KVIEQLGTPCPEFMKK 289 (464)
T ss_dssp ----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHHHHCSCCHHHHTT
T ss_pred ecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHhcCCCCHHHHHH
Confidence 765432 2345679999999999999999999999999999999999999998765433211 110000 0000
Q ss_pred c--------------cCCChhhhcchhhhcCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 570 L--------------DDGNFNEIADPYLEKNY---PTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 570 ~--------------~~~~~~~~vd~~l~~~~---~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+ ....+..+....+.... .......+.+++.+||+.||++||++.|++++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00011111111110000 11225678999999999999999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=350.73 Aligned_cols=259 Identities=19% Similarity=0.322 Sum_probs=196.8
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
.++|++.+.||+|+||.||+|.. .+++.||||+++.. .......+.+|+.+|++++|+||+++++++..++..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35799999999999999999985 47899999999753 223345789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 421 YEYVPNNNLEFHLHG--KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~--~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
|||+++++|.+++.. .....+++..++.|+.||++||.|||++ +|+|||||++||||+.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999998864 2234589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhh
Q 040832 499 DNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEI 578 (724)
Q Consensus 499 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 578 (724)
..... .....|+..|+|||++....++.++||||||++||||++|+.||.........+... +....+..+
T Consensus 188 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------~~~~~~~~~ 258 (310)
T 2wqm_A 188 SKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK--------IEQCDYPPL 258 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHH--------HHTTCSCCC
T ss_pred CCCcc-ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHH--------hhcccCCCC
Confidence 43322 233568999999999999999999999999999999999999997542221111111 011111110
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 579 ADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 579 vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
. .......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 259 ~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 259 P--------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp C--------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c--------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0 012234688899999999999999999999999854
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=355.54 Aligned_cols=255 Identities=30% Similarity=0.465 Sum_probs=198.8
Q ss_pred hCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
.++|++.++||+|+||.||+|.+ .++.||||++... ...+.|.+|+++|++++|+||+++++++.+ ..+|||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 35788999999999999999998 4788999999753 345679999999999999999999998874 478999999
Q ss_pred CCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCC-EEEEEeccccccCCCCC
Q 040832 425 PNNNLEFHLHGKGR-PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFE-TKVADFGLAKLTTDNNT 502 (724)
Q Consensus 425 ~~gsL~~~L~~~~~-~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~-vkL~DFGla~~~~~~~~ 502 (724)
++++|.+++..... ..+.+..++.|+.||++||+|||+.+..+|+|||||++||||+.++. +||+|||++.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~- 160 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM- 160 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-
Confidence 99999999986542 24788999999999999999999943238999999999999998886 7999999997654321
Q ss_pred ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchh
Q 040832 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~ 582 (724)
....|+..|+|||++.+..++.++|||||||+||||++|+.||+........+ .|.. ..+... .
T Consensus 161 ---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~-------~~~~~~-----~ 224 (307)
T 2eva_A 161 ---TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI-MWAV-------HNGTRP-----P 224 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH-HHHH-------HTTCCC-----C
T ss_pred ---ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH-HHHH-------hcCCCC-----C
Confidence 23458999999999999999999999999999999999999997643222111 1111 001000 0
Q ss_pred hhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 583 LEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 583 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
+ .......+.+++.+||+.+|++||++.+|+++|+....
T Consensus 225 ~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 225 L----IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp C----BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred c----ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1 11123457889999999999999999999999987543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=354.70 Aligned_cols=260 Identities=21% Similarity=0.282 Sum_probs=200.1
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch---hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ---GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~---~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
.++|.+.++||+|+||.||+|.+. +++.||||+++..... ..+.|.+|+.++++++|+||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999964 6889999999754322 236789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+++++|.+++...+ .+++..++.|+.||++||.|||++ +|+|||||++||||+.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999998654 389999999999999999999999 9999999999999999999999999999877654
Q ss_pred CCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
.........|+..|+|||++.+..++.++||||||++||||++|+.||...... .+... +..... ..
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~----~~~~~~--~~----- 254 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAH----INQAIP--RP----- 254 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHH----HHSCCC--CG-----
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHH----hccCCC--Cc-----
Confidence 433334567899999999999999999999999999999999999999764221 11110 000000 00
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHhCCCCc
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRP-KISQIVRALEGDVSL 626 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evv~~L~~~~~~ 626 (724)
..+.......+.+++.+||+.+|++|| ++.++++.|+..+..
T Consensus 255 ----~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 255 ----STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp ----GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred ----cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 011112234588899999999999999 999999999976543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=358.78 Aligned_cols=249 Identities=22% Similarity=0.311 Sum_probs=180.2
Q ss_pred cceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCeeEEeeEEEeCCeEEEEEEecCCCC
Q 040832 351 SNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVH-HRHLVSLVGYCIAGGKRLLVYEYVPNNN 428 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~gs 428 (724)
+++||+|+||.||+|.+. +++.||||++.. .....+.+|+.+|+++. |+||+++++++.++...+|||||+++++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999964 588999999965 34567889999999997 9999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC---CEEEEEeccccccCCCCCccc
Q 040832 429 LEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF---ETKVADFGLAKLTTDNNTHVS 505 (724)
Q Consensus 429 L~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~---~vkL~DFGla~~~~~~~~~~~ 505 (724)
|.+++.... .+++.+++.|+.||++||+|||++ +|+||||||+||||+.++ .+||+|||+++........ .
T Consensus 93 L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-~ 166 (325)
T 3kn6_A 93 LFERIKKKK--HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-L 166 (325)
T ss_dssp HHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-c
Confidence 999998764 389999999999999999999999 999999999999997665 8999999999876543322 2
Q ss_pred cccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhh--hHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 506 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMED--CLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 506 ~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~--~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
....|+..|+|||++.+..++.++|||||||+||||++|+.||........ ..... ...+..+.+.. ....
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-----~~~i~~~~~~~--~~~~ 239 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI-----MKKIKKGDFSF--EGEA 239 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHH-----HHHHTTTCCCC--CSHH
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHH-----HHHHHcCCCCC--Cccc
Confidence 345689999999999999999999999999999999999999976432110 00000 01111111100 0000
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
. ......+.+++.+||+.+|++||++.||+++
T Consensus 240 ~----~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 W----KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp H----HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred c----cCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 0 1123568899999999999999999998753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=371.35 Aligned_cols=276 Identities=21% Similarity=0.255 Sum_probs=213.2
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC--eEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGG--KRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~--~~~lV 420 (724)
.++|.+.++||+|+||.||+|.+. +++.||||+++... ....+.+.+|+++|++++|+||+++++++...+ ..+||
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 357999999999999999999965 48999999997543 233567889999999999999999999998765 77999
Q ss_pred EEecCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEE----cCCCCEEEEEecccc
Q 040832 421 YEYVPNNNLEFHLHGKGR-PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILL----DYTFETKVADFGLAK 495 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~-~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl----~~~~~vkL~DFGla~ 495 (724)
|||+++++|.+++..... ..+++..++.|+.||+.||+|||++ +|+||||||+|||| +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999976432 2389999999999999999999999 99999999999999 778889999999998
Q ss_pred ccCCCCCccccccccCCCcCCcchhcC--------CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhh---hHHhhhhh
Q 040832 496 LTTDNNTHVSTRVMGTFGYLAPEYASS--------GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMED---CLVDWARP 564 (724)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~---~l~~w~~~ 564 (724)
....... .....|+..|+|||++.. ..++.++|||||||+||||++|+.||........ .+......
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp ECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred EccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 7654322 234569999999999865 5678899999999999999999999965432211 11111110
Q ss_pred hhh------hcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 565 LCL------RALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 565 ~~~------~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
... .....+.+...-+-.....+.......+..++.+||+.||++|+++.|+++.|+..+.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 000 0000111100000011223456778889999999999999999999999999976554
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=351.06 Aligned_cols=257 Identities=25% Similarity=0.401 Sum_probs=208.1
Q ss_pred hCCCcccc-eeeccCcEEEEEEEcC---CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 345 TGGFSQSN-LLGQGGFGYVHKGVLP---NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 345 ~~~f~~~~-~LG~G~fG~Vyk~~~~---~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
.++|.+.+ .||+|+||.||+|.+. +++.||||+++.... ...+.+.+|+++|++++|+||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 34566665 9999999999999853 577899999987533 3456799999999999999999999999 5566899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
||||+.+++|.+++.... ..+++..++.|+.||++||.|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 87 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999997543 3489999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCcc--ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChh
Q 040832 500 NNTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 500 ~~~~~--~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
..... .....++..|+|||++.+..++.++|||||||+||||++ |+.||......+. .... ..+..
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~i--------~~~~~- 231 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--MAFI--------EQGKR- 231 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH--HHHH--------HTTCC-
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH--HHHH--------hcCCc-
Confidence 43321 223456889999999998889999999999999999998 9999976543221 1110 01100
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
..++......+.+++.+||+.+|++||++.+|+++|+....
T Consensus 232 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 232 --------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp --------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11222334578899999999999999999999999987654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=354.73 Aligned_cols=258 Identities=25% Similarity=0.366 Sum_probs=206.2
Q ss_pred HHhhCCCcccc-eeeccCcEEEEEEEc---CCCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC
Q 040832 342 SAATGGFSQSN-LLGQGGFGYVHKGVL---PNGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAGG 415 (724)
Q Consensus 342 ~~~~~~f~~~~-~LG~G~fG~Vyk~~~---~~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 415 (724)
....++|.+.+ .||+|+||.||+|.+ ..++.||||+++.... ...++|.+|++++++++|+||+++++++ ..+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 34456788887 999999999999964 2467899999975432 2356799999999999999999999999 566
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 416 KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
..++||||+.+++|.+++..... +++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CcEEEEEeCCCCCHHHHHHhCcC--CCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 78999999999999999987543 89999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcc--ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccC
Q 040832 496 LTTDNNTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDD 572 (724)
Q Consensus 496 ~~~~~~~~~--~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~ 572 (724)
......... .....++..|+|||.+.+..++.++||||||++||||++ |+.||......+ +.... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~--------~~ 235 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAML--------EK 235 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHH--------HT
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHH--------Hc
Confidence 775544322 122346788999999998889999999999999999999 999997654322 11110 01
Q ss_pred CChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 573 GNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 573 ~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
+.. ..++......+.+++.+||+.+|++||++.+|++.|+..+
T Consensus 236 ~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 236 GER---------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp TCC---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 100 1112233456889999999999999999999999998654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=345.35 Aligned_cols=252 Identities=22% Similarity=0.340 Sum_probs=204.9
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
..++|++.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999864 5889999998654 233446788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCC---EEEEEecccccc
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFE---TKVADFGLAKLT 497 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~---vkL~DFGla~~~ 497 (724)
|||+.+++|.+++..... +++..++.|+.||+.||.|||++ +|+|||||++||||+.++. +||+|||++...
T Consensus 84 ~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp ECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999999888876543 89999999999999999999999 9999999999999976655 999999999876
Q ss_pred CCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 498 TDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 498 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
...... ....|+..|+|||++.+..++.++||||||++||||++|+.||......+. ...... +.+..
T Consensus 159 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~---------~~~~~ 226 (284)
T 3kk8_A 159 NDSEAW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-YAQIKA---------GAYDY 226 (284)
T ss_dssp CSSCBC--CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHH---------TCCCC
T ss_pred ccCccc--cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH-HHHHHh---------ccccC
Confidence 544322 345689999999999999999999999999999999999999976532221 111100 00000
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
.... .......+.+++.+||+.+|++||++.|+++
T Consensus 227 -~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 227 -PSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp -CTTT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -Cchh-----hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000 0112345788999999999999999999997
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=350.01 Aligned_cols=248 Identities=28% Similarity=0.436 Sum_probs=201.9
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
+.++|.+.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3467999999999999999999854 56789999986432 1224568999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
||||+++++|.+++..... +++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||++.....
T Consensus 87 v~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999999876543 89999999999999999999998 999999999999999999999999999865543
Q ss_pred CCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 500 NNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 500 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
.. .....|+..|+|||++.+..++.++||||||++||||++|+.||......+.. .....
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~---------------- 221 (279)
T 3fdn_A 162 SR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-KRISR---------------- 221 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHHHH----------------
T ss_pred cc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH-HHHHh----------------
Confidence 32 23456899999999999999999999999999999999999999765322211 00000
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
....++......+.+++.+||+.+|++||++.||+++
T Consensus 222 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 222 ---VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ---TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ---CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0001112233457889999999999999999999974
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=356.48 Aligned_cols=261 Identities=22% Similarity=0.294 Sum_probs=204.5
Q ss_pred hhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEe----CCeEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA----GGKRL 418 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~ 418 (724)
..++|++.+.||+|+||.||++.. .+++.||||++........+.+.+|++++++++|+||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 346899999999999999999996 5789999999977655666789999999999999999999999873 34778
Q ss_pred EEEEecCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 419 LVYEYVPNNNLEFHLHGK--GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
+||||+.+++|.+++... ....+++..++.|+.||++||.|||++ +|+|||||++||||+.++.+||+|||+++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999988752 234589999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCc--------cccccccCCCcCCcchhcCCC---CChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhh
Q 040832 497 TTDNNTH--------VSTRVMGTFGYLAPEYASSGK---LTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPL 565 (724)
Q Consensus 497 ~~~~~~~--------~~~~~~gt~~y~APE~~~~~~---~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~ 565 (724)
....... ......|+..|+|||++.... ++.++|||||||+||||++|+.||+........+...
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---- 259 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA---- 259 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH----
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH----
Confidence 5422111 012245799999999987543 6899999999999999999999995311000000000
Q ss_pred hhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 566 CLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 566 ~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
+...+...........+.+++.+||+.+|++||++.+|+++|+...
T Consensus 260 -------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 260 -------------VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp -------------HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred -------------hhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 0000000111122356889999999999999999999999998654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=354.36 Aligned_cols=252 Identities=24% Similarity=0.314 Sum_probs=206.6
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch------hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ------GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKR 417 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~------~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 417 (724)
.++|.+.+.||+|+||.||+|.+. +++.||||+++..... ..+.|.+|+.+|++++|+||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 457999999999999999999965 5889999999754322 356799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC----CEEEEEecc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF----ETKVADFGL 493 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~----~vkL~DFGl 493 (724)
++||||+.+++|.+++.... .+++..++.|+.||++||+|||++ +|+||||||+||||+.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 99999999999999998654 389999999999999999999999 999999999999999887 799999999
Q ss_pred ccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCC
Q 040832 494 AKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDG 573 (724)
Q Consensus 494 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~ 573 (724)
++....... .....|+..|+|||++.+..++.++|||||||+||||++|+.||......+. +..+.. .
T Consensus 166 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~---------~ 233 (321)
T 2a2a_A 166 AHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANITS---------V 233 (321)
T ss_dssp CEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHT---------T
T ss_pred ceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHh---------c
Confidence 987765332 2345689999999999999999999999999999999999999976532221 111110 0
Q ss_pred ChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 574 NFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 574 ~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+ ..+..+...+ ...+.+++.+||+.+|++||++.|++++
T Consensus 234 ~~--~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 234 SY--DFDEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CC--CCCHHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cc--ccChhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0001111111 2457889999999999999999999974
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=389.79 Aligned_cols=256 Identities=25% Similarity=0.414 Sum_probs=203.4
Q ss_pred hCCCcccc-eeeccCcEEEEEEEcC---CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 345 TGGFSQSN-LLGQGGFGYVHKGVLP---NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 345 ~~~f~~~~-~LG~G~fG~Vyk~~~~---~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
.++|.+.+ .||+|+||.||+|.+. ++..||||+++.... ...++|.+|+++|++|+|+||++++++|.. +..+|
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 34455555 7999999999999864 456799999986533 356789999999999999999999999976 56899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
|||||.+|+|.++|.... ..+++..++.|+.||++||+|||++ +|||||||++||||+.++.+||+|||+++....
T Consensus 413 v~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999999997643 3589999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCccc--cccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChh
Q 040832 500 NNTHVS--TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 500 ~~~~~~--~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
...... ....++..|+|||++..+.++.++|||||||+||||++ |+.||......+. ... +..+.
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~--~~~--------i~~~~-- 556 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--MAF--------IEQGK-- 556 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH--HHH--------HHTTC--
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--HHH--------HHcCC--
Confidence 332221 22345689999999999999999999999999999998 9999986543321 111 11111
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
...++......+.+++.+||+.+|++||++.+|++.|+...
T Consensus 557 -------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 557 -------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp -------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 01122334467889999999999999999999999998654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=346.84 Aligned_cols=254 Identities=26% Similarity=0.352 Sum_probs=207.6
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
..++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++++++|+||+++++++.+++..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3467999999999999999999965 68899999986442 234567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+++++|.+++.... .+++..++.++.||++||.|||++ +|+|||||++||||+.++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 85 EYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp ECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999999987543 389999999999999999999999 99999999999999999999999999998664332
Q ss_pred C-ccccccccCCCcCCcchhcCCCC-ChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 502 T-HVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 502 ~-~~~~~~~gt~~y~APE~~~~~~~-t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
. .......|+..|+|||.+.+..+ +.++||||||++||||++|+.||+........+..|..... .+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------~~---- 228 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-------YL---- 228 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT-------TS----
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc-------cc----
Confidence 2 12334568999999999987665 78999999999999999999999876443333333322110 00
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
. ........+.+++.+||+.+|++||++.||+++
T Consensus 229 ~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 229 N------PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp T------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred C------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0 001123457789999999999999999999863
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=366.10 Aligned_cols=269 Identities=22% Similarity=0.337 Sum_probs=195.4
Q ss_pred HhhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccC--CchhHHHHHHHHHHHHhcC-CCCeeEEeeEEEeCC--e
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSG--SGQGEREFKAEVEIISRVH-HRHLVSLVGYCIAGG--K 416 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~--~ 416 (724)
...++|.+.+.||+|+||.||+|.+ .+++.||||++... .....+.+.+|+.+|+++. |+||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3467899999999999999999985 46899999998643 2334557889999999997 999999999998644 6
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
.+||||||+ ++|..++... .+++..+..|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 899999997 5888888764 489999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCC--------------------CccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchh
Q 040832 497 TTDNN--------------------THVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAME 555 (724)
Q Consensus 497 ~~~~~--------------------~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~ 555 (724)
..... .......+||.+|+|||++.+ ..++.++|||||||+||||++|+.||......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 54311 112234679999999999976 679999999999999999999999998765433
Q ss_pred hhHHhhhhhh------hhhcccCCChhhhcc----------------------hhhhcCCCHHHHHHHHHHHHHhhccCC
Q 040832 556 DCLVDWARPL------CLRALDDGNFNEIAD----------------------PYLEKNYPTEEMARMVACAAASIRHSA 607 (724)
Q Consensus 556 ~~l~~w~~~~------~~~~~~~~~~~~~vd----------------------~~l~~~~~~~~~~~l~~l~~~cl~~~P 607 (724)
.... ....+ ....+.......+++ ..............+.+++.+||+.||
T Consensus 239 ~~~~-i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 239 QLER-IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHH-HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHH-HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 2111 10000 000000000000000 000000111223468899999999999
Q ss_pred CCCCCHHHHHHH
Q 040832 608 RRRPKISQIVRA 619 (724)
Q Consensus 608 ~~RPs~~evv~~ 619 (724)
++||++.|++++
T Consensus 318 ~~R~t~~e~l~H 329 (388)
T 3oz6_A 318 NKRISANDALKH 329 (388)
T ss_dssp GGSCCHHHHTTS
T ss_pred ccCCCHHHHhCC
Confidence 999999999976
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=368.23 Aligned_cols=252 Identities=24% Similarity=0.301 Sum_probs=196.0
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc---hhHHHHHHHHHH-HHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG---QGEREFKAEVEI-ISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~---~~~~~f~~Ei~i-l~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
.++|.+.++||+|+||.||+++.+ +++.||||+++.... ...+.+..|..+ ++.++|+||+++++++.+.+..||
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357999999999999999999965 578899999975422 233456677776 577899999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
||||+.+|+|.++|...+. +.+..++.++.||+.||+|||++ +|+||||||+||||+.++++||+|||+++....
T Consensus 117 v~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 9999999999999986543 88999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 500 NNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 500 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
... .....+||..|+|||++.+..++.++|||||||+||||++|+.||......+.. ... +. +.
T Consensus 192 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~-~~i----~~-----~~----- 255 (373)
T 2r5t_A 192 HNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY-DNI----LN-----KP----- 255 (373)
T ss_dssp CCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH-HHH----HH-----SC-----
T ss_pred CCC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH-HHH----Hh-----cc-----
Confidence 322 234567999999999999999999999999999999999999999765322211 000 00 00
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
..++......+.+++.+||+.+|++|+++.+.++.+..
T Consensus 256 -----~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~ 293 (373)
T 2r5t_A 256 -----LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKS 293 (373)
T ss_dssp -----CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHT
T ss_pred -----cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhC
Confidence 01112233467889999999999999998654444443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=364.24 Aligned_cols=263 Identities=14% Similarity=0.204 Sum_probs=207.3
Q ss_pred hCCCcccceeeccCcEEEEEEEcCC---------CcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeE---------
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPN---------GKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVS--------- 406 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~---------g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~--------- 406 (724)
.++|.+.+.||+|+||.||+|.+.. ++.||||++... +.+.+|+++|++++|+||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3679999999999999999999763 788999999753 46889999999999999987
Q ss_pred ------EeeEEEe-CCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEE
Q 040832 407 ------LVGYCIA-GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNIL 479 (724)
Q Consensus 407 ------l~g~~~~-~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NIL 479 (724)
+++++.. ++..+|||||+ +++|.+++.......+++..++.|+.||++||.|||++ +|+||||||+|||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEE
Confidence 6778776 67889999999 99999999876444599999999999999999999999 9999999999999
Q ss_pred EcCCC--CEEEEEeccccccCCCCCc------cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCC
Q 040832 480 LDYTF--ETKVADFGLAKLTTDNNTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPT 551 (724)
Q Consensus 480 l~~~~--~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~ 551 (724)
|+.++ .+||+|||+++........ ......|+..|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 9999999999876543221 113357999999999999999999999999999999999999999765
Q ss_pred CchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 552 GAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 552 ~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
......+..+...+.. ....+.+.... .......+.+++.+||+.+|++||++.+|++.|+..+.
T Consensus 272 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVD------KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp TTCHHHHHHHHHHHHH------SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHhccC------Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 3222222222111100 00111111100 01123568889999999999999999999999987543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=360.95 Aligned_cols=268 Identities=19% Similarity=0.268 Sum_probs=196.3
Q ss_pred HhhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchh--HHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQG--EREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~--~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
...++|.+.++||+|+||.||+|.+ .+++.||||+++...... .+.+.+|+++|++++|+||+++++++.+++..+|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3456899999999999999999984 468899999997553322 3468899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEc-----CCCCEEEEEeccc
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLD-----YTFETKVADFGLA 494 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~-----~~~~vkL~DFGla 494 (724)
||||++ ++|.+++..... +++..++.|+.||++||+|||++ +|+|||||++||||+ .++.+||+|||++
T Consensus 111 v~e~~~-~~L~~~~~~~~~--~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEECCS-EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEecCC-CCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 999997 589998877654 89999999999999999999999 999999999999994 4556999999999
Q ss_pred cccCCCCCccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhc----
Q 040832 495 KLTTDNNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRA---- 569 (724)
Q Consensus 495 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~---- 569 (724)
+........ .....|+..|+|||++.+. .++.++|||||||+||||++|+.||......+... .....+....
T Consensus 185 ~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 185 RAFGIPIRQ-FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF-KIFEVLGLPDDTTW 262 (329)
T ss_dssp HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHHHHCCCCTTTS
T ss_pred cccCCcccc-cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHH-HHHHHhCCCchhhh
Confidence 876543222 2345689999999999874 58999999999999999999999998764433221 1111000000
Q ss_pred -----c--cCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 570 -----L--DDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 570 -----~--~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
+ ....+..+....+...........+.+++.+||+.||++||++.||++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0 000000000000110011112356789999999999999999999987
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=360.36 Aligned_cols=252 Identities=16% Similarity=0.160 Sum_probs=203.9
Q ss_pred HhhCCCcccceeeccCcEEEEEEE------cCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcC---CCCeeEEeeEEEe
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGV------LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVH---HRHLVSLVGYCIA 413 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~------~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~---HpnIv~l~g~~~~ 413 (724)
...++|.+.++||+|+||.||+|. ...++.||||+++.. ...++..|++++++++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345779999999999999999994 446889999999764 3557888888888886 9999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC--------
Q 040832 414 GGKRLLVYEYVPNNNLEFHLHGK---GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY-------- 482 (724)
Q Consensus 414 ~~~~~lV~E~~~~gsL~~~L~~~---~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~-------- 482 (724)
.+..+||||||++|+|.++|+.. ....+++..++.|+.||++||+|||++ +||||||||+||||+.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccc
Confidence 99999999999999999999742 234599999999999999999999998 9999999999999998
Q ss_pred ---CCCEEEEEeccccccCCC-CCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhH
Q 040832 483 ---TFETKVADFGLAKLTTDN-NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCL 558 (724)
Q Consensus 483 ---~~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l 558 (724)
++.+||+|||+++..... ........+||.+|+|||++.+..++.++|||||||+||||++|+.||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 899999999999765422 2223455679999999999999999999999999999999999999985321110
Q ss_pred HhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCC-CCHHHHHHHHhCCC
Q 040832 559 VDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRR-PKISQIVRALEGDV 624 (724)
Q Consensus 559 ~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~R-Ps~~evv~~L~~~~ 624 (724)
|. ++..+.... ....+.+++..|++.+|.+| +++.++.+.|+..+
T Consensus 293 --~~----------------~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 293 --CK----------------PEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp --EE----------------ECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred --ee----------------echhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 10 000111111 13456778889999999988 67888888887543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=357.83 Aligned_cols=264 Identities=25% Similarity=0.372 Sum_probs=199.5
Q ss_pred HHHHHhhCCCcccceeeccCcEEEEEEEcC----CCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEE
Q 040832 339 EELSAATGGFSQSNLLGQGGFGYVHKGVLP----NGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCI 412 (724)
Q Consensus 339 ~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 412 (724)
+++....++|.++++||+|+||.||+|.+. .++.||||+++... ....+.|.+|+.+|++++|+||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 344556678999999999999999999854 34579999997543 233467999999999999999999999998
Q ss_pred eCCe-----EEEEEEecCCCCHHHHHhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCC
Q 040832 413 AGGK-----RLLVYEYVPNNNLEFHLHG----KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYT 483 (724)
Q Consensus 413 ~~~~-----~~lV~E~~~~gsL~~~L~~----~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~ 483 (724)
+... .++||||+.+++|.+++.. .....+++..++.|+.||++||.|||++ +|+||||||+||||+.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence 7653 4999999999999999843 2334589999999999999999999998 99999999999999999
Q ss_pred CCEEEEEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhh
Q 040832 484 FETKVADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDW 561 (724)
Q Consensus 484 ~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w 561 (724)
+.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++||||++ |+.||......+.. ..
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--~~ 261 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY--DY 261 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH--HH
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH--HH
Confidence 99999999999876543322 2233457889999999999999999999999999999999 88999765432211 10
Q ss_pred hhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 562 ARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 562 ~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
. ..+.. ...+......+.+++.+||+.+|++||++.+|+++|+..+
T Consensus 262 ~--------~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 262 L--------LHGHR---------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp H--------HTTCC---------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H--------HcCCC---------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 00000 0111223356889999999999999999999999998653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=353.74 Aligned_cols=262 Identities=21% Similarity=0.301 Sum_probs=204.2
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCeeEEeeEEEe--CCeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVH-HRHLVSLVGYCIA--GGKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~--~~~~~lV 420 (724)
.++|++.+.||+|+||.||+|.+ .+++.||||+++.. ..+.+.+|+.+|++|+ |+||+++++++.+ ....+||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36799999999999999999985 57889999999753 3567999999999997 9999999999988 6678999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC-CEEEEEeccccccCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF-ETKVADFGLAKLTTD 499 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~-~vkL~DFGla~~~~~ 499 (724)
|||+.+++|..++.. +.+..++.|+.||++||+|||++ +|+||||||+||||+.++ .+||+|||+++....
T Consensus 112 ~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 999999999999864 78899999999999999999999 999999999999999776 899999999987654
Q ss_pred CCCccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhc----cc---
Q 040832 500 NNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRA----LD--- 571 (724)
Q Consensus 500 ~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~----~~--- 571 (724)
.... ....|+..|+|||++.+ ..++.++|||||||+||||++|+.||.........+......+.... +.
T Consensus 184 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 184 GQEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp TCCC--CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CCcc--ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 3322 33568999999999877 67899999999999999999999999655433333222211110000 00
Q ss_pred ---CCChhhh--------cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 572 ---DGNFNEI--------ADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 572 ---~~~~~~~--------vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
...+.++ ....+...........+.+++.+||+.||++||++.||+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 00111111112234668899999999999999999999974
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=358.43 Aligned_cols=248 Identities=22% Similarity=0.370 Sum_probs=205.1
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
.++|.++++||+|+||.||++.+. +++.||+|++.... ....+.|.+|+.++++++|+||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467999999999999999999965 47889999986532 23345789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+.+++|.+++.... .+++.+++.|+.||++||.|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 120 ~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999999887654 389999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
... .....|+..|+|||++.+..++.++|||||||+||||++|+.||......+. +..+.. +.+
T Consensus 195 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~---------~~~----- 258 (335)
T 2owb_A 195 GER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLRIKK---------NEY----- 258 (335)
T ss_dssp TCC-BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHH---------TCC-----
T ss_pred ccc-ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHhc---------CCC-----
Confidence 222 2345689999999999998999999999999999999999999976532221 111100 000
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
.++......+.+++.+||+.+|++||++.||++
T Consensus 259 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 -----SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011122245788999999999999999999987
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=358.11 Aligned_cols=262 Identities=19% Similarity=0.289 Sum_probs=207.9
Q ss_pred CHHHHHHhhCCCccc-ceeeccCcEEEEEEEcC-CCcEEEEEEeccC--CchhHHHHHHHHHHHHhc-CCCCeeEEeeEE
Q 040832 337 TYEELSAATGGFSQS-NLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG--SGQGEREFKAEVEIISRV-HHRHLVSLVGYC 411 (724)
Q Consensus 337 ~~~el~~~~~~f~~~-~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~ 411 (724)
-|+..+...+.|.+. +.||+|+||.||+|... +++.||||+++.. .......+.+|+.+|+++ +|+||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 344455567778887 89999999999999865 5899999998753 233457899999999999 579999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC---CCCEEE
Q 040832 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY---TFETKV 488 (724)
Q Consensus 412 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~---~~~vkL 488 (724)
.+.+..+|||||+.+++|.+++.......+++..++.|+.||++||+|||++ +|+|||||++||||+. ++.+||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEE
Confidence 9999999999999999999999766556699999999999999999999999 9999999999999987 789999
Q ss_pred EEeccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhh
Q 040832 489 ADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLR 568 (724)
Q Consensus 489 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~ 568 (724)
+|||+++....... .....|+..|+|||++....++.++|||||||+||||++|+.||......+.... ....
T Consensus 176 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-i~~~---- 248 (327)
T 3lm5_A 176 VDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN-ISQV---- 248 (327)
T ss_dssp CCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHT----
T ss_pred eeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH-HHhc----
Confidence 99999987754322 2345699999999999999999999999999999999999999976543322111 1000
Q ss_pred cccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 569 ALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 569 ~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..... ..........+.+++.+||+.+|++||++.||+++
T Consensus 249 --~~~~~---------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 --NVDYS---------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp --CCCCC---------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred --ccccC---------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00000 00111223457889999999999999999999874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=359.23 Aligned_cols=272 Identities=25% Similarity=0.356 Sum_probs=209.5
Q ss_pred hCCCcccceeeccCcEEEEEEEc-----CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC--eE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-----PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGG--KR 417 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-----~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~--~~ 417 (724)
.++|++.+.||+|+||.||++.+ .+++.||||++........+.|.+|+++|++++|+||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45689999999999999999983 368899999998776666778999999999999999999999987654 67
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
++||||+++++|.+++..... .+++..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTT-SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 999999999999999986532 489999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCc--cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCCh
Q 040832 498 TDNNTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 498 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~ 575 (724)
...... ......++..|+|||.+.+..++.++|||||||+||||++|+.||..... .+................+
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA---EFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH---HHHHHHCTTCCTHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH---HHHHhhccccchhhhHHHH
Confidence 654332 12234577789999999988899999999999999999999998753210 0000000000000000000
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 576 NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 576 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
.+.+........+......+.+++.+||+.+|++||++.||++.|+..
T Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011111001112233446788999999999999999999999999854
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=358.59 Aligned_cols=269 Identities=22% Similarity=0.303 Sum_probs=199.3
Q ss_pred HHhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchh-----HHHHHHHHHHHHhcCCCCeeEEeeEEEeCC
Q 040832 342 SAATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQG-----EREFKAEVEIISRVHHRHLVSLVGYCIAGG 415 (724)
Q Consensus 342 ~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~-----~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 415 (724)
....++|.+.++||+|+||.||+|.+. +|+.||||+++...... .+.+.+|+++|++++|+||+++++++.+.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 344578999999999999999999975 58899999997542221 236889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 416 KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
..++||||+++ +|..++.... ..+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred ceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 99999999986 7888876543 3488899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCC
Q 040832 496 LTTDNNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGN 574 (724)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~ 574 (724)
........ .....|+..|+|||++.+. .++.++|||||||+||||++|..+|......+.....+.. ... .....
T Consensus 161 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~-~~~--~~~~~ 236 (346)
T 1ua2_A 161 SFGSPNRA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET-LGT--PTEEQ 236 (346)
T ss_dssp TTTSCCCC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH-HCC--CCTTT
T ss_pred eccCCccc-CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH-cCC--CChhh
Confidence 76543322 2345689999999999764 5899999999999999999999999776543322111110 000 00000
Q ss_pred hhh---hcchhhh---cCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 575 FNE---IADPYLE---KNYP-----TEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 575 ~~~---~vd~~l~---~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+.. +.+.... ...+ ......+.+++.+||+.+|++||++.||+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 0000000 0001 1223568999999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=347.36 Aligned_cols=261 Identities=21% Similarity=0.267 Sum_probs=201.9
Q ss_pred hhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEE-EeCCeEEEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYC-IAGGKRLLVY 421 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~-~~~~~~~lV~ 421 (724)
..++|.+.+.||+|+||.||+|.+ .+++.||||++..... ...+.+|++++++++|++++..++++ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999995 5788999998765422 23588999999999887776666555 6677889999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEE---cCCCCEEEEEeccccccC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILL---DYTFETKVADFGLAKLTT 498 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl---~~~~~vkL~DFGla~~~~ 498 (724)
||+ +++|.+++..... .+++..++.|+.||++||+|||++ +|+||||||+|||| +.++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 9999999975433 489999999999999999999999 99999999999999 789999999999998775
Q ss_pred CCCCc------cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhh--hHHhhhhhhhhhcc
Q 040832 499 DNNTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMED--CLVDWARPLCLRAL 570 (724)
Q Consensus 499 ~~~~~------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~--~l~~w~~~~~~~~~ 570 (724)
..... ......|+..|+|||.+.+..++.++|||||||+||||++|+.||........ .+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----- 234 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK----- 234 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH-----
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc-----
Confidence 54331 22346799999999999999999999999999999999999999976432211 111110000
Q ss_pred cCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 571 DDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 571 ~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
+.. ....+...+ ...+.+++.+||+.+|++||++.+|++.|+....
T Consensus 235 ----~~~-~~~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 235 ----MST-PIEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp ----HHS-CHHHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred ----ccc-hhhhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 000 000111112 3468899999999999999999999999986543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=357.48 Aligned_cols=263 Identities=22% Similarity=0.347 Sum_probs=199.1
Q ss_pred hCCCccc-ceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEEE
Q 040832 345 TGGFSQS-NLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 345 ~~~f~~~-~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
.+.|.+. ++||+|+||.||+|.. .+++.||||+++.......+.+.+|+++|.++ +|+||+++++++.+++..+|||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4567774 7899999999999995 46899999999876656677899999999995 7999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCC---EEEEEeccccccC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFE---TKVADFGLAKLTT 498 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~---vkL~DFGla~~~~ 498 (724)
||+++++|.+++.... .+++..++.|+.||++||+|||++ +|+||||||+||||+.++. +||+|||+++...
T Consensus 91 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999998654 389999999999999999999999 9999999999999988766 9999999998654
Q ss_pred CCCC------ccccccccCCCcCCcchhcC-----CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhh
Q 040832 499 DNNT------HVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCL 567 (724)
Q Consensus 499 ~~~~------~~~~~~~gt~~y~APE~~~~-----~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~ 567 (724)
.... .......|+..|+|||++.. ..++.++|||||||+||||++|+.||......+. .|......
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~ 242 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC---GWDRGEAC 242 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCS---CC----CC
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccc---cccccccc
Confidence 3211 11223459999999999875 4578899999999999999999999976532210 01100000
Q ss_pred hcccCCChhhhcchhhhc--CCCH----HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 568 RALDDGNFNEIADPYLEK--NYPT----EEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 568 ~~~~~~~~~~~vd~~l~~--~~~~----~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.. ....+.+..... .++. .....+.+++.+||+.||++||++.||+++
T Consensus 243 ~~----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 243 PA----CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HH----HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hh----HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00 000000000000 1111 123468899999999999999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=351.79 Aligned_cols=251 Identities=27% Similarity=0.436 Sum_probs=199.5
Q ss_pred hhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC-CeEEEEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAG-GKRLLVYE 422 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~-~~~~lV~E 422 (724)
..++|++.+.||+|+||.||++.+ .++.||||.++... ..+.|.+|++++++++|+||+++++++.+. +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 346799999999999999999987 58899999997643 456799999999999999999999997654 47899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|+++++|.+++.......+++..+++++.||++||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 99999999999765443478999999999999999999999 99999999999999999999999999998654332
Q ss_pred ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
....++..|+|||.+.+..++.++||||||++||||++ |+.||......+. ... +..+.
T Consensus 172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-~~~---------~~~~~------- 231 (278)
T 1byg_A 172 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-VPR---------VEKGY------- 231 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-HHH---------HTTTC-------
T ss_pred ---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHH---------HhcCC-------
Confidence 22357889999999999999999999999999999998 9999976532211 100 01110
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
...........+.+++.+||+.+|++||++.||++.|+..
T Consensus 232 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 232 --KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 0111222345688999999999999999999999999854
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=359.20 Aligned_cols=260 Identities=27% Similarity=0.400 Sum_probs=205.7
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC------CCcEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCe
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP------NGKEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGK 416 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 416 (724)
..++|.+.+.||+|+||.||+|.+. +++.||||++.... .....+|.+|+.+|++++|+||+++++++.+.+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 3468999999999999999999842 46789999997543 3445679999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC---CCCEEE
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGR-----PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY---TFETKV 488 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~-----~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~---~~~vkL 488 (724)
.+|||||+++++|.+++..... ..+++..++.|+.||++||.|||++ +|+|||||++||||+. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999986532 3488999999999999999999999 9999999999999984 456999
Q ss_pred EEeccccccCCCCC-ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhh
Q 040832 489 ADFGLAKLTTDNNT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLC 566 (724)
Q Consensus 489 ~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~ 566 (724)
+|||+++....... .......|+..|+|||++.++.++.++|||||||+||||++ |+.||......+ +..+..
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~--- 259 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VLEFVT--- 259 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHH---
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH--HHHHHh---
Confidence 99999986543322 22234568899999999999999999999999999999998 999997653221 111110
Q ss_pred hhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 567 LRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 567 ~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
.+.. ..........+.+++.+||+.+|++||++.+|+++|+....
T Consensus 260 -----~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 260 -----SGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp -----TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----cCCC---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 0000 01112223468889999999999999999999999986544
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=366.20 Aligned_cols=255 Identities=28% Similarity=0.412 Sum_probs=193.8
Q ss_pred CCcccceeeccCcEEEEEEEcC--CC--cEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEe-CCeEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP--NG--KEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIA-GGKRLLV 420 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~--~g--~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~lV 420 (724)
.|.+.++||+|+||.||+|.+. ++ ..||||.++... ....+.|.+|+.+|++++|+||++++++|.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4677899999999999999863 22 358999987543 3445679999999999999999999999765 4578999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+++++|.+++.... ..+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999997644 3478999999999999999999999 9999999999999999999999999999876443
Q ss_pred CCc---cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChh
Q 040832 501 NTH---VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 501 ~~~---~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
... ......++..|+|||++.+..++.++|||||||+||||++ |..||......+.... . ..+..
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~-~---------~~~~~- 314 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-L---------LQGRR- 314 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH-H---------HTTCC-
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH-H---------HcCCC-
Confidence 221 1233457788999999999999999999999999999999 6777765433221110 0 00000
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
. ..+......+.+++.+||+.+|++||++.||++.|+..+
T Consensus 315 -~-------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 315 -L-------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp -C-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -C-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 011122346888999999999999999999999998654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=374.17 Aligned_cols=247 Identities=27% Similarity=0.408 Sum_probs=205.1
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
.++|.+++.||+|+||.||+|.+. +|+.||||+++... ......+.+|+.+|+.++|+||+++++++...+..+||
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 368999999999999999999965 68999999996431 12345789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+.+++|.+++...+. +++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 95 ~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EECCSSEEHHHHTTSSSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 999999999999976543 89999999999999999999998 9999999999999999999999999999877553
Q ss_pred CCccccccccCCCcCCcchhcCCCC-ChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~-t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
.. .....|+..|+|||++.+..+ +.++|||||||+||||++|+.||+....... +.. +..+.+
T Consensus 170 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-~~~---------i~~~~~---- 233 (476)
T 2y94_A 170 EF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL-FKK---------ICDGIF---- 233 (476)
T ss_dssp CC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH-HHH---------HHTTCC----
T ss_pred cc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH-HHH---------HhcCCc----
Confidence 32 234569999999999988765 6899999999999999999999986532221 100 111111
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
..+......+.+++.+||+.||++||++.||++
T Consensus 234 ------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 ------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 011112345788999999999999999999997
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=358.35 Aligned_cols=260 Identities=22% Similarity=0.352 Sum_probs=208.5
Q ss_pred CHHHHHHhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch--------hHHHHHHHHHHHHhc-CCCCeeE
Q 040832 337 TYEELSAATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ--------GEREFKAEVEIISRV-HHRHLVS 406 (724)
Q Consensus 337 ~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~--------~~~~f~~Ei~il~~l-~HpnIv~ 406 (724)
.++......++|.+.+.||+|+||.||+|.+. +|+.||||+++..... ..+.+.+|+++|+++ +|+||++
T Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 34555666788999999999999999999975 6899999998754311 134578999999999 7999999
Q ss_pred EeeEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCE
Q 040832 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFET 486 (724)
Q Consensus 407 l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~v 486 (724)
+++++...+..+|||||+++++|.+++.... .+++..++.|+.||++||.|||++ +|+||||||+||||+.++.+
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 9999999999999999999999999997654 389999999999999999999999 99999999999999999999
Q ss_pred EEEEeccccccCCCCCccccccccCCCcCCcchhcC------CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHh
Q 040832 487 KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS------GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVD 560 (724)
Q Consensus 487 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~ 560 (724)
||+|||++........ .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||........ +..
T Consensus 240 kl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~~~ 316 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM-LRM 316 (365)
T ss_dssp EECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH
T ss_pred EEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH-HHH
Confidence 9999999987754332 234679999999999863 3588999999999999999999999976432211 100
Q ss_pred hhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 561 WARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 561 w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
. ..+.+. ...+.. .. ....+.+++.+||+.+|++||++.||+++
T Consensus 317 i---------~~~~~~-~~~~~~-~~----~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 317 I---------MEGQYQ-FSSPEW-DD----RSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp H---------HHTCCC-CCHHHH-SS----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred H---------HhCCCC-CCCccc-cc----CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 000000 000000 11 12458889999999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=359.09 Aligned_cols=269 Identities=21% Similarity=0.315 Sum_probs=201.6
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ--GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~--~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
.++|++.++||+|+||.||+|.+. +++.||||++...... ..+.+.+|+++|++++|+||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 367999999999999999999965 4889999998654332 2456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+++++|.+++...+. +++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 104 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNG--LDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp ECCSEEHHHHHHHSTTC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecCCcchHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 99999999988765543 89999999999999999999999 99999999999999999999999999998765432
Q ss_pred CccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhh--hh--------hhhh-c
Q 040832 502 THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWA--RP--------LCLR-A 569 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~--~~--------~~~~-~ 569 (724)
.. .....|+..|+|||++.+. .++.++|||||||+||||++|+.||......+....... .. +... .
T Consensus 179 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 179 EV-YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred cc-cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 22 2345689999999999875 789999999999999999999999987654332111000 00 0000 0
Q ss_pred ccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 570 LDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 570 ~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.....+.++................+.+++.+||+.+|++||++.||+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000111100000000011234568899999999999999999999863
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=362.33 Aligned_cols=252 Identities=21% Similarity=0.321 Sum_probs=200.4
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
..++|.+.+.||+|+||.||++... +++.||||+++.... .+.+|+++|.++ +|+||+++++++.+++..+|||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4567999999999999999999965 588999999976432 345688888888 7999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCC----CCEEEEEecccccc
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYT----FETKVADFGLAKLT 497 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~----~~vkL~DFGla~~~ 497 (724)
|||.+|+|.+++...+. +++..++.|+.||+.||+|||++ +|+||||||+||||.++ +.+||+|||+++..
T Consensus 96 E~~~gg~L~~~i~~~~~--~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKF--FSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHTCTT--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999999976553 89999999999999999999999 99999999999998443 35999999999876
Q ss_pred CCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCch-hhhHHhhhhhhhhhcccCCChh
Q 040832 498 TDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAM-EDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 498 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~-~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
...... .....||..|+|||++.+..++.++|||||||+||||++|+.||...... ...+... +..+.+.
T Consensus 171 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~--------i~~~~~~ 241 (342)
T 2qr7_A 171 RAENGL-LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR--------IGSGKFS 241 (342)
T ss_dssp BCTTCC-BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH--------HHHCCCC
T ss_pred cCCCCc-eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH--------HccCCcc
Confidence 544322 23456899999999998888899999999999999999999999754211 1111110 0111110
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+...+.......+.+++.+||+.||++||++.||+++
T Consensus 242 ------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 ------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0001111233567889999999999999999999863
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=347.21 Aligned_cols=246 Identities=20% Similarity=0.270 Sum_probs=199.9
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC--CchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG--SGQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~l 419 (724)
..++|.+.+.||+|+||.||+|.+. +++.||||+++.. ......++.+|+.++.++ +|+||+++++++.+.+..+|
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3467999999999999999999965 7899999999764 333456789999999999 99999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC---------------
Q 040832 420 VYEYVPNNNLEFHLHGKG--RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY--------------- 482 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~--~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~--------------- 482 (724)
||||+++++|.+++.... ...+++..++.|+.||++||+|||++ +|+||||||+||||+.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999997532 13489999999999999999999999 9999999999999984
Q ss_pred ----CCCEEEEEeccccccCCCCCccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhh
Q 040832 483 ----TFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC 557 (724)
Q Consensus 483 ----~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~ 557 (724)
...+||+|||++....... ...|+..|+|||++.+. .++.++|||||||+||||++|+.++.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---- 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence 4489999999998775432 23489999999999876 566899999999999999999887643211
Q ss_pred HHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 558 LVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 558 l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
...+ ..+.+. ..+......+.+++.+||+.+|++||++.||+++
T Consensus 237 ~~~~---------~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 WHEI---------RQGRLP---------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHHH---------HTTCCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHH---------HcCCCC---------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1111 111111 1111223468899999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=350.67 Aligned_cols=255 Identities=24% Similarity=0.370 Sum_probs=204.5
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEe--CCeEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIA--GGKRLL 419 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~l 419 (724)
.++|++.+.||+|+||.||++.+. +++.||||.+.... ....+.|.+|+.+|++++|+||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467999999999999999999965 68899999997543 2334579999999999999999999998864 568899
Q ss_pred EEEecCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEecCCCCccEEEcCCCCEEEEEec
Q 040832 420 VYEYVPNNNLEFHLHGK--GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR-----IIHRDIKSSNILLDYTFETKVADFG 492 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~-----iiHrDIkp~NILl~~~~~vkL~DFG 492 (724)
||||+++++|.+++... ....+++..++.|+.||+.||+|||+. + |+|||||++||||+.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999998753 233489999999999999999999998 7 9999999999999999999999999
Q ss_pred cccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccC
Q 040832 493 LAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDD 572 (724)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~ 572 (724)
+++....... ......|+..|+|||.+.+..++.++||||||++||||++|+.||......+ +... +..
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~--------i~~ 230 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAGK--------IRE 230 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH--------HHH
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH--HHHH--------Hhh
Confidence 9987654322 2233568999999999999999999999999999999999999997653221 1110 011
Q ss_pred CChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 573 GNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 573 ~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
+.+. ..+......+.+++.+||+.+|++||++.||++++..
T Consensus 231 ~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 231 GKFR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp TCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cccc---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1110 1111233568899999999999999999999987653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=344.07 Aligned_cols=259 Identities=21% Similarity=0.270 Sum_probs=204.9
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEE-EeCCeEEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYC-IAGGKRLLVYE 422 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~-~~~~~~~lV~E 422 (724)
.++|++.+.||+|+||.||+|.+ .+++.||||++..... .+.+.+|+.++++++|++++..++++ ..++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 57899999999999999999995 5789999999876432 34689999999999887766655554 56778899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEE---cCCCCEEEEEeccccccCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILL---DYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl---~~~~~vkL~DFGla~~~~~ 499 (724)
|+ +++|.+++..... .+++..++.|+.||++||+|||++ +|+||||||+|||| +.++.+||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 9999999975432 489999999999999999999999 99999999999999 5889999999999987765
Q ss_pred CCCc------cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchh--hhHHhhhhhhhhhccc
Q 040832 500 NNTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAME--DCLVDWARPLCLRALD 571 (724)
Q Consensus 500 ~~~~------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~--~~l~~w~~~~~~~~~~ 571 (724)
.... ......|+..|+|||++.+..++.++|||||||+||||++|+.||....... ..+.......
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------ 234 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK------ 234 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH------
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc------
Confidence 4332 1244679999999999999999999999999999999999999997643211 1111111000
Q ss_pred CCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 572 DGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 572 ~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
+.. ....+...+ ...+.+++.+||+.+|++||++.+|++.|+..+
T Consensus 235 ---~~~-~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 235 ---MST-PIEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp ---HHS-CHHHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred ---cCC-chHHHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 000 000111122 246889999999999999999999999998654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=361.41 Aligned_cols=268 Identities=19% Similarity=0.253 Sum_probs=207.6
Q ss_pred hCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchh-----------------HHHHHHHHHHHHhcCCCCeeEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQG-----------------EREFKAEVEIISRVHHRHLVSL 407 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~-----------------~~~f~~Ei~il~~l~HpnIv~l 407 (724)
.++|.+.+.||+|+||.||+|.+ +++.||||++....... .+.|.+|+.+|++++|+||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 47899999999999999999999 89999999986431111 1779999999999999999999
Q ss_pred eeEEEeCCeEEEEEEecCCCCHHHH------HhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCccEEE
Q 040832 408 VGYCIAGGKRLLVYEYVPNNNLEFH------LHGKGRPVMDWPTRLKIAMGSAKGLAYLHE-DCHPRIIHRDIKSSNILL 480 (724)
Q Consensus 408 ~g~~~~~~~~~lV~E~~~~gsL~~~------L~~~~~~~l~~~~~~~i~~qia~gL~yLHs-~~~~~iiHrDIkp~NILl 480 (724)
++++.+.+..++||||+++++|.++ +.......+++..++.|+.||++||.|||+ + +|+|||||++||||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 9999999999999999999999998 665445569999999999999999999999 7 99999999999999
Q ss_pred cCCCCEEEEEeccccccCCCCCccccccccCCCcCCcchhcCC-CCCh-hHHHHHHHHHHHHHHhCCCCCCCCCchhhhH
Q 040832 481 DYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSG-KLTE-KSDVFSFGVMLLELITGRRPIDPTGAMEDCL 558 (724)
Q Consensus 481 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~-ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l 558 (724)
+.++.+||+|||++...... ......|+..|+|||++.+. .++. ++|||||||+||||++|+.||.........+
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 99999999999999876543 23445689999999999877 6666 9999999999999999999998764422222
Q ss_pred HhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 559 VDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 559 ~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
................+...................+.+++.+||+.+|.+||++.||+++
T Consensus 263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2111110000000000000000000001112234568899999999999999999999973
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=348.17 Aligned_cols=257 Identities=25% Similarity=0.331 Sum_probs=202.6
Q ss_pred CCcccceeeccCcEEEEEEEcCC----CcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeE-EEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLPN----GKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKR-LLV 420 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~~----g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~-~lV 420 (724)
.|.++++||+|+||.||+|.+.+ +..||||.+..... ...+.|.+|+.+|++++|+||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45667899999999999998532 23699999976443 3346799999999999999999999999876655 999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+.+++|.+++.... ..+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999999997643 3589999999999999999999999 9999999999999999999999999999866443
Q ss_pred CC---ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 501 NT---HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 501 ~~---~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
.. .......++..|+|||.+.+..++.++|||||||+||||++|..|+........... +.. .+.
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~-~~~--------~~~--- 245 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH-FLA--------QGR--- 245 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHH-HHH--------TTC---
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHH-Hhh--------cCC---
Confidence 21 122335678899999999999999999999999999999996666543322211111 100 000
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
....+......+.+++.+||+.+|.+||++.+|++.|+..+.
T Consensus 246 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 246 ------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 001111223468899999999999999999999999987543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=380.55 Aligned_cols=253 Identities=26% Similarity=0.383 Sum_probs=209.2
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
..++|.+.++||+|+||.||+|... +|+.||||++... .......+.+|+++|++++|+||+++++++.+.+..+|
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999964 6899999999643 12234568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
||||+.+|+|.+++...+...+++..++.|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+++....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999999876666699999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchh--hhHHhhhhhhhhhcccCCChhh
Q 040832 500 NNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAME--DCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 500 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~--~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
... ....+||..|+|||++.+..++.++|||||||+||||++|+.||....... ..+......
T Consensus 339 ~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~------------- 403 (576)
T 2acx_A 339 GQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE------------- 403 (576)
T ss_dssp TCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-------------
T ss_pred Ccc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-------------
Confidence 432 233579999999999999899999999999999999999999997653211 111110000
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRP-----KISQIVRA 619 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evv~~ 619 (724)
....++......+.+++.+||+.+|.+|+ ++.||+++
T Consensus 404 -----~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 404 -----VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -----CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -----ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 00112223345688999999999999999 78888764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=348.19 Aligned_cols=249 Identities=22% Similarity=0.365 Sum_probs=205.5
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
.++|.+.++||+|+||.||++.+. +++.||+|++.... ....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357899999999999999999965 47889999986542 23345789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+++++|.+++.... .+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 94 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 99999999999887654 389999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
... .....|+..|+|||++.+..++.++||||||++||||++|+.||+.....+. ...+. .+.+
T Consensus 169 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~---------~~~~----- 232 (294)
T 2rku_A 169 GER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLRIK---------KNEY----- 232 (294)
T ss_dssp TCC-BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHH---------TTCC-----
T ss_pred ccc-cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHh---------hccC-----
Confidence 222 2345689999999999988899999999999999999999999976542221 11110 0000
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+......+.+++.+||+.+|++||++.||+++
T Consensus 233 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 -----SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -----CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0111223457889999999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=356.63 Aligned_cols=255 Identities=27% Similarity=0.440 Sum_probs=203.3
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcE--EEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKE--VAVKSLRSGS-GQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~--vaVK~l~~~~-~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 420 (724)
++|++.+.||+|+||.||+|.+. +++. ||||.++... ....+.|.+|+++|+++ +|+||+++++++.+.+..+||
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57899999999999999999964 4554 4899887542 23345799999999999 899999999999999999999
Q ss_pred EEecCCCCHHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCE
Q 040832 421 YEYVPNNNLEFHLHGKG--------------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFET 486 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~v 486 (724)
|||+++++|.+++.... ...+++..++.|+.||++||+|||++ +|+||||||+||||+.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997643 23589999999999999999999999 99999999999999999999
Q ss_pred EEEEeccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhh
Q 040832 487 KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPL 565 (724)
Q Consensus 487 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~ 565 (724)
||+|||+++....... .....++..|+|||++....++.++|||||||+||||++ |+.||......+. ...
T Consensus 182 kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~--~~~---- 253 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--YEK---- 253 (327)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHH----
T ss_pred EEcccCcCcccccccc--ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH--HHH----
Confidence 9999999975432211 123456889999999998889999999999999999998 9999976542221 100
Q ss_pred hhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 566 CLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 566 ~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
+..+. ....+......+.+++.+||+.+|++||++.||+++|+..+
T Consensus 254 ----~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 254 ----LPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp ----GGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----hhcCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00000 00111222356889999999999999999999999998654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=362.87 Aligned_cols=267 Identities=24% Similarity=0.345 Sum_probs=206.8
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
.++|.+.+.||+|+||.||++.+. +++.||+|+++..... ..+.+.+|+.+|++++|+||+++++++.+++..+||||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 367999999999999999999965 6889999999865333 34679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|+++++|.+++...+. +++..++.|+.||+.||.|||+.+ +|+|||||++||||+.++.+||+|||+++......
T Consensus 112 ~~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 186 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 186 (360)
T ss_dssp CCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC-
T ss_pred CCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccccc-
Confidence 9999999999987543 899999999999999999999842 79999999999999999999999999997654321
Q ss_pred ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhh-----------------h-
Q 040832 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWAR-----------------P- 564 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~-----------------~- 564 (724)
.....|+..|+|||++.+..++.++|||||||+||||++|+.||......+........ .
T Consensus 187 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 187 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp ------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred --ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 23456899999999999999999999999999999999999999765432221110000 0
Q ss_pred --hhhhcccCCChhhhcchhhhcC----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 565 --LCLRALDDGNFNEIADPYLEKN----YPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 565 --~~~~~~~~~~~~~~vd~~l~~~----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
+.........+.++++...... ........+.+++.+||+.+|++||++.|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000000011112222221111 11122446889999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=360.89 Aligned_cols=258 Identities=23% Similarity=0.316 Sum_probs=189.6
Q ss_pred HHhhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCeeEEeeEEEe------
Q 040832 342 SAATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVH-HRHLVSLVGYCIA------ 413 (724)
Q Consensus 342 ~~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~------ 413 (724)
.....+|++.++||+|+||.||+|.+ .+++.||||++........+.+.+|+.+|+++. |+||+++++++..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 34456899999999999999999995 468899999997766666678999999999995 9999999999853
Q ss_pred --CCeEEEEEEecCCCCHHHHHhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCccEEEcCCCCEEE
Q 040832 414 --GGKRLLVYEYVPNNNLEFHLHG-KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR--IIHRDIKSSNILLDYTFETKV 488 (724)
Q Consensus 414 --~~~~~lV~E~~~~gsL~~~L~~-~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~--iiHrDIkp~NILl~~~~~vkL 488 (724)
....++||||+. |+|.+++.. .....+++..++.|+.||++||+|||++ + |+||||||+||||+.++.+||
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence 345789999996 788887764 2233589999999999999999999998 7 999999999999999999999
Q ss_pred EEeccccccCCCCCcc-----------ccccccCCCcCCcchh---cCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCch
Q 040832 489 ADFGLAKLTTDNNTHV-----------STRVMGTFGYLAPEYA---SSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAM 554 (724)
Q Consensus 489 ~DFGla~~~~~~~~~~-----------~~~~~gt~~y~APE~~---~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~ 554 (724)
+|||+++......... .....|+..|+|||++ .+..++.++|||||||+||||++|+.||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 9999998775433211 1134589999999998 5667899999999999999999999999754221
Q ss_pred hhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 555 EDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 555 ~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
.... +.+. ..........+..++.+||+.+|++||++.||+++|+....
T Consensus 260 ~~~~--------------~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 260 RIVN--------------GKYS--------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp --------------------CC--------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Hhhc--------------Cccc--------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1100 0000 00001111237789999999999999999999999986543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=389.24 Aligned_cols=247 Identities=27% Similarity=0.395 Sum_probs=198.3
Q ss_pred ceeeccCcEEEEEEEcC---CCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCC
Q 040832 352 NLLGQGGFGYVHKGVLP---NGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPN 426 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~---~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 426 (724)
+.||+|+||.||+|.+. .++.||||+++... ....++|.+|+++|++|+|+||++++++|.. +..+|||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 46789999997642 2335789999999999999999999999965 457899999999
Q ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc--c
Q 040832 427 NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH--V 504 (724)
Q Consensus 427 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~--~ 504 (724)
|+|.++|..... +++..++.|+.||++||+|||++ +|||||||++||||+.++.+||+|||+++........ .
T Consensus 454 g~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhCCC--CCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 999999986543 89999999999999999999999 9999999999999999999999999999877544322 2
Q ss_pred ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 505 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
.....++..|+|||++....++.++|||||||+||||++ |+.||......+. ... +..+.
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~--~~~--------i~~~~--------- 589 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--TAM--------LEKGE--------- 589 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HHH--------HHTTC---------
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHH--------HHcCC---------
Confidence 233457789999999999999999999999999999998 9999976543221 110 01110
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
...++......+.+++..||+.+|++||++.+|++.|+..
T Consensus 590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 0112223346788999999999999999999999999853
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=359.17 Aligned_cols=243 Identities=25% Similarity=0.351 Sum_probs=202.7
Q ss_pred hhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCch--------hHHHHHHHHHHHHhcCCCCeeEEeeEEEeC
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQ--------GEREFKAEVEIISRVHHRHLVSLVGYCIAG 414 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~--------~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 414 (724)
..++|.+.+.||+|+||.||+|.+ .+++.||||+++..... ..+.+.+|+.+|++++|+||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 356899999999999999999984 46889999999764321 223578899999999999999999999999
Q ss_pred CeEEEEEEecCCC-CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecc
Q 040832 415 GKRLLVYEYVPNN-NLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGL 493 (724)
Q Consensus 415 ~~~~lV~E~~~~g-sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGl 493 (724)
+..+|||||+.+| +|..++..... +++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~--l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCC--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 9999999999777 99999987654 89999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCCcCCcchhcCCCC-ChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccC
Q 040832 494 AKLTTDNNTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDD 572 (724)
Q Consensus 494 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~ 572 (724)
++....... .....|+..|+|||++.+..+ +.++|||||||+||||++|+.||....... .
T Consensus 177 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------------~- 238 (335)
T 3dls_A 177 AAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV---------------E- 238 (335)
T ss_dssp CEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT---------------T-
T ss_pred ceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH---------------h-
Confidence 987765432 234569999999999988776 889999999999999999999996421100 0
Q ss_pred CChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 573 GNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 573 ~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+ ..+......+.+++.+||+.+|++||++.||+++
T Consensus 239 ~~~----------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 AAI----------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TCC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred hcc----------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0001123458889999999999999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=346.76 Aligned_cols=250 Identities=24% Similarity=0.329 Sum_probs=197.0
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
++|.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|+++|++++|+||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 56899999999999999999864 58899999987543 33457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEE---cCCCCEEEEEeccccccC
Q 040832 424 VPNNNLEFHLHGK--GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILL---DYTFETKVADFGLAKLTT 498 (724)
Q Consensus 424 ~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl---~~~~~vkL~DFGla~~~~ 498 (724)
+++++|.+++... ....+++..++.|+.||++||+|||++ +|+|||||++|||| +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999888542 223589999999999999999999999 99999999999999 456889999999998765
Q ss_pred CCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhh
Q 040832 499 DNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEI 578 (724)
Q Consensus 499 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 578 (724)
.... .....|+..|+|||++. +.++.++|||||||+||||++|+.||......+....... ....+..
T Consensus 179 ~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~--------~~~~~~~- 246 (285)
T 3is5_A 179 SDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY--------KEPNYAV- 246 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------CCCCCCC-
T ss_pred Cccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc--------CCccccc-
Confidence 4322 23456899999999885 5789999999999999999999999976543221111000 0000000
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 579 ADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 579 vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
.... ....+.+++.+||+.+|++||++.||++
T Consensus 247 ----~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 ----ECRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ------CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ----ccCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001 1245778999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=371.85 Aligned_cols=194 Identities=25% Similarity=0.361 Sum_probs=154.7
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC-----Ce
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAG-----GK 416 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~-----~~ 416 (724)
.++|.+.++||+|+||.||+|.+. +++.||||++... .....+.+.+|+++|++|+|+||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999854 6889999998653 223446799999999999999999999998543 56
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
.||||||+ +++|..++.... .+++..++.|+.||++||+|||++ +||||||||+||||+.++.+||+|||+++.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchh
Confidence 89999998 578888887654 389999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC--------------------------ccccccccCCCcCCcchh-cCCCCChhHHHHHHHHHHHHHHhC
Q 040832 497 TTDNNT--------------------------HVSTRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELITG 544 (724)
Q Consensus 497 ~~~~~~--------------------------~~~~~~~gt~~y~APE~~-~~~~~t~ksDV~SlGvlL~eLltG 544 (724)
...... ......+||.+|+|||++ ....++.++||||||||||||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 643221 122445789999999986 456799999999999999999993
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=349.86 Aligned_cols=251 Identities=21% Similarity=0.342 Sum_probs=203.4
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
.++|.+.++||+|+||.||++... +|+.||||.++.......+.+.+|+.+|++++|+||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 467999999999999999999964 6899999999866544556799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEE---cCCCCEEEEEeccccccCCC
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILL---DYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl---~~~~~vkL~DFGla~~~~~~ 500 (724)
+++++|.+++...+. +++..++.++.||+.||.|||++ +|+|||||++|||| +.++.+||+|||+++.....
T Consensus 88 ~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 88 VSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred CCCccHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 999999998876543 89999999999999999999999 99999999999999 78899999999999765432
Q ss_pred CCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
......|+..|+|||++.+..++.++|||||||+||||++|+.||......+. +..+.. +.+ .+ .
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~---------~~~-~~-~ 227 (304)
T 2jam_A 163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL-FEKIKE---------GYY-EF-E 227 (304)
T ss_dssp ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHH---------CCC-CC-C
T ss_pred ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHc---------CCC-CC-C
Confidence 22335689999999999999999999999999999999999999976532211 111100 100 00 0
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..........+.+++.+||+.+|++||++.|++++
T Consensus 228 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 228 ----SPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp ----TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ----ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00111223568899999999999999999999873
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=347.74 Aligned_cols=256 Identities=29% Similarity=0.399 Sum_probs=200.8
Q ss_pred CCCcccceeeccCcEEEEEEEcCCC----cEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEe-CCeEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPNG----KEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIA-GGKRLL 419 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~g----~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~l 419 (724)
..|.+.++||+|+||.||+|.+.++ ..||||.++..... ..+.|.+|+.+|++++|+||++++++|.. ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 4688899999999999999985432 25899998765433 34679999999999999999999998654 557799
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
||||+.+++|.+++.... ..+++..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999997643 3478999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCc---cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCCh
Q 040832 500 NNTH---VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 500 ~~~~---~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~ 575 (724)
.... ......|+..|+|||.+.+..++.++||||||++||||++ |..||......+. ...+.. +..
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~-~~~~~~---------~~~ 250 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-TVYLLQ---------GRR 250 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH-HHHHHT---------TCC
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH-HHHHhc---------CCC
Confidence 3221 1233457788999999999999999999999999999999 5555554332221 111100 000
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 576 NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 576 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
...+......+.+++.+||+.+|++||++.||++.|+..+
T Consensus 251 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 251 ---------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0001112346889999999999999999999999998654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=346.00 Aligned_cols=251 Identities=25% Similarity=0.334 Sum_probs=202.4
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc------hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG------QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKR 417 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~------~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 417 (724)
.++|.+.+.||+|+||.||++.+. +++.||||.++.... ...+.|.+|+.+|++++|+||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999975 689999999875422 1356799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC----CEEEEEecc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF----ETKVADFGL 493 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~----~vkL~DFGl 493 (724)
++||||+.+++|.+++.... .+++..++.|+.||++||.|||++ +|+|||||++||||+.++ .+||+|||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999997644 389999999999999999999999 999999999999998877 899999999
Q ss_pred ccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCC
Q 040832 494 AKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDG 573 (724)
Q Consensus 494 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~ 573 (724)
+........ .....|+..|+|||++....++.++||||||++||||++|+.||......+ .+..+.. .
T Consensus 159 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~---------~ 226 (283)
T 3bhy_A 159 AHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-TLTNISA---------V 226 (283)
T ss_dssp CEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHT---------T
T ss_pred ceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-HHHHhHh---------c
Confidence 987654332 234568999999999999999999999999999999999999997653222 1111100 0
Q ss_pred ChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 574 NFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 574 ~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
... ........ ....+.+++.+||+.+|++||++.|+++
T Consensus 227 ~~~--~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 227 NYD--FDEEYFSN----TSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CCC--CCHHHHTT----CCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccC--Ccchhccc----CCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 000 00001111 1345788999999999999999999997
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=360.80 Aligned_cols=267 Identities=24% Similarity=0.316 Sum_probs=203.3
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcC--------CCCeeEEeeEEE---
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVH--------HRHLVSLVGYCI--- 412 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~--------HpnIv~l~g~~~--- 412 (724)
.++|.+.++||+|+||.||+|++ .+++.||||+++.. ....+.+.+|+++|++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 47899999999999999999985 46889999999753 234567899999999995 788999999987
Q ss_pred -eCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC-------
Q 040832 413 -AGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF------- 484 (724)
Q Consensus 413 -~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~------- 484 (724)
.....+|||||+ +++|.+++.......+++..++.|+.||++||+|||+++ +|+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhh
Confidence 455789999999 555555555444445899999999999999999999964 799999999999998775
Q ss_pred ------------------------------------------CEEEEEeccccccCCCCCccccccccCCCcCCcchhcC
Q 040832 485 ------------------------------------------ETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS 522 (724)
Q Consensus 485 ------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~ 522 (724)
.+||+|||+++..... .....||..|+|||++.+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence 8999999999876543 233568999999999999
Q ss_pred CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhh-----hHHhhhh---hhhhhcc-----------cCCChhhhcc---
Q 040832 523 GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMED-----CLVDWAR---PLCLRAL-----------DDGNFNEIAD--- 580 (724)
Q Consensus 523 ~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~-----~l~~w~~---~~~~~~~-----------~~~~~~~~vd--- 580 (724)
..++.++|||||||+||||++|+.||......+. .+..... ......+ ..+.+..+.+
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 9999999999999999999999999976532211 1100000 0000000 0000000000
Q ss_pred ----hhh--hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 581 ----PYL--EKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 581 ----~~l--~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+ ...+..++...+.+++.+||+.+|++||++.||+++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 000 113466778889999999999999999999999873
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=359.55 Aligned_cols=246 Identities=25% Similarity=0.347 Sum_probs=199.0
Q ss_pred CCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCch---hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQ---GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~---~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
+.|.+.+.||+|+||.||+|.. .+++.||||++...... ..+.|.+|+++|++++|+||+++++++..++..+|||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4589999999999999999985 57889999999754322 2356899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+. |+|.+++.... ..+++..++.|+.||++||.|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 9997 57777765432 2489999999999999999999999 9999999999999999999999999999876532
Q ss_pred CccccccccCCCcCCcchhc---CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhh
Q 040832 502 THVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEI 578 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~---~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 578 (724)
....|+..|+|||++. .+.++.++|||||||+||||++|+.||......... ..... +....+
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-~~~~~---------~~~~~~ 273 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQ---------NESPAL 273 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHHHH---------SCCCCC
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHh---------cCCCCC
Confidence 2356899999999984 567899999999999999999999999765433221 11100 000000
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 579 ADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 579 vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.... ....+.+++.+||+.+|++||++.+|+++
T Consensus 274 ----~~~~----~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 274 ----QSGH----WSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ----CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----CCCC----CCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0011 22457889999999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=346.03 Aligned_cols=246 Identities=26% Similarity=0.403 Sum_probs=204.3
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
.++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367999999999999999999965 57789999986431 12346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+++++|.+++...+. +++..++.|+.||++||.|||++ +|+|||||++||||+.++.+||+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp ECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 999999999999976543 89999999999999999999998 9999999999999999999999999999766543
Q ss_pred CCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
. .....|+..|+|||++.+..++.++||||||++||||++|+.||+.....+.. .. .. ...
T Consensus 168 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~----~~-----~~~------ 228 (284)
T 2vgo_A 168 R---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH-RR----IV-----NVD------ 228 (284)
T ss_dssp C---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HH----HH-----TTC------
T ss_pred c---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH-HH----Hh-----ccc------
Confidence 2 23356899999999999999999999999999999999999999765432211 00 00 000
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
..++......+.+++.+||+.+|++||++.||++
T Consensus 229 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 ----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 0111222346788999999999999999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=347.35 Aligned_cols=250 Identities=26% Similarity=0.379 Sum_probs=184.3
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999986 478999999996431 12246789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+++++|.+++.... ..+++..++.|+.||++||.|||++ +|+|||||++||||+.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999998643 3489999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
... .....|+..|+|||.+.+..++.++||||||++||||++|+.||......+. +. .+....+
T Consensus 166 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~---------~~~~~~~----- 229 (278)
T 3cok_A 166 HEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-LN---------KVVLADY----- 229 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------CCSSCC-----
T ss_pred CCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-HH---------HHhhccc-----
Confidence 222 2335689999999999988899999999999999999999999976432211 00 0000000
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+......+.+++.+||+.+|++||++.+|+++
T Consensus 230 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 230 -----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -----CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 1111223467899999999999999999999873
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=348.46 Aligned_cols=250 Identities=27% Similarity=0.392 Sum_probs=207.0
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
.+.|.+.+.||+|+||.||+|.+ .+++.||||++.... ....+.+.+|+.+|++++|+||+++++++.+++..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 35689999999999999999985 468899999997553 3345789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|+++++|.+++... .+++..++.|+.||++||.|||++ +|+|||||++||||+.++.+||+|||++........
T Consensus 101 ~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 101 YLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp CCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred eCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 99999999998753 489999999999999999999999 999999999999999999999999999987654332
Q ss_pred ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchh
Q 040832 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~ 582 (724)
. .....|+..|+|||++.+..++.++||||||++||||++|+.||......+... ... .+. ...
T Consensus 175 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~--------~~~-----~~~ 238 (303)
T 3a7i_A 175 K-RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF--LIP--------KNN-----PPT 238 (303)
T ss_dssp C-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HHH--------HSC-----CCC
T ss_pred c-cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH--Hhh--------cCC-----CCC
Confidence 2 234568999999999999999999999999999999999999997654322111 000 000 011
Q ss_pred hhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 040832 583 LEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRAL 620 (724)
Q Consensus 583 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L 620 (724)
+... ....+..++.+||+.+|++||++.+|+++.
T Consensus 239 ~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 239 LEGN----YSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CCSS----CCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred Cccc----cCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 1112 234588999999999999999999998753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=344.49 Aligned_cols=253 Identities=23% Similarity=0.373 Sum_probs=200.7
Q ss_pred CCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
++|....+||+|+||.||+|.+ .+++.||||.+........+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455566899999999999995 467899999998766666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC-CCCEEEEEeccccccCCCCC
Q 040832 425 PNNNLEFHLHGKG-RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY-TFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 425 ~~gsL~~~L~~~~-~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~-~~~vkL~DFGla~~~~~~~~ 502 (724)
.+++|.+++.... ...+++..++.|+.||++||.|||++ +|+|||||++||||+. ++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 9999999997653 33467889999999999999999999 9999999999999987 89999999999987654322
Q ss_pred ccccccccCCCcCCcchhcCCC--CChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 503 HVSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~--~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
. .....|+..|+|||++..+. ++.++||||||++||||++|+.||.............. ..
T Consensus 179 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~-------------- 241 (295)
T 2clq_A 179 C-TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG--MF-------------- 241 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH--HH--------------
T ss_pred c-ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc--cc--------------
Confidence 1 23456899999999987653 88999999999999999999999965432221111100 00
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
......+......+.+++.+||+.+|++||++.+|+++
T Consensus 242 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 242 -KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp -CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred -cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00011122234567889999999999999999999863
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=342.61 Aligned_cols=248 Identities=26% Similarity=0.342 Sum_probs=199.5
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEe----CCeEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIA----GGKRL 418 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~ 418 (724)
..|.+.+.||+|+||.||+|.+. ++..||+|.+... .....+.|.+|+.+|++++|+||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34788889999999999999864 5778999998753 23345679999999999999999999999875 35679
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCccEEEc-CCCCEEEEEecccc
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR--IIHRDIKSSNILLD-YTFETKVADFGLAK 495 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~--iiHrDIkp~NILl~-~~~~vkL~DFGla~ 495 (724)
+||||+++++|.+++..... +++..++.|+.||+.||.|||++ + |+|||||++||||+ .++.+||+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHHccC--CCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 99999999999999986543 89999999999999999999998 7 99999999999997 78999999999997
Q ss_pred ccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCCh
Q 040832 496 LTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~ 575 (724)
...... .....|+..|+|||++. +.++.++|||||||+||||++|+.||............... +..
T Consensus 181 ~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---------~~~ 247 (290)
T 1t4h_A 181 LKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS---------GVK 247 (290)
T ss_dssp GCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT---------TCC
T ss_pred cccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc---------cCC
Confidence 654432 23456899999999876 56999999999999999999999999765433322211111 100
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 576 NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 576 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
. ..+...+ ...+.+++.+||+.+|++||++.||+++
T Consensus 248 ~----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 248 P----ASFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp C----GGGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred c----cccCCCC----CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0 0111111 2458899999999999999999999874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=369.93 Aligned_cols=263 Identities=24% Similarity=0.311 Sum_probs=195.5
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC----C--eEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAG----G--KRL 418 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~----~--~~~ 418 (724)
..|.+.++||+|+||.||+|.+. +++.||||++..+. +.+.+|+++|++|+|+||++++++|... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46889999999999999999975 58999999997542 2345799999999999999999998642 1 357
Q ss_pred EEEEecCCCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCC-CCEEEEEecccc
Q 040832 419 LVYEYVPNNNLEFHLHG--KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYT-FETKVADFGLAK 495 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~--~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~-~~vkL~DFGla~ 495 (724)
|||||+++ +|.+++.. .....+++..++.|+.||++||+|||++ +|+|||||++||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 55554432 2234589999999999999999999998 99999999999999965 568999999998
Q ss_pred ccCCCCCccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhh--------
Q 040832 496 LTTDNNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLC-------- 566 (724)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~-------- 566 (724)
........ ....|+..|+|||++.+. .++.++|||||||+||||++|+.||......+. +..+.+.+.
T Consensus 206 ~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~-l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 206 QLVRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTREQIR 282 (420)
T ss_dssp ECCTTCCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCSCCHHHHH
T ss_pred hcccCCCc--eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHH
Confidence 76543322 345689999999999764 799999999999999999999999987654332 222211100
Q ss_pred --hhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 567 --LRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 567 --~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
...+....+..+....+...+.......+.+++.+||..+|++|+++.|++++
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00000001111111111111222334578899999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=341.98 Aligned_cols=248 Identities=26% Similarity=0.385 Sum_probs=196.7
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
.++|.+.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999965 68999999986431 12345789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+.+++|.+++...+. +++..++.++.||++||.|||++ +|+|||||++||||+.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EeccCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 999999999999976543 89999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCccccccccCCCcCCcchhcCCCC-ChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~-t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
.. .....|+..|+|||.+.+..+ +.++||||||++||||++|+.||+.....+ +.... ..+.+
T Consensus 165 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~--------~~~~~---- 228 (276)
T 2h6d_A 165 EF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--LFKKI--------RGGVF---- 228 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH--------HHCCC----
T ss_pred cc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HHHHh--------hcCcc----
Confidence 22 233568999999999987765 689999999999999999999997643221 11100 00000
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+......+.+++.+||+.+|++||++.||+++
T Consensus 229 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 ------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0111223457889999999999999999999984
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=352.95 Aligned_cols=270 Identities=19% Similarity=0.265 Sum_probs=200.2
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEe--------
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIA-------- 413 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~-------- 413 (724)
.++|.+.+.||+|+||.||+|.+ .+++.||||++..... .....+.+|+++|++++|+||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36799999999999999999996 5789999999865432 224578899999999999999999999987
Q ss_pred CCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecc
Q 040832 414 GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGL 493 (724)
Q Consensus 414 ~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGl 493 (724)
.+..+|||||+.+ +|...+..... .+++..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLV-KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCC-CHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 4568999999975 66666654432 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC---ccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhH--Hhhhhhhh-
Q 040832 494 AKLTTDNNT---HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCL--VDWARPLC- 566 (724)
Q Consensus 494 a~~~~~~~~---~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l--~~w~~~~~- 566 (724)
++....... .......|+..|+|||++.+ ..++.++|||||||+||||++|+.||.......... ........
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 987653221 12234568999999999876 458999999999999999999999998764332211 11000000
Q ss_pred --hhcccCCChhhhcchhhhcCCC-HHH------HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 567 --LRALDDGNFNEIADPYLEKNYP-TEE------MARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 567 --~~~~~~~~~~~~vd~~l~~~~~-~~~------~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
...+....+.+.+......... .+. ...+.+++.+||+.||++||++.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000000000000000000000 111 2347889999999999999999999974
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=363.60 Aligned_cols=254 Identities=23% Similarity=0.328 Sum_probs=192.8
Q ss_pred HhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC--------chhHHHHHHHHHHHHhcCCCCeeEEeeEEEe
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS--------GQGEREFKAEVEIISRVHHRHLVSLVGYCIA 413 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~--------~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 413 (724)
...++|.+.+.||+|+||.||+|.+. +++.||||++.... ......|.+|+++|++|+|+||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45689999999999999999999854 57899999986431 111224889999999999999999999975
Q ss_pred CCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCC---CCEEEEE
Q 040832 414 GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYT---FETKVAD 490 (724)
Q Consensus 414 ~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~---~~vkL~D 490 (724)
.+..+|||||+.+++|.+++...+ .+++..++.|+.||++||+|||++ +|+||||||+||||+.+ +.+||+|
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred cCceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence 456799999999999999887654 389999999999999999999999 99999999999999654 4599999
Q ss_pred eccccccCCCCCccccccccCCCcCCcchhcC---CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhh
Q 040832 491 FGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCL 567 (724)
Q Consensus 491 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~ 567 (724)
||+++...... ......|+..|+|||++.. ..++.++|||||||+||||++|+.||.............
T Consensus 286 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i------ 357 (419)
T 3i6u_A 286 FGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI------ 357 (419)
T ss_dssp SSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHH------
T ss_pred cccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHH------
Confidence 99998765432 2344679999999999863 678899999999999999999999997543221111111
Q ss_pred hcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 568 RALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 568 ~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+.+.. .+.... .....+.+++.+||+.+|++||++.|++++
T Consensus 358 ---~~~~~~~--~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 358 ---TSGKYNF--IPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp ---HTTCCCC--CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---hcCCCCC--Cchhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1111100 000001 123468899999999999999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=355.38 Aligned_cols=261 Identities=24% Similarity=0.390 Sum_probs=202.5
Q ss_pred cCHHHHHHhhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEe
Q 040832 336 FTYEELSAATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGYCIA 413 (724)
Q Consensus 336 f~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~ 413 (724)
+.+.++....++|.+.+.||+|+||.||+|.+ .+++.||||++.... ...+.+.+|+.+|+++ +|+||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 34445556678999999999999999999996 468899999987543 3356789999999999 79999999999987
Q ss_pred ------CCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEE
Q 040832 414 ------GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETK 487 (724)
Q Consensus 414 ------~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vk 487 (724)
.+..+|||||+++++|.+++.......+++..++.|+.||+.||.|||++ +|+|||||++||||+.++.+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEE
Confidence 46889999999999999999876545689999999999999999999999 999999999999999999999
Q ss_pred EEEeccccccCCCCCccccccccCCCcCCcchhc-----CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhh
Q 040832 488 VADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWA 562 (724)
Q Consensus 488 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~ 562 (724)
|+|||++........ ......|+..|+|||++. ...++.++|||||||+||||++|+.||........... +.
T Consensus 170 l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~ 247 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-IP 247 (326)
T ss_dssp ECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-HH
T ss_pred EeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH-hh
Confidence 999999987653322 123356899999999987 56789999999999999999999999976543322111 10
Q ss_pred hhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 563 RPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 563 ~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
. .....+ .... ....+.+++.+||..+|++||++.+|+++
T Consensus 248 ~---------~~~~~~----~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 248 R---------NPAPRL----KSKK----WSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp H---------SCCCCC----SCSC----SCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred c---------CccccC----Cccc----cCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 000000 0111 23468889999999999999999999873
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=364.98 Aligned_cols=260 Identities=20% Similarity=0.262 Sum_probs=208.0
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCC-CCeeEEeeEEEeCCeEEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHH-RHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~lV~E 422 (724)
.++|.++++||+|+||.||+|.+ .+++.||||++..... ..++..|+++++.|+| .+|..+..++...+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 47899999999999999999995 5689999998875432 2358899999999976 666677777788889999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEE---cCCCCEEEEEeccccccCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILL---DYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl---~~~~~vkL~DFGla~~~~~ 499 (724)
|+ +++|.+++..... .+++..++.|+.||+.||+|||++ +|||||||++|||| +.++.+||+|||+++....
T Consensus 84 ~~-g~sL~~ll~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 9999999985433 489999999999999999999999 99999999999999 6889999999999987765
Q ss_pred CCCc------cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhh--hHHhhhhhhhhhccc
Q 040832 500 NNTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMED--CLVDWARPLCLRALD 571 (724)
Q Consensus 500 ~~~~------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~--~l~~w~~~~~~~~~~ 571 (724)
.... ......|+..|+|||++.+..++.++|||||||+||||++|+.||........ .+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~------ 232 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------ 232 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH------
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc------
Confidence 4332 12356799999999999999999999999999999999999999986533211 111111100
Q ss_pred CCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 572 DGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 572 ~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
+...+. .+...+ ...|.+++..||+.+|++||++.+|++.|+..+.
T Consensus 233 ---~~~~~~-~l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 233 ---VATSIE-ALCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp ---HHSCHH-HHHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred ---ccccHH-HHhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 001111 111122 3468899999999999999999999999887644
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=355.32 Aligned_cols=264 Identities=22% Similarity=0.308 Sum_probs=195.5
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhH-HHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGE-REFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~-~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
++|.+.+.||+|+||.||+|.+. +++.||||+++....... ..+.+|+++|++++|+||+++++++.+++..+|||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999965 688999999975432221 2466899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
++ ++|.+++...+. .+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++........
T Consensus 82 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp CS-EEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence 97 588888876543 589999999999999999999999 9999999999999999999999999999866533222
Q ss_pred cccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch-
Q 040832 504 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP- 581 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~- 581 (724)
.....|+..|+|||++.+ ..++.++|||||||+||||++|+.||......+.. ....+.+ . ......+..+...
T Consensus 157 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~i~~~~-~-~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 157 -YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL-HFIFRIL-G-TPTEETWPGILSNE 232 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHH-C-CCCTTTSTTGGGCH
T ss_pred -cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHh-C-CCChHhchhhhcch
Confidence 234568999999999876 56899999999999999999999999876433321 1111100 0 0000001110000
Q ss_pred --------hhhc----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 582 --------YLEK----NYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 582 --------~l~~----~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
.... .........+.+++.+||+.||++||++.||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000 000112345789999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=355.81 Aligned_cols=287 Identities=21% Similarity=0.266 Sum_probs=206.3
Q ss_pred cCHHHHHHhhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCch-----------hHHHHHHHHHHHHhcCCCCe
Q 040832 336 FTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQ-----------GEREFKAEVEIISRVHHRHL 404 (724)
Q Consensus 336 f~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~-----------~~~~f~~Ei~il~~l~HpnI 404 (724)
..++++....++|.+.++||+|+||.||+|.+.+++.||||++...... ..+.|.+|+++|++++|+||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 4567889999999999999999999999999888999999998643221 13679999999999999999
Q ss_pred eEEeeEEEeC-----CeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEE
Q 040832 405 VSLVGYCIAG-----GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNIL 479 (724)
Q Consensus 405 v~l~g~~~~~-----~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NIL 479 (724)
+++++++... ...+|||||+. ++|.+++.... ..+++..++.|+.||++||.|||++ +|+||||||+|||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL 166 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence 9999998643 36799999998 57777776543 3589999999999999999999999 9999999999999
Q ss_pred EcCCCCEEEEEeccccccCCCCCccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhh-
Q 040832 480 LDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC- 557 (724)
Q Consensus 480 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~- 557 (724)
|+.++.+||+|||+++....... .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||......+..
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 244 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244 (362)
T ss_dssp ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EcCCCCEEEEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999986544322 234568999999999877 67899999999999999999999999875432221
Q ss_pred -HHhhhhhhhhh---cccCCChhhhcchhhhc-------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HhCCC
Q 040832 558 -LVDWARPLCLR---ALDDGNFNEIADPYLEK-------NYPTEEMARMVACAAASIRHSARRRPKISQIVRA--LEGDV 624 (724)
Q Consensus 558 -l~~w~~~~~~~---~~~~~~~~~~vd~~l~~-------~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~--L~~~~ 624 (724)
+..+....... ........+.+...+.. .........+.+++.+||+.+|++||++.||+++ ++...
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 11100000000 00000000000000000 0011223458899999999999999999999974 44444
Q ss_pred Ccccc
Q 040832 625 SLEDL 629 (724)
Q Consensus 625 ~~~~l 629 (724)
...++
T Consensus 325 ~~~~~ 329 (362)
T 3pg1_A 325 DPLDL 329 (362)
T ss_dssp CGGGG
T ss_pred Ccccc
Confidence 33333
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=363.78 Aligned_cols=200 Identities=25% Similarity=0.313 Sum_probs=175.7
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhc------CCCCeeEEeeEEEeCCeE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRV------HHRHLVSLVGYCIAGGKR 417 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l------~HpnIv~l~g~~~~~~~~ 417 (724)
.++|.+.++||+|+||.||+|.+. +++.||||+++.. ....+.+.+|+++|+.+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457999999999999999999854 5889999999753 23345788899998888 477999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCC--EEEEEecccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFE--TKVADFGLAK 495 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~--vkL~DFGla~ 495 (724)
+|||||+. ++|.+++.......+++..++.|+.||++||+|||++ +||||||||+||||+.++. +||+|||+++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999996 6888888876656699999999999999999999999 9999999999999999887 9999999997
Q ss_pred ccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCc
Q 040832 496 LTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGA 553 (724)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~ 553 (724)
...... ....|+..|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 251 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 251 YEHQRV----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp ETTCCC----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ecCCcc----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 654332 235689999999999999999999999999999999999999987643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=360.12 Aligned_cols=267 Identities=22% Similarity=0.294 Sum_probs=198.2
Q ss_pred HHHhhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC-----
Q 040832 341 LSAATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAG----- 414 (724)
Q Consensus 341 l~~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~----- 414 (724)
++...++|.+++.||+|+||.||+|.+ .+|+.||||++..+.. .+.+|+++|+.++|+||+++++++...
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 345678999999999999999999985 5789999999975432 234799999999999999999998543
Q ss_pred ---------------------------------CeEEEEEEecCCCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHH
Q 040832 415 ---------------------------------GKRLLVYEYVPNNNLEFHLHG--KGRPVMDWPTRLKIAMGSAKGLAY 459 (724)
Q Consensus 415 ---------------------------------~~~~lV~E~~~~gsL~~~L~~--~~~~~l~~~~~~~i~~qia~gL~y 459 (724)
...+|||||++ ++|.++|.. .....+++..++.|+.||++||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 34789999998 577766653 223358999999999999999999
Q ss_pred HHhcCCCCeEecCCCCccEEEc-CCCCEEEEEeccccccCCCCCccccccccCCCcCCcchhcCC-CCChhHHHHHHHHH
Q 040832 460 LHEDCHPRIIHRDIKSSNILLD-YTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVM 537 (724)
Q Consensus 460 LHs~~~~~iiHrDIkp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvl 537 (724)
||++ +|+||||||+||||+ .++.+||+|||+++........ ....|+..|+|||++.+. .++.++|||||||+
T Consensus 157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS--VAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC--CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC--cCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9998 999999999999997 6889999999999876544322 345689999999998765 58999999999999
Q ss_pred HHHHHhCCCCCCCCCchhhhHHhhhhhhhh----------hcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCC
Q 040832 538 LLELITGRRPIDPTGAMEDCLVDWARPLCL----------RALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSA 607 (724)
Q Consensus 538 L~eLltG~~P~~~~~~~~~~l~~w~~~~~~----------~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P 607 (724)
||||++|+.||......+. +......+.. .......+..+....+...++......+.+++.+||+.+|
T Consensus 232 l~ell~g~~pf~~~~~~~~-~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQ-LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 9999999999987644332 1111110000 0000001111111111111222344568899999999999
Q ss_pred CCCCCHHHHHH
Q 040832 608 RRRPKISQIVR 618 (724)
Q Consensus 608 ~~RPs~~evv~ 618 (724)
++||++.|+++
T Consensus 311 ~~R~t~~e~l~ 321 (383)
T 3eb0_A 311 DLRINPYEAMA 321 (383)
T ss_dssp GGSCCHHHHHT
T ss_pred hhCCCHHHHhc
Confidence 99999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=355.26 Aligned_cols=264 Identities=20% Similarity=0.242 Sum_probs=194.8
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC------
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGG------ 415 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~------ 415 (724)
.++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+|+.++|+||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 478999999999999999999854 68899999997542 233457899999999999999999999998765
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 416 KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
..+|||||+++ +|.+++.. .+++..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 78999999975 67777753 288999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhh------hh--
Q 040832 496 LTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPL------CL-- 567 (724)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~------~~-- 567 (724)
...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||......+.... ....+ ..
T Consensus 176 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 176 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK-VIEQLGTPCPEFMKK 252 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHC-CCCCCHHHHTT
T ss_pred cccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCCCHHHHHH
Confidence 765432 22345789999999999999999999999999999999999999987643322110 00000 00
Q ss_pred ------------hcccCCChhhhcchhhhcCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 568 ------------RALDDGNFNEIADPYLEKNY---PTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 568 ------------~~~~~~~~~~~vd~~l~~~~---~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.......+..+....+.... .......+.+++.+||+.||++||++.|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00001111111111111110 12235678999999999999999999999973
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=350.58 Aligned_cols=266 Identities=20% Similarity=0.266 Sum_probs=195.9
Q ss_pred hCCCcccceeeccCcEEEEEEEcCC-CcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEE-----------
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPN-GKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCI----------- 412 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~----------- 412 (724)
.++|.+.+.||+|+||.||+|.+.. ++.||||++........+.+.+|+++|++++|+||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4689999999999999999999754 8899999998766566678999999999999999999999873
Q ss_pred ---eCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEc-CCCCEEE
Q 040832 413 ---AGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLD-YTFETKV 488 (724)
Q Consensus 413 ---~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~-~~~~vkL 488 (724)
+....++||||+. ++|.+++... .+.+..++.|+.||++||+|||++ +|+|||||++||||+ +++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEE
Confidence 3467899999997 6899988653 388999999999999999999999 999999999999997 5679999
Q ss_pred EEeccccccCCCCCc--cccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhh
Q 040832 489 ADFGLAKLTTDNNTH--VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPL 565 (724)
Q Consensus 489 ~DFGla~~~~~~~~~--~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~ 565 (724)
+|||+++........ ......++..|+|||.+.. ..++.++|||||||+||||++|+.||......+... ......
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-~~~~~~ 241 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ-LILESI 241 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHHHS
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHhc
Confidence 999999876533221 2233567899999998865 689999999999999999999999998765432211 110000
Q ss_pred --h----hhcccCCChhhhcchhhh-cCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 566 --C----LRALDDGNFNEIADPYLE-KNY-----PTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 566 --~----~~~~~~~~~~~~vd~~l~-~~~-----~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
. ...+. ..+...+...+. ... .......+.+++.+||+.+|++||++.||+++
T Consensus 242 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 242 PVVHEEDRQELL-SVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCCCHHHHHHHH-TTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCchhhhhhhh-hcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0 00000 000000000000 000 01224568899999999999999999999873
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=367.91 Aligned_cols=241 Identities=16% Similarity=0.167 Sum_probs=188.8
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccC---CchhHHHHHHHHH---HHHhcCCCCeeEEe-------eE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSG---SGQGEREFKAEVE---IISRVHHRHLVSLV-------GY 410 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~---~~~~~~~f~~Ei~---il~~l~HpnIv~l~-------g~ 410 (724)
.++|.+.+.||+|+||.||+|.+ .+|+.||||+++.. .....+.|.+|+. +|++++|+||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788999999999999999996 46899999999743 3334567999994 55556899999998 66
Q ss_pred EEeCC-----------------eEEEEEEecCCCCHHHHHhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 040832 411 CIAGG-----------------KRLLVYEYVPNNNLEFHLHGKGR-----PVMDWPTRLKIAMGSAKGLAYLHEDCHPRI 468 (724)
Q Consensus 411 ~~~~~-----------------~~~lV~E~~~~gsL~~~L~~~~~-----~~l~~~~~~~i~~qia~gL~yLHs~~~~~i 468 (724)
+.+.+ ..+|||||+ +|+|.+++...+. ..+.+..++.|+.||++||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 65543 278999999 6899999975432 1133588889999999999999999 99
Q ss_pred EecCCCCccEEEcCCCCEEEEEeccccccCCCCCccccccccCCCcCCcchhcCC-----------CCChhHHHHHHHHH
Q 040832 469 IHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSG-----------KLTEKSDVFSFGVM 537 (724)
Q Consensus 469 iHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----------~~t~ksDV~SlGvl 537 (724)
+||||||+||||+.++.+||+|||+++.... ......| ..|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986433 2234567 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 040832 538 LLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIV 617 (724)
Q Consensus 538 L~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv 617 (724)
||||++|+.||........ +..+.... ..+ ...+.+++.+||+.+|++||++.||+
T Consensus 303 l~elltg~~Pf~~~~~~~~------------------~~~~~~~~--~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l 358 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGG------------------SEWIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAM 358 (377)
T ss_dssp HHHHHHSSCCC------CC------------------SGGGGSSC--CCC----CHHHHHHHHHHTCSSGGGCCCHHHHH
T ss_pred HHHHHHCCCCCcccccccc------------------hhhhhhhc--cCC----CHHHHHHHHHHcCCCchhCCCHHHHh
Confidence 9999999999965432110 00000000 122 24578899999999999999999998
Q ss_pred H
Q 040832 618 R 618 (724)
Q Consensus 618 ~ 618 (724)
+
T Consensus 359 ~ 359 (377)
T 3byv_A 359 E 359 (377)
T ss_dssp T
T ss_pred h
Confidence 6
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=343.78 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=199.4
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC----chhHHHHHHHHHHHHhcCCCCeeEEeeEEE--eCCe
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS----GQGEREFKAEVEIISRVHHRHLVSLVGYCI--AGGK 416 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~----~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~--~~~~ 416 (724)
..++|.+++.||+|+||.||++.+. +++.||||+++... ....+.|.+|+++|++++|+||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3578999999999999999999964 67899999997532 234567999999999999999999999985 4457
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
.++||||+.++ |.+++.......+++..++.|+.||++||.|||++ +|+|||||++||||+.++.+||+|||++..
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 89999999877 77777665555689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC-ccccccccCCCcCCcchhcCCC--CChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCC
Q 040832 497 TTDNNT-HVSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDG 573 (724)
Q Consensus 497 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~--~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~ 573 (724)
...... .......|+..|+|||++.+.. ++.++||||||++||||++|+.||......+. .... ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~i---------~~~ 228 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL-FENI---------GKG 228 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHH---------HHC
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH-HHHH---------hcC
Confidence 653322 2223456899999999997644 47899999999999999999999976432211 1100 000
Q ss_pred ChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 574 NFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 574 ~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+ .++......+.+++.+||+.+|++||++.||+++
T Consensus 229 ~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 229 SY----------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CC----------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CC----------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 1111233467889999999999999999999974
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=373.46 Aligned_cols=254 Identities=26% Similarity=0.374 Sum_probs=205.9
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
.++|.+.++||+|+||.||++++. +|+.||||++.... ......+.+|+++|++++|+||+++++++.+.+..+||
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367899999999999999999965 68999999996431 12345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 421 YEYVPNNNLEFHLHGKG--RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~--~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
|||+.+|+|..+|.... ...+++..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999997643 44589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhh
Q 040832 499 DNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEI 578 (724)
Q Consensus 499 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 578 (724)
..... .....||..|+|||++.+..++.++|||||||+||||++|+.||......... ..+...... ..
T Consensus 341 ~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~-~~~~~~i~~-----~~---- 409 (543)
T 3c4z_A 341 AGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQRVLE-----QA---- 409 (543)
T ss_dssp TTCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH-HHHHHHHHH-----CC----
T ss_pred CCCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH-HHHHHHHhh-----cc----
Confidence 44322 23457999999999999999999999999999999999999999764321110 011110000 00
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 040832 579 ADPYLEKNYPTEEMARMVACAAASIRHSARRRPKI-----SQIVR 618 (724)
Q Consensus 579 vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evv~ 618 (724)
..++......+..++.+||+.+|++||++ .+|++
T Consensus 410 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 410 ------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 01222334567889999999999999975 56654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=351.00 Aligned_cols=263 Identities=23% Similarity=0.365 Sum_probs=188.6
Q ss_pred HhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
...++|.+.+.||+|+||.||+|.+. +++.||||++.... ....+++.+|+.++++++|+||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34578999999999999999999864 68899999987543 23345788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccc
Q 040832 421 YEYVPNNNLEFHLHG------KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLA 494 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~------~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla 494 (724)
|||+++++|.+++.. .....+++..++.|+.||++||.|||++ +|+|||||++||||+.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999998864 1233589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC----ccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhc
Q 040832 495 KLTTDNNT----HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRA 569 (724)
Q Consensus 495 ~~~~~~~~----~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~ 569 (724)
........ .......|+..|+|||++.. ..++.++|||||||+||||++|+.||...............
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------ 242 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN------ 242 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS------
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc------
Confidence 87653321 11233568999999999875 56899999999999999999999999876543322111110
Q ss_pred ccCCChh-hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 570 LDDGNFN-EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 570 ~~~~~~~-~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
....+. ...+..+... ....+.+++.+||+.+|++||++.+|+++
T Consensus 243 -~~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 243 -DPPSLETGVQDKEMLKK----YGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp -SCCCTTC-----CCCCC----CCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -CCCccccccccchhhhh----hhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 000000 0001111112 23467889999999999999999999873
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=350.67 Aligned_cols=269 Identities=23% Similarity=0.315 Sum_probs=204.3
Q ss_pred HhhCCCcccceeeccCcEEEEEEEc--CCCcEEEEEEeccCCch--hHHHHHHHHHHHHhc---CCCCeeEEeeEEE---
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVL--PNGKEVAVKSLRSGSGQ--GEREFKAEVEIISRV---HHRHLVSLVGYCI--- 412 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~--~~g~~vaVK~l~~~~~~--~~~~f~~Ei~il~~l---~HpnIv~l~g~~~--- 412 (724)
.+.++|++.+.||+|+||.||+|.+ .+++.||||+++..... ....+.+|+.+++++ +|+||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4567899999999999999999996 46788999998643221 223567788777776 8999999999987
Q ss_pred --eCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEE
Q 040832 413 --AGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVAD 490 (724)
Q Consensus 413 --~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~D 490 (724)
.....++||||+. ++|.+++.......+++..++.|+.||++||.|||++ +|+|||||++||||+.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 6999999876655689999999999999999999999 999999999999999999999999
Q ss_pred eccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhh---
Q 040832 491 FGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCL--- 567 (724)
Q Consensus 491 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~--- 567 (724)
||+++...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||......+.. ......+..
T Consensus 164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~i~~~~~~~~~ 240 (326)
T 1blx_A 164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL-GKILDVIGLPGE 240 (326)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCCCCG
T ss_pred CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHHHcCCCCc
Confidence 99998765322 223456899999999999999999999999999999999999999876433221 111100000
Q ss_pred hccc------CCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 568 RALD------DGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 568 ~~~~------~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+. ...+.......+ ..+.......+.+++.+||+.+|++||++.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCccccccchhhhcccCcchh-hhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 000000000000 01112234567899999999999999999999963
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=361.53 Aligned_cols=265 Identities=24% Similarity=0.327 Sum_probs=198.8
Q ss_pred hCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCe------EE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGK------RL 418 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~------~~ 418 (724)
..+|.+.++||+|+||.||+|.+.++..||||++..... ...+|+++|++++|+||+++++++...+. .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 356999999999999999999987777799998865422 23469999999999999999999865443 78
Q ss_pred EEEEecCCCCHHHHHhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEc-CCCCEEEEEeccccc
Q 040832 419 LVYEYVPNNNLEFHLHG-KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLD-YTFETKVADFGLAKL 496 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~-~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~-~~~~vkL~DFGla~~ 496 (724)
|||||+.++.+..+.+. .....+++..++.|+.||++||+|||++ +|+||||||+||||+ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999987665544321 1233589999999999999999999999 999999999999999 799999999999987
Q ss_pred cCCCCCccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhh---------
Q 040832 497 TTDNNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLC--------- 566 (724)
Q Consensus 497 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~--------- 566 (724)
....... ....|+..|+|||++.+. .++.++|||||||+||||++|+.||......+. +....+.+.
T Consensus 192 ~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 192 LIAGEPN--VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ-LVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CCTTCCC--CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHH
T ss_pred ccCCCCC--cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHh
Confidence 6543332 345689999999998764 589999999999999999999999987654332 221111100
Q ss_pred -hhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 567 -LRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 567 -~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
........+.......+...+.......+.+++.+||+.+|++||++.|++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000111111111111111222234578999999999999999999999974
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=341.28 Aligned_cols=253 Identities=24% Similarity=0.300 Sum_probs=203.9
Q ss_pred HhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc---------hhHHHHHHHHHHHHhcC-CCCeeEEeeEE
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG---------QGEREFKAEVEIISRVH-HRHLVSLVGYC 411 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~---------~~~~~f~~Ei~il~~l~-HpnIv~l~g~~ 411 (724)
...++|.+.+.||+|+||.||+|.+. +++.||||+++.... ...+.+.+|+++|+++. |+||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999965 588999999975431 12346889999999995 99999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEe
Q 040832 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADF 491 (724)
Q Consensus 412 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DF 491 (724)
...+..+|||||+++++|.+++.... .+++..++.|+.||+.||.|||++ +|+|||||++||||+.++.+||+||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999999998654 389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCccccccccCCCcCCcchhc------CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhh
Q 040832 492 GLAKLTTDNNTHVSTRVMGTFGYLAPEYAS------SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPL 565 (724)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~ 565 (724)
|++........ .....|+..|+|||++. ...++.++||||||++||||++|+.||........ +...
T Consensus 169 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~---- 241 (298)
T 1phk_A 169 GFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-LRMI---- 241 (298)
T ss_dssp TTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH----
T ss_pred cchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH-HHHH----
Confidence 99987654332 23456899999999885 45688999999999999999999999976532221 1100
Q ss_pred hhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 566 CLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 566 ~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
. .+.+.. ..+ ........+.+++.+||+.+|++||++.||++
T Consensus 242 ~-----~~~~~~-~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 242 M-----SGNYQF-GSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp H-----HTCCCC-CTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred h-----cCCccc-Ccc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 0 000000 000 00122356889999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=351.75 Aligned_cols=261 Identities=22% Similarity=0.328 Sum_probs=201.8
Q ss_pred ccCHHHHHHhhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCC--chhHHHHHHHHHHHHhcC--CCCeeEEeeE
Q 040832 335 AFTYEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGS--GQGEREFKAEVEIISRVH--HRHLVSLVGY 410 (724)
Q Consensus 335 ~f~~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~--HpnIv~l~g~ 410 (724)
.+.++.+....++|++.+.||+|+||.||++.+.+++.||||++.... ....+.|.+|+++|++++ |+||++++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 444455556677899999999999999999998889999999997542 234467999999999996 5999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEE
Q 040832 411 CIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVAD 490 (724)
Q Consensus 411 ~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~D 490 (724)
+.+++..+|||| +.+++|.+++.... .+++..++.|+.||++||.|||++ +|+|||||++||||++ +.+||+|
T Consensus 97 ~~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 97 EITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECC
T ss_pred eecCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEee
Confidence 999999999999 56889999998754 489999999999999999999999 9999999999999965 7999999
Q ss_pred eccccccCCCCCc-cccccccCCCcCCcchhcC-----------CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhH
Q 040832 491 FGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASS-----------GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCL 558 (724)
Q Consensus 491 FGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~-----------~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l 558 (724)
||+++........ ......|+..|+|||++.. ..++.++|||||||+||||++|+.||.........+
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 249 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH
Confidence 9999876544322 2234568999999999875 478899999999999999999999997643222211
Q ss_pred HhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 559 VDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 559 ~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+. +......++......+.+++.+||+.+|++||++.||+++
T Consensus 250 ~~~~-----------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 250 HAII-----------------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHH-----------------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHH-----------------hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1111 1111111111123468889999999999999999999974
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=347.39 Aligned_cols=257 Identities=27% Similarity=0.396 Sum_probs=197.3
Q ss_pred hCCCcccceeeccCcEEEEEEEcC--CCc--EEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP--NGK--EVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKR 417 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~--~g~--~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 417 (724)
.++|++.+.||+|+||.||+|.+. +++ .||||+++.. .....+.|.+|++++++++|+||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357899999999999999999853 233 5899998754 2234567999999999999999999999998765 7
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
++||||+.+++|.+++.... ..+++..+++|+.||++||.|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccc
Confidence 89999999999999987642 2388999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCc--cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCC
Q 040832 498 TDNNTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGN 574 (724)
Q Consensus 498 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~ 574 (724)
...... ......++..|+|||++.+..++.++||||||++||||++ |+.||......+. +..... ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~~~~~--------~~~ 242 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-LHKIDK--------EGE 242 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HHHHHT--------SCC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH-HHHHHc--------cCC
Confidence 554332 2233457888999999998889999999999999999999 9999976543221 111000 000
Q ss_pred hhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 575 FNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 575 ~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
. ..........+.+++.+||+.+|++||++.+|+++|+...
T Consensus 243 ~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 243 R---------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred C---------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 0 0011123356889999999999999999999999998654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=345.83 Aligned_cols=266 Identities=20% Similarity=0.308 Sum_probs=207.2
Q ss_pred hCCCcccceeeccCcEEEEEEEc--CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCC------CeeEEeeEEEeCCe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL--PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHR------HLVSLVGYCIAGGK 416 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~--~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~Hp------nIv~l~g~~~~~~~ 416 (724)
.++|++.+.||+|+||.||+|.+ .+++.||||+++.. ....+.+.+|++++++++|+ +|+++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999985 36889999999753 23346788999999999765 49999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC--------------
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY-------------- 482 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~-------------- 482 (724)
.+|||||+ +++|.+++...+...+++..++.|+.||++||+|||++ +|+||||||+||||+.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 88999999877655689999999999999999999999 9999999999999987
Q ss_pred -----CCCEEEEEeccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhh
Q 040832 483 -----TFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC 557 (724)
Q Consensus 483 -----~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~ 557 (724)
++.+||+|||+++...... ....|+..|+|||++.+..++.++|||||||+||||++|+.||......+..
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred cccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 6789999999998754432 3356899999999999999999999999999999999999999866433221
Q ss_pred H--Hhhhhhh---hhhcccCCC------------------hhhhcchhh-hcCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 040832 558 L--VDWARPL---CLRALDDGN------------------FNEIADPYL-EKNYPTEEMARMVACAAASIRHSARRRPKI 613 (724)
Q Consensus 558 l--~~w~~~~---~~~~~~~~~------------------~~~~vd~~l-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 613 (724)
. ......+ +........ +........ .......+...+.+++.+||+.||++||++
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 1 0000000 000000000 000000000 011234566789999999999999999999
Q ss_pred HHHHHH
Q 040832 614 SQIVRA 619 (724)
Q Consensus 614 ~evv~~ 619 (724)
.||+++
T Consensus 324 ~ell~h 329 (339)
T 1z57_A 324 REALKH 329 (339)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=360.24 Aligned_cols=253 Identities=12% Similarity=0.053 Sum_probs=182.6
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc---hhHHHHHHHHHHHHhc--CCCCeeEEe-------eEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG---QGEREFKAEVEIISRV--HHRHLVSLV-------GYCI 412 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~---~~~~~f~~Ei~il~~l--~HpnIv~l~-------g~~~ 412 (724)
..|.+.+.||+|+||.||+|.+. +++.||||+++.... ...+.+++|+.+++.| +|+||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 35888999999999999999954 788999999987543 2344678886666655 599988755 4444
Q ss_pred eC-----------------CeEEEEEEecCCCCHHHHHhcCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCeE
Q 040832 413 AG-----------------GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTR------LKIAMGSAKGLAYLHEDCHPRII 469 (724)
Q Consensus 413 ~~-----------------~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~------~~i~~qia~gL~yLHs~~~~~ii 469 (724)
.. ...+|||||++ ++|.+++...+. .+.+..+ +.|+.||++||+|||++ +||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv 216 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSK---GLV 216 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence 33 23799999998 899999976432 2455566 78889999999999999 999
Q ss_pred ecCCCCccEEEcCCCCEEEEEeccccccCCCCCccccccccCCCcCCcchhcC--CCCChhHHHHHHHHHHHHHHhCCCC
Q 040832 470 HRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRP 547 (724)
Q Consensus 470 HrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~t~ksDV~SlGvlL~eLltG~~P 547 (724)
||||||+||||+.++.+||+|||+++...... ....++..|+|||++.+ ..++.++|||||||+||||++|+.|
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998764321 13457799999999987 6799999999999999999999999
Q ss_pred CCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 548 IDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 548 ~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
|........ ..|...... ......+...........+.+++.+||+.+|++||++.|+++
T Consensus 293 f~~~~~~~~--~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 293 FGLVTPGIK--GSWKRPSLR---------VPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTBCCTTCT--TCCCBCCTT---------SCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCcCcccc--cchhhhhhh---------hccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 976532211 111110000 000000000001123456888999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=353.80 Aligned_cols=268 Identities=20% Similarity=0.289 Sum_probs=202.3
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeC-----CeE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAG-----GKR 417 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~-----~~~ 417 (724)
.++|++.++||+|+||.||+|.+. +++.||||++...... ..+.+.+|+++|++++|+||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999854 6788999999754333 346799999999999999999999999765 368
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
++||||+. ++|.+++.... +++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~~~---~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999997 58988887643 89999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc--cccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHH--hhhhhhhh---hc
Q 040832 498 TDNNTH--VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLV--DWARPLCL---RA 569 (724)
Q Consensus 498 ~~~~~~--~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~--~w~~~~~~---~~ 569 (724)
...... ......|+..|+|||++.+ ..++.++|||||||+||||++|+.||......+.... ........ ..
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 543222 1244579999999998765 4589999999999999999999999987654332111 00000000 00
Q ss_pred ccCCChhhhcchhhh-cCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 570 LDDGNFNEIADPYLE-KNYP-----TEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 570 ~~~~~~~~~vd~~l~-~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+.............. .... ......+.+++.+||+.+|++||++.||+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000000 0000 1123457899999999999999999999974
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=342.55 Aligned_cols=253 Identities=24% Similarity=0.331 Sum_probs=187.2
Q ss_pred hhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchh-H-HHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQG-E-REFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~-~-~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
..++|++.+.||+|+||.||+|.+ .+++.||||+++...... . +.+.++..+++.++|+||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 356899999999999999999996 478899999997653322 2 3355566668888999999999999999999999
Q ss_pred EEecCCCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 421 YEYVPNNNLEFHLHG--KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~--~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
|||++ ++|.+++.. .....+++..++.|+.||+.||+|||+++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99997 477776653 12335899999999999999999999864 79999999999999999999999999998765
Q ss_pred CCCCccccccccCCCcCCcchh----cCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCC
Q 040832 499 DNNTHVSTRVMGTFGYLAPEYA----SSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGN 574 (724)
Q Consensus 499 ~~~~~~~~~~~gt~~y~APE~~----~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~ 574 (724)
..... ....|+..|+|||++ ....++.++|||||||+||||++|+.||+........+....... .
T Consensus 162 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~ 231 (290)
T 3fme_A 162 DDVAK--DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP--------S 231 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC--------C
T ss_pred ccccc--cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC--------C
Confidence 43322 234689999999996 556789999999999999999999999976433322222111100 0
Q ss_pred hhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 575 FNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 575 ~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
. ..........+.+++.+||+.+|++||++.||++
T Consensus 232 -~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 -P--------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -C--------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -C--------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0 0001122345889999999999999999999987
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=345.82 Aligned_cols=252 Identities=23% Similarity=0.329 Sum_probs=196.9
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc--------hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG--------QGEREFKAEVEIISRVHHRHLVSLVGYCIAG 414 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~--------~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 414 (724)
..++|.+.+.||+|+||.||+|.+. +++.||||++..... .....|.+|+++|++++|+||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999864 578999999865321 1223588999999999999999999998766
Q ss_pred CeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCC---EEEEEe
Q 040832 415 GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFE---TKVADF 491 (724)
Q Consensus 415 ~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~---vkL~DF 491 (724)
. .++||||+++++|.+++.... .+++..++.|+.||++||.|||++ +|+|||||++||||+.++. +||+||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred c-eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 5 799999999999999887654 489999999999999999999999 9999999999999987654 999999
Q ss_pred ccccccCCCCCccccccccCCCcCCcchhc---CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhh
Q 040832 492 GLAKLTTDNNTHVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLR 568 (724)
Q Consensus 492 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~ 568 (724)
|+++...... ......|+..|+|||++. ...++.++|||||||+||||++|+.||..............
T Consensus 162 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------ 233 (322)
T 2ycf_A 162 GHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT------ 233 (322)
T ss_dssp TTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHH------
T ss_pred ccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHH------
Confidence 9998765432 223456899999999974 56789999999999999999999999975432211111000
Q ss_pred cccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 569 ALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 569 ~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
.+.+. ..+.+.. .....+.+++.+||+.+|++||++.++++
T Consensus 234 ---~~~~~--~~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 ---SGKYN--FIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ---HTCCC--CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---hCccc--cCchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00000 0001111 12346889999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=356.99 Aligned_cols=262 Identities=21% Similarity=0.299 Sum_probs=197.4
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC------
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGG------ 415 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~------ 415 (724)
.++|.+.+.||+|+||.||+|.+ .+|+.||||++.... ....+.+.+|+++|++++|+||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46899999999999999999996 468999999996532 223457899999999999999999999998753
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 416 KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
..+|||||+ +++|.+++... .+++..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 459999999 88999998763 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhh------hhh
Q 040832 496 LTTDNNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPL------CLR 568 (724)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~------~~~ 568 (724)
..... .....||.+|+|||++.+ ..++.++|||||||+||||++|+.||......+... ...... ...
T Consensus 177 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~-~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 177 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK-EIMKVTGTPPAEFVQ 251 (367)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHHHHCCCCHHHHH
T ss_pred ccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHhcCCCCHHHHH
Confidence 76542 234568999999999887 689999999999999999999999998765433211 110000 000
Q ss_pred cccCCChhhhcc-------hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 569 ALDDGNFNEIAD-------PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 569 ~~~~~~~~~~vd-------~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+........+. ..+. .........+.+++.+||..||++||++.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000000000000 0000 0111234568899999999999999999999984
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=360.51 Aligned_cols=198 Identities=25% Similarity=0.349 Sum_probs=167.0
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC-----Ce
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAG-----GK 416 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~-----~~ 416 (724)
.++|.+.++||+|+||.||+|.+. +++.||||+++.. .....+.+.+|+++|++|+|+||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999864 5788999999754 223446799999999999999999999999876 57
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
.||||||++ ++|..++.... .+++..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 899999996 59999987654 389999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc---------------------cccccccCCCcCCcchh-cCCCCChhHHHHHHHHHHHHHHhCCCCC
Q 040832 497 TTDNNTH---------------------VSTRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELITGRRPI 548 (724)
Q Consensus 497 ~~~~~~~---------------------~~~~~~gt~~y~APE~~-~~~~~t~ksDV~SlGvlL~eLltG~~P~ 548 (724)
....... .....+||.+|+|||++ ....++.++|||||||+||||++|..||
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 6543211 22456799999999986 5567999999999999999999865554
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=343.98 Aligned_cols=251 Identities=26% Similarity=0.367 Sum_probs=200.6
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
..++|.+.+.||+|+||.||+|.+. +|+.||||++.... ..+.+.+|+.+|++++|+||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4568999999999999999999865 58999999997643 34678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|+++++|.+++.... ..+++..++.|+.||++||.|||+. +|+|||||++||||+.++.+||+|||++........
T Consensus 105 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 105 YCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp CCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 999999999987432 2489999999999999999999999 999999999999999999999999999987654322
Q ss_pred ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchh
Q 040832 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~ 582 (724)
. .....|+..|+|||++.+..++.++||||||++||||++|+.||........... . ... ....+
T Consensus 181 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~-----~~~-~~~~~------- 245 (314)
T 3com_A 181 K-RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM-I-----PTN-PPPTF------- 245 (314)
T ss_dssp C-BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-H-----HHS-CCCCC-------
T ss_pred c-cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH-H-----hcC-CCccc-------
Confidence 2 2345689999999999999999999999999999999999999976543322110 0 000 00000
Q ss_pred hhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 583 LEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 583 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
.........+.+++.+||+.+|++||++.+|++
T Consensus 246 ---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 ---RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 001112346889999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=345.73 Aligned_cols=253 Identities=23% Similarity=0.382 Sum_probs=199.7
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
..+.|++.+.||+|+||.||+|.+. +++.||||++........+.|.+|+++|++++|+||+++++++..++..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3467999999999999999999975 588999999987666667789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|+++++|.+++..... .+++..++.|+.||++||.|||++ +|+|||||++||||+.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDR-GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp CCTTEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred eCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 9999999998875332 389999999999999999999999 99999999999999999999999999986432211
Q ss_pred ccccccccCCCcCCcchhc-----CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 503 HVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~-----~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
.......|+..|+|||++. ...++.++||||||++||||++|+.||........ +..+.. .....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~---------~~~~~ 241 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LLKIAK---------SDPPT 241 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHH---------SCCCC
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-HHHHhc---------cCCcc
Confidence 1112346899999999983 66789999999999999999999999976543321 111111 00000
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
+. .+......+.+++.+||+.+|++||++.||++
T Consensus 242 ~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 LL-------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CS-------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cC-------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 01112346889999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=383.33 Aligned_cols=249 Identities=26% Similarity=0.356 Sum_probs=205.3
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC---CchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG---SGQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRL 418 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~ 418 (724)
..++|.+.++||+|+||.||+|.+. +++.||||+++.. .....+.+..|..+|..+ +|+||+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999965 5788999999743 122345688899999988 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
|||||+.+|+|.++|+..+. +++..++.|+.||+.||+|||++ +||||||||+||||+.++++||+|||+++...
T Consensus 419 lV~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEeCcCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 99999999999999987654 89999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhh
Q 040832 499 DNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEI 578 (724)
Q Consensus 499 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 578 (724)
.... ......||..|+|||++.+..++.++|||||||+||||++|+.||......+.... +..+.
T Consensus 494 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~----------i~~~~---- 558 (674)
T 3pfq_A 494 WDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----------IMEHN---- 558 (674)
T ss_dssp CTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----------HHSSC----
T ss_pred cCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHH----------HHhCC----
Confidence 3322 23456799999999999999999999999999999999999999986543221110 00010
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 040832 579 ADPYLEKNYPTEEMARMVACAAASIRHSARRRPKI-----SQIVR 618 (724)
Q Consensus 579 vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evv~ 618 (724)
..++......+.+++.+||+.+|++|+++ .||++
T Consensus 559 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 559 ------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 01223334568899999999999999997 66664
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=368.27 Aligned_cols=250 Identities=23% Similarity=0.359 Sum_probs=204.7
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
.++|.+.++||+|+||.||+|... +++.||||++.... ....+.+.+|+.+|++++|+||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457999999999999999999965 68999999986432 33467799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEE---cCCCCEEEEEecccccc
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILL---DYTFETKVADFGLAKLT 497 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl---~~~~~vkL~DFGla~~~ 497 (724)
|||+.+++|.+++...+. +++..++.|+.||+.||.|||++ +|+||||||+|||| +.++.+||+|||+++..
T Consensus 105 ~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKR--FSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHHTCSC--CBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 999999999999876554 89999999999999999999999 99999999999999 56789999999999877
Q ss_pred CCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 498 TDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 498 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
..... .....|+..|+|||++.+ .++.++|||||||+||||++|+.||......+. +... ..+.+..
T Consensus 180 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i---------~~~~~~~ 246 (484)
T 3nyv_A 180 EASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI-LKKV---------EKGKYTF 246 (484)
T ss_dssp CCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH---------HHCCCCC
T ss_pred ccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH-HHHH---------HcCCCCC
Confidence 55432 234569999999999865 699999999999999999999999986543221 1111 1111100
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
.. +.. ......+.+++.+||+.+|++||++.|+++
T Consensus 247 ~~-~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 247 EL-PQW-----KKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CS-GGG-----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC-ccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00 000 112345789999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=361.86 Aligned_cols=200 Identities=24% Similarity=0.352 Sum_probs=154.8
Q ss_pred CCCcc-cceeeccCcEEEEEEEcC---CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEe--CCeEEE
Q 040832 346 GGFSQ-SNLLGQGGFGYVHKGVLP---NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA--GGKRLL 419 (724)
Q Consensus 346 ~~f~~-~~~LG~G~fG~Vyk~~~~---~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~l 419 (724)
+.|.+ +++||+|+||.||+|.+. +++.||||++.... ....+.+|+.+|++|+|+||+++++++.. +...+|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34665 568999999999999965 57889999997542 23468899999999999999999999965 678899
Q ss_pred EEEecCCCCHHHHHhc-------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEE----cCCCCEEE
Q 040832 420 VYEYVPNNNLEFHLHG-------KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILL----DYTFETKV 488 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~-------~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl----~~~~~vkL 488 (724)
||||+.+ +|.+++.. .....+++..++.|+.||+.||+|||++ +|+||||||+|||| +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 66666642 1222489999999999999999999999 99999999999999 77889999
Q ss_pred EEeccccccCCCCC--ccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCC
Q 040832 489 ADFGLAKLTTDNNT--HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPT 551 (724)
Q Consensus 489 ~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~ 551 (724)
+|||+++....... .......||..|+|||++.+. .++.++|||||||+||||++|+.||...
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 99999987754322 223446799999999999874 5999999999999999999999999754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=365.68 Aligned_cols=251 Identities=24% Similarity=0.321 Sum_probs=200.7
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc-------------hhHHHHHHHHHHHHhcCCCCeeEEee
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG-------------QGEREFKAEVEIISRVHHRHLVSLVG 409 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~-------------~~~~~f~~Ei~il~~l~HpnIv~l~g 409 (724)
..++|.+++.||+|+||.||+|... +++.||||+++.... ...+.+.+|+.+|++|+|+||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999965 578999999875421 23467899999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC---CE
Q 040832 410 YCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF---ET 486 (724)
Q Consensus 410 ~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~---~v 486 (724)
++.+.+..+||||||.+|+|.+++..... +++..++.|+.||+.||+|||++ +|+||||||+||||+.++ .+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccE
Confidence 99999999999999999999998876543 89999999999999999999999 999999999999998775 69
Q ss_pred EEEEeccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhh
Q 040832 487 KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLC 566 (724)
Q Consensus 487 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~ 566 (724)
||+|||+++....... .....|+..|+|||++. +.++.++|||||||+||+|++|+.||......+. +...
T Consensus 189 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i----- 259 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI-IKKV----- 259 (504)
T ss_dssp EECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH-----
T ss_pred EEEECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH-----
Confidence 9999999987754322 23456999999999987 5689999999999999999999999976543221 1110
Q ss_pred hhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 567 LRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 567 ~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
..+.+.. ....... ....+.+++.+||+.+|.+||++.|+++
T Consensus 260 ----~~~~~~~--~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 260 ----EKGKYYF--DFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp ----HHCCCCC--CHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----HcCCCCC--CccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1111000 0000011 1245889999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=366.66 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=201.7
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
.++|.+.++||+|+||.||+|... +++.||||++... .......+.+|+++|++|+|+||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 457999999999999999999964 6889999998542 2234567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEc---CCCCEEEEEeccccccC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLD---YTFETKVADFGLAKLTT 498 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~---~~~~vkL~DFGla~~~~ 498 (724)
|||.+++|.+++..... +++..++.|+.||+.||.|||++ +|+||||||+||||+ .++.+||+|||+++...
T Consensus 101 e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 99999999988876543 89999999999999999999999 999999999999995 46689999999998765
Q ss_pred CCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhh
Q 040832 499 DNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEI 578 (724)
Q Consensus 499 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 578 (724)
.... .....|+..|+|||++.+ .++.++|||||||+||+|++|+.||......+. +... ..+.+...
T Consensus 176 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i---------~~~~~~~~ 242 (486)
T 3mwu_A 176 QNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI-LKRV---------ETGKYAFD 242 (486)
T ss_dssp CC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH---------HHTCCCSC
T ss_pred CCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH---------HhCCCCCC
Confidence 4322 234569999999999875 599999999999999999999999976543221 1111 01111000
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 579 ADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 579 vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
. +.. ......+.+++.+||+.+|++||++.|++++
T Consensus 243 ~-~~~-----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 L-PQW-----RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp S-GGG-----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred C-ccc-----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 000 1123457899999999999999999999974
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=367.71 Aligned_cols=250 Identities=25% Similarity=0.361 Sum_probs=197.8
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
.+.|.+.+.||+|+||.||+|... +++.||||+++... ......+.+|+.+|++++|+||++++++|.+.+..+|||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 346999999999999999999965 68899999997542 233567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC---CCCEEEEEeccccccC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY---TFETKVADFGLAKLTT 498 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~---~~~vkL~DFGla~~~~ 498 (724)
|||.+|+|.+++..... +++..++.|+.||++||.|||++ +|+||||||+||||+. ++.+||+|||+++...
T Consensus 116 e~~~~g~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 99999999988876543 89999999999999999999999 9999999999999976 4559999999998775
Q ss_pred CCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhh
Q 040832 499 DNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEI 578 (724)
Q Consensus 499 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 578 (724)
.... .....||..|+|||++. +.++.++|||||||+||||++|+.||......+. +.... .+.+. +
T Consensus 191 ~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~---------~~~~~-~ 256 (494)
T 3lij_A 191 NQKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI-LRKVE---------KGKYT-F 256 (494)
T ss_dssp TTBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHH---------HTCCC-C
T ss_pred CCcc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH---------hCCCC-C
Confidence 4322 23456999999999886 5699999999999999999999999976543221 11110 01000 0
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 579 ADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 579 vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
..+.. . .....+.+++.+||+.+|++||++.|+++
T Consensus 257 ~~~~~-~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 257 DSPEW-K----NVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CSGGG-T----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Cchhc-c----cCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 00000 1 12245788999999999999999999885
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=350.09 Aligned_cols=269 Identities=20% Similarity=0.226 Sum_probs=205.8
Q ss_pred HhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcC-CC-----CeeEEeeEEEeCC
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVH-HR-----HLVSLVGYCIAGG 415 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~-Hp-----nIv~l~g~~~~~~ 415 (724)
...++|.+.++||+|+||.||+|.+. +++.||||+++.. ....+++..|+.+++.++ |+ +|+++++++...+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 34678999999999999999999864 5788999999753 233456888999999885 55 4999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEc--CCCCEEEEEecc
Q 040832 416 KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLD--YTFETKVADFGL 493 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~--~~~~vkL~DFGl 493 (724)
..+|||||+. ++|.+++.......+++..++.|+.||+.||.|||.+ ..+||||||||+||||+ .++.+||+|||+
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 9999999996 5999998876555689999999999999999999952 22899999999999994 578899999999
Q ss_pred ccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhh------h-
Q 040832 494 AKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPL------C- 566 (724)
Q Consensus 494 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~------~- 566 (724)
++...... ....|+..|+|||++.+..++.++|||||||+||||++|+.||......+.. ......+ .
T Consensus 208 a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~-~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 208 SCQLGQRI----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQM-NKIVEVLGIPPAHIL 282 (382)
T ss_dssp CEETTCCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHHCSCCHHHH
T ss_pred ceeccccc----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHH
Confidence 98775432 3456899999999999999999999999999999999999999876443221 1110000 0
Q ss_pred ---------hhcccCCC--------------------hhhhcch---------hhhcCCCHHHHHHHHHHHHHhhccCCC
Q 040832 567 ---------LRALDDGN--------------------FNEIADP---------YLEKNYPTEEMARMVACAAASIRHSAR 608 (724)
Q Consensus 567 ---------~~~~~~~~--------------------~~~~vd~---------~l~~~~~~~~~~~l~~l~~~cl~~~P~ 608 (724)
...+..+. +.+++.. .-.......+...+.+++.+||+.||+
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 00000000 0000000 000112345567899999999999999
Q ss_pred CCCCHHHHHHH
Q 040832 609 RRPKISQIVRA 619 (724)
Q Consensus 609 ~RPs~~evv~~ 619 (724)
+||++.|++++
T Consensus 363 ~Rpta~e~L~h 373 (382)
T 2vx3_A 363 TRIQPYYALQH 373 (382)
T ss_dssp TSCCHHHHTTS
T ss_pred hCCCHHHHhcC
Confidence 99999999873
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=348.02 Aligned_cols=268 Identities=20% Similarity=0.293 Sum_probs=201.3
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC-----CeE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAG-----GKR 417 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~-----~~~ 417 (724)
.++|.+.+.||+|+||.||+|.+. +|+.||||+++.... .....+.+|+++|++++|+||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 478999999999999999999965 688999999975433 2345788999999999999999999998764 678
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
++||||+. ++|.+++... .+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999997 6898888763 389999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc---------cccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhh---h
Q 040832 498 TDNNTH---------VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWAR---P 564 (724)
Q Consensus 498 ~~~~~~---------~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~---~ 564 (724)
...... ......|+..|+|||++.. ..++.++|||||||+||||++|+.||......+.....+.. +
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 543221 1123568999999998765 67999999999999999999999999876533321111100 0
Q ss_pred h---hhhcccCCChhhhcchhhh-cC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 565 L---CLRALDDGNFNEIADPYLE-KN-----YPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 565 ~---~~~~~~~~~~~~~vd~~l~-~~-----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
. ....+......+.+..... .. ........+.+++.+||+.||++||++.||+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 0000000000111000000 00 001223567899999999999999999999973
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=354.25 Aligned_cols=263 Identities=22% Similarity=0.296 Sum_probs=185.2
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC------C
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIAG------G 415 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~------~ 415 (724)
.++|.+.+.||+|+||.||+|.+ .+|+.||||++.... ....+.+.+|+++|++++|+||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999984 468899999997542 23456788999999999999999999998754 5
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 416 KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
..++||||+ +++|..++... .+++..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC-----C---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 679999999 78998888653 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhh------hhh
Q 040832 496 LTTDNNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPL------CLR 568 (724)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~------~~~ 568 (724)
..... .....||.+|+|||++.+ ..++.++|||||||+||||++|+.||......+.. ....+.+ ...
T Consensus 181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l-~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 181 HTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL-KLILRLVGTPGAELLK 255 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCSCCHHHHT
T ss_pred ccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHHH
Confidence 76542 234578999999999877 67899999999999999999999999876543321 1111100 000
Q ss_pred cccCCChhhhcchhhh-cCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 569 ALDDGNFNEIADPYLE-KNYP-----TEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 569 ~~~~~~~~~~vd~~l~-~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+.......++..... .... ......+.+++.+||+.||++||++.|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 1111111111110000 0000 0123457899999999999999999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=350.07 Aligned_cols=263 Identities=22% Similarity=0.315 Sum_probs=203.0
Q ss_pred HHHHHHhhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC
Q 040832 338 YEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIAGG 415 (724)
Q Consensus 338 ~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 415 (724)
+++.....++|++.++||+|+||.||+|.+.+ .||||+++... ....+.|.+|+.++++++|+||+++++++.+.+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34445567889999999999999999998743 59999987542 222346889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 416 KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
..++||||+++++|.+++...+ ..+++..++.|+.||++||+|||++ +|+|||||++||||+ ++.+||+|||+++
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred ceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 9999999999999999997654 3589999999999999999999999 999999999999998 6799999999987
Q ss_pred ccCCCCC----ccccccccCCCcCCcchhcC---------CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhh
Q 040832 496 LTTDNNT----HVSTRVMGTFGYLAPEYASS---------GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWA 562 (724)
Q Consensus 496 ~~~~~~~----~~~~~~~gt~~y~APE~~~~---------~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~ 562 (724)
....... .......|+..|+|||++.. ..++.++|||||||+||||++|+.||......... ...
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~- 255 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII-WQM- 255 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH-HHH-
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHh-
Confidence 6532211 12233458899999999864 45789999999999999999999999765432211 100
Q ss_pred hhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 563 RPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 563 ~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
..+....+.. ......+.+++.+||..+|++||++.+|+++|+....
T Consensus 256 --------~~~~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 256 --------GTGMKPNLSQ--------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp --------HTTCCCCCCC--------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred --------ccCCCCCCCc--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 0010000000 0112347889999999999999999999999997654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=348.93 Aligned_cols=274 Identities=21% Similarity=0.249 Sum_probs=193.4
Q ss_pred HHHHHhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCe-
Q 040832 339 EELSAATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGK- 416 (724)
Q Consensus 339 ~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~- 416 (724)
++.....++|.+.++||+|+||.||+|.+. +++.||||++..... ....+.+|++.++.++|+||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 456677899999999999999999999964 688999999865432 23456788889999999999999999976443
Q ss_pred ------EEEEEEecCCCCHHHHHh-cCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCccEEEcC-CCCE
Q 040832 417 ------RLLVYEYVPNNNLEFHLH-GKGRPVMDWPTRLKIAMGSAKGLAYLH--EDCHPRIIHRDIKSSNILLDY-TFET 486 (724)
Q Consensus 417 ------~~lV~E~~~~gsL~~~L~-~~~~~~l~~~~~~~i~~qia~gL~yLH--s~~~~~iiHrDIkp~NILl~~-~~~v 486 (724)
.++||||+.++.+..+.. ......+.+..++.|+.||+.||.||| ++ +|+||||||+||||+. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence 789999998754333222 123345889999999999999999999 77 9999999999999996 8999
Q ss_pred EEEEeccccccCCCCCccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhh
Q 040832 487 KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPL 565 (724)
Q Consensus 487 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~ 565 (724)
||+|||+++........ ....|+..|+|||++.+. .++.++|||||||+||||++|+.||......+. +..+.+.+
T Consensus 172 kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~~~~~~~~ 248 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEPN--VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ-LHEIVRVL 248 (360)
T ss_dssp EECCCTTCBCCCTTSCC--CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHH
T ss_pred EEeeCCCceecCCCCCc--ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH-HHHHHHHc
Confidence 99999999877644332 345689999999998765 489999999999999999999999987643322 11111100
Q ss_pred h------hhcccC--CChhhh-----cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 566 C------LRALDD--GNFNEI-----ADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 566 ~------~~~~~~--~~~~~~-----vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
. ...+.. ..+... .-..+...........+.+++.+||+.+|++||++.||+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 000000 000000 00000111222345679999999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=339.43 Aligned_cols=253 Identities=24% Similarity=0.360 Sum_probs=194.0
Q ss_pred hhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEe---------
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA--------- 413 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~--------- 413 (724)
..++|++.+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+.+|++++|+||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 356799999999999999999996 47899999999643 2334678999999999999999999998865
Q ss_pred ----CCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEE
Q 040832 414 ----GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVA 489 (724)
Q Consensus 414 ----~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~ 489 (724)
.+..++||||+++++|.+++.... ..+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEe
Confidence 356789999999999999998643 2478899999999999999999999 99999999999999999999999
Q ss_pred EeccccccCCCC-------------CccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchh
Q 040832 490 DFGLAKLTTDNN-------------THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAME 555 (724)
Q Consensus 490 DFGla~~~~~~~-------------~~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~ 555 (724)
|||+++...... ........|+..|+|||++.+. .++.++|||||||+||||++ ||.......
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~ 235 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV 235 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence 999998764321 1112345689999999999764 78999999999999999998 553221111
Q ss_pred hhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 556 DCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 556 ~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+..+ .... ..+...+.......+.+++.+||+.||++||++.+|+++
T Consensus 236 ~~~~~~---------~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 236 NILKKL---------RSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHH---------HSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHhc---------cccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111100 0000 001122333445668899999999999999999999974
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=380.83 Aligned_cols=259 Identities=22% Similarity=0.375 Sum_probs=206.0
Q ss_pred HhhCCCcccceeeccCcEEEEEEEcCC----CcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeE
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVLPN----GKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKR 417 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~~~----g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 417 (724)
...++|.+++.||+|+||.||+|.+.. +..||||+++..... ..+.|.+|+.+|++++|+||+++++++. ++..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 345779999999999999999998642 457999998765333 3467999999999999999999999985 4567
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
+|||||+.+|+|.+++...+ ..+++..++.|+.||++||.|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 99999999999999998653 2489999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChh
Q 040832 498 TDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 498 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
............++..|+|||++....++.++|||||||+||||++ |+.||......+. + ... ..+..
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~-~-~~i--------~~~~~- 610 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-I-GRI--------ENGER- 610 (656)
T ss_dssp CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-H-HHH--------HHTCC-
T ss_pred CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH-H-HHH--------HcCCC-
Confidence 6544433344567889999999998999999999999999999997 9999976543221 1 110 00000
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
...+......+.+++.+||+.+|++||++.+|++.|+..++
T Consensus 611 --------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 611 --------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 01122234568899999999999999999999999987543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=341.53 Aligned_cols=265 Identities=20% Similarity=0.314 Sum_probs=202.7
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CC-cEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC------eeEEeeEEEeCCe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NG-KEVAVKSLRSGSGQGEREFKAEVEIISRVHHRH------LVSLVGYCIAGGK 416 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g-~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~Hpn------Iv~l~g~~~~~~~ 416 (724)
.++|.+.+.||+|+||.||+|.+. ++ +.||||+++.. ....+.+.+|+.+|++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999864 34 68999999753 234567889999999997655 8999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEE----------------
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILL---------------- 480 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl---------------- 480 (724)
.+|||||+ +++|.+++.......+++..++.|+.||++||+|||++ +|+||||||+||||
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 56666666655545689999999999999999999998 99999999999999
Q ss_pred ---cCCCCEEEEEeccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhh
Q 040832 481 ---DYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC 557 (724)
Q Consensus 481 ---~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~ 557 (724)
+.++.+||+|||+++...... ....|+..|+|||++.+..++.++|||||||+||||++|+.||......+..
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 668899999999998754432 3356899999999999999999999999999999999999999876433221
Q ss_pred HH--hhhhhh---hhhcccCCC------------------hhhhcchhh-hcCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 040832 558 LV--DWARPL---CLRALDDGN------------------FNEIADPYL-EKNYPTEEMARMVACAAASIRHSARRRPKI 613 (724)
Q Consensus 558 l~--~w~~~~---~~~~~~~~~------------------~~~~vd~~l-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 613 (724)
.. ...... +........ +.+...... .......+...+.+++.+||+.||++||++
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 10 000000 000000000 000000000 011233456689999999999999999999
Q ss_pred HHHHH
Q 040832 614 SQIVR 618 (724)
Q Consensus 614 ~evv~ 618 (724)
.||++
T Consensus 329 ~e~l~ 333 (355)
T 2eu9_A 329 AEALL 333 (355)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=345.31 Aligned_cols=246 Identities=24% Similarity=0.366 Sum_probs=192.8
Q ss_pred HHHHhhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCch------hHHHHHHHHHHHHhc----CCCCeeEEe
Q 040832 340 ELSAATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQ------GEREFKAEVEIISRV----HHRHLVSLV 408 (724)
Q Consensus 340 el~~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~------~~~~f~~Ei~il~~l----~HpnIv~l~ 408 (724)
+.....++|.+.++||+|+||.||+|.+ .+++.||||+++..... ....+.+|+.++.++ +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 4455678999999999999999999985 46889999999764322 123466799999999 899999999
Q ss_pred eEEEeCCeEEEEEEe-cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEc-CCCCE
Q 040832 409 GYCIAGGKRLLVYEY-VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLD-YTFET 486 (724)
Q Consensus 409 g~~~~~~~~~lV~E~-~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~-~~~~v 486 (724)
+++...+..++|||| +.+++|.+++...+. +++..++.|+.||++||+|||++ +|+|||||++||||+ .++.+
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence 999999999999999 789999999987543 89999999999999999999999 999999999999999 88999
Q ss_pred EEEEeccccccCCCCCccccccccCCCcCCcchhcCCCCC-hhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhh
Q 040832 487 KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPL 565 (724)
Q Consensus 487 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t-~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~ 565 (724)
||+|||+++....... ....|+..|+|||++.+..+. .++|||||||+||||++|+.||.... . +..
T Consensus 180 kl~dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~-~~~----- 247 (312)
T 2iwi_A 180 KLIDFGSGALLHDEPY---TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---E-ILE----- 247 (312)
T ss_dssp EECCCSSCEECCSSCB---CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---H-HHH-----
T ss_pred EEEEcchhhhcccCcc---cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---H-Hhh-----
Confidence 9999999987765332 345689999999999877664 59999999999999999999996421 0 000
Q ss_pred hhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 566 CLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 566 ~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.. ..++......+.+++.+||+.+|++||++.||+++
T Consensus 248 --~~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 248 --AE---------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp --TC---------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --hc---------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00111223457889999999999999999999974
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=348.09 Aligned_cols=265 Identities=23% Similarity=0.344 Sum_probs=203.7
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcC-----------CCCeeEEeeEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVH-----------HRHLVSLVGYCI 412 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~-----------HpnIv~l~g~~~ 412 (724)
.++|.+.+.||+|+||.||+|.+ .+++.||||+++.. ....+.+.+|+++|++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999995 46889999999753 234567889999999886 889999999988
Q ss_pred eCC----eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEc------C
Q 040832 413 AGG----KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLD------Y 482 (724)
Q Consensus 413 ~~~----~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~------~ 482 (724)
..+ ..++||||+ +++|.+++.......+++..++.|+.||+.||+|||+++ +|+||||||+||||+ .
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcC
Confidence 654 789999999 999999998765556899999999999999999999954 799999999999994 4
Q ss_pred CCCEEEEEeccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCch-----hhh
Q 040832 483 TFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAM-----EDC 557 (724)
Q Consensus 483 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~-----~~~ 557 (724)
++.+||+|||+++...... ....|+..|+|||++.+..++.++|||||||+||||++|+.||...... ...
T Consensus 174 ~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 4589999999998765432 3346899999999999999999999999999999999999999754311 111
Q ss_pred HHhhhhhh---h-------------------hhcccCCC---hhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCC
Q 040832 558 LVDWARPL---C-------------------LRALDDGN---FNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPK 612 (724)
Q Consensus 558 l~~w~~~~---~-------------------~~~~~~~~---~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs 612 (724)
+......+ - ...+.... +..++.. ...++......+.+++.+||+.||++||+
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhccCccccCC
Confidence 11110000 0 00000000 0011110 12356677889999999999999999999
Q ss_pred HHHHHHH
Q 040832 613 ISQIVRA 619 (724)
Q Consensus 613 ~~evv~~ 619 (724)
+.||+++
T Consensus 328 ~~ell~h 334 (373)
T 1q8y_A 328 AGGLVNH 334 (373)
T ss_dssp HHHHHTC
T ss_pred HHHHhhC
Confidence 9999873
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=335.82 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=202.7
Q ss_pred HhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
...++|++.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34568999999999999999999965 6889999998643 22345679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCC---CCEEEEEeccccc
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYT---FETKVADFGLAKL 496 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~---~~vkL~DFGla~~ 496 (724)
||||+.+++|.+++.... .+++..++.|+.||++||.|||++ +|+|||||++||||+.+ +.+||+|||++..
T Consensus 99 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp EECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 999999999998887654 389999999999999999999999 99999999999999654 4799999999987
Q ss_pred cCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChh
Q 040832 497 TTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 497 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
....... ....|+..|+|||.+.+ .++.++||||||++||||++|+.||......+ .+..+ ..+.+.
T Consensus 174 ~~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~---------~~~~~~ 240 (287)
T 2wei_A 174 FQQNTKM--KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRV---------ETGKYA 240 (287)
T ss_dssp BCCCSSC--SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH---------HHCCCC
T ss_pred ecCCCcc--ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHH---------HcCCCC
Confidence 6543322 33458899999998865 58999999999999999999999997653222 11111 011110
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
.... . ... ....+.+++.+||+.+|++||++.||++
T Consensus 241 ~~~~-~-~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 FDLP-Q-WRT----ISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCSG-G-GTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCch-h-hhh----cCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0000 0 011 2345788999999999999999999997
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.86 Aligned_cols=252 Identities=22% Similarity=0.276 Sum_probs=174.6
Q ss_pred hCCCccc-ceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEe----CCeEE
Q 040832 345 TGGFSQS-NLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA----GGKRL 418 (724)
Q Consensus 345 ~~~f~~~-~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~ 418 (724)
.++|.+. ++||+|+||.||+|.+. +++.||||++... .+...+....++.++|+||+++++++.. +...+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 5678885 57999999999999965 6899999999652 2223333445667799999999999876 44579
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC---CCCEEEEEecccc
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY---TFETKVADFGLAK 495 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~---~~~vkL~DFGla~ 495 (724)
|||||+++++|.+++.......+++.+++.|+.||++||.|||++ +|+|||||++||||+. ++.+||+|||+++
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 999999999999999887666799999999999999999999999 9999999999999976 4559999999998
Q ss_pred ccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCCh
Q 040832 496 LTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~ 575 (724)
...... .....|+..|+|||++....++.++|||||||+||||++|+.||.......... .+. ..+..+.+
T Consensus 180 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~-----~~~~~~~~ 250 (336)
T 3fhr_A 180 ETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP-GMK-----RRIRLGQY 250 (336)
T ss_dssp EC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred eccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh-hHH-----Hhhhcccc
Confidence 765432 234568999999999988889999999999999999999999996543221100 000 00000000
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 576 NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 576 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
. +...........+.+++.+||+.+|++||++.||++
T Consensus 251 ~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 251 G------FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp C------CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred c------cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 000001123356888999999999999999999998
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=350.70 Aligned_cols=262 Identities=19% Similarity=0.288 Sum_probs=197.5
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeE----
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKR---- 417 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~---- 417 (724)
.++|.+.+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+|++++|+||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999854 688999999976432 2346789999999999999999999999877654
Q ss_pred --EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 418 --LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 418 --~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
++||||+. ++|..++.. .+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999997 678777743 289999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhh------hhh
Q 040832 496 LTTDNNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPL------CLR 568 (724)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~------~~~ 568 (724)
..... .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||......+.... ..... ...
T Consensus 193 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 193 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ-ILKVTGVPGTEFVQ 267 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHCCCCHHHHT
T ss_pred ccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHhCCCcHHHHH
Confidence 66433 234568999999999987 6889999999999999999999999987653332111 10000 000
Q ss_pred cccCCChhhhcchhhhc-C-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 569 ALDDGNFNEIADPYLEK-N-----YPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 569 ~~~~~~~~~~vd~~l~~-~-----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+............... . +.......+.+++.+||+.+|++||++.|++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000000000000000 0 001224568899999999999999999999974
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=342.16 Aligned_cols=255 Identities=27% Similarity=0.400 Sum_probs=178.2
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch-hHHHHHHHHH-HHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ-GEREFKAEVE-IISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~-~~~~f~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
.++|.+.+.||+|+||.||+|.+. +++.||||+++..... ...++..|+. +++.++|+||+++++++.+.+..+|||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467899999999999999999974 6889999999765332 3345666666 677789999999999999999999999
Q ss_pred EecCCCCHHHHHhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 422 EYVPNNNLEFHLHG---KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 422 E~~~~gsL~~~L~~---~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
||+.+ +|.+++.. .....+++..+++|+.||++||.|||+.+ +|+|||||++||||+.++.+||+|||+++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99985 77766652 22345899999999999999999999853 79999999999999999999999999998765
Q ss_pred CCCCccccccccCCCcCCcchh----cCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCC
Q 040832 499 DNNTHVSTRVMGTFGYLAPEYA----SSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGN 574 (724)
Q Consensus 499 ~~~~~~~~~~~gt~~y~APE~~----~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~ 574 (724)
.... .....|+..|+|||++ .+..++.++|||||||+||||++|+.||.........+.. +..+.
T Consensus 178 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---------~~~~~ 246 (327)
T 3aln_A 178 DSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ---------VVKGD 246 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CC---------CCCSC
T ss_pred cccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHH---------HhcCC
Confidence 4322 2334689999999998 4567899999999999999999999999764321111110 01111
Q ss_pred hhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 575 FNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 575 ~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
... +...........+.+++.+||+.+|++||++.+|++
T Consensus 247 ~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 PPQ-----LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCC-----CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCC-----CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 100 111111122356889999999999999999999976
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=353.95 Aligned_cols=251 Identities=22% Similarity=0.287 Sum_probs=190.2
Q ss_pred CCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
+.|.+.++||+|+||.||.+...+|+.||||++... ..+.+.+|+.+|+++ +|+||+++++++.+++..+||||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 445667899999999998766668999999998752 345688999999987 8999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCC-----CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCC-------------CCE
Q 040832 425 PNNNLEFHLHGKGRPV-----MDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYT-------------FET 486 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~-----l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~-------------~~v 486 (724)
. |+|.+++....... ..+..++.|+.||+.||+|||++ +|+||||||+||||+.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 69999998654311 12334578999999999999999 99999999999999654 489
Q ss_pred EEEEeccccccCCCCCc---cccccccCCCcCCcchhcC-------CCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchh
Q 040832 487 KVADFGLAKLTTDNNTH---VSTRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAME 555 (724)
Q Consensus 487 kL~DFGla~~~~~~~~~---~~~~~~gt~~y~APE~~~~-------~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~ 555 (724)
||+|||+++........ ......||..|+|||++.+ ..++.++|||||||+||||++ |+.||+.....+
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999987654322 1234579999999999975 678999999999999999999 999997653322
Q ss_pred hhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 556 DCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 556 ~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
..+... ......+ ...........+.+++.+||+.+|++||++.||++
T Consensus 248 ~~i~~~-------~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 SNIIRG-------IFSLDEM--------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHHT-------CCCCCCC--------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHhcC-------CCCcccc--------cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 211111 0010111 11123455678999999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=343.77 Aligned_cols=262 Identities=19% Similarity=0.297 Sum_probs=197.3
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCe-----
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGK----- 416 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~----- 416 (724)
.++|.+.+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+|++++|+||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999864 688999999975432 234578999999999999999999999987654
Q ss_pred -EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 417 -RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 417 -~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
.++||||+. ++|..++.. .+++..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999997 588777643 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhh------hhh
Q 040832 496 LTTDNNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPL------CLR 568 (724)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~------~~~ 568 (724)
..... .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||......+. +....... ...
T Consensus 175 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 175 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH-HHHHHHHHCBCCHHHHT
T ss_pred CCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHH
Confidence 65432 233568999999999887 6789999999999999999999999987643322 11110000 000
Q ss_pred cccCCChhhhcchh---hh---cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 569 ALDDGNFNEIADPY---LE---KNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 569 ~~~~~~~~~~vd~~---l~---~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+........+... .. ..........+.+++.+||+.+|++||++.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000000000 00 01112335678899999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=334.66 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=180.7
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchh-H-HHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQG-E-REFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~-~-~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
.++|.+.+.||+|+||.||+|.+. +++.||||+++...... . +.+.++..+++.++|+||+++++++.+.+..+|||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467899999999999999999975 68999999997653332 2 33555666788889999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHE-DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs-~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
||+ ++.+..++... ...+++..++.|+.||++||.|||+ . +|+|||||++||||+.++.+||+|||+++.....
T Consensus 104 e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 55666555432 2348999999999999999999998 5 8999999999999999999999999999876543
Q ss_pred CCccccccccCCCcCCcchhc-----CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCCh
Q 040832 501 NTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~-----~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~ 575 (724)
.. .....|+..|+|||++. ...++.++|||||||+||||++|+.||.........+...... ..
T Consensus 179 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------~~ 247 (318)
T 2dyl_A 179 KA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE---------EP 247 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS---------CC
T ss_pred cc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc---------CC
Confidence 22 23456899999999994 5678899999999999999999999997643322221111110 00
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 576 NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 576 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
..+.. .......+.+++.+||+.+|.+||++.||++
T Consensus 248 -----~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 -----PLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp -----CCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -----CCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00000 0112345788999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=345.16 Aligned_cols=247 Identities=21% Similarity=0.326 Sum_probs=200.4
Q ss_pred HHHHHhhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCch------hHHHHHHHHHHHHhcC--CCCeeEEee
Q 040832 339 EELSAATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQ------GEREFKAEVEIISRVH--HRHLVSLVG 409 (724)
Q Consensus 339 ~el~~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~------~~~~f~~Ei~il~~l~--HpnIv~l~g 409 (724)
++.....++|.+.++||+|+||.||+|.+ .+++.||||+++..... ..+.+.+|+.+|++++ |+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 34455678899999999999999999985 46889999999754221 2245778999999996 599999999
Q ss_pred EEEeCCeEEEEEEecCC-CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEc-CCCCEE
Q 040832 410 YCIAGGKRLLVYEYVPN-NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLD-YTFETK 487 (724)
Q Consensus 410 ~~~~~~~~~lV~E~~~~-gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~-~~~~vk 487 (724)
++...+..++||||+.+ ++|.+++...+ .+++..++.|+.||++||+|||++ +|+|||||++||||+ +++.+|
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEE
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEE
Confidence 99999999999999986 89999987654 389999999999999999999999 999999999999999 788999
Q ss_pred EEEeccccccCCCCCccccccccCCCcCCcchhcCCCC-ChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhh
Q 040832 488 VADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLC 566 (724)
Q Consensus 488 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~ 566 (724)
|+|||+++...... .....|+..|+|||++....+ +.++|||||||+||||++|+.||.... .+..
T Consensus 191 L~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----~~~~------ 257 (320)
T 3a99_A 191 LIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----EIIR------ 257 (320)
T ss_dssp ECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HHHH------
T ss_pred EeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----hhhc------
Confidence 99999998775432 234568999999999987665 688999999999999999999996421 0000
Q ss_pred hhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 567 LRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 567 ~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
... . +... ....+.+++.+||+.+|++||++.||+++
T Consensus 258 -~~~---~--------~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 258 -GQV---F--------FRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -CCC---C--------CSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -ccc---c--------cccc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0 0111 22457889999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=346.28 Aligned_cols=249 Identities=21% Similarity=0.285 Sum_probs=188.2
Q ss_pred hCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
..+|.+.++||+|+||.||.....+++.||||++..... ..+.+|+++|+++ +|+||+++++++.+....+|||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 346888999999999986655555889999999975432 2367899999999 799999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC-----CCCEEEEEeccccccC
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY-----TFETKVADFGLAKLTT 498 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~-----~~~vkL~DFGla~~~~ 498 (724)
|. |+|.+++..... .+.+..++.|+.||++||.|||++ +||||||||+||||+. ...+||+|||+++...
T Consensus 100 ~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 100 CA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 96 689999876543 244556789999999999999999 9999999999999943 3468899999998775
Q ss_pred CCCC--ccccccccCCCcCCcchhc---CCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccC
Q 040832 499 DNNT--HVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDD 572 (724)
Q Consensus 499 ~~~~--~~~~~~~gt~~y~APE~~~---~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~ 572 (724)
.... .......||.+|+|||++. ...++.++|||||||+||||++ |+.||............ ..
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~----------~~ 244 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL----------GA 244 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT----------TC
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh----------cc
Confidence 4322 1234467999999999997 4577889999999999999999 99999654322211100 00
Q ss_pred CChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 573 GNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 573 ~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
..+.. ..........+.+++.+||+.+|++||++.||++
T Consensus 245 ~~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 245 CSLDC-------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCCTT-------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCccc-------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00000 0111234455788999999999999999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.05 Aligned_cols=232 Identities=13% Similarity=0.104 Sum_probs=184.0
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCch---hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQ---GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~---~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
.++|++.+.||+|+||.||+|.+. +++.||||+++..... ..+.|.+|+.++++++|+||+++++++.+++..|||
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467999999999999999999975 4889999999865332 236799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+++++|.+++... ....++++|+.||++||+|||++ +|+||||||+||||+.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 9999999999999542 35567899999999999999999 99999999999999999999998443
Q ss_pred CCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
|++ .++.++|||||||+||||++|+.||......+.....+ ..+ .+.... .
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~------~~~-~~~~~~--~ 225 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE------RDT-AGQPIE--P 225 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC------BCT-TSCBCC--H
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH------HHh-ccCCCC--h
Confidence 333 36889999999999999999999998654322100000 000 000000 0
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
..+.. +....+.+++.+||+.||++| ++.|+++.|+....
T Consensus 226 ~~~~~----~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 226 ADIDR----DIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp HHHCT----TSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred hhccc----CCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 01111 223458899999999999999 99999999987543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=362.61 Aligned_cols=238 Identities=22% Similarity=0.341 Sum_probs=192.2
Q ss_pred hCCCcccceeeccCcEEEEEEEcC--CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCe-----
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP--NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGK----- 416 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~--~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~----- 416 (724)
.++|.+.++||+|+||.||+|.+. +++.||||++..... .....|.+|+++|++++|+||++++++|...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999975 588999999875433 334578999999999999999999999987665
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
.||||||+++++|.+++.. .+++.+++.|+.||++||.|||++ +||||||||+||||+.+ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchh
Confidence 6999999999999987754 489999999999999999999999 99999999999999986 899999999987
Q ss_pred cCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChh
Q 040832 497 TTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 497 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
.... ....||.+|+|||++.++. +.++|||||||+||||++|..+|..... . .+.
T Consensus 231 ~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~---------~-----~~~----- 285 (681)
T 2pzi_A 231 INSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV---------D-----GLP----- 285 (681)
T ss_dssp TTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC---------S-----SCC-----
T ss_pred cccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc---------c-----ccc-----
Confidence 6543 3456999999999987654 8999999999999999999888753210 0 000
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHHHhC
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPK-ISQIVRALEG 622 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~evv~~L~~ 622 (724)
. ... .......+..++.+||+.+|++||+ +.++.+.|.+
T Consensus 286 ~-~~~------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 E-DDP------VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp T-TCH------HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred c-ccc------ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0 000 0112356889999999999999995 5556665554
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=360.23 Aligned_cols=262 Identities=27% Similarity=0.376 Sum_probs=200.5
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCeeEEeeEEEe------CCeE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS-GQGEREFKAEVEIISRVHHRHLVSLVGYCIA------GGKR 417 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~------~~~~ 417 (724)
++|.+.+.||+|+||.||+|.+. +|+.||||+++... ....+.|.+|+++|++++|+||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 68999999999999999999864 58899999997653 3345679999999999999999999998765 6677
Q ss_pred EEEEEecCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCC---EEEEEecc
Q 040832 418 LLVYEYVPNNNLEFHLHGKG-RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFE---TKVADFGL 493 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~-~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~---vkL~DFGl 493 (724)
+|||||+.+++|.+++.... ...+++..++.|+.||+.||+|||+. +|+||||||+||||+.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999998643 23588999999999999999999998 9999999999999987665 99999999
Q ss_pred ccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhccc--
Q 040832 494 AKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALD-- 571 (724)
Q Consensus 494 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~-- 571 (724)
++....... .....|+..|+|||++.+..++.++|||||||+||||++|+.||..... ...|..........
T Consensus 171 a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 171 AKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQWHGKVREKSNEHI 244 (676)
T ss_dssp CCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHSSTTCC------C
T ss_pred ccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhhhhhhhcccchhh
Confidence 987755432 2446799999999999999999999999999999999999999975422 12232221111000
Q ss_pred ------CCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 040832 572 ------DGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQI 616 (724)
Q Consensus 572 ------~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev 616 (724)
.+.+...........+.......+.+++..||+.||++||++.|+
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 010000000001123444567889999999999999999999873
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=319.45 Aligned_cols=232 Identities=22% Similarity=0.281 Sum_probs=180.6
Q ss_pred hCCCccc-ceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHH-HhcCCCCeeEEeeEEEe----CCeE
Q 040832 345 TGGFSQS-NLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEII-SRVHHRHLVSLVGYCIA----GGKR 417 (724)
Q Consensus 345 ~~~f~~~-~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il-~~l~HpnIv~l~g~~~~----~~~~ 417 (724)
.++|.+. ++||+|+||.||++.. .+++.||||+++. ...+.+|+.++ +.++|+||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567776 8899999999999986 4688999999964 34678899988 55589999999999887 6678
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC---CCCEEEEEeccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY---TFETKVADFGLA 494 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~---~~~vkL~DFGla 494 (724)
+|||||+++++|.+++.......+++..++.|+.||+.||.|||++ +|+||||||+||||+. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 9999999999999999887666799999999999999999999999 9999999999999998 789999999999
Q ss_pred cccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCC
Q 040832 495 KLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGN 574 (724)
Q Consensus 495 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~ 574 (724)
..... ..++.++|||||||+||||++|+.||.......... .....+..+.
T Consensus 168 ~~~~~-----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~------~~~~~~~~~~ 218 (299)
T 3m2w_A 168 KETTG-----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------GMKTRIRMGQ 218 (299)
T ss_dssp EECTT-----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C------CSCCSSCTTC
T ss_pred ccccc-----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH------HHHHHHhhcc
Confidence 75432 346789999999999999999999997543221100 0000000010
Q ss_pred hhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 575 FNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 575 ~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+. + ...... .....+.+++.+||+.+|++||++.||+++
T Consensus 219 ~~-~-~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 219 YE-F-PNPEWS----EVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CS-S-CHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cc-C-Cchhcc----cCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00 0 000001 123568889999999999999999999973
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=338.97 Aligned_cols=241 Identities=16% Similarity=0.157 Sum_probs=180.2
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCch---hHHHHHHHHHHHHhcCC-CCee--------------
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQ---GEREFKAEVEIISRVHH-RHLV-------------- 405 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~---~~~~f~~Ei~il~~l~H-pnIv-------------- 405 (724)
...|..+++||+|+||.||+|.+ .+|+.||||+++..... ..+.|.+|+.+++.|+| .|+.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34578889999999999999994 56899999999843322 24679999999999977 2211
Q ss_pred -EE------eeEEEe-----CCeEEEEEEecCCCCHHHHHh-----cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 040832 406 -SL------VGYCIA-----GGKRLLVYEYVPNNNLEFHLH-----GKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRI 468 (724)
Q Consensus 406 -~l------~g~~~~-----~~~~~lV~E~~~~gsL~~~L~-----~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~i 468 (724)
.+ +.++.. ....+++|+++ +++|.+++. ......+++..++.|+.||++||+|||++ +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 11 111111 12346677765 788998884 22233477889999999999999999999 99
Q ss_pred EecCCCCccEEEcCCCCEEEEEeccccccCCCCCccccccccCCCcCCcchh----------cCCCCChhHHHHHHHHHH
Q 040832 469 IHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYA----------SSGKLTEKSDVFSFGVML 538 (724)
Q Consensus 469 iHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~----------~~~~~t~ksDV~SlGvlL 538 (724)
|||||||+||||+.++.+||+|||+++..... .....| ..|+|||++ ....++.++|||||||+|
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999999876543 234567 999999999 555688999999999999
Q ss_pred HHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 539 LELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 539 ~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
|||++|+.||......+. +..++... ..+ ...+.+++.+||+.+|++||++.|+++
T Consensus 308 ~elltg~~Pf~~~~~~~~------------------~~~~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGG------------------SEWIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTGGGSC------------------SGGGGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchhhh------------------HHHHHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999975432110 00000100 122 256889999999999999999887754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=324.76 Aligned_cols=242 Identities=16% Similarity=0.178 Sum_probs=184.1
Q ss_pred hCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCc--------hhHHHHHHHHHHHHhcC---------CCCeeEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSG--------QGEREFKAEVEIISRVH---------HRHLVSL 407 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~--------~~~~~f~~Ei~il~~l~---------HpnIv~l 407 (724)
.++|.+.+.||+|+||.||+|++ +|+.||||+++.... ...+.+.+|+.+|++|+ |+||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788999999999999999998 789999999975421 22367899999999886 8888888
Q ss_pred eeEEE------------------------------eCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHH
Q 040832 408 VGYCI------------------------------AGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGL 457 (724)
Q Consensus 408 ~g~~~------------------------------~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL 457 (724)
++++. ..+..+|||||+.+|+|.+.+.+ ..+++..++.|+.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 77653 26789999999999976665543 2489999999999999999
Q ss_pred HHHH-hcCCCCeEecCCCCccEEEcCCC--------------------CEEEEEeccccccCCCCCccccccccCCCcCC
Q 040832 458 AYLH-EDCHPRIIHRDIKSSNILLDYTF--------------------ETKVADFGLAKLTTDNNTHVSTRVMGTFGYLA 516 (724)
Q Consensus 458 ~yLH-s~~~~~iiHrDIkp~NILl~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~A 516 (724)
+||| ++ +||||||||+||||+.++ .+||+|||+++..... ...||..|||
T Consensus 175 ~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTC
T ss_pred HHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccC
Confidence 9999 88 999999999999999887 8999999999877542 3469999999
Q ss_pred cchhcCCCCChhHHHHHHHHH-HHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHH
Q 040832 517 PEYASSGKLTEKSDVFSFGVM-LLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARM 595 (724)
Q Consensus 517 PE~~~~~~~t~ksDV~SlGvl-L~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l 595 (724)
||++.+.. +.++|||||+++ +++++.|..||... .|...+....+....+..... ..........+
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--------~~~~~~~~~~~~~~~~~~~~~----~~~~~~~s~~~ 312 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--------LWLHYLTDKMLKQMTFKTKCN----TPAMKQIKRKI 312 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--------HHHHHHHHHHHHTCCCSSCCC----SHHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcch--------hhhhHHHHhhhhhhccCcccc----hhhhhhcCHHH
Confidence 99998665 899999998777 77888899888321 121111100000000000000 00123456779
Q ss_pred HHHHHHhhccCCCCCCCHHHHH
Q 040832 596 VACAAASIRHSARRRPKISQIV 617 (724)
Q Consensus 596 ~~l~~~cl~~~P~~RPs~~evv 617 (724)
.+++.+||+.+ ++.|++
T Consensus 313 ~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHhccC-----CHHHHH
Confidence 99999999977 888888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-30 Score=299.81 Aligned_cols=185 Identities=17% Similarity=0.127 Sum_probs=130.6
Q ss_pred eeeccCcEEEEEEE-cCCCcEEEEEEeccCCc----------hhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEE
Q 040832 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSG----------QGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 353 ~LG~G~fG~Vyk~~-~~~g~~vaVK~l~~~~~----------~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 420 (724)
.++.|++|.+..++ .-.|+.|+||++..... ...++|.+|+++|+++ +|+||++|++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35666666666544 23588899999965411 1234699999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
||||+|++|.++|...+. ++.. +|+.||+.||+|||++ +||||||||+||||+.++++||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~~~~~--l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEE--IDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHHTTCC--CCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHHhCCC--CCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 999999999999987654 5543 5889999999999999 9999999999999999999999999999877654
Q ss_pred CCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCC
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P 547 (724)
... ....+||++|||||++.+ .+..++|+|++|+++++|+++..+
T Consensus 393 ~~~-~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CSW-PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CC-SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred Ccc-ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 333 344679999999999864 567789999999999887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.1e-28 Score=275.00 Aligned_cols=184 Identities=16% Similarity=0.217 Sum_probs=146.6
Q ss_pred cccceeeccCcEEEEEEEcCCCcEEEEEEeccCCch--------hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 349 SQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQ--------GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 349 ~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~--------~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
...++||+|+||.||+|.+ .++.+++|++...... ..+.|.+|+++|++++|+||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999965 5688899876543211 123589999999999999999777777788888999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
|||+++++|.+++.. ++.|+.||++||+|||++ +|+||||||+||||+. ++||+|||+++.....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999875 568999999999999999 9999999999999998 9999999999987653
Q ss_pred CCcc------ccccccCCCcCCcchhcC--CCCChhHHHHHHHHHHHHHHhCCCCC
Q 040832 501 NTHV------STRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPI 548 (724)
Q Consensus 501 ~~~~------~~~~~gt~~y~APE~~~~--~~~t~ksDV~SlGvlL~eLltG~~P~ 548 (724)
.... ...+.||..|||||++.. ..|+.+.|+|+..+-.++.+.++..|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2221 235679999999999976 56888899999999888888877665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.9e-24 Score=227.27 Aligned_cols=153 Identities=14% Similarity=0.072 Sum_probs=124.6
Q ss_pred HHHHHHhhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCc------------------hhHHHHHHHHHHHHhc
Q 040832 338 YEELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSG------------------QGEREFKAEVEIISRV 399 (724)
Q Consensus 338 ~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~------------------~~~~~f~~Ei~il~~l 399 (724)
+..+......|.+++.||+|+||.||+|.+.+|+.||||+++.... .....+.+|+++|+++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 4455666677888999999999999999997799999999964321 1235689999999999
Q ss_pred CCCCeeEEeeEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEE
Q 040832 400 HHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNIL 479 (724)
Q Consensus 400 ~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NIL 479 (724)
+ | +++++++.. +..++||||+++++|.+ +.. .....|+.||++||.|||++ +|+||||||+|||
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NIL 225 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL 225 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEE
Confidence 9 5 677776544 45699999999999988 421 23457999999999999999 9999999999999
Q ss_pred EcCCCCEEEEEeccccccCCCCCccccccccCCCcCCcchhc
Q 040832 480 LDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYAS 521 (724)
Q Consensus 480 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~ 521 (724)
|+ ++.+||+|||+++.. ..|+|||++.
T Consensus 226 l~-~~~vkl~DFG~a~~~--------------~~~~a~e~l~ 252 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVEV--------------GEEGWREILE 252 (282)
T ss_dssp EE-TTEEEECCCTTCEET--------------TSTTHHHHHH
T ss_pred EE-CCcEEEEECCCCeEC--------------CCCCHHHHHH
Confidence 99 999999999999733 3478899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.1e-20 Score=195.76 Aligned_cols=146 Identities=19% Similarity=0.119 Sum_probs=111.3
Q ss_pred HHHHHhhCCCcccceeeccCcEEEEEEEc-CCCcE--EEEEEeccCCch------------------------hHHHHHH
Q 040832 339 EELSAATGGFSQSNLLGQGGFGYVHKGVL-PNGKE--VAVKSLRSGSGQ------------------------GEREFKA 391 (724)
Q Consensus 339 ~el~~~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~--vaVK~l~~~~~~------------------------~~~~f~~ 391 (724)
..+.....-|.+.+.||+|+||.||+|.+ .+|+. ||||+++..... ....+.+
T Consensus 40 ~~~~~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (258)
T 1zth_A 40 YKLSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK 119 (258)
T ss_dssp HHHHHTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHH
T ss_pred HHHHhCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH
Confidence 33433333467889999999999999997 68888 999987643111 1135889
Q ss_pred HHHHHHhcCCCCe--eEEeeEEEeCCeEEEEEEecCC-C----CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hc
Q 040832 392 EVEIISRVHHRHL--VSLVGYCIAGGKRLLVYEYVPN-N----NLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLH-ED 463 (724)
Q Consensus 392 Ei~il~~l~HpnI--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH-s~ 463 (724)
|+.+|.+|+|.+| ..++++ ...+|||||+.+ | .|.+++.. +.+..+..++.||+.+|.||| ++
T Consensus 120 E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~ 190 (258)
T 1zth_A 120 EFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA 190 (258)
T ss_dssp HHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC
Confidence 9999999988764 334432 245899999942 3 67666533 224467889999999999999 87
Q ss_pred CCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 464 CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 464 ~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
+||||||||+||||+. .++|+|||+|....
T Consensus 191 ---givHrDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 191 ---ELVHADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp ---CEECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred ---CEEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence 9999999999999998 99999999997653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=3.3e-18 Score=185.75 Aligned_cols=146 Identities=14% Similarity=0.087 Sum_probs=105.4
Q ss_pred HHHHhhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCc--------------hhHHH--------HHHHHHHHH
Q 040832 340 ELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSG--------------QGERE--------FKAEVEIIS 397 (724)
Q Consensus 340 el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~--------------~~~~~--------f~~Ei~il~ 397 (724)
.|.....-|.+++.||+|+||.||+|...+|+.||||+++.... ..... ...|...|.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 33343345999999999999999999998999999998763210 00111 234667777
Q ss_pred hcCCCCeeEEeeEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCcc
Q 040832 398 RVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSN 477 (724)
Q Consensus 398 ~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~N 477 (724)
+|++.++.-..-+... ..+|||||++++.|..++.. .....++.||+.+|.|||++ +||||||||.|
T Consensus 169 rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~N 235 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKH---GLIHGDFNEFN 235 (397)
T ss_dssp HHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred HHHhcCCCCCeeeecc--CceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHH
Confidence 7755443222112222 23799999999988665321 23457889999999999998 99999999999
Q ss_pred EEEcCCC----------CEEEEEeccccccC
Q 040832 478 ILLDYTF----------ETKVADFGLAKLTT 498 (724)
Q Consensus 478 ILl~~~~----------~vkL~DFGla~~~~ 498 (724)
|||++++ .+.|+||+-+....
T Consensus 236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 236 ILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred EEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 9998776 38999999886543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.3e-13 Score=142.30 Aligned_cols=148 Identities=14% Similarity=0.026 Sum_probs=117.0
Q ss_pred HHHHhhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCeeEEeeEEEeCCeEE
Q 040832 340 ELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVH-HRHLVSLVGYCIAGGKRL 418 (724)
Q Consensus 340 el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~ 418 (724)
.+....++|.+...++.|+++.||+.... ++.+++|+...........+.+|+++|+.|. +..+.++++++.+.+..|
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 34455578998899999999999998864 6889999987532122346899999999995 677889999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHED----------------------------------- 463 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~----------------------------------- 463 (724)
+||||++|.+|...+.. ......++.+++++|+.||+.
T Consensus 87 lv~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 99999999999876421 123457889999999999981
Q ss_pred ---------------------CCCCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 464 ---------------------CHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 464 ---------------------~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
....++|+|+++.|||++++..+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01358999999999999876556799998875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.35 E-value=8.1e-13 Score=135.26 Aligned_cols=139 Identities=17% Similarity=0.105 Sum_probs=104.0
Q ss_pred hCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC--eeEEeeEEEeCCeEEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRH--LVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~Hpn--Iv~l~g~~~~~~~~~lV~E 422 (724)
..+|.+..+.+.|.++.||+....+|+.++||..... ....+..|+.+|+.|.+.+ +.++++++..++..++|||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 3445554444566679999998777888999998654 2245788999999996544 5678888888888899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC-------------------------------------- 464 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~-------------------------------------- 464 (724)
|++|.+|. +.. .+ ...++.++++.|..||+..
T Consensus 96 ~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 96 EVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred ecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 99999884 221 12 2356778888888888741
Q ss_pred -----------------CCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 465 -----------------HPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 465 -----------------~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
...++|+||++.|||++++..+.|+||+.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998776667999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.22 E-value=1.3e-11 Score=130.44 Aligned_cols=186 Identities=19% Similarity=0.235 Sum_probs=124.7
Q ss_pred cceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCC--eeEEeeEEEeCC---eEEEEEEec
Q 040832 351 SNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVH-HRH--LVSLVGYCIAGG---KRLLVYEYV 424 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~-Hpn--Iv~l~g~~~~~~---~~~lV~E~~ 424 (724)
.+.|+.|.+..||+.. +.++||+.... .....+.+|+++|+.|. +.. +.+++.++...+ ..|+||||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4668999999999853 56889987542 33567899999999984 332 344555443332 347999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHED----------------------------------------- 463 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~----------------------------------------- 463 (724)
+|..|...... .++..++..++.++++.|+.||+.
T Consensus 99 ~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 99998754332 267788889999999999999961
Q ss_pred --------------CCCCeEecCCCCccEEEcC--CCCEEEEEeccccccCCCCCcc-------------ccccccCCCc
Q 040832 464 --------------CHPRIIHRDIKSSNILLDY--TFETKVADFGLAKLTTDNNTHV-------------STRVMGTFGY 514 (724)
Q Consensus 464 --------------~~~~iiHrDIkp~NILl~~--~~~vkL~DFGla~~~~~~~~~~-------------~~~~~gt~~y 514 (724)
....++|+|+++.|||+++ +..+.|+||+.+.......... ...+...+++
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 1235899999999999988 4567899999987542210000 0001111112
Q ss_pred CC-cchhcCCCCChhHHHHHHHHHHHHHHhCCCCC
Q 040832 515 LA-PEYASSGKLTEKSDVFSFGVMLLELITGRRPI 548 (724)
Q Consensus 515 ~A-PE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~ 548 (724)
.. |++... .....+.|++++++|++.+|+.+|
T Consensus 255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 22 222211 122368999999999999998765
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.21 E-value=2.9e-11 Score=130.65 Aligned_cols=145 Identities=17% Similarity=0.197 Sum_probs=109.2
Q ss_pred CcccceeeccCcEEEEEEEcCCCcEEEEEEec--cCCc-hhHHHHHHHHHHHHhcC--CCCeeEEeeEEEeC---CeEEE
Q 040832 348 FSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLR--SGSG-QGEREFKAEVEIISRVH--HRHLVSLVGYCIAG---GKRLL 419 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~--~~~~-~~~~~f~~Ei~il~~l~--HpnIv~l~g~~~~~---~~~~l 419 (724)
....+.|+.|.++.||+....+ +.+++|+.. .... .....+.+|+.+|+.|. +..+.++++++.+. +..|+
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred CceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 3446779999999999988754 678888876 3321 22356889999999997 45578899988776 45799
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC----------------------------------- 464 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~----------------------------------- 464 (724)
||||++|..|.+.. ...++..++..++.++++.|+.||+..
T Consensus 119 vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 99999998874321 123678888999999999999999730
Q ss_pred --------------------CCCeEecCCCCccEEEcCCCC--EEEEEecccccc
Q 040832 465 --------------------HPRIIHRDIKSSNILLDYTFE--TKVADFGLAKLT 497 (724)
Q Consensus 465 --------------------~~~iiHrDIkp~NILl~~~~~--vkL~DFGla~~~ 497 (724)
...++|||+++.|||++.++. +.|+||+++.+.
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 247999999999999987753 689999998753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.77 E-value=5.9e-08 Score=99.95 Aligned_cols=142 Identities=15% Similarity=0.088 Sum_probs=103.3
Q ss_pred hCCCcccceeeccCcE-EEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCeeEEeeEEEeCCeEEEEE
Q 040832 345 TGGFSQSNLLGQGGFG-YVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVH-HRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG-~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~ 421 (724)
..+|+.. .+..|..| .||+.... ++..++||+-.. ....++.+|+.+|+.|. +--+.++++++.+.+..+|||
T Consensus 24 l~g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm 99 (272)
T 4gkh_A 24 LYGYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT 99 (272)
T ss_dssp HTTCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred ccCCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence 3444433 34455554 68987754 456789998764 24557889999999985 444678899999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHED-------------------------------------- 463 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~-------------------------------------- 463 (724)
|++++.++.+..... ......++.++++.|+.||..
T Consensus 100 e~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (272)
T 4gkh_A 100 TAIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG 173 (272)
T ss_dssp ECCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred EeeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence 999999887765432 123445677777888888753
Q ss_pred -----------------CCCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 464 -----------------CHPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 464 -----------------~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
....++|+|+++.|||++.++.+-|+||+.+.+
T Consensus 174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012379999999999999877677999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.74 E-value=7.2e-08 Score=101.81 Aligned_cols=137 Identities=20% Similarity=0.249 Sum_probs=98.8
Q ss_pred cceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCC---CeeEEeeEEE-eCCeEEEEEEecCC
Q 040832 351 SNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHR---HLVSLVGYCI-AGGKRLLVYEYVPN 426 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~Hp---nIv~l~g~~~-~~~~~~lV~E~~~~ 426 (724)
.+.|+.|....||+. ++.++||+... ......+.+|+++|+.|.+. .+.+++.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456889999999997 56788888532 23345789999999999753 3556677764 45567899999999
Q ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 040832 427 NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHED------------------------------------------- 463 (724)
Q Consensus 427 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~------------------------------------------- 463 (724)
..|...... .++..++..++.++++.|+.||+.
T Consensus 98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 988763221 145556666666666666666642
Q ss_pred --------------CCCCeEecCCCCccEEEcC---CCCE-EEEEecccccc
Q 040832 464 --------------CHPRIIHRDIKSSNILLDY---TFET-KVADFGLAKLT 497 (724)
Q Consensus 464 --------------~~~~iiHrDIkp~NILl~~---~~~v-kL~DFGla~~~ 497 (724)
....++|+|+++.|||++. ++.+ .|+||+.+...
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2235699999999999987 4565 89999988643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.59 E-value=4.3e-08 Score=105.48 Aligned_cols=80 Identities=10% Similarity=0.022 Sum_probs=57.0
Q ss_pred ccee-eccCcEEEEEEEcC-------CCcEEEEEEeccCC---chhHHHHHHHHHHHHhcC-C--CCeeEEeeEEEeC--
Q 040832 351 SNLL-GQGGFGYVHKGVLP-------NGKEVAVKSLRSGS---GQGEREFKAEVEIISRVH-H--RHLVSLVGYCIAG-- 414 (724)
Q Consensus 351 ~~~L-G~G~fG~Vyk~~~~-------~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~~l~-H--pnIv~l~g~~~~~-- 414 (724)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+|+.|. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 88889999998764 26778999765432 101245788999998884 3 3567888887665
Q ss_pred -CeEEEEEEecCCCCHH
Q 040832 415 -GKRLLVYEYVPNNNLE 430 (724)
Q Consensus 415 -~~~~lV~E~~~~gsL~ 430 (724)
+..++||||++|..|.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.43 E-value=7.8e-07 Score=94.43 Aligned_cols=139 Identities=17% Similarity=0.258 Sum_probs=82.6
Q ss_pred ceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcC--CCCeeEEee------EEEeCCeEEEEEEe
Q 040832 352 NLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVH--HRHLVSLVG------YCIAGGKRLLVYEY 423 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~--HpnIv~l~g------~~~~~~~~~lV~E~ 423 (724)
+.|+.|..+.||+....+| .+++|+.... ..++..|+.+++.|. .-.+.+++. +...++..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999887554 5899988752 234455666666663 113344443 22356778999999
Q ss_pred cCCCCHH--------------HHHhc--CCC----------CCCCHHHH-------------------------------
Q 040832 424 VPNNNLE--------------FHLHG--KGR----------PVMDWPTR------------------------------- 446 (724)
Q Consensus 424 ~~~gsL~--------------~~L~~--~~~----------~~l~~~~~------------------------------- 446 (724)
++|..+. ..||. ... ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 11221 110 01123211
Q ss_pred HHHHHHHHHHHHHHHh----------cCCCCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 447 LKIAMGSAKGLAYLHE----------DCHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 447 ~~i~~qia~gL~yLHs----------~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
..+...+.+++.+|+. .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111224446677763 123479999999999999888899999999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=5.4e-07 Score=98.41 Aligned_cols=75 Identities=12% Similarity=0.080 Sum_probs=50.2
Q ss_pred cceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc-------hhHHHHHHHHHHHHhcCC--C-CeeEEeeEEEeCCeEEE
Q 040832 351 SNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG-------QGEREFKAEVEIISRVHH--R-HLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~-------~~~~~f~~Ei~il~~l~H--p-nIv~l~g~~~~~~~~~l 419 (724)
.+.||.|.++.||++.+. +++.|+||....... .....+..|+++|+.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 567999999999999754 467899998654321 122356789999988842 3 34456544 3445689
Q ss_pred EEEecCCC
Q 040832 420 VYEYVPNN 427 (724)
Q Consensus 420 V~E~~~~g 427 (724)
||||+.+.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.28 E-value=9.3e-07 Score=97.49 Aligned_cols=79 Identities=11% Similarity=0.049 Sum_probs=47.8
Q ss_pred CCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccccccccCCCcCCcchhcCC---CCChhHHHHHHHHHHHHH
Q 040832 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSG---KLTEKSDVFSFGVMLLEL 541 (724)
Q Consensus 465 ~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~---~~t~ksDV~SlGvlL~eL 541 (724)
...++|+|+++.|||++.++ ++|+||+.+.+..........-..-...|++++..... .-....+++.+...+|++
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 34799999999999998876 99999999875432111000000001235666554311 112345666778888887
Q ss_pred HhC
Q 040832 542 ITG 544 (724)
Q Consensus 542 ltG 544 (724)
+.+
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.24 E-value=4.2e-06 Score=87.11 Aligned_cols=79 Identities=18% Similarity=0.177 Sum_probs=59.6
Q ss_pred CCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCC---CCeeEEeeEEEeCCeEEEEEEe
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHH---RHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~H---pnIv~l~g~~~~~~~~~lV~E~ 423 (724)
.+...+.+|.|..+.||+..+.||+.|+||+...........|..|+..|+.|.. --+.+++++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 4666788999999999999999999999998765544444568899999999852 2344555442 23799999
Q ss_pred cCCCCH
Q 040832 424 VPNNNL 429 (724)
Q Consensus 424 ~~~gsL 429 (724)
++++.+
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.23 E-value=7.1e-06 Score=86.76 Aligned_cols=139 Identities=16% Similarity=0.143 Sum_probs=94.5
Q ss_pred cccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcC---CCCeeEEeeEEEeCCeEEEEEEecC
Q 040832 349 SQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVH---HRHLVSLVGYCIAGGKRLLVYEYVP 425 (724)
Q Consensus 349 ~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~lV~E~~~ 425 (724)
...+.|+.|.+..+|+... +++.++||+.... ....|..|++.|+.|. .-.+.++++++...+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3456789999999999886 5678889987642 3567899999999884 3568889998888889999999999
Q ss_pred CCCHH--------H---HHhcCCC-C-------------------CCCHHHHH---HHH--H--------------HHHH
Q 040832 426 NNNLE--------F---HLHGKGR-P-------------------VMDWPTRL---KIA--M--------------GSAK 455 (724)
Q Consensus 426 ~gsL~--------~---~L~~~~~-~-------------------~l~~~~~~---~i~--~--------------qia~ 455 (724)
+..+. . .||.... . .-+|.... ++. . .+++
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 98652 1 2333221 0 11454322 111 1 1111
Q ss_pred HH-HHHHh-cCCCCeEecCCCCccEEEcCCCCEEEEEec
Q 040832 456 GL-AYLHE-DCHPRIIHRDIKSSNILLDYTFETKVADFG 492 (724)
Q Consensus 456 gL-~yLHs-~~~~~iiHrDIkp~NILl~~~~~vkL~DFG 492 (724)
.| ..|.. ...+.+||+|+.+.|||++.++ +.|+||+
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11 23321 1245799999999999999887 8899984
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.03 E-value=2.4e-05 Score=82.51 Aligned_cols=158 Identities=11% Similarity=0.090 Sum_probs=92.4
Q ss_pred ccCHHHHHHhhCCCccc-----ceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC--eeEE
Q 040832 335 AFTYEELSAATGGFSQS-----NLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRH--LVSL 407 (724)
Q Consensus 335 ~f~~~el~~~~~~f~~~-----~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~Hpn--Iv~l 407 (724)
.++.+++......|.++ +.|+.|....+|+....+| .+++|+..... ...++..|+.+++.|.... +.++
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 35567777776667653 3466788889999887555 68899887521 1234667888888774222 3333
Q ss_pred ee------EEEeCCeEEEEEEecCCCCHHH--------------HHhcC----CCCC---C---CHHHHHH---------
Q 040832 408 VG------YCIAGGKRLLVYEYVPNNNLEF--------------HLHGK----GRPV---M---DWPTRLK--------- 448 (724)
Q Consensus 408 ~g------~~~~~~~~~lV~E~~~~gsL~~--------------~L~~~----~~~~---l---~~~~~~~--------- 448 (724)
+. +...++..++||+|++|..+.. .||.. .... . .|...+.
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 32 1233567799999999865421 12221 1110 1 1222111
Q ss_pred ---HHHHHHHHHHHHHhc----CCCCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 449 ---IAMGSAKGLAYLHED----CHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 449 ---i~~qia~gL~yLHs~----~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
+...+.+.+++|++. ....++|+|+++.|||++.+..+.|+||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244556666643 13479999999999999887556899998775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.94 E-value=7.7e-05 Score=78.76 Aligned_cols=142 Identities=16% Similarity=0.141 Sum_probs=85.6
Q ss_pred ceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCC--CeeEEeeE-----EEeCCeEEEEEEec
Q 040832 352 NLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHR--HLVSLVGY-----CIAGGKRLLVYEYV 424 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~Hp--nIv~l~g~-----~~~~~~~~lV~E~~ 424 (724)
+.|+ |....||+....+|+.+++|...... .....+..|+.+++.|... .+.+++.. ...++..++||||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 77889999887777789999987432 2345677888888888422 24444442 23356778999999
Q ss_pred CCCCHH-----H---------HHhc--C-----CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 040832 425 PNNNLE-----F---------HLHG--K-----GRPVMDWPTR----LKI---------------AMGSAKGLAYLHED- 463 (724)
Q Consensus 425 ~~gsL~-----~---------~L~~--~-----~~~~l~~~~~----~~i---------------~~qia~gL~yLHs~- 463 (724)
+|..+. . .||. . ....+++... ..+ ...+.+.++.|.+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 885432 1 1221 1 0111222211 011 11111223334332
Q ss_pred ---CCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 464 ---CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 464 ---~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
....++|+|+++.|||++ + .+.|+||+.+...
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 234689999999999999 4 8999999987643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.85 E-value=7.5e-05 Score=79.19 Aligned_cols=142 Identities=17% Similarity=0.126 Sum_probs=75.7
Q ss_pred ceeeccCcEE-EEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCC--CCeeEEeeEEEeCCeEEEEEEecCCCC
Q 040832 352 NLLGQGGFGY-VHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHH--RHLVSLVGYCIAGGKRLLVYEYVPNNN 428 (724)
Q Consensus 352 ~~LG~G~fG~-Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~H--pnIv~l~g~~~~~~~~~lV~E~~~~gs 428 (724)
+.|+.|.... +|+....+++.+++|....... .++..|+.+++.|.. -.+.+++.++...+ ++|||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4466565554 6676654467788876544321 234567777777742 23556776654444 78999998766
Q ss_pred HHHHHhc---------------------CC---CCCCCHHHHH-------HHH-------------HHHHHHHHHHHh--
Q 040832 429 LEFHLHG---------------------KG---RPVMDWPTRL-------KIA-------------MGSAKGLAYLHE-- 462 (724)
Q Consensus 429 L~~~L~~---------------------~~---~~~l~~~~~~-------~i~-------------~qia~gL~yLHs-- 462 (724)
+..++.. .. ...++..... .+. ..+.+.++.|.+
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 6543321 11 1111211110 000 011122333321
Q ss_pred -cCCCCeEecCCCCccEEEcCC----CCEEEEEeccccccC
Q 040832 463 -DCHPRIIHRDIKSSNILLDYT----FETKVADFGLAKLTT 498 (724)
Q Consensus 463 -~~~~~iiHrDIkp~NILl~~~----~~vkL~DFGla~~~~ 498 (724)
.....++|||+++.|||++.+ +.+.|+||+.+....
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 123479999999999999874 679999999987543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.76 E-value=5.7e-05 Score=79.00 Aligned_cols=138 Identities=12% Similarity=0.094 Sum_probs=77.3
Q ss_pred cceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCe-eEEeeEEEeCCeEEEEEEec-CCCC
Q 040832 351 SNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHL-VSLVGYCIAGGKRLLVYEYV-PNNN 428 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~E~~-~~gs 428 (724)
.+.|+.|....+|+. +.+++|+....... .....+|+.+++.+....+ .++++++ .+.-++|+||+ ++..
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 678999999999998 56888987653211 1123568888887753233 4565543 33347899999 6655
Q ss_pred HHH------------------HHhcCCCC---CCC-HHHHHHHHH--------------HHHHHHHHHH----h-cCCCC
Q 040832 429 LEF------------------HLHGKGRP---VMD-WPTRLKIAM--------------GSAKGLAYLH----E-DCHPR 467 (724)
Q Consensus 429 L~~------------------~L~~~~~~---~l~-~~~~~~i~~--------------qia~gL~yLH----s-~~~~~ 467 (724)
|.. .||..... ... +..+.++.. .+.+.+..|. . .....
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 431 11221110 011 111111111 0111111111 1 12335
Q ss_pred eEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 468 IIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 468 iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
++|+|+.+.||| ..++.+.|+||..+...
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 899999999999 55668999999988643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.68 E-value=5.1e-05 Score=83.80 Aligned_cols=73 Identities=21% Similarity=0.203 Sum_probs=50.5
Q ss_pred cceeeccCcEEEEEEEcCC--------CcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC-eeEEeeEEEeCCeEEEEE
Q 040832 351 SNLLGQGGFGYVHKGVLPN--------GKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRH-LVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~~--------g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~lV~ 421 (724)
.+.|+.|....||+....+ ++.|++|+..... ....+..|+.+++.|...+ ..++++++.+ .+||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4568888889999998653 4789999884421 1245668999999885333 3567766542 3899
Q ss_pred EecCCCCH
Q 040832 422 EYVPNNNL 429 (724)
Q Consensus 422 E~~~~gsL 429 (724)
||++|..|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00015 Score=78.59 Aligned_cols=140 Identities=19% Similarity=0.173 Sum_probs=84.6
Q ss_pred ceeeccCcEEEEEEEcC--------CCcEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCeeEEeeEEEeCCeEEEEEE
Q 040832 352 NLLGQGGFGYVHKGVLP--------NGKEVAVKSLRSGSGQGEREFKAEVEIISRVH-HRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~--------~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E 422 (724)
+.|..|-...+|+.... +++.|++|+.... ......+.+|+++++.|. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45777878889998864 2478999986332 123456778999999884 3334567666543 29999
Q ss_pred ecCCCCHHH-----------------HHhcCCC---CCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 040832 423 YVPNNNLEF-----------------HLHGKGR---PVMD--WPTRLKIAMGSAK-------------------GLAYLH 461 (724)
Q Consensus 423 ~~~~gsL~~-----------------~L~~~~~---~~l~--~~~~~~i~~qia~-------------------gL~yLH 461 (724)
|++|..|.. .||.... .... |.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999866531 1222211 1112 3455555544322 233443
Q ss_pred hc-----CCCCeEecCCCCccEEEcCC----CCEEEEEeccccc
Q 040832 462 ED-----CHPRIIHRDIKSSNILLDYT----FETKVADFGLAKL 496 (724)
Q Consensus 462 s~-----~~~~iiHrDIkp~NILl~~~----~~vkL~DFGla~~ 496 (724)
+. ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22 23368999999999999876 7899999988853
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00016 Score=80.52 Aligned_cols=74 Identities=8% Similarity=0.040 Sum_probs=48.3
Q ss_pred cceeeccCcEEEEEEEcCC-CcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCe-eEEeeEEEeCCeEEEEEEecCCCC
Q 040832 351 SNLLGQGGFGYVHKGVLPN-GKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHL-VSLVGYCIAGGKRLLVYEYVPNNN 428 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~~-g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~E~~~~gs 428 (724)
.+.|+.|-...+|+....+ ++.|++|+....... ..+..+|+.+|+.|...++ .++++++. + .+||||++|..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4567888889999988754 477889987543211 1122579999999965444 56777662 2 35999998755
Q ss_pred H
Q 040832 429 L 429 (724)
Q Consensus 429 L 429 (724)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00014 Score=78.40 Aligned_cols=74 Identities=12% Similarity=0.056 Sum_probs=45.3
Q ss_pred cceeeccCcEEEEEEEcCC---------CcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC-eeEEeeEEEeCCeEEEE
Q 040832 351 SNLLGQGGFGYVHKGVLPN---------GKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRH-LVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~~---------g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~lV 420 (724)
.+.|+.|....+|+....+ ++.+++|+...... ...+...|+++|+.|...+ +.++++.+ .+ ++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEE
Confidence 3567788888999988644 26788998764321 1113467888888885333 44666544 22 789
Q ss_pred EEecCCCCH
Q 040832 421 YEYVPNNNL 429 (724)
Q Consensus 421 ~E~~~~gsL 429 (724)
|||++|..|
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999988543
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=97.45 E-value=6.4e-05 Score=52.62 Aligned_cols=33 Identities=18% Similarity=0.118 Sum_probs=23.5
Q ss_pred CCCCccceeehhhHHHHHHHHHHHHHHHHHhhh
Q 040832 212 GSMLSIPLVAAVAAGAAFLIIVMLLVFFACRRK 244 (724)
Q Consensus 212 ~~~~s~~~i~~i~~g~~~~lv~l~~~~~~~~rk 244 (724)
+++++.++|++|++|+++.++++++++||++||
T Consensus 5 ~~~ls~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 5 SRGLTGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp STTCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 457888999999999887666655555554444
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.43 E-value=0.0006 Score=72.68 Aligned_cols=132 Identities=12% Similarity=0.135 Sum_probs=77.9
Q ss_pred cEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcC---CCCeeEEeeE------EEeCCeEEEEEEecCCCCH
Q 040832 359 FGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVH---HRHLVSLVGY------CIAGGKRLLVYEYVPNNNL 429 (724)
Q Consensus 359 fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~---HpnIv~l~g~------~~~~~~~~lV~E~~~~gsL 429 (724)
...||+....+| .+++|+...... ..|+.+++.|. -+++.+++.. +..++..++||+|++|..+
T Consensus 36 ~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~~ 108 (339)
T 3i1a_A 36 NAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNG 108 (339)
T ss_dssp SCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCBT
T ss_pred ccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCcC
Confidence 579999987666 899998765432 34666666663 2224555432 3445778999999998765
Q ss_pred H-------------H---HHhcCCC----------CCCC--HHH-HHHHH---------------------------HHH
Q 040832 430 E-------------F---HLHGKGR----------PVMD--WPT-RLKIA---------------------------MGS 453 (724)
Q Consensus 430 ~-------------~---~L~~~~~----------~~l~--~~~-~~~i~---------------------------~qi 453 (724)
. . .||.... ..+. |.. +.++. ..+
T Consensus 109 ~~~~~~~~~~~~lg~~La~LH~~~~~~~~~~~~~~~~~~~~w~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (339)
T 3i1a_A 109 FTQNLTGKQWKQLGKVLRQIHETSVPISIQQQLRKEIYSPKWREIVRSFYNQIEFDNSDDKLTAAFKSFFNQNSAAIHRL 188 (339)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTCCCCHHHHTTSEECCCCCHHHHHHHHHGGGGSCCTTCCHHHHHHHHHHHHTHHHHHHH
T ss_pred cccCCCHHHHHHHHHHHHHHhCcCCCCCCccCccccccCcchHHHHHHHHHhhhccccCCcHHHHHHHHHHHhHHHHHHH
Confidence 1 1 1222211 0011 111 11111 112
Q ss_pred HHHHHHHHhc-----CCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 454 AKGLAYLHED-----CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 454 a~gL~yLHs~-----~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
+..+..|... ....++|+|+.+.|||++.++.+.|+||+.+...
T Consensus 189 ~~~~~~l~~~l~~~~~~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 189 VDTSEKLSKKIQPDLDKYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp HHHHHHHHHHCCCCGGGCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred HHHHHHHHHHHhhCCCCceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 2222222221 1346999999999999998888999999887643
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0002 Score=51.47 Aligned_cols=31 Identities=32% Similarity=0.528 Sum_probs=14.2
Q ss_pred cceeehhhHHHHHHHHHHHHH-HHHHhhhccc
Q 040832 217 IPLVAAVAAGAAFLIIVMLLV-FFACRRKKNR 247 (724)
Q Consensus 217 ~~~i~~i~~g~~~~lv~l~~~-~~~~~rk~~~ 247 (724)
+..|++.|+|.++++++++++ |||+|||+++
T Consensus 9 ~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 9 TPLIAAGVIGGLFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred cceEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence 345555555544444444444 4444444333
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=97.13 E-value=0.00025 Score=50.88 Aligned_cols=31 Identities=10% Similarity=0.310 Sum_probs=19.2
Q ss_pred eeehhhHHHHHHHHHHHHHHHHHhhhccccc
Q 040832 219 LVAAVAAGAAFLIIVMLLVFFACRRKKNRER 249 (724)
Q Consensus 219 ~i~~i~~g~~~~lv~l~~~~~~~~rk~~~~r 249 (724)
.|+++++|+++++++++++++|+|||+.+++
T Consensus 13 ~Ia~~vVGvll~vi~~l~~~~~~RRR~~~~k 43 (44)
T 2jwa_A 13 SIISAVVGILLVVVLGVVFGILIKRRQQKIR 43 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHCSCCC
T ss_pred chHHHHHHHHHHHHHHHHHHhheehhhhhcc
Confidence 4777777765555555666666666655543
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.00044 Score=49.84 Aligned_cols=28 Identities=29% Similarity=0.343 Sum_probs=12.3
Q ss_pred eeehhhHHH-HHHHHHHHHHHHHHhhhcc
Q 040832 219 LVAAVAAGA-AFLIIVMLLVFFACRRKKN 246 (724)
Q Consensus 219 ~i~~i~~g~-~~~lv~l~~~~~~~~rk~~ 246 (724)
.|++.|+|. ++++++++++|||+|||++
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred eEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 455555544 4444444444444444433
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0087 Score=59.06 Aligned_cols=102 Identities=13% Similarity=0.032 Sum_probs=66.7
Q ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcccc
Q 040832 427 NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVST 506 (724)
Q Consensus 427 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 506 (724)
-+|.++|...+. .++++++|.++.|.++.|.-+-... .-..+=+.+..|+|..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~-PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ-PINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCC-CcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 368899987665 5899999999999999987763211 111233446899999999887753 1110
Q ss_pred ccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCC
Q 040832 507 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRR 546 (724)
Q Consensus 507 ~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~ 546 (724)
.....+.+||... ...+++.=|||||++||..+--..
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 0112356888763 355789999999999999987443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.67 E-value=0.003 Score=69.33 Aligned_cols=140 Identities=11% Similarity=0.088 Sum_probs=84.5
Q ss_pred cceeeccCcEEEEEEEcCC--------CcEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCeeEEeeEEEeCCeEEEEE
Q 040832 351 SNLLGQGGFGYVHKGVLPN--------GKEVAVKSLRSGSGQGEREFKAEVEIISRVH-HRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~~--------g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~ 421 (724)
.+.|..|-...+|+....+ ++.|++|+..... ....+..+|+.+++.|. +.-..++++.+ .+ ++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence 4567778888999988653 5789999865432 11123467888888884 33345566543 22 7899
Q ss_pred EecCCCCHHH-----------------HHhcC-----------CCCCCCHHHHHHHHHHH-------------------H
Q 040832 422 EYVPNNNLEF-----------------HLHGK-----------GRPVMDWPTRLKIAMGS-------------------A 454 (724)
Q Consensus 422 E~~~~gsL~~-----------------~L~~~-----------~~~~l~~~~~~~i~~qi-------------------a 454 (724)
||++|..|.. .||.. +....-|.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999876421 01110 11111244444443322 2
Q ss_pred HHHHHHHhc---------------------CCCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 455 KGLAYLHED---------------------CHPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 455 ~gL~yLHs~---------------------~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
+.+.+|.+. ....++|+|+.+.||| +.++.+.|+||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 233343321 1235899999999999 7788999999988853
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.23 E-value=0.043 Score=59.60 Aligned_cols=29 Identities=28% Similarity=0.399 Sum_probs=24.6
Q ss_pred eEecCCCCccEEE------cCCCCEEEEEeccccc
Q 040832 468 IIHRDIKSSNILL------DYTFETKVADFGLAKL 496 (724)
Q Consensus 468 iiHrDIkp~NILl------~~~~~vkL~DFGla~~ 496 (724)
++|+|+...|||+ +++..++|+||-+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999988853
|
| >2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B | Back alignment and structure |
|---|
Probab=93.50 E-value=0.035 Score=37.41 Aligned_cols=30 Identities=20% Similarity=0.368 Sum_probs=23.4
Q ss_pred CCccceeehhhHHHHHHHHHHHHHHHHHhh
Q 040832 214 MLSIPLVAAVAAGAAFLIIVMLLVFFACRR 243 (724)
Q Consensus 214 ~~s~~~i~~i~~g~~~~lv~l~~~~~~~~r 243 (724)
.++.+.+++|+++.+++.+++++++||+.|
T Consensus 3 ~L~~gaIaGIVvgdi~~t~~i~~~vy~~~r 32 (33)
T 2l34_A 3 TVSPGVLAGIVVGDLVLTVLIALAVYFLGR 32 (33)
T ss_dssp CCCTHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred ccCcceEEeEeHHHHHHHHHHHHHHhheec
Confidence 356778999999988888877777777655
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.27 E-value=0.029 Score=39.88 Aligned_cols=8 Identities=38% Similarity=0.114 Sum_probs=3.0
Q ss_pred HHHHHHhh
Q 040832 236 LVFFACRR 243 (724)
Q Consensus 236 ~~~~~~~r 243 (724)
+++|+++|
T Consensus 31 ~~~~~~~r 38 (41)
T 2k9y_A 31 GVGFFIHR 38 (41)
T ss_dssp HHHHSSSS
T ss_pred HHheeEee
Confidence 33333333
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.33 E-value=0.3 Score=47.95 Aligned_cols=115 Identities=7% Similarity=0.072 Sum_probs=79.3
Q ss_pred CCCCeeEEeeEEEeCCeEEEEEEecCCC-CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccE
Q 040832 400 HHRHLVSLVGYCIAGGKRLLVYEYVPNN-NLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNI 478 (724)
Q Consensus 400 ~HpnIv~l~g~~~~~~~~~lV~E~~~~g-sL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NI 478 (724)
.|++++.. .+-.+++.+.+.|+.-..+ ++.. +.. ++...+++++.+|+....+++. -+|--|+|+||
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik~-----~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IKS-----FTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GGG-----SCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HHh-----cCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 57887765 4556666666666554322 2222 332 6788999999999998866654 47889999999
Q ss_pred EEcCCCCEEEEEeccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCC
Q 040832 479 LLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPID 549 (724)
Q Consensus 479 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~ 549 (724)
+++.++.++++-.|+-..+.. . .+++..=.-.+=|++..+++++..|+
T Consensus 111 ~f~~~~~p~i~~RGik~~l~P------------------~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVVDP------------------L-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTTBSC------------------C-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccCCCC------------------C-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999987776433322 1 22333444567789999999988774
|
| >1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1 | Back alignment and structure |
|---|
Probab=92.13 E-value=0.028 Score=38.13 Aligned_cols=25 Identities=20% Similarity=0.470 Sum_probs=12.7
Q ss_pred eehhhHHHHHHHHHHHHHHHHHhhh
Q 040832 220 VAAVAAGAAFLIIVMLLVFFACRRK 244 (724)
Q Consensus 220 i~~i~~g~~~~lv~l~~~~~~~~rk 244 (724)
|++.++|+++++++++++++|+|||
T Consensus 10 IaagVvglll~vii~l~~~~~iRRr 34 (35)
T 1iij_A 10 IIATVVGVLLFLILVVVVGILIKRR 34 (35)
T ss_dssp HHHHHHHHHHHHHHTTTTTHHHHHC
T ss_pred eHHHHHHHHHHHHHHHHhheEEeec
Confidence 4455555444444445555555554
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.84 E-value=0.84 Score=44.93 Aligned_cols=115 Identities=10% Similarity=0.088 Sum_probs=77.0
Q ss_pred CCCCeeEEeeEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEecCCCCccE
Q 040832 400 HHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLA-YLHEDCHPRIIHRDIKSSNI 478 (724)
Q Consensus 400 ~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~-yLHs~~~~~iiHrDIkp~NI 478 (724)
.|+++ -..+-.+++.+.+.|+.-+++.=...+.. ++...+++++.+|+.... +++ .-+|--|+|+||
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-----~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-----TTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-----SCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-----cCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceE
Confidence 57777 33444667777777776534332333432 678899999988887666 554 358889999999
Q ss_pred EEcCCCCEEEEEeccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCC
Q 040832 479 LLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPID 549 (724)
Q Consensus 479 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~ 549 (724)
+++.++.++|.-.|+-..+. |.- +++.-=+-.+=|++..++.++.-|+
T Consensus 116 ~f~~~~~p~i~hRGi~~~lp------------------P~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKESLP------------------PDE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EECTTCCEEESCCEETTTBS------------------SCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEeCCCcEEEEEcCCcccCC------------------CCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999998777654332 221 2222333466778888888877663
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.78 E-value=0.2 Score=36.04 Aligned_cols=31 Identities=16% Similarity=0.252 Sum_probs=16.9
Q ss_pred eeehhhHHHHHHHHHHHHHHH-HHhhhccccc
Q 040832 219 LVAAVAAGAAFLIIVMLLVFF-ACRRKKNRER 249 (724)
Q Consensus 219 ~i~~i~~g~~~~lv~l~~~~~-~~~rk~~~~r 249 (724)
-+.+|++|++..++++++++. ++...|||+.
T Consensus 9 ~~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 9 KIPSIATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp CSSSSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred CcceEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 366677766666665543333 4555555444
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.23 E-value=0.26 Score=35.37 Aligned_cols=22 Identities=18% Similarity=0.268 Sum_probs=10.4
Q ss_pred eehhhHHHHHHHHHHHHHHHHH
Q 040832 220 VAAVAAGAAFLIIVMLLVFFAC 241 (724)
Q Consensus 220 i~~i~~g~~~~lv~l~~~~~~~ 241 (724)
+.+|++|++..+++++++...+
T Consensus 9 ~~aIA~gVVgGv~~v~ii~~~~ 30 (44)
T 2l2t_A 9 TPLIAAGVIGGLFILVIVGLTF 30 (44)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHH
T ss_pred cceEEEeehHHHHHHHHHHHHH
Confidence 3344444444445555555443
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.45 E-value=0.08 Score=58.70 Aligned_cols=62 Identities=5% Similarity=0.005 Sum_probs=18.6
Q ss_pred cccceeeccCcEEEEEEEcCC-CcEEEE------EEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEe
Q 040832 349 SQSNLLGQGGFGYVHKGVLPN-GKEVAV------KSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIA 413 (724)
Q Consensus 349 ~~~~~LG~G~fG~Vyk~~~~~-g~~vaV------K~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 413 (724)
.+.+.|| ||+||+|.+.. ...||| |.++.+.. +....|.+|..+++.++|+|+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 3455666 99999999854 357888 77765322 223468899999999999999999887653
|
| >2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.40 E-value=1.1 Score=33.55 Aligned_cols=12 Identities=17% Similarity=0.667 Sum_probs=4.4
Q ss_pred HHHHHHHHHHHH
Q 040832 228 AFLIIVMLLVFF 239 (724)
Q Consensus 228 ~~~lv~l~~~~~ 239 (724)
++++++++++.|
T Consensus 23 LllL~li~~~Lw 34 (54)
T 2knc_A 23 LLLLTILVLAMW 34 (54)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 333333333333
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=84.17 E-value=2.1 Score=44.74 Aligned_cols=142 Identities=16% Similarity=0.095 Sum_probs=73.6
Q ss_pred cccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEE-----------------
Q 040832 349 SQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYC----------------- 411 (724)
Q Consensus 349 ~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~----------------- 411 (724)
..++.+..|..| ||.+.. ++..|+||-.. ....+.|-.++...-.|.-|+.. ++.+.
T Consensus 72 ~~I~~s~~Gstg-vff~~t-d~~~~VVK~s~---~l~~E~l~s~LA~~LGlpiP~~R-iv~~~~~E~~e~~~~L~~~~~~ 145 (342)
T 1cja_A 72 KGIERSEKGTEG-LFFVET-ESGVFIVKRST---NIESETFCSLLCMRLGLHAPKVR-VVSSNSEEGTNMLECLAAIDKS 145 (342)
T ss_dssp EEEEECCSTTSC-EEEEEE-SSCEEEEECCT---THHHHHHHHHHHHHHTCCCCCEE-EEESSSHHHHHHHHHHHHHCSS
T ss_pred eEEEeccCCCCC-eEEEEe-CCCEEEEeCcH---HHHHHHHHHHHHHHhCCCCCCee-EEeeCcHHHHHHHHHHHHhhhh
Confidence 334445556544 555544 57889999552 22223344455544445555522 11111
Q ss_pred ------EeCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEe-cCCCCccEEEcCC
Q 040832 412 ------IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR-IIH-RDIKSSNILLDYT 483 (724)
Q Consensus 412 ------~~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~-iiH-rDIkp~NILl~~~ 483 (724)
......+++|||+.|..|...-+..-...+...... .++-+-+++++..++.+- .++ .--.+.|||++++
T Consensus 146 ~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~~k--~LG~Ii~FDi~InN~DR~Pl~W~n~GN~~NIL~~~~ 223 (342)
T 1cja_A 146 FRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQ--QLGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSER 223 (342)
T ss_dssp SCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHH--HHHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESB
T ss_pred hHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHHHHH--hhchhheehhhhcCCccCcccccCCCChhheEEeCC
Confidence 012245799999987665432111000002212211 112244677777665432 121 1258899999765
Q ss_pred C-CEEEEEeccccccC
Q 040832 484 F-ETKVADFGLAKLTT 498 (724)
Q Consensus 484 ~-~vkL~DFGla~~~~ 498 (724)
+ .+.++|-+++....
T Consensus 224 n~~~~~IDhn~af~~~ 239 (342)
T 1cja_A 224 GATVVPIDSKIIPLDA 239 (342)
T ss_dssp TTCEEECSCCCCCCCS
T ss_pred CCeEEEEcCCccccCC
Confidence 4 48999999986544
|
| >2klu_A T-cell surface glycoprotein CD4; cell membrane, disulfide bond, HOST- virus interaction, immune response, immunoglobulin domain, lipoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.92 E-value=0.75 Score=35.57 Aligned_cols=12 Identities=8% Similarity=0.321 Sum_probs=5.1
Q ss_pred hhHHHHHHHHHH
Q 040832 223 VAAGAAFLIIVM 234 (724)
Q Consensus 223 i~~g~~~~lv~l 234 (724)
|++|+++.++++
T Consensus 12 ivlGg~~~lll~ 23 (70)
T 2klu_A 12 IVLGGVAGLLLF 23 (70)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHhHHHHHHHH
Confidence 444444443333
|
| >2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* | Back alignment and structure |
|---|
Probab=83.82 E-value=36 Score=39.15 Aligned_cols=45 Identities=22% Similarity=0.112 Sum_probs=32.5
Q ss_pred HHHHHHHHHHH--HHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 444 PTRLKIAMGSA--KGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 444 ~~~~~i~~qia--~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
..+..++..+| ..+.|+=.. +|=+++||||+.+|++.=+|||.+.
T Consensus 529 ~ar~nF~~SlA~~Svv~YILGl-------GDRH~~NILid~tG~v~HIDFG~~f 575 (696)
T 2x6h_A 529 EVMDTYIKSCAGYCVITYLLGV-------GDRHLDNLLLTTNGKLFHIDFGYIL 575 (696)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTC-------CCCCTTTEEECTTSCEEECCCCSCT
T ss_pred HHHHHHHHHHHHHHHHHHHccC-------CCCCCcceEEeCCCCEEEEeehhhh
Confidence 34555555554 234444332 7889999999999999999999975
|
| >3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A | Back alignment and structure |
|---|
Probab=82.48 E-value=45 Score=37.75 Aligned_cols=83 Identities=16% Similarity=0.093 Sum_probs=51.0
Q ss_pred eEEeeEEEeCCeEEEEEEecCCCCHHHHHhcCC-----------CC----CCCHHHHHHHHHHHHH--HHHHHHhcCCCC
Q 040832 405 VSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKG-----------RP----VMDWPTRLKIAMGSAK--GLAYLHEDCHPR 467 (724)
Q Consensus 405 v~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~-----------~~----~l~~~~~~~i~~qia~--gL~yLHs~~~~~ 467 (724)
++.|.+.......- ++|++++.++.+++...+ .. ...+..+..++..+|- .+.|+=.-
T Consensus 402 i~~Y~Vipls~~~G-lIE~V~~~tl~~il~~~~~l~~~f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YILGi---- 476 (614)
T 3ls8_A 402 LTPYKVLATSTKHG-FMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGV---- 476 (614)
T ss_dssp CCCCCEEESSSSEE-EEECCCCEEHHHHHHHTSSHHHHHHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHHHTC----
T ss_pred eeccEEEEecCCCc-eEEEeCCccHHHHHHccChHHHHHHHhCCCccccccccHHHHHHHHHHHHHHhHhheeeec----
Confidence 34455555444433 457887766655553211 00 0124455566665553 35555433
Q ss_pred eEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 468 IIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 468 iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
+|=+.+||||+.+|++.=+|||.+.
T Consensus 477 ---gDRH~~NILld~tG~v~HIDFG~~f 501 (614)
T 3ls8_A 477 ---GDRHLDNLLLTKTGKLFHIDFGYIL 501 (614)
T ss_dssp ---CCCCTTSEEECTTSCEEECCCSSCT
T ss_pred ---cCCCCcceeEcCCCCEeeeehHHhh
Confidence 6788999999999999999999984
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 724 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-72 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-72 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-70 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-69 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-69 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-66 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-64 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-63 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-62 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-62 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-62 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-61 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-61 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-61 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-59 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-59 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-58 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-53 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-48 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-48 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-48 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-48 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-47 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-45 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-42 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-31 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-29 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (598), Expect = 2e-72
Identities = 80/270 (29%), Positives = 116/270 (42%), Gaps = 23/270 (8%)
Query: 352 NLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
LG G FG V G +VAVKSL+ GS F AE ++ ++ H+ LV L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHR 471
++ EY+ N +L L + L +A A+G+A++ E IHR
Sbjct: 78 T-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 472 DIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 531
D++++NIL+ T K+ADFGLA+L DN + APE + G T KSDV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 532 FSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEE 591
+SFG++L E++T R P P ++ L+ G N P E
Sbjct: 194 WSFGILLTEIVTHGRIPYP---------GMTNPEVIQNLERGY-----RMVRPDNCPEEL 239
Query: 592 MARMVACAAASIRHSARRRPKISQIVRALE 621
M C + RP + LE
Sbjct: 240 YQLMRLC----WKERPEDRPTFDYLRSVLE 265
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (599), Expect = 2e-72
Identities = 71/274 (25%), Positives = 127/274 (46%), Gaps = 23/274 (8%)
Query: 352 NLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
+G G FG V+KG V + ++ + + Q + FK EV ++ + H +++ +GY
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHR 471
+ +V ++ ++L HLH + + IA +A+G+ YLH IIHR
Sbjct: 74 T-APQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSIIHR 128
Query: 472 DIKSSNILLDYTFETKVADFGLAKL-TTDNNTHVSTRVMGTFGYLAPEYA---SSGKLTE 527
D+KS+NI L K+ DFGLA + + + +H ++ G+ ++APE +
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 528 KSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNY 587
+SDV++FG++L EL+TG+ P D + R + +++ N
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYS-----NINNRDQIIFMVGRGYLSPDLSKVRS-----NC 238
Query: 588 PTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
P M C ++ RP QI+ ++E
Sbjct: 239 PKAMKRLMAEC----LKKKRDERPLFPQILASIE 268
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 2e-70
Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 9/214 (4%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE-FKAEVEIISRVHHRHLV 405
F + + LG G G V K P+G +A K + R E++++ + ++V
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 406 SLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCH 465
G + G+ + E++ +L+ L GR + K+++ KGL YL E
Sbjct: 68 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH- 124
Query: 466 PRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKL 525
+I+HRD+K SNIL++ E K+ DFG++ D+ +GT Y++PE
Sbjct: 125 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTHY 180
Query: 526 TEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLV 559
+ +SD++S G+ L+E+ GR PI P A E L+
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 4e-69
Identities = 70/274 (25%), Positives = 119/274 (43%), Gaps = 23/274 (8%)
Query: 348 FSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSL 407
+ +G G FG VH G N +VA+K++R G+ E +F E E++ ++ H LV L
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR 467
G C+ LV+E++ + L R + T L + + +G+AYL
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCL-SDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEAC 121
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTE 527
+IHRD+ + N L+ KV+DFG+ + D+ ST + +PE S + +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 528 KSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNY 587
KSDV+SFGV++ E+ + + + + + D + Y +
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF--------------RLYKPRLA 227
Query: 588 PTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
T M C + RP S+++R L
Sbjct: 228 STHVYQIMNHC----WKERPEDRPAFSRLLRQLA 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (577), Expect = 5e-69
Identities = 63/288 (21%), Positives = 115/288 (39%), Gaps = 25/288 (8%)
Query: 354 LGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIA 413
+G+G FG V +G G+EVAVK S + +AE+ + H +++ +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 414 GG----KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC----- 464
+ LV +Y + +L +L+ + +K+A+ +A GLA+LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAKL---TTDNNTHVSTRVMGTFGYLAPEYAS 521
P I HRD+KS NIL+ +AD GLA TD +GT Y+APE
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 522 S------GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWA-RPLCLRALDDGN 574
+ +++D+++ G++ E+ + D + +
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245
Query: 575 FNEIADPYLEKNYPTEEMARMVA-CAAASIRHSARRRPKISQIVRALE 621
+ P + + + E R++A + R +I + L
Sbjct: 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 6e-66
Identities = 70/271 (25%), Positives = 116/271 (42%), Gaps = 29/271 (10%)
Query: 352 NLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
+G+G FG V G G +VAVK +++ + + F AE +++++ H +LV L+G
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 412 IAGGKRL-LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIH 470
+ L +V EY+ +L +L +GR V+ LK ++ + + YL +H
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126
Query: 471 RDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSD 530
RD+ + N+L+ KV+DFGL K + + APE K + KSD
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----KLPVKWTAPEALREKKFSTKSD 182
Query: 531 VFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTE 590
V+SFG++L E+ + R P ++D + ++ G P
Sbjct: 183 VWSFGILLWEIYSFGRVPYPRIPLKD---------VVPRVEKGY-----KMDAPDGCPPA 228
Query: 591 EMARMVACAAASIRHSARRRPKISQIVRALE 621
M C A RP Q+ LE
Sbjct: 229 VYEVMKNC----WHLDAAMRPSFLQLREQLE 255
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 216 bits (552), Expect = 2e-65
Identities = 70/305 (22%), Positives = 129/305 (42%), Gaps = 42/305 (13%)
Query: 336 FTYEELSAATGGFSQS---------NLLGQGGFGYVHKGVLPNGKE----VAVKSLRSG- 381
FT+E+ + A F++ ++G G FG V G L + VA+K+L+SG
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 382 SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVM 441
+ + R+F +E I+ + H +++ L G +++ E++ N +L+ L
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-F 125
Query: 442 DWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501
+ + G A G+ YL +HRD+ + NIL++ KV+DFGL++ D+
Sbjct: 126 TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 502 THVSTR----VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMED 556
+ + + APE K T SDV+S+G+++ E+++ G RP +
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD- 241
Query: 557 CLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQI 616
+ A++ P + + + + RPK QI
Sbjct: 242 ---------VINAIEQD---------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283
Query: 617 VRALE 621
V L+
Sbjct: 284 VNTLD 288
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 5e-65
Identities = 60/274 (21%), Positives = 104/274 (37%), Gaps = 23/274 (8%)
Query: 348 FSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSL 407
+ LG G FG V G +VA+K ++ GS E EF E +++ + H LV L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR 467
G C ++ EY+ N L +L L++ + + YL +
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQ 120
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTE 527
+HRD+ + N L++ KV+DFGL++ D+ S + PE K +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 528 KSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNY 587
KSD+++FGV++ E+ + + + + G Y
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYE---------RFTNSETAEHIAQGL-----RLYRPHLA 226
Query: 588 PTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
+ M +C A RP ++ +
Sbjct: 227 SEKVYTIMYSC----WHEKADERPTFKILLSNIL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 6e-64
Identities = 75/270 (27%), Positives = 110/270 (40%), Gaps = 23/270 (8%)
Query: 352 NLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
LGQG FG V G VA+K+L+ G+ F E +++ ++ H LV L
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV 81
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHR 471
+V EY+ +L L G+ + P + +A A G+AY+ +HR
Sbjct: 82 S-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 137
Query: 472 DIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 531
D++++NIL+ KVADFGLA+L DN + APE A G+ T KSDV
Sbjct: 138 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 197
Query: 532 FSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEE 591
+SFG++L EL T R P + L + + P E
Sbjct: 198 WSFGILLTELTTKGRVPYPGMVNREVL------------------DQVERGYRMPCPPEC 239
Query: 592 MARMVACAAASIRHSARRRPKISQIVRALE 621
+ R RP + LE
Sbjct: 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 210 bits (535), Expect = 4e-63
Identities = 71/285 (24%), Positives = 120/285 (42%), Gaps = 23/285 (8%)
Query: 348 FSQSNLLGQGGFGYVHKGVLPN-GKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVS 406
+ + LG G +G V++GV VAVK+L+ + + E EF E ++ + H +LV
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 77
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHP 466
L+G C ++ E++ NL +L R + L +A + + YL +
Sbjct: 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---K 134
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLT 526
IHRD+ + N L+ KVADFGL++L T + + APE + K +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 527 EKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKN 586
KSDV++FGV+L E+ T P +D E+ +
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYP------------------GIDLSQVYELLEKDYRME 236
Query: 587 YPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSLEDLND 631
P ++ A + + RP ++I +A E ++D
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 2e-62
Identities = 78/299 (26%), Positives = 122/299 (40%), Gaps = 45/299 (15%)
Query: 352 NLLGQGGFGYVHKGVL------PNGKEVAVKSLRSGSGQGERE-FKAEVEIISRV-HHRH 403
LG G FG V + VAVK L+ + ERE +E++++S + +H +
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 404 LVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKG----------------RPVMDWPTRL 447
+V+L+G C GG L++ EY +L L K +D L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 448 KIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK-LTTDNNTHVST 506
+ AKG+A+L IHRD+ + NILL + TK+ DFGLA+ + D+N V
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 507 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLC 566
++APE + T +SDV+S+G+ L EL + P ++
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---------- 255
Query: 567 LRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625
F ++ P A M +RP QIV+ +E +S
Sbjct: 256 -------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 6e-62
Identities = 65/280 (23%), Positives = 109/280 (38%), Gaps = 33/280 (11%)
Query: 350 QSNLLGQGGFGYVHKGVLPN---GKEVAVKSLRSGSGQGE--REFKAEVEIISRVHHRHL 404
+ LG G FG V KG K VAVK L++ + E AE ++ ++ + ++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 405 VSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC 464
V ++G C +LV E L +L + +++ + G+ YL
Sbjct: 71 VRMIGICE-AESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLE--- 124
Query: 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTR--VMGTFGYLAPEYASS 522
+HRD+ + N+LL K++DFGL+K + + + + APE +
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 523 GKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581
K + KSDV+SFGV++ E + G++P E L+ G
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----------VTAMLEKGERMGCPA- 233
Query: 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
P E M C + RP + + L
Sbjct: 234 ----GCPREMYDLMNLC----WTYDVENRPGFAAVELRLR 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (524), Expect = 7e-62
Identities = 63/276 (22%), Positives = 109/276 (39%), Gaps = 29/276 (10%)
Query: 352 NLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLV 408
+G G +G K +GK + K L GS ++ +EV ++ + H ++V
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 409 GYCI--AGGKRLLVYEYVPNNNLEFHLH--GKGRPVMDWPTRLKIAMGSAKGLAYLHE-- 462
I +V EY +L + K R +D L++ L H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 463 DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS 522
D ++HRD+K +N+ LD K+ DFGLA++ + + +GT Y++PE +
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQMNR 188
Query: 523 GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582
EKSD++S G +L EL P E + +G F I Y
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE----------LAGKIREGKFRRIPYRY 238
Query: 583 LEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618
++E+ ++ + RP + +I+
Sbjct: 239 ------SDELNEIITRM---LNLKDYHRPSVEEILE 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 1e-61
Identities = 68/289 (23%), Positives = 127/289 (43%), Gaps = 30/289 (10%)
Query: 348 FSQSNLLGQGGFGYVHKGVLPNGKE-----VAVKSLRSGSGQGER-EFKAEVEIISRVHH 401
++ ++G G FG V+KG+L VA+K+L++G + +R +F E I+ + H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 402 RHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLH 461
+++ L G +++ EY N + + + G A G+ YL
Sbjct: 69 HNIIRLEGVISKYKPMMIITEY-MENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 127
Query: 462 EDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN--NTHVSTRVMGTFGYLAPEY 519
+ +HRD+ + NIL++ KV+DFGL+++ D+ T+ ++ + APE
Sbjct: 128 ---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 520 ASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579
S K T SDV+SFG+++ E++T + + ++A++DG
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---------VMKAINDG------ 229
Query: 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSLED 628
P + + + + RRPK + IV L+ + D
Sbjct: 230 ---FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 3e-61
Identities = 77/281 (27%), Positives = 121/281 (43%), Gaps = 33/281 (11%)
Query: 351 SNLLGQGGFGYVHKGVLPNGK----EVAVKSLRSGSGQGE-REFKAEVEIISRVHHRHLV 405
+ ++G+G FG V+ G L + AVKSL + GE +F E I+ H +++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 406 SLVGYCI-AGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC 464
SL+G C+ + G L+V Y+ + +L + + + + AKG+
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGM---KFLA 147
Query: 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN---THVSTRVMGTFGYLAPEYAS 521
+ +HRD+ + N +LD F KVADFGLA+ D H T ++A E
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 522 SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581
+ K T KSDV+SFGV+L EL+T P P + D L + P
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPPYP----DVNTFDITVYLL-------QGRRLLQP 256
Query: 582 YLEKNYPTEEMAR-MVACAAASIRHSARRRPKISQIVRALE 621
Y + + M+ C A RP S++V +
Sbjct: 257 ----EYCPDPLYEVMLKC----WHPKAEMRPSFSELVSRIS 289
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 3e-61
Identities = 66/275 (24%), Positives = 117/275 (42%), Gaps = 31/275 (11%)
Query: 354 LGQGGFGYVHKGVL---PNGKEVAVKSLRSGSGQGERE-FKAEVEIISRVHHRHLVSLVG 409
LG G FG V +GV +VA+K L+ G+ + + E E +I+ ++ + ++V L+G
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 410 YCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRII 469
C +LV E L L GK + ++ + G+ YL +
Sbjct: 77 VCQ-AEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLE---EKNFV 131
Query: 470 HRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTR--VMGTFGYLAPEYASSGKLTE 527
HRD+ + N+LL K++DFGL+K ++++ + R + APE + K +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 528 KSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKN 586
+SDV+S+GV + E ++ G++P E + ++ G E
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKGPE----------VMAFIEQGKRMECPP-----E 236
Query: 587 YPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
P E A M C + RP + + +
Sbjct: 237 CPPELYALMSDC----WIYKWEDRPDFLTVEQRMR 267
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 204 bits (520), Expect = 6e-61
Identities = 65/304 (21%), Positives = 112/304 (36%), Gaps = 51/304 (16%)
Query: 348 FSQSNLLGQGGFGYVHKGVLPN------GKEVAVKSLR-SGSGQGEREFKAEVEIISRVH 400
+G+G FG V + P VAVK L+ S + +F+ E +++
Sbjct: 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD 74
Query: 401 HRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGR---------------------- 438
+ ++V L+G C G L++EY+ +L L
Sbjct: 75 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 134
Query: 439 PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK-LT 497
P + +L IA A G+AYL + +HRD+ + N L+ K+ADFGL++ +
Sbjct: 135 PPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 498 TDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDC 557
+ + ++ PE + T +SDV+++GV+L E+ + A E+
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE- 250
Query: 558 LVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIV 617
+ + DGN P + RP I
Sbjct: 251 --------VIYYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIH 293
Query: 618 RALE 621
R L+
Sbjct: 294 RILQ 297
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 204 bits (520), Expect = 9e-61
Identities = 67/278 (24%), Positives = 112/278 (40%), Gaps = 35/278 (12%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGE---REFKAEVEIISRVHHRH 403
FS +G G FG V+ + N + VA+K + Q ++ EV + ++ H +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 404 LVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHED 463
+ G + LV EY + + K + + G+ +GLAYLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHS- 133
Query: 464 CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS- 522
+IHRD+K+ NILL K+ DFG A + N+ V GT ++APE +
Sbjct: 134 --HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAM 186
Query: 523 --GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580
G+ K DV+S G+ +EL + P+ AM L +
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----------ALYHIAQNES----- 231
Query: 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618
P L+ + +E V ++ + RP +++
Sbjct: 232 PALQSGHWSEYFRNFVDSC---LQKIPQDRPTSEVLLK 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 9e-61
Identities = 64/273 (23%), Positives = 104/273 (38%), Gaps = 32/273 (11%)
Query: 354 LGQGGFGYVHKGVLP-NGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGY 410
+G+G F V+KG+ EVA L+ + + FK E E++ + H ++V
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 411 CIAGGKR----LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHP 466
+ K +LV E + + L+ +L M KGL +LH P
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHT-RTP 133
Query: 467 RIIHRDIKSSNILL-DYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKL 525
IIHRD+K NI + T K+ D GLA L + V+GT ++APE K
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFMAPEMYE-EKY 189
Query: 526 TEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEK 585
E DV++FG+ +LE+ T P + +
Sbjct: 190 DESVDVYAFGMCMLEMATSEYPYSECQNAAQI-----------------YRRVTSGVKPA 232
Query: 586 NYPTEEMARMVACAAASIRHSARRRPKISQIVR 618
++ + + IR + R I ++
Sbjct: 233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 2e-60
Identities = 58/273 (21%), Positives = 107/273 (39%), Gaps = 28/273 (10%)
Query: 352 NLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGY 410
LG G FG V+K A K + + S + ++ E++I++ H ++V L+
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 411 CIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIH 470
++ E+ ++ + RP + + + L YLH+ +IIH
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQTLDALNYLHD---NKIIH 133
Query: 471 RDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYA-----SSGKL 525
RD+K+ NIL + K+ADFG++ T + + GT ++APE
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPY 192
Query: 526 TEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEK 585
K+DV+S G+ L+E+ P M L + +A P
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHHELNPMR----------VLLKIAKSEPPTLAQP---S 239
Query: 586 NYPTEEMARMVACAAASIRHSARRRPKISQIVR 618
+ + + C + + R SQ+++
Sbjct: 240 RWSSNFKDFLKKC----LEKNVDARWTTSQLLQ 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 3e-59
Identities = 61/208 (29%), Positives = 89/208 (42%), Gaps = 12/208 (5%)
Query: 352 NLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSL 407
LG+G FG V+ + +A+K L E + + EVEI S + H +++ L
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR 467
GY + L+ EY P + L + D A L+Y H R
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHS---KR 126
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTE 527
+IHRDIK N+LL E K+ADFG + + + GT YL PE E
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEGRMHDE 183
Query: 528 KSDVFSFGVMLLELITGRRPIDPTGAME 555
K D++S GV+ E + G+ P + E
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQE 211
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 6e-59
Identities = 63/275 (22%), Positives = 118/275 (42%), Gaps = 30/275 (10%)
Query: 353 LLGQGGFGYVHKGVLPNGKE----VAVKSLRSGSGQGERE-FKAEVEIISRVHHRHLVSL 407
+G+G FG VH+G+ + + VA+K+ ++ + RE F E + + H H+V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR 467
+G ++ E L L + +D + + A + LAYL R
Sbjct: 74 IGVIT-ENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLES---KR 128
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTE 527
+HRDI + N+L+ K+ DFGL++ D+ + +++ ++APE + + T
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 528 KSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKN 586
SDV+ FGV + E++ G +P + + +++G + N
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNND----------VIGRIENGE-----RLPMPPN 233
Query: 587 YPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
P + M C + RRP+ +++ L
Sbjct: 234 CPPTLYSLMTKC----WAYDPSRRPRFTELKAQLS 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 7e-59
Identities = 69/299 (23%), Positives = 123/299 (41%), Gaps = 50/299 (16%)
Query: 353 LLGQGGFGYVHKGVLPN------GKEVAVKSLRSGSGQGERE-FKAEVEIISRV-HHRHL 404
+LG G FG V +VAVK L+ + ERE +E+++++++ H ++
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 405 VSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRP---------------------VMDW 443
V+L+G C G L++EY +L +L K V+ +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 444 PTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK-LTTDNNT 502
L A AKG+ +L +HRD+ + N+L+ + K+ DFGLA+ + +D+N
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWA 562
V ++APE G T KSDV+S+G++L E+ + P ++
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA------ 274
Query: 563 RPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
NF ++ + + P + + +R+RP + L
Sbjct: 275 -----------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-58
Identities = 62/217 (28%), Positives = 90/217 (41%), Gaps = 9/217 (4%)
Query: 352 NLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE-FKAEVEIISRVHHRHLVSLVG 409
LG+G +G V V + VAVK + E K E+ I ++H ++V G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 410 YCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRII 469
+ G + L EY L + M P + G+ YLH I
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH---GIGIT 125
Query: 470 HRDIKSSNILLDYTFETKVADFGLAK-LTTDNNTHVSTRVMGTFGYLAPEYASSGKL-TE 527
HRDIK N+LLD K++DFGLA +N + ++ GT Y+APE + E
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185
Query: 528 KSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARP 564
DV+S G++L ++ G P D DW
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 222
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-56
Identities = 70/278 (25%), Positives = 104/278 (37%), Gaps = 33/278 (11%)
Query: 354 LGQGGFGYVHKGVLP----NGKEVAVKSLRS---GSGQGEREFKAEVEIISRVHHRHLVS 406
LG G FG V +G VAVK L+ + +F EV + + HR+L+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHP 466
L G + +V E P +L L T + A+ A+G+ YL
Sbjct: 76 LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLES---K 130
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH--VSTRVMGTFGYLAPEYASSGK 524
R IHRD+ + N+LL K+ DFGL + N+ H + F + APE +
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 525 LTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583
+ SD + FGV L E+ T G+ P + L +D
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----------ILHKIDKEGE----RLPR 236
Query: 584 EKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
++ P + MV C H RP + L
Sbjct: 237 PEDCPQDIYNVMVQC----WAHKPEDRPTFVALRDFLL 270
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 1e-55
Identities = 73/282 (25%), Positives = 123/282 (43%), Gaps = 32/282 (11%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKE----VAVKSLR-SGSGQGEREFKAEVEIISRVHH 401
F + +LG G FG V+KG+ +P G++ VA+K LR + S + +E E +++ V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 402 RHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLH 461
H+ L+G C+ +L + + +P L ++ + L + AKG+ YL
Sbjct: 71 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYL- 127
Query: 462 EDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK-LTTDNNTHVSTRVMGTFGYLAPEYA 520
R++HRD+ + N+L+ K+ DFGLAK L + + + ++A E
Sbjct: 128 --EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 521 SSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579
T +SDV+S+GV + EL+T G +P D A E L+ G
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------ISSILEKGERLPQ- 234
Query: 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
+ MV C A RPK +++
Sbjct: 235 ----PPICTIDVYMIMVKC----WMIDADSRPKFRELIIEFS 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 3e-55
Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 8/205 (3%)
Query: 352 NLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGY 410
+GQG G V+ + + G+EVA++ + + E+ ++ + ++V+ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 411 CIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIH 470
+ G + +V EY+ +L + MD + + L +LH + ++IH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 471 RDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSD 530
RDIKS NILL K+ DFG T + ST V GT ++APE + K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 531 VFSFGVMLLELITGRRPIDPTGAME 555
++S G+M +E+I G P +
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLR 223
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 6e-55
Identities = 73/308 (23%), Positives = 122/308 (39%), Gaps = 44/308 (14%)
Query: 348 FSQSNLLGQGGFGYVHKGVLPNG---KEVAVKSLR-SGSGQGEREFKAEVEIISRV-HHR 402
+++G+G FG V K + + A+K ++ S R+F E+E++ ++ HH
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 403 HLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGK--------------GRPVMDWPTRLK 448
++++L+G C G L EY P+ NL L + L
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 449 IAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRV 508
A A+G+ YL + + IHRD+ + NIL+ + K+ADFGL++ T
Sbjct: 132 FAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMG 186
Query: 509 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLR 568
++A E + T SDV+S+GV+L E+++ P M +
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAEL-------YE 237
Query: 569 ALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSLED 628
L G N E M C R RP +QI+ +L LE+
Sbjct: 238 KLPQGY-----RLEKPLNCDDEVYDLMRQC----WREKPYERPSFAQILVSLNR--MLEE 286
Query: 629 LNDGIKPS 636
+ +
Sbjct: 287 RKTYVNTT 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-53
Identities = 73/300 (24%), Positives = 124/300 (41%), Gaps = 46/300 (15%)
Query: 352 NLLGQGGFGYVHKGVLP--------NGKEVAVKSLRSGSGQGE-REFKAEVEIISRV-HH 401
LG+G FG V +VAVK L+S + + + + +E+E++ + H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 402 RHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRP--------------VMDWPTRL 447
+++++L+G C G ++ EY NL +L + P + +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 448 KIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTR 507
A A+G+ YL + IHRD+ + N+L+ K+ADFGLA+ + + T
Sbjct: 139 SCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 508 VM-GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLC 566
++APE T +SDV+SFGV+L E+ T P +E+
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------L 246
Query: 567 LRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVSL 626
+ L +G+ + N E M C +RP Q+V L+ V+L
Sbjct: 247 FKLLKEGHRMDKPS-----NCTNELYMMMRDC----WHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 4e-52
Identities = 77/295 (26%), Positives = 124/295 (42%), Gaps = 46/295 (15%)
Query: 352 NLLGQGGFGYVHKGV------LPNGKEVAVKSLRSGSGQGE-REFKAEVEIISR-VHHRH 403
LG+G FG V + + VAVK L+ G+ E R +E++I+ HH +
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 404 LVSLVGYCI-AGGKRLLVYEYVPNNNLEFHLHGKG--------------RPVMDWPTRLK 448
+V+L+G C GG +++ E+ NL +L K + + +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 449 IAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV-STR 507
+ AKG+ +L + IHRD+ + NILL K+ DFGLA+ + +V
Sbjct: 139 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 508 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCL 567
++APE T +SDV+SFGV+L E+ + P +++
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--------C 247
Query: 568 RALDDGNFNEIADPYLEKNYPTEEMAR-MVACAAASIRHSARRRPKISQIVRALE 621
R L +G D Y T EM + M+ C +RP S++V L
Sbjct: 248 RRLKEGTRMRAPD------YTTPEMYQTMLDC----WHGEPSQRPTFSELVEHLG 292
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 1e-50
Identities = 68/293 (23%), Positives = 124/293 (42%), Gaps = 37/293 (12%)
Query: 348 FSQSNLLGQGGFGYVHKGVLPN------GKEVAVKSLRSGSGQGER-EFKAEVEIISRVH 400
+ S LGQG FG V++GV VA+K++ + ER EF E ++ +
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 401 HRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGR--------PVMDWPTRLKIAMG 452
H+V L+G G L++ E + +L+ +L +++A
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 453 SAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN-THVSTRVMGT 511
A G+AYL + +HRD+ + N ++ F K+ DFG+ + + + + +
Sbjct: 142 IADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 512 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALD 571
+++PE G T SDV+SFGV+L E+ T + E LR +
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---------VLRFVM 249
Query: 572 DGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624
+G + D N P M C +++ + RP +I+ +++ ++
Sbjct: 250 EGGLLDKPD-----NCPDMLFELMRMC----WQYNPKMRPSFLEIISSIKEEM 293
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 176 bits (448), Expect = 5e-50
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 9/206 (4%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
LG G FG VH+ G A K + + + + E++ +S + H LV+L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHR 471
+ +++YE++ L + + M ++ KGL ++HE+ +H
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENN---YVHL 148
Query: 472 DIKSSNILL--DYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKS 529
D+K NI+ + E K+ DFGL + T GT + APE A + +
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYYT 206
Query: 530 DVFSFGVMLLELITGRRPIDPTGAME 555
D++S GV+ L++G P E
Sbjct: 207 DMWSVGVLSYILLSGLSPFGGENDDE 232
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 176 bits (446), Expect = 9e-50
Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 9/206 (4%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
LG G FG VH+ V G+ K + + + K E+ I++++HH L++L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHR 471
+ +L+ E++ L + + M + + +GL ++HE I+H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHE---HSIVHL 151
Query: 472 DIKSSNILLDYTFET--KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKS 529
DIK NI+ + + K+ DFGLA + T T + APE + +
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDREPVGFYT 209
Query: 530 DVFSFGVMLLELITGRRPIDPTGAME 555
D+++ GV+ L++G P +E
Sbjct: 210 DMWAIGVLGYVLLSGLSPFAGEDDLE 235
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 2e-49
Identities = 54/205 (26%), Positives = 85/205 (41%), Gaps = 10/205 (4%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGE---REFKAEVEIISRVHHRH 403
F +LG+G F V L +E A+K L E E +++SR+ H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 404 LVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHED 463
V L K Y N L ++ G D L YLH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG- 126
Query: 464 CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT-DNNTHVSTRVMGTFGYLAPEYASS 522
IIHRD+K NILL+ ++ DFG AK+ + ++ + +GT Y++PE +
Sbjct: 127 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 523 GKLTEKSDVFSFGVMLLELITGRRP 547
+ SD+++ G ++ +L+ G P
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (434), Expect = 1e-48
Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 12/209 (5%)
Query: 352 NLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE-FKAEVEIISRVHHRHLVSLVG 409
++LG G F V K VA+K + + +G+ + E+ ++ ++ H ++V+L
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 410 YCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRII 469
+GG L+ + V L + KG ++ + YLH+ I+
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDLG---IV 129
Query: 470 HRDIKSSNILL---DYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLT 526
HRD+K N+L D + ++DFGL+K+ V + GT GY+APE + +
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPGYVAPEVLAQKPYS 187
Query: 527 EKSDVFSFGVMLLELITGRRPIDPTGAME 555
+ D +S GV+ L+ G P +
Sbjct: 188 KAVDCWSIGVIAYILLCGYPPFYDENDAK 216
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 172 bits (437), Expect = 2e-48
Identities = 60/216 (27%), Positives = 91/216 (42%), Gaps = 16/216 (7%)
Query: 348 FSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSL---RSGSGQGEREFKAEVEIISRVH--- 400
FS ++G+GGFG V+ GK A+K L R QGE E ++S V
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 401 HRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYL 460
+V + K + + + +L +HL G A GL ++
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHM 123
Query: 461 HEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYA 520
H +++RD+K +NILLD +++D GLA + H +GT GY+APE
Sbjct: 124 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVL 177
Query: 521 SSGK-LTEKSDVFSFGVMLLELITGRRPIDPTGAME 555
G +D FS G ML +L+ G P +
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 213
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 169 bits (429), Expect = 3e-48
Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 15/213 (7%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGE---REFKAEVEIISRVHHRHLVSLV 408
+LG GG VH L ++VAVK LR+ + F+ E + + ++H +V++
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 409 GYCI----AGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC 464
AG +V EYV L +H +G M +++ + + L + H+
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQ-- 129
Query: 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV--STRVMGTFGYLAPEYASS 522
IIHRD+K +NI++ T KV DFG+A+ D+ V + V+GT YL+PE A
Sbjct: 130 -NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188
Query: 523 GKLTEKSDVFSFGVMLLELITGRRPIDPTGAME 555
+ +SDV+S G +L E++TG P +
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 221
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 168 bits (427), Expect = 5e-48
Identities = 55/217 (25%), Positives = 87/217 (40%), Gaps = 24/217 (11%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSG---------QGEREFKAEVEIIS 397
+ +LG+G V + + P KE AVK + G + EV+I+
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 398 RVH-HRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKG 456
+V H +++ L LV++ + L +L K + KI +
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEV 122
Query: 457 LAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLA 516
+ LH+ I+HRD+K NILLD K+ DFG + V GT YLA
Sbjct: 123 ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYLA 177
Query: 517 PEYASSG------KLTEKSDVFSFGVMLLELITGRRP 547
PE ++ D++S GV++ L+ G P
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (427), Expect = 8e-48
Identities = 56/280 (20%), Positives = 94/280 (33%), Gaps = 30/280 (10%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
+G G FG ++ G + G+EVA+K + + E +I + + + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 412 IA-GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIH 470
A G ++V E + + + + T L +A + Y+H IH
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS---KNFIH 126
Query: 471 RDIKSSNIL---LDYTFETKVADFGLAKLTTDNNTHV------STRVMGTFGYLAPEYAS 521
RD+K N L + DFGLAK D TH + + GT Y +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 522 SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581
+ + + D+ S G +L+ G P A
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT--------KRQKYERISEKKMSTPIE 238
Query: 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
L K YP+E + C +P S + +
Sbjct: 239 VLCKGYPSEFATYLNFC----RSLRFDDKPDYSYLRQLFR 274
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 8e-48
Identities = 41/206 (19%), Positives = 88/206 (42%), Gaps = 10/206 (4%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
LG+G FG VH+ V + K K ++ G + K E+ I++ HR+++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 412 IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHR 471
+ + ++++E++ ++ ++ ++ + + L +LH I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHS---HNIGHF 126
Query: 472 DIKSSNILLDYTFET--KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKS 529
DI+ NI+ + K+ +FG A+ + + Y APE ++ +
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 530 DVFSFGVMLLELITGRRPIDPTGAME 555
D++S G ++ L++G P +
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQ 210
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 166 bits (420), Expect = 7e-47
Identities = 51/282 (18%), Positives = 92/282 (32%), Gaps = 32/282 (11%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGY 410
+G+G FG + +G L N ++VA+K S + + E + + ++ +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 411 CIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIH 470
G +LV + + + E L GR T A + +HE +++
Sbjct: 70 GQEGLHNVLVIDLLGPSL-EDLLDLCGRK-FSVKTVAMAAKQMLARVQSIHE---KSLVY 124
Query: 471 RDIKSSNILLD-----YTFETKVADFGLAKLTTDNNTHV------STRVMGTFGYLAPEY 519
RDIK N L+ V DFG+ K D T + GT Y++
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 520 ASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579
+ + + D+ + G + + + G P A E
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT---NKQKYERIGEKKQSTPLRE-- 239
Query: 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621
L +P EE + + A + P +
Sbjct: 240 ---LCAGFP-EEFYKYMHYA---RNLAFDATPDYDYLQGLFS 274
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 165 bits (419), Expect = 8e-47
Identities = 45/206 (21%), Positives = 89/206 (43%), Gaps = 7/206 (3%)
Query: 352 NLLGQGGFGYVHKGVLPNGKEVAVKSLR--SGSGQGEREFKAEVEIISRVHHRHLVSLVG 409
+G+G +G V+K G+ A+K +R E+ I+ + H ++V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 410 YCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRII 469
+ +LV+E++ + + +G ++ T + G+AY H+ R++
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHD---RRVL 122
Query: 470 HRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKS 529
HRD+K N+L++ E K+ADFGLA+ + ++ + S K +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 530 DVFSFGVMLLELITGRRPIDPTGAME 555
D++S G + E++ G +
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEAD 208
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 9e-46
Identities = 54/287 (18%), Positives = 104/287 (36%), Gaps = 31/287 (10%)
Query: 352 NLLGQGGFGYVHKG--VLPNGKEVAVKSLRSGSGQGEREFKAEVEI-----ISRVHHRHL 404
+G+G +G V K + G+ VA+K +R +G+ E+ + H ++
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 405 VSLVGYCIAGGKRLLVYEYVPNNNLE----FHLHGKGRPVMDWPTRLKIAMGSAKGLAYL 460
V L C + +++ +L P + T + +GL +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 461 HEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYA 520
H ++HRD+K NIL+ + + K+ADFGLA++ + T V+ T Y APE
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEVL 187
Query: 521 SSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAME-----------DCLVDWARPLCLRA 569
D++S G + E+ + + ++ DW R + L
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247
Query: 570 LDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQI 616
+ + + ++ C + + +R
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKC----LTFNPAKRISAYSA 290
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 1e-45
Identities = 45/211 (21%), Positives = 92/211 (43%), Gaps = 7/211 (3%)
Query: 348 FSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLR--SGSGQGEREFKAEVEIISRVHHRHL 404
F + +G+G +G V+K G+ VA+K +R + + E+ ++ ++H ++
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 405 VSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC 464
V L+ K LV+E++ + +L+ + + P +GLA+ H
Sbjct: 64 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 465 HPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGK 524
++HRD+K N+L++ K+ADFGLA+ + V+ +
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 525 LTEKSDVFSFGVMLLELITGRRPIDPTGAME 555
+ D++S G + E++T R ++
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEID 210
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 4e-45
Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 11/209 (5%)
Query: 352 NLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE---FKAEVEIISRV-HHRHLVS 406
+LG+G FG V + A+K+L+ + + E ++S H L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 407 LVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHP 466
+ V EY+ +L +H+ + D A GL +LH
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHS---K 122
Query: 467 RIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLT 526
I++RD+K NILLD K+ADFG+ K + +T GT Y+APE K
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQKYN 181
Query: 527 EKSDVFSFGVMLLELITGRRPIDPTGAME 555
D +SFGV+L E++ G+ P E
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSPFHGQDEEE 210
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 161 bits (409), Expect = 4e-45
Identities = 54/208 (25%), Positives = 84/208 (40%), Gaps = 13/208 (6%)
Query: 352 NLLGQGGFGYVHKGV-LPNGKEVAVKSLR---SGSGQGEREFKAEVEIISRVHHRHLVSL 407
LG G FG VH NG+ A+K L+ + E ++S V H ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR 467
G + ++ +Y+ L L R + L
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----CLALEYLHSKD 124
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTE 527
II+RD+K NILLD K+ DFG AK D + GT Y+APE S+ +
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVSTKPYNK 180
Query: 528 KSDVFSFGVMLLELITGRRPIDPTGAME 555
D +SFG+++ E++ G P + M+
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMK 208
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-43
Identities = 53/212 (25%), Positives = 85/212 (40%), Gaps = 19/212 (8%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGY 410
+LG G G V + ++ A+K L+ + + EVE+ R H+V +V
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDV 73
Query: 411 C----IAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHP 466
L+V E + L + +G +I + + YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---I 130
Query: 467 RIIHRDIKSSNILLDYTFET---KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSG 523
I HRD+K N+L K+ DFG AK TT +N+ + T Y+APE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVLGPE 188
Query: 524 KLTEKSDVFSFGVMLLELITGRRPIDPTGAME 555
K + D++S GV++ L+ G P +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 220
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-43
Identities = 57/228 (25%), Positives = 89/228 (39%), Gaps = 27/228 (11%)
Query: 348 FSQSNL---------LGQGGFGYVHKGV-LPNGKEVAVKSLR------SGSGQGEREFKA 391
F Q N+ LG G F V K G + A K ++ S G + +
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 392 EVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAM 451
EV I+ + H ++++L +L+ E V L L K + +
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLK 120
Query: 452 GSAKGLAYLHEDCHPRIIHRDIKSSNILLD----YTFETKVADFGLAKLTTDNNTHVSTR 507
G+ YLH +I H D+K NI+L K+ DFGLA N
Sbjct: 121 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KN 175
Query: 508 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAME 555
+ GT ++APE + L ++D++S GV+ L++G P E
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 223
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 2e-43
Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 13/211 (6%)
Query: 345 TGGFSQSNLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE-FKAEVEIISRVHHR 402
++ + +G+G +G V N VA+K + Q + E++I+ R H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 403 HLVSLVGYCIAGGKRLLVYEYVPN---NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAY 459
+++ + A + Y+ + L + +GL Y
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKY 124
Query: 460 LHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVS--TRVMGTFGYLAP 517
+H ++HRD+K SN+LL+ T + K+ DFGLA++ ++ H T + T Y AP
Sbjct: 125 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 518 EYASSGKL-TEKSDVFSFGVMLLELITGRRP 547
E + K T+ D++S G +L E+++ R
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 5e-43
Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 348 FSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVS 406
++ + ++G G FG V++ L +G+ VA+K + Q +R E++I+ ++ H ++V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 407 LVGYCIAGGKR------LLVYEYVPNNNLEFHLH-GKGRPVMDWPTRLKIAMGSAKGLAY 459
L + + G++ LV +YVP H + + + + LAY
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 460 LHEDCHPRIIHRDIKSSNILLD-YTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPE 518
+H I HRDIK N+LLD T K+ DFG AK +V + + +
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRYYRAPEL 193
Query: 519 YASSGKLTEKSDVFSFGVMLLELITGRRP 547
+ T DV+S G +L EL+ G+
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-42
Identities = 58/267 (21%), Positives = 100/267 (37%), Gaps = 31/267 (11%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE------FKAEVEIISRVHHRH-- 403
LLG GGFG V+ G+ + + VA+K + E EV ++ +V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 404 LVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHED 463
++ L+ + +L+ E F + + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHN- 128
Query: 464 CHPRIIHRDIKSSNILLDY-TFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS 522
++HRDIK NIL+D E K+ DFG L D T GT Y PE+
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWIRY 183
Query: 523 GKL-TEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDW-------ARPLCLRALDD-- 572
+ + V+S G++L +++ G P + + V + + L L
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRP 243
Query: 573 ---GNFNEI-ADPYLEKNYPTEEMARM 595
F EI P+++ +E A +
Sbjct: 244 SDRPTFEEIQNHPWMQDVLLPQETAEI 270
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (383), Expect = 9e-42
Identities = 55/282 (19%), Positives = 105/282 (37%), Gaps = 22/282 (7%)
Query: 352 NLLGQGGFGYVHKGV-LPNGKEVAVKSLR--SGSGQGEREFKAEVEIISRVHHRHLVSLV 408
+G+G +G V K + VA+K +R E+ ++ + H+++V L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 409 GYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRI 468
+ K LV+E+ + ++ G +D KGL + H +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGFCH---SRNV 122
Query: 469 IHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEK 528
+HRD+K N+L++ E K+A+FGLA+ S V+ + + +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 529 SDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYP 588
D++S G + EL RP+ P ++D L R L + + + K YP
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR--LLGTPTEEQWPSMTKLPDYKPYP 240
Query: 589 TEEMARMVACAAASIRHSAR------------RRPKISQIVR 618
+ + + R +R + ++
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-41
Identities = 51/211 (24%), Positives = 94/211 (44%), Gaps = 13/211 (6%)
Query: 352 NLLGQGGFGYVHKGVLPN-GKEVAVKSLRSGSGQG-----EREFKAEVEIISRVHHRHLV 405
+ LG+G F V+K N + VA+K ++ G R E++++ + H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 406 SLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCH 465
L+ LV++++ + + + + +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV--LTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 466 PRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKL 525
I+HRD+K +N+LLD K+ADFGLAK N + +V T Y APE ++
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGARM 177
Query: 526 -TEKSDVFSFGVMLLELITGRRPIDPTGAME 555
D+++ G +L EL+ + ++
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLD 208
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-39
Identities = 47/219 (21%), Positives = 93/219 (42%), Gaps = 20/219 (9%)
Query: 352 NLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQG--EREFKAEVEIISRVHHRHLVSLV 408
+GQG FG V K G++VA+K + + + E++I+ + H ++V+L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 409 GYCIAG--------GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYL 460
C G LV+++ ++ + + + R+ + L L
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML-----LNGL 130
Query: 461 HEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK---LTTDNNTHVSTRVMGTFGYLAP 517
+ +I+HRD+K++N+L+ K+ADFGLA+ L ++ + T + T Y P
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 518 EYASSGKL-TEKSDVFSFGVMLLELITGRRPIDPTGAME 555
E + D++ G ++ E+ T +
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 229
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 4e-39
Identities = 53/200 (26%), Positives = 78/200 (39%), Gaps = 10/200 (5%)
Query: 352 NLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE---FKAEVEIISRVHHRHLVSL 407
LLG+G FG V G+ A+K LR + E E ++ H L +L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 408 VGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR 467
+ V EY L FHL + + A+ ++ L
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEYLHSRD 125
Query: 468 IIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTE 527
+++RDIK N++LD K+ DFGL K + GT YLAPE
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLEDNDYGR 184
Query: 528 KSDVFSFGVMLLELITGRRP 547
D + GV++ E++ GR P
Sbjct: 185 AVDWWGLGVVMYEMMCGRLP 204
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 8e-38
Identities = 46/225 (20%), Positives = 90/225 (40%), Gaps = 23/225 (10%)
Query: 336 FTYEELSAATGGFSQS----NLLGQGGFGYVHKGV-LPNGKEVAVKSLRSG--SGQGERE 388
F +E++ +G G +G V V G +VA+K L S +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 389 FKAEVEIISRVHHRHLVSLVGYCIAGGKR------LLVYEYVPNNNLEFHLHGKGRPVMD 442
E+ ++ + H +++ L+ LV ++ + + H K +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK----LG 119
Query: 443 WPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502
+ KGL Y+H HRD+K N+ ++ E K+ DFGLA+ ++
Sbjct: 120 EDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA---DS 173
Query: 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 547
++ V+ + + + T+ D++S G ++ E+ITG+
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (356), Expect = 2e-37
Identities = 58/256 (22%), Positives = 91/256 (35%), Gaps = 14/256 (5%)
Query: 354 LGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGERE---FKAEVEIISRVHHRHLVSLVG 409
LG G FG V +G A+K L ++ E I+ V+ LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 410 YCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRII 469
+V EYV + HL GR P A YLH +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 470 HRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKS 529
+RD+K N+L+D +V DFG AK + GT LAPE S +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LCGTPEALAPEIILSKGYNKAV 219
Query: 530 DVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPT 589
D ++ GV++ E+ G P ++ + + + + ++ L+ + T
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD-LT 278
Query: 590 EEMARMVACAAASIRH 605
+ + H
Sbjct: 279 KRFGNLKNGVNDIKNH 294
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-35
Identities = 55/215 (25%), Positives = 86/215 (40%), Gaps = 16/215 (7%)
Query: 352 NLLGQGGFGYVHKGVL----PNGKEVAVKSLR----SGSGQGEREFKAEVEIISRV-HHR 402
+LG G +G V GK A+K L+ + + E +++ +
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 403 HLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHE 462
LV+L K L+ +Y+ L HL + R + + + + L
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEIVLALEH 144
Query: 463 DCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASS 522
II+RDIK NILLD + DFGL+K + T + GT Y+AP+
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204
Query: 523 GK--LTEKSDVFSFGVMLLELITGRRPIDPTGAME 555
G + D +S GV++ EL+TG P G
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 6e-34
Identities = 46/204 (22%), Positives = 80/204 (39%), Gaps = 19/204 (9%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVG 409
+G G G V + VA+K L + + E+ ++ V+H++++SL+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 410 YCIA------GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHED 463
LV E + N + +D + G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 138
Query: 464 CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSG 523
IHRD+K SNI++ K+ DFGLA+ + T + T Y APE
Sbjct: 139 GI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYRAPEVILGM 193
Query: 524 KLTEKSDVFSFGVMLLELITGRRP 547
E D++S G ++ E++ +
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (316), Expect = 2e-32
Identities = 43/205 (20%), Positives = 87/205 (42%), Gaps = 19/205 (9%)
Query: 352 NLLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVG 409
LG+G + V + + + N ++V VK L+ +++ K E++I+ + ++++L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLAD 97
Query: 410 YCIAGGKRL--LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR 467
R LV+E+V N + + + K L Y H
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMG--- 149
Query: 468 IIHRDIKSSNILLDYTFET-KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKL- 525
I+HRD+K N+++D+ ++ D+GLA+ + + + + PE ++
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMY 207
Query: 526 TEKSDVFSFGVMLLELITGRRPIDP 550
D++S G ML +I + P
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFFH 232
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 122 bits (306), Expect = 7e-31
Identities = 48/219 (21%), Positives = 80/219 (36%), Gaps = 28/219 (12%)
Query: 353 LLGQGGFGYVHKGV-LPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYC 411
LG G F V + N VA+K +R E + E++++ RV+
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTKEDSMG 78
Query: 412 IAGGKRLLVYEYVPNNNLEF--------------HLHGKGRPVMDWPTRLKIAMGSAKGL 457
+LL + N + + +I+ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 458 AYLHEDCHPRIIHRDIKSSNILLD------YTFETKVADFGLAKLTTDNNTHVSTRVMGT 511
Y+H IIH DIK N+L++ + K+AD G A ++ T+ + T
Sbjct: 139 DYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS----IQT 192
Query: 512 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDP 550
Y +PE +D++S ++ ELITG +P
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 112 bits (281), Expect = 4e-29
Identities = 33/204 (16%), Positives = 60/204 (29%), Gaps = 33/204 (16%)
Query: 352 NLLGQGGFGYVHKGVLPNGKEVAVKSLRSGS----------GQGEREFKAEVEIISRVHH 401
L+G+G V E VK + G G+ F +R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 402 RHLVSLVGYCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLH 461
R L L G + VY + N L + K + ++ + +A +
Sbjct: 66 RALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 462 EDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYAS 521
I+H D+ N+L+ + DF + + L + +
Sbjct: 121 HRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWR---------EILERDVRN 167
Query: 522 -----SGKLTEKSDVFSFGVMLLE 540
S + D+ S +L+
Sbjct: 168 IITYFSRTYRTEKDINSAIDRILQ 191
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 7e-29
Identities = 43/212 (20%), Positives = 85/212 (40%), Gaps = 17/212 (8%)
Query: 352 NLLGQGGFGYVHKGV-LPNGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLV 408
+ +G G +G V G VAVK L S + E+ ++ + H +++ L+
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 409 GYCIAG-----GKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHED 463
+ + ++ +L + + + + +GL Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSA 140
Query: 464 CHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSG 523
HRD+K SN+ ++ E K+ DFGLA+ T + ++ V + +
Sbjct: 141 DII---HRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWM 194
Query: 524 KLTEKSDVFSFGVMLLELITGRRPIDPTGAME 555
+ D++S G ++ EL+TGR T ++
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 226
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 724 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.86 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.45 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.92 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.73 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.28 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.15 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=428.59 Aligned_cols=255 Identities=27% Similarity=0.443 Sum_probs=200.6
Q ss_pred CCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecC
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVP 425 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 425 (724)
++|++.+.||+|+||.||+|.+.+++.||||+++.+. ...++|.+|+++|++++|+|||+++|+|.+++..+|||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5788999999999999999999888999999997643 345789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccc
Q 040832 426 NNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVS 505 (724)
Q Consensus 426 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 505 (724)
+|+|.+++.... ..+++..+++|+.|||+||+|||++ +|+||||||+||||+.++.+||+|||+++..........
T Consensus 84 ~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 999999987653 3589999999999999999999999 999999999999999999999999999998766554444
Q ss_pred cccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhc
Q 040832 506 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEK 585 (724)
Q Consensus 506 ~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~ 585 (724)
....||..|||||++.+..++.++|||||||+||||+|+..|+.........+..... + ...
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~---------~---------~~~ 221 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---------G---------FRL 221 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH---------T---------CCC
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh---------c---------CCC
Confidence 5567999999999999999999999999999999999965554333222221111110 0 000
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 586 NYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
..+.....++.+++.+||+.+|++||+|+||+++|++.
T Consensus 222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11122335688999999999999999999999999854
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-52 Score=437.39 Aligned_cols=261 Identities=26% Similarity=0.360 Sum_probs=218.6
Q ss_pred HhhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 343 AATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 343 ~~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
...++|++.+.||+|+||.||+|.+. +++.||||+++.+. ...++|++|+++|++|+|+|||+++|+|.+++..+|||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 34567899999999999999999975 58889999997654 34567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
|||++|+|..+|.......+++..++.|+.||++||+|||++ +||||||||+||||+.++.+||+|||+++......
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 999999999999877667799999999999999999999998 99999999999999999999999999999877665
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
........|+..|||||++.++.++.++|||||||+||||++|..||........... .. ..+
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~-~i--------~~~-------- 232 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LL--------EKD-------- 232 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH-HH--------HTT--------
T ss_pred ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHH-HH--------hcC--------
Confidence 5555556789999999999999999999999999999999998777654433222111 10 000
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
.....+......+.+++.+||+.+|++||+|.||++.|+....
T Consensus 233 -~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 233 -YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred -CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0111222334568899999999999999999999999986543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=426.93 Aligned_cols=256 Identities=29% Similarity=0.411 Sum_probs=211.9
Q ss_pred hCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
.++|++.+.||+|+||.||+|.+++++.||||+++... ...+.|.+|+++|++++|+|||+++|++.+ +..+||||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 46788999999999999999999888899999997643 345679999999999999999999998865 5669999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
++|+|.+++.......+++..+++|+.||++||.|||++ +||||||||+||||++++.+||+|||+|+.........
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 999999988765544589999999999999999999998 99999999999999999999999999999887655555
Q ss_pred ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhh
Q 040832 505 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLE 584 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~ 584 (724)
.....|+..|||||++..+.++.++|||||||+||||+||..|+.........+.... .+. +
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~---------~~~-----~---- 228 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---------RGY-----R---- 228 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---------TTC-----C----
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH---------hcC-----C----
Confidence 5566799999999999999999999999999999999997666544332222211111 110 0
Q ss_pred cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 585 KNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
...+......+.+++.+||+.+|++||+|.||++.|+..
T Consensus 229 ~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 011122334688899999999999999999999999853
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-51 Score=424.64 Aligned_cols=257 Identities=29% Similarity=0.464 Sum_probs=203.5
Q ss_pred hCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
.++|.+++.||+|+||.||+|+++ ..||||+++.. .....+.|++|+++|++++|+|||+++|++.+ +..+||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 568999999999999999999874 35999999754 33445689999999999999999999999765 56799999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
||++|+|.++|+..+. .+++..++.|+.||++||+|||++ +||||||||+||||+.++.+||+|||+|+.......
T Consensus 84 y~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCCEEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred cCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 9999999999976543 489999999999999999999998 999999999999999999999999999987754332
Q ss_pred -ccccccccCCCcCCcchhcC---CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhh
Q 040832 503 -HVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEI 578 (724)
Q Consensus 503 -~~~~~~~gt~~y~APE~~~~---~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 578 (724)
.......||+.|||||++.. +.|+.++|||||||+||||+||+.||..............+ ......+.
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~-----~~~~p~~~-- 232 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR-----GYLSPDLS-- 232 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH-----TSCCCCGG--
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhc-----CCCCCcch--
Confidence 23455679999999999864 45899999999999999999999999876443322211111 11111111
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 579 ADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 579 vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
....+....+.+++.+||+.+|++||+|.||+++|+.
T Consensus 233 -------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 233 -------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp -------GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1122233568899999999999999999999999974
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.8e-51 Score=430.89 Aligned_cols=256 Identities=25% Similarity=0.426 Sum_probs=198.4
Q ss_pred CCCcccceeeccCcEEEEEEEcCC-C---cEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPN-G---KEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~-g---~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
+.|++.++||+|+||+||+|.+.. + ..||||++..... ...++|.+|+++|++|+|||||+++|+|.+.+..+||
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 456778999999999999998643 2 2588999876533 3456799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
||||++|+|.+++..... .+++.++++|+.||++||.|||++ +||||||||+||||+.++.+||+|||+++.....
T Consensus 106 ~Ey~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EECCTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEecCCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 999999999998876433 489999999999999999999998 9999999999999999999999999999877544
Q ss_pred CCcc----ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCCh
Q 040832 501 NTHV----STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 501 ~~~~----~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~ 575 (724)
.... .....|+..|||||++.++.++.++|||||||+||||+| |+.||......+ +.... ..+.
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~--~~~~i--------~~~~- 250 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--VINAI--------EQDY- 250 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHH--------HTTC-
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH--HHHHH--------HcCC-
Confidence 3221 122457899999999999999999999999999999998 899997654322 11111 1110
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 576 NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 576 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
....+.+....+.+++.+||+.+|++||+|.||++.|+..+
T Consensus 251 --------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 251 --------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 01122234456889999999999999999999999998643
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=419.75 Aligned_cols=252 Identities=26% Similarity=0.365 Sum_probs=205.2
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
.++|++.+.||+|+||+||+|.+. +|+.||||+++.... +..+.|++|+++|++|+|+||+++++++.+++..|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 467999999999999999999964 689999999975432 234569999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
||++|+|.++|...+ .+++.+++.|+.||++||+|||++ +||||||||+||||++++.+||+|||+|+.......
T Consensus 84 y~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999999997654 489999999999999999999999 999999999999999999999999999997754432
Q ss_pred -ccccccccCCCcCCcchhcCCCC-ChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 503 -HVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 503 -~~~~~~~gt~~y~APE~~~~~~~-t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
......+||+.|||||++.+..+ +.++|||||||+||||++|+.||+........+..+.... ....
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~--------~~~~--- 227 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--------TYLN--- 227 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC--------TTST---
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--------CCCC---
Confidence 23455789999999999988776 5789999999999999999999976543333222221110 0000
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
........+.+++.+||+.+|++||++.||++
T Consensus 228 ------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 ------PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00111245678899999999999999999976
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=415.64 Aligned_cols=253 Identities=24% Similarity=0.383 Sum_probs=214.3
Q ss_pred CCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecC
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVP 425 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 425 (724)
++|++++.||+|+||+||+|++++++.||||+++.... .+++|++|+.++++++|+||++++|+|.+++..++||||+.
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 68899999999999999999998888999999986543 45789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccc
Q 040832 426 NNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVS 505 (724)
Q Consensus 426 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 505 (724)
+|+|..++..... .+.+..+++|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++..........
T Consensus 83 ~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 9999998765433 478999999999999999999998 999999999999999999999999999987766554444
Q ss_pred cccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhh
Q 040832 506 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLE 584 (724)
Q Consensus 506 ~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~ 584 (724)
....|+..|+|||++....++.|+|||||||++|||+| |+.||+.....+. .... ..+. .
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~-~~~i---------~~~~---------~ 219 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-AEHI---------AQGL---------R 219 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-HHHH---------HTTC---------C
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH-HHHH---------HhCC---------C
Confidence 55679999999999999999999999999999999998 8999987643321 1100 1110 0
Q ss_pred cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 585 KNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
...+......+.+++.+||+.+|++||++.+|+++|.+
T Consensus 220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 01112233568899999999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-50 Score=419.85 Aligned_cols=249 Identities=22% Similarity=0.367 Sum_probs=208.6
Q ss_pred CCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
++|++.+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|+++|++++|+|||++++++.+++..|||||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999985 468999999997655455678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
++|+|.+++..+ .+++.+++.|+.||+.||+|||++ +||||||||+||||+.++++||+|||+++........
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~- 172 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccccc-
Confidence 999999988764 389999999999999999999999 9999999999999999999999999999987554332
Q ss_pred ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhh
Q 040832 505 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLE 584 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~ 584 (724)
.....||+.|||||++.++.++.++|||||||+||||++|+.||......+... .... ..... +
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~----~~~~~--~--------- 236 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIAT----NGTPE--L--------- 236 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHH----HCSCC--C---------
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH-HHHh----CCCCC--C---------
Confidence 344679999999999999999999999999999999999999997654332211 1100 00000 0
Q ss_pred cCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 585 KNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
..+......+.+++.+||+.||++||++.||++
T Consensus 237 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011122346788999999999999999999986
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-50 Score=414.99 Aligned_cols=245 Identities=28% Similarity=0.437 Sum_probs=206.2
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|++++.||+|+||.||+|++. +++.||||++... .....+.+.+|+++|++++||||+++++++.+++..+|||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46999999999999999999964 6889999998642 1233567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
|||++|+|.++|...+. +++..++.|+.||++||+|||++ +||||||||+||||+.++.+||+|||+++......
T Consensus 86 Ey~~~g~L~~~l~~~~~--l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp ECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred eecCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 99999999999986554 89999999999999999999999 99999999999999999999999999998765433
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
. ....||+.|||||++.+..++.++|||||||+||||++|+.||......+. +... ....+
T Consensus 161 ~---~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~~~i---------~~~~~------ 221 (263)
T d2j4za1 161 R---TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-YKRI---------SRVEF------ 221 (263)
T ss_dssp C---EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHH---------HTTCC------
T ss_pred c---cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH-HHHH---------HcCCC------
Confidence 2 346799999999999999999999999999999999999999976543221 1111 01110
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
.++......+.+++.+||+.||++||++.||++
T Consensus 222 ----~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 ----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 111222346788999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-50 Score=418.57 Aligned_cols=257 Identities=30% Similarity=0.431 Sum_probs=206.4
Q ss_pred CCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecC
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVP 425 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 425 (724)
++|++++.||+|+||+||+|++++++.||||+++... ...+.|.+|+.+|++++|+|||+++|+|.+ +..+||||||.
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 5799999999999999999999888899999997553 345789999999999999999999999855 56799999999
Q ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCccc
Q 040832 426 NNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHVS 505 (724)
Q Consensus 426 ~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 505 (724)
+|+|..++.......++|.++++|+.||+.||+|||++ +|+||||||+||||+.++++||+|||+++..........
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 99999998765545699999999999999999999999 999999999999999999999999999998765544444
Q ss_pred cccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhc
Q 040832 506 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEK 585 (724)
Q Consensus 506 ~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~ 585 (724)
....|+..|+|||++..+.++.++|||||||+||||++|..||.........+..+.+ +. ..
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~---------~~---------~~ 233 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---------GY---------RM 233 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---------TC---------CC
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh---------cC---------CC
Confidence 5567999999999999999999999999999999999977776544333322221111 00 01
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 586 NYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
..+......+.+++.+||+.+|++||+|.+|+++|+..+.
T Consensus 234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 1122234568899999999999999999999999997654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-50 Score=418.46 Aligned_cols=258 Identities=26% Similarity=0.404 Sum_probs=201.9
Q ss_pred CCCcccceeeccCcEEEEEEEcCCC-----cEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPNG-----KEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~g-----~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
..|++.++||+|+||.||+|.+++. ..||||+++..... ...+|++|+++|++|+|+|||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4688899999999999999986542 36999999765443 34579999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
|||||.+++|.+++.... ..+++.++++|+.||++||+|||++ +||||||||+||||+.++.+||+|||+++....
T Consensus 87 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999998877543 3489999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCc--cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 500 NNTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 500 ~~~~--~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
.... ......||..|||||++.++.++.++|||||||+||||++|..|+.........+... ..+
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i---------~~~---- 229 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI---------NDG---- 229 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---------HTT----
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHH---------hcc----
Confidence 3322 2234568999999999999999999999999999999999766664432222211111 111
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
.....+.+....+.+++.+||+.+|++||+|.||++.|+..+.
T Consensus 230 -----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 230 -----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp -----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 0112223344678899999999999999999999999986543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=416.74 Aligned_cols=255 Identities=25% Similarity=0.424 Sum_probs=207.5
Q ss_pred hCCCcccce-eeccCcEEEEEEEcC---CCcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 345 TGGFSQSNL-LGQGGFGYVHKGVLP---NGKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 345 ~~~f~~~~~-LG~G~fG~Vyk~~~~---~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
.++|.+.++ ||+|+||.||+|.+. ++..||||+++..... ..++|++|+++|++|+|+|||+++|+|.. +..+|
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 356777775 999999999999754 3457999999765433 35679999999999999999999999875 45799
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
|||||++|+|.+++.... ..+++..+++|+.||++||+|||++ +||||||||+||||+.++.+||+|||+++....
T Consensus 86 vmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999999886543 2489999999999999999999998 999999999999999999999999999998765
Q ss_pred CCCc--cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChh
Q 040832 500 NNTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 500 ~~~~--~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
.... ......||..|||||++..+.++.++|||||||+||||+| |+.||......+. ... +..+..
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~--~~~--------i~~~~~- 230 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--MAF--------IEQGKR- 230 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH--HHH--------HHTTCC-
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH--HHH--------HHcCCC-
Confidence 4432 2234568999999999999999999999999999999998 9999976543221 110 111111
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
...+......+.+++.+||+.+|++||+|.+|++.|+..
T Consensus 231 --------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 231 --------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp --------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 012223345688999999999999999999999998754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=425.25 Aligned_cols=256 Identities=25% Similarity=0.421 Sum_probs=207.8
Q ss_pred hCCCcccceeeccCcEEEEEEEcCC-C-----cEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPN-G-----KEVAVKSLRSGSG-QGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGK 416 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~-g-----~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 416 (724)
.++|+++++||+|+||+||+|++.. + ..||||++..... .....|.+|+.+|.++ +|+|||+++++|.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4678999999999999999998643 2 3699999865432 3345799999999998 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGR---------------------PVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKS 475 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~---------------------~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp 475 (724)
.+||||||++|+|.++|+.+.. ..+++..++.|+.||++||+|||++ +||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence 9999999999999999976432 3488999999999999999999999 999999999
Q ss_pred ccEEEcCCCCEEEEEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCc
Q 040832 476 SNILLDYTFETKVADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGA 553 (724)
Q Consensus 476 ~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~ 553 (724)
+||||+.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||+||||++ |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999877654433 3345678999999999999999999999999999999998 8999976543
Q ss_pred hhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 040832 554 MEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALE 621 (724)
Q Consensus 554 ~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~ 621 (724)
.+.. .... ..+ .....+......+.+++.+||+.+|++||+++||+++|.
T Consensus 273 ~~~~-~~~~--------~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DANF-YKLI--------QNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SHHH-HHHH--------HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHH-HHHH--------hcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 3221 1110 000 001122223456889999999999999999999999996
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-50 Score=428.05 Aligned_cols=269 Identities=24% Similarity=0.325 Sum_probs=208.7
Q ss_pred hhCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
..++|++.+.||+|+||.||+|++ .+|+.||||+++.... .....+.+|+.+|++++|||||+++++|.+.+..+|||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 457899999999999999999995 4688999999976533 33467999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
|||++|+|.+++.+.+. +++..++.++.||++||.|||+++ +||||||||+||||+.++++||+|||+|+......
T Consensus 84 Ey~~gg~L~~~l~~~~~--l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp ECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred EcCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence 99999999999987554 899999999999999999999732 79999999999999999999999999998764422
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhh--------------
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCL-------------- 567 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~-------------- 567 (724)
....+||..|||||++.+..|+.++|||||||+||||++|+.||......+..+.........
T Consensus 160 ---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 160 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp ---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred ---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 234679999999999999999999999999999999999999997654332221111000000
Q ss_pred ------hcccCCChhhhcchhhhcCC----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 568 ------RALDDGNFNEIADPYLEKNY----PTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 568 ------~~~~~~~~~~~vd~~l~~~~----~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.........+..+....... .......+.+++.+||+.||++||++.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000011111111111100 01123568889999999999999999999873
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=414.54 Aligned_cols=253 Identities=23% Similarity=0.368 Sum_probs=193.5
Q ss_pred CCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEe--CCeEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIA--GGKRLLV 420 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~lV 420 (724)
++|++.+.||+|+||+||+|+. .+|+.||||.++.... ...+.|.+|+++|++++|||||++++++.+ ++..|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5799999999999999999985 4689999999976532 234568999999999999999999999875 4567999
Q ss_pred EEecCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 421 YEYVPNNNLEFHLHGK--GRPVMDWPTRLKIAMGSAKGLAYLHEDC--HPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~--~~~~l~~~~~~~i~~qia~gL~yLHs~~--~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
||||++|+|.+++... ....+++..++.|+.||+.||.|||+++ ..+||||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998642 2345899999999999999999999972 12499999999999999999999999999998
Q ss_pred cCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChh
Q 040832 497 TTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 497 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
...... ......||+.|||||++.+..++.++|||||||+||||++|+.||......+. +.. +..+.+.
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~-~~~---------i~~~~~~ 232 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-AGK---------IREGKFR 232 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHH---------HHHTCCC
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH-HHH---------HHcCCCC
Confidence 765332 23456799999999999999999999999999999999999999976543221 111 1111111
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
. .+......+.+++.+||+.||++||++.||++
T Consensus 233 ~---------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 R---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp C---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1 11122346888999999999999999999986
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=415.59 Aligned_cols=252 Identities=22% Similarity=0.326 Sum_probs=207.0
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
+.|++.+.||+|+||.||+|++. +++.||||+++.......+.|++|+++|++|+|||||++++++.+++..+||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999964 68899999998766666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
++|+|.+++..... .+++.+++.|+.||++||.|||++ +||||||||+||||+.++.+||+|||+|+....... .
T Consensus 92 ~~g~L~~~~~~~~~-~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 166 (288)
T ss_dssp TTEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-H
T ss_pred CCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc-c
Confidence 99999998765432 489999999999999999999999 999999999999999999999999999976543211 2
Q ss_pred ccccccCCCcCCcchhc-----CCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 505 STRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~-----~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
.....||+.|||||++. ...|+.++|||||||+||||++|+.||......+... .... +....+
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~-~i~~---------~~~~~~- 235 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL-KIAK---------SEPPTL- 235 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH-HHHH---------SCCCCC-
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH-HHHc---------CCCCCC-
Confidence 23467999999999984 4568999999999999999999999997654433211 1100 000000
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+......+.+++.+||+.||++||++.||+++
T Consensus 236 ------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 236 ------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp ------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0112223567889999999999999999999863
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=412.35 Aligned_cols=246 Identities=27% Similarity=0.396 Sum_probs=198.6
Q ss_pred ceeeccCcEEEEEEEcCC---CcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEecCC
Q 040832 352 NLLGQGGFGYVHKGVLPN---GKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYVPN 426 (724)
Q Consensus 352 ~~LG~G~fG~Vyk~~~~~---g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 426 (724)
+.||+|+||.||+|.+.+ ++.||||+++.... ...++|++|+++|++|+|+|||+++|+|..+ ..+||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 579999999999998643 46799999975432 2346799999999999999999999998654 56899999999
Q ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc--
Q 040832 427 NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV-- 504 (724)
Q Consensus 427 gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-- 504 (724)
|+|.++++.... +++..+++|+.||++||+|||++ +||||||||+||||+.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~~--l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhccC--CCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 999999987554 89999999999999999999998 99999999999999999999999999999776544332
Q ss_pred ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 505 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
.....||..|||||.+..+.++.++|||||||+||||++ |+.||......+. ... +..+..
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~--~~~--------i~~~~~-------- 228 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--TAM--------LEKGER-------- 228 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HHH--------HHTTCC--------
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH--HHH--------HHcCCC--------
Confidence 234568999999999999999999999999999999998 8999976543221 111 111110
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
...+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 229 -~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 229 -MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 01122234568889999999999999999999998875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=404.06 Aligned_cols=246 Identities=26% Similarity=0.355 Sum_probs=197.6
Q ss_pred CcccceeeccCcEEEEEEEcC-CCcEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEe----CCeEEEE
Q 040832 348 FSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSG--SGQGEREFKAEVEIISRVHHRHLVSLVGYCIA----GGKRLLV 420 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~lV 420 (724)
|++.+.||+|+||+||+|.+. +++.||||++... .....+.|.+|+++|++|+|+|||++++++.+ +...+||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 366778999999999999964 5789999998654 23334579999999999999999999999875 3467899
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCccEEEc-CCCCEEEEEecccccc
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPR--IIHRDIKSSNILLD-YTFETKVADFGLAKLT 497 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~--iiHrDIkp~NILl~-~~~~vkL~DFGla~~~ 497 (724)
||||++|+|.++|..... +++..++.|+.||++||+|||++ + ||||||||+||||+ +++.+||+|||+++..
T Consensus 91 mE~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHhcccc--ccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 999999999999976543 89999999999999999999998 6 99999999999996 5789999999999865
Q ss_pred CCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 498 TDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 498 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
.... ....+||+.|||||++.+ .++.++|||||||+||||++|+.||............. ..+...
T Consensus 166 ~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i---------~~~~~~- 231 (270)
T d1t4ha_ 166 RASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV---------TSGVKP- 231 (270)
T ss_dssp CTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH---------TTTCCC-
T ss_pred cCCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHH---------HcCCCC-
Confidence 4432 235679999999998865 69999999999999999999999997654333221111 111110
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+...+ ...+.+++.+||+.+|++||++.||+++
T Consensus 232 ---~~~~~~~----~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 232 ---ASFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ---GGGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---cccCccC----CHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 1111122 2347889999999999999999999863
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=415.04 Aligned_cols=248 Identities=22% Similarity=0.335 Sum_probs=203.7
Q ss_pred CCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|+++++||+|+||+||+|.+ .+++.||||+++.. .....+.|.+|+++|++|+|+||+++++++.+++..||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5699999999999999999996 46899999998642 1223457999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
|||++|+|.+++...+. +++..++.|+.||+.||+|||++ +||||||||+||||++++.+||+|||+|+......
T Consensus 88 Ey~~gg~L~~~~~~~~~--l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhccCC--CCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 99999999999887654 89999999999999999999999 99999999999999999999999999999875433
Q ss_pred C-ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 502 T-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 502 ~-~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
. ......+||+.|||||++.+..++.++|||||||+||||++|+.||......+.. .. +..+.+
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-~~---------i~~~~~----- 227 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF-QK---------IIKLEY----- 227 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HH---------HHTTCC-----
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH-HH---------HHcCCC-----
Confidence 2 2334567999999999999999999999999999999999999999865432211 10 011111
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
.++......+.+++.+||+.||++||++.|+++
T Consensus 228 -----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 112223346789999999999999999998754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.3e-48 Score=415.10 Aligned_cols=253 Identities=22% Similarity=0.309 Sum_probs=208.8
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
.++|++++.||+|+||.||+|.+ .+|+.||||++........+.|.+|+++|++|+|+|||++++++.+++..+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999996 46899999999876656667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEc--CCCCEEEEEeccccccCCCC
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLD--YTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~--~~~~vkL~DFGla~~~~~~~ 501 (724)
|++|+|.++|..... .+++..++.|+.||+.||.|||++ +||||||||+||||+ .++.+||+|||+++......
T Consensus 105 ~~gg~L~~~l~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 105 MSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCSCBHHHHHTCTTS-CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 999999999865432 489999999999999999999999 999999999999995 46889999999999876543
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
. .....||..|||||++.+..++.++|||||||+||||++|+.||......+. +..... . ...+..
T Consensus 181 ~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~~~i~~----~---~~~~~~---- 246 (350)
T d1koaa2 181 S--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-LRNVKS----C---DWNMDD---- 246 (350)
T ss_dssp C--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHH----T---CCCSCC----
T ss_pred c--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHh----C---CCCCCc----
Confidence 3 2446799999999999999999999999999999999999999976543221 111100 0 000000
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
... ......+.+++.+||+.||++||++.||+++
T Consensus 247 ~~~----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 247 SAF----SGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGG----GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ccc----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 1122457889999999999999999999874
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-48 Score=411.95 Aligned_cols=253 Identities=21% Similarity=0.314 Sum_probs=191.7
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
..+.|++.++||+|+||+||+|... +++.||||++..... .....|.+|+++|++|+|||||++++++.+++..||||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3567999999999999999999964 688999999975432 23456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEc---CCCCEEEEEeccccccC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLD---YTFETKVADFGLAKLTT 498 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~---~~~~vkL~DFGla~~~~ 498 (724)
|||++|+|.++|..++. +++.++..|+.||+.||+|||++ +||||||||+|||+. +++.+||+|||+++...
T Consensus 87 E~~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCCSCBHHHHHHTCSC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred eccCCCcHHHhhhcccC--CCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 99999999999987554 99999999999999999999999 999999999999994 57899999999998765
Q ss_pred CCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhh
Q 040832 499 DNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEI 578 (724)
Q Consensus 499 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 578 (724)
.... ....+||+.|||||++.+..|+.++|||||||+||||++|+.||......+.... . + .+.+.
T Consensus 162 ~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~-i----~-----~~~~~-- 227 (307)
T d1a06a_ 162 PGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ-I----L-----KAEYE-- 227 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-H----H-----TTCCC--
T ss_pred CCCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHH-H----h-----ccCCC--
Confidence 4332 2346799999999999999999999999999999999999999976543221110 0 0 00000
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 579 ADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 579 vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.. .....+....+.+++.+||+.||++||++.||+++
T Consensus 228 ~~----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 FD----SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CC----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CC----CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00 00111223468899999999999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-48 Score=410.02 Aligned_cols=265 Identities=25% Similarity=0.399 Sum_probs=214.7
Q ss_pred HHHHHHhhCCCcccceeeccCcEEEEEEEcC------CCcEEEEEEeccCCchh-HHHHHHHHHHHHhcCCCCeeEEeeE
Q 040832 338 YEELSAATGGFSQSNLLGQGGFGYVHKGVLP------NGKEVAVKSLRSGSGQG-EREFKAEVEIISRVHHRHLVSLVGY 410 (724)
Q Consensus 338 ~~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vaVK~l~~~~~~~-~~~f~~Ei~il~~l~HpnIv~l~g~ 410 (724)
+.+++...++|++.+.||+|+||.||+|++. +++.||||+++...... .++|++|+++|++++|+||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3455666788999999999999999999853 35789999998654443 4579999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHHhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 040832 411 CIAGGKRLLVYEYVPNNNLEFHLHGKG----------------------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRI 468 (724)
Q Consensus 411 ~~~~~~~~lV~E~~~~gsL~~~L~~~~----------------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~i 468 (724)
|.+.+..++||||+.+|+|.++|+... ...+++..+++|+.||+.||+|||++ +|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 999999999999999999999986432 23478999999999999999999999 99
Q ss_pred EecCCCCccEEEcCCCCEEEEEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCC-C
Q 040832 469 IHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR-R 546 (724)
Q Consensus 469 iHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~-~ 546 (724)
||||||++||||+.++.+||+|||+++........ ......|+..|+|||++.+..++.++|||||||+||||++|. .
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 99999999999999999999999999876443322 334567889999999999999999999999999999999986 5
Q ss_pred CCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 547 PIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 547 P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
||......+. + .. +..+... ..+.....++.+++.+||+.+|++||+|.||+++|+.+.
T Consensus 242 p~~~~~~~e~-~-~~--------v~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMAHEEV-I-YY--------VRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTSCHHHH-H-HH--------HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCHHHH-H-HH--------HHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 6665433221 1 11 1111111 112233456889999999999999999999999998754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.9e-48 Score=416.04 Aligned_cols=252 Identities=20% Similarity=0.318 Sum_probs=209.2
Q ss_pred CCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEec
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEYV 424 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 424 (724)
++|++++.||+|+||.||+|+. .+|+.||||+++.......+.+.+|+++|++|+|+|||++++++.+++..|||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999995 469999999998766556667899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEc--CCCCEEEEEeccccccCCCCC
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLD--YTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~--~~~~vkL~DFGla~~~~~~~~ 502 (724)
++|+|.+++...+ ..+++.+++.|+.||++||+|||++ +||||||||+||||+ .++.+||+|||+|+.......
T Consensus 109 ~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 109 SGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp CCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 9999988876543 2489999999999999999999998 999999999999997 678999999999998765432
Q ss_pred ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchh
Q 040832 503 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPY 582 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~ 582 (724)
.....|+..|||||++.+..++.++|||||||+||||++|+.||......+.. .... .+.+.
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-~~i~---------~~~~~------ 246 (352)
T d1koba_ 185 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL-QNVK---------RCDWE------ 246 (352)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-HHHH---------HCCCC------
T ss_pred --eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHH---------hCCCC------
Confidence 34467999999999999999999999999999999999999999765433221 1110 00000
Q ss_pred hhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 583 LEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 583 l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+...........+.+++.+||+.||++||++.||+++
T Consensus 247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0001111223457889999999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-48 Score=411.38 Aligned_cols=244 Identities=25% Similarity=0.347 Sum_probs=201.1
Q ss_pred CCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCch---hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQ---GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~---~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
.|+..+.||+|+||.||+|++ .+++.||||+++..... ..+.|.+|+++|++|+|||||++++++.+++..|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 489999999999999999985 46889999999765332 23468999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
||.+|+|..++..++ .+++.+++.|+.||+.||.|||++ +||||||||+||||+.++.+||+|||+++.....
T Consensus 96 ~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp CCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence 999999987766554 389999999999999999999999 9999999999999999999999999999876542
Q ss_pred ccccccccCCCcCCcchhcC---CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhc
Q 040832 503 HVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIA 579 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~---~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~v 579 (724)
....||+.|||||++.+ +.|+.++|||||||+||||++|+.||......+...... .+....+.
T Consensus 169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~----------~~~~~~~~ 235 (309)
T d1u5ra_ 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----------QNESPALQ 235 (309)
T ss_dssp ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH----------HSCCCCCS
T ss_pred ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH----------hCCCCCCC
Confidence 33569999999999863 468999999999999999999999997654332211100 00000000
Q ss_pred chhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 580 DPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 580 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
.......+.+++.+||+.||++||++.||++
T Consensus 236 --------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 --------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1112346888999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-48 Score=402.93 Aligned_cols=256 Identities=23% Similarity=0.378 Sum_probs=197.2
Q ss_pred hCCCcccceeeccCcEEEEEEEcCC----CcEEEEEEeccCCchh-HHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPN----GKEVAVKSLRSGSGQG-EREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~----g~~vaVK~l~~~~~~~-~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
.++|.++++||+|+||.||+|++.. +..||||+++...... .+.|.+|+++|++++|||||+++|+|. ++..+|
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4679999999999999999998643 3468899987654443 456999999999999999999999986 467899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
||||+.+|+|.+++.... ..+++..++.++.||++||.|||++ +||||||||+||||+.++.+||+|||+++....
T Consensus 85 v~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccC
Confidence 999999999999876543 3489999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhh
Q 040832 500 NNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEI 578 (724)
Q Consensus 500 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 578 (724)
..........||+.|+|||++..+.++.++|||||||+||||++ |+.||......+... . +..+...
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~--~--------i~~~~~~-- 228 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG--R--------IENGERL-- 228 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH--H--------HHTTCCC--
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHH--H--------HHcCCCC--
Confidence 55545556678999999999999999999999999999999998 899997654332111 0 1111100
Q ss_pred cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 579 ADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 579 vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
..+......+.+++.+||..+|++||++.||++.|+..+
T Consensus 229 -------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 229 -------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 112233456889999999999999999999999998543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=409.20 Aligned_cols=254 Identities=28% Similarity=0.412 Sum_probs=202.2
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCc----EEEEEEeccC-CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGK----EVAVKSLRSG-SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~----~vaVK~l~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 419 (724)
.+|+++++||+|+||.||+|.+. +|+ .||||+++.. ..+..++|++|+++|++++|+|||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999864 343 5899988754 334567899999999999999999999999875 5578
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCC
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTD 499 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 499 (724)
||||+.+++|.+++.... ..+++..+++|+.||++||+|||++ +||||||||+||||+.++.+||+|||+++....
T Consensus 88 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 899999999998887653 3589999999999999999999998 999999999999999999999999999998765
Q ss_pred CCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhh
Q 040832 500 NNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNE 577 (724)
Q Consensus 500 ~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 577 (724)
.... ......||..|||||++.++.++.++|||||||+||||+| |+.||+.....+. ... +..+
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~--~~~--------i~~~---- 229 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--SSI--------LEKG---- 229 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH--HHH--------HHHT----
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH--HHH--------HHcC----
Confidence 4433 2334568999999999999999999999999999999999 8888876543221 100 0001
Q ss_pred hcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 578 IADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 578 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
.....+......+.+++.+||+.+|++||++.||+++|+..
T Consensus 230 -----~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 230 -----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp -----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 00112223345688999999999999999999999998753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=404.27 Aligned_cols=252 Identities=23% Similarity=0.298 Sum_probs=206.5
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCc------hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSG------QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKR 417 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~------~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 417 (724)
.+.|++++.||+|+||+||+|++ .+|+.||||+++.... ...+.|.+|+++|++|+|+|||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46799999999999999999996 4689999999864321 2356799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC----CEEEEEecc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF----ETKVADFGL 493 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~----~vkL~DFGl 493 (724)
+||||||++|+|.++|...+. +++..++.|+.||+.||+|||++ +||||||||+||||+.++ .+||+|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~--l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhccccc--cchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence 999999999999999977553 89999999999999999999999 999999999999998776 599999999
Q ss_pred ccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCC
Q 040832 494 AKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDG 573 (724)
Q Consensus 494 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~ 573 (724)
++....... .....|+..|||||++.+..++.++|||||||+||||++|+.||......+. +... ..+
T Consensus 164 a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~~~i---------~~~ 231 (293)
T d1jksa_ 164 AHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANV---------SAV 231 (293)
T ss_dssp CEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH---------HTT
T ss_pred hhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH-HHHH---------Hhc
Confidence 987754432 2345689999999999999999999999999999999999999986543321 1111 001
Q ss_pred ChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 574 NFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 574 ~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+. ....+.. .....+.+++.+||+.||++||++.||+++
T Consensus 232 ~~~--~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 232 NYE--FEDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CCC--CCHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCC--CCchhcC----CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0000111 123457889999999999999999999873
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=402.46 Aligned_cols=248 Identities=28% Similarity=0.452 Sum_probs=198.3
Q ss_pred CCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC-CeEEEEEEec
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAG-GKRLLVYEYV 424 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~-~~~~lV~E~~ 424 (724)
++|++++.||+|+||.||+|.+ .|+.||||+++.. ...+.|++|+++|++++|+||++++|+|.+. +..+|||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 5678899999999999999998 5788999999764 3346799999999999999999999999654 5679999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCcc
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTHV 504 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 504 (724)
++|+|.++|+......+++..+++|+.||++||.|||+. +|||||||++|||++.++.+||+|||+++......
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence 999999999765444589999999999999999999998 99999999999999999999999999998765432
Q ss_pred ccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcchhh
Q 040832 505 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADPYL 583 (724)
Q Consensus 505 ~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~~l 583 (724)
....++..|+|||++.++.++.++|||||||+||||+| |+.||......+ +..+. ..+.
T Consensus 158 -~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--~~~~i--------~~~~--------- 217 (262)
T d1byga_ 158 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRV--------EKGY--------- 217 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHH--------TTTC---------
T ss_pred -ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--HHHHH--------HcCC---------
Confidence 23457899999999999999999999999999999998 677776543222 11111 1111
Q ss_pred hcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 584 EKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
....+.....++.+++.+||+.||++||+|.+|+++|+.
T Consensus 218 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 111222333568899999999999999999999999975
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=404.86 Aligned_cols=263 Identities=26% Similarity=0.375 Sum_probs=200.5
Q ss_pred HHHHhhCCCcccceeeccCcEEEEEEEcC------CCcEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCeeEEeeEE
Q 040832 340 ELSAATGGFSQSNLLGQGGFGYVHKGVLP------NGKEVAVKSLRSGSG-QGEREFKAEVEIISRV-HHRHLVSLVGYC 411 (724)
Q Consensus 340 el~~~~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l-~HpnIv~l~g~~ 411 (724)
+.+...++|++++.||+|+||.||+|.+. +++.||||+++.... ...+.|.+|+.++.++ +|+||+.+++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 33344578999999999999999999853 346899999976533 3455688888888887 689999999998
Q ss_pred EeCC-eEEEEEEecCCCCHHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCc
Q 040832 412 IAGG-KRLLVYEYVPNNNLEFHLHGKG--------------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSS 476 (724)
Q Consensus 412 ~~~~-~~~lV~E~~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~ 476 (724)
...+ ..++|||||++|+|.++|+... ...+++.+++.|+.||++||.|||++ +||||||||+
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~ 163 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR 163 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcc
Confidence 7654 6799999999999999997542 23488999999999999999999999 9999999999
Q ss_pred cEEEcCCCCEEEEEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCC-CCCCCCCch
Q 040832 477 NILLDYTFETKVADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR-RPIDPTGAM 554 (724)
Q Consensus 477 NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~-~P~~~~~~~ 554 (724)
||||+.++.+||+|||+|+........ ......||..|||||++.++.++.++|||||||+||||++|. .||......
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999876544333 334567999999999999999999999999999999999965 567654333
Q ss_pred hhhHHhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 555 EDCLVDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 555 ~~~l~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
+........ +.. ...+......+.+++.+||+.+|++||++.||+++|+..
T Consensus 244 ~~~~~~~~~---------~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 244 EEFCRRLKE---------GTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp HHHHHHHHH---------TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhc---------CCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 221111111 100 011222334688999999999999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-47 Score=405.50 Aligned_cols=249 Identities=23% Similarity=0.315 Sum_probs=207.3
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
.++|.++++||+|+||.||+|+. .+|+.||||+++.. .....+.+.+|+.+|++++|+||+++++++.+.+.+|||
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 35799999999999999999995 46899999999643 122356789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
||||.+|+|..++...+. +++..++.++.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|+.....
T Consensus 84 ~ey~~gg~L~~~~~~~~~--~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eeccCCCchhhhhhcccC--CcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 999999999999987654 89999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
.. .....+||+.|||||++.+..|+.++|||||||+||||++|+.||...+..+.... + ..+.+
T Consensus 159 ~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~-i---------~~~~~----- 222 (337)
T d1o6la_ 159 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL-I---------LMEEI----- 222 (337)
T ss_dssp TC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-H---------HHCCC-----
T ss_pred Cc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHH-H---------hcCCC-----
Confidence 32 23456799999999999999999999999999999999999999976543221111 0 00100
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPK-----ISQIVRA 619 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evv~~ 619 (724)
.++......+.+++.+||+.||++|++ +.||+++
T Consensus 223 -----~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 223 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 112223345788999999999999995 7888763
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.8e-47 Score=403.07 Aligned_cols=245 Identities=26% Similarity=0.367 Sum_probs=205.8
Q ss_pred CCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|++++.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.+|++++|||||++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5699999999999999999996 46899999999643 1233567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
|||.+|+|..++..... +.+..++.|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+......
T Consensus 84 E~~~gg~l~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp CCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred eecCCcccccccccccc--ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecccc
Confidence 99999999999887664 78899999999999999999999 99999999999999999999999999999875432
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
....||+.|||||++.+..++.++|||||||+||||++|+.||......+... .. + .+.+
T Consensus 159 ----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~i----~-----~~~~------ 218 (316)
T d1fota_ 159 ----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE-KI----L-----NAEL------ 218 (316)
T ss_dssp ----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-HH----H-----HCCC------
T ss_pred ----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH-HH----H-----cCCC------
Confidence 34679999999999999999999999999999999999999997654322110 00 0 0100
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRP-----KISQIVRA 619 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evv~~ 619 (724)
.++......+.+++.+||..+|.+|+ ++++|+++
T Consensus 219 ----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 ----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 11222234578899999999999996 89999874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2e-46 Score=391.55 Aligned_cols=257 Identities=26% Similarity=0.390 Sum_probs=201.1
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCch---hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC----e
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQ---GEREFKAEVEIISRVHHRHLVSLVGYCIAGG----K 416 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~---~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~----~ 416 (724)
.++|++.+.||+|+||.||+|.+ .+|+.||||+++..... ..+.|.+|+++|++++|+||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999985 57899999999764332 2356999999999999999999999988654 4
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
.|||||||++++|..++...+. +++.+++.|+.||++||+|||++ +||||||||+||||+.++.++|+|||+++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~--l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhcccCC--CCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhh
Confidence 7899999999999998876654 89999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCC--ccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCC
Q 040832 497 TTDNNT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGN 574 (724)
Q Consensus 497 ~~~~~~--~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~ 574 (724)
...... .......||..|||||++.+..++.++|||||||+||||+||+.||......+...... ....
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~---------~~~~ 231 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV---------REDP 231 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---------HCCC
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHH---------hcCC
Confidence 643322 23345679999999999999999999999999999999999999998654333211110 0100
Q ss_pred hhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHhC
Q 040832 575 FNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRP-KISQIVRALEG 622 (724)
Q Consensus 575 ~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evv~~L~~ 622 (724)
.. . .....+....+.+++.+||..||++|| +++++++.|..
T Consensus 232 ~~----~---~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 232 IP----P---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CC----G---GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CC----C---chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 00 0 001112235688899999999999999 89999887763
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=399.06 Aligned_cols=252 Identities=29% Similarity=0.420 Sum_probs=201.4
Q ss_pred cceeeccCcEEEEEEEcCCC----cEEEEEEeccC-CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEe-CCeEEEEEEec
Q 040832 351 SNLLGQGGFGYVHKGVLPNG----KEVAVKSLRSG-SGQGEREFKAEVEIISRVHHRHLVSLVGYCIA-GGKRLLVYEYV 424 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~~g----~~vaVK~l~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~lV~E~~ 424 (724)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++|+|+||++++|+|.+ ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999996542 25899999754 33344679999999999999999999999876 46889999999
Q ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc-
Q 040832 425 PNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH- 503 (724)
Q Consensus 425 ~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~- 503 (724)
.+|+|.++++.... .+.+..+++|+.||++||.|||+. +|+|||||++||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~-~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhccccc-cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 99999999886543 478889999999999999999999 9999999999999999999999999999977554332
Q ss_pred --cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 504 --VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 504 --~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
......|+..|+|||.+..+.++.++||||||++||||++|+.||.......+ +..+ + ..+.. .
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~-~~~~---i-----~~g~~--~--- 253 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVY---L-----LQGRR--L--- 253 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHH---H-----HTTCC--C---
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH-HHHH---H-----HcCCC--C---
Confidence 22345789999999999999999999999999999999998888865322111 1111 0 11110 0
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
..+......+.+++.+||+.+|++||+|.||+++|+...
T Consensus 254 ----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 254 ----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 011122346889999999999999999999999998653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=398.56 Aligned_cols=254 Identities=26% Similarity=0.391 Sum_probs=196.2
Q ss_pred CCCcccceeeccCcEEEEEEEcCC--C--cEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPN--G--KEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRL 418 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~--g--~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 418 (724)
++|++.+.||+|+||.||+|++.. + ..||||+++.. ..+..++|.+|+++|++|+|+||++++|+|.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568999999999999999998532 2 36899998754 22334679999999999999999999999976 4668
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
+||||+++|+|.+++..... .+++..++.|+.||++||.|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 99999999999988765432 489999999999999999999998 99999999999999999999999999999875
Q ss_pred CCCCc--cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhHHhhhhhhhhhcccCCCh
Q 040832 499 DNNTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCLVDWARPLCLRALDDGNF 575 (724)
Q Consensus 499 ~~~~~--~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~ 575 (724)
..... ......|+..|+|||++.+..++.++|||||||+||||+| |+.||......+. ..+.. ..+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~--~~~i~-------~~~~~ 233 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--LHKID-------KEGER 233 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHHH-------TSCCC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH--HHHHH-------hCCCC
Confidence 54433 2334568899999999999999999999999999999998 8999976543332 11110 01100
Q ss_pred hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhC
Q 040832 576 NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEG 622 (724)
Q Consensus 576 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~ 622 (724)
..........+.+++.+||+.+|++||+|.||++.|++
T Consensus 234 ---------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 234 ---------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 01112223468899999999999999999999999874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-47 Score=401.59 Aligned_cols=258 Identities=28% Similarity=0.381 Sum_probs=210.6
Q ss_pred hCCCcccceeeccCcEEEEEEEc------CCCcEEEEEEeccCCch-hHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL------PNGKEVAVKSLRSGSGQ-GEREFKAEVEIISRV-HHRHLVSLVGYCIAGGK 416 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 416 (724)
.++|+++++||+|+||.||+|.+ .+++.||||+++..... ...+|.+|+.+++++ +|+|||+++|+|.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 35788999999999999999974 34568999999865443 345799999999999 79999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEE
Q 040832 417 RLLVYEYVPNNNLEFHLHGKG----------------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILL 480 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~----------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl 480 (724)
.+||||||++|+|..+|+... ...+++..+++|+.||++||+|||++ +|||||||++||||
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 999999999999999997543 23588999999999999999999999 99999999999999
Q ss_pred cCCCCEEEEEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCC-CCCCCchhhhH
Q 040832 481 DYTFETKVADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP-IDPTGAMEDCL 558 (724)
Q Consensus 481 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P-~~~~~~~~~~l 558 (724)
+.++.+||+|||+++........ ......|++.|+|||++..+.++.++|||||||+||||+|++.| |......+ .+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~-~~ 257 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-KF 257 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-HH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH-HH
Confidence 99999999999999987654433 34456899999999999999999999999999999999995555 44433222 11
Q ss_pred HhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 559 VDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 559 ~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
..+. +..+....+......+.+++.+||+.||++||+|.||+++|++.
T Consensus 258 ~~~i-----------------~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 258 YKMI-----------------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHH-----------------HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH-----------------hcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1111 11111112222345689999999999999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-47 Score=400.29 Aligned_cols=255 Identities=27% Similarity=0.427 Sum_probs=203.9
Q ss_pred CCCcccceeeccCcEEEEEEEcCC-Cc--EEEEEEeccC-CchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEeCCeEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPN-GK--EVAVKSLRSG-SGQGEREFKAEVEIISRV-HHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~-g~--~vaVK~l~~~-~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 420 (724)
++|+++++||+|+||.||+|++.+ +. .||||+++.. ..+..++|.+|+++|+++ +|+|||+++|+|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 678899999999999999999754 33 4788888644 333455799999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHHhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCE
Q 040832 421 YEYVPNNNLEFHLHGK--------------GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFET 486 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~--------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~v 486 (724)
|||+++|+|.++|+.. ....+++..+++++.||++||.|||++ +|||||||++|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999999754 234689999999999999999999999 99999999999999999999
Q ss_pred EEEEeccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCC-CCCCCCchhhhHHhhhhhh
Q 040832 487 KVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRR-PIDPTGAMEDCLVDWARPL 565 (724)
Q Consensus 487 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~-P~~~~~~~~~~l~~w~~~~ 565 (724)
||+|||+++........ ....||..|+|||.+..+.++.++|||||||+||||++|.. ||......+ +..+.
T Consensus 167 kl~DfG~a~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~--~~~~i--- 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKL--- 239 (309)
T ss_dssp EECCTTCEESSCEECCC------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHG---
T ss_pred EEccccccccccccccc--cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH--HHHHH---
Confidence 99999999866543322 23458999999999999999999999999999999999765 565443222 11111
Q ss_pred hhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 566 CLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 566 ~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
..+.. ...+......+.+++.+||+.+|++||+|.||+++|++.+
T Consensus 240 -----~~~~~---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 240 -----PQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp -----GGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----HhcCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11100 1112223457889999999999999999999999998754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-47 Score=398.68 Aligned_cols=258 Identities=27% Similarity=0.411 Sum_probs=206.3
Q ss_pred hCCCcccceeeccCcEEEEEEEcCC--------CcEEEEEEeccCCch-hHHHHHHHHHHHHhc-CCCCeeEEeeEEEeC
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLPN--------GKEVAVKSLRSGSGQ-GEREFKAEVEIISRV-HHRHLVSLVGYCIAG 414 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~~--------g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~ 414 (724)
.++|.+++.||+|+||.||+|+... +..||||+++.+... ...++.+|+.++.++ +|+|||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3578899999999999999998532 247999999876543 346789999999988 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEE
Q 040832 415 GKRLLVYEYVPNNNLEFHLHGKG--------------RPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILL 480 (724)
Q Consensus 415 ~~~~lV~E~~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl 480 (724)
+..++|||||++|+|.++|..+. ...+++.++++|+.||+.||+|||++ +||||||||+||||
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence 99999999999999999997543 23589999999999999999999999 99999999999999
Q ss_pred cCCCCEEEEEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHh-CCCCCCCCCchhhhH
Q 040832 481 DYTFETKVADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPIDPTGAMEDCL 558 (724)
Q Consensus 481 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLlt-G~~P~~~~~~~~~~l 558 (724)
+.++.+||+|||+++........ ......|+..|+|||.+.++.|+.++|||||||+||||++ |+.||......+ +
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--~ 246 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--L 246 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--H
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH--H
Confidence 99999999999999977654433 3344678999999999999999999999999999999998 688886544322 1
Q ss_pred HhhhhhhhhhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 559 VDWARPLCLRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 559 ~~w~~~~~~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
..+. ..+. ....+......+.+++.+||+.+|++||++.||++.|+..+
T Consensus 247 ~~~i--------~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 247 FKLL--------KEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHH--------HTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH--------HcCC---------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 1111 1110 00111223356889999999999999999999999998653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-46 Score=404.01 Aligned_cols=244 Identities=25% Similarity=0.304 Sum_probs=204.5
Q ss_pred CCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSG---SGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 421 (724)
++|++++.||+|+||.||+|++ .+|+.||||++... .....+.+.+|+++|++++|+|||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999986 46899999998642 1223456899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 501 (724)
||+.+|+|..++...+. +++..++.|+.||+.||.|||++ +||||||||+||||+.++.+||+|||+|+......
T Consensus 121 e~~~~g~l~~~l~~~~~--l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~ 195 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp ECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred ccccccchhhhHhhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence 99999999999977654 89999999999999999999999 99999999999999999999999999999875432
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
....||+.|||||++.+..++.++|||||||+||||++|+.||........ +... ..+.+
T Consensus 196 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i---------~~~~~------ 255 (350)
T d1rdqe_ 196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-YEKI---------VSGKV------ 255 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH---------HHCCC------
T ss_pred ----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH-HHHH---------hcCCC------
Confidence 346799999999999999999999999999999999999999976532221 1100 00100
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRP-----KISQIVR 618 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evv~ 618 (724)
.++......+.+++.+||+.||.+|+ ++.+|++
T Consensus 256 ----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 ----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11122234678999999999999994 8899886
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=397.08 Aligned_cols=268 Identities=23% Similarity=0.290 Sum_probs=201.5
Q ss_pred CCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHH--HHHHHHhcCCCCeeEEeeEEEeCC----eEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKA--EVEIISRVHHRHLVSLVGYCIAGG----KRLL 419 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~--Ei~il~~l~HpnIv~l~g~~~~~~----~~~l 419 (724)
..|.+.+.||+|+||.||+|++ +|+.||||+++.. ..+++.. |+..+.+++|+||++++|+|.+.+ .++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4578889999999999999997 6889999999753 3344444 555556789999999999998754 5789
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCccEEEcCCCCEEEEEeccc
Q 040832 420 VYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDC-----HPRIIHRDIKSSNILLDYTFETKVADFGLA 494 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~-----~~~iiHrDIkp~NILl~~~~~vkL~DFGla 494 (724)
|||||.+|+|.++|++.. ++|..+++|+.|++.||+|||+.+ .++||||||||+||||+.++.+||+|||++
T Consensus 79 v~Ey~~~g~L~~~l~~~~---l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEecccCCCHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 999999999999998753 899999999999999999999732 348999999999999999999999999999
Q ss_pred cccCCCCCc---cccccccCCCcCCcchhcCC------CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhh----
Q 040832 495 KLTTDNNTH---VSTRVMGTFGYLAPEYASSG------KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDW---- 561 (724)
Q Consensus 495 ~~~~~~~~~---~~~~~~gt~~y~APE~~~~~------~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w---- 561 (724)
+........ .....+||..|||||++... .++.|+|||||||+||||+||..+|......+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 987554432 23446799999999998754 26779999999999999999998875432221111100
Q ss_pred -hhhhhhhcccCCChhhhcchhhhcC-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCC
Q 040832 562 -ARPLCLRALDDGNFNEIADPYLEKN-YPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDV 624 (724)
Q Consensus 562 -~~~~~~~~~~~~~~~~~vd~~l~~~-~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~ 624 (724)
....+...+..+ ..++.+... ...+....+.+++.+||+.+|++||++.||++.|+...
T Consensus 236 ~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 236 PSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CCHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred chHHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 000000000000 111111111 13356677999999999999999999999999998543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8e-46 Score=386.94 Aligned_cols=252 Identities=23% Similarity=0.298 Sum_probs=205.2
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCch---------hHHHHHHHHHHHHhcC-CCCeeEEeeEEEe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQ---------GEREFKAEVEIISRVH-HRHLVSLVGYCIA 413 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~---------~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~ 413 (724)
.++|++.+.||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+.+|++|+ |+||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 46899999999999999999995 47899999998654211 1235889999999997 9999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecc
Q 040832 414 GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGL 493 (724)
Q Consensus 414 ~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGl 493 (724)
++..|||||||++|+|.++|...+. +++.+++.|+.||++||+|||++ +||||||||+||||+.++.+||+|||+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CcceEEEEEcCCCchHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence 9999999999999999999987554 89999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCCcCCcchhcC------CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhh
Q 040832 494 AKLTTDNNTHVSTRVMGTFGYLAPEYASS------GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCL 567 (724)
Q Consensus 494 a~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~ 567 (724)
++....... .....||..|+|||++.+ ..++.++|||||||+||||++|+.||......+.. ... +
T Consensus 157 a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~-~~i----~- 228 (277)
T d1phka_ 157 SCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-RMI----M- 228 (277)
T ss_dssp CEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHH----H-
T ss_pred eeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH-HHH----H-
Confidence 998765432 345679999999999853 35788999999999999999999999865432211 000 0
Q ss_pred hcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 568 RALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 568 ~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+.+. +.. .........+.+++.+||+.+|++||++.||+++
T Consensus 229 ----~~~~~-~~~-----~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 229 ----SGNYQ-FGS-----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp ----HTCCC-CCT-----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ----hCCCC-CCC-----cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 01000 000 0011223468899999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=398.24 Aligned_cols=260 Identities=24% Similarity=0.402 Sum_probs=210.9
Q ss_pred hhCCCcccceeeccCcEEEEEEEcC------CCcEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCe
Q 040832 344 ATGGFSQSNLLGQGGFGYVHKGVLP------NGKEVAVKSLRSGSGQ-GEREFKAEVEIISRVHHRHLVSLVGYCIAGGK 416 (724)
Q Consensus 344 ~~~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vaVK~l~~~~~~-~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 416 (724)
..++|.+++.||+|+||.||+|.+. +++.||||+++..... ....|++|+++|++++|+||++++|+|..++.
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 3467899999999999999999863 3578999999765333 33469999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEE
Q 040832 417 RLLVYEYVPNNNLEFHLHGK--------GRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKV 488 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~--------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL 488 (724)
.++||||+.+|+|.++++.. ....+++..+++|+.||++||.|||++ +|+|||||++||||+.++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEE
Confidence 99999999999999988642 223478999999999999999999998 9999999999999999999999
Q ss_pred EEeccccccCCCCCc-cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCC-CCCCCCCchhhhHHhhhhhhh
Q 040832 489 ADFGLAKLTTDNNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR-RPIDPTGAMEDCLVDWARPLC 566 (724)
Q Consensus 489 ~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~-~P~~~~~~~~~~l~~w~~~~~ 566 (724)
+|||+++........ ......|++.|+|||.+.++.++.++|||||||+||||+||+ .||......+. +. .
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~-~~-~----- 247 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-LR-F----- 247 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH-HH-H-----
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH-HH-H-----
Confidence 999999877554333 234457999999999999999999999999999999999985 66654432211 11 0
Q ss_pred hhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCCCC
Q 040832 567 LRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGDVS 625 (724)
Q Consensus 567 ~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~~~ 625 (724)
+..+... ..+......+.+++.+||+.+|++||+|.||+++|++.++
T Consensus 248 ---i~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 248 ---VMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ---HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ---HHhCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1111110 1112223568999999999999999999999999987654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=394.27 Aligned_cols=252 Identities=17% Similarity=0.269 Sum_probs=205.9
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
.++|.+++.||+|+||.||+|.+. +++.||||+++... .+...+.+|+++|++++|+|||++++++.+++..||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 478999999999999999999965 68899999997653 3345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC--CCCEEEEEeccccccCCCC
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY--TFETKVADFGLAKLTTDNN 501 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~--~~~vkL~DFGla~~~~~~~ 501 (724)
|.+|+|.++|...+. .+++.+++.|+.||++||+|||++ +|+||||||+||||+. .+.+||+|||+++......
T Consensus 83 ~~gg~L~~~i~~~~~-~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 83 ISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSSSC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 999999999976542 489999999999999999999999 9999999999999975 4589999999998765433
Q ss_pred CccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcch
Q 040832 502 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIADP 581 (724)
Q Consensus 502 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd~ 581 (724)
. .....|+..|+|||.+.+..++.++|||||||+||||++|+.||......+.. ... ..+.+. ...
T Consensus 159 ~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~-~~i---------~~~~~~--~~~ 224 (321)
T d1tkia_ 159 N--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII-ENI---------MNAEYT--FDE 224 (321)
T ss_dssp E--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHH---------HHTCCC--CCH
T ss_pred c--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHH-HHH---------HhCCCC--CCh
Confidence 2 23456899999999999999999999999999999999999999765432211 100 000000 000
Q ss_pred hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 582 YLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 582 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..... ....+.+++.+||..||++||++.|++++
T Consensus 225 ~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 225 EAFKE----ISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhccC----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011 12457889999999999999999999873
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-46 Score=391.31 Aligned_cols=262 Identities=21% Similarity=0.255 Sum_probs=197.0
Q ss_pred ccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchh-----HHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 350 QSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQG-----EREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 350 ~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~-----~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
.+++||+|+||+||+|++. +|+.||||+++...... .+.+.+|+++|++++|+|||++++++.+++..+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999964 58999999997542221 23688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+.++++..++.... .+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~~~~~~~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 82 METDLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp CSEEHHHHHTTCCS--SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred hcchHHhhhhhccc--CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 99988777665443 488899999999999999999999 9999999999999999999999999999877654433
Q ss_pred cccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhh---hhccc-------C
Q 040832 504 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLC---LRALD-------D 572 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~---~~~~~-------~ 572 (724)
. ...+||..|+|||++..+ .++.++|||||||+||||++|+.||......+.... ..+.+. ...+. .
T Consensus 157 ~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~-i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 157 Y-THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR-IFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp C-CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHHHCCCCTTTSSSTTSSTTC
T ss_pred c-cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHH-HHHhcCCCChhhccchhccchh
Confidence 2 335699999999998754 579999999999999999999999976654432111 110000 00000 0
Q ss_pred CChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 573 GNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 573 ~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
..+.......+.. ........+.+++.+||+.||++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~-~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 235 VTFKSFPGIPLHH-IFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCHHH-HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCCCCChHH-hcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0000000000000 001123468899999999999999999999873
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.3e-46 Score=401.22 Aligned_cols=249 Identities=25% Similarity=0.362 Sum_probs=198.7
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHH---HHHHHhcCCCCeeEEeeEEEeCCeE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAE---VEIISRVHHRHLVSLVGYCIAGGKR 417 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~E---i~il~~l~HpnIv~l~g~~~~~~~~ 417 (724)
.++|+++++||+|+||.||+|+.. +|+.||||++.... ......+.+| +.+|+.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 368999999999999999999964 68999999985321 1122334444 6666777899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLT 497 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~ 497 (724)
|||||||++|+|.++|..... +.+..++.|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+..
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEEecCCCcHHHHHHhccc--ccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 999999999999999987554 78999999999999999999999 9999999999999999999999999999977
Q ss_pred CCCCCccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChh
Q 040832 498 TDNNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFN 576 (724)
Q Consensus 498 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 576 (724)
..... ....||+.|||||++..+ .++.++|||||||+||||++|+.||......+..... + ......
T Consensus 158 ~~~~~---~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~--~-----~~~~~~-- 225 (364)
T d1omwa3 158 SKKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--R-----MTLTMA-- 225 (364)
T ss_dssp SSSCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH--H-----HSSSCC--
T ss_pred CCCcc---cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH--H-----hcccCC--
Confidence 65432 345799999999999754 6899999999999999999999999765322211100 0 000000
Q ss_pred hhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 040832 577 EIADPYLEKNYPTEEMARMVACAAASIRHSARRRPK-----ISQIVR 618 (724)
Q Consensus 577 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evv~ 618 (724)
..++......+.+++.+||+.||++|++ ++||++
T Consensus 226 --------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 --------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0111122345789999999999999999 578875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=396.28 Aligned_cols=253 Identities=23% Similarity=0.306 Sum_probs=200.6
Q ss_pred hCCCccc-ceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCeeEEeeEEEe----CCeE
Q 040832 345 TGGFSQS-NLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRV-HHRHLVSLVGYCIA----GGKR 417 (724)
Q Consensus 345 ~~~f~~~-~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~----~~~~ 417 (724)
.++|.+. ++||+|+||.||+|++ .+++.||||+++. ...+.+|++++.++ +|+|||+++++|.+ +..+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 3578876 5699999999999985 5689999999964 34678899987665 89999999999875 4568
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC---CCCEEEEEeccc
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY---TFETKVADFGLA 494 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~---~~~vkL~DFGla 494 (724)
|||||||++|+|.++|..++...+++.+++.|+.||++||+|||++ +|+||||||+||||+. ++.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccccee
Confidence 9999999999999999877666799999999999999999999999 9999999999999975 567999999999
Q ss_pred cccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCC
Q 040832 495 KLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGN 574 (724)
Q Consensus 495 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~ 574 (724)
+........ ....||+.|||||++.+..|+.++|||||||+||||++|+.||......+... . +...+..+.
T Consensus 162 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~--~----~~~~i~~~~ 233 (335)
T d2ozaa1 162 KETTSHNSL--TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--G----MKTRIRMGQ 233 (335)
T ss_dssp EECCCCCCC--CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------CCCSCS
T ss_pred eeccCCCcc--ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH--H----HHHHHhcCC
Confidence 877654332 44679999999999999999999999999999999999999997543222100 0 001111111
Q ss_pred hhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 575 FNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 575 ~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+. +... ........+.+++.+||+.||++||++.||+++
T Consensus 234 ~~-~~~~-----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 234 YE-FPNP-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SS-CCTT-----HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CC-CCCc-----ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 10 0000 001233568899999999999999999999874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-46 Score=395.55 Aligned_cols=247 Identities=25% Similarity=0.354 Sum_probs=202.3
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC---chhHHHHHHHHHHHH-hcCCCCeeEEeeEEEeCCeEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS---GQGEREFKAEVEIIS-RVHHRHLVSLVGYCIAGGKRLLV 420 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~---~~~~~~f~~Ei~il~-~l~HpnIv~l~g~~~~~~~~~lV 420 (724)
++|.+++.||+|+||+||+|... +++.||||+++... ....+.+..|+.++. .++|||||++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 67999999999999999999964 68899999996431 223345666777665 68999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCC
Q 040832 421 YEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 421 ~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 500 (724)
||||++|+|.++|..... +++.+++.|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~~~--~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccCC--CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 999999999999987654 88999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD 580 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd 580 (724)
.. ......||..|+|||++.+..++.++|||||||+||||++|+.||......+... . +..+.+
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~----~------i~~~~~----- 220 (320)
T d1xjda_ 157 DA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH----S------IRMDNP----- 220 (320)
T ss_dssp TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----H------HHHCCC-----
T ss_pred cc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHH----H------HHcCCC-----
Confidence 32 2344679999999999999999999999999999999999999997654322110 0 000100
Q ss_pred hhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 040832 581 PYLEKNYPTEEMARMVACAAASIRHSARRRPKIS-QIVR 618 (724)
Q Consensus 581 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evv~ 618 (724)
.++......+.+++.+||..+|++||++. ||++
T Consensus 221 -----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 -----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11122234588999999999999999995 6754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=387.47 Aligned_cols=269 Identities=20% Similarity=0.280 Sum_probs=202.1
Q ss_pred CCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
++|++.+.||+|+||.||+|.+ .+|+.||||+++.... ...+.+.+|+++|++++|+|||++++++.+++..+||||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999995 5689999999965432 224578999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
|+.++.+. ++.......+++..++.|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~-~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 82 FLHQDLKK-FMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp CCSEEHHH-HHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred ecCCchhh-hhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 99766554 44433344599999999999999999999999 999999999999999999999999999987765433
Q ss_pred ccccccccCCCcCCcchhcCCC-CChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCChhhhcc-
Q 040832 503 HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGNFNEIAD- 580 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~-~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~vd- 580 (724)
. .....|+..|+|||.+.... ++.++|||||||+||||++|+.||......+.....+..................+
T Consensus 158 ~-~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 158 T-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp C-TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred c-ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 2 33456999999999877655 57899999999999999999999987654332211111000000000000000000
Q ss_pred -----hhhhcC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 581 -----PYLEKN---YPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 581 -----~~l~~~---~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
...... ........+.+++.+||..||++||++.||+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000 001122567889999999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.8e-45 Score=384.44 Aligned_cols=266 Identities=21% Similarity=0.291 Sum_probs=203.6
Q ss_pred CCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEEe
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQ--GEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~--~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 423 (724)
++|++.+.||+|+||.||+|++++|+.||||+++..... ..+.|.+|+.+|++++|+||+++++++.+++..++||||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 589999999999999999999989999999999765322 246799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCCc
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNTH 503 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 503 (724)
+.+++|..+....+ .+++..++.|+.||++||+|||++ +||||||||+||||+.++.+||+|||++.........
T Consensus 82 ~~~~~~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp CSEEHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhhcC--CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence 98888777766554 499999999999999999999998 9999999999999999999999999999877543322
Q ss_pred cccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhc-ccCCChhhh---
Q 040832 504 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRA-LDDGNFNEI--- 578 (724)
Q Consensus 504 ~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~-~~~~~~~~~--- 578 (724)
.....|+..|+|||.+... .++.++|||||||+||||++|+.||......+.....+.. +.... .........
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 157 -YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI-LGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HCCCCTTTSTTGGGSTTC
T ss_pred -cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHh-hCCCChhhccchhhhhhc
Confidence 2334588999999998754 5689999999999999999999999876543332111110 00000 000000000
Q ss_pred ------cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 579 ------ADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 579 ------vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
........+.......+.+++.+||+.||++||+++||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000001111223356789999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=384.79 Aligned_cols=241 Identities=22% Similarity=0.345 Sum_probs=196.5
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCch------hHHHHHHHHHHHHhcC--CCCeeEEeeEEEeCC
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQ------GEREFKAEVEIISRVH--HRHLVSLVGYCIAGG 415 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~------~~~~f~~Ei~il~~l~--HpnIv~l~g~~~~~~ 415 (724)
.++|+++++||+|+||.||+|++ .+|+.||||+++..... ....+.+|+.+|++++ |+|||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46899999999999999999995 46899999998643111 1234778999999996 899999999999999
Q ss_pred eEEEEEEecCC-CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC-CCCEEEEEecc
Q 040832 416 KRLLVYEYVPN-NNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY-TFETKVADFGL 493 (724)
Q Consensus 416 ~~~lV~E~~~~-gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~-~~~vkL~DFGl 493 (724)
..++||||+.+ ++|.+++..... +++.+++.|+.||++||+|||++ +||||||||+||||+. ++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~--l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEEEeccCcchHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence 99999999976 677777765543 89999999999999999999999 9999999999999985 47999999999
Q ss_pred ccccCCCCCccccccccCCCcCCcchhcCCCC-ChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccC
Q 040832 494 AKLTTDNNTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDD 572 (724)
Q Consensus 494 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~ 572 (724)
++...... .....||..|||||++.+..+ +.++|||||||+||||++|+.||.... .+.. ..+
T Consensus 158 a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~i~~-------~~~-- 221 (273)
T d1xwsa_ 158 GALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----EIIR-------GQV-- 221 (273)
T ss_dssp CEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HHHH-------CCC--
T ss_pred ceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----HHhh-------ccc--
Confidence 98765432 245679999999999987665 577999999999999999999996421 1100 000
Q ss_pred CChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 573 GNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 573 ~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+...+ ...+.+++.+||..||++||++.||+++
T Consensus 222 ---------~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 222 ---------FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ---------CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---------CCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 011122 2457889999999999999999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-44 Score=379.27 Aligned_cols=267 Identities=22% Similarity=0.299 Sum_probs=198.4
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CC-CcEEEEEEeccCCch--hHHHHHHHHHHHHhc---CCCCeeEEeeEEEe----
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PN-GKEVAVKSLRSGSGQ--GEREFKAEVEIISRV---HHRHLVSLVGYCIA---- 413 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~-g~~vaVK~l~~~~~~--~~~~f~~Ei~il~~l---~HpnIv~l~g~~~~---- 413 (724)
.++|++++.||+|+||+||+|++ .+ ++.||||+++..... ....+.+|+.+|+.| +|+||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999986 34 567999998643221 223466778777766 79999999999863
Q ss_pred -CCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEec
Q 040832 414 -GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFG 492 (724)
Q Consensus 414 -~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFG 492 (724)
+...+++|||+.++++...... ....+++..++.|+.||+.||+|||++ +||||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence 3467899999998877655543 334589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhh---hhc
Q 040832 493 LAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLC---LRA 569 (724)
Q Consensus 493 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~---~~~ 569 (724)
+++...... ......||..|||||++.+..|+.++|||||||+||||++|+.||......+... .....+. ...
T Consensus 162 ~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~-~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 162 LARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG-KILDVIGLPGEED 238 (305)
T ss_dssp SCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHHHCCCCGGG
T ss_pred hhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHH-HHHHhhCCCchhc
Confidence 998654332 2345679999999999999999999999999999999999999998764433211 1000000 000
Q ss_pred ccC------CChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 570 LDD------GNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 570 ~~~------~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
+.. ..+.......+ ..+.......+.+++.+||+.||++||++.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccccchhhhhccccccch-hhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00000000000 01112223457789999999999999999999874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=381.34 Aligned_cols=263 Identities=23% Similarity=0.303 Sum_probs=196.6
Q ss_pred CCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCeeEEeeEEEeC------CeEEE
Q 040832 347 GFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHLVSLVGYCIAG------GKRLL 419 (724)
Q Consensus 347 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~------~~~~l 419 (724)
+|+..++||+|+||+||+|++. +|+.||||+++.... .+.+|+++|++|+|+||++++++|... ..++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5788899999999999999964 689999999976432 245799999999999999999998643 34789
Q ss_pred EEEecCCCCHHHHHhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC-CEEEEEecccccc
Q 040832 420 VYEYVPNNNLEFHLHG-KGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF-ETKVADFGLAKLT 497 (724)
Q Consensus 420 V~E~~~~gsL~~~L~~-~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~-~vkL~DFGla~~~ 497 (724)
|||||+++++..+++. .....+++.+++.|+.||++||+|||++ +||||||||+||||+.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987765554432 2334589999999999999999999998 999999999999999775 8999999999877
Q ss_pred CCCCCccccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhh----------h
Q 040832 498 TDNNTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPL----------C 566 (724)
Q Consensus 498 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~----------~ 566 (724)
...... ....|+..|+|||.+.+ ..++.++|||||||+||||++|+.||......+.. ....+.+ .
T Consensus 174 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l-~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL-VEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTSCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH-HHHHHHHCCCCHHHHHHH
T ss_pred cCCccc--ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHH-HHHHHHhCCChHHhhhhh
Confidence 554332 34569999999998865 57899999999999999999999999766543321 1111000 0
Q ss_pred hhcccCCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 567 LRALDDGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 567 ~~~~~~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
........+.......+...........+.+++.+||+.||++||++.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011111111111111111222334568889999999999999999999874
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-43 Score=370.80 Aligned_cols=270 Identities=19% Similarity=0.251 Sum_probs=197.0
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEe--------
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIA-------- 413 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~-------- 413 (724)
.++|++.+.||+|+||+||+|++ .+|+.||||++.... ....+.+.+|+++|++|+|+||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36899999999999999999996 478999999986432 2234678999999999999999999998865
Q ss_pred CCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecc
Q 040832 414 GGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGL 493 (724)
Q Consensus 414 ~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGl 493 (724)
++..++||||+.++++..+..... .+.+..++.|+.||++||.|||++ +|+||||||+||||+.++.+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~--~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCccchhhhccc--ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecce
Confidence 345789999998887776554433 488999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc---cccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhH--Hhhhhhhhh
Q 040832 494 AKLTTDNNTH---VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCL--VDWARPLCL 567 (724)
Q Consensus 494 a~~~~~~~~~---~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l--~~w~~~~~~ 567 (724)
++........ .....+||..|+|||.+.+. .++.++|||||||+||||++|+.||......+... .........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9876543322 22335799999999998765 68999999999999999999999998654332211 111000000
Q ss_pred ---hcccCCChhhhcchhhhcCCCHH-------HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 568 ---RALDDGNFNEIADPYLEKNYPTE-------EMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 568 ---~~~~~~~~~~~vd~~l~~~~~~~-------~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
....................... ....+++++.+||+.||++|+++.||+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00000001111110000011111 12346679999999999999999999974
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-43 Score=366.48 Aligned_cols=268 Identities=21% Similarity=0.267 Sum_probs=205.7
Q ss_pred CCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCCeEEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 422 (724)
++|++.+.||+|+||+||+|++ .+++.||||+++.... .....+++|+.+|++++|+||+++++++.+....++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999996 4688999999975432 335679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccCCCCC
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTTDNNT 502 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 502 (724)
++.+++|..++...+. +.+..++.++.|+++||+|||++ +||||||||+||||+.++.+||+|||+++.......
T Consensus 82 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTTTC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eccccccccccccccc--cchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 9999999888876544 88999999999999999999998 999999999999999999999999999998765433
Q ss_pred ccccccccCCCcCCcchhcCCC-CChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhh----------hhccc
Q 040832 503 HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLC----------LRALD 571 (724)
Q Consensus 503 ~~~~~~~gt~~y~APE~~~~~~-~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~----------~~~~~ 571 (724)
. .....++..|+|||.+.... ++.++|||||||+||||++|+.||.......+.+........ .....
T Consensus 157 ~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 157 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp C-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred c-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 2 22345778899999987654 689999999999999999999997654433322211100000 00000
Q ss_pred CCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 572 DGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 572 ~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.......................+.+++.+||+.||++||+++||+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000001112233567889999999999999999999873
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-42 Score=364.16 Aligned_cols=257 Identities=21% Similarity=0.232 Sum_probs=196.3
Q ss_pred CCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC-eeEEeeEEEeCCeEEEEEEe
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRH-LVSLVGYCIAGGKRLLVYEY 423 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~lV~E~ 423 (724)
++|++++.||+|+||.||+|++ .+|+.||||++..... ..++..|++++++++|+| |+.+.+++.+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5799999999999999999985 4688999999876432 245889999999997666 45555666778888999999
Q ss_pred cCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEc---CCCCEEEEEeccccccCCC
Q 040832 424 VPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLD---YTFETKVADFGLAKLTTDN 500 (724)
Q Consensus 424 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~---~~~~vkL~DFGla~~~~~~ 500 (724)
+. ++|.+.+.... ..+++..++.++.||+.||+|||++ +||||||||+|||++ .+..+||+|||+|+.....
T Consensus 85 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 LG-PSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CC-CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred cC-Cchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 95 55555554433 2489999999999999999999999 999999999999985 4567999999999987654
Q ss_pred CCc------cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhH--HhhhhhhhhhcccC
Q 040832 501 NTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCL--VDWARPLCLRALDD 572 (724)
Q Consensus 501 ~~~------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l--~~w~~~~~~~~~~~ 572 (724)
... ......||..|||||.+.+..++.++|||||||+||||++|+.||.......... ..+.....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~------ 233 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM------ 233 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH------
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC------
Confidence 332 2234679999999999999999999999999999999999999997653322211 11111000
Q ss_pred CChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 573 GNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 573 ~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
......+...+ ...+.+++..||+.+|++||++.+|.+.|+..
T Consensus 234 ----~~~~~~~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 234 ----STPIEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp ----HSCHHHHTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred ----CCChhHhccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 00001111122 24578899999999999999999998888754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.7e-42 Score=370.40 Aligned_cols=260 Identities=20% Similarity=0.294 Sum_probs=197.7
Q ss_pred CCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCeeEEeeEEEeC--CeEEEEE
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVH-HRHLVSLVGYCIAG--GKRLLVY 421 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~--~~~~lV~ 421 (724)
++|+++++||+|+||+||+|++ .+|+.||||+++.. ..+.+.+|+++|+++. |+||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999996 46899999999753 3567899999999995 99999999998753 5689999
Q ss_pred EecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCC-CEEEEEeccccccCCC
Q 040832 422 EYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTF-ETKVADFGLAKLTTDN 500 (724)
Q Consensus 422 E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~-~vkL~DFGla~~~~~~ 500 (724)
|||.+++|..++. .+++..++.|+.||+.||+|||++ +||||||||+||||+.++ .+||+|||+++.....
T Consensus 112 e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 9999999977642 389999999999999999999999 999999999999998655 6899999999877654
Q ss_pred CCccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhh--------h-hhcc
Q 040832 501 NTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPL--------C-LRAL 570 (724)
Q Consensus 501 ~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~--------~-~~~~ 570 (724)
.. .....||..|+|||.+.+. .++.++|||||||+||||++|+.||................+ . ....
T Consensus 184 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 184 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred Cc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 32 2345689999999998765 579999999999999999999999976543322111110000 0 0000
Q ss_pred c-CCChhhh--------cchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040832 571 D-DGNFNEI--------ADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVR 618 (724)
Q Consensus 571 ~-~~~~~~~--------vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~ 618 (724)
. ...+... ................+.+++.+||+.||++|++++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000000 0001111111122345788999999999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-43 Score=375.45 Aligned_cols=275 Identities=20% Similarity=0.263 Sum_probs=201.1
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC----eEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSG-QGEREFKAEVEIISRVHHRHLVSLVGYCIAGG----KRL 418 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~----~~~ 418 (724)
..+|++++.||+|+||.||+|.. .+|+.||||+++.... ...+.+++|+++|++|+|+||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999985 5799999999975433 33457899999999999999999999997653 335
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccccC
Q 040832 419 LVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKLTT 498 (724)
Q Consensus 419 lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~~~ 498 (724)
++++|+.+++|.+++... .+++..++.|+.||++||+|||++ +||||||||+||||+.++.+||+|||+++...
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 566677799999999764 389999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc--cccccccCCCcCCcchhcC-CCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhh---hhhhhhcccC
Q 040832 499 DNNTH--VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWA---RPLCLRALDD 572 (724)
Q Consensus 499 ~~~~~--~~~~~~gt~~y~APE~~~~-~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~---~~~~~~~~~~ 572 (724)
..... .....+|+..|+|||++.. ..++.++|||||||++|||++|+.||......+....... .+........
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 43222 2344679999999999854 5678999999999999999999999987654332211100 0000000000
Q ss_pred CC--hhhhcchhh-hcCCCH-----HHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HhCCCC
Q 040832 573 GN--FNEIADPYL-EKNYPT-----EEMARMVACAAASIRHSARRRPKISQIVRA--LEGDVS 625 (724)
Q Consensus 573 ~~--~~~~vd~~l-~~~~~~-----~~~~~l~~l~~~cl~~~P~~RPs~~evv~~--L~~~~~ 625 (724)
.. ......... ....+. ....++.+++.+||+.||++||++.|++++ |+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 00 000000000 000010 112357899999999999999999999985 554433
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-43 Score=373.96 Aligned_cols=252 Identities=27% Similarity=0.339 Sum_probs=203.1
Q ss_pred CCCcccceeeccCcEEEEEEEc----CCCcEEEEEEeccCC----chhHHHHHHHHHHHHhcCC-CCeeEEeeEEEeCCe
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL----PNGKEVAVKSLRSGS----GQGEREFKAEVEIISRVHH-RHLVSLVGYCIAGGK 416 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~----~~g~~vaVK~l~~~~----~~~~~~f~~Ei~il~~l~H-pnIv~l~g~~~~~~~ 416 (724)
++|++++.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|+++|++++| +||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999974 247899999986431 1234568899999999966 899999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
.++||||+.+|+|.+++...+. +.+..++.++.||+.||+|||++ +||||||||+||||+.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhh
Confidence 9999999999999999987654 67889999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCccccccccCCCcCCcchhcCC--CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhcccCCC
Q 040832 497 TTDNNTHVSTRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALDDGN 574 (724)
Q Consensus 497 ~~~~~~~~~~~~~gt~~y~APE~~~~~--~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~~~~ 574 (724)
.............|+..|++||.+... .++.++|||||||+||||++|+.||......+.....+....
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~--------- 249 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL--------- 249 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH---------
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc---------
Confidence 765544444556799999999999754 478899999999999999999999976533222111111000
Q ss_pred hhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 040832 575 FNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPK-----ISQIVR 618 (724)
Q Consensus 575 ~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evv~ 618 (724)
. ....++.....++.+++.+||..+|++|++ ++||++
T Consensus 250 -----~--~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 -----K--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -----H--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -----c--CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0 001122334567888999999999999994 788876
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-42 Score=370.92 Aligned_cols=265 Identities=21% Similarity=0.301 Sum_probs=196.2
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEeCC------
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIAGG------ 415 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~------ 415 (724)
.++|++++.||+|+||.||+|.+ .+|+.||||+++.... ...+.+.+|+++|++|+|+|||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999995 4689999999975422 23457899999999999999999999998654
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 416 KRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 416 ~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
..+|||||+ +.+|..+++.. .+++..++.|+.||+.||.|||++ +||||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccccee
Confidence 569999999 66787777653 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhh------hh
Q 040832 496 LTTDNNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLC------LR 568 (724)
Q Consensus 496 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~------~~ 568 (724)
...... ....|+..|+|||.+.+. .++.++|||||||+||||++|+.||......+.... ...... ..
T Consensus 170 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 170 QADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE-IMKVTGTPPAEFVQ 244 (346)
T ss_dssp ECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHHHCCCCHHHHH
T ss_pred ccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHH-HHhccCCCcHHHHh
Confidence 765432 345689999999998764 578999999999999999999999987654332111 000000 00
Q ss_pred cccCCCh-------hhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HhC
Q 040832 569 ALDDGNF-------NEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRA--LEG 622 (724)
Q Consensus 569 ~~~~~~~-------~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~--L~~ 622 (724)
....... .+.....+. .........+.+++.+||..||++||++.||+++ |+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred hhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence 0000000 000000000 0111223456789999999999999999999985 543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1e-41 Score=358.68 Aligned_cols=260 Identities=19% Similarity=0.251 Sum_probs=204.9
Q ss_pred hCCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCCchhHHHHHHHHHHHHhcCC-CCeeEEeeEEEeCCeEEEEEE
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGSGQGEREFKAEVEIISRVHH-RHLVSLVGYCIAGGKRLLVYE 422 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~lV~E 422 (724)
.++|++++.||+|+||.||+|++. +|+.||||++.... ....+++|+++++.|.| +||+.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999954 68899999886542 23457889999999965 899999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcC-----CCCEEEEEecccccc
Q 040832 423 YVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDY-----TFETKVADFGLAKLT 497 (724)
Q Consensus 423 ~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~-----~~~vkL~DFGla~~~ 497 (724)
|+ +++|.++++..+. .+.+..++.|+.|++.||+|||++ +||||||||+||||+. ++.+||+|||+|+..
T Consensus 82 ~~-~~~l~~~~~~~~~-~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHhhcc-chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99 7899888876543 489999999999999999999999 9999999999999964 578999999999987
Q ss_pred CCCCCc------cccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHHhhhhhhhhhccc
Q 040832 498 TDNNTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLVDWARPLCLRALD 571 (724)
Q Consensus 498 ~~~~~~------~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~~w~~~~~~~~~~ 571 (724)
...... ......||+.|||||.+.+..++.++|||||||+||||++|+.||........... +.+ ..... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~-~~~-i~~~~-~ 233 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK-YER-IGEKK-Q 233 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH-HHH-HHHHH-H
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHH-HHH-HHhcc-C
Confidence 543321 12346799999999999999999999999999999999999999976533222110 000 00000 0
Q ss_pred CCChhhhcchhhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhCC
Q 040832 572 DGNFNEIADPYLEKNYPTEEMARMVACAAASIRHSARRRPKISQIVRALEGD 623 (724)
Q Consensus 572 ~~~~~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~L~~~ 623 (724)
.....+ +...++ ..|.+++..|++.++++||+++.|.+.|+..
T Consensus 234 ~~~~~~-----l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 234 STPLRE-----LCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HSCHHH-----HTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CCChHH-----hcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 001111 112222 4578888999999999999999998888754
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-41 Score=365.03 Aligned_cols=264 Identities=19% Similarity=0.210 Sum_probs=191.9
Q ss_pred CCCcccceeeccCcEEEEEEEcC-CCcEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCeeEEeeEEEe------CCe
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVLP-NGKEVAVKSLRSGS--GQGEREFKAEVEIISRVHHRHLVSLVGYCIA------GGK 416 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vaVK~l~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~------~~~ 416 (724)
++|++.++||+|+||+||+|++. +|+.||||++.... ......+.+|+.+|++++|+||++++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999965 68999999997543 2334568999999999999999999999964 368
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
.|+|||||.+++|.. ++. .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~~iv~Ey~~~~l~~~-~~~----~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLCQV-IQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHHHH-HTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchHHHHh-hhc----CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhc
Confidence 899999997765554 432 378999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHH-----------hhhh--
Q 040832 497 TTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLV-----------DWAR-- 563 (724)
Q Consensus 497 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~-----------~w~~-- 563 (724)
..... ......||..|+|||++.+..++.++|||||||++|||++|+.||...+....... .|..
T Consensus 169 ~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 169 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred ccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 65433 23456799999999999999999999999999999999999999976543222100 0000
Q ss_pred ----hhhhhcc--cCCChhhhcchhhhcC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 564 ----PLCLRAL--DDGNFNEIADPYLEKN---YPTEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 564 ----~~~~~~~--~~~~~~~~vd~~l~~~---~~~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.+..... ....+..+....+... ........+.+++.+||..||++||+++||+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 0011111111111111 112345678899999999999999999999874
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-42 Score=367.68 Aligned_cols=265 Identities=20% Similarity=0.281 Sum_probs=195.9
Q ss_pred hCCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCeeEEeeEEEe-----CCe
Q 040832 345 TGGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSG--QGEREFKAEVEIISRVHHRHLVSLVGYCIA-----GGK 416 (724)
Q Consensus 345 ~~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~-----~~~ 416 (724)
.++|++.+.||+|+||+||+|++ .+|+.||||+++.... ...+.+.+|+++|++|+|+|||++++++.. +..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56899999999999999999995 5799999999975432 334578999999999999999999999864 334
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 417 RLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 417 ~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
.++||+|+.+|+|.++++.+ .+++..++.|+.||+.||+|||++ +||||||||+|||++.++.+||+|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcc
Confidence 57778888899999999654 389999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCccccccccCCCcCCcchhcCC-CCChhHHHHHHHHHHHHHHhCCCCCCCCCchhhhHH--hhhhhh---hhhcc
Q 040832 497 TTDNNTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPIDPTGAMEDCLV--DWARPL---CLRAL 570 (724)
Q Consensus 497 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~~~~l~--~w~~~~---~~~~~ 570 (724)
.... .....|+..|+|||.+.+. .++.++|||||||+||||++|+.||...+....... ...... .....
T Consensus 171 ~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 171 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp CTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred cCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 5432 2345688999999987665 568999999999999999999999987643322111 000000 00000
Q ss_pred cCCChhhhcchhhh-cCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040832 571 DDGNFNEIADPYLE-KNYP-----TEEMARMVACAAASIRHSARRRPKISQIVRA 619 (724)
Q Consensus 571 ~~~~~~~~vd~~l~-~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evv~~ 619 (724)
.............. .... ......+.+++.+||+.||++|+++.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000000000000 0000 1123457889999999999999999999973
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.8e-37 Score=330.55 Aligned_cols=271 Identities=21% Similarity=0.269 Sum_probs=196.6
Q ss_pred CCCcccceeeccCcEEEEEEEc-CCCcEEEEEEeccCCchhHHHHHHHHHHHHhcC-----------CCCeeEEeeEEEe
Q 040832 346 GGFSQSNLLGQGGFGYVHKGVL-PNGKEVAVKSLRSGSGQGEREFKAEVEIISRVH-----------HRHLVSLVGYCIA 413 (724)
Q Consensus 346 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~-----------HpnIv~l~g~~~~ 413 (724)
++|+++++||+|+||.||+|++ .+|+.||||+++... ...+.+.+|+++|++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4599999999999999999996 578999999998643 22456788999998885 4789999988764
Q ss_pred --CCeEEEEEEecCCCCH-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCccEEEcCCC-----
Q 040832 414 --GGKRLLVYEYVPNNNL-EFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHE-DCHPRIIHRDIKSSNILLDYTF----- 484 (724)
Q Consensus 414 --~~~~~lV~E~~~~gsL-~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs-~~~~~iiHrDIkp~NILl~~~~----- 484 (724)
....+++|+++..+.+ ...........+.+..++.++.||++||+|||+ . +|+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccc
Confidence 3466677777765543 333444555568999999999999999999998 5 899999999999997654
Q ss_pred -CEEEEEeccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHHHHHHhCCCCCCCCCch-----hhhH
Q 040832 485 -ETKVADFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPIDPTGAM-----EDCL 558 (724)
Q Consensus 485 -~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL~eLltG~~P~~~~~~~-----~~~l 558 (724)
.+||+|||++....... ...+|+..|+|||++....++.++|||||||+|+||++|+.||...... ...+
T Consensus 169 ~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceeeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 39999999998665432 3456999999999999999999999999999999999999999654221 1111
Q ss_pred Hhhhhhhh-------------h---------hcccCCChhhhcch-hhhcCCCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 040832 559 VDWARPLC-------------L---------RALDDGNFNEIADP-YLEKNYPTEEMARMVACAAASIRHSARRRPKISQ 615 (724)
Q Consensus 559 ~~w~~~~~-------------~---------~~~~~~~~~~~vd~-~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~e 615 (724)
..+...+. . ..+.......+.+. .............+.+++.+||..||++||+++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 11111000 0 00000000000000 0112345677888999999999999999999999
Q ss_pred HHHH--HhCCC
Q 040832 616 IVRA--LEGDV 624 (724)
Q Consensus 616 vv~~--L~~~~ 624 (724)
|+++ |+...
T Consensus 325 ~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 325 LVNHPWLKDTL 335 (362)
T ss_dssp HHTCGGGTTCT
T ss_pred HhcCcccCCCC
Confidence 9985 55433
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=1.5e-24 Score=212.20 Aligned_cols=170 Identities=14% Similarity=0.100 Sum_probs=122.4
Q ss_pred CcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCch------------------hHHHHHHHHHHHHhcCCCCeeEEee
Q 040832 348 FSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQ------------------GEREFKAEVEIISRVHHRHLVSLVG 409 (724)
Q Consensus 348 f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~------------------~~~~f~~Ei~il~~l~HpnIv~l~g 409 (724)
+.+++.||+|+||.||+|.+.+|+.||||+++..... ....+..|+.+|.+++|.+++.+++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 3568899999999999999889999999987642110 0123456889999999999998876
Q ss_pred EEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCccEEEcCCCCEEEE
Q 040832 410 YCIAGGKRLLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHEDCHPRIIHRDIKSSNILLDYTFETKVA 489 (724)
Q Consensus 410 ~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iiHrDIkp~NILl~~~~~vkL~ 489 (724)
+.. .+|||||+++..+.. +.......++.||+++|+|||++ +|+||||||+||||+++ .++|+
T Consensus 82 ~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp EET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred ecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 532 279999998876543 33445678999999999999998 99999999999999866 59999
Q ss_pred EeccccccCCCCCccccccccCCCcCCcchhcCCCCChhHHHHHHHHHH
Q 040832 490 DFGLAKLTTDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVML 538 (724)
Q Consensus 490 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDV~SlGvlL 538 (724)
|||+|+............. ....+ -|++ ...|..++||||+.--+
T Consensus 145 DFG~a~~~~~~~~~~~l~r--d~~~~-~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWREILER--DVRNI-ITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHHHHHHH--HHHHH-HHHH-HHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcHHHHHH--HHHHH-HHHH-cCCCCCcccHHHHHHHH
Confidence 9999987654332110000 00000 0122 35677788999965443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.86 E-value=4e-09 Score=105.75 Aligned_cols=150 Identities=14% Similarity=0.035 Sum_probs=107.5
Q ss_pred HHHHHhhCCCcccceeeccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCeeEEeeEEEeCCeE
Q 040832 339 EELSAATGGFSQSNLLGQGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVH-HRHLVSLVGYCIAGGKR 417 (724)
Q Consensus 339 ~el~~~~~~f~~~~~LG~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~ 417 (724)
.||...-..|+..+..+.+....||+... +++.++||+...........+.+|+.+|+.|. +--+.+++.++.+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 45666667888777665555679999875 55667888876543333445788999998884 44467888888888999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 040832 418 LLVYEYVPNNNLEFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLHED---------------------------------- 463 (724)
Q Consensus 418 ~lV~E~~~~gsL~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLHs~---------------------------------- 463 (724)
++||+++++..+...+... .....++.++++.|+.||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999999886654321 12334566667777777742
Q ss_pred ----------------------CCCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 464 ----------------------CHPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 464 ----------------------~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
....++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 012378999999999999876667999998863
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.45 E-value=1.6e-07 Score=93.14 Aligned_cols=131 Identities=18% Similarity=0.125 Sum_probs=87.4
Q ss_pred eeeccCc-EEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCC--CCeeEEeeEEEeCCeEEEEEEecCCCCH
Q 040832 353 LLGQGGF-GYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHH--RHLVSLVGYCIAGGKRLLVYEYVPNNNL 429 (724)
Q Consensus 353 ~LG~G~f-G~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~H--pnIv~l~g~~~~~~~~~lV~E~~~~gsL 429 (724)
.+..|.. +.||+....++..+++|...... ...+..|+.+|+.|.. -.+.++++++.+++..++||+|++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445543 68999988788889999876543 2347778888887743 3356788888888899999999988765
Q ss_pred HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH------------------------------------------------
Q 040832 430 EFHLHGKGRPVMDWPTRLKIAMGSAKGLAYLH------------------------------------------------ 461 (724)
Q Consensus 430 ~~~L~~~~~~~l~~~~~~~i~~qia~gL~yLH------------------------------------------------ 461 (724)
.... +.. ..++.++++.|+-||
T Consensus 94 ~~~~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 94 LSSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TTSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred cccc-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 3210 110 111222233333333
Q ss_pred ---hcC----CCCeEecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 462 ---EDC----HPRIIHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 462 ---s~~----~~~iiHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
... ...++|+|+.+.|||++.+..+-|+||+.+..
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 221 22479999999999999876678999988753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.92 E-value=1.3e-05 Score=84.79 Aligned_cols=77 Identities=13% Similarity=0.118 Sum_probs=48.9
Q ss_pred cceeeccCcEEEEEEEcCC-CcEEEEEEeccC----C---chhHHHHHHHHHHHHhcC-C--CCeeEEeeEEEeCCeEEE
Q 040832 351 SNLLGQGGFGYVHKGVLPN-GKEVAVKSLRSG----S---GQGEREFKAEVEIISRVH-H--RHLVSLVGYCIAGGKRLL 419 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~~-g~~vaVK~l~~~----~---~~~~~~f~~Ei~il~~l~-H--pnIv~l~g~~~~~~~~~l 419 (724)
.+.||.|....||+....+ ++.|+||.-... . .....+...|++.|+.+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4568999999999998654 678999964321 1 111233556888887773 2 345666655 4445589
Q ss_pred EEEecCCCCH
Q 040832 420 VYEYVPNNNL 429 (724)
Q Consensus 420 V~E~~~~gsL 429 (724)
||||+.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.73 E-value=3.8e-05 Score=78.93 Aligned_cols=134 Identities=16% Similarity=0.131 Sum_probs=81.9
Q ss_pred EEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCe--eEEe-----eEEEeCCeEEEEEEecCCCCHH--
Q 040832 360 GYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHL--VSLV-----GYCIAGGKRLLVYEYVPNNNLE-- 430 (724)
Q Consensus 360 G~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnI--v~l~-----g~~~~~~~~~lV~E~~~~gsL~-- 430 (724)
-.||+...++|+.|++|+.+.+. ...+++..|+++|..|....| +..+ ..+..++..+.|++|+.|..++
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 48999999999999999987642 245678889999988853222 1111 1334567788999999875432
Q ss_pred ---H------H---Hhc----C---CCCCCCHH-------------------HHHHHHHHHHHHHHHHHhc----CCCCe
Q 040832 431 ---F------H---LHG----K---GRPVMDWP-------------------TRLKIAMGSAKGLAYLHED----CHPRI 468 (724)
Q Consensus 431 ---~------~---L~~----~---~~~~l~~~-------------------~~~~i~~qia~gL~yLHs~----~~~~i 468 (724)
. . ||. . .+..+++. .+..+...+.+.++.+... ...++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 1 0 111 0 11122221 1112222233333444332 24478
Q ss_pred EecCCCCccEEEcCCCCEEEEEeccccc
Q 040832 469 IHRDIKSSNILLDYTFETKVADFGLAKL 496 (724)
Q Consensus 469 iHrDIkp~NILl~~~~~vkL~DFGla~~ 496 (724)
||+|+.+.|||++++ ..|+||+.+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899998864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.28 E-value=0.00064 Score=68.78 Aligned_cols=157 Identities=12% Similarity=0.030 Sum_probs=88.0
Q ss_pred cCHHHHHHhhCCCcccceee-----ccCcEEEEEEEcCCCcEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCe-----e
Q 040832 336 FTYEELSAATGGFSQSNLLG-----QGGFGYVHKGVLPNGKEVAVKSLRSGSGQGEREFKAEVEIISRVHHRHL-----V 405 (724)
Q Consensus 336 f~~~el~~~~~~f~~~~~LG-----~G~fG~Vyk~~~~~g~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~HpnI-----v 405 (724)
.+.+||+....+|.+++++. .|---..|+....+|+ +++|+..... ...++..|+++|..|...++ +
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 46788888889998876654 4444678998876654 8999886532 23355667778877743222 2
Q ss_pred EEe---eEEEeCCeEEEEEEecCCCCHHH--------------HHhc----CC----CCCCCH-----------------
Q 040832 406 SLV---GYCIAGGKRLLVYEYVPNNNLEF--------------HLHG----KG----RPVMDW----------------- 443 (724)
Q Consensus 406 ~l~---g~~~~~~~~~lV~E~~~~gsL~~--------------~L~~----~~----~~~l~~----------------- 443 (724)
... .+....+..+.++.++.+..... .++. .. .....+
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 111 12233456677788777654311 0010 00 000000
Q ss_pred HHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCccEEEcCCCCEEEEEecccc
Q 040832 444 PTRLKIAMGSAKGLAYLHE-DCHPRIIHRDIKSSNILLDYTFETKVADFGLAK 495 (724)
Q Consensus 444 ~~~~~i~~qia~gL~yLHs-~~~~~iiHrDIkp~NILl~~~~~vkL~DFGla~ 495 (724)
......+..+...+..++. ....+|||+|+...|||++.+...-|+||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0111222222222222221 124479999999999999988777899999885
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.15 E-value=0.00042 Score=72.85 Aligned_cols=73 Identities=18% Similarity=0.148 Sum_probs=50.3
Q ss_pred cceeeccCcEEEEEEEcCCC--------cEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCeeEEeeEEEeCCeEEEEE
Q 040832 351 SNLLGQGGFGYVHKGVLPNG--------KEVAVKSLRSGSGQGEREFKAEVEIISRVH-HRHLVSLVGYCIAGGKRLLVY 421 (724)
Q Consensus 351 ~~~LG~G~fG~Vyk~~~~~g--------~~vaVK~l~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~ 421 (724)
.+.|+.|-.-.+|+....++ +.|++++.-.. .......+|..+++.+. +.-..++++++.+ .+||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 35688888899999886542 45777766422 23445678999999885 4334578777643 6899
Q ss_pred EecCCCCH
Q 040832 422 EYVPNNNL 429 (724)
Q Consensus 422 E~~~~gsL 429 (724)
||+++..|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987654
|